data_1bpv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bpv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.446 HD12 ' CB ' ' A' ' 86' ' ' SER . 2.7 tt . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.845 0.355 . . . . 1.26 110.982 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.17 120.11 25.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 2.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 159.24 54.07 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.141 1.894 . . . . 0.58999999999999997 111.696 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.8 Cg_endo -52.43 172.93 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 1.6100000000000001 112.502 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 164.8 52.63 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.723 -0.671 . . . . 0.97999999999999998 112.999 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.91 123.92 61.78 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.463 -0.199 . . . . 2.04 110.463 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' CG ' HG21 ' A' ' 76' ' ' VAL . 21.7 Cg_exo -67.3 133.89 31.87 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.345 2.03 . . . . 0.54000000000000004 112.713 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -131.47 117.54 16.66 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.006 -0.543 . . . . 1.6799999999999999 110.794 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.9 Cg_exo -67.66 125.99 14.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.464 2.109 . . . . 0.64000000000000001 113.801 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.402 ' N ' HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.22 -31.84 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.485 -0.932 . . . . 2.1699999999999999 108.485 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.48 145.82 34.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.075 -0.966 . . . . 0.84999999999999998 109.48 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -138.73 96.36 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.166 0.508 . . . . 1.5700000000000001 111.573 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.54 156.58 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 1.46 110.814 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -50.67 -22.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 2.9100000000000001 112.043 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 67' ' ' THR . 1.5 m-70 -139.06 12.18 2.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.254 0.464 . . . . 1.3300000000000001 112.254 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.85 106.32 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 1.28 111.326 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 74' ' ' PHE . 96.0 t -100.59 117.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.49 110.629 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.401 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 18.1 m -98.33 125.05 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.802 -0.636 . . . . 1.1399999999999999 111.632 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.47 154.75 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.821 0.82 . . . . 1.3100000000000001 112.163 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -135.61 164.39 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.369 -1.287 . . . . 2.3100000000000001 109.11 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 7.0 p90 -141.98 -175.14 4.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.165 0.507 . . . . 0.40000000000000002 112.117 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.94 128.38 47.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 1.1100000000000001 110.895 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -59.46 146.68 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 2.5600000000000001 110.815 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 53.4 Cg_exo -52.47 171.39 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 1.1100000000000001 112.682 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.67 -18.49 6.57 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 2.77 112.137 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -127.17 -71.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 121.003 -0.279 . . . . 1.6899999999999999 111.581 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 11.4 p 55.88 47.37 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 1.3500000000000001 110.987 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.14 0.01 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.889 -0.672 . . . . 1.01 112.515 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.19 38.03 1.2 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 109.796 -1.322 . . . . 0.97999999999999998 109.796 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -126.29 -179.53 4.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.685 -0.758 . . . . 0.98999999999999999 111.033 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 -1.07 3.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.302 0.482 . . . . 2.6899999999999999 112.302 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.9 mt 61.98 132.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.785 0.326 . . . . 1.71 110.952 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 p -128.63 39.75 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.6599999999999999 111.193 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t 172.29 134.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 1.97 110.658 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 78' ' ' ALA . 26.3 m-85 -122.94 83.82 2.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.48 -0.327 . . . . 1.23 111.313 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.56 162.7 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 1.76 110.417 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -150.75 126.51 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 1.6100000000000001 110.474 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.62 137.67 32.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 1.6699999999999999 110.949 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HG2' ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -107.06 141.54 38.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.889 -0.596 . . . . 2.4399999999999999 110.839 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -110.97 116.66 31.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.69 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -84.67 87.39 7.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.809 -0.632 . . . . 1.5900000000000001 110.025 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.3 mt -75.33 154.42 86.05 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 1.4299999999999999 111.084 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 66.8 Cg_endo -89.33 34.02 7.12 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.862 -1.308 . . . . 1.47 113.044 0.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.413 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p30 -155.02 64.06 0.64 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.303 . . . . 2.6600000000000001 111.288 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.01 -163.2 22.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.887 -0.673 . . . . 1.6200000000000001 112.446 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.414 ' CZ ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -170.86 30.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.677 0.251 . . . . 3.0600000000000001 111.677 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.553 ' CE3' ' CD ' ' A' ' 75' ' ' ARG . 48.8 m95 52.49 109.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.925 0.342 . . . . 1.0600000000000001 111.925 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.414 HD22 ' CZ ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -137.7 117.38 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.8400000000000001 111.244 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -53.31 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 1.77 110.874 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 40' ' ' LYS . . . -65.78 -55.11 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 1.4099999999999999 111.193 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 p-10 -50.84 149.02 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 2.0099999999999998 111.215 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.36 24.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 2.6400000000000001 110.786 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 m -122.52 25.7 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 2.0299999999999998 111.153 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.36 106.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 1.8700000000000001 110.648 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 73.3 mt -97.28 84.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.474 . . . . 1.3700000000000001 110.774 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.9 -40.1 65.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 2.1499999999999999 111.563 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 139.92 30.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.527 -0.306 . . . . 1.54 110.225 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.498 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 27.5 p-10 -72.63 62.64 0.56 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.248 0.547 . . . . 1.75 111.19 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE2' ' CB ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -166.81 91.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 2.0499999999999998 108.872 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.0 t80 -126.95 165.13 19.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.176 0.512 . . . . 0.56999999999999995 111.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -123.93 121.14 34.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.505 -0.771 . . . . 1.1399999999999999 110.76 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.0 t -86.35 105.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.19 0.519 . . . . 1.72 111.43 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 p -99.18 -157.17 0.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 1.6399999999999999 110.73 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.65 17.75 42.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.95999999999999996 112.42 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 18' ' ' VAL . 17.7 mt -81.68 -163.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.36 . . . . 2.02 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 94.9 m -144.52 154.82 43.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.996 -0.547 . . . . 1.55 110.567 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 157.96 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 1.9099999999999999 110.765 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t0 51.87 50.3 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 1.8700000000000001 110.746 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.83 124.58 5.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 1.2 111.245 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.72 124.39 26.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 1.1100000000000001 110.391 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -123.96 129.57 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.078 0.466 . . . . 1.0800000000000001 111.897 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 7.6 tt0 -104.15 150.18 24.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.956 -0.757 . . . . 1.5 108.956 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.491 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -141.21 119.65 12.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.893 1.442 . . . . 0.79000000000000004 114.893 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.553 ' CD ' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -106.41 161.74 14.31 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.223 -0.658 . . . . 2.6899999999999999 109.223 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 HG21 ' CG ' ' A' ' 8' ' ' PRO . 85.0 t -117.21 109.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.054 -0.658 . . . . 1.5700000000000001 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 87.0 mt -97.15 139.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.619 -1.252 . . . . 1.3200000000000001 107.619 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -155.05 140.68 17.97 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.572 -0.851 . . . . 1.1100000000000001 112.691 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.5 mttt -86.53 -174.63 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 2.3500000000000001 110.449 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 33.6 p30 -130.36 162.66 28.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 2.7000000000000002 110.761 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -43.18 -26.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.3400000000000001 112.22 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -81.93 -18.68 42.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.554 0.576 . . . . 1.4299999999999999 112.554 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.27 -20.43 25.78 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.407 -0.901 . . . . 1.3799999999999999 112.033 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 166.68 0.64 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.828 -0.434 . . . . 1.49 109.828 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -117.56 103.39 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.563 0.579 . . . . 1.48 112.563 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.446 ' CB ' HD12 ' A' ' 2' ' ' ILE . 1.2 p -63.03 122.46 75.26 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 108.962 -0.755 . . . . 0.81000000000000005 108.962 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.54 162.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.016 2.477 . . . . 1.25 113.098 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 33.6 Cg_endo -64.1 135.62 48.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.826 2.351 . . . . 1.2 112.747 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.434 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -78.35 124.84 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.91 -0.586 . . . . 1.76 109.555 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 4.6 mt-10 -24.85 99.59 0.08 OUTLIER Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 123.732 0.813 . . . . 1.77 113.074 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 93.7 Cg_exo -32.35 154.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.425 2.75 . . . . 1.01 114.02 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -94.07 143.85 26.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.419 -0.809 . . . . 1.55 109.388 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -34.27 138.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.217 0.948 . . . . 1.6299999999999999 111.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -75.16 117.51 17.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 1.0900000000000001 111.339 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.58 122.88 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 111.241 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.6 m -51.51 -25.03 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 1.1299999999999999 111.248 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 90.7 m 57.75 49.06 12.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 1.5700000000000001 110.204 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -146.82 -39.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.693 -0.685 . . . . 3.7000000000000002 111.603 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.42 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -46.21 -26.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 2.1400000000000001 111.73 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 2.0600000000000001 111.92 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.474 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.944 0.402 . . . . 1.26 111.002 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.1 t0 -128.65 128.44 23.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.333 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.22 157.33 57.49 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.317 2.011 . . . . 0.58999999999999997 112.633 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.63 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 1.6100000000000001 112.34 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.17 -153.9 5.85 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.954 -0.641 . . . . 0.97999999999999998 112.753 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 22' ' ' TRP . 1.7 ttpt -95.13 141.28 23.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.697 -0.112 . . . . 2.04 110.697 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 1.8 Cg_endo -86.79 143.89 7.25 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.071 2.514 . . . . 0.54000000000000004 112.285 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -159.48 125.07 2.3 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.685 -0.234 . . . . 1.6799999999999999 111.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 19' ' ' THR . 7.3 Cg_exo -70.92 97.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.235 1.957 . . . . 0.64000000000000001 112.714 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.449 HD12 ' CD ' ' A' ' 60' ' ' GLU . 1.7 mp -60.62 -30.4 69.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.228 0.537 . . . . 2.1699999999999999 109.982 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.404 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.4 t30 -146.73 157.33 43.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.342 -0.844 . . . . 0.84999999999999998 109.443 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -143.39 105.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.103 0.478 . . . . 1.5700000000000001 111.415 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -91.62 47.71 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.74 -0.663 . . . . 1.46 111.652 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.51 -73.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.876 0.735 . . . . 2.9100000000000001 112.07 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' THR . 16.0 m170 -81.35 -31.83 33.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 1.3300000000000001 111.718 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -125.2 105.21 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.717 0.294 . . . . 1.28 110.832 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 6.6 m -92.02 156.22 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.44 -0.346 . . . . 1.49 110.713 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.6 m -123.76 113.03 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.708 -0.223 . . . . 1.1399999999999999 111.594 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -127.06 149.31 49.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.615 0.721 . . . . 1.3100000000000001 111.265 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.309 ' CB ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -138.49 166.25 24.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.716 -1.129 . . . . 2.3100000000000001 109.847 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 8.8 p90 -141.42 -122.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.372 -0.377 . . . . 0.40000000000000002 110.852 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.53 136.47 10.53 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.499 0.59 . . . . 1.1100000000000001 111.174 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -51.8 140.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.55 -0.295 . . . . 2.5600000000000001 110.631 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.443 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 6.7 Cg_endo -48.93 -174.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.932 2.422 . . . . 1.1100000000000001 112.473 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -120.88 -34.08 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -115.78 -69.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.317 0.488 . . . . 1.6899999999999999 112.317 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.478 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 32.2 p 53.65 30.16 10.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 1.3500000000000001 110.068 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.96 -101.39 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.643 -0.789 . . . . 1.01 111.928 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.41 30.96 2.73 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.633 -0.987 . . . . 0.97999999999999998 110.633 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -110.9 -171.62 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.065 -0.567 . . . . 0.98999999999999999 111.541 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.94 21.8 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.769 -0.651 . . . . 2.6899999999999999 111.381 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.528 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 15.8 mm 67.45 -69.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 1.71 110.878 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p 75.97 9.66 3.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.945 -0.57 . . . . 1.6599999999999999 112.402 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t 168.16 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.765 0.317 . . . . 1.97 111.686 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.528 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 38.4 m-85 -120.26 95.09 4.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 1.23 110.554 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.4 mt -70.13 152.12 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.409 -0.36 . . . . 1.76 111.347 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' A' ' 56' ' ' ILE . 2.2 t -124.63 104.43 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 1.6100000000000001 111.27 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 1.043 ' CD ' ' HB3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -76.43 115.44 16.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 1.6699999999999999 110.168 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.448 ' HG3' ' CB ' ' A' ' 51' ' ' ALA . 5.5 mtmt -93.32 149.74 21.0 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.469 0.652 . . . . 2.4399999999999999 112.484 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 8.2 ttm180 -135.02 86.18 2.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.92 -1.036 . . . . 1.79 108.969 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.734 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -64.69 87.94 0.06 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.62 -0.718 . . . . 1.5900000000000001 109.703 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 94' ' ' ALA . 15.8 mt -67.95 146.56 98.31 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.976 -0.556 . . . . 1.4299999999999999 111.517 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.89 39.43 4.52 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.854 -1.311 . . . . 1.47 112.34 0.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -144.72 43.02 1.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 2.6600000000000001 111.597 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.03 -176.7 46.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.632 -0.794 . . . . 1.6200000000000001 112.339 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -167.88 30.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.641 0.258 . . . . 3.0600000000000001 111.167 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 1.043 ' HB3' ' CD ' ' A' ' 39' ' ' GLU . 24.5 m95 46.99 87.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 1.0600000000000001 111.192 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.61 135.98 49.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.998 0.428 . . . . 1.8400000000000001 111.487 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 15.9 ptmt -65.19 79.32 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 1.77 111.023 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -65.7 -43.82 88.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.555 . . . . 1.4099999999999999 111.87 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.9 p-10 -42.02 -56.6 2.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.64 -0.255 . . . . 2.0099999999999998 111.591 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 75.21 -49.94 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.984 0.364 . . . . 2.6400000000000001 111.984 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -173.7 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.954 0.407 . . . . 2.0299999999999998 111.193 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.37 107.0 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.949 -0.569 . . . . 1.8700000000000001 111.339 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 61' ' ' PHE . 29.4 mt -86.35 87.84 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 1.3700000000000001 110.919 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -74.23 -45.15 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 2.1499999999999999 111.438 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.49 149.66 22.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.99 -0.374 . . . . 1.54 109.99 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.496 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.1 p30 -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 1.75 111.302 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.309 ' OE1' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tp10 -101.35 93.92 5.66 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.929 -0.767 . . . . 2.0499999999999998 108.929 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.488 ' CD1' HG12 ' A' ' 56' ' ' ILE . 66.3 t80 -118.6 164.76 14.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.974 -0.557 . . . . 0.56999999999999995 111.805 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 84.2 m -121.94 119.53 31.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 1.1399999999999999 110.564 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG1' ' HD3' ' A' ' 40' ' ' LYS . 57.8 t -80.76 125.61 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 1.72 111.724 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -119.8 163.33 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 1.6399999999999999 110.558 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.18 57.72 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.95999999999999996 112.138 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.54 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 2.0 mp -53.0 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.02 110.313 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.9 m -143.77 152.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.41 . . . . 1.55 110.57 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -69.01 151.77 46.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 1.9099999999999999 111.181 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.5 OUTLIER 54.7 51.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 1.8700000000000001 111.149 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -160.77 122.6 3.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 1.2 111.332 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.86 134.76 47.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.383 -0.371 . . . . 1.1100000000000001 110.335 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.9 m-85 -128.26 119.79 25.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.782 0.66 . . . . 1.0800000000000001 112.782 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.38 136.63 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.261 -0.644 . . . . 1.5 109.261 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -133.77 119.39 19.21 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.414 1.264 . . . . 0.79000000000000004 114.414 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -95.97 162.92 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 2.6899999999999999 109.907 178.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 61.8 t -113.95 128.56 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.243 0.544 . . . . 1.5700000000000001 112.206 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mt -130.74 141.42 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.578 -1.267 . . . . 1.3200000000000001 107.578 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -157.09 127.28 6.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.81 -0.756 . . . . 1.1100000000000001 112.763 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.6 mttt -75.64 -157.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.687 -0.405 . . . . 2.3500000000000001 110.072 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' CD1' ' A' ' 2' ' ' ILE . 33.7 p30 -159.26 162.99 36.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 2.7000000000000002 111.515 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 31' ' ' PHE . . . -38.54 -43.79 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.323 -0.853 . . . . 1.3400000000000001 112.816 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.526 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -66.14 -23.94 66.57 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.133 0.42 . . . . 1.4299999999999999 112.133 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 107.9 -8.19 36.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.698 -0.763 . . . . 1.3799999999999999 112.208 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.23 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.667 0.234 . . . . 1.49 110.377 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.9 OUTLIER -148.7 111.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.382 0.512 . . . . 1.48 112.382 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.6 p -70.84 110.73 7.71 Favored Pre-proline 0 C--O 1.235 0.337 0 N-CA-C 107.233 -1.395 . . . . 0.81000000000000005 107.233 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.38 171.9 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.499 2.133 . . . . 1.25 113.816 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 76.5 Cg_exo -50.42 145.0 22.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.338 2.692 . . . . 1.2 113.594 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -125.19 102.42 7.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 1.76 110.729 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.0 mm-40 12.63 108.64 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.737 1.215 . . . . 1.77 113.881 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 51.6 Cg_exo -56.05 143.67 82.54 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.437 2.092 . . . . 1.01 113.272 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -70.55 139.26 51.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.874 -0.787 . . . . 1.55 108.874 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -37.14 133.9 0.61 Allowed 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 124.254 0.971 . . . . 1.6299999999999999 111.517 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -63.85 118.56 8.54 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 1.0900000000000001 111.144 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.1 mp -98.11 111.15 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.333 -0.394 . . . . 1.1299999999999999 110.677 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 70' ' ' ALA . 22.1 m -49.36 -25.83 2.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.319 -0.4 . . . . 1.1299999999999999 110.595 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 99.6 m 49.02 81.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 1.5700000000000001 110.845 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 -85.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.35 . . . . 3.7000000000000002 110.593 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.58 17.83 21.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.039 -0.528 . . . . 2.1400000000000001 110.879 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 3.7 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.061 0.458 . . . . 2.0600000000000001 111.251 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.408 HG12 ' N ' ' A' ' 3' ' ' ASP . 5.5 tt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 1.26 110.741 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.7 t70 -138.59 119.87 10.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.0 -0.545 . . . . 2.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 61.9 Cg_endo -70.51 163.04 40.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.245 1.963 . . . . 0.58999999999999997 112.014 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 40.5 Cg_exo -57.71 -169.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.701 2.268 . . . . 1.6100000000000001 112.75 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.56 -177.19 50.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.87 -0.681 . . . . 0.97999999999999998 112.685 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.9 tttt -73.35 133.65 80.56 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.277 0.085 . . . . 2.04 110.962 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 7.6 Cg_exo -76.81 130.61 11.61 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.688 2.259 . . . . 0.54000000000000004 112.071 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.02 105.97 6.2 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.545 -0.298 . . . . 1.6799999999999999 111.759 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.2 Cg_exo -44.28 131.31 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.206 1.937 . . . . 0.64000000000000001 112.794 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.481 ' CD2' ' CB ' ' A' ' 21' ' ' LYS . 1.6 mt -90.27 -31.78 16.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.239 -1.023 . . . . 2.1699999999999999 108.239 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.4 t30 -149.7 160.82 43.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 0.84999999999999998 108.35 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -143.39 97.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.569 -0.453 . . . . 1.5700000000000001 111.598 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -87.56 49.11 1.75 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.723 -0.671 . . . . 1.46 111.708 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.76 -74.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.874 0.734 . . . . 2.9100000000000001 112.335 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.5 m-70 -72.2 -39.52 68.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.3300000000000001 111.365 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.8 p -125.71 118.05 24.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.37 . . . . 1.28 110.163 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.543 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 5.9 m -107.61 135.96 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.442 0.639 . . . . 1.49 112.368 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.0 m -90.59 144.16 26.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 1.1399999999999999 109.771 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -150.52 158.95 44.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.145 0.498 . . . . 1.3100000000000001 111.586 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' CB ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -150.82 146.36 26.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.543 -0.753 . . . . 2.3100000000000001 110.792 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.0 p90 -136.18 -176.24 4.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.40000000000000002 111.064 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.7 155.9 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 110.973 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 150.83 80.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.5600000000000001 110.699 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 92.1 Cg_exo -43.94 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.969 2.446 . . . . 1.1100000000000001 113.236 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -22.38 8.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.01 -0.541 . . . . 2.77 111.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.79 -65.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.059 0.392 . . . . 1.6899999999999999 112.059 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 14.9 p 57.73 46.07 17.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 1.3500000000000001 110.155 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.51 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.6 -0.809 . . . . 1.01 111.828 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.17 25.71 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.902 -0.879 . . . . 0.97999999999999998 110.902 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -103.68 -176.88 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.98999999999999999 111.641 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.54 1.0 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 2.6899999999999999 111.792 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.492 HG22 ' CE1' ' A' ' 36' ' ' TYR . 22.9 mt 60.26 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.125 0.488 . . . . 1.71 110.952 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -140.34 23.69 2.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 1.6599999999999999 111.711 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.33 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.741 0.645 . . . . 1.97 112.741 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' CE1' HG22 ' A' ' 33' ' ' ILE . 24.0 m-85 -105.3 85.91 2.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.031 -0.729 . . . . 1.23 109.031 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.98 120.87 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 1.76 111.266 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 1.4 p -112.04 129.21 67.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.06 -0.518 . . . . 1.6100000000000001 110.681 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 4.8 mt-10 -90.43 136.25 33.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.303 -0.408 . . . . 1.6699999999999999 111.17 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 3.8 pttt -98.6 150.12 22.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.989 -0.55 . . . . 2.4399999999999999 110.585 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 6.5 ttp180 -134.69 109.03 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.388 -0.369 . . . . 1.79 110.888 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -78.59 101.2 7.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 1.5900000000000001 110.608 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 3.8 mt -88.27 153.41 51.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 1.4299999999999999 111.062 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.35 17.33 42.28 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.793 -1.336 . . . . 1.47 112.739 0.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -138.21 81.01 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.931 0.396 . . . . 2.6600000000000001 111.189 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.91 -167.3 19.44 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.898 -0.668 . . . . 1.6200000000000001 112.258 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 159.06 37.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 3.0600000000000001 110.945 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.522 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 64.8 m95 -65.01 122.17 16.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.793 -0.639 . . . . 1.0600000000000001 111.166 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -150.68 140.63 21.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.439 . . . . 1.8400000000000001 110.635 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -44.09 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.363 -0.38 . . . . 1.77 111.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -70.81 -40.89 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 1.4099999999999999 110.889 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 9.4 p-10 -68.8 -44.34 73.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.842 -0.617 . . . . 2.0099999999999998 111.287 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 54.85 22.63 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 2.6400000000000001 110.706 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -136.42 -157.01 0.75 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 2.0299999999999998 110.724 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.92 88.55 2.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.746 0.308 . . . . 1.8700000000000001 111.163 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 16.4 mm -70.39 63.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 1.3700000000000001 110.731 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.86 -56.78 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 2.1499999999999999 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.13 159.73 18.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 1.54 109.409 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.9 p30 -77.98 1.45 20.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.155 0.428 . . . . 1.75 112.155 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.43 95.18 6.31 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.902 -0.407 . . . . 2.0499999999999998 109.902 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 80.8 t80 -130.99 162.82 28.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.391 0.615 . . . . 0.56999999999999995 111.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.9 m -129.69 122.42 28.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.844 -1.071 . . . . 1.1399999999999999 108.803 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' CG2' ' CG2' ' A' ' 18' ' ' VAL . 33.5 m -80.18 108.97 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.204 0.526 . . . . 1.72 111.832 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 135.26 40.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.522 -0.763 . . . . 1.6399999999999999 110.436 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.55 -8.44 7.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.586 -0.816 . . . . 0.95999999999999996 112.681 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 33.6 mt -57.88 -162.29 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.847 0.323 . . . . 2.02 110.146 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -148.02 160.68 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.857 0.36 . . . . 1.55 111.222 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.82 144.5 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 1.9099999999999999 110.975 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t0 63.97 59.13 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 1.8700000000000001 110.862 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -174.76 124.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 1.2 111.429 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.65 129.84 40.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.401 . . . . 1.1100000000000001 110.31 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 50.7 m-85 -123.96 118.81 27.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 1.0800000000000001 112.103 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -101.95 139.47 37.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.234 -0.654 . . . . 1.5 109.234 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.4 122.62 19.28 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.147 1.166 . . . . 0.79000000000000004 114.147 -179.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HD2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.73 152.4 19.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.058 -0.519 . . . . 2.6899999999999999 110.02 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.468 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 97.2 t -111.44 101.57 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.589 0.589 . . . . 1.5700000000000001 112.589 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.464 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 53.3 mt -98.55 155.36 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.629 -1.248 . . . . 1.3200000000000001 107.629 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.19 137.67 2.48 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.898 -1.121 . . . . 1.1100000000000001 113.253 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -78.39 -159.3 0.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 2.3500000000000001 109.482 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.569 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 33.1 p30 -139.5 -130.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.79 -0.448 . . . . 2.7000000000000002 109.79 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -110.83 -7.66 14.59 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.402 0.546 . . . . 1.3400000000000001 111.12 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -108.66 3.56 22.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.865 0.32 . . . . 1.4299999999999999 111.865 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.95 50.94 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.4 -0.905 . . . . 1.3799999999999999 112.77 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 126.41 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.35 . . . . 1.49 110.426 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp -85.87 110.9 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.247 -0.433 . . . . 1.48 111.669 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -68.52 124.71 90.61 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 109.393 -0.595 . . . . 0.81000000000000005 109.393 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -37.68 162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.252 2.634 . . . . 1.25 113.206 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 7.4 Cg_exo -71.79 145.96 47.15 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.699 2.266 . . . . 1.2 112.724 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 90' ' ' GLU . 12.4 m -99.05 106.33 18.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.644 -0.707 . . . . 1.76 110.555 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.4 mt-10 -1.46 107.27 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.828 1.251 . . . . 1.77 114.017 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 92.4 Cg_exo -38.49 149.2 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.782 2.321 . . . . 1.01 113.145 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.89 137.32 33.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.697 -0.853 . . . . 1.55 108.697 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -37.13 129.83 0.88 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.155 0.909 . . . . 1.6299999999999999 111.805 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -60.22 119.12 7.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 1.0900000000000001 110.963 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 4.2 mp -97.56 111.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 1.1299999999999999 110.473 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.1 m -45.68 -29.73 1.35 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.157 -0.474 . . . . 1.1299999999999999 111.294 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.0 m 48.05 70.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.5700000000000001 110.776 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -103.29 -99.56 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.459 -0.337 . . . . 3.7000000000000002 111.268 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -97.82 20.66 11.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 2.1400000000000001 111.008 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 38.3 t0 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 2.0600000000000001 111.156 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.489 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 4.4 tt . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 110.412 -0.218 . . . . 1.26 110.412 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.7 m-20 -136.93 126.17 15.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.826 -0.35 . . . . 2.0 111.92 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.61 171.79 1.79 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.563 2.175 . . . . 0.58999999999999997 112.015 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 52.4 Cg_endo -69.09 -178.6 2.16 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.59 2.193 . . . . 1.6100000000000001 112.36 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.78 174.35 54.82 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.897 -0.668 . . . . 0.97999999999999998 112.585 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.6 tptm -61.83 119.06 44.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 110.707 -0.109 . . . . 2.04 110.707 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 12.6 Cg_exo -70.4 146.47 56.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.161 . . . . 0.54000000000000004 112.453 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 14.8 p -143.51 112.78 5.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.015 -0.539 . . . . 1.6799999999999999 111.4 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 34.3 Cg_exo -62.69 107.93 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.727 2.285 . . . . 0.64000000000000001 113.876 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -62.68 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.658 -0.867 . . . . 2.1699999999999999 108.658 178.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.408 ' O ' HG21 ' A' ' 13' ' ' ILE . 4.1 t30 -132.79 151.16 52.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.439 -1.255 . . . . 0.84999999999999998 108.514 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.452 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -141.91 99.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.091 -0.644 . . . . 1.5700000000000001 112.266 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -90.04 134.66 34.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 1.46 110.301 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -33.88 -30.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.867 1.062 . . . . 2.9100000000000001 113.867 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.427 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 5.0 m-70 -116.51 -24.16 7.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.663 0.616 . . . . 1.3300000000000001 112.663 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' THR . 75.0 p -136.54 132.32 35.06 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.747 -0.464 . . . . 1.28 109.747 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' CE2' ' A' ' 74' ' ' PHE . 4.4 m -123.28 142.78 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.886 -0.726 . . . . 1.49 112.453 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.0 m -103.87 124.63 49.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.641 -0.709 . . . . 1.1399999999999999 111.994 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -135.2 151.56 50.75 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 121.687 0.755 . . . . 1.3100000000000001 111.744 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 15.8 tptm -134.43 153.64 51.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.508 -1.224 . . . . 2.3100000000000001 109.702 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 22.8 p90 -143.1 -176.35 4.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.266 0.555 . . . . 0.40000000000000002 112.182 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.4 -159.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 1.1100000000000001 110.953 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -128.13 141.66 41.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 2.5600000000000001 110.094 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 84.1 Cg_exo -42.65 168.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.228 1.952 . . . . 1.1100000000000001 112.222 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -107.89 -30.3 8.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 2.77 111.724 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -119.24 -69.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.854 0.316 . . . . 1.6899999999999999 111.854 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.488 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 18.6 p 50.92 45.34 27.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.3500000000000001 110.444 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.4 -93.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.068 -0.587 . . . . 1.01 112.683 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.28 36.18 0.7 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.515 -1.034 . . . . 0.97999999999999998 110.515 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.85 -172.81 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.908 -0.646 . . . . 0.98999999999999999 111.577 -178.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 23.03 4.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 2.6899999999999999 112.132 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 45.5 mm 68.82 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 111.903 0.334 . . . . 1.71 111.903 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' ILE . 1.7 p 87.67 -16.93 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.128 0.571 . . . . 1.6599999999999999 112.34 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t 177.86 169.44 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.848 0.356 . . . . 1.97 111.861 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 5' ' ' PRO . 54.1 m-85 -140.19 105.12 4.97 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 116.075 -0.511 . . . . 1.23 111.403 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.483 ' CG2' ' CD ' ' A' ' 50' ' ' LYS . 4.9 mt -89.37 91.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.038 -0.528 . . . . 1.76 110.839 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 1.3 p -82.76 123.39 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.022 0.439 . . . . 1.6100000000000001 110.748 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -97.83 156.68 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.699 . . . . 1.6699999999999999 111.345 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.16 139.74 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 2.4399999999999999 110.62 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.4 ttm180 -121.02 113.68 20.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.181 -0.463 . . . . 1.79 110.568 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -71.48 86.93 0.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 1.5900000000000001 109.654 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.472 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -70.35 142.39 89.47 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.949 -0.569 . . . . 1.4299999999999999 110.759 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.96 47.85 1.94 Allowed 'Cis proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.182 -1.174 . . . . 1.47 112.869 0.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -158.58 60.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.679 0.276 . . . . 2.6600000000000001 111.546 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.521 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -114.79 -177.48 18.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.636 -0.792 . . . . 1.6200000000000001 112.325 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -151.6 24.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 3.0600000000000001 111.123 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 54.0 m95 51.77 95.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 1.0600000000000001 111.332 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 mp -118.23 137.7 52.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 1.8400000000000001 110.328 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' CD ' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -45.3 93.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 1.77 111.689 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -70.09 -40.52 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 1.4099999999999999 110.306 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -63.66 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0099999999999998 110.481 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 68.96 41.08 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 2.6400000000000001 110.803 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 t -154.37 -72.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.993 -0.549 . . . . 2.0299999999999998 110.972 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 175.48 136.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.8700000000000001 110.659 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 61' ' ' PHE . 8.1 mt -140.69 79.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.3700000000000001 110.967 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 tp -68.62 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 2.1499999999999999 110.825 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.59 169.66 17.86 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.305 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -80.67 -2.0 44.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.293 -0.412 . . . . 1.75 111.672 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.87 102.55 13.62 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.853 0.358 . . . . 2.0499999999999998 110.33 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.488 ' CE2' ' O ' ' A' ' 62' ' ' THR . 66.5 t80 -139.02 164.05 30.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.56999999999999995 111.872 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 54.0 m -127.12 128.43 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.451 -0.795 . . . . 1.1399999999999999 109.795 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 ' CG2' HG21 ' A' ' 18' ' ' VAL . 29.7 m -91.62 128.7 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 120.221 -0.591 . . . . 1.72 112.168 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.81 127.01 55.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.546 -0.752 . . . . 1.6399999999999999 109.821 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.72 -13.04 1.97 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.521 -0.847 . . . . 0.95999999999999996 112.59 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -52.08 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.013 0.435 . . . . 2.02 110.553 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -152.53 157.07 40.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 1.55 110.601 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 4.4 mt-10 -76.76 143.76 39.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 1.9099999999999999 110.675 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 65.87 38.04 5.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.214 -0.448 . . . . 1.8700000000000001 110.929 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.41 117.3 5.5 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.565 -0.289 . . . . 1.2 111.731 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.25 121.31 21.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.655 -0.498 . . . . 1.1100000000000001 109.655 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 131.77 56.85 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 1.0800000000000001 112.696 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.2 tt0 -105.83 142.46 35.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.239 -1.022 . . . . 1.5 108.239 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -126.92 114.98 18.58 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.247 1.203 . . . . 0.79000000000000004 114.247 -178.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -93.5 144.87 24.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.313 -0.858 . . . . 2.6899999999999999 110.229 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG21 ' CG ' ' A' ' 8' ' ' PRO . 52.9 t -106.7 119.77 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 1.5700000000000001 112.368 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 5.9 mt -110.1 165.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.978 -1.119 . . . . 1.3200000000000001 107.978 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -179.3 130.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.965 -0.694 . . . . 1.1100000000000001 112.345 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.4 pttm -81.26 -158.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.969 -0.752 . . . . 2.3500000000000001 108.969 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.6 m-80 -155.78 167.62 29.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 2.7000000000000002 112.029 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.26 -53.25 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 1.3400000000000001 111.864 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -69.32 -5.84 25.76 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.313 0.486 . . . . 1.4299999999999999 112.313 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.94 63.31 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.39 -0.91 . . . . 1.3799999999999999 112.714 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -63.31 124.84 22.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 1.49 110.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -92.4 110.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.649 0.611 . . . . 1.48 112.649 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 4.5 p -74.89 120.28 80.84 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.812 -0.81 . . . . 0.81000000000000005 108.812 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 88.3 Cg_endo -70.95 172.97 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.574 2.182 . . . . 1.25 112.961 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' CA ' ' HG2' ' A' ' 75' ' ' ARG . 2.9 Cg_exo -36.93 121.56 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.395 2.73 . . . . 1.2 112.819 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' GLU . 5.1 p -107.88 104.23 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.76 111.037 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 21.6 mt-10 18.36 110.48 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.505 1.122 . . . . 1.77 113.809 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 34.5 Cg_exo -63.38 155.79 60.04 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.496 2.13 . . . . 1.01 114.374 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.5 146.11 27.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.903 -1.044 . . . . 1.55 108.839 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -32.23 143.96 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.256 0.972 . . . . 1.6299999999999999 112.478 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -79.64 114.32 18.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.428 -0.805 . . . . 1.0900000000000001 110.326 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.509 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.8 mp -99.37 110.17 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 1.1299999999999999 111.452 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.427 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 63.0 m -45.19 -39.79 6.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.044 -0.526 . . . . 1.1299999999999999 111.224 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 69' ' ' ASP . 90.9 m 54.96 106.8 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.5700000000000001 110.448 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -141.87 -75.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.987 0.423 . . . . 3.7000000000000002 110.957 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -122.86 3.09 9.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.577 . . . . 2.1400000000000001 111.496 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.766 0.317 . . . . 2.0600000000000001 111.444 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.81 0.338 . . . . 1.26 111.16 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.64 132.8 24.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 2.0 110.318 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 68.5 Cg_endo -81.86 162.38 18.54 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.157 . . . . 0.58999999999999997 112.451 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 71.4 Cg_exo -53.11 177.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.906 2.404 . . . . 1.6100000000000001 112.611 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.17 -175.58 50.15 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.043 -0.598 . . . . 0.97999999999999998 113.128 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 tmtp? -69.69 123.29 88.27 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.974 0.11 . . . . 2.04 110.848 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 10.7 Cg_exo -75.47 128.12 10.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.669 2.246 . . . . 0.54000000000000004 112.741 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' HD12 ' A' ' 11' ' ' LEU . 3.8 t -134.15 115.63 13.03 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.375 -0.375 . . . . 1.6799999999999999 111.439 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 19' ' ' THR . 22.0 Cg_exo -61.98 108.11 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.224 1.949 . . . . 0.64000000000000001 113.448 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -65.57 -41.18 93.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.46 0.648 . . . . 2.1699999999999999 109.298 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 13' ' ' ILE . 3.4 t30 -136.66 154.73 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.891 -1.05 . . . . 0.84999999999999998 109.379 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 pt -143.32 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.904 0.383 . . . . 1.5700000000000001 111.22 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.82 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -101.71 56.86 0.82 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.023 -0.535 . . . . 1.46 112.266 -179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.254 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.74 -74.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.614 -0.721 . . . . 2.9100000000000001 112.754 178.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' THR . 18.0 m170 -78.28 -35.28 48.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.072 0.397 . . . . 1.3300000000000001 112.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 p -126.09 117.47 23.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.853 0.359 . . . . 1.28 110.98 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.531 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 11.3 m -110.29 141.8 24.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.0 -0.546 . . . . 1.49 111.137 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.2 m -107.33 127.99 54.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.57 . . . . 1.1399999999999999 111.768 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -133.25 156.38 47.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.371 0.605 . . . . 1.3100000000000001 111.377 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.044 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -138.14 142.93 40.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.079 -0.964 . . . . 2.3100000000000001 109.973 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 42.8 p90 -137.8 163.29 31.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.144 0.497 . . . . 0.40000000000000002 111.885 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.88 164.93 24.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 1.1100000000000001 110.318 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.82 157.15 35.13 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 2.5600000000000001 110.873 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 76.9 Cg_exo -50.34 -173.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.233 . . . . 1.1100000000000001 112.658 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.11 -25.57 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.897 -0.592 . . . . 2.77 111.829 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -129.05 -69.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.057 0.391 . . . . 1.6899999999999999 112.057 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.5 p 59.45 50.79 7.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.346 . . . . 1.3500000000000001 110.725 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.82 -98.86 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.163 -0.541 . . . . 1.01 112.64 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.05 32.74 1.66 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 109.735 -1.346 . . . . 0.97999999999999998 109.735 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.95 -169.98 1.58 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.62 -0.79 . . . . 0.98999999999999999 111.262 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 34' ' ' THR . 1.9 pttt -142.2 24.1 1.98 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 2.6899999999999999 112.008 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mm 66.44 -69.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.7 0.286 . . . . 1.71 110.902 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.6 p 87.33 -20.72 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.188 0.595 . . . . 1.6599999999999999 112.058 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 5.8 t -177.25 165.31 2.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 1.97 111.464 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE1' HG22 ' A' ' 33' ' ' ILE . 54.1 m-85 -133.75 109.1 8.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 1.23 111.073 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 37' ' ' ILE . 2.7 mt -85.33 156.26 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.22 -0.289 . . . . 1.76 110.22 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 63' ' ' VAL . 7.1 t -135.06 124.31 42.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 1.6100000000000001 111.807 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -96.51 131.56 42.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.6699999999999999 110.174 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 138.99 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.038 0.447 . . . . 2.4399999999999999 111.964 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -122.14 109.65 14.79 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.825 -0.625 . . . . 1.79 110.374 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD2' ' NE ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -77.15 95.67 4.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 1.5900000000000001 110.578 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -65.49 151.62 94.01 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 1.4299999999999999 111.106 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -88.79 4.12 69.96 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.803 -1.332 . . . . 1.47 113.212 0.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -77.18 -84.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.672 0.272 . . . . 2.6600000000000001 110.502 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.76 161.61 12.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.639 -0.791 . . . . 1.6200000000000001 113.326 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' NE ' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 168.72 55.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 3.0600000000000001 110.008 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 74.9 m95 -36.78 120.48 0.71 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.838 -0.619 . . . . 1.0600000000000001 112.544 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -155.49 131.1 9.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 1.8400000000000001 110.008 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 1.8 ptpt -52.11 117.41 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 1.77 110.84 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.87 -41.32 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.131 -0.486 . . . . 1.4099999999999999 111.268 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.418 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 16.9 p-10 -44.79 -48.27 10.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.373 -0.376 . . . . 2.0099999999999998 111.376 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.74 29.73 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.259 -0.428 . . . . 2.6400000000000001 111.329 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -133.39 -170.11 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 2.0299999999999998 110.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -99.69 89.29 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 1.8700000000000001 111.181 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.484 HD12 ' CE1' ' A' ' 61' ' ' PHE . 36.4 mt -86.78 72.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 1.3700000000000001 110.768 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.7 tp -63.08 -38.31 90.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 2.1499999999999999 111.455 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -100.6 160.49 14.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.379 . . . . 1.54 110.528 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.502 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -74.25 -7.92 54.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.211 -0.45 . . . . 1.75 111.323 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.044 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.3 tp10 -90.55 97.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.322 -0.621 . . . . 2.0499999999999998 109.322 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 58.4 t80 -135.79 165.35 25.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.56999999999999995 111.985 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 94.3 m -123.21 123.37 40.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.325 -0.852 . . . . 1.1399999999999999 110.281 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 38' ' ' VAL . 17.3 t -82.02 119.62 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 1.72 111.71 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.26 145.36 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.792 -0.64 . . . . 1.6399999999999999 110.663 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.03 -19.35 5.48 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.746 -0.74 . . . . 0.95999999999999996 112.171 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -55.9 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.666 0.27 . . . . 2.02 110.46 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -157.88 143.58 17.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.848 0.356 . . . . 1.55 110.765 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.92 129.88 27.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.063 -0.517 . . . . 1.9099999999999999 111.127 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.61 66.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.073 -0.512 . . . . 1.8700000000000001 111.397 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -175.5 118.44 0.16 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 1.2 111.468 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.54 129.73 40.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 1.1100000000000001 109.519 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 73.3 m-85 -128.87 124.46 35.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.053 0.76 . . . . 1.0800000000000001 113.053 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' CG ' ' HB1' ' A' ' 94' ' ' ALA . 10.5 mt-10 -103.52 142.36 34.41 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.498 -0.927 . . . . 1.5 108.498 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -133.15 111.98 11.36 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.478 1.288 . . . . 0.79000000000000004 114.478 -178.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.498 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.01 157.39 16.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.495 -0.928 . . . . 2.6899999999999999 108.495 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.479 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -125.21 124.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.535 -0.866 . . . . 1.5700000000000001 112.878 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.458 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 63.6 mt -108.03 139.71 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.407 -1.331 . . . . 1.3200000000000001 107.407 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -149.18 117.52 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.529 -0.869 . . . . 1.1100000000000001 112.603 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.4 ptpt -71.57 -172.73 0.82 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.191 -0.459 . . . . 2.3500000000000001 110.149 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.487 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 5.1 m-80 -135.09 168.08 19.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.263 0.554 . . . . 2.7000000000000002 111.915 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 31' ' ' PHE . . . -41.59 -44.04 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 1.3400000000000001 111.828 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.69 -18.0 58.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.998 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 113.68 -16.75 21.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.551 -0.833 . . . . 1.3799999999999999 112.1 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 123.46 8.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.663 0.268 . . . . 1.49 110.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.3 tp -87.91 109.81 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.694 0.627 . . . . 1.48 112.694 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.7 p -68.58 107.34 1.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 107.811 -1.181 . . . . 0.81000000000000005 107.811 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.0 Cg_endo -45.98 155.41 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.091 . . . . 1.25 112.841 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 2.3 Cg_endo -45.18 128.76 9.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.372 2.714 . . . . 1.2 113.483 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 p -97.43 109.14 21.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.364 -0.835 . . . . 1.76 109.862 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 7.6 mt-10 1.72 119.22 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.093 0 O-C-N 124.858 1.349 . . . . 1.77 113.927 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.7 Cg_exo -62.18 139.97 81.0 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.051 . . . . 1.01 113.768 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.406 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.89 144.3 57.18 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.063 -0.718 . . . . 1.55 109.063 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -40.43 134.2 1.75 Allowed 'General case' 0 C--N 1.333 -0.11 0 O-C-N 124.006 0.816 . . . . 1.6299999999999999 111.633 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 43' ' ' LEU . . . -60.68 127.09 29.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 1.0900000000000001 111.255 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.519 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.0 mp -109.4 114.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.364 -0.38 . . . . 1.1299999999999999 110.478 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.414 HG22 ' NH1' ' A' ' 98' ' ' ARG . 65.2 m -48.13 -39.04 19.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.929 0.395 . . . . 1.1299999999999999 111.03 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.9 m 60.29 65.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 110.881 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HD3' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -107.63 -89.53 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.784 0.326 . . . . 3.7000000000000002 110.52 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.64 ' OD2' ' HD3' ' A' ' 98' ' ' ARG . 3.6 p30 -102.27 12.82 36.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.412 -0.358 . . . . 2.1400000000000001 110.635 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.254 ' OD1' ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.864 0.364 . . . . 2.0600000000000001 111.189 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 84' ' ' ALA . 2.7 tt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.883 0.373 . . . . 1.26 110.874 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.39 128.53 18.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.618 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 157.02 43.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.394 2.062 . . . . 0.58999999999999997 112.161 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.55 -164.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.801 2.334 . . . . 1.6100000000000001 113.228 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.94 -175.41 44.02 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.423 -0.808 . . . . 0.97999999999999998 112.799 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -78.08 134.64 63.41 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 110.382 -0.229 . . . . 2.04 110.382 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 3.0 Cg_exo -79.04 147.04 20.72 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.652 2.234 . . . . 0.54000000000000004 112.83 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 11.2 p -138.69 115.06 8.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.625 -0.716 . . . . 1.6799999999999999 110.647 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.7 Cg_exo -63.34 112.74 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.201 1.934 . . . . 0.64000000000000001 113.149 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -76.9 -40.37 47.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.305 0.574 . . . . 2.1699999999999999 109.848 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.22 114.01 13.95 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.233 -0.894 . . . . 0.84999999999999998 109.215 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -113.0 126.26 70.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.73 0.641 . . . . 1.5700000000000001 112.73 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -116.63 144.7 44.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.339 -0.846 . . . . 1.46 109.674 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -52.29 -18.36 1.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.94 0.719 . . . . 2.9100000000000001 112.94 -178.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.426 ' O ' ' CG2' ' A' ' 17' ' ' THR . 3.1 m-70 -124.33 -7.75 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.543 0.571 . . . . 1.3300000000000001 112.543 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.449 ' CA ' HD11 ' A' ' 66' ' ' LEU . 77.8 p -161.0 124.7 3.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.408 -0.219 . . . . 1.28 110.408 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 74' ' ' PHE . 3.9 m -113.88 156.79 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.253 -0.579 . . . . 1.49 112.066 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.5 m -125.2 123.01 38.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.1 -0.5 . . . . 1.1399999999999999 110.943 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -130.64 162.13 30.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.731 0.777 . . . . 1.3100000000000001 112.454 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -136.1 159.01 43.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.502 -1.226 . . . . 2.3100000000000001 109.762 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 19.7 p90 -149.4 -175.8 5.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.40000000000000002 112.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.39 -173.99 4.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.617 -0.72 . . . . 1.1100000000000001 112.072 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -120.94 140.58 31.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.289 -0.869 . . . . 2.5600000000000001 110.272 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.469 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 83.9 Cg_exo -46.07 175.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.43 2.087 . . . . 1.1100000000000001 112.578 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -21.01 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 2.77 111.687 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.52 -68.71 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.991 0.367 . . . . 1.6899999999999999 111.991 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.487 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.2 p 51.79 49.62 20.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 1.3500000000000001 110.496 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.75 -94.11 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.057 -0.592 . . . . 1.01 112.825 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.32 43.27 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.472 -1.051 . . . . 0.97999999999999998 110.472 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -122.32 -168.97 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.458 . . . . 0.98999999999999999 111.487 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.35 20.68 1.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.619 0.6 . . . . 2.6899999999999999 112.619 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.6 mp 59.61 -85.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.927 -0.309 . . . . 1.71 110.483 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' A' ' 35' ' ' SER . 1.2 p 77.59 30.84 0.47 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.982 0.364 . . . . 1.6599999999999999 111.982 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.5 OUTLIER 160.95 146.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.368 -0.378 . . . . 1.97 110.362 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -140.1 117.12 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.022 0.439 . . . . 1.23 111.679 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 23.9 mt -85.43 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 1.76 110.346 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -109.53 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.158 0.429 . . . . 1.6100000000000001 112.158 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.718 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 4.6 mm-40 -64.22 132.59 50.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.382 -0.599 . . . . 1.6699999999999999 109.382 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -114.75 134.53 55.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 2.4399999999999999 111.718 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.0 ttm180 -113.92 111.9 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.599 -0.728 . . . . 1.79 110.007 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.823 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.96 108.7 13.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 1.5900000000000001 110.902 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 1.2 mm? -84.34 143.68 42.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.436 -0.347 . . . . 1.4299999999999999 110.985 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 63.5 Cg_endo -98.43 45.34 2.67 Favored 'Cis proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.36 -1.1 . . . . 1.47 112.755 0.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 m-80 -153.1 58.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 2.6600000000000001 111.306 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -116.05 167.57 12.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.848 -0.691 . . . . 1.6200000000000001 112.762 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.35 27.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.001 0.429 . . . . 3.0600000000000001 110.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.476 ' CH2' ' HB3' ' A' ' 91' ' ' PRO . 72.3 m95 53.23 110.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 1.0600000000000001 111.638 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 118.4 10.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.233 -0.44 . . . . 1.8400000000000001 110.459 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.718 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 7.2 ptpt -49.69 118.0 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.181 0.515 . . . . 1.77 111.2 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . . . -102.37 -40.29 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 1.4099999999999999 110.956 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -40.28 -48.27 2.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 2.0099999999999998 111.765 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 43.19 44.02 4.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.372 -0.376 . . . . 2.6400000000000001 111.721 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.1 p -162.46 158.49 23.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 2.0299999999999998 110.912 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' ND2' HD21 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.8 105.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 1.8700000000000001 110.681 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CG ' ' A' ' 61' ' ' PHE . 53.5 mt -100.19 63.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 1.3700000000000001 110.261 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD21 ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -41.94 -76.22 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.566 -0.743 . . . . 2.1499999999999999 111.821 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -64.82 170.02 4.6 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.772 0.32 . . . . 1.54 110.147 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.515 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 43.7 p30 -88.8 13.4 12.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.403 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 49.3 tt0 -111.55 107.3 16.42 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.621 -0.511 . . . . 2.0499999999999998 109.621 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 62' ' ' THR . 58.6 t80 -142.49 164.97 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.56999999999999995 112.049 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 30.5 m -125.02 122.9 38.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.581 -0.736 . . . . 1.1399999999999999 110.8 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' CG2' HG21 ' A' ' 18' ' ' VAL . 3.7 m -91.53 96.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 120.24 -0.584 . . . . 1.72 110.714 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.425 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 0.8 OUTLIER -82.85 -165.28 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 1.6399999999999999 110.885 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.89 20.44 59.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.685 -0.769 . . . . 0.95999999999999996 112.371 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.543 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 69.9 mt -74.28 -176.58 2.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.848 0.356 . . . . 2.02 110.75 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 m -132.68 154.9 49.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 1.55 110.875 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 22.9 tt0 -88.28 160.22 17.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 1.9099999999999999 110.906 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.874 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 52.33 43.59 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 1.8700000000000001 110.858 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -158.45 120.7 3.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 1.2 111.33 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -69.36 132.68 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 1.1100000000000001 110.107 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 48.3 m-85 -125.69 118.97 26.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.681 0.622 . . . . 1.0800000000000001 112.681 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 5.1 mt-10 -99.45 142.95 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.46 -0.941 . . . . 1.5 108.46 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -125.81 115.1 19.49 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.289 1.218 . . . . 0.79000000000000004 114.289 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 2.5 ttp85 -94.91 139.49 31.26 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.341 -0.845 . . . . 2.6899999999999999 109.537 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.458 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 80.6 t -106.98 138.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.71 0.767 . . . . 1.5700000000000001 112.349 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 77' ' ' ILE . 29.0 mt -134.66 156.64 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.557 -1.646 . . . . 1.3200000000000001 106.557 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.42 121.07 0.84 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.652 -1.219 . . . . 1.1100000000000001 112.987 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mmtt -61.91 -173.33 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.003 -0.679 . . . . 2.3500000000000001 109.725 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.482 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 5.4 m120 -136.8 161.2 36.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.033 0.444 . . . . 2.7000000000000002 110.908 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -36.87 -30.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.155 0.798 . . . . 1.3400000000000001 113.155 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -109.73 24.37 13.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.979 0.733 . . . . 1.4299999999999999 112.979 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.17 -11.1 51.1 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.561 -0.828 . . . . 1.3799999999999999 113.222 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -53.82 102.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.946 0.373 . . . . 1.49 110.217 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -70.0 104.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.444 0.535 . . . . 1.48 112.444 -179.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.5 p -65.96 111.74 7.21 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.777 -0.823 . . . . 0.81000000000000005 108.777 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 72.6 Cg_exo -48.8 -179.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.236 2.624 . . . . 1.25 114.311 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 68.1 Cg_exo -52.61 144.17 43.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.404 2.736 . . . . 1.2 113.544 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 10.9 m -123.04 122.05 37.55 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.906 -0.588 . . . . 1.76 110.505 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -18.53 102.47 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.161 0.985 . . . . 1.77 113.36 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 76.2 Cg_exo -48.42 169.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.043 2.495 . . . . 1.01 114.93 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.88 142.28 28.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.178 -1.374 . . . . 1.55 109.784 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -44.85 133.61 6.11 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.77 0.669 . . . . 1.6299999999999999 110.457 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . -65.07 119.65 11.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.984 -0.553 . . . . 1.0900000000000001 111.754 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.483 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.0 mp -97.37 109.55 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 1.1299999999999999 110.408 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 13.6 m -46.89 -37.63 9.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.363 -0.38 . . . . 1.1299999999999999 111.379 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 3.0 m 52.76 88.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.371 . . . . 1.5700000000000001 110.227 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -134.75 -91.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.63 -0.259 . . . . 3.7000000000000002 111.113 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -91.45 -6.1 53.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.625 -0.261 . . . . 2.1400000000000001 111.421 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.973 0.416 . . . . 2.0600000000000001 111.122 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.391 -0.226 . . . . 1.26 110.391 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.7 142.31 45.06 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 2.0 111.53 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 87.0 Cg_endo -83.44 161.79 14.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.84 2.36 . . . . 0.58999999999999997 112.276 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.53 177.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.597 2.198 . . . . 1.6100000000000001 112.625 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.01 -176.69 51.06 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.036 -0.602 . . . . 0.97999999999999998 113.309 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -66.64 127.32 93.34 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 122.197 0.199 . . . . 2.04 110.79 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 4.9 Cg_exo -80.34 135.9 10.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.532 2.155 . . . . 0.54000000000000004 112.797 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 10.7 p -137.11 114.0 9.79 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.786 -0.643 . . . . 1.6799999999999999 110.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 69.3 Cg_exo -48.52 135.02 26.9 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.144 1.896 . . . . 0.64000000000000001 113.123 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.06 -30.37 12.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 2.1699999999999999 110.061 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.99 121.61 4.45 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.319 -0.855 . . . . 0.84999999999999998 109.356 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.37 132.68 61.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.828 0.677 . . . . 1.5700000000000001 112.828 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.88 151.46 46.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.879 -1.055 . . . . 1.46 109.68 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.467 ' HG2' ' CA ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -57.74 -18.1 19.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.339 -0.391 . . . . 2.9100000000000001 111.706 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.421 ' O ' ' CG2' ' A' ' 17' ' ' THR . 4.5 m-70 -131.44 18.75 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.811 0.3 . . . . 1.3300000000000001 111.811 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -178.56 114.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 1.28 111.422 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' CG1' ' CE2' ' A' ' 74' ' ' PHE . 81.3 t -104.82 135.13 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.001 -0.545 . . . . 1.49 110.178 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 61.6 m -111.52 132.27 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 1.1399999999999999 110.661 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.521 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -140.83 143.19 34.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.96 0.886 . . . . 1.3100000000000001 111.766 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -123.79 134.92 53.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.955 -1.475 . . . . 2.3100000000000001 109.51 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 35.7 p90 -126.4 172.0 10.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 0.40000000000000002 111.196 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.83 -157.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.762 -0.654 . . . . 1.1100000000000001 110.84 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.75 159.31 69.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.47 -0.332 . . . . 2.5600000000000001 110.607 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 55.4 Cg_endo -70.38 169.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.104 1.87 . . . . 1.1100000000000001 111.815 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.33 -19.84 11.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.196 0.443 . . . . 2.77 112.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -112.74 -74.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.343 0.498 . . . . 1.6899999999999999 112.343 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.494 ' CG2' ' CG ' ' A' ' 25' ' ' PRO . 11.9 p 47.31 57.76 5.5 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.527 0.203 . . . . 1.3500000000000001 110.704 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.75 -95.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.966 -0.635 . . . . 1.01 112.384 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -148.69 27.56 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.693 -0.963 . . . . 0.97999999999999998 110.693 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CE1' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.22 -177.56 3.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.471 . . . . 0.98999999999999999 111.477 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.88 5.24 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 2.6899999999999999 111.319 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 33' ' ' ILE . 22.8 mt 60.53 145.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 1.71 110.605 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -133.31 18.27 4.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.842 0.312 . . . . 1.6599999999999999 111.842 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -179.96 151.23 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.168 0.509 . . . . 1.97 111.971 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 60.3 m-85 -134.4 100.31 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.736 . . . . 1.23 110.002 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.43 114.62 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 1.76 111.008 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -103.61 106.28 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.35 0.595 . . . . 1.6100000000000001 110.596 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 25.2 mt-10 -75.31 154.92 37.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.251 -0.886 . . . . 1.6699999999999999 111.212 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -117.07 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.4399999999999999 111.134 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 2.8 ttm180 -112.85 101.65 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 1.79 109.788 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -68.54 141.47 55.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.848 -0.614 . . . . 1.5900000000000001 110.622 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 6.9 mt -126.87 153.71 76.12 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 1.4299999999999999 111.252 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.8 24.08 8.27 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.962 -1.266 . . . . 1.47 113.616 0.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.46 100.25 2.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.363 . . . . 2.6600000000000001 110.903 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -165.9 167.9 39.42 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.84 -0.695 . . . . 1.6200000000000001 112.419 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.14 148.43 52.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 3.0600000000000001 111.188 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 72.1 m95 -55.45 105.88 0.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.156 -0.474 . . . . 1.0600000000000001 111.227 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' HB3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -134.2 122.54 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 1.8400000000000001 110.354 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -44.47 118.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 1.77 111.346 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.84 -9.83 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.4099999999999999 111.993 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 12.6 p-10 -77.71 -54.72 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.201 -0.2 . . . . 2.0099999999999998 111.467 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 38.34 35.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.999 0.37 . . . . 2.6400000000000001 111.999 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 26.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.442 -0.345 . . . . 2.0299999999999998 111.42 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.24 130.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.378 . . . . 1.8700000000000001 111.211 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CD1' ' A' ' 61' ' ' PHE . 48.1 mt -129.99 84.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 1.3700000000000001 110.633 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.34 -43.79 76.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 2.1499999999999999 111.985 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.45 154.74 17.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.834 0.349 . . . . 1.54 110.866 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -72.81 -4.59 32.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 1.75 111.672 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -96.86 98.2 9.92 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.167 -0.679 . . . . 2.0499999999999998 109.167 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 62' ' ' THR . 69.8 t80 -128.48 164.53 22.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.452 0.644 . . . . 0.56999999999999995 112.146 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -125.76 114.87 19.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.077 -0.965 . . . . 1.1399999999999999 110.783 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.66 109.09 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 1.72 110.817 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.77 151.45 26.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 1.6399999999999999 111.055 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.93 4.57 10.27 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.574 -0.739 . . . . 0.95999999999999996 112.396 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -68.54 -167.19 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.947 0.403 . . . . 2.02 110.918 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -150.25 139.32 21.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 1.55 110.76 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE1' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -58.86 130.45 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.9099999999999999 111.063 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t0 76.16 49.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 1.8700000000000001 111.277 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -160.03 127.42 4.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 1.2 111.356 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.24 134.23 41.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.218 -0.446 . . . . 1.1100000000000001 110.134 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 54.6 m-85 -133.2 125.2 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.798 0.666 . . . . 1.0800000000000001 112.798 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.12 150.06 22.88 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.04 -0.726 . . . . 1.5 109.04 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CE2' ' CG1' ' A' ' 18' ' ' VAL . 1.4 m-85 -134.71 117.24 15.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.146 1.165 . . . . 0.79000000000000004 114.146 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 24.1 ttm-85 -111.82 159.5 18.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.132 -0.94 . . . . 2.6899999999999999 109.412 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -136.88 144.83 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.982 0.896 . . . . 1.5700000000000001 112.803 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 78' ' ' ALA . 22.8 mt -130.32 145.19 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.828 -1.533 . . . . 1.3200000000000001 107.655 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -145.87 130.62 18.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.586 -0.846 . . . . 1.1100000000000001 112.575 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -91.77 123.96 35.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 2.3500000000000001 111.308 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.4 p-10 -66.28 -174.82 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.851 . . . . 2.7000000000000002 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -65.68 -26.04 67.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.844 -0.616 . . . . 1.3400000000000001 112.063 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -88.19 1.47 54.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.435 0.531 . . . . 1.4299999999999999 112.435 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.8 79.76 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.369 -0.919 . . . . 1.3799999999999999 113.078 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 2' ' ' ILE . . . -77.31 68.08 3.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.239 0.543 . . . . 1.49 109.616 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -27.47 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 114.695 1.369 . . . . 1.48 114.695 -178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 10.7 p -75.29 106.81 3.2 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.491 -1.67 . . . . 0.81000000000000005 106.491 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.437 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 9.8 Cg_endo -50.32 169.08 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.88 2.387 . . . . 1.25 114.605 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 72.6 Cg_exo -31.04 136.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.251 3.3 . . . . 1.2 114.078 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 2.8 p -122.01 103.2 8.65 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.589 -0.732 . . . . 1.76 109.972 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -1.8 120.16 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.014 1.326 . . . . 1.77 113.872 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 4.6 Cg_exo -76.77 163.5 31.35 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.268 1.978 . . . . 1.01 113.882 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 2.0 t -90.97 146.71 23.64 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.002 -0.999 . . . . 1.55 109.401 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -38.75 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 O-C-N 123.72 0.637 . . . . 1.6299999999999999 111.596 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -87.43 120.92 29.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.033 -0.53 . . . . 1.0900000000000001 111.532 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mp -98.55 114.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.1299999999999999 111.073 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 70' ' ' ALA . 38.2 m -47.89 -28.68 2.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.839 -0.618 . . . . 1.1299999999999999 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.869 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 m 50.14 60.6 3.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 1.5700000000000001 110.973 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.702 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -95.41 -74.17 0.56 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.933 0.397 . . . . 3.7000000000000002 111.147 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.467 ' CA ' ' HG2' ' A' ' 15' ' ' ARG . 7.2 p-10 -131.08 20.0 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.974 -0.557 . . . . 2.1400000000000001 111.633 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 42.4 t0 . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 112.649 0.611 . . . . 2.0600000000000001 112.649 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.9 tt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.882 0.373 . . . . 1.26 111.274 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.425 ' N ' HG12 ' A' ' 2' ' ' ILE . 23.9 m-20 -132.22 129.97 21.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 2.0 110.475 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.22 157.98 15.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.532 2.155 . . . . 0.58999999999999997 112.604 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.418 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 4.5 Cg_endo -48.35 -177.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.122 2.548 . . . . 1.6100000000000001 113.514 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 168.78 29.26 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.53 -0.759 . . . . 0.97999999999999998 112.957 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -53.39 128.13 50.18 Favored Pre-proline 0 CA--C 1.53 0.197 0 O-C-N 122.987 -0.126 . . . . 2.04 110.811 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 11.8 Cg_exo -74.98 113.95 3.91 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.506 2.137 . . . . 0.54000000000000004 112.701 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 14.7 p -104.72 107.76 59.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 1.6799999999999999 110.652 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 27.2 Cg_exo -61.7 105.71 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.525 2.15 . . . . 0.64000000000000001 113.789 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -63.22 -32.92 74.44 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.89 -0.782 . . . . 2.1699999999999999 108.89 178.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.99 143.92 32.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.878 -1.055 . . . . 0.84999999999999998 109.061 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 HG12 ' A' ' 95' ' ' ILE . 3.2 pt -138.74 81.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.146 0.424 . . . . 1.5700000000000001 112.146 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.268 HG21 ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -79.97 151.44 30.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 1.46 110.237 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -56.48 -20.67 21.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.982 -0.554 . . . . 2.9100000000000001 111.877 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.86 11.4 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.252 0.464 . . . . 1.3300000000000001 112.252 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -169.85 115.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 1.28 110.709 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 74' ' ' PHE . 24.9 t -109.83 119.51 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.061 0.458 . . . . 1.49 111.232 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 11.0 m -99.8 124.77 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.675 -0.693 . . . . 1.1399999999999999 110.811 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.18 150.33 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.805 0.812 . . . . 1.3100000000000001 112.315 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -132.35 154.35 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.313 -1.312 . . . . 2.3100000000000001 109.798 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.4 p90 -142.21 -176.05 4.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.278 0.561 . . . . 0.40000000000000002 112.397 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.65 24.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.44 -0.8 . . . . 1.1100000000000001 111.154 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 4.0 tmmm? -84.91 139.21 37.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 2.5600000000000001 110.758 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 93.0 Cg_exo -43.84 160.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.216 1.944 . . . . 1.1100000000000001 111.837 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -106.94 -15.92 14.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.77 111.749 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 -70.62 0.7 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.863 0.32 . . . . 1.6899999999999999 111.863 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.423 HG21 ' CB ' ' A' ' 25' ' ' PRO . 14.4 p 50.59 54.78 10.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.971 0.415 . . . . 1.3500000000000001 110.382 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.33 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.927 -0.579 . . . . 1.01 112.55 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.66 24.06 2.77 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.35 -0.7 . . . . 0.97999999999999998 111.35 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.548 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -92.04 -176.64 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 0.98999999999999999 111.923 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -130.87 -13.48 3.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.646 -0.706 . . . . 2.6899999999999999 112.209 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 33' ' ' ILE . 11.4 mt 64.1 132.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.701 -0.481 . . . . 1.71 109.701 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -124.42 11.82 8.69 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.575 0.583 . . . . 1.6599999999999999 112.575 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 146.35 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.999 0.428 . . . . 1.97 112.138 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' HH ' ' HG2' ' A' ' 24' ' ' LYS . 51.1 m-85 -118.52 122.16 42.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.717 -0.674 . . . . 1.23 109.972 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -107.85 129.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 1.76 110.765 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -119.28 130.22 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 1.6100000000000001 110.584 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.5 mt-10 -94.54 136.66 34.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.442 -0.799 . . . . 1.6699999999999999 110.668 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -99.94 159.36 15.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 2.4399999999999999 111.112 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -140.73 105.29 4.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.543 . . . . 1.79 110.546 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.685 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -75.11 80.41 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.5900000000000001 110.97 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD22 ' CB ' ' A' ' 94' ' ' ALA . 1.2 mm? -65.63 155.82 84.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 1.4299999999999999 110.763 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -91.81 36.7 5.99 Favored 'Cis proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.063 -1.224 . . . . 1.47 112.639 0.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -162.18 57.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.923 0.392 . . . . 2.6600000000000001 111.11 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.685 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -127.05 172.79 18.51 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.973 -0.632 . . . . 1.6200000000000001 112.156 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.62 51.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.217 0.532 . . . . 3.0600000000000001 111.348 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.543 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 50.5 m95 -60.94 124.05 19.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.391 -0.822 . . . . 1.0600000000000001 110.527 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.95 124.05 6.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.841 0.353 . . . . 1.8400000000000001 111.295 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -50.95 115.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.77 110.537 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.26 -35.22 10.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 1.4099999999999999 111.545 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 7.1 p-10 -53.54 -62.5 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.316 . . . . 2.0099999999999998 111.85 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 3.5 t80 80.05 -51.39 0.37 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.544 0.211 . . . . 2.6400000000000001 111.259 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -64.04 -171.31 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.886 0.374 . . . . 2.0299999999999998 110.975 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.2 106.13 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 1.8700000000000001 110.814 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 56' ' ' ILE . 26.4 mt -92.42 74.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 1.3700000000000001 111.268 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -73.65 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 2.1499999999999999 111.018 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.51 174.12 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.54 110.189 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 44.4 p30 -92.86 17.38 10.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.267 -0.424 . . . . 1.75 111.452 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.69 103.01 9.28 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.049 -0.352 . . . . 2.0499999999999998 110.049 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 52' ' ' ASN . 59.1 t80 -134.68 164.18 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.068 0.461 . . . . 0.56999999999999995 111.537 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 17.3 m -122.03 119.68 32.12 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.672 -0.694 . . . . 1.1399999999999999 111.152 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.92 97.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.995 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.28 150.74 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.665 -0.698 . . . . 1.6399999999999999 110.951 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.57 7.45 8.92 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.711 -0.677 . . . . 0.95999999999999996 112.338 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 72' ' ' TYR . 4.4 mm? -51.81 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.018 0.437 . . . . 2.02 110.928 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 m -142.71 111.01 6.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.813 -0.631 . . . . 1.55 110.112 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.0 138.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.9099999999999999 111.869 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.79 56.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.897 -0.592 . . . . 1.8700000000000001 111.583 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.44 123.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 1.2 111.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.12 134.43 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.1100000000000001 110.536 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.503 ' CD2' HD13 ' A' ' 66' ' ' LEU . 49.4 m-85 -130.6 118.89 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.317 0.488 . . . . 1.0800000000000001 112.317 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -100.08 143.09 30.69 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.311 -0.626 . . . . 1.5 109.311 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -139.57 119.89 13.86 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.486 1.291 . . . . 0.79000000000000004 114.486 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.538 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.06 173.57 6.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.444 -0.947 . . . . 2.6899999999999999 108.444 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.85 113.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 114.116 1.154 . . . . 1.5700000000000001 114.116 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.434 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 41.6 mt -97.32 154.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 106.479 -1.674 . . . . 1.3200000000000001 106.479 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -168.16 128.27 1.29 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.434 -0.906 . . . . 1.1100000000000001 111.656 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 20.6 mttt -63.57 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.047 -0.723 . . . . 2.3500000000000001 109.047 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 2.1 m-80 -146.01 -94.21 0.09 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.66 -0.416 . . . . 2.7000000000000002 110.925 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -137.15 -42.28 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 1.3400000000000001 110.952 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.18 30.45 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.4299999999999999 111.996 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.16 -12.37 58.34 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.541 -0.838 . . . . 1.3799999999999999 113.353 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.11 115.75 2.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.973 0.386 . . . . 1.49 110.894 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -87.78 104.37 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.034 0.445 . . . . 1.48 111.519 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' CB ' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -68.65 119.76 71.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 109.803 -0.443 . . . . 0.81000000000000005 109.803 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.24 162.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.177 2.585 . . . . 1.25 113.122 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 36.7 Cg_endo -66.26 142.3 66.19 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.695 2.263 . . . . 1.2 112.409 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 90' ' ' GLU . 45.8 m -94.59 105.32 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 1.76 110.332 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 89' ' ' SER . 3.5 tt0 -4.27 115.27 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 124.705 1.202 . . . . 1.77 113.681 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.2 Cg_exo -56.2 141.8 87.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.125 1.883 . . . . 1.01 113.6 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 15.7 m -72.31 143.17 48.79 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.753 -0.832 . . . . 1.55 108.753 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -41.12 137.27 1.36 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.768 0.668 . . . . 1.6299999999999999 110.752 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' CB ' HD22 ' A' ' 43' ' ' LEU . . . -62.85 117.76 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.036 -0.529 . . . . 1.0900000000000001 111.779 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 74' ' ' PHE . 3.9 mp -92.35 110.82 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.615 -0.72 . . . . 1.1299999999999999 110.422 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.0 m -46.95 -39.04 11.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.919 0.39 . . . . 1.1299999999999999 110.655 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.1 m 61.46 89.13 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.504 . . . . 1.5700000000000001 110.91 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.543 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.4 -82.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 3.7000000000000002 110.672 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.543 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 11.7 p-10 -96.02 30.28 2.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.752 -0.658 . . . . 2.1400000000000001 110.653 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.268 ' CG ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 2.0600000000000001 112.036 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.559 0.219 . . . . 1.26 110.657 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.74 151.57 68.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 2.0 111.773 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.71 164.62 12.1 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.907 2.405 . . . . 0.58999999999999997 112.043 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.33 -164.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.501 2.134 . . . . 1.6100000000000001 112.637 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.34 -153.59 27.95 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.939 -0.648 . . . . 0.97999999999999998 113.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 125.05 61.7 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.407 0.146 . . . . 2.04 111.008 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 23.3 Cg_exo -66.52 130.89 24.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.489 2.126 . . . . 0.54000000000000004 112.327 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.05 98.42 17.38 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.163 -0.471 . . . . 1.6799999999999999 111.19 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.9 Cg_exo -47.14 130.41 16.58 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.64000000000000001 113.081 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 21' ' ' LYS . 2.2 mt -90.71 -30.75 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.055 -0.721 . . . . 2.1699999999999999 109.055 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.49 119.65 6.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.167 -0.924 . . . . 0.84999999999999998 109.218 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.923 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -117.39 122.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 1.5700000000000001 112.448 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.939 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -124.52 160.5 28.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.831 . . . . 1.46 110.237 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -59.02 -13.97 8.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.394 0.516 . . . . 2.9100000000000001 112.394 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.425 ' O ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -140.44 23.9 2.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.285 0.476 . . . . 1.3300000000000001 112.285 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -175.98 113.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.841 0.353 . . . . 1.28 110.232 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HG23 ' A' ' 13' ' ' ILE . 44.7 t -116.24 99.28 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.153 0.427 . . . . 1.49 112.153 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 46.1 m -83.66 144.85 29.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 1.1399999999999999 110.68 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -148.55 163.97 35.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.649 0.737 . . . . 1.3100000000000001 112.499 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 28.4 tptp -145.58 137.86 25.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.595 -1.184 . . . . 2.3100000000000001 109.601 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.486 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 37.4 p90 -133.81 177.93 7.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.183 0.516 . . . . 0.40000000000000002 111.709 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.3 -163.95 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 1.1100000000000001 110.838 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -128.68 140.38 38.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.901 -0.59 . . . . 2.5600000000000001 110.185 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.505 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 95.9 Cg_exo -39.05 161.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.166 . . . . 1.1100000000000001 112.2 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.44 -43.22 5.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -108.91 -70.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.482 0.549 . . . . 1.6899999999999999 112.482 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 19.5 p 55.77 40.78 30.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.429 . . . . 1.3500000000000001 109.951 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.67 -100.21 0.02 OUTLIER Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.804 -0.635 . . . . 1.01 112.53 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.35 27.62 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.295 -0.722 . . . . 0.97999999999999998 111.295 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -111.85 -171.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.98999999999999999 111.267 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.29 35.3 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 2.6899999999999999 111.24 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.831 HG13 ' HH ' ' A' ' 36' ' ' TYR . 2.9 mm 59.44 158.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.465 -0.334 . . . . 1.71 110.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -138.87 1.74 2.1 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.656 0.613 . . . . 1.6599999999999999 112.656 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t 168.59 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.7 0.286 . . . . 1.97 111.539 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.831 ' HH ' HG13 ' A' ' 33' ' ' ILE . 36.9 m-85 -99.82 87.06 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.113 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 1.1 mp -73.74 120.47 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 1.76 110.796 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.15 107.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.111 0.481 . . . . 1.6100000000000001 111.563 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.82 139.24 31.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 1.6699999999999999 110.616 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' CE ' ' HB3' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -108.12 138.93 43.54 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.904 0.383 . . . . 2.4399999999999999 111.568 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -119.12 97.41 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.564 -0.902 . . . . 1.79 108.564 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.843 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -65.48 97.16 0.28 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.403 -0.817 . . . . 1.5900000000000001 110.603 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' HD2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -69.3 148.01 97.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 1.4299999999999999 110.837 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -93.93 32.22 11.17 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.966 -1.264 . . . . 1.47 112.861 0.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.79 64.63 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.754 0.311 . . . . 2.6600000000000001 111.547 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.843 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -95.85 -174.77 36.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 1.6200000000000001 112.032 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 26.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 3.0600000000000001 110.777 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.572 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.8 m95 41.38 88.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.099 0.476 . . . . 1.0600000000000001 111.202 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 137.86 54.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.8400000000000001 111.27 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 1.4 mtmt -53.89 129.14 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 1.77 110.4 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . . . -110.29 -31.55 7.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 1.4099999999999999 110.645 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.7 p-10 -57.18 -43.31 82.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 2.0099999999999998 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.87 25.08 10.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 2.6400000000000001 110.766 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -169.77 3.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 2.0299999999999998 110.956 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -94.9 116.08 28.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.8700000000000001 110.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.505 HG22 HD11 ' A' ' 56' ' ' ILE . 27.1 mt -105.71 90.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.54 . . . . 1.3700000000000001 110.636 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mt -74.62 -61.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 2.1499999999999999 111.336 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -75.02 159.16 32.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.934 0.397 . . . . 1.54 110.621 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.486 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -74.85 -3.22 30.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 1.75 111.039 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 1.7 tt0 -100.46 103.53 14.89 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.413 -0.588 . . . . 2.0499999999999998 109.413 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 60.9 t80 -140.19 165.35 27.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.56999999999999995 111.779 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 8.1 m -121.29 114.78 21.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 1.1399999999999999 111.391 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.71 90.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.143 0.497 . . . . 1.72 111.041 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.67 151.69 19.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.6399999999999999 111.0 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.34 14.65 7.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.95999999999999996 112.354 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 72' ' ' TYR . 3.6 mm? -58.25 -179.67 0.06 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.132 0.491 . . . . 2.02 111.357 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 m -133.37 109.23 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.589 -0.732 . . . . 1.55 110.199 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.91 135.7 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.087 -0.506 . . . . 1.9099999999999999 111.816 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 97' ' ' CYS . 9.5 m-20 65.64 62.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.8700000000000001 111.215 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -174.7 114.74 0.17 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.509 -0.314 . . . . 1.2 111.588 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -64.18 135.34 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.731 -0.47 . . . . 1.1100000000000001 109.731 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 33.3 m-85 -128.61 121.51 28.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.162 0.801 . . . . 1.0800000000000001 113.162 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.3 133.7 43.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.618 -1.253 . . . . 1.5 107.618 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 7.8 m-85 -117.94 114.87 23.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.138 1.532 . . . . 0.79000000000000004 115.138 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HD3' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -100.72 135.34 42.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.193 -0.912 . . . . 2.6899999999999999 108.998 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -108.24 127.39 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 119.288 -0.965 . . . . 1.5700000000000001 111.721 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 78' ' ' ALA . 94.1 mt -115.52 143.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.811 -1.086 . . . . 1.3200000000000001 108.126 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -156.11 134.45 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.833 -0.747 . . . . 1.1100000000000001 112.395 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -84.85 -178.6 6.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.28 -0.568 . . . . 2.3500000000000001 110.626 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.3 p-10 -127.84 -173.23 2.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.36 -0.836 . . . . 2.7000000000000002 110.104 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -69.66 -11.96 61.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.041 -0.527 . . . . 1.3400000000000001 112.095 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' HB1' ' ND2' ' A' ' 80' ' ' ASN . . . -104.01 -4.23 23.6 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.228 0.455 . . . . 1.4299999999999999 112.228 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.98 87.93 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.452 -0.88 . . . . 1.3799999999999999 113.291 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 71.98 3.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.341 0.591 . . . . 1.49 109.951 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.9 tt -36.56 123.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.96 1.096 . . . . 1.48 113.96 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 9.6 p -76.2 107.81 5.12 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.372 -1.344 . . . . 0.81000000000000005 107.372 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 14.6 Cg_endo -55.18 171.4 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.592 2.194 . . . . 1.25 113.454 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 48.0 Cg_exo -31.95 122.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.973 3.115 . . . . 1.2 113.317 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 90' ' ' GLU . 4.1 p -106.85 103.82 13.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 1.76 110.121 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 9.98 113.85 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 125.045 1.466 . . . . 1.77 113.416 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 15.4 Cg_exo -68.31 162.39 40.67 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.88 1.72 . . . . 1.01 114.292 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.82 152.75 18.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.153 -0.93 . . . . 1.55 109.345 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -33.75 156.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.112 0.882 . . . . 1.6299999999999999 112.294 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -90.64 103.3 16.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 1.0900000000000001 111.363 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 13' ' ' ILE . 5.0 mp -82.81 110.24 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 1.1299999999999999 111.497 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 90.8 m -48.74 -35.37 14.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.13 0.491 . . . . 1.1299999999999999 110.612 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.408 ' CA ' ' HA ' ' A' ' 15' ' ' ARG . 91.7 m 56.93 79.6 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.673 -0.694 . . . . 1.5700000000000001 111.046 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -87.68 0.47 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.506 -0.315 . . . . 3.7000000000000002 111.381 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -111.17 0.43 16.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.426 -0.352 . . . . 2.1400000000000001 111.666 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.939 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.907 0.385 . . . . 2.0600000000000001 111.215 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.986 0.422 . . . . 1.26 111.434 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.432 ' N ' HG12 ' A' ' 2' ' ' ILE . 5.1 m-20 -122.02 142.97 37.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 2.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HG3' ' HG2' ' A' ' 87' ' ' PRO . 91.3 Cg_endo -80.53 168.64 17.84 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.569 2.179 . . . . 0.58999999999999997 112.402 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 174.29 2.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.654 2.236 . . . . 1.6100000000000001 112.898 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.4 177.12 40.61 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.97999999999999998 112.493 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.0 tttt -60.77 127.53 87.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.533 -0.173 . . . . 2.04 110.533 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 7.0 Cg_exo -74.29 156.89 46.13 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.352 2.035 . . . . 0.54000000000000004 112.074 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.7 p -152.47 114.56 2.85 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.415 -0.357 . . . . 1.6799999999999999 111.677 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 25.6 Cg_exo -61.44 111.31 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.691 2.26 . . . . 0.64000000000000001 113.405 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD22 ' OE2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -69.58 -33.85 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.661 -0.866 . . . . 2.1699999999999999 108.661 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.871 -1.059 . . . . 0.84999999999999998 108.995 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 13' ' ' ILE . 2.6 pt -133.98 105.3 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 1.5700000000000001 112.041 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 151.23 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.7 -0.682 . . . . 1.46 110.35 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -16.06 30.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.422 . . . . 2.9100000000000001 111.439 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' A' ' 17' ' ' THR . 6.1 m-70 -132.29 16.96 4.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.48 0.181 . . . . 1.3300000000000001 111.464 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -176.27 106.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.946 0.403 . . . . 1.28 110.917 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.48 HG13 ' CE2' ' A' ' 74' ' ' PHE . 49.7 t -102.57 117.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.966 -0.561 . . . . 1.49 110.971 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.425 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 19.8 m -98.33 128.9 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 1.1399999999999999 111.571 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.77 156.47 46.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.935 0.874 . . . . 1.3100000000000001 112.412 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.909 ' HG2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -124.71 -170.45 2.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.04 -1.437 . . . . 2.3100000000000001 109.219 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.485 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.7 p90 -179.83 161.14 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.40000000000000002 111.836 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.77 168.06 19.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 1.1100000000000001 111.797 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.27 141.42 32.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.53 -0.759 . . . . 2.5600000000000001 110.236 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.435 ' CG ' HG23 ' A' ' 28' ' ' THR . 4.5 Cg_endo -46.51 166.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.369 2.046 . . . . 1.1100000000000001 111.716 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -102.93 -55.62 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.238 -0.437 . . . . 2.77 111.518 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -113.15 61.92 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.567 -0.288 . . . . 1.6899999999999999 111.331 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.49 ' O ' ' CE2' ' A' ' 31' ' ' PHE . 44.4 p -57.68 -25.08 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.709 0.29 . . . . 1.3500000000000001 110.452 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.09 -65.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.579 -0.819 . . . . 1.01 111.886 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 40.09 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.991 -1.244 . . . . 0.97999999999999998 109.991 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -137.87 -176.92 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.087 -0.557 . . . . 0.98999999999999999 111.024 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 15.21 1.66 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.5 0.556 . . . . 2.6899999999999999 112.5 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.1 mp 64.22 -74.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 111.905 0.335 . . . . 1.71 111.905 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p 79.53 21.43 0.6 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.573 -0.285 . . . . 1.6599999999999999 111.696 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER 169.96 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.924 -0.126 . . . . 1.97 111.232 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.8 m-85 -118.06 128.71 55.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.94 0.4 . . . . 1.23 112.001 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -119.4 120.67 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.513 -0.312 . . . . 1.76 110.433 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -105.69 140.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.879 0.371 . . . . 1.6100000000000001 110.813 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.96 135.52 43.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.259 0.552 . . . . 1.6699999999999999 111.966 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 49' ' ' LEU . 1.4 mtmp? -101.26 139.19 37.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.273 -0.876 . . . . 2.4399999999999999 111.336 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.556 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 7.6 ptt180 -132.63 115.65 15.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.454 0.645 . . . . 1.79 109.84 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -75.65 113.11 12.72 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.123 -0.944 . . . . 1.5900000000000001 111.053 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 44' ' ' PRO . 2.5 mm? -73.58 161.04 80.76 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 1.4299999999999999 110.412 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 80.6 Cg_endo -83.8 14.89 33.18 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 124.115 -1.202 . . . . 1.47 113.427 0.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -98.65 -77.81 0.51 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.938 -0.393 . . . . 2.6600000000000001 109.938 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' CA ' ' HB2' ' A' ' 41' ' ' ARG . . . 92.22 130.81 5.26 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.633 -0.794 . . . . 1.6200000000000001 113.206 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 1.68 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.64 0.237 . . . . 3.0600000000000001 111.64 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.557 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 40.4 m95 44.31 94.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.205 0.202 . . . . 1.0600000000000001 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 40' ' ' LYS . 1.4 mp -123.62 135.55 54.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.955 0.407 . . . . 1.8400000000000001 111.615 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -62.99 82.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 1.77 110.662 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.401 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -49.11 -53.94 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 1.4099999999999999 111.231 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -60.31 138.28 57.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 2.0099999999999998 111.06 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -136.77 23.07 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 2.6400000000000001 111.031 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 t -120.73 -83.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 2.0299999999999998 110.72 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 178.48 120.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 1.8700000000000001 110.86 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.49 HG12 ' CD1' ' A' ' 61' ' ' PHE . 14.0 mt -107.02 98.99 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 1.3700000000000001 110.986 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -76.68 -68.25 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 2.1499999999999999 111.087 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -74.85 -179.12 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 1.54 110.65 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.9 OUTLIER -86.93 -2.91 58.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 1.75 111.482 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.909 ' CD ' ' HG2' ' A' ' 21' ' ' LYS . 9.0 tp10 -97.42 101.86 13.49 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.749 0.309 . . . . 2.0499999999999998 110.179 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.517 ' CG ' ' N ' ' A' ' 62' ' ' THR . 40.3 t80 -135.81 165.49 25.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.055 0.455 . . . . 0.56999999999999995 111.584 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.517 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 5.7 m -122.21 120.69 34.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.758 -0.655 . . . . 1.1399999999999999 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' A' ' 20' ' ' LEU . 4.8 t -85.77 112.07 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.995 -0.548 . . . . 1.72 111.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -173.38 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 1.6399999999999999 110.944 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.8 9.58 71.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.747 . . . . 0.95999999999999996 112.847 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 72' ' ' TYR . 1.6 mt -61.72 -177.19 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 2.02 110.83 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.801 HG21 ' HH ' ' A' ' 72' ' ' TYR . 3.8 t -138.93 11.49 2.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.026 0.38 . . . . 1.55 112.026 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.9 159.31 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.006 0.432 . . . . 1.9099999999999999 111.382 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 45.76 66.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 1.8700000000000001 111.368 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 174.76 119.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.251 -0.431 . . . . 1.2 111.067 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.83 132.82 55.12 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.205 -0.598 . . . . 1.1100000000000001 110.281 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.801 ' HH ' HG21 ' A' ' 67' ' ' THR . 25.0 m-85 -130.34 121.0 25.2 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.003 0.742 . . . . 1.0800000000000001 113.003 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 92' ' ' SER . 2.4 tt0 -102.66 141.05 36.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.516 -0.55 . . . . 1.5 109.516 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -137.65 128.01 26.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.126 1.158 . . . . 0.79000000000000004 114.126 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.557 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -111.32 160.98 16.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.31 -0.626 . . . . 2.6899999999999999 109.31 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG23 ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -121.3 112.32 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.057 -0.657 . . . . 1.5700000000000001 111.955 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -105.05 179.81 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.237 -0.892 . . . . 1.3200000000000001 108.852 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -179.37 -162.59 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.106 0.479 . . . . 1.1100000000000001 111.395 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.7 mttt -136.85 -171.53 2.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.275 -1.009 . . . . 2.3500000000000001 108.275 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 8.8 p-10 -135.72 156.62 48.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.056 0.455 . . . . 2.7000000000000002 110.54 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -39.35 -29.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.601 -0.727 . . . . 1.3400000000000001 112.084 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -77.07 -24.5 51.88 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.815 0.672 . . . . 1.4299999999999999 112.815 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 112.29 -11.5 26.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.431 -0.89 . . . . 1.3799999999999999 112.341 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . -59.89 -156.63 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.958 -0.386 . . . . 1.49 109.958 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -145.15 114.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.059 0.762 . . . . 1.48 113.059 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 52.1 p -64.71 109.91 3.43 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.81000000000000005 107.028 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 12.3 Cg_endo -54.48 147.63 46.8 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.159 1.906 . . . . 1.25 112.767 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 47.8 Cg_exo -37.22 120.53 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.378 2.719 . . . . 1.2 113.666 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 90' ' ' GLU . 28.2 p -87.21 101.98 14.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.05 -0.523 . . . . 1.76 110.128 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.8 tt0 0.41 111.05 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.991 1.316 . . . . 1.77 114.292 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 51.9 Cg_exo -48.61 167.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.156 1.904 . . . . 1.01 113.19 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -105.91 143.88 33.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.064 -0.971 . . . . 1.55 109.038 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -28.36 144.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.187 0.929 . . . . 1.6299999999999999 112.555 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' TYR . . . -79.67 111.02 15.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.0900000000000001 110.911 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.8 120.29 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 1.1299999999999999 111.7 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.7 m -57.82 -13.02 3.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.812 -0.631 . . . . 1.1299999999999999 112.408 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 26.4 p 43.77 70.62 0.3 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.887 0.375 . . . . 1.5700000000000001 111.287 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -101.1 -87.95 0.38 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.982 -0.554 . . . . 3.7000000000000002 111.187 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.38 8.61 7.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 2.1400000000000001 111.485 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.9 t0 . . . . . 0 C--N 1.334 -0.108 0 CA-C-O 120.844 0.354 . . . . 2.0600000000000001 110.93 -179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.475 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 7.3 tt . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 121.464 0.65 . . . . 1.26 112.341 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -134.22 119.71 14.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 2.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 88.2 Cg_endo -75.8 171.35 18.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.501 2.134 . . . . 0.58999999999999997 112.79 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 45.6 Cg_exo -56.72 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.805 2.337 . . . . 1.6100000000000001 112.556 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 -171.33 39.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.85 -0.691 . . . . 0.97999999999999998 112.576 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 33.8 tttt -73.76 128.96 85.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.369 0.128 . . . . 2.04 110.825 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 20.4 Cg_exo -69.19 143.92 55.24 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.54000000000000004 112.713 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.19 97.41 5.23 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 1.6799999999999999 110.586 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.3 Cg_exo -50.14 128.82 23.51 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.252 1.968 . . . . 0.64000000000000001 113.493 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 21' ' ' LYS . 2.8 mm? -83.97 -35.43 23.97 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.184 -1.043 . . . . 2.1699999999999999 108.184 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.48 37.32 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.583 -1.19 . . . . 0.84999999999999998 107.891 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.438 ' CG2' HG12 ' A' ' 18' ' ' VAL . 2.1 pt -136.35 102.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.778 0.659 . . . . 1.5700000000000001 112.778 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 144.3 33.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.33 -0.85 . . . . 1.46 110.173 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -46.33 -23.69 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.693 -0.685 . . . . 2.9100000000000001 112.78 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 7.8 m170 -125.9 -1.59 7.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.505 0.557 . . . . 1.3300000000000001 112.505 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 p -157.91 115.23 2.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.943 0.401 . . . . 1.28 110.487 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.439 ' HB ' ' CG2' ' A' ' 63' ' ' VAL . 57.9 t -119.0 114.57 45.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 1.49 112.032 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 12.7 m -83.34 146.82 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 1.1399999999999999 109.928 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.28 160.17 43.38 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.847 0.684 . . . . 1.3100000000000001 112.847 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' CB ' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.49 147.92 32.69 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.854 -1.066 . . . . 2.3100000000000001 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.481 ' CZ3' ' O ' ' A' ' 59' ' ' ASN . 26.4 p90 -142.68 -177.8 5.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.40000000000000002 111.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 176.62 7.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 1.1100000000000001 112.049 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -115.95 143.33 30.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.742 -0.663 . . . . 2.5600000000000001 110.899 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 73.5 Cg_exo -51.55 -179.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.531 2.154 . . . . 1.1100000000000001 112.426 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 1.157 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 3.1 pm0 -125.69 -35.27 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 2.77 111.927 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -106.73 -69.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.173 0.434 . . . . 1.6899999999999999 112.173 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 40.9 p 56.2 40.42 30.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 1.3500000000000001 110.426 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.22 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.873 -0.68 . . . . 1.01 112.109 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.34 35.0 1.59 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.362 -1.095 . . . . 0.97999999999999998 110.362 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 3.1 m-85 -113.16 -178.11 3.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.812 -0.694 . . . . 0.98999999999999999 111.71 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 1.41 2.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.697 -0.683 . . . . 2.6899999999999999 112.224 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' CE1' ' A' ' 36' ' ' TYR . 7.3 mt 57.97 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.117 0.484 . . . . 1.71 111.769 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -132.79 6.97 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.021 -0.536 . . . . 1.6599999999999999 111.997 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -179.41 142.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.865 0.364 . . . . 1.97 111.474 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . 35.6 m-85 -113.85 109.6 18.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.844 -0.617 . . . . 1.23 111.423 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.29 104.6 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.76 110.63 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.4 p -99.3 119.0 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 1.6100000000000001 111.209 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -80.12 163.08 24.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.649 -0.705 . . . . 1.6699999999999999 111.236 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -118.82 168.07 11.11 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.658 -0.701 . . . . 2.4399999999999999 109.285 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -156.94 87.05 0.98 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.793 -0.763 . . . . 1.79 111.386 177.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.842 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -66.51 85.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 1.5900000000000001 110.963 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -61.94 159.4 36.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.136 -0.484 . . . . 1.4299999999999999 110.595 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.9 Cg_exo -80.83 21.67 9.18 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.261 -1.141 . . . . 1.47 113.703 0.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.41 -85.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.027 -0.269 . . . . 2.6600000000000001 110.536 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.94 -164.7 0.02 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.073 -0.584 . . . . 1.6200000000000001 112.945 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.51 145.07 3.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 3.0600000000000001 110.491 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 53.7 m95 -65.58 77.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.638 -0.71 . . . . 1.0600000000000001 111.786 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HB2' ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -112.78 156.65 22.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.998 -0.547 . . . . 1.8400000000000001 109.855 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -50.25 90.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.689 0.281 . . . . 1.77 111.24 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -60.2 -31.63 70.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.29 0.567 . . . . 1.4099999999999999 109.514 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.528 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 12.9 p-10 -91.69 -145.41 0.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.289 -0.868 . . . . 2.0099999999999998 110.492 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 175.85 -33.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.86 0.362 . . . . 2.6400000000000001 110.194 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -91.92 171.53 9.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 2.0299999999999998 110.738 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.63 105.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.8700000000000001 111.086 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 56' ' ' ILE . 14.4 mt -87.98 53.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 1.3700000000000001 110.306 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 3.3 tm? -44.2 -54.6 5.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.978 -0.556 . . . . 2.1499999999999999 111.233 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -84.07 158.95 21.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.089 -0.505 . . . . 1.54 109.974 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.481 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 12.4 p30 -80.37 4.68 17.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.43 -0.35 . . . . 1.75 111.587 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -98.38 94.34 6.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.013 -0.736 . . . . 2.0499999999999998 109.013 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 74.3 t80 -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.142 0.496 . . . . 0.56999999999999995 112.052 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.507 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 10.9 m -133.74 109.62 9.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.567 -0.742 . . . . 1.1399999999999999 110.954 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 18' ' ' VAL . 27.8 m -67.42 114.31 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 1.72 111.238 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.42 129.44 55.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.892 -0.594 . . . . 1.6399999999999999 111.21 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.21 6.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.95999999999999996 112.857 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.33 -158.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 2.02 110.548 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.6 m -138.04 147.78 44.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.496 -0.32 . . . . 1.55 110.181 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -82.5 142.01 32.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 1.9099999999999999 111.332 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t0 65.94 60.08 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.547 . . . . 1.8700000000000001 111.36 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.66 128.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 1.2 110.919 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -59.81 143.53 50.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.806 0.336 . . . . 1.1100000000000001 110.422 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 66' ' ' LEU . 2.0 m-85 -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.529 0.566 . . . . 1.0800000000000001 112.529 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 91' ' ' PRO . 6.5 tp10 -101.54 140.55 35.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.018 -0.734 . . . . 1.5 109.018 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 91' ' ' PRO . 8.6 m-85 -123.82 110.54 15.02 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.668 0.988 . . . . 0.79000000000000004 113.668 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -90.32 159.83 16.43 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.636 -0.711 . . . . 2.6899999999999999 109.962 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 47.8 t -130.7 120.7 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.536 0.939 . . . . 1.5700000000000001 113.536 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.432 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 55.6 mt -123.33 153.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.703 -1.591 . . . . 1.3200000000000001 106.703 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -173.21 123.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.417 -1.313 . . . . 1.1100000000000001 113.937 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.4 mttt -68.21 158.8 32.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.205 -1.035 . . . . 2.3500000000000001 108.205 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.6 m-80 -99.8 -91.35 0.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.843 -0.743 . . . . 2.7000000000000002 111.805 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -133.89 -42.63 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.276 0.472 . . . . 1.3400000000000001 112.276 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -95.05 40.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.33 0.493 . . . . 1.4299999999999999 112.33 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.73 8.72 41.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 1.3799999999999999 113.196 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -77.75 92.66 4.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.0 0.4 . . . . 1.49 109.947 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -62.71 107.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.28 0.474 . . . . 1.48 112.28 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 8.3 p -62.89 121.92 71.46 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.005 -0.739 . . . . 0.81000000000000005 109.005 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.59 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.266 . . . . 1.25 112.624 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 4.2 Cg_exo -73.3 155.37 51.34 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.822 2.348 . . . . 1.2 112.829 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.26 135.34 53.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.626 -0.715 . . . . 1.76 110.304 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.4 tt0 -35.24 110.89 0.42 Allowed Pre-proline 0 N--CA 1.469 0.503 0 O-C-N 124.0 0.812 . . . . 1.77 111.848 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 75.3 Cg_exo -50.96 145.46 24.55 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.827 2.351 . . . . 1.01 114.4 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.62 149.86 41.76 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.608 -0.886 . . . . 1.55 108.608 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -34.12 155.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.076 0.86 . . . . 1.6299999999999999 112.093 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -89.31 110.82 21.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 1.0900000000000001 111.847 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 13' ' ' ILE . 5.2 mp -88.22 112.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 111.167 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.444 HG22 ' NH1' ' A' ' 98' ' ' ARG . 85.6 m -42.77 -29.9 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.004 0.43 . . . . 1.1299999999999999 110.87 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 84.7 m 51.07 69.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 1.5700000000000001 110.439 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' NH1' HG22 ' A' ' 96' ' ' THR . 1.5 ptp85 -111.87 -87.51 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 3.7000000000000002 110.824 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 1.2 p30 -123.49 0.27 8.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.111 -0.495 . . . . 2.1400000000000001 110.884 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.2 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 2.0600000000000001 111.71 -179.886 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.477 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 1.9 tt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.818 0.342 . . . . 1.26 110.89 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 2' ' ' ILE . 9.8 m-20 -130.12 135.08 26.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 2.0 110.193 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -83.3 175.16 8.5 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.558 2.172 . . . . 0.58999999999999997 112.837 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -65.18 171.64 8.71 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.914 2.409 . . . . 1.6100000000000001 112.676 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.74 173.04 53.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.007 -0.616 . . . . 0.97999999999999998 112.831 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 tttt -63.9 123.23 81.12 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.498 0.149 . . . . 2.04 110.677 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 34.8 Cg_exo -65.27 131.1 27.25 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.453 2.102 . . . . 0.54000000000000004 112.699 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 108.01 20.74 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.007 -0.542 . . . . 1.6799999999999999 110.575 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 39.0 Cg_exo -58.94 115.07 2.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.471 2.114 . . . . 0.64000000000000001 113.976 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -77.71 -38.43 47.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.885 -0.783 . . . . 2.1699999999999999 108.885 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.73 145.36 49.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.8 -1.091 . . . . 0.84999999999999998 108.701 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.412 ' CG2' HG12 ' A' ' 18' ' ' VAL . 1.7 pt -141.0 97.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.598 0.592 . . . . 1.5700000000000001 112.598 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.96 147.7 23.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.643 -0.708 . . . . 1.46 109.34 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -53.5 -18.28 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.226 0.454 . . . . 2.9100000000000001 112.226 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.442 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 2.5 m-70 -126.78 -4.22 6.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.272 0.471 . . . . 1.3300000000000001 112.272 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 116.46 5.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.873 0.368 . . . . 1.28 111.107 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' CE2' ' A' ' 74' ' ' PHE . 66.6 t -105.25 134.41 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.009 0.433 . . . . 1.49 111.167 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.0 m -111.96 122.47 47.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 1.1399999999999999 110.669 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.98 149.23 52.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.753 0.787 . . . . 1.3100000000000001 112.203 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.919 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 7.0 tptt -133.09 139.01 46.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.427 -1.261 . . . . 2.3100000000000001 109.704 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.9 p90 -128.64 -174.98 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.056 0.455 . . . . 0.40000000000000002 111.881 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.23 179.33 5.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 1.1100000000000001 112.044 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD3' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -107.88 138.68 20.13 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 2.5600000000000001 110.221 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 79.9 Cg_exo -44.21 171.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.418 2.079 . . . . 1.1100000000000001 112.613 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -110.89 -25.06 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 2.77 111.992 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.51 -69.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.158 0.429 . . . . 1.6899999999999999 112.158 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 64.4 p 51.37 56.22 8.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 1.3500000000000001 110.704 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.12 -93.46 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.966 -0.561 . . . . 1.01 112.844 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.02 32.95 1.05 Allowed Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.008 -1.237 . . . . 0.97999999999999998 110.008 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -114.99 179.54 3.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.738 -0.731 . . . . 0.98999999999999999 111.009 -178.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.34 -3.17 3.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.179 -0.464 . . . . 2.6899999999999999 112.185 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 3.1 mt 61.27 138.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.921 0.391 . . . . 1.71 110.606 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -140.78 24.72 2.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 1.6599999999999999 111.525 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.2 m -166.51 102.69 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 1.97 111.618 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -98.12 115.64 28.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 1.23 110.454 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.63 112.71 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.76 111.199 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -101.54 114.59 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 1.6100000000000001 110.74 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -79.6 151.24 30.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.522 -0.763 . . . . 1.6699999999999999 110.347 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -121.27 140.13 52.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 2.4399999999999999 111.168 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 9.5 ttp180 -121.73 116.4 24.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.79 110.371 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.716 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -76.57 102.69 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 1.5900000000000001 110.798 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 71' ' ' ALA . 1.6 mm? -88.65 156.83 50.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.531 -0.304 . . . . 1.4299999999999999 110.738 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -91.54 36.27 6.24 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.152 -1.187 . . . . 1.47 112.377 0.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -165.47 83.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 2.6600000000000001 111.163 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.716 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -155.74 -164.82 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.913 -0.661 . . . . 1.6200000000000001 112.207 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.77 172.57 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 3.0600000000000001 111.279 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.552 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 68.4 m95 -78.8 118.36 20.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.57 -0.741 . . . . 1.0600000000000001 112.212 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.37 127.03 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.8400000000000001 110.649 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.24 99.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 1.77 111.625 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -62.31 -38.37 89.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.246 0.546 . . . . 1.4099999999999999 110.338 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.5 p-10 -70.4 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.0099999999999998 110.963 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 172.44 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.76 0.314 . . . . 2.6400000000000001 110.461 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -81.33 -159.77 0.29 Allowed 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.35 -0.386 . . . . 2.0299999999999998 110.641 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.94 97.83 7.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 1.8700000000000001 111.05 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 61' ' ' PHE . 28.8 mt -81.25 87.94 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 1.3700000000000001 111.127 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.45 -53.74 9.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 2.1499999999999999 111.074 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.64 164.82 21.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.54 110.562 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.505 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -81.21 4.55 19.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.46 . . . . 1.75 111.644 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.919 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.9 tp10 -106.93 96.21 6.27 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 120.802 0.335 . . . . 2.0499999999999998 110.179 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 67.3 t80 -124.43 164.36 19.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.56999999999999995 111.298 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.0 m -132.14 114.06 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 1.1399999999999999 110.959 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.6 m -76.21 133.05 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.72 111.064 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 133.01 49.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.973 -0.558 . . . . 1.6399999999999999 110.949 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.89 -2.16 4.76 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.683 -0.77 . . . . 0.95999999999999996 113.145 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.38 -173.67 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.975 0.417 . . . . 2.02 111.232 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -139.76 141.61 36.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.806 -0.634 . . . . 1.55 110.634 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -64.57 146.51 54.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.283 -0.417 . . . . 1.9099999999999999 111.095 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 5.9 m-20 63.83 57.36 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 1.8700000000000001 111.344 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -171.03 124.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.706 0.289 . . . . 1.2 111.611 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 43' ' ' LEU . . . -66.4 138.07 57.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.522 -0.308 . . . . 1.1100000000000001 110.172 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 39.9 m-85 -133.71 117.57 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.448 0.536 . . . . 1.0800000000000001 112.448 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -98.72 144.2 28.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.906 -0.776 . . . . 1.5 108.906 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -135.59 115.39 12.98 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.24 1.2 . . . . 0.79000000000000004 114.24 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.2 ptp180 -105.59 177.97 4.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.987 -1.116 . . . . 2.6899999999999999 107.987 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -154.24 126.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 122.257 1.027 . . . . 1.5700000000000001 113.225 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.447 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 11.3 mt -105.45 152.99 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 1.3200000000000001 106.958 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.421 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -160.11 135.92 8.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.01 -1.076 . . . . 1.1100000000000001 112.762 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 5.5 mttt -80.16 -169.63 2.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.526 -0.761 . . . . 2.3500000000000001 110.384 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 3.7 p30 -135.54 171.74 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.195 0.522 . . . . 2.7000000000000002 111.336 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -47.94 -25.07 1.22 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.754 . . . . 1.3400000000000001 111.859 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -86.15 -20.67 28.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.267 0.469 . . . . 1.4299999999999999 112.267 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 110.32 -18.37 28.02 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.279 -0.962 . . . . 1.3799999999999999 112.319 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -62.09 144.35 55.41 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 110.203 -0.295 . . . . 1.49 110.203 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -94.17 117.8 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 1.48 112.008 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -78.77 127.94 78.54 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.549 -0.75 . . . . 0.81000000000000005 110.259 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -34.69 159.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.592 2.861 . . . . 1.25 114.076 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 6.2 Cg_exo -74.28 138.74 25.37 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.06 2.507 . . . . 1.2 112.555 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.1 p -88.76 130.47 35.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.132 -0.485 . . . . 1.76 110.016 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -34.53 122.51 0.55 Allowed Pre-proline 0 N--CA 1.469 0.478 0 O-C-N 123.743 0.652 . . . . 1.77 112.338 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 33.7 Cg_exo -55.97 145.58 73.39 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.456 2.104 . . . . 1.01 113.345 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.12 149.12 35.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.048 -0.723 . . . . 1.55 109.048 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.0 142.26 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.829 0.705 . . . . 1.6299999999999999 112.128 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.09 112.69 14.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.761 -0.654 . . . . 1.0900000000000001 110.606 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.11 118.16 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.145 -0.48 . . . . 1.1299999999999999 111.252 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.7 m -48.51 -37.83 18.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 1.1299999999999999 111.202 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 69' ' ' ASP . 66.9 m 55.49 90.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.809 0.338 . . . . 1.5700000000000001 110.767 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.65 -86.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 3.7000000000000002 110.378 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.847 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -107.8 -11.09 15.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 2.1400000000000001 110.849 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.209 -0.45 . . . . 2.0600000000000001 111.716 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.74 0.305 . . . . 1.26 111.245 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -128.65 148.45 68.47 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0 111.551 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 85.0 Cg_endo -83.38 160.12 14.94 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.98 2.453 . . . . 0.58999999999999997 112.937 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.4 Cg_endo -54.64 -176.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.898 2.399 . . . . 1.6100000000000001 112.378 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -176.45 51.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.901 -0.666 . . . . 0.97999999999999998 112.492 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 128.05 86.93 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.412 -0.218 . . . . 2.04 110.412 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 14.2 Cg_exo -72.28 126.72 11.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.297 1.998 . . . . 0.54000000000000004 112.872 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.73 105.99 50.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.613 -0.721 . . . . 1.6799999999999999 109.502 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.6 Cg_exo -43.12 92.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.364 2.043 . . . . 0.64000000000000001 113.98 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.74 -29.45 64.77 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.315 -0.857 . . . . 2.1699999999999999 109.335 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -159.99 153.35 22.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.161 -0.927 . . . . 0.84999999999999998 108.966 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 1.136 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 1.4 pt -142.72 141.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.361 0.6 . . . . 1.5700000000000001 112.446 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.634 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -138.56 142.91 39.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.154 -0.93 . . . . 1.46 109.886 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.429 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -44.92 -24.47 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.609 0.596 . . . . 2.9100000000000001 112.609 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -125.19 -6.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.402 0.519 . . . . 1.3300000000000001 112.402 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.11 111.09 5.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 1.28 110.92 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.43 ' CG1' HG23 ' A' ' 13' ' ' ILE . 69.6 t -106.1 122.02 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.49 111.514 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 6.8 m -99.38 135.47 40.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 1.1399999999999999 110.825 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.7 143.36 41.23 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.662 0.744 . . . . 1.3100000000000001 111.338 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -126.81 149.59 49.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.66 -1.155 . . . . 2.3100000000000001 110.011 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.1 p90 -143.61 -175.69 4.67 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.279 0.561 . . . . 0.40000000000000002 112.367 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.63 -174.03 4.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.1100000000000001 111.428 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -111.56 137.3 21.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 109.941 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 6.2 Cg_exo -36.12 153.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.245 2.63 . . . . 1.1100000000000001 112.736 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.06 -40.31 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 2.77 111.862 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -130.98 -63.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 1.6899999999999999 111.804 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.482 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.1 p 52.31 45.22 28.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 1.3500000000000001 110.793 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.25 -112.11 0.91 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.188 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.44 28.35 5.3 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.408 -1.077 . . . . 0.97999999999999998 110.408 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -114.07 173.97 6.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.159 -0.52 . . . . 0.98999999999999999 110.991 -178.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.72 10.4 2.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.6899999999999999 111.759 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 33' ' ' ILE . 2.6 mt 59.33 116.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.942 0.401 . . . . 1.71 111.103 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -109.25 28.81 8.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 1.6599999999999999 111.425 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.3 106.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.747 0.308 . . . . 1.97 111.329 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CE1' HG22 ' A' ' 33' ' ' ILE . 57.7 m-85 -94.38 124.74 38.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.901 0.381 . . . . 1.23 110.969 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 2.4 mm -97.23 142.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 1.76 109.594 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.86 94.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.754 -0.378 . . . . 1.6100000000000001 111.994 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.13 137.85 55.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.244 -0.651 . . . . 1.6699999999999999 109.244 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 134.67 53.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 2.4399999999999999 111.589 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 8.7 ttp180 -108.6 104.46 13.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.78 -0.646 . . . . 1.79 109.895 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.28 82.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 1.5900000000000001 110.665 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.486 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 3.6 mp -50.56 155.83 1.73 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.4299999999999999 111.088 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.34 32.71 7.58 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.653 -1.395 . . . . 1.47 112.836 0.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 -77.24 0.38 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.79 0.328 . . . . 2.6600000000000001 111.108 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . 51.16 -175.2 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.913 -0.661 . . . . 1.6200000000000001 112.82 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' CD ' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -162.92 30.54 0.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.962 0.41 . . . . 3.0600000000000001 110.646 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 71.2 m95 45.25 96.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 1.0600000000000001 111.59 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.01 123.55 29.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.841 -0.618 . . . . 1.8400000000000001 110.217 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -48.42 137.92 10.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.77 110.967 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.66 -36.51 2.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 1.4099999999999999 111.553 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.4 ' HB3' HD12 ' A' ' 56' ' ' ILE . 2.5 p-10 -41.75 -62.56 0.87 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.509 -0.314 . . . . 2.0099999999999998 111.696 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 t80 45.91 30.22 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.507 -0.315 . . . . 2.6400000000000001 111.39 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.41 30.36 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 2.0299999999999998 111.284 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.74 95.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.44 -0.345 . . . . 1.8700000000000001 111.337 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 7.5 mt -86.32 90.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 1.3700000000000001 111.246 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 -44.13 67.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 2.1499999999999999 111.158 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -100.13 153.36 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.92 0.39 . . . . 1.54 110.658 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 20.9 p-10 -66.3 -10.46 42.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 1.75 111.527 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG3' ' CG ' ' A' ' 21' ' ' LYS . 2.9 tt0 -93.77 99.19 11.63 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.938 -0.764 . . . . 2.0499999999999998 108.938 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 81.6 t80 -129.35 162.61 27.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.947 -0.701 . . . . 0.56999999999999995 112.596 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 71.8 m -125.16 114.52 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.198 -0.91 . . . . 1.1399999999999999 111.222 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.73 120.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.841 -0.618 . . . . 1.72 110.958 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -117.28 162.33 18.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.243 0.544 . . . . 1.6399999999999999 110.988 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.26 -2.22 31.19 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.381 -0.827 . . . . 0.95999999999999996 112.903 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -67.17 -176.1 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.077 0.465 . . . . 2.02 110.732 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.466 HG23 ' OH ' ' A' ' 72' ' ' TYR . 1.7 t -140.55 144.11 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.745 -0.661 . . . . 1.55 110.453 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 tt0 -64.55 144.28 57.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.25 -0.432 . . . . 1.9099999999999999 110.782 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.4 t0 71.76 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.8700000000000001 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -170.61 122.56 0.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.497 -0.32 . . . . 1.2 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -72.04 132.11 43.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 109.96 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' OH ' HG23 ' A' ' 67' ' ' THR . 52.1 m-85 -128.72 123.26 32.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.392 0.515 . . . . 1.0800000000000001 112.392 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -101.7 144.15 30.76 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.699 -0.852 . . . . 1.5 108.699 178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -130.51 114.93 16.11 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.27 1.582 . . . . 0.79000000000000004 115.27 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 21.4 ttm-85 -99.7 157.51 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.361 -0.977 . . . . 2.6899999999999999 108.361 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -135.05 128.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.232 -0.987 . . . . 1.5700000000000001 112.819 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 57.0 mt -117.96 156.04 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.094 -1.412 . . . . 1.3200000000000001 107.371 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -167.45 116.78 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 118.896 -1.122 . . . . 1.1100000000000001 112.657 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 1.6 mmtp -59.13 -177.83 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.077 -0.649 . . . . 2.3500000000000001 109.552 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' OD1' ' CD1' ' A' ' 2' ' ' ILE . 3.1 m120 -130.61 163.3 27.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.093 0.473 . . . . 2.7000000000000002 111.498 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.141 0.793 . . . . 1.3400000000000001 113.141 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -102.84 11.57 37.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.907 0.706 . . . . 1.4299999999999999 112.907 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 88.56 -2.16 84.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.266 -0.969 . . . . 1.3799999999999999 113.273 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.97 120.53 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.139 0.47 . . . . 1.49 109.887 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -79.81 102.05 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.603 -0.439 . . . . 1.48 111.88 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 9.5 p -61.81 111.3 4.23 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.369 -0.604 . . . . 0.81000000000000005 109.369 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -40.81 173.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.676 2.918 . . . . 1.25 114.608 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.07 128.88 24.07 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.098 2.532 . . . . 1.2 112.824 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.436 ' OG ' ' CG1' ' A' ' 76' ' ' VAL . 3.8 p -97.89 119.03 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.811 -0.631 . . . . 1.76 109.957 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -20.24 119.8 0.1 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.009 0.924 . . . . 1.77 112.673 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.499 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 27.8 Cg_exo -63.39 156.51 55.75 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.655 2.237 . . . . 1.01 114.385 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.444 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.67 149.73 25.11 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.022 -0.99 . . . . 1.55 109.316 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -37.44 158.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.869 0.731 . . . . 1.6299999999999999 111.771 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.486 ' CB ' ' CD2' ' A' ' 43' ' ' LEU . . . -91.08 108.08 19.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 1.0900000000000001 111.053 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.93 114.35 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.36 -0.382 . . . . 1.1299999999999999 111.541 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 85.4 m -52.4 -31.16 32.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 1.1299999999999999 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.1 m 57.04 93.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.34 . . . . 1.5700000000000001 110.113 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.447 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -143.87 -86.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 3.7000000000000002 111.501 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.67 -2.52 24.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 2.1400000000000001 111.716 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.136 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.301 0 N-CA-C 112.564 0.579 . . . . 2.0600000000000001 112.564 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 86' ' ' SER . 11.8 tt . . . . . 0 CA--C 1.521 -0.15 0 CA-C-O 120.95 0.405 . . . . 1.26 111.135 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.43 ' N ' HG12 ' A' ' 2' ' ' ILE . 79.0 m-20 -137.7 127.3 15.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.76 154.2 34.21 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.256 1.971 . . . . 0.58999999999999997 112.054 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.65 -179.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.717 2.278 . . . . 1.6100000000000001 113.098 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.81 -157.15 3.69 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.97999999999999998 112.749 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 31.1 tttt -91.41 134.08 30.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.7 -0.111 . . . . 2.04 110.7 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 6.0 Cg_exo -77.44 132.44 12.33 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.647 2.232 . . . . 0.54000000000000004 112.157 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.1 123.29 10.33 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.445 -0.343 . . . . 1.6799999999999999 111.538 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.8 Cg_exo -68.39 129.83 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.282 1.988 . . . . 0.64000000000000001 112.822 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.8 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.379 -0.6 . . . . 2.1699999999999999 109.379 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.65 100.89 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.84999999999999998 109.609 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -98.68 140.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.92 -0.582 . . . . 1.5700000000000001 112.071 -179.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -135.74 144.26 45.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.534 -0.757 . . . . 1.46 111.001 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -33.05 -47.97 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.58 0.956 . . . . 2.9100000000000001 113.58 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -106.73 -14.49 15.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.338 0.866 . . . . 1.3300000000000001 113.338 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.426 ' HA ' HD23 ' A' ' 66' ' ' LEU . 15.3 p -147.77 129.51 15.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.65 -0.42 . . . . 1.28 111.42 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.537 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 4.4 m -117.1 152.49 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.641 -0.423 . . . . 1.49 110.604 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.1 m -119.39 118.84 32.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 1.1399999999999999 111.168 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.28 155.63 47.98 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.428 0.632 . . . . 1.3100000000000001 111.288 179.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.61 159.64 42.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.031 -0.986 . . . . 2.3100000000000001 109.905 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.469 ' CZ3' ' O ' ' A' ' 59' ' ' ASN . 11.8 p90 -137.93 -171.83 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.40000000000000002 111.756 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.6 -171.93 3.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.919 -0.582 . . . . 1.1100000000000001 111.591 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -124.22 139.71 33.35 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 2.5600000000000001 111.0 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 16.8 Cg_endo -58.65 179.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 1.1100000000000001 112.106 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.17 0.29 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.156 0.428 . . . . 2.77 112.156 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -132.56 -72.6 0.52 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 121.082 -0.247 . . . . 1.6899999999999999 111.126 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.0 p 42.77 55.28 4.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.614 0.245 . . . . 1.3500000000000001 111.22 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.54 1.3 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.217 -0.516 . . . . 1.01 112.671 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.57 30.29 5.8 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.444 -1.063 . . . . 0.97999999999999998 110.444 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.38 177.91 4.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.971 -0.614 . . . . 0.98999999999999999 111.531 -178.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 -2.14 3.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.715 -0.675 . . . . 2.6899999999999999 111.941 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.483 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 14.9 mt 55.75 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-O 121.007 0.432 . . . . 1.71 110.746 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -106.18 17.82 22.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 1.6599999999999999 111.651 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.67 138.98 0.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.804 0.335 . . . . 1.97 111.594 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.483 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 48.3 m-85 -120.25 141.94 49.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.115 -0.493 . . . . 1.23 110.342 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.433 ' CG2' ' HE3' ' A' ' 50' ' ' LYS . 10.9 mm -108.17 156.24 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 1.76 110.767 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.452 -0.34 . . . . 1.6100000000000001 111.123 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt-10 -77.85 120.81 23.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 1.6699999999999999 109.574 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.33 148.84 27.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.362 0.601 . . . . 2.4399999999999999 111.961 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 3.2 ttp180 -131.06 111.42 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.158 -0.928 . . . . 1.79 109.557 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.3 79.88 1.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.611 -0.722 . . . . 1.5900000000000001 110.528 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 HD13 ' CB ' ' A' ' 94' ' ' ALA . 16.0 mt -63.54 142.66 97.96 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 1.4299999999999999 110.858 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -93.64 13.42 47.9 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.059 -1.226 . . . . 1.47 112.765 0.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -130.44 86.77 2.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.751 0.31 . . . . 2.6600000000000001 111.007 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.52 173.17 44.37 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.584 -0.817 . . . . 1.6200000000000001 112.718 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 143.2 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 3.0600000000000001 110.589 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 83.2 m95 -50.02 103.43 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 111.234 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.79 141.57 47.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.488 -0.323 . . . . 1.8400000000000001 110.603 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HE3' ' CG2' ' A' ' 37' ' ' ILE . 46.2 mtpt -44.87 104.7 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.872 0.368 . . . . 1.77 111.36 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -69.98 -51.04 35.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.079 -0.51 . . . . 1.4099999999999999 110.655 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -53.22 -64.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 2.0099999999999998 109.872 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 t80 62.33 38.23 13.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.405 -0.361 . . . . 2.6400000000000001 111.487 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -160.44 -89.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.71 -0.223 . . . . 2.0299999999999998 111.495 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -158.87 141.21 14.01 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.913 0.387 . . . . 1.8700000000000001 110.688 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.48 HG12 ' CD1' ' A' ' 61' ' ' PHE . 41.7 mt -139.28 65.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 1.3700000000000001 110.729 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.71 -63.28 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 2.1499999999999999 111.2 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -82.74 160.72 22.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.936 0.398 . . . . 1.54 110.527 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.469 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -72.25 -7.25 48.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.958 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.41 97.91 9.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.79 -0.448 . . . . 2.0499999999999998 109.79 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.48 ' CD1' HG12 ' A' ' 56' ' ' ILE . 62.4 t80 -129.82 165.2 22.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.0 -0.546 . . . . 0.56999999999999995 111.354 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 43.9 m -122.03 121.75 37.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.962 -0.563 . . . . 1.1399999999999999 110.508 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.483 ' CG1' ' CB ' ' A' ' 51' ' ' ALA . 25.1 t -80.61 100.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.952 -0.567 . . . . 1.72 111.56 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.29 138.16 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 110.78 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.3 -13.11 4.63 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.869 -0.681 . . . . 0.95999999999999996 112.385 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.489 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -55.74 -173.83 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.708 0.29 . . . . 2.02 110.462 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 m -152.01 163.71 38.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 1.55 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 tt0 -74.97 123.42 25.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 1.9099999999999999 110.887 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.4 t0 75.11 65.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.043 -0.526 . . . . 1.8700000000000001 111.498 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.6 113.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 1.2 110.899 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -64.46 133.73 53.06 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.766 -0.374 . . . . 1.1100000000000001 110.202 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.43 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 29.3 m-85 -126.29 118.11 24.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.21 -0.45 . . . . 1.0800000000000001 112.191 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.15 141.45 34.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 1.5 109.933 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.61 115.81 10.44 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.366 1.247 . . . . 0.79000000000000004 114.366 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' CG ' ' HG3' ' A' ' 91' ' ' PRO . 6.0 ptt85 -97.63 163.75 12.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.927 -0.768 . . . . 2.6899999999999999 108.927 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.449 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 48.7 t -116.94 133.82 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.778 0.659 . . . . 1.5700000000000001 112.778 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 40.6 mt -132.98 165.62 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.726 -1.213 . . . . 1.3200000000000001 107.726 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . 177.07 134.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.908 -0.717 . . . . 1.1100000000000001 112.107 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.4 ptpt -67.17 -99.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.653 -0.819 . . . . 2.3500000000000001 109.289 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.52 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 6.1 p30 170.43 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 110.497 -0.186 . . . . 2.7000000000000002 110.497 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.66 -42.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.029 -0.419 . . . . 1.3400000000000001 110.729 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -80.08 -10.27 59.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.574 . . . . 1.4299999999999999 112.237 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.21 -11.29 40.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.178 -1.01 . . . . 1.3799999999999999 112.501 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.86 115.87 4.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.112 -0.329 . . . . 1.49 110.112 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.9 tp -72.81 122.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.374 0.509 . . . . 1.48 112.374 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' HD12 ' A' ' 2' ' ' ILE . 2.6 p -89.36 131.74 39.52 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.959 -0.386 . . . . 0.81000000000000005 109.959 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -41.11 173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.571 2.847 . . . . 1.25 114.311 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 87.9 Cg_endo -87.56 172.79 5.63 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.235 2.623 . . . . 1.2 113.727 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -130.57 125.29 33.8 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.165 -0.925 . . . . 1.76 109.561 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -19.98 114.63 0.11 Allowed Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.228 0.955 . . . . 1.77 113.224 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 87.1 Cg_exo -47.7 144.02 11.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.699 2.266 . . . . 1.01 113.653 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.402 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.67 143.12 46.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.422 -0.808 . . . . 1.55 108.83 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.69 135.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.294 0.996 . . . . 1.6299999999999999 112.568 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -71.25 99.78 1.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.623 -0.717 . . . . 1.0900000000000001 109.718 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.9 mp -77.46 109.4 11.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 1.1299999999999999 110.946 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 59.5 m -49.12 -25.67 2.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 111.065 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 80.4 m 52.43 38.39 25.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 1.5700000000000001 110.744 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 1.021 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 17.2 ptp180 -71.98 -47.53 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 3.7000000000000002 111.696 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 1.021 ' OD1' ' HG3' ' A' ' 98' ' ' ARG . 20.1 p-10 -161.34 33.98 0.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.468 -0.787 . . . . 2.1400000000000001 110.284 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 2.0600000000000001 111.61 -179.136 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.477 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 5.5 tt . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.975 0.416 . . . . 1.26 111.753 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.141 ' OD2' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.82 114.53 13.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 2.0 110.458 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.24 171.73 13.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.996 1.797 . . . . 0.58999999999999997 112.126 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 34.5 Cg_exo -59.24 179.32 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.839 2.359 . . . . 1.6100000000000001 112.789 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -86.91 171.44 42.85 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.094 -0.574 . . . . 0.97999999999999998 113.051 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 tttt -59.72 125.14 79.25 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 110.326 -0.25 . . . . 2.04 110.326 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 19.4 Cg_exo -71.53 143.74 43.32 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.54000000000000004 113.035 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.24 105.45 7.89 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 1.6799999999999999 110.537 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 31.7 Cg_exo -54.11 128.76 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.277 1.985 . . . . 0.64000000000000001 113.676 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD22 ' CB ' ' A' ' 21' ' ' LYS . 1.3 mm? -95.81 -26.68 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.697 -0.683 . . . . 2.1699999999999999 109.531 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -152.52 152.41 31.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.737 -0.665 . . . . 0.84999999999999998 110.478 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.59 111.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.94 0.4 . . . . 1.5700000000000001 110.287 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -109.16 69.0 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.841 0.682 . . . . 1.46 112.841 -178.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 1.7 mtp180 28.1 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 2.9100000000000001 113.147 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.2 m-70 176.69 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.213 0.53 . . . . 1.3300000000000001 109.596 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 p -112.25 93.7 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 1.28 110.708 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 20' ' ' LEU . 48.0 t -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.558 -0.746 . . . . 1.49 110.789 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 56.0 m -90.13 144.27 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 1.1399999999999999 111.9 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -150.62 165.65 32.72 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.962 -1.017 . . . . 1.3100000000000001 111.903 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' CB ' HD22 ' A' ' 11' ' ' LEU . 15.6 tptm -143.47 138.72 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.744 -1.117 . . . . 2.3100000000000001 110.13 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.0 p90 -125.83 -176.56 3.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.40000000000000002 111.962 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -100.71 116.98 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.528 -0.76 . . . . 1.1100000000000001 110.972 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 144.21 49.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.523 -0.308 . . . . 2.5600000000000001 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 58.2 Cg_endo -70.19 169.92 18.32 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.614 2.209 . . . . 1.1100000000000001 112.412 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.32 -45.8 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 2.77 111.048 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.141 ' C ' ' OD2' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -89.75 66.06 6.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.846 -0.342 . . . . 1.6899999999999999 111.286 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.541 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 61.5 p -95.88 50.9 1.22 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.631 -0.507 . . . . 1.3500000000000001 109.631 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.16 -93.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.74 -0.663 . . . . 1.01 112.303 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.32 26.81 2.79 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.22 -0.752 . . . . 0.97999999999999998 111.22 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.508 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -118.28 -175.5 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.143 0.497 . . . . 0.98999999999999999 111.41 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 5.48 2.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.579 -0.737 . . . . 2.6899999999999999 111.876 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.496 HG22 ' CE1' ' A' ' 36' ' ' TYR . 14.1 mt 60.91 134.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.081 0.467 . . . . 1.71 110.654 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 p -108.1 2.37 22.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.6599999999999999 112.087 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 8.7 t -176.63 -176.12 0.7 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.97 111.85 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 40.7 m-85 -149.45 100.36 3.0 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.359 -0.837 . . . . 1.23 109.664 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.411 HG23 ' CB ' ' A' ' 50' ' ' LYS . 1.6 mt -84.65 121.87 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.943 -0.303 . . . . 1.76 111.304 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 2.8 t -96.17 103.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.534 -0.303 . . . . 1.6100000000000001 111.161 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 18.5 mt-10 -74.74 133.74 41.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.659 -0.497 . . . . 1.6699999999999999 109.659 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -116.88 147.68 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 2.4399999999999999 111.853 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 16.0 ttp180 -123.66 114.44 19.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.405 -0.816 . . . . 1.79 109.79 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -77.42 78.67 3.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.022 -0.535 . . . . 1.5900000000000001 110.655 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 94' ' ' ALA . 20.6 mt -52.78 154.27 5.05 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 1.4299999999999999 110.827 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.19 0.35 34.38 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.688 -1.38 . . . . 1.47 113.213 0.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -97.64 -85.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.28 . . . . 2.6600000000000001 111.11 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.31 175.98 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.697 -0.763 . . . . 1.6200000000000001 112.581 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.2 30.1 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.097 0.475 . . . . 3.0600000000000001 110.309 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 57.8 m95 50.21 94.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 1.0600000000000001 110.984 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -127.64 126.67 42.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 1.8400000000000001 110.622 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' CB ' HG23 ' A' ' 37' ' ' ILE . 1.8 ptpt -42.14 93.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 1.77 111.522 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -54.71 -51.31 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 1.4099999999999999 110.971 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.433 ' CB ' HD13 ' A' ' 56' ' ' ILE . 9.7 p-10 -65.08 114.45 4.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 110.943 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.35 16.13 7.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 2.6400000000000001 111.198 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -136.72 -160.15 1.03 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 2.0299999999999998 110.981 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 1.7 t-20 -98.77 113.48 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.8700000000000001 111.134 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.553 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 20.3 mm -87.56 59.03 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 1.3700000000000001 110.854 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.4 tp -43.59 -57.87 2.93 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.91 0.386 . . . . 2.1499999999999999 110.613 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -79.0 165.94 22.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -88.11 15.65 7.16 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.995 0.368 . . . . 1.75 111.995 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.7 111.6 18.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.372 -0.603 . . . . 2.0499999999999998 109.372 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.553 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 73.7 t80 -139.73 163.36 32.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.56999999999999995 112.051 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.2 m -114.03 106.13 14.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.06 -0.973 . . . . 1.1399999999999999 110.668 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 90.8 t -66.8 82.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.44 -0.8 . . . . 1.72 111.312 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -88.03 -175.3 5.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 1.6399999999999999 110.936 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 23.93 72.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.95999999999999996 112.782 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 18' ' ' VAL . 14.0 mt -97.1 -162.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 2.02 111.021 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 52.0 m -138.0 159.4 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 1.55 111.025 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -90.13 148.34 23.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 1.9099999999999999 111.109 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.4 40.69 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.8700000000000001 111.224 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -155.37 131.45 10.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 1.2 110.845 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 135.41 45.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.483 -0.326 . . . . 1.1100000000000001 110.361 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.403 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 30.5 m-85 -130.89 124.79 31.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.399 0.518 . . . . 1.0800000000000001 112.399 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.4 tt0 -102.97 139.24 38.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.631 -0.878 . . . . 1.5 108.631 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -139.08 118.85 13.15 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.26 1.578 . . . . 0.79000000000000004 115.26 -178.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -105.22 179.67 4.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.283 -1.006 . . . . 2.6899999999999999 108.283 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.486 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -144.43 121.3 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.439 -0.905 . . . . 1.5700000000000001 113.328 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.46 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 61.7 mt -106.99 152.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.138 -1.43 . . . . 1.3200000000000001 107.138 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -163.92 115.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.029 -1.068 . . . . 1.1100000000000001 112.809 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -62.29 -175.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.85 -0.74 . . . . 2.3500000000000001 109.644 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.508 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 3.1 m-80 -120.9 -114.13 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.569 -0.453 . . . . 2.7000000000000002 111.572 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.93 -38.38 2.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.412 0.551 . . . . 1.3400000000000001 111.361 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.19 23.46 3.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 1.4299999999999999 111.588 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.83 0.74 89.87 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.628 -0.796 . . . . 1.3799999999999999 113.311 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -69.94 112.83 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.987 0.394 . . . . 1.49 110.635 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -79.66 112.41 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.071 0.397 . . . . 1.48 112.071 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 5.4 p -71.59 121.45 84.44 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 120.433 -0.507 . . . . 0.81000000000000005 109.81 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.51 164.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.827 2.352 . . . . 1.25 112.609 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 3.8 Cg_exo -76.47 130.22 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.892 2.395 . . . . 1.2 112.895 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.5 OUTLIER -76.88 131.71 38.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.76 109.482 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 10.8 mt-10 -32.98 119.57 0.43 Allowed Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 123.689 0.618 . . . . 1.77 112.349 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 52.4 Cg_exo -52.4 150.43 20.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.465 2.11 . . . . 1.01 113.197 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 142.57 29.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.475 -0.784 . . . . 1.55 109.207 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.74 140.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.07 0.856 . . . . 1.6299999999999999 112.142 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -74.08 112.3 10.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.773 -0.648 . . . . 1.0900000000000001 110.699 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -98.8 117.75 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 1.1299999999999999 111.369 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 70' ' ' ALA . 48.3 m -48.38 -28.33 3.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 1.1299999999999999 111.327 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.1 m 55.6 59.2 4.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 1.5700000000000001 110.44 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 1.03 ' HD2' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.9 -42.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.252 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 1.03 ' OD1' ' HD2' ' A' ' 98' ' ' ARG . 7.7 p-10 -116.05 22.65 12.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.761 -0.654 . . . . 2.1400000000000001 111.428 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.426 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 4.8 p-10 . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.841 0.829 . . . . 2.0600000000000001 111.314 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' CB ' ' A' ' 86' ' ' SER . 2.0 tt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.861 0.362 . . . . 1.26 111.049 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.71 123.25 38.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.67 172.75 10.02 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.241 1.961 . . . . 0.58999999999999997 112.276 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.485 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.9 Cg_endo -61.39 171.15 4.5 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.839 2.359 . . . . 1.6100000000000001 112.68 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 -177.66 30.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.947 -0.644 . . . . 0.97999999999999998 112.671 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 91' ' ' PRO . 8.7 tptt -68.5 118.47 60.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.253 -0.277 . . . . 2.04 110.253 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 21.8 Cg_exo -67.51 122.91 10.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.387 2.058 . . . . 0.54000000000000004 111.733 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.76 112.69 28.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.518 -0.31 . . . . 1.6799999999999999 111.303 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.6 Cg_exo -61.88 120.27 7.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.547 2.164 . . . . 0.64000000000000001 113.5 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.56 -31.83 24.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 2.1699999999999999 109.665 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.22 145.78 33.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.84999999999999998 109.635 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.695 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -144.07 96.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.7 0.63 . . . . 1.5700000000000001 112.7 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.108 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -82.87 158.65 22.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.225 -0.658 . . . . 1.46 109.225 178.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -60.61 -13.23 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.068 0.396 . . . . 2.9100000000000001 112.068 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -139.08 25.55 2.49 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.952 0.353 . . . . 1.3300000000000001 111.952 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.95 116.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.696 0.284 . . . . 1.28 110.922 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG12 ' CG2' ' A' ' 13' ' ' ILE . 86.4 t -105.38 137.26 35.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.392 . . . . 1.49 111.114 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.6 m -117.91 122.37 43.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 1.1399999999999999 111.552 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -132.33 152.67 51.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.739 0.78 . . . . 1.3100000000000001 112.07 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 9.5 tptt -133.35 155.03 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.411 -1.268 . . . . 2.3100000000000001 109.707 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.9 p90 -145.34 -177.54 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 0.40000000000000002 112.176 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.75 159.48 15.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.48 -0.782 . . . . 1.1100000000000001 111.357 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -88.23 137.52 30.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.012 -0.54 . . . . 2.5600000000000001 110.238 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' CB ' HG22 ' A' ' 28' ' ' THR . 2.6 Cg_endo -41.27 160.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.595 2.197 . . . . 1.1100000000000001 111.929 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.74 -29.6 11.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.498 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -122.85 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 1.6899999999999999 111.562 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.48 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER 46.54 54.44 8.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.809 0.337 . . . . 1.3500000000000001 110.863 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 37.79 -131.83 1.34 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.803 -0.635 . . . . 1.01 113.128 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 29.87 9.12 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.178 -1.169 . . . . 0.97999999999999998 110.178 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.543 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -96.49 175.3 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.679 -0.761 . . . . 0.98999999999999999 111.286 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -136.89 0.2 2.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.551 . . . . 2.6899999999999999 112.255 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.481 HD11 ' CE1' ' A' ' 36' ' ' TYR . 27.7 mt 60.69 138.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 121.007 0.432 . . . . 1.71 111.004 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 p -120.2 -11.91 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.202 0.445 . . . . 1.6599999999999999 112.202 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -167.61 138.51 2.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 1.97 111.54 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.481 ' CE1' HD11 ' A' ' 33' ' ' ILE . 25.0 m-85 -105.08 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 1.23 110.855 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.17 165.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.764 -0.458 . . . . 1.76 109.764 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -157.46 137.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.563 0.697 . . . . 1.6100000000000001 111.164 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.441 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 6.1 mt-10 -105.35 134.53 48.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.767 -1.106 . . . . 1.6699999999999999 110.185 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 146.97 27.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 2.4399999999999999 111.194 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.7 ttm180 -119.44 113.96 21.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 1.79 110.581 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 92.79 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.316 -0.856 . . . . 1.5900000000000001 109.69 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.478 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 7.8 mt -76.73 150.65 81.93 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 1.4299999999999999 111.23 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -88.54 -2.22 62.59 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.741 -1.358 . . . . 1.47 113.038 0.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -123.67 79.46 1.7 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.886 0.374 . . . . 2.6600000000000001 110.993 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.59 -166.16 10.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.797 -0.716 . . . . 1.6200000000000001 112.377 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.95 151.25 23.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 3.0600000000000001 110.898 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 59.2 m95 -64.35 116.76 6.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.88 -0.6 . . . . 1.0600000000000001 110.406 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.427 ' N ' ' HB3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -144.68 136.66 25.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.831 0.348 . . . . 1.8400000000000001 111.206 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -44.82 110.09 0.21 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 1.77 111.3 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.428 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -84.85 -37.3 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 1.4099999999999999 110.633 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 10.6 p-10 -82.43 178.6 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.569 . . . . 2.0099999999999998 110.475 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 178.92 36.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 2.6400000000000001 111.035 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.56 32.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 2.0299999999999998 111.285 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.77 121.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.8700000000000001 110.956 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.492 HD12 ' CD1' ' A' ' 61' ' ' PHE . 22.3 mt -116.28 76.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 1.3700000000000001 111.083 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.43 -66.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 2.1499999999999999 111.463 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 168.24 9.08 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.874 0.369 . . . . 1.54 110.674 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 3.2 m-20 -86.61 8.06 23.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.077 -0.51 . . . . 1.75 111.419 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.84 103.88 12.74 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.694 0.283 . . . . 2.0499999999999998 110.35 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.492 ' CD1' HD12 ' A' ' 56' ' ' ILE . 65.1 t80 -135.16 163.12 30.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.56999999999999995 111.677 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.464 ' N ' ' CD2' ' A' ' 61' ' ' PHE . 9.1 m -122.93 117.23 25.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.644 -0.707 . . . . 1.1399999999999999 111.216 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 51' ' ' ALA . 47.8 t -83.31 101.92 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.037 -0.529 . . . . 1.72 110.942 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 p -94.15 162.91 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.366 0.603 . . . . 1.6399999999999999 110.997 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.49 7.35 24.38 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.969 -1.014 . . . . 0.95999999999999996 111.983 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.33 168.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.264 0.554 . . . . 2.02 111.449 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -139.26 98.88 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.245 -0.889 . . . . 1.55 109.284 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.5 tm-20 -37.24 139.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.5 0.556 . . . . 1.9099999999999999 112.5 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.18 42.34 0.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.726 -0.67 . . . . 1.8700000000000001 110.827 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.27 124.48 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.2 111.532 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.79 137.77 54.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.945 -0.391 . . . . 1.1100000000000001 109.945 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 30.6 m-85 -129.43 124.18 33.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.419 0.526 . . . . 1.0800000000000001 112.419 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.96 141.72 33.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.473 -0.566 . . . . 1.5 109.473 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -136.29 114.81 11.85 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.712 1.375 . . . . 0.79000000000000004 114.712 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.523 ' CD ' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.29 151.89 22.16 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.345 -0.613 . . . . 2.6899999999999999 109.345 177.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -114.61 118.05 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.622 -0.831 . . . . 1.5700000000000001 112.922 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 66.7 mt -103.41 136.45 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.993 -1.484 . . . . 1.3200000000000001 106.993 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -151.33 139.28 19.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.502 -0.879 . . . . 1.1100000000000001 111.965 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.5 mttp -66.8 -133.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.727 -0.789 . . . . 2.3500000000000001 109.625 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -167.55 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.127 0.422 . . . . 2.7000000000000002 110.153 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -154.15 -42.14 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.824 0.345 . . . . 1.3400000000000001 110.754 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.38 -2.57 58.68 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.514 0.561 . . . . 1.4299999999999999 112.514 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.09 62.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.249 -0.977 . . . . 1.3799999999999999 113.332 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' O ' HD11 ' A' ' 2' ' ' ILE . . . -76.25 81.16 3.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.155 0.502 . . . . 1.49 109.895 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -40.2 119.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 114.397 1.258 . . . . 1.48 114.397 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 3.8 p -73.06 109.36 6.08 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 106.765 -1.568 . . . . 0.81000000000000005 106.765 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 9.4 Cg_endo -49.72 162.98 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.652 2.235 . . . . 1.25 113.799 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 53.2 Cg_exo -40.42 128.56 2.4 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.714 2.942 . . . . 1.2 114.53 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' GLU . 78.2 p -102.19 100.88 11.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.127 -0.942 . . . . 1.76 110.268 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 89' ' ' SER . 0.4 OUTLIER 11.8 115.84 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 125.037 1.335 . . . . 1.77 114.387 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.535 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 6.5 Cg_exo -67.21 135.16 36.16 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.02 1.813 . . . . 1.01 113.011 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.33 144.05 56.18 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.339 -0.615 . . . . 1.55 109.339 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -40.25 149.31 0.07 Allowed 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.66 0.6 . . . . 1.6299999999999999 111.235 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -76.06 119.17 19.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.945 -0.571 . . . . 1.0900000000000001 111.812 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.421 ' CG2' HD13 ' A' ' 13' ' ' ILE . 4.5 mp -99.52 118.73 46.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 110.695 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 m -50.03 -38.0 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 1.1299999999999999 111.124 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 2.8 m 62.23 43.96 8.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 1.5700000000000001 110.503 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.546 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 1.4 ptp85 -84.96 -91.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 3.7000000000000002 111.64 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.546 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 20.2 p-10 -113.46 28.19 8.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.541 -0.299 . . . . 2.1400000000000001 110.406 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.108 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.228 0.537 . . . . 2.0600000000000001 110.895 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 tt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.737 0.303 . . . . 1.26 111.057 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.12 131.71 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 2.0 110.654 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 96.2 Cg_endo -81.73 168.6 15.81 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.589 2.193 . . . . 0.58999999999999997 112.385 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 73.0 Cg_exo -49.12 179.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.453 2.102 . . . . 1.6100000000000001 112.182 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.21 -167.17 42.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.97999999999999998 112.815 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.69 114.21 22.93 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.642 -0.133 . . . . 2.04 110.642 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 13.3 Cg_exo -70.49 131.32 19.98 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.423 2.082 . . . . 0.54000000000000004 112.494 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 8.9 p -142.55 106.92 5.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 1.6799999999999999 111.66 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 78.3 Cg_exo -36.18 141.74 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.991 2.461 . . . . 0.64000000000000001 112.79 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -30.83 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.507 -0.553 . . . . 2.1699999999999999 109.507 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER -153.06 97.81 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 0.84999999999999998 109.988 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.69 133.23 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.997 0.74 . . . . 1.5700000000000001 112.997 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -127.85 137.86 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.95 -1.023 . . . . 1.46 110.092 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.433 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -29.35 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.006 1.113 . . . . 2.9100000000000001 114.006 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.1 m170 -120.16 -22.33 6.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.641 0.608 . . . . 1.3300000000000001 112.641 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' A' ' 14' ' ' THR . 13.6 p -134.44 130.33 36.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.25 -0.278 . . . . 1.28 110.25 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.52 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 4.5 m -124.91 141.34 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.142 0.496 . . . . 1.49 112.103 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.3 m -106.95 151.64 25.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 1.1399999999999999 109.788 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.51 152.02 37.32 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.532 0.682 . . . . 1.3100000000000001 112.021 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.71 147.46 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.581 -1.19 . . . . 2.3100000000000001 109.675 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 26.4 p90 -146.69 -174.0 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.40000000000000002 111.282 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -164.79 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.784 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -137.08 139.87 29.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 2.5600000000000001 110.858 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 93.3 Cg_exo -41.24 158.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.415 2.076 . . . . 1.1100000000000001 111.952 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -112.49 -21.67 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.284 -0.417 . . . . 2.77 111.651 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -129.33 -71.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.049 -0.26 . . . . 1.6899999999999999 111.66 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.476 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 1.5 p 51.26 45.42 27.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 1.3500000000000001 110.37 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.79 -124.36 4.96 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.881 -0.6 . . . . 1.01 112.446 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.46 36.64 3.95 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.099 -1.201 . . . . 0.97999999999999998 110.099 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -105.28 177.58 4.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.639 -0.781 . . . . 0.98999999999999999 111.929 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 7.81 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.85 -0.613 . . . . 2.6899999999999999 111.869 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.4 HD12 ' HG2' ' A' ' 25' ' ' PRO . 12.7 mt 59.18 146.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 121.077 0.465 . . . . 1.71 111.251 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 p -114.14 -31.99 6.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.021 -0.536 . . . . 1.6599999999999999 112.44 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -169.64 135.43 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.947 0.351 . . . . 1.97 111.947 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 57' ' ' LEU . 60.5 m-85 -88.74 89.34 7.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 1.23 111.263 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt -78.77 109.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 1.76 110.641 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 p -106.48 127.19 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 1.6100000000000001 111.208 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 27.1 mt-10 -92.65 149.53 21.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.83 -0.623 . . . . 1.6699999999999999 110.404 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.448 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.73 157.97 21.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.05 0.452 . . . . 2.4399999999999999 110.975 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CZ ' ' CZ2' ' A' ' 48' ' ' TRP . 12.9 ttp180 -133.52 112.71 11.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.438 -0.801 . . . . 1.79 109.576 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.88 107.13 6.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 1.5900000000000001 110.868 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -89.38 147.79 38.99 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 121.077 -0.249 . . . . 1.4299999999999999 110.627 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -93.17 15.94 44.35 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.8 -1.333 . . . . 1.47 112.493 0.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.18 93.68 2.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.856 0.36 . . . . 2.6600000000000001 110.966 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.21 -167.94 35.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.938 -0.648 . . . . 1.6200000000000001 112.365 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 171.44 20.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.719 0.295 . . . . 3.0600000000000001 111.211 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.494 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 62.3 m95 -70.06 121.78 18.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.995 -0.548 . . . . 1.0600000000000001 111.941 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -142.06 137.62 31.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 1.8400000000000001 110.598 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -46.94 92.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.4 . . . . 1.77 111.484 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -57.95 -61.45 2.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 1.4099999999999999 110.232 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -74.32 132.8 42.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.501 -0.772 . . . . 2.0099999999999998 110.266 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.57 35.49 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.167 -0.47 . . . . 2.6400000000000001 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -142.28 -68.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 2.0299999999999998 110.873 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 176.03 153.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.8700000000000001 110.847 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 HG22 ' CB ' ' A' ' 61' ' ' PHE . 13.6 mt -148.78 62.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 1.3700000000000001 110.596 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.41 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 7.7 tp -54.29 -60.51 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.986 -0.552 . . . . 2.1499999999999999 111.21 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -73.39 166.4 23.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.486 -0.325 . . . . 1.54 110.587 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 36.1 p30 -83.88 8.36 15.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 1.75 112.009 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -114.42 107.77 15.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.615 -0.513 . . . . 2.0499999999999998 109.615 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 39.9 t80 -141.94 165.51 27.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.471 . . . . 0.56999999999999995 111.832 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 33.4 m -119.52 121.49 39.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.698 -0.683 . . . . 1.1399999999999999 111.059 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 15.0 t -86.05 109.05 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.287 -0.415 . . . . 1.72 111.189 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.03 132.16 44.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.981 -0.554 . . . . 1.6399999999999999 110.841 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.03 -12.75 2.84 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.757 -0.735 . . . . 0.95999999999999996 112.721 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -57.45 -171.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 2.02 110.667 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -160.59 155.14 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 1.55 110.629 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.97 144.11 56.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 1.9099999999999999 111.101 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.929 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 62.44 43.79 7.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 1.8700000000000001 111.443 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -156.35 115.65 3.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.869 0.366 . . . . 1.2 111.787 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . . . -70.25 130.74 42.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 1.1100000000000001 109.954 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 51.8 m-85 -124.15 118.97 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.424 0.527 . . . . 1.0800000000000001 112.424 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 92' ' ' SER . 2.1 mt-10 -99.04 145.14 27.41 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.364 -0.606 . . . . 1.5 109.364 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.93 119.41 14.87 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.319 1.229 . . . . 0.79000000000000004 114.319 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -93.99 142.99 26.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.845 -0.616 . . . . 2.6899999999999999 109.623 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 8' ' ' PRO . 51.5 t -99.79 107.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.59 0.589 . . . . 1.5700000000000001 112.59 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 11.0 mt -106.76 151.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.536 -1.283 . . . . 1.3200000000000001 107.536 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -177.18 140.93 0.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.835 -0.746 . . . . 1.1100000000000001 111.816 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.3 mtmt -74.97 -155.64 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.101 -0.64 . . . . 2.3500000000000001 109.424 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -139.67 -80.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.85 0.357 . . . . 2.7000000000000002 110.603 -179.272 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -159.73 -41.77 0.05 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.098 -0.501 . . . . 1.3400000000000001 110.377 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -75.14 -13.67 60.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.955 -0.566 . . . . 1.4299999999999999 111.93 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.79 58.49 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.424 -0.893 . . . . 1.3799999999999999 113.0 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 85' ' ' ILE . . . -51.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.032 0.416 . . . . 1.49 110.389 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' CB ' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER 128.88 112.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.734 1.272 . . . . 1.48 112.495 178.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -75.74 110.53 10.99 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 107.834 -1.173 . . . . 0.81000000000000005 107.834 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 11.1 Cg_endo -52.8 165.07 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.341 2.027 . . . . 1.25 112.629 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 9.5 Cg_endo -51.56 135.37 48.09 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.132 2.554 . . . . 1.2 113.155 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -105.51 107.21 18.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.757 -0.656 . . . . 1.76 110.756 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 8.49 104.39 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.818 1.247 . . . . 1.77 114.013 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 73.4 Cg_exo -49.58 126.4 16.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.673 2.249 . . . . 1.01 113.579 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -57.51 149.31 21.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.006 -0.739 . . . . 1.55 109.006 178.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.85 149.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.729 0.643 . . . . 1.6299999999999999 111.27 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HB2' ' CB ' ' A' ' 71' ' ' ALA . . . -78.89 115.36 18.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.496 -0.775 . . . . 1.0900000000000001 110.13 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.5 mp -89.41 107.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 1.1299999999999999 111.075 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 91.1 m -44.05 -38.94 3.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.846 -0.615 . . . . 1.1299999999999999 111.58 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' ASP . 71.2 m 54.07 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.998 -0.371 . . . . 1.5700000000000001 109.998 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -88.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.881 0.372 . . . . 3.7000000000000002 111.466 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -96.21 -10.59 27.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.298 -0.41 . . . . 2.1400000000000001 111.226 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 t0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 2.0600000000000001 110.977 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.43 HG13 ' ND2' ' A' ' 80' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.744 0.307 . . . . 1.26 110.799 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.101 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.11 121.41 15.62 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 2.0 111.058 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.92 156.6 52.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.428 2.085 . . . . 0.58999999999999997 112.211 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.4 Cg_endo -52.44 -175.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.948 2.432 . . . . 1.6100000000000001 112.58 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.69 168.41 43.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.97999999999999998 112.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -56.23 125.29 64.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.63 -0.137 . . . . 2.04 110.63 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 6.5 Cg_exo -73.96 133.81 18.8 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.268 1.978 . . . . 0.54000000000000004 111.242 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.8 p -136.23 111.07 9.96 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.318 0.488 . . . . 1.6799999999999999 112.318 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 19' ' ' THR . 27.4 Cg_exo -58.68 94.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.458 2.105 . . . . 0.64000000000000001 113.296 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.64 -36.8 62.45 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.254 0.549 . . . . 2.1699999999999999 109.753 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.1 t30 -138.53 152.55 48.32 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.286 -0.87 . . . . 0.84999999999999998 109.582 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 13' ' ' ILE . 1.9 pt -141.34 97.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.411 . . . . 1.5700000000000001 111.509 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -90.02 45.02 1.24 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.82 -0.627 . . . . 1.46 112.428 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 16.5 mtp180 56.73 -73.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.514 0.561 . . . . 2.9100000000000001 112.514 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 14' ' ' THR . 10.0 m170 -76.92 -32.45 57.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 1.3300000000000001 110.832 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.2 p -127.78 113.09 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 1.28 109.865 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.51 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 10.3 m -110.9 119.15 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.634 0.73 . . . . 1.49 111.833 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.1 m -83.99 142.92 30.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 1.1399999999999999 110.637 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.52 164.51 33.2 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.121 0.888 . . . . 1.3100000000000001 111.76 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.09 152.56 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.449 -0.796 . . . . 2.3100000000000001 110.808 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.481 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.5 p90 -140.57 -174.42 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.047 0.451 . . . . 0.40000000000000002 111.76 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.92 -174.82 3.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 1.1100000000000001 111.407 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -119.42 138.02 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.5600000000000001 110.533 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.19 173.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.416 2.078 . . . . 1.1100000000000001 112.11 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.8 -19.2 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 2.77 111.803 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.4 t80 -123.79 -70.92 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.22 0.452 . . . . 1.6899999999999999 112.22 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 1.101 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 70.7 p 51.72 52.0 15.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.065 0.459 . . . . 1.3500000000000001 110.078 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.7 -106.27 0.06 OUTLIER Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.689 -0.687 . . . . 1.01 112.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.39 37.39 2.14 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.468 -1.053 . . . . 0.97999999999999998 110.468 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.3 m-85 -117.82 -178.58 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.094 -0.553 . . . . 0.98999999999999999 111.583 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -140.66 -0.38 1.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.583 -0.735 . . . . 2.6899999999999999 112.375 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 11.8 mt 56.34 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.976 0.417 . . . . 1.71 111.437 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -114.25 23.72 12.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 1.6599999999999999 111.605 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t 178.55 135.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 1.97 111.352 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 49.9 m-85 -121.62 102.22 8.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 1.23 110.979 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -79.58 140.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.066 -0.346 . . . . 1.76 110.066 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.92 105.35 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.477 -0.329 . . . . 1.6100000000000001 111.885 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 80.1 mt-10 -75.59 150.34 38.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.92 -0.77 . . . . 1.6699999999999999 108.92 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.57 145.91 51.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 2.4399999999999999 112.202 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 16.2 ttp180 -121.0 105.09 10.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.177 -0.919 . . . . 1.79 109.595 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.837 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 82.9 0.45 Allowed 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.861 -0.608 . . . . 1.5900000000000001 110.491 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.473 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 3.1 mt -61.02 149.68 80.91 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.785 -0.643 . . . . 1.4299999999999999 110.904 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.29 18.9 26.59 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.096 -1.21 . . . . 1.47 113.067 0.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.74 83.13 1.34 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.668 0.27 . . . . 2.6600000000000001 111.386 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.83 -169.16 25.31 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.827 -0.701 . . . . 1.6200000000000001 112.518 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -139.77 8.84 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.735 0.272 . . . . 3.0600000000000001 111.735 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 19.5 m95 52.52 72.26 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 1.0600000000000001 110.959 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.63 137.77 54.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 1.8400000000000001 110.943 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.34 98.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 1.77 111.228 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HB2' HG11 ' A' ' 63' ' ' VAL . . . -58.25 -51.11 71.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 1.4099999999999999 110.498 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 12.7 p-10 -60.8 131.51 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 2.0099999999999998 110.937 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 30.4 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 2.6400000000000001 110.978 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t -138.89 -161.06 1.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 2.0299999999999998 110.701 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.91 114.5 28.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.384 . . . . 1.8700000000000001 111.186 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 61' ' ' PHE . 33.6 mt -100.86 80.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 1.3700000000000001 110.852 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.19 -59.72 4.08 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.191 -0.459 . . . . 2.1499999999999999 111.52 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -77.31 167.07 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.909 0.385 . . . . 1.54 110.695 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.481 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 53.3 p30 -84.01 4.93 27.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 1.75 111.615 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.17 100.69 10.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.702 -0.481 . . . . 2.0499999999999998 109.702 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 56' ' ' ILE . 75.4 t80 -131.66 163.02 29.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.234 0.54 . . . . 0.56999999999999995 112.2 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.45 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 42.8 m -131.61 124.54 30.17 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.254 -0.884 . . . . 1.1399999999999999 110.01 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 51' ' ' ALA . 7.4 t -82.81 94.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.072 0.463 . . . . 1.72 111.209 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -89.02 165.09 14.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.661 -0.699 . . . . 1.6399999999999999 111.078 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.5 8.46 83.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.95999999999999996 112.705 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 4.7 mt -58.82 -175.02 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.982 0.42 . . . . 2.02 110.775 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -131.5 133.23 44.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 1.55 110.471 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.13 149.92 45.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 1.9099999999999999 111.149 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.846 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 66.19 38.17 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 1.8700000000000001 110.788 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -156.1 116.74 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 1.2 111.535 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 131.94 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 1.1100000000000001 110.129 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 53.5 m-85 -125.33 127.15 46.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.658 0.614 . . . . 1.0800000000000001 112.658 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.437 ' HG3' ' CA ' ' A' ' 94' ' ' ALA . 4.7 mt-10 -108.45 134.04 51.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.974 -1.121 . . . . 1.5 107.974 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CE1' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -131.17 121.64 25.23 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.753 1.39 . . . . 0.79000000000000004 114.753 -178.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' CA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -97.08 167.9 10.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.077 -0.51 . . . . 2.6899999999999999 109.828 178.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 71.6 t -116.3 145.41 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.397 0.617 . . . . 1.5700000000000001 111.974 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -141.45 152.91 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.549 -0.908 . . . . 1.3200000000000001 108.549 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -166.8 124.84 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.533 -0.867 . . . . 1.1100000000000001 112.457 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.55 95.92 7.28 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.067 -0.653 . . . . 2.3500000000000001 109.898 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 1.3 m120 -40.34 156.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 2.7000000000000002 111.667 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -20.77 -47.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.193 1.183 . . . . 1.3400000000000001 114.193 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -109.45 48.63 0.87 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.933 0.716 . . . . 1.4299999999999999 112.933 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.83 37.65 9.45 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.4 -0.905 . . . . 1.3799999999999999 113.248 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 31' ' ' PHE . . . -78.3 1.02 23.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.88 0.371 . . . . 1.49 111.202 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 37.24 111.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 114.972 1.471 . . . . 1.48 114.972 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -93.27 111.45 51.98 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 113.909 -1.496 . . . . 0.81000000000000005 107.022 177.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.3 Cg_endo -45.67 172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.026 2.484 . . . . 1.25 113.656 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' CB ' ' HD3' ' A' ' 75' ' ' ARG . 19.0 Cg_exo -65.32 92.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.085 2.524 . . . . 1.2 113.141 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.65 105.33 0.29 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.941 -0.572 . . . . 1.76 110.035 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.401 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.1 tt0 4.83 117.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.15 1.38 . . . . 1.77 114.346 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 48.5 Cg_exo -42.62 170.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.943 2.429 . . . . 1.01 114.03 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -102.19 139.1 38.26 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 114.944 -1.025 . . . . 1.55 109.355 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -38.08 127.54 1.3 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.273 0.983 . . . . 1.6299999999999999 111.282 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.473 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -58.26 131.14 49.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.507 -0.769 . . . . 1.0900000000000001 111.384 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 3.2 mp -117.38 108.0 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.933 -0.576 . . . . 1.1299999999999999 110.961 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.2 m -46.64 -37.23 7.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 1.1299999999999999 110.824 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.435 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 59.7 m 59.85 37.71 21.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 1.5700000000000001 110.777 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.16 -39.78 16.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 3.7000000000000002 112.036 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.405 ' HA ' ' NE ' ' A' ' 15' ' ' ARG . 17.8 p-10 -156.09 24.65 0.37 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.382 -0.372 . . . . 2.1400000000000001 111.457 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 2.0600000000000001 112.088 -179.947 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.444 HD13 ' ND2' ' A' ' 80' ' ' ASN . 1.6 tt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.769 0.318 . . . . 1.26 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -122.52 134.86 25.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 2.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.55 160.7 10.9 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.593 2.195 . . . . 0.58999999999999997 113.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 77.1 Cg_exo -52.53 167.61 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.058 2.506 . . . . 1.6100000000000001 113.125 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.32 -179.88 38.47 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.37 -0.832 . . . . 0.97999999999999998 112.226 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -66.9 124.21 88.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 O-C-N 122.846 -0.208 . . . . 2.04 110.688 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.6 Cg_exo -70.64 135.65 28.84 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.355 2.037 . . . . 0.54000000000000004 112.178 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -130.41 115.44 17.28 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.288 -0.414 . . . . 1.6799999999999999 111.214 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.5 Cg_exo -70.42 114.45 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.209 1.94 . . . . 0.64000000000000001 113.575 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -33.56 57.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.497 -0.927 . . . . 2.1699999999999999 108.497 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -140.5 151.2 44.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.754 -1.112 . . . . 0.84999999999999998 109.043 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.642 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 4.2 pt -140.87 97.59 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.489 0.551 . . . . 1.5700000000000001 112.489 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.259 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -85.7 140.28 30.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 1.46 110.007 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -24.48 1.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 2.9100000000000001 112.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -120.44 -1.75 10.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.393 0.516 . . . . 1.3300000000000001 112.393 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 p -160.5 119.61 2.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.601 0.239 . . . . 1.28 110.672 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.495 HG13 ' CE2' ' A' ' 74' ' ' PHE . 46.5 t -102.97 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.474 . . . . 1.49 111.668 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 22.7 m -109.85 121.82 46.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.819 -0.628 . . . . 1.1399999999999999 111.405 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.94 161.8 35.04 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.676 0.75 . . . . 1.3100000000000001 112.139 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -138.6 151.54 47.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.574 -1.194 . . . . 2.3100000000000001 110.295 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.7 p90 -136.77 -178.05 5.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.264 0.554 . . . . 0.40000000000000002 112.073 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.61 -154.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.417 -0.81 . . . . 1.1100000000000001 110.395 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -155.08 127.16 3.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.748 -0.381 . . . . 2.5600000000000001 111.727 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -46.32 179.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.181 2.587 . . . . 1.1100000000000001 112.772 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -122.36 -10.06 8.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 2.77 111.971 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -116.76 -72.65 0.68 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.615 -0.434 . . . . 1.6899999999999999 112.107 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.6 p 49.63 47.03 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.1 0.476 . . . . 1.3500000000000001 110.364 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.12 -93.39 0.01 OUTLIER Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.615 -0.721 . . . . 1.01 112.306 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.35 32.99 1.48 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.265 -1.134 . . . . 0.97999999999999998 110.265 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.96 -172.8 2.46 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.752 -0.724 . . . . 0.98999999999999999 111.314 -178.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 8.1 ptmt -145.33 39.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 2.6899999999999999 111.077 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.58 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 1.4 mp 62.48 -81.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 1.71 110.492 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.419 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 2.9 p 59.6 29.59 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.6599999999999999 111.493 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 172.23 94.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 1.97 111.4 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 58.6 m-85 -102.61 81.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 1.23 111.172 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.45 HG23 ' CB ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -72.53 110.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.461 -0.495 . . . . 1.76 110.359 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 61' ' ' PHE . 4.9 t -85.28 81.55 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 111.991 0.367 . . . . 1.6100000000000001 111.991 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.78 138.75 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.457 -0.572 . . . . 1.6699999999999999 109.457 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.7 153.62 26.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.371 0.605 . . . . 2.4399999999999999 112.152 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.39 98.52 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.054 -0.975 . . . . 1.79 110.201 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -75.2 76.74 2.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 1.5900000000000001 110.875 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD13 ' CB ' ' A' ' 94' ' ' ALA . 12.3 mt -57.27 138.26 80.65 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 1.4299999999999999 111.131 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -92.2 17.36 42.15 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 124.009 -1.246 . . . . 1.47 112.763 0.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.6 p30 -121.84 53.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.51 -0.314 . . . . 2.6600000000000001 111.398 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -104.35 173.89 21.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.507 -0.854 . . . . 1.6200000000000001 112.329 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HG2' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -165.92 42.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 3.0600000000000001 110.997 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.569 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 20.8 m95 40.85 69.26 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.958 -0.565 . . . . 1.0600000000000001 111.855 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' CD2' ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -101.29 121.32 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.765 0.317 . . . . 1.8400000000000001 110.389 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.45 ' CB ' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -43.94 92.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 1.77 111.454 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -62.61 -46.39 88.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 1.4099999999999999 110.438 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 12.1 p-10 -62.57 127.11 29.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 2.0099999999999998 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.73 -17.34 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 2.6400000000000001 111.113 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -110.63 145.93 37.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 2.0299999999999998 110.814 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.8 111.43 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 1.8700000000000001 110.915 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 19.7 mm -75.63 90.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.315 -0.402 . . . . 1.3700000000000001 110.871 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.51 -38.23 65.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.965 0.412 . . . . 2.1499999999999999 110.457 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 154.33 18.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 1.54 109.589 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.505 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 26.1 p-10 -75.3 -0.71 20.6 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.093 0.405 . . . . 1.75 112.093 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.652 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 2.5 tp10 -100.73 105.47 16.81 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.44 -0.578 . . . . 2.0499999999999998 109.44 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 58.2 t80 -137.15 165.99 24.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.346 0.594 . . . . 0.56999999999999995 111.922 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -133.06 100.4 4.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.205 -0.907 . . . . 1.1399999999999999 110.843 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 14.9 m -57.29 142.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 1.72 111.04 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -136.12 154.17 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.72 0.772 . . . . 1.6399999999999999 111.131 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.16 -5.9 19.61 Favored Glycine 0 C--N 1.313 -0.711 0 CA-C-N 114.48 -1.236 . . . . 0.95999999999999996 112.3 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.85 -175.52 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.834 0.349 . . . . 2.02 110.815 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 m -149.35 130.66 14.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.435 . . . . 1.55 110.634 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.92 149.35 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 1.9099999999999999 111.085 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.84 48.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.8700000000000001 110.793 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.2 130.81 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 1.2 111.625 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -74.82 135.13 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 1.1100000000000001 110.243 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -131.8 121.77 24.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.926 0.393 . . . . 1.0800000000000001 111.99 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.3 137.74 35.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.86 -0.792 . . . . 1.5 108.86 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -122.21 106.76 11.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.42 1.267 . . . . 0.79000000000000004 114.42 -179.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.491 ' HB2' ' HG3' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -104.49 143.47 32.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.136 -0.938 . . . . 2.6899999999999999 108.927 178.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -116.51 136.33 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.958 -0.697 . . . . 1.5700000000000001 112.001 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 77' ' ' ILE . 33.9 mt -117.21 153.17 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.907 -1.042 . . . . 1.3200000000000001 108.513 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -146.35 117.4 7.77 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.371 -0.531 . . . . 1.1100000000000001 111.735 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 23.0 ptmt -86.89 14.75 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.15 0.796 . . . . 2.3500000000000001 113.15 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 2.6 m-80 43.51 -179.91 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.074 1.138 . . . . 2.7000000000000002 114.074 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . . . -57.61 -50.26 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.972 -1.467 . . . . 1.3400000000000001 112.372 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -88.79 34.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.584 0.587 . . . . 1.4299999999999999 112.584 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.1 39.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.544 -0.836 . . . . 1.3799999999999999 113.045 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . -69.11 94.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 1.49 109.257 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.4 tp -61.04 107.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.294 0.85 . . . . 1.48 113.294 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.455 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 16.2 p -87.52 108.5 20.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.978 -1.119 . . . . 0.81000000000000005 107.978 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.5 Cg_endo -42.01 172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.125 2.55 . . . . 1.25 113.883 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 54.1 Cg_exo -51.81 129.04 28.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.9 2.4 . . . . 1.2 112.466 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 15.2 m -99.94 106.12 17.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.334 -0.394 . . . . 1.76 110.419 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER 1.92 117.69 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.243 0 O-C-N 124.696 1.248 . . . . 1.77 113.355 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.569 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 9.1 Cg_exo -69.29 160.59 49.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.803 1.669 . . . . 1.01 113.915 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -87.28 141.1 28.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.779 -1.193 . . . . 1.55 107.779 178.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.447 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -32.12 138.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.042 0.839 . . . . 1.6299999999999999 112.201 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.449 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -67.53 101.25 0.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.158 -0.473 . . . . 1.0900000000000001 111.063 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.447 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 4.6 mp -84.2 115.03 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.926 0.393 . . . . 1.1299999999999999 111.053 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 23.8 m -52.45 -23.52 6.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.875 -0.602 . . . . 1.1299999999999999 110.6 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.6 m 50.12 84.34 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.089 0.471 . . . . 1.5700000000000001 109.875 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.35 -87.36 0.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.716 -0.675 . . . . 3.7000000000000002 110.979 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 26.7 p-10 -93.28 21.9 5.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.125 -0.489 . . . . 2.1400000000000001 110.631 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.259 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.273 0.559 . . . . 2.0600000000000001 111.54 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.884 0.373 . . . . 1.26 111.422 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -111.61 130.45 23.11 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 2.0 110.186 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.72 162.43 24.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.412 2.075 . . . . 0.58999999999999997 112.38 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.448 ' N ' ' HG3' ' A' ' 25' ' ' PRO . 53.7 Cg_exo -54.39 178.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.929 2.419 . . . . 1.6100000000000001 113.37 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.69 161.02 30.59 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.97999999999999998 112.517 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.4 tttt -53.23 132.53 51.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 110.244 -0.28 . . . . 2.04 110.244 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 4.5 Cg_exo -82.01 136.89 9.44 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.445 2.097 . . . . 0.54000000000000004 112.396 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.87 121.23 18.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.6799999999999999 110.849 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 19' ' ' THR . 16.7 Cg_exo -65.71 100.71 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.439 2.093 . . . . 0.64000000000000001 113.417 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.7 OUTLIER -58.95 -35.01 72.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.869 -0.789 . . . . 2.1699999999999999 108.869 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -142.07 151.45 42.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.661 -1.154 . . . . 0.84999999999999998 108.339 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 1.053 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -139.84 113.61 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.129 -0.629 . . . . 1.5700000000000001 112.301 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.017 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.61 151.27 23.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.65 -0.705 . . . . 1.46 109.865 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -10.52 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.61 0.596 . . . . 2.9100000000000001 112.61 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -135.07 20.09 3.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.273 . . . . 1.3300000000000001 111.323 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.429 ' O ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 168.13 114.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 1.28 109.956 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 74' ' ' PHE . 14.5 m -108.4 146.68 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.594 -0.442 . . . . 1.49 110.632 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 4.1 m -110.58 120.21 41.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 1.1399999999999999 111.979 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.36 171.1 14.16 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.662 0.744 . . . . 1.3100000000000001 111.804 178.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.67 173.22 16.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.024 -0.989 . . . . 2.3100000000000001 109.123 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 3.1 p90 -138.37 -168.36 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.595 0.591 . . . . 0.40000000000000002 112.595 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.67 -13.41 22.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.416 0.895 . . . . 1.1100000000000001 113.416 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.453 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 74.34 149.84 0.13 Allowed Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 110.121 -0.325 . . . . 2.5600000000000001 110.121 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 20.0 Cg_exo -65.96 -167.35 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.33 2.02 . . . . 1.1100000000000001 113.047 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -148.74 -45.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 2.77 110.787 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.1 77.16 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.6899999999999999 111.283 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 22.6 p -92.47 46.73 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.3500000000000001 109.95 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.16 -98.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.546 -0.835 . . . . 1.01 111.653 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.2 29.48 2.92 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.578 -1.009 . . . . 0.97999999999999998 110.578 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -117.38 174.39 6.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.091 -0.555 . . . . 0.98999999999999999 111.071 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -0.58 4.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 2.6899999999999999 111.457 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 23.3 mt 63.25 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.178 -0.304 . . . . 1.71 110.178 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -107.69 -15.25 14.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.715 0.635 . . . . 1.6599999999999999 112.715 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.5 m -167.43 158.58 11.68 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.397 0.518 . . . . 1.97 112.397 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 78' ' ' ALA . 26.3 m-85 -117.36 131.4 56.79 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.014 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 5.6 mt -104.84 132.49 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.852 -0.613 . . . . 1.76 111.023 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 63' ' ' VAL . 5.1 t -110.33 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.265 -0.425 . . . . 1.6100000000000001 111.278 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 14.0 mt-10 -85.42 131.2 34.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.532 -0.544 . . . . 1.6699999999999999 109.532 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 129.26 48.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 111.854 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 5.4 ttp180 -105.9 92.59 4.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.634 -0.712 . . . . 1.79 109.488 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -62.96 146.75 52.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.54 . . . . 1.5900000000000001 109.574 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 10.0 mt -127.12 131.0 23.65 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.871 -0.332 . . . . 1.4299999999999999 110.808 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -88.5 38.98 3.14 Favored 'Cis proline' 0 C--N 1.352 0.726 0 C-N-CA 124.542 -1.024 . . . . 1.47 113.026 0.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -114.2 56.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.314 . . . . 2.6600000000000001 110.607 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -62.17 169.61 13.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.792 -0.718 . . . . 1.6200000000000001 113.262 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.51 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.657 0.265 . . . . 3.0600000000000001 111.628 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 68.5 m95 63.17 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.248 -0.279 . . . . 1.0600000000000001 110.248 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.34 121.58 11.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.838 0.351 . . . . 1.8400000000000001 110.796 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 6.2 ptpt -51.03 111.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 1.77 111.105 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.92 -11.94 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 111.258 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.1 p-10 -74.21 -60.94 2.04 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.654 -0.418 . . . . 2.0099999999999998 111.871 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 4.8 t80 78.37 -51.32 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.549 0.214 . . . . 2.6400000000000001 111.409 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -173.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.036 0.446 . . . . 2.0299999999999998 111.47 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.0 80.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.786 -0.643 . . . . 1.8700000000000001 110.764 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.48 HD12 ' CD1' ' A' ' 61' ' ' PHE . 70.3 mt -71.11 103.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 1.3700000000000001 110.733 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.36 -50.82 2.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 2.1499999999999999 111.665 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -56.66 -20.26 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.137 0.421 . . . . 1.54 112.137 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.2 p-10 89.17 -25.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.71 0.804 . . . . 1.75 111.65 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -81.93 86.56 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.751 -0.833 . . . . 2.0499999999999998 108.751 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 62' ' ' THR . 55.0 t80 -120.8 165.56 14.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.328 0.585 . . . . 0.56999999999999995 111.998 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.514 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 54.9 m -123.7 122.26 37.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 110.84 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 20' ' ' LEU . 9.6 t -81.91 95.7 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.159 0.504 . . . . 1.72 110.834 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -83.26 -158.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.495 -0.775 . . . . 1.6399999999999999 110.74 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.72 19.62 36.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.511 -0.852 . . . . 0.95999999999999996 112.248 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.528 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 68.7 mt -75.12 -176.97 3.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 2.02 110.607 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -144.59 144.29 31.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 1.55 110.68 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -70.67 146.92 49.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 1.9099999999999999 110.971 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.2 t0 60.4 41.23 16.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.551 . . . . 1.8700000000000001 111.16 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -150.69 124.67 9.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.732 0.301 . . . . 1.2 111.347 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 1.1100000000000001 110.056 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 68.8 m-85 -126.86 126.15 42.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.143 0.794 . . . . 1.0800000000000001 113.143 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -100.01 137.72 38.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.219 -0.66 . . . . 1.5 109.219 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.55 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.89 116.88 23.64 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.486 0.921 . . . . 0.79000000000000004 113.486 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -102.25 145.76 28.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.855 -0.612 . . . . 2.6899999999999999 110.967 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.457 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -105.94 104.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.479 0.548 . . . . 1.5700000000000001 112.479 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 30.2 mt -105.03 147.77 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.9 -1.519 . . . . 1.3200000000000001 106.9 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 36' ' ' TYR . . . -166.04 144.04 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.16 -1.016 . . . . 1.1100000000000001 112.74 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.02 -172.35 4.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 2.3500000000000001 110.136 179.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 50.0 p30 -126.09 -128.52 0.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.391 -0.368 . . . . 2.7000000000000002 110.279 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -116.06 -28.15 6.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.158 0.89 . . . . 1.3400000000000001 111.24 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -82.02 4.75 21.66 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.179 0.437 . . . . 1.4299999999999999 112.179 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.13 78.73 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.425 -0.893 . . . . 1.3799999999999999 113.303 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.8 161.98 28.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.118 0.459 . . . . 1.49 110.448 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 2.9 tp -115.26 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.48 112.629 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 2.0 p -74.48 113.72 26.76 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.262 -0.644 . . . . 0.81000000000000005 109.262 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.35 163.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.749 2.3 . . . . 1.25 113.041 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 28.1 Cg_endo -63.99 144.96 89.18 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.826 2.351 . . . . 1.2 113.126 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -98.99 127.17 44.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.593 -0.73 . . . . 1.76 109.963 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt0 -20.97 98.33 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 O-C-N 124.587 1.179 . . . . 1.77 113.067 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 42.0 Cg_exo -35.67 166.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.57 2.847 . . . . 1.01 115.574 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 1.5 m -93.32 141.49 28.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 113.696 -1.593 . . . . 1.55 109.02 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.87 139.42 0.65 Allowed 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 123.731 0.644 . . . . 1.6299999999999999 111.412 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -70.37 102.23 2.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.017 -0.538 . . . . 1.0900000000000001 109.923 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.474 HD12 ' CE2' ' A' ' 74' ' ' PHE . 4.4 mp -84.26 111.74 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.941 0.401 . . . . 1.1299999999999999 111.226 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' ALA . 66.8 m -47.63 -30.11 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 1.1299999999999999 111.254 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 69' ' ' ASP . 79.2 m 49.6 89.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 1.5700000000000001 110.323 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.486 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.77 -85.95 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 3.7000000000000002 111.28 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.486 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.5 p-10 -101.72 2.37 38.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 2.1400000000000001 111.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.053 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 112.359 0.503 . . . . 2.0600000000000001 112.359 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' ASP . 4.9 tt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.067 0.461 . . . . 1.26 111.312 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.325 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -133.86 128.17 19.65 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.615 -0.721 . . . . 2.0 109.875 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.62 176.37 9.17 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.42 2.08 . . . . 0.58999999999999997 112.379 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 21.0 Cg_exo -65.39 178.29 2.17 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.809 2.339 . . . . 1.6100000000000001 112.729 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.06 172.49 55.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.988 -0.625 . . . . 0.97999999999999998 112.614 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.826 ' HZ3' ' CD ' ' A' ' 90' ' ' GLU . 10.0 tttp -58.66 120.44 45.49 Favored Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.021 -0.105 . . . . 2.04 110.722 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 22.2 Cg_exo -67.58 127.09 15.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.077 . . . . 0.54000000000000004 112.802 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 11.6 p -133.18 107.46 12.37 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 115.821 -0.627 . . . . 1.6799999999999999 111.158 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.1 Cg_exo -37.67 142.58 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.827 2.352 . . . . 0.64000000000000001 113.292 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.71 -44.63 6.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.747 -1.115 . . . . 2.1699999999999999 108.372 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.8 t30 -148.11 155.61 41.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.997 -1.456 . . . . 0.84999999999999998 109.061 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 1.01 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -143.85 100.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.436 -0.505 . . . . 1.5700000000000001 111.69 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.252 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -98.87 50.13 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.943 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.842 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.68 -70.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.998 0.811 . . . . 2.9100000000000001 112.075 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 8.4 m170 -77.41 -26.85 52.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 1.3300000000000001 111.255 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -125.23 112.12 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.819 0.343 . . . . 1.28 111.148 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 13' ' ' ILE . 72.9 t -107.23 110.68 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.086 -0.506 . . . . 1.49 111.171 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 79.4 m -88.43 149.19 23.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 1.1399999999999999 110.678 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.88 154.71 38.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.533 0.682 . . . . 1.3100000000000001 112.148 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' O ' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -143.86 144.83 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.737 -1.12 . . . . 2.3100000000000001 110.171 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 10.9 p90 -140.57 -172.31 3.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 0.40000000000000002 111.545 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.73 159.36 14.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.319 0.581 . . . . 1.1100000000000001 112.337 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.422 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.4 139.59 28.36 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.32 -0.854 . . . . 2.5600000000000001 110.057 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -44.85 169.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.336 2.024 . . . . 1.1100000000000001 111.869 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -119.04 -4.87 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.099 0.407 . . . . 2.77 112.099 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.727 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.5 t80 -141.42 -73.89 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 1.6899999999999999 111.933 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 1.325 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.8 p 79.6 -39.28 0.2 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.225 0.61 . . . . 1.3500000000000001 112.315 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.7 -82.81 0.33 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.498 -0.858 . . . . 1.01 111.554 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.18 27.57 0.79 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.114 -1.194 . . . . 0.97999999999999998 110.114 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.523 ' CE2' ' OD1' ' A' ' 80' ' ' ASN . 1.7 m-85 -116.94 -177.07 3.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.705 -0.748 . . . . 0.98999999999999999 111.404 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.56 -3.06 2.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.652 -0.704 . . . . 2.6899999999999999 111.923 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 25' ' ' PRO . 15.0 mt 60.76 140.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 120.8 0.334 . . . . 1.71 110.506 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -123.96 6.74 8.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.359 0.503 . . . . 1.6599999999999999 112.359 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.0 162.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.134 0.492 . . . . 1.97 111.965 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 42.5 m-85 -128.76 101.11 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.411 -0.813 . . . . 1.23 110.3 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -87.62 122.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.623 -0.262 . . . . 1.76 110.888 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.84 128.61 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.044 0.449 . . . . 1.6100000000000001 110.815 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.458 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mt-10 -90.0 136.17 33.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.91 -0.586 . . . . 1.6699999999999999 112.227 -179.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HG3' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -99.8 132.43 45.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.419 0.896 . . . . 2.4399999999999999 113.419 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 7.5 ttm180 -115.4 107.61 15.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.484 . . . . 1.79 110.077 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 90.6 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.869 -0.605 . . . . 1.5900000000000001 111.015 -179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 15.8 mt -66.05 150.22 96.9 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.45 -0.341 . . . . 1.4299999999999999 110.611 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.78 -9.25 47.24 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.086 -1.214 . . . . 1.47 112.794 0.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -60.26 -61.98 2.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.907 0.384 . . . . 2.6600000000000001 110.725 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.36 142.92 6.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.916 -0.659 . . . . 1.6200000000000001 112.839 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 176.3 64.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 3.0600000000000001 110.692 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 80.9 m95 -33.89 98.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.446 -0.797 . . . . 1.0600000000000001 111.881 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.23 139.52 53.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.189 0.519 . . . . 1.8400000000000001 112.271 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 mtmt -57.33 86.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.549 -0.751 . . . . 1.77 110.868 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -59.31 -51.98 67.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 1.4099999999999999 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.476 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 7.0 p-10 -61.49 150.94 34.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.0099999999999998 111.189 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.88 27.67 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.786 -0.643 . . . . 2.6400000000000001 110.544 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -130.68 30.41 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 2.0299999999999998 110.727 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.52 111.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 1.8700000000000001 110.734 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.491 HD12 ' CG ' ' A' ' 61' ' ' PHE . 19.6 mt -101.32 71.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 1.3700000000000001 111.275 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -50.84 -80.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.489 . . . . 2.1499999999999999 110.85 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.97 168.63 5.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.996 -0.372 . . . . 1.54 109.996 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -88.81 47.11 1.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.992 0.425 . . . . 1.75 111.533 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -144.32 101.28 3.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 2.0499999999999998 109.308 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CG ' HD12 ' A' ' 56' ' ' ILE . 77.0 t80 -134.53 165.22 25.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.56999999999999995 112.135 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 85.1 m -131.27 116.59 17.82 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.489 -0.778 . . . . 1.1399999999999999 110.861 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 63' ' ' VAL . 7.2 m -77.42 110.06 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.72 111.045 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.24 126.18 51.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.059 -0.518 . . . . 1.6399999999999999 111.098 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.97 -1.31 2.8 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.539 -0.839 . . . . 0.95999999999999996 113.659 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.453 HD12 ' NZ ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -51.77 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.189 0.519 . . . . 2.02 111.302 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.1 m -135.45 117.02 14.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.631 -0.713 . . . . 1.55 110.7 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.3 132.53 12.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.061 -0.518 . . . . 1.9099999999999999 111.32 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 73.77 67.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 1.8700000000000001 111.243 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.27 124.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.2 111.064 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.433 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -69.37 130.81 43.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 1.1100000000000001 110.454 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.514 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 38.4 m-85 -126.07 122.93 37.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 1.0800000000000001 112.017 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.2 tt0 -107.22 141.32 38.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.282 -0.636 . . . . 1.5 109.282 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -141.55 125.16 16.8 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.153 1.168 . . . . 0.79000000000000004 114.153 -179.24 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HB3' ' CD ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -100.38 165.83 11.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.034 -0.53 . . . . 2.6899999999999999 109.78 178.592 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -122.95 114.08 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 113.557 0.947 . . . . 1.5700000000000001 113.557 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.451 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 56.6 mt -108.11 154.85 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.562 -1.644 . . . . 1.3200000000000001 106.562 177.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -167.39 131.27 1.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.955 -1.098 . . . . 1.1100000000000001 113.473 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -83.67 143.32 30.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.655 -0.702 . . . . 2.3500000000000001 109.288 178.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -78.89 -106.71 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.077 -0.511 . . . . 2.7000000000000002 111.902 -178.952 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.01 -28.36 2.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.783 0.72 . . . . 1.3400000000000001 112.622 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -94.85 20.78 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.429 0.529 . . . . 1.4299999999999999 112.429 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 87.72 -17.04 47.49 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.378 -0.915 . . . . 1.3799999999999999 112.772 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.339 . . . . 1.49 110.414 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 2.4 tt -77.81 112.18 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.494 . . . . 1.48 112.005 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.5 p -66.06 122.11 79.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.854 -0.612 . . . . 0.81000000000000005 109.896 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -35.04 158.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.415 2.744 . . . . 1.25 113.45 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 12.0 Cg_exo -71.22 148.21 55.23 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.871 2.381 . . . . 1.2 112.423 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -97.32 129.49 44.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 1.76 109.748 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.826 ' CD ' ' HZ3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -30.8 111.67 0.29 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.805 0.691 . . . . 1.77 112.372 -179.476 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.7 Cg_exo -37.93 148.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.762 2.308 . . . . 1.01 113.629 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -85.66 139.66 31.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.062 -0.972 . . . . 1.55 109.457 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -32.72 139.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.28 0.988 . . . . 1.6299999999999999 112.363 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.483 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -75.47 109.93 9.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.558 -0.746 . . . . 1.0900000000000001 110.731 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -92.54 115.77 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.029 0.443 . . . . 1.1299999999999999 111.225 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.1 m -47.22 -30.81 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.869 -0.605 . . . . 1.1299999999999999 111.535 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 91.5 m 54.19 62.39 2.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.91 0.386 . . . . 1.5700000000000001 110.182 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.71 -86.84 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 3.7000000000000002 111.623 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -116.83 28.33 8.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 2.1400000000000001 110.662 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.252 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 2.0600000000000001 111.543 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.418 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 2.0 tt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.917 0.389 . . . . 1.26 111.842 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.42 137.0 23.69 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.055 -0.52 . . . . 2.0 110.419 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 160.14 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.443 2.096 . . . . 0.58999999999999997 112.418 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 46.3 Cg_exo -56.32 172.3 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.822 2.348 . . . . 1.6100000000000001 112.98 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.88 174.21 20.69 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.97999999999999998 112.817 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -66.63 138.08 95.36 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 110.544 -0.169 . . . . 2.04 110.544 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 7.2 Cg_exo -77.87 139.32 17.43 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.818 2.345 . . . . 0.54000000000000004 112.502 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.9 126.37 7.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.33 -0.395 . . . . 1.6799999999999999 111.456 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -66.87 141.21 58.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.76 2.307 . . . . 0.64000000000000001 113.757 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 21' ' ' LYS . 1.4 mm? -107.32 -36.17 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.627 -0.879 . . . . 2.1699999999999999 108.627 178.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.411 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.4 t30 -139.36 150.73 45.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.614 -1.176 . . . . 0.84999999999999998 108.297 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' CG2' HG12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -143.86 101.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.259 -0.576 . . . . 1.5700000000000001 112.068 -179.279 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -93.89 56.89 2.37 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 115.881 -0.599 . . . . 1.46 110.863 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.84 -74.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.024 0.827 . . . . 2.9100000000000001 112.886 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -73.99 -37.8 64.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.99 0.367 . . . . 1.3300000000000001 111.99 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.3 p -122.46 110.27 15.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.718 0.294 . . . . 1.28 111.02 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.531 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 4.1 m -99.29 152.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.886 0.374 . . . . 1.49 111.288 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.9 m -118.21 123.92 46.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 1.1399999999999999 111.32 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.52 162.74 32.27 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.413 0.625 . . . . 1.3100000000000001 111.336 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.956 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -151.3 158.46 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 2.3100000000000001 110.12 179.384 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.6 p90 -137.42 -167.82 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.40000000000000002 111.316 -179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.11 -166.59 1.45 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.354 0.597 . . . . 1.1100000000000001 112.367 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HD3' ' HG2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -114.59 141.45 26.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.148 -0.933 . . . . 2.5600000000000001 110.228 -179.858 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 12.1 Cg_endo -55.35 172.63 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.247 1.965 . . . . 1.1100000000000001 112.186 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.26 -39.17 2.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 2.77 111.106 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.28 71.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 1.6899999999999999 111.478 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 73.8 p -91.01 44.24 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.501 -0.318 . . . . 1.3500000000000001 110.539 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.07 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.704 -0.76 . . . . 1.01 112.501 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.95 49.26 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.987 -1.245 . . . . 0.97999999999999998 109.987 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -136.57 177.45 7.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.984 -0.608 . . . . 0.98999999999999999 110.929 -178.208 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -138.53 6.31 2.5 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.09 0.404 . . . . 2.6899999999999999 112.09 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 3.5 mt 58.52 150.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 120.851 0.358 . . . . 1.71 111.042 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -131.73 15.09 4.87 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.0 0.37 . . . . 1.6599999999999999 112.0 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 42.3 t 179.25 124.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 1.97 111.092 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 22.8 m-85 -105.38 88.21 2.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 1.23 111.195 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.458 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.4 mm -69.39 151.96 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.95 -0.3 . . . . 1.76 110.323 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.17 103.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.272 0.558 . . . . 1.6100000000000001 110.782 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.51 161.92 29.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.367 -0.833 . . . . 1.6699999999999999 110.04 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HG2' ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -136.41 153.35 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 2.4399999999999999 111.391 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 23.7 ttm180 -134.69 121.33 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 1.79 110.801 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.809 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.56 91.62 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.593 . . . . 1.5900000000000001 110.859 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -56.3 152.52 23.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 1.4299999999999999 110.53 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.37 30.4 11.85 Favored 'Cis proline' 0 C--N 1.348 0.533 0 C-N-CA 123.911 -1.287 . . . . 1.47 112.573 0.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.99 99.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.368 . . . . 2.6600000000000001 111.139 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.809 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -135.35 -123.12 2.29 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.685 -0.769 . . . . 1.6200000000000001 112.89 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -135.03 -169.83 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.431 0.158 . . . . 3.0600000000000001 110.716 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.497 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 4.4 m95 -136.33 49.67 2.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 1.0600000000000001 110.946 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.5 148.3 25.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.8400000000000001 111.231 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 8.2 ptmm? -79.16 89.61 4.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.127 -0.488 . . . . 1.77 110.875 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.422 ' HB1' ' HG2' ' A' ' 40' ' ' LYS . . . -49.02 -41.83 36.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.01 0.433 . . . . 1.4099999999999999 110.575 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 8.8 t30 -60.46 100.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.796 -0.638 . . . . 2.0099999999999998 110.159 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -104.86 28.66 6.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 2.6400000000000001 111.321 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.3 t -130.47 -70.64 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.344 . . . . 2.0299999999999998 111.005 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 170.58 153.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 1.8700000000000001 110.588 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 56' ' ' ILE . 16.8 mt -142.09 56.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 1.3700000000000001 111.253 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 tp -48.46 -38.24 19.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 2.1499999999999999 110.747 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.77 166.74 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 1.54 110.161 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 56.6 p30 -89.22 15.12 9.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.496 -0.32 . . . . 1.75 111.651 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.956 ' OE1' ' HB3' ' A' ' 21' ' ' LYS . 19.7 tp10 -122.71 99.56 6.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 2.0499999999999998 109.615 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 52' ' ' ASN . 26.1 t80 -131.71 166.6 21.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.007 0.432 . . . . 0.56999999999999995 111.424 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.498 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 21.6 m -117.58 120.67 38.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.713 -0.676 . . . . 1.1399999999999999 111.076 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -84.14 104.29 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.16 0.505 . . . . 1.72 111.507 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -168.64 1.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.461 -0.79 . . . . 1.6399999999999999 110.404 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.44 11.82 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.572 -0.823 . . . . 0.95999999999999996 112.893 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 16.2 mt -69.18 -159.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.927 -0.397 . . . . 2.02 109.927 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.7 m -147.69 147.73 30.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.902 0.382 . . . . 1.55 110.594 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.78 145.82 30.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 1.9099999999999999 110.988 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t0 67.65 39.4 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 1.8700000000000001 111.058 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.95 122.91 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 1.2 111.452 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -68.78 133.22 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.884 -0.413 . . . . 1.1100000000000001 109.884 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 35.6 m-85 -124.38 127.37 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.691 0.626 . . . . 1.0800000000000001 112.691 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CG ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -98.05 138.24 35.66 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.178 -1.045 . . . . 1.5 108.178 178.225 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.42 108.7 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.523 -1.271 . . . . 0.79000000000000004 113.937 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' NH1' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -88.67 159.72 17.7 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.112 -0.329 . . . . 2.6899999999999999 110.112 179.041 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.458 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 64.6 t -121.2 122.84 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.427 0.632 . . . . 1.5700000000000001 112.585 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 39.5 mt -117.06 155.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.719 -1.215 . . . . 1.3200000000000001 107.719 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -172.4 138.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.378 -0.929 . . . . 1.1100000000000001 112.178 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 5.2 ptpt -84.57 176.53 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 2.3500000000000001 110.766 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 2.4 p-10 -124.57 163.61 21.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.871 -0.604 . . . . 2.7000000000000002 111.208 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -47.82 -25.53 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 1.3400000000000001 111.906 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -77.22 -12.39 59.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.897 0.332 . . . . 1.4299999999999999 111.897 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 -17.75 57.68 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.49 -0.862 . . . . 1.3799999999999999 112.425 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.33 -162.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.54 0.209 . . . . 1.49 110.492 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -145.0 105.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 1.48 112.001 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -63.44 119.56 54.55 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.81000000000000005 108.734 179.175 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.98 159.25 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.89 2.393 . . . . 1.25 113.242 -179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 24.0 Cg_endo -62.56 150.78 86.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.907 2.405 . . . . 1.2 113.264 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 m -106.53 132.8 52.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.805 . . . . 1.76 109.651 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 13.7 tt0 -30.25 111.91 0.29 Allowed Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.867 0.73 . . . . 1.77 112.325 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.49 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 71.7 Cg_exo -45.66 139.57 10.15 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.787 2.324 . . . . 1.01 114.324 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.479 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -53.75 144.54 17.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.834 -0.802 . . . . 1.55 108.834 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 4.7 m-20 -14.62 -89.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.743 1.902 . . . . 1.6299999999999999 113.793 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . 158.43 106.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.967 0.907 . . . . 1.0900000000000001 109.239 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.9 mp -98.04 112.99 31.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.756 -0.378 . . . . 1.1299999999999999 111.956 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.4 m -47.44 -32.53 5.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.869 -0.605 . . . . 1.1299999999999999 110.276 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 92.8 m 55.65 82.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.839 -0.618 . . . . 1.5700000000000001 110.163 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -88.19 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.743 -0.662 . . . . 3.7000000000000002 111.392 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -124.77 9.02 8.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.478 -0.328 . . . . 2.1400000000000001 111.568 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.3 t0 . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.969 0.414 . . . . 2.0600000000000001 110.893 179.862 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.431 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.914 0.387 . . . . 1.26 111.22 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.3 m-20 -128.87 132.09 24.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.077 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 158.1 53.15 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.368 2.045 . . . . 0.58999999999999997 112.4 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 9.9 Cg_endo -52.03 175.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.943 2.429 . . . . 1.6100000000000001 112.763 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.91 168.62 49.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.024 -0.608 . . . . 0.97999999999999998 112.665 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.73 121.89 61.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 110.461 -0.199 . . . . 2.04 110.461 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 32.1 Cg_exo -62.17 147.85 94.29 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.426 2.084 . . . . 0.54000000000000004 112.451 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.52 110.48 2.97 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.314 -0.403 . . . . 1.6799999999999999 111.954 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.5 Cg_exo -59.63 127.34 23.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.613 2.209 . . . . 0.64000000000000001 113.52 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.483 HD22 ' OE2' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -94.16 -26.37 16.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.373 -0.831 . . . . 2.1699999999999999 109.081 178.512 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 7.5 t30 -145.85 149.53 34.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.696 -0.684 . . . . 0.84999999999999998 109.897 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -151.56 103.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.415 . . . . 1.5700000000000001 111.132 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.218 ' CA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.48 60.42 0.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.883 -0.599 . . . . 1.46 111.544 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.166 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 59.12 -70.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.671 0.607 . . . . 2.9100000000000001 112.445 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.0 m170 -87.31 -27.18 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.185 -0.461 . . . . 1.3300000000000001 111.762 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.8 p -111.86 103.47 11.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 1.28 111.424 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 74' ' ' PHE . 86.9 t -102.07 95.73 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.038 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 12' ' ' ASN . 78.3 m -80.96 142.52 33.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.248 -0.433 . . . . 1.1399999999999999 111.636 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -154.85 164.77 38.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.43 -0.805 . . . . 1.3100000000000001 112.009 -179.702 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.836 ' HB3' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.47 176.14 10.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.107 -0.951 . . . . 2.3100000000000001 109.302 178.448 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 18.8 p90 -158.01 -177.54 6.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.275 0.56 . . . . 0.40000000000000002 112.303 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.28 178.65 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.147 -0.933 . . . . 1.1100000000000001 110.65 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 157.07 40.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.403 -0.362 . . . . 2.5600000000000001 110.21 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 37.1 Cg_exo -56.45 -157.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.506 2.138 . . . . 1.1100000000000001 112.443 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -26.19 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.32 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -134.24 -67.73 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.856 0.317 . . . . 1.6899999999999999 111.856 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 2.8 p 65.31 34.63 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 1.3500000000000001 110.515 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.39 -95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.53 -0.843 . . . . 1.01 111.813 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.65 28.85 1.46 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.526 -1.029 . . . . 0.97999999999999998 110.526 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -107.01 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.193 -0.503 . . . . 0.98999999999999999 111.591 -178.947 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -133.41 -0.41 3.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.66 -0.7 . . . . 2.6899999999999999 111.706 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 mt 60.89 129.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 120.932 0.396 . . . . 1.71 110.901 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -116.71 25.99 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.442 -0.345 . . . . 1.6599999999999999 111.63 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m 172.09 164.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 1.97 111.169 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 40.7 m-85 -142.36 106.18 4.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 1.23 110.504 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.35 94.62 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 1.76 111.039 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -86.42 114.58 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 1.6100000000000001 110.75 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 2.0 mm-40 -86.0 156.79 20.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.634 -0.712 . . . . 1.6699999999999999 110.922 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.62 142.99 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.4399999999999999 111.316 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -119.03 114.01 21.84 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.037 -0.529 . . . . 1.79 110.584 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.74 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.7 102.08 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.5900000000000001 110.492 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 46.8 mt -80.09 156.12 74.52 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.964 -0.562 . . . . 1.4299999999999999 110.583 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 89.1 Cg_endo -86.26 28.64 9.63 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.88 -1.3 . . . . 1.47 113.489 0.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.3 -86.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.636 0.255 . . . . 2.6600000000000001 110.555 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 117.43 170.69 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.456 -0.878 . . . . 1.6200000000000001 113.208 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.74 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 1.0 OUTLIER 176.68 -35.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.407 . . . . 3.0600000000000001 110.566 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 34.0 m95 62.92 81.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 1.0600000000000001 111.406 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -122.54 128.67 51.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.759 -0.655 . . . . 1.8400000000000001 110.234 179.786 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -55.11 87.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 1.77 110.76 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -51.4 -47.56 62.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.4099999999999999 111.226 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.441 ' O ' ' CB ' ' A' ' 53' ' ' PHE . 2.0 t30 -44.79 -79.2 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 2.0099999999999998 110.983 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER 84.46 -43.12 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.181 0.437 . . . . 2.6400000000000001 112.181 179.624 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.2 m -67.02 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 2.0299999999999998 111.28 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 140.13 1.05 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 1.8700000000000001 110.798 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.501 HG12 ' CD1' ' A' ' 61' ' ' PHE . 51.4 mt -130.16 67.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 1.3700000000000001 110.982 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.09 -65.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.463 . . . . 2.1499999999999999 110.751 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.42 179.27 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.549 . . . . 1.54 110.115 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 5.3 p-10 -93.7 13.24 22.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.398 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.836 ' CD ' ' HB3' ' A' ' 21' ' ' LYS . 16.1 tp10 -117.63 105.48 12.08 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.981 -0.377 . . . . 2.0499999999999998 109.981 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 62' ' ' THR . 37.3 t80 -137.51 165.99 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.56999999999999995 111.156 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.51 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -122.53 120.42 33.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.919 -0.582 . . . . 1.1399999999999999 111.372 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 5.5 t -83.17 85.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 1.72 111.029 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -86.98 -169.78 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.618 -0.719 . . . . 1.6399999999999999 110.632 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.22 25.1 46.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.95999999999999996 112.411 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 44.1 mt -77.63 -178.04 5.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 2.02 111.104 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 134.14 54.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 1.55 110.496 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.68 152.09 28.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 1.9099999999999999 111.223 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.73 60.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 1.8700000000000001 110.985 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.13 130.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 1.2 111.359 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 94' ' ' ALA . . . -71.72 128.63 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 1.1100000000000001 110.194 179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -124.21 124.92 43.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.846 0.684 . . . . 1.0800000000000001 112.846 -178.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 19.8 mt-10 -100.03 141.12 33.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.798 -0.815 . . . . 1.5 108.798 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -130.88 120.8 24.17 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.358 1.244 . . . . 0.79000000000000004 114.358 -178.704 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -105.47 169.85 8.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.746 -0.661 . . . . 2.6899999999999999 109.778 178.493 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 61.2 t -125.54 105.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.428 0.899 . . . . 1.5700000000000001 113.428 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.44 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 44.3 mt -100.59 130.57 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 106.934 -1.506 . . . . 1.3200000000000001 106.934 177.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 36' ' ' TYR . . . -156.91 147.74 21.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.452 -0.899 . . . . 1.1100000000000001 113.046 -178.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.3 mttt -77.31 -167.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 2.3500000000000001 110.345 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 49.7 p30 -129.78 -119.5 0.23 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.475 -0.565 . . . . 2.7000000000000002 109.475 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.02 1.14 5.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.49 1.041 . . . . 1.3400000000000001 111.71 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -112.01 4.32 18.02 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.597 0.221 . . . . 1.4299999999999999 111.597 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.84 -11.76 64.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.344 -0.932 . . . . 1.3799999999999999 112.929 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.96 177.03 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.936 0.368 . . . . 1.49 110.394 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -130.88 101.31 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 1.48 111.989 -179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -57.57 118.35 24.91 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.553 -0.906 . . . . 0.81000000000000005 108.553 178.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.8 171.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.896 2.397 . . . . 1.25 113.313 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 6.7 Cg_exo -71.3 130.73 17.9 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.778 2.318 . . . . 1.2 112.778 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -87.86 108.26 19.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.765 -0.652 . . . . 1.76 109.932 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 89' ' ' SER . 1.6 mt-10 -10.3 115.3 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.458 1.103 . . . . 1.77 113.401 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 89.2 Cg_exo -47.91 163.34 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.736 2.291 . . . . 1.01 114.217 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.38 151.99 19.95 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 1.55 109.48 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -32.33 140.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 124.3 1.0 . . . . 1.6299999999999999 112.455 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -79.01 113.08 16.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.767 -0.651 . . . . 1.0900000000000001 111.138 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.57 116.29 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 1.1299999999999999 110.828 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.6 m -46.17 -26.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.885 -0.598 . . . . 1.1299999999999999 111.47 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.2 m 47.34 78.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.571 -0.286 . . . . 1.5700000000000001 111.273 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -121.87 -79.55 0.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.096 0.474 . . . . 3.7000000000000002 110.99 179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.66 26.33 8.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.52 -0.764 . . . . 2.1400000000000001 110.451 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.218 ' OD1' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.002 -0.545 . . . . 2.0600000000000001 111.225 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.0 tt . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.735 0.302 . . . . 1.26 111.064 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 13.1 m-20 -136.77 133.48 18.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 2.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.67 174.95 9.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.665 2.243 . . . . 0.58999999999999997 112.439 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 24.5 Cg_exo -63.97 -164.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.9 2.4 . . . . 1.6100000000000001 113.175 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -102.38 -151.89 24.0 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.675 -0.693 . . . . 0.97999999999999998 112.852 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.24 125.24 64.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.056 -0.085 . . . . 2.04 110.791 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 4.3 Cg_exo -80.09 141.79 14.95 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.763 2.308 . . . . 0.54000000000000004 112.314 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.23 116.11 4.7 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.077 -0.511 . . . . 1.6799999999999999 111.463 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 19' ' ' THR . 23.0 Cg_exo -62.0 104.22 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.577 2.185 . . . . 0.64000000000000001 113.081 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -64.99 -35.05 79.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.48 0.657 . . . . 2.1699999999999999 109.601 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.6 t30 -140.3 153.49 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.941 -1.027 . . . . 0.84999999999999998 108.77 179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 13' ' ' ILE . 1.2 pt -144.88 108.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.704 -0.399 . . . . 1.5700000000000001 111.882 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -101.48 59.89 0.89 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.106 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 49.34 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.951 0.782 . . . . 2.9100000000000001 112.59 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 14' ' ' THR . 31.8 m170 -82.27 -34.72 28.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.231 -0.441 . . . . 1.3300000000000001 111.609 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -119.05 106.19 12.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.883 0.373 . . . . 1.28 110.923 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 10.3 m -104.57 154.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 1.49 111.163 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.4 m -123.07 123.63 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.1399999999999999 111.259 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -131.2 159.58 37.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 111.714 179.212 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 2.0 tppt? -140.83 157.24 45.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.814 -1.085 . . . . 2.3100000000000001 109.776 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 25.5 p90 -149.12 -176.1 5.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.294 0.568 . . . . 0.40000000000000002 112.264 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -94.49 121.87 36.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.399 -0.819 . . . . 1.1100000000000001 110.7 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 150.12 96.41 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 121.0 -0.28 . . . . 2.5600000000000001 110.576 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.472 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 77.6 Cg_exo -43.52 173.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 1.1100000000000001 112.823 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -26.16 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.145 0.424 . . . . 2.77 112.145 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -124.45 -70.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.178 0.436 . . . . 1.6899999999999999 112.178 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 20.0 p 56.04 55.01 7.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.713 0.292 . . . . 1.3500000000000001 110.655 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.82 -93.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.055 -0.521 . . . . 1.01 112.657 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.54 34.48 0.89 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.127 -1.589 . . . . 0.97999999999999998 109.127 178.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.474 ' HB3' ' CB ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -113.63 142.99 45.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.275 -0.963 . . . . 0.98999999999999999 111.54 -178.318 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -92.25 -8.18 46.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.112 -0.495 . . . . 2.6899999999999999 111.459 179.606 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 16.2 mt 71.47 -75.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 1.71 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p 72.96 18.34 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.838 0.31 . . . . 1.6599999999999999 111.838 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.5 OUTLIER 179.85 145.8 0.21 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.073 0.463 . . . . 1.97 112.121 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -133.05 104.14 6.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.859 -0.61 . . . . 1.23 111.083 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 15.3 mt -78.66 93.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 1.76 110.463 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 1.5 p -91.08 106.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 1.6100000000000001 111.384 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.4 mm-40 -71.29 167.13 20.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.372 -0.831 . . . . 1.6699999999999999 111.143 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.74 151.99 49.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 2.4399999999999999 111.399 -179.716 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.3 ttm180 -138.49 104.61 5.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 1.79 109.904 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.35 105.84 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.5900000000000001 111.027 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.94 151.06 81.84 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 1.4299999999999999 110.641 179.742 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -92.87 22.15 30.1 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.987 -1.256 . . . . 1.47 112.576 0.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -148.64 75.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 2.6600000000000001 111.274 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -131.67 177.46 18.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 1.6200000000000001 112.415 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.69 -148.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.595 -0.15 . . . . 3.0600000000000001 110.595 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 16.1 m95 -136.71 74.27 1.48 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.996 0.427 . . . . 1.0600000000000001 110.981 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.81 137.16 48.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.829 -0.623 . . . . 1.8400000000000001 110.795 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 14.9 ptmt -52.54 92.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.06 -0.518 . . . . 1.77 111.837 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.458 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -54.15 -49.11 70.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.456 0.646 . . . . 1.4099999999999999 109.867 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 3.1 t30 -44.43 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.1 -0.955 . . . . 2.0099999999999998 110.822 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.7 43.09 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 2.6400000000000001 110.774 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -152.35 -71.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 2.0299999999999998 111.119 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 179.24 143.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.8700000000000001 110.888 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.494 HG12 ' CD1' ' A' ' 61' ' ' PHE . 37.2 mt -149.14 64.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 1.3700000000000001 110.975 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -46.22 -69.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 2.1499999999999999 111.345 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.56 179.57 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.502 -0.317 . . . . 1.54 110.741 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -86.53 10.62 14.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.699 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -107.98 104.32 13.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.551 -0.537 . . . . 2.0499999999999998 109.551 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 52' ' ' ASN . 43.6 t80 -131.13 164.27 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.391 0.615 . . . . 0.56999999999999995 111.84 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.6 m -127.91 115.74 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.966 -1.016 . . . . 1.1399999999999999 109.506 179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 15.4 t -76.09 111.6 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.042 0.448 . . . . 1.72 111.701 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 140.23 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.637 -0.71 . . . . 1.6399999999999999 110.706 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.07 7.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 0.95999999999999996 112.569 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -50.94 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.963 0.411 . . . . 2.02 111.042 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -142.43 154.69 44.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 1.55 110.568 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.97 143.74 47.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 1.9099999999999999 110.937 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 67.43 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 1.8700000000000001 111.418 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.53 124.66 0.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.746 0.307 . . . . 1.2 111.564 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 137.53 51.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 1.1100000000000001 110.147 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -131.78 118.83 20.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.291 0.848 . . . . 1.0800000000000001 113.291 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -100.59 140.5 34.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.157 -0.683 . . . . 1.5 109.157 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 2.2 m-85 -123.06 106.72 11.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.419 1.266 . . . . 0.79000000000000004 114.419 -178.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -76.08 151.81 36.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.643 -0.708 . . . . 2.6899999999999999 110.292 178.602 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.439 HG22 ' CG ' ' A' ' 8' ' ' PRO . 45.2 t -125.42 118.3 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.092 0.473 . . . . 1.5700000000000001 112.242 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 65.4 mt -124.69 163.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.849 -0.797 . . . . 1.3200000000000001 108.849 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -163.13 127.64 2.99 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.826 -0.749 . . . . 1.1100000000000001 112.124 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.433 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -87.44 24.4 1.66 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.622 0.601 . . . . 2.3500000000000001 112.622 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' A' ' 28' ' ' THR . 2.8 m120 44.4 -173.31 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.502 0.668 . . . . 2.7000000000000002 112.643 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -63.7 -37.07 85.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.299 -0.864 . . . . 1.3400000000000001 112.347 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.06 33.71 3.17 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.964 0.728 . . . . 1.4299999999999999 112.964 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' LYS . . . 65.24 9.89 44.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.255 -0.974 . . . . 1.3799999999999999 113.37 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . -66.4 103.17 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.177 -0.675 . . . . 1.49 109.177 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.32 110.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.678 0.752 . . . . 1.48 112.579 -178.486 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 41.1 p -87.88 110.87 38.53 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.651 -1.159 . . . . 0.81000000000000005 108.673 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -35.03 160.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.641 2.894 . . . . 1.25 113.609 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 24.1 Cg_exo -62.46 150.52 87.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.78 2.32 . . . . 1.2 112.8 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.0 m -120.88 108.9 14.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.587 -0.733 . . . . 1.76 109.8 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -6.0 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 124.534 1.146 . . . . 1.77 113.317 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HG2' ' CZ2' ' A' ' 48' ' ' TRP . 56.7 Cg_exo -50.4 135.63 39.69 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.508 2.139 . . . . 1.01 113.763 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -53.48 152.13 5.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.648 -0.871 . . . . 1.55 108.648 178.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -41.87 154.72 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.769 0.668 . . . . 1.6299999999999999 110.616 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -85.41 114.16 22.25 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.658 -0.701 . . . . 1.0900000000000001 110.03 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.53 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.2 mp -92.94 113.15 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 1.1299999999999999 111.084 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.6 m -51.13 -27.07 7.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.53 . . . . 1.1299999999999999 110.678 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.6 m 53.22 84.82 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.5700000000000001 110.539 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -97.38 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.547 -0.297 . . . . 3.7000000000000002 111.499 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.611 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -93.21 0.67 57.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.651 0.241 . . . . 2.1400000000000001 111.651 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.13 0 N-CA-C 112.016 0.376 . . . . 2.0600000000000001 112.016 179.72 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.426 HD13 ' ND2' ' A' ' 80' ' ' ASN . 4.5 tt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.873 0.368 . . . . 1.26 110.844 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.267 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.62 127.65 18.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 2.0 110.596 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 154.62 31.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.405 2.07 . . . . 0.58999999999999997 112.186 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 1.9 Cg_endo -45.68 176.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.897 2.398 . . . . 1.6100000000000001 112.79 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.65 170.64 50.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.896 -0.668 . . . . 0.97999999999999998 112.649 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.2 tttp -56.59 128.62 75.19 Favored Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 110.185 -0.302 . . . . 2.04 110.185 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 6.2 Cg_exo -80.35 133.56 9.72 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.628 2.219 . . . . 0.54000000000000004 112.109 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 9.4 p -126.85 117.27 22.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 1.6799999999999999 110.948 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 19' ' ' THR . 25.3 Cg_exo -63.03 93.05 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.479 2.119 . . . . 0.64000000000000001 113.032 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD13 ' CB ' ' A' ' 21' ' ' LYS . 1.8 mt -52.85 -42.08 64.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.636 0.732 . . . . 2.1699999999999999 109.14 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.44 151.69 51.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.626 -1.17 . . . . 0.84999999999999998 108.456 178.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 13' ' ' ILE . 2.3 pt -142.84 100.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.386 -0.525 . . . . 1.5700000000000001 112.346 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.77 144.19 27.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 1.46 110.211 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -47.63 -24.34 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.389 0.514 . . . . 2.9100000000000001 112.389 -179.091 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.444 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 6.7 m-70 -130.37 30.76 4.69 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.904 -0.318 . . . . 1.3300000000000001 111.633 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER 172.2 111.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.28 110.62 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 4.4 m -111.21 133.34 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.154 0.502 . . . . 1.49 110.375 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.2 m -102.99 111.47 23.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 1.1399999999999999 111.996 -178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.17 143.53 48.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 1.3100000000000001 111.235 178.646 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' CB ' HD13 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -131.92 144.24 50.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.746 -1.116 . . . . 2.3100000000000001 110.206 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 27.4 p90 -129.15 -177.1 4.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.362 0.601 . . . . 0.40000000000000002 112.304 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.14 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.506 -0.77 . . . . 1.1100000000000001 111.162 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -84.4 140.09 38.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 2.5600000000000001 110.251 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 33' ' ' ILE . 1.7 Cg_endo -44.63 172.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.668 2.245 . . . . 1.1100000000000001 112.236 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.55 -29.03 9.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 2.77 111.479 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.43 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.2 t80 -130.44 -69.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.877 0.325 . . . . 1.6899999999999999 111.877 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 1.267 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.4 p 52.43 48.67 22.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.154 0.502 . . . . 1.3500000000000001 110.495 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.51 -94.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.681 -0.691 . . . . 1.01 112.77 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.69 35.57 0.93 Allowed Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.891 -0.884 . . . . 0.97999999999999998 110.891 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -116.85 -172.16 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.276 -0.462 . . . . 0.98999999999999999 111.152 -178.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.4 ptmt -147.23 26.24 1.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 2.6899999999999999 111.476 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.5 mp 65.71 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 1.71 110.676 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.4 p 81.68 -12.12 1.0 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.318 0.488 . . . . 1.6599999999999999 112.318 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.72 102.63 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.56 0.219 . . . . 1.97 111.32 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 47.8 m-85 -80.0 147.96 31.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.205 -0.295 . . . . 1.23 110.205 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -129.39 111.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.319 . . . . 1.76 111.115 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.41 99.14 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.69 0.281 . . . . 1.6100000000000001 111.392 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -75.63 128.34 35.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.978 -0.378 . . . . 1.6699999999999999 109.978 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -109.16 131.28 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.252 0.464 . . . . 2.4399999999999999 112.252 -179.425 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.18 111.56 24.22 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.789 -1.189 . . . . 1.79 107.789 177.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.449 ' N ' ' HA3' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.69 81.54 2.05 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.269 -0.878 . . . . 1.5900000000000001 111.088 -179.034 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -53.54 155.87 5.0 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.825 -0.625 . . . . 1.4299999999999999 110.694 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.13 1.64 33.22 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.027 -1.239 . . . . 1.47 113.029 0.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -104.5 -75.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 2.6600000000000001 110.881 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . 50.22 179.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.831 -0.7 . . . . 1.6200000000000001 112.957 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.417 ' HD3' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.49 32.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 3.0600000000000001 110.905 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 65.5 m95 40.34 97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.705 -0.68 . . . . 1.0600000000000001 112.203 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -133.52 128.99 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.8400000000000001 110.679 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 1.1 ptmm? -56.68 83.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 1.77 111.494 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.451 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -67.26 -38.86 85.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.88 0.371 . . . . 1.4099999999999999 110.244 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -36.82 -44.42 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 111.71 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.13 43.47 2.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.115 -0.493 . . . . 2.6400000000000001 111.785 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -152.79 -175.45 5.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 2.0299999999999998 111.622 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.1 89.28 5.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.8700000000000001 110.641 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 25.2 mt -85.43 75.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 1.3700000000000001 111.251 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.0 -61.97 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 2.1499999999999999 111.223 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.2 163.13 27.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 1.54 110.27 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 20.2 p30 -80.5 2.7 24.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.281 -0.418 . . . . 1.75 111.675 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 21.1 tt0 -102.13 101.54 11.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.586 -0.524 . . . . 2.0499999999999998 109.586 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 70.2 t80 -135.27 164.38 27.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.56999999999999995 111.506 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 92.9 m -124.31 123.49 40.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.414 -0.812 . . . . 1.1399999999999999 110.36 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.94 94.53 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 116.063 -0.517 . . . . 1.72 110.49 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.6 p -86.61 -171.18 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.494 -0.775 . . . . 1.6399999999999999 110.811 -179.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.82 9.75 53.45 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.449 -0.881 . . . . 0.95999999999999996 112.525 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 13.8 mt -60.85 -179.34 0.13 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.827 0.313 . . . . 2.02 110.407 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -137.13 128.11 27.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 1.55 110.809 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.17 155.5 13.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.9099999999999999 111.133 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 97' ' ' CYS . 3.5 t70 53.37 46.07 27.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 1.8700000000000001 110.959 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -159.58 118.71 2.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.402 -0.363 . . . . 1.2 111.371 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -70.29 133.64 47.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 1.1100000000000001 110.114 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 55.5 m-85 -129.92 126.44 37.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.605 0.595 . . . . 1.0800000000000001 112.605 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.441 ' CG ' HD12 ' A' ' 43' ' ' LEU . 1.9 mt-10 -102.85 143.36 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.143 -1.058 . . . . 1.5 108.143 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.69 115.93 12.58 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.16 1.541 . . . . 0.79000000000000004 115.16 -178.89 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.36 169.22 9.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.171 -1.418 . . . . 2.6899999999999999 107.171 176.778 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -134.75 112.54 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 118.867 -1.133 . . . . 1.5700000000000001 113.323 -179.836 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.439 HG12 ' N ' ' A' ' 88' ' ' PRO . 79.0 mt -102.73 145.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.227 -1.397 . . . . 1.3200000000000001 107.227 177.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -159.78 119.88 2.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.72 -0.792 . . . . 1.1100000000000001 111.898 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -59.07 -161.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.461 -0.496 . . . . 2.3500000000000001 109.954 179.523 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.496 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 6.1 m-80 -150.91 165.72 32.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.249 0.547 . . . . 2.7000000000000002 110.885 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.25 -29.57 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.282 -0.872 . . . . 1.3400000000000001 112.656 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.54 11.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.136 0.421 . . . . 1.4299999999999999 112.136 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.36 2.2 53.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.623 -0.799 . . . . 1.3799999999999999 113.294 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.63 102.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.088 0.444 . . . . 1.49 109.914 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -68.23 114.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 113.023 0.749 . . . . 1.48 113.023 -178.798 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 14.2 p -78.94 115.0 48.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.29 -0.868 . . . . 0.81000000000000005 109.927 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.11 155.85 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.16 1.907 . . . . 1.25 111.881 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.439 ' N ' HG12 ' A' ' 77' ' ' ILE . 15.0 Cg_endo -58.69 126.85 22.45 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 122.807 2.338 . . . . 1.2 113.443 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 132.46 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.156 -0.683 . . . . 1.76 109.156 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -22.42 107.34 0.12 Allowed Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 124.168 0.917 . . . . 1.77 113.33 -179.414 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.452 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 86.8 Cg_exo -45.3 142.87 5.82 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.825 2.35 . . . . 1.01 113.26 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.455 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -79.48 150.38 31.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.758 -0.46 . . . . 1.55 109.758 179.029 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.16 151.2 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.143 0.902 . . . . 1.6299999999999999 111.656 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -80.5 113.8 18.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 1.0900000000000001 110.364 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.3 mp -96.6 112.77 29.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.917 0.389 . . . . 1.1299999999999999 111.468 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 84.5 m -54.4 -36.13 63.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 111.074 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 61.0 93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.38 . . . . 1.5700000000000001 110.27 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.07 -84.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.418 . . . . 3.7000000000000002 111.788 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.806 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -108.16 -9.53 15.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 2.1400000000000001 111.94 -179.631 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 2.0600000000000001 111.075 179.76 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.435 HG13 ' OD1' ' A' ' 80' ' ' ASN . 9.0 tt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.032 0.444 . . . . 1.26 111.475 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 2' ' ' ILE . 91.7 m-20 -129.82 132.63 24.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 2.0 110.548 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.59 171.12 16.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.494 2.129 . . . . 0.58999999999999997 112.66 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.523 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 12.4 Cg_endo -55.7 171.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.043 2.495 . . . . 1.6100000000000001 112.837 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -93.97 113.6 4.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.049 -0.596 . . . . 0.97999999999999998 113.083 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER 10.87 109.15 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 124.572 1.149 . . . . 2.04 113.767 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.453 ' CG ' HG21 ' A' ' 76' ' ' VAL . 19.9 Cg_exo -68.8 139.08 42.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.787 2.325 . . . . 0.54000000000000004 112.96 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.02 112.21 10.37 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.038 -0.528 . . . . 1.6799999999999999 111.508 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.9 Cg_exo -64.89 112.39 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.829 2.352 . . . . 0.64000000000000001 113.696 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.794 HD22 ' OE2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -70.72 -35.85 72.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.854 -0.795 . . . . 2.1699999999999999 108.854 178.7 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.93 135.97 40.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.774 -1.103 . . . . 0.84999999999999998 108.895 179.099 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 13' ' ' ILE . 2.1 pt -134.27 70.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.269 0.47 . . . . 1.5700000000000001 112.269 -178.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 156.96 34.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.46 110.151 179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -8.65 36.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.887 -0.325 . . . . 2.9100000000000001 111.464 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -128.88 18.2 6.16 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.507 0.194 . . . . 1.3300000000000001 111.357 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 177.23 124.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.806 0.336 . . . . 1.28 110.925 -179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.28 113.81 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 1.49 111.104 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 17.4 m -100.26 127.4 46.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.984 -0.553 . . . . 1.1399999999999999 111.23 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -138.07 150.3 46.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.745 0.783 . . . . 1.3100000000000001 111.976 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.085 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -132.52 147.36 52.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.425 -1.262 . . . . 2.3100000000000001 109.337 179.596 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.523 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 8.3 p90 -132.47 -175.75 3.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.236 0.541 . . . . 0.40000000000000002 112.375 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 6' ' ' GLY . . . -93.85 177.31 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.332 -0.849 . . . . 1.1100000000000001 111.329 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -98.16 139.4 21.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.625 -0.716 . . . . 2.5600000000000001 110.25 179.733 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.497 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 2.9 Cg_endo -47.52 178.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 1.1100000000000001 112.039 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -113.15 -15.44 12.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 2.77 112.081 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -139.15 -66.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.313 0.486 . . . . 1.6899999999999999 112.313 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.497 ' CG2' ' CG ' ' A' ' 25' ' ' PRO . 54.4 p 54.57 45.03 27.77 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.308 -0.405 . . . . 1.3500000000000001 110.532 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.46 -93.99 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.738 -0.744 . . . . 1.01 112.379 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.68 42.19 0.8 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.662 -1.375 . . . . 0.97999999999999998 109.662 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -127.98 -177.32 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.997 -0.602 . . . . 0.98999999999999999 111.298 -178.211 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -136.54 19.97 3.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.338 -0.392 . . . . 2.6899999999999999 111.747 -179.456 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.438 HG22 ' CB ' ' A' ' 78' ' ' ALA . 3.5 mp 64.15 -74.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.282 . . . . 1.71 111.279 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' LYS . 2.5 p 58.05 32.39 21.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 1.6599999999999999 111.132 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 t 170.72 110.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.97 110.845 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -111.75 87.8 2.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.971 0.415 . . . . 1.23 111.061 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -79.03 88.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.78 -0.645 . . . . 1.76 111.43 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.27 127.58 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.8 -0.444 . . . . 1.6100000000000001 109.8 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.9 143.73 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.812 -0.631 . . . . 1.6699999999999999 111.563 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HD3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mtmp? -98.35 148.38 23.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 2.4399999999999999 110.871 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -144.77 86.58 1.81 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 1.79 110.604 179.126 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 1.173 ' OD2' ' O ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -48.51 150.02 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.125 -0.489 . . . . 1.5900000000000001 110.725 179.236 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 1.8 mm? -123.78 101.11 36.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.033 -0.667 . . . . 1.4299999999999999 111.291 179.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 6.3 Cg_endo -87.57 -136.56 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.053 -1.228 . . . . 1.47 110.212 -0.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 1.173 ' O ' ' OD2' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 42.63 42.22 2.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.783 0.325 . . . . 2.6600000000000001 111.441 179.708 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -118.23 148.26 18.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.183 -1.008 . . . . 1.6200000000000001 113.861 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -147.91 122.17 9.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.432 -0.581 . . . . 3.0600000000000001 109.432 179.44 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 40.9 m95 -43.81 94.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 1.0600000000000001 111.149 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -119.32 130.88 55.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.849 -0.614 . . . . 1.8400000000000001 110.712 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.67 69.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 1.77 110.819 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.82 16.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 1.4099999999999999 111.355 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.3 p-10 -51.28 -58.65 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 2.0099999999999998 111.616 -179.574 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER 80.0 -51.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.585 0.231 . . . . 2.6400000000000001 111.221 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -169.93 0.19 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.806 0.336 . . . . 2.0299999999999998 111.111 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.27 107.5 19.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.8700000000000001 111.014 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 56' ' ' ILE . 24.0 mt -87.13 75.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 1.3700000000000001 110.728 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.52 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 2.1499999999999999 111.289 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 175.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.677 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 51.1 p30 -94.1 21.89 6.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.889 -0.596 . . . . 1.75 111.157 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.085 ' OE2' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -125.43 109.49 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 2.0499999999999998 110.196 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 62' ' ' THR . 64.5 t80 -136.45 164.61 27.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.56999999999999995 111.669 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.9 m -127.26 117.37 22.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.612 -0.722 . . . . 1.1399999999999999 110.783 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' CG1' ' HD3' ' A' ' 40' ' ' LYS . 6.6 t -82.05 118.77 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.72 111.158 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -173.42 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 1.6399999999999999 110.89 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.54 28.36 73.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.639 -0.791 . . . . 0.95999999999999996 112.281 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.04 174.25 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 2.02 111.318 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.599 ' HB ' ' HH ' ' A' ' 72' ' ' TYR . 55.9 m -125.38 99.25 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.686 . . . . 1.55 110.224 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 42.9 tt0 -43.74 148.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 1.9099999999999999 111.728 -179.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 35.0 t0 75.41 65.48 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.8700000000000001 111.059 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 171.49 127.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.2 111.006 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -67.55 136.3 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.068 -0.345 . . . . 1.1100000000000001 110.068 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.599 ' HH ' ' HB ' ' A' ' 67' ' ' THR . 37.3 m-85 -133.31 121.95 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.293 0.849 . . . . 1.0800000000000001 113.293 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.58 131.96 48.98 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.391 -0.596 . . . . 1.5 109.391 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -124.87 118.99 27.55 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.673 0.99 . . . . 0.79000000000000004 113.673 -178.77 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' NH1' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -94.67 144.73 25.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 2.6899999999999999 110.381 178.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG21 ' CG ' ' A' ' 8' ' ' PRO . 86.8 t -98.23 115.82 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.357 -0.537 . . . . 1.5700000000000001 110.845 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 2.3 mt -110.29 167.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.542 -0.911 . . . . 1.3200000000000001 108.542 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.497 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -159.14 -174.41 4.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.412 -0.588 . . . . 1.1100000000000001 109.412 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -117.32 -77.75 0.57 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.157 0.503 . . . . 2.3500000000000001 110.535 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER 125.79 140.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.196 1.798 . . . . 2.7000000000000002 109.93 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.466 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -32.75 -44.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.217 0.821 . . . . 1.3400000000000001 113.217 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.75 49.53 0.8 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.489 0.552 . . . . 1.4299999999999999 112.489 -179.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.56 40.93 5.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.662 -0.78 . . . . 1.3799999999999999 113.314 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -89.1 24.46 2.12 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.554 0.216 . . . . 1.49 111.227 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp 18.5 112.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 115.373 1.62 . . . . 1.48 115.373 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.408 ' HA ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -85.64 111.81 40.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.66 -0.867 . . . . 0.81000000000000005 108.66 177.957 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.98 167.26 9.16 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.209 1.94 . . . . 1.25 112.523 -179.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 9.7 Cg_endo -53.8 136.31 65.32 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.052 2.501 . . . . 1.2 113.269 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.34 112.71 24.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.966 -0.561 . . . . 1.76 110.794 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 5.96 100.18 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.019 1.328 . . . . 1.77 114.435 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 82.7 Cg_exo -46.29 145.8 5.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.8 2.333 . . . . 1.01 113.358 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.19 143.9 36.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.074 -0.713 . . . . 1.55 109.074 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' HD13 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -30.93 148.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.298 0.999 . . . . 1.6299999999999999 112.016 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 72' ' ' TYR . . . -81.75 103.82 11.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.347 -0.388 . . . . 1.0900000000000001 110.794 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.408 HG22 ' HB ' ' A' ' 13' ' ' ILE . 5.3 mp -83.86 116.01 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 1.1299999999999999 111.537 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 48.2 m -56.21 -30.41 62.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.401 . . . . 1.1299999999999999 110.425 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 53.62 61.31 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 1.5700000000000001 111.148 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.73 -77.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.04 0.448 . . . . 3.7000000000000002 110.309 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 2.2 p-10 -126.08 -0.13 7.17 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.616 -0.72 . . . . 2.1400000000000001 111.244 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 CA--C 1.516 -0.33 0 CA-C-O 121.108 0.48 . . . . 2.0600000000000001 112.167 -179.942 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.495 HG13 ' ND2' ' A' ' 80' ' ' ASN . 9.9 tt . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 112.803 0.668 . . . . 1.26 112.803 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.343 ' OD2' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.57 120.71 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.853 179.693 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.41 170.44 20.28 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.202 1.935 . . . . 0.58999999999999997 112.398 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 7.1 Cg_endo -54.48 -171.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.754 2.303 . . . . 1.6100000000000001 113.21 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.07 166.64 22.37 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.557 -0.747 . . . . 0.97999999999999998 112.867 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -49.03 122.72 11.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.059 -0.348 . . . . 2.04 110.059 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.5 Cg_exo -77.41 128.77 9.81 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.242 1.961 . . . . 0.54000000000000004 112.401 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.9 p -120.12 112.85 34.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 1.6799999999999999 111.1 -179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.3 Cg_exo -60.59 124.74 15.67 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.142 1.894 . . . . 0.64000000000000001 113.223 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 21' ' ' LYS . 1.4 mp -89.76 -29.42 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.83 -0.623 . . . . 2.1699999999999999 109.809 179.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.45 110.14 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.783 . . . . 0.84999999999999998 110.226 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -114.8 131.74 66.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.394 0.616 . . . . 1.5700000000000001 112.151 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -119.55 157.53 28.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.309 -0.86 . . . . 1.46 110.125 179.914 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.48 -9.07 16.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.325 0.491 . . . . 2.9100000000000001 112.325 -179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.433 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.5 m-70 -135.38 17.47 3.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.793 0.294 . . . . 1.3300000000000001 111.793 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER 171.31 117.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.509 -0.182 . . . . 1.28 110.509 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.534 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -104.14 165.0 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 120.592 -0.443 . . . . 1.49 111.64 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 22.6 m -140.87 123.9 16.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 1.1399999999999999 111.251 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.55 159.56 41.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.664 0.745 . . . . 1.3100000000000001 112.007 179.225 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HD3' ' CA ' ' A' ' 60' ' ' GLU . 24.0 tptp -139.1 136.36 35.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.407 -1.27 . . . . 2.3100000000000001 109.803 179.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 24.0 p90 -123.35 -177.93 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.281 0.562 . . . . 0.40000000000000002 112.336 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.93 161.08 16.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.201 -0.909 . . . . 1.1100000000000001 111.042 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -90.06 135.96 29.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 2.5600000000000001 110.715 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 11.5 Cg_endo -56.12 171.77 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.455 2.103 . . . . 1.1100000000000001 112.005 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -50.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.658 0.265 . . . . 2.77 111.208 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.343 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.2 t80 -98.92 71.09 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.74 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.8 p -94.27 48.72 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.3500000000000001 110.131 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.02 -94.92 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.967 -0.561 . . . . 1.01 112.344 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.55 33.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.936 -0.865 . . . . 0.97999999999999998 110.936 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.4 OUTLIER -118.66 175.76 5.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.253 -0.473 . . . . 0.98999999999999999 111.299 -178.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.73 3.88 3.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.068 -0.514 . . . . 2.6899999999999999 111.505 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 36' ' ' TYR . 1.1 mt 59.75 144.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 120.96 0.409 . . . . 1.71 111.864 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -129.51 -5.11 4.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.946 -0.57 . . . . 1.6599999999999999 112.258 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -168.27 143.86 3.68 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.919 0.34 . . . . 1.97 111.919 -179.844 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CE1' HG23 ' A' ' 33' ' ' ILE . 33.7 m-85 -116.3 113.1 22.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 1.23 110.269 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.7 mt -92.12 119.59 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.799 0.333 . . . . 1.76 110.987 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.29 93.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.442 0.534 . . . . 1.6100000000000001 112.442 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.97 ' OE1' ' CA ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -72.93 146.33 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.147 -0.686 . . . . 1.6699999999999999 109.147 178.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.35 141.62 51.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.215 0.531 . . . . 2.4399999999999999 112.025 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.7 ttm180 -104.64 106.55 17.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.389 -0.823 . . . . 1.79 109.464 179.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 1.052 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.84 91.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.475 -0.784 . . . . 1.5900000000000001 111.071 -179.379 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD13 ' CB ' ' A' ' 94' ' ' ALA . 13.7 mt -75.96 146.0 78.45 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.4299999999999999 110.328 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.78 27.85 15.27 Favored 'Cis proline' 0 C--N 1.347 0.467 0 C-N-CA 123.801 -1.333 . . . . 1.47 112.88 0.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -88.73 -73.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.761 0.315 . . . . 2.6600000000000001 111.169 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 100.27 152.58 26.54 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.624 -0.798 . . . . 1.6200000000000001 112.778 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 1.052 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 170.91 -31.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.303 . . . . 3.0600000000000001 111.181 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.908 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 61.4 m95 58.62 75.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.361 . . . . 1.0600000000000001 111.375 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.97 ' CA ' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mm? -117.42 130.91 56.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 1.8400000000000001 110.341 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 5.2 ptmm? -52.69 97.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.926 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . . . -58.94 -41.05 86.46 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.194 -0.669 . . . . 1.4099999999999999 109.194 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 10.1 t30 -58.56 164.35 2.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.061 -0.972 . . . . 2.0099999999999998 110.405 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.37 31.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.471 . . . . 2.6400000000000001 110.801 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.1 37.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 2.0299999999999998 110.91 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 61.57 153.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 1.8700000000000001 110.757 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 47.9 mt -147.23 60.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 1.3700000000000001 110.44 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 tm? -46.03 -50.66 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 2.1499999999999999 111.841 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.23 160.19 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.422 . . . . 1.54 111.048 -179.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.502 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.3 m-20 -76.27 -1.15 25.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.89 -0.596 . . . . 1.75 111.694 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.849 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -102.54 103.92 14.29 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.745 -0.465 . . . . 2.0499999999999998 109.745 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 43.6 t80 -140.22 166.4 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.124 0.488 . . . . 0.56999999999999995 111.9 -178.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.4 m -117.23 119.42 35.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.48 -0.782 . . . . 1.1399999999999999 110.797 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.12 99.31 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.204 0.526 . . . . 1.72 111.297 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 1.1 p -81.56 -157.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.533 -0.758 . . . . 1.6399999999999999 111.207 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 54.03 45.54 71.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.727 -0.749 . . . . 0.95999999999999996 112.154 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.534 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 9.8 mt -87.61 -176.85 5.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.167 0.508 . . . . 2.02 111.205 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -153.36 115.04 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.717 . . . . 1.55 110.332 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 132.83 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 1.9099999999999999 111.236 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.33 60.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 1.8700000000000001 111.089 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.92 119.12 0.61 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 1.2 111.652 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.97 28.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.631 -0.507 . . . . 1.1100000000000001 109.631 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -121.95 122.18 38.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.4 0.518 . . . . 1.0800000000000001 112.4 -178.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.18 131.95 46.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.312 -0.996 . . . . 1.5 108.312 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.2 109.69 19.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.157 1.54 . . . . 0.79000000000000004 115.157 -177.849 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 ttp180 -97.72 124.54 42.1 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.681 -1.6 . . . . 2.6899999999999999 106.681 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -105.87 119.64 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 119.103 -1.039 . . . . 1.5700000000000001 113.716 -178.476 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.436 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 80.8 mt -101.41 163.78 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.537 -1.653 . . . . 1.3200000000000001 106.537 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -174.32 123.15 0.3 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.022 -1.071 . . . . 1.1100000000000001 112.755 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 21.9 mttt -60.8 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.002 -0.74 . . . . 2.3500000000000001 109.002 178.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' A' ' 2' ' ' ILE . 36.3 m-20 -138.38 -101.95 0.18 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.514 -0.474 . . . . 2.7000000000000002 111.387 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.32 -41.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 1.3400000000000001 111.598 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.97 40.96 1.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 1.4299999999999999 111.962 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.91 9.6 53.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.579 -0.82 . . . . 1.3799999999999999 113.154 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.81 87.3 4.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 1.49 110.322 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -58.76 111.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 1.48 111.682 -179.378 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -73.57 119.05 73.94 Favored Pre-proline 0 C--O 1.238 0.454 0 N-CA-C 109.454 -0.573 . . . . 0.81000000000000005 109.454 179.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.4 166.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.677 2.251 . . . . 1.25 112.461 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.9 Cg_exo -64.36 149.21 90.54 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.676 2.251 . . . . 1.2 112.571 -179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 90' ' ' GLU . 5.8 m -103.12 125.4 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.533 -0.758 . . . . 1.76 109.263 179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 62.9 mt-10 -22.07 117.45 0.15 Allowed Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 124.094 0.871 . . . . 1.77 112.793 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.473 ' HG3' ' CH2' ' A' ' 48' ' ' TRP . 66.1 Cg_exo -45.27 165.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.981 2.454 . . . . 1.01 114.513 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -100.82 146.36 27.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.339 -1.3 . . . . 1.55 109.166 178.764 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -37.09 130.66 0.83 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.864 0.728 . . . . 1.6299999999999999 111.644 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.444 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -65.92 101.33 0.65 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.879 -0.6 . . . . 1.0900000000000001 110.854 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.49 HD12 ' CE2' ' A' ' 74' ' ' PHE . 4.8 mp -82.22 113.55 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.059 -0.519 . . . . 1.1299999999999999 110.462 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 HG23 ' NH1' ' A' ' 98' ' ' ARG . 22.1 m -51.64 -28.06 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 1.1299999999999999 111.159 -179.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m 55.24 76.07 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.505 -0.316 . . . . 1.5700000000000001 110.841 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.421 ' NH1' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -134.43 -87.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 3.7000000000000002 111.073 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.652 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -103.14 -3.06 26.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 2.1400000000000001 111.356 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.333 -0.13 0 CA-C-O 120.888 0.375 . . . . 2.0600000000000001 111.415 -179.769 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.428 HD11 ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.052 0.453 . . . . 1.26 111.685 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.927 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -114.06 135.56 22.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.65 . . . . 2.0 109.937 179.395 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.36 174.04 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.672 2.248 . . . . 0.58999999999999997 113.101 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 32.0 Cg_exo -59.68 174.6 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.119 2.546 . . . . 1.6100000000000001 113.462 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.08 169.67 42.37 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.297 -0.865 . . . . 0.97999999999999998 112.627 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 65.4 tttt -58.57 127.28 81.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 110.581 -0.155 . . . . 2.04 110.581 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 3.0 Cg_exo -76.79 149.38 29.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.502 2.135 . . . . 0.54000000000000004 113.078 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.8 p -144.16 113.4 5.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.284 -0.871 . . . . 1.6799999999999999 110.015 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.7 Cg_exo -49.0 94.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.283 1.989 . . . . 0.64000000000000001 113.553 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.66 -27.73 63.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.268 -0.878 . . . . 2.1699999999999999 110.135 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.41 161.33 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.84999999999999998 109.91 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.477 HG21 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.84 115.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 1.5700000000000001 111.301 179.731 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -104.48 47.62 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.793 -0.64 . . . . 1.46 110.79 -179.908 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.81 -70.63 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.746 -0.661 . . . . 2.9100000000000001 111.516 179.473 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' THR . 1.5 m-70 -82.79 -22.98 34.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 1.3300000000000001 111.289 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.16 102.9 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.578 -0.283 . . . . 1.28 111.224 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -93.66 120.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 1.49 110.816 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 19.8 m -98.6 126.42 44.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 1.1399999999999999 111.346 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.47 139.88 50.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.948 0.88 . . . . 1.3100000000000001 111.69 178.437 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.78 7.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.192 -1.367 . . . . 2.3100000000000001 109.317 179.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 46.0 p90 -168.34 165.51 12.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.126 -0.63 . . . . 0.40000000000000002 112.503 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 156.07 23.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.963 -1.017 . . . . 1.1100000000000001 110.685 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.98 156.46 52.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.725 -0.472 . . . . 2.5600000000000001 109.725 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.15 -170.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.371 2.048 . . . . 1.1100000000000001 111.954 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.53 13.21 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.883 0.327 . . . . 2.77 111.883 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.747 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 3.6 t80 -168.91 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.572 0.582 . . . . 1.6899999999999999 112.572 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.927 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 52.0 p 53.8 38.81 29.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.003 0.43 . . . . 1.3500000000000001 110.074 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.64 -125.15 4.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.852 -0.613 . . . . 1.01 112.175 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.45 4.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.451 -1.859 . . . . 0.97999999999999998 108.451 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -112.99 -165.78 1.02 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.888 -1.156 . . . . 0.98999999999999999 111.607 -178.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -163.84 38.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 2.6899999999999999 112.084 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.8 mp 66.29 -61.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.94 0.719 . . . . 1.71 112.94 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 81' ' ' ALA . 2.4 p 83.08 -38.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.631 0.772 . . . . 1.6599999999999999 111.856 -178.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.61 140.08 3.23 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.832 0.348 . . . . 1.97 111.406 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.479 ' CE1' HG22 ' A' ' 33' ' ' ILE . 52.7 m-85 -99.6 139.94 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 1.23 110.218 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -129.97 98.1 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.671 -0.24 . . . . 1.76 111.05 -179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -91.69 126.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.133 0.492 . . . . 1.6100000000000001 110.862 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.37 152.28 19.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.532 -0.758 . . . . 1.6699999999999999 110.675 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 6.4 ptpt -116.14 144.14 44.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 2.4399999999999999 111.521 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 1.1 ttt180 -119.38 104.86 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.78 -0.645 . . . . 1.79 109.979 179.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.72 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.65 89.1 2.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.741 -0.663 . . . . 1.5900000000000001 110.556 -179.863 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.468 HD13 ' CB ' ' A' ' 94' ' ' ALA . 10.0 mt -67.09 144.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.686 . . . . 1.4299999999999999 110.895 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -95.24 27.92 17.96 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.052 -1.229 . . . . 1.47 112.807 0.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.68 42.6 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 2.6600000000000001 111.368 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -95.13 150.66 19.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.828 . . . . 1.6200000000000001 112.224 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.45 29.0 4.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 3.0600000000000001 110.935 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.9 m95 51.36 100.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.999 -0.546 . . . . 1.0600000000000001 111.133 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -127.67 141.84 51.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.967 -0.561 . . . . 1.8400000000000001 110.558 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 49.5 mtpt -49.36 91.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.77 110.95 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -65.26 -48.21 74.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.4099999999999999 110.754 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -74.28 114.61 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.95 -0.568 . . . . 2.0099999999999998 110.746 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.54 30.34 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 2.6400000000000001 110.913 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -138.02 21.2 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 2.0299999999999998 111.352 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.15 144.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 1.8700000000000001 111.174 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 26.0 mt -134.87 112.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.082 -0.508 . . . . 1.3700000000000001 111.009 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -47.75 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 2.1499999999999999 110.862 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.57 157.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.891 -0.411 . . . . 1.54 109.891 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.511 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -73.53 -3.76 29.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.417 -0.356 . . . . 1.75 111.521 -179.924 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -97.76 96.15 8.04 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.421 -0.585 . . . . 2.0499999999999998 109.421 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 72.3 t80 -121.68 163.86 18.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.56999999999999995 111.57 -178.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 59.9 m -132.19 112.67 12.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.529 -0.759 . . . . 1.1399999999999999 111.06 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 51' ' ' ALA . 4.6 t -74.73 113.43 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 1.72 110.872 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.96 136.49 44.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.705 -0.679 . . . . 1.6399999999999999 111.012 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.3 9.16 6.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.95999999999999996 112.714 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.19 -177.6 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.05 0.452 . . . . 2.02 110.954 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.936 ' CB ' ' HH ' ' A' ' 72' ' ' TYR . 58.9 m -143.7 96.7 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 1.55 110.0 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -40.56 139.17 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.526 . . . . 1.9099999999999999 111.839 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.57 33.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.913 -0.585 . . . . 1.8700000000000001 110.902 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.37 136.34 13.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.358 -0.383 . . . . 1.2 111.212 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.89 132.13 35.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 1.1100000000000001 110.701 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.936 ' HH ' ' CB ' ' A' ' 67' ' ' THR . 46.9 m-85 -127.31 130.67 49.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0800000000000001 111.94 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.448 ' CG ' HD13 ' A' ' 43' ' ' LEU . 3.7 mt-10 -104.65 148.81 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.596 -0.52 . . . . 1.5 109.596 178.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.487 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.19 116.08 10.87 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.821 1.415 . . . . 0.79000000000000004 114.821 -179.264 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.507 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 4.8 ptp180 -109.99 178.65 4.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.455 -0.943 . . . . 2.6899999999999999 108.455 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.66 133.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.678 1.228 . . . . 1.5700000000000001 114.198 179.15 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -115.17 152.72 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 112.599 -2.092 . . . . 1.3200000000000001 106.964 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.26 147.56 16.17 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.229 -0.989 . . . . 1.1100000000000001 112.146 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.0 mmtp -68.81 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 2.3500000000000001 110.442 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 6.9 p-10 -156.08 -66.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.843 0.83 . . . . 2.7000000000000002 111.513 -179.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . 179.52 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.351 -0.84 . . . . 1.3400000000000001 110.879 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.69 -4.01 57.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 112.192 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.83 -16.2 40.07 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.317 -0.944 . . . . 1.3799999999999999 112.506 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.18 149.99 48.87 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.797 -0.446 . . . . 1.49 109.797 179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.1 tp -102.41 112.21 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.381 0.511 . . . . 1.48 112.381 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -68.33 123.73 88.17 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.81000000000000005 109.936 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -38.57 162.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.26 2.64 . . . . 1.25 113.394 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' N ' HG21 ' A' ' 77' ' ' ILE . 21.0 Cg_exo -67.95 170.84 13.41 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.227 2.618 . . . . 1.2 112.927 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.4 127.32 42.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.363 -0.835 . . . . 1.76 109.474 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.2 tt0 -27.06 129.58 0.19 Allowed Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 123.89 0.743 . . . . 1.77 112.597 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.0 Cg_exo -62.33 169.84 7.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.385 2.057 . . . . 1.01 113.765 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.34 136.62 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.754 -1.112 . . . . 1.55 109.042 179.109 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -37.68 135.34 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.006 0.817 . . . . 1.6299999999999999 111.584 -179.748 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.468 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -63.07 132.33 51.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 1.0900000000000001 111.415 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.39 119.73 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 1.1299999999999999 110.917 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m -48.07 -30.01 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.927 -0.579 . . . . 1.1299999999999999 111.173 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 15.4 m 55.45 36.79 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 1.5700000000000001 111.032 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 3.7000000000000002 110.941 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 41.3 p30 -106.3 23.99 13.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 2.1400000000000001 110.547 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 49.3 t0 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.991 -0.55 . . . . 2.0600000000000001 111.966 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.469 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 1.4 tt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.846 0.355 . . . . 1.26 111.278 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.907 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -126.34 133.16 24.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 2.0 110.055 179.451 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 94.4 Cg_endo -77.89 172.0 16.35 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.353 2.035 . . . . 0.58999999999999997 112.655 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.511 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.7 Cg_endo -59.64 148.89 85.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.078 2.519 . . . . 1.6100000000000001 112.623 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.64 161.81 4.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.97999999999999998 112.092 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -58.01 132.67 83.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.982 -0.377 . . . . 2.04 109.982 179.757 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -79.26 127.91 7.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.493 2.129 . . . . 0.54000000000000004 112.812 -179.409 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.21 110.38 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.863 -0.608 . . . . 1.6799999999999999 110.379 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 33.6 Cg_exo -56.42 102.57 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.122 1.881 . . . . 0.64000000000000001 113.599 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 1.177 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -66.82 -31.05 71.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.02 -0.733 . . . . 2.1699999999999999 109.02 178.674 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -150.33 161.65 42.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.098 -0.956 . . . . 0.84999999999999998 110.161 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -151.79 86.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.286 0.565 . . . . 1.5700000000000001 110.228 179.593 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -77.7 64.15 2.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 1.46 112.427 -179.1 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.473 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 19.84 47.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.447 0.906 . . . . 2.9100000000000001 113.447 179.281 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 165.31 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.582 -0.736 . . . . 1.3300000000000001 110.395 179.239 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.96 89.5 3.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 1.28 109.713 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' CG2' HD23 ' A' ' 66' ' ' LEU . 75.3 t -78.68 114.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.49 110.046 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.1 m -96.68 109.22 21.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 1.1399999999999999 112.527 -178.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.1 145.79 44.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.569 0.699 . . . . 1.3100000000000001 111.463 178.81 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.431 ' HB2' ' CD ' ' A' ' 60' ' ' GLU . 7.3 tptp -134.07 143.39 48.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.733 -1.121 . . . . 2.3100000000000001 109.508 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.525 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 13.6 p90 -132.68 -177.04 4.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.239 0.542 . . . . 0.40000000000000002 111.983 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.59 -173.93 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.475 -0.784 . . . . 1.1100000000000001 111.109 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -114.62 131.69 23.25 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 2.5600000000000001 110.727 179.929 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.44 ' CB ' HG21 ' A' ' 28' ' ' THR . 3.0 Cg_exo -35.84 157.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.487 2.791 . . . . 1.1100000000000001 112.809 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.29 -15.57 20.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 2.77 111.63 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.774 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.8 t80 -134.52 -72.01 0.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.324 0.49 . . . . 1.6899999999999999 112.324 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.907 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 4.4 p 50.44 57.55 6.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.95 0.405 . . . . 1.3500000000000001 110.49 -179.148 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.84 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.748 -0.66 . . . . 1.01 112.52 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -155.25 32.8 0.65 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.376 -1.09 . . . . 0.97999999999999998 110.376 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.98 -167.68 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -0.667 . . . . 0.98999999999999999 111.649 -178.561 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 34' ' ' THR . 29.5 ttpt -144.04 20.44 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.607 -0.724 . . . . 2.6899999999999999 111.581 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.6 mp 62.82 -77.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.623 0.249 . . . . 1.71 111.037 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.3 p 80.08 -7.9 1.59 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.607 0.595 . . . . 1.6599999999999999 112.607 179.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.94 117.96 2.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.401 0.519 . . . . 1.97 112.401 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 61.1 m-85 -103.7 146.22 28.91 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.32 -0.4 . . . . 1.23 110.414 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 ' CG2' ' HE3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -137.11 107.47 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.553 -0.294 . . . . 1.76 110.219 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.45 117.72 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 1.6100000000000001 111.387 -179.747 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 3.0 mm-40 -85.95 159.78 19.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.247 -0.888 . . . . 1.6699999999999999 110.57 179.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HE3' ' CB ' ' A' ' 51' ' ' ALA . 3.0 mtmp? -120.99 154.04 36.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.513 0.673 . . . . 2.4399999999999999 111.804 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 10.5 ttm180 -128.67 96.2 4.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.223 -1.029 . . . . 1.79 108.223 177.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 83.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.109 -0.951 . . . . 1.5900000000000001 110.053 -179.149 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD13 ' CB ' ' A' ' 94' ' ' ALA . 19.1 mt -59.45 150.87 63.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.055 -0.521 . . . . 1.4299999999999999 110.736 -179.815 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.03 3.19 37.28 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.713 -1.37 . . . . 1.47 113.207 0.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.82 -89.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.116 -0.234 . . . . 2.6600000000000001 111.019 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 158.38 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.818 -0.706 . . . . 1.6200000000000001 113.036 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.57 24.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 3.0600000000000001 110.988 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 31.7 m95 53.8 83.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 1.0600000000000001 111.423 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.33 124.27 42.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.756 0.313 . . . . 1.8400000000000001 110.667 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HE3' ' CG2' ' A' ' 37' ' ' ILE . 15.5 ptmt -54.27 95.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 1.77 111.033 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.458 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . . . -65.75 -35.47 80.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.109 0.48 . . . . 1.4099999999999999 110.281 179.517 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 1.8 t30 -66.09 120.58 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 2.0099999999999998 110.546 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 23.7 14.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.072 -0.513 . . . . 2.6400000000000001 110.501 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.25 130.4 22.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.949 -0.568 . . . . 2.0299999999999998 110.6 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.15 114.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 1.8700000000000001 111.861 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 55.2 mt -96.04 88.29 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 1.3700000000000001 110.426 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.77 -64.87 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.48 -0.327 . . . . 2.1499999999999999 111.198 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.08 165.91 12.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.435 -0.348 . . . . 1.54 110.418 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.4 p30 -90.47 15.5 10.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.194 -0.457 . . . . 1.75 111.357 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.431 ' CD ' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tp10 -116.42 95.65 5.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.696 -0.483 . . . . 2.0499999999999998 109.696 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 93.6 t80 -118.14 162.85 17.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.299 0.571 . . . . 0.56999999999999995 112.091 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 97.5 m -135.01 108.77 8.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.294 -0.866 . . . . 1.1399999999999999 110.397 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.34 105.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.689 -0.687 . . . . 1.72 111.052 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 t -100.92 164.3 11.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.058 -0.519 . . . . 1.6399999999999999 110.754 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.11 28.53 68.19 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.098 -0.801 . . . . 0.95999999999999996 111.098 -179.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD23 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -84.31 155.84 22.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.425 -0.388 . . . . 2.02 110.344 -179.521 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.901 ' HB ' ' HH ' ' A' ' 72' ' ' TYR . 2.5 m -91.7 127.17 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 1.55 111.482 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 2.2 tt0 -76.95 163.32 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.9099999999999999 111.208 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.81 43.21 5.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.832 -0.622 . . . . 1.8700000000000001 111.002 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.41 122.99 1.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.009 -0.541 . . . . 1.2 110.736 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.72 116.55 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.008 0.432 . . . . 1.1100000000000001 110.772 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.901 ' HH ' ' HB ' ' A' ' 67' ' ' THR . 42.5 m-85 -110.05 132.48 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.824 -0.626 . . . . 1.0800000000000001 112.139 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -102.08 134.28 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.193 -1.04 . . . . 1.5 108.193 177.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -128.82 118.92 23.56 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.215 1.561 . . . . 0.79000000000000004 115.215 -178.588 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.01 -175.27 2.73 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.832 -1.173 . . . . 2.6899999999999999 107.832 177.232 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -155.99 125.86 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.233 -0.987 . . . . 1.5700000000000001 113.213 179.09 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 20.2 mt -103.33 150.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 113.644 -1.616 . . . . 1.3200000000000001 107.9 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.35 120.99 2.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.025 -1.07 . . . . 1.1100000000000001 113.254 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.0 mttp -66.6 -176.07 0.44 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 2.3500000000000001 109.994 178.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 4.1 p30 -135.0 169.11 17.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.829 -0.623 . . . . 2.7000000000000002 110.599 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.79 -27.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.693 -0.685 . . . . 1.3400000000000001 112.155 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 -16.97 28.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.798 0.666 . . . . 1.4299999999999999 112.798 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.27 -23.07 27.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.297 -0.954 . . . . 1.3799999999999999 112.128 -179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -55.05 115.43 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.999 -0.371 . . . . 1.49 109.999 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -72.62 110.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.578 0.584 . . . . 1.48 112.578 -179.061 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.7 p -65.86 116.4 32.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.81000000000000005 110.087 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.78 157.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.888 2.392 . . . . 1.25 112.844 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 31.7 Cg_endo -64.28 121.56 9.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.753 2.302 . . . . 1.2 113.34 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 7.8 p -71.38 132.9 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 1.76 109.62 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 46.0 mt-10 -28.89 125.7 0.25 Allowed Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.868 0.73 . . . . 1.77 112.625 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 63.0 Cg_exo -54.12 174.15 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.541 2.161 . . . . 1.01 113.822 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.38 142.18 36.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 1.55 109.927 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 3.5 t0 -38.83 136.12 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.872 0.733 . . . . 1.6299999999999999 111.051 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.454 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -68.28 103.34 1.57 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.487 -0.324 . . . . 1.0900000000000001 111.479 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.437 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 4.8 mp -88.41 115.15 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.437 -0.347 . . . . 1.1299999999999999 110.751 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.0 m -49.02 -35.94 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 1.1299999999999999 111.408 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 68' ' ' GLU . 51.6 t 61.59 95.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.197 -0.297 . . . . 1.5700000000000001 110.197 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -147.22 -86.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.271 0.471 . . . . 3.7000000000000002 112.271 -179.26 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.819 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -104.56 7.09 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.192 0.441 . . . . 2.1400000000000001 112.192 -179.308 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 112.484 0.549 . . . . 2.0600000000000001 112.484 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.429 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.6 tt . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.76 0.314 . . . . 1.26 110.923 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' N ' HG12 ' A' ' 2' ' ' ILE . 17.4 m-20 -136.89 121.85 12.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.357 -0.383 . . . . 2.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.87 169.46 17.7 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.307 2.005 . . . . 0.58999999999999997 111.716 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.7 Cg_endo -53.74 162.98 3.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.655 2.237 . . . . 1.6100000000000001 112.542 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.69 170.74 27.37 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.934 -0.651 . . . . 0.97999999999999998 112.66 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 127.19 68.19 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.639 -0.134 . . . . 2.04 110.639 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 6.1 Cg_exo -76.0 128.81 10.98 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.119 1.879 . . . . 0.54000000000000004 112.199 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 14.8 p -130.5 110.19 16.22 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.216 -0.447 . . . . 1.6799999999999999 111.462 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.0 Cg_exo -58.24 103.28 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.64000000000000001 113.476 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -29.68 70.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 2.1699999999999999 109.629 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -150.79 154.01 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.27 -0.877 . . . . 0.84999999999999998 109.22 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.03 114.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.039 0.447 . . . . 1.5700000000000001 112.018 -179.621 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.22 156.29 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.713 -0.676 . . . . 1.46 110.268 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -56.9 -23.24 43.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.349 -0.387 . . . . 2.9100000000000001 110.995 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.442 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 75.9 m-70 -140.12 26.5 2.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 1.3300000000000001 111.117 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.424 ' CA ' HD22 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -170.43 97.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 1.28 111.147 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 13' ' ' ILE . 89.4 t -94.77 129.11 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 1.49 110.964 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.9 m -106.0 125.92 51.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.681 -0.69 . . . . 1.1399999999999999 111.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.87 153.19 49.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.808 0.813 . . . . 1.3100000000000001 111.895 179.424 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -128.35 -174.54 3.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.254 -1.339 . . . . 2.3100000000000001 109.871 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.5 p90 179.98 160.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.42 . . . . 0.40000000000000002 111.687 179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.53 146.13 45.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 1.1100000000000001 111.319 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -82.39 139.76 44.92 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 2.5600000000000001 110.573 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.435 ' CB ' HG22 ' A' ' 28' ' ' THR . 93.9 Cg_exo -43.69 163.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.381 2.054 . . . . 1.1100000000000001 112.066 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -121.55 -38.51 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.482 . . . . 2.77 111.282 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.93 -70.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.896 -0.321 . . . . 1.6899999999999999 111.476 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.453 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 21.1 p 46.75 41.3 10.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.215 0.531 . . . . 1.3500000000000001 110.568 -179.598 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.9 -97.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.488 -0.778 . . . . 1.01 112.506 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.75 60.71 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.739 -0.944 . . . . 0.97999999999999998 110.739 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 5.2 m-85 -130.45 -172.28 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.19 0.519 . . . . 0.98999999999999999 112.023 -178.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 14.69 1.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.482 -0.781 . . . . 2.6899999999999999 111.647 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 17.5 mt 56.61 153.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.401 0.62 . . . . 1.71 112.538 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 35' ' ' SER . 2.9 p -127.98 55.74 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.273 -0.876 . . . . 1.6599999999999999 110.566 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER 87.18 154.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.565 -0.743 . . . . 1.97 110.485 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' A' ' 33' ' ' ILE . 82.0 m-85 -105.99 156.64 18.18 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.277 0.561 . . . . 1.23 111.921 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.69 168.0 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.299 -0.864 . . . . 1.76 109.563 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 74' ' ' PHE . 4.7 t -146.03 99.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.982 0.364 . . . . 1.6100000000000001 111.982 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HG3' HG13 ' A' ' 77' ' ' ILE . 6.3 mt-10 -77.26 126.85 31.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.154 0.502 . . . . 1.6699999999999999 110.27 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' TRP . 2.5 mmtp -94.2 131.37 39.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.29 -0.868 . . . . 2.4399999999999999 112.63 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.1 ttm180 -111.07 105.32 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.784 -0.45 . . . . 1.79 109.784 178.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 1.309 ' OD1' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.43 94.14 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.996 -0.547 . . . . 1.5900000000000001 111.191 -179.611 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.474 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 12.9 mt -79.23 153.34 76.88 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.99 -0.55 . . . . 1.4299999999999999 110.557 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.18 29.74 7.34 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.123 -1.199 . . . . 1.47 113.149 0.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -100.8 -85.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.61 0.243 . . . . 2.6600000000000001 111.312 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.89 162.78 11.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.663 -0.78 . . . . 1.6200000000000001 112.78 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 1.309 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 173.7 -32.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 3.0600000000000001 111.522 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 40.6 m95 48.87 75.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.667 -0.242 . . . . 1.0600000000000001 110.517 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.03 137.57 52.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.896 0.379 . . . . 1.8400000000000001 111.809 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.8 ptmt -65.26 85.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.509 . . . . 1.77 111.125 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.64 76.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 1.4099999999999999 111.179 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 t30 -47.26 -67.03 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.0099999999999998 110.546 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.37 35.19 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.425 -0.352 . . . . 2.6400000000000001 111.181 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 t -139.8 -78.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 2.0299999999999998 111.014 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' ND2' ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -179.22 142.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 1.8700000000000001 111.027 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.479 HG22 HD11 ' A' ' 56' ' ' ILE . 3.5 mt -144.98 74.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.3700000000000001 111.016 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.16 -37.1 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 2.1499999999999999 111.157 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.68 167.19 10.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 1.54 110.597 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -77.0 -9.94 59.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.499 . . . . 1.75 111.613 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -96.3 102.43 14.22 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.833 0.349 . . . . 2.0499999999999998 110.296 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 62' ' ' THR . 57.9 t80 -136.57 163.37 30.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.107 -0.497 . . . . 0.56999999999999995 111.677 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 75.7 m -126.05 119.55 27.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.851 -0.613 . . . . 1.1399999999999999 111.252 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 t -83.88 102.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.72 111.009 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -102.38 168.15 9.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 1.6399999999999999 111.012 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.25 12.04 52.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.787 -0.72 . . . . 0.95999999999999996 112.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER -86.55 -174.1 4.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.778 0.289 . . . . 2.02 110.835 179.947 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 2.0 m -128.31 154.69 45.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 1.55 111.099 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 3.2 tm-20 -77.42 158.19 30.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 1.9099999999999999 110.93 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.3 t70 56.54 59.98 3.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 1.8700000000000001 110.943 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.32 123.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 1.2 111.144 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -71.48 129.79 39.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 1.1100000000000001 110.453 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 51.5 m-85 -126.77 129.51 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 1.0800000000000001 112.075 -179.142 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 3.5 mt-10 -107.78 144.99 34.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -138.73 119.43 14.09 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.543 1.312 . . . . 0.79000000000000004 114.543 -178.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.85 146.59 26.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.466 -0.333 . . . . 2.6899999999999999 110.366 178.434 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 57.1 t -93.98 119.54 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 1.5700000000000001 110.935 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 87' ' ' PRO . 1.1 mt -118.99 144.39 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.271 -1.011 . . . . 1.3200000000000001 108.271 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 35' ' ' SER . . . -178.57 142.52 0.23 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.817 -0.753 . . . . 1.1100000000000001 111.959 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 12.5 mttp -77.35 -178.64 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.152 -0.619 . . . . 2.3500000000000001 109.677 179.015 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 4.4 m120 -112.69 -86.93 0.56 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.921 -0.581 . . . . 2.7000000000000002 110.3 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -155.19 -42.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.491 0.552 . . . . 1.3400000000000001 112.491 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.64 46.14 0.98 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.658 0.614 . . . . 1.4299999999999999 112.658 -178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.14 -2.02 62.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.163 -1.017 . . . . 1.3799999999999999 113.288 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.05 105.47 8.15 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.039 -0.726 . . . . 1.49 109.039 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 4.1 tt -97.31 111.0 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.548 0.944 . . . . 1.48 113.548 -178.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.75 111.38 6.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.411 -1.7 . . . . 0.81000000000000005 106.411 177.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.692 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 73.0 Cg_endo -66.39 -99.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.814 1.676 . . . . 1.25 113.843 -177.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.692 ' HD3' ' HB2' ' A' ' 87' ' ' PRO . 72.5 Cg_endo -106.73 134.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 CA-C-N 124.815 2.755 . . . . 1.2 114.168 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 29.3 m -109.22 88.51 2.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.254 -0.43 . . . . 1.76 110.181 178.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 18.88 100.53 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.541 1.136 . . . . 1.77 113.973 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 53.0 Cg_exo -51.17 145.72 25.39 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.479 2.119 . . . . 1.01 113.616 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 75.2 m -73.49 141.21 46.79 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.55 109.274 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -39.73 144.94 0.15 Allowed 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 124.035 0.834 . . . . 1.6299999999999999 110.865 179.462 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -71.15 110.78 6.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.551 -0.46 . . . . 1.0900000000000001 110.491 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.444 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.9 mp -92.55 109.87 22.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.007 0.432 . . . . 1.1299999999999999 111.333 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 33.8 m -45.43 -32.94 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.657 -0.701 . . . . 1.1299999999999999 111.708 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.5 m 52.53 59.3 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.949 0.404 . . . . 1.5700000000000001 110.379 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.811 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -90.47 -75.65 0.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 3.7000000000000002 112.463 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.811 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.0 p-10 -119.75 30.56 6.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.121 -0.49 . . . . 2.1400000000000001 111.754 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 53.0 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.076 0.465 . . . . 2.0600000000000001 111.835 -179.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.44 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.3 tt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.871 0.367 . . . . 1.26 110.754 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -125.81 133.23 24.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 2.0 110.636 179.858 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.0 160.7 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.28 1.987 . . . . 0.58999999999999997 112.097 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.0 176.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.665 2.243 . . . . 1.6100000000000001 113.067 -179.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.78 171.44 53.56 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.557 -0.747 . . . . 0.97999999999999998 112.882 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -63.52 118.29 42.86 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 110.19 -0.3 . . . . 2.04 110.19 179.585 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 31.5 Cg_exo -64.74 135.49 45.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.067 . . . . 0.54000000000000004 112.801 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.45 103.65 11.31 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.036 -0.529 . . . . 1.6799999999999999 111.693 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' THR . 33.1 Cg_exo -48.7 117.69 2.88 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.055 1.836 . . . . 0.64000000000000001 112.366 179.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.879 HD13 ' OE2' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -75.5 -32.72 60.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.1 -0.704 . . . . 2.1699999999999999 109.1 178.86 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.5 t30 -148.81 157.48 43.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.878 -1.055 . . . . 0.84999999999999998 108.914 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 13' ' ' ILE . 1.9 pt -140.34 97.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.513 . . . . 1.5700000000000001 111.437 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -87.13 48.09 1.6 Allowed 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 115.635 -0.711 . . . . 1.46 112.279 -179.259 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.431 ' CD ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 52.85 -75.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.678 0.621 . . . . 2.9100000000000001 112.678 178.698 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.2 m-70 -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 1.3300000000000001 111.614 -179.39 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.6 p -139.48 121.97 16.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.465 -0.334 . . . . 1.28 110.309 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.531 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 16.8 m -109.45 135.57 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.486 0.66 . . . . 1.49 112.168 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 18.9 m -93.6 140.19 29.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.68 -0.691 . . . . 1.1399999999999999 109.942 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.96 152.54 38.8 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.657 0.598 . . . . 1.3100000000000001 112.251 -179.854 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.435 ' CG ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -140.94 145.41 36.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.127 -0.942 . . . . 2.3100000000000001 110.438 179.825 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.3 p90 -140.03 -176.91 4.76 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.058 0.456 . . . . 0.40000000000000002 111.864 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.45 165.97 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 1.1100000000000001 110.705 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.24 147.07 32.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 2.5600000000000001 110.801 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.453 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 1.9 Cg_endo -42.77 167.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.032 2.488 . . . . 1.1100000000000001 112.047 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.58 -28.47 8.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 2.77 111.759 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -123.15 -69.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 1.6899999999999999 111.312 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 13.7 p 51.14 53.04 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 1.3500000000000001 111.007 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.14 -92.26 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.789 -0.72 . . . . 1.01 112.31 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.96 32.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.776 -0.93 . . . . 0.97999999999999998 110.776 179.379 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -120.1 -179.2 3.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.22 -0.49 . . . . 0.98999999999999999 111.509 -178.787 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 11.36 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 2.6899999999999999 111.398 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.478 HG22 ' CE1' ' A' ' 36' ' ' TYR . 4.6 mp 60.09 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.064 0.459 . . . . 1.71 110.897 -179.747 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 p -126.68 5.61 6.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 1.6599999999999999 111.277 179.861 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.58 123.14 0.64 Allowed 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.746 0.308 . . . . 1.97 110.987 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.478 ' CE1' HG22 ' A' ' 33' ' ' ILE . 22.3 m-85 -100.88 92.4 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.23 110.575 179.561 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.482 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 5.8 mm -69.69 138.23 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.463 -0.335 . . . . 1.76 111.0 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.93 101.19 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.45 -0.341 . . . . 1.6100000000000001 111.677 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.501 ' OE2' ' HA ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -77.46 138.69 39.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.914 -0.772 . . . . 1.6699999999999999 108.914 178.815 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -121.1 135.23 55.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 2.4399999999999999 111.64 -179.45 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' NH2' ' CD1' ' A' ' 48' ' ' TRP . 20.0 ttm180 -114.17 113.28 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.605 -0.725 . . . . 1.79 110.455 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.16 112.98 11.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.5900000000000001 110.502 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 2.2 mm? -80.39 149.22 68.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 1.4299999999999999 110.975 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.55 17.21 41.12 Favored 'Cis proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.885 -1.298 . . . . 1.47 112.66 0.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -151.08 93.16 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 2.6600000000000001 111.372 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -144.07 -165.52 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 1.6200000000000001 112.138 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 148.38 33.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 3.0600000000000001 110.842 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 50.6 m95 -68.88 97.56 0.85 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.678 -0.692 . . . . 1.0600000000000001 110.907 -179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -128.37 126.42 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.454 . . . . 1.8400000000000001 110.604 179.919 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 10.2 ptmm? -58.32 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 1.77 110.871 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -74.29 -35.23 63.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.953 0.406 . . . . 1.4099999999999999 110.373 179.794 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -44.28 -47.75 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.849 -0.614 . . . . 2.0099999999999998 111.386 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 41.27 30.03 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 2.6400000000000001 111.982 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 -161.34 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.44 -0.345 . . . . 2.0299999999999998 110.711 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.85 61.86 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 1.8700000000000001 110.935 -179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.552 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 2.4 mm -57.95 95.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 1.3700000000000001 110.131 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.21 -8.03 9.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.017 0.377 . . . . 2.1499999999999999 112.017 -179.536 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.28 9.14 23.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.157 0.428 . . . . 1.54 112.157 -179.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 13.0 p30 53.05 21.26 2.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 1.75 111.59 -179.075 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.435 ' OE1' ' CG ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -130.85 78.67 1.85 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.679 -1.23 . . . . 2.0499999999999998 107.679 178.902 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.552 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 82.3 t80 -120.03 164.63 15.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.519 0.676 . . . . 0.56999999999999995 112.378 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 48.8 m -124.43 120.86 33.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.765 -1.107 . . . . 1.1399999999999999 109.972 178.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' CG2' HD12 ' A' ' 20' ' ' LEU . 21.3 t -76.26 100.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.962 -0.563 . . . . 1.72 111.307 -179.521 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.23 137.13 32.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.243 -0.89 . . . . 1.6399999999999999 110.44 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.14 -17.41 4.33 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.787 -0.72 . . . . 0.95999999999999996 111.945 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -52.05 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.676 0.274 . . . . 2.02 110.311 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -148.03 141.81 25.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.481 -0.327 . . . . 1.55 110.563 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.49 139.26 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 1.9099999999999999 110.967 -179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.885 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 67.86 61.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 1.8700000000000001 111.06 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.29 120.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 1.2 111.443 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.74 135.56 51.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.159 -0.682 . . . . 1.1100000000000001 109.159 179.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.496 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 33.1 m-85 -129.94 115.87 17.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.258 0.836 . . . . 1.0800000000000001 113.258 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -99.27 134.18 42.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.5 107.917 178.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.42 118.34 14.24 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.901 1.074 . . . . 0.79000000000000004 113.901 -179.066 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.498 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.46 172.98 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.028 -1.101 . . . . 2.6899999999999999 108.028 177.945 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -138.78 116.22 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.927 . . . . 1.5700000000000001 112.176 179.446 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 69.6 mt -99.2 142.15 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.784 -1.191 . . . . 1.3200000000000001 107.784 178.3 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -148.91 116.08 6.09 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.433 -0.907 . . . . 1.1100000000000001 112.729 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 mtpt -63.28 -167.66 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.638 -0.505 . . . . 2.3500000000000001 109.638 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.53 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 22.5 p30 -143.95 169.86 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.267 0.556 . . . . 2.7000000000000002 111.684 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -45.01 -30.18 0.99 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.315 -0.857 . . . . 1.3400000000000001 111.941 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -81.85 -22.55 36.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.848 0.314 . . . . 1.4299999999999999 111.848 -179.48 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.67 -21.54 18.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.368 -0.92 . . . . 1.3799999999999999 111.935 -179.51 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -52.22 161.03 0.68 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.087 -0.338 . . . . 1.49 110.087 179.581 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -112.56 109.76 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.247 0.462 . . . . 1.48 112.247 -179.596 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 16.0 p -66.88 115.87 29.5 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 109.167 -0.679 . . . . 0.81000000000000005 109.167 179.009 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -38.87 159.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.672 2.248 . . . . 1.25 112.812 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 28.4 Cg_endo -64.75 124.4 13.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.704 2.269 . . . . 1.2 112.976 -179.665 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLU . 45.6 m -76.76 115.64 16.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 1.76 109.636 179.062 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -12.19 118.44 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.588 1.155 . . . . 1.77 113.534 -179.34 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.516 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 70.2 Cg_exo -52.26 131.68 40.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.575 2.184 . . . . 1.01 113.606 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.406 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.97 144.99 56.92 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.585 -0.895 . . . . 1.55 108.585 178.687 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -34.21 141.75 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.956 0.785 . . . . 1.6299999999999999 112.352 -179.553 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -73.15 107.19 5.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.76 -0.655 . . . . 1.0900000000000001 109.977 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.79 112.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.1299999999999999 110.874 -179.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.2 m -48.09 -32.32 6.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.088 -0.506 . . . . 1.1299999999999999 110.656 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.5 m 54.83 83.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.86 -0.609 . . . . 1.5700000000000001 110.993 179.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 -91.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.314 -0.403 . . . . 3.7000000000000002 110.269 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.44 17.86 16.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.846 0.355 . . . . 2.1400000000000001 110.063 179.064 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 p30 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-N 116.04 -0.527 . . . . 2.0600000000000001 111.436 -179.77 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.457 ' CG1' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 1.26 111.882 . . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.7 134.29 13.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 2.0 111.067 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.19 159.96 26.49 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.607 2.205 . . . . 0.58999999999999997 112.719 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 51.1 Cg_exo -55.09 172.63 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.713 2.275 . . . . 1.6100000000000001 112.491 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.8 -163.42 0.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.97999999999999998 112.221 179.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 4.7 tttp -87.4 142.9 33.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.57 0.185 . . . . 2.04 110.532 179.849 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 2.2 Cg_endo -83.24 132.5 6.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.659 2.239 . . . . 0.54000000000000004 112.494 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.74 110.73 10.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 1.6799999999999999 110.69 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.9 Cg_exo -59.54 139.93 91.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.117 1.878 . . . . 0.64000000000000001 113.887 -179.152 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -105.71 -26.83 11.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.957 -1.019 . . . . 2.1699999999999999 109.162 178.971 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -161.79 158.01 25.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.84999999999999998 110.452 -179.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 ' CG2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.4 95.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.127 0.489 . . . . 1.5700000000000001 110.469 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.21 56.61 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 1.46 112.166 -179.258 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.07 -68.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.548 0.573 . . . . 2.9100000000000001 112.548 178.371 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' THR . 24.4 m-70 -95.89 -7.25 37.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 1.3300000000000001 111.883 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -133.0 98.73 4.37 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.721 -0.392 . . . . 1.28 111.762 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG12 ' CG2' ' A' ' 13' ' ' ILE . 84.6 t -86.62 141.84 13.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.242 -0.435 . . . . 1.49 109.945 179.356 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' HG ' ' A' ' 11' ' ' LEU . 88.0 m -123.89 115.53 21.44 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.872 0.693 . . . . 1.1399999999999999 112.872 -178.708 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -129.54 150.03 51.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.639 0.733 . . . . 1.3100000000000001 111.465 178.499 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.61 140.86 37.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.721 -1.127 . . . . 2.3100000000000001 110.207 -179.417 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.51 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -131.25 -176.81 4.14 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.443 0.639 . . . . 0.40000000000000002 112.47 -179.34 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.44 -162.5 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.592 -0.731 . . . . 1.1100000000000001 111.026 179.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -122.44 153.07 62.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 111.005 -179.76 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.447 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 50.4 Cg_exo -55.81 179.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.771 2.314 . . . . 1.1100000000000001 113.248 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.85 -28.59 4.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 2.77 111.914 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -124.81 -69.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.015 0.376 . . . . 1.6899999999999999 112.015 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.447 HG22 ' CB ' ' A' ' 25' ' ' PRO . 4.1 p 51.61 49.8 20.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 1.3500000000000001 110.648 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.27 -104.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.113 -0.565 . . . . 1.01 112.692 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.16 2.56 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 110.563 -1.015 . . . . 0.97999999999999998 110.563 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CD2' ' OD1' ' A' ' 80' ' ' ASN . 1.2 m-85 -108.85 178.14 4.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.634 -0.783 . . . . 0.98999999999999999 111.47 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.13 6.02 2.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.889 -0.596 . . . . 2.6899999999999999 111.84 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 33' ' ' ILE . 18.8 mt 60.02 134.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-O 121.126 0.488 . . . . 1.71 111.083 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -122.92 -3.65 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 1.6599999999999999 112.201 -179.331 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -168.63 116.1 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.103 0.408 . . . . 1.97 112.103 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -90.52 142.15 28.04 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.849 0.356 . . . . 1.23 110.152 179.038 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.94 166.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.123 -0.49 . . . . 1.76 110.712 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.44 101.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.442 -0.345 . . . . 1.6100000000000001 111.386 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -75.93 137.9 40.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 1.6699999999999999 109.677 179.279 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -115.62 152.54 32.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.14 0.495 . . . . 2.4399999999999999 111.532 -179.426 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -143.04 118.8 10.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.634 -0.712 . . . . 1.79 110.62 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 1.08 ' OD1' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -62.35 -15.41 48.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.305 -0.407 . . . . 1.5900000000000001 111.862 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.502 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 77.5 mt 57.05 148.42 0.05 OUTLIER Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.771 -0.65 . . . . 1.4299999999999999 111.755 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.86 13.22 46.17 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.744 -1.357 . . . . 1.47 112.4 -0.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -124.29 -67.9 0.89 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.383 -0.371 . . . . 2.6600000000000001 110.418 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 1.08 ' CA ' ' OD1' ' A' ' 42' ' ' ASP . . . 42.04 -129.7 4.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.118 -0.563 . . . . 1.6200000000000001 113.107 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.414 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 170.67 110.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 3.0600000000000001 110.781 -179.863 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.504 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.4 m95 -52.0 104.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.735 -0.666 . . . . 1.0600000000000001 110.648 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.75 136.29 28.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 1.8400000000000001 111.106 -179.654 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -52.61 119.08 4.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 1.77 111.167 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -109.21 -29.51 8.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 1.4099999999999999 110.619 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 15.1 p-10 -52.45 -50.21 63.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 2.0099999999999998 111.174 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 51.77 24.95 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.396 -0.366 . . . . 2.6400000000000001 110.808 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -159.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 2.0299999999999998 110.719 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.36 59.36 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.8700000000000001 111.134 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.488 HD12 ' CG ' ' A' ' 61' ' ' PHE . 15.4 mt -52.42 155.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.762 -0.459 . . . . 1.3700000000000001 109.762 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -164.79 -36.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.81 0.671 . . . . 2.1499999999999999 112.81 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.83 22.94 2.9 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.241 0.46 . . . . 1.54 112.241 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 17.9 p30 50.52 22.82 1.13 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.962 -0.563 . . . . 1.75 111.775 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -133.0 91.84 2.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.261 -1.014 . . . . 2.0499999999999998 108.261 178.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 62' ' ' THR . 72.1 t80 -122.31 165.55 16.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.245 0.545 . . . . 0.56999999999999995 111.946 -178.385 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.518 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 24.6 m -129.24 107.05 9.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.404 -0.816 . . . . 1.1399999999999999 111.124 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.1 t -67.47 108.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 1.72 110.718 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 p -110.15 144.24 39.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.658 -0.701 . . . . 1.6399999999999999 110.966 -179.849 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.67 10.54 14.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.686 -0.769 . . . . 0.95999999999999996 112.902 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 3.7 mm? -52.58 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.105 0.452 . . . . 2.02 110.68 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -105.71 -18.56 14.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.55 110.955 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 68.0 141.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.894 0.378 . . . . 1.9099999999999999 110.63 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.49 25.05 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 1.8700000000000001 110.203 -179.367 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.09 141.58 25.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.878 -0.601 . . . . 1.2 110.693 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -80.81 132.41 35.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 1.1100000000000001 110.9 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 49.5 m-85 -132.39 133.39 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.773 . . . . 1.0800000000000001 112.154 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -106.21 143.75 33.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.173 -1.047 . . . . 1.5 108.173 178.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -134.83 117.96 16.48 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.066 1.506 . . . . 0.79000000000000004 115.066 -178.337 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.9 156.52 17.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 2.6899999999999999 109.895 177.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.57 128.89 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.252 0.548 . . . . 1.5700000000000001 111.498 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.436 ' CG2' HD13 ' A' ' 85' ' ' ILE . 11.0 mt -132.85 155.74 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.551 -1.278 . . . . 1.3200000000000001 107.551 179.131 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -176.86 131.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.467 -0.893 . . . . 1.1100000000000001 112.799 -179.628 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 ptpt -87.92 111.73 21.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.738 -0.838 . . . . 2.3500000000000001 108.738 178.407 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -46.39 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.851 1.056 . . . . 2.7000000000000002 113.851 -177.933 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB1' ' HB3' ' A' ' 31' ' ' PHE . . . -125.15 -52.05 1.65 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.043 0.757 . . . . 1.3400000000000001 113.043 -178.615 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -74.14 0.76 12.92 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.084 0.772 . . . . 1.4299999999999999 113.084 -178.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.7 -17.6 38.9 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.184 -1.008 . . . . 1.3799999999999999 112.259 -179.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -55.6 97.13 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.08 -0.711 . . . . 1.49 109.08 179.23 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 HD13 ' CG2' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -67.11 118.53 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.486 0.921 . . . . 1.48 113.486 -178.173 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.2 p -71.29 110.45 7.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 107.945 -1.132 . . . . 0.81000000000000005 107.945 178.123 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -56.44 175.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.82 2.347 . . . . 1.25 114.324 -178.168 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 86.2 Cg_exo -45.79 135.78 13.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.621 2.881 . . . . 1.2 113.866 -179.373 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 m -119.84 95.55 4.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.036 -0.529 . . . . 1.76 111.416 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 20.96 105.83 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.996 1.11 . . . . 1.77 113.996 179.435 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.6 Cg_exo -60.66 136.86 69.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.531 2.154 . . . . 1.01 112.643 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.4 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -71.6 146.85 48.11 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.021 -0.536 . . . . 1.55 110.23 179.627 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -34.09 146.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.348 1.03 . . . . 1.6299999999999999 112.159 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -81.56 118.13 22.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.784 -0.644 . . . . 1.0900000000000001 110.947 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.59 119.47 58.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.342 -0.39 . . . . 1.1299999999999999 111.503 -179.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 53.1 m -52.21 -22.81 4.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.005 -0.543 . . . . 1.1299999999999999 111.056 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 m 57.93 58.0 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.235 0.541 . . . . 1.5700000000000001 110.176 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -78.82 -132.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.433 -0.803 . . . . 3.7000000000000002 110.759 -179.594 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 2.6 p30 -93.41 35.81 1.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.175 0.443 . . . . 2.1400000000000001 110.824 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 24.2 t0 . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.26 0.552 . . . . 2.0600000000000001 112.312 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.441 HD12 ' CB ' ' A' ' 86' ' ' SER . 1.6 tt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.888 0.375 . . . . 1.26 111.181 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.6 m-20 -130.41 138.61 33.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 2.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.27 161.91 13.2 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.854 2.369 . . . . 0.58999999999999997 112.552 -179.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 12.3 Cg_endo -56.33 -174.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.062 2.508 . . . . 1.6100000000000001 112.981 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 178.05 49.14 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.967 -0.56 . . . . 0.97999999999999998 112.838 -179.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 122.81 85.28 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.198 -0.297 . . . . 2.04 110.198 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 29.3 Cg_exo -67.66 141.78 56.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.54000000000000004 112.816 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.55 108.01 7.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.7 -0.682 . . . . 1.6799999999999999 110.848 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' THR . 24.4 Cg_exo -51.06 123.2 11.37 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.14 1.893 . . . . 0.64000000000000001 113.048 -179.518 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 21' ' ' LYS . 1.5 mm? -84.03 -31.67 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.084 -0.71 . . . . 2.1699999999999999 109.084 178.41 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.11 147.97 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.879 -1.055 . . . . 0.84999999999999998 108.934 179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.504 HG22 HD11 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -132.58 98.39 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.335 -0.546 . . . . 1.5700000000000001 111.441 -179.556 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.45 50.96 2.06 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.628 -0.714 . . . . 1.46 111.576 -179.719 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.77 -75.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.661 0.615 . . . . 2.9100000000000001 112.661 178.933 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.3 m-70 -73.6 -24.92 60.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.333 0.494 . . . . 1.3300000000000001 112.333 -179.132 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -137.59 122.09 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.226 -0.287 . . . . 1.28 110.226 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.526 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 12.6 m -111.64 121.92 65.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.625 0.726 . . . . 1.49 112.647 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.5 m -83.69 138.37 33.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.92 -1.037 . . . . 1.1399999999999999 110.35 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.453 ' CD2' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.61 164.12 34.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.642 0.588 . . . . 1.3100000000000001 111.724 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' N ' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.31 178.93 6.84 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.648 -0.706 . . . . 2.3100000000000001 110.352 179.437 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 47.6 p90 -172.31 167.18 5.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.393 0.616 . . . . 0.40000000000000002 112.533 179.717 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.83 148.95 29.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.19 -0.914 . . . . 1.1100000000000001 110.657 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.61 149.13 43.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.496 -0.32 . . . . 2.5600000000000001 110.842 179.819 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 86.5 Cg_exo -44.65 176.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.024 2.483 . . . . 1.1100000000000001 112.919 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -30.64 4.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.908 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -114.01 -71.72 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.143 0.423 . . . . 1.6899999999999999 112.143 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 12.1 p 54.38 37.11 26.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 1.3500000000000001 110.808 -179.451 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.38 -92.65 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.788 . . . . 1.01 112.229 179.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.3 27.38 1.54 Allowed Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.46 -0.656 . . . . 0.97999999999999998 111.46 179.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CE1' ' HB1' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -102.55 -177.27 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.98999999999999999 111.567 -179.17 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.81 2.99 2.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.431 0.53 . . . . 2.6899999999999999 112.431 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG22 ' CE1' ' A' ' 36' ' ' TYR . 2.7 mp 60.65 136.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.107 0.479 . . . . 1.71 111.436 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 p -124.7 9.64 8.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 1.6599999999999999 111.779 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 t -179.29 138.39 0.14 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.831 0.348 . . . . 1.97 111.752 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' A' ' 33' ' ' ILE . 32.8 m-85 -114.35 103.96 11.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 1.23 110.496 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.5 mm -79.83 128.36 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 1.76 110.883 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.98 111.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.832 0.308 . . . . 1.6100000000000001 111.832 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.429 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mt-10 -86.81 136.36 33.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 1.6699999999999999 108.834 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HD3' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.54 143.78 50.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.338 0.59 . . . . 2.4399999999999999 112.274 -179.001 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' A' ' 46' ' ' GLY . 20.3 ttp180 -110.53 108.5 18.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.151 -0.931 . . . . 1.79 109.905 179.426 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.954 ' OD2' ' NH2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.83 92.69 3.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.698 -0.683 . . . . 1.5900000000000001 109.839 179.809 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -68.17 142.86 95.37 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 1.4299999999999999 111.172 -179.405 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -94.2 16.25 41.64 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.047 -1.231 . . . . 1.47 112.793 0.109 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.37 67.78 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.579 -0.282 . . . . 2.6600000000000001 111.642 -179.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -110.57 176.54 18.93 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.571 -0.823 . . . . 1.6200000000000001 112.681 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.954 ' NH2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -151.58 19.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 3.0600000000000001 111.246 -179.827 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.454 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 82.2 m95 49.74 98.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 1.0600000000000001 111.106 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -143.14 155.29 44.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 1.8400000000000001 110.851 179.198 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -71.84 116.83 12.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.089 0.471 . . . . 1.77 111.563 -179.427 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.442 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . . . -93.14 -39.79 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 1.4099999999999999 110.609 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 13.9 p-10 -49.92 -48.62 51.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 2.0099999999999998 111.049 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.05 30.43 0.59 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 2.6400000000000001 111.297 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 m -139.29 -164.64 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 2.0299999999999998 111.153 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.86 107.7 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 1.8700000000000001 111.022 -179.854 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.491 HD12 ' CE1' ' A' ' 61' ' ' PHE . 44.1 mt -108.48 65.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 1.3700000000000001 110.704 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mt -47.66 -66.75 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 2.1499999999999999 111.475 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.15 162.47 27.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.933 0.397 . . . . 1.54 110.555 179.975 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.505 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.7 p30 -75.9 -2.39 30.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.894 -0.594 . . . . 1.75 111.659 -179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB3' ' HG3' ' A' ' 58' ' ' GLU . 16.7 tt0 -93.48 99.55 12.01 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.457 -0.571 . . . . 2.0499999999999998 109.457 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 73.0 t80 -134.51 164.58 27.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.316 0.579 . . . . 0.56999999999999995 112.024 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.508 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.8 m -124.3 124.86 43.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.246 -0.888 . . . . 1.1399999999999999 109.974 179.32 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 20' ' ' LEU . 9.9 t -80.55 96.07 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.098 0.475 . . . . 1.72 111.365 -179.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.25 132.51 35.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 1.6399999999999999 110.83 179.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.82 -25.65 2.93 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.529 -0.76 . . . . 0.95999999999999996 111.325 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.518 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 6.9 mp -49.14 158.29 0.37 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.958 0.408 . . . . 2.02 110.928 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -124.91 144.14 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 1.55 110.805 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 143.73 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 1.9099999999999999 111.16 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER 69.87 44.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 1.8700000000000001 111.213 179.891 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -157.41 122.2 4.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.858 0.361 . . . . 1.2 111.808 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.451 ' CB ' HD11 ' A' ' 43' ' ' LEU . . . -74.81 128.84 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 1.1100000000000001 109.861 179.168 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 47.0 m-85 -125.13 125.14 43.26 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.082 0.771 . . . . 1.0800000000000001 113.082 -178.701 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -102.37 137.94 39.96 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.885 -1.154 . . . . 1.5 107.885 178.013 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -142.75 126.58 17.13 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.208 1.558 . . . . 0.79000000000000004 115.208 -178.781 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -106.02 -173.04 2.2 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.954 -1.128 . . . . 2.6899999999999999 107.954 177.384 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.469 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -151.34 117.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 118.989 -1.084 . . . . 1.5700000000000001 113.336 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 65.4 mt -100.18 146.11 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.832 -1.544 . . . . 1.3200000000000001 106.832 177.288 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -158.33 135.69 10.15 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.75 -0.78 . . . . 1.1100000000000001 112.286 -178.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.1 mttp -73.6 -152.38 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.733 -0.84 . . . . 2.3500000000000001 108.733 178.792 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' OD1' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -147.29 -108.91 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.452 -0.499 . . . . 2.7000000000000002 110.724 179.576 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.36 -12.06 4.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.978 0.808 . . . . 1.3400000000000001 112.5 179.617 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.522 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -105.1 -1.07 26.03 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.754 0.279 . . . . 1.4299999999999999 111.754 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.88 43.63 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.427 -0.892 . . . . 1.3799999999999999 112.481 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.28 153.61 11.88 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.744 -0.268 . . . . 1.49 110.316 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -113.63 106.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.069 0.462 . . . . 1.48 111.681 -179.725 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.441 ' CB ' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -65.42 127.44 92.95 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 115.93 -0.577 . . . . 0.81000000000000005 109.738 179.585 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -41.35 168.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.88 2.387 . . . . 1.25 113.365 -179.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 2.9 Cg_exo -75.74 121.35 6.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.254 2.636 . . . . 1.2 112.6 -179.744 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -66.79 132.84 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.156 -0.683 . . . . 1.76 109.156 178.998 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -33.6 121.71 0.48 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 122.869 0.468 . . . . 1.77 112.169 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 56.3 Cg_exo -52.98 155.31 11.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.94 2.426 . . . . 1.01 113.977 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.94 149.72 21.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 1.55 109.832 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -42.47 148.26 0.23 Allowed 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 124.21 0.944 . . . . 1.6299999999999999 111.222 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -75.24 124.23 26.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.825 -0.625 . . . . 1.0900000000000001 111.62 -179.636 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.46 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 4.0 mp -102.99 109.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 1.1299999999999999 110.517 179.483 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 70' ' ' ALA . 80.6 m -46.63 -28.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 1.1299999999999999 111.004 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' ASP . 94.9 m 52.04 83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.5700000000000001 110.515 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -87.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 3.7000000000000002 111.278 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.525 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.5 p-10 -98.59 9.88 42.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.337 -0.392 . . . . 2.1400000000000001 111.304 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.4 p30 . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.999 0.428 . . . . 2.0600000000000001 111.252 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 2.2 tt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.78 0.324 . . . . 1.26 110.722 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.12 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -129.0 119.39 19.82 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 2.0 110.537 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.9 161.89 37.46 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.164 1.909 . . . . 0.58999999999999997 111.983 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.96 167.0 18.87 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.645 2.23 . . . . 1.6100000000000001 113.158 -179.312 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.68 154.96 25.87 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.789 -0.641 . . . . 0.97999999999999998 112.94 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.6 tttt -53.65 138.83 51.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 2.04 110.103 179.704 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 4.2 Cg_exo -80.63 115.35 3.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.448 2.098 . . . . 0.54000000000000004 111.901 179.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 12.5 p -109.29 109.74 60.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.538 -0.301 . . . . 1.6799999999999999 110.649 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 72.9 Cg_exo -41.66 125.0 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.341 2.027 . . . . 0.64000000000000001 113.123 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.59 -33.26 16.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.49 -0.777 . . . . 2.1699999999999999 109.61 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.35 111.1 2.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.84999999999999998 109.565 179.22 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' CG2' HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -102.74 140.07 22.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.357 0.598 . . . . 1.5700000000000001 112.4 -179.229 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.91 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -136.42 141.59 43.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.299 -0.864 . . . . 1.46 110.197 179.777 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -43.14 -24.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.155 0.798 . . . . 2.9100000000000001 113.155 -179.239 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -122.73 -0.15 9.17 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.784 -0.572 . . . . 1.3300000000000001 112.497 -179.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.27 120.29 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 1.28 110.95 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 13' ' ' ILE . 61.2 t -108.16 128.31 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.168 -0.469 . . . . 1.49 111.176 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 21.7 m -106.48 133.43 51.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.938 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.34 147.0 47.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.681 0.753 . . . . 1.3100000000000001 112.033 179.493 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -130.25 131.12 45.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.473 -1.24 . . . . 2.3100000000000001 109.646 179.682 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 6.5 p90 -118.01 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.003 0.43 . . . . 0.40000000000000002 111.946 -179.565 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.32 177.94 4.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.721 -0.672 . . . . 1.1100000000000001 112.052 -179.498 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.442 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.27 142.17 25.83 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.34 -0.845 . . . . 2.5600000000000001 110.266 179.801 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.442 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 78.3 Cg_exo -51.86 -161.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.888 2.392 . . . . 1.1100000000000001 113.595 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.3 -43.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.267 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.006 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.7 t80 -111.2 -70.66 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.453 -0.34 . . . . 1.6899999999999999 111.885 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 1.12 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 p 55.16 43.84 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.922 -0.399 . . . . 1.3500000000000001 109.922 -179.243 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.37 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.733 -0.667 . . . . 1.01 112.769 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.95 37.87 0.81 Allowed Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 109.872 -1.291 . . . . 0.97999999999999998 109.872 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -117.65 -179.27 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.631 -0.785 . . . . 0.98999999999999999 111.055 -178.67 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -6.77 4.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 2.6899999999999999 112.29 -179.744 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG22 HD12 ' A' ' 33' ' ' ILE . 11.9 mt 62.26 142.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 1.71 110.648 -179.642 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.431 ' N ' HG21 ' A' ' 33' ' ' ILE . 3.1 p -138.93 42.66 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.3 . . . . 1.6599999999999999 111.428 -179.57 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.31 165.45 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.416 -0.356 . . . . 1.97 110.69 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' OD1' ' A' ' 59' ' ' ASN . 61.2 m-85 -153.53 74.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 1.23 110.889 179.839 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.484 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.6 mt -57.42 133.52 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 1.76 110.865 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.1 104.79 17.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 111.302 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.948 ' OE2' ' O ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -78.98 130.12 35.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.686 -0.487 . . . . 1.6699999999999999 109.686 179.394 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.67 143.92 43.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.886 0.374 . . . . 2.4399999999999999 110.983 -179.877 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 4.1 ttm180 -117.36 105.38 12.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.944 -0.571 . . . . 1.79 110.575 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.728 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.59 98.56 3.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 1.5900000000000001 110.907 -179.742 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 15.6 mt -83.2 154.7 66.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 1.4299999999999999 110.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.33 37.96 5.76 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.056 -1.227 . . . . 1.47 112.835 0.297 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -167.19 79.46 0.2 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 2.6600000000000001 111.305 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.728 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -152.92 -169.71 18.42 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.932 -0.576 . . . . 1.6200000000000001 111.85 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 159.75 42.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.138 0.494 . . . . 3.0600000000000001 111.278 179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.948 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 70.0 m95 -64.52 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 1.0600000000000001 111.017 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.69 128.49 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.351 -0.386 . . . . 1.8400000000000001 111.086 -179.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.89 117.57 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 1.77 111.234 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -95.86 -33.72 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 1.4099999999999999 110.811 179.702 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.3 p-10 -47.64 -59.12 3.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 2.0099999999999998 111.558 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.41 37.76 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 2.6400000000000001 111.181 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -145.44 20.37 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 2.0299999999999998 111.422 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.71 116.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.999 0.428 . . . . 1.8700000000000001 111.262 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 15.4 mm -105.4 85.04 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.3700000000000001 111.324 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.12 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.1499999999999999 110.45 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.22 176.72 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 1.54 110.35 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -95.74 32.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 1.75 111.746 -179.616 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -131.58 97.85 4.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.727 -0.471 . . . . 2.0499999999999998 109.727 179.513 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 83.3 t80 -133.29 163.16 29.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.259 0.552 . . . . 0.56999999999999995 111.927 -179.345 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.528 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 46.0 m -130.25 112.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.175 -0.92 . . . . 1.1399999999999999 110.824 179.152 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -72.06 119.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.72 111.05 179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.78 142.47 46.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.923 -0.58 . . . . 1.6399999999999999 110.992 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.18 5.44 6.17 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.786 -0.721 . . . . 0.95999999999999996 112.798 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -71.92 -172.54 0.86 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.071 0.435 . . . . 2.02 110.929 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -142.12 147.26 36.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 1.55 111.017 -179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 5.8 tt0 -63.82 138.53 58.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 1.9099999999999999 111.455 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.14 57.68 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 1.8700000000000001 111.008 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -166.62 118.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 1.2 111.182 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . . . -71.34 123.73 22.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 1.1100000000000001 110.464 179.563 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 37.8 m-85 -119.12 127.93 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.583 0.586 . . . . 1.0800000000000001 112.583 -178.875 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.2 tt0 -104.32 145.88 29.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.9 -0.778 . . . . 1.5 108.9 178.641 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -142.45 130.04 21.41 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.228 1.195 . . . . 0.79000000000000004 114.228 -179.186 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -115.67 -178.85 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.684 -0.689 . . . . 2.6899999999999999 109.814 178.312 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.439 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 39.5 t -132.56 110.35 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.132 -0.627 . . . . 1.5700000000000001 112.632 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' A' ' 39' ' ' GLU . 59.2 mt -105.48 142.17 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.067 -1.457 . . . . 1.3200000000000001 107.067 177.514 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.66 -171.23 3.87 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.765 -0.774 . . . . 1.1100000000000001 111.655 -179.749 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 83' ' ' GLY . 7.1 mttt -129.78 -175.38 3.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 2.3500000000000001 109.705 179.419 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.4 m-80 -132.9 162.07 32.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.978 0.418 . . . . 2.7000000000000002 111.464 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . . . -43.36 -28.69 0.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 1.3400000000000001 112.544 -179.706 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.525 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -85.87 -7.6 58.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.709 0.633 . . . . 1.4299999999999999 112.709 -179.125 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 102.91 -16.71 54.09 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.241 -0.981 . . . . 1.3799999999999999 112.458 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.18 161.92 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 1.49 109.93 179.731 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -115.73 98.5 6.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 1.48 111.583 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.09 116.58 10.69 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.32 -0.622 . . . . 0.81000000000000005 109.32 179.237 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.58 168.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.938 2.425 . . . . 1.25 113.072 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 22.5 Cg_exo -65.15 121.54 9.03 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.937 2.425 . . . . 1.2 113.281 -179.651 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -78.35 124.2 27.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.663 -0.699 . . . . 1.76 109.233 179.021 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 mm-40 -22.68 117.97 0.17 Allowed Pre-proline 0 N--CA 1.479 0.986 0 O-C-N 124.015 0.822 . . . . 1.77 113.084 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.4 Cg_exo -60.28 163.72 14.18 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.881 2.387 . . . . 1.01 113.999 -179.233 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -98.94 147.78 24.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.207 -0.906 . . . . 1.55 109.661 179.317 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -36.73 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 124.016 0.823 . . . . 1.6299999999999999 111.86 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.453 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -87.9 111.16 21.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.969 -0.559 . . . . 1.0900000000000001 111.494 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.06 110.56 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.1299999999999999 110.516 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -46.09 -38.35 7.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.014 0.435 . . . . 1.1299999999999999 110.645 179.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 15' ' ' ARG . 70.8 m 59.37 68.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 1.5700000000000001 110.189 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -103.64 -77.61 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 3.7000000000000002 111.288 -179.265 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.469 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 33.8 p30 -138.49 17.81 2.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.884 -0.598 . . . . 2.1400000000000001 111.034 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.91 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.376 0.608 . . . . 2.0600000000000001 111.653 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.427 HG13 ' ND2' ' A' ' 80' ' ' ASN . 1.1 tt . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.762 0.315 . . . . 1.26 111.45 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -117.84 133.82 23.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 2.0 111.148 -179.653 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.0 146.15 12.71 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.482 2.121 . . . . 0.58999999999999997 112.176 179.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 77.6 Cg_exo -46.41 159.7 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.282 2.655 . . . . 1.6100000000000001 114.011 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.39 -158.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.136 -0.938 . . . . 0.97999999999999998 112.802 179.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.24 124.62 69.88 Favored Pre-proline 0 C--O 1.233 0.193 0 N-CA-C 110.684 -0.117 . . . . 2.04 110.684 179.728 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 5.5 Cg_exo -74.13 117.12 4.88 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.472 2.114 . . . . 0.54000000000000004 111.633 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 111.84 26.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.189 -0.46 . . . . 1.6799999999999999 110.438 -179.827 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 80.5 Cg_exo -33.84 145.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.839 2.359 . . . . 0.64000000000000001 113.581 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 1.349 HD13 ' CD ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -107.76 -41.74 4.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.402 -1.272 . . . . 2.1699999999999999 108.932 -179.941 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.405 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -164.35 107.77 0.93 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.497 -1.229 . . . . 0.84999999999999998 110.135 179.903 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -88.56 102.27 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.6 -0.727 . . . . 1.5700000000000001 111.877 -179.75 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -91.51 43.53 1.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.453 -0.794 . . . . 1.46 111.079 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.407 ' CA ' ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER 55.61 -74.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.591 -0.731 . . . . 2.9100000000000001 112.287 179.269 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-70 -74.27 -27.67 60.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 1.3300000000000001 111.053 -179.251 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -129.08 104.09 7.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.007 -0.542 . . . . 1.28 109.621 179.312 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 73.8 t -89.44 114.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.949 -0.568 . . . . 1.49 111.548 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 70.4 m -88.41 148.81 24.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.931 0.396 . . . . 1.1399999999999999 111.425 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.68 158.7 42.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.44 -0.8 . . . . 1.3100000000000001 111.269 179.628 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.046 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.0 142.16 28.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 2.3100000000000001 110.225 179.593 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 11.6 p90 -125.05 -174.06 2.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.871 0.367 . . . . 0.40000000000000002 111.941 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -94.25 -23.04 18.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.984 -0.553 . . . . 1.1100000000000001 112.47 -179.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.431 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER 75.39 166.03 0.13 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.5600000000000001 110.403 -179.387 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.436 ' CG ' HG23 ' A' ' 28' ' ' THR . 59.8 Cg_endo -70.59 -173.85 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 1.1100000000000001 112.785 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -129.71 -40.11 1.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 2.77 111.359 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -93.58 -70.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.938 -0.305 . . . . 1.6899999999999999 111.268 -179.858 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 7.4 p 58.43 42.44 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 1.3500000000000001 110.907 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.601 -0.809 . . . . 1.01 112.337 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.15 30.5 2.53 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.478 -1.049 . . . . 0.97999999999999998 110.478 179.164 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -114.55 171.57 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -0.659 . . . . 0.98999999999999999 111.097 -178.845 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 4.15 3.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.183 -0.462 . . . . 2.6899999999999999 111.75 179.44 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.476 HG22 ' CE1' ' A' ' 36' ' ' TYR . 1.3 mt 55.01 117.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 CA-C-O 121.362 0.601 . . . . 1.71 112.21 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 p -98.38 -11.53 22.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.47 -0.787 . . . . 1.6599999999999999 110.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.68 138.01 4.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.807 0.337 . . . . 1.97 111.562 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CE1' HG22 ' A' ' 33' ' ' ILE . 93.1 m-85 -108.21 115.25 29.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.945 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.426 HG21 ' CB ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -95.77 106.46 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.337 -0.392 . . . . 1.76 110.66 179.65 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.65 135.88 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.41 0.624 . . . . 1.6100000000000001 111.475 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 4.9 mt-10 -91.13 143.9 26.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.872 -1.058 . . . . 1.6699999999999999 110.845 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 151.58 25.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.199 -0.455 . . . . 2.4399999999999999 111.007 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.11 102.82 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 1.79 110.527 179.709 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.83 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -77.17 96.28 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.341 -0.39 . . . . 1.5900000000000001 110.548 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 94' ' ' ALA . 1.3 mm? -75.12 147.31 83.18 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 1.4299999999999999 110.687 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -90.38 3.66 68.12 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.942 -1.274 . . . . 1.47 113.226 0.304 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -125.38 74.67 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 2.6600000000000001 110.913 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -136.96 -177.76 15.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.686 . . . . 1.6200000000000001 112.644 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 140.82 17.52 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.034 0.445 . . . . 3.0600000000000001 110.698 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.522 ' NE1' ' CZ ' ' A' ' 41' ' ' ARG . 64.6 m95 -55.11 104.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.625 -0.716 . . . . 1.0600000000000001 110.818 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -136.77 117.36 13.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 1.8400000000000001 110.67 179.958 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' CB ' HG21 ' A' ' 37' ' ' ILE . 3.1 ptmm? -45.45 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.942 -0.572 . . . . 1.77 111.339 -179.661 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -72.9 -17.49 61.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 1.4099999999999999 111.244 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -81.94 113.05 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 2.0099999999999998 110.817 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.69 25.44 11.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.206 -0.452 . . . . 2.6400000000000001 110.659 179.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -125.9 -160.91 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 2.0299999999999998 110.806 -179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 88.5 2.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 1.8700000000000001 111.177 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.515 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 12.8 mt -75.74 62.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 1.3700000000000001 111.065 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.29 -75.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.988 -0.551 . . . . 2.1499999999999999 111.095 -179.894 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -179.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 1.54 110.721 179.822 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 33.3 p30 -93.98 17.01 13.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.75 111.361 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.349 ' CD ' HD13 ' A' ' 11' ' ' LEU . 3.1 tp10 -118.34 108.29 14.9 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.897 -0.409 . . . . 2.0499999999999998 109.897 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.7 t80 -141.12 165.56 27.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.097 0.475 . . . . 0.56999999999999995 111.379 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 12.0 m -127.37 115.74 19.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 110.769 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.403 HG11 ' N ' ' A' ' 64' ' ' SER . 22.6 t -75.42 139.16 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.67 -0.696 . . . . 1.72 111.382 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.403 ' N ' HG11 ' A' ' 63' ' ' VAL . 61.5 p -124.11 -171.08 2.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.738 -0.664 . . . . 1.6399999999999999 110.607 179.598 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.88 90.09 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.59 -0.732 . . . . 0.95999999999999996 112.479 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 3.6 mp -71.23 163.91 26.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.336 0.589 . . . . 2.02 111.839 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -128.73 112.19 13.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 1.55 109.809 179.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.444 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 7.8 tt0 -41.23 150.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.557 . . . . 1.9099999999999999 112.453 -179.09 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.845 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 73.18 39.84 0.58 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.398 -0.819 . . . . 1.8700000000000001 110.782 -179.867 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.39 135.16 7.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 1.2 111.352 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.69 129.41 37.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 1.1100000000000001 110.191 179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.509 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 49.4 m-85 -124.34 118.21 26.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.063 0.394 . . . . 1.0800000000000001 112.063 -179.5 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.441 ' CG ' ' HB1' ' A' ' 94' ' ' ALA . 1.4 mt-10 -101.39 135.4 42.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 1.5 109.139 179.072 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -130.53 122.1 26.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.895 1.443 . . . . 0.79000000000000004 114.895 -178.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.51 ' CD ' ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -104.54 154.48 19.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.505 -0.924 . . . . 2.6899999999999999 108.505 177.254 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -114.24 119.13 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 119.323 -0.951 . . . . 1.5700000000000001 113.41 -179.243 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 78' ' ' ALA . 61.3 mt -111.25 150.64 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.018 -1.446 . . . . 1.3200000000000001 107.423 178.323 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -168.14 127.54 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.066 -1.053 . . . . 1.1100000000000001 113.278 -179.642 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -85.19 80.12 9.32 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.733 -0.839 . . . . 2.3500000000000001 108.733 178.185 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 18.1 m-20 -17.1 -92.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 113.88 -1.509 . . . . 2.7000000000000002 114.339 -178.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -128.61 -48.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.051 0.759 . . . . 1.3400000000000001 113.051 -179.101 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.93 43.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.264 0.468 . . . . 1.4299999999999999 112.264 -178.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 76.43 -3.13 55.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.462 -0.875 . . . . 1.3799999999999999 113.246 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -58.93 85.98 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.111 0.455 . . . . 1.49 109.946 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -66.47 117.2 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.086 -0.506 . . . . 1.48 112.344 -179.083 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 t -80.69 110.61 17.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 107.669 -1.234 . . . . 0.81000000000000005 107.669 178.346 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.45 162.79 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.403 2.069 . . . . 1.25 113.185 -178.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 75' ' ' ARG . 63.4 Cg_exo -36.18 91.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.32 2.68 . . . . 1.2 113.288 -179.728 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.9 p -73.13 99.0 2.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.657 -0.417 . . . . 1.76 110.707 179.705 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 mt-10 18.61 107.66 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 124.688 1.242 . . . . 1.77 113.917 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 98.5 Cg_exo -44.87 177.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.498 2.132 . . . . 1.01 113.741 179.483 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -113.15 140.52 47.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.225 -1.352 . . . . 1.55 108.764 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -36.94 134.42 0.52 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.638 0.586 . . . . 1.6299999999999999 111.634 -179.925 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HB1' ' CG ' ' A' ' 73' ' ' GLU . . . -70.18 107.92 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 1.0900000000000001 110.966 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -91.05 112.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.878 0.37 . . . . 1.1299999999999999 110.882 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.1 m -59.03 -23.79 62.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.892 -0.594 . . . . 1.1299999999999999 111.174 -179.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 68' ' ' GLU . 18.9 t 56.02 101.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.14 0.495 . . . . 1.5700000000000001 110.218 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -77.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 3.7000000000000002 109.638 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -106.35 21.36 17.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.267 -0.879 . . . . 2.1400000000000001 110.099 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.231 0.101 0 CA-C-N 115.983 -0.553 . . . . 2.0600000000000001 111.03 -179.639 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.928 0.394 . . . . 1.26 111.406 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.863 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.46 128.24 28.64 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.423 179.798 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.45 173.1 14.77 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.58999999999999997 112.926 -179.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 33.7 Cg_exo -58.91 177.46 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.052 2.501 . . . . 1.6100000000000001 113.172 -179.577 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.62 22.13 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.97999999999999998 112.734 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -85.48 122.3 73.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.301 0.096 . . . . 2.04 111.102 -179.897 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' CG ' HG22 ' A' ' 76' ' ' VAL . 4.2 Cg_exo -76.95 134.08 14.34 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.498 2.132 . . . . 0.54000000000000004 111.69 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.09 120.07 8.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.951 0.352 . . . . 1.6799999999999999 111.951 -179.207 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.3 Cg_exo -65.78 102.21 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.683 2.256 . . . . 0.64000000000000001 112.92 -179.956 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -60.21 -45.27 93.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.847 -0.797 . . . . 2.1699999999999999 108.847 179.046 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.17 138.27 54.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.741 -1.118 . . . . 0.84999999999999998 108.426 178.718 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.437 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -133.64 99.05 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.094 -0.642 . . . . 1.5700000000000001 112.203 -179.331 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.39 148.97 23.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.46 110.079 179.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -60.93 -13.66 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.979 0.363 . . . . 2.9100000000000001 111.979 -179.412 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.436 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.9 m-70 -134.68 31.45 3.37 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.673 0.273 . . . . 1.3300000000000001 111.656 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.441 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER 162.14 125.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.627 -0.508 . . . . 1.28 109.627 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.535 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 11.8 m -120.4 149.41 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.269 -0.572 . . . . 1.49 111.492 179.774 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 3.2 m -120.73 123.44 42.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 1.1399999999999999 111.046 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.56 161.71 29.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.808 0.813 . . . . 1.3100000000000001 112.48 179.647 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.905 ' HG2' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -133.55 168.78 18.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.212 -1.358 . . . . 2.3100000000000001 110.153 179.853 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.6 p90 -158.03 172.38 18.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.426 . . . . 0.40000000000000002 111.304 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.12 139.77 30.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.877 -0.601 . . . . 1.1100000000000001 111.964 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -79.04 140.93 57.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 2.5600000000000001 109.733 179.274 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 10.5 Cg_endo -53.14 -175.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.215 1.943 . . . . 1.1100000000000001 111.619 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.3 -37.56 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.379 . . . . 2.77 111.55 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.863 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 5.5 t80 -95.03 -71.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.551 -0.295 . . . . 1.6899999999999999 111.579 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.844 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 68.9 p 49.59 43.76 24.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.971 0.415 . . . . 1.3500000000000001 110.509 -179.448 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.24 -93.89 0.01 OUTLIER Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.996 -0.547 . . . . 1.01 112.614 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -142.48 39.71 1.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.057 -0.817 . . . . 0.97999999999999998 111.057 179.537 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.489 ' CE1' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -124.5 176.99 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.529 -0.336 . . . . 0.98999999999999999 110.909 -179.05 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.75 3.59 3.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.27 -0.423 . . . . 2.6899999999999999 111.775 179.66 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 33' ' ' ILE . 10.7 mt 58.77 117.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 121.091 0.472 . . . . 1.71 111.241 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -102.73 11.19 37.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.658 . . . . 1.6599999999999999 111.731 -179.585 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -168.62 170.92 9.18 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.037 0.446 . . . . 1.97 111.502 -179.92 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 33' ' ' ILE . 48.6 m-85 -154.06 75.47 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.534 -0.757 . . . . 1.23 109.917 179.578 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 37' ' ' ILE . 3.1 mt -50.14 144.11 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.564 -0.744 . . . . 1.76 111.497 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.489 ' CG1' ' CG2' ' A' ' 63' ' ' VAL . 3.6 t -129.23 107.01 14.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.348 -0.387 . . . . 1.6100000000000001 111.407 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -93.2 149.03 21.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.092 -0.504 . . . . 1.6699999999999999 110.431 179.735 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' NZ ' ' CD1' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -115.49 139.62 49.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.196 0.522 . . . . 2.4399999999999999 112.116 179.737 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -112.37 96.34 5.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.185 -0.916 . . . . 1.79 108.622 178.304 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.769 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -67.89 105.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 1.5900000000000001 110.798 -179.136 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CD2' ' HD2' ' A' ' 41' ' ' ARG . 10.6 mt -76.73 150.72 81.99 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.857 -0.61 . . . . 1.4299999999999999 111.147 -179.807 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -87.89 9.05 64.13 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.756 -1.352 . . . . 1.47 113.179 0.281 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -80.5 -88.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 2.6600000000000001 110.49 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' CA ' ' HG2' ' A' ' 41' ' ' ARG . . . 115.72 175.37 18.13 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.647 -0.787 . . . . 1.6200000000000001 113.568 179.258 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.8 -25.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.267 0.227 . . . . 3.0600000000000001 111.381 -179.923 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 85.4 m95 50.81 87.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.793 0.33 . . . . 1.0600000000000001 111.065 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.77 127.96 46.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.365 . . . . 1.8400000000000001 111.018 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 50' ' ' LYS . 16.8 ptmt -54.16 109.86 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 1.77 110.905 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HD2' ' A' ' 40' ' ' LYS . . . -81.77 -35.95 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 1.4099999999999999 110.709 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -48.36 -62.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 2.0099999999999998 110.661 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 51.61 37.18 19.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 2.6400000000000001 111.101 179.761 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 t -145.02 -82.91 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 2.0299999999999998 110.811 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 172.85 120.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 1.8700000000000001 111.192 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 8.2 mm -103.46 69.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 1.3700000000000001 110.8 179.756 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -46.48 71.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 2.1499999999999999 110.259 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -99.61 154.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 1.54 109.996 179.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -68.21 -9.55 47.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.468 -0.333 . . . . 1.75 111.414 179.98 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.905 ' OE1' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tp10 -93.59 98.61 11.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.836 -0.431 . . . . 2.0499999999999998 109.836 179.711 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 70.4 t80 -133.98 164.01 28.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.103 0.478 . . . . 0.56999999999999995 111.566 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.531 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 19.2 m -117.38 116.44 27.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.626 -0.716 . . . . 1.1399999999999999 110.808 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.489 ' CG2' ' CG1' ' A' ' 38' ' ' VAL . 65.1 t -86.53 96.38 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.0 0.428 . . . . 1.72 110.471 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.408 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 1.2 p -85.59 158.54 20.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.6399999999999999 110.373 179.799 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.5 -8.4 8.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.347 -0.842 . . . . 0.95999999999999996 111.793 -179.304 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 72' ' ' TYR . 3.3 mm? -44.7 171.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.096 0.474 . . . . 2.02 111.356 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.6 m -147.59 123.86 10.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.868 -0.605 . . . . 1.55 110.714 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.43 137.14 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 1.9099999999999999 111.191 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER 61.12 46.77 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 1.8700000000000001 111.523 179.905 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -156.81 122.51 4.78 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 1.2 111.526 179.791 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . . . -72.57 135.71 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 1.1100000000000001 110.086 179.318 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CD1' ' NZ ' ' A' ' 40' ' ' LYS . 42.5 m-85 -131.56 126.71 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.769 0.655 . . . . 1.0800000000000001 112.769 -178.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.56 139.28 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.868 -0.789 . . . . 1.5 108.868 178.354 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.535 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.65 114.99 19.41 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.367 1.247 . . . . 0.79000000000000004 114.367 -178.52 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.3 ttp85 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.119 -0.492 . . . . 2.6899999999999999 111.247 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG22 ' CG ' ' A' ' 8' ' ' PRO . 58.6 t -100.16 134.39 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.32 0.581 . . . . 1.5700000000000001 111.0 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 77' ' ' ILE . 9.9 mt -132.48 149.55 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.563 -1.273 . . . . 1.3200000000000001 107.563 178.863 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -171.3 141.26 1.56 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.079 -1.048 . . . . 1.1100000000000001 112.526 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.2 mttt -82.1 -123.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 2.3500000000000001 110.65 179.634 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 54.5 p30 -170.02 -122.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.394 0.543 . . . . 2.7000000000000002 109.583 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.0 -1.16 5.24 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.432 1.014 . . . . 1.3400000000000001 112.085 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -113.13 -1.32 14.42 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.894 0.331 . . . . 1.4299999999999999 111.894 -179.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.75 -19.53 41.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.188 -1.006 . . . . 1.3799999999999999 113.014 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.41 158.53 14.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.949 -0.389 . . . . 1.49 109.949 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.7 tt -120.99 118.18 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.09 0.774 . . . . 1.48 113.09 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -74.02 111.93 14.56 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 107.205 -1.406 . . . . 0.81000000000000005 107.205 177.835 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 18.7 Cg_endo -57.86 170.82 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.149 2.566 . . . . 1.25 114.557 -178.051 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 7.6 Cg_exo -32.48 142.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.385 3.39 . . . . 1.2 113.821 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.9 m -131.24 104.74 7.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.518 -0.764 . . . . 1.76 110.243 179.185 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 3.6 110.27 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.872 1.269 . . . . 1.77 113.568 -179.974 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 23.9 Cg_exo -63.71 153.19 76.78 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 1.01 114.421 -179.3 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.96 145.94 44.28 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.945 -1.025 . . . . 1.55 109.491 179.023 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -34.71 154.5 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 O-C-N 124.135 0.897 . . . . 1.6299999999999999 112.207 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -84.21 111.23 19.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 109.48 179.252 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.1 mp -94.2 111.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.914 -0.314 . . . . 1.1299999999999999 111.391 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' ALA . 12.4 m -48.37 -30.53 5.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.023 -0.535 . . . . 1.1299999999999999 110.72 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ASP . 82.5 m 49.85 86.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.065 -0.516 . . . . 1.5700000000000001 111.088 179.678 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 -84.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.34 -0.391 . . . . 3.7000000000000002 110.519 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -11.61 20.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.059 -0.519 . . . . 2.1400000000000001 111.011 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.417 -0.356 . . . . 2.0600000000000001 111.562 179.642 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.435 HD13 ' CB ' ' A' ' 84' ' ' ALA . 1.2 tt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.84 0.352 . . . . 1.26 110.714 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -130.56 131.89 23.63 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 2.0 110.738 179.83 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 162.43 28.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.435 2.09 . . . . 0.58999999999999997 112.509 -179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.2 Cg_endo -57.09 -179.56 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.01 2.474 . . . . 1.6100000000000001 112.554 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.29 -161.83 8.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.869 -0.681 . . . . 0.97999999999999998 112.813 -179.794 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -87.94 118.88 70.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.559 -0.163 . . . . 2.04 110.559 179.953 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 36.7 Cg_exo -62.52 133.77 44.44 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.54 2.16 . . . . 0.54000000000000004 112.74 -179.84 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.0 104.91 9.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 1.6799999999999999 111.02 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 47.0 Cg_exo -51.01 99.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.261 1.974 . . . . 0.64000000000000001 113.206 -179.594 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 21' ' ' LYS . 1.5 mt -55.56 -37.21 67.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.054 -0.721 . . . . 2.1699999999999999 109.054 179.065 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 4.2 t30 -136.5 153.72 50.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.765 -1.107 . . . . 0.84999999999999998 108.648 179.007 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 1.278 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 3.6 pt -143.78 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.402 -0.519 . . . . 1.5700000000000001 112.208 -179.004 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.637 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -94.7 137.91 33.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 1.46 110.117 179.412 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -40.47 -26.11 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.359 0.874 . . . . 2.9100000000000001 113.359 -178.9 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -115.53 -19.96 10.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.53 -0.468 . . . . 1.3300000000000001 111.966 -179.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.464 ' HA ' HD21 ' A' ' 66' ' ' LEU . 49.9 p -147.8 122.26 9.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.555 0.216 . . . . 1.28 110.659 -179.843 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.522 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 17.7 m -111.04 125.59 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.954 0.353 . . . . 1.49 111.954 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 47.2 m -87.05 144.53 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.035 -0.357 . . . . 1.1399999999999999 110.035 179.083 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.91 151.45 39.83 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.82 0.7 . . . . 1.3100000000000001 112.521 -179.885 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 19.3 tptp -144.66 148.15 33.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.765 -1.107 . . . . 2.3100000000000001 110.091 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.2 p90 -140.87 -176.51 4.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.40000000000000002 112.248 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.44 -159.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.384 -0.825 . . . . 1.1100000000000001 111.068 179.956 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -130.83 142.42 45.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 2.5600000000000001 110.158 179.952 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.76 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 88.2 Cg_exo -43.96 171.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.349 2.033 . . . . 1.1100000000000001 112.458 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.76 ' OE1' ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -106.92 -42.16 5.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 2.77 112.059 -179.608 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -118.03 -70.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.218 0.451 . . . . 1.6899999999999999 112.218 -179.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.4 p 60.31 46.23 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 1.3500000000000001 110.454 -179.253 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.71 -109.63 0.35 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.814 -0.708 . . . . 1.01 112.193 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.69 31.9 3.45 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.525 -1.03 . . . . 0.97999999999999998 110.525 179.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -114.38 -177.59 3.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.098 -0.551 . . . . 0.98999999999999999 111.468 -178.908 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 15.38 1.44 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 2.6899999999999999 111.743 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 61.05 152.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.551 0.215 . . . . 1.71 111.27 179.699 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -140.5 8.26 2.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.548 0.573 . . . . 1.6599999999999999 112.548 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 t -178.06 125.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 1.97 110.979 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.64 98.14 7.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 1.23 111.553 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.21 124.72 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 1.76 110.157 179.477 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -110.18 119.1 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 1.6100000000000001 111.538 -179.507 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.91 137.45 43.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.402 -0.817 . . . . 1.6699999999999999 109.397 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HD2' ' CD1' ' A' ' 72' ' ' TYR . 3.9 ttpm? -104.1 146.32 28.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.344 -0.389 . . . . 2.4399999999999999 110.348 -179.226 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.75 86.55 2.46 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.05 0.452 . . . . 1.79 110.579 179.711 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.857 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -62.36 86.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.509 -0.769 . . . . 1.5900000000000001 110.612 -179.828 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD2' ' HG2' ' A' ' 41' ' ' ARG . 76.5 mt -66.36 149.02 98.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.974 -0.557 . . . . 1.4299999999999999 111.049 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -93.23 27.38 18.68 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.893 -1.295 . . . . 1.47 112.719 0.337 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.25 45.16 2.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.512 -0.313 . . . . 2.6600000000000001 111.369 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -87.28 179.0 48.03 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.474 -0.87 . . . . 1.6200000000000001 112.344 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.79 31.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 3.0600000000000001 110.952 -179.727 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 53.4 m95 45.32 74.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 1.0600000000000001 111.236 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.31 133.08 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.016 -179.764 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -50.17 98.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.046 -0.524 . . . . 1.77 110.79 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -64.73 -53.56 45.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 1.4099999999999999 110.772 -179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.7 p-10 -71.0 129.12 38.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 110.873 179.843 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -124.62 34.92 4.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.372 -0.376 . . . . 2.6400000000000001 111.077 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 m -130.41 -84.93 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 2.0299999999999998 110.923 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.37 118.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 1.8700000000000001 110.964 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.5 HG22 HD11 ' A' ' 56' ' ' ILE . 15.9 mt -109.04 74.34 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 1.3700000000000001 110.968 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.74 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 111.001 -179.945 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.94 -178.48 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.547 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.9 p30 -92.56 2.88 56.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 1.75 111.672 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -102.98 101.82 11.83 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 110.049 -0.352 . . . . 2.0499999999999998 110.049 179.524 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 52' ' ' ASN . 72.8 t80 -135.06 163.92 28.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.56999999999999995 111.44 -179.454 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 80.2 m -125.63 125.22 42.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.699 -0.682 . . . . 1.1399999999999999 110.387 179.345 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 51' ' ' ALA . 17.0 t -83.43 90.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.208 0.527 . . . . 1.72 111.691 -179.355 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -92.46 137.9 31.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 1.6399999999999999 110.623 179.784 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.83 -5.61 7.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.95999999999999996 112.456 -179.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -48.91 -179.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.121 0.486 . . . . 2.02 111.591 179.807 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -141.19 118.72 11.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 1.55 110.132 179.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.416 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -45.59 155.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 1.9099999999999999 111.483 -179.561 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.0 m-20 52.87 55.03 9.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 1.8700000000000001 111.175 -179.884 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.71 121.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 1.2 111.296 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 43' ' ' LEU . . . -68.15 138.03 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.92 -0.4 . . . . 1.1100000000000001 109.92 179.481 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.8 m-85 -128.83 112.97 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.713 1.005 . . . . 1.0800000000000001 113.713 -178.37 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.6 tt0 -102.35 134.7 45.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.234 -1.024 . . . . 1.5 108.234 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.519 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.35 125.89 19.06 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.819 1.415 . . . . 0.79000000000000004 114.819 -178.644 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HB3' ' CD ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -103.62 165.49 11.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.257 -0.883 . . . . 2.6899999999999999 109.025 178.202 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -131.68 122.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 113.487 0.921 . . . . 1.5700000000000001 113.487 179.688 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.472 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 29.4 mt -106.59 147.91 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.667 -1.606 . . . . 1.3200000000000001 107.486 177.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -159.16 112.78 2.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.152 -1.019 . . . . 1.1100000000000001 112.688 -179.412 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 mttp -56.21 -175.87 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.31 -0.626 . . . . 2.3500000000000001 109.31 178.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' CD1' ' A' ' 2' ' ' ILE . 3.5 m120 -133.52 170.78 15.01 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.858 -0.337 . . . . 2.7000000000000002 110.559 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -41.1 -27.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.58 0.585 . . . . 1.3400000000000001 112.58 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -106.6 14.68 26.7 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 1.4299999999999999 112.852 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.96 -18.07 46.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.465 -0.874 . . . . 1.3799999999999999 112.947 179.659 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.435 ' CB ' HD13 ' A' ' 2' ' ' ILE . . . -46.5 105.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 1.49 110.903 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -68.98 97.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 1.48 111.65 -179.462 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 21.5 p -60.38 111.54 4.17 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 120.203 -0.599 . . . . 0.81000000000000005 109.939 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.18 146.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.758 2.305 . . . . 1.25 112.683 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 1.6 Cg_endo -46.52 140.57 11.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.691 2.26 . . . . 1.2 112.807 -179.665 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 90' ' ' GLU . 2.0 m -96.42 108.67 21.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.811 . . . . 1.76 110.386 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -2.95 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.715 1.206 . . . . 1.77 113.748 -179.935 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 78.3 Cg_exo -46.73 139.36 13.93 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.328 2.019 . . . . 1.01 113.28 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -76.27 147.41 38.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.893 -0.594 . . . . 1.55 109.51 179.338 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -39.08 147.1 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.967 0.792 . . . . 1.6299999999999999 111.577 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -77.79 117.22 18.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.719 -0.673 . . . . 1.0900000000000001 111.261 -179.71 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.6 mp -95.48 113.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 1.1299999999999999 110.597 179.408 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.443 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 84.5 m -51.82 -32.96 33.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.1299999999999999 111.036 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ASP . 3.6 m 54.57 89.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.5700000000000001 110.138 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.443 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -129.21 -78.0 0.56 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.223 0.535 . . . . 3.7000000000000002 110.69 -179.803 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.19 0.98 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.49 -0.777 . . . . 2.1400000000000001 111.052 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.278 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.784 0.326 . . . . 2.0600000000000001 111.244 -179.706 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 tt . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.955 0.407 . . . . 1.26 111.238 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.666 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.12 125.95 20.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 2.0 110.497 179.982 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 161.18 41.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.357 2.038 . . . . 0.58999999999999997 112.324 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.42 -173.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.792 2.328 . . . . 1.6100000000000001 112.969 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 -154.13 6.84 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.97999999999999998 113.017 -179.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -94.36 141.83 24.05 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.293 0.092 . . . . 2.04 110.932 -179.83 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 1.4 Cg_endo -83.34 127.11 4.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.901 2.401 . . . . 0.54000000000000004 112.411 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.99 102.75 10.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.6799999999999999 110.97 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.9 Cg_exo -37.05 140.13 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.818 2.345 . . . . 0.64000000000000001 112.88 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.418 ' CG ' HG23 ' A' ' 19' ' ' THR . 0.1 OUTLIER -108.39 -28.76 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 2.1699999999999999 110.151 -179.769 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.45 109.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.797 -0.638 . . . . 0.84999999999999998 109.911 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -106.6 148.51 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.714 1.005 . . . . 1.5700000000000001 113.714 -178.883 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.437 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -141.38 165.88 26.29 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.197 -0.91 . . . . 1.46 110.867 179.382 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.196 ' HD2' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -42.69 -41.72 3.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.241 -0.891 . . . . 2.9100000000000001 112.865 -179.44 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.5 m-70 -132.87 27.46 4.27 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.938 0.718 . . . . 1.3300000000000001 112.938 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -166.3 112.74 0.85 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.499 -0.48 . . . . 1.28 111.354 179.04 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 74' ' ' PHE . 1.7 m -110.61 127.64 67.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 C-N-CA 120.156 -0.618 . . . . 1.49 111.82 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.5 m -97.81 144.61 27.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.307 -0.627 . . . . 1.1399999999999999 109.307 179.161 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.86 152.98 39.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.413 0.625 . . . . 1.3100000000000001 112.323 -179.732 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -133.24 137.71 46.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.007 -0.997 . . . . 2.3100000000000001 110.238 179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.7 p90 -138.0 178.25 7.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 0.40000000000000002 111.062 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.0 -167.78 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.899 179.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.15 161.58 60.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.849 0.357 . . . . 2.5600000000000001 111.129 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 24' ' ' LYS . 31.4 Cg_exo -59.66 -177.67 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.878 2.386 . . . . 1.1100000000000001 113.192 -179.568 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.17 7.51 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.536 179.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.666 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 20.8 t80 -142.84 -67.37 0.37 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.369 . . . . 1.6899999999999999 110.858 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.643 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 50.8 p 48.23 44.92 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 1.3500000000000001 110.776 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.61 -102.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 1.01 112.254 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.05 26.68 4.18 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.204 -0.759 . . . . 0.97999999999999998 111.204 179.234 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -115.03 -174.57 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.98999999999999999 111.055 -179.34 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -145.04 25.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 2.6899999999999999 110.833 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.518 HG22 ' CE1' ' A' ' 36' ' ' TYR . 2.2 mm 60.77 148.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 1.71 110.712 -179.897 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -135.46 17.93 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.266 -0.424 . . . . 1.6599999999999999 111.025 179.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.1 t 170.55 160.34 0.07 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.156 0.503 . . . . 1.97 111.383 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.518 ' CE1' HG22 ' A' ' 33' ' ' ILE . 37.8 m-85 -137.41 78.49 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 1.23 109.946 179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 50' ' ' LYS . 12.7 mt -80.66 118.26 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 1.76 111.663 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -100.19 127.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 1.6100000000000001 110.266 179.732 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -84.5 131.96 34.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.6699999999999999 111.375 -179.583 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HD3' ' CE2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -95.23 140.59 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.719 -0.673 . . . . 2.4399999999999999 112.659 -179.435 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.7 ttt180 -127.34 104.57 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 1.79 110.098 178.527 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.679 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.48 84.96 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 1.5900000000000001 110.681 -179.79 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.5 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.01 154.7 2.41 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.485 -0.779 . . . . 1.4299999999999999 110.828 -179.96 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.89 15.35 36.5 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 123.875 -1.302 . . . . 1.47 112.951 0.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -117.61 -77.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 2.6600000000000001 111.111 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.499 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . 52.87 -178.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.63 -0.795 . . . . 1.6200000000000001 112.006 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.94 29.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 3.0600000000000001 111.257 -179.823 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 61.1 m95 47.5 93.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 1.0600000000000001 110.92 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.14 131.74 47.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.692 -0.403 . . . . 1.8400000000000001 111.29 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HB3' HG23 ' A' ' 37' ' ' ILE . 17.7 ptpt -63.19 74.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.824 -0.626 . . . . 1.77 111.389 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.443 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -55.64 -43.11 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 1.4099999999999999 110.26 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -42.07 -46.51 4.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.987 -0.551 . . . . 2.0099999999999998 111.253 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.65 36.84 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 2.6400000000000001 110.997 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -144.35 -162.99 1.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 2.0299999999999998 110.624 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -111.58 88.69 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 1.8700000000000001 110.828 -179.906 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 10.2 mm -70.52 67.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 1.3700000000000001 111.1 179.861 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.19 -58.88 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 2.1499999999999999 110.363 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.88 160.67 29.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.173 -0.677 . . . . 1.54 109.173 179.055 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.527 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.6 p30 -84.16 10.28 10.64 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.561 -0.456 . . . . 1.75 112.057 -179.651 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.02 98.79 7.01 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.605 . . . . 2.0499999999999998 109.365 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 81.2 t80 -130.02 163.65 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.447 0.641 . . . . 0.56999999999999995 112.251 -179.041 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 25.7 m -117.15 114.91 24.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.013 -0.994 . . . . 1.1399999999999999 110.872 179.232 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' CG1' ' HD3' ' A' ' 40' ' ' LYS . 44.8 t -81.65 84.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.777 -0.647 . . . . 1.72 110.739 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.411 ' CB ' HG21 ' A' ' 17' ' ' THR . 51.8 p -83.37 -179.78 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.72 . . . . 1.6399999999999999 110.673 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.18 -20.83 34.58 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.581 -0.819 . . . . 0.95999999999999996 112.446 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.498 HD23 HG11 ' A' ' 18' ' ' VAL . 1.3 pp -51.95 179.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.683 0.278 . . . . 2.02 110.482 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 3.0 m -140.55 127.56 20.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 1.55 111.247 -179.482 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -54.52 157.34 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.11 0.481 . . . . 1.9099999999999999 111.477 -179.877 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.4 OUTLIER 68.84 47.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 1.8700000000000001 110.649 -179.605 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -172.9 123.78 0.43 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 1.2 111.594 179.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -70.05 134.16 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.659 -0.497 . . . . 1.1100000000000001 109.659 179.11 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.538 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 43.0 m-85 -127.37 118.22 23.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.819 0.674 . . . . 1.0800000000000001 112.819 -178.677 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -103.53 139.18 39.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.348 -0.612 . . . . 1.5 109.348 178.709 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -141.02 127.24 19.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.63 1.344 . . . . 0.79000000000000004 114.63 -179.438 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -96.59 163.23 13.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.492 -0.777 . . . . 2.6899999999999999 109.344 178.184 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 60.6 t -115.52 123.5 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 112.807 0.669 . . . . 1.5700000000000001 112.807 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -114.05 155.61 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 114.79 -1.095 . . . . 1.3200000000000001 109.248 179.023 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -165.52 127.77 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.884 -0.726 . . . . 1.1100000000000001 111.931 179.02 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mttt -77.85 -157.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 2.3500000000000001 110.358 179.828 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 6.9 p-10 -155.64 162.88 40.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.336 0.589 . . . . 2.7000000000000002 111.415 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.11 -41.17 1.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 1.3400000000000001 112.784 -179.756 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -70.34 -14.12 62.44 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.411 0.523 . . . . 1.4299999999999999 112.411 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.83 59.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.435 -0.888 . . . . 1.3799999999999999 112.108 -179.201 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.56 170.02 6.83 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.004 -0.369 . . . . 1.49 110.004 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.02 120.25 63.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.512 0.56 . . . . 1.48 112.512 -179.294 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.2 p -81.64 118.8 73.58 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.076 -1.083 . . . . 0.81000000000000005 108.076 178.344 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.47 158.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.761 2.307 . . . . 1.25 113.08 -178.863 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.449 ' CA ' HG13 ' A' ' 77' ' ' ILE . 37.0 Cg_endo -67.59 162.53 38.74 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.82 2.347 . . . . 1.2 113.896 -179.208 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 m -114.14 135.26 54.23 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.099 -0.955 . . . . 1.76 109.839 179.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -19.69 106.71 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 124.497 1.123 . . . . 1.77 113.48 -179.445 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 87.6 Cg_exo -43.83 141.79 3.95 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 1.01 113.222 -179.944 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.11 147.13 38.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.626 -0.715 . . . . 1.55 109.817 179.418 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -37.21 146.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 O-C-N 124.207 0.942 . . . . 1.6299999999999999 111.797 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 43' ' ' LEU . . . -77.78 108.91 11.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.66 179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 13' ' ' ILE . 4.6 mp -86.23 113.44 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 1.1299999999999999 110.72 179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 92.6 m -50.89 -46.32 60.53 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 1.1299999999999999 110.033 179.748 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 69' ' ' ASP . 2.3 m 57.53 107.76 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.685 -0.689 . . . . 1.5700000000000001 109.697 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.93 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -140.6 -85.35 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.975 0.417 . . . . 3.7000000000000002 110.474 -179.602 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.93 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 12.2 p-10 -106.65 32.18 4.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 2.1400000000000001 109.183 179.245 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.437 ' OD1' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.192 -0.913 . . . . 2.0600000000000001 111.356 -179.126 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 86' ' ' SER . 13.3 tt . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 121.688 0.756 . . . . 1.26 112.794 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -135.62 109.59 10.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.277 -0.874 . . . . 2.0 110.053 179.903 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.65 153.23 79.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.272 1.981 . . . . 0.58999999999999997 112.271 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.64 179.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.889 2.392 . . . . 1.6100000000000001 112.976 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.22 -178.22 47.16 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.909 -0.587 . . . . 0.97999999999999998 113.088 -179.644 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.6 tttt -69.28 136.11 88.95 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.448 0.166 . . . . 2.04 111.276 -179.875 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 5.1 Cg_exo -75.72 131.34 13.38 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.521 2.148 . . . . 0.54000000000000004 112.201 179.665 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 21' ' ' LYS . 2.5 p -132.5 100.06 15.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.6799999999999999 110.797 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 17.3 Cg_exo -52.63 122.66 11.3 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.025 1.816 . . . . 0.64000000000000001 113.697 -179.234 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.501 HD12 ' CD ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -82.95 -31.73 27.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.551 -0.907 . . . . 2.1699999999999999 108.551 178.347 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.59 138.16 37.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.979 -1.009 . . . . 0.84999999999999998 108.634 179.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -139.43 94.92 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.306 -0.558 . . . . 1.5700000000000001 112.308 -179.139 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 163.12 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.46 110.133 179.264 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -61.46 -21.38 64.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.36 -0.382 . . . . 2.9100000000000001 111.944 -179.42 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -126.34 16.02 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 1.3300000000000001 111.471 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -158.68 159.28 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 1.28 109.826 179.683 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' CG2' ' CD2' ' A' ' 66' ' ' LEU . 82.5 t -156.2 91.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.924 -0.311 . . . . 1.49 111.563 -179.161 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 30.9 m -79.07 145.47 33.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.309 -0.405 . . . . 1.1399999999999999 110.363 179.432 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.13 161.8 41.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.736 0.779 . . . . 1.3100000000000001 112.898 -179.072 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.223 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -141.18 142.03 34.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.32 -1.309 . . . . 2.3100000000000001 109.249 179.213 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 14.7 p90 -137.88 -174.28 3.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.73 0.3 . . . . 0.40000000000000002 111.145 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.63 163.4 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 1.1100000000000001 111.267 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.56 145.1 31.93 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 110.077 179.874 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.428 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 5.2 Cg_exo -77.82 162.61 29.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.31 2.007 . . . . 1.1100000000000001 112.169 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -112.78 -22.62 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 2.77 111.192 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -85.01 -72.61 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 1.6899999999999999 111.137 -179.839 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.486 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.7 p 41.4 45.56 2.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.67 -0.241 . . . . 1.3500000000000001 111.497 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.25 -92.53 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.703 -0.76 . . . . 1.01 112.409 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -153.14 43.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.187 -1.165 . . . . 0.97999999999999998 110.187 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -123.72 -176.43 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.527 . . . . 0.98999999999999999 111.368 -178.519 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -123.63 -20.28 5.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.084 -0.507 . . . . 2.6899999999999999 111.975 -179.53 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt 68.51 112.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.688 -0.486 . . . . 1.71 109.688 -178.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -114.07 33.13 5.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.917 0.339 . . . . 1.6599999999999999 111.917 -179.211 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.09 144.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.278 0.473 . . . . 1.97 112.278 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 57.0 m-85 -127.48 85.15 2.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.678 . . . . 1.23 110.282 179.243 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' CG2' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -79.76 105.02 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 1.76 111.487 -179.795 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -96.07 138.34 21.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.991 -0.744 . . . . 1.6100000000000001 108.991 179.065 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.429 ' HA ' ' CA ' ' A' ' 50' ' ' LYS . 6.0 mt-10 -96.76 152.36 18.75 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.052 0.22 . . . . 1.6699999999999999 110.492 -179.782 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HD2' ' CE1' ' A' ' 72' ' ' TYR . 8.8 ttpp -108.42 155.46 20.54 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.417 -0.356 . . . . 2.4399999999999999 110.651 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.596 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -134.08 103.6 5.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.733 -0.387 . . . . 1.79 110.085 178.993 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.98 83.15 5.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 1.5900000000000001 110.349 -179.741 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 44' ' ' PRO . 20.4 mt -61.24 159.67 28.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 1.4299999999999999 111.077 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.1 Cg_endo -82.63 24.47 9.08 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 124.561 -1.016 . . . . 1.47 113.775 0.715 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -142.11 -80.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.844 0.354 . . . . 2.6600000000000001 110.631 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 38.31 -161.9 0.01 OUTLIER Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.925 -0.579 . . . . 1.6200000000000001 113.7 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.44 145.75 17.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.592 -0.522 . . . . 3.0600000000000001 109.592 179.676 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.596 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 74.7 m95 -63.61 78.59 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.267 -0.424 . . . . 1.0600000000000001 110.08 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -116.54 106.29 13.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.796 -0.638 . . . . 1.8400000000000001 111.001 -179.615 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER 20.4 -151.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.82 1.325 . . . . 1.77 113.924 179.303 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . 175.98 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.001 -0.437 . . . . 1.4099999999999999 110.451 -179.451 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -75.28 -38.04 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 2.0099999999999998 110.81 -179.969 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 57.75 34.57 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.948 0.351 . . . . 2.6400000000000001 111.948 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 11.2 t -170.23 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.797 0.295 . . . . 2.0299999999999998 111.797 179.691 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 10.1 t-20 -165.52 125.64 1.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 1.8700000000000001 110.412 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 61' ' ' PHE . 25.5 mt -109.86 75.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 1.3700000000000001 110.977 -179.916 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.22 -70.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 2.1499999999999999 110.947 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.2 170.4 13.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.137 -0.32 . . . . 1.54 110.137 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.496 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 46.8 p-10 -84.69 6.1 25.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 1.75 111.874 -179.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.223 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -115.06 105.57 13.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.134 -0.691 . . . . 2.0499999999999998 109.134 179.121 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 62' ' ' THR . 55.9 t80 -136.7 164.17 28.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.331 0.493 . . . . 0.56999999999999995 112.331 -178.813 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 91.6 m -115.71 105.64 12.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.854 -0.612 . . . . 1.1399999999999999 111.647 179.673 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 ' CG1' ' CB ' ' A' ' 51' ' ' ALA . 73.9 t -75.44 118.79 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.475 -0.784 . . . . 1.72 111.012 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.0 p -123.65 155.0 38.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 1.6399999999999999 111.371 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.36 -4.03 8.24 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.95999999999999996 112.862 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 ' CD2' ' CG2' ' A' ' 18' ' ' VAL . 6.6 mp -65.81 165.94 11.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.105 0.479 . . . . 2.02 111.866 -179.592 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -121.49 127.38 50.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 1.55 110.347 179.72 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -48.97 145.25 4.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.124 -0.489 . . . . 1.9099999999999999 111.486 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 97' ' ' CYS . 18.8 t0 68.22 54.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 1.8700000000000001 111.527 179.576 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.77 120.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 1.2 111.335 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -67.56 135.86 53.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.467 -0.333 . . . . 1.1100000000000001 110.236 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.511 ' CE1' ' HD2' ' A' ' 40' ' ' LYS . 20.7 m-85 -128.06 123.47 34.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.433 0.901 . . . . 1.0800000000000001 113.433 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -106.19 140.72 38.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.378 -0.971 . . . . 1.5 108.378 178.119 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -137.51 129.02 28.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.719 1.377 . . . . 0.79000000000000004 114.719 -178.482 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.82 146.2 28.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.031 -0.531 . . . . 2.6899999999999999 110.142 178.282 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 44.8 t -99.71 108.78 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.28 -0.568 . . . . 1.5700000000000001 112.427 -179.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.462 HG12 ' CA ' ' A' ' 88' ' ' PRO . 77.1 mt -101.5 150.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.579 -1.267 . . . . 1.3200000000000001 107.579 177.768 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.414 ' O ' ' OG ' ' A' ' 86' ' ' SER . . . -161.51 145.13 12.69 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.073 -1.051 . . . . 1.1100000000000001 112.505 -179.642 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.4 ptpt -92.66 -161.23 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.555 . . . . 2.3500000000000001 110.402 179.545 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.511 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 4.8 p-10 -150.46 165.92 31.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.989 0.423 . . . . 2.7000000000000002 111.233 -179.274 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -43.47 -26.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 1.3400000000000001 112.251 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -92.15 -20.34 21.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.969 0.359 . . . . 1.4299999999999999 111.969 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.62 -1.45 60.04 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.702 -0.761 . . . . 1.3799999999999999 112.81 -179.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.1 76.84 1.24 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.991 0.424 . . . . 1.49 110.421 179.672 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -34.24 125.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 1.48 113.879 -178.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 14.0 p -90.6 124.97 61.07 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.05 -0.977 . . . . 0.81000000000000005 109.596 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -40.55 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.852 2.368 . . . . 1.25 112.832 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' CA ' HG12 ' A' ' 77' ' ' ILE . 8.0 Cg_exo -72.21 149.35 51.46 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.804 2.336 . . . . 1.2 112.885 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m -95.2 129.11 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 1.76 109.733 179.349 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.5 tp10 -20.17 103.15 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.991 0 O-C-N 124.494 1.121 . . . . 1.77 112.886 -179.575 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 36.5 Cg_exo -38.12 150.04 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.806 2.337 . . . . 1.01 114.041 -179.443 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.21 145.6 26.32 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.336 -0.847 . . . . 1.55 109.054 178.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -35.12 151.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 124.229 0.956 . . . . 1.6299999999999999 111.894 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -84.69 121.12 27.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 1.0900000000000001 111.251 -179.536 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.6 112.12 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 1.1299999999999999 111.169 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 88.0 m -42.82 -34.11 0.88 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 1.1299999999999999 111.965 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 94.9 m 51.4 82.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 1.5700000000000001 110.586 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 -81.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.112 0.482 . . . . 3.7000000000000002 110.761 -179.733 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -117.79 -11.38 10.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.738 -0.664 . . . . 2.1400000000000001 111.24 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 111.782 0.29 . . . . 2.0600000000000001 111.782 -179.931 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 6.8 tt . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.065 0.46 . . . . 1.26 111.199 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.95 130.09 23.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.829 -0.623 . . . . 2.0 110.023 179.644 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.59 173.86 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.189 1.926 . . . . 0.58999999999999997 112.739 -179.453 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.521 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 53.1 Cg_exo -54.98 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.201 2.601 . . . . 1.6100000000000001 113.419 -179.401 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.15 -163.41 39.18 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.759 -0.655 . . . . 0.97999999999999998 112.773 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.3 tmtt? -78.63 114.83 46.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 110.549 -0.167 . . . . 2.04 110.549 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 20.4 Cg_exo -72.17 149.56 52.1 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.969 2.446 . . . . 0.54000000000000004 113.487 -179.26 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -146.97 107.99 3.97 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.629 -0.714 . . . . 1.6799999999999999 111.201 179.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 19' ' ' THR . 38.7 Cg_exo -59.06 94.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.508 2.139 . . . . 0.64000000000000001 113.041 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -51.25 -46.02 62.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.503 0.668 . . . . 2.1699999999999999 109.454 179.244 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -122.3 150.27 42.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.959 -1.018 . . . . 0.84999999999999998 108.408 178.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.07 80.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.29 -0.564 . . . . 1.5700000000000001 111.956 -179.219 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.08 156.53 35.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.46 110.288 179.594 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -61.4 -11.84 11.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.887 0.699 . . . . 2.9100000000000001 112.887 -179.043 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 2.3 m-70 -140.07 20.19 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.811 -0.356 . . . . 1.3300000000000001 111.581 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.482 ' CA ' HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER 179.14 109.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 1.28 110.383 179.742 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.535 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 25.9 m -108.6 126.16 65.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 1.49 111.364 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.7 m -96.61 137.76 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 1.1399999999999999 111.054 179.709 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -139.56 164.25 30.4 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.061 0.85 . . . . 1.3100000000000001 112.426 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.48 153.7 34.04 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.933 -1.031 . . . . 2.3100000000000001 110.519 179.614 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.521 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 31.7 p90 -146.93 -171.5 3.78 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.533 0.568 . . . . 0.40000000000000002 112.533 -179.462 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.31 -158.37 0.18 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 110.834 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -142.75 139.21 16.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 2.5600000000000001 110.475 -179.963 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.573 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 84.3 Cg_exo -34.42 148.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.124 2.549 . . . . 1.1100000000000001 112.778 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.726 ' OE1' ' CA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -98.48 11.67 37.51 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 2.77 111.802 -179.592 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -169.95 -66.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.6899999999999999 111.753 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 1.2 p 52.05 47.6 24.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.008 0.432 . . . . 1.3500000000000001 110.197 -179.307 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.29 -108.65 0.23 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.802 -0.713 . . . . 1.01 112.31 -179.758 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.39 29.56 4.03 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.784 -0.926 . . . . 0.97999999999999998 110.784 179.176 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -114.74 -174.48 2.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.13 -0.535 . . . . 0.98999999999999999 110.814 -178.967 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.0 pttt -143.08 32.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 2.6899999999999999 111.594 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' ' 36' ' ' TYR . 7.7 mm 65.56 -71.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 1.71 111.365 179.861 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.4 p 81.59 -10.18 1.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.634 0.605 . . . . 1.6599999999999999 112.634 179.63 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 2.1 t -179.65 140.93 0.15 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.763 -0.375 . . . . 1.97 111.995 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.488 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 69.2 m-85 -116.59 138.73 51.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.164 -0.471 . . . . 1.23 110.852 179.409 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 5.0 mt -116.43 129.32 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.446 -0.343 . . . . 1.76 110.423 179.707 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.57 113.52 44.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.814 0.34 . . . . 1.6100000000000001 111.813 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 50.8 mt-10 -83.02 132.85 35.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 1.6699999999999999 110.151 179.271 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HD3' ' CD1' ' A' ' 72' ' ' TYR . 2.1 tttp -95.42 128.14 42.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 113.554 0.946 . . . . 2.4399999999999999 113.554 -178.426 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -108.52 95.16 5.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.873 -0.603 . . . . 1.79 110.196 178.539 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 1.077 ' OD2' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -64.17 142.17 58.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.15 -0.477 . . . . 1.5900000000000001 109.753 179.619 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 29.9 mt -123.71 133.11 24.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.754 -0.378 . . . . 1.4299999999999999 110.919 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -90.96 47.7 1.32 Allowed 'Cis proline' 0 C--N 1.351 0.689 0 C-N-CA 124.28 -1.134 . . . . 1.47 113.125 0.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 42' ' ' ASP . 1.7 m120 -127.13 57.5 1.47 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 2.6600000000000001 110.801 -179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -42.65 160.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.044 -0.526 . . . . 1.6200000000000001 113.42 -179.634 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 1.077 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 5.4 ptm180 -179.86 -32.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.041 0.385 . . . . 3.0600000000000001 112.041 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 64.0 m95 61.41 81.53 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.296 -0.631 . . . . 1.0600000000000001 109.296 -179.12 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.57 135.92 54.15 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.386 0.513 . . . . 1.8400000000000001 112.386 -178.739 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtpm? -46.96 94.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.77 111.015 179.782 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.45 -42.29 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.4099999999999999 111.551 -179.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 8.0 p-10 -54.21 -58.76 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.639 -0.255 . . . . 2.0099999999999998 111.319 -179.678 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 39.56 49.27 1.96 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.053 0.39 . . . . 2.6400000000000001 112.053 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -161.22 26.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.729 0.27 . . . . 2.0299999999999998 111.729 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.32 113.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 1.8700000000000001 111.225 179.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' A' ' 61' ' ' PHE . 28.1 mt -109.94 71.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 1.3700000000000001 110.827 179.587 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.9 mt -50.39 -59.57 3.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 2.1499999999999999 111.3 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -86.93 158.91 19.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.917 0.389 . . . . 1.54 110.334 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 4.7 p-10 -69.99 -7.93 44.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.024 -0.535 . . . . 1.75 111.772 -179.764 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -98.22 105.07 17.17 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.443 -0.577 . . . . 2.0499999999999998 109.443 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 52' ' ' ASN . 53.2 t80 -142.47 165.42 27.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 111.711 -179.002 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 87.5 m -120.96 121.37 37.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.772 -0.649 . . . . 1.1399999999999999 111.074 179.778 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 t -81.7 110.8 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.113 -0.494 . . . . 1.72 111.637 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -97.38 -159.54 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.858 -0.61 . . . . 1.6399999999999999 110.495 179.877 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.19 23.48 62.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.64 -0.79 . . . . 0.95999999999999996 112.114 -179.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 14.2 mt -76.03 169.8 17.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 2.02 110.944 -179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.899 ' HB ' ' HH ' ' A' ' 72' ' ' TYR . 2.1 m -134.17 141.32 47.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 1.55 110.564 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 29.8 mt-10 -75.12 144.41 42.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.128 -0.487 . . . . 1.9099999999999999 111.215 -179.783 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.9 t0 67.82 40.32 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.8700000000000001 110.849 179.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -155.53 115.34 3.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 1.2 111.42 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -67.72 130.34 42.69 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.49 -0.559 . . . . 1.1100000000000001 109.49 179.082 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.899 ' HH ' ' HB ' ' A' ' 67' ' ' THR . 57.8 m-85 -124.89 119.44 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.871 1.064 . . . . 1.0800000000000001 113.871 -177.968 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 5.8 mt-10 -102.66 139.97 37.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.684 -1.228 . . . . 1.5 107.684 177.631 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.91 122.07 23.79 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.028 1.492 . . . . 0.79000000000000004 115.028 -178.574 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 19.9 ttm-85 -94.93 143.81 26.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 114.509 -1.223 . . . . 2.6899999999999999 109.086 178.087 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.491 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -121.06 120.1 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 119.121 -1.031 . . . . 1.5700000000000001 112.538 179.458 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -110.58 165.42 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.861 -1.518 . . . . 1.3200000000000001 107.689 178.537 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.414 ' O ' ' OG ' ' A' ' 86' ' ' SER . . . -165.81 149.23 7.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 118.934 -1.106 . . . . 1.1100000000000001 112.376 -179.839 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.0 mttt -99.12 -177.61 3.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.308 -0.406 . . . . 2.3500000000000001 109.973 179.097 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 p-10 -136.41 166.72 22.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.06 -0.518 . . . . 2.7000000000000002 110.907 -179.682 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 112.482 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -89.08 -20.28 24.52 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.654 0.613 . . . . 1.4299999999999999 112.654 -179.25 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.09 57.95 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.423 -0.894 . . . . 1.3799999999999999 112.603 -179.59 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.452 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -74.23 77.89 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.964 0.411 . . . . 1.49 110.297 179.74 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -36.23 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 1.48 113.285 -179.152 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 33.8 p -62.93 117.66 34.71 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.599 -0.728 . . . . 0.81000000000000005 109.415 178.718 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -35.32 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.363 2.709 . . . . 1.25 113.398 -179.342 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HB3' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -59.22 168.28 4.99 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.219 2.613 . . . . 1.2 113.499 -179.612 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -124.61 129.62 50.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.084 -0.962 . . . . 1.76 109.706 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -25.03 118.57 0.21 Allowed Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.688 0.795 . . . . 1.77 112.604 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 51.5 Cg_exo -55.53 154.68 23.87 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.363 2.042 . . . . 1.01 114.249 -179.211 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -84.78 146.43 27.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.08 -0.963 . . . . 1.55 109.092 178.961 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -40.31 146.81 0.12 Allowed 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.623 0.577 . . . . 1.6299999999999999 111.428 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.45 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -76.14 122.13 23.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.659 . . . . 1.0900000000000001 110.671 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 13' ' ' ILE . 3.9 mp -102.28 109.09 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 1.1299999999999999 111.632 -179.565 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 76.0 m -48.18 -36.11 13.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.173 -0.467 . . . . 1.1299999999999999 111.087 -179.897 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.3 m 50.65 98.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 1.5700000000000001 111.173 179.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -72.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.152 -0.476 . . . . 3.7000000000000002 110.513 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -141.52 10.91 2.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.769 -0.65 . . . . 2.1400000000000001 111.726 179.677 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.083 0.468 . . . . 2.0600000000000001 111.624 -179.787 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.485 HG12 ' N ' ' A' ' 3' ' ' ASP . 3.1 tt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.186 0.517 . . . . 1.26 111.88 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.485 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -125.99 136.51 28.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.436 -0.802 . . . . 2.0 109.55 179.262 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.21 161.37 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.192 1.928 . . . . 0.58999999999999997 112.429 -179.616 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.22 164.5 2.69 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.864 2.376 . . . . 1.6100000000000001 113.108 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.45 169.17 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.511 -0.768 . . . . 0.97999999999999998 112.229 179.803 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -68.55 126.61 92.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.066 -0.346 . . . . 2.04 110.066 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 32.9 Cg_exo -62.85 153.19 74.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.28 1.987 . . . . 0.54000000000000004 113.422 -179.289 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.79 96.19 3.6 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 1.6799999999999999 109.641 179.368 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.2 Cg_exo -40.36 118.84 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.178 1.919 . . . . 0.64000000000000001 113.224 -179.129 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.949 ' CD2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -84.99 -26.84 26.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.509 -0.923 . . . . 2.1699999999999999 108.509 178.844 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 2.0 t30 -147.87 153.08 38.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.642 -1.244 . . . . 0.84999999999999998 107.642 178.169 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.51 134.72 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.118 -0.633 . . . . 1.5700000000000001 112.225 -179.133 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 146.93 31.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.958 -0.565 . . . . 1.46 111.251 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -24.62 -48.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.541 -1.209 . . . . 2.9100000000000001 114.002 -179.336 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.479 ' CD2' ' HG2' ' A' ' 68' ' ' GLU . 29.3 m-70 -128.78 22.03 5.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.675 0.621 . . . . 1.3300000000000001 112.675 -179.016 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 38.7 p -162.49 114.42 1.62 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.28 109.995 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.537 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -128.83 121.6 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.953 0.882 . . . . 1.49 113.025 -179.405 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.1 m -82.33 148.91 28.03 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.184 -0.916 . . . . 1.1399999999999999 110.686 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -150.71 147.73 27.7 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 124.337 1.023 . . . . 1.3100000000000001 111.189 179.721 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.194 ' HD3' ' OE1' ' A' ' 60' ' ' GLU . 19.3 tptm -129.54 151.86 49.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.275 -0.875 . . . . 2.3100000000000001 110.718 179.793 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CD1' ' HB3' ' A' ' 59' ' ' ASN . 49.1 p90 -150.36 -179.04 6.88 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.057 0.455 . . . . 0.40000000000000002 112.17 179.801 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.78 162.15 13.16 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.722 -0.672 . . . . 1.1100000000000001 111.597 -179.417 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.13 152.85 38.22 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.421 -0.354 . . . . 2.5600000000000001 110.891 179.802 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 11.7 Cg_endo -55.1 141.28 80.03 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.013 2.475 . . . . 1.1100000000000001 113.524 -179.501 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -7.28 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 2.77 112.095 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -134.1 -67.11 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.883 -0.327 . . . . 1.6899999999999999 111.677 -179.877 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 4.5 t 35.85 49.59 0.58 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.302 0.573 . . . . 1.3500000000000001 111.838 -179.201 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.47 -123.06 8.08 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.574 -0.739 . . . . 1.01 112.416 179.995 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.64 31.84 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.952 -0.859 . . . . 0.97999999999999998 110.952 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -103.47 -170.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.351 0.596 . . . . 0.98999999999999999 112.238 -178.875 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' THR . 9.5 ttpt -145.84 24.74 1.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.069 -0.969 . . . . 2.6899999999999999 110.744 179.856 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.538 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 24.2 mm 66.49 -70.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.248 -0.433 . . . . 1.71 111.119 179.918 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.4 p 83.36 -11.52 0.91 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.909 -0.587 . . . . 1.6599999999999999 112.232 179.684 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -178.98 140.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.321 . . . . 1.97 111.807 -179.875 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.538 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 59.2 m-85 -119.65 139.84 51.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.126 0.489 . . . . 1.23 111.11 179.596 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 17.3 mt -116.97 130.84 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 1.76 110.088 179.367 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -104.68 109.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 1.6100000000000001 112.293 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' CB ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -81.87 107.93 14.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.557 -0.534 . . . . 1.6699999999999999 109.557 178.979 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 51' ' ' ALA . 2.3 ptmt -97.46 151.53 19.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 2.4399999999999999 111.322 -179.368 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.434 ' HG2' ' CD2' ' A' ' 43' ' ' LEU . 12.2 ttp180 -139.01 120.29 14.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.123 -0.49 . . . . 1.79 111.366 -179.905 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.488 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -82.86 90.76 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 1.5900000000000001 109.616 179.432 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' CD2' ' HG2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -83.82 150.61 59.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 111.414 -179.228 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -94.01 28.35 17.24 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.003 -1.249 . . . . 1.47 112.705 0.081 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -139.69 69.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 2.6600000000000001 110.941 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.42 -169.88 30.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.814 -0.708 . . . . 1.6200000000000001 112.297 179.986 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HD3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.05 168.28 25.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 3.0600000000000001 111.223 179.971 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.524 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 70.7 m95 -69.71 118.43 12.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.715 -0.675 . . . . 1.0600000000000001 111.393 -179.764 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.412 HD21 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -147.38 127.55 13.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 1.8400000000000001 110.705 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -65.27 83.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.77 111.368 -179.737 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . . . -60.6 -38.67 85.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.838 0.351 . . . . 1.4099999999999999 110.434 179.672 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' CE1' ' A' ' 61' ' ' PHE . 4.2 t30 -40.13 -84.47 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.91 -0.586 . . . . 2.0099999999999998 111.197 -179.997 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 t80 60.22 15.7 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.036 0.384 . . . . 2.6400000000000001 112.036 179.568 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -122.75 22.42 9.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 2.0299999999999998 110.939 179.826 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.99 133.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.936 0.398 . . . . 1.8700000000000001 111.224 179.834 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.435 HG13 ' ND2' ' A' ' 52' ' ' ASN . 13.2 mt -129.38 74.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 1.3700000000000001 110.857 179.993 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -56.69 16.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 2.1499999999999999 111.057 -179.957 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.28 160.53 15.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 1.54 110.808 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 1.7 m-20 -70.46 -8.4 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 1.75 111.525 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 1.194 ' OE1' ' HD3' ' A' ' 21' ' ' LYS . 14.7 tp10 -93.13 96.11 9.84 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.732 -0.47 . . . . 2.0499999999999998 109.732 179.68 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 62' ' ' THR . 60.1 t80 -131.65 165.9 22.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 111.576 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.0 m -121.92 121.96 38.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.801 -0.636 . . . . 1.1399999999999999 111.256 179.636 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 20' ' ' LEU . 7.5 t -81.16 74.57 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.197 0.522 . . . . 1.72 110.294 -179.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 83.2 p -78.66 164.39 24.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.326 -0.852 . . . . 1.6399999999999999 110.91 -179.589 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -9.97 64.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.586 -0.816 . . . . 0.95999999999999996 113.009 179.922 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 18' ' ' VAL . 4.4 pp -60.89 166.1 3.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 117.244 0.522 . . . . 2.02 110.694 -179.977 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.454 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -104.64 157.94 16.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.55 111.185 -179.478 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.85 167.24 10.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 112.413 -179.289 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 t70 73.27 55.94 0.11 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.542 -0.753 . . . . 1.8700000000000001 111.214 179.887 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 165.58 138.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 1.2 110.363 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -56.87 133.85 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 1.1100000000000001 110.393 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 2.3 m-85 -126.35 116.68 21.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 1.0800000000000001 111.898 -178.852 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.13 145.85 30.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.93 -0.577 . . . . 1.5 109.495 179.027 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.98 115.52 10.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.348 1.24 . . . . 0.79000000000000004 114.348 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.435 ' NH1' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -98.9 -178.45 3.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.794 -0.817 . . . . 2.6899999999999999 108.794 177.922 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.489 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -150.48 130.7 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 119.309 -0.956 . . . . 1.5700000000000001 112.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.463 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 55.6 mt -114.7 151.91 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.45 -1.25 . . . . 1.3200000000000001 108.593 178.916 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -161.89 136.54 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.62 -0.832 . . . . 1.1100000000000001 112.771 -179.662 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.58 -158.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.576 . . . . 2.3500000000000001 109.912 179.228 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.461 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 2.8 p-10 -160.34 176.31 11.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 2.7000000000000002 111.82 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.068 -0.969 . . . . 1.3400000000000001 112.169 179.796 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.22 -20.33 19.93 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.91 0.337 . . . . 1.4299999999999999 111.91 -179.453 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.36 -2.7 61.16 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.48 -0.867 . . . . 1.3799999999999999 112.981 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.409 ' O ' HD11 ' A' ' 2' ' ' ILE . . . -68.22 85.93 0.26 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 1.49 110.391 179.77 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 5.3 tp -46.32 122.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.658 0.614 . . . . 1.48 112.658 -179.116 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 77' ' ' ILE . 26.7 p -82.31 120.98 78.17 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.297 -0.865 . . . . 0.81000000000000005 109.258 178.889 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -38.54 163.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.904 2.403 . . . . 1.25 113.219 -179.495 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 4.2 Cg_exo -75.1 118.1 5.12 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.781 2.321 . . . . 1.2 112.72 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 3.3 t -68.5 137.84 54.73 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.822 -0.626 . . . . 1.76 109.968 179.516 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -32.68 125.74 0.39 Allowed Pre-proline 0 N--CA 1.47 0.525 0 O-C-N 124.027 0.829 . . . . 1.77 112.347 -179.451 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.6 Cg_exo -60.98 134.12 51.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.543 2.162 . . . . 1.01 113.206 -179.679 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.415 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.46 153.43 38.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.742 -0.663 . . . . 1.55 109.955 179.193 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -30.42 145.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.387 1.054 . . . . 1.6299999999999999 112.652 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -84.56 112.24 20.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.702 -0.681 . . . . 1.0900000000000001 109.718 179.376 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.8 mp -97.77 113.89 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 1.1299999999999999 111.813 -179.276 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 71.7 m -46.36 -28.89 1.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.128 0.49 . . . . 1.1299999999999999 110.025 179.153 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.3 OUTLIER 45.27 55.44 6.4 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.634 -0.712 . . . . 1.5700000000000001 111.266 179.555 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -79.88 -93.59 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.714 -0.394 . . . . 3.7000000000000002 110.97 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.93 39.22 2.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 2.1400000000000001 109.707 179.829 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.465 ' HB2' ' CD ' ' A' ' 15' ' ' ARG . 28.1 t0 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.866 -0.606 . . . . 2.0600000000000001 111.192 -178.558 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.462 HD12 ' CB ' ' A' ' 86' ' ' SER . 5.0 tt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.973 0.416 . . . . 1.26 111.975 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 2' ' ' ILE . 73.1 m-20 -139.67 130.71 14.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.651 . . . . 2.0 110.226 179.496 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.21 164.07 29.63 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.262 1.975 . . . . 0.58999999999999997 112.511 -179.654 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 11.9 Cg_endo -56.52 177.25 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.155 2.57 . . . . 1.6100000000000001 113.219 -179.579 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.05 171.88 54.54 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.828 -0.624 . . . . 0.97999999999999998 112.375 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.59 127.73 89.06 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.227 -0.286 . . . . 2.04 110.227 179.718 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 14.8 Cg_exo -73.67 150.04 44.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.566 2.178 . . . . 0.54000000000000004 112.874 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 14.7 p -146.24 106.08 4.13 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 115.839 -0.619 . . . . 1.6799999999999999 110.98 179.717 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -59.89 111.45 0.98 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.346 2.031 . . . . 0.64000000000000001 113.305 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -71.64 -39.35 70.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.643 -0.873 . . . . 2.1699999999999999 108.643 178.791 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.7 t30 -129.65 148.99 51.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.591 -1.186 . . . . 0.84999999999999998 108.572 179.119 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.435 ' CD1' HG22 ' A' ' 95' ' ' ILE . 4.4 pt -142.78 89.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.989 0.423 . . . . 1.5700000000000001 111.539 -179.253 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.431 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -79.58 149.01 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 1.46 110.785 -179.866 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' CB ' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -40.41 -35.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.083 0.772 . . . . 2.9100000000000001 113.083 -179.212 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 3.4 m-70 -135.25 31.62 3.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 1.3300000000000001 111.437 -179.332 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -178.62 108.54 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 1.28 110.226 179.578 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 9.5 m -112.82 143.38 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.415 -0.514 . . . . 1.49 111.159 -179.91 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 53.2 m -106.72 136.82 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.438 -0.346 . . . . 1.1399999999999999 110.817 179.565 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.04 160.81 37.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.094 0.871 . . . . 1.3100000000000001 112.569 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -148.4 147.11 28.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.909 -1.041 . . . . 2.3100000000000001 110.456 179.465 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 30.3 p90 -137.68 -175.12 3.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.133 0.492 . . . . 0.40000000000000002 111.927 -179.575 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.86 16.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.577 -0.738 . . . . 1.1100000000000001 110.908 179.725 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.97 147.39 33.8 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.336 -0.393 . . . . 2.5600000000000001 110.408 179.621 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 35.1 Cg_endo -63.72 173.08 4.94 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.325 2.017 . . . . 1.1100000000000001 112.325 179.941 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -123.79 13.49 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.627 -179.853 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -144.01 -73.91 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 1.6899999999999999 111.919 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.5 p 43.63 56.81 4.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.878 0.371 . . . . 1.3500000000000001 110.811 -179.542 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.16 -100.4 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.543 . . . . 1.01 112.483 -179.528 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.8 34.33 1.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.009 -1.237 . . . . 0.97999999999999998 110.009 179.152 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -116.11 -168.01 1.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.664 -0.768 . . . . 0.98999999999999999 111.388 -178.717 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.21 45.74 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.621 -0.718 . . . . 2.6899999999999999 111.305 -179.958 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 HG22 ' CE1' ' A' ' 36' ' ' TYR . 12.2 mm 52.98 -87.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.086 179.731 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.2 p 74.39 23.58 1.96 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.564 0.579 . . . . 1.6599999999999999 112.564 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 4.3 t 168.91 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.937 0.347 . . . . 1.97 111.937 179.562 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 18.4 m-85 -102.61 93.52 5.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 1.23 110.831 179.498 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.0 mt -85.9 114.68 26.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.747 0.308 . . . . 1.76 110.922 179.96 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 14.4 t -89.27 121.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.278 -0.419 . . . . 1.6100000000000001 111.737 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -95.16 129.86 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 1.6699999999999999 109.895 179.214 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.444 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -110.21 140.13 44.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.217 0.532 . . . . 2.4399999999999999 111.968 -179.416 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 13.0 ttm180 -111.9 112.63 24.43 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.366 -0.834 . . . . 1.79 109.616 179.047 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -81.8 101.22 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.601 -0.727 . . . . 1.5900000000000001 110.644 -179.594 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 HD13 ' CB ' ' A' ' 94' ' ' ALA . 10.0 mt -76.67 155.53 83.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.055 -0.521 . . . . 1.4299999999999999 110.48 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -87.57 9.06 63.62 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.142 -1.191 . . . . 1.47 113.287 0.519 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.77 -74.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 2.6600000000000001 110.195 179.75 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 98.06 155.96 29.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.735 . . . . 1.6200000000000001 113.915 179.018 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.26 62.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 122.928 0.491 . . . . 3.0600000000000001 109.799 -179.939 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.508 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 80.9 m95 -28.79 105.08 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.469 0.708 . . . . 1.0600000000000001 112.593 -179.422 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.66 130.66 42.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.2 -0.454 . . . . 1.8400000000000001 110.986 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 2.5 ptmm? -56.19 91.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 1.77 111.481 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -61.36 -55.41 31.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.1 0.476 . . . . 1.4099999999999999 110.142 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -44.58 112.55 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.717 . . . . 2.0099999999999998 111.023 179.707 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.56 43.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.6400000000000001 111.598 -179.604 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 t -168.18 172.2 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 2.0299999999999998 111.221 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 115.37 18.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 1.8700000000000001 110.869 179.946 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.485 HD12 ' CD2' ' A' ' 61' ' ' PHE . 35.6 mt -96.63 89.53 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 1.3700000000000001 110.929 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.22 -79.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 2.1499999999999999 111.253 -179.798 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 172.18 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.54 110.726 -179.995 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.2 p30 -88.15 12.35 13.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 1.75 111.687 -179.851 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -109.49 108.9 19.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.621 -0.511 . . . . 2.0499999999999998 109.621 179.278 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE1' ' O ' ' A' ' 62' ' ' THR . 55.4 t80 -145.0 165.08 29.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.56999999999999995 112.055 -178.874 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.566 ' O ' ' CE1' ' A' ' 61' ' ' PHE . 99.5 m -119.22 112.89 20.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.671 -0.695 . . . . 1.1399999999999999 110.26 179.497 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -79.76 89.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.762 -0.654 . . . . 1.72 110.51 -179.495 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 25.4 t -88.05 -178.07 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.908 . . . . 1.6399999999999999 110.929 -179.49 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 84.01 7.17 85.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.687 -0.768 . . . . 0.95999999999999996 112.79 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD23 ' CG1' ' A' ' 18' ' ' VAL . 2.8 pp -84.61 172.07 11.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.186 0.493 . . . . 2.02 110.887 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 1.7 m -121.41 173.3 7.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 1.55 111.376 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HG3' ' CB ' ' A' ' 15' ' ' ARG . 2.7 tt0 -91.86 170.52 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 1.9099999999999999 111.202 -179.93 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.814 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 47.03 35.26 3.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 1.8700000000000001 111.194 179.831 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.7 114.84 6.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 1.2 111.395 -179.832 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . . . -68.19 123.47 20.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.672 -0.492 . . . . 1.1100000000000001 109.672 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 58.0 m-85 -116.99 121.85 42.57 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.357 0.873 . . . . 1.0800000000000001 113.357 -178.361 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.4 tt0 -102.85 136.76 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.829 -1.175 . . . . 1.5 107.829 177.832 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.638 ' CZ ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.26 126.53 21.39 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.933 1.457 . . . . 0.79000000000000004 114.933 -178.519 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -101.0 -177.16 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.846 -1.07 . . . . 2.6899999999999999 108.423 177.756 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -147.89 106.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 119.656 -0.818 . . . . 1.5700000000000001 112.655 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.45 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 42.7 mt -88.07 154.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.557 -1.646 . . . . 1.3200000000000001 106.557 177.455 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 35' ' ' SER . . . -160.18 126.72 4.28 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.927 -1.109 . . . . 1.1100000000000001 113.198 -179.144 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.1 mttt -76.6 -159.87 0.13 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.71 . . . . 2.3500000000000001 109.394 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.5 m-80 -149.82 176.94 10.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.056 0.455 . . . . 2.7000000000000002 111.338 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -45.6 -26.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 1.3400000000000001 111.682 179.773 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.26 10.36 29.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.427 0.528 . . . . 1.4299999999999999 112.427 -179.571 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.46 -14.61 57.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.349 -0.929 . . . . 1.3799999999999999 112.853 179.875 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.42 102.51 0.03 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.813 0.34 . . . . 1.49 111.258 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 2.0 tp -69.98 101.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 1.48 111.819 -179.623 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.462 ' CB ' HD12 ' A' ' 2' ' ' ILE . 1.1 p -69.56 126.35 92.54 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 109.502 -0.555 . . . . 0.81000000000000005 109.502 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -39.2 160.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.716 2.278 . . . . 1.25 112.446 -179.53 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 14.5 Cg_exo -67.53 124.61 12.21 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.684 2.256 . . . . 1.2 113.054 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 3.2 m -70.99 130.47 41.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.776 -0.647 . . . . 1.76 109.44 179.17 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -31.99 124.34 0.37 Allowed Pre-proline 0 N--CA 1.474 0.727 0 N-CA-C 112.538 0.57 . . . . 1.77 112.538 -179.316 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.444 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 32.2 Cg_exo -59.39 147.6 90.47 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.833 2.355 . . . . 1.01 113.387 -179.559 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -82.15 147.59 28.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.695 -0.684 . . . . 1.55 109.885 179.291 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -39.63 137.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 124.186 0.929 . . . . 1.6299999999999999 111.736 -179.921 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.438 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -66.38 120.49 13.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.655 . . . . 1.0900000000000001 110.789 179.88 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.481 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 4.0 mp -100.42 109.54 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 1.1299999999999999 111.337 -179.886 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -45.79 -48.88 15.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.32 -179.702 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 64.65 86.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.446 . . . . 1.5700000000000001 110.42 -179.952 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.31 -86.24 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 3.7000000000000002 111.071 -179.758 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.568 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 14.7 p30 -105.43 14.59 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.162 -0.472 . . . . 2.1400000000000001 111.097 179.886 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 C--N 1.333 -0.123 0 CA-C-O 121.023 0.44 . . . . 2.0600000000000001 110.606 -179.827 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.441 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.3 tt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 1.26 111.52 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 8.1 t70 -126.49 129.06 24.22 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 2.0 110.78 179.932 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.01 171.87 14.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.489 2.126 . . . . 0.58999999999999997 112.276 -179.957 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 19.5 Cg_exo -66.86 -174.72 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.803 2.335 . . . . 1.6100000000000001 113.182 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.35 -177.81 49.67 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.4 -0.818 . . . . 0.97999999999999998 112.852 -179.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 116.4 35.65 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.391 0.139 . . . . 2.04 110.681 179.866 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 31.7 Cg_exo -62.76 142.75 90.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.595 2.197 . . . . 0.54000000000000004 112.374 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 14.6 p -145.95 104.42 4.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 1.6799999999999999 111.976 -179.476 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.9 Cg_exo -50.26 113.24 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.532 2.155 . . . . 0.64000000000000001 112.751 -179.963 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -63.86 -46.49 84.72 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.774 -0.825 . . . . 2.1699999999999999 108.774 178.977 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.29 151.25 50.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.28 -1.327 . . . . 0.84999999999999998 108.321 179.016 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' CG2' HG12 ' A' ' 95' ' ' ILE . 4.4 pt -143.17 70.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.399 -0.52 . . . . 1.5700000000000001 111.567 -179.104 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -72.44 146.88 46.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.613 -0.721 . . . . 1.46 110.468 179.864 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -65.99 61.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.764 0.792 . . . . 2.9100000000000001 112.387 -179.413 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 15' ' ' ARG . 0.9 OUTLIER 167.82 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.758 -0.655 . . . . 1.3300000000000001 110.509 179.09 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.4 126.12 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.472 -0.566 . . . . 1.28 109.472 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.545 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -116.77 120.57 65.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.189 0.44 . . . . 1.49 112.189 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 97.6 m -91.63 142.34 27.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.692 -0.231 . . . . 1.1399999999999999 110.892 179.303 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -140.4 156.03 46.53 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.146 0.904 . . . . 1.3100000000000001 112.992 -179.641 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 1.8 tppp? -145.15 159.11 43.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.316 -1.311 . . . . 2.3100000000000001 109.59 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 40.0 p90 -155.66 -176.45 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.13 0.49 . . . . 0.40000000000000002 112.086 -179.879 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.95 133.37 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.569 -0.741 . . . . 1.1100000000000001 111.685 -179.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HG2' ' HH ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -70.64 141.56 87.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 2.5600000000000001 109.686 179.35 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.46 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 6.3 Cg_endo -48.62 175.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.095 1.863 . . . . 1.1100000000000001 111.431 179.705 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.7 -25.66 4.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.33 0.493 . . . . 2.77 112.33 -179.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -106.45 -70.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.005 0.372 . . . . 1.6899999999999999 112.005 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 3.2 p 52.08 41.18 29.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.649 0.261 . . . . 1.3500000000000001 110.36 -179.313 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.87 -91.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.861 -0.685 . . . . 1.01 112.232 -179.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.73 35.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.077 -1.209 . . . . 0.97999999999999998 110.077 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -117.39 172.31 7.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.898 -0.651 . . . . 0.98999999999999999 111.635 -178.464 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -123.86 -3.45 8.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.852 -0.613 . . . . 2.6899999999999999 111.519 179.828 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 33' ' ' ILE . 16.2 mt 64.01 155.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 110.505 -0.183 . . . . 1.71 110.505 -179.908 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 p -139.56 8.27 2.38 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.482 0.549 . . . . 1.6599999999999999 112.482 -179.522 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER 178.49 149.39 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.826 0.346 . . . . 1.97 111.923 -179.994 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' HH ' ' HG2' ' A' ' 24' ' ' LYS . 1.8 m-85 -126.38 119.83 28.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.983 -0.553 . . . . 1.23 110.101 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.84 116.15 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.73 0.3 . . . . 1.76 111.471 -179.585 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -106.44 104.48 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.303 0.573 . . . . 1.6100000000000001 110.671 179.588 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 4.8 mt-10 -73.52 157.33 36.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.284 -0.871 . . . . 1.6699999999999999 110.38 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.23 137.41 53.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 2.4399999999999999 111.466 -179.569 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -113.9 120.2 39.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 1.79 110.726 179.656 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.837 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.71 77.7 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 1.5900000000000001 110.552 179.846 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 52.8 mt -53.3 145.16 27.33 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.637 -0.71 . . . . 1.4299999999999999 111.151 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -93.42 27.03 19.26 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.903 -1.29 . . . . 1.47 112.708 0.174 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -153.6 81.89 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.781 0.324 . . . . 2.6600000000000001 111.861 -179.835 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.75 -152.83 10.44 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.942 -0.647 . . . . 1.6200000000000001 111.968 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.15 29.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.027 0.413 . . . . 3.0600000000000001 111.759 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 69.1 m95 41.06 101.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.832 0.678 . . . . 1.0600000000000001 112.832 179.422 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.434 ' N ' ' HB3' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -131.48 117.97 19.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 1.8400000000000001 110.045 179.085 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -43.5 106.54 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.935 0.398 . . . . 1.77 111.484 -179.503 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.54 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 1.4099999999999999 111.285 -179.867 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 8.3 p-10 -69.58 -173.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.336 -0.393 . . . . 2.0099999999999998 110.958 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 4.0 t80 176.93 -22.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.515 -0.766 . . . . 2.6400000000000001 111.799 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.99 35.78 0.8 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.075 0.398 . . . . 2.0299999999999998 112.075 -179.497 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.51 122.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 1.8700000000000001 111.294 179.594 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 HG12 ' CD1' ' A' ' 61' ' ' PHE . 35.2 mt -114.27 68.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.3700000000000001 110.987 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 2.1499999999999999 111.158 -179.892 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -70.2 166.53 19.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.99 0.424 . . . . 1.54 110.759 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -78.83 1.69 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.904 -0.589 . . . . 1.75 111.537 179.873 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 7.1 tt0 -98.56 100.14 11.35 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.966 -0.383 . . . . 2.0499999999999998 109.966 179.608 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CG ' ' N ' ' A' ' 62' ' ' THR . 60.8 t80 -136.81 164.45 28.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.238 0.542 . . . . 0.56999999999999995 111.648 -179.502 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 5.6 m -125.55 125.14 42.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.463 -0.79 . . . . 1.1399999999999999 110.398 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HB ' HG21 ' A' ' 18' ' ' VAL . 9.1 t -87.53 91.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.214 0.531 . . . . 1.72 110.747 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.2 p -85.52 -157.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.375 -0.829 . . . . 1.6399999999999999 110.825 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.78 9.19 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.578 -0.82 . . . . 0.95999999999999996 112.086 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 27.8 mt -75.61 164.98 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 2.02 111.025 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 1.8 m -115.27 101.59 9.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.557 . . . . 1.55 110.363 179.756 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 7.6 tt0 -49.25 150.15 1.84 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.489 -0.323 . . . . 1.9099999999999999 111.179 -179.748 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 20.2 m-20 70.92 46.73 0.46 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.983 -0.553 . . . . 1.8700000000000001 110.676 -179.625 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.83 121.42 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.034 -0.53 . . . . 1.2 111.139 -179.927 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 95' ' ' ILE . . . -74.86 117.41 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.055 -0.35 . . . . 1.1100000000000001 110.055 179.477 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' OH ' ' HB ' ' A' ' 67' ' ' THR . 78.2 m-85 -113.78 128.95 56.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 1.0800000000000001 113.014 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -95.41 146.4 24.43 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.469 -0.937 . . . . 1.5 108.469 178.271 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.85 108.94 13.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.376 1.621 . . . . 0.79000000000000004 115.376 -178.177 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.71 133.8 41.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.133 -0.94 . . . . 2.6899999999999999 109.374 178.304 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -117.01 125.36 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 119.141 -1.023 . . . . 1.5700000000000001 113.678 179.811 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 78' ' ' ALA . 37.0 mt -114.74 145.57 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 113.589 -1.642 . . . . 1.3200000000000001 108.03 178.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -154.34 125.39 7.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.858 -0.737 . . . . 1.1100000000000001 112.541 -179.521 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 15.5 ptpt -79.85 156.14 27.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 2.3500000000000001 110.25 179.276 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 5.0 p30 -102.36 172.92 6.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 2.7000000000000002 112.185 -179.32 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -44.26 -46.73 9.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.949 -1.023 . . . . 1.3400000000000001 111.963 179.72 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.559 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -65.64 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 1.4299999999999999 111.887 -179.273 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.22 -21.56 21.98 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.532 -0.842 . . . . 1.3799999999999999 112.208 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -49.18 154.03 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.989 -0.374 . . . . 1.49 109.989 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 4.1 tp -108.58 115.78 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.255 0.465 . . . . 1.48 112.255 -179.38 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 24.1 p -69.72 113.84 20.23 Favored Pre-proline 0 C--O 1.235 0.34 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.583 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.19 150.25 14.6 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.319 2.013 . . . . 1.25 113.005 -178.905 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 10.7 Cg_exo -38.93 141.51 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.46 2.774 . . . . 1.2 113.961 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' GLU . 16.0 m -106.01 110.6 22.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.957 -1.02 . . . . 1.76 109.698 179.054 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.44 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tp10 -5.12 116.08 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 124.815 1.322 . . . . 1.77 113.471 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 81.2 Cg_exo -51.05 142.29 35.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.451 2.1 . . . . 1.01 114.554 -179.14 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 152.15 37.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.345 -0.983 . . . . 1.55 108.345 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.89 145.73 0.31 Allowed 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.343 0.402 . . . . 1.6299999999999999 110.978 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -78.8 121.48 24.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.993 -0.549 . . . . 1.0900000000000001 111.07 -179.416 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.1 mp -100.77 114.94 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.266 -0.425 . . . . 1.1299999999999999 111.175 -179.995 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.0 m -51.47 -44.21 62.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.919 -0.582 . . . . 1.1299999999999999 110.655 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 50.3 t 62.43 67.94 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 116.17 -0.468 . . . . 1.5700000000000001 110.958 179.651 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.77 -84.61 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 3.7000000000000002 111.132 -179.973 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.58 -0.67 9.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 2.1400000000000001 111.109 179.719 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.991 0.424 . . . . 2.0600000000000001 111.236 -179.969 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.448 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 5.5 tt . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 121.023 0.44 . . . . 1.26 111.475 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -129.78 124.99 22.02 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.787 -0.642 . . . . 2.0 111.194 179.699 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 161.76 35.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.427 2.084 . . . . 0.58999999999999997 111.976 179.793 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.06 170.39 2.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.592 2.195 . . . . 1.6100000000000001 112.783 -179.677 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 167.66 49.94 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.695 -0.684 . . . . 0.97999999999999998 112.882 -179.749 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 tmtt? -51.43 119.37 12.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.505 -0.183 . . . . 2.04 110.505 179.806 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.435 ' CG ' HG21 ' A' ' 76' ' ' VAL . 16.5 Cg_exo -70.06 152.8 67.91 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.398 2.066 . . . . 0.54000000000000004 111.491 179.909 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 p -151.96 121.22 3.42 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.243 0.46 . . . . 1.6799999999999999 112.243 -179.068 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.2 Cg_exo -65.75 111.95 2.07 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.552 2.168 . . . . 0.64000000000000001 112.192 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER -76.45 -33.09 58.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 2.1699999999999999 110.625 179.711 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.56 126.02 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.84999999999999998 110.113 179.891 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -114.9 128.11 72.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 1.5700000000000001 111.606 -179.605 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -115.18 44.51 1.81 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.784 -0.644 . . . . 1.46 112.099 -179.318 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.8 mtm180 55.64 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.138 0.792 . . . . 2.9100000000000001 113.138 178.749 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m170 -75.8 -29.89 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 1.3300000000000001 110.934 -179.441 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.4 p -134.27 128.84 34.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.656 -0.498 . . . . 1.28 109.656 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 3.6 m -115.44 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.452 -0.499 . . . . 1.49 111.215 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 13.4 m -119.72 114.76 22.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.334 -0.394 . . . . 1.1399999999999999 111.779 -178.997 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.04 158.0 40.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.686 0.755 . . . . 1.3100000000000001 111.154 178.879 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -138.18 -179.2 5.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.652 -1.158 . . . . 2.3100000000000001 109.591 179.813 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 24.7 p90 -162.08 175.46 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.328 0.585 . . . . 0.40000000000000002 112.24 179.521 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.18 175.21 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.315 -0.857 . . . . 1.1100000000000001 110.699 179.807 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 141.47 24.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.41 -0.359 . . . . 2.5600000000000001 110.476 179.883 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 11.1 Cg_endo -54.48 -176.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.7 2.267 . . . . 1.1100000000000001 112.464 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.23 -27.25 4.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 2.77 111.948 -179.77 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -113.84 -69.54 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.95 0.352 . . . . 1.6899999999999999 111.95 -179.556 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 46.0 p 52.59 48.27 22.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.919 0.39 . . . . 1.3500000000000001 110.227 -179.359 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.78 -101.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.657 -0.782 . . . . 1.01 112.03 -179.837 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.63 31.77 2.1 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.516 -1.034 . . . . 0.97999999999999998 110.516 179.22 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.6 m-85 -107.44 -172.76 2.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.836 -0.682 . . . . 0.98999999999999999 111.92 -178.806 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' CE ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.25 7.08 1.34 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.923 -1.035 . . . . 2.6899999999999999 111.832 179.187 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 2.1 mt 52.25 115.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.26 0.552 . . . . 1.71 112.329 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -117.12 22.76 12.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 1.6599999999999999 111.357 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.69 113.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.226 0.454 . . . . 1.97 112.226 -179.865 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 43.2 m-85 -97.45 138.08 35.43 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.095 -0.335 . . . . 1.23 110.095 178.884 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 HG23 ' CB ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -125.77 111.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.894 0.378 . . . . 1.76 110.67 179.485 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -99.37 115.8 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.152 -0.476 . . . . 1.6100000000000001 111.364 -179.644 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 2.2 mt-10 -76.51 142.65 40.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.714 -0.675 . . . . 1.6699999999999999 110.32 179.7 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.474 ' HD3' ' CE1' ' A' ' 72' ' ' TYR . 27.5 ttmt -106.11 146.02 30.72 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 120.749 0.309 . . . . 2.4399999999999999 110.642 -179.577 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.507 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -129.8 100.77 5.6 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.547 -0.461 . . . . 1.79 110.483 178.931 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -70.6 78.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.618 -0.719 . . . . 1.5900000000000001 110.689 -179.927 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 81.2 mt -50.44 154.88 1.98 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 1.4299999999999999 111.02 -179.932 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.91 27.57 13.36 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.76 -1.35 . . . . 1.47 112.759 0.349 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -126.33 -79.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.574 0.225 . . . . 2.6600000000000001 110.996 -179.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 1.6200000000000001 112.907 179.845 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.27 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 3.0600000000000001 110.552 179.95 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.507 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 62.2 m95 43.93 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 1.0600000000000001 111.635 179.94 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -121.25 127.91 51.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 1.8400000000000001 110.602 179.915 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -52.32 90.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.347 . . . . 1.77 110.627 -179.992 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -60.2 -46.06 91.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 1.4099999999999999 110.635 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 10.9 p-10 -64.99 102.01 0.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 2.0099999999999998 111.587 -179.828 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -15.65 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.085 -0.507 . . . . 2.6400000000000001 110.664 179.27 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 p -86.62 -155.82 0.28 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.38 -0.373 . . . . 2.0299999999999998 110.471 179.913 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.22 107.77 15.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.333 . . . . 1.8700000000000001 111.618 -179.708 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 6.9 mm -79.53 143.11 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.635 -0.505 . . . . 1.3700000000000001 109.635 178.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -145.34 -68.02 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.33 . . . . 2.1499999999999999 111.716 -179.843 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -54.93 -18.32 4.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 1.54 112.228 -179.731 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER 91.29 -18.45 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.877 0.871 . . . . 1.75 110.803 -179.58 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -88.92 85.26 6.69 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.555 -0.905 . . . . 2.0499999999999998 108.555 178.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 50.2 t80 -114.47 165.2 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.484 0.659 . . . . 0.56999999999999995 111.694 -178.61 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.53 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 91.9 m -123.4 116.99 24.16 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.893 -1.049 . . . . 1.1399999999999999 110.025 178.994 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' A' ' 51' ' ' ALA . 48.8 t -83.9 86.54 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.117 -0.492 . . . . 1.72 111.375 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.56 134.41 35.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.734 . . . . 1.6399999999999999 110.509 179.81 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.85 -14.3 2.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.83 . . . . 0.95999999999999996 112.919 -179.847 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -53.31 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.881 0.372 . . . . 2.02 110.609 179.94 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.2 m -148.75 142.3 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.55 111.11 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 1.286 ' OE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.0 137.27 58.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.9099999999999999 111.193 179.879 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 97' ' ' CYS . 21.1 t70 70.09 49.33 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 1.8700000000000001 111.221 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.87 120.51 2.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.873 0.368 . . . . 1.2 111.49 179.916 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -71.58 132.63 44.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 1.1100000000000001 109.983 179.239 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 14.7 m-85 -127.52 122.11 32.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 1.0800000000000001 113.014 -178.662 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.89 138.12 43.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.603 -0.888 . . . . 1.5 108.603 178.502 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.519 ' CZ ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.21 115.39 14.12 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.41 1.263 . . . . 0.79000000000000004 114.41 -178.702 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -93.32 167.77 11.52 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.806 -0.442 . . . . 2.6899999999999999 109.806 178.395 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 8' ' ' PRO . 28.5 t -122.43 121.18 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 113.706 1.002 . . . . 1.5700000000000001 113.706 -179.531 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 78' ' ' ALA . 70.1 mt -120.46 143.46 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.967 -1.494 . . . . 1.3200000000000001 106.967 178.007 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.425 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -164.61 132.09 3.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.701 1.0 . . . . 1.1100000000000001 113.701 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.61 105.95 14.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.709 -0.848 . . . . 2.3500000000000001 108.709 178.245 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 3.3 m120 -40.1 -93.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.69 . . . . 2.7000000000000002 112.712 -178.721 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -131.93 -41.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.178 -0.327 . . . . 1.3400000000000001 111.643 -179.426 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.46 31.67 1.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 1.4299999999999999 111.796 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 77.84 -2.35 64.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.477 -0.868 . . . . 1.3799999999999999 112.994 179.971 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -60.64 83.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 1.49 110.256 179.728 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.6 OUTLIER -59.92 110.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 1.48 111.904 -179.325 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.0 p -70.64 118.13 61.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.101 -0.704 . . . . 0.81000000000000005 109.101 179.205 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 3.1 Cg_endo -47.15 172.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.623 2.215 . . . . 1.25 112.615 -179.192 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 17.0 Cg_endo -56.66 132.28 50.77 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.799 2.333 . . . . 1.2 112.46 -179.847 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m -105.99 98.14 7.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 1.76 111.155 -179.985 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mt-10 15.55 106.53 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 124.394 1.078 . . . . 1.77 113.858 179.58 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.493 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.1 Cg_exo -54.84 126.11 21.36 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.439 2.092 . . . . 1.01 113.89 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.77 147.64 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.431 -0.581 . . . . 1.55 109.431 178.996 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.77 143.48 0.08 Allowed 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 124.181 0.926 . . . . 1.6299999999999999 111.779 179.951 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -78.01 109.83 12.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 1.0900000000000001 109.901 179.712 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.4 HD13 ' HG2' ' A' ' 10' ' ' PRO . 4.8 mp -91.53 109.46 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 1.1299999999999999 111.485 -179.444 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 98.8 m -45.96 -28.54 1.17 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 110.77 179.677 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.76 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 87.0 m 52.6 80.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 1.5700000000000001 110.172 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 1.286 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.2 -79.74 0.62 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.947 0.403 . . . . 3.7000000000000002 111.686 -179.394 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -112.44 22.23 14.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.01 -0.541 . . . . 2.1400000000000001 111.402 -179.824 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 2.0600000000000001 111.675 -179.767 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.406 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 2.6 tt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.842 0.353 . . . . 1.26 111.31 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.022 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -122.11 129.77 24.98 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 2.0 110.294 179.88 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 154.28 15.41 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.424 2.083 . . . . 0.58999999999999997 112.809 -179.628 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.522 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 78.2 Cg_exo -46.02 152.12 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.187 2.592 . . . . 1.6100000000000001 113.485 -179.854 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.36 -171.35 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.432 -0.804 . . . . 0.97999999999999998 113.103 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.7 tttt -77.07 129.39 78.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.457 -0.201 . . . . 2.04 110.457 179.824 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -78.48 128.43 8.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.608 2.206 . . . . 0.54000000000000004 112.896 -179.555 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.59 116.21 17.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.6799999999999999 111.103 179.713 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.1 Cg_exo -62.91 128.52 23.3 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.707 2.271 . . . . 0.64000000000000001 113.605 -179.467 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 21' ' ' LYS . 1.6 mp -93.63 -27.79 16.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 2.1699999999999999 109.693 179.059 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.42 151.16 32.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.715 -0.675 . . . . 0.84999999999999998 110.229 179.836 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 1.193 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -149.08 111.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 1.5700000000000001 111.503 -179.794 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.333 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -106.46 56.72 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.68 -0.691 . . . . 1.46 111.171 -179.956 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.955 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER 56.27 -69.97 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.881 0.738 . . . . 2.9100000000000001 112.853 179.016 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m-70 -83.99 -20.28 33.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 1.3300000000000001 111.82 -179.33 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.7 p -126.01 112.25 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 1.28 111.745 -179.603 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.502 HG13 ' CE2' ' A' ' 74' ' ' PHE . 95.2 t -106.39 120.55 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 1.49 110.478 179.606 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.417 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 19.8 m -104.34 128.16 52.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 1.1399999999999999 111.843 -179.16 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -137.45 160.41 39.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.722 0.772 . . . . 1.3100000000000001 111.8 178.964 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' N ' HD13 ' A' ' 11' ' ' LEU . 8.6 tptm -142.57 139.19 31.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.514 -1.221 . . . . 2.3100000000000001 109.861 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 14.5 p90 -126.55 -174.86 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.40000000000000002 111.555 -179.714 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 171.81 8.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 1.1100000000000001 111.475 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 2.2 tptm -116.2 124.47 29.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.924 -0.58 . . . . 2.5600000000000001 110.06 179.842 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 6.5 Cg_endo -46.98 175.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.719 2.28 . . . . 1.1100000000000001 112.725 -179.908 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.54 3.35 5.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.77 110.846 179.718 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.022 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 3.7 t80 -121.87 -74.04 0.63 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.557 0.206 . . . . 1.6899999999999999 111.557 -179.558 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 1.006 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 16.6 p 41.29 56.75 3.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.524 0.202 . . . . 1.3500000000000001 111.254 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.13 -102.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.04 -0.527 . . . . 1.01 113.418 -179.717 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.68 28.85 3.2 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.968 -0.853 . . . . 0.97999999999999998 110.968 179.232 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -110.42 -176.19 2.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.356 -0.422 . . . . 0.98999999999999999 111.14 -179.138 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -137.89 1.01 2.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.976 -0.556 . . . . 2.6899999999999999 112.218 179.685 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 HG23 ' CE1' ' A' ' 36' ' ' TYR . 8.3 mt 57.51 116.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-O 121.071 0.462 . . . . 1.71 111.088 -179.749 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -103.16 10.84 37.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.435 0.532 . . . . 1.6599999999999999 112.435 -179.12 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -179.01 156.85 0.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.961 0.41 . . . . 1.97 111.898 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.479 ' CE1' HG23 ' A' ' 33' ' ' ILE . 28.5 m-85 -126.21 112.48 15.81 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.893 -0.594 . . . . 1.23 110.84 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -94.55 99.79 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 1.76 110.718 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -92.26 113.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 1.6100000000000001 110.488 179.861 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -81.5 144.73 31.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.605 -0.725 . . . . 1.6699999999999999 110.911 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -111.79 139.13 47.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 2.4399999999999999 110.917 179.893 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 15.7 ttm180 -106.97 110.83 23.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.438 . . . . 1.79 110.382 179.405 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -82.66 91.21 6.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 110.307 179.866 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -68.0 154.53 93.62 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.519 -0.764 . . . . 1.4299999999999999 110.983 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.05 4.41 66.12 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.685 -1.381 . . . . 1.47 112.999 0.255 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -78.86 -68.03 0.69 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 2.6600000000000001 110.451 179.896 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.438 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 88.06 177.14 47.68 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.769 -0.729 . . . . 1.6200000000000001 113.016 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.47 -28.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.699 0.285 . . . . 3.0600000000000001 110.718 179.938 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 51.4 m95 63.31 87.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 1.0600000000000001 111.138 179.894 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 141.47 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.8400000000000001 111.116 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -58.5 117.64 4.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 1.77 110.747 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -86.95 -49.59 7.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 1.4099999999999999 111.267 -179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -42.41 -54.18 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 2.0099999999999998 112.101 -179.707 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 t80 46.59 44.24 13.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.686 0.279 . . . . 2.6400000000000001 111.347 -179.87 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 t -152.5 -84.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 2.0299999999999998 111.156 179.924 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -178.13 110.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 1.8700000000000001 110.556 179.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.481 HG12 ' CD2' ' A' ' 61' ' ' PHE . 11.2 mt -108.74 80.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.3700000000000001 111.103 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.7 -65.69 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.1499999999999999 110.961 -179.962 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.43 160.16 30.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.989 -0.374 . . . . 1.54 109.989 179.737 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -74.16 -3.57 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.304 -0.407 . . . . 1.75 111.556 -179.87 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -100.0 101.34 12.4 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.801 0.334 . . . . 2.0499999999999998 110.151 179.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 62' ' ' THR . 50.3 t80 -135.07 162.97 30.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.258 0.551 . . . . 0.56999999999999995 111.719 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 51.6 m -122.58 109.94 14.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.52 -0.764 . . . . 1.1399999999999999 110.354 179.167 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG11 ' CB ' ' A' ' 51' ' ' ALA . 98.9 t -81.79 93.96 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.74 -0.664 . . . . 1.72 111.002 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -98.79 144.56 27.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 1.6399999999999999 110.872 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.44 -9.31 5.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.672 -0.775 . . . . 0.95999999999999996 112.986 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.03 0.443 . . . . 2.02 111.063 -179.93 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 m -129.27 131.8 47.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 1.55 110.442 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.31 150.27 35.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.306 -0.406 . . . . 1.9099999999999999 111.104 -179.758 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t0 62.75 48.56 4.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 1.8700000000000001 110.814 -179.999 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.02 126.13 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.498 . . . . 1.2 111.319 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 43' ' ' LEU . . . -71.52 134.57 46.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.242 -0.436 . . . . 1.1100000000000001 110.604 179.694 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -133.02 130.82 39.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 1.0800000000000001 112.414 -179.19 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 2.0 mt-10 -105.94 148.42 27.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.791 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.502 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.59 117.89 13.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.717 1.377 . . . . 0.79000000000000004 114.717 -179.228 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -104.56 158.33 16.56 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.931 -0.766 . . . . 2.6899999999999999 108.931 177.663 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 99.3 t -115.19 109.93 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.584 -0.846 . . . . 1.5700000000000001 113.02 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 68.3 mt -105.37 157.18 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.021 -1.474 . . . . 1.3200000000000001 107.021 177.723 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -176.88 136.28 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.054 -1.058 . . . . 1.1100000000000001 112.684 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.0 ptpp? -75.63 -150.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.106 -0.701 . . . . 2.3500000000000001 109.106 178.846 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.541 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 25.4 p30 -147.43 -107.33 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.212 -0.595 . . . . 2.7000000000000002 111.291 -179.723 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -127.47 -43.04 1.62 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.709 0.686 . . . . 1.3400000000000001 110.423 179.847 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.94 -9.9 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 1.4299999999999999 111.749 179.803 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.81 -18.84 28.84 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.475 -0.869 . . . . 1.3799999999999999 112.398 -179.743 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.82 158.29 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.58 0.229 . . . . 1.49 110.72 179.959 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 6.3 tp -114.79 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.352 . . . . 1.48 111.649 -179.931 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -77.83 122.7 85.99 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 109.719 -0.474 . . . . 0.81000000000000005 109.719 179.328 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -41.47 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.353 2.702 . . . . 1.25 113.649 -179.419 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 1.1 Cg_endo -83.56 129.67 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.361 2.707 . . . . 1.2 112.469 -179.91 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.402 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 78.2 p -85.19 125.06 32.53 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.994 -0.372 . . . . 1.76 109.994 179.349 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -17.65 106.89 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 124.696 1.248 . . . . 1.77 113.497 -179.476 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 54.4 Cg_exo -45.25 152.53 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.503 2.135 . . . . 1.01 113.302 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.436 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -83.76 144.04 29.59 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.421 -0.808 . . . . 1.55 109.005 179.063 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -34.93 146.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.213 0.946 . . . . 1.6299999999999999 111.73 -179.624 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -76.66 125.31 29.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.694 -0.684 . . . . 1.0900000000000001 110.69 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.56 115.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 1.1299999999999999 110.956 179.72 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.0 m -48.2 -30.61 4.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.981 -0.554 . . . . 1.1299999999999999 111.262 -179.642 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 57.2 m 51.88 72.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 1.5700000000000001 110.212 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.73 -80.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 3.7000000000000002 111.421 -179.485 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -114.73 27.95 9.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.667 -0.697 . . . . 2.1400000000000001 110.819 -179.734 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.333 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.085 0.469 . . . . 2.0600000000000001 111.091 -179.323 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.432 HD12 ' CB ' ' A' ' 86' ' ' SER . 7.0 tt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.97 0.414 . . . . 1.26 111.506 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 1.24 ' OD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -140.55 130.77 13.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 2.0 110.132 179.757 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 166.94 17.2 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.437 2.091 . . . . 0.58999999999999997 112.843 -179.592 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 24.1 Cg_endo -61.74 -175.86 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.111 2.541 . . . . 1.6100000000000001 113.404 -179.489 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.45 168.61 36.68 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.578 -0.737 . . . . 0.97999999999999998 112.445 179.938 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -59.32 130.56 87.35 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.724 0.262 . . . . 2.04 110.353 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.4 Cg_exo -79.46 153.99 24.09 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.523 2.149 . . . . 0.54000000000000004 112.86 -179.413 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 10.7 p -140.34 116.35 7.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 1.6799999999999999 110.351 179.977 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 19' ' ' THR . 14.2 Cg_exo -66.81 91.54 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.953 1.769 . . . . 0.64000000000000001 113.191 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.47 ' CD1' ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER -46.75 -42.77 17.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.293 0.568 . . . . 2.1699999999999999 110.283 179.449 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.0 t30 -134.58 153.21 52.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.216 -0.902 . . . . 0.84999999999999998 109.278 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' CG2' HG13 ' A' ' 18' ' ' VAL . 2.6 pt -140.4 94.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.48 . . . . 1.5700000000000001 111.235 -179.543 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -91.63 55.61 2.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.677 -0.692 . . . . 1.46 112.282 -179.202 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 2.5 mtm180 53.58 -71.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.678 0.992 . . . . 2.9100000000000001 113.678 178.638 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.6 m170 -84.8 -32.61 23.27 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.281 0.474 . . . . 1.3300000000000001 112.281 -178.726 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.432 ' CB ' ' HA ' ' A' ' 64' ' ' SER . 19.9 p -126.4 101.7 6.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.673 0.273 . . . . 1.28 111.075 -179.714 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.547 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 32.5 m -98.72 138.28 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.378 . . . . 1.49 110.423 179.505 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 91.1 m -101.13 119.95 39.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.74 0.644 . . . . 1.1399999999999999 112.74 -179.099 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -129.95 150.81 51.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.794 0.806 . . . . 1.3100000000000001 111.834 178.221 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.49 159.2 42.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.719 -1.128 . . . . 2.3100000000000001 109.364 179.607 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -141.93 -176.87 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.087 0.773 . . . . 0.40000000000000002 113.087 -178.922 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 -158.13 0.27 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.774 -1.103 . . . . 1.1100000000000001 110.643 179.387 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 148.84 71.69 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.417 -0.356 . . . . 2.5600000000000001 110.738 179.606 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 80.7 Cg_exo -49.1 -173.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.983 2.455 . . . . 1.1100000000000001 113.084 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.78 -29.79 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 2.77 111.649 -179.834 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.24 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 t80 -129.4 -69.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.961 0.356 . . . . 1.6899999999999999 111.961 -179.563 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.852 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 16.1 p 58.49 46.16 15.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 1.3500000000000001 110.566 -179.308 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.22 -98.51 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.929 -0.653 . . . . 1.01 112.551 179.905 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.36 22.85 2.87 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.336 -0.706 . . . . 0.97999999999999998 111.336 179.354 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -103.29 -176.12 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 0.98999999999999999 111.206 -179.178 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -134.89 5.69 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 2.6899999999999999 111.437 179.482 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.486 HG22 ' CE1' ' A' ' 36' ' ' TYR . 12.1 mt 57.55 97.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-O 121.151 0.5 . . . . 1.71 110.868 -179.725 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -104.63 29.44 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.52 -0.764 . . . . 1.6599999999999999 111.306 -179.424 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.83 116.77 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.917 0.389 . . . . 1.97 111.996 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.488 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 48.2 m-85 -110.42 107.46 17.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 1.23 110.3 179.267 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' CB ' ' A' ' 50' ' ' LYS . 1.6 mm -90.92 116.47 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.658 0.266 . . . . 1.76 111.075 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.74 118.27 35.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.31 -0.404 . . . . 1.6100000000000001 111.811 -179.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 2.8 mm-40 -96.9 135.03 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.422 -0.584 . . . . 1.6699999999999999 109.422 178.901 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.32 145.75 39.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 2.4399999999999999 112.229 -179.269 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.2 ttm180 -117.86 103.42 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.295 -0.866 . . . . 1.79 110.233 179.46 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -73.05 92.7 1.7 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.031 0.443 . . . . 1.5900000000000001 110.9 -179.771 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' CB ' ' A' ' 94' ' ' ALA . 27.5 mt -70.82 149.42 95.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.786 -0.643 . . . . 1.4299999999999999 110.692 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.5 -18.1 18.52 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.845 -1.315 . . . . 1.47 113.01 0.423 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -52.22 -90.95 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.062 -0.255 . . . . 2.6600000000000001 110.672 -179.717 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' CA ' ' CG ' ' A' ' 41' ' ' ARG . . . 88.06 123.36 1.94 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.318 -0.944 . . . . 1.6200000000000001 113.305 179.52 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' NE ' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.94 17.22 0.67 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.858 0.318 . . . . 3.0600000000000001 111.858 179.678 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.5 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 69.0 m95 28.66 98.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.953 0.723 . . . . 1.0600000000000001 112.953 179.901 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.427 HD21 ' NE ' ' A' ' 47' ' ' ARG . 1.1 mp -135.65 133.48 38.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 1.8400000000000001 111.214 179.929 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' CB ' HG23 ' A' ' 37' ' ' ILE . 9.8 ptmm? -51.11 106.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 1.77 111.112 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.39 -56.84 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 1.4099999999999999 110.714 179.819 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 9.4 p-10 -57.66 113.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 2.0099999999999998 110.571 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.21 24.0 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 2.6400000000000001 111.224 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 t -125.56 -82.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 2.0299999999999998 110.77 -179.935 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.95 141.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 1.8700000000000001 110.56 179.947 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 30.9 mt -125.56 79.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 1.3700000000000001 111.19 -179.651 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.84 -66.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 2.1499999999999999 110.923 179.998 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -179.72 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.481 -0.327 . . . . 1.54 110.424 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 30.1 p30 -96.69 10.05 39.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 1.75 111.618 179.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -111.28 95.84 5.76 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.757 -0.46 . . . . 2.0499999999999998 109.757 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.531 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 76.6 t80 -128.26 164.83 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.196 0.522 . . . . 0.56999999999999995 111.531 -179.26 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.9 m -127.38 124.03 37.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.578 -0.737 . . . . 1.1399999999999999 110.333 179.253 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -81.36 82.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.17 0.509 . . . . 1.72 109.941 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' A' ' 17' ' ' THR . 33.2 t -68.27 -39.05 82.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.403 -0.817 . . . . 1.6399999999999999 111.514 -179.18 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.68 62.22 0.47 Allowed Glycine 0 C--N 1.321 -0.301 0 C-N-CA 120.811 -0.709 . . . . 0.95999999999999996 111.69 179.733 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -131.66 149.19 52.58 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.385 -0.598 . . . . 2.02 109.385 -179.118 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.405 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -105.23 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 1.55 111.87 -179.207 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 16' ' ' HIS . 19.7 tt0 -103.75 165.14 11.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 1.9099999999999999 111.28 -179.46 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.65 68.91 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.993 -0.549 . . . . 1.8700000000000001 111.125 179.826 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . 176.87 110.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.882 179.904 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . . . -63.05 110.2 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.21 0.529 . . . . 1.1100000000000001 110.641 -179.866 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 82.7 m-85 -103.75 125.54 50.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 1.0800000000000001 112.728 -178.999 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HG3' HD13 ' A' ' 43' ' ' LEU . 20.1 mt-10 -103.36 137.2 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.863 -1.162 . . . . 1.5 107.863 177.704 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -129.61 116.97 19.66 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.307 1.595 . . . . 0.79000000000000004 115.307 -178.717 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -102.21 177.8 4.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.579 -1.267 . . . . 2.6899999999999999 107.579 176.856 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -145.14 111.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 118.969 -1.093 . . . . 1.5700000000000001 112.753 -179.835 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.449 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 25.1 mt -92.99 142.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.691 -1.226 . . . . 1.3200000000000001 107.691 177.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -154.1 120.7 5.51 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.746 . . . . 1.1100000000000001 111.945 -178.951 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -56.3 -100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.367 -0.533 . . . . 2.3500000000000001 109.969 179.633 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.536 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 18.6 p30 171.41 -111.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.935 -0.765 . . . . 2.7000000000000002 108.935 179.65 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -135.09 5.54 3.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.054 0.843 . . . . 1.3400000000000001 111.53 179.015 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.94 0.02 7.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.736 -0.211 . . . . 1.4299999999999999 111.236 179.956 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.82 61.16 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 120.334 -0.936 . . . . 1.3799999999999999 113.186 179.864 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.87 114.35 6.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 1.49 110.335 179.866 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -72.77 121.3 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 1.48 112.255 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.432 ' CB ' HD12 ' A' ' 2' ' ' ILE . 1.3 p -89.36 127.0 56.65 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 109.674 -0.491 . . . . 0.81000000000000005 109.674 179.264 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -32.97 155.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.547 2.832 . . . . 1.25 113.844 -179.16 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.449 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 14.6 Cg_exo -68.06 120.97 7.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.698 2.265 . . . . 1.2 112.685 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 133.07 54.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.351 -0.611 . . . . 1.76 109.351 179.167 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.43 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -31.53 116.58 0.37 Allowed Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 123.682 0.614 . . . . 1.77 112.425 -179.305 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 68.6 Cg_exo -40.67 169.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.011 2.474 . . . . 1.01 114.252 -179.565 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.08 141.46 35.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.73 -1.123 . . . . 1.55 109.729 179.834 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -41.85 130.54 3.37 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.71 0.631 . . . . 1.6299999999999999 111.078 179.606 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.453 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -59.88 133.97 56.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.861 -0.609 . . . . 1.0900000000000001 111.552 -179.557 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.5 mp -116.79 113.19 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 1.1299999999999999 110.71 179.507 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.1 m -53.42 -16.0 1.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.056 0.761 . . . . 1.1299999999999999 113.056 -179.106 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 p 42.08 64.9 0.98 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.254 0.55 . . . . 1.5700000000000001 111.127 -179.644 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -90.28 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.399 -0.819 . . . . 3.7000000000000002 111.429 -179.492 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -133.19 31.29 3.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.846 0.355 . . . . 2.1400000000000001 110.713 -179.748 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 26.0 t0 . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 116.019 -0.537 . . . . 2.0600000000000001 112.249 -179.617 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 1.6 tt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.769 0.319 . . . . 1.26 111.012 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.36 122.7 26.67 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.13 -0.486 . . . . 2.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 59.6 Cg_endo -71.57 155.88 58.63 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.036 1.824 . . . . 0.58999999999999997 112.181 -179.751 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -59.73 172.75 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.317 2.011 . . . . 1.6100000000000001 112.242 -179.757 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.55 168.58 51.05 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.93 -0.652 . . . . 0.97999999999999998 113.031 -179.693 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 5.6 tttt -63.17 141.13 97.75 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.026 -0.361 . . . . 2.04 110.026 179.663 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' HG2' ' A' ' 7' ' ' LYS . 3.6 Cg_exo -83.4 142.08 10.41 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.417 2.078 . . . . 0.54000000000000004 112.589 -179.729 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.74 118.33 6.11 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 1.6799999999999999 110.588 179.749 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.6 Cg_exo -67.0 123.02 10.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.196 1.931 . . . . 0.64000000000000001 113.521 -179.439 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -34.38 20.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.901 -0.778 . . . . 2.1699999999999999 108.901 178.701 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 143.48 35.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.794 -1.094 . . . . 0.84999999999999998 109.047 179.386 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' CG2' HG12 ' A' ' 18' ' ' VAL . 2.6 pt -136.94 102.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.026 0.441 . . . . 1.5700000000000001 112.044 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.72 59.17 1.47 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.756 -0.656 . . . . 1.46 111.115 -179.999 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 51.53 -74.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.553 -0.748 . . . . 2.9100000000000001 112.273 179.045 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' THR . 7.2 m-70 -79.69 -45.85 18.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 1.3300000000000001 110.894 -179.944 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -99.12 104.61 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.28 111.061 -179.905 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 66' ' ' LEU . 61.7 t -101.22 118.95 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 1.49 110.219 179.761 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 27.3 m -95.29 117.72 30.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.979 -0.555 . . . . 1.1399999999999999 112.12 -179.117 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -134.37 159.49 40.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.447 0.641 . . . . 1.3100000000000001 111.165 178.541 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.64 148.21 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.911 -1.04 . . . . 2.3100000000000001 109.692 -179.987 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 1.2 p90 -116.46 -111.06 0.35 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.487 -0.485 . . . . 0.40000000000000002 112.078 -179.994 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -157.48 -159.55 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.993 -0.442 . . . . 1.1100000000000001 111.196 -179.189 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' HD3' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.73 132.61 24.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 2.5600000000000001 110.61 179.981 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.3 Cg_endo -57.04 -175.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.432 2.088 . . . . 1.1100000000000001 112.102 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.51 -43.19 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.955 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -97.03 -66.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 1.6899999999999999 112.047 -179.32 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 27.8 p 55.18 32.0 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 1.3500000000000001 110.493 -179.345 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.14 -94.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.481 -0.866 . . . . 1.01 111.866 -179.824 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.89 41.68 1.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.513 -1.035 . . . . 0.97999999999999998 110.513 179.261 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.471 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 6.4 m-85 -121.7 -179.15 4.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.181 -0.51 . . . . 0.98999999999999999 111.752 -178.859 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -133.13 -32.96 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 2.6899999999999999 111.998 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 4.0 mt 80.98 107.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.083 0.468 . . . . 1.71 110.821 -179.542 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -102.7 12.32 36.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.686 -0.688 . . . . 1.6599999999999999 111.69 -179.546 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -178.23 137.09 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.485 0.55 . . . . 1.97 112.485 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CE1' HG23 ' A' ' 33' ' ' ILE . 55.2 m-85 -112.6 151.17 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.819 . . . . 1.23 109.637 178.684 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.73 123.98 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.74 0.305 . . . . 1.76 111.055 -179.529 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.75 101.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 1.6100000000000001 111.36 -179.959 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -74.54 144.61 43.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.34 -0.615 . . . . 1.6699999999999999 109.34 179.267 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -122.02 145.73 47.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.133 0.492 . . . . 2.4399999999999999 111.6 -179.226 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.8 ttm180 -133.57 94.32 3.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.789 -0.641 . . . . 1.79 111.056 -179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.696 ' CG ' ' HH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -57.43 164.67 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.409 -0.96 . . . . 1.5900000000000001 108.409 179.121 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 35.2 mt -142.25 129.97 11.48 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.227 -0.589 . . . . 1.4299999999999999 111.067 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.79 33.83 3.92 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.08 -1.217 . . . . 1.47 113.653 0.743 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -112.12 51.92 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 2.6600000000000001 111.202 179.895 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -60.65 -178.58 2.14 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.773 -0.727 . . . . 1.6200000000000001 112.815 -179.998 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.74 -28.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.585 0.217 . . . . 3.0600000000000001 111.585 -179.968 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 24.3 m95 65.42 72.59 0.42 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.792 0.329 . . . . 1.0600000000000001 111.251 -179.981 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.6 mp -119.86 133.84 55.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 1.8400000000000001 110.605 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 86.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 1.77 110.787 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -53.22 -41.62 65.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 1.4099999999999999 111.175 -179.668 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 5.4 t30 -44.37 -90.59 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.309 -0.405 . . . . 2.0099999999999998 111.427 -179.768 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 t80 73.1 39.55 0.61 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.724 0.297 . . . . 2.6400000000000001 110.712 -179.609 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -157.13 24.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 2.0299999999999998 111.551 -179.911 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.85 121.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.82 0.343 . . . . 1.8700000000000001 111.219 179.611 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.605 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 38.9 mm -108.5 75.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 1.3700000000000001 110.972 179.58 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -67.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.731 0.301 . . . . 2.1499999999999999 111.001 -179.995 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.38 163.43 21.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.54 110.158 179.635 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 34.1 p30 -76.89 -1.09 26.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.369 -0.378 . . . . 1.75 111.73 -179.829 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -104.52 98.35 8.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.865 0.364 . . . . 2.0499999999999998 110.051 179.711 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.605 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 64.6 t80 -128.84 164.72 22.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.56999999999999995 111.439 -179.39 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 51.1 m -128.76 106.85 9.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.319 -0.855 . . . . 1.1399999999999999 110.826 179.302 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 27.0 m -61.77 134.92 26.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.72 110.868 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 133.45 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 1.6399999999999999 111.502 -179.524 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.25 21.83 4.33 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.95999999999999996 112.293 179.917 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HG ' ' CD2' ' A' ' 72' ' ' TYR . 3.0 mp -79.69 176.65 9.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.185 0.517 . . . . 2.02 111.749 -179.504 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 134.27 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.394 -0.821 . . . . 1.55 110.124 179.419 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 mt-10 -73.73 174.2 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 1.9099999999999999 111.736 -179.501 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 6.2 t70 52.83 27.44 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.905 -0.588 . . . . 1.8700000000000001 110.973 -179.962 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.33 126.02 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 1.2 110.871 179.803 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -66.03 127.87 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.362 -0.381 . . . . 1.1100000000000001 110.607 179.78 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.696 ' HH ' ' CG ' ' A' ' 42' ' ' ASP . 3.6 m-85 -115.91 125.71 52.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 1.0800000000000001 112.014 -179.087 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.2 tt0 -106.33 148.41 28.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.873 -0.788 . . . . 1.5 108.873 179.001 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -139.93 118.76 12.47 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.79000000000000004 115.032 -178.718 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -100.35 178.06 4.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.004 -0.544 . . . . 2.6899999999999999 109.831 178.102 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 75.4 t -134.68 122.07 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 113.245 0.831 . . . . 1.5700000000000001 113.245 -179.53 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 91.9 mt -122.56 142.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.147 -1.427 . . . . 1.3200000000000001 107.147 178.188 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 36' ' ' TYR . . . -169.31 134.35 1.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.49 1.292 . . . . 1.1100000000000001 114.49 -178.836 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -83.75 136.93 33.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.887 -1.153 . . . . 2.3500000000000001 107.887 177.529 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 5.9 m-20 -76.69 -92.5 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.468 0.544 . . . . 2.7000000000000002 112.468 -178.566 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -126.31 -40.96 1.93 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.444 0.535 . . . . 1.3400000000000001 112.444 -178.99 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -100.43 36.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.339 0.496 . . . . 1.4299999999999999 112.339 -179.078 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.96 -0.67 57.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 1.3799999999999999 113.486 179.575 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -63.11 85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.032 0.416 . . . . 1.49 110.176 179.677 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -64.41 121.39 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.169 0.509 . . . . 1.48 111.98 -179.26 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 22.9 p -78.31 123.94 85.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.81000000000000005 109.311 179.159 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.54 171.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.872 2.381 . . . . 1.25 113.172 -179.211 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 14.4 Cg_exo -67.53 112.79 2.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 1.2 112.862 -179.596 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -74.36 132.58 42.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 1.76 110.037 179.367 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.7 mm-40 -31.01 113.75 0.33 Allowed Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 123.761 0.663 . . . . 1.77 112.355 -179.599 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 75' ' ' ARG . 44.1 Cg_exo -56.07 138.63 83.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 1.01 113.057 -179.658 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -69.94 146.49 51.13 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.279 -0.638 . . . . 1.55 109.279 179.193 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -35.76 139.43 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.094 0.871 . . . . 1.6299999999999999 111.843 -179.865 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -75.65 108.86 8.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 1.0900000000000001 111.175 -179.709 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mp -91.29 114.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.197 -0.456 . . . . 1.1299999999999999 111.122 -179.712 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 97.5 m -36.22 -32.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.214 -0.448 . . . . 1.1299999999999999 111.862 -179.96 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 69' ' ' ASP . 9.3 m 51.28 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.428 -0.351 . . . . 1.5700000000000001 110.117 179.773 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.99 -90.92 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 3.7000000000000002 111.669 -179.317 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.634 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -105.71 6.59 32.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.805 0.298 . . . . 2.1400000000000001 111.805 -179.609 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 53.5 t0 . . . . . 0 C--N 1.331 -0.218 0 N-CA-C 111.862 0.319 . . . . 2.0600000000000001 111.862 179.755 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.477 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 6.9 tt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.766 0.317 . . . . 1.26 111.041 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.81 114.26 19.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 2.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.75 154.61 54.16 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.395 2.063 . . . . 0.58999999999999997 112.007 179.907 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.81 174.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.692 2.261 . . . . 1.6100000000000001 112.826 -179.708 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.77 171.48 44.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.993 -0.622 . . . . 0.97999999999999998 112.658 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -63.64 135.9 96.48 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 110.49 -0.189 . . . . 2.04 110.49 179.802 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 3.0 Cg_endo -80.9 129.76 7.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.457 2.104 . . . . 0.54000000000000004 112.861 -179.697 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 7.9 p -132.83 106.01 12.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.917 -0.583 . . . . 1.6799999999999999 110.793 179.613 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.5 Cg_exo -49.03 131.76 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.334 2.022 . . . . 0.64000000000000001 113.691 -179.069 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.75 -39.92 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.861 -0.792 . . . . 2.1699999999999999 108.861 178.689 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -136.35 150.37 48.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.406 -1.27 . . . . 0.84999999999999998 108.607 179.576 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 13' ' ' ILE . 1.9 pt -143.44 83.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.262 -0.575 . . . . 1.5700000000000001 112.516 -179.157 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.23 159.73 29.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.729 -0.669 . . . . 1.46 110.507 179.476 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -17.37 7.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.9100000000000001 111.961 -179.554 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.408 ' O ' ' CG2' ' A' ' 17' ' ' THR . 10.7 m-70 -141.91 34.39 1.57 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.973 0.36 . . . . 1.3300000000000001 111.973 -179.754 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 179.66 120.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.648 -0.251 . . . . 1.28 110.387 179.714 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.438 ' HB ' HG21 ' A' ' 63' ' ' VAL . 95.2 t -117.86 111.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.18 0.514 . . . . 1.49 112.045 -179.317 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 92.4 m -85.21 142.28 29.54 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.004 -0.543 . . . . 1.1399999999999999 110.266 179.154 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.79 161.13 41.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.428 0.633 . . . . 1.3100000000000001 112.298 -179.857 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -149.3 144.37 26.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.878 -1.056 . . . . 2.3100000000000001 110.49 179.742 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.4 p90 -138.23 -173.38 3.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.431 . . . . 0.40000000000000002 110.734 -179.973 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 -166.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.1100000000000001 110.381 179.534 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -132.23 155.61 81.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.786 0.327 . . . . 2.5600000000000001 110.942 179.907 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.6 Cg_exo -69.25 163.41 37.96 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.097 . . . . 1.1100000000000001 111.835 179.802 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.96 -0.66 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 2.77 111.493 179.652 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -128.6 -70.34 0.68 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.658 0.266 . . . . 1.6899999999999999 111.644 -179.805 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 30.4 p 48.83 57.43 6.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.598 -0.274 . . . . 1.3500000000000001 110.733 -179.575 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.46 -92.17 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.301 -0.476 . . . . 1.01 112.799 -179.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -145.96 32.66 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.236 -1.146 . . . . 0.97999999999999998 110.236 179.177 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -119.44 -179.04 3.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.953 -0.624 . . . . 0.98999999999999999 111.374 -178.716 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.08 3.75 2.92 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.249 -0.432 . . . . 2.6899999999999999 112.164 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 33' ' ' ILE . 10.1 mt 60.05 154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.752 0.31 . . . . 1.71 110.635 -179.935 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -145.2 15.14 1.49 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.002 0.371 . . . . 1.6599999999999999 112.002 -179.646 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 9.1 t -177.65 133.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 1.97 111.214 -179.915 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 25.9 m-85 -109.58 105.18 14.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 1.23 110.642 179.592 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -84.91 152.02 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.019 -0.537 . . . . 1.76 111.039 -179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 2.5 t -131.53 111.76 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 1.6100000000000001 110.568 179.65 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -87.12 143.88 27.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.006 -0.368 . . . . 1.6699999999999999 110.006 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 141.24 51.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.122 0.487 . . . . 2.4399999999999999 112.23 -179.0 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 23.0 ttp180 -112.02 112.14 23.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.614 178.932 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 1.368 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.9 96.99 4.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 1.5900000000000001 110.887 -179.594 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' CD2' ' HG2' ' A' ' 41' ' ' ARG . 7.6 mt -80.26 154.1 74.45 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 1.4299999999999999 110.785 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.61 12.32 51.47 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.691 -1.379 . . . . 1.47 112.89 0.192 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -77.96 -82.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.402 . . . . 2.6600000000000001 110.632 179.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 123.8 143.2 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.864 -0.684 . . . . 1.6200000000000001 112.484 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 1.368 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 171.83 55.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.466 0.174 . . . . 3.0600000000000001 111.158 -179.847 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.582 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 14.1 m95 -36.97 107.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0600000000000001 111.725 -179.994 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 136.89 28.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.049 0.452 . . . . 1.8400000000000001 111.065 179.976 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.22 104.33 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 1.77 111.173 -179.921 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.01 87.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.037 0.446 . . . . 1.4099999999999999 110.259 179.557 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 61' ' ' PHE . 1.9 t30 -68.35 116.98 9.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.788 -0.642 . . . . 2.0099999999999998 110.189 179.639 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -114.31 46.69 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 2.6400000000000001 111.117 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 t -150.12 -83.91 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.409 -0.36 . . . . 2.0299999999999998 110.962 -179.958 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.78 147.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 1.8700000000000001 110.777 -179.961 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.499 HG12 ' CD2' ' A' ' 61' ' ' PHE . 14.3 mt -142.0 75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 1.3700000000000001 111.31 -179.827 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.76 -53.06 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 2.1499999999999999 110.718 179.835 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.29 161.58 25.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.127 179.684 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 45.2 p-10 -81.45 6.08 15.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 1.75 111.918 -179.756 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.58 104.31 13.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.591 -0.522 . . . . 2.0499999999999998 109.591 179.413 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 62' ' ' THR . 63.9 t80 -137.77 163.81 30.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.56999999999999995 112.184 -179.255 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 65.5 m -122.2 107.15 11.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.628 -0.715 . . . . 1.1399999999999999 111.358 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 18' ' ' VAL . 2.2 m -72.05 94.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.759 -0.655 . . . . 1.72 110.436 179.57 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -100.44 155.62 17.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.589 0.709 . . . . 1.6399999999999999 111.068 179.989 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.0 22.67 3.81 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.664 -1.153 . . . . 0.95999999999999996 112.314 179.793 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -172.49 4.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.898 0.38 . . . . 2.02 110.932 -179.753 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -148.28 116.11 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 1.55 110.654 179.998 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -41.53 137.86 1.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.096 -0.502 . . . . 1.9099999999999999 111.563 -179.953 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t70 75.69 47.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 1.8700000000000001 111.085 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.6 121.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 1.2 110.983 179.778 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -72.0 127.42 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 1.1100000000000001 111.086 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 55.3 m-85 -124.35 127.28 47.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.503 -0.771 . . . . 1.0800000000000001 112.307 -179.225 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 3.1 tp10 -99.8 147.41 25.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.036 -0.727 . . . . 1.5 109.036 178.812 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 15.0 m-85 -137.18 116.95 13.07 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.969 1.47 . . . . 0.79000000000000004 114.969 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.582 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -107.43 171.05 7.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.963 -0.755 . . . . 2.6899999999999999 108.963 177.587 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.454 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 77.0 t -126.24 108.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.951 0.723 . . . . 1.5700000000000001 112.951 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 88' ' ' PRO . 31.4 mt -102.83 139.19 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.528 -1.286 . . . . 1.3200000000000001 107.528 177.946 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -153.76 129.75 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.64 -0.824 . . . . 1.1100000000000001 112.064 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 40.8 mttt -78.75 -178.22 5.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 2.3500000000000001 110.486 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.481 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 3.5 m-80 -129.02 172.58 11.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.003 -0.544 . . . . 2.7000000000000002 110.812 179.839 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -44.1 -28.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.719 -0.673 . . . . 1.3400000000000001 111.785 179.658 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.14 34.77 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.136 0.421 . . . . 1.4299999999999999 112.136 -179.439 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 42.68 37.81 2.87 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.67 -0.776 . . . . 1.3799999999999999 113.02 179.611 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.01 8.24 8.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.287 0.477 . . . . 1.49 112.287 -179.956 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 35.7 97.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 113.496 0.924 . . . . 1.48 113.496 179.738 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -75.73 116.64 57.13 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.53 -0.915 . . . . 0.81000000000000005 108.53 178.461 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -35.16 158.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.405 2.737 . . . . 1.25 113.39 -178.843 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 77' ' ' ILE . 12.6 Cg_exo -68.06 142.77 57.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.627 2.218 . . . . 1.2 112.23 179.871 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLU . 50.5 m -92.25 118.64 31.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.958 -0.565 . . . . 1.76 110.125 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 42.5 mt-10 -19.66 104.94 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.021 0.929 . . . . 1.77 113.151 -179.461 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 55.5 Cg_exo -39.98 161.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.608 2.205 . . . . 1.01 113.246 -179.471 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.431 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -97.04 143.51 27.81 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.501 -0.772 . . . . 1.55 109.339 179.175 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.439 ' O ' HD13 ' A' ' 95' ' ' ILE . 2.6 m-20 -35.31 129.01 0.54 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.027 0.83 . . . . 1.6299999999999999 112.077 -179.286 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.435 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -50.19 133.06 23.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 1.0900000000000001 111.397 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.497 HD11 ' CE2' ' A' ' 74' ' ' PHE . 3.2 mp -113.24 106.76 21.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 1.1299999999999999 111.686 -179.789 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.7 m -52.54 -23.02 5.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.233 -0.44 . . . . 1.1299999999999999 110.841 179.688 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 60.29 38.35 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.5700000000000001 110.235 -179.834 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -132.97 -38.42 0.98 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 3.7000000000000002 111.946 -179.635 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 3.9 p-10 -49.0 -26.27 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 2.1400000000000001 111.624 -179.405 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 116.115 -0.493 . . . . 2.0600000000000001 111.531 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 2' ' ' ILE . 5.2 tt . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.596 0.712 . . . . 1.26 112.439 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.981 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -141.93 123.59 8.91 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.43 -179.962 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.08 166.92 28.43 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.321 2.014 . . . . 0.58999999999999997 112.256 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.2 Cg_exo -52.24 173.96 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.667 2.245 . . . . 1.6100000000000001 112.749 -179.626 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.56 39.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.071 -0.585 . . . . 0.97999999999999998 112.78 -179.831 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -65.44 118.12 47.44 Favored Pre-proline 0 CA--C 1.532 0.254 0 O-C-N 123.043 -0.092 . . . . 2.04 110.772 179.879 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 15.5 Cg_exo -69.77 127.94 15.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.418 2.079 . . . . 0.54000000000000004 112.731 -179.68 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 8.4 p -131.96 113.6 14.97 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.74 -0.664 . . . . 1.6799999999999999 111.405 -179.491 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 71.5 Cg_exo -47.32 112.1 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.52 2.146 . . . . 0.64000000000000001 113.193 -179.61 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -74.12 -35.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.736 -0.838 . . . . 2.1699999999999999 108.736 179.174 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 3.9 t30 -143.91 153.29 42.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.486 -1.234 . . . . 0.84999999999999998 107.718 178.621 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.424 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -142.93 141.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.809 -0.756 . . . . 1.5700000000000001 113.019 -178.793 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.94 136.44 33.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.21 -0.904 . . . . 1.46 109.863 179.263 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -42.68 -24.83 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.005 0.743 . . . . 2.9100000000000001 113.005 -179.023 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -118.11 -12.98 9.96 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.744 -0.598 . . . . 1.3300000000000001 112.517 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -153.46 125.6 7.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.246 -0.279 . . . . 1.28 110.246 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -118.64 145.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 1.49 111.81 -179.809 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 12' ' ' ASN . 9.0 m -111.36 127.72 55.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.04 -0.527 . . . . 1.1399999999999999 111.072 -179.745 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.06 139.27 52.09 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.865 0.841 . . . . 1.3100000000000001 111.355 178.769 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 15.6 tptp -121.67 155.49 35.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.124 -1.398 . . . . 2.3100000000000001 108.973 179.632 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.6 p90 -152.55 -174.48 4.92 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.213 -0.595 . . . . 0.40000000000000002 111.966 -179.729 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.77 168.2 10.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.052 -0.522 . . . . 1.1100000000000001 112.046 -179.389 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -97.76 141.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.775 -0.648 . . . . 2.5600000000000001 110.434 179.888 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.464 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 88.8 Cg_exo -47.38 176.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.346 2.031 . . . . 1.1100000000000001 112.246 179.958 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -121.18 -29.54 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.418 -0.355 . . . . 2.77 111.799 -179.7 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 10.8 t80 -113.77 -71.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.986 0.365 . . . . 1.6899999999999999 111.986 -179.376 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.981 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 47.7 p 50.48 43.92 27.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 1.3500000000000001 110.985 -179.593 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.18 -91.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.814 -0.707 . . . . 1.01 112.49 179.89 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.27 32.6 1.04 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.637 -0.985 . . . . 0.97999999999999998 110.637 179.561 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.471 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -112.08 175.14 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.007 -0.596 . . . . 0.98999999999999999 111.147 -179.076 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 18.1 ttpt -126.17 -17.71 5.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.061 -0.518 . . . . 2.6899999999999999 112.015 -179.799 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 33' ' ' ILE . 35.9 mt 70.84 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.685 0.279 . . . . 1.71 110.713 -179.589 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -126.77 25.46 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 1.6599999999999999 111.671 -179.619 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.6 t -178.75 127.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 1.97 111.259 179.903 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.432 ' CE1' HG23 ' A' ' 33' ' ' ILE . 5.5 m-85 -114.36 95.46 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 1.23 111.172 -179.916 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -87.32 112.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 1.76 111.003 -179.972 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 p -102.58 116.68 46.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 1.6100000000000001 111.103 -179.69 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.12 154.92 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 1.6699999999999999 109.857 179.502 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -127.94 146.57 50.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.187 0.518 . . . . 2.4399999999999999 111.494 -179.759 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 10.3 ttp180 -116.08 108.19 15.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 1.79 110.045 179.472 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.826 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.97 87.3 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.881 -0.6 . . . . 1.5900000000000001 110.54 -179.836 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD13 ' CB ' ' A' ' 94' ' ' ALA . 33.1 mt -65.07 153.95 87.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 1.4299999999999999 110.879 -179.88 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.62 24.49 20.2 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.846 -1.314 . . . . 1.47 112.976 0.386 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -154.8 70.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.781 0.324 . . . . 2.6600000000000001 111.592 -179.936 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.41 -161.59 35.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.676 -0.773 . . . . 1.6200000000000001 112.019 179.606 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -160.03 26.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.296 . . . . 3.0600000000000001 111.166 -179.991 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 38.5 m95 42.71 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.205 -0.452 . . . . 1.0600000000000001 111.544 179.828 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -132.27 130.41 40.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 1.8400000000000001 111.202 -179.961 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -54.96 88.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 1.77 110.787 179.989 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.427 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -52.5 -54.59 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 1.4099999999999999 110.907 179.979 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.4 p-10 -62.47 128.81 37.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 2.0099999999999998 110.814 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.71 -2.36 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 2.6400000000000001 111.714 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -168.8 1.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.815 0.341 . . . . 2.0299999999999998 110.941 179.939 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.77 115.97 26.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 1.8700000000000001 111.18 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.508 HG12 ' CD1' ' A' ' 61' ' ' PHE . 54.5 mt -99.27 60.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 1.3700000000000001 110.59 179.711 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -43.38 -64.48 0.63 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.242 -0.435 . . . . 2.1499999999999999 111.648 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -72.57 171.52 12.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 1.54 110.533 179.847 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.478 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -89.49 11.76 18.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.75 111.412 179.978 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -110.66 100.07 8.91 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 110.099 -0.334 . . . . 2.0499999999999998 110.099 179.446 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CD1' HG12 ' A' ' 56' ' ' ILE . 61.3 t80 -131.66 164.75 25.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.139 0.495 . . . . 0.56999999999999995 111.715 -179.465 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 2.1 m -124.76 123.46 40.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.657 -0.702 . . . . 1.1399999999999999 110.744 179.631 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 51' ' ' ALA . 16.5 t -83.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.171 0.51 . . . . 1.72 111.189 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 134.98 36.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 1.6399999999999999 110.701 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.09 -16.28 4.45 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.552 -0.749 . . . . 0.95999999999999996 111.469 -179.295 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -51.38 172.16 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.805 0.335 . . . . 2.02 110.649 179.656 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.4 m -137.27 152.8 50.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.184 -0.462 . . . . 1.55 111.057 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 2.5 tt0 -61.1 155.49 20.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.9099999999999999 111.197 179.943 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 97' ' ' CYS . 60.2 m-20 47.36 60.62 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 1.8700000000000001 111.55 179.952 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.34 116.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.688 0.28 . . . . 1.2 111.375 179.646 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 43' ' ' LEU . . . -71.66 125.4 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.677 -0.49 . . . . 1.1100000000000001 109.677 179.234 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 44.1 m-85 -117.28 124.37 48.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.066 0.765 . . . . 1.0800000000000001 113.066 -178.869 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.46 135.1 44.68 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.496 -0.928 . . . . 1.5 108.496 178.208 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.555 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.46 111.28 12.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.082 1.142 . . . . 0.79000000000000004 114.082 -178.337 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.7 ptp180 -91.27 146.67 23.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 2.6899999999999999 109.694 178.471 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 98.7 t -106.13 110.09 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.919 0.711 . . . . 1.5700000000000001 112.919 -179.297 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 85.0 mt -106.59 154.54 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.805 -1.183 . . . . 1.3200000000000001 107.805 177.991 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -167.63 120.87 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.203 -0.999 . . . . 1.1100000000000001 113.145 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.8 ptpt -72.41 156.94 38.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.556 -0.535 . . . . 2.3500000000000001 109.556 178.795 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' ND2' ' CD1' ' A' ' 2' ' ' ILE . 2.6 m-80 -100.86 170.87 8.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.533 0.682 . . . . 2.7000000000000002 112.406 -178.842 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -39.2 -58.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 1.3400000000000001 112.112 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.4 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -61.51 -12.94 17.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 1.4299999999999999 112.296 -179.686 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 -14.61 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.536 -0.84 . . . . 1.3799999999999999 112.176 -179.733 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.46 155.96 1.38 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 110.171 -0.307 . . . . 1.49 110.171 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -107.71 117.37 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.29 0.478 . . . . 1.48 112.29 -179.399 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.0 p -79.88 111.43 21.58 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.667 -0.697 . . . . 0.81000000000000005 109.581 179.051 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.74 160.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.004 2.469 . . . . 1.25 112.932 -179.782 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 41.0 Cg_endo -68.77 134.79 31.08 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.675 2.25 . . . . 1.2 112.853 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 90' ' ' GLU . 19.8 m -90.84 111.07 22.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 1.76 109.919 179.28 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -4.12 108.33 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.717 1.207 . . . . 1.77 113.573 -179.677 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 84.3 Cg_exo -41.8 131.31 4.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.677 2.251 . . . . 1.01 113.712 -179.711 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.412 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.21 148.21 48.76 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.884 -0.598 . . . . 1.55 109.468 178.959 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -33.07 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.386 1.054 . . . . 1.6299999999999999 112.409 -179.999 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.454 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -77.46 106.61 9.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 1.0900000000000001 110.372 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 5.0 mp -85.69 108.66 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.743 0.306 . . . . 1.1299999999999999 110.571 -179.923 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.9 m -42.53 -40.07 2.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.959 0.409 . . . . 1.1299999999999999 111.027 179.956 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 69' ' ' ASP . 94.0 m 60.84 75.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.5700000000000001 111.415 179.31 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -108.88 -79.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 3.7000000000000002 110.109 179.605 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -126.03 0.22 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.703 -0.681 . . . . 2.1400000000000001 111.314 179.471 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.463 0.193 0 N-CA-C 112.676 0.621 . . . . 2.0600000000000001 112.676 179.629 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.441 HG12 ' N ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.01 0.433 . . . . 1.26 111.854 . . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 4.2 m-20 -134.56 127.24 18.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.0 110.127 179.69 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 74.5 Cg_endo -73.26 163.08 38.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.239 1.959 . . . . 0.58999999999999997 112.444 -179.714 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 37.0 Cg_exo -57.8 178.19 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.779 2.319 . . . . 1.6100000000000001 112.782 -179.732 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.89 174.56 43.02 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.913 -0.66 . . . . 0.97999999999999998 112.819 -179.988 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 130.66 91.78 Favored Pre-proline 0 N--CA 1.462 0.152 0 CA-C-N 116.64 0.22 . . . . 2.04 110.415 179.813 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.0 Cg_exo -72.7 138.37 29.02 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.386 2.057 . . . . 0.54000000000000004 113.124 -179.287 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.93 116.74 7.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.819 -0.628 . . . . 1.6799999999999999 110.534 179.535 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.7 Cg_exo -58.91 138.36 85.21 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.546 2.164 . . . . 0.64000000000000001 113.973 -179.207 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.17 -33.13 8.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.525 -0.761 . . . . 2.1699999999999999 109.064 178.649 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.23 153.29 41.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.051 -0.977 . . . . 0.84999999999999998 109.498 179.557 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -148.62 108.68 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.124 0.487 . . . . 1.5700000000000001 111.929 -179.549 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 1.092 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -105.41 53.04 0.72 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.679 -0.691 . . . . 1.46 111.212 -179.924 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 1.084 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.26 -73.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.98 0.8 . . . . 2.9100000000000001 112.548 179.239 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' THR . 9.0 m-70 -70.64 -29.49 65.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.269 -0.423 . . . . 1.3300000000000001 111.598 -179.349 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -128.78 126.2 39.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.759 0.314 . . . . 1.28 111.332 -179.815 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 74' ' ' PHE . 87.4 t -113.06 128.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.49 110.802 179.836 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 m -102.41 124.1 47.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 1.1399999999999999 111.461 -179.392 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.14 162.09 34.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.535 0.683 . . . . 1.3100000000000001 111.585 179.384 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.35 151.64 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.97 -1.014 . . . . 2.3100000000000001 110.536 -179.635 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 11.1 p90 -136.88 -173.58 3.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.022 0.439 . . . . 0.40000000000000002 111.463 -179.948 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.91 173.52 8.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 1.1100000000000001 111.088 179.922 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -100.47 149.54 36.18 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.451 -0.34 . . . . 2.5600000000000001 110.631 179.857 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 9.6 Cg_endo -53.12 -162.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.938 2.426 . . . . 1.1100000000000001 113.036 -179.652 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -146.37 -48.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.77 111.139 -179.67 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.413 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.2 t80 -95.03 -72.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.479 -0.328 . . . . 1.6899999999999999 111.35 -179.846 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 27' ' ' TYR . 13.6 p 69.39 -45.14 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.055 0.761 . . . . 1.3500000000000001 113.055 -179.7 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.57 -22.32 10.16 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.269 -0.967 . . . . 1.01 112.302 -179.889 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.74 -26.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.496 -1.442 . . . . 0.97999999999999998 109.496 -179.241 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 8.8 m-85 -60.9 -175.31 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.275 -0.963 . . . . 0.98999999999999999 110.366 179.13 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 24.33 0.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.136 -0.484 . . . . 2.6899999999999999 111.098 179.584 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' CE1' ' A' ' 36' ' ' TYR . 7.0 mt 42.97 98.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.136 0.493 . . . . 1.71 112.195 179.845 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 14.13 21.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 1.6599999999999999 111.282 179.755 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t 176.68 122.86 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.797 0.332 . . . . 1.97 111.568 -179.939 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 33' ' ' ILE . 1.4 m-85 -106.86 117.28 33.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 1.23 110.226 179.502 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' OD1' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -97.28 135.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.654 -0.248 . . . . 1.76 110.959 -179.624 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 t -112.99 113.49 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.755 0.312 . . . . 1.6100000000000001 111.249 179.84 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -87.57 127.52 35.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 1.6699999999999999 110.158 179.474 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 3.9 pttm -106.56 147.31 29.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 2.4399999999999999 111.724 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.3 ttp180 -129.13 117.48 20.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.59 -0.732 . . . . 1.79 110.428 179.455 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.936 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.77 123.92 25.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 1.5900000000000001 110.178 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.479 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.2 mt -113.99 150.23 43.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 1.4299999999999999 111.479 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 8.8 Cg_endo -88.71 33.01 7.61 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.994 -1.253 . . . . 1.47 112.499 0.308 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.419 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 m-80 -154.17 98.82 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 2.6600000000000001 110.852 -179.989 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.936 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . 177.28 -168.69 40.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.752 . . . . 1.6200000000000001 112.179 -179.953 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.34 166.19 32.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.442 . . . . 3.0600000000000001 111.37 179.877 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 73.2 m95 -68.47 120.12 14.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.574 -0.739 . . . . 1.0600000000000001 111.894 -179.536 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -143.38 129.39 19.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 1.8400000000000001 110.585 179.79 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -50.54 92.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.77 110.805 -179.778 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -62.68 -52.76 62.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 1.4099999999999999 110.871 179.893 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 4.6 p-10 -59.22 157.01 11.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.801 -0.636 . . . . 2.0099999999999998 111.261 -179.891 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -165.52 28.81 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.702 -0.681 . . . . 2.6400000000000001 110.716 179.558 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 p -128.71 36.56 4.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.459 -0.337 . . . . 2.0299999999999998 111.234 -179.761 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.14 99.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.8700000000000001 110.896 179.962 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 61' ' ' PHE . 15.8 mt -90.63 93.7 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.503 . . . . 1.3700000000000001 111.467 -179.842 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.83 -55.09 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 2.1499999999999999 111.197 -179.974 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.05 173.11 12.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 1.54 110.511 179.871 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 35.1 p30 -84.66 -2.12 57.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.75 111.502 179.98 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -104.17 102.07 11.8 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.162 -0.31 . . . . 2.0499999999999998 110.162 179.741 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 44.8 t80 -135.22 164.85 26.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.286 -0.415 . . . . 0.56999999999999995 111.329 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 93.1 m -121.04 114.09 20.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.978 -0.556 . . . . 1.1399999999999999 111.529 -179.925 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 74' ' ' PHE . 6.8 m -76.72 91.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.723 -0.671 . . . . 1.72 111.424 179.752 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 p -93.01 178.73 5.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 1.6399999999999999 110.896 179.932 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.9 10.89 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.806 -0.712 . . . . 0.95999999999999996 112.478 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.58 -161.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 2.02 111.168 -179.837 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -141.15 146.85 37.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.044 -0.525 . . . . 1.55 111.159 -179.892 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.14 149.19 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 1.9099999999999999 110.916 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.36 43.97 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 1.8700000000000001 110.733 -179.977 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -162.96 125.01 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 1.2 111.439 -179.833 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.4 137.24 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 1.1100000000000001 110.256 179.521 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.3 119.4 20.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.598 0.592 . . . . 1.0800000000000001 112.598 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -98.41 147.31 24.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.602 -0.888 . . . . 1.5 108.602 178.531 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.74 115.48 11.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.648 1.351 . . . . 0.79000000000000004 114.648 -178.632 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.473 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 ptt85 -104.84 167.95 9.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.6 -0.889 . . . . 2.6899999999999999 108.6 177.674 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.478 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -134.28 129.8 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 119.472 -0.891 . . . . 1.5700000000000001 113.386 -179.654 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.46 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 76.5 mt -118.63 151.89 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.376 -1.284 . . . . 1.3200000000000001 108.045 178.366 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -158.09 130.83 7.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.646 -0.822 . . . . 1.1100000000000001 112.676 -179.543 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.18 63.88 8.26 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.566 0.698 . . . . 2.3500000000000001 109.537 178.831 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.488 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 4.3 m-20 9.22 -104.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.302 -1.772 . . . . 2.7000000000000002 114.201 -179.949 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.57 -44.68 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 122.014 -0.429 . . . . 1.3400000000000001 111.859 -179.66 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.82 45.07 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.068 0.396 . . . . 1.4299999999999999 112.068 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.41 1.35 60.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.378 -0.915 . . . . 1.3799999999999999 113.276 179.622 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.431 ' CB ' HD13 ' A' ' 2' ' ' ILE . . . -63.06 88.05 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.675 -0.491 . . . . 1.49 109.675 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -59.35 112.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.399 0.618 . . . . 1.48 112.516 -178.824 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 49.5 p -85.55 111.7 39.01 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.941 -1.027 . . . . 0.81000000000000005 108.973 178.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -38.32 157.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.9 2.4 . . . . 1.25 112.879 -179.053 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 18.4 Cg_endo -60.66 132.06 40.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.803 2.335 . . . . 1.2 113.081 -179.709 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -89.02 108.27 19.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.411 -0.813 . . . . 1.76 109.498 179.155 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -6.24 120.93 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.803 1.314 . . . . 1.77 113.674 -179.492 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 50.4 Cg_exo -54.58 143.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.383 2.056 . . . . 1.01 113.307 -179.695 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.75 146.77 35.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.048 -0.723 . . . . 1.55 109.048 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -33.41 131.23 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.175 0.922 . . . . 1.6299999999999999 112.238 -179.849 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -70.67 116.53 11.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 1.0900000000000001 111.232 -179.843 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 13' ' ' ILE . 4.9 mp -99.86 120.15 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.822 0.344 . . . . 1.1299999999999999 111.16 179.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.5 m -46.99 -36.51 7.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 1.1299999999999999 111.127 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 92.8 m 60.39 88.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.5700000000000001 110.498 179.932 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 -81.94 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 3.7000000000000002 110.953 -179.678 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.5 OUTLIER -108.25 5.99 26.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.825 -0.625 . . . . 2.1400000000000001 111.325 179.751 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 1.092 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 121.23 0.538 . . . . 2.0600000000000001 112.225 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.76 0.314 . . . . 3.1699999999999999 111.183 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -92.64 -166.93 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.054 2.503 . . . . 2.0600000000000001 112.488 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.446 HD12 ' CB ' ' A' ' 86' ' ' SER . 2.7 tt -148.47 144.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 1.26 110.982 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.17 120.11 25.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 2.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 159.24 54.07 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.141 1.894 . . . . 0.58999999999999997 111.696 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.8 Cg_endo -52.43 172.93 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 1.6100000000000001 112.502 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 164.8 52.63 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.723 -0.671 . . . . 0.97999999999999998 112.999 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.91 123.92 61.78 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.463 -0.199 . . . . 2.04 110.463 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' CG ' HG21 ' A' ' 76' ' ' VAL . 21.7 Cg_exo -67.3 133.89 31.87 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.345 2.03 . . . . 0.54000000000000004 112.713 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.3 p -131.47 117.54 16.66 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.006 -0.543 . . . . 1.6799999999999999 110.794 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.9 Cg_exo -67.66 125.99 14.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.464 2.109 . . . . 0.64000000000000001 113.801 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.402 ' N ' HD11 ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.22 -31.84 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.485 -0.932 . . . . 2.1699999999999999 108.485 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.48 145.82 34.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.075 -0.966 . . . . 0.84999999999999998 109.48 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.454 HD13 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -138.73 96.36 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.166 0.508 . . . . 1.5700000000000001 111.573 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.54 156.58 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 1.46 110.814 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -50.67 -22.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 2.9100000000000001 112.043 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 67' ' ' THR . 1.5 m-70 -139.06 12.18 2.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.254 0.464 . . . . 1.3300000000000001 112.254 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.85 106.32 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 1.28 111.326 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 74' ' ' PHE . 96.0 t -100.59 117.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 1.49 110.629 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.401 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 18.1 m -98.33 125.05 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.802 -0.636 . . . . 1.1399999999999999 111.632 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.47 154.75 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.821 0.82 . . . . 1.3100000000000001 112.163 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -135.61 164.39 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.369 -1.287 . . . . 2.3100000000000001 109.11 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 7.0 p90 -141.98 -175.14 4.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.165 0.507 . . . . 0.40000000000000002 112.117 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.94 128.38 47.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 1.1100000000000001 110.895 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -59.46 146.68 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 2.5600000000000001 110.815 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 53.4 Cg_exo -52.47 171.39 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 1.1100000000000001 112.682 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.67 -18.49 6.57 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 2.77 112.137 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -127.17 -71.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 121.003 -0.279 . . . . 1.6899999999999999 111.581 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 11.4 p 55.88 47.37 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 1.3500000000000001 110.987 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.14 0.01 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.889 -0.672 . . . . 1.01 112.515 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.19 38.03 1.2 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 109.796 -1.322 . . . . 0.97999999999999998 109.796 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -126.29 -179.53 4.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.685 -0.758 . . . . 0.98999999999999999 111.033 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.66 -1.07 3.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.302 0.482 . . . . 2.6899999999999999 112.302 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.9 mt 61.98 132.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.785 0.326 . . . . 1.71 110.952 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 p -128.63 39.75 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.6599999999999999 111.193 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 t 172.29 134.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 1.97 110.658 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 78' ' ' ALA . 26.3 m-85 -122.94 83.82 2.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.48 -0.327 . . . . 1.23 111.313 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.56 162.7 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 1.76 110.417 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -150.75 126.51 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 1.6100000000000001 110.474 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.62 137.67 32.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 1.6699999999999999 110.949 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HG2' ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -107.06 141.54 38.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.889 -0.596 . . . . 2.4399999999999999 110.839 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -110.97 116.66 31.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.69 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -84.67 87.39 7.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.809 -0.632 . . . . 1.5900000000000001 110.025 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.3 mt -75.33 154.42 86.05 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 1.4299999999999999 111.084 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 66.8 Cg_endo -89.33 34.02 7.12 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.862 -1.308 . . . . 1.47 113.044 0.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.413 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p30 -155.02 64.06 0.64 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.303 . . . . 2.6600000000000001 111.288 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.01 -163.2 22.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.887 -0.673 . . . . 1.6200000000000001 112.446 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.414 ' CZ ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -170.86 30.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.677 0.251 . . . . 3.0600000000000001 111.677 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.553 ' CE3' ' CD ' ' A' ' 75' ' ' ARG . 48.8 m95 52.49 109.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.925 0.342 . . . . 1.0600000000000001 111.925 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.414 HD22 ' CZ ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -137.7 117.38 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.8400000000000001 111.244 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -53.31 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 1.77 110.874 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 40' ' ' LYS . . . -65.78 -55.11 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 1.4099999999999999 111.193 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 p-10 -50.84 149.02 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 2.0099999999999998 111.215 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.36 24.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 2.6400000000000001 110.786 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 m -122.52 25.7 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 2.0299999999999998 111.153 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.36 106.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 1.8700000000000001 110.648 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 73.3 mt -97.28 84.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.474 . . . . 1.3700000000000001 110.774 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.9 -40.1 65.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 2.1499999999999999 111.563 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 139.92 30.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.527 -0.306 . . . . 1.54 110.225 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.498 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 27.5 p-10 -72.63 62.64 0.56 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.248 0.547 . . . . 1.75 111.19 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE2' ' CB ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -166.81 91.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 2.0499999999999998 108.872 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.0 t80 -126.95 165.13 19.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.176 0.512 . . . . 0.56999999999999995 111.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -123.93 121.14 34.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.505 -0.771 . . . . 1.1399999999999999 110.76 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.0 t -86.35 105.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.19 0.519 . . . . 1.72 111.43 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 p -99.18 -157.17 0.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 1.6399999999999999 110.73 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.65 17.75 42.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.95999999999999996 112.42 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 ' CD1' HG22 ' A' ' 18' ' ' VAL . 17.7 mt -81.68 -163.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.36 . . . . 2.02 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 94.9 m -144.52 154.82 43.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.996 -0.547 . . . . 1.55 110.567 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 157.96 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 1.9099999999999999 110.765 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t0 51.87 50.3 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 1.8700000000000001 110.746 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.83 124.58 5.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 1.2 111.245 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.72 124.39 26.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 1.1100000000000001 110.391 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -123.96 129.57 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.078 0.466 . . . . 1.0800000000000001 111.897 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 7.6 tt0 -104.15 150.18 24.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.956 -0.757 . . . . 1.5 108.956 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.491 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -141.21 119.65 12.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.893 1.442 . . . . 0.79000000000000004 114.893 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.553 ' CD ' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -106.41 161.74 14.31 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.223 -0.658 . . . . 2.6899999999999999 109.223 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 HG21 ' CG ' ' A' ' 8' ' ' PRO . 85.0 t -117.21 109.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.054 -0.658 . . . . 1.5700000000000001 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 87.0 mt -97.15 139.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.619 -1.252 . . . . 1.3200000000000001 107.619 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -155.05 140.68 17.97 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.572 -0.851 . . . . 1.1100000000000001 112.691 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.5 mttt -86.53 -174.63 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 2.3500000000000001 110.449 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 33.6 p30 -130.36 162.66 28.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 2.7000000000000002 110.761 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -43.18 -26.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.3400000000000001 112.22 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -81.93 -18.68 42.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.554 0.576 . . . . 1.4299999999999999 112.554 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.27 -20.43 25.78 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.407 -0.901 . . . . 1.3799999999999999 112.033 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 166.68 0.64 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.828 -0.434 . . . . 1.49 109.828 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -117.56 103.39 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.563 0.579 . . . . 1.48 112.563 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.446 ' CB ' HD12 ' A' ' 2' ' ' ILE . 1.2 p -63.03 122.46 75.26 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 108.962 -0.755 . . . . 0.81000000000000005 108.962 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.54 162.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.016 2.477 . . . . 1.25 113.098 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 33.6 Cg_endo -64.1 135.62 48.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.826 2.351 . . . . 1.2 112.747 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.434 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -78.35 124.84 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.91 -0.586 . . . . 1.76 109.555 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 4.6 mt-10 -24.85 99.59 0.08 OUTLIER Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 123.732 0.813 . . . . 1.77 113.074 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 93.7 Cg_exo -32.35 154.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.425 2.75 . . . . 1.01 114.02 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -94.07 143.85 26.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.419 -0.809 . . . . 1.55 109.388 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -34.27 138.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.217 0.948 . . . . 1.6299999999999999 111.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -75.16 117.51 17.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 1.0900000000000001 111.339 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -102.58 122.88 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 111.241 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.6 m -51.51 -25.03 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 1.1299999999999999 111.248 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 90.7 m 57.75 49.06 12.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 1.5700000000000001 110.204 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.42 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -146.82 -39.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.693 -0.685 . . . . 3.7000000000000002 111.603 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.42 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -46.21 -26.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 2.1400000000000001 111.73 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -6.09 38.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 2.0600000000000001 111.92 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 98' ' ' ARG . 11.4 p -119.98 -1.21 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 3.0800000000000001 110.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.4 ' HG2' ' HD3' ' A' ' 98' ' ' ARG . 1.9 pp20? -140.58 -50.13 0.45 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.865 -0.334 . . . . 4.5800000000000001 111.297 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.221 -0.895 . . . . 3.79 111.154 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.669 0.271 . . . . 3.1699999999999999 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.91 -159.03 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.128 2.552 . . . . 2.0600000000000001 111.883 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.474 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -170.01 145.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.26 111.002 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.1 t0 -128.65 128.44 23.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.333 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.22 157.33 57.49 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.317 2.011 . . . . 0.58999999999999997 112.633 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.63 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 1.6100000000000001 112.34 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.17 -153.9 5.85 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.954 -0.641 . . . . 0.97999999999999998 112.753 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 22' ' ' TRP . 1.7 ttpt -95.13 141.28 23.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.697 -0.112 . . . . 2.04 110.697 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 1.8 Cg_endo -86.79 143.89 7.25 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.071 2.514 . . . . 0.54000000000000004 112.285 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -159.48 125.07 2.3 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.685 -0.234 . . . . 1.6799999999999999 111.577 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 19' ' ' THR . 7.3 Cg_exo -70.92 97.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.235 1.957 . . . . 0.64000000000000001 112.714 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.449 HD12 ' CD ' ' A' ' 60' ' ' GLU . 1.7 mp -60.62 -30.4 69.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.228 0.537 . . . . 2.1699999999999999 109.982 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.404 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.4 t30 -146.73 157.33 43.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.342 -0.844 . . . . 0.84999999999999998 109.443 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -143.39 105.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.103 0.478 . . . . 1.5700000000000001 111.415 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -91.62 47.71 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.74 -0.663 . . . . 1.46 111.652 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.51 -73.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.876 0.735 . . . . 2.9100000000000001 112.07 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' THR . 16.0 m170 -81.35 -31.83 33.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 1.3300000000000001 111.718 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -125.2 105.21 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.717 0.294 . . . . 1.28 110.832 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 6.6 m -92.02 156.22 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.44 -0.346 . . . . 1.49 110.713 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.6 m -123.76 113.03 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.708 -0.223 . . . . 1.1399999999999999 111.594 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -127.06 149.31 49.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.615 0.721 . . . . 1.3100000000000001 111.265 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.309 ' CB ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -138.49 166.25 24.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.716 -1.129 . . . . 2.3100000000000001 109.847 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 8.8 p90 -141.42 -122.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.372 -0.377 . . . . 0.40000000000000002 110.852 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.53 136.47 10.53 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.499 0.59 . . . . 1.1100000000000001 111.174 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -51.8 140.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.55 -0.295 . . . . 2.5600000000000001 110.631 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.443 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 6.7 Cg_endo -48.93 -174.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.932 2.422 . . . . 1.1100000000000001 112.473 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -120.88 -34.08 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -115.78 -69.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.317 0.488 . . . . 1.6899999999999999 112.317 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.478 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 32.2 p 53.65 30.16 10.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 1.3500000000000001 110.068 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.96 -101.39 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.643 -0.789 . . . . 1.01 111.928 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.41 30.96 2.73 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.633 -0.987 . . . . 0.97999999999999998 110.633 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -110.9 -171.62 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.065 -0.567 . . . . 0.98999999999999999 111.541 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -139.94 21.8 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.769 -0.651 . . . . 2.6899999999999999 111.381 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.528 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 15.8 mm 67.45 -69.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 1.71 110.878 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p 75.97 9.66 3.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.945 -0.57 . . . . 1.6599999999999999 112.402 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.5 t 168.16 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.765 0.317 . . . . 1.97 111.686 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.528 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 38.4 m-85 -120.26 95.09 4.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 1.23 110.554 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.4 mt -70.13 152.12 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.409 -0.36 . . . . 1.76 111.347 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' A' ' 56' ' ' ILE . 2.2 t -124.63 104.43 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 1.6100000000000001 111.27 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 1.043 ' CD ' ' HB3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -76.43 115.44 16.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 1.6699999999999999 110.168 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.448 ' HG3' ' CB ' ' A' ' 51' ' ' ALA . 5.5 mtmt -93.32 149.74 21.0 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.469 0.652 . . . . 2.4399999999999999 112.484 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 8.2 ttm180 -135.02 86.18 2.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.92 -1.036 . . . . 1.79 108.969 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.734 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -64.69 87.94 0.06 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.62 -0.718 . . . . 1.5900000000000001 109.703 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.464 HD13 ' CB ' ' A' ' 94' ' ' ALA . 15.8 mt -67.95 146.56 98.31 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.976 -0.556 . . . . 1.4299999999999999 111.517 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.89 39.43 4.52 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.854 -1.311 . . . . 1.47 112.34 0.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -144.72 43.02 1.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 2.6600000000000001 111.597 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.03 -176.7 46.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.632 -0.794 . . . . 1.6200000000000001 112.339 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -167.88 30.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.641 0.258 . . . . 3.0600000000000001 111.167 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 1.043 ' HB3' ' CD ' ' A' ' 39' ' ' GLU . 24.5 m95 46.99 87.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 1.0600000000000001 111.192 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.61 135.98 49.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.998 0.428 . . . . 1.8400000000000001 111.487 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 15.9 ptmt -65.19 79.32 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 1.77 111.023 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -65.7 -43.82 88.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.555 . . . . 1.4099999999999999 111.87 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.9 p-10 -42.02 -56.6 2.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.64 -0.255 . . . . 2.0099999999999998 111.591 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 75.21 -49.94 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.984 0.364 . . . . 2.6400000000000001 111.984 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -173.7 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.954 0.407 . . . . 2.0299999999999998 111.193 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.37 107.0 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.949 -0.569 . . . . 1.8700000000000001 111.339 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.488 HG12 ' CD1' ' A' ' 61' ' ' PHE . 29.4 mt -86.35 87.84 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 1.3700000000000001 110.919 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -74.23 -45.15 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 2.1499999999999999 111.438 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.49 149.66 22.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.99 -0.374 . . . . 1.54 109.99 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.496 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.1 p30 -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 1.75 111.302 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.309 ' OE1' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tp10 -101.35 93.92 5.66 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.929 -0.767 . . . . 2.0499999999999998 108.929 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.488 ' CD1' HG12 ' A' ' 56' ' ' ILE . 66.3 t80 -118.6 164.76 14.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.974 -0.557 . . . . 0.56999999999999995 111.805 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 84.2 m -121.94 119.53 31.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 1.1399999999999999 110.564 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' CG1' ' HD3' ' A' ' 40' ' ' LYS . 57.8 t -80.76 125.61 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 1.72 111.724 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -119.8 163.33 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 1.6399999999999999 110.558 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.18 57.72 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.95999999999999996 112.138 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.54 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 2.0 mp -53.0 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.808 0.337 . . . . 2.02 110.313 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.9 m -143.77 152.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.41 . . . . 1.55 110.57 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -69.01 151.77 46.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 1.9099999999999999 111.181 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.5 OUTLIER 54.7 51.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 1.8700000000000001 111.149 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -160.77 122.6 3.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 1.2 111.332 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.86 134.76 47.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.383 -0.371 . . . . 1.1100000000000001 110.335 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.9 m-85 -128.26 119.79 25.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.782 0.66 . . . . 1.0800000000000001 112.782 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.38 136.63 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.261 -0.644 . . . . 1.5 109.261 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -133.77 119.39 19.21 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.414 1.264 . . . . 0.79000000000000004 114.414 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -95.97 162.92 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 2.6899999999999999 109.907 178.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.41 ' HB ' ' OG ' ' A' ' 89' ' ' SER . 61.8 t -113.95 128.56 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.243 0.544 . . . . 1.5700000000000001 112.206 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 mt -130.74 141.42 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.578 -1.267 . . . . 1.3200000000000001 107.578 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -157.09 127.28 6.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.81 -0.756 . . . . 1.1100000000000001 112.763 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.6 mttt -75.64 -157.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.687 -0.405 . . . . 2.3500000000000001 110.072 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.474 ' ND2' ' CD1' ' A' ' 2' ' ' ILE . 33.7 p30 -159.26 162.99 36.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 2.7000000000000002 111.515 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' A' ' 31' ' ' PHE . . . -38.54 -43.79 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.323 -0.853 . . . . 1.3400000000000001 112.816 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.526 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -66.14 -23.94 66.57 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.133 0.42 . . . . 1.4299999999999999 112.133 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 107.9 -8.19 36.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.698 -0.763 . . . . 1.3799999999999999 112.208 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.23 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.667 0.234 . . . . 1.49 110.377 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.9 OUTLIER -148.7 111.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.382 0.512 . . . . 1.48 112.382 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.6 p -70.84 110.73 7.71 Favored Pre-proline 0 C--O 1.235 0.337 0 N-CA-C 107.233 -1.395 . . . . 0.81000000000000005 107.233 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.38 171.9 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.499 2.133 . . . . 1.25 113.816 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 76.5 Cg_exo -50.42 145.0 22.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.338 2.692 . . . . 1.2 113.594 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -125.19 102.42 7.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 1.76 110.729 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.0 mm-40 12.63 108.64 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.737 1.215 . . . . 1.77 113.881 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 51.6 Cg_exo -56.05 143.67 82.54 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.437 2.092 . . . . 1.01 113.272 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -70.55 139.26 51.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.874 -0.787 . . . . 1.55 108.874 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -37.14 133.9 0.61 Allowed 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 124.254 0.971 . . . . 1.6299999999999999 111.517 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.464 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -63.85 118.56 8.54 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 1.0900000000000001 111.144 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.1 mp -98.11 111.15 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.333 -0.394 . . . . 1.1299999999999999 110.677 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 70' ' ' ALA . 22.1 m -49.36 -25.83 2.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.319 -0.4 . . . . 1.1299999999999999 110.595 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 99.6 m 49.02 81.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 1.5700000000000001 110.845 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 -85.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.35 . . . . 3.7000000000000002 110.593 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.601 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 5.2 p-10 -108.58 17.83 21.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.039 -0.528 . . . . 2.1400000000000001 110.879 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 3.7 p-10 47.18 26.55 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.061 0.458 . . . . 2.0600000000000001 111.251 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.601 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 67.2 t -119.77 -19.44 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 3.0800000000000001 111.079 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 44.42 82.37 0.03 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 4.5800000000000001 111.607 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.161 -0.923 . . . . 3.79 111.02 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.748 0.309 . . . . 3.1699999999999999 111.055 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -90.33 69.32 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.831 2.354 . . . . 2.0600000000000001 112.338 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.408 HG12 ' N ' ' A' ' 3' ' ' ASP . 5.5 tt -50.22 149.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 1.26 110.741 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.7 t70 -138.59 119.87 10.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.0 -0.545 . . . . 2.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB3' ' OG ' ' A' ' 86' ' ' SER . 61.9 Cg_endo -70.51 163.04 40.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.245 1.963 . . . . 0.58999999999999997 112.014 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 40.5 Cg_exo -57.71 -169.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.701 2.268 . . . . 1.6100000000000001 112.75 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.56 -177.19 50.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.87 -0.681 . . . . 0.97999999999999998 112.685 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.9 tttt -73.35 133.65 80.56 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.277 0.085 . . . . 2.04 110.962 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 7.6 Cg_exo -76.81 130.61 11.61 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.688 2.259 . . . . 0.54000000000000004 112.071 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.02 105.97 6.2 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.545 -0.298 . . . . 1.6799999999999999 111.759 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.2 Cg_exo -44.28 131.31 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.206 1.937 . . . . 0.64000000000000001 112.794 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' CD2' ' CB ' ' A' ' 21' ' ' LYS . 1.6 mt -90.27 -31.78 16.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.239 -1.023 . . . . 2.1699999999999999 108.239 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.4 t30 -149.7 160.82 43.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 0.84999999999999998 108.35 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -143.39 97.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.569 -0.453 . . . . 1.5700000000000001 111.598 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -87.56 49.11 1.75 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.723 -0.671 . . . . 1.46 111.708 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.76 -74.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.874 0.734 . . . . 2.9100000000000001 112.335 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.5 m-70 -72.2 -39.52 68.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.3300000000000001 111.365 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.8 p -125.71 118.05 24.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.37 . . . . 1.28 110.163 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.543 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 5.9 m -107.61 135.96 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.442 0.639 . . . . 1.49 112.368 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.0 m -90.59 144.16 26.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 1.1399999999999999 109.771 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -150.52 158.95 44.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.145 0.498 . . . . 1.3100000000000001 111.586 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' CB ' ' CD2' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -150.82 146.36 26.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.543 -0.753 . . . . 2.3100000000000001 110.792 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.0 p90 -136.18 -176.24 4.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.40000000000000002 111.064 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.7 155.9 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 1.1100000000000001 110.973 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 150.83 80.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.5600000000000001 110.699 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.483 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 92.1 Cg_exo -43.94 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.969 2.446 . . . . 1.1100000000000001 113.236 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -22.38 8.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.01 -0.541 . . . . 2.77 111.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.79 -65.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.059 0.392 . . . . 1.6899999999999999 112.059 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 14.9 p 57.73 46.07 17.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 1.3500000000000001 110.155 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.51 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.6 -0.809 . . . . 1.01 111.828 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.17 25.71 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.902 -0.879 . . . . 0.97999999999999998 110.902 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -103.68 -176.88 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.98999999999999999 111.641 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.54 1.0 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 2.6899999999999999 111.792 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.492 HG22 ' CE1' ' A' ' 36' ' ' TYR . 22.9 mt 60.26 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.125 0.488 . . . . 1.71 110.952 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -140.34 23.69 2.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 1.6599999999999999 111.711 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.33 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.741 0.645 . . . . 1.97 112.741 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' CE1' HG22 ' A' ' 33' ' ' ILE . 24.0 m-85 -105.3 85.91 2.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.031 -0.729 . . . . 1.23 109.031 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -80.98 120.87 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 1.76 111.266 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 1.4 p -112.04 129.21 67.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.06 -0.518 . . . . 1.6100000000000001 110.681 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 4.8 mt-10 -90.43 136.25 33.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.303 -0.408 . . . . 1.6699999999999999 111.17 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 3.8 pttt -98.6 150.12 22.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.989 -0.55 . . . . 2.4399999999999999 110.585 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 6.5 ttp180 -134.69 109.03 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.388 -0.369 . . . . 1.79 110.888 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -78.59 101.2 7.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 1.5900000000000001 110.608 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 3.8 mt -88.27 153.41 51.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 1.4299999999999999 111.062 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.35 17.33 42.28 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.793 -1.336 . . . . 1.47 112.739 0.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -138.21 81.01 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.931 0.396 . . . . 2.6600000000000001 111.189 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.91 -167.3 19.44 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.898 -0.668 . . . . 1.6200000000000001 112.258 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.75 159.06 37.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 3.0600000000000001 110.945 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 64.8 m95 -65.01 122.17 16.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.793 -0.639 . . . . 1.0600000000000001 111.166 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' CD2' ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -150.68 140.63 21.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.439 . . . . 1.8400000000000001 110.635 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -44.09 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.363 -0.38 . . . . 1.77 111.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -70.81 -40.89 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 1.4099999999999999 110.889 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 9.4 p-10 -68.8 -44.34 73.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.842 -0.617 . . . . 2.0099999999999998 111.287 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 54.85 22.63 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 2.6400000000000001 110.706 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -136.42 -157.01 0.75 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 2.0299999999999998 110.724 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.92 88.55 2.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.746 0.308 . . . . 1.8700000000000001 111.163 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 16.4 mm -70.39 63.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 1.3700000000000001 110.731 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.86 -56.78 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 2.1499999999999999 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.13 159.73 18.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 1.54 109.409 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.9 p30 -77.98 1.45 20.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.155 0.428 . . . . 1.75 112.155 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.43 95.18 6.31 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.902 -0.407 . . . . 2.0499999999999998 109.902 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 80.8 t80 -130.99 162.82 28.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.391 0.615 . . . . 0.56999999999999995 111.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.9 m -129.69 122.42 28.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.844 -1.071 . . . . 1.1399999999999999 108.803 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' CG2' ' CG2' ' A' ' 18' ' ' VAL . 33.5 m -80.18 108.97 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.204 0.526 . . . . 1.72 111.832 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 135.26 40.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.522 -0.763 . . . . 1.6399999999999999 110.436 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.55 -8.44 7.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.586 -0.816 . . . . 0.95999999999999996 112.681 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 33.6 mt -57.88 -162.29 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.847 0.323 . . . . 2.02 110.146 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -148.02 160.68 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.857 0.36 . . . . 1.55 111.222 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -83.82 144.5 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 1.9099999999999999 110.975 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.8 t0 63.97 59.13 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 1.8700000000000001 110.862 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -174.76 124.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 1.2 111.429 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.65 129.84 40.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.401 . . . . 1.1100000000000001 110.31 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 50.7 m-85 -123.96 118.81 27.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 1.0800000000000001 112.103 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -101.95 139.47 37.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.234 -0.654 . . . . 1.5 109.234 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.527 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.4 122.62 19.28 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.147 1.166 . . . . 0.79000000000000004 114.147 -179.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HD2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.73 152.4 19.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.058 -0.519 . . . . 2.6899999999999999 110.02 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.468 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 97.2 t -111.44 101.57 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.589 0.589 . . . . 1.5700000000000001 112.589 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.464 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 53.3 mt -98.55 155.36 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.629 -1.248 . . . . 1.3200000000000001 107.629 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.19 137.67 2.48 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.898 -1.121 . . . . 1.1100000000000001 113.253 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -78.39 -159.3 0.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 2.3500000000000001 109.482 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.569 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 33.1 p30 -139.5 -130.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.79 -0.448 . . . . 2.7000000000000002 109.79 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -110.83 -7.66 14.59 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.402 0.546 . . . . 1.3400000000000001 111.12 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -108.66 3.56 22.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.865 0.32 . . . . 1.4299999999999999 111.865 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.95 50.94 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.4 -0.905 . . . . 1.3799999999999999 112.77 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.68 126.41 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.35 . . . . 1.49 110.426 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp -85.87 110.9 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.247 -0.433 . . . . 1.48 111.669 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -68.52 124.71 90.61 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 109.393 -0.595 . . . . 0.81000000000000005 109.393 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -37.68 162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.252 2.634 . . . . 1.25 113.206 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 7.4 Cg_exo -71.79 145.96 47.15 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.699 2.266 . . . . 1.2 112.724 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 90' ' ' GLU . 12.4 m -99.05 106.33 18.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.644 -0.707 . . . . 1.76 110.555 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.4 mt-10 -1.46 107.27 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.828 1.251 . . . . 1.77 114.017 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 92.4 Cg_exo -38.49 149.2 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.782 2.321 . . . . 1.01 113.145 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.89 137.32 33.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.697 -0.853 . . . . 1.55 108.697 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -37.13 129.83 0.88 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.155 0.909 . . . . 1.6299999999999999 111.805 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -60.22 119.12 7.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 1.0900000000000001 110.963 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.409 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 4.2 mp -97.56 111.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 1.1299999999999999 110.473 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.1 m -45.68 -29.73 1.35 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.157 -0.474 . . . . 1.1299999999999999 111.294 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 63.0 m 48.05 70.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.5700000000000001 110.776 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -103.29 -99.56 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.459 -0.337 . . . . 3.7000000000000002 111.268 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 2.5 p30 -97.82 20.66 11.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 2.1400000000000001 111.008 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.462 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 38.3 t0 54.12 21.56 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 2.0600000000000001 111.156 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.464 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 7.6 p -125.9 -7.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 3.0800000000000001 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.952 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 43.85 32.18 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.923 0.392 . . . . 4.5800000000000001 111.588 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.203 -0.903 . . . . 3.79 111.087 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.562 0.22 . . . . 3.1699999999999999 111.425 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.47 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 59.6 Cg_endo -91.37 -165.6 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.884 2.389 . . . . 2.0600000000000001 112.373 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.489 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 4.4 tt -165.65 151.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 1.26 110.412 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.7 m-20 -136.93 126.17 15.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.826 -0.35 . . . . 2.0 111.92 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -58.61 171.79 1.79 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.563 2.175 . . . . 0.58999999999999997 112.015 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 52.4 Cg_endo -69.09 -178.6 2.16 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.59 2.193 . . . . 1.6100000000000001 112.36 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.78 174.35 54.82 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.897 -0.668 . . . . 0.97999999999999998 112.585 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.6 tptm -61.83 119.06 44.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 110.707 -0.109 . . . . 2.04 110.707 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 12.6 Cg_exo -70.4 146.47 56.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.161 . . . . 0.54000000000000004 112.453 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 14.8 p -143.51 112.78 5.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.015 -0.539 . . . . 1.6799999999999999 111.4 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 34.3 Cg_exo -62.69 107.93 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.727 2.285 . . . . 0.64000000000000001 113.876 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -62.68 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.658 -0.867 . . . . 2.1699999999999999 108.658 178.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.408 ' O ' HG21 ' A' ' 13' ' ' ILE . 4.1 t30 -132.79 151.16 52.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.439 -1.255 . . . . 0.84999999999999998 108.514 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.452 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -141.91 99.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.091 -0.644 . . . . 1.5700000000000001 112.266 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -90.04 134.66 34.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 1.46 110.301 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -33.88 -30.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.867 1.062 . . . . 2.9100000000000001 113.867 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.427 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 5.0 m-70 -116.51 -24.16 7.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.663 0.616 . . . . 1.3300000000000001 112.663 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 14' ' ' THR . 75.0 p -136.54 132.32 35.06 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.747 -0.464 . . . . 1.28 109.747 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' CE2' ' A' ' 74' ' ' PHE . 4.4 m -123.28 142.78 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.886 -0.726 . . . . 1.49 112.453 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.0 m -103.87 124.63 49.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.641 -0.709 . . . . 1.1399999999999999 111.994 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -135.2 151.56 50.75 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 121.687 0.755 . . . . 1.3100000000000001 111.744 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 15.8 tptm -134.43 153.64 51.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.508 -1.224 . . . . 2.3100000000000001 109.702 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 22.8 p90 -143.1 -176.35 4.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.266 0.555 . . . . 0.40000000000000002 112.182 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.4 -159.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 1.1100000000000001 110.953 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -128.13 141.66 41.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 2.5600000000000001 110.094 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 84.1 Cg_exo -42.65 168.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.228 1.952 . . . . 1.1100000000000001 112.222 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -107.89 -30.3 8.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 2.77 111.724 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.47 ' CE2' ' HG2' ' A' ' 1' ' ' PRO . 8.7 t80 -119.24 -69.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.854 0.316 . . . . 1.6899999999999999 111.854 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.488 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 18.6 p 50.92 45.34 27.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.3500000000000001 110.444 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.4 -93.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.068 -0.587 . . . . 1.01 112.683 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.28 36.18 0.7 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.515 -1.034 . . . . 0.97999999999999998 110.515 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.85 -172.81 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.908 -0.646 . . . . 0.98999999999999999 111.577 -178.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.02 23.03 4.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 2.6899999999999999 112.132 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 45.5 mm 68.82 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 111.903 0.334 . . . . 1.71 111.903 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 33' ' ' ILE . 1.7 p 87.67 -16.93 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.128 0.571 . . . . 1.6599999999999999 112.34 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.3 t 177.86 169.44 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.848 0.356 . . . . 1.97 111.861 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 5' ' ' PRO . 54.1 m-85 -140.19 105.12 4.97 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 116.075 -0.511 . . . . 1.23 111.403 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.483 ' CG2' ' CD ' ' A' ' 50' ' ' LYS . 4.9 mt -89.37 91.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.038 -0.528 . . . . 1.76 110.839 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 1.3 p -82.76 123.39 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.022 0.439 . . . . 1.6100000000000001 110.748 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -97.83 156.68 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.699 . . . . 1.6699999999999999 111.345 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.407 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.16 139.74 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 2.4399999999999999 110.62 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.4 ttm180 -121.02 113.68 20.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.181 -0.463 . . . . 1.79 110.568 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -71.48 86.93 0.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 1.5900000000000001 109.654 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.472 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -70.35 142.39 89.47 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.949 -0.569 . . . . 1.4299999999999999 110.759 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.96 47.85 1.94 Allowed 'Cis proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.182 -1.174 . . . . 1.47 112.869 0.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -158.58 60.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.679 0.276 . . . . 2.6600000000000001 111.546 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.521 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -114.79 -177.48 18.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.636 -0.792 . . . . 1.6200000000000001 112.325 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -151.6 24.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 3.0600000000000001 111.123 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 54.0 m95 51.77 95.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 1.0600000000000001 111.332 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 51' ' ' ALA . 1.2 mp -118.23 137.7 52.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 1.8400000000000001 110.328 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' CD ' ' CG2' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -45.3 93.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 1.77 111.689 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -70.09 -40.52 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 1.4099999999999999 110.306 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -63.66 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0099999999999998 110.481 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 68.96 41.08 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 2.6400000000000001 110.803 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 t -154.37 -72.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.993 -0.549 . . . . 2.0299999999999998 110.972 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 175.48 136.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.8700000000000001 110.659 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 61' ' ' PHE . 8.1 mt -140.69 79.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.3700000000000001 110.967 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.5 tp -68.62 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 2.1499999999999999 110.825 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.59 169.66 17.86 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.305 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -80.67 -2.0 44.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.293 -0.412 . . . . 1.75 111.672 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.87 102.55 13.62 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.853 0.358 . . . . 2.0499999999999998 110.33 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.488 ' CE2' ' O ' ' A' ' 62' ' ' THR . 66.5 t80 -139.02 164.05 30.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.56999999999999995 111.872 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 54.0 m -127.12 128.43 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.451 -0.795 . . . . 1.1399999999999999 109.795 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 ' CG2' HG21 ' A' ' 18' ' ' VAL . 29.7 m -91.62 128.7 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 120.221 -0.591 . . . . 1.72 112.168 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.81 127.01 55.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.546 -0.752 . . . . 1.6399999999999999 109.821 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.72 -13.04 1.97 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.521 -0.847 . . . . 0.95999999999999996 112.59 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -52.08 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.013 0.435 . . . . 2.02 110.553 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -152.53 157.07 40.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 1.55 110.601 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 4.4 mt-10 -76.76 143.76 39.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 1.9099999999999999 110.675 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 65.87 38.04 5.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.214 -0.448 . . . . 1.8700000000000001 110.929 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.41 117.3 5.5 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.565 -0.289 . . . . 1.2 111.731 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.25 121.31 21.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.655 -0.498 . . . . 1.1100000000000001 109.655 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -116.15 131.77 56.85 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 1.0800000000000001 112.696 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 1.2 tt0 -105.83 142.46 35.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.239 -1.022 . . . . 1.5 108.239 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.56 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -126.92 114.98 18.58 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.247 1.203 . . . . 0.79000000000000004 114.247 -178.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -93.5 144.87 24.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.313 -0.858 . . . . 2.6899999999999999 110.229 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG21 ' CG ' ' A' ' 8' ' ' PRO . 52.9 t -106.7 119.77 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 1.5700000000000001 112.368 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 5.9 mt -110.1 165.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.978 -1.119 . . . . 1.3200000000000001 107.978 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -179.3 130.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.965 -0.694 . . . . 1.1100000000000001 112.345 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.4 pttm -81.26 -158.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.969 -0.752 . . . . 2.3500000000000001 108.969 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.6 m-80 -155.78 167.62 29.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 2.7000000000000002 112.029 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.26 -53.25 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 1.3400000000000001 111.864 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -69.32 -5.84 25.76 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.313 0.486 . . . . 1.4299999999999999 112.313 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.94 63.31 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.39 -0.91 . . . . 1.3799999999999999 112.714 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -63.31 124.84 22.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 1.49 110.157 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -92.4 110.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.649 0.611 . . . . 1.48 112.649 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 4.5 p -74.89 120.28 80.84 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.812 -0.81 . . . . 0.81000000000000005 108.812 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 88.3 Cg_endo -70.95 172.97 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.574 2.182 . . . . 1.25 112.961 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' CA ' ' HG2' ' A' ' 75' ' ' ARG . 2.9 Cg_exo -36.93 121.56 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.395 2.73 . . . . 1.2 112.819 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' GLU . 5.1 p -107.88 104.23 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.76 111.037 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 21.6 mt-10 18.36 110.48 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.505 1.122 . . . . 1.77 113.809 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 34.5 Cg_exo -63.38 155.79 60.04 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.496 2.13 . . . . 1.01 114.374 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.5 146.11 27.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.903 -1.044 . . . . 1.55 108.839 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -32.23 143.96 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.256 0.972 . . . . 1.6299999999999999 112.478 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -79.64 114.32 18.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.428 -0.805 . . . . 1.0900000000000001 110.326 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.509 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.8 mp -99.37 110.17 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 1.1299999999999999 111.452 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.427 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 63.0 m -45.19 -39.79 6.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.044 -0.526 . . . . 1.1299999999999999 111.224 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 69' ' ' ASP . 90.9 m 54.96 106.8 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.5700000000000001 110.448 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -141.87 -75.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.987 0.423 . . . . 3.7000000000000002 110.957 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.294 ' OD2' HG11 ' A' ' 101' ' ' VAL . 3.1 p-10 -122.86 3.09 9.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.577 . . . . 2.1400000000000001 111.496 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t0 53.2 22.59 2.71 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.766 0.317 . . . . 2.0600000000000001 111.444 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.294 HG11 ' OD2' ' A' ' 99' ' ' ASP . 11.1 p -153.39 22.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 3.0800000000000001 110.931 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.541 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 1.5 mt-10 -115.88 -24.69 8.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.289 -0.414 . . . . 4.5800000000000001 111.331 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.227 -0.892 . . . . 3.79 111.183 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.721 0.296 . . . . 3.1699999999999999 111.227 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.51 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 95.0 Cg_endo -78.16 68.12 7.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.619 2.212 . . . . 2.0600000000000001 112.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -52.77 141.89 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.26 111.16 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.64 132.8 24.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 2.0 110.318 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 68.5 Cg_endo -81.86 162.38 18.54 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.157 . . . . 0.58999999999999997 112.451 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 71.4 Cg_exo -53.11 177.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.906 2.404 . . . . 1.6100000000000001 112.611 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.17 -175.58 50.15 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.043 -0.598 . . . . 0.97999999999999998 113.128 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 tmtp? -69.69 123.29 88.27 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.974 0.11 . . . . 2.04 110.848 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 10.7 Cg_exo -75.47 128.12 10.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.669 2.246 . . . . 0.54000000000000004 112.741 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' HD12 ' A' ' 11' ' ' LEU . 3.8 t -134.15 115.63 13.03 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.375 -0.375 . . . . 1.6799999999999999 111.439 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 19' ' ' THR . 22.0 Cg_exo -61.98 108.11 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.224 1.949 . . . . 0.64000000000000001 113.448 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -65.57 -41.18 93.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.46 0.648 . . . . 2.1699999999999999 109.298 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 13' ' ' ILE . 3.4 t30 -136.66 154.73 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.891 -1.05 . . . . 0.84999999999999998 109.379 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 13' ' ' ILE . 2.6 pt -143.32 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.904 0.383 . . . . 1.5700000000000001 111.22 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.82 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -101.71 56.86 0.82 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.023 -0.535 . . . . 1.46 112.266 -179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.254 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.74 -74.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.614 -0.721 . . . . 2.9100000000000001 112.754 178.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' THR . 18.0 m170 -78.28 -35.28 48.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.072 0.397 . . . . 1.3300000000000001 112.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 p -126.09 117.47 23.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.853 0.359 . . . . 1.28 110.98 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.531 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 11.3 m -110.29 141.8 24.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.0 -0.546 . . . . 1.49 111.137 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.2 m -107.33 127.99 54.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.57 . . . . 1.1399999999999999 111.768 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -133.25 156.38 47.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.371 0.605 . . . . 1.3100000000000001 111.377 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.044 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -138.14 142.93 40.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.079 -0.964 . . . . 2.3100000000000001 109.973 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 42.8 p90 -137.8 163.29 31.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.144 0.497 . . . . 0.40000000000000002 111.885 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.88 164.93 24.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 1.1100000000000001 110.318 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.82 157.15 35.13 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 2.5600000000000001 110.873 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 76.9 Cg_exo -50.34 -173.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.233 . . . . 1.1100000000000001 112.658 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.11 -25.57 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.897 -0.592 . . . . 2.77 111.829 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.51 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 10.1 t80 -129.05 -69.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.057 0.391 . . . . 1.6899999999999999 112.057 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.5 p 59.45 50.79 7.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.346 . . . . 1.3500000000000001 110.725 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.82 -98.86 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.163 -0.541 . . . . 1.01 112.64 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.05 32.74 1.66 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 109.735 -1.346 . . . . 0.97999999999999998 109.735 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.95 -169.98 1.58 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.62 -0.79 . . . . 0.98999999999999999 111.262 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 34' ' ' THR . 1.9 pttt -142.2 24.1 1.98 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 2.6899999999999999 112.008 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mm 66.44 -69.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.7 0.286 . . . . 1.71 110.902 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.6 p 87.33 -20.72 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.188 0.595 . . . . 1.6599999999999999 112.058 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 5.8 t -177.25 165.31 2.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 1.97 111.464 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE1' HG22 ' A' ' 33' ' ' ILE . 54.1 m-85 -133.75 109.1 8.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 1.23 111.073 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 37' ' ' ILE . 2.7 mt -85.33 156.26 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.22 -0.289 . . . . 1.76 110.22 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 63' ' ' VAL . 7.1 t -135.06 124.31 42.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 1.6100000000000001 111.807 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -96.51 131.56 42.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.6699999999999999 110.174 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.34 138.99 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.038 0.447 . . . . 2.4399999999999999 111.964 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -122.14 109.65 14.79 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.825 -0.625 . . . . 1.79 110.374 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD2' ' NE ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -77.15 95.67 4.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 1.5900000000000001 110.578 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -65.49 151.62 94.01 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 1.4299999999999999 111.106 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -88.79 4.12 69.96 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.803 -1.332 . . . . 1.47 113.212 0.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -77.18 -84.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.672 0.272 . . . . 2.6600000000000001 110.502 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.76 161.61 12.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.639 -0.791 . . . . 1.6200000000000001 113.326 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' NE ' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 168.72 55.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 3.0600000000000001 110.008 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 74.9 m95 -36.78 120.48 0.71 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.838 -0.619 . . . . 1.0600000000000001 112.544 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -155.49 131.1 9.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 1.8400000000000001 110.008 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 1.8 ptpt -52.11 117.41 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 1.77 110.84 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.87 -41.32 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.131 -0.486 . . . . 1.4099999999999999 111.268 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.418 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 16.9 p-10 -44.79 -48.27 10.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.373 -0.376 . . . . 2.0099999999999998 111.376 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.74 29.73 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.259 -0.428 . . . . 2.6400000000000001 111.329 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -133.39 -170.11 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 2.0299999999999998 110.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -99.69 89.29 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 1.8700000000000001 111.181 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.484 HD12 ' CE1' ' A' ' 61' ' ' PHE . 36.4 mt -86.78 72.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 1.3700000000000001 110.768 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.7 tp -63.08 -38.31 90.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 2.1499999999999999 111.455 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -100.6 160.49 14.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.379 . . . . 1.54 110.528 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.502 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -74.25 -7.92 54.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.211 -0.45 . . . . 1.75 111.323 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.044 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.3 tp10 -90.55 97.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.322 -0.621 . . . . 2.0499999999999998 109.322 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 58.4 t80 -135.79 165.35 25.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.56999999999999995 111.985 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 94.3 m -123.21 123.37 40.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.325 -0.852 . . . . 1.1399999999999999 110.281 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 38' ' ' VAL . 17.3 t -82.02 119.62 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 1.72 111.71 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.26 145.36 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.792 -0.64 . . . . 1.6399999999999999 110.663 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.03 -19.35 5.48 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.746 -0.74 . . . . 0.95999999999999996 112.171 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -55.9 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.666 0.27 . . . . 2.02 110.46 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -157.88 143.58 17.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.848 0.356 . . . . 1.55 110.765 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.92 129.88 27.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.063 -0.517 . . . . 1.9099999999999999 111.127 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.61 66.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.073 -0.512 . . . . 1.8700000000000001 111.397 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -175.5 118.44 0.16 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 1.2 111.468 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.54 129.73 40.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 1.1100000000000001 109.519 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 73.3 m-85 -128.87 124.46 35.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.053 0.76 . . . . 1.0800000000000001 113.053 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' CG ' ' HB1' ' A' ' 94' ' ' ALA . 10.5 mt-10 -103.52 142.36 34.41 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.498 -0.927 . . . . 1.5 108.498 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -133.15 111.98 11.36 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.478 1.288 . . . . 0.79000000000000004 114.478 -178.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.498 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.01 157.39 16.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.495 -0.928 . . . . 2.6899999999999999 108.495 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.479 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -125.21 124.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.535 -0.866 . . . . 1.5700000000000001 112.878 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.458 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 63.6 mt -108.03 139.71 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.407 -1.331 . . . . 1.3200000000000001 107.407 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -149.18 117.52 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.529 -0.869 . . . . 1.1100000000000001 112.603 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.4 ptpt -71.57 -172.73 0.82 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.191 -0.459 . . . . 2.3500000000000001 110.149 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.487 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 5.1 m-80 -135.09 168.08 19.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.263 0.554 . . . . 2.7000000000000002 111.915 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 31' ' ' PHE . . . -41.59 -44.04 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 1.3400000000000001 111.828 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.69 -18.0 58.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 1.4299999999999999 111.998 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 113.68 -16.75 21.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.551 -0.833 . . . . 1.3799999999999999 112.1 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 123.46 8.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.663 0.268 . . . . 1.49 110.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.3 tp -87.91 109.81 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.694 0.627 . . . . 1.48 112.694 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.7 p -68.58 107.34 1.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 107.811 -1.181 . . . . 0.81000000000000005 107.811 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.0 Cg_endo -45.98 155.41 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.091 . . . . 1.25 112.841 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 2.3 Cg_endo -45.18 128.76 9.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.372 2.714 . . . . 1.2 113.483 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.1 p -97.43 109.14 21.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.364 -0.835 . . . . 1.76 109.862 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 7.6 mt-10 1.72 119.22 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.093 0 O-C-N 124.858 1.349 . . . . 1.77 113.927 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.7 Cg_exo -62.18 139.97 81.0 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.051 . . . . 1.01 113.768 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.89 144.3 57.18 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.063 -0.718 . . . . 1.55 109.063 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -40.43 134.2 1.75 Allowed 'General case' 0 C--N 1.333 -0.11 0 O-C-N 124.006 0.816 . . . . 1.6299999999999999 111.633 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' A' ' 43' ' ' LEU . . . -60.68 127.09 29.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 1.0900000000000001 111.255 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.519 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.0 mp -109.4 114.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.364 -0.38 . . . . 1.1299999999999999 110.478 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.414 HG22 ' NH1' ' A' ' 98' ' ' ARG . 65.2 m -48.13 -39.04 19.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.929 0.395 . . . . 1.1299999999999999 111.03 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 78.9 m 60.29 65.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.246 -0.434 . . . . 1.5700000000000001 110.881 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.64 ' HD3' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -107.63 -89.53 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.784 0.326 . . . . 3.7000000000000002 110.52 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.714 ' OD1' ' HB ' ' A' ' 101' ' ' VAL . 3.6 p30 -102.27 12.82 36.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.412 -0.358 . . . . 2.1400000000000001 110.635 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.254 ' OD1' ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER 48.96 25.06 0.97 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.864 0.364 . . . . 2.0600000000000001 111.189 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.714 ' HB ' ' OD1' ' A' ' 99' ' ' ASP . 15.7 t -131.43 -7.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 3.0800000000000001 112.071 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.988 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 39.44 83.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.062 0.458 . . . . 4.5800000000000001 112.186 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.236 -0.888 . . . . 3.79 111.157 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.459 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 111.665 0.246 . . . . 3.1699999999999999 111.665 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 0' ' ' SER . 14.1 Cg_exo -69.11 -163.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.592 2.194 . . . . 2.0600000000000001 112.053 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 84' ' ' ALA . 2.7 tt -166.02 143.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.26 110.874 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.39 128.53 18.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.618 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 157.02 43.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.394 2.062 . . . . 0.58999999999999997 112.161 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.55 -164.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.801 2.334 . . . . 1.6100000000000001 113.228 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.94 -175.41 44.02 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.423 -0.808 . . . . 0.97999999999999998 112.799 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -78.08 134.64 63.41 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 110.382 -0.229 . . . . 2.04 110.382 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 3.0 Cg_exo -79.04 147.04 20.72 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.652 2.234 . . . . 0.54000000000000004 112.83 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 11.2 p -138.69 115.06 8.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.625 -0.716 . . . . 1.6799999999999999 110.647 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.7 Cg_exo -63.34 112.74 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.201 1.934 . . . . 0.64000000000000001 113.149 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER -76.9 -40.37 47.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.305 0.574 . . . . 2.1699999999999999 109.848 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.22 114.01 13.95 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.233 -0.894 . . . . 0.84999999999999998 109.215 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.423 ' CG2' ' HB2' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -113.0 126.26 70.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.73 0.641 . . . . 1.5700000000000001 112.73 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.405 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -116.63 144.7 44.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.339 -0.846 . . . . 1.46 109.674 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -52.29 -18.36 1.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.94 0.719 . . . . 2.9100000000000001 112.94 -178.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.426 ' O ' ' CG2' ' A' ' 17' ' ' THR . 3.1 m-70 -124.33 -7.75 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.543 0.571 . . . . 1.3300000000000001 112.543 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.449 ' CA ' HD11 ' A' ' 66' ' ' LEU . 77.8 p -161.0 124.7 3.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.408 -0.219 . . . . 1.28 110.408 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 74' ' ' PHE . 3.9 m -113.88 156.79 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.253 -0.579 . . . . 1.49 112.066 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.5 m -125.2 123.01 38.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.1 -0.5 . . . . 1.1399999999999999 110.943 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -130.64 162.13 30.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.731 0.777 . . . . 1.3100000000000001 112.454 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -136.1 159.01 43.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.502 -1.226 . . . . 2.3100000000000001 109.762 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.515 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 19.7 p90 -149.4 -175.8 5.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.40000000000000002 112.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.39 -173.99 4.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.617 -0.72 . . . . 1.1100000000000001 112.072 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -120.94 140.58 31.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.289 -0.869 . . . . 2.5600000000000001 110.272 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.469 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 83.9 Cg_exo -46.07 175.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.43 2.087 . . . . 1.1100000000000001 112.578 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -21.01 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 2.77 111.687 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.52 -68.71 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.991 0.367 . . . . 1.6899999999999999 111.991 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.487 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.2 p 51.79 49.62 20.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 1.3500000000000001 110.496 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.75 -94.11 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.057 -0.592 . . . . 1.01 112.825 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.32 43.27 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.472 -1.051 . . . . 0.97999999999999998 110.472 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -122.32 -168.97 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.458 . . . . 0.98999999999999999 111.487 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.35 20.68 1.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.619 0.6 . . . . 2.6899999999999999 112.619 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.6 mp 59.61 -85.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.927 -0.309 . . . . 1.71 110.483 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' A' ' 35' ' ' SER . 1.2 p 77.59 30.84 0.47 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.982 0.364 . . . . 1.6599999999999999 111.982 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.5 OUTLIER 160.95 146.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.368 -0.378 . . . . 1.97 110.362 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -140.1 117.12 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.022 0.439 . . . . 1.23 111.679 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 23.9 mt -85.43 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 1.76 110.346 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -109.53 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.158 0.429 . . . . 1.6100000000000001 112.158 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.718 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 4.6 mm-40 -64.22 132.59 50.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.382 -0.599 . . . . 1.6699999999999999 109.382 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -114.75 134.53 55.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 2.4399999999999999 111.718 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.0 ttm180 -113.92 111.9 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.599 -0.728 . . . . 1.79 110.007 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.823 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.96 108.7 13.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 1.5900000000000001 110.902 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 1.2 mm? -84.34 143.68 42.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.436 -0.347 . . . . 1.4299999999999999 110.985 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 63.5 Cg_endo -98.43 45.34 2.67 Favored 'Cis proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.36 -1.1 . . . . 1.47 112.755 0.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 m-80 -153.1 58.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 2.6600000000000001 111.306 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -116.05 167.57 12.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.848 -0.691 . . . . 1.6200000000000001 112.762 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.35 27.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.001 0.429 . . . . 3.0600000000000001 110.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.476 ' CH2' ' HB3' ' A' ' 91' ' ' PRO . 72.3 m95 53.23 110.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 1.0600000000000001 111.638 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.32 118.4 10.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.233 -0.44 . . . . 1.8400000000000001 110.459 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.718 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 7.2 ptpt -49.69 118.0 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.181 0.515 . . . . 1.77 111.2 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . . . -102.37 -40.29 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 1.4099999999999999 110.956 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -40.28 -48.27 2.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 2.0099999999999998 111.765 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 43.19 44.02 4.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.372 -0.376 . . . . 2.6400000000000001 111.721 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.1 p -162.46 158.49 23.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 2.0299999999999998 110.912 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' ND2' HD21 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.8 105.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 1.8700000000000001 110.681 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CG ' ' A' ' 61' ' ' PHE . 53.5 mt -100.19 63.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 1.3700000000000001 110.261 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD21 ' ND2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -41.94 -76.22 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.566 -0.743 . . . . 2.1499999999999999 111.821 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -64.82 170.02 4.6 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.772 0.32 . . . . 1.54 110.147 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.515 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 43.7 p30 -88.8 13.4 12.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.403 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 49.3 tt0 -111.55 107.3 16.42 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.621 -0.511 . . . . 2.0499999999999998 109.621 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 62' ' ' THR . 58.6 t80 -142.49 164.97 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.56999999999999995 112.049 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.491 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 30.5 m -125.02 122.9 38.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.581 -0.736 . . . . 1.1399999999999999 110.8 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' CG2' HG21 ' A' ' 18' ' ' VAL . 3.7 m -91.53 96.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 120.24 -0.584 . . . . 1.72 110.714 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.425 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 0.8 OUTLIER -82.85 -165.28 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 1.6399999999999999 110.885 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.89 20.44 59.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.685 -0.769 . . . . 0.95999999999999996 112.371 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.543 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 69.9 mt -74.28 -176.58 2.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.848 0.356 . . . . 2.02 110.75 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 m -132.68 154.9 49.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 1.55 110.875 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 22.9 tt0 -88.28 160.22 17.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 1.9099999999999999 110.906 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.874 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 52.33 43.59 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 1.8700000000000001 110.858 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -158.45 120.7 3.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 1.2 111.33 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -69.36 132.68 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 1.1100000000000001 110.107 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 48.3 m-85 -125.69 118.97 26.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.681 0.622 . . . . 1.0800000000000001 112.681 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 5.1 mt-10 -99.45 142.95 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.46 -0.941 . . . . 1.5 108.46 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -125.81 115.1 19.49 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.289 1.218 . . . . 0.79000000000000004 114.289 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 2.5 ttp85 -94.91 139.49 31.26 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.341 -0.845 . . . . 2.6899999999999999 109.537 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.458 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 80.6 t -106.98 138.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.71 0.767 . . . . 1.5700000000000001 112.349 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 77' ' ' ILE . 29.0 mt -134.66 156.64 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.557 -1.646 . . . . 1.3200000000000001 106.557 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.42 121.07 0.84 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.652 -1.219 . . . . 1.1100000000000001 112.987 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mmtt -61.91 -173.33 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.003 -0.679 . . . . 2.3500000000000001 109.725 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.482 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 5.4 m120 -136.8 161.2 36.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.033 0.444 . . . . 2.7000000000000002 110.908 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -36.87 -30.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.155 0.798 . . . . 1.3400000000000001 113.155 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -109.73 24.37 13.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.979 0.733 . . . . 1.4299999999999999 112.979 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.17 -11.1 51.1 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.561 -0.828 . . . . 1.3799999999999999 113.222 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -53.82 102.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.946 0.373 . . . . 1.49 110.217 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -70.0 104.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.444 0.535 . . . . 1.48 112.444 -179.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.5 p -65.96 111.74 7.21 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.777 -0.823 . . . . 0.81000000000000005 108.777 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 72.6 Cg_exo -48.8 -179.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.236 2.624 . . . . 1.25 114.311 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 68.1 Cg_exo -52.61 144.17 43.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.404 2.736 . . . . 1.2 113.544 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 10.9 m -123.04 122.05 37.55 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.906 -0.588 . . . . 1.76 110.505 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -18.53 102.47 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.161 0.985 . . . . 1.77 113.36 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 76.2 Cg_exo -48.42 169.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.043 2.495 . . . . 1.01 114.93 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.88 142.28 28.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.178 -1.374 . . . . 1.55 109.784 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -44.85 133.61 6.11 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.77 0.669 . . . . 1.6299999999999999 110.457 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . -65.07 119.65 11.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.984 -0.553 . . . . 1.0900000000000001 111.754 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.483 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.0 mp -97.37 109.55 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 1.1299999999999999 110.408 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 13.6 m -46.89 -37.63 9.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.363 -0.38 . . . . 1.1299999999999999 111.379 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 3.0 m 52.76 88.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.371 . . . . 1.5700000000000001 110.227 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -134.75 -91.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.63 -0.259 . . . . 3.7000000000000002 111.113 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -91.45 -6.1 53.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.625 -0.261 . . . . 2.1400000000000001 111.421 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.31 24.66 14.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.973 0.416 . . . . 2.0600000000000001 111.122 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.1 t -114.91 -21.2 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.979 -0.555 . . . . 3.0800000000000001 110.786 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.909 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 57.6 83.35 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.012 0.434 . . . . 4.5800000000000001 111.103 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.208 -0.901 . . . . 3.79 111.101 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.719 0.295 . . . . 3.1699999999999999 111.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.429 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 87.2 Cg_endo -87.81 122.51 1.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.919 2.413 . . . . 2.0600000000000001 112.659 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -99.8 145.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 1.26 110.391 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.7 142.31 45.06 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 2.0 111.53 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 87.0 Cg_endo -83.44 161.79 14.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.84 2.36 . . . . 0.58999999999999997 112.276 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.53 177.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.597 2.198 . . . . 1.6100000000000001 112.625 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.01 -176.69 51.06 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.036 -0.602 . . . . 0.97999999999999998 113.309 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -66.64 127.32 93.34 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 122.197 0.199 . . . . 2.04 110.79 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 4.9 Cg_exo -80.34 135.9 10.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.532 2.155 . . . . 0.54000000000000004 112.797 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 10.7 p -137.11 114.0 9.79 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.786 -0.643 . . . . 1.6799999999999999 110.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 69.3 Cg_exo -48.52 135.02 26.9 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.144 1.896 . . . . 0.64000000000000001 113.123 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.06 -30.37 12.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 2.1699999999999999 110.061 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.99 121.61 4.45 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.319 -0.855 . . . . 0.84999999999999998 109.356 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.37 132.68 61.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.828 0.677 . . . . 1.5700000000000001 112.828 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.88 151.46 46.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.879 -1.055 . . . . 1.46 109.68 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.467 ' HG2' ' CA ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -57.74 -18.1 19.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.339 -0.391 . . . . 2.9100000000000001 111.706 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.421 ' O ' ' CG2' ' A' ' 17' ' ' THR . 4.5 m-70 -131.44 18.75 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.811 0.3 . . . . 1.3300000000000001 111.811 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -178.56 114.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 1.28 111.422 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' CG1' ' CE2' ' A' ' 74' ' ' PHE . 81.3 t -104.82 135.13 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.001 -0.545 . . . . 1.49 110.178 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 61.6 m -111.52 132.27 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 1.1399999999999999 110.661 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -140.83 143.19 34.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.96 0.886 . . . . 1.3100000000000001 111.766 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -123.79 134.92 53.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.955 -1.475 . . . . 2.3100000000000001 109.51 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 35.7 p90 -126.4 172.0 10.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 0.40000000000000002 111.196 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.83 -157.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.762 -0.654 . . . . 1.1100000000000001 110.84 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.75 159.31 69.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.47 -0.332 . . . . 2.5600000000000001 110.607 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 55.4 Cg_endo -70.38 169.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.104 1.87 . . . . 1.1100000000000001 111.815 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.33 -19.84 11.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.196 0.443 . . . . 2.77 112.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CE1' ' HG2' ' A' ' 1' ' ' PRO . 2.7 t80 -112.74 -74.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.343 0.498 . . . . 1.6899999999999999 112.343 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.494 ' CG2' ' CG ' ' A' ' 25' ' ' PRO . 11.9 p 47.31 57.76 5.5 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.527 0.203 . . . . 1.3500000000000001 110.704 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.75 -95.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.966 -0.635 . . . . 1.01 112.384 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -148.69 27.56 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.693 -0.963 . . . . 0.97999999999999998 110.693 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CE1' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.22 -177.56 3.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.471 . . . . 0.98999999999999999 111.477 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.88 5.24 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 2.6899999999999999 111.319 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 33' ' ' ILE . 22.8 mt 60.53 145.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 1.71 110.605 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -133.31 18.27 4.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.842 0.312 . . . . 1.6599999999999999 111.842 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -179.96 151.23 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.168 0.509 . . . . 1.97 111.971 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 60.3 m-85 -134.4 100.31 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.736 . . . . 1.23 110.002 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.43 114.62 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 1.76 111.008 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -103.61 106.28 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.35 0.595 . . . . 1.6100000000000001 110.596 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 25.2 mt-10 -75.31 154.92 37.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.251 -0.886 . . . . 1.6699999999999999 111.212 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -117.07 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.4399999999999999 111.134 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 2.8 ttm180 -112.85 101.65 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 1.79 109.788 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -68.54 141.47 55.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.848 -0.614 . . . . 1.5900000000000001 110.622 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 6.9 mt -126.87 153.71 76.12 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 1.4299999999999999 111.252 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.8 24.08 8.27 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.962 -1.266 . . . . 1.47 113.616 0.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -154.46 100.25 2.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.363 . . . . 2.6600000000000001 110.903 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -165.9 167.9 39.42 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.84 -0.695 . . . . 1.6200000000000001 112.419 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.14 148.43 52.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 3.0600000000000001 111.188 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 72.1 m95 -55.45 105.88 0.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.156 -0.474 . . . . 1.0600000000000001 111.227 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' N ' ' HB3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -134.2 122.54 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 1.8400000000000001 110.354 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -44.47 118.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 1.77 111.346 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -103.84 -9.83 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 1.4099999999999999 111.993 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 12.6 p-10 -77.71 -54.72 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.201 -0.2 . . . . 2.0099999999999998 111.467 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 38.34 35.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.999 0.37 . . . . 2.6400000000000001 111.999 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 26.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.442 -0.345 . . . . 2.0299999999999998 111.42 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.24 130.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.378 . . . . 1.8700000000000001 111.211 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' CD1' ' A' ' 61' ' ' PHE . 48.1 mt -129.99 84.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 1.3700000000000001 110.633 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.34 -43.79 76.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 2.1499999999999999 111.985 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.45 154.74 17.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.834 0.349 . . . . 1.54 110.866 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -72.81 -4.59 32.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 1.75 111.672 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -96.86 98.2 9.92 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.167 -0.679 . . . . 2.0499999999999998 109.167 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.52 ' CG ' ' N ' ' A' ' 62' ' ' THR . 69.8 t80 -128.48 164.53 22.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.452 0.644 . . . . 0.56999999999999995 112.146 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -125.76 114.87 19.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.077 -0.965 . . . . 1.1399999999999999 110.783 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.3 t -77.66 109.09 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 1.72 110.817 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.77 151.45 26.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 1.6399999999999999 111.055 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.93 4.57 10.27 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.574 -0.739 . . . . 0.95999999999999996 112.396 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -68.54 -167.19 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.947 0.403 . . . . 2.02 110.918 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -150.25 139.32 21.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 1.55 110.76 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE1' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -58.86 130.45 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.9099999999999999 111.063 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t0 76.16 49.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 1.8700000000000001 111.277 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -160.03 127.42 4.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 1.2 111.356 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.24 134.23 41.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.218 -0.446 . . . . 1.1100000000000001 110.134 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 54.6 m-85 -133.2 125.2 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.798 0.666 . . . . 1.0800000000000001 112.798 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.12 150.06 22.88 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.04 -0.726 . . . . 1.5 109.04 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.463 ' CE2' ' CG1' ' A' ' 18' ' ' VAL . 1.4 m-85 -134.71 117.24 15.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.146 1.165 . . . . 0.79000000000000004 114.146 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 24.1 ttm-85 -111.82 159.5 18.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.132 -0.94 . . . . 2.6899999999999999 109.412 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -136.88 144.83 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.982 0.896 . . . . 1.5700000000000001 112.803 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 78' ' ' ALA . 22.8 mt -130.32 145.19 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.828 -1.533 . . . . 1.3200000000000001 107.655 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -145.87 130.62 18.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.586 -0.846 . . . . 1.1100000000000001 112.575 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -91.77 123.96 35.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 2.3500000000000001 111.308 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.4 p-10 -66.28 -174.82 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.851 . . . . 2.7000000000000002 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -65.68 -26.04 67.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.844 -0.616 . . . . 1.3400000000000001 112.063 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -88.19 1.47 54.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.435 0.531 . . . . 1.4299999999999999 112.435 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.8 79.76 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.369 -0.919 . . . . 1.3799999999999999 113.078 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' O ' HD13 ' A' ' 2' ' ' ILE . . . -77.31 68.08 3.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.239 0.543 . . . . 1.49 109.616 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -27.47 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 114.695 1.369 . . . . 1.48 114.695 -178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 10.7 p -75.29 106.81 3.2 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.491 -1.67 . . . . 0.81000000000000005 106.491 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 9.8 Cg_endo -50.32 169.08 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.88 2.387 . . . . 1.25 114.605 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 72.6 Cg_exo -31.04 136.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.251 3.3 . . . . 1.2 114.078 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 2.8 p -122.01 103.2 8.65 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.589 -0.732 . . . . 1.76 109.972 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -1.8 120.16 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.014 1.326 . . . . 1.77 113.872 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 4.6 Cg_exo -76.77 163.5 31.35 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.268 1.978 . . . . 1.01 113.882 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 2.0 t -90.97 146.71 23.64 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.002 -0.999 . . . . 1.55 109.401 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -38.75 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 O-C-N 123.72 0.637 . . . . 1.6299999999999999 111.596 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -87.43 120.92 29.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.033 -0.53 . . . . 1.0900000000000001 111.532 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mp -98.55 114.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.1299999999999999 111.073 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 70' ' ' ALA . 38.2 m -47.89 -28.68 2.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.839 -0.618 . . . . 1.1299999999999999 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.869 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 m 50.14 60.6 3.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 1.5700000000000001 110.973 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.702 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -95.41 -74.17 0.56 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.933 0.397 . . . . 3.7000000000000002 111.147 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.497 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 7.2 p-10 -131.08 20.0 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.974 -0.557 . . . . 2.1400000000000001 111.633 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' CB ' ' HD2' ' A' ' 15' ' ' ARG . 42.4 t0 44.07 24.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.649 0.611 . . . . 2.0600000000000001 112.649 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 28.1 t -143.75 15.41 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 3.0800000000000001 111.416 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.443 ' HB2' ' CD ' ' A' ' 98' ' ' ARG . 17.7 mm-40 -113.92 -17.47 12.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.346 . . . . 4.5800000000000001 111.238 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.217 -0.897 . . . . 3.79 110.93 -179.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.58 0.229 . . . . 3.1699999999999999 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.06 -153.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.562 2.175 . . . . 2.0600000000000001 111.967 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.9 tt -164.81 147.19 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 1.26 111.274 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.425 ' N ' HG12 ' A' ' 2' ' ' ILE . 23.9 m-20 -132.22 129.97 21.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 2.0 110.475 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.22 157.98 15.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.532 2.155 . . . . 0.58999999999999997 112.604 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.418 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 4.5 Cg_endo -48.35 -177.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.122 2.548 . . . . 1.6100000000000001 113.514 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 168.78 29.26 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.53 -0.759 . . . . 0.97999999999999998 112.957 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -53.39 128.13 50.18 Favored Pre-proline 0 CA--C 1.53 0.197 0 O-C-N 122.987 -0.126 . . . . 2.04 110.811 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 11.8 Cg_exo -74.98 113.95 3.91 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.506 2.137 . . . . 0.54000000000000004 112.701 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 14.7 p -104.72 107.76 59.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 1.6799999999999999 110.652 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 27.2 Cg_exo -61.7 105.71 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.525 2.15 . . . . 0.64000000000000001 113.789 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -63.22 -32.92 74.44 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.89 -0.782 . . . . 2.1699999999999999 108.89 178.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.99 143.92 32.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.878 -1.055 . . . . 0.84999999999999998 109.061 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.409 HG23 HG12 ' A' ' 95' ' ' ILE . 3.2 pt -138.74 81.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.146 0.424 . . . . 1.5700000000000001 112.146 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.268 HG21 ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -79.97 151.44 30.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 1.46 110.237 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -56.48 -20.67 21.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.982 -0.554 . . . . 2.9100000000000001 111.877 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.86 11.4 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.252 0.464 . . . . 1.3300000000000001 112.252 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -169.85 115.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 1.28 110.709 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 74' ' ' PHE . 24.9 t -109.83 119.51 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.061 0.458 . . . . 1.49 111.232 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 11.0 m -99.8 124.77 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.675 -0.693 . . . . 1.1399999999999999 110.811 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.18 150.33 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.805 0.812 . . . . 1.3100000000000001 112.315 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -132.35 154.35 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.313 -1.312 . . . . 2.3100000000000001 109.798 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.4 p90 -142.21 -176.05 4.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.278 0.561 . . . . 0.40000000000000002 112.397 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.65 24.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.44 -0.8 . . . . 1.1100000000000001 111.154 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 4.0 tmmm? -84.91 139.21 37.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 2.5600000000000001 110.758 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 93.0 Cg_exo -43.84 160.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.216 1.944 . . . . 1.1100000000000001 111.837 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -106.94 -15.92 14.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.77 111.749 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 -70.62 0.7 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.863 0.32 . . . . 1.6899999999999999 111.863 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.423 HG21 ' CB ' ' A' ' 25' ' ' PRO . 14.4 p 50.59 54.78 10.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.971 0.415 . . . . 1.3500000000000001 110.382 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.33 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.927 -0.579 . . . . 1.01 112.55 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.66 24.06 2.77 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.35 -0.7 . . . . 0.97999999999999998 111.35 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.548 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -92.04 -176.64 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 0.98999999999999999 111.923 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -130.87 -13.48 3.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.646 -0.706 . . . . 2.6899999999999999 112.209 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 33' ' ' ILE . 11.4 mt 64.1 132.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.701 -0.481 . . . . 1.71 109.701 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -124.42 11.82 8.69 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.575 0.583 . . . . 1.6599999999999999 112.575 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 146.35 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.999 0.428 . . . . 1.97 112.138 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' HH ' ' HG2' ' A' ' 24' ' ' LYS . 51.1 m-85 -118.52 122.16 42.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.717 -0.674 . . . . 1.23 109.972 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -107.85 129.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 1.76 110.765 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -119.28 130.22 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 1.6100000000000001 110.584 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.5 mt-10 -94.54 136.66 34.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.442 -0.799 . . . . 1.6699999999999999 110.668 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -99.94 159.36 15.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 2.4399999999999999 111.112 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -140.73 105.29 4.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.543 . . . . 1.79 110.546 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.685 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -75.11 80.41 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.5900000000000001 110.97 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD22 ' CB ' ' A' ' 94' ' ' ALA . 1.2 mm? -65.63 155.82 84.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 1.4299999999999999 110.763 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -91.81 36.7 5.99 Favored 'Cis proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.063 -1.224 . . . . 1.47 112.639 0.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -162.18 57.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.923 0.392 . . . . 2.6600000000000001 111.11 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.685 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -127.05 172.79 18.51 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.973 -0.632 . . . . 1.6200000000000001 112.156 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.62 51.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.217 0.532 . . . . 3.0600000000000001 111.348 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.543 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 50.5 m95 -60.94 124.05 19.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.391 -0.822 . . . . 1.0600000000000001 110.527 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.95 124.05 6.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.841 0.353 . . . . 1.8400000000000001 111.295 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -50.95 115.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.77 110.537 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.26 -35.22 10.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 1.4099999999999999 111.545 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 7.1 p-10 -53.54 -62.5 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.316 . . . . 2.0099999999999998 111.85 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 3.5 t80 80.05 -51.39 0.37 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.544 0.211 . . . . 2.6400000000000001 111.259 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -64.04 -171.31 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.886 0.374 . . . . 2.0299999999999998 110.975 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.2 106.13 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 1.8700000000000001 110.814 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 56' ' ' ILE . 26.4 mt -92.42 74.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 1.3700000000000001 111.268 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -73.65 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 2.1499999999999999 111.018 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.51 174.12 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.54 110.189 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 44.4 p30 -92.86 17.38 10.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.267 -0.424 . . . . 1.75 111.452 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.69 103.01 9.28 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.049 -0.352 . . . . 2.0499999999999998 110.049 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 52' ' ' ASN . 59.1 t80 -134.68 164.18 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.068 0.461 . . . . 0.56999999999999995 111.537 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 17.3 m -122.03 119.68 32.12 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.672 -0.694 . . . . 1.1399999999999999 111.152 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.3 t -86.92 97.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.995 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.28 150.74 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.665 -0.698 . . . . 1.6399999999999999 110.951 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.57 7.45 8.92 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.711 -0.677 . . . . 0.95999999999999996 112.338 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 HD13 ' CD2' ' A' ' 72' ' ' TYR . 4.4 mm? -51.81 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.018 0.437 . . . . 2.02 110.928 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 m -142.71 111.01 6.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.813 -0.631 . . . . 1.55 110.112 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.0 138.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.9099999999999999 111.869 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.79 56.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.897 -0.592 . . . . 1.8700000000000001 111.583 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.44 123.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 1.2 111.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.12 134.43 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 1.1100000000000001 110.536 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.503 ' CD2' HD13 ' A' ' 66' ' ' LEU . 49.4 m-85 -130.6 118.89 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.317 0.488 . . . . 1.0800000000000001 112.317 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -100.08 143.09 30.69 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.311 -0.626 . . . . 1.5 109.311 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CE2' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -139.57 119.89 13.86 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.486 1.291 . . . . 0.79000000000000004 114.486 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.06 173.57 6.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.444 -0.947 . . . . 2.6899999999999999 108.444 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.85 113.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 114.116 1.154 . . . . 1.5700000000000001 114.116 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.434 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 41.6 mt -97.32 154.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 106.479 -1.674 . . . . 1.3200000000000001 106.479 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -168.16 128.27 1.29 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.434 -0.906 . . . . 1.1100000000000001 111.656 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 20.6 mttt -63.57 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.047 -0.723 . . . . 2.3500000000000001 109.047 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.548 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 2.1 m-80 -146.01 -94.21 0.09 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.66 -0.416 . . . . 2.7000000000000002 110.925 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -137.15 -42.28 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 1.3400000000000001 110.952 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.18 30.45 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.4299999999999999 111.996 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.16 -12.37 58.34 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.541 -0.838 . . . . 1.3799999999999999 113.353 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.11 115.75 2.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.973 0.386 . . . . 1.49 110.894 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -87.78 104.37 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.034 0.445 . . . . 1.48 111.519 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' CB ' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -68.65 119.76 71.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 109.803 -0.443 . . . . 0.81000000000000005 109.803 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.24 162.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.177 2.585 . . . . 1.25 113.122 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 36.7 Cg_endo -66.26 142.3 66.19 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.695 2.263 . . . . 1.2 112.409 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 90' ' ' GLU . 45.8 m -94.59 105.32 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 1.76 110.332 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 89' ' ' SER . 3.5 tt0 -4.27 115.27 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 124.705 1.202 . . . . 1.77 113.681 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.2 Cg_exo -56.2 141.8 87.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.125 1.883 . . . . 1.01 113.6 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 15.7 m -72.31 143.17 48.79 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.753 -0.832 . . . . 1.55 108.753 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -41.12 137.27 1.36 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.768 0.668 . . . . 1.6299999999999999 110.752 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' CB ' HD22 ' A' ' 43' ' ' LEU . . . -62.85 117.76 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.036 -0.529 . . . . 1.0900000000000001 111.779 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.495 HD12 ' CE2' ' A' ' 74' ' ' PHE . 3.9 mp -92.35 110.82 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.615 -0.72 . . . . 1.1299999999999999 110.422 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 1.198 ' HB ' ' OE2' ' A' ' 102' ' ' GLU . 26.0 m -46.95 -39.04 11.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.919 0.39 . . . . 1.1299999999999999 110.655 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.1 m 61.46 89.13 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.504 . . . . 1.5700000000000001 110.91 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.543 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.4 -82.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 3.7000000000000002 110.672 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.088 ' OD2' HG11 ' A' ' 101' ' ' VAL . 11.7 p-10 -96.02 30.28 2.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.752 -0.658 . . . . 2.1400000000000001 110.653 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.268 ' CG ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER 44.58 26.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 2.0600000000000001 112.036 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.088 HG11 ' OD2' ' A' ' 99' ' ' ASP . 7.7 p -164.4 25.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.658 -0.701 . . . . 3.0800000000000001 110.393 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.198 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 6.3 mm-40 31.88 54.39 0.29 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.656 -0.702 . . . . 4.5800000000000001 112.646 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB1' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.252 -0.88 . . . . 3.79 111.143 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.423 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.674 0.273 . . . . 3.1699999999999999 111.146 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 65.0 Cg_endo -74.35 -167.6 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.65 2.234 . . . . 2.0600000000000001 112.552 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.63 149.72 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 1.26 110.657 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.74 151.57 68.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 2.0 111.773 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.71 164.62 12.1 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.907 2.405 . . . . 0.58999999999999997 112.043 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.33 -164.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.501 2.134 . . . . 1.6100000000000001 112.637 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.34 -153.59 27.95 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.939 -0.648 . . . . 0.97999999999999998 113.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.09 125.05 61.7 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.407 0.146 . . . . 2.04 111.008 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 23.3 Cg_exo -66.52 130.89 24.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.489 2.126 . . . . 0.54000000000000004 112.327 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.05 98.42 17.38 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.163 -0.471 . . . . 1.6799999999999999 111.19 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.9 Cg_exo -47.14 130.41 16.58 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.64000000000000001 113.081 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' CD1' ' HB2' ' A' ' 21' ' ' LYS . 2.2 mt -90.71 -30.75 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.055 -0.721 . . . . 2.1699999999999999 109.055 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.49 119.65 6.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.167 -0.924 . . . . 0.84999999999999998 109.218 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.923 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -117.39 122.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 1.5700000000000001 112.448 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.939 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -124.52 160.5 28.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.831 . . . . 1.46 110.237 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -59.02 -13.97 8.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.394 0.516 . . . . 2.9100000000000001 112.394 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.425 ' O ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -140.44 23.9 2.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.285 0.476 . . . . 1.3300000000000001 112.285 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -175.98 113.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.841 0.353 . . . . 1.28 110.232 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HG23 ' A' ' 13' ' ' ILE . 44.7 t -116.24 99.28 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.153 0.427 . . . . 1.49 112.153 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 46.1 m -83.66 144.85 29.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 1.1399999999999999 110.68 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -148.55 163.97 35.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.649 0.737 . . . . 1.3100000000000001 112.499 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 28.4 tptp -145.58 137.86 25.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.595 -1.184 . . . . 2.3100000000000001 109.601 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.486 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 37.4 p90 -133.81 177.93 7.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.183 0.516 . . . . 0.40000000000000002 111.709 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.3 -163.95 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 1.1100000000000001 110.838 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -128.68 140.38 38.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.901 -0.59 . . . . 2.5600000000000001 110.185 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.505 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 95.9 Cg_exo -39.05 161.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.166 . . . . 1.1100000000000001 112.2 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.44 -43.22 5.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 3.5 t80 -108.91 -70.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.482 0.549 . . . . 1.6899999999999999 112.482 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 19.5 p 55.77 40.78 30.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.429 . . . . 1.3500000000000001 109.951 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 0' ' ' SER . . . 44.67 -100.21 0.02 OUTLIER Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.804 -0.635 . . . . 1.01 112.53 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.35 27.62 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.295 -0.722 . . . . 0.97999999999999998 111.295 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -111.85 -171.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.98999999999999999 111.267 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.29 35.3 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 2.6899999999999999 111.24 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.831 HG13 ' HH ' ' A' ' 36' ' ' TYR . 2.9 mm 59.44 158.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.465 -0.334 . . . . 1.71 110.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.1 p -138.87 1.74 2.1 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.656 0.613 . . . . 1.6599999999999999 112.656 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t 168.59 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.7 0.286 . . . . 1.97 111.539 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.831 ' HH ' HG13 ' A' ' 33' ' ' ILE . 36.9 m-85 -99.82 87.06 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 1.23 111.113 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 1.1 mp -73.74 120.47 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 1.76 110.796 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.15 107.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.111 0.481 . . . . 1.6100000000000001 111.563 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.82 139.24 31.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 1.6699999999999999 110.616 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' CE ' ' HB3' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -108.12 138.93 43.54 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.904 0.383 . . . . 2.4399999999999999 111.568 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -119.12 97.41 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.564 -0.902 . . . . 1.79 108.564 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.843 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -65.48 97.16 0.28 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.403 -0.817 . . . . 1.5900000000000001 110.603 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' HD2' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -69.3 148.01 97.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 1.4299999999999999 110.837 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -93.93 32.22 11.17 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.966 -1.264 . . . . 1.47 112.861 0.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.79 64.63 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.754 0.311 . . . . 2.6600000000000001 111.547 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.843 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -95.85 -174.77 36.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 1.6200000000000001 112.032 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 26.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 3.0600000000000001 110.777 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.572 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.8 m95 41.38 88.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.099 0.476 . . . . 1.0600000000000001 111.202 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 137.86 54.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.8400000000000001 111.27 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 1.4 mtmt -53.89 129.14 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 1.77 110.4 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB3' ' CE ' ' A' ' 40' ' ' LYS . . . -110.29 -31.55 7.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 1.4099999999999999 110.645 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.7 p-10 -57.18 -43.31 82.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 2.0099999999999998 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.87 25.08 10.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 2.6400000000000001 110.766 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -169.77 3.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 2.0299999999999998 110.956 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -94.9 116.08 28.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.8700000000000001 110.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.505 HG22 HD11 ' A' ' 56' ' ' ILE . 27.1 mt -105.71 90.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.54 . . . . 1.3700000000000001 110.636 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mt -74.62 -61.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 2.1499999999999999 111.336 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -75.02 159.16 32.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.934 0.397 . . . . 1.54 110.621 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.486 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -74.85 -3.22 30.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 1.75 111.039 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 1.7 tt0 -100.46 103.53 14.89 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.413 -0.588 . . . . 2.0499999999999998 109.413 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 60.9 t80 -140.19 165.35 27.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.56999999999999995 111.779 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 8.1 m -121.29 114.78 21.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 1.1399999999999999 111.391 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.71 90.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.143 0.497 . . . . 1.72 111.041 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.67 151.69 19.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.6399999999999999 111.0 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.34 14.65 7.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.95999999999999996 112.354 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 72' ' ' TYR . 3.6 mm? -58.25 -179.67 0.06 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.132 0.491 . . . . 2.02 111.357 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 m -133.37 109.23 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.589 -0.732 . . . . 1.55 110.199 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.91 135.7 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.087 -0.506 . . . . 1.9099999999999999 111.816 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 97' ' ' CYS . 9.5 m-20 65.64 62.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.8700000000000001 111.215 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -174.7 114.74 0.17 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.509 -0.314 . . . . 1.2 111.588 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -64.18 135.34 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.731 -0.47 . . . . 1.1100000000000001 109.731 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 33.3 m-85 -128.61 121.51 28.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.162 0.801 . . . . 1.0800000000000001 113.162 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.3 133.7 43.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.618 -1.253 . . . . 1.5 107.618 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 7.8 m-85 -117.94 114.87 23.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.138 1.532 . . . . 0.79000000000000004 115.138 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HD3' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -100.72 135.34 42.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.193 -0.912 . . . . 2.6899999999999999 108.998 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -108.24 127.39 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 119.288 -0.965 . . . . 1.5700000000000001 111.721 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 78' ' ' ALA . 94.1 mt -115.52 143.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.811 -1.086 . . . . 1.3200000000000001 108.126 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.456 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -156.11 134.45 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.833 -0.747 . . . . 1.1100000000000001 112.395 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -84.85 -178.6 6.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.28 -0.568 . . . . 2.3500000000000001 110.626 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.3 p-10 -127.84 -173.23 2.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.36 -0.836 . . . . 2.7000000000000002 110.104 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -69.66 -11.96 61.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.041 -0.527 . . . . 1.3400000000000001 112.095 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' HB1' ' ND2' ' A' ' 80' ' ' ASN . . . -104.01 -4.23 23.6 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.228 0.455 . . . . 1.4299999999999999 112.228 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.98 87.93 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.452 -0.88 . . . . 1.3799999999999999 113.291 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.57 71.98 3.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.341 0.591 . . . . 1.49 109.951 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.9 tt -36.56 123.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.96 1.096 . . . . 1.48 113.96 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 9.6 p -76.2 107.81 5.12 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.372 -1.344 . . . . 0.81000000000000005 107.372 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 14.6 Cg_endo -55.18 171.4 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.592 2.194 . . . . 1.25 113.454 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 48.0 Cg_exo -31.95 122.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.973 3.115 . . . . 1.2 113.317 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 90' ' ' GLU . 4.1 p -106.85 103.82 13.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 1.76 110.121 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 9.98 113.85 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 125.045 1.466 . . . . 1.77 113.416 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 15.4 Cg_exo -68.31 162.39 40.67 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.88 1.72 . . . . 1.01 114.292 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.82 152.75 18.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.153 -0.93 . . . . 1.55 109.345 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.405 ' O ' HD13 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -33.75 156.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.112 0.882 . . . . 1.6299999999999999 112.294 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -90.64 103.3 16.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 1.0900000000000001 111.363 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 13' ' ' ILE . 5.0 mp -82.81 110.24 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 1.1299999999999999 111.497 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 90.8 m -48.74 -35.37 14.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.13 0.491 . . . . 1.1299999999999999 110.612 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.408 ' CA ' ' HA ' ' A' ' 15' ' ' ARG . 91.7 m 56.93 79.6 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.673 -0.694 . . . . 1.5700000000000001 111.046 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -87.68 0.47 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.506 -0.315 . . . . 3.7000000000000002 111.381 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.69 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.17 0.43 16.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.426 -0.352 . . . . 2.1400000000000001 111.666 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.939 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 47.73 26.2 0.83 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.907 0.385 . . . . 2.0600000000000001 111.215 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.69 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 27.1 m -115.87 -19.01 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 116.032 -0.531 . . . . 3.0800000000000001 110.953 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -135.01 -45.87 0.72 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.901 0.381 . . . . 4.5800000000000001 110.773 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.224 -0.893 . . . . 3.79 110.928 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.733 0.302 . . . . 3.1699999999999999 111.287 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 96.0 Cg_endo -92.11 170.91 2.68 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.086 2.524 . . . . 2.0600000000000001 112.248 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -135.58 137.25 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.986 0.422 . . . . 1.26 111.434 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.432 ' N ' HG12 ' A' ' 2' ' ' ILE . 5.1 m-20 -122.02 142.97 37.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 2.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HG3' ' HG2' ' A' ' 87' ' ' PRO . 91.3 Cg_endo -80.53 168.64 17.84 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.569 2.179 . . . . 0.58999999999999997 112.402 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 174.29 2.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.654 2.236 . . . . 1.6100000000000001 112.898 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.4 177.12 40.61 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.97999999999999998 112.493 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.0 tttt -60.77 127.53 87.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.533 -0.173 . . . . 2.04 110.533 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 7.0 Cg_exo -74.29 156.89 46.13 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.352 2.035 . . . . 0.54000000000000004 112.074 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.7 p -152.47 114.56 2.85 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.415 -0.357 . . . . 1.6799999999999999 111.677 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 25.6 Cg_exo -61.44 111.31 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.691 2.26 . . . . 0.64000000000000001 113.405 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD22 ' OE2' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -69.58 -33.85 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.661 -0.866 . . . . 2.1699999999999999 108.661 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.871 -1.059 . . . . 0.84999999999999998 108.995 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 13' ' ' ILE . 2.6 pt -133.98 105.3 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 1.5700000000000001 112.041 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 151.23 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.7 -0.682 . . . . 1.46 110.35 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -16.06 30.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.422 . . . . 2.9100000000000001 111.439 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.424 ' O ' ' CG2' ' A' ' 17' ' ' THR . 6.1 m-70 -132.29 16.96 4.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.48 0.181 . . . . 1.3300000000000001 111.464 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -176.27 106.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.946 0.403 . . . . 1.28 110.917 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.48 HG13 ' CE2' ' A' ' 74' ' ' PHE . 49.7 t -102.57 117.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.966 -0.561 . . . . 1.49 110.971 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.425 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 19.8 m -98.33 128.9 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 1.1399999999999999 111.571 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.77 156.47 46.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.935 0.874 . . . . 1.3100000000000001 112.412 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.909 ' HG2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -124.71 -170.45 2.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.04 -1.437 . . . . 2.3100000000000001 109.219 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.485 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.7 p90 -179.83 161.14 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.40000000000000002 111.836 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.77 168.06 19.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 1.1100000000000001 111.797 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.27 141.42 32.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.53 -0.759 . . . . 2.5600000000000001 110.236 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' CG ' HG23 ' A' ' 28' ' ' THR . 4.5 Cg_endo -46.51 166.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.369 2.046 . . . . 1.1100000000000001 111.716 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -102.93 -55.62 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.238 -0.437 . . . . 2.77 111.518 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 1' ' ' PRO . 2.8 t80 -113.15 61.92 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.567 -0.288 . . . . 1.6899999999999999 111.331 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.49 ' O ' ' CE2' ' A' ' 31' ' ' PHE . 44.4 p -57.68 -25.08 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.709 0.29 . . . . 1.3500000000000001 110.452 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.09 -65.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.579 -0.819 . . . . 1.01 111.886 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 40.09 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.991 -1.244 . . . . 0.97999999999999998 109.991 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -137.87 -176.92 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.087 -0.557 . . . . 0.98999999999999999 111.024 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.3 15.21 1.66 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.5 0.556 . . . . 2.6899999999999999 112.5 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.1 mp 64.22 -74.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 111.905 0.335 . . . . 1.71 111.905 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p 79.53 21.43 0.6 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.573 -0.285 . . . . 1.6599999999999999 111.696 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.1 OUTLIER 169.96 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.924 -0.126 . . . . 1.97 111.232 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.8 m-85 -118.06 128.71 55.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.94 0.4 . . . . 1.23 112.001 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -119.4 120.67 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.513 -0.312 . . . . 1.76 110.433 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -105.69 140.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.879 0.371 . . . . 1.6100000000000001 110.813 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -101.96 135.52 43.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.259 0.552 . . . . 1.6699999999999999 111.966 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 49' ' ' LEU . 1.4 mtmp? -101.26 139.19 37.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.273 -0.876 . . . . 2.4399999999999999 111.336 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.556 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 7.6 ptt180 -132.63 115.65 15.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.454 0.645 . . . . 1.79 109.84 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -75.65 113.11 12.72 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.123 -0.944 . . . . 1.5900000000000001 111.053 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 44' ' ' PRO . 2.5 mm? -73.58 161.04 80.76 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 1.4299999999999999 110.412 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 80.6 Cg_endo -83.8 14.89 33.18 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 124.115 -1.202 . . . . 1.47 113.427 0.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -98.65 -77.81 0.51 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.938 -0.393 . . . . 2.6600000000000001 109.938 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' CA ' ' HB2' ' A' ' 41' ' ' ARG . . . 92.22 130.81 5.26 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.633 -0.794 . . . . 1.6200000000000001 113.206 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.47 1.68 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.64 0.237 . . . . 3.0600000000000001 111.64 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.557 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 40.4 m95 44.31 94.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.205 0.202 . . . . 1.0600000000000001 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 40' ' ' LYS . 1.4 mp -123.62 135.55 54.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.955 0.407 . . . . 1.8400000000000001 111.615 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -62.99 82.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 1.77 110.662 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.401 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -49.11 -53.94 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 1.4099999999999999 111.231 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -60.31 138.28 57.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 2.0099999999999998 111.06 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -136.77 23.07 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 2.6400000000000001 111.031 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 t -120.73 -83.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 2.0299999999999998 110.72 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 178.48 120.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 1.8700000000000001 110.86 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.49 HG12 ' CD1' ' A' ' 61' ' ' PHE . 14.0 mt -107.02 98.99 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 1.3700000000000001 110.986 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -76.68 -68.25 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 2.1499999999999999 111.087 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -74.85 -179.12 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 1.54 110.65 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.9 OUTLIER -86.93 -2.91 58.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 1.75 111.482 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.909 ' CD ' ' HG2' ' A' ' 21' ' ' LYS . 9.0 tp10 -97.42 101.86 13.49 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.749 0.309 . . . . 2.0499999999999998 110.179 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.517 ' CG ' ' N ' ' A' ' 62' ' ' THR . 40.3 t80 -135.81 165.49 25.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.055 0.455 . . . . 0.56999999999999995 111.584 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.517 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 5.7 m -122.21 120.69 34.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.758 -0.655 . . . . 1.1399999999999999 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' A' ' 20' ' ' LEU . 4.8 t -85.77 112.07 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.995 -0.548 . . . . 1.72 111.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -173.38 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 1.6399999999999999 110.944 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.8 9.58 71.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.747 . . . . 0.95999999999999996 112.847 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 72' ' ' TYR . 1.6 mt -61.72 -177.19 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 2.02 110.83 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.801 HG21 ' HH ' ' A' ' 72' ' ' TYR . 3.8 t -138.93 11.49 2.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.026 0.38 . . . . 1.55 112.026 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 56.9 159.31 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.006 0.432 . . . . 1.9099999999999999 111.382 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 45.76 66.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 1.8700000000000001 111.368 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 174.76 119.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.251 -0.431 . . . . 1.2 111.067 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.83 132.82 55.12 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.205 -0.598 . . . . 1.1100000000000001 110.281 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.801 ' HH ' HG21 ' A' ' 67' ' ' THR . 25.0 m-85 -130.34 121.0 25.2 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.003 0.742 . . . . 1.0800000000000001 113.003 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 92' ' ' SER . 2.4 tt0 -102.66 141.05 36.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.516 -0.55 . . . . 1.5 109.516 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -137.65 128.01 26.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.126 1.158 . . . . 0.79000000000000004 114.126 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.557 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -111.32 160.98 16.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.31 -0.626 . . . . 2.6899999999999999 109.31 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG23 ' CE2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -121.3 112.32 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.057 -0.657 . . . . 1.5700000000000001 111.955 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.464 ' CG2' ' N ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -105.05 179.81 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.237 -0.892 . . . . 1.3200000000000001 108.852 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -179.37 -162.59 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.106 0.479 . . . . 1.1100000000000001 111.395 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.7 mttt -136.85 -171.53 2.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.275 -1.009 . . . . 2.3500000000000001 108.275 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 8.8 p-10 -135.72 156.62 48.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.056 0.455 . . . . 2.7000000000000002 110.54 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -39.35 -29.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.601 -0.727 . . . . 1.3400000000000001 112.084 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -77.07 -24.5 51.88 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.815 0.672 . . . . 1.4299999999999999 112.815 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 112.29 -11.5 26.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.431 -0.89 . . . . 1.3799999999999999 112.341 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . -59.89 -156.63 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.958 -0.386 . . . . 1.49 109.958 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -145.15 114.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.059 0.762 . . . . 1.48 113.059 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 52.1 p -64.71 109.91 3.43 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.81000000000000005 107.028 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 12.3 Cg_endo -54.48 147.63 46.8 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.159 1.906 . . . . 1.25 112.767 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' N ' ' CG2' ' A' ' 77' ' ' ILE . 47.8 Cg_exo -37.22 120.53 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.378 2.719 . . . . 1.2 113.666 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 90' ' ' GLU . 28.2 p -87.21 101.98 14.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.05 -0.523 . . . . 1.76 110.128 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.8 tt0 0.41 111.05 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.991 1.316 . . . . 1.77 114.292 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 51.9 Cg_exo -48.61 167.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.156 1.904 . . . . 1.01 113.19 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -105.91 143.88 33.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.064 -0.971 . . . . 1.55 109.038 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -28.36 144.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.187 0.929 . . . . 1.6299999999999999 112.555 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 72' ' ' TYR . . . -79.67 111.02 15.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 1.0900000000000001 110.911 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.8 120.29 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 1.1299999999999999 111.7 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.7 m -57.82 -13.02 3.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.812 -0.631 . . . . 1.1299999999999999 112.408 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 26.4 p 43.77 70.62 0.3 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.887 0.375 . . . . 1.5700000000000001 111.287 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -101.1 -87.95 0.38 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.982 -0.554 . . . . 3.7000000000000002 111.187 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -126.38 8.61 7.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 2.1400000000000001 111.485 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.9 t0 50.39 25.24 1.82 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.844 0.354 . . . . 2.0600000000000001 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.486 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 14.8 p -141.36 9.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 3.0800000000000001 111.83 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 29.65 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.844 0.683 . . . . 4.5800000000000001 112.844 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.219 -0.896 . . . . 3.79 111.048 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.653 0.263 . . . . 3.1699999999999999 111.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.472 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 72.3 Cg_endo -79.41 -28.94 3.29 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.455 2.104 . . . . 2.0600000000000001 112.404 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.475 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 7.3 tt 53.9 146.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 124.047 0.842 . . . . 1.26 112.341 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -134.22 119.71 14.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 2.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 88.2 Cg_endo -75.8 171.35 18.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.501 2.134 . . . . 0.58999999999999997 112.79 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 45.6 Cg_exo -56.72 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.805 2.337 . . . . 1.6100000000000001 112.556 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 -171.33 39.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.85 -0.691 . . . . 0.97999999999999998 112.576 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 33.8 tttt -73.76 128.96 85.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.369 0.128 . . . . 2.04 110.825 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 20.4 Cg_exo -69.19 143.92 55.24 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.54000000000000004 112.713 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.19 97.41 5.23 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 1.6799999999999999 110.586 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.3 Cg_exo -50.14 128.82 23.51 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.252 1.968 . . . . 0.64000000000000001 113.493 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 21' ' ' LYS . 2.8 mm? -83.97 -35.43 23.97 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.184 -1.043 . . . . 2.1699999999999999 108.184 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.48 37.32 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.583 -1.19 . . . . 0.84999999999999998 107.891 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.438 ' CG2' HG12 ' A' ' 18' ' ' VAL . 2.1 pt -136.35 102.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.778 0.659 . . . . 1.5700000000000001 112.778 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 144.3 33.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.33 -0.85 . . . . 1.46 110.173 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -46.33 -23.69 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.693 -0.685 . . . . 2.9100000000000001 112.78 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 7.8 m170 -125.9 -1.59 7.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.505 0.557 . . . . 1.3300000000000001 112.505 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 p -157.91 115.23 2.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.943 0.401 . . . . 1.28 110.487 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.439 ' HB ' ' CG2' ' A' ' 63' ' ' VAL . 57.9 t -119.0 114.57 45.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 1.49 112.032 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 12.7 m -83.34 146.82 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 1.1399999999999999 109.928 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.28 160.17 43.38 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.847 0.684 . . . . 1.3100000000000001 112.847 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' CB ' HD22 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.49 147.92 32.69 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.854 -1.066 . . . . 2.3100000000000001 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.481 ' CZ3' ' O ' ' A' ' 59' ' ' ASN . 26.4 p90 -142.68 -177.8 5.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.40000000000000002 111.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 176.62 7.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 1.1100000000000001 112.049 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -115.95 143.33 30.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.742 -0.663 . . . . 2.5600000000000001 110.899 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 73.5 Cg_exo -51.55 -179.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.531 2.154 . . . . 1.1100000000000001 112.426 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 1.157 ' N ' ' OE1' ' A' ' 26' ' ' GLU . 3.1 pm0 -125.69 -35.27 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 2.77 111.927 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -106.73 -69.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.173 0.434 . . . . 1.6899999999999999 112.173 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 40.9 p 56.2 40.42 30.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 1.3500000000000001 110.426 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.22 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.873 -0.68 . . . . 1.01 112.109 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.34 35.0 1.59 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.362 -1.095 . . . . 0.97999999999999998 110.362 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 3.1 m-85 -113.16 -178.11 3.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.812 -0.694 . . . . 0.98999999999999999 111.71 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 1.41 2.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.697 -0.683 . . . . 2.6899999999999999 112.224 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG23 ' CE1' ' A' ' 36' ' ' TYR . 7.3 mt 57.97 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.117 0.484 . . . . 1.71 111.769 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -132.79 6.97 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.021 -0.536 . . . . 1.6599999999999999 111.997 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -179.41 142.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.865 0.364 . . . . 1.97 111.474 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HA ' ' CB ' ' A' ' 78' ' ' ALA . 35.6 m-85 -113.85 109.6 18.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.844 -0.617 . . . . 1.23 111.423 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.29 104.6 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.76 110.63 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.4 p -99.3 119.0 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 1.6100000000000001 111.209 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -80.12 163.08 24.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.649 -0.705 . . . . 1.6699999999999999 111.236 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -118.82 168.07 11.11 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.658 -0.701 . . . . 2.4399999999999999 109.285 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -156.94 87.05 0.98 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.793 -0.763 . . . . 1.79 111.386 177.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.842 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -66.51 85.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 1.5900000000000001 110.963 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -61.94 159.4 36.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.136 -0.484 . . . . 1.4299999999999999 110.595 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.9 Cg_exo -80.83 21.67 9.18 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.261 -1.141 . . . . 1.47 113.703 0.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -132.41 -85.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.027 -0.269 . . . . 2.6600000000000001 110.536 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.94 -164.7 0.02 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.073 -0.584 . . . . 1.6200000000000001 112.945 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.51 145.07 3.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 3.0600000000000001 110.491 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 53.7 m95 -65.58 77.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.638 -0.71 . . . . 1.0600000000000001 111.786 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' HB2' ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -112.78 156.65 22.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.998 -0.547 . . . . 1.8400000000000001 109.855 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -50.25 90.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.689 0.281 . . . . 1.77 111.24 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -60.2 -31.63 70.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.29 0.567 . . . . 1.4099999999999999 109.514 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.528 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 12.9 p-10 -91.69 -145.41 0.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.289 -0.868 . . . . 2.0099999999999998 110.492 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 175.85 -33.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.86 0.362 . . . . 2.6400000000000001 110.194 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -91.92 171.53 9.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 2.0299999999999998 110.738 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.63 105.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.8700000000000001 111.086 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 56' ' ' ILE . 14.4 mt -87.98 53.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 1.3700000000000001 110.306 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 3.3 tm? -44.2 -54.6 5.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.978 -0.556 . . . . 2.1499999999999999 111.233 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -84.07 158.95 21.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.089 -0.505 . . . . 1.54 109.974 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.481 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 12.4 p30 -80.37 4.68 17.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.43 -0.35 . . . . 1.75 111.587 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -98.38 94.34 6.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.013 -0.736 . . . . 2.0499999999999998 109.013 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 74.3 t80 -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.142 0.496 . . . . 0.56999999999999995 112.052 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.507 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 10.9 m -133.74 109.62 9.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.567 -0.742 . . . . 1.1399999999999999 110.954 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' CG2' ' HB ' ' A' ' 18' ' ' VAL . 27.8 m -67.42 114.31 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 1.72 111.238 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.42 129.44 55.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.892 -0.594 . . . . 1.6399999999999999 111.21 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.21 6.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.95999999999999996 112.857 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.33 -158.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 2.02 110.548 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.6 m -138.04 147.78 44.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.496 -0.32 . . . . 1.55 110.181 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -82.5 142.01 32.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 1.9099999999999999 111.332 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t0 65.94 60.08 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.547 . . . . 1.8700000000000001 111.36 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.66 128.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 1.2 110.919 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -59.81 143.53 50.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.806 0.336 . . . . 1.1100000000000001 110.422 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 66' ' ' LEU . 2.0 m-85 -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.529 0.566 . . . . 1.0800000000000001 112.529 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 91' ' ' PRO . 6.5 tp10 -101.54 140.55 35.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.018 -0.734 . . . . 1.5 109.018 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 91' ' ' PRO . 8.6 m-85 -123.82 110.54 15.02 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.668 0.988 . . . . 0.79000000000000004 113.668 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.479 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -90.32 159.83 16.43 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.636 -0.711 . . . . 2.6899999999999999 109.962 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 47.8 t -130.7 120.7 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.536 0.939 . . . . 1.5700000000000001 113.536 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.432 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 55.6 mt -123.33 153.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.703 -1.591 . . . . 1.3200000000000001 106.703 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -173.21 123.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.417 -1.313 . . . . 1.1100000000000001 113.937 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 18.4 mttt -68.21 158.8 32.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.205 -1.035 . . . . 2.3500000000000001 108.205 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 2.6 m-80 -99.8 -91.35 0.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.843 -0.743 . . . . 2.7000000000000002 111.805 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -133.89 -42.63 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.276 0.472 . . . . 1.3400000000000001 112.276 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -95.05 40.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.33 0.493 . . . . 1.4299999999999999 112.33 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.73 8.72 41.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 1.3799999999999999 113.196 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -77.75 92.66 4.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.0 0.4 . . . . 1.49 109.947 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -62.71 107.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.28 0.474 . . . . 1.48 112.28 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 8.3 p -62.89 121.92 71.46 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.005 -0.739 . . . . 0.81000000000000005 109.005 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.59 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.266 . . . . 1.25 112.624 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.432 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 4.2 Cg_exo -73.3 155.37 51.34 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.822 2.348 . . . . 1.2 112.829 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.26 135.34 53.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.626 -0.715 . . . . 1.76 110.304 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.4 tt0 -35.24 110.89 0.42 Allowed Pre-proline 0 N--CA 1.469 0.503 0 O-C-N 124.0 0.812 . . . . 1.77 111.848 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 75.3 Cg_exo -50.96 145.46 24.55 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.827 2.351 . . . . 1.01 114.4 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.62 149.86 41.76 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.608 -0.886 . . . . 1.55 108.608 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -34.12 155.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.076 0.86 . . . . 1.6299999999999999 112.093 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -89.31 110.82 21.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 1.0900000000000001 111.847 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 13' ' ' ILE . 5.2 mp -88.22 112.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 111.167 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.444 HG22 ' NH1' ' A' ' 98' ' ' ARG . 85.6 m -42.77 -29.9 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.004 0.43 . . . . 1.1299999999999999 110.87 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 84.7 m 51.07 69.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 1.5700000000000001 110.439 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 1.011 ' HD3' ' CD ' ' A' ' 102' ' ' GLU . 1.5 ptp85 -111.87 -87.51 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 3.7000000000000002 110.824 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.303 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 1.2 p30 -123.49 0.27 8.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.111 -0.495 . . . . 2.1400000000000001 110.884 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.2 t0 45.39 26.95 0.32 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 2.0600000000000001 111.71 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.849 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 10.6 p -153.38 19.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 3.0800000000000001 111.542 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.303 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -145.16 12.09 1.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.095 0.405 . . . . 4.5800000000000001 112.095 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 1.012 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.232 -0.89 . . . . 3.79 111.097 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.719 0.295 . . . . 3.1699999999999999 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.29 124.83 2.89 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.747 2.298 . . . . 2.0600000000000001 112.615 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.477 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 1.9 tt -99.54 146.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 1.26 110.89 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 2' ' ' ILE . 9.8 m-20 -130.12 135.08 26.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 2.0 110.193 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -83.3 175.16 8.5 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.558 2.172 . . . . 0.58999999999999997 112.837 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -65.18 171.64 8.71 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.914 2.409 . . . . 1.6100000000000001 112.676 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.74 173.04 53.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.007 -0.616 . . . . 0.97999999999999998 112.831 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 28.9 tttt -63.9 123.23 81.12 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.498 0.149 . . . . 2.04 110.677 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 34.8 Cg_exo -65.27 131.1 27.25 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.453 2.102 . . . . 0.54000000000000004 112.699 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 108.01 20.74 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.007 -0.542 . . . . 1.6799999999999999 110.575 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 39.0 Cg_exo -58.94 115.07 2.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.471 2.114 . . . . 0.64000000000000001 113.976 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' CD1' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -77.71 -38.43 47.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.885 -0.783 . . . . 2.1699999999999999 108.885 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.73 145.36 49.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.8 -1.091 . . . . 0.84999999999999998 108.701 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.412 ' CG2' HG12 ' A' ' 18' ' ' VAL . 1.7 pt -141.0 97.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.598 0.592 . . . . 1.5700000000000001 112.598 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.96 147.7 23.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.643 -0.708 . . . . 1.46 109.34 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -53.5 -18.28 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.226 0.454 . . . . 2.9100000000000001 112.226 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.442 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 2.5 m-70 -126.78 -4.22 6.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.272 0.471 . . . . 1.3300000000000001 112.272 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 116.46 5.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.873 0.368 . . . . 1.28 111.107 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG13 ' CE2' ' A' ' 74' ' ' PHE . 66.6 t -105.25 134.41 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.009 0.433 . . . . 1.49 111.167 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.0 m -111.96 122.47 47.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 1.1399999999999999 110.669 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.98 149.23 52.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.753 0.787 . . . . 1.3100000000000001 112.203 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.919 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 7.0 tptt -133.09 139.01 46.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.427 -1.261 . . . . 2.3100000000000001 109.704 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.9 p90 -128.64 -174.98 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.056 0.455 . . . . 0.40000000000000002 111.881 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.23 179.33 5.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 1.1100000000000001 112.044 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD3' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -107.88 138.68 20.13 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 2.5600000000000001 110.221 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 79.9 Cg_exo -44.21 171.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.418 2.079 . . . . 1.1100000000000001 112.613 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -110.89 -25.06 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 2.77 111.992 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.51 -69.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.158 0.429 . . . . 1.6899999999999999 112.158 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 64.4 p 51.37 56.22 8.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 1.3500000000000001 110.704 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.12 -93.46 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.966 -0.561 . . . . 1.01 112.844 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.02 32.95 1.05 Allowed Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.008 -1.237 . . . . 0.97999999999999998 110.008 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -114.99 179.54 3.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.738 -0.731 . . . . 0.98999999999999999 111.009 -178.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.34 -3.17 3.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.179 -0.464 . . . . 2.6899999999999999 112.185 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 3.1 mt 61.27 138.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.921 0.391 . . . . 1.71 110.606 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -140.78 24.72 2.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 1.6599999999999999 111.525 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.2 m -166.51 102.69 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 1.97 111.618 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -98.12 115.64 28.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 1.23 110.454 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.63 112.71 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.76 111.199 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -101.54 114.59 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 1.6100000000000001 110.74 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -79.6 151.24 30.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.522 -0.763 . . . . 1.6699999999999999 110.347 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -121.27 140.13 52.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 2.4399999999999999 111.168 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 9.5 ttp180 -121.73 116.4 24.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.79 110.371 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.716 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -76.57 102.69 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 1.5900000000000001 110.798 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HB2' ' CB ' ' A' ' 71' ' ' ALA . 1.6 mm? -88.65 156.83 50.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.531 -0.304 . . . . 1.4299999999999999 110.738 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -91.54 36.27 6.24 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.152 -1.187 . . . . 1.47 112.377 0.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -165.47 83.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 2.6600000000000001 111.163 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.716 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -155.74 -164.82 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.913 -0.661 . . . . 1.6200000000000001 112.207 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.77 172.57 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 3.0600000000000001 111.279 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.552 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 68.4 m95 -78.8 118.36 20.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.57 -0.741 . . . . 1.0600000000000001 112.212 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.37 127.03 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.8400000000000001 110.649 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.24 99.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 1.77 111.625 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -62.31 -38.37 89.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.246 0.546 . . . . 1.4099999999999999 110.338 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.5 p-10 -70.4 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.0099999999999998 110.963 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 172.44 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.76 0.314 . . . . 2.6400000000000001 110.461 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -81.33 -159.77 0.29 Allowed 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.35 -0.386 . . . . 2.0299999999999998 110.641 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.94 97.83 7.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 1.8700000000000001 111.05 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.49 HD12 ' CD1' ' A' ' 61' ' ' PHE . 28.8 mt -81.25 87.94 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 1.3700000000000001 111.127 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.45 -53.74 9.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 2.1499999999999999 111.074 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.64 164.82 21.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.54 110.562 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.505 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -81.21 4.55 19.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.46 . . . . 1.75 111.644 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.919 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.9 tp10 -106.93 96.21 6.27 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 120.802 0.335 . . . . 2.0499999999999998 110.179 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 67.3 t80 -124.43 164.36 19.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.56999999999999995 111.298 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.0 m -132.14 114.06 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 1.1399999999999999 110.959 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.6 m -76.21 133.05 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.72 111.064 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 133.01 49.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.973 -0.558 . . . . 1.6399999999999999 110.949 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.89 -2.16 4.76 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.683 -0.77 . . . . 0.95999999999999996 113.145 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -58.38 -173.67 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.975 0.417 . . . . 2.02 111.232 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -139.76 141.61 36.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.806 -0.634 . . . . 1.55 110.634 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -64.57 146.51 54.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.283 -0.417 . . . . 1.9099999999999999 111.095 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 5.9 m-20 63.83 57.36 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 1.8700000000000001 111.344 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -171.03 124.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.706 0.289 . . . . 1.2 111.611 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 43' ' ' LEU . . . -66.4 138.07 57.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.522 -0.308 . . . . 1.1100000000000001 110.172 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 39.9 m-85 -133.71 117.57 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.448 0.536 . . . . 1.0800000000000001 112.448 -179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -98.72 144.2 28.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.906 -0.776 . . . . 1.5 108.906 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -135.59 115.39 12.98 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.24 1.2 . . . . 0.79000000000000004 114.24 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.2 ptp180 -105.59 177.97 4.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.987 -1.116 . . . . 2.6899999999999999 107.987 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -154.24 126.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 122.257 1.027 . . . . 1.5700000000000001 113.225 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.447 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 11.3 mt -105.45 152.99 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 1.3200000000000001 106.958 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.421 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -160.11 135.92 8.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.01 -1.076 . . . . 1.1100000000000001 112.762 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 5.5 mttt -80.16 -169.63 2.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.526 -0.761 . . . . 2.3500000000000001 110.384 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 3.7 p30 -135.54 171.74 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.195 0.522 . . . . 2.7000000000000002 111.336 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -47.94 -25.07 1.22 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.754 . . . . 1.3400000000000001 111.859 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -86.15 -20.67 28.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.267 0.469 . . . . 1.4299999999999999 112.267 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 110.32 -18.37 28.02 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.279 -0.962 . . . . 1.3799999999999999 112.319 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -62.09 144.35 55.41 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 110.203 -0.295 . . . . 1.49 110.203 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -94.17 117.8 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 1.48 112.008 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -78.77 127.94 78.54 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.549 -0.75 . . . . 0.81000000000000005 110.259 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -34.69 159.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.592 2.861 . . . . 1.25 114.076 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 6.2 Cg_exo -74.28 138.74 25.37 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.06 2.507 . . . . 1.2 112.555 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.1 p -88.76 130.47 35.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.132 -0.485 . . . . 1.76 110.016 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -34.53 122.51 0.55 Allowed Pre-proline 0 N--CA 1.469 0.478 0 O-C-N 123.743 0.652 . . . . 1.77 112.338 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 33.7 Cg_exo -55.97 145.58 73.39 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.456 2.104 . . . . 1.01 113.345 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.12 149.12 35.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.048 -0.723 . . . . 1.55 109.048 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.0 142.26 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.829 0.705 . . . . 1.6299999999999999 112.128 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.09 112.69 14.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.761 -0.654 . . . . 1.0900000000000001 110.606 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.2 mp -93.11 118.16 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.145 -0.48 . . . . 1.1299999999999999 111.252 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 88.7 m -48.51 -37.83 18.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 1.1299999999999999 111.202 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 69' ' ' ASP . 66.9 m 55.49 90.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.809 0.338 . . . . 1.5700000000000001 110.767 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.65 -86.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 3.7000000000000002 110.378 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.147 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.8 -11.09 15.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 2.1400000000000001 110.849 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.56 21.29 1.76 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.209 -0.45 . . . . 2.0600000000000001 111.716 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.147 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.3 t -123.38 -11.09 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.338 -0.392 . . . . 3.0800000000000001 111.302 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.76 ' N ' ' OE1' ' A' ' 102' ' ' GLU . 1.3 mp0 -115.91 -14.84 11.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.586 0.231 . . . . 4.5800000000000001 111.006 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.253 -0.88 . . . . 3.79 111.299 -179.881 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.818 0.342 . . . . 3.1699999999999999 111.28 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.411 ' HD2' ' CE2' ' A' ' 27' ' ' TYR . 88.1 Cg_endo -90.69 72.16 1.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.07 2.514 . . . . 2.0600000000000001 112.158 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -56.37 135.51 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 1.26 111.245 -179.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -128.65 148.45 68.47 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0 111.551 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 85.0 Cg_endo -83.38 160.12 14.94 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.98 2.453 . . . . 0.58999999999999997 112.937 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.4 Cg_endo -54.64 -176.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.898 2.399 . . . . 1.6100000000000001 112.378 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -176.45 51.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.901 -0.666 . . . . 0.97999999999999998 112.492 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.13 128.05 86.93 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.412 -0.218 . . . . 2.04 110.412 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 14.2 Cg_exo -72.28 126.72 11.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.297 1.998 . . . . 0.54000000000000004 112.872 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.73 105.99 50.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.613 -0.721 . . . . 1.6799999999999999 109.502 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.6 Cg_exo -43.12 92.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.364 2.043 . . . . 0.64000000000000001 113.98 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tp -57.74 -29.45 64.77 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.315 -0.857 . . . . 2.1699999999999999 109.335 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -159.99 153.35 22.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.161 -0.927 . . . . 0.84999999999999998 108.966 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 1.136 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 1.4 pt -142.72 141.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.361 0.6 . . . . 1.5700000000000001 112.446 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.634 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -138.56 142.91 39.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.154 -0.93 . . . . 1.46 109.886 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.429 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -44.92 -24.47 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.609 0.596 . . . . 2.9100000000000001 112.609 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -125.19 -6.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.402 0.519 . . . . 1.3300000000000001 112.402 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.11 111.09 5.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 1.28 110.92 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.43 ' CG1' HG23 ' A' ' 13' ' ' ILE . 69.6 t -106.1 122.02 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 1.49 111.514 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 6.8 m -99.38 135.47 40.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 1.1399999999999999 110.825 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.7 143.36 41.23 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.662 0.744 . . . . 1.3100000000000001 111.338 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -126.81 149.59 49.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.66 -1.155 . . . . 2.3100000000000001 110.011 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.1 p90 -143.61 -175.69 4.67 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.279 0.561 . . . . 0.40000000000000002 112.367 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.63 -174.03 4.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 1.1100000000000001 111.428 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -111.56 137.3 21.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 2.5600000000000001 109.941 179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 6.2 Cg_exo -36.12 153.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.245 2.63 . . . . 1.1100000000000001 112.736 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.06 -40.31 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 2.77 111.862 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' CE2' ' HD2' ' A' ' 1' ' ' PRO . 23.2 t80 -130.98 -63.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 1.6899999999999999 111.804 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.482 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.1 p 52.31 45.22 28.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 1.3500000000000001 110.793 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.25 -112.11 0.91 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.188 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.44 28.35 5.3 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.408 -1.077 . . . . 0.97999999999999998 110.408 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -114.07 173.97 6.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.159 -0.52 . . . . 0.98999999999999999 110.991 -178.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.72 10.4 2.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.6899999999999999 111.759 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 33' ' ' ILE . 2.6 mt 59.33 116.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.942 0.401 . . . . 1.71 111.103 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -109.25 28.81 8.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 1.6599999999999999 111.425 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 174.3 106.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.747 0.308 . . . . 1.97 111.329 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CE1' HG22 ' A' ' 33' ' ' ILE . 57.7 m-85 -94.38 124.74 38.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.901 0.381 . . . . 1.23 110.969 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 2.4 mm -97.23 142.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 1.76 109.594 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.86 94.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.754 -0.378 . . . . 1.6100000000000001 111.994 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.13 137.85 55.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.244 -0.651 . . . . 1.6699999999999999 109.244 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.1 134.67 53.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 2.4399999999999999 111.589 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 8.7 ttp180 -108.6 104.46 13.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.78 -0.646 . . . . 1.79 109.895 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.28 82.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 1.5900000000000001 110.665 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.486 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 3.6 mp -50.56 155.83 1.73 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.4299999999999999 111.088 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.34 32.71 7.58 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.653 -1.395 . . . . 1.47 112.836 0.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 -77.24 0.38 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.79 0.328 . . . . 2.6600000000000001 111.108 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . 51.16 -175.2 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.913 -0.661 . . . . 1.6200000000000001 112.82 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' CD ' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -162.92 30.54 0.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.962 0.41 . . . . 3.0600000000000001 110.646 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 71.2 m95 45.25 96.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 1.0600000000000001 111.59 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.01 123.55 29.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.841 -0.618 . . . . 1.8400000000000001 110.217 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -48.42 137.92 10.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.77 110.967 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -123.66 -36.51 2.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 1.4099999999999999 111.553 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.4 ' HB3' HD12 ' A' ' 56' ' ' ILE . 2.5 p-10 -41.75 -62.56 0.87 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.509 -0.314 . . . . 2.0099999999999998 111.696 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 t80 45.91 30.22 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.507 -0.315 . . . . 2.6400000000000001 111.39 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.41 30.36 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 2.0299999999999998 111.284 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.74 95.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.44 -0.345 . . . . 1.8700000000000001 111.337 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.541 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 7.5 mt -86.32 90.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 1.3700000000000001 111.246 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.67 -44.13 67.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 2.1499999999999999 111.158 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -100.13 153.36 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.92 0.39 . . . . 1.54 110.658 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 20.9 p-10 -66.3 -10.46 42.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 1.75 111.527 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG3' ' CG ' ' A' ' 21' ' ' LYS . 2.9 tt0 -93.77 99.19 11.63 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.938 -0.764 . . . . 2.0499999999999998 108.938 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 81.6 t80 -129.35 162.61 27.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.947 -0.701 . . . . 0.56999999999999995 112.596 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 71.8 m -125.16 114.52 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.198 -0.91 . . . . 1.1399999999999999 111.222 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.73 120.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.841 -0.618 . . . . 1.72 110.958 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -117.28 162.33 18.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.243 0.544 . . . . 1.6399999999999999 110.988 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.26 -2.22 31.19 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.381 -0.827 . . . . 0.95999999999999996 112.903 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -67.17 -176.1 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.077 0.465 . . . . 2.02 110.732 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.466 HG23 ' OH ' ' A' ' 72' ' ' TYR . 1.7 t -140.55 144.11 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.745 -0.661 . . . . 1.55 110.453 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.447 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 tt0 -64.55 144.28 57.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.25 -0.432 . . . . 1.9099999999999999 110.782 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.4 t0 71.76 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.8700000000000001 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -170.61 122.56 0.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.497 -0.32 . . . . 1.2 111.51 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -72.04 132.11 43.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 109.96 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' OH ' HG23 ' A' ' 67' ' ' THR . 52.1 m-85 -128.72 123.26 32.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.392 0.515 . . . . 1.0800000000000001 112.392 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -101.7 144.15 30.76 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.699 -0.852 . . . . 1.5 108.699 178.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -130.51 114.93 16.11 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.27 1.582 . . . . 0.79000000000000004 115.27 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 21.4 ttm-85 -99.7 157.51 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.361 -0.977 . . . . 2.6899999999999999 108.361 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -135.05 128.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.232 -0.987 . . . . 1.5700000000000001 112.819 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 57.0 mt -117.96 156.04 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.094 -1.412 . . . . 1.3200000000000001 107.371 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -167.45 116.78 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 118.896 -1.122 . . . . 1.1100000000000001 112.657 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 1.6 mmtp -59.13 -177.83 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.077 -0.649 . . . . 2.3500000000000001 109.552 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' OD1' ' CD1' ' A' ' 2' ' ' ILE . 3.1 m120 -130.61 163.3 27.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.093 0.473 . . . . 2.7000000000000002 111.498 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.2 -26.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.141 0.793 . . . . 1.3400000000000001 113.141 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -102.84 11.57 37.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.907 0.706 . . . . 1.4299999999999999 112.907 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 88.56 -2.16 84.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.266 -0.969 . . . . 1.3799999999999999 113.273 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.97 120.53 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.139 0.47 . . . . 1.49 109.887 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -79.81 102.05 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.603 -0.439 . . . . 1.48 111.88 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 9.5 p -61.81 111.3 4.23 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.369 -0.604 . . . . 0.81000000000000005 109.369 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -40.81 173.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.676 2.918 . . . . 1.25 114.608 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.07 128.88 24.07 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.098 2.532 . . . . 1.2 112.824 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.436 ' OG ' ' CG1' ' A' ' 76' ' ' VAL . 3.8 p -97.89 119.03 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.811 -0.631 . . . . 1.76 109.957 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -20.24 119.8 0.1 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.009 0.924 . . . . 1.77 112.673 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.499 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 27.8 Cg_exo -63.39 156.51 55.75 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.655 2.237 . . . . 1.01 114.385 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.444 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.67 149.73 25.11 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.022 -0.99 . . . . 1.55 109.316 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -37.44 158.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.869 0.731 . . . . 1.6299999999999999 111.771 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.486 ' CB ' ' CD2' ' A' ' 43' ' ' LEU . . . -91.08 108.08 19.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 1.0900000000000001 111.053 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.93 114.35 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.36 -0.382 . . . . 1.1299999999999999 111.541 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 85.4 m -52.4 -31.16 32.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 1.1299999999999999 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.1 m 57.04 93.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.34 . . . . 1.5700000000000001 110.113 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.447 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -143.87 -86.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 3.7000000000000002 111.501 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.229 ' OD2' HG11 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -104.67 -2.52 24.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 2.1400000000000001 111.716 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.136 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER 43.78 27.58 0.18 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 112.564 0.579 . . . . 2.0600000000000001 112.564 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.229 HG11 ' OD2' ' A' ' 99' ' ' ASP . 5.5 p -156.39 21.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.319 0.581 . . . . 3.0800000000000001 111.302 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.438 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.28 -38.88 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 4.5800000000000001 110.012 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.252 -0.88 . . . . 3.79 111.051 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.62 0.248 . . . . 3.1699999999999999 111.277 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.27 -166.57 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.737 2.291 . . . . 2.0600000000000001 111.774 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.437 HD12 ' CB ' ' A' ' 86' ' ' SER . 11.8 tt -150.61 154.0 9.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 1.26 111.135 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' N ' HG12 ' A' ' 2' ' ' ILE . 79.0 m-20 -137.7 127.3 15.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.76 154.2 34.21 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.256 1.971 . . . . 0.58999999999999997 112.054 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.65 -179.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.717 2.278 . . . . 1.6100000000000001 113.098 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.81 -157.15 3.69 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.97999999999999998 112.749 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 31.1 tttt -91.41 134.08 30.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.7 -0.111 . . . . 2.04 110.7 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 6.0 Cg_exo -77.44 132.44 12.33 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.647 2.232 . . . . 0.54000000000000004 112.157 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.1 123.29 10.33 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.445 -0.343 . . . . 1.6799999999999999 111.538 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.8 Cg_exo -68.39 129.83 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.282 1.988 . . . . 0.64000000000000001 112.822 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.8 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.379 -0.6 . . . . 2.1699999999999999 109.379 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.65 100.89 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.84999999999999998 109.609 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -98.68 140.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.92 -0.582 . . . . 1.5700000000000001 112.071 -179.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -135.74 144.26 45.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.534 -0.757 . . . . 1.46 111.001 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -33.05 -47.97 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.58 0.956 . . . . 2.9100000000000001 113.58 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -106.73 -14.49 15.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.338 0.866 . . . . 1.3300000000000001 113.338 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.426 ' HA ' HD23 ' A' ' 66' ' ' LEU . 15.3 p -147.77 129.51 15.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.65 -0.42 . . . . 1.28 111.42 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.537 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 4.4 m -117.1 152.49 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.641 -0.423 . . . . 1.49 110.604 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.1 m -119.39 118.84 32.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 1.1399999999999999 111.168 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.28 155.63 47.98 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.428 0.632 . . . . 1.3100000000000001 111.288 179.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.61 159.64 42.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.031 -0.986 . . . . 2.3100000000000001 109.905 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.469 ' CZ3' ' O ' ' A' ' 59' ' ' ASN . 11.8 p90 -137.93 -171.83 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.40000000000000002 111.756 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.6 -171.93 3.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.919 -0.582 . . . . 1.1100000000000001 111.591 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -124.22 139.71 33.35 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 2.5600000000000001 111.0 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 16.8 Cg_endo -58.65 179.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 1.1100000000000001 112.106 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.17 0.29 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.156 0.428 . . . . 2.77 112.156 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -132.56 -72.6 0.52 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 121.082 -0.247 . . . . 1.6899999999999999 111.126 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.0 p 42.77 55.28 4.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.614 0.245 . . . . 1.3500000000000001 111.22 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.54 1.3 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.217 -0.516 . . . . 1.01 112.671 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.57 30.29 5.8 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.444 -1.063 . . . . 0.97999999999999998 110.444 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.38 177.91 4.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.971 -0.614 . . . . 0.98999999999999999 111.531 -178.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 -2.14 3.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.715 -0.675 . . . . 2.6899999999999999 111.941 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.483 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 14.9 mt 55.75 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-O 121.007 0.432 . . . . 1.71 110.746 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -106.18 17.82 22.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 1.6599999999999999 111.651 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.67 138.98 0.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.804 0.335 . . . . 1.97 111.594 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.483 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 48.3 m-85 -120.25 141.94 49.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.115 -0.493 . . . . 1.23 110.342 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.433 ' CG2' ' HE3' ' A' ' 50' ' ' LYS . 10.9 mm -108.17 156.24 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 1.76 110.767 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.452 -0.34 . . . . 1.6100000000000001 111.123 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt-10 -77.85 120.81 23.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 1.6699999999999999 109.574 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -106.33 148.84 27.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.362 0.601 . . . . 2.4399999999999999 111.961 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 3.2 ttp180 -131.06 111.42 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.158 -0.928 . . . . 1.79 109.557 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.3 79.88 1.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.611 -0.722 . . . . 1.5900000000000001 110.528 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 HD13 ' CB ' ' A' ' 94' ' ' ALA . 16.0 mt -63.54 142.66 97.96 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 1.4299999999999999 110.858 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -93.64 13.42 47.9 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.059 -1.226 . . . . 1.47 112.765 0.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -130.44 86.77 2.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.751 0.31 . . . . 2.6600000000000001 111.007 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.52 173.17 44.37 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.584 -0.817 . . . . 1.6200000000000001 112.718 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.16 143.2 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 3.0600000000000001 110.589 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 83.2 m95 -50.02 103.43 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 1.0600000000000001 111.234 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.79 141.57 47.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.488 -0.323 . . . . 1.8400000000000001 110.603 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HE3' ' CG2' ' A' ' 37' ' ' ILE . 46.2 mtpt -44.87 104.7 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.872 0.368 . . . . 1.77 111.36 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -69.98 -51.04 35.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.079 -0.51 . . . . 1.4099999999999999 110.655 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 1.0 OUTLIER -53.22 -64.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 2.0099999999999998 109.872 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 t80 62.33 38.23 13.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.405 -0.361 . . . . 2.6400000000000001 111.487 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -160.44 -89.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.71 -0.223 . . . . 2.0299999999999998 111.495 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -158.87 141.21 14.01 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.913 0.387 . . . . 1.8700000000000001 110.688 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.48 HG12 ' CD1' ' A' ' 61' ' ' PHE . 41.7 mt -139.28 65.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 1.3700000000000001 110.729 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.71 -63.28 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 2.1499999999999999 111.2 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -82.74 160.72 22.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.936 0.398 . . . . 1.54 110.527 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.469 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -72.25 -7.25 48.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.958 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.41 97.91 9.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.79 -0.448 . . . . 2.0499999999999998 109.79 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.48 ' CD1' HG12 ' A' ' 56' ' ' ILE . 62.4 t80 -129.82 165.2 22.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.0 -0.546 . . . . 0.56999999999999995 111.354 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 43.9 m -122.03 121.75 37.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.962 -0.563 . . . . 1.1399999999999999 110.508 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.483 ' CG1' ' CB ' ' A' ' 51' ' ' ALA . 25.1 t -80.61 100.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.952 -0.567 . . . . 1.72 111.56 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.29 138.16 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 110.78 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.3 -13.11 4.63 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.869 -0.681 . . . . 0.95999999999999996 112.385 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.489 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -55.74 -173.83 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.708 0.29 . . . . 2.02 110.462 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 m -152.01 163.71 38.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 1.55 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 tt0 -74.97 123.42 25.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 1.9099999999999999 110.887 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.4 t0 75.11 65.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.043 -0.526 . . . . 1.8700000000000001 111.498 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.6 113.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 1.2 110.899 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -64.46 133.73 53.06 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.766 -0.374 . . . . 1.1100000000000001 110.202 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.43 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 29.3 m-85 -126.29 118.11 24.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.21 -0.45 . . . . 1.0800000000000001 112.191 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.15 141.45 34.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 1.5 109.933 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.61 115.81 10.44 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.366 1.247 . . . . 0.79000000000000004 114.366 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.43 ' CG ' ' HG3' ' A' ' 91' ' ' PRO . 6.0 ptt85 -97.63 163.75 12.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.927 -0.768 . . . . 2.6899999999999999 108.927 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.449 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 48.7 t -116.94 133.82 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.778 0.659 . . . . 1.5700000000000001 112.778 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.479 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 40.6 mt -132.98 165.62 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.726 -1.213 . . . . 1.3200000000000001 107.726 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.479 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . 177.07 134.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.908 -0.717 . . . . 1.1100000000000001 112.107 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.4 ptpt -67.17 -99.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.653 -0.819 . . . . 2.3500000000000001 109.289 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 6.1 p30 170.43 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 110.497 -0.186 . . . . 2.7000000000000002 110.497 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.66 -42.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.029 -0.419 . . . . 1.3400000000000001 110.729 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -80.08 -10.27 59.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.574 . . . . 1.4299999999999999 112.237 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.21 -11.29 40.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.178 -1.01 . . . . 1.3799999999999999 112.501 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.86 115.87 4.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.112 -0.329 . . . . 1.49 110.112 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.9 tp -72.81 122.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.374 0.509 . . . . 1.48 112.374 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' HD12 ' A' ' 2' ' ' ILE . 2.6 p -89.36 131.74 39.52 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.959 -0.386 . . . . 0.81000000000000005 109.959 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -41.11 173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.571 2.847 . . . . 1.25 114.311 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 87.9 Cg_endo -87.56 172.79 5.63 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.235 2.623 . . . . 1.2 113.727 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -130.57 125.29 33.8 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.165 -0.925 . . . . 1.76 109.561 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -19.98 114.63 0.11 Allowed Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.228 0.955 . . . . 1.77 113.224 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 87.1 Cg_exo -47.7 144.02 11.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.699 2.266 . . . . 1.01 113.653 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.402 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.67 143.12 46.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.422 -0.808 . . . . 1.55 108.83 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -31.69 135.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.294 0.996 . . . . 1.6299999999999999 112.568 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -71.25 99.78 1.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.623 -0.717 . . . . 1.0900000000000001 109.718 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.9 mp -77.46 109.4 11.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 1.1299999999999999 110.946 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 59.5 m -49.12 -25.67 2.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 111.065 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 80.4 m 52.43 38.39 25.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 1.5700000000000001 110.744 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 1.021 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 17.2 ptp180 -71.98 -47.53 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 3.7000000000000002 111.696 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.309 ' OD2' HG23 ' A' ' 101' ' ' VAL . 20.1 p-10 -161.34 33.98 0.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.468 -0.787 . . . . 2.1400000000000001 110.284 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 50.97 21.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 2.0600000000000001 111.61 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.309 HG23 ' OD2' ' A' ' 99' ' ' ASP . 2.3 m -114.1 -26.57 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.936 -0.574 . . . . 3.0800000000000001 110.101 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.73 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 40.62 64.77 0.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.033 -0.531 . . . . 4.5800000000000001 111.549 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.195 -0.907 . . . . 3.79 111.066 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.445 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.582 0.23 . . . . 3.1699999999999999 111.149 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 4.7 Cg_exo -79.0 169.91 18.65 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.718 2.279 . . . . 2.0600000000000001 111.489 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.477 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 5.5 tt -171.03 140.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.416 . . . . 1.26 111.753 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.141 ' OD2' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.82 114.53 13.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 2.0 110.458 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.24 171.73 13.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.996 1.797 . . . . 0.58999999999999997 112.126 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 34.5 Cg_exo -59.24 179.32 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.839 2.359 . . . . 1.6100000000000001 112.789 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -86.91 171.44 42.85 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.094 -0.574 . . . . 0.97999999999999998 113.051 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 tttt -59.72 125.14 79.25 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 110.326 -0.25 . . . . 2.04 110.326 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 19.4 Cg_exo -71.53 143.74 43.32 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.54000000000000004 113.035 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.24 105.45 7.89 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 1.6799999999999999 110.537 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 31.7 Cg_exo -54.11 128.76 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.277 1.985 . . . . 0.64000000000000001 113.676 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD22 ' CB ' ' A' ' 21' ' ' LYS . 1.3 mm? -95.81 -26.68 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.697 -0.683 . . . . 2.1699999999999999 109.531 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -152.52 152.41 31.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.737 -0.665 . . . . 0.84999999999999998 110.478 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -150.59 111.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.94 0.4 . . . . 1.5700000000000001 110.287 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -109.16 69.0 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.841 0.682 . . . . 1.46 112.841 -178.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 1.7 mtp180 28.1 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 2.9100000000000001 113.147 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.2 m-70 176.69 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.213 0.53 . . . . 1.3300000000000001 109.596 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 p -112.25 93.7 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 1.28 110.708 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' CG1' HD22 ' A' ' 20' ' ' LEU . 48.0 t -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.558 -0.746 . . . . 1.49 110.789 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 56.0 m -90.13 144.27 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 1.1399999999999999 111.9 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -150.62 165.65 32.72 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.962 -1.017 . . . . 1.3100000000000001 111.903 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' CB ' HD22 ' A' ' 11' ' ' LEU . 15.6 tptm -143.47 138.72 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.744 -1.117 . . . . 2.3100000000000001 110.13 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.0 p90 -125.83 -176.56 3.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.40000000000000002 111.962 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -100.71 116.98 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.528 -0.76 . . . . 1.1100000000000001 110.972 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 144.21 49.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.523 -0.308 . . . . 2.5600000000000001 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 58.2 Cg_endo -70.19 169.92 18.32 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.614 2.209 . . . . 1.1100000000000001 112.412 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.32 -45.8 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 2.77 111.048 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.141 ' C ' ' OD2' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -89.75 66.06 6.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.846 -0.342 . . . . 1.6899999999999999 111.286 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.541 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 61.5 p -95.88 50.9 1.22 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.631 -0.507 . . . . 1.3500000000000001 109.631 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.16 -93.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.74 -0.663 . . . . 1.01 112.303 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.32 26.81 2.79 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.22 -0.752 . . . . 0.97999999999999998 111.22 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.508 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -118.28 -175.5 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.143 0.497 . . . . 0.98999999999999999 111.41 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 5.48 2.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.579 -0.737 . . . . 2.6899999999999999 111.876 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.496 HG22 ' CE1' ' A' ' 36' ' ' TYR . 14.1 mt 60.91 134.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.081 0.467 . . . . 1.71 110.654 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 p -108.1 2.37 22.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.6599999999999999 112.087 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 8.7 t -176.63 -176.12 0.7 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.97 111.85 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 40.7 m-85 -149.45 100.36 3.0 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.359 -0.837 . . . . 1.23 109.664 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.411 HG23 ' CB ' ' A' ' 50' ' ' LYS . 1.6 mt -84.65 121.87 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.943 -0.303 . . . . 1.76 111.304 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 2.8 t -96.17 103.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.534 -0.303 . . . . 1.6100000000000001 111.161 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 18.5 mt-10 -74.74 133.74 41.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.659 -0.497 . . . . 1.6699999999999999 109.659 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -116.88 147.68 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 2.4399999999999999 111.853 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 16.0 ttp180 -123.66 114.44 19.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.405 -0.816 . . . . 1.79 109.79 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -77.42 78.67 3.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.022 -0.535 . . . . 1.5900000000000001 110.655 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD13 ' CB ' ' A' ' 94' ' ' ALA . 20.6 mt -52.78 154.27 5.05 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 1.4299999999999999 110.827 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.19 0.35 34.38 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.688 -1.38 . . . . 1.47 113.213 0.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -97.64 -85.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.28 . . . . 2.6600000000000001 111.11 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.31 175.98 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.697 -0.763 . . . . 1.6200000000000001 112.581 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.2 30.1 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.097 0.475 . . . . 3.0600000000000001 110.309 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 57.8 m95 50.21 94.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 1.0600000000000001 110.984 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 0.5 OUTLIER -127.64 126.67 42.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 1.8400000000000001 110.622 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' CB ' HG23 ' A' ' 37' ' ' ILE . 1.8 ptpt -42.14 93.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 1.77 111.522 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -54.71 -51.31 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 1.4099999999999999 110.971 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.433 ' CB ' HD13 ' A' ' 56' ' ' ILE . 9.7 p-10 -65.08 114.45 4.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 110.943 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.35 16.13 7.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 2.6400000000000001 111.198 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -136.72 -160.15 1.03 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 2.0299999999999998 110.981 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 1.7 t-20 -98.77 113.48 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.8700000000000001 111.134 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.553 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 20.3 mm -87.56 59.03 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 1.3700000000000001 110.854 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.4 tp -43.59 -57.87 2.93 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.91 0.386 . . . . 2.1499999999999999 110.613 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -79.0 165.94 22.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -88.11 15.65 7.16 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.995 0.368 . . . . 1.75 111.995 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.7 111.6 18.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.372 -0.603 . . . . 2.0499999999999998 109.372 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.553 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 73.7 t80 -139.73 163.36 32.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.56999999999999995 112.051 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.2 m -114.03 106.13 14.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.06 -0.973 . . . . 1.1399999999999999 110.668 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HA ' ' HE2' ' A' ' 61' ' ' PHE . 90.8 t -66.8 82.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.44 -0.8 . . . . 1.72 111.312 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -88.03 -175.3 5.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 1.6399999999999999 110.936 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 23.93 72.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.95999999999999996 112.782 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.428 ' CD1' HG22 ' A' ' 18' ' ' VAL . 14.0 mt -97.1 -162.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 2.02 111.021 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 52.0 m -138.0 159.4 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 1.55 111.025 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -90.13 148.34 23.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 1.9099999999999999 111.109 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.4 40.69 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.8700000000000001 111.224 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -155.37 131.45 10.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 1.2 110.845 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 135.41 45.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.483 -0.326 . . . . 1.1100000000000001 110.361 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.403 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 30.5 m-85 -130.89 124.79 31.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.399 0.518 . . . . 1.0800000000000001 112.399 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.4 tt0 -102.97 139.24 38.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.631 -0.878 . . . . 1.5 108.631 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -139.08 118.85 13.15 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.26 1.578 . . . . 0.79000000000000004 115.26 -178.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -105.22 179.67 4.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.283 -1.006 . . . . 2.6899999999999999 108.283 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -144.43 121.3 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.439 -0.905 . . . . 1.5700000000000001 113.328 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.46 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 61.7 mt -106.99 152.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.138 -1.43 . . . . 1.3200000000000001 107.138 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -163.92 115.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.029 -1.068 . . . . 1.1100000000000001 112.809 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -62.29 -175.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.85 -0.74 . . . . 2.3500000000000001 109.644 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.508 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 3.1 m-80 -120.9 -114.13 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.569 -0.453 . . . . 2.7000000000000002 111.572 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.93 -38.38 2.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.412 0.551 . . . . 1.3400000000000001 111.361 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.19 23.46 3.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 1.4299999999999999 111.588 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.83 0.74 89.87 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.628 -0.796 . . . . 1.3799999999999999 113.311 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -69.94 112.83 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.987 0.394 . . . . 1.49 110.635 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -79.66 112.41 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.071 0.397 . . . . 1.48 112.071 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 5.4 p -71.59 121.45 84.44 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 120.433 -0.507 . . . . 0.81000000000000005 109.81 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.51 164.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.827 2.352 . . . . 1.25 112.609 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 3.8 Cg_exo -76.47 130.22 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.892 2.395 . . . . 1.2 112.895 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.5 OUTLIER -76.88 131.71 38.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.76 109.482 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 10.8 mt-10 -32.98 119.57 0.43 Allowed Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 123.689 0.618 . . . . 1.77 112.349 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.431 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 52.4 Cg_exo -52.4 150.43 20.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.465 2.11 . . . . 1.01 113.197 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 142.57 29.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.475 -0.784 . . . . 1.55 109.207 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.74 140.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.07 0.856 . . . . 1.6299999999999999 112.142 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -74.08 112.3 10.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.773 -0.648 . . . . 1.0900000000000001 110.699 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -98.8 117.75 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 1.1299999999999999 111.369 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.973 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 48.3 m -48.38 -28.33 3.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 1.1299999999999999 111.327 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 3.1 m 55.6 59.2 4.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 1.5700000000000001 110.44 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 1.03 ' HD2' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.9 -42.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 3.7000000000000002 111.252 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.287 ' OD1' ' HA ' ' A' ' 102' ' ' GLU . 7.7 p-10 -116.05 22.65 12.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.761 -0.654 . . . . 2.1400000000000001 111.428 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.475 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 36.58 47.12 0.5 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.841 0.829 . . . . 2.0600000000000001 111.314 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.944 HG11 ' OD2' ' A' ' 99' ' ' ASP . 11.7 p 164.87 -25.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.072 -1.876 . . . . 3.0800000000000001 109.511 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.287 ' HA ' ' OD1' ' A' ' 99' ' ' ASP . 3.0 mm-40 59.65 91.98 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.981 -0.554 . . . . 4.5800000000000001 110.88 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' N ' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.202 -0.904 . . . . 3.79 111.215 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.755 0.312 . . . . 3.1699999999999999 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -92.76 99.76 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.093 2.529 . . . . 2.0600000000000001 112.544 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.433 HD12 ' CB ' ' A' ' 86' ' ' SER . 2.0 tt -93.17 127.78 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 1.26 111.049 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.71 123.25 38.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.62 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.67 172.75 10.02 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.241 1.961 . . . . 0.58999999999999997 112.276 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.9 Cg_endo -61.39 171.15 4.5 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.839 2.359 . . . . 1.6100000000000001 112.68 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 -177.66 30.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.947 -0.644 . . . . 0.97999999999999998 112.671 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 91' ' ' PRO . 8.7 tptt -68.5 118.47 60.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.253 -0.277 . . . . 2.04 110.253 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 21.8 Cg_exo -67.51 122.91 10.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.387 2.058 . . . . 0.54000000000000004 111.733 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.76 112.69 28.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.518 -0.31 . . . . 1.6799999999999999 111.303 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.6 Cg_exo -61.88 120.27 7.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.547 2.164 . . . . 0.64000000000000001 113.5 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.56 -31.83 24.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 2.1699999999999999 109.665 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.22 145.78 33.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.84999999999999998 109.635 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.695 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.9 OUTLIER -144.07 96.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.7 0.63 . . . . 1.5700000000000001 112.7 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.108 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -82.87 158.65 22.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.225 -0.658 . . . . 1.46 109.225 178.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -60.61 -13.23 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.068 0.396 . . . . 2.9100000000000001 112.068 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -139.08 25.55 2.49 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.952 0.353 . . . . 1.3300000000000001 111.952 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.95 116.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.696 0.284 . . . . 1.28 110.922 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG12 ' CG2' ' A' ' 13' ' ' ILE . 86.4 t -105.38 137.26 35.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.392 . . . . 1.49 111.114 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.6 m -117.91 122.37 43.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 1.1399999999999999 111.552 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -132.33 152.67 51.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.739 0.78 . . . . 1.3100000000000001 112.07 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 9.5 tptt -133.35 155.03 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.411 -1.268 . . . . 2.3100000000000001 109.707 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.9 p90 -145.34 -177.54 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 0.40000000000000002 112.176 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.75 159.48 15.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.48 -0.782 . . . . 1.1100000000000001 111.357 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -88.23 137.52 30.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.012 -0.54 . . . . 2.5600000000000001 110.238 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' CB ' HG22 ' A' ' 28' ' ' THR . 2.6 Cg_endo -41.27 160.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.595 2.197 . . . . 1.1100000000000001 111.929 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.74 -29.6 11.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.498 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -122.85 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 1.6899999999999999 111.562 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.48 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 0.2 OUTLIER 46.54 54.44 8.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.809 0.337 . . . . 1.3500000000000001 110.863 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 37.79 -131.83 1.34 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.803 -0.635 . . . . 1.01 113.128 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 29.87 9.12 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.178 -1.169 . . . . 0.97999999999999998 110.178 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.543 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -96.49 175.3 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.679 -0.761 . . . . 0.98999999999999999 111.286 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -136.89 0.2 2.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.551 . . . . 2.6899999999999999 112.255 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.481 HD11 ' CE1' ' A' ' 36' ' ' TYR . 27.7 mt 60.69 138.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 121.007 0.432 . . . . 1.71 111.004 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 p -120.2 -11.91 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.202 0.445 . . . . 1.6599999999999999 112.202 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -167.61 138.51 2.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 1.97 111.54 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.481 ' CE1' HD11 ' A' ' 33' ' ' ILE . 25.0 m-85 -105.08 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 1.23 110.855 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -82.17 165.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.764 -0.458 . . . . 1.76 109.764 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -157.46 137.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.563 0.697 . . . . 1.6100000000000001 111.164 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.441 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 6.1 mt-10 -105.35 134.53 48.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.767 -1.106 . . . . 1.6699999999999999 110.185 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 146.97 27.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 2.4399999999999999 111.194 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.7 ttm180 -119.44 113.96 21.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 1.79 110.581 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 92.79 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.316 -0.856 . . . . 1.5900000000000001 109.69 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.478 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 7.8 mt -76.73 150.65 81.93 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 1.4299999999999999 111.23 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -88.54 -2.22 62.59 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.741 -1.358 . . . . 1.47 113.038 0.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -123.67 79.46 1.7 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.886 0.374 . . . . 2.6600000000000001 110.993 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.59 -166.16 10.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.797 -0.716 . . . . 1.6200000000000001 112.377 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.95 151.25 23.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 3.0600000000000001 110.898 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 59.2 m95 -64.35 116.76 6.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.88 -0.6 . . . . 1.0600000000000001 110.406 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.427 ' N ' ' HB3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -144.68 136.66 25.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.831 0.348 . . . . 1.8400000000000001 111.206 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -44.82 110.09 0.21 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 1.77 111.3 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.428 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -84.85 -37.3 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 1.4099999999999999 110.633 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 10.6 p-10 -82.43 178.6 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.569 . . . . 2.0099999999999998 110.475 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 178.92 36.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 2.6400000000000001 111.035 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.56 32.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 2.0299999999999998 111.285 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.77 121.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.8700000000000001 110.956 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.492 HD12 ' CD1' ' A' ' 61' ' ' PHE . 22.3 mt -116.28 76.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 1.3700000000000001 111.083 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 mt -59.43 -66.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 2.1499999999999999 111.463 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 168.24 9.08 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.874 0.369 . . . . 1.54 110.674 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 3.2 m-20 -86.61 8.06 23.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.077 -0.51 . . . . 1.75 111.419 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.84 103.88 12.74 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.694 0.283 . . . . 2.0499999999999998 110.35 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.492 ' CD1' HD12 ' A' ' 56' ' ' ILE . 65.1 t80 -135.16 163.12 30.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.56999999999999995 111.677 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.464 ' N ' ' CD2' ' A' ' 61' ' ' PHE . 9.1 m -122.93 117.23 25.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.644 -0.707 . . . . 1.1399999999999999 111.216 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 51' ' ' ALA . 47.8 t -83.31 101.92 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.037 -0.529 . . . . 1.72 110.942 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 p -94.15 162.91 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.366 0.603 . . . . 1.6399999999999999 110.997 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.49 7.35 24.38 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.969 -1.014 . . . . 0.95999999999999996 111.983 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.33 168.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.264 0.554 . . . . 2.02 111.449 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -139.26 98.88 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.245 -0.889 . . . . 1.55 109.284 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.5 tm-20 -37.24 139.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.5 0.556 . . . . 1.9099999999999999 112.5 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.18 42.34 0.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.726 -0.67 . . . . 1.8700000000000001 110.827 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.27 124.48 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 1.2 111.532 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.79 137.77 54.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.945 -0.391 . . . . 1.1100000000000001 109.945 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 30.6 m-85 -129.43 124.18 33.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.419 0.526 . . . . 1.0800000000000001 112.419 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.96 141.72 33.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.473 -0.566 . . . . 1.5 109.473 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -136.29 114.81 11.85 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.712 1.375 . . . . 0.79000000000000004 114.712 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' CD ' ' CD2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.29 151.89 22.16 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.345 -0.613 . . . . 2.6899999999999999 109.345 177.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -114.61 118.05 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.622 -0.831 . . . . 1.5700000000000001 112.922 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 66.7 mt -103.41 136.45 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.993 -1.484 . . . . 1.3200000000000001 106.993 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -151.33 139.28 19.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.502 -0.879 . . . . 1.1100000000000001 111.965 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.5 mttp -66.8 -133.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.727 -0.789 . . . . 2.3500000000000001 109.625 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -167.55 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.127 0.422 . . . . 2.7000000000000002 110.153 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -154.15 -42.14 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.824 0.345 . . . . 1.3400000000000001 110.754 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.38 -2.57 58.68 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.514 0.561 . . . . 1.4299999999999999 112.514 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.09 62.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.249 -0.977 . . . . 1.3799999999999999 113.332 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' O ' HD11 ' A' ' 2' ' ' ILE . . . -76.25 81.16 3.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.155 0.502 . . . . 1.49 109.895 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -40.2 119.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 114.397 1.258 . . . . 1.48 114.397 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 3.8 p -73.06 109.36 6.08 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 106.765 -1.568 . . . . 0.81000000000000005 106.765 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 9.4 Cg_endo -49.72 162.98 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.652 2.235 . . . . 1.25 113.799 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 53.2 Cg_exo -40.42 128.56 2.4 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.714 2.942 . . . . 1.2 114.53 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' GLU . 78.2 p -102.19 100.88 11.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.127 -0.942 . . . . 1.76 110.268 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 89' ' ' SER . 0.4 OUTLIER 11.8 115.84 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 125.037 1.335 . . . . 1.77 114.387 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.535 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 6.5 Cg_exo -67.21 135.16 36.16 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.02 1.813 . . . . 1.01 113.011 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.33 144.05 56.18 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.339 -0.615 . . . . 1.55 109.339 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -40.25 149.31 0.07 Allowed 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.66 0.6 . . . . 1.6299999999999999 111.235 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -76.06 119.17 19.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.945 -0.571 . . . . 1.0900000000000001 111.812 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.421 ' CG2' HD13 ' A' ' 13' ' ' ILE . 4.5 mp -99.52 118.73 46.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 110.695 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 m -50.03 -38.0 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 1.1299999999999999 111.124 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 2.8 m 62.23 43.96 8.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 1.5700000000000001 110.503 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.546 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 1.4 ptp85 -84.96 -91.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 3.7000000000000002 111.64 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.546 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 20.2 p-10 -113.46 28.19 8.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.541 -0.299 . . . . 2.1400000000000001 110.406 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.108 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.41 25.61 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.228 0.537 . . . . 2.0600000000000001 110.895 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.433 HG12 ' OD2' ' A' ' 99' ' ' ASP . 3.4 m -112.65 -26.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.387 -0.824 . . . . 3.0800000000000001 110.405 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.881 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.4 35.34 1.28 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.811 -0.631 . . . . 4.5800000000000001 111.485 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.695 ' HB1' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.261 -0.876 . . . . 3.79 111.213 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.736 0.303 . . . . 3.1699999999999999 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.48 150.1 21.82 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.175 2.583 . . . . 2.0600000000000001 112.23 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 tt -131.93 132.13 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.365 -0.38 . . . . 1.26 111.057 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.12 131.71 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 2.0 110.654 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 96.2 Cg_endo -81.73 168.6 15.81 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.589 2.193 . . . . 0.58999999999999997 112.385 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 73.0 Cg_exo -49.12 179.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.453 2.102 . . . . 1.6100000000000001 112.182 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.21 -167.17 42.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.97999999999999998 112.815 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.69 114.21 22.93 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.642 -0.133 . . . . 2.04 110.642 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 13.3 Cg_exo -70.49 131.32 19.98 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.423 2.082 . . . . 0.54000000000000004 112.494 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 8.9 p -142.55 106.92 5.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 1.6799999999999999 111.66 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 78.3 Cg_exo -36.18 141.74 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.991 2.461 . . . . 0.64000000000000001 112.79 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.14 -30.83 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.507 -0.553 . . . . 2.1699999999999999 109.507 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER -153.06 97.81 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 0.84999999999999998 109.988 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.69 133.23 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.997 0.74 . . . . 1.5700000000000001 112.997 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -127.85 137.86 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.95 -1.023 . . . . 1.46 110.092 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.433 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -29.35 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.006 1.113 . . . . 2.9100000000000001 114.006 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.1 m170 -120.16 -22.33 6.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.641 0.608 . . . . 1.3300000000000001 112.641 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' A' ' 14' ' ' THR . 13.6 p -134.44 130.33 36.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.25 -0.278 . . . . 1.28 110.25 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 4.5 m -124.91 141.34 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.142 0.496 . . . . 1.49 112.103 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.3 m -106.95 151.64 25.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 1.1399999999999999 109.788 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.51 152.02 37.32 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.532 0.682 . . . . 1.3100000000000001 112.021 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.71 147.46 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.581 -1.19 . . . . 2.3100000000000001 109.675 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 26.4 p90 -146.69 -174.0 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.40000000000000002 111.282 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -164.79 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 1.1100000000000001 110.784 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -137.08 139.87 29.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 2.5600000000000001 110.858 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 93.3 Cg_exo -41.24 158.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.415 2.076 . . . . 1.1100000000000001 111.952 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -112.49 -21.67 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.284 -0.417 . . . . 2.77 111.651 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -129.33 -71.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.049 -0.26 . . . . 1.6899999999999999 111.66 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.476 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 1.5 p 51.26 45.42 27.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 1.3500000000000001 110.37 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.79 -124.36 4.96 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.881 -0.6 . . . . 1.01 112.446 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.46 36.64 3.95 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.099 -1.201 . . . . 0.97999999999999998 110.099 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.549 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -105.28 177.58 4.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.639 -0.781 . . . . 0.98999999999999999 111.929 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 7.81 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.85 -0.613 . . . . 2.6899999999999999 111.869 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.4 HD12 ' HG2' ' A' ' 25' ' ' PRO . 12.7 mt 59.18 146.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 121.077 0.465 . . . . 1.71 111.251 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 p -114.14 -31.99 6.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.021 -0.536 . . . . 1.6599999999999999 112.44 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -169.64 135.43 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.947 0.351 . . . . 1.97 111.947 -179.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 57' ' ' LEU . 60.5 m-85 -88.74 89.34 7.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 1.23 111.263 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt -78.77 109.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 1.76 110.641 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 p -106.48 127.19 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 1.6100000000000001 111.208 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 27.1 mt-10 -92.65 149.53 21.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.83 -0.623 . . . . 1.6699999999999999 110.404 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.448 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.73 157.97 21.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.05 0.452 . . . . 2.4399999999999999 110.975 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CZ ' ' CZ2' ' A' ' 48' ' ' TRP . 12.9 ttp180 -133.52 112.71 11.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.438 -0.801 . . . . 1.79 109.576 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.88 107.13 6.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 1.5900000000000001 110.868 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -89.38 147.79 38.99 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 121.077 -0.249 . . . . 1.4299999999999999 110.627 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -93.17 15.94 44.35 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.8 -1.333 . . . . 1.47 112.493 0.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.18 93.68 2.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.856 0.36 . . . . 2.6600000000000001 110.966 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.21 -167.94 35.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.938 -0.648 . . . . 1.6200000000000001 112.365 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.55 171.44 20.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.719 0.295 . . . . 3.0600000000000001 111.211 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.494 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 62.3 m95 -70.06 121.78 18.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.995 -0.548 . . . . 1.0600000000000001 111.941 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -142.06 137.62 31.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 1.8400000000000001 110.598 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -46.94 92.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.4 . . . . 1.77 111.484 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -57.95 -61.45 2.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 1.4099999999999999 110.232 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -74.32 132.8 42.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.501 -0.772 . . . . 2.0099999999999998 110.266 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.57 35.49 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.167 -0.47 . . . . 2.6400000000000001 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -142.28 -68.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 2.0299999999999998 110.873 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 176.03 153.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.8700000000000001 110.847 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 HG22 ' CB ' ' A' ' 61' ' ' PHE . 13.6 mt -148.78 62.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 1.3700000000000001 110.596 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.41 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 7.7 tp -54.29 -60.51 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.986 -0.552 . . . . 2.1499999999999999 111.21 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -73.39 166.4 23.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.486 -0.325 . . . . 1.54 110.587 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 36.1 p30 -83.88 8.36 15.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 1.75 112.009 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -114.42 107.77 15.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.615 -0.513 . . . . 2.0499999999999998 109.615 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 39.9 t80 -141.94 165.51 27.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.471 . . . . 0.56999999999999995 111.832 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 33.4 m -119.52 121.49 39.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.698 -0.683 . . . . 1.1399999999999999 111.059 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 51' ' ' ALA . 15.0 t -86.05 109.05 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.287 -0.415 . . . . 1.72 111.189 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.03 132.16 44.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.981 -0.554 . . . . 1.6399999999999999 110.841 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.03 -12.75 2.84 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.757 -0.735 . . . . 0.95999999999999996 112.721 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -57.45 -171.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 2.02 110.667 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -160.59 155.14 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 1.55 110.629 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.97 144.11 56.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 1.9099999999999999 111.101 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.929 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 62.44 43.79 7.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 1.8700000000000001 111.443 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -156.35 115.65 3.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.869 0.366 . . . . 1.2 111.787 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . . . -70.25 130.74 42.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 1.1100000000000001 109.954 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 51.8 m-85 -124.15 118.97 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.424 0.527 . . . . 1.0800000000000001 112.424 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 92' ' ' SER . 2.1 mt-10 -99.04 145.14 27.41 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.364 -0.606 . . . . 1.5 109.364 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.93 119.41 14.87 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.319 1.229 . . . . 0.79000000000000004 114.319 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -93.99 142.99 26.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.845 -0.616 . . . . 2.6899999999999999 109.623 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG21 ' CG ' ' A' ' 8' ' ' PRO . 51.5 t -99.79 107.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.59 0.589 . . . . 1.5700000000000001 112.59 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 11.0 mt -106.76 151.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.536 -1.283 . . . . 1.3200000000000001 107.536 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -177.18 140.93 0.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.835 -0.746 . . . . 1.1100000000000001 111.816 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.3 mtmt -74.97 -155.64 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.101 -0.64 . . . . 2.3500000000000001 109.424 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.549 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -139.67 -80.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.85 0.357 . . . . 2.7000000000000002 110.603 -179.272 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -159.73 -41.77 0.05 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.098 -0.501 . . . . 1.3400000000000001 110.377 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -75.14 -13.67 60.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.955 -0.566 . . . . 1.4299999999999999 111.93 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.79 58.49 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.424 -0.893 . . . . 1.3799999999999999 113.0 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' A' ' 85' ' ' ILE . . . -51.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.032 0.416 . . . . 1.49 110.389 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' CB ' ' O ' ' A' ' 84' ' ' ALA . 0.9 OUTLIER 128.88 112.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.734 1.272 . . . . 1.48 112.495 178.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -75.74 110.53 10.99 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 107.834 -1.173 . . . . 0.81000000000000005 107.834 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 11.1 Cg_endo -52.8 165.07 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.341 2.027 . . . . 1.25 112.629 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 9.5 Cg_endo -51.56 135.37 48.09 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.132 2.554 . . . . 1.2 113.155 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -105.51 107.21 18.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.757 -0.656 . . . . 1.76 110.756 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 8.49 104.39 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.818 1.247 . . . . 1.77 114.013 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 73.4 Cg_exo -49.58 126.4 16.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.673 2.249 . . . . 1.01 113.579 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -57.51 149.31 21.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.006 -0.739 . . . . 1.55 109.006 178.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.85 149.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.729 0.643 . . . . 1.6299999999999999 111.27 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HB2' ' CB ' ' A' ' 71' ' ' ALA . . . -78.89 115.36 18.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.496 -0.775 . . . . 1.0900000000000001 110.13 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.476 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.5 mp -89.41 107.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 1.1299999999999999 111.075 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 91.1 m -44.05 -38.94 3.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.846 -0.615 . . . . 1.1299999999999999 111.58 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' ASP . 71.2 m 54.07 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.998 -0.371 . . . . 1.5700000000000001 109.998 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -88.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.881 0.372 . . . . 3.7000000000000002 111.466 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.734 ' OD2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.21 -10.59 27.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.298 -0.41 . . . . 2.1400000000000001 111.226 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 t0 51.53 24.01 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 2.0600000000000001 110.977 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.696 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.0 p -140.79 10.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 3.0800000000000001 111.631 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.734 ' HG2' ' OD2' ' A' ' 99' ' ' ASP . 13.2 pt-20 -133.05 -44.62 0.86 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.872 0.368 . . . . 4.5800000000000001 111.064 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.275 -0.869 . . . . 3.79 111.133 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.46 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 1.5 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 111.612 0.227 . . . . 3.1699999999999999 111.612 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 0' ' ' SER . 96.4 Cg_endo -81.62 177.9 7.11 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.645 2.23 . . . . 2.0600000000000001 112.561 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.43 HG13 ' ND2' ' A' ' 80' ' ' ASN . 3.7 tt -137.97 148.81 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 1.26 110.799 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.101 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.11 121.41 15.62 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 2.0 111.058 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.92 156.6 52.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.428 2.085 . . . . 0.58999999999999997 112.211 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.4 Cg_endo -52.44 -175.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.948 2.432 . . . . 1.6100000000000001 112.58 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.69 168.41 43.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.97999999999999998 112.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -56.23 125.29 64.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.63 -0.137 . . . . 2.04 110.63 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 6.5 Cg_exo -73.96 133.81 18.8 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.268 1.978 . . . . 0.54000000000000004 111.242 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.8 p -136.23 111.07 9.96 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.318 0.488 . . . . 1.6799999999999999 112.318 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 19' ' ' THR . 27.4 Cg_exo -58.68 94.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.458 2.105 . . . . 0.64000000000000001 113.296 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD23 ' N ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.64 -36.8 62.45 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.254 0.549 . . . . 2.1699999999999999 109.753 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.1 t30 -138.53 152.55 48.32 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.286 -0.87 . . . . 0.84999999999999998 109.582 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 13' ' ' ILE . 1.9 pt -141.34 97.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.411 . . . . 1.5700000000000001 111.509 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -90.02 45.02 1.24 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.82 -0.627 . . . . 1.46 112.428 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 16.5 mtp180 56.73 -73.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.514 0.561 . . . . 2.9100000000000001 112.514 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 14' ' ' THR . 10.0 m170 -76.92 -32.45 57.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 1.3300000000000001 110.832 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.2 p -127.78 113.09 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 1.28 109.865 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.51 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 10.3 m -110.9 119.15 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.634 0.73 . . . . 1.49 111.833 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.1 m -83.99 142.92 30.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 1.1399999999999999 110.637 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.52 164.51 33.2 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.121 0.888 . . . . 1.3100000000000001 111.76 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.09 152.56 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.449 -0.796 . . . . 2.3100000000000001 110.808 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.481 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.5 p90 -140.57 -174.42 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.047 0.451 . . . . 0.40000000000000002 111.76 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.92 -174.82 3.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 1.1100000000000001 111.407 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -119.42 138.02 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.5600000000000001 110.533 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.19 173.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.416 2.078 . . . . 1.1100000000000001 112.11 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.8 -19.2 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 2.77 111.803 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.4 t80 -123.79 -70.92 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.22 0.452 . . . . 1.6899999999999999 112.22 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 1.101 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 70.7 p 51.72 52.0 15.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.065 0.459 . . . . 1.3500000000000001 110.078 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 40.7 -106.27 0.06 OUTLIER Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.689 -0.687 . . . . 1.01 112.636 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.39 37.39 2.14 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.468 -1.053 . . . . 0.97999999999999998 110.468 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.3 m-85 -117.82 -178.58 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.094 -0.553 . . . . 0.98999999999999999 111.583 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -140.66 -0.38 1.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.583 -0.735 . . . . 2.6899999999999999 112.375 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 11.8 mt 56.34 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.976 0.417 . . . . 1.71 111.437 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -114.25 23.72 12.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 1.6599999999999999 111.605 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.1 t 178.55 135.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 1.97 111.352 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 49.9 m-85 -121.62 102.22 8.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 1.23 110.979 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -79.58 140.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.066 -0.346 . . . . 1.76 110.066 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.92 105.35 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.477 -0.329 . . . . 1.6100000000000001 111.885 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 80.1 mt-10 -75.59 150.34 38.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.92 -0.77 . . . . 1.6699999999999999 108.92 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.57 145.91 51.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 2.4399999999999999 112.202 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 16.2 ttp180 -121.0 105.09 10.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.177 -0.919 . . . . 1.79 109.595 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.837 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 82.9 0.45 Allowed 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.861 -0.608 . . . . 1.5900000000000001 110.491 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.473 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 3.1 mt -61.02 149.68 80.91 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.785 -0.643 . . . . 1.4299999999999999 110.904 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.29 18.9 26.59 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.096 -1.21 . . . . 1.47 113.067 0.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.74 83.13 1.34 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.668 0.27 . . . . 2.6600000000000001 111.386 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -103.83 -169.16 25.31 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.827 -0.701 . . . . 1.6200000000000001 112.518 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -139.77 8.84 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.735 0.272 . . . . 3.0600000000000001 111.735 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 19.5 m95 52.52 72.26 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 1.0600000000000001 110.959 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.63 137.77 54.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 1.8400000000000001 110.943 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.34 98.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 1.77 111.228 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HB2' HG11 ' A' ' 63' ' ' VAL . . . -58.25 -51.11 71.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 1.4099999999999999 110.498 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 12.7 p-10 -60.8 131.51 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 2.0099999999999998 110.937 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 30.4 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 2.6400000000000001 110.978 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t -138.89 -161.06 1.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 2.0299999999999998 110.701 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.91 114.5 28.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.384 . . . . 1.8700000000000001 111.186 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.502 HD12 ' CE1' ' A' ' 61' ' ' PHE . 33.6 mt -100.86 80.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 1.3700000000000001 110.852 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.19 -59.72 4.08 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.191 -0.459 . . . . 2.1499999999999999 111.52 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -77.31 167.07 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.909 0.385 . . . . 1.54 110.695 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.481 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 53.3 p30 -84.01 4.93 27.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 1.75 111.615 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.17 100.69 10.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.702 -0.481 . . . . 2.0499999999999998 109.702 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.502 ' CE1' HD12 ' A' ' 56' ' ' ILE . 75.4 t80 -131.66 163.02 29.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.234 0.54 . . . . 0.56999999999999995 112.2 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.45 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 42.8 m -131.61 124.54 30.17 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.254 -0.884 . . . . 1.1399999999999999 110.01 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 51' ' ' ALA . 7.4 t -82.81 94.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.072 0.463 . . . . 1.72 111.209 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -89.02 165.09 14.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.661 -0.699 . . . . 1.6399999999999999 111.078 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.5 8.46 83.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.95999999999999996 112.705 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 4.7 mt -58.82 -175.02 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.982 0.42 . . . . 2.02 110.775 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -131.5 133.23 44.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 1.55 110.471 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.13 149.92 45.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 1.9099999999999999 111.149 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.846 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 66.19 38.17 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 1.8700000000000001 110.788 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -156.1 116.74 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 1.2 111.535 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 131.94 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 1.1100000000000001 110.129 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 53.5 m-85 -125.33 127.15 46.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.658 0.614 . . . . 1.0800000000000001 112.658 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.437 ' HG3' ' CA ' ' A' ' 94' ' ' ALA . 4.7 mt-10 -108.45 134.04 51.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.974 -1.121 . . . . 1.5 107.974 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.52 ' CE1' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -131.17 121.64 25.23 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.753 1.39 . . . . 0.79000000000000004 114.753 -178.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' CA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -97.08 167.9 10.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.077 -0.51 . . . . 2.6899999999999999 109.828 178.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 71.6 t -116.3 145.41 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.397 0.617 . . . . 1.5700000000000001 111.974 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -141.45 152.91 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.549 -0.908 . . . . 1.3200000000000001 108.549 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -166.8 124.84 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.533 -0.867 . . . . 1.1100000000000001 112.457 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.55 95.92 7.28 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.067 -0.653 . . . . 2.3500000000000001 109.898 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 1.3 m120 -40.34 156.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 2.7000000000000002 111.667 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -20.77 -47.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.193 1.183 . . . . 1.3400000000000001 114.193 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -109.45 48.63 0.87 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.933 0.716 . . . . 1.4299999999999999 112.933 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.83 37.65 9.45 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.4 -0.905 . . . . 1.3799999999999999 113.248 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HB1' ' CZ ' ' A' ' 31' ' ' PHE . . . -78.3 1.02 23.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.88 0.371 . . . . 1.49 111.202 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 37.24 111.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 114.972 1.471 . . . . 1.48 114.972 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -93.27 111.45 51.98 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 113.909 -1.496 . . . . 0.81000000000000005 107.022 177.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.3 Cg_endo -45.67 172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.026 2.484 . . . . 1.25 113.656 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' CB ' ' HD3' ' A' ' 75' ' ' ARG . 19.0 Cg_exo -65.32 92.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.085 2.524 . . . . 1.2 113.141 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.65 105.33 0.29 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.941 -0.572 . . . . 1.76 110.035 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.401 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.1 tt0 4.83 117.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.15 1.38 . . . . 1.77 114.346 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.489 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 48.5 Cg_exo -42.62 170.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.943 2.429 . . . . 1.01 114.03 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -102.19 139.1 38.26 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 114.944 -1.025 . . . . 1.55 109.355 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -38.08 127.54 1.3 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.273 0.983 . . . . 1.6299999999999999 111.282 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.473 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -58.26 131.14 49.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.507 -0.769 . . . . 1.0900000000000001 111.384 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 3.2 mp -117.38 108.0 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.933 -0.576 . . . . 1.1299999999999999 110.961 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.2 m -46.64 -37.23 7.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 1.1299999999999999 110.824 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.435 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 59.7 m 59.85 37.71 21.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 1.5700000000000001 110.777 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.16 -39.78 16.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 3.7000000000000002 112.036 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.227 ' CG ' HG23 ' A' ' 101' ' ' VAL . 17.8 p-10 -156.09 24.65 0.37 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.382 -0.372 . . . . 2.1400000000000001 111.457 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 p30 51.91 19.81 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 2.0600000000000001 112.088 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.227 HG23 ' CG ' ' A' ' 99' ' ' ASP . 15.7 m -114.73 -20.22 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 120.706 0.289 . . . . 3.0800000000000001 110.711 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 45.87 55.27 7.12 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.949 0.404 . . . . 4.5800000000000001 111.25 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.267 -0.873 . . . . 3.79 111.129 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.657 0.265 . . . . 3.1699999999999999 111.131 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.467 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 98.5 Cg_endo -89.62 -174.6 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.899 2.399 . . . . 2.0600000000000001 112.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.444 HD13 ' ND2' ' A' ' 80' ' ' ASN . 1.6 tt -158.12 140.49 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 1.26 111.074 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -122.52 134.86 25.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 2.0 110.462 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.55 160.7 10.9 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.593 2.195 . . . . 0.58999999999999997 113.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 77.1 Cg_exo -52.53 167.61 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.058 2.506 . . . . 1.6100000000000001 113.125 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.32 -179.88 38.47 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.37 -0.832 . . . . 0.97999999999999998 112.226 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -66.9 124.21 88.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 O-C-N 122.846 -0.208 . . . . 2.04 110.688 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.6 Cg_exo -70.64 135.65 28.84 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.355 2.037 . . . . 0.54000000000000004 112.178 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -130.41 115.44 17.28 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.288 -0.414 . . . . 1.6799999999999999 111.214 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.5 Cg_exo -70.42 114.45 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.209 1.94 . . . . 0.64000000000000001 113.575 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.84 -33.56 57.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.497 -0.927 . . . . 2.1699999999999999 108.497 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -140.5 151.2 44.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.754 -1.112 . . . . 0.84999999999999998 109.043 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.642 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 4.2 pt -140.87 97.59 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.489 0.551 . . . . 1.5700000000000001 112.489 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.259 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -85.7 140.28 30.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 1.46 110.007 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -24.48 1.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 2.9100000000000001 112.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -120.44 -1.75 10.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.393 0.516 . . . . 1.3300000000000001 112.393 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.2 p -160.5 119.61 2.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.601 0.239 . . . . 1.28 110.672 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.495 HG13 ' CE2' ' A' ' 74' ' ' PHE . 46.5 t -102.97 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.474 . . . . 1.49 111.668 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 22.7 m -109.85 121.82 46.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.819 -0.628 . . . . 1.1399999999999999 111.405 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.94 161.8 35.04 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.676 0.75 . . . . 1.3100000000000001 112.139 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -138.6 151.54 47.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.574 -1.194 . . . . 2.3100000000000001 110.295 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.7 p90 -136.77 -178.05 5.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.264 0.554 . . . . 0.40000000000000002 112.073 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.61 -154.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.417 -0.81 . . . . 1.1100000000000001 110.395 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -155.08 127.16 3.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.748 -0.381 . . . . 2.5600000000000001 111.727 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -46.32 179.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.181 2.587 . . . . 1.1100000000000001 112.772 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -122.36 -10.06 8.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 2.77 111.971 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.467 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 5.6 t80 -116.76 -72.65 0.68 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.615 -0.434 . . . . 1.6899999999999999 112.107 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 68.6 p 49.63 47.03 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.1 0.476 . . . . 1.3500000000000001 110.364 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.12 -93.39 0.01 OUTLIER Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.615 -0.721 . . . . 1.01 112.306 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.35 32.99 1.48 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.265 -1.134 . . . . 0.97999999999999998 110.265 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -120.96 -172.8 2.46 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.752 -0.724 . . . . 0.98999999999999999 111.314 -178.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 8.1 ptmt -145.33 39.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 2.6899999999999999 111.077 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.58 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 1.4 mp 62.48 -81.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 1.71 110.492 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.419 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 2.9 p 59.6 29.59 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.6599999999999999 111.493 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 172.23 94.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 1.97 111.4 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.58 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 58.6 m-85 -102.61 81.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 1.23 111.172 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.45 HG23 ' CB ' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -72.53 110.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.461 -0.495 . . . . 1.76 110.359 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 61' ' ' PHE . 4.9 t -85.28 81.55 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 111.991 0.367 . . . . 1.6100000000000001 111.991 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.78 138.75 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.457 -0.572 . . . . 1.6699999999999999 109.457 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.7 153.62 26.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.371 0.605 . . . . 2.4399999999999999 112.152 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.39 98.52 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.054 -0.975 . . . . 1.79 110.201 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -75.2 76.74 2.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 1.5900000000000001 110.875 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD13 ' CB ' ' A' ' 94' ' ' ALA . 12.3 mt -57.27 138.26 80.65 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 1.4299999999999999 111.131 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -92.2 17.36 42.15 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 124.009 -1.246 . . . . 1.47 112.763 0.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.6 p30 -121.84 53.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.51 -0.314 . . . . 2.6600000000000001 111.398 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -104.35 173.89 21.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.507 -0.854 . . . . 1.6200000000000001 112.329 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HG2' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -165.92 42.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 3.0600000000000001 110.997 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.569 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 20.8 m95 40.85 69.26 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.958 -0.565 . . . . 1.0600000000000001 111.855 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' CD2' ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -101.29 121.32 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.765 0.317 . . . . 1.8400000000000001 110.389 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' CB ' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -43.94 92.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 1.77 111.454 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -62.61 -46.39 88.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 1.4099999999999999 110.438 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 12.1 p-10 -62.57 127.11 29.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 2.0099999999999998 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.73 -17.34 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 2.6400000000000001 111.113 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -110.63 145.93 37.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 2.0299999999999998 110.814 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.8 111.43 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 1.8700000000000001 110.915 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 19.7 mm -75.63 90.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.315 -0.402 . . . . 1.3700000000000001 110.871 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.51 -38.23 65.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.965 0.412 . . . . 2.1499999999999999 110.457 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.73 154.33 18.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 1.54 109.589 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.505 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 26.1 p-10 -75.3 -0.71 20.6 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.093 0.405 . . . . 1.75 112.093 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.652 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 2.5 tp10 -100.73 105.47 16.81 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.44 -0.578 . . . . 2.0499999999999998 109.44 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 58.2 t80 -137.15 165.99 24.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.346 0.594 . . . . 0.56999999999999995 111.922 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -133.06 100.4 4.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.205 -0.907 . . . . 1.1399999999999999 110.843 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 14.9 m -57.29 142.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 1.72 111.04 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -136.12 154.17 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.72 0.772 . . . . 1.6399999999999999 111.131 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.16 -5.9 19.61 Favored Glycine 0 C--N 1.313 -0.711 0 CA-C-N 114.48 -1.236 . . . . 0.95999999999999996 112.3 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -62.85 -175.52 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.834 0.349 . . . . 2.02 110.815 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 m -149.35 130.66 14.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.435 . . . . 1.55 110.634 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.92 149.35 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 1.9099999999999999 111.085 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.84 48.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.8700000000000001 110.793 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.2 130.81 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 1.2 111.625 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -74.82 135.13 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 1.1100000000000001 110.243 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -131.8 121.77 24.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.926 0.393 . . . . 1.0800000000000001 111.99 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.3 137.74 35.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.86 -0.792 . . . . 1.5 108.86 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -122.21 106.76 11.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.42 1.267 . . . . 0.79000000000000004 114.42 -179.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.491 ' HB2' ' HG3' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -104.49 143.47 32.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.136 -0.938 . . . . 2.6899999999999999 108.927 178.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.445 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -116.51 136.33 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.958 -0.697 . . . . 1.5700000000000001 112.001 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 77' ' ' ILE . 33.9 mt -117.21 153.17 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.907 -1.042 . . . . 1.3200000000000001 108.513 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -146.35 117.4 7.77 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.371 -0.531 . . . . 1.1100000000000001 111.735 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 23.0 ptmt -86.89 14.75 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.15 0.796 . . . . 2.3500000000000001 113.15 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 2.6 m-80 43.51 -179.91 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.074 1.138 . . . . 2.7000000000000002 114.074 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . . . -57.61 -50.26 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.972 -1.467 . . . . 1.3400000000000001 112.372 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -88.79 34.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.584 0.587 . . . . 1.4299999999999999 112.584 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.1 39.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.544 -0.836 . . . . 1.3799999999999999 113.045 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . -69.11 94.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 1.49 109.257 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.4 tp -61.04 107.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.294 0.85 . . . . 1.48 113.294 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.455 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 16.2 p -87.52 108.5 20.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.978 -1.119 . . . . 0.81000000000000005 107.978 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.5 Cg_endo -42.01 172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.125 2.55 . . . . 1.25 113.883 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 54.1 Cg_exo -51.81 129.04 28.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.9 2.4 . . . . 1.2 112.466 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 15.2 m -99.94 106.12 17.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.334 -0.394 . . . . 1.76 110.419 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER 1.92 117.69 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.243 0 O-C-N 124.696 1.248 . . . . 1.77 113.355 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 9.1 Cg_exo -69.29 160.59 49.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.803 1.669 . . . . 1.01 113.915 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -87.28 141.1 28.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.779 -1.193 . . . . 1.55 107.779 178.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.447 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -32.12 138.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.042 0.839 . . . . 1.6299999999999999 112.201 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.449 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -67.53 101.25 0.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.158 -0.473 . . . . 1.0900000000000001 111.063 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 4.6 mp -84.2 115.03 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.926 0.393 . . . . 1.1299999999999999 111.053 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 23.8 m -52.45 -23.52 6.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.875 -0.602 . . . . 1.1299999999999999 110.6 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 7.6 m 50.12 84.34 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.089 0.471 . . . . 1.5700000000000001 109.875 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.654 ' HD2' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -132.35 -87.36 0.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.716 -0.675 . . . . 3.7000000000000002 110.979 -179.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.903 ' CG ' HG11 ' A' ' 101' ' ' VAL . 26.7 p-10 -93.28 21.9 5.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.125 -0.489 . . . . 2.1400000000000001 110.631 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.259 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER 43.07 29.93 0.23 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.273 0.559 . . . . 2.0600000000000001 111.54 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.903 HG11 ' CG ' ' A' ' 99' ' ' ASP . 7.3 p -164.57 25.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 3.0800000000000001 110.599 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.747 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 29.3 74.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.17 0.804 . . . . 4.5800000000000001 113.17 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.178 -0.915 . . . . 3.79 111.111 179.922 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.756 0.312 . . . . 3.1699999999999999 111.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.5 -151.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 2.0600000000000001 111.545 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 tt -166.69 131.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 1.26 111.422 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -111.61 130.45 23.11 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 2.0 110.186 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.72 162.43 24.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.412 2.075 . . . . 0.58999999999999997 112.38 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' N ' ' HG3' ' A' ' 25' ' ' PRO . 53.7 Cg_exo -54.39 178.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.929 2.419 . . . . 1.6100000000000001 113.37 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.69 161.02 30.59 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.97999999999999998 112.517 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.4 tttt -53.23 132.53 51.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 110.244 -0.28 . . . . 2.04 110.244 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 4.5 Cg_exo -82.01 136.89 9.44 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.445 2.097 . . . . 0.54000000000000004 112.396 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.87 121.23 18.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.6799999999999999 110.849 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 19' ' ' THR . 16.7 Cg_exo -65.71 100.71 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.439 2.093 . . . . 0.64000000000000001 113.417 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.7 OUTLIER -58.95 -35.01 72.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.869 -0.789 . . . . 2.1699999999999999 108.869 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -142.07 151.45 42.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.661 -1.154 . . . . 0.84999999999999998 108.339 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 1.053 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -139.84 113.61 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.129 -0.629 . . . . 1.5700000000000001 112.301 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.017 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.61 151.27 23.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.65 -0.705 . . . . 1.46 109.865 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -10.52 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.61 0.596 . . . . 2.9100000000000001 112.61 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -135.07 20.09 3.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.273 . . . . 1.3300000000000001 111.323 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.429 ' O ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 168.13 114.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 1.28 109.956 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' A' ' 74' ' ' PHE . 14.5 m -108.4 146.68 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.594 -0.442 . . . . 1.49 110.632 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 4.1 m -110.58 120.21 41.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 1.1399999999999999 111.979 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.36 171.1 14.16 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.662 0.744 . . . . 1.3100000000000001 111.804 178.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.67 173.22 16.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.024 -0.989 . . . . 2.3100000000000001 109.123 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 3.1 p90 -138.37 -168.36 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.595 0.591 . . . . 0.40000000000000002 112.595 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.67 -13.41 22.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.416 0.895 . . . . 1.1100000000000001 113.416 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.453 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 74.34 149.84 0.13 Allowed Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 110.121 -0.325 . . . . 2.5600000000000001 110.121 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 20.0 Cg_exo -65.96 -167.35 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.33 2.02 . . . . 1.1100000000000001 113.047 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -148.74 -45.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 2.77 110.787 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.1 77.16 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.6899999999999999 111.283 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 22.6 p -92.47 46.73 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.3500000000000001 109.95 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.16 -98.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.546 -0.835 . . . . 1.01 111.653 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.2 29.48 2.92 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.578 -1.009 . . . . 0.97999999999999998 110.578 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -117.38 174.39 6.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.091 -0.555 . . . . 0.98999999999999999 111.071 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -0.58 4.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 2.6899999999999999 111.457 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.435 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 23.3 mt 63.25 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.178 -0.304 . . . . 1.71 110.178 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -107.69 -15.25 14.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.715 0.635 . . . . 1.6599999999999999 112.715 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 1.5 m -167.43 158.58 11.68 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.397 0.518 . . . . 1.97 112.397 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 78' ' ' ALA . 26.3 m-85 -117.36 131.4 56.79 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.861 -0.609 . . . . 1.23 110.014 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 5.6 mt -104.84 132.49 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.852 -0.613 . . . . 1.76 111.023 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.401 HG12 HG23 ' A' ' 63' ' ' VAL . 5.1 t -110.33 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.265 -0.425 . . . . 1.6100000000000001 111.278 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 14.0 mt-10 -85.42 131.2 34.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.532 -0.544 . . . . 1.6699999999999999 109.532 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.32 129.26 48.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 111.854 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 5.4 ttp180 -105.9 92.59 4.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.634 -0.712 . . . . 1.79 109.488 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -62.96 146.75 52.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.54 . . . . 1.5900000000000001 109.574 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 10.0 mt -127.12 131.0 23.65 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.871 -0.332 . . . . 1.4299999999999999 110.808 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -88.5 38.98 3.14 Favored 'Cis proline' 0 C--N 1.352 0.726 0 C-N-CA 124.542 -1.024 . . . . 1.47 113.026 0.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -114.2 56.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.314 . . . . 2.6600000000000001 110.607 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -62.17 169.61 13.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.792 -0.718 . . . . 1.6200000000000001 113.262 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.51 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.657 0.265 . . . . 3.0600000000000001 111.628 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 68.5 m95 63.17 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.248 -0.279 . . . . 1.0600000000000001 110.248 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.34 121.58 11.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.838 0.351 . . . . 1.8400000000000001 110.796 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 6.2 ptpt -51.03 111.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 1.77 111.105 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.92 -11.94 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 111.258 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 6.1 p-10 -74.21 -60.94 2.04 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.654 -0.418 . . . . 2.0099999999999998 111.871 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 4.8 t80 78.37 -51.32 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.549 0.214 . . . . 2.6400000000000001 111.409 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -173.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.036 0.446 . . . . 2.0299999999999998 111.47 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.0 80.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.786 -0.643 . . . . 1.8700000000000001 110.764 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.48 HD12 ' CD1' ' A' ' 61' ' ' PHE . 70.3 mt -71.11 103.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 1.3700000000000001 110.733 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.36 -50.82 2.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 2.1499999999999999 111.665 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -56.66 -20.26 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.137 0.421 . . . . 1.54 112.137 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.2 p-10 89.17 -25.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.71 0.804 . . . . 1.75 111.65 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -81.93 86.56 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.751 -0.833 . . . . 2.0499999999999998 108.751 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 62' ' ' THR . 55.0 t80 -120.8 165.56 14.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.328 0.585 . . . . 0.56999999999999995 111.998 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.514 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 54.9 m -123.7 122.26 37.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 110.84 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 20' ' ' LEU . 9.6 t -81.91 95.7 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.159 0.504 . . . . 1.72 110.834 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 t -83.26 -158.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.495 -0.775 . . . . 1.6399999999999999 110.74 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.72 19.62 36.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.511 -0.852 . . . . 0.95999999999999996 112.248 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.528 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 68.7 mt -75.12 -176.97 3.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 2.02 110.607 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -144.59 144.29 31.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 1.55 110.68 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -70.67 146.92 49.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 1.9099999999999999 110.971 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.2 t0 60.4 41.23 16.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.551 . . . . 1.8700000000000001 111.16 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -150.69 124.67 9.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.732 0.301 . . . . 1.2 111.347 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 1.1100000000000001 110.056 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 68.8 m-85 -126.86 126.15 42.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.143 0.794 . . . . 1.0800000000000001 113.143 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -100.01 137.72 38.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.219 -0.66 . . . . 1.5 109.219 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.55 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.89 116.88 23.64 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.486 0.921 . . . . 0.79000000000000004 113.486 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -102.25 145.76 28.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.855 -0.612 . . . . 2.6899999999999999 110.967 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -105.94 104.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.479 0.548 . . . . 1.5700000000000001 112.479 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 30.2 mt -105.03 147.77 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.9 -1.519 . . . . 1.3200000000000001 106.9 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 36' ' ' TYR . . . -166.04 144.04 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.16 -1.016 . . . . 1.1100000000000001 112.74 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.02 -172.35 4.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 2.3500000000000001 110.136 179.123 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 50.0 p30 -126.09 -128.52 0.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.391 -0.368 . . . . 2.7000000000000002 110.279 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -116.06 -28.15 6.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.158 0.89 . . . . 1.3400000000000001 111.24 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -82.02 4.75 21.66 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.179 0.437 . . . . 1.4299999999999999 112.179 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.13 78.73 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.425 -0.893 . . . . 1.3799999999999999 113.303 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.8 161.98 28.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.118 0.459 . . . . 1.49 110.448 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 2.9 tp -115.26 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.48 112.629 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 2.0 p -74.48 113.72 26.76 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.262 -0.644 . . . . 0.81000000000000005 109.262 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.35 163.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.749 2.3 . . . . 1.25 113.041 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 28.1 Cg_endo -63.99 144.96 89.18 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.826 2.351 . . . . 1.2 113.126 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -98.99 127.17 44.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.593 -0.73 . . . . 1.76 109.963 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt0 -20.97 98.33 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 O-C-N 124.587 1.179 . . . . 1.77 113.067 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 42.0 Cg_exo -35.67 166.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.57 2.847 . . . . 1.01 115.574 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 1.5 m -93.32 141.49 28.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 113.696 -1.593 . . . . 1.55 109.02 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.87 139.42 0.65 Allowed 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 123.731 0.644 . . . . 1.6299999999999999 111.412 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -70.37 102.23 2.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.017 -0.538 . . . . 1.0900000000000001 109.923 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.474 HD12 ' CE2' ' A' ' 74' ' ' PHE . 4.4 mp -84.26 111.74 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.941 0.401 . . . . 1.1299999999999999 111.226 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' ALA . 66.8 m -47.63 -30.11 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 1.1299999999999999 111.254 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 69' ' ' ASP . 79.2 m 49.6 89.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 1.5700000000000001 110.323 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.486 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.77 -85.95 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 3.7000000000000002 111.28 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.074 ' OD1' ' HB2' ' A' ' 102' ' ' GLU . 4.5 p-10 -101.72 2.37 38.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 2.1400000000000001 111.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.053 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 43.4 29.2 0.22 Allowed 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.359 0.503 . . . . 2.0600000000000001 112.359 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.053 HG11 ' OD2' ' A' ' 99' ' ' ASP . 7.7 p -162.62 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.781 -0.645 . . . . 3.0800000000000001 110.507 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.074 ' HB2' ' OD1' ' A' ' 99' ' ' ASP . 1.4 mt-10 -137.96 -43.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.61 . . . . 4.5800000000000001 110.966 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.28 -0.867 . . . . 3.79 111.212 -179.968 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.748 0.309 . . . . 3.1699999999999999 111.322 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -90.89 156.21 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.098 2.532 . . . . 2.0600000000000001 112.472 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' ASP . 4.9 tt -113.36 151.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.067 0.461 . . . . 1.26 111.312 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.325 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -133.86 128.17 19.65 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.615 -0.721 . . . . 2.0 109.875 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.62 176.37 9.17 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.42 2.08 . . . . 0.58999999999999997 112.379 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 21.0 Cg_exo -65.39 178.29 2.17 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.809 2.339 . . . . 1.6100000000000001 112.729 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.06 172.49 55.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.988 -0.625 . . . . 0.97999999999999998 112.614 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.826 ' HZ3' ' CD ' ' A' ' 90' ' ' GLU . 10.0 tttp -58.66 120.44 45.49 Favored Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.021 -0.105 . . . . 2.04 110.722 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 22.2 Cg_exo -67.58 127.09 15.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.077 . . . . 0.54000000000000004 112.802 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 11.6 p -133.18 107.46 12.37 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 115.821 -0.627 . . . . 1.6799999999999999 111.158 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.1 Cg_exo -37.67 142.58 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.827 2.352 . . . . 0.64000000000000001 113.292 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.71 -44.63 6.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.747 -1.115 . . . . 2.1699999999999999 108.372 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.8 t30 -148.11 155.61 41.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.997 -1.456 . . . . 0.84999999999999998 109.061 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 1.01 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -143.85 100.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.436 -0.505 . . . . 1.5700000000000001 111.69 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.252 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -98.87 50.13 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.943 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.842 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.68 -70.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.998 0.811 . . . . 2.9100000000000001 112.075 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 8.4 m170 -77.41 -26.85 52.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 1.3300000000000001 111.255 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -125.23 112.12 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.819 0.343 . . . . 1.28 111.148 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' CG1' HG23 ' A' ' 13' ' ' ILE . 72.9 t -107.23 110.68 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.086 -0.506 . . . . 1.49 111.171 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 79.4 m -88.43 149.19 23.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 1.1399999999999999 110.678 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.88 154.71 38.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.533 0.682 . . . . 1.3100000000000001 112.148 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' O ' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -143.86 144.83 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.737 -1.12 . . . . 2.3100000000000001 110.171 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 10.9 p90 -140.57 -172.31 3.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 0.40000000000000002 111.545 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.73 159.36 14.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.319 0.581 . . . . 1.1100000000000001 112.337 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.422 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.4 139.59 28.36 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.32 -0.854 . . . . 2.5600000000000001 110.057 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -44.85 169.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.336 2.024 . . . . 1.1100000000000001 111.869 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -119.04 -4.87 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.099 0.407 . . . . 2.77 112.099 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.727 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.5 t80 -141.42 -73.89 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 1.6899999999999999 111.933 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 1.325 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.8 p 79.6 -39.28 0.2 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.225 0.61 . . . . 1.3500000000000001 112.315 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.7 -82.81 0.33 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.498 -0.858 . . . . 1.01 111.554 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.18 27.57 0.79 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.114 -1.194 . . . . 0.97999999999999998 110.114 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.523 ' CE2' ' OD1' ' A' ' 80' ' ' ASN . 1.7 m-85 -116.94 -177.07 3.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.705 -0.748 . . . . 0.98999999999999999 111.404 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.56 -3.06 2.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.652 -0.704 . . . . 2.6899999999999999 111.923 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 25' ' ' PRO . 15.0 mt 60.76 140.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 120.8 0.334 . . . . 1.71 110.506 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -123.96 6.74 8.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.359 0.503 . . . . 1.6599999999999999 112.359 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 178.0 162.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.134 0.492 . . . . 1.97 111.965 179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 42.5 m-85 -128.76 101.11 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.411 -0.813 . . . . 1.23 110.3 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -87.62 122.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.623 -0.262 . . . . 1.76 110.888 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 p -110.84 128.61 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.044 0.449 . . . . 1.6100000000000001 110.815 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.458 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mt-10 -90.0 136.17 33.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.91 -0.586 . . . . 1.6699999999999999 112.227 -179.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.472 ' HG3' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -99.8 132.43 45.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.419 0.896 . . . . 2.4399999999999999 113.419 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 7.5 ttm180 -115.4 107.61 15.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.484 . . . . 1.79 110.077 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 90.6 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.869 -0.605 . . . . 1.5900000000000001 111.015 -179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 15.8 mt -66.05 150.22 96.9 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.45 -0.341 . . . . 1.4299999999999999 110.611 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.78 -9.25 47.24 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.086 -1.214 . . . . 1.47 112.794 0.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -60.26 -61.98 2.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.907 0.384 . . . . 2.6600000000000001 110.725 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.36 142.92 6.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.916 -0.659 . . . . 1.6200000000000001 112.839 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 176.3 64.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 3.0600000000000001 110.692 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 80.9 m95 -33.89 98.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.446 -0.797 . . . . 1.0600000000000001 111.881 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.23 139.52 53.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.189 0.519 . . . . 1.8400000000000001 112.271 -179.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' CG2' ' A' ' 37' ' ' ILE . 4.2 mtmt -57.33 86.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.549 -0.751 . . . . 1.77 110.868 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -59.31 -51.98 67.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 1.4099999999999999 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.476 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 7.0 p-10 -61.49 150.94 34.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.0099999999999998 111.189 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.88 27.67 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.786 -0.643 . . . . 2.6400000000000001 110.544 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -130.68 30.41 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 2.0299999999999998 110.727 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.52 111.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 1.8700000000000001 110.734 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.491 HD12 ' CG ' ' A' ' 61' ' ' PHE . 19.6 mt -101.32 71.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 1.3700000000000001 111.275 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -50.84 -80.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.489 . . . . 2.1499999999999999 110.85 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.97 168.63 5.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.996 -0.372 . . . . 1.54 109.996 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -88.81 47.11 1.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.992 0.425 . . . . 1.75 111.533 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -144.32 101.28 3.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 2.0499999999999998 109.308 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CG ' HD12 ' A' ' 56' ' ' ILE . 77.0 t80 -134.53 165.22 25.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.56999999999999995 112.135 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 85.1 m -131.27 116.59 17.82 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.489 -0.778 . . . . 1.1399999999999999 110.861 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 63' ' ' VAL . 7.2 m -77.42 110.06 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.72 111.045 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.24 126.18 51.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.059 -0.518 . . . . 1.6399999999999999 111.098 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.97 -1.31 2.8 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.539 -0.839 . . . . 0.95999999999999996 113.659 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.453 HD12 ' NZ ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -51.77 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.189 0.519 . . . . 2.02 111.302 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.1 m -135.45 117.02 14.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.631 -0.713 . . . . 1.55 110.7 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.3 132.53 12.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.061 -0.518 . . . . 1.9099999999999999 111.32 -179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.3 t0 73.77 67.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 1.8700000000000001 111.243 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 177.27 124.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.2 111.064 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.433 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -69.37 130.81 43.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 1.1100000000000001 110.454 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.514 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 38.4 m-85 -126.07 122.93 37.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 1.0800000000000001 112.017 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.2 tt0 -107.22 141.32 38.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.282 -0.636 . . . . 1.5 109.282 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -141.55 125.16 16.8 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.153 1.168 . . . . 0.79000000000000004 114.153 -179.24 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.421 ' HB3' ' CD ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -100.38 165.83 11.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.034 -0.53 . . . . 2.6899999999999999 109.78 178.592 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -122.95 114.08 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 113.557 0.947 . . . . 1.5700000000000001 113.557 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.451 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 56.6 mt -108.11 154.85 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.562 -1.644 . . . . 1.3200000000000001 106.562 177.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . . . -167.39 131.27 1.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.955 -1.098 . . . . 1.1100000000000001 113.473 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -83.67 143.32 30.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.655 -0.702 . . . . 2.3500000000000001 109.288 178.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' OD1' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -78.89 -106.71 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.077 -0.511 . . . . 2.7000000000000002 111.902 -178.952 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.01 -28.36 2.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.783 0.72 . . . . 1.3400000000000001 112.622 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -94.85 20.78 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.429 0.529 . . . . 1.4299999999999999 112.429 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 87.72 -17.04 47.49 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.378 -0.915 . . . . 1.3799999999999999 112.772 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.339 . . . . 1.49 110.414 179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 2.4 tt -77.81 112.18 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.494 . . . . 1.48 112.005 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.5 p -66.06 122.11 79.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.854 -0.612 . . . . 0.81000000000000005 109.896 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -35.04 158.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.415 2.744 . . . . 1.25 113.45 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 12.0 Cg_exo -71.22 148.21 55.23 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.871 2.381 . . . . 1.2 112.423 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -97.32 129.49 44.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 1.76 109.748 179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.826 ' CD ' ' HZ3' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -30.8 111.67 0.29 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.805 0.691 . . . . 1.77 112.372 -179.476 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.7 Cg_exo -37.93 148.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.762 2.308 . . . . 1.01 113.629 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -85.66 139.66 31.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.062 -0.972 . . . . 1.55 109.457 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -32.72 139.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.28 0.988 . . . . 1.6299999999999999 112.363 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.483 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -75.47 109.93 9.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.558 -0.746 . . . . 1.0900000000000001 110.731 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -92.54 115.77 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.029 0.443 . . . . 1.1299999999999999 111.225 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.1 m -47.22 -30.81 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.869 -0.605 . . . . 1.1299999999999999 111.535 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 91.5 m 54.19 62.39 2.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.91 0.386 . . . . 1.5700000000000001 110.182 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.71 -86.84 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 3.7000000000000002 111.623 -179.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -116.83 28.33 8.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 2.1400000000000001 110.662 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.252 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 49.05 22.86 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 2.0600000000000001 111.543 -179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.98 -20.96 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 116.244 -0.434 . . . . 3.0800000000000001 110.849 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.093 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.61 43.31 6.45 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.092 0.472 . . . . 4.5800000000000001 111.458 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.179 -0.915 . . . . 3.79 111.27 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.422 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.429 0.157 . . . . 3.1699999999999999 111.362 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.467 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 1.1 Cg_endo -82.72 53.04 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.883 2.388 . . . . 2.0600000000000001 111.765 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.418 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 2.0 tt -49.43 136.14 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 1.26 111.842 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.42 137.0 23.69 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.055 -0.52 . . . . 2.0 110.419 179.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 160.14 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.443 2.096 . . . . 0.58999999999999997 112.418 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 46.3 Cg_exo -56.32 172.3 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.822 2.348 . . . . 1.6100000000000001 112.98 -179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.88 174.21 20.69 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.97999999999999998 112.817 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -66.63 138.08 95.36 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 110.544 -0.169 . . . . 2.04 110.544 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 7.2 Cg_exo -77.87 139.32 17.43 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.818 2.345 . . . . 0.54000000000000004 112.502 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.9 p -145.9 126.37 7.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.33 -0.395 . . . . 1.6799999999999999 111.456 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -66.87 141.21 58.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.76 2.307 . . . . 0.64000000000000001 113.757 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 21' ' ' LYS . 1.4 mm? -107.32 -36.17 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.627 -0.879 . . . . 2.1699999999999999 108.627 178.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.4 t30 -139.36 150.73 45.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.614 -1.176 . . . . 0.84999999999999998 108.297 179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' CG2' HG12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -143.86 101.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.259 -0.576 . . . . 1.5700000000000001 112.068 -179.279 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -93.89 56.89 2.37 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 115.881 -0.599 . . . . 1.46 110.863 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.84 -74.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.024 0.827 . . . . 2.9100000000000001 112.886 179.389 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -73.99 -37.8 64.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.99 0.367 . . . . 1.3300000000000001 111.99 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.3 p -122.46 110.27 15.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.718 0.294 . . . . 1.28 111.02 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.531 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 4.1 m -99.29 152.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.886 0.374 . . . . 1.49 111.288 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.9 m -118.21 123.92 46.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 1.1399999999999999 111.32 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.52 162.74 32.27 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.413 0.625 . . . . 1.3100000000000001 111.336 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.956 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -151.3 158.46 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 2.3100000000000001 110.12 179.384 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.491 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.6 p90 -137.42 -167.82 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.40000000000000002 111.316 -179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.11 -166.59 1.45 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.354 0.597 . . . . 1.1100000000000001 112.367 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HD3' ' HG2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -114.59 141.45 26.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.148 -0.933 . . . . 2.5600000000000001 110.228 -179.858 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 12.1 Cg_endo -55.35 172.63 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.247 1.965 . . . . 1.1100000000000001 112.186 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.26 -39.17 2.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 2.77 111.106 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.467 ' CE1' ' HG2' ' A' ' 1' ' ' PRO . 1.8 t80 -120.28 71.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 1.6899999999999999 111.478 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 73.8 p -91.01 44.24 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.501 -0.318 . . . . 1.3500000000000001 110.539 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.07 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.704 -0.76 . . . . 1.01 112.501 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.95 49.26 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.987 -1.245 . . . . 0.97999999999999998 109.987 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -136.57 177.45 7.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.984 -0.608 . . . . 0.98999999999999999 110.929 -178.208 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -138.53 6.31 2.5 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.09 0.404 . . . . 2.6899999999999999 112.09 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.451 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 3.5 mt 58.52 150.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 120.851 0.358 . . . . 1.71 111.042 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -131.73 15.09 4.87 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.0 0.37 . . . . 1.6599999999999999 112.0 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 42.3 t 179.25 124.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 1.97 111.092 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 22.8 m-85 -105.38 88.21 2.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 1.23 111.195 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.458 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.4 mm -69.39 151.96 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.95 -0.3 . . . . 1.76 110.323 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.17 103.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.272 0.558 . . . . 1.6100000000000001 110.782 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.51 161.92 29.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.367 -0.833 . . . . 1.6699999999999999 110.04 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HG2' ' HB1' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -136.41 153.35 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 2.4399999999999999 111.391 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 23.7 ttm180 -134.69 121.33 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 1.79 110.801 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.809 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.56 91.62 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.593 . . . . 1.5900000000000001 110.859 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.47 HD23 ' CG ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -56.3 152.52 23.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 1.4299999999999999 110.53 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.37 30.4 11.85 Favored 'Cis proline' 0 C--N 1.348 0.533 0 C-N-CA 123.911 -1.287 . . . . 1.47 112.573 0.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.99 99.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.368 . . . . 2.6600000000000001 111.139 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.809 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -135.35 -123.12 2.29 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.685 -0.769 . . . . 1.6200000000000001 112.89 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -135.03 -169.83 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.431 0.158 . . . . 3.0600000000000001 110.716 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.497 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 4.4 m95 -136.33 49.67 2.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 1.0600000000000001 110.946 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.5 148.3 25.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.8400000000000001 111.231 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 8.2 ptmm? -79.16 89.61 4.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.127 -0.488 . . . . 1.77 110.875 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.422 ' HB1' ' HG2' ' A' ' 40' ' ' LYS . . . -49.02 -41.83 36.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.01 0.433 . . . . 1.4099999999999999 110.575 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 8.8 t30 -60.46 100.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.796 -0.638 . . . . 2.0099999999999998 110.159 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -104.86 28.66 6.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 2.6400000000000001 111.321 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.3 t -130.47 -70.64 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.344 . . . . 2.0299999999999998 111.005 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 170.58 153.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 1.8700000000000001 110.588 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 56' ' ' ILE . 16.8 mt -142.09 56.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 1.3700000000000001 111.253 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 tp -48.46 -38.24 19.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 2.1499999999999999 110.747 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.77 166.74 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 1.54 110.161 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.491 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 56.6 p30 -89.22 15.12 9.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.496 -0.32 . . . . 1.75 111.651 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.956 ' OE1' ' HB3' ' A' ' 21' ' ' LYS . 19.7 tp10 -122.71 99.56 6.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 2.0499999999999998 109.615 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CZ ' ' HB2' ' A' ' 52' ' ' ASN . 26.1 t80 -131.71 166.6 21.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.007 0.432 . . . . 0.56999999999999995 111.424 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.498 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 21.6 m -117.58 120.67 38.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.713 -0.676 . . . . 1.1399999999999999 111.076 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -84.14 104.29 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.16 0.505 . . . . 1.72 111.507 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.5 -168.64 1.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.461 -0.79 . . . . 1.6399999999999999 110.404 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.44 11.82 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.572 -0.823 . . . . 0.95999999999999996 112.893 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 16.2 mt -69.18 -159.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.927 -0.397 . . . . 2.02 109.927 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.7 m -147.69 147.73 30.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.902 0.382 . . . . 1.55 110.594 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.78 145.82 30.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 1.9099999999999999 110.988 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t0 67.65 39.4 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 1.8700000000000001 111.058 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.95 122.91 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 1.2 111.452 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -68.78 133.22 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.884 -0.413 . . . . 1.1100000000000001 109.884 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 35.6 m-85 -124.38 127.37 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.691 0.626 . . . . 1.0800000000000001 112.691 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' CG ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -98.05 138.24 35.66 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.178 -1.045 . . . . 1.5 108.178 178.225 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.42 108.7 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.523 -1.271 . . . . 0.79000000000000004 113.937 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' NH1' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -88.67 159.72 17.7 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.112 -0.329 . . . . 2.6899999999999999 110.112 179.041 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.458 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 64.6 t -121.2 122.84 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.427 0.632 . . . . 1.5700000000000001 112.585 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.455 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 39.5 mt -117.06 155.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.719 -1.215 . . . . 1.3200000000000001 107.719 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -172.4 138.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.378 -0.929 . . . . 1.1100000000000001 112.178 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 5.2 ptpt -84.57 176.53 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 2.3500000000000001 110.766 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 2.4 p-10 -124.57 163.61 21.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.871 -0.604 . . . . 2.7000000000000002 111.208 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -47.82 -25.53 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 1.3400000000000001 111.906 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -77.22 -12.39 59.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.897 0.332 . . . . 1.4299999999999999 111.897 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 -17.75 57.68 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.49 -0.862 . . . . 1.3799999999999999 112.425 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.33 -162.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.54 0.209 . . . . 1.49 110.492 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -145.0 105.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 1.48 112.001 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -63.44 119.56 54.55 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.81000000000000005 108.734 179.175 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.98 159.25 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.89 2.393 . . . . 1.25 113.242 -179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 24.0 Cg_endo -62.56 150.78 86.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.907 2.405 . . . . 1.2 113.264 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 m -106.53 132.8 52.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.805 . . . . 1.76 109.651 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 13.7 tt0 -30.25 111.91 0.29 Allowed Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.867 0.73 . . . . 1.77 112.325 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.49 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 71.7 Cg_exo -45.66 139.57 10.15 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.787 2.324 . . . . 1.01 114.324 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.479 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -53.75 144.54 17.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.834 -0.802 . . . . 1.55 108.834 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 4.7 m-20 -14.62 -89.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.743 1.902 . . . . 1.6299999999999999 113.793 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . 158.43 106.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.967 0.907 . . . . 1.0900000000000001 109.239 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.9 mp -98.04 112.99 31.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.756 -0.378 . . . . 1.1299999999999999 111.956 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.4 m -47.44 -32.53 5.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.869 -0.605 . . . . 1.1299999999999999 110.276 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 92.8 m 55.65 82.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.839 -0.618 . . . . 1.5700000000000001 110.163 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -88.19 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.743 -0.662 . . . . 3.7000000000000002 111.392 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.13 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 2.4 p30 -124.77 9.02 8.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.478 -0.328 . . . . 2.1400000000000001 111.568 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 42.3 t0 50.46 26.14 2.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.969 0.414 . . . . 2.0600000000000001 110.893 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.54 14.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 3.0800000000000001 111.667 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.13 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -136.29 -58.22 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.063 0.458 . . . . 4.5800000000000001 110.328 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.336 -0.84 . . . . 3.79 111.196 179.787 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.551 0.215 . . . . 3.1699999999999999 111.078 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.76 -167.01 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 2.0600000000000001 112.318 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -158.26 145.78 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.22 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.3 m-20 -128.87 132.09 24.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.077 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 158.1 53.15 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.368 2.045 . . . . 0.58999999999999997 112.4 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 9.9 Cg_endo -52.03 175.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.943 2.429 . . . . 1.6100000000000001 112.763 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.91 168.62 49.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.024 -0.608 . . . . 0.97999999999999998 112.665 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.73 121.89 61.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 110.461 -0.199 . . . . 2.04 110.461 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 32.1 Cg_exo -62.17 147.85 94.29 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.426 2.084 . . . . 0.54000000000000004 112.451 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.52 110.48 2.97 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.314 -0.403 . . . . 1.6799999999999999 111.954 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.5 Cg_exo -59.63 127.34 23.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.613 2.209 . . . . 0.64000000000000001 113.52 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.483 HD22 ' OE2' ' A' ' 60' ' ' GLU . 0.7 OUTLIER -94.16 -26.37 16.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.373 -0.831 . . . . 2.1699999999999999 109.081 178.512 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 7.5 t30 -145.85 149.53 34.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.696 -0.684 . . . . 0.84999999999999998 109.897 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -151.56 103.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.415 . . . . 1.5700000000000001 111.132 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.218 ' CA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.48 60.42 0.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.883 -0.599 . . . . 1.46 111.544 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.166 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 59.12 -70.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.671 0.607 . . . . 2.9100000000000001 112.445 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.0 m170 -87.31 -27.18 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.185 -0.461 . . . . 1.3300000000000001 111.762 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.8 p -111.86 103.47 11.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 1.28 111.424 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.495 HG13 ' CE1' ' A' ' 74' ' ' PHE . 86.9 t -102.07 95.73 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 1.49 111.038 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 12' ' ' ASN . 78.3 m -80.96 142.52 33.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.248 -0.433 . . . . 1.1399999999999999 111.636 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -154.85 164.77 38.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.43 -0.805 . . . . 1.3100000000000001 112.009 -179.702 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.836 ' HB3' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.47 176.14 10.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.107 -0.951 . . . . 2.3100000000000001 109.302 178.448 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 18.8 p90 -158.01 -177.54 6.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.275 0.56 . . . . 0.40000000000000002 112.303 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.28 178.65 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.147 -0.933 . . . . 1.1100000000000001 110.65 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 157.07 40.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.403 -0.362 . . . . 2.5600000000000001 110.21 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 37.1 Cg_exo -56.45 -157.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.506 2.138 . . . . 1.1100000000000001 112.443 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -26.19 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.32 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -134.24 -67.73 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.856 0.317 . . . . 1.6899999999999999 111.856 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 2.8 p 65.31 34.63 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 1.3500000000000001 110.515 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.39 -95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.53 -0.843 . . . . 1.01 111.813 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.65 28.85 1.46 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.526 -1.029 . . . . 0.97999999999999998 110.526 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -107.01 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.193 -0.503 . . . . 0.98999999999999999 111.591 -178.947 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -133.41 -0.41 3.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.66 -0.7 . . . . 2.6899999999999999 111.706 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 mt 60.89 129.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 120.932 0.396 . . . . 1.71 110.901 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -116.71 25.99 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.442 -0.345 . . . . 1.6599999999999999 111.63 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m 172.09 164.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 1.97 111.169 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.451 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 40.7 m-85 -142.36 106.18 4.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 1.23 110.504 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.35 94.62 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 1.76 111.039 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -86.42 114.58 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 1.6100000000000001 110.75 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 2.0 mm-40 -86.0 156.79 20.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.634 -0.712 . . . . 1.6699999999999999 110.922 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.62 142.99 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.4399999999999999 111.316 -179.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -119.03 114.01 21.84 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.037 -0.529 . . . . 1.79 110.584 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.74 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.7 102.08 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.5900000000000001 110.492 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 46.8 mt -80.09 156.12 74.52 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.964 -0.562 . . . . 1.4299999999999999 110.583 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 89.1 Cg_endo -86.26 28.64 9.63 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.88 -1.3 . . . . 1.47 113.489 0.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.3 -86.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.636 0.255 . . . . 2.6600000000000001 110.555 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 117.43 170.69 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.456 -0.878 . . . . 1.6200000000000001 113.208 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.74 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 1.0 OUTLIER 176.68 -35.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.407 . . . . 3.0600000000000001 110.566 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 34.0 m95 62.92 81.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 1.0600000000000001 111.406 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -122.54 128.67 51.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.759 -0.655 . . . . 1.8400000000000001 110.234 179.786 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -55.11 87.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 1.77 110.76 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -51.4 -47.56 62.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.4099999999999999 111.226 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.441 ' O ' ' CB ' ' A' ' 53' ' ' PHE . 2.0 t30 -44.79 -79.2 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 2.0099999999999998 110.983 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER 84.46 -43.12 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.181 0.437 . . . . 2.6400000000000001 112.181 179.624 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.2 m -67.02 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 2.0299999999999998 111.28 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 140.13 1.05 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 1.8700000000000001 110.798 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.501 HG12 ' CD1' ' A' ' 61' ' ' PHE . 51.4 mt -130.16 67.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 1.3700000000000001 110.982 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.09 -65.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.463 . . . . 2.1499999999999999 110.751 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.42 179.27 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.549 . . . . 1.54 110.115 179.568 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 5.3 p-10 -93.7 13.24 22.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.398 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.836 ' CD ' ' HB3' ' A' ' 21' ' ' LYS . 16.1 tp10 -117.63 105.48 12.08 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.981 -0.377 . . . . 2.0499999999999998 109.981 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.51 ' CG ' ' N ' ' A' ' 62' ' ' THR . 37.3 t80 -137.51 165.99 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.56999999999999995 111.156 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.51 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -122.53 120.42 33.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.919 -0.582 . . . . 1.1399999999999999 111.372 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 5.5 t -83.17 85.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 1.72 111.029 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -86.98 -169.78 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.618 -0.719 . . . . 1.6399999999999999 110.632 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.22 25.1 46.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.95999999999999996 112.411 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 44.1 mt -77.63 -178.04 5.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 2.02 111.104 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 134.14 54.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 1.55 110.496 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.68 152.09 28.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 1.9099999999999999 111.223 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.73 60.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 1.8700000000000001 110.985 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 178.13 130.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 1.2 111.359 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 94' ' ' ALA . . . -71.72 128.63 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 1.1100000000000001 110.194 179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -124.21 124.92 43.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.846 0.684 . . . . 1.0800000000000001 112.846 -178.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.411 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 19.8 mt-10 -100.03 141.12 33.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.798 -0.815 . . . . 1.5 108.798 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.495 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -130.88 120.8 24.17 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.358 1.244 . . . . 0.79000000000000004 114.358 -178.704 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -105.47 169.85 8.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.746 -0.661 . . . . 2.6899999999999999 109.778 178.493 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 61.2 t -125.54 105.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.428 0.899 . . . . 1.5700000000000001 113.428 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.44 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 44.3 mt -100.59 130.57 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 106.934 -1.506 . . . . 1.3200000000000001 106.934 177.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 36' ' ' TYR . . . -156.91 147.74 21.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.452 -0.899 . . . . 1.1100000000000001 113.046 -178.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.3 mttt -77.31 -167.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 2.3500000000000001 110.345 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 49.7 p30 -129.78 -119.5 0.23 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.475 -0.565 . . . . 2.7000000000000002 109.475 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.02 1.14 5.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.49 1.041 . . . . 1.3400000000000001 111.71 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -112.01 4.32 18.02 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.597 0.221 . . . . 1.4299999999999999 111.597 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.84 -11.76 64.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.344 -0.932 . . . . 1.3799999999999999 112.929 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.96 177.03 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.936 0.368 . . . . 1.49 110.394 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -130.88 101.31 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 1.48 111.989 -179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -57.57 118.35 24.91 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.553 -0.906 . . . . 0.81000000000000005 108.553 178.817 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -42.8 171.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.896 2.397 . . . . 1.25 113.313 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 6.7 Cg_exo -71.3 130.73 17.9 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.778 2.318 . . . . 1.2 112.778 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -87.86 108.26 19.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.765 -0.652 . . . . 1.76 109.932 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 89' ' ' SER . 1.6 mt-10 -10.3 115.3 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.458 1.103 . . . . 1.77 113.401 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 89.2 Cg_exo -47.91 163.34 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.736 2.291 . . . . 1.01 114.217 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.38 151.99 19.95 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 1.55 109.48 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -32.33 140.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 124.3 1.0 . . . . 1.6299999999999999 112.455 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -79.01 113.08 16.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.767 -0.651 . . . . 1.0900000000000001 111.138 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.57 116.29 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 1.1299999999999999 110.828 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.6 m -46.17 -26.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.885 -0.598 . . . . 1.1299999999999999 111.47 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 34.2 m 47.34 78.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.571 -0.286 . . . . 1.5700000000000001 111.273 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -121.87 -79.55 0.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.096 0.474 . . . . 3.7000000000000002 110.99 179.999 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.022 ' OD1' ' HB ' ' A' ' 101' ' ' VAL . 3.3 p30 -122.66 26.33 8.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.52 -0.764 . . . . 2.1400000000000001 110.451 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.218 ' OD1' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.98 24.1 0.82 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.002 -0.545 . . . . 2.0600000000000001 111.225 -179.237 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.022 ' HB ' ' OD1' ' A' ' 99' ' ' ASP . 58.9 t -123.77 -13.96 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 3.0800000000000001 111.435 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.31 28.96 0.33 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.841 0.353 . . . . 4.5800000000000001 111.468 179.841 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.31 -0.853 . . . . 3.79 111.095 179.916 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.68 0.276 . . . . 3.1699999999999999 111.148 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.62 110.26 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.687 2.258 . . . . 2.0600000000000001 112.332 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.448 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.0 tt -81.47 147.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 1.26 111.064 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 13.1 m-20 -136.77 133.48 18.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 2.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.67 174.95 9.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.665 2.243 . . . . 0.58999999999999997 112.439 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 24.5 Cg_exo -63.97 -164.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.9 2.4 . . . . 1.6100000000000001 113.175 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -102.38 -151.89 24.0 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.675 -0.693 . . . . 0.97999999999999998 112.852 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.24 125.24 64.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.056 -0.085 . . . . 2.04 110.791 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 4.3 Cg_exo -80.09 141.79 14.95 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.763 2.308 . . . . 0.54000000000000004 112.314 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.23 116.11 4.7 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.077 -0.511 . . . . 1.6799999999999999 111.463 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 19' ' ' THR . 23.0 Cg_exo -62.0 104.22 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.577 2.185 . . . . 0.64000000000000001 113.081 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -64.99 -35.05 79.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.48 0.657 . . . . 2.1699999999999999 109.601 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.6 t30 -140.3 153.49 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.941 -1.027 . . . . 0.84999999999999998 108.77 179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 13' ' ' ILE . 1.2 pt -144.88 108.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.704 -0.399 . . . . 1.5700000000000001 111.882 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -101.48 59.89 0.89 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.106 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 49.34 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.951 0.782 . . . . 2.9100000000000001 112.59 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 14' ' ' THR . 31.8 m170 -82.27 -34.72 28.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.231 -0.441 . . . . 1.3300000000000001 111.609 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -119.05 106.19 12.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.883 0.373 . . . . 1.28 110.923 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 10.3 m -104.57 154.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 1.49 111.163 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.4 m -123.07 123.63 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.1399999999999999 111.259 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -131.2 159.58 37.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 111.714 179.212 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 2.0 tppt? -140.83 157.24 45.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.814 -1.085 . . . . 2.3100000000000001 109.776 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.473 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 25.5 p90 -149.12 -176.1 5.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.294 0.568 . . . . 0.40000000000000002 112.264 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -94.49 121.87 36.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.399 -0.819 . . . . 1.1100000000000001 110.7 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 150.12 96.41 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 121.0 -0.28 . . . . 2.5600000000000001 110.576 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.472 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 77.6 Cg_exo -43.52 173.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 1.1100000000000001 112.823 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -26.16 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.145 0.424 . . . . 2.77 112.145 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -124.45 -70.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.178 0.436 . . . . 1.6899999999999999 112.178 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 20.0 p 56.04 55.01 7.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.713 0.292 . . . . 1.3500000000000001 110.655 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.82 -93.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.055 -0.521 . . . . 1.01 112.657 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.54 34.48 0.89 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.127 -1.589 . . . . 0.97999999999999998 109.127 178.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.474 ' HB3' ' CB ' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -113.63 142.99 45.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.275 -0.963 . . . . 0.98999999999999999 111.54 -178.318 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -92.25 -8.18 46.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.112 -0.495 . . . . 2.6899999999999999 111.459 179.606 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.434 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 16.2 mt 71.47 -75.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 1.71 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p 72.96 18.34 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.838 0.31 . . . . 1.6599999999999999 111.838 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.5 OUTLIER 179.85 145.8 0.21 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.073 0.463 . . . . 1.97 112.121 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -133.05 104.14 6.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.859 -0.61 . . . . 1.23 111.083 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 15.3 mt -78.66 93.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 1.76 110.463 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 1.5 p -91.08 106.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 1.6100000000000001 111.384 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.4 mm-40 -71.29 167.13 20.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.372 -0.831 . . . . 1.6699999999999999 111.143 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.74 151.99 49.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 2.4399999999999999 111.399 -179.716 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.3 ttm180 -138.49 104.61 5.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 1.79 109.904 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.35 105.84 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.5900000000000001 111.027 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.94 151.06 81.84 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 1.4299999999999999 110.641 179.742 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -92.87 22.15 30.1 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.987 -1.256 . . . . 1.47 112.576 0.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -148.64 75.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 2.6600000000000001 111.274 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -131.67 177.46 18.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 1.6200000000000001 112.415 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.69 -148.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.595 -0.15 . . . . 3.0600000000000001 110.595 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 16.1 m95 -136.71 74.27 1.48 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.996 0.427 . . . . 1.0600000000000001 110.981 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.81 137.16 48.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.829 -0.623 . . . . 1.8400000000000001 110.795 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 14.9 ptmt -52.54 92.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.06 -0.518 . . . . 1.77 111.837 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.458 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -54.15 -49.11 70.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.456 0.646 . . . . 1.4099999999999999 109.867 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 3.1 t30 -44.43 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.1 -0.955 . . . . 2.0099999999999998 110.822 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.7 43.09 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 2.6400000000000001 110.774 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -152.35 -71.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 2.0299999999999998 111.119 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 179.24 143.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.8700000000000001 110.888 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.494 HG12 ' CD1' ' A' ' 61' ' ' PHE . 37.2 mt -149.14 64.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 1.3700000000000001 110.975 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -46.22 -69.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 2.1499999999999999 111.345 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.56 179.57 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.502 -0.317 . . . . 1.54 110.741 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -86.53 10.62 14.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.699 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -107.98 104.32 13.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.551 -0.537 . . . . 2.0499999999999998 109.551 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 52' ' ' ASN . 43.6 t80 -131.13 164.27 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.391 0.615 . . . . 0.56999999999999995 111.84 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.6 m -127.91 115.74 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.966 -1.016 . . . . 1.1399999999999999 109.506 179.308 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 15.4 t -76.09 111.6 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.042 0.448 . . . . 1.72 111.701 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 140.23 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.637 -0.71 . . . . 1.6399999999999999 110.706 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.07 7.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 0.95999999999999996 112.569 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' CD2' HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -50.94 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.963 0.411 . . . . 2.02 111.042 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -142.43 154.69 44.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 1.55 110.568 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.97 143.74 47.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 1.9099999999999999 110.937 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 67.43 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 1.8700000000000001 111.418 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.53 124.66 0.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.746 0.307 . . . . 1.2 111.564 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.98 137.53 51.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 1.1100000000000001 110.147 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -131.78 118.83 20.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.291 0.848 . . . . 1.0800000000000001 113.291 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -100.59 140.5 34.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.157 -0.683 . . . . 1.5 109.157 178.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 2.2 m-85 -123.06 106.72 11.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.419 1.266 . . . . 0.79000000000000004 114.419 -178.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -76.08 151.81 36.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.643 -0.708 . . . . 2.6899999999999999 110.292 178.602 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.439 HG22 ' CG ' ' A' ' 8' ' ' PRO . 45.2 t -125.42 118.3 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.092 0.473 . . . . 1.5700000000000001 112.242 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 65.4 mt -124.69 163.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.849 -0.797 . . . . 1.3200000000000001 108.849 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -163.13 127.64 2.99 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.826 -0.749 . . . . 1.1100000000000001 112.124 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.433 ' O ' ' CA ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -87.44 24.4 1.66 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.622 0.601 . . . . 2.3500000000000001 112.622 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' A' ' 28' ' ' THR . 2.8 m120 44.4 -173.31 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.502 0.668 . . . . 2.7000000000000002 112.643 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -63.7 -37.07 85.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.299 -0.864 . . . . 1.3400000000000001 112.347 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.06 33.71 3.17 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.964 0.728 . . . . 1.4299999999999999 112.964 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' LYS . . . 65.24 9.89 44.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.255 -0.974 . . . . 1.3799999999999999 113.37 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . -66.4 103.17 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.177 -0.675 . . . . 1.49 109.177 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.32 110.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.678 0.752 . . . . 1.48 112.579 -178.486 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 41.1 p -87.88 110.87 38.53 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.651 -1.159 . . . . 0.81000000000000005 108.673 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -35.03 160.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.641 2.894 . . . . 1.25 113.609 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 24.1 Cg_exo -62.46 150.52 87.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.78 2.32 . . . . 1.2 112.8 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.0 m -120.88 108.9 14.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.587 -0.733 . . . . 1.76 109.8 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -6.0 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 124.534 1.146 . . . . 1.77 113.317 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HG2' ' CZ2' ' A' ' 48' ' ' TRP . 56.7 Cg_exo -50.4 135.63 39.69 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.508 2.139 . . . . 1.01 113.763 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -53.48 152.13 5.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.648 -0.871 . . . . 1.55 108.648 178.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -41.87 154.72 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.769 0.668 . . . . 1.6299999999999999 110.616 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -85.41 114.16 22.25 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.658 -0.701 . . . . 1.0900000000000001 110.03 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.53 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.2 mp -92.94 113.15 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 1.1299999999999999 111.084 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.6 m -51.13 -27.07 7.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.53 . . . . 1.1299999999999999 110.678 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 76.6 m 53.22 84.82 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.5700000000000001 110.539 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -97.38 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.547 -0.297 . . . . 3.7000000000000002 111.499 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.878 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -93.21 0.67 57.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.651 0.241 . . . . 2.1400000000000001 111.651 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.4 p30 52.52 21.63 1.86 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.016 0.376 . . . . 2.0600000000000001 112.016 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.878 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -119.5 -13.04 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.649 -0.25 . . . . 3.0800000000000001 110.972 179.57 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -162.55 27.99 0.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.784 0.326 . . . . 4.5800000000000001 111.221 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.213 -0.899 . . . . 3.79 111.082 179.9 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.437 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.748 0.309 . . . . 3.1699999999999999 111.014 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 0' ' ' SER . 94.0 Cg_endo -90.11 66.3 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.934 2.422 . . . . 2.0600000000000001 112.439 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.426 HD13 ' ND2' ' A' ' 80' ' ' ASN . 4.5 tt -52.28 149.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 1.26 110.844 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.267 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.62 127.65 18.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 2.0 110.596 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 154.62 31.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.405 2.07 . . . . 0.58999999999999997 112.186 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 1.9 Cg_endo -45.68 176.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.897 2.398 . . . . 1.6100000000000001 112.79 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.65 170.64 50.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.896 -0.668 . . . . 0.97999999999999998 112.649 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.2 tttp -56.59 128.62 75.19 Favored Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 110.185 -0.302 . . . . 2.04 110.185 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 6.2 Cg_exo -80.35 133.56 9.72 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.628 2.219 . . . . 0.54000000000000004 112.109 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 9.4 p -126.85 117.27 22.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 1.6799999999999999 110.948 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 19' ' ' THR . 25.3 Cg_exo -63.03 93.05 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.479 2.119 . . . . 0.64000000000000001 113.032 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD13 ' CB ' ' A' ' 21' ' ' LYS . 1.8 mt -52.85 -42.08 64.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.636 0.732 . . . . 2.1699999999999999 109.14 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.44 151.69 51.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.626 -1.17 . . . . 0.84999999999999998 108.456 178.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 13' ' ' ILE . 2.3 pt -142.84 100.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.386 -0.525 . . . . 1.5700000000000001 112.346 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.77 144.19 27.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 1.46 110.211 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.444 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -47.63 -24.34 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.389 0.514 . . . . 2.9100000000000001 112.389 -179.091 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.444 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 6.7 m-70 -130.37 30.76 4.69 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.904 -0.318 . . . . 1.3300000000000001 111.633 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER 172.2 111.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 1.28 110.62 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 4.4 m -111.21 133.34 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.154 0.502 . . . . 1.49 110.375 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.2 m -102.99 111.47 23.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 1.1399999999999999 111.996 -178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.17 143.53 48.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 1.3100000000000001 111.235 178.646 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' CB ' HD13 ' A' ' 11' ' ' LEU . 1.0 OUTLIER -131.92 144.24 50.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.746 -1.116 . . . . 2.3100000000000001 110.206 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 27.4 p90 -129.15 -177.1 4.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.362 0.601 . . . . 0.40000000000000002 112.304 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.14 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.506 -0.77 . . . . 1.1100000000000001 111.162 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -84.4 140.09 38.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 2.5600000000000001 110.251 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 33' ' ' ILE . 1.7 Cg_endo -44.63 172.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.668 2.245 . . . . 1.1100000000000001 112.236 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.55 -29.03 9.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 2.77 111.479 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.43 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.2 t80 -130.44 -69.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.877 0.325 . . . . 1.6899999999999999 111.877 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 1.267 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.4 p 52.43 48.67 22.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.154 0.502 . . . . 1.3500000000000001 110.495 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.51 -94.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.681 -0.691 . . . . 1.01 112.77 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.69 35.57 0.93 Allowed Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.891 -0.884 . . . . 0.97999999999999998 110.891 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -116.85 -172.16 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.276 -0.462 . . . . 0.98999999999999999 111.152 -178.982 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.4 ptmt -147.23 26.24 1.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 2.6899999999999999 111.476 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.5 mp 65.71 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 1.71 110.676 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.4 p 81.68 -12.12 1.0 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.318 0.488 . . . . 1.6599999999999999 112.318 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.72 102.63 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.56 0.219 . . . . 1.97 111.32 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 47.8 m-85 -80.0 147.96 31.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.205 -0.295 . . . . 1.23 110.205 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.455 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -129.39 111.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.319 . . . . 1.76 111.115 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.41 99.14 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.69 0.281 . . . . 1.6100000000000001 111.392 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -75.63 128.34 35.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.978 -0.378 . . . . 1.6699999999999999 109.978 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -109.16 131.28 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.252 0.464 . . . . 2.4399999999999999 112.252 -179.425 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.18 111.56 24.22 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.789 -1.189 . . . . 1.79 107.789 177.976 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.449 ' N ' ' HA3' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.69 81.54 2.05 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.269 -0.878 . . . . 1.5900000000000001 111.088 -179.034 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 HD12 ' CG ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -53.54 155.87 5.0 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.825 -0.625 . . . . 1.4299999999999999 110.694 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.13 1.64 33.22 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.027 -1.239 . . . . 1.47 113.029 0.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -104.5 -75.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 2.6600000000000001 110.881 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . 50.22 179.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.831 -0.7 . . . . 1.6200000000000001 112.957 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.417 ' HD3' ' CD2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.49 32.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 3.0600000000000001 110.905 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 65.5 m95 40.34 97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.705 -0.68 . . . . 1.0600000000000001 112.203 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -133.52 128.99 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.8400000000000001 110.679 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 1.1 ptmm? -56.68 83.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 1.77 111.494 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.451 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -67.26 -38.86 85.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.88 0.371 . . . . 1.4099999999999999 110.244 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -36.82 -44.42 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 111.71 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.13 43.47 2.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.115 -0.493 . . . . 2.6400000000000001 111.785 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -152.79 -175.45 5.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 2.0299999999999998 111.622 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.1 89.28 5.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.8700000000000001 110.641 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.523 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 25.2 mt -85.43 75.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 1.3700000000000001 111.251 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.0 -61.97 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 2.1499999999999999 111.223 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.2 163.13 27.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 1.54 110.27 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 20.2 p30 -80.5 2.7 24.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.281 -0.418 . . . . 1.75 111.675 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 21.1 tt0 -102.13 101.54 11.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.586 -0.524 . . . . 2.0499999999999998 109.586 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 70.2 t80 -135.27 164.38 27.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.56999999999999995 111.506 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 92.9 m -124.31 123.49 40.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.414 -0.812 . . . . 1.1399999999999999 110.36 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.94 94.53 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 116.063 -0.517 . . . . 1.72 110.49 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.6 p -86.61 -171.18 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.494 -0.775 . . . . 1.6399999999999999 110.811 -179.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.82 9.75 53.45 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.449 -0.881 . . . . 0.95999999999999996 112.525 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.527 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 13.8 mt -60.85 -179.34 0.13 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.827 0.313 . . . . 2.02 110.407 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -137.13 128.11 27.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 1.55 110.809 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.17 155.5 13.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.9099999999999999 111.133 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 97' ' ' CYS . 3.5 t70 53.37 46.07 27.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 1.8700000000000001 110.959 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -159.58 118.71 2.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.402 -0.363 . . . . 1.2 111.371 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -70.29 133.64 47.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 1.1100000000000001 110.114 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 70' ' ' ALA . 55.5 m-85 -129.92 126.44 37.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.605 0.595 . . . . 1.0800000000000001 112.605 -178.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' CG ' HD12 ' A' ' 43' ' ' LEU . 1.9 mt-10 -102.85 143.36 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.143 -1.058 . . . . 1.5 108.143 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.69 115.93 12.58 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.16 1.541 . . . . 0.79000000000000004 115.16 -178.89 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.36 169.22 9.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.171 -1.418 . . . . 2.6899999999999999 107.171 176.778 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -134.75 112.54 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 118.867 -1.133 . . . . 1.5700000000000001 113.323 -179.836 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 HG12 ' N ' ' A' ' 88' ' ' PRO . 79.0 mt -102.73 145.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.227 -1.397 . . . . 1.3200000000000001 107.227 177.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -159.78 119.88 2.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.72 -0.792 . . . . 1.1100000000000001 111.898 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -59.07 -161.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.461 -0.496 . . . . 2.3500000000000001 109.954 179.523 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.496 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 6.1 m-80 -150.91 165.72 32.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.249 0.547 . . . . 2.7000000000000002 110.885 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.25 -29.57 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.282 -0.872 . . . . 1.3400000000000001 112.656 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.54 11.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.136 0.421 . . . . 1.4299999999999999 112.136 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.36 2.2 53.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.623 -0.799 . . . . 1.3799999999999999 113.294 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.63 102.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.088 0.444 . . . . 1.49 109.914 179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -68.23 114.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 113.023 0.749 . . . . 1.48 113.023 -178.798 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 14.2 p -78.94 115.0 48.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.29 -0.868 . . . . 0.81000000000000005 109.927 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.11 155.85 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.16 1.907 . . . . 1.25 111.881 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.439 ' N ' HG12 ' A' ' 77' ' ' ILE . 15.0 Cg_endo -58.69 126.85 22.45 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 122.807 2.338 . . . . 1.2 113.443 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 132.46 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.156 -0.683 . . . . 1.76 109.156 178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.448 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -22.42 107.34 0.12 Allowed Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 124.168 0.917 . . . . 1.77 113.33 -179.414 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.452 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 86.8 Cg_exo -45.3 142.87 5.82 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.825 2.35 . . . . 1.01 113.26 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.455 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -79.48 150.38 31.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.758 -0.46 . . . . 1.55 109.758 179.029 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -37.16 151.2 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.143 0.902 . . . . 1.6299999999999999 111.656 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.434 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -80.5 113.8 18.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 1.0900000000000001 110.364 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.48 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.3 mp -96.6 112.77 29.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.917 0.389 . . . . 1.1299999999999999 111.468 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 84.5 m -54.4 -36.13 63.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.896 -0.593 . . . . 1.1299999999999999 111.074 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 61.0 93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.38 . . . . 1.5700000000000001 110.27 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -140.07 -84.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.418 . . . . 3.7000000000000002 111.788 -179.625 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.521 ' CG ' HG11 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.16 -9.53 15.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 2.1400000000000001 111.94 -179.631 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 54.22 27.92 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 2.0600000000000001 111.075 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.521 HG11 ' CG ' ' A' ' 99' ' ' ASP . 8.6 p -135.36 5.27 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 3.0800000000000001 111.842 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 98' ' ' ARG . 1.1 pp20? -156.84 -41.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 111.649 0.24 . . . . 4.5800000000000001 111.649 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.205 -0.902 . . . . 3.79 111.23 -179.947 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.537 0.208 . . . . 3.1699999999999999 111.204 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.03 150.35 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.766 2.311 . . . . 2.0600000000000001 111.887 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.435 HG13 ' OD1' ' A' ' 80' ' ' ASN . 9.0 tt -118.07 150.91 20.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.032 0.444 . . . . 1.26 111.475 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 2' ' ' ILE . 91.7 m-20 -129.82 132.63 24.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 2.0 110.548 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.59 171.12 16.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.494 2.129 . . . . 0.58999999999999997 112.66 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 12.4 Cg_endo -55.7 171.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.043 2.495 . . . . 1.6100000000000001 112.837 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 23' ' ' ALA . . . -93.97 113.6 4.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.049 -0.596 . . . . 0.97999999999999998 113.083 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER 10.87 109.15 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 124.572 1.149 . . . . 2.04 113.767 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' CG ' HG21 ' A' ' 76' ' ' VAL . 19.9 Cg_exo -68.8 139.08 42.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.787 2.325 . . . . 0.54000000000000004 112.96 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.02 112.21 10.37 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.038 -0.528 . . . . 1.6799999999999999 111.508 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.9 Cg_exo -64.89 112.39 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.829 2.352 . . . . 0.64000000000000001 113.696 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.794 HD22 ' OE2' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -70.72 -35.85 72.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.854 -0.795 . . . . 2.1699999999999999 108.854 178.7 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.93 135.97 40.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.774 -1.103 . . . . 0.84999999999999998 108.895 179.099 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 13' ' ' ILE . 2.1 pt -134.27 70.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.269 0.47 . . . . 1.5700000000000001 112.269 -178.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 156.96 34.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.46 110.151 179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -8.65 36.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.887 -0.325 . . . . 2.9100000000000001 111.464 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -128.88 18.2 6.16 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.507 0.194 . . . . 1.3300000000000001 111.357 179.73 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 177.23 124.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.806 0.336 . . . . 1.28 110.925 -179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.28 113.81 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 1.49 111.104 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 17.4 m -100.26 127.4 46.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.984 -0.553 . . . . 1.1399999999999999 111.23 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -138.07 150.3 46.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.745 0.783 . . . . 1.3100000000000001 111.976 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.085 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -132.52 147.36 52.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.425 -1.262 . . . . 2.3100000000000001 109.337 179.596 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.523 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 8.3 p90 -132.47 -175.75 3.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.236 0.541 . . . . 0.40000000000000002 112.375 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 6' ' ' GLY . . . -93.85 177.31 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.332 -0.849 . . . . 1.1100000000000001 111.329 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -98.16 139.4 21.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.625 -0.716 . . . . 2.5600000000000001 110.25 179.733 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 2.9 Cg_endo -47.52 178.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 1.1100000000000001 112.039 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -113.15 -15.44 12.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 2.77 112.081 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -139.15 -66.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.313 0.486 . . . . 1.6899999999999999 112.313 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.497 ' CG2' ' CG ' ' A' ' 25' ' ' PRO . 54.4 p 54.57 45.03 27.77 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.308 -0.405 . . . . 1.3500000000000001 110.532 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.46 -93.99 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.738 -0.744 . . . . 1.01 112.379 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.68 42.19 0.8 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.662 -1.375 . . . . 0.97999999999999998 109.662 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.495 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -127.98 -177.32 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.997 -0.602 . . . . 0.98999999999999999 111.298 -178.211 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.421 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -136.54 19.97 3.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.338 -0.392 . . . . 2.6899999999999999 111.747 -179.456 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.438 HG22 ' CB ' ' A' ' 78' ' ' ALA . 3.5 mp 64.15 -74.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.282 . . . . 1.71 111.279 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' LYS . 2.5 p 58.05 32.39 21.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 1.6599999999999999 111.132 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.1 t 170.72 110.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.97 110.845 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -111.75 87.8 2.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.971 0.415 . . . . 1.23 111.061 179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -79.03 88.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.78 -0.645 . . . . 1.76 111.43 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.27 127.58 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.8 -0.444 . . . . 1.6100000000000001 109.8 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.9 143.73 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.812 -0.631 . . . . 1.6699999999999999 111.563 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.453 ' HD3' ' CG1' ' A' ' 63' ' ' VAL . 3.5 mtmp? -98.35 148.38 23.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 2.4399999999999999 110.871 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -144.77 86.58 1.81 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 1.79 110.604 179.126 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 1.173 ' OD2' ' O ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -48.51 150.02 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.125 -0.489 . . . . 1.5900000000000001 110.725 179.236 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 1.8 mm? -123.78 101.11 36.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.033 -0.667 . . . . 1.4299999999999999 111.291 179.022 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 6.3 Cg_endo -87.57 -136.56 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.053 -1.228 . . . . 1.47 110.212 -0.401 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 1.173 ' O ' ' OD2' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 42.63 42.22 2.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.783 0.325 . . . . 2.6600000000000001 111.441 179.708 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -118.23 148.26 18.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.183 -1.008 . . . . 1.6200000000000001 113.861 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -147.91 122.17 9.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.432 -0.581 . . . . 3.0600000000000001 109.432 179.44 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 40.9 m95 -43.81 94.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 1.0600000000000001 111.149 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -119.32 130.88 55.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.849 -0.614 . . . . 1.8400000000000001 110.712 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.67 69.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 1.77 110.819 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.82 16.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 1.4099999999999999 111.355 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.3 p-10 -51.28 -58.65 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 2.0099999999999998 111.616 -179.574 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER 80.0 -51.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.585 0.231 . . . . 2.6400000000000001 111.221 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -169.93 0.19 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.806 0.336 . . . . 2.0299999999999998 111.111 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.27 107.5 19.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.8700000000000001 111.014 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 56' ' ' ILE . 24.0 mt -87.13 75.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 1.3700000000000001 110.728 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.52 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 2.1499999999999999 111.289 -179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 175.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.677 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 51.1 p30 -94.1 21.89 6.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.889 -0.596 . . . . 1.75 111.157 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.085 ' OE2' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -125.43 109.49 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 2.0499999999999998 110.196 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CG ' ' N ' ' A' ' 62' ' ' THR . 64.5 t80 -136.45 164.61 27.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.56999999999999995 111.669 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.9 m -127.26 117.37 22.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.612 -0.722 . . . . 1.1399999999999999 110.783 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' CG1' ' HD3' ' A' ' 40' ' ' LYS . 6.6 t -82.05 118.77 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.72 111.158 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -173.42 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 1.6399999999999999 110.89 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.54 28.36 73.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.639 -0.791 . . . . 0.95999999999999996 112.281 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.04 174.25 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 2.02 111.318 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.599 ' HB ' ' HH ' ' A' ' 72' ' ' TYR . 55.9 m -125.38 99.25 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.686 . . . . 1.55 110.224 179.533 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 42.9 tt0 -43.74 148.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 1.9099999999999999 111.728 -179.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 35.0 t0 75.41 65.48 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.8700000000000001 111.059 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 171.49 127.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 1.2 111.006 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -67.55 136.3 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.068 -0.345 . . . . 1.1100000000000001 110.068 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.599 ' HH ' ' HB ' ' A' ' 67' ' ' THR . 37.3 m-85 -133.31 121.95 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.293 0.849 . . . . 1.0800000000000001 113.293 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -102.58 131.96 48.98 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.391 -0.596 . . . . 1.5 109.391 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.6 OUTLIER -124.87 118.99 27.55 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.673 0.99 . . . . 0.79000000000000004 113.673 -178.77 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' NH1' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -94.67 144.73 25.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 2.6899999999999999 110.381 178.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG21 ' CG ' ' A' ' 8' ' ' PRO . 86.8 t -98.23 115.82 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.357 -0.537 . . . . 1.5700000000000001 110.845 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 2.3 mt -110.29 167.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.542 -0.911 . . . . 1.3200000000000001 108.542 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.497 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -159.14 -174.41 4.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.412 -0.588 . . . . 1.1100000000000001 109.412 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -117.32 -77.75 0.57 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.157 0.503 . . . . 2.3500000000000001 110.535 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER 125.79 140.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.196 1.798 . . . . 2.7000000000000002 109.93 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.466 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -32.75 -44.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.217 0.821 . . . . 1.3400000000000001 113.217 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.75 49.53 0.8 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.489 0.552 . . . . 1.4299999999999999 112.489 -179.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.56 40.93 5.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.662 -0.78 . . . . 1.3799999999999999 113.314 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 85' ' ' ILE . . . -89.1 24.46 2.12 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.554 0.216 . . . . 1.49 111.227 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp 18.5 112.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 115.373 1.62 . . . . 1.48 115.373 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.408 ' HA ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -85.64 111.81 40.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.66 -0.867 . . . . 0.81000000000000005 108.66 177.957 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.98 167.26 9.16 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.209 1.94 . . . . 1.25 112.523 -179.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.44 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 9.7 Cg_endo -53.8 136.31 65.32 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.052 2.501 . . . . 1.2 113.269 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.34 112.71 24.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.966 -0.561 . . . . 1.76 110.794 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 5.96 100.18 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.019 1.328 . . . . 1.77 114.435 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 82.7 Cg_exo -46.29 145.8 5.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.8 2.333 . . . . 1.01 113.358 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.19 143.9 36.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.074 -0.713 . . . . 1.55 109.074 179.068 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.404 ' O ' HD13 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -30.93 148.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.298 0.999 . . . . 1.6299999999999999 112.016 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 72' ' ' TYR . . . -81.75 103.82 11.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.347 -0.388 . . . . 1.0900000000000001 110.794 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.408 HG22 ' HB ' ' A' ' 13' ' ' ILE . 5.3 mp -83.86 116.01 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 1.1299999999999999 111.537 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 48.2 m -56.21 -30.41 62.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.401 . . . . 1.1299999999999999 110.425 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 53.62 61.31 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 1.5700000000000001 111.148 179.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.434 ' HD3' ' CG ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -101.73 -77.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.04 0.448 . . . . 3.7000000000000002 110.309 179.895 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.055 ' OD2' ' HB3' ' A' ' 102' ' ' GLU . 2.2 p-10 -126.08 -0.13 7.17 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.616 -0.72 . . . . 2.1400000000000001 111.244 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 p30 46.85 26.03 0.52 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.108 0.48 . . . . 2.0600000000000001 112.167 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 101' ' ' VAL . 7.2 p -170.35 30.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.595 -0.729 . . . . 3.0800000000000001 110.28 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.055 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -123.18 -30.6 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.702 -0.681 . . . . 4.5800000000000001 111.613 -179.843 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 3.79 111.106 -179.988 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.619 0.247 . . . . 3.1699999999999999 111.163 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.485 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 5.6 Cg_exo -78.77 -38.18 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.808 2.339 . . . . 2.0600000000000001 112.131 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.495 HG13 ' ND2' ' A' ' 80' ' ' ASN . 9.9 tt 53.64 138.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 123.952 0.783 . . . . 1.26 112.803 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.343 ' OD2' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.57 120.71 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.853 179.693 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.41 170.44 20.28 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.202 1.935 . . . . 0.58999999999999997 112.398 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.493 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 7.1 Cg_endo -54.48 -171.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.754 2.303 . . . . 1.6100000000000001 113.21 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.07 166.64 22.37 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.557 -0.747 . . . . 0.97999999999999998 112.867 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -49.03 122.72 11.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.059 -0.348 . . . . 2.04 110.059 179.487 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.5 Cg_exo -77.41 128.77 9.81 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.242 1.961 . . . . 0.54000000000000004 112.401 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.9 p -120.12 112.85 34.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 1.6799999999999999 111.1 -179.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.3 Cg_exo -60.59 124.74 15.67 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.142 1.894 . . . . 0.64000000000000001 113.223 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD13 ' N ' ' A' ' 21' ' ' LYS . 1.4 mp -89.76 -29.42 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.83 -0.623 . . . . 2.1699999999999999 109.809 179.118 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.45 110.14 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.783 . . . . 0.84999999999999998 110.226 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -114.8 131.74 66.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.394 0.616 . . . . 1.5700000000000001 112.151 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -119.55 157.53 28.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.309 -0.86 . . . . 1.46 110.125 179.914 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.48 -9.07 16.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.325 0.491 . . . . 2.9100000000000001 112.325 -179.637 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.433 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.5 m-70 -135.38 17.47 3.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.793 0.294 . . . . 1.3300000000000001 111.793 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER 171.31 117.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.509 -0.182 . . . . 1.28 110.509 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.534 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -104.14 165.0 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 120.592 -0.443 . . . . 1.49 111.64 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 22.6 m -140.87 123.9 16.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 1.1399999999999999 111.251 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CD1' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.55 159.56 41.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.664 0.745 . . . . 1.3100000000000001 112.007 179.225 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HD3' ' CA ' ' A' ' 60' ' ' GLU . 24.0 tptp -139.1 136.36 35.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.407 -1.27 . . . . 2.3100000000000001 109.803 179.722 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 24.0 p90 -123.35 -177.93 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.281 0.562 . . . . 0.40000000000000002 112.336 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.93 161.08 16.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.201 -0.909 . . . . 1.1100000000000001 111.042 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -90.06 135.96 29.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 2.5600000000000001 110.715 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 11.5 Cg_endo -56.12 171.77 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.455 2.103 . . . . 1.1100000000000001 112.005 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -50.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.658 0.265 . . . . 2.77 111.208 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.343 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.2 t80 -98.92 71.09 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.74 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.8 p -94.27 48.72 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 1.3500000000000001 110.131 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.02 -94.92 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.967 -0.561 . . . . 1.01 112.344 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.55 33.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.936 -0.865 . . . . 0.97999999999999998 110.936 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.486 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.4 OUTLIER -118.66 175.76 5.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.253 -0.473 . . . . 0.98999999999999999 111.299 -178.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.73 3.88 3.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.068 -0.514 . . . . 2.6899999999999999 111.505 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 36' ' ' TYR . 1.1 mt 59.75 144.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 120.96 0.409 . . . . 1.71 111.864 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -129.51 -5.11 4.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.946 -0.57 . . . . 1.6599999999999999 112.258 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -168.27 143.86 3.68 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.919 0.34 . . . . 1.97 111.919 -179.844 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CE1' HG23 ' A' ' 33' ' ' ILE . 33.7 m-85 -116.3 113.1 22.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 1.23 110.269 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.7 mt -92.12 119.59 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.799 0.333 . . . . 1.76 110.987 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.29 93.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.442 0.534 . . . . 1.6100000000000001 112.442 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.97 ' OE1' ' CA ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -72.93 146.33 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.147 -0.686 . . . . 1.6699999999999999 109.147 178.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.35 141.62 51.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.215 0.531 . . . . 2.4399999999999999 112.025 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.7 ttm180 -104.64 106.55 17.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.389 -0.823 . . . . 1.79 109.464 179.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 1.052 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.84 91.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.475 -0.784 . . . . 1.5900000000000001 111.071 -179.379 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD13 ' CB ' ' A' ' 94' ' ' ALA . 13.7 mt -75.96 146.0 78.45 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.112 -0.495 . . . . 1.4299999999999999 110.328 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.78 27.85 15.27 Favored 'Cis proline' 0 C--N 1.347 0.467 0 C-N-CA 123.801 -1.333 . . . . 1.47 112.88 0.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -88.73 -73.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.761 0.315 . . . . 2.6600000000000001 111.169 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 100.27 152.58 26.54 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.624 -0.798 . . . . 1.6200000000000001 112.778 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 1.052 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 170.91 -31.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.303 . . . . 3.0600000000000001 111.181 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.908 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 61.4 m95 58.62 75.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.361 . . . . 1.0600000000000001 111.375 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.97 ' CA ' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mm? -117.42 130.91 56.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 1.8400000000000001 110.341 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 5.2 ptmm? -52.69 97.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.926 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . . . -58.94 -41.05 86.46 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.194 -0.669 . . . . 1.4099999999999999 109.194 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 10.1 t30 -58.56 164.35 2.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.061 -0.972 . . . . 2.0099999999999998 110.405 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.37 31.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.471 . . . . 2.6400000000000001 110.801 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.1 37.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 2.0299999999999998 110.91 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 61.57 153.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 1.8700000000000001 110.757 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.526 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 47.9 mt -147.23 60.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 1.3700000000000001 110.44 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 tm? -46.03 -50.66 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 2.1499999999999999 111.841 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.23 160.19 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.422 . . . . 1.54 111.048 -179.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.502 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.3 m-20 -76.27 -1.15 25.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.89 -0.596 . . . . 1.75 111.694 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.849 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -102.54 103.92 14.29 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.745 -0.465 . . . . 2.0499999999999998 109.745 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 43.6 t80 -140.22 166.4 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.124 0.488 . . . . 0.56999999999999995 111.9 -178.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.4 m -117.23 119.42 35.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.48 -0.782 . . . . 1.1399999999999999 110.797 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.12 99.31 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.204 0.526 . . . . 1.72 111.297 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 1.1 p -81.56 -157.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.533 -0.758 . . . . 1.6399999999999999 111.207 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 54.03 45.54 71.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.727 -0.749 . . . . 0.95999999999999996 112.154 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.534 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 9.8 mt -87.61 -176.85 5.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.167 0.508 . . . . 2.02 111.205 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -153.36 115.04 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.717 . . . . 1.55 110.332 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 132.83 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 1.9099999999999999 111.236 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.33 60.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 1.8700000000000001 111.089 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.92 119.12 0.61 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 1.2 111.652 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.3 125.97 28.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.631 -0.507 . . . . 1.1100000000000001 109.631 179.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -121.95 122.18 38.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.4 0.518 . . . . 1.0800000000000001 112.4 -178.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.18 131.95 46.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.312 -0.996 . . . . 1.5 108.312 178.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.2 109.69 19.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.157 1.54 . . . . 0.79000000000000004 115.157 -177.849 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 ttp180 -97.72 124.54 42.1 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.681 -1.6 . . . . 2.6899999999999999 106.681 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -105.87 119.64 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 119.103 -1.039 . . . . 1.5700000000000001 113.716 -178.476 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.436 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 80.8 mt -101.41 163.78 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.537 -1.653 . . . . 1.3200000000000001 106.537 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -174.32 123.15 0.3 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.022 -1.071 . . . . 1.1100000000000001 112.755 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 21.9 mttt -60.8 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.002 -0.74 . . . . 2.3500000000000001 109.002 178.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' ND2' HG13 ' A' ' 2' ' ' ILE . 36.3 m-20 -138.38 -101.95 0.18 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.514 -0.474 . . . . 2.7000000000000002 111.387 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.32 -41.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 1.3400000000000001 111.598 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -101.97 40.96 1.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 1.4299999999999999 111.962 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.91 9.6 53.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.579 -0.82 . . . . 1.3799999999999999 113.154 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.81 87.3 4.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 1.49 110.322 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -58.76 111.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 1.48 111.682 -179.378 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -73.57 119.05 73.94 Favored Pre-proline 0 C--O 1.238 0.454 0 N-CA-C 109.454 -0.573 . . . . 0.81000000000000005 109.454 179.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -43.4 166.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.677 2.251 . . . . 1.25 112.461 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.436 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.9 Cg_exo -64.36 149.21 90.54 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.676 2.251 . . . . 1.2 112.571 -179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 90' ' ' GLU . 5.8 m -103.12 125.4 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.533 -0.758 . . . . 1.76 109.263 179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 62.9 mt-10 -22.07 117.45 0.15 Allowed Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 124.094 0.871 . . . . 1.77 112.793 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.473 ' HG3' ' CH2' ' A' ' 48' ' ' TRP . 66.1 Cg_exo -45.27 165.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.981 2.454 . . . . 1.01 114.513 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -100.82 146.36 27.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.339 -1.3 . . . . 1.55 109.166 178.764 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.42 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -37.09 130.66 0.83 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.864 0.728 . . . . 1.6299999999999999 111.644 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.444 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -65.92 101.33 0.65 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.879 -0.6 . . . . 1.0900000000000001 110.854 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.49 HD12 ' CE2' ' A' ' 74' ' ' PHE . 4.8 mp -82.22 113.55 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.059 -0.519 . . . . 1.1299999999999999 110.462 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 HG23 ' NH1' ' A' ' 98' ' ' ARG . 22.1 m -51.64 -28.06 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 1.1299999999999999 111.159 -179.667 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 60.7 m 55.24 76.07 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.505 -0.316 . . . . 1.5700000000000001 110.841 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.421 ' NH1' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -134.43 -87.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 3.7000000000000002 111.073 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.976 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.14 -3.06 26.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 2.1400000000000001 111.356 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 49.72 25.75 1.61 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.888 0.375 . . . . 2.0600000000000001 111.415 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.976 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 11.9 t -116.65 -22.76 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 110.643 179.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -117.31 -15.05 10.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 4.5800000000000001 111.295 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.223 -0.894 . . . . 3.79 111.096 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.45 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.653 0.263 . . . . 3.1699999999999999 111.131 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 0' ' ' SER . 7.9 Cg_exo -72.22 137.12 28.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.864 2.376 . . . . 2.0600000000000001 111.675 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.428 HD11 ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -115.2 124.46 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 1.26 111.685 -179.737 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.927 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -114.06 135.56 22.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.65 . . . . 2.0 109.937 179.395 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.36 174.04 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.672 2.248 . . . . 0.58999999999999997 113.101 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 32.0 Cg_exo -59.68 174.6 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.119 2.546 . . . . 1.6100000000000001 113.462 -179.622 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.08 169.67 42.37 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.297 -0.865 . . . . 0.97999999999999998 112.627 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 65.4 tttt -58.57 127.28 81.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 110.581 -0.155 . . . . 2.04 110.581 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 3.0 Cg_exo -76.79 149.38 29.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.502 2.135 . . . . 0.54000000000000004 113.078 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.8 p -144.16 113.4 5.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.284 -0.871 . . . . 1.6799999999999999 110.015 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.7 Cg_exo -49.0 94.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.283 1.989 . . . . 0.64000000000000001 113.553 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.66 -27.73 63.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.268 -0.878 . . . . 2.1699999999999999 110.135 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -161.41 161.33 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.84999999999999998 109.91 179.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.477 HG21 ' CG1' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.84 115.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 1.5700000000000001 111.301 179.731 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -104.48 47.62 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.793 -0.64 . . . . 1.46 110.79 -179.908 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.81 -70.63 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.746 -0.661 . . . . 2.9100000000000001 111.516 179.473 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' THR . 1.5 m-70 -82.79 -22.98 34.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 1.3300000000000001 111.289 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.16 102.9 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.578 -0.283 . . . . 1.28 111.224 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.487 HG13 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -93.66 120.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 1.49 110.816 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 19.8 m -98.6 126.42 44.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 1.1399999999999999 111.346 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.47 139.88 50.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.948 0.88 . . . . 1.3100000000000001 111.69 178.437 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.97 172.78 7.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.192 -1.367 . . . . 2.3100000000000001 109.317 179.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 46.0 p90 -168.34 165.51 12.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.126 -0.63 . . . . 0.40000000000000002 112.503 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 156.07 23.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.963 -1.017 . . . . 1.1100000000000001 110.685 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.98 156.46 52.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.725 -0.472 . . . . 2.5600000000000001 109.725 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.15 -170.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.371 2.048 . . . . 1.1100000000000001 111.954 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.53 13.21 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.883 0.327 . . . . 2.77 111.883 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.747 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 3.6 t80 -168.91 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.572 0.582 . . . . 1.6899999999999999 112.572 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.927 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 52.0 p 53.8 38.81 29.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.003 0.43 . . . . 1.3500000000000001 110.074 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 42.64 -125.15 4.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.852 -0.613 . . . . 1.01 112.175 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.45 4.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.451 -1.859 . . . . 0.97999999999999998 108.451 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -112.99 -165.78 1.02 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.888 -1.156 . . . . 0.98999999999999999 111.607 -178.03 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -163.84 38.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 2.6899999999999999 112.084 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.8 mp 66.29 -61.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.94 0.719 . . . . 1.71 112.94 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 81' ' ' ALA . 2.4 p 83.08 -38.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.631 0.772 . . . . 1.6599999999999999 111.856 -178.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.61 140.08 3.23 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.832 0.348 . . . . 1.97 111.406 -179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.479 ' CE1' HG22 ' A' ' 33' ' ' ILE . 52.7 m-85 -99.6 139.94 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 1.23 110.218 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.428 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 0.9 OUTLIER -129.97 98.1 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.671 -0.24 . . . . 1.76 111.05 -179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -91.69 126.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.133 0.492 . . . . 1.6100000000000001 110.862 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.37 152.28 19.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.532 -0.758 . . . . 1.6699999999999999 110.675 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 6.4 ptpt -116.14 144.14 44.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 2.4399999999999999 111.521 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 1.1 ttt180 -119.38 104.86 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.78 -0.645 . . . . 1.79 109.979 179.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.72 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.65 89.1 2.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.741 -0.663 . . . . 1.5900000000000001 110.556 -179.863 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.468 HD13 ' CB ' ' A' ' 94' ' ' ALA . 10.0 mt -67.09 144.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.686 . . . . 1.4299999999999999 110.895 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -95.24 27.92 17.96 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.052 -1.229 . . . . 1.47 112.807 0.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.68 42.6 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 2.6600000000000001 111.368 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -95.13 150.66 19.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.828 . . . . 1.6200000000000001 112.224 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.45 29.0 4.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 3.0600000000000001 110.935 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.9 m95 51.36 100.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.999 -0.546 . . . . 1.0600000000000001 111.133 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.9 OUTLIER -127.67 141.84 51.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.967 -0.561 . . . . 1.8400000000000001 110.558 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 49.5 mtpt -49.36 91.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.77 110.95 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -65.26 -48.21 74.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 1.4099999999999999 110.754 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -74.28 114.61 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.95 -0.568 . . . . 2.0099999999999998 110.746 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.54 30.34 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 2.6400000000000001 110.913 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -138.02 21.2 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 2.0299999999999998 111.352 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.15 144.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 1.8700000000000001 111.174 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 26.0 mt -134.87 112.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.082 -0.508 . . . . 1.3700000000000001 111.009 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -47.75 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 2.1499999999999999 110.862 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.57 157.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.891 -0.411 . . . . 1.54 109.891 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.511 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -73.53 -3.76 29.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.417 -0.356 . . . . 1.75 111.521 -179.924 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -97.76 96.15 8.04 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.421 -0.585 . . . . 2.0499999999999998 109.421 179.309 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 72.3 t80 -121.68 163.86 18.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.56999999999999995 111.57 -178.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 59.9 m -132.19 112.67 12.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.529 -0.759 . . . . 1.1399999999999999 111.06 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 51' ' ' ALA . 4.6 t -74.73 113.43 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 1.72 110.872 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.96 136.49 44.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.705 -0.679 . . . . 1.6399999999999999 111.012 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.3 9.16 6.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.95999999999999996 112.714 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.19 -177.6 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.05 0.452 . . . . 2.02 110.954 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.936 ' CB ' ' HH ' ' A' ' 72' ' ' TYR . 58.9 m -143.7 96.7 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 1.55 110.0 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -40.56 139.17 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.526 . . . . 1.9099999999999999 111.839 -179.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.57 33.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.913 -0.585 . . . . 1.8700000000000001 110.902 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.37 136.34 13.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.358 -0.383 . . . . 1.2 111.212 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.89 132.13 35.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 1.1100000000000001 110.701 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.936 ' HH ' ' CB ' ' A' ' 67' ' ' THR . 46.9 m-85 -127.31 130.67 49.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 1.0800000000000001 111.94 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.448 ' CG ' HD13 ' A' ' 43' ' ' LEU . 3.7 mt-10 -104.65 148.81 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.596 -0.52 . . . . 1.5 109.596 178.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.487 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.19 116.08 10.87 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.821 1.415 . . . . 0.79000000000000004 114.821 -179.264 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.507 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 4.8 ptp180 -109.99 178.65 4.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.455 -0.943 . . . . 2.6899999999999999 108.455 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.66 133.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.678 1.228 . . . . 1.5700000000000001 114.198 179.15 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -115.17 152.72 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 112.599 -2.092 . . . . 1.3200000000000001 106.964 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.26 147.56 16.17 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.229 -0.989 . . . . 1.1100000000000001 112.146 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.0 mmtp -68.81 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 2.3500000000000001 110.442 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 6.9 p-10 -156.08 -66.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.843 0.83 . . . . 2.7000000000000002 111.513 -179.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . 179.52 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.351 -0.84 . . . . 1.3400000000000001 110.879 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.69 -4.01 57.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 1.4299999999999999 112.192 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.83 -16.2 40.07 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.317 -0.944 . . . . 1.3799999999999999 112.506 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.18 149.99 48.87 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.797 -0.446 . . . . 1.49 109.797 179.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.1 tp -102.41 112.21 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.381 0.511 . . . . 1.48 112.381 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -68.33 123.73 88.17 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.81000000000000005 109.936 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -38.57 162.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.26 2.64 . . . . 1.25 113.394 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' N ' HG21 ' A' ' 77' ' ' ILE . 21.0 Cg_exo -67.95 170.84 13.41 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.227 2.618 . . . . 1.2 112.927 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.4 127.32 42.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.363 -0.835 . . . . 1.76 109.474 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.2 tt0 -27.06 129.58 0.19 Allowed Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 123.89 0.743 . . . . 1.77 112.597 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.0 Cg_exo -62.33 169.84 7.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.385 2.057 . . . . 1.01 113.765 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.34 136.62 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.754 -1.112 . . . . 1.55 109.042 179.109 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -37.68 135.34 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.006 0.817 . . . . 1.6299999999999999 111.584 -179.748 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.468 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -63.07 132.33 51.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 1.0900000000000001 111.415 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.39 119.73 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 1.1299999999999999 110.917 179.501 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m -48.07 -30.01 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.927 -0.579 . . . . 1.1299999999999999 111.173 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 15.4 m 55.45 36.79 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 1.5700000000000001 111.032 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 3.7000000000000002 110.941 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 41.3 p30 -106.3 23.99 13.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 2.1400000000000001 110.547 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 49.3 t0 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.991 -0.55 . . . . 2.0600000000000001 111.966 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.0 OUTLIER -107.18 -23.72 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.912 -0.403 . . . . 3.0800000000000001 109.912 179.118 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.883 ' OE2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 37.69 96.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.745 -0.661 . . . . 4.5800000000000001 112.013 179.759 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.228 -0.892 . . . . 3.79 111.193 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.745 0.307 . . . . 3.1699999999999999 111.295 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.49 ' HD2' ' CE1' ' A' ' 27' ' ' TYR . 84.8 Cg_endo -86.29 137.98 5.41 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.895 2.396 . . . . 2.0600000000000001 112.341 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.469 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 1.4 tt -106.04 145.94 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 1.26 111.278 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.907 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -126.34 133.16 24.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 2.0 110.055 179.451 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 94.4 Cg_endo -77.89 172.0 16.35 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.353 2.035 . . . . 0.58999999999999997 112.655 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.511 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.7 Cg_endo -59.64 148.89 85.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.078 2.519 . . . . 1.6100000000000001 112.623 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.64 161.81 4.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.97999999999999998 112.092 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -58.01 132.67 83.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.982 -0.377 . . . . 2.04 109.982 179.757 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -79.26 127.91 7.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.493 2.129 . . . . 0.54000000000000004 112.812 -179.409 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.21 110.38 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.863 -0.608 . . . . 1.6799999999999999 110.379 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 33.6 Cg_exo -56.42 102.57 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.122 1.881 . . . . 0.64000000000000001 113.599 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 1.177 ' CD1' ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -66.82 -31.05 71.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.02 -0.733 . . . . 2.1699999999999999 109.02 178.674 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -150.33 161.65 42.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.098 -0.956 . . . . 0.84999999999999998 110.161 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -151.79 86.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.286 0.565 . . . . 1.5700000000000001 110.228 179.593 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -77.7 64.15 2.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 1.46 112.427 -179.1 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.473 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 19.84 47.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.447 0.906 . . . . 2.9100000000000001 113.447 179.281 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.473 ' CD2' ' O ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 165.31 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.582 -0.736 . . . . 1.3300000000000001 110.395 179.239 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.96 89.5 3.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 1.28 109.713 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' CG2' HD23 ' A' ' 66' ' ' LEU . 75.3 t -78.68 114.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 1.49 110.046 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.1 m -96.68 109.22 21.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 1.1399999999999999 112.527 -178.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.1 145.79 44.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.569 0.699 . . . . 1.3100000000000001 111.463 178.81 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.431 ' HB2' ' CD ' ' A' ' 60' ' ' GLU . 7.3 tptp -134.07 143.39 48.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.733 -1.121 . . . . 2.3100000000000001 109.508 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.525 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 13.6 p90 -132.68 -177.04 4.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.239 0.542 . . . . 0.40000000000000002 111.983 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.59 -173.93 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.475 -0.784 . . . . 1.1100000000000001 111.109 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -114.62 131.69 23.25 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 2.5600000000000001 110.727 179.929 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.44 ' CB ' HG21 ' A' ' 28' ' ' THR . 3.0 Cg_exo -35.84 157.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.487 2.791 . . . . 1.1100000000000001 112.809 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.29 -15.57 20.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 2.77 111.63 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.774 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.8 t80 -134.52 -72.01 0.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.324 0.49 . . . . 1.6899999999999999 112.324 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.907 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 4.4 p 50.44 57.55 6.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.95 0.405 . . . . 1.3500000000000001 110.49 -179.148 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.84 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.748 -0.66 . . . . 1.01 112.52 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -155.25 32.8 0.65 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.376 -1.09 . . . . 0.97999999999999998 110.376 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.98 -167.68 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -0.667 . . . . 0.98999999999999999 111.649 -178.561 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 34' ' ' THR . 29.5 ttpt -144.04 20.44 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.607 -0.724 . . . . 2.6899999999999999 111.581 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.6 mp 62.82 -77.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.623 0.249 . . . . 1.71 111.037 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.3 p 80.08 -7.9 1.59 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.607 0.595 . . . . 1.6599999999999999 112.607 179.299 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.94 117.96 2.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.401 0.519 . . . . 1.97 112.401 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 61.1 m-85 -103.7 146.22 28.91 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.32 -0.4 . . . . 1.23 110.414 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 ' CG2' ' HE3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -137.11 107.47 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.553 -0.294 . . . . 1.76 110.219 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.45 117.72 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 1.6100000000000001 111.387 -179.747 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 3.0 mm-40 -85.95 159.78 19.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.247 -0.888 . . . . 1.6699999999999999 110.57 179.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HE3' ' CB ' ' A' ' 51' ' ' ALA . 3.0 mtmp? -120.99 154.04 36.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.513 0.673 . . . . 2.4399999999999999 111.804 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 10.5 ttm180 -128.67 96.2 4.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.223 -1.029 . . . . 1.79 108.223 177.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 83.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.109 -0.951 . . . . 1.5900000000000001 110.053 -179.149 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD13 ' CB ' ' A' ' 94' ' ' ALA . 19.1 mt -59.45 150.87 63.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.055 -0.521 . . . . 1.4299999999999999 110.736 -179.815 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.03 3.19 37.28 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.713 -1.37 . . . . 1.47 113.207 0.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.82 -89.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.116 -0.234 . . . . 2.6600000000000001 111.019 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 158.38 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.818 -0.706 . . . . 1.6200000000000001 113.036 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.57 24.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 3.0600000000000001 110.988 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 31.7 m95 53.8 83.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 1.0600000000000001 111.423 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.33 124.27 42.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.756 0.313 . . . . 1.8400000000000001 110.667 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' HE3' ' CG2' ' A' ' 37' ' ' ILE . 15.5 ptmt -54.27 95.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 1.77 111.033 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.458 ' CB ' ' HE3' ' A' ' 40' ' ' LYS . . . -65.75 -35.47 80.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.109 0.48 . . . . 1.4099999999999999 110.281 179.517 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 1.8 t30 -66.09 120.58 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 2.0099999999999998 110.546 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 23.7 14.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.072 -0.513 . . . . 2.6400000000000001 110.501 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.25 130.4 22.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.949 -0.568 . . . . 2.0299999999999998 110.6 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.15 114.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 1.8700000000000001 111.861 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 55.2 mt -96.04 88.29 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 1.3700000000000001 110.426 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.77 -64.87 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.48 -0.327 . . . . 2.1499999999999999 111.198 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.08 165.91 12.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.435 -0.348 . . . . 1.54 110.418 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.4 p30 -90.47 15.5 10.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.194 -0.457 . . . . 1.75 111.357 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.431 ' CD ' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tp10 -116.42 95.65 5.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.696 -0.483 . . . . 2.0499999999999998 109.696 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.536 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 93.6 t80 -118.14 162.85 17.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.299 0.571 . . . . 0.56999999999999995 112.091 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 97.5 m -135.01 108.77 8.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.294 -0.866 . . . . 1.1399999999999999 110.397 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.34 105.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.689 -0.687 . . . . 1.72 111.052 -179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 t -100.92 164.3 11.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.058 -0.519 . . . . 1.6399999999999999 110.754 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.11 28.53 68.19 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.098 -0.801 . . . . 0.95999999999999996 111.098 -179.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD23 ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -84.31 155.84 22.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.425 -0.388 . . . . 2.02 110.344 -179.521 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.901 ' HB ' ' HH ' ' A' ' 72' ' ' TYR . 2.5 m -91.7 127.17 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 1.55 111.482 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 2.2 tt0 -76.95 163.32 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.9099999999999999 111.208 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.81 43.21 5.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.832 -0.622 . . . . 1.8700000000000001 111.002 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.41 122.99 1.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.009 -0.541 . . . . 1.2 110.736 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.72 116.55 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.008 0.432 . . . . 1.1100000000000001 110.772 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.901 ' HH ' ' HB ' ' A' ' 67' ' ' THR . 42.5 m-85 -110.05 132.48 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.824 -0.626 . . . . 1.0800000000000001 112.139 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -102.08 134.28 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.193 -1.04 . . . . 1.5 108.193 177.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -128.82 118.92 23.56 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.215 1.561 . . . . 0.79000000000000004 115.215 -178.588 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.01 -175.27 2.73 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.832 -1.173 . . . . 2.6899999999999999 107.832 177.232 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -155.99 125.86 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.233 -0.987 . . . . 1.5700000000000001 113.213 179.09 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 20.2 mt -103.33 150.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 113.644 -1.616 . . . . 1.3200000000000001 107.9 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.35 120.99 2.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.025 -1.07 . . . . 1.1100000000000001 113.254 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.0 mttp -66.6 -176.07 0.44 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 2.3500000000000001 109.994 178.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.526 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 4.1 p30 -135.0 169.11 17.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.829 -0.623 . . . . 2.7000000000000002 110.599 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.79 -27.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.693 -0.685 . . . . 1.3400000000000001 112.155 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 -16.97 28.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.798 0.666 . . . . 1.4299999999999999 112.798 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.27 -23.07 27.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.297 -0.954 . . . . 1.3799999999999999 112.128 -179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -55.05 115.43 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.999 -0.371 . . . . 1.49 109.999 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -72.62 110.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.578 0.584 . . . . 1.48 112.578 -179.061 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.7 p -65.86 116.4 32.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.81000000000000005 110.087 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.78 157.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.888 2.392 . . . . 1.25 112.844 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 31.7 Cg_endo -64.28 121.56 9.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.753 2.302 . . . . 1.2 113.34 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 7.8 p -71.38 132.9 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 1.76 109.62 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 46.0 mt-10 -28.89 125.7 0.25 Allowed Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.868 0.73 . . . . 1.77 112.625 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 63.0 Cg_exo -54.12 174.15 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.541 2.161 . . . . 1.01 113.822 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.38 142.18 36.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 1.55 109.927 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 3.5 t0 -38.83 136.12 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.872 0.733 . . . . 1.6299999999999999 111.051 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.454 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -68.28 103.34 1.57 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.487 -0.324 . . . . 1.0900000000000001 111.479 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.437 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 4.8 mp -88.41 115.15 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.437 -0.347 . . . . 1.1299999999999999 110.751 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.0 m -49.02 -35.94 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 1.1299999999999999 111.408 -179.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 68' ' ' GLU . 51.6 t 61.59 95.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.197 -0.297 . . . . 1.5700000000000001 110.197 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -147.22 -86.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.271 0.471 . . . . 3.7000000000000002 112.271 -179.26 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.282 ' OD1' HG11 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.56 7.09 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.192 0.441 . . . . 2.1400000000000001 112.192 -179.308 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 43.09 27.72 0.12 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.484 0.549 . . . . 2.0600000000000001 112.484 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.282 HG11 ' OD1' ' A' ' 99' ' ' ASP . 6.2 p -158.32 25.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.356 0.598 . . . . 3.0800000000000001 111.061 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.626 ' HG2' ' CG ' ' A' ' 99' ' ' ASP . 21.6 pt-20 -159.93 -44.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 4.5800000000000001 110.9 179.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.212 -0.899 . . . . 3.79 111.146 179.958 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.616 0.246 . . . . 3.1699999999999999 111.115 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.3 158.11 41.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.872 2.381 . . . . 2.0600000000000001 112.264 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.429 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.6 tt -141.2 147.12 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 1.26 110.923 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' N ' HG12 ' A' ' 2' ' ' ILE . 17.4 m-20 -136.89 121.85 12.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.357 -0.383 . . . . 2.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.87 169.46 17.7 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.307 2.005 . . . . 0.58999999999999997 111.716 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.7 Cg_endo -53.74 162.98 3.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.655 2.237 . . . . 1.6100000000000001 112.542 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.69 170.74 27.37 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.934 -0.651 . . . . 0.97999999999999998 112.66 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.93 127.19 68.19 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.639 -0.134 . . . . 2.04 110.639 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 6.1 Cg_exo -76.0 128.81 10.98 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.119 1.879 . . . . 0.54000000000000004 112.199 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 14.8 p -130.5 110.19 16.22 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.216 -0.447 . . . . 1.6799999999999999 111.462 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.0 Cg_exo -58.24 103.28 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.64000000000000001 113.476 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.35 -29.68 70.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 2.1699999999999999 109.629 178.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -150.79 154.01 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.27 -0.877 . . . . 0.84999999999999998 109.22 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.03 114.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.039 0.447 . . . . 1.5700000000000001 112.018 -179.621 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.22 156.29 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.713 -0.676 . . . . 1.46 110.268 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -56.9 -23.24 43.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.349 -0.387 . . . . 2.9100000000000001 110.995 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.442 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 75.9 m-70 -140.12 26.5 2.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 1.3300000000000001 111.117 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.424 ' CA ' HD22 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -170.43 97.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 1.28 111.147 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 13' ' ' ILE . 89.4 t -94.77 129.11 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 1.49 110.964 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.9 m -106.0 125.92 51.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.681 -0.69 . . . . 1.1399999999999999 111.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.547 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.87 153.19 49.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.808 0.813 . . . . 1.3100000000000001 111.895 179.424 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -128.35 -174.54 3.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.254 -1.339 . . . . 2.3100000000000001 109.871 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.5 p90 179.98 160.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.42 . . . . 0.40000000000000002 111.687 179.724 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.53 146.13 45.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 1.1100000000000001 111.319 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -82.39 139.76 44.92 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 2.5600000000000001 110.573 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' CB ' HG22 ' A' ' 28' ' ' THR . 93.9 Cg_exo -43.69 163.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.381 2.054 . . . . 1.1100000000000001 112.066 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -121.55 -38.51 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.482 . . . . 2.77 111.282 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.93 -70.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.896 -0.321 . . . . 1.6899999999999999 111.476 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.453 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 21.1 p 46.75 41.3 10.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.215 0.531 . . . . 1.3500000000000001 110.568 -179.598 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.9 -97.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.488 -0.778 . . . . 1.01 112.506 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.75 60.71 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.739 -0.944 . . . . 0.97999999999999998 110.739 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 5.2 m-85 -130.45 -172.28 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.19 0.519 . . . . 0.98999999999999999 112.023 -178.451 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 14.69 1.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.482 -0.781 . . . . 2.6899999999999999 111.647 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 17.5 mt 56.61 153.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.401 0.62 . . . . 1.71 112.538 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 35' ' ' SER . 2.9 p -127.98 55.74 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.273 -0.876 . . . . 1.6599999999999999 110.566 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER 87.18 154.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.565 -0.743 . . . . 1.97 110.485 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' A' ' 33' ' ' ILE . 82.0 m-85 -105.99 156.64 18.18 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.277 0.561 . . . . 1.23 111.921 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.69 168.0 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.299 -0.864 . . . . 1.76 109.563 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 74' ' ' PHE . 4.7 t -146.03 99.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.982 0.364 . . . . 1.6100000000000001 111.982 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' HG3' HG13 ' A' ' 77' ' ' ILE . 6.3 mt-10 -77.26 126.85 31.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.154 0.502 . . . . 1.6699999999999999 110.27 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' TRP . 2.5 mmtp -94.2 131.37 39.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.29 -0.868 . . . . 2.4399999999999999 112.63 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.1 ttm180 -111.07 105.32 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.784 -0.45 . . . . 1.79 109.784 178.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 1.309 ' OD1' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.43 94.14 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.996 -0.547 . . . . 1.5900000000000001 111.191 -179.611 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.474 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 12.9 mt -79.23 153.34 76.88 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.99 -0.55 . . . . 1.4299999999999999 110.557 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.18 29.74 7.34 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.123 -1.199 . . . . 1.47 113.149 0.627 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -100.8 -85.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.61 0.243 . . . . 2.6600000000000001 111.312 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.89 162.78 11.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.663 -0.78 . . . . 1.6200000000000001 112.78 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 1.309 ' HD2' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 173.7 -32.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 3.0600000000000001 111.522 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.525 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 40.6 m95 48.87 75.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.667 -0.242 . . . . 1.0600000000000001 110.517 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.03 137.57 52.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.896 0.379 . . . . 1.8400000000000001 111.809 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.8 ptmt -65.26 85.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.509 . . . . 1.77 111.125 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.64 -37.64 76.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 1.4099999999999999 111.179 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 t30 -47.26 -67.03 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.0099999999999998 110.546 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.37 35.19 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.425 -0.352 . . . . 2.6400000000000001 111.181 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 t -139.8 -78.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 2.0299999999999998 111.014 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' ND2' ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -179.22 142.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 1.8700000000000001 111.027 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.479 HG22 HD11 ' A' ' 56' ' ' ILE . 3.5 mt -144.98 74.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.3700000000000001 111.016 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.16 -37.1 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 2.1499999999999999 111.157 -179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -100.68 167.19 10.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 1.54 110.597 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -77.0 -9.94 59.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.499 . . . . 1.75 111.613 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -96.3 102.43 14.22 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.833 0.349 . . . . 2.0499999999999998 110.296 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 62' ' ' THR . 57.9 t80 -136.57 163.37 30.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.107 -0.497 . . . . 0.56999999999999995 111.677 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 75.7 m -126.05 119.55 27.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.851 -0.613 . . . . 1.1399999999999999 111.252 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.1 t -83.88 102.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.72 111.009 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -102.38 168.15 9.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 1.6399999999999999 111.012 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.25 12.04 52.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.787 -0.72 . . . . 0.95999999999999996 112.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER -86.55 -174.1 4.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.778 0.289 . . . . 2.02 110.835 179.947 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 2.0 m -128.31 154.69 45.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 1.55 111.099 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 3.2 tm-20 -77.42 158.19 30.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 1.9099999999999999 110.93 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.3 t70 56.54 59.98 3.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 1.8700000000000001 110.943 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.32 123.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 1.2 111.144 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -71.48 129.79 39.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 1.1100000000000001 110.453 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 51.5 m-85 -126.77 129.51 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 1.0800000000000001 112.075 -179.142 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 3.5 mt-10 -107.78 144.99 34.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -138.73 119.43 14.09 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.543 1.312 . . . . 0.79000000000000004 114.543 -178.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.85 146.59 26.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.466 -0.333 . . . . 2.6899999999999999 110.366 178.434 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 57.1 t -93.98 119.54 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 1.5700000000000001 110.935 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 87' ' ' PRO . 1.1 mt -118.99 144.39 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.271 -1.011 . . . . 1.3200000000000001 108.271 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 35' ' ' SER . . . -178.57 142.52 0.23 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.817 -0.753 . . . . 1.1100000000000001 111.959 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 12.5 mttp -77.35 -178.64 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.152 -0.619 . . . . 2.3500000000000001 109.677 179.015 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 4.4 m120 -112.69 -86.93 0.56 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.921 -0.581 . . . . 2.7000000000000002 110.3 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -155.19 -42.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.491 0.552 . . . . 1.3400000000000001 112.491 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.64 46.14 0.98 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.658 0.614 . . . . 1.4299999999999999 112.658 -178.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.14 -2.02 62.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.163 -1.017 . . . . 1.3799999999999999 113.288 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.05 105.47 8.15 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.039 -0.726 . . . . 1.49 109.039 179.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 4.1 tt -97.31 111.0 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.548 0.944 . . . . 1.48 113.548 -178.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.75 111.38 6.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.411 -1.7 . . . . 0.81000000000000005 106.411 177.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.692 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 73.0 Cg_endo -66.39 -99.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.814 1.676 . . . . 1.25 113.843 -177.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.692 ' HD3' ' HB2' ' A' ' 87' ' ' PRO . 72.5 Cg_endo -106.73 134.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 CA-C-N 124.815 2.755 . . . . 1.2 114.168 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 29.3 m -109.22 88.51 2.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.254 -0.43 . . . . 1.76 110.181 178.585 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 18.88 100.53 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.541 1.136 . . . . 1.77 113.973 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 53.0 Cg_exo -51.17 145.72 25.39 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.479 2.119 . . . . 1.01 113.616 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 75.2 m -73.49 141.21 46.79 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.55 109.274 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -39.73 144.94 0.15 Allowed 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 124.035 0.834 . . . . 1.6299999999999999 110.865 179.462 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -71.15 110.78 6.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.551 -0.46 . . . . 1.0900000000000001 110.491 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.444 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.9 mp -92.55 109.87 22.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.007 0.432 . . . . 1.1299999999999999 111.333 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 33.8 m -45.43 -32.94 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.657 -0.701 . . . . 1.1299999999999999 111.708 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.5 m 52.53 59.3 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.949 0.404 . . . . 1.5700000000000001 110.379 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.811 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -90.47 -75.65 0.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 3.7000000000000002 112.463 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.811 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.0 p-10 -119.75 30.56 6.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.121 -0.49 . . . . 2.1400000000000001 111.754 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 53.0 t0 44.39 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.076 0.465 . . . . 2.0600000000000001 111.835 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 p -162.23 27.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 3.0800000000000001 110.417 179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -42.3 139.04 1.54 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.991 -0.549 . . . . 4.5800000000000001 111.48 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 3.79 111.096 -179.954 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.802 0.334 . . . . 3.1699999999999999 111.313 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -89.6 75.08 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.182 2.588 . . . . 2.0600000000000001 112.363 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.44 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.3 tt -67.1 147.27 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.096 -0.502 . . . . 1.26 110.754 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -125.81 133.23 24.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 2.0 110.636 179.858 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.0 160.7 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.28 1.987 . . . . 0.58999999999999997 112.097 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.0 176.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.665 2.243 . . . . 1.6100000000000001 113.067 -179.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.78 171.44 53.56 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.557 -0.747 . . . . 0.97999999999999998 112.882 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -63.52 118.29 42.86 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 110.19 -0.3 . . . . 2.04 110.19 179.585 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 31.5 Cg_exo -64.74 135.49 45.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.067 . . . . 0.54000000000000004 112.801 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.45 103.65 11.31 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.036 -0.529 . . . . 1.6799999999999999 111.693 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' THR . 33.1 Cg_exo -48.7 117.69 2.88 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.055 1.836 . . . . 0.64000000000000001 112.366 179.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.879 HD13 ' OE2' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -75.5 -32.72 60.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.1 -0.704 . . . . 2.1699999999999999 109.1 178.86 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.5 t30 -148.81 157.48 43.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.878 -1.055 . . . . 0.84999999999999998 108.914 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 13' ' ' ILE . 1.9 pt -140.34 97.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.513 . . . . 1.5700000000000001 111.437 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -87.13 48.09 1.6 Allowed 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 115.635 -0.711 . . . . 1.46 112.279 -179.259 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.431 ' CD ' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 52.85 -75.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.678 0.621 . . . . 2.9100000000000001 112.678 178.698 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.2 m-70 -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 1.3300000000000001 111.614 -179.39 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.6 p -139.48 121.97 16.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.465 -0.334 . . . . 1.28 110.309 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.531 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 16.8 m -109.45 135.57 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.486 0.66 . . . . 1.49 112.168 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 18.9 m -93.6 140.19 29.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.68 -0.691 . . . . 1.1399999999999999 109.942 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.96 152.54 38.8 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.657 0.598 . . . . 1.3100000000000001 112.251 -179.854 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.435 ' CG ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -140.94 145.41 36.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.127 -0.942 . . . . 2.3100000000000001 110.438 179.825 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.3 p90 -140.03 -176.91 4.76 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.058 0.456 . . . . 0.40000000000000002 111.864 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.45 165.97 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 1.1100000000000001 110.705 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.24 147.07 32.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 2.5600000000000001 110.801 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 1.9 Cg_endo -42.77 167.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.032 2.488 . . . . 1.1100000000000001 112.047 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.58 -28.47 8.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 2.77 111.759 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -123.15 -69.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 1.6899999999999999 111.312 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 13.7 p 51.14 53.04 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 1.3500000000000001 111.007 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.14 -92.26 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.789 -0.72 . . . . 1.01 112.31 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.96 32.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.776 -0.93 . . . . 0.97999999999999998 110.776 179.379 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -120.1 -179.2 3.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.22 -0.49 . . . . 0.98999999999999999 111.509 -178.787 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 11.36 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 2.6899999999999999 111.398 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.478 HG22 ' CE1' ' A' ' 36' ' ' TYR . 4.6 mp 60.09 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.064 0.459 . . . . 1.71 110.897 -179.747 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 p -126.68 5.61 6.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 1.6599999999999999 111.277 179.861 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.58 123.14 0.64 Allowed 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.746 0.308 . . . . 1.97 110.987 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.478 ' CE1' HG22 ' A' ' 33' ' ' ILE . 22.3 m-85 -100.88 92.4 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.23 110.575 179.561 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.482 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 5.8 mm -69.69 138.23 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.463 -0.335 . . . . 1.76 111.0 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.93 101.19 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.45 -0.341 . . . . 1.6100000000000001 111.677 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.501 ' OE2' ' HA ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -77.46 138.69 39.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.914 -0.772 . . . . 1.6699999999999999 108.914 178.815 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -121.1 135.23 55.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 2.4399999999999999 111.64 -179.45 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' NH2' ' CD1' ' A' ' 48' ' ' TRP . 20.0 ttm180 -114.17 113.28 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.605 -0.725 . . . . 1.79 110.455 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.16 112.98 11.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.5900000000000001 110.502 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 2.2 mm? -80.39 149.22 68.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 1.4299999999999999 110.975 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.55 17.21 41.12 Favored 'Cis proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.885 -1.298 . . . . 1.47 112.66 0.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -151.08 93.16 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 2.6600000000000001 111.372 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -144.07 -165.52 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 1.6200000000000001 112.138 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 148.38 33.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 3.0600000000000001 110.842 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 50.6 m95 -68.88 97.56 0.85 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.678 -0.692 . . . . 1.0600000000000001 110.907 -179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -128.37 126.42 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.454 . . . . 1.8400000000000001 110.604 179.919 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 10.2 ptmm? -58.32 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 1.77 110.871 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -74.29 -35.23 63.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.953 0.406 . . . . 1.4099999999999999 110.373 179.794 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -44.28 -47.75 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.849 -0.614 . . . . 2.0099999999999998 111.386 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 41.27 30.03 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 2.6400000000000001 111.982 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 -161.34 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.44 -0.345 . . . . 2.0299999999999998 110.711 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.85 61.86 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 1.8700000000000001 110.935 -179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.552 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 2.4 mm -57.95 95.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 1.3700000000000001 110.131 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.21 -8.03 9.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.017 0.377 . . . . 2.1499999999999999 112.017 -179.536 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.28 9.14 23.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.157 0.428 . . . . 1.54 112.157 -179.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.482 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 13.0 p30 53.05 21.26 2.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 1.75 111.59 -179.075 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.435 ' OE1' ' CG ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -130.85 78.67 1.85 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.679 -1.23 . . . . 2.0499999999999998 107.679 178.902 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.552 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 82.3 t80 -120.03 164.63 15.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.519 0.676 . . . . 0.56999999999999995 112.378 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 48.8 m -124.43 120.86 33.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.765 -1.107 . . . . 1.1399999999999999 109.972 178.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' CG2' HD12 ' A' ' 20' ' ' LEU . 21.3 t -76.26 100.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.962 -0.563 . . . . 1.72 111.307 -179.521 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.23 137.13 32.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.243 -0.89 . . . . 1.6399999999999999 110.44 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.14 -17.41 4.33 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.787 -0.72 . . . . 0.95999999999999996 111.945 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -52.05 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.676 0.274 . . . . 2.02 110.311 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -148.03 141.81 25.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.481 -0.327 . . . . 1.55 110.563 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.49 139.26 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 1.9099999999999999 110.967 -179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.885 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 67.86 61.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 1.8700000000000001 111.06 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.29 120.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 1.2 111.443 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.74 135.56 51.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.159 -0.682 . . . . 1.1100000000000001 109.159 179.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.496 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 33.1 m-85 -129.94 115.87 17.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.258 0.836 . . . . 1.0800000000000001 113.258 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -99.27 134.18 42.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.5 107.917 178.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CZ ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.42 118.34 14.24 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.901 1.074 . . . . 0.79000000000000004 113.901 -179.066 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.498 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -97.46 172.98 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.028 -1.101 . . . . 2.6899999999999999 108.028 177.945 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -138.78 116.22 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.927 . . . . 1.5700000000000001 112.176 179.446 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 69.6 mt -99.2 142.15 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.784 -1.191 . . . . 1.3200000000000001 107.784 178.3 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -148.91 116.08 6.09 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.433 -0.907 . . . . 1.1100000000000001 112.729 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.6 mtpt -63.28 -167.66 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.638 -0.505 . . . . 2.3500000000000001 109.638 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.53 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 22.5 p30 -143.95 169.86 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.267 0.556 . . . . 2.7000000000000002 111.684 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.429 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -45.01 -30.18 0.99 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.315 -0.857 . . . . 1.3400000000000001 111.941 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -81.85 -22.55 36.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.848 0.314 . . . . 1.4299999999999999 111.848 -179.48 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.67 -21.54 18.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.368 -0.92 . . . . 1.3799999999999999 111.935 -179.51 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -52.22 161.03 0.68 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.087 -0.338 . . . . 1.49 110.087 179.581 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -112.56 109.76 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.247 0.462 . . . . 1.48 112.247 -179.596 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 16.0 p -66.88 115.87 29.5 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 109.167 -0.679 . . . . 0.81000000000000005 109.167 179.009 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -38.87 159.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.672 2.248 . . . . 1.25 112.812 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 28.4 Cg_endo -64.75 124.4 13.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.704 2.269 . . . . 1.2 112.976 -179.665 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLU . 45.6 m -76.76 115.64 16.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 1.76 109.636 179.062 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -12.19 118.44 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.588 1.155 . . . . 1.77 113.534 -179.34 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 70.2 Cg_exo -52.26 131.68 40.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.575 2.184 . . . . 1.01 113.606 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.406 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.97 144.99 56.92 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.585 -0.895 . . . . 1.55 108.585 178.687 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -34.21 141.75 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.956 0.785 . . . . 1.6299999999999999 112.352 -179.553 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . . . -73.15 107.19 5.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.76 -0.655 . . . . 1.0900000000000001 109.977 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.1 mp -86.79 112.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 1.1299999999999999 110.874 -179.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.2 m -48.09 -32.32 6.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.088 -0.506 . . . . 1.1299999999999999 110.656 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 81.5 m 54.83 83.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.86 -0.609 . . . . 1.5700000000000001 110.993 179.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 -91.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.314 -0.403 . . . . 3.7000000000000002 110.269 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.69 ' OD2' HG22 ' A' ' 101' ' ' VAL . 5.8 p-10 -97.44 17.86 16.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.846 0.355 . . . . 2.1400000000000001 110.063 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 p30 47.82 26.02 0.83 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.04 -0.527 . . . . 2.0600000000000001 111.436 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.69 HG22 ' OD2' ' A' ' 99' ' ' ASP . 23.5 t -119.99 -20.92 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 3.0800000000000001 111.188 179.586 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.741 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 37.69 63.04 0.82 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.02 0.438 . . . . 4.5800000000000001 112.089 179.933 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.227 -0.892 . . . . 3.79 111.21 179.855 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.602 0.239 . . . . 3.1699999999999999 111.112 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 2' ' ' ILE . 36.1 Cg_exo -60.37 -54.03 2.47 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.411 2.074 . . . . 2.0600000000000001 111.761 179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.457 ' CG1' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER 57.31 142.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.519 -0.764 . . . . 1.26 111.882 179.754 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.7 134.29 13.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 2.0 111.067 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.19 159.96 26.49 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.607 2.205 . . . . 0.58999999999999997 112.719 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 51.1 Cg_exo -55.09 172.63 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.713 2.275 . . . . 1.6100000000000001 112.491 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.8 -163.42 0.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.97999999999999998 112.221 179.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 4.7 tttp -87.4 142.9 33.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.57 0.185 . . . . 2.04 110.532 179.849 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 2.2 Cg_endo -83.24 132.5 6.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.659 2.239 . . . . 0.54000000000000004 112.494 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.74 110.73 10.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 1.6799999999999999 110.69 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.9 Cg_exo -59.54 139.93 91.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.117 1.878 . . . . 0.64000000000000001 113.887 -179.152 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -105.71 -26.83 11.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.957 -1.019 . . . . 2.1699999999999999 109.162 178.971 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -161.79 158.01 25.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.84999999999999998 110.452 -179.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 ' CG2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.4 95.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.127 0.489 . . . . 1.5700000000000001 110.469 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.21 56.61 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 1.46 112.166 -179.258 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.07 -68.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.548 0.573 . . . . 2.9100000000000001 112.548 178.371 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' THR . 24.4 m-70 -95.89 -7.25 37.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 1.3300000000000001 111.883 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 p -133.0 98.73 4.37 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.721 -0.392 . . . . 1.28 111.762 -179.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG12 ' CG2' ' A' ' 13' ' ' ILE . 84.6 t -86.62 141.84 13.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.242 -0.435 . . . . 1.49 109.945 179.356 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' HG ' ' A' ' 11' ' ' LEU . 88.0 m -123.89 115.53 21.44 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.872 0.693 . . . . 1.1399999999999999 112.872 -178.708 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -129.54 150.03 51.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.639 0.733 . . . . 1.3100000000000001 111.465 178.499 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.61 140.86 37.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.721 -1.127 . . . . 2.3100000000000001 110.207 -179.417 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.51 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -131.25 -176.81 4.14 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.443 0.639 . . . . 0.40000000000000002 112.47 -179.34 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.44 -162.5 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.592 -0.731 . . . . 1.1100000000000001 111.026 179.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -122.44 153.07 62.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 2.5600000000000001 111.005 -179.76 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 50.4 Cg_exo -55.81 179.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.771 2.314 . . . . 1.1100000000000001 113.248 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.85 -28.59 4.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 2.77 111.914 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -124.81 -69.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.015 0.376 . . . . 1.6899999999999999 112.015 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 HG22 ' CB ' ' A' ' 25' ' ' PRO . 4.1 p 51.61 49.8 20.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 1.3500000000000001 110.648 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.27 -104.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.113 -0.565 . . . . 1.01 112.692 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.16 2.56 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 110.563 -1.015 . . . . 0.97999999999999998 110.563 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CD2' ' OD1' ' A' ' 80' ' ' ASN . 1.2 m-85 -108.85 178.14 4.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.634 -0.783 . . . . 0.98999999999999999 111.47 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.13 6.02 2.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.889 -0.596 . . . . 2.6899999999999999 111.84 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 33' ' ' ILE . 18.8 mt 60.02 134.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-O 121.126 0.488 . . . . 1.71 111.083 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -122.92 -3.65 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 1.6599999999999999 112.201 -179.331 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 0.6 OUTLIER -168.63 116.1 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.103 0.408 . . . . 1.97 112.103 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -90.52 142.15 28.04 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.849 0.356 . . . . 1.23 110.152 179.038 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -111.94 166.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.123 -0.49 . . . . 1.76 110.712 -179.904 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.44 101.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.442 -0.345 . . . . 1.6100000000000001 111.386 -179.918 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -75.93 137.9 40.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 1.6699999999999999 109.677 179.279 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -115.62 152.54 32.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.14 0.495 . . . . 2.4399999999999999 111.532 -179.426 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -143.04 118.8 10.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.634 -0.712 . . . . 1.79 110.62 179.869 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 1.08 ' OD1' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -62.35 -15.41 48.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.305 -0.407 . . . . 1.5900000000000001 111.862 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.502 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 77.5 mt 57.05 148.42 0.05 OUTLIER Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.771 -0.65 . . . . 1.4299999999999999 111.755 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.86 13.22 46.17 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.744 -1.357 . . . . 1.47 112.4 -0.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -124.29 -67.9 0.89 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.383 -0.371 . . . . 2.6600000000000001 110.418 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 1.08 ' CA ' ' OD1' ' A' ' 42' ' ' ASP . . . 42.04 -129.7 4.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.118 -0.563 . . . . 1.6200000000000001 113.107 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.414 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 170.67 110.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 3.0600000000000001 110.781 -179.863 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.504 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.4 m95 -52.0 104.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.735 -0.666 . . . . 1.0600000000000001 110.648 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.75 136.29 28.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 1.8400000000000001 111.106 -179.654 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -52.61 119.08 4.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 1.77 111.167 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -109.21 -29.51 8.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 1.4099999999999999 110.619 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 15.1 p-10 -52.45 -50.21 63.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 2.0099999999999998 111.174 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 51.77 24.95 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.396 -0.366 . . . . 2.6400000000000001 110.808 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -159.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 2.0299999999999998 110.719 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.36 59.36 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.8700000000000001 111.134 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.488 HD12 ' CG ' ' A' ' 61' ' ' PHE . 15.4 mt -52.42 155.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.762 -0.459 . . . . 1.3700000000000001 109.762 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -164.79 -36.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.81 0.671 . . . . 2.1499999999999999 112.81 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.83 22.94 2.9 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.241 0.46 . . . . 1.54 112.241 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 17.9 p30 50.52 22.82 1.13 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.962 -0.563 . . . . 1.75 111.775 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -133.0 91.84 2.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.261 -1.014 . . . . 2.0499999999999998 108.261 178.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.518 ' CG ' ' N ' ' A' ' 62' ' ' THR . 72.1 t80 -122.31 165.55 16.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.245 0.545 . . . . 0.56999999999999995 111.946 -178.385 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.518 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 24.6 m -129.24 107.05 9.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.404 -0.816 . . . . 1.1399999999999999 111.124 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.1 t -67.47 108.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 1.72 110.718 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 p -110.15 144.24 39.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.658 -0.701 . . . . 1.6399999999999999 110.966 -179.849 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.67 10.54 14.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.686 -0.769 . . . . 0.95999999999999996 112.902 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 3.7 mm? -52.58 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.105 0.452 . . . . 2.02 110.68 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -105.71 -18.56 14.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.55 110.955 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 68.0 141.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.894 0.378 . . . . 1.9099999999999999 110.63 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.49 25.05 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 1.8700000000000001 110.203 -179.367 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.09 141.58 25.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.878 -0.601 . . . . 1.2 110.693 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -80.81 132.41 35.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 1.1100000000000001 110.9 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 49.5 m-85 -132.39 133.39 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.773 . . . . 1.0800000000000001 112.154 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -106.21 143.75 33.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.173 -1.047 . . . . 1.5 108.173 178.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -134.83 117.96 16.48 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.066 1.506 . . . . 0.79000000000000004 115.066 -178.337 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.9 156.52 17.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 2.6899999999999999 109.895 177.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.9 t -104.57 128.89 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.252 0.548 . . . . 1.5700000000000001 111.498 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.436 ' CG2' HD13 ' A' ' 85' ' ' ILE . 11.0 mt -132.85 155.74 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.551 -1.278 . . . . 1.3200000000000001 107.551 179.131 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -176.86 131.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.467 -0.893 . . . . 1.1100000000000001 112.799 -179.628 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 ptpt -87.92 111.73 21.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.738 -0.838 . . . . 2.3500000000000001 108.738 178.407 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -46.39 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.851 1.056 . . . . 2.7000000000000002 113.851 -177.933 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB1' ' HB3' ' A' ' 31' ' ' PHE . . . -125.15 -52.05 1.65 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.043 0.757 . . . . 1.3400000000000001 113.043 -178.615 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.514 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -74.14 0.76 12.92 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.084 0.772 . . . . 1.4299999999999999 113.084 -178.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.7 -17.6 38.9 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.184 -1.008 . . . . 1.3799999999999999 112.259 -179.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -55.6 97.13 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.08 -0.711 . . . . 1.49 109.08 179.23 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 HD13 ' CG2' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -67.11 118.53 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.486 0.921 . . . . 1.48 113.486 -178.173 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.2 p -71.29 110.45 7.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 107.945 -1.132 . . . . 0.81000000000000005 107.945 178.123 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -56.44 175.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.82 2.347 . . . . 1.25 114.324 -178.168 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 86.2 Cg_exo -45.79 135.78 13.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.621 2.881 . . . . 1.2 113.866 -179.373 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 m -119.84 95.55 4.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.036 -0.529 . . . . 1.76 111.416 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 20.96 105.83 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.996 1.11 . . . . 1.77 113.996 179.435 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.6 Cg_exo -60.66 136.86 69.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.531 2.154 . . . . 1.01 112.643 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.4 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -71.6 146.85 48.11 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.021 -0.536 . . . . 1.55 110.23 179.627 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -34.09 146.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.348 1.03 . . . . 1.6299999999999999 112.159 -179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -81.56 118.13 22.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.784 -0.644 . . . . 1.0900000000000001 110.947 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mp -108.59 119.47 58.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.342 -0.39 . . . . 1.1299999999999999 111.503 -179.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 53.1 m -52.21 -22.81 4.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.005 -0.543 . . . . 1.1299999999999999 111.056 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.9 m 57.93 58.0 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.235 0.541 . . . . 1.5700000000000001 110.176 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.44 ' HD3' ' CG ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -78.82 -132.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.433 -0.803 . . . . 3.7000000000000002 110.759 -179.594 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.25 ' OD1' HG11 ' A' ' 101' ' ' VAL . 2.6 p30 -93.41 35.81 1.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.175 0.443 . . . . 2.1400000000000001 110.824 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 24.2 t0 34.44 32.38 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.26 0.552 . . . . 2.0600000000000001 112.312 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.25 HG11 ' OD1' ' A' ' 99' ' ' ASP . 9.9 p -169.84 27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.857 -0.61 . . . . 3.0800000000000001 111.449 179.742 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.513 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -113.06 -19.93 11.69 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.728 -0.389 . . . . 4.5800000000000001 111.279 179.848 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' NH1' ' A' ' 98' ' ' ARG . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.221 -0.895 . . . . 3.79 111.048 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.691 0.281 . . . . 3.1699999999999999 111.203 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.4 Cg_exo -78.17 122.05 5.55 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.977 2.451 . . . . 2.0600000000000001 111.937 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.441 HD12 ' CB ' ' A' ' 86' ' ' SER . 1.6 tt -113.33 145.95 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 1.26 111.181 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.6 m-20 -130.41 138.61 33.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 2.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.27 161.91 13.2 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.854 2.369 . . . . 0.58999999999999997 112.552 -179.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 12.3 Cg_endo -56.33 -174.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.062 2.508 . . . . 1.6100000000000001 112.981 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 178.05 49.14 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.967 -0.56 . . . . 0.97999999999999998 112.838 -179.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.9 122.81 85.28 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.198 -0.297 . . . . 2.04 110.198 179.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 29.3 Cg_exo -67.66 141.78 56.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.54000000000000004 112.816 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.55 108.01 7.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.7 -0.682 . . . . 1.6799999999999999 110.848 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 19' ' ' THR . 24.4 Cg_exo -51.06 123.2 11.37 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.14 1.893 . . . . 0.64000000000000001 113.048 -179.518 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 21' ' ' LYS . 1.5 mm? -84.03 -31.67 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.084 -0.71 . . . . 2.1699999999999999 109.084 178.41 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.11 147.97 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.879 -1.055 . . . . 0.84999999999999998 108.934 179.634 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.504 HG22 HD11 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -132.58 98.39 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.335 -0.546 . . . . 1.5700000000000001 111.441 -179.556 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.45 50.96 2.06 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.628 -0.714 . . . . 1.46 111.576 -179.719 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.77 -75.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.661 0.615 . . . . 2.9100000000000001 112.661 178.933 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.3 m-70 -73.6 -24.92 60.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.333 0.494 . . . . 1.3300000000000001 112.333 -179.132 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -137.59 122.09 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.226 -0.287 . . . . 1.28 110.226 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.526 HG23 ' CZ ' ' A' ' 74' ' ' PHE . 12.6 m -111.64 121.92 65.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.625 0.726 . . . . 1.49 112.647 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.5 m -83.69 138.37 33.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.92 -1.037 . . . . 1.1399999999999999 110.35 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' CD2' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.61 164.12 34.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.642 0.588 . . . . 1.3100000000000001 111.724 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' N ' HD23 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.31 178.93 6.84 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.648 -0.706 . . . . 2.3100000000000001 110.352 179.437 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 47.6 p90 -172.31 167.18 5.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.393 0.616 . . . . 0.40000000000000002 112.533 179.717 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.83 148.95 29.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.19 -0.914 . . . . 1.1100000000000001 110.657 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.61 149.13 43.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.496 -0.32 . . . . 2.5600000000000001 110.842 179.819 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 86.5 Cg_exo -44.65 176.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.024 2.483 . . . . 1.1100000000000001 112.919 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -30.64 4.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.908 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -114.01 -71.72 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.143 0.423 . . . . 1.6899999999999999 112.143 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 12.1 p 54.38 37.11 26.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 1.3500000000000001 110.808 -179.451 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 50.38 -92.65 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.788 . . . . 1.01 112.229 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.3 27.38 1.54 Allowed Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.46 -0.656 . . . . 0.97999999999999998 111.46 179.516 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CE1' ' HB1' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -102.55 -177.27 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.98999999999999999 111.567 -179.17 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.81 2.99 2.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.431 0.53 . . . . 2.6899999999999999 112.431 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG22 ' CE1' ' A' ' 36' ' ' TYR . 2.7 mp 60.65 136.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.107 0.479 . . . . 1.71 111.436 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 p -124.7 9.64 8.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 1.6599999999999999 111.779 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 t -179.29 138.39 0.14 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.831 0.348 . . . . 1.97 111.752 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CE1' HG22 ' A' ' 33' ' ' ILE . 32.8 m-85 -114.35 103.96 11.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 1.23 110.496 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.5 mm -79.83 128.36 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 1.76 110.883 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.98 111.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.832 0.308 . . . . 1.6100000000000001 111.832 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 1.8 mt-10 -86.81 136.36 33.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 1.6699999999999999 108.834 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.442 ' HD3' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.54 143.78 50.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.338 0.59 . . . . 2.4399999999999999 112.274 -179.001 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HG3' ' HA3' ' A' ' 46' ' ' GLY . 20.3 ttp180 -110.53 108.5 18.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.151 -0.931 . . . . 1.79 109.905 179.426 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.954 ' OD2' ' NH2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.83 92.69 3.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.698 -0.683 . . . . 1.5900000000000001 109.839 179.809 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -68.17 142.86 95.37 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 1.4299999999999999 111.172 -179.405 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -94.2 16.25 41.64 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.047 -1.231 . . . . 1.47 112.793 0.109 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.37 67.78 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.579 -0.282 . . . . 2.6600000000000001 111.642 -179.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -110.57 176.54 18.93 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.571 -0.823 . . . . 1.6200000000000001 112.681 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.954 ' NH2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -151.58 19.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 3.0600000000000001 111.246 -179.827 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.454 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 82.2 m95 49.74 98.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 1.0600000000000001 111.106 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -143.14 155.29 44.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 1.8400000000000001 110.851 179.198 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -71.84 116.83 12.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.089 0.471 . . . . 1.77 111.563 -179.427 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.442 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . . . -93.14 -39.79 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 1.4099999999999999 110.609 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 13.9 p-10 -49.92 -48.62 51.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 2.0099999999999998 111.049 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.05 30.43 0.59 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 2.6400000000000001 111.297 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 m -139.29 -164.64 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 2.0299999999999998 111.153 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.86 107.7 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 1.8700000000000001 111.022 -179.854 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.491 HD12 ' CE1' ' A' ' 61' ' ' PHE . 44.1 mt -108.48 65.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 1.3700000000000001 110.704 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mt -47.66 -66.75 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 2.1499999999999999 111.475 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.15 162.47 27.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.933 0.397 . . . . 1.54 110.555 179.975 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.505 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.7 p30 -75.9 -2.39 30.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.894 -0.594 . . . . 1.75 111.659 -179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB3' ' HG3' ' A' ' 58' ' ' GLU . 16.7 tt0 -93.48 99.55 12.01 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.457 -0.571 . . . . 2.0499999999999998 109.457 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 73.0 t80 -134.51 164.58 27.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.316 0.579 . . . . 0.56999999999999995 112.024 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.508 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.8 m -124.3 124.86 43.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.246 -0.888 . . . . 1.1399999999999999 109.974 179.32 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.441 HG22 ' CD1' ' A' ' 20' ' ' LEU . 9.9 t -80.55 96.07 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.098 0.475 . . . . 1.72 111.365 -179.442 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.25 132.51 35.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 1.6399999999999999 110.83 179.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.82 -25.65 2.93 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.529 -0.76 . . . . 0.95999999999999996 111.325 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.518 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 6.9 mp -49.14 158.29 0.37 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.958 0.408 . . . . 2.02 110.928 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -124.91 144.14 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 1.55 110.805 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.21 143.73 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 1.9099999999999999 111.16 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER 69.87 44.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 1.8700000000000001 111.213 179.891 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -157.41 122.2 4.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.858 0.361 . . . . 1.2 111.808 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.451 ' CB ' HD11 ' A' ' 43' ' ' LEU . . . -74.81 128.84 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 1.1100000000000001 109.861 179.168 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 47.0 m-85 -125.13 125.14 43.26 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.082 0.771 . . . . 1.0800000000000001 113.082 -178.701 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.401 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -102.37 137.94 39.96 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.885 -1.154 . . . . 1.5 107.885 178.013 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -142.75 126.58 17.13 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.208 1.558 . . . . 0.79000000000000004 115.208 -178.781 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.454 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -106.02 -173.04 2.2 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.954 -1.128 . . . . 2.6899999999999999 107.954 177.384 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.469 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -151.34 117.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 118.989 -1.084 . . . . 1.5700000000000001 113.336 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 65.4 mt -100.18 146.11 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.832 -1.544 . . . . 1.3200000000000001 106.832 177.288 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -158.33 135.69 10.15 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.75 -0.78 . . . . 1.1100000000000001 112.286 -178.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.1 mttp -73.6 -152.38 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.733 -0.84 . . . . 2.3500000000000001 108.733 178.792 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' OD1' ' CE2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -147.29 -108.91 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.452 -0.499 . . . . 2.7000000000000002 110.724 179.576 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.36 -12.06 4.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.978 0.808 . . . . 1.3400000000000001 112.5 179.617 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.522 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -105.1 -1.07 26.03 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.754 0.279 . . . . 1.4299999999999999 111.754 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.88 43.63 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.427 -0.892 . . . . 1.3799999999999999 112.481 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.28 153.61 11.88 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.744 -0.268 . . . . 1.49 110.316 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -113.63 106.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.069 0.462 . . . . 1.48 111.681 -179.725 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.441 ' CB ' HD12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -65.42 127.44 92.95 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 115.93 -0.577 . . . . 0.81000000000000005 109.738 179.585 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -41.35 168.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.88 2.387 . . . . 1.25 113.365 -179.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 2.9 Cg_exo -75.74 121.35 6.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.254 2.636 . . . . 1.2 112.6 -179.744 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -66.79 132.84 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.156 -0.683 . . . . 1.76 109.156 178.998 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -33.6 121.71 0.48 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 122.869 0.468 . . . . 1.77 112.169 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 56.3 Cg_exo -52.98 155.31 11.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.94 2.426 . . . . 1.01 113.977 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.94 149.72 21.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 1.55 109.832 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -42.47 148.26 0.23 Allowed 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 124.21 0.944 . . . . 1.6299999999999999 111.222 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -75.24 124.23 26.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.825 -0.625 . . . . 1.0900000000000001 111.62 -179.636 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.46 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 4.0 mp -102.99 109.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 1.1299999999999999 110.517 179.483 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 70' ' ' ALA . 80.6 m -46.63 -28.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 1.1299999999999999 111.004 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' ASP . 94.9 m 52.04 83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.5700000000000001 110.515 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.79 -87.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 3.7000000000000002 111.278 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.604 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 3.5 p-10 -98.59 9.88 42.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.337 -0.392 . . . . 2.1400000000000001 111.304 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.4 p30 44.92 27.97 0.32 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.999 0.428 . . . . 2.0600000000000001 111.252 -179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.604 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 47.8 t -130.29 -4.78 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.926 -0.579 . . . . 3.0800000000000001 111.932 -179.834 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.39 43.75 6.38 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.051 0.453 . . . . 4.5800000000000001 111.614 179.681 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.233 -0.889 . . . . 3.79 110.979 179.882 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.454 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.603 0.24 . . . . 3.1699999999999999 111.403 . . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 0' ' ' SER . 10.6 Cg_exo -71.83 -179.42 3.8 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 2.0600000000000001 112.128 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 2.2 tt -156.11 141.42 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.939 -0.573 . . . . 1.26 110.722 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.12 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -129.0 119.39 19.82 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 2.0 110.537 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.9 161.89 37.46 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.164 1.909 . . . . 0.58999999999999997 111.983 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.96 167.0 18.87 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.645 2.23 . . . . 1.6100000000000001 113.158 -179.312 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.68 154.96 25.87 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.789 -0.641 . . . . 0.97999999999999998 112.94 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.6 tttt -53.65 138.83 51.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 2.04 110.103 179.704 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 4.2 Cg_exo -80.63 115.35 3.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.448 2.098 . . . . 0.54000000000000004 111.901 179.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 12.5 p -109.29 109.74 60.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.538 -0.301 . . . . 1.6799999999999999 110.649 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 72.9 Cg_exo -41.66 125.0 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.341 2.027 . . . . 0.64000000000000001 113.123 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.59 -33.26 16.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.49 -0.777 . . . . 2.1699999999999999 109.61 179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.35 111.1 2.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.84999999999999998 109.565 179.22 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' CG2' HG12 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -102.74 140.07 22.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.357 0.598 . . . . 1.5700000000000001 112.4 -179.229 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.91 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -136.42 141.59 43.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.299 -0.864 . . . . 1.46 110.197 179.777 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -43.14 -24.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.155 0.798 . . . . 2.9100000000000001 113.155 -179.239 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -122.73 -0.15 9.17 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.784 -0.572 . . . . 1.3300000000000001 112.497 -179.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -161.27 120.29 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 1.28 110.95 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG12 ' CG2' ' A' ' 13' ' ' ILE . 61.2 t -108.16 128.31 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.168 -0.469 . . . . 1.49 111.176 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 21.7 m -106.48 133.43 51.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 1.1399999999999999 110.938 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.34 147.0 47.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.681 0.753 . . . . 1.3100000000000001 112.033 179.493 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -130.25 131.12 45.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.473 -1.24 . . . . 2.3100000000000001 109.646 179.682 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 6.5 p90 -118.01 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.003 0.43 . . . . 0.40000000000000002 111.946 -179.565 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.32 177.94 4.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.721 -0.672 . . . . 1.1100000000000001 112.052 -179.498 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.442 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.27 142.17 25.83 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.34 -0.845 . . . . 2.5600000000000001 110.266 179.801 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 78.3 Cg_exo -51.86 -161.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.888 2.392 . . . . 1.1100000000000001 113.595 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.3 -43.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.267 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.006 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.7 t80 -111.2 -70.66 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.453 -0.34 . . . . 1.6899999999999999 111.885 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 1.12 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 p 55.16 43.84 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.922 -0.399 . . . . 1.3500000000000001 109.922 -179.243 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.37 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.733 -0.667 . . . . 1.01 112.769 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.95 37.87 0.81 Allowed Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 109.872 -1.291 . . . . 0.97999999999999998 109.872 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -117.65 -179.27 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.631 -0.785 . . . . 0.98999999999999999 111.055 -178.67 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -6.77 4.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 2.6899999999999999 112.29 -179.744 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG22 HD12 ' A' ' 33' ' ' ILE . 11.9 mt 62.26 142.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 1.71 110.648 -179.642 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.431 ' N ' HG21 ' A' ' 33' ' ' ILE . 3.1 p -138.93 42.66 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.3 . . . . 1.6599999999999999 111.428 -179.57 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.31 165.45 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.416 -0.356 . . . . 1.97 110.69 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.477 ' CE2' ' OD1' ' A' ' 59' ' ' ASN . 61.2 m-85 -153.53 74.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 1.23 110.889 179.839 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.484 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.6 mt -57.42 133.52 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 1.76 110.865 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.1 104.79 17.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.342 -0.39 . . . . 1.6100000000000001 111.302 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.948 ' OE2' ' O ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -78.98 130.12 35.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.686 -0.487 . . . . 1.6699999999999999 109.686 179.394 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.67 143.92 43.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.886 0.374 . . . . 2.4399999999999999 110.983 -179.877 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 4.1 ttm180 -117.36 105.38 12.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.944 -0.571 . . . . 1.79 110.575 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.728 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.59 98.56 3.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 1.5900000000000001 110.907 -179.742 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 15.6 mt -83.2 154.7 66.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 1.4299999999999999 110.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.33 37.96 5.76 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.056 -1.227 . . . . 1.47 112.835 0.297 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -167.19 79.46 0.2 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 2.6600000000000001 111.305 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.728 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -152.92 -169.71 18.42 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.932 -0.576 . . . . 1.6200000000000001 111.85 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 159.75 42.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.138 0.494 . . . . 3.0600000000000001 111.278 179.828 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.948 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 70.0 m95 -64.52 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 1.0600000000000001 111.017 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.69 128.49 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.351 -0.386 . . . . 1.8400000000000001 111.086 -179.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.89 117.57 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 1.77 111.234 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -95.86 -33.72 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 1.4099999999999999 110.811 179.702 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.3 p-10 -47.64 -59.12 3.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 2.0099999999999998 111.558 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.41 37.76 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 2.6400000000000001 111.181 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -145.44 20.37 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 2.0299999999999998 111.422 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.71 116.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.999 0.428 . . . . 1.8700000000000001 111.262 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 15.4 mm -105.4 85.04 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.3700000000000001 111.324 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.12 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 2.1499999999999999 110.45 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.22 176.72 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 1.54 110.35 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -95.74 32.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 1.75 111.746 -179.616 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -131.58 97.85 4.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.727 -0.471 . . . . 2.0499999999999998 109.727 179.513 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.547 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 83.3 t80 -133.29 163.16 29.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.259 0.552 . . . . 0.56999999999999995 111.927 -179.345 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.528 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 46.0 m -130.25 112.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.175 -0.92 . . . . 1.1399999999999999 110.824 179.152 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.0 t -72.06 119.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.72 111.05 179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.78 142.47 46.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.923 -0.58 . . . . 1.6399999999999999 110.992 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.18 5.44 6.17 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.786 -0.721 . . . . 0.95999999999999996 112.798 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -71.92 -172.54 0.86 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.071 0.435 . . . . 2.02 110.929 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -142.12 147.26 36.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 1.55 111.017 -179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 5.8 tt0 -63.82 138.53 58.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 1.9099999999999999 111.455 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.14 57.68 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 1.8700000000000001 111.008 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -166.62 118.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 1.2 111.182 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . . . -71.34 123.73 22.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 1.1100000000000001 110.464 179.563 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 37.8 m-85 -119.12 127.93 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.583 0.586 . . . . 1.0800000000000001 112.583 -178.875 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.2 tt0 -104.32 145.88 29.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.9 -0.778 . . . . 1.5 108.9 178.641 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -142.45 130.04 21.41 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.228 1.195 . . . . 0.79000000000000004 114.228 -179.186 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -115.67 -178.85 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.684 -0.689 . . . . 2.6899999999999999 109.814 178.312 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.439 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 39.5 t -132.56 110.35 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.132 -0.627 . . . . 1.5700000000000001 112.632 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' A' ' 39' ' ' GLU . 59.2 mt -105.48 142.17 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.067 -1.457 . . . . 1.3200000000000001 107.067 177.514 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -150.66 -171.23 3.87 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.765 -0.774 . . . . 1.1100000000000001 111.655 -179.749 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 83' ' ' GLY . 7.1 mttt -129.78 -175.38 3.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 2.3500000000000001 109.705 179.419 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.4 m-80 -132.9 162.07 32.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.978 0.418 . . . . 2.7000000000000002 111.464 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . . . -43.36 -28.69 0.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 1.3400000000000001 112.544 -179.706 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.525 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -85.87 -7.6 58.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.709 0.633 . . . . 1.4299999999999999 112.709 -179.125 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 102.91 -16.71 54.09 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.241 -0.981 . . . . 1.3799999999999999 112.458 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.18 161.92 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 1.49 109.93 179.731 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -115.73 98.5 6.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 1.48 111.583 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.09 116.58 10.69 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.32 -0.622 . . . . 0.81000000000000005 109.32 179.237 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.58 168.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.938 2.425 . . . . 1.25 113.072 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 22.5 Cg_exo -65.15 121.54 9.03 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.937 2.425 . . . . 1.2 113.281 -179.651 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -78.35 124.2 27.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.663 -0.699 . . . . 1.76 109.233 179.021 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 mm-40 -22.68 117.97 0.17 Allowed Pre-proline 0 N--CA 1.479 0.986 0 O-C-N 124.015 0.822 . . . . 1.77 113.084 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.4 Cg_exo -60.28 163.72 14.18 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.881 2.387 . . . . 1.01 113.999 -179.233 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -98.94 147.78 24.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.207 -0.906 . . . . 1.55 109.661 179.317 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -36.73 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 124.016 0.823 . . . . 1.6299999999999999 111.86 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.453 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -87.9 111.16 21.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.969 -0.559 . . . . 1.0900000000000001 111.494 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.06 110.56 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 1.1299999999999999 110.516 179.68 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -46.09 -38.35 7.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.014 0.435 . . . . 1.1299999999999999 110.645 179.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 15' ' ' ARG . 70.8 m 59.37 68.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 1.5700000000000001 110.189 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -103.64 -77.61 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 3.7000000000000002 111.288 -179.265 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.387 ' CG ' ' HG2' ' A' ' 102' ' ' GLU . 33.8 p30 -138.49 17.81 2.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.884 -0.598 . . . . 2.1400000000000001 111.034 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.91 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 44.2 30.18 0.42 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.376 0.608 . . . . 2.0600000000000001 111.653 -179.919 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' OD1' ' A' ' 99' ' ' ASP . 7.3 p -170.94 33.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.06 -0.973 . . . . 3.0800000000000001 110.172 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.387 ' HG2' ' CG ' ' A' ' 99' ' ' ASP . 7.1 mm-40 -113.97 -25.18 8.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.434 -0.803 . . . . 4.5800000000000001 110.896 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.337 -0.839 . . . . 3.79 111.238 -179.95 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.435 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.682 0.277 . . . . 3.1699999999999999 111.278 . . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.459 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 88.8 Cg_endo -93.57 52.37 0.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.092 2.528 . . . . 2.0600000000000001 112.365 -179.945 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.427 HG13 ' ND2' ' A' ' 80' ' ' ASN . 1.1 tt -43.13 142.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 1.26 111.45 -179.833 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -117.84 133.82 23.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 2.0 111.148 -179.653 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.0 146.15 12.71 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.482 2.121 . . . . 0.58999999999999997 112.176 179.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.497 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 77.6 Cg_exo -46.41 159.7 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.282 2.655 . . . . 1.6100000000000001 114.011 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.39 -158.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.136 -0.938 . . . . 0.97999999999999998 112.802 179.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.24 124.62 69.88 Favored Pre-proline 0 C--O 1.233 0.193 0 N-CA-C 110.684 -0.117 . . . . 2.04 110.684 179.728 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 5.5 Cg_exo -74.13 117.12 4.88 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.472 2.114 . . . . 0.54000000000000004 111.633 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 111.84 26.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.189 -0.46 . . . . 1.6799999999999999 110.438 -179.827 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 80.5 Cg_exo -33.84 145.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.839 2.359 . . . . 0.64000000000000001 113.581 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 1.349 HD13 ' CD ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -107.76 -41.74 4.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.402 -1.272 . . . . 2.1699999999999999 108.932 -179.941 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.405 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -164.35 107.77 0.93 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.497 -1.229 . . . . 0.84999999999999998 110.135 179.903 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -88.56 102.27 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.6 -0.727 . . . . 1.5700000000000001 111.877 -179.75 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -91.51 43.53 1.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.453 -0.794 . . . . 1.46 111.079 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' CA ' ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER 55.61 -74.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.591 -0.731 . . . . 2.9100000000000001 112.287 179.269 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-70 -74.27 -27.67 60.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 1.3300000000000001 111.053 -179.251 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -129.08 104.09 7.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.007 -0.542 . . . . 1.28 109.621 179.312 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 73.8 t -89.44 114.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.949 -0.568 . . . . 1.49 111.548 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 70.4 m -88.41 148.81 24.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.931 0.396 . . . . 1.1399999999999999 111.425 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.68 158.7 42.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.44 -0.8 . . . . 1.3100000000000001 111.269 179.628 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.046 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.0 142.16 28.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 2.3100000000000001 110.225 179.593 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.497 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 11.6 p90 -125.05 -174.06 2.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.871 0.367 . . . . 0.40000000000000002 111.941 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -94.25 -23.04 18.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.984 -0.553 . . . . 1.1100000000000001 112.47 -179.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER 75.39 166.03 0.13 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.5600000000000001 110.403 -179.387 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' CG ' HG23 ' A' ' 28' ' ' THR . 59.8 Cg_endo -70.59 -173.85 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 1.1100000000000001 112.785 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -129.71 -40.11 1.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 2.77 111.359 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 1' ' ' PRO . 28.2 t80 -93.58 -70.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.938 -0.305 . . . . 1.6899999999999999 111.268 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 7.4 p 58.43 42.44 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 1.3500000000000001 110.907 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.601 -0.809 . . . . 1.01 112.337 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.15 30.5 2.53 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.478 -1.049 . . . . 0.97999999999999998 110.478 179.164 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -114.55 171.57 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -0.659 . . . . 0.98999999999999999 111.097 -178.845 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 4.15 3.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.183 -0.462 . . . . 2.6899999999999999 111.75 179.44 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.476 HG22 ' CE1' ' A' ' 36' ' ' TYR . 1.3 mt 55.01 117.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 CA-C-O 121.362 0.601 . . . . 1.71 112.21 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 p -98.38 -11.53 22.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.47 -0.787 . . . . 1.6599999999999999 110.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.68 138.01 4.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.807 0.337 . . . . 1.97 111.562 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.476 ' CE1' HG22 ' A' ' 33' ' ' ILE . 93.1 m-85 -108.21 115.25 29.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.945 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.426 HG21 ' CB ' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -95.77 106.46 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.337 -0.392 . . . . 1.76 110.66 179.65 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.65 135.88 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.41 0.624 . . . . 1.6100000000000001 111.475 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 4.9 mt-10 -91.13 143.9 26.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.872 -1.058 . . . . 1.6699999999999999 110.845 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 151.58 25.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.199 -0.455 . . . . 2.4399999999999999 111.007 -179.99 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -132.11 102.82 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 1.79 110.527 179.709 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.83 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -77.17 96.28 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.341 -0.39 . . . . 1.5900000000000001 110.548 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD22 ' HB3' ' A' ' 94' ' ' ALA . 1.3 mm? -75.12 147.31 83.18 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 1.4299999999999999 110.687 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -90.38 3.66 68.12 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.942 -1.274 . . . . 1.47 113.226 0.304 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -125.38 74.67 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 2.6600000000000001 110.913 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -136.96 -177.76 15.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.686 . . . . 1.6200000000000001 112.644 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 140.82 17.52 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.034 0.445 . . . . 3.0600000000000001 110.698 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' NE1' ' CZ ' ' A' ' 41' ' ' ARG . 64.6 m95 -55.11 104.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.625 -0.716 . . . . 1.0600000000000001 110.818 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -136.77 117.36 13.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 1.8400000000000001 110.67 179.958 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' CB ' HG21 ' A' ' 37' ' ' ILE . 3.1 ptmm? -45.45 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.942 -0.572 . . . . 1.77 111.339 -179.661 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -72.9 -17.49 61.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 1.4099999999999999 111.244 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -81.94 113.05 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 2.0099999999999998 110.817 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.69 25.44 11.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.206 -0.452 . . . . 2.6400000000000001 110.659 179.916 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -125.9 -160.91 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 2.0299999999999998 110.806 -179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 88.5 2.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 1.8700000000000001 111.177 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.515 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 12.8 mt -75.74 62.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 1.3700000000000001 111.065 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.29 -75.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.988 -0.551 . . . . 2.1499999999999999 111.095 -179.894 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -179.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 1.54 110.721 179.822 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 33.3 p30 -93.98 17.01 13.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.75 111.361 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.349 ' CD ' HD13 ' A' ' 11' ' ' LEU . 3.1 tp10 -118.34 108.29 14.9 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.897 -0.409 . . . . 2.0499999999999998 109.897 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.7 t80 -141.12 165.56 27.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.097 0.475 . . . . 0.56999999999999995 111.379 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 12.0 m -127.37 115.74 19.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.703 -0.681 . . . . 1.1399999999999999 110.769 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.403 HG11 ' N ' ' A' ' 64' ' ' SER . 22.6 t -75.42 139.16 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.67 -0.696 . . . . 1.72 111.382 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.403 ' N ' HG11 ' A' ' 63' ' ' VAL . 61.5 p -124.11 -171.08 2.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.738 -0.664 . . . . 1.6399999999999999 110.607 179.598 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.88 90.09 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.59 -0.732 . . . . 0.95999999999999996 112.479 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 3.6 mp -71.23 163.91 26.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.336 0.589 . . . . 2.02 111.839 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -128.73 112.19 13.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 1.55 109.809 179.464 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 7.8 tt0 -41.23 150.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.557 . . . . 1.9099999999999999 112.453 -179.09 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.845 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 73.18 39.84 0.58 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.398 -0.819 . . . . 1.8700000000000001 110.782 -179.867 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.39 135.16 7.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 1.2 111.352 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.69 129.41 37.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 1.1100000000000001 110.191 179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.509 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 49.4 m-85 -124.34 118.21 26.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.063 0.394 . . . . 1.0800000000000001 112.063 -179.5 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' CG ' ' HB1' ' A' ' 94' ' ' ALA . 1.4 mt-10 -101.39 135.4 42.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 1.5 109.139 179.072 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -130.53 122.1 26.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.895 1.443 . . . . 0.79000000000000004 114.895 -178.857 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' CD ' ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -104.54 154.48 19.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.505 -0.924 . . . . 2.6899999999999999 108.505 177.254 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -114.24 119.13 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 119.323 -0.951 . . . . 1.5700000000000001 113.41 -179.243 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 78' ' ' ALA . 61.3 mt -111.25 150.64 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.018 -1.446 . . . . 1.3200000000000001 107.423 178.323 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -168.14 127.54 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.066 -1.053 . . . . 1.1100000000000001 113.278 -179.642 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -85.19 80.12 9.32 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.733 -0.839 . . . . 2.3500000000000001 108.733 178.185 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 18.1 m-20 -17.1 -92.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 113.88 -1.509 . . . . 2.7000000000000002 114.339 -178.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -128.61 -48.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.051 0.759 . . . . 1.3400000000000001 113.051 -179.101 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.93 43.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.264 0.468 . . . . 1.4299999999999999 112.264 -178.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 76.43 -3.13 55.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.462 -0.875 . . . . 1.3799999999999999 113.246 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -58.93 85.98 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.111 0.455 . . . . 1.49 109.946 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -66.47 117.2 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.086 -0.506 . . . . 1.48 112.344 -179.083 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 3.2 t -80.69 110.61 17.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 107.669 -1.234 . . . . 0.81000000000000005 107.669 178.346 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.45 162.79 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.403 2.069 . . . . 1.25 113.185 -178.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 75' ' ' ARG . 63.4 Cg_exo -36.18 91.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.32 2.68 . . . . 1.2 113.288 -179.728 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.9 p -73.13 99.0 2.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.657 -0.417 . . . . 1.76 110.707 179.705 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 mt-10 18.61 107.66 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 124.688 1.242 . . . . 1.77 113.917 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 98.5 Cg_exo -44.87 177.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.498 2.132 . . . . 1.01 113.741 179.483 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -113.15 140.52 47.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.225 -1.352 . . . . 1.55 108.764 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' O ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -36.94 134.42 0.52 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.638 0.586 . . . . 1.6299999999999999 111.634 -179.925 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HB1' ' CG ' ' A' ' 73' ' ' GLU . . . -70.18 107.92 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 1.0900000000000001 110.966 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CD1' ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -91.05 112.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.878 0.37 . . . . 1.1299999999999999 110.882 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.1 m -59.03 -23.79 62.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.892 -0.594 . . . . 1.1299999999999999 111.174 -179.77 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' A' ' 68' ' ' GLU . 18.9 t 56.02 101.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.14 0.495 . . . . 1.5700000000000001 110.218 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -77.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 3.7000000000000002 109.638 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.445 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 20.7 p-10 -106.35 21.36 17.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.267 -0.879 . . . . 2.1400000000000001 110.099 179.019 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p30 47.25 27.79 0.91 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.983 -0.553 . . . . 2.0600000000000001 111.03 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 57.7 t -119.46 -21.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.576 -0.738 . . . . 3.0800000000000001 111.355 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.788 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 42.75 85.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.081 0.467 . . . . 4.5800000000000001 111.703 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.238 -0.887 . . . . 3.79 111.17 179.957 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.775 0.321 . . . . 3.1699999999999999 111.256 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.479 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 94.4 Cg_endo -85.13 72.47 4.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.846 2.364 . . . . 2.0600000000000001 112.345 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 tt -57.56 124.53 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.42 . . . . 1.26 111.406 -179.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.863 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.46 128.24 28.64 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.423 179.798 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.45 173.1 14.77 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.58999999999999997 112.926 -179.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 33.7 Cg_exo -58.91 177.46 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.052 2.501 . . . . 1.6100000000000001 113.172 -179.577 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.62 22.13 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.97999999999999998 112.734 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -85.48 122.3 73.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.301 0.096 . . . . 2.04 111.102 -179.897 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' CG ' HG22 ' A' ' 76' ' ' VAL . 4.2 Cg_exo -76.95 134.08 14.34 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.498 2.132 . . . . 0.54000000000000004 111.69 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -141.09 120.07 8.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.951 0.352 . . . . 1.6799999999999999 111.951 -179.207 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.3 Cg_exo -65.78 102.21 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.683 2.256 . . . . 0.64000000000000001 112.92 -179.956 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -60.21 -45.27 93.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.847 -0.797 . . . . 2.1699999999999999 108.847 179.046 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.17 138.27 54.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.741 -1.118 . . . . 0.84999999999999998 108.426 178.718 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.437 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -133.64 99.05 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.094 -0.642 . . . . 1.5700000000000001 112.203 -179.331 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.39 148.97 23.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.46 110.079 179.346 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -60.93 -13.66 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.979 0.363 . . . . 2.9100000000000001 111.979 -179.412 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.436 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.9 m-70 -134.68 31.45 3.37 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.673 0.273 . . . . 1.3300000000000001 111.656 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.441 ' HA ' HD21 ' A' ' 66' ' ' LEU . 0.3 OUTLIER 162.14 125.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.627 -0.508 . . . . 1.28 109.627 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.535 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 11.8 m -120.4 149.41 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.269 -0.572 . . . . 1.49 111.492 179.774 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 3.2 m -120.73 123.44 42.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 1.1399999999999999 111.046 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.56 161.71 29.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.808 0.813 . . . . 1.3100000000000001 112.48 179.647 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.905 ' HG2' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -133.55 168.78 18.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.212 -1.358 . . . . 2.3100000000000001 110.153 179.853 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.6 p90 -158.03 172.38 18.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.426 . . . . 0.40000000000000002 111.304 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.12 139.77 30.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.877 -0.601 . . . . 1.1100000000000001 111.964 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -79.04 140.93 57.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 2.5600000000000001 109.733 179.274 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 10.5 Cg_endo -53.14 -175.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.215 1.943 . . . . 1.1100000000000001 111.619 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.3 -37.56 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.379 . . . . 2.77 111.55 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.863 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 5.5 t80 -95.03 -71.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.551 -0.295 . . . . 1.6899999999999999 111.579 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.844 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 68.9 p 49.59 43.76 24.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.971 0.415 . . . . 1.3500000000000001 110.509 -179.448 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.24 -93.89 0.01 OUTLIER Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.996 -0.547 . . . . 1.01 112.614 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -142.48 39.71 1.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.057 -0.817 . . . . 0.97999999999999998 111.057 179.537 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.489 ' CE1' ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -124.5 176.99 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.529 -0.336 . . . . 0.98999999999999999 110.909 -179.05 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.75 3.59 3.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.27 -0.423 . . . . 2.6899999999999999 111.775 179.66 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 33' ' ' ILE . 10.7 mt 58.77 117.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 121.091 0.472 . . . . 1.71 111.241 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -102.73 11.19 37.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.658 . . . . 1.6599999999999999 111.731 -179.585 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -168.62 170.92 9.18 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.037 0.446 . . . . 1.97 111.502 -179.92 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' CE1' HG23 ' A' ' 33' ' ' ILE . 48.6 m-85 -154.06 75.47 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.534 -0.757 . . . . 1.23 109.917 179.578 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 37' ' ' ILE . 3.1 mt -50.14 144.11 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.564 -0.744 . . . . 1.76 111.497 -179.532 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.489 ' CG1' ' CG2' ' A' ' 63' ' ' VAL . 3.6 t -129.23 107.01 14.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.348 -0.387 . . . . 1.6100000000000001 111.407 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -93.2 149.03 21.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.092 -0.504 . . . . 1.6699999999999999 110.431 179.735 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' NZ ' ' CD1' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -115.49 139.62 49.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.196 0.522 . . . . 2.4399999999999999 112.116 179.737 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -112.37 96.34 5.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.185 -0.916 . . . . 1.79 108.622 178.304 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.769 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -67.89 105.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 1.5900000000000001 110.798 -179.136 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CD2' ' HD2' ' A' ' 41' ' ' ARG . 10.6 mt -76.73 150.72 81.99 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.857 -0.61 . . . . 1.4299999999999999 111.147 -179.807 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -87.89 9.05 64.13 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.756 -1.352 . . . . 1.47 113.179 0.281 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -80.5 -88.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 2.6600000000000001 110.49 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' CA ' ' HG2' ' A' ' 41' ' ' ARG . . . 115.72 175.37 18.13 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.647 -0.787 . . . . 1.6200000000000001 113.568 179.258 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.8 -25.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.267 0.227 . . . . 3.0600000000000001 111.381 -179.923 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 85.4 m95 50.81 87.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.793 0.33 . . . . 1.0600000000000001 111.065 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.77 127.96 46.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.365 . . . . 1.8400000000000001 111.018 179.589 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 50' ' ' LYS . 16.8 ptmt -54.16 109.86 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 1.77 110.905 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' CB ' ' HD2' ' A' ' 40' ' ' LYS . . . -81.77 -35.95 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 1.4099999999999999 110.709 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -48.36 -62.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 2.0099999999999998 110.661 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 51.61 37.18 19.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 2.6400000000000001 111.101 179.761 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 t -145.02 -82.91 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 2.0299999999999998 110.811 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 172.85 120.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 1.8700000000000001 111.192 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 8.2 mm -103.46 69.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 1.3700000000000001 110.8 179.756 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -46.48 71.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 2.1499999999999999 110.259 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -99.61 154.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 1.54 109.996 179.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -68.21 -9.55 47.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.468 -0.333 . . . . 1.75 111.414 179.98 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.905 ' OE1' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tp10 -93.59 98.61 11.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.836 -0.431 . . . . 2.0499999999999998 109.836 179.711 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 70.4 t80 -133.98 164.01 28.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.103 0.478 . . . . 0.56999999999999995 111.566 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.531 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 19.2 m -117.38 116.44 27.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.626 -0.716 . . . . 1.1399999999999999 110.808 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' CG2' ' CG1' ' A' ' 38' ' ' VAL . 65.1 t -86.53 96.38 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.0 0.428 . . . . 1.72 110.471 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.408 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 1.2 p -85.59 158.54 20.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.6399999999999999 110.373 179.799 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.5 -8.4 8.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.347 -0.842 . . . . 0.95999999999999996 111.793 -179.304 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.515 HD11 ' CD2' ' A' ' 72' ' ' TYR . 3.3 mm? -44.7 171.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.096 0.474 . . . . 2.02 111.356 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.6 m -147.59 123.86 10.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.868 -0.605 . . . . 1.55 110.714 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.43 137.14 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 1.9099999999999999 111.191 -179.883 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER 61.12 46.77 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 1.8700000000000001 111.523 179.905 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -156.81 122.51 4.78 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 1.2 111.526 179.791 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . . . -72.57 135.71 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 1.1100000000000001 110.086 179.318 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CD1' ' NZ ' ' A' ' 40' ' ' LYS . 42.5 m-85 -131.56 126.71 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.769 0.655 . . . . 1.0800000000000001 112.769 -178.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.56 139.28 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.868 -0.789 . . . . 1.5 108.868 178.354 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.535 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.65 114.99 19.41 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.367 1.247 . . . . 0.79000000000000004 114.367 -178.52 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.3 ttp85 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.119 -0.492 . . . . 2.6899999999999999 111.247 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG22 ' CG ' ' A' ' 8' ' ' PRO . 58.6 t -100.16 134.39 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.32 0.581 . . . . 1.5700000000000001 111.0 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 77' ' ' ILE . 9.9 mt -132.48 149.55 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.563 -1.273 . . . . 1.3200000000000001 107.563 178.863 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -171.3 141.26 1.56 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.079 -1.048 . . . . 1.1100000000000001 112.526 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.2 mttt -82.1 -123.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 2.3500000000000001 110.65 179.634 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 54.5 p30 -170.02 -122.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.394 0.543 . . . . 2.7000000000000002 109.583 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.0 -1.16 5.24 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.432 1.014 . . . . 1.3400000000000001 112.085 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.489 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -113.13 -1.32 14.42 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.894 0.331 . . . . 1.4299999999999999 111.894 -179.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.75 -19.53 41.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.188 -1.006 . . . . 1.3799999999999999 113.014 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.41 158.53 14.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.949 -0.389 . . . . 1.49 109.949 179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.7 tt -120.99 118.18 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.09 0.774 . . . . 1.48 113.09 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -74.02 111.93 14.56 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 107.205 -1.406 . . . . 0.81000000000000005 107.205 177.835 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.441 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 18.7 Cg_endo -57.86 170.82 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.149 2.566 . . . . 1.25 114.557 -178.051 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 7.6 Cg_exo -32.48 142.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.385 3.39 . . . . 1.2 113.821 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.9 m -131.24 104.74 7.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.518 -0.764 . . . . 1.76 110.243 179.185 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 3.6 110.27 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.872 1.269 . . . . 1.77 113.568 -179.974 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 23.9 Cg_exo -63.71 153.19 76.78 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 1.01 114.421 -179.3 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.96 145.94 44.28 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.945 -1.025 . . . . 1.55 109.491 179.023 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -34.71 154.5 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 O-C-N 124.135 0.897 . . . . 1.6299999999999999 112.207 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -84.21 111.23 19.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 1.0900000000000001 109.48 179.252 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.1 mp -94.2 111.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.914 -0.314 . . . . 1.1299999999999999 111.391 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' ALA . 12.4 m -48.37 -30.53 5.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.023 -0.535 . . . . 1.1299999999999999 110.72 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 69' ' ' ASP . 82.5 m 49.85 86.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.065 -0.516 . . . . 1.5700000000000001 111.088 179.678 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 -84.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.34 -0.391 . . . . 3.7000000000000002 110.519 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -11.61 20.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.059 -0.519 . . . . 2.1400000000000001 111.011 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 57.55 20.06 5.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.417 -0.356 . . . . 2.0600000000000001 111.562 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.68 -2.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.671 -0.24 . . . . 3.0800000000000001 111.446 179.766 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.1 -69.13 0.51 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.973 0.416 . . . . 4.5800000000000001 110.436 -179.828 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.203 -0.903 . . . . 3.79 111.623 179.745 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.476 0.179 . . . . 3.1699999999999999 111.041 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.41 175.48 9.58 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.506 2.137 . . . . 2.0600000000000001 112.439 -179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.435 HD13 ' CB ' ' A' ' 84' ' ' ALA . 1.2 tt -143.12 144.62 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 1.26 110.714 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -130.56 131.89 23.63 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 2.0 110.738 179.83 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 162.43 28.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.435 2.09 . . . . 0.58999999999999997 112.509 -179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.2 Cg_endo -57.09 -179.56 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.01 2.474 . . . . 1.6100000000000001 112.554 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.29 -161.83 8.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.869 -0.681 . . . . 0.97999999999999998 112.813 -179.794 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -87.94 118.88 70.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.559 -0.163 . . . . 2.04 110.559 179.953 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 36.7 Cg_exo -62.52 133.77 44.44 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.54 2.16 . . . . 0.54000000000000004 112.74 -179.84 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.0 104.91 9.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 1.6799999999999999 111.02 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 47.0 Cg_exo -51.01 99.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.261 1.974 . . . . 0.64000000000000001 113.206 -179.594 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' A' ' 21' ' ' LYS . 1.5 mt -55.56 -37.21 67.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.054 -0.721 . . . . 2.1699999999999999 109.054 179.065 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 4.2 t30 -136.5 153.72 50.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.765 -1.107 . . . . 0.84999999999999998 108.648 179.007 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 1.278 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 3.6 pt -143.78 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.402 -0.519 . . . . 1.5700000000000001 112.208 -179.004 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.637 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -94.7 137.91 33.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 1.46 110.117 179.412 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -40.47 -26.11 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.359 0.874 . . . . 2.9100000000000001 113.359 -178.9 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -115.53 -19.96 10.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.53 -0.468 . . . . 1.3300000000000001 111.966 -179.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.464 ' HA ' HD21 ' A' ' 66' ' ' LEU . 49.9 p -147.8 122.26 9.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.555 0.216 . . . . 1.28 110.659 -179.843 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.522 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 17.7 m -111.04 125.59 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.954 0.353 . . . . 1.49 111.954 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 47.2 m -87.05 144.53 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.035 -0.357 . . . . 1.1399999999999999 110.035 179.083 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.91 151.45 39.83 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.82 0.7 . . . . 1.3100000000000001 112.521 -179.885 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 19.3 tptp -144.66 148.15 33.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.765 -1.107 . . . . 2.3100000000000001 110.091 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.2 p90 -140.87 -176.51 4.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.40000000000000002 112.248 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.44 -159.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.384 -0.825 . . . . 1.1100000000000001 111.068 179.956 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -130.83 142.42 45.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 2.5600000000000001 110.158 179.952 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.76 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 88.2 Cg_exo -43.96 171.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.349 2.033 . . . . 1.1100000000000001 112.458 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.76 ' OE1' ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -106.92 -42.16 5.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 2.77 112.059 -179.608 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -118.03 -70.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.218 0.451 . . . . 1.6899999999999999 112.218 -179.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.4 p 60.31 46.23 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 1.3500000000000001 110.454 -179.253 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.71 -109.63 0.35 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.814 -0.708 . . . . 1.01 112.193 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.69 31.9 3.45 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.525 -1.03 . . . . 0.97999999999999998 110.525 179.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -114.38 -177.59 3.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.098 -0.551 . . . . 0.98999999999999999 111.468 -178.908 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 15.38 1.44 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 2.6899999999999999 111.743 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 61.05 152.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.551 0.215 . . . . 1.71 111.27 179.699 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -140.5 8.26 2.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.548 0.573 . . . . 1.6599999999999999 112.548 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 t -178.06 125.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 1.97 110.979 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.64 98.14 7.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 1.23 111.553 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.21 124.72 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 1.76 110.157 179.477 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -110.18 119.1 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 1.6100000000000001 111.538 -179.507 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.91 137.45 43.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.402 -0.817 . . . . 1.6699999999999999 109.397 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.489 ' HD2' ' CD1' ' A' ' 72' ' ' TYR . 3.9 ttpm? -104.1 146.32 28.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.344 -0.389 . . . . 2.4399999999999999 110.348 -179.226 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.75 86.55 2.46 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.05 0.452 . . . . 1.79 110.579 179.711 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.857 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -62.36 86.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.509 -0.769 . . . . 1.5900000000000001 110.612 -179.828 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD2' ' HG2' ' A' ' 41' ' ' ARG . 76.5 mt -66.36 149.02 98.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.974 -0.557 . . . . 1.4299999999999999 111.049 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -93.23 27.38 18.68 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.893 -1.295 . . . . 1.47 112.719 0.337 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.25 45.16 2.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.512 -0.313 . . . . 2.6600000000000001 111.369 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -87.28 179.0 48.03 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.474 -0.87 . . . . 1.6200000000000001 112.344 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.79 31.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 3.0600000000000001 110.952 -179.727 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 53.4 m95 45.32 74.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 1.0600000000000001 111.236 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.31 133.08 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.016 -179.764 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -50.17 98.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.046 -0.524 . . . . 1.77 110.79 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -64.73 -53.56 45.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 1.4099999999999999 110.772 -179.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.7 p-10 -71.0 129.12 38.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 2.0099999999999998 110.873 179.843 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -124.62 34.92 4.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.372 -0.376 . . . . 2.6400000000000001 111.077 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 m -130.41 -84.93 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 2.0299999999999998 110.923 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.37 118.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 1.8700000000000001 110.964 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.5 HG22 HD11 ' A' ' 56' ' ' ILE . 15.9 mt -109.04 74.34 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 1.3700000000000001 110.968 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.74 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 111.001 -179.945 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.94 -178.48 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.547 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.9 p30 -92.56 2.88 56.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 1.75 111.672 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -102.98 101.82 11.83 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 110.049 -0.352 . . . . 2.0499999999999998 110.049 179.524 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 52' ' ' ASN . 72.8 t80 -135.06 163.92 28.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.56999999999999995 111.44 -179.454 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 80.2 m -125.63 125.22 42.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.699 -0.682 . . . . 1.1399999999999999 110.387 179.345 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 51' ' ' ALA . 17.0 t -83.43 90.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.208 0.527 . . . . 1.72 111.691 -179.355 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -92.46 137.9 31.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 1.6399999999999999 110.623 179.784 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.83 -5.61 7.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.95999999999999996 112.456 -179.642 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -48.91 -179.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.121 0.486 . . . . 2.02 111.591 179.807 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -141.19 118.72 11.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 1.55 110.132 179.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.416 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -45.59 155.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 1.9099999999999999 111.483 -179.561 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.0 m-20 52.87 55.03 9.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 1.8700000000000001 111.175 -179.884 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.71 121.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 1.2 111.296 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB2' HD11 ' A' ' 43' ' ' LEU . . . -68.15 138.03 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.92 -0.4 . . . . 1.1100000000000001 109.92 179.481 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.8 m-85 -128.83 112.97 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.713 1.005 . . . . 1.0800000000000001 113.713 -178.37 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.6 tt0 -102.35 134.7 45.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.234 -1.024 . . . . 1.5 108.234 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.519 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.35 125.89 19.06 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.819 1.415 . . . . 0.79000000000000004 114.819 -178.644 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HB3' ' CD ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -103.62 165.49 11.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.257 -0.883 . . . . 2.6899999999999999 109.025 178.202 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.56 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -131.68 122.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 113.487 0.921 . . . . 1.5700000000000001 113.487 179.688 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 29.4 mt -106.59 147.91 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.667 -1.606 . . . . 1.3200000000000001 107.486 177.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -159.16 112.78 2.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.152 -1.019 . . . . 1.1100000000000001 112.688 -179.412 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 mttp -56.21 -175.87 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.31 -0.626 . . . . 2.3500000000000001 109.31 178.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.434 ' OD1' ' CD1' ' A' ' 2' ' ' ILE . 3.5 m120 -133.52 170.78 15.01 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.858 -0.337 . . . . 2.7000000000000002 110.559 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -41.1 -27.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.58 0.585 . . . . 1.3400000000000001 112.58 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -106.6 14.68 26.7 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 1.4299999999999999 112.852 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.96 -18.07 46.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.465 -0.874 . . . . 1.3799999999999999 112.947 179.659 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.435 ' CB ' HD13 ' A' ' 2' ' ' ILE . . . -46.5 105.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 1.49 110.903 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -68.98 97.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 1.48 111.65 -179.462 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 21.5 p -60.38 111.54 4.17 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 120.203 -0.599 . . . . 0.81000000000000005 109.939 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.18 146.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.758 2.305 . . . . 1.25 112.683 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 1.6 Cg_endo -46.52 140.57 11.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.691 2.26 . . . . 1.2 112.807 -179.665 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 90' ' ' GLU . 2.0 m -96.42 108.67 21.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.811 . . . . 1.76 110.386 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -2.95 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.715 1.206 . . . . 1.77 113.748 -179.935 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 78.3 Cg_exo -46.73 139.36 13.93 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.328 2.019 . . . . 1.01 113.28 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -76.27 147.41 38.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.893 -0.594 . . . . 1.55 109.51 179.338 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -39.08 147.1 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.967 0.792 . . . . 1.6299999999999999 111.577 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -77.79 117.22 18.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.719 -0.673 . . . . 1.0900000000000001 111.261 -179.71 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' A' ' 13' ' ' ILE . 4.6 mp -95.48 113.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 1.1299999999999999 110.597 179.408 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.443 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 84.5 m -51.82 -32.96 33.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.1299999999999999 111.036 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 69' ' ' ASP . 3.6 m 54.57 89.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.5700000000000001 110.138 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -129.21 -78.0 0.56 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.223 0.535 . . . . 3.7000000000000002 110.69 -179.803 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.144 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -126.19 0.98 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.49 -0.777 . . . . 2.1400000000000001 111.052 179.717 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.278 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 49.43 24.22 1.04 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.784 0.326 . . . . 2.0600000000000001 111.244 -179.706 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.144 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 53.5 t -132.37 0.64 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.317 -0.402 . . . . 3.0800000000000001 112.016 179.876 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.986 ' HG2' ' OD1' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -119.75 -4.53 10.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.694 0.283 . . . . 4.5800000000000001 111.21 179.702 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.247 -0.883 . . . . 3.79 111.069 179.797 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.454 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 111.52 0.193 . . . . 3.1699999999999999 111.52 . . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 0' ' ' SER . 13.0 Cg_exo -71.1 -175.94 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.536 2.158 . . . . 2.0600000000000001 111.85 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 tt -160.75 144.82 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.955 0.407 . . . . 1.26 111.238 -179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.666 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.12 125.95 20.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 2.0 110.497 179.982 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 161.18 41.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.357 2.038 . . . . 0.58999999999999997 112.324 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.42 -173.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.792 2.328 . . . . 1.6100000000000001 112.969 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.02 -154.13 6.84 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.97999999999999998 113.017 -179.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -94.36 141.83 24.05 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.293 0.092 . . . . 2.04 110.932 -179.83 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 1.4 Cg_endo -83.34 127.11 4.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.901 2.401 . . . . 0.54000000000000004 112.411 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.99 102.75 10.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.6799999999999999 110.97 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.9 Cg_exo -37.05 140.13 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.818 2.345 . . . . 0.64000000000000001 112.88 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' CG ' HG23 ' A' ' 19' ' ' THR . 0.1 OUTLIER -108.39 -28.76 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 2.1699999999999999 110.151 -179.769 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.45 109.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.797 -0.638 . . . . 0.84999999999999998 109.911 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -106.6 148.51 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.714 1.005 . . . . 1.5700000000000001 113.714 -178.883 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.437 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -141.38 165.88 26.29 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.197 -0.91 . . . . 1.46 110.867 179.382 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.196 ' HD2' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -42.69 -41.72 3.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.241 -0.891 . . . . 2.9100000000000001 112.865 -179.44 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.5 m-70 -132.87 27.46 4.27 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.938 0.718 . . . . 1.3300000000000001 112.938 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -166.3 112.74 0.85 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.499 -0.48 . . . . 1.28 111.354 179.04 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.521 HG22 ' CE1' ' A' ' 74' ' ' PHE . 1.7 m -110.61 127.64 67.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 C-N-CA 120.156 -0.618 . . . . 1.49 111.82 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.5 m -97.81 144.61 27.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.307 -0.627 . . . . 1.1399999999999999 109.307 179.161 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.86 152.98 39.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.413 0.625 . . . . 1.3100000000000001 112.323 -179.732 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -133.24 137.71 46.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.007 -0.997 . . . . 2.3100000000000001 110.238 179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.7 p90 -138.0 178.25 7.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 0.40000000000000002 111.062 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.0 -167.78 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 1.1100000000000001 110.899 179.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.15 161.58 60.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.849 0.357 . . . . 2.5600000000000001 111.129 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 24' ' ' LYS . 31.4 Cg_exo -59.66 -177.67 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.878 2.386 . . . . 1.1100000000000001 113.192 -179.568 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.17 7.51 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.536 179.761 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.666 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 20.8 t80 -142.84 -67.37 0.37 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.369 . . . . 1.6899999999999999 110.858 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.643 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 50.8 p 48.23 44.92 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 1.3500000000000001 110.776 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.61 -102.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 1.01 112.254 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.05 26.68 4.18 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.204 -0.759 . . . . 0.97999999999999998 111.204 179.234 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.497 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -115.03 -174.57 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.98999999999999999 111.055 -179.34 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -145.04 25.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 2.6899999999999999 110.833 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.518 HG22 ' CE1' ' A' ' 36' ' ' TYR . 2.2 mm 60.77 148.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 1.71 110.712 -179.897 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -135.46 17.93 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.266 -0.424 . . . . 1.6599999999999999 111.025 179.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.446 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.1 t 170.55 160.34 0.07 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.156 0.503 . . . . 1.97 111.383 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.518 ' CE1' HG22 ' A' ' 33' ' ' ILE . 37.8 m-85 -137.41 78.49 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 1.23 109.946 179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 50' ' ' LYS . 12.7 mt -80.66 118.26 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 1.76 111.663 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -100.19 127.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 1.6100000000000001 110.266 179.732 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -84.5 131.96 34.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.6699999999999999 111.375 -179.583 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' HD3' ' CE2' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -95.23 140.59 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.719 -0.673 . . . . 2.4399999999999999 112.659 -179.435 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.7 ttt180 -127.34 104.57 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 1.79 110.098 178.527 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.679 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.48 84.96 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 1.5900000000000001 110.681 -179.79 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.5 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.01 154.7 2.41 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.485 -0.779 . . . . 1.4299999999999999 110.828 -179.96 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.89 15.35 36.5 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 123.875 -1.302 . . . . 1.47 112.951 0.376 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -117.61 -77.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 2.6600000000000001 111.111 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.499 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . 52.87 -178.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.63 -0.795 . . . . 1.6200000000000001 112.006 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.94 29.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 3.0600000000000001 111.257 -179.823 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 61.1 m95 47.5 93.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 1.0600000000000001 110.92 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.14 131.74 47.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.692 -0.403 . . . . 1.8400000000000001 111.29 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HB3' HG23 ' A' ' 37' ' ' ILE . 17.7 ptpt -63.19 74.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.824 -0.626 . . . . 1.77 111.389 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.443 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -55.64 -43.11 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 1.4099999999999999 110.26 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -42.07 -46.51 4.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.987 -0.551 . . . . 2.0099999999999998 111.253 179.713 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.65 36.84 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 2.6400000000000001 110.997 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -144.35 -162.99 1.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 2.0299999999999998 110.624 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -111.58 88.69 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 1.8700000000000001 110.828 -179.906 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 10.2 mm -70.52 67.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 1.3700000000000001 111.1 179.861 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.19 -58.88 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 2.1499999999999999 110.363 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -76.88 160.67 29.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.173 -0.677 . . . . 1.54 109.173 179.055 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.527 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.6 p30 -84.16 10.28 10.64 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.561 -0.456 . . . . 1.75 112.057 -179.651 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.02 98.79 7.01 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.605 . . . . 2.0499999999999998 109.365 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 81.2 t80 -130.02 163.65 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.447 0.641 . . . . 0.56999999999999995 112.251 -179.041 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 25.7 m -117.15 114.91 24.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.013 -0.994 . . . . 1.1399999999999999 110.872 179.232 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' CG1' ' HD3' ' A' ' 40' ' ' LYS . 44.8 t -81.65 84.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.777 -0.647 . . . . 1.72 110.739 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.411 ' CB ' HG21 ' A' ' 17' ' ' THR . 51.8 p -83.37 -179.78 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.72 . . . . 1.6399999999999999 110.673 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.18 -20.83 34.58 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.581 -0.819 . . . . 0.95999999999999996 112.446 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.498 HD23 HG11 ' A' ' 18' ' ' VAL . 1.3 pp -51.95 179.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.683 0.278 . . . . 2.02 110.482 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.413 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 3.0 m -140.55 127.56 20.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 1.55 111.247 -179.482 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -54.52 157.34 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.11 0.481 . . . . 1.9099999999999999 111.477 -179.877 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.4 OUTLIER 68.84 47.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 1.8700000000000001 110.649 -179.605 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -172.9 123.78 0.43 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 1.2 111.594 179.958 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -70.05 134.16 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.659 -0.497 . . . . 1.1100000000000001 109.659 179.11 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.538 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 43.0 m-85 -127.37 118.22 23.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.819 0.674 . . . . 1.0800000000000001 112.819 -178.677 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -103.53 139.18 39.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.348 -0.612 . . . . 1.5 109.348 178.709 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -141.02 127.24 19.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.63 1.344 . . . . 0.79000000000000004 114.63 -179.438 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -96.59 163.23 13.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.492 -0.777 . . . . 2.6899999999999999 109.344 178.184 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 60.6 t -115.52 123.5 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 112.807 0.669 . . . . 1.5700000000000001 112.807 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 HG13 ' CA ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -114.05 155.61 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 114.79 -1.095 . . . . 1.3200000000000001 109.248 179.023 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -165.52 127.77 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.884 -0.726 . . . . 1.1100000000000001 111.931 179.02 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mttt -77.85 -157.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 2.3500000000000001 110.358 179.828 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 6.9 p-10 -155.64 162.88 40.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.336 0.589 . . . . 2.7000000000000002 111.415 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.11 -41.17 1.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 1.3400000000000001 112.784 -179.756 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -70.34 -14.12 62.44 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.411 0.523 . . . . 1.4299999999999999 112.411 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.83 59.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.435 -0.888 . . . . 1.3799999999999999 112.108 -179.201 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.56 170.02 6.83 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.004 -0.369 . . . . 1.49 110.004 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -119.02 120.25 63.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.512 0.56 . . . . 1.48 112.512 -179.294 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.2 p -81.64 118.8 73.58 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.076 -1.083 . . . . 0.81000000000000005 108.076 178.344 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.47 158.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.761 2.307 . . . . 1.25 113.08 -178.863 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' CA ' HG13 ' A' ' 77' ' ' ILE . 37.0 Cg_endo -67.59 162.53 38.74 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.82 2.347 . . . . 1.2 113.896 -179.208 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 m -114.14 135.26 54.23 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.099 -0.955 . . . . 1.76 109.839 179.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -19.69 106.71 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 124.497 1.123 . . . . 1.77 113.48 -179.445 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 87.6 Cg_exo -43.83 141.79 3.95 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 1.01 113.222 -179.944 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.11 147.13 38.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.626 -0.715 . . . . 1.55 109.817 179.418 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -37.21 146.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 O-C-N 124.207 0.942 . . . . 1.6299999999999999 111.797 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.5 ' CB ' ' CD2' ' A' ' 43' ' ' LEU . . . -77.78 108.91 11.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.932 -0.576 . . . . 1.0900000000000001 110.66 179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 13' ' ' ILE . 4.6 mp -86.23 113.44 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 1.1299999999999999 110.72 179.856 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 92.6 m -50.89 -46.32 60.53 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 1.1299999999999999 110.033 179.748 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 69' ' ' ASP . 2.3 m 57.53 107.76 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.685 -0.689 . . . . 1.5700000000000001 109.697 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.93 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -140.6 -85.35 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.975 0.417 . . . . 3.7000000000000002 110.474 -179.602 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.93 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 12.2 p-10 -106.65 32.18 4.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 2.1400000000000001 109.183 179.245 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.437 ' OD1' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER 47.93 24.17 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.192 -0.913 . . . . 2.0600000000000001 111.356 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.734 HG22 ' OD2' ' A' ' 99' ' ' ASP . 21.0 t -123.87 -17.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 3.0800000000000001 111.444 179.502 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.782 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 39.35 95.22 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.945 0.403 . . . . 4.5800000000000001 111.772 179.97 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.344 -0.836 . . . . 3.79 111.065 179.911 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.678 0.275 . . . . 3.1699999999999999 111.049 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.466 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 14.5 Cg_exo -70.98 -41.52 2.68 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.878 2.385 . . . . 2.0600000000000001 111.808 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 1' ' ' PRO . 13.3 tt 52.87 150.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 124.114 0.884 . . . . 1.26 112.794 179.861 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -135.62 109.59 10.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.277 -0.874 . . . . 2.0 110.053 179.903 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.65 153.23 79.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.272 1.981 . . . . 0.58999999999999997 112.271 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.64 179.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.889 2.392 . . . . 1.6100000000000001 112.976 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.22 -178.22 47.16 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.909 -0.587 . . . . 0.97999999999999998 113.088 -179.644 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.6 tttt -69.28 136.11 88.95 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.448 0.166 . . . . 2.04 111.276 -179.875 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.466 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 5.1 Cg_exo -75.72 131.34 13.38 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.521 2.148 . . . . 0.54000000000000004 112.201 179.665 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 21' ' ' LYS . 2.5 p -132.5 100.06 15.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.6799999999999999 110.797 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 17.3 Cg_exo -52.63 122.66 11.3 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.025 1.816 . . . . 0.64000000000000001 113.697 -179.234 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.501 HD12 ' CD ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -82.95 -31.73 27.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.551 -0.907 . . . . 2.1699999999999999 108.551 178.347 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.59 138.16 37.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.979 -1.009 . . . . 0.84999999999999998 108.634 179.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -139.43 94.92 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.306 -0.558 . . . . 1.5700000000000001 112.308 -179.139 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 163.12 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.46 110.133 179.264 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -61.46 -21.38 64.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.36 -0.382 . . . . 2.9100000000000001 111.944 -179.42 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -126.34 16.02 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 1.3300000000000001 111.471 179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -158.68 159.28 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 1.28 109.826 179.683 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' CG2' ' CD2' ' A' ' 66' ' ' LEU . 82.5 t -156.2 91.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.924 -0.311 . . . . 1.49 111.563 -179.161 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 30.9 m -79.07 145.47 33.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.309 -0.405 . . . . 1.1399999999999999 110.363 179.432 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.13 161.8 41.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.736 0.779 . . . . 1.3100000000000001 112.898 -179.072 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.223 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -141.18 142.03 34.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.32 -1.309 . . . . 2.3100000000000001 109.249 179.213 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.496 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 14.7 p90 -137.88 -174.28 3.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.73 0.3 . . . . 0.40000000000000002 111.145 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.63 163.4 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 1.1100000000000001 111.267 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.56 145.1 31.93 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.108 -0.496 . . . . 2.5600000000000001 110.077 179.874 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.428 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 5.2 Cg_exo -77.82 162.61 29.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.31 2.007 . . . . 1.1100000000000001 112.169 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -112.78 -22.62 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 2.77 111.192 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -85.01 -72.61 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 1.6899999999999999 111.137 -179.839 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.486 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 31.7 p 41.4 45.56 2.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.67 -0.241 . . . . 1.3500000000000001 111.497 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.25 -92.53 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.703 -0.76 . . . . 1.01 112.409 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -153.14 43.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.187 -1.165 . . . . 0.97999999999999998 110.187 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -123.72 -176.43 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.527 . . . . 0.98999999999999999 111.368 -178.519 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -123.63 -20.28 5.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.084 -0.507 . . . . 2.6899999999999999 111.975 -179.53 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt 68.51 112.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.688 -0.486 . . . . 1.71 109.688 -178.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -114.07 33.13 5.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.917 0.339 . . . . 1.6599999999999999 111.917 -179.211 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.09 144.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.278 0.473 . . . . 1.97 112.278 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.408 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 57.0 m-85 -127.48 85.15 2.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.678 . . . . 1.23 110.282 179.243 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' CG2' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -79.76 105.02 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 1.76 111.487 -179.795 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -96.07 138.34 21.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.991 -0.744 . . . . 1.6100000000000001 108.991 179.065 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.429 ' HA ' ' CA ' ' A' ' 50' ' ' LYS . 6.0 mt-10 -96.76 152.36 18.75 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.052 0.22 . . . . 1.6699999999999999 110.492 -179.782 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.511 ' HD2' ' CE1' ' A' ' 72' ' ' TYR . 8.8 ttpp -108.42 155.46 20.54 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.417 -0.356 . . . . 2.4399999999999999 110.651 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.596 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -134.08 103.6 5.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.733 -0.387 . . . . 1.79 110.085 178.993 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.98 83.15 5.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 1.5900000000000001 110.349 -179.741 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 44' ' ' PRO . 20.4 mt -61.24 159.67 28.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 1.4299999999999999 111.077 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.1 Cg_endo -82.63 24.47 9.08 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 124.561 -1.016 . . . . 1.47 113.775 0.715 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -142.11 -80.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.844 0.354 . . . . 2.6600000000000001 110.631 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 38.31 -161.9 0.01 OUTLIER Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.925 -0.579 . . . . 1.6200000000000001 113.7 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.44 145.75 17.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.592 -0.522 . . . . 3.0600000000000001 109.592 179.676 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.596 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 74.7 m95 -63.61 78.59 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.267 -0.424 . . . . 1.0600000000000001 110.08 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -116.54 106.29 13.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.796 -0.638 . . . . 1.8400000000000001 111.001 -179.615 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER 20.4 -151.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.82 1.325 . . . . 1.77 113.924 179.303 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . 175.98 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.001 -0.437 . . . . 1.4099999999999999 110.451 -179.451 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -75.28 -38.04 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 2.0099999999999998 110.81 -179.969 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 57.75 34.57 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.948 0.351 . . . . 2.6400000000000001 111.948 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 11.2 t -170.23 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.797 0.295 . . . . 2.0299999999999998 111.797 179.691 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 10.1 t-20 -165.52 125.64 1.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 1.8700000000000001 110.412 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 61' ' ' PHE . 25.5 mt -109.86 75.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 1.3700000000000001 110.977 -179.916 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.22 -70.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 2.1499999999999999 110.947 -179.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.2 170.4 13.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.137 -0.32 . . . . 1.54 110.137 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.496 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 46.8 p-10 -84.69 6.1 25.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 1.75 111.874 -179.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.223 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -115.06 105.57 13.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.134 -0.691 . . . . 2.0499999999999998 109.134 179.121 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 62' ' ' THR . 55.9 t80 -136.7 164.17 28.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.331 0.493 . . . . 0.56999999999999995 112.331 -178.813 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 91.6 m -115.71 105.64 12.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.854 -0.612 . . . . 1.1399999999999999 111.647 179.673 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 ' CG1' ' CB ' ' A' ' 51' ' ' ALA . 73.9 t -75.44 118.79 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.475 -0.784 . . . . 1.72 111.012 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.0 p -123.65 155.0 38.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 1.6399999999999999 111.371 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.36 -4.03 8.24 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.95999999999999996 112.862 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 ' CD2' ' CG2' ' A' ' 18' ' ' VAL . 6.6 mp -65.81 165.94 11.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.105 0.479 . . . . 2.02 111.866 -179.592 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -121.49 127.38 50.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 1.55 110.347 179.72 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -48.97 145.25 4.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.124 -0.489 . . . . 1.9099999999999999 111.486 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 97' ' ' CYS . 18.8 t0 68.22 54.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 1.8700000000000001 111.527 179.576 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.77 120.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 1.2 111.335 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -67.56 135.86 53.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.467 -0.333 . . . . 1.1100000000000001 110.236 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.511 ' CE1' ' HD2' ' A' ' 40' ' ' LYS . 20.7 m-85 -128.06 123.47 34.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.433 0.901 . . . . 1.0800000000000001 113.433 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -106.19 140.72 38.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.378 -0.971 . . . . 1.5 108.378 178.119 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -137.51 129.02 28.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.719 1.377 . . . . 0.79000000000000004 114.719 -178.482 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.82 146.2 28.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.031 -0.531 . . . . 2.6899999999999999 110.142 178.282 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 44.8 t -99.71 108.78 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.28 -0.568 . . . . 1.5700000000000001 112.427 -179.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.462 HG12 ' CA ' ' A' ' 88' ' ' PRO . 77.1 mt -101.5 150.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.579 -1.267 . . . . 1.3200000000000001 107.579 177.768 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' O ' ' OG ' ' A' ' 86' ' ' SER . . . -161.51 145.13 12.69 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.073 -1.051 . . . . 1.1100000000000001 112.505 -179.642 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.4 ptpt -92.66 -161.23 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.555 . . . . 2.3500000000000001 110.402 179.545 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.511 ' HB2' ' CG ' ' A' ' 31' ' ' PHE . 4.8 p-10 -150.46 165.92 31.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.989 0.423 . . . . 2.7000000000000002 111.233 -179.274 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -43.47 -26.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 1.3400000000000001 112.251 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -92.15 -20.34 21.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.969 0.359 . . . . 1.4299999999999999 111.969 -179.382 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.62 -1.45 60.04 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.702 -0.761 . . . . 1.3799999999999999 112.81 -179.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -73.1 76.84 1.24 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.991 0.424 . . . . 1.49 110.421 179.672 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -34.24 125.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 1.48 113.879 -178.922 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 14.0 p -90.6 124.97 61.07 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.05 -0.977 . . . . 0.81000000000000005 109.596 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -40.55 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.852 2.368 . . . . 1.25 112.832 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' CA ' HG12 ' A' ' 77' ' ' ILE . 8.0 Cg_exo -72.21 149.35 51.46 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.804 2.336 . . . . 1.2 112.885 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m -95.2 129.11 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 1.76 109.733 179.349 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.5 tp10 -20.17 103.15 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.991 0 O-C-N 124.494 1.121 . . . . 1.77 112.886 -179.575 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 36.5 Cg_exo -38.12 150.04 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.806 2.337 . . . . 1.01 114.041 -179.443 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.21 145.6 26.32 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.336 -0.847 . . . . 1.55 109.054 178.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -35.12 151.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 124.229 0.956 . . . . 1.6299999999999999 111.894 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -84.69 121.12 27.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 1.0900000000000001 111.251 -179.536 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.6 112.12 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 1.1299999999999999 111.169 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 88.0 m -42.82 -34.11 0.88 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 1.1299999999999999 111.965 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 69' ' ' ASP . 94.9 m 51.4 82.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 1.5700000000000001 110.586 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 -81.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.112 0.482 . . . . 3.7000000000000002 110.761 -179.733 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.235 ' CG ' ' HG3' ' A' ' 102' ' ' GLU . 2.4 p30 -117.79 -11.38 10.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.738 -0.664 . . . . 2.1400000000000001 111.24 179.588 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 58.25 16.5 4.02 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.782 0.29 . . . . 2.0600000000000001 111.782 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 101' ' ' VAL . 86.4 t -136.45 6.95 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.926 0.393 . . . . 3.0800000000000001 111.148 179.627 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.235 ' HG3' ' CG ' ' A' ' 99' ' ' ASP . 6.1 mt-10 -126.02 -0.2 7.21 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.287 -0.258 . . . . 4.5800000000000001 111.12 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.142 -0.932 . . . . 3.79 111.135 179.717 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.435 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.642 0.258 . . . . 3.1699999999999999 111.261 . . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 91.9 Cg_endo -83.77 -167.75 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.723 2.282 . . . . 2.0600000000000001 112.282 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 6.8 tt -155.59 146.36 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 1.26 111.199 179.807 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.95 130.09 23.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.829 -0.623 . . . . 2.0 110.023 179.644 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.59 173.86 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.189 1.926 . . . . 0.58999999999999997 112.739 -179.453 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 53.1 Cg_exo -54.98 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.201 2.601 . . . . 1.6100000000000001 113.419 -179.401 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.15 -163.41 39.18 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.759 -0.655 . . . . 0.97999999999999998 112.773 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.3 tmtt? -78.63 114.83 46.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 110.549 -0.167 . . . . 2.04 110.549 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 20.4 Cg_exo -72.17 149.56 52.1 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.969 2.446 . . . . 0.54000000000000004 113.487 -179.26 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -146.97 107.99 3.97 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.629 -0.714 . . . . 1.6799999999999999 111.201 179.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 19' ' ' THR . 38.7 Cg_exo -59.06 94.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.508 2.139 . . . . 0.64000000000000001 113.041 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -51.25 -46.02 62.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.503 0.668 . . . . 2.1699999999999999 109.454 179.244 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -122.3 150.27 42.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.959 -1.018 . . . . 0.84999999999999998 108.408 178.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -144.07 80.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.29 -0.564 . . . . 1.5700000000000001 111.956 -179.219 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.08 156.53 35.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.46 110.288 179.594 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -61.4 -11.84 11.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.887 0.699 . . . . 2.9100000000000001 112.887 -179.043 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.443 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 2.3 m-70 -140.07 20.19 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.811 -0.356 . . . . 1.3300000000000001 111.581 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.482 ' CA ' HD11 ' A' ' 66' ' ' LEU . 0.6 OUTLIER 179.14 109.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 1.28 110.383 179.742 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.535 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 25.9 m -108.6 126.16 65.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 1.49 111.364 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.7 m -96.61 137.76 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 1.1399999999999999 111.054 179.709 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -139.56 164.25 30.4 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.061 0.85 . . . . 1.3100000000000001 112.426 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.48 153.7 34.04 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.933 -1.031 . . . . 2.3100000000000001 110.519 179.614 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.521 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 31.7 p90 -146.93 -171.5 3.78 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.533 0.568 . . . . 0.40000000000000002 112.533 -179.462 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.31 -158.37 0.18 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.584 -0.735 . . . . 1.1100000000000001 110.834 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -142.75 139.21 16.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 2.5600000000000001 110.475 -179.963 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.573 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 84.3 Cg_exo -34.42 148.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.124 2.549 . . . . 1.1100000000000001 112.778 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.726 ' OE1' ' CA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -98.48 11.67 37.51 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 2.77 111.802 -179.592 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -169.95 -66.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.6899999999999999 111.753 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 1.2 p 52.05 47.6 24.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.008 0.432 . . . . 1.3500000000000001 110.197 -179.307 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.29 -108.65 0.23 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.802 -0.713 . . . . 1.01 112.31 -179.758 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.39 29.56 4.03 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.784 -0.926 . . . . 0.97999999999999998 110.784 179.176 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -114.74 -174.48 2.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.13 -0.535 . . . . 0.98999999999999999 110.814 -178.967 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.0 pttt -143.08 32.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 2.6899999999999999 111.594 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 ' CE1' ' A' ' 36' ' ' TYR . 7.7 mm 65.56 -71.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 1.71 111.365 179.861 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.4 p 81.59 -10.18 1.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.634 0.605 . . . . 1.6599999999999999 112.634 179.63 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 2.1 t -179.65 140.93 0.15 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.763 -0.375 . . . . 1.97 111.995 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.488 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 69.2 m-85 -116.59 138.73 51.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.164 -0.471 . . . . 1.23 110.852 179.409 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 5.0 mt -116.43 129.32 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.446 -0.343 . . . . 1.76 110.423 179.707 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.57 113.52 44.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.814 0.34 . . . . 1.6100000000000001 111.813 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 50.8 mt-10 -83.02 132.85 35.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 1.6699999999999999 110.151 179.271 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.483 ' HD3' ' CD1' ' A' ' 72' ' ' TYR . 2.1 tttp -95.42 128.14 42.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 113.554 0.946 . . . . 2.4399999999999999 113.554 -178.426 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -108.52 95.16 5.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.873 -0.603 . . . . 1.79 110.196 178.539 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 1.077 ' OD2' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -64.17 142.17 58.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.15 -0.477 . . . . 1.5900000000000001 109.753 179.619 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 29.9 mt -123.71 133.11 24.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.754 -0.378 . . . . 1.4299999999999999 110.919 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -90.96 47.7 1.32 Allowed 'Cis proline' 0 C--N 1.351 0.689 0 C-N-CA 124.28 -1.134 . . . . 1.47 113.125 0.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 42' ' ' ASP . 1.7 m120 -127.13 57.5 1.47 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 2.6600000000000001 110.801 -179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -42.65 160.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.044 -0.526 . . . . 1.6200000000000001 113.42 -179.634 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 1.077 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 5.4 ptm180 -179.86 -32.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.041 0.385 . . . . 3.0600000000000001 112.041 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 64.0 m95 61.41 81.53 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.296 -0.631 . . . . 1.0600000000000001 109.296 -179.12 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.57 135.92 54.15 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.386 0.513 . . . . 1.8400000000000001 112.386 -178.739 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtpm? -46.96 94.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.77 111.015 179.782 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.45 -42.29 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 1.4099999999999999 111.551 -179.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 8.0 p-10 -54.21 -58.76 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.639 -0.255 . . . . 2.0099999999999998 111.319 -179.678 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 39.56 49.27 1.96 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.053 0.39 . . . . 2.6400000000000001 112.053 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -161.22 26.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.729 0.27 . . . . 2.0299999999999998 111.729 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.32 113.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 1.8700000000000001 111.225 179.67 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.494 HD12 ' CD2' ' A' ' 61' ' ' PHE . 28.1 mt -109.94 71.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 1.3700000000000001 110.827 179.587 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.9 mt -50.39 -59.57 3.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 2.1499999999999999 111.3 -179.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -86.93 158.91 19.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.917 0.389 . . . . 1.54 110.334 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 4.7 p-10 -69.99 -7.93 44.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.024 -0.535 . . . . 1.75 111.772 -179.764 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -98.22 105.07 17.17 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.443 -0.577 . . . . 2.0499999999999998 109.443 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 52' ' ' ASN . 53.2 t80 -142.47 165.42 27.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.56999999999999995 111.711 -179.002 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.497 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 87.5 m -120.96 121.37 37.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.772 -0.649 . . . . 1.1399999999999999 111.074 179.778 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.5 t -81.7 110.8 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.113 -0.494 . . . . 1.72 111.637 -179.654 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -97.38 -159.54 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.858 -0.61 . . . . 1.6399999999999999 110.495 179.877 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.19 23.48 62.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.64 -0.79 . . . . 0.95999999999999996 112.114 -179.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 14.2 mt -76.03 169.8 17.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 2.02 110.944 -179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.899 ' HB ' ' HH ' ' A' ' 72' ' ' TYR . 2.1 m -134.17 141.32 47.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 1.55 110.564 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 29.8 mt-10 -75.12 144.41 42.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.128 -0.487 . . . . 1.9099999999999999 111.215 -179.783 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.9 t0 67.82 40.32 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.8700000000000001 110.849 179.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB2' ' CE2' ' A' ' 72' ' ' TYR . . . -155.53 115.34 3.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 1.2 111.42 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -67.72 130.34 42.69 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.49 -0.559 . . . . 1.1100000000000001 109.49 179.082 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.899 ' HH ' ' HB ' ' A' ' 67' ' ' THR . 57.8 m-85 -124.89 119.44 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.871 1.064 . . . . 1.0800000000000001 113.871 -177.968 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 5.8 mt-10 -102.66 139.97 37.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.684 -1.228 . . . . 1.5 107.684 177.631 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' CZ ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.91 122.07 23.79 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.028 1.492 . . . . 0.79000000000000004 115.028 -178.574 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 19.9 ttm-85 -94.93 143.81 26.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 114.509 -1.223 . . . . 2.6899999999999999 109.086 178.087 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.491 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -121.06 120.1 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 119.121 -1.031 . . . . 1.5700000000000001 112.538 179.458 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -110.58 165.42 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.861 -1.518 . . . . 1.3200000000000001 107.689 178.537 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' O ' ' OG ' ' A' ' 86' ' ' SER . . . -165.81 149.23 7.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 118.934 -1.106 . . . . 1.1100000000000001 112.376 -179.839 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.0 mttt -99.12 -177.61 3.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.308 -0.406 . . . . 2.3500000000000001 109.973 179.097 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.514 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 7.8 p-10 -136.41 166.72 22.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.06 -0.518 . . . . 2.7000000000000002 110.907 -179.682 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.756 -0.656 . . . . 1.3400000000000001 112.482 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -89.08 -20.28 24.52 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.654 0.613 . . . . 1.4299999999999999 112.654 -179.25 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.09 57.95 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.423 -0.894 . . . . 1.3799999999999999 112.603 -179.59 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.452 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -74.23 77.89 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.964 0.411 . . . . 1.49 110.297 179.74 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -36.23 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 1.48 113.285 -179.152 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . 33.8 p -62.93 117.66 34.71 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.599 -0.728 . . . . 0.81000000000000005 109.415 178.718 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -35.32 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.363 2.709 . . . . 1.25 113.398 -179.342 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HB3' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -59.22 168.28 4.99 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.219 2.613 . . . . 1.2 113.499 -179.612 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -124.61 129.62 50.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.084 -0.962 . . . . 1.76 109.706 178.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -25.03 118.57 0.21 Allowed Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.688 0.795 . . . . 1.77 112.604 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 51.5 Cg_exo -55.53 154.68 23.87 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.363 2.042 . . . . 1.01 114.249 -179.211 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -84.78 146.43 27.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.08 -0.963 . . . . 1.55 109.092 178.961 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -40.31 146.81 0.12 Allowed 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.623 0.577 . . . . 1.6299999999999999 111.428 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.45 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -76.14 122.13 23.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.659 . . . . 1.0900000000000001 110.671 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 13' ' ' ILE . 3.9 mp -102.28 109.09 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 1.1299999999999999 111.632 -179.565 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 76.0 m -48.18 -36.11 13.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.173 -0.467 . . . . 1.1299999999999999 111.087 -179.897 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.3 m 50.65 98.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 1.5700000000000001 111.173 179.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -72.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.152 -0.476 . . . . 3.7000000000000002 110.513 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.176 ' OD2' HG11 ' A' ' 101' ' ' VAL . 6.4 p-10 -141.52 10.91 2.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.769 -0.65 . . . . 2.1400000000000001 111.726 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 38.72 31.63 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.083 0.468 . . . . 2.0600000000000001 111.624 -179.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.176 HG11 ' OD2' ' A' ' 99' ' ' ASP . 14.2 p -159.29 24.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.676 -0.693 . . . . 3.0800000000000001 110.928 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 -42.44 0.27 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.408 -0.36 . . . . 4.5800000000000001 111.512 -179.776 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.161 -0.924 . . . . 3.79 111.207 179.99 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.744 0.307 . . . . 3.1699999999999999 111.47 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.05 -164.7 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.449 2.766 . . . . 2.0600000000000001 111.944 179.889 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.485 HG12 ' N ' ' A' ' 3' ' ' ASP . 3.1 tt -164.36 150.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.186 0.517 . . . . 1.26 111.88 179.624 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.485 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -125.99 136.51 28.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.436 -0.802 . . . . 2.0 109.55 179.262 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.21 161.37 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.192 1.928 . . . . 0.58999999999999997 112.429 -179.616 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.22 164.5 2.69 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.864 2.376 . . . . 1.6100000000000001 113.108 -179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.45 169.17 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.511 -0.768 . . . . 0.97999999999999998 112.229 179.803 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -68.55 126.61 92.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.066 -0.346 . . . . 2.04 110.066 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 32.9 Cg_exo -62.85 153.19 74.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.28 1.987 . . . . 0.54000000000000004 113.422 -179.289 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.79 96.19 3.6 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 1.6799999999999999 109.641 179.368 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.2 Cg_exo -40.36 118.84 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.178 1.919 . . . . 0.64000000000000001 113.224 -179.129 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.949 ' CD2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -84.99 -26.84 26.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.509 -0.923 . . . . 2.1699999999999999 108.509 178.844 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 2.0 t30 -147.87 153.08 38.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.642 -1.244 . . . . 0.84999999999999998 107.642 178.169 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.51 134.72 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.118 -0.633 . . . . 1.5700000000000001 112.225 -179.133 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.92 146.93 31.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.958 -0.565 . . . . 1.46 111.251 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.465 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -24.62 -48.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.541 -1.209 . . . . 2.9100000000000001 114.002 -179.336 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.479 ' CD2' ' HG2' ' A' ' 68' ' ' GLU . 29.3 m-70 -128.78 22.03 5.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.675 0.621 . . . . 1.3300000000000001 112.675 -179.016 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 38.7 p -162.49 114.42 1.62 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 1.28 109.995 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.537 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -128.83 121.6 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.953 0.882 . . . . 1.49 113.025 -179.405 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.1 m -82.33 148.91 28.03 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.184 -0.916 . . . . 1.1399999999999999 110.686 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -150.71 147.73 27.7 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 124.337 1.023 . . . . 1.3100000000000001 111.189 179.721 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.194 ' HD3' ' OE1' ' A' ' 60' ' ' GLU . 19.3 tptm -129.54 151.86 49.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.275 -0.875 . . . . 2.3100000000000001 110.718 179.793 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CD1' ' HB3' ' A' ' 59' ' ' ASN . 49.1 p90 -150.36 -179.04 6.88 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.057 0.455 . . . . 0.40000000000000002 112.17 179.801 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.78 162.15 13.16 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.722 -0.672 . . . . 1.1100000000000001 111.597 -179.417 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.13 152.85 38.22 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.421 -0.354 . . . . 2.5600000000000001 110.891 179.802 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 11.7 Cg_endo -55.1 141.28 80.03 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.013 2.475 . . . . 1.1100000000000001 113.524 -179.501 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -7.28 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 2.77 112.095 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -134.1 -67.11 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.883 -0.327 . . . . 1.6899999999999999 111.677 -179.877 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 4.5 t 35.85 49.59 0.58 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.302 0.573 . . . . 1.3500000000000001 111.838 -179.201 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.47 -123.06 8.08 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.574 -0.739 . . . . 1.01 112.416 179.995 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.64 31.84 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.952 -0.859 . . . . 0.97999999999999998 110.952 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.4 OUTLIER -103.47 -170.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.351 0.596 . . . . 0.98999999999999999 112.238 -178.875 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' THR . 9.5 ttpt -145.84 24.74 1.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.069 -0.969 . . . . 2.6899999999999999 110.744 179.856 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.538 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 24.2 mm 66.49 -70.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.248 -0.433 . . . . 1.71 111.119 179.918 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.4 p 83.36 -11.52 0.91 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.909 -0.587 . . . . 1.6599999999999999 112.232 179.684 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.9 t -178.98 140.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.321 . . . . 1.97 111.807 -179.875 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.538 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 59.2 m-85 -119.65 139.84 51.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.126 0.489 . . . . 1.23 111.11 179.596 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 17.3 mt -116.97 130.84 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 1.76 110.088 179.367 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.9 t -104.68 109.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 1.6100000000000001 112.293 -179.317 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' CB ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -81.87 107.93 14.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.557 -0.534 . . . . 1.6699999999999999 109.557 178.979 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 51' ' ' ALA . 2.3 ptmt -97.46 151.53 19.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 2.4399999999999999 111.322 -179.368 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.434 ' HG2' ' CD2' ' A' ' 43' ' ' LEU . 12.2 ttp180 -139.01 120.29 14.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.123 -0.49 . . . . 1.79 111.366 -179.905 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.488 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -82.86 90.76 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 1.5900000000000001 109.616 179.432 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' CD2' ' HG2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -83.82 150.61 59.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 111.414 -179.228 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -94.01 28.35 17.24 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.003 -1.249 . . . . 1.47 112.705 0.081 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -139.69 69.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 2.6600000000000001 110.941 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.42 -169.88 30.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.814 -0.708 . . . . 1.6200000000000001 112.297 179.986 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' HD3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.05 168.28 25.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 3.0600000000000001 111.223 179.971 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.524 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 70.7 m95 -69.71 118.43 12.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.715 -0.675 . . . . 1.0600000000000001 111.393 -179.764 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.412 HD21 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -147.38 127.55 13.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 1.8400000000000001 110.705 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -65.27 83.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.77 111.368 -179.737 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . . . -60.6 -38.67 85.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.838 0.351 . . . . 1.4099999999999999 110.434 179.672 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' CE1' ' A' ' 61' ' ' PHE . 4.2 t30 -40.13 -84.47 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.91 -0.586 . . . . 2.0099999999999998 111.197 -179.997 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 t80 60.22 15.7 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.036 0.384 . . . . 2.6400000000000001 112.036 179.568 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -122.75 22.42 9.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 2.0299999999999998 110.939 179.826 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.99 133.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.936 0.398 . . . . 1.8700000000000001 111.224 179.834 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.435 HG13 ' ND2' ' A' ' 52' ' ' ASN . 13.2 mt -129.38 74.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 1.3700000000000001 110.857 179.993 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -56.69 16.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 2.1499999999999999 111.057 -179.957 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.28 160.53 15.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 1.54 110.808 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 1.7 m-20 -70.46 -8.4 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 1.75 111.525 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 1.194 ' OE1' ' HD3' ' A' ' 21' ' ' LYS . 14.7 tp10 -93.13 96.11 9.84 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.732 -0.47 . . . . 2.0499999999999998 109.732 179.68 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.526 ' CG ' ' N ' ' A' ' 62' ' ' THR . 60.1 t80 -131.65 165.9 22.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.56999999999999995 111.576 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.0 m -121.92 121.96 38.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.801 -0.636 . . . . 1.1399999999999999 111.256 179.636 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 20' ' ' LEU . 7.5 t -81.16 74.57 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.197 0.522 . . . . 1.72 110.294 -179.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 83.2 p -78.66 164.39 24.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.326 -0.852 . . . . 1.6399999999999999 110.91 -179.589 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -9.97 64.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.586 -0.816 . . . . 0.95999999999999996 113.009 179.922 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 18' ' ' VAL . 4.4 pp -60.89 166.1 3.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 117.244 0.522 . . . . 2.02 110.694 -179.977 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.454 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -104.64 157.94 16.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.55 111.185 -179.478 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.479 ' HG2' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.85 167.24 10.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 112.413 -179.289 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 t70 73.27 55.94 0.11 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.542 -0.753 . . . . 1.8700000000000001 111.214 179.887 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 165.58 138.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 1.2 110.363 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -56.87 133.85 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 1.1100000000000001 110.393 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 2.3 m-85 -126.35 116.68 21.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 1.0800000000000001 111.898 -178.852 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -106.13 145.85 30.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.93 -0.577 . . . . 1.5 109.495 179.027 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.537 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.98 115.52 10.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.348 1.24 . . . . 0.79000000000000004 114.348 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.435 ' NH1' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -98.9 -178.45 3.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.794 -0.817 . . . . 2.6899999999999999 108.794 177.922 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.489 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -150.48 130.7 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 119.309 -0.956 . . . . 1.5700000000000001 112.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.463 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 55.6 mt -114.7 151.91 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.45 -1.25 . . . . 1.3200000000000001 108.593 178.916 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -161.89 136.54 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.62 -0.832 . . . . 1.1100000000000001 112.771 -179.662 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.58 -158.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.576 . . . . 2.3500000000000001 109.912 179.228 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.461 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 2.8 p-10 -160.34 176.31 11.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 2.7000000000000002 111.82 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.068 -0.969 . . . . 1.3400000000000001 112.169 179.796 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.22 -20.33 19.93 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.91 0.337 . . . . 1.4299999999999999 111.91 -179.453 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.36 -2.7 61.16 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.48 -0.867 . . . . 1.3799999999999999 112.981 -179.974 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' O ' HD11 ' A' ' 2' ' ' ILE . . . -68.22 85.93 0.26 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 1.49 110.391 179.77 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 5.3 tp -46.32 122.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.658 0.614 . . . . 1.48 112.658 -179.116 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 77' ' ' ILE . 26.7 p -82.31 120.98 78.17 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.297 -0.865 . . . . 0.81000000000000005 109.258 178.889 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -38.54 163.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.904 2.403 . . . . 1.25 113.219 -179.495 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 4.2 Cg_exo -75.1 118.1 5.12 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.781 2.321 . . . . 1.2 112.72 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 3.3 t -68.5 137.84 54.73 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.822 -0.626 . . . . 1.76 109.968 179.516 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -32.68 125.74 0.39 Allowed Pre-proline 0 N--CA 1.47 0.525 0 O-C-N 124.027 0.829 . . . . 1.77 112.347 -179.451 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.6 Cg_exo -60.98 134.12 51.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.543 2.162 . . . . 1.01 113.206 -179.679 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.415 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.46 153.43 38.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.742 -0.663 . . . . 1.55 109.955 179.193 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -30.42 145.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.387 1.054 . . . . 1.6299999999999999 112.652 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -84.56 112.24 20.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.702 -0.681 . . . . 1.0900000000000001 109.718 179.376 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.8 mp -97.77 113.89 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 1.1299999999999999 111.813 -179.276 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 71.7 m -46.36 -28.89 1.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.128 0.49 . . . . 1.1299999999999999 110.025 179.153 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.3 OUTLIER 45.27 55.44 6.4 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.634 -0.712 . . . . 1.5700000000000001 111.266 179.555 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -79.88 -93.59 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.714 -0.394 . . . . 3.7000000000000002 110.97 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.93 39.22 2.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 2.1400000000000001 109.707 179.829 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.465 ' HB2' ' CD ' ' A' ' 15' ' ' ARG . 28.1 t0 47.73 22.38 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.866 -0.606 . . . . 2.0600000000000001 111.192 -178.558 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.15 -26.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.928 -0.578 . . . . 3.0800000000000001 110.06 179.405 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.59 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 50.4 54.07 11.8 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.869 -0.605 . . . . 4.5800000000000001 110.774 -179.939 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.24 -0.886 . . . . 3.79 111.098 -179.862 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.599 0.237 . . . . 3.1699999999999999 111.239 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -84.24 160.5 13.23 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.809 2.339 . . . . 2.0600000000000001 111.762 179.677 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.462 HD12 ' CB ' ' A' ' 86' ' ' SER . 5.0 tt -167.7 150.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.973 0.416 . . . . 1.26 111.975 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 2' ' ' ILE . 73.1 m-20 -139.67 130.71 14.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.651 . . . . 2.0 110.226 179.496 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.21 164.07 29.63 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.262 1.975 . . . . 0.58999999999999997 112.511 -179.654 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 11.9 Cg_endo -56.52 177.25 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.155 2.57 . . . . 1.6100000000000001 113.219 -179.579 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.05 171.88 54.54 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.828 -0.624 . . . . 0.97999999999999998 112.375 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.59 127.73 89.06 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.227 -0.286 . . . . 2.04 110.227 179.718 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.47 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 14.8 Cg_exo -73.67 150.04 44.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.566 2.178 . . . . 0.54000000000000004 112.874 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 14.7 p -146.24 106.08 4.13 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 115.839 -0.619 . . . . 1.6799999999999999 110.98 179.717 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -59.89 111.45 0.98 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.346 2.031 . . . . 0.64000000000000001 113.305 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.476 ' CD2' ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -71.64 -39.35 70.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.643 -0.873 . . . . 2.1699999999999999 108.643 178.791 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.409 ' O ' HG21 ' A' ' 13' ' ' ILE . 1.7 t30 -129.65 148.99 51.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.591 -1.186 . . . . 0.84999999999999998 108.572 179.119 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.435 ' CD1' HG22 ' A' ' 95' ' ' ILE . 4.4 pt -142.78 89.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.989 0.423 . . . . 1.5700000000000001 111.539 -179.253 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.431 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -79.58 149.01 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 1.46 110.785 -179.866 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' CB ' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -40.41 -35.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.083 0.772 . . . . 2.9100000000000001 113.083 -179.212 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 3.4 m-70 -135.25 31.62 3.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 1.3300000000000001 111.437 -179.332 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -178.62 108.54 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 1.28 110.226 179.578 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.638 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 9.5 m -112.82 143.38 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.415 -0.514 . . . . 1.49 111.159 -179.91 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 53.2 m -106.72 136.82 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.438 -0.346 . . . . 1.1399999999999999 110.817 179.565 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -136.04 160.81 37.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.094 0.871 . . . . 1.3100000000000001 112.569 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -148.4 147.11 28.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.909 -1.041 . . . . 2.3100000000000001 110.456 179.465 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 30.3 p90 -137.68 -175.12 3.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.133 0.492 . . . . 0.40000000000000002 111.927 -179.575 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.86 16.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.577 -0.738 . . . . 1.1100000000000001 110.908 179.725 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.97 147.39 33.8 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.336 -0.393 . . . . 2.5600000000000001 110.408 179.621 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 35.1 Cg_endo -63.72 173.08 4.94 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.325 2.017 . . . . 1.1100000000000001 112.325 179.941 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -123.79 13.49 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.627 -179.853 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -144.01 -73.91 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 1.6899999999999999 111.919 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 46.5 p 43.63 56.81 4.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.878 0.371 . . . . 1.3500000000000001 110.811 -179.542 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.16 -100.4 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.543 . . . . 1.01 112.483 -179.528 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.8 34.33 1.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.009 -1.237 . . . . 0.97999999999999998 110.009 179.152 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -116.11 -168.01 1.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.664 -0.768 . . . . 0.98999999999999999 111.388 -178.717 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.21 45.74 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.621 -0.718 . . . . 2.6899999999999999 111.305 -179.958 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 HG22 ' CE1' ' A' ' 36' ' ' TYR . 12.2 mm 52.98 -87.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.086 179.731 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' LYS . 1.2 p 74.39 23.58 1.96 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.564 0.579 . . . . 1.6599999999999999 112.564 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 4.3 t 168.91 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.937 0.347 . . . . 1.97 111.937 179.562 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.482 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 18.4 m-85 -102.61 93.52 5.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 1.23 110.831 179.498 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.0 mt -85.9 114.68 26.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.747 0.308 . . . . 1.76 110.922 179.96 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 14.4 t -89.27 121.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.278 -0.419 . . . . 1.6100000000000001 111.737 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -95.16 129.86 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 1.6699999999999999 109.895 179.214 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.444 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -110.21 140.13 44.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.217 0.532 . . . . 2.4399999999999999 111.968 -179.416 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.508 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 13.0 ttm180 -111.9 112.63 24.43 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.366 -0.834 . . . . 1.79 109.616 179.047 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -81.8 101.22 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.601 -0.727 . . . . 1.5900000000000001 110.644 -179.594 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 HD13 ' CB ' ' A' ' 94' ' ' ALA . 10.0 mt -76.67 155.53 83.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.055 -0.521 . . . . 1.4299999999999999 110.48 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -87.57 9.06 63.62 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.142 -1.191 . . . . 1.47 113.287 0.519 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.77 -74.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 2.6600000000000001 110.195 179.75 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 98.06 155.96 29.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.735 . . . . 1.6200000000000001 113.915 179.018 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.26 62.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 122.928 0.491 . . . . 3.0600000000000001 109.799 -179.939 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.508 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 80.9 m95 -28.79 105.08 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.469 0.708 . . . . 1.0600000000000001 112.593 -179.422 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.66 130.66 42.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.2 -0.454 . . . . 1.8400000000000001 110.986 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 2.5 ptmm? -56.19 91.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 1.77 111.481 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -61.36 -55.41 31.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.1 0.476 . . . . 1.4099999999999999 110.142 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -44.58 112.55 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.717 . . . . 2.0099999999999998 111.023 179.707 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.56 43.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.6400000000000001 111.598 -179.604 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 t -168.18 172.2 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 2.0299999999999998 111.221 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 115.37 18.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 1.8700000000000001 110.869 179.946 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.485 HD12 ' CD2' ' A' ' 61' ' ' PHE . 35.6 mt -96.63 89.53 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 1.3700000000000001 110.929 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mt -61.22 -79.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 2.1499999999999999 111.253 -179.798 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 172.18 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.54 110.726 -179.995 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.2 p30 -88.15 12.35 13.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 1.75 111.687 -179.851 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -109.49 108.9 19.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.621 -0.511 . . . . 2.0499999999999998 109.621 179.278 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE1' ' O ' ' A' ' 62' ' ' THR . 55.4 t80 -145.0 165.08 29.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.56999999999999995 112.055 -178.874 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.566 ' O ' ' CE1' ' A' ' 61' ' ' PHE . 99.5 m -119.22 112.89 20.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.671 -0.695 . . . . 1.1399999999999999 110.26 179.497 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 HG21 HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -79.76 89.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.762 -0.654 . . . . 1.72 110.51 -179.495 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 25.4 t -88.05 -178.07 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.908 . . . . 1.6399999999999999 110.929 -179.49 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 84.01 7.17 85.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.687 -0.768 . . . . 0.95999999999999996 112.79 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD23 ' CG1' ' A' ' 18' ' ' VAL . 2.8 pp -84.61 172.07 11.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.186 0.493 . . . . 2.02 110.887 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 1.7 m -121.41 173.3 7.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 1.55 111.376 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HG3' ' CB ' ' A' ' 15' ' ' ARG . 2.7 tt0 -91.86 170.52 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 1.9099999999999999 111.202 -179.93 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.814 ' O ' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 47.03 35.26 3.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 1.8700000000000001 111.194 179.831 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.7 114.84 6.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 1.2 111.395 -179.832 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . . . -68.19 123.47 20.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.672 -0.492 . . . . 1.1100000000000001 109.672 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 58.0 m-85 -116.99 121.85 42.57 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.357 0.873 . . . . 1.0800000000000001 113.357 -178.361 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.4 tt0 -102.85 136.76 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.829 -1.175 . . . . 1.5 107.829 177.832 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.638 ' CZ ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.26 126.53 21.39 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.933 1.457 . . . . 0.79000000000000004 114.933 -178.519 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -101.0 -177.16 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.846 -1.07 . . . . 2.6899999999999999 108.423 177.756 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -147.89 106.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 119.656 -0.818 . . . . 1.5700000000000001 112.655 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.45 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 42.7 mt -88.07 154.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.557 -1.646 . . . . 1.3200000000000001 106.557 177.455 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 35' ' ' SER . . . -160.18 126.72 4.28 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.927 -1.109 . . . . 1.1100000000000001 113.198 -179.144 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.1 mttt -76.6 -159.87 0.13 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.71 . . . . 2.3500000000000001 109.394 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.49 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.5 m-80 -149.82 176.94 10.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.056 0.455 . . . . 2.7000000000000002 111.338 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.462 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -45.6 -26.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 1.3400000000000001 111.682 179.773 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.26 10.36 29.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.427 0.528 . . . . 1.4299999999999999 112.427 -179.571 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.46 -14.61 57.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.349 -0.929 . . . . 1.3799999999999999 112.853 179.875 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.42 102.51 0.03 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.813 0.34 . . . . 1.49 111.258 -179.97 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 2.0 tp -69.98 101.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 1.48 111.819 -179.623 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.462 ' CB ' HD12 ' A' ' 2' ' ' ILE . 1.1 p -69.56 126.35 92.54 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 109.502 -0.555 . . . . 0.81000000000000005 109.502 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -39.2 160.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.716 2.278 . . . . 1.25 112.446 -179.53 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 14.5 Cg_exo -67.53 124.61 12.21 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.684 2.256 . . . . 1.2 113.054 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 3.2 m -70.99 130.47 41.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.776 -0.647 . . . . 1.76 109.44 179.17 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -31.99 124.34 0.37 Allowed Pre-proline 0 N--CA 1.474 0.727 0 N-CA-C 112.538 0.57 . . . . 1.77 112.538 -179.316 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.444 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 32.2 Cg_exo -59.39 147.6 90.47 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.833 2.355 . . . . 1.01 113.387 -179.559 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -82.15 147.59 28.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.695 -0.684 . . . . 1.55 109.885 179.291 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -39.63 137.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 124.186 0.929 . . . . 1.6299999999999999 111.736 -179.921 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.438 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -66.38 120.49 13.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.655 . . . . 1.0900000000000001 110.789 179.88 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.481 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 4.0 mp -100.42 109.54 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 1.1299999999999999 111.337 -179.886 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -45.79 -48.88 15.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 111.32 -179.702 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 64.65 86.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.446 . . . . 1.5700000000000001 110.42 -179.952 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.31 -86.24 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 3.7000000000000002 111.071 -179.758 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.707 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 14.7 p30 -105.43 14.59 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.162 -0.472 . . . . 2.1400000000000001 111.097 179.886 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.5 t0 50.35 26.76 2.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.023 0.44 . . . . 2.0600000000000001 110.606 -179.827 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.707 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.8 p -125.02 -9.63 6.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.688 -0.687 . . . . 3.0800000000000001 111.607 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -144.21 -78.07 0.21 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.759 0.314 . . . . 4.5800000000000001 111.213 -179.969 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.92 . . . . 3.79 110.94 -179.92 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.731 0.301 . . . . 3.1699999999999999 111.461 . . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 0' ' ' SER . 1.3 Cg_endo -85.25 57.49 4.7 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.248 2.632 . . . . 2.0600000000000001 112.047 -179.918 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.441 HG12 ' N ' ' A' ' 3' ' ' ASP . 2.3 tt -44.33 148.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 1.26 111.52 -179.926 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 8.1 t70 -126.49 129.06 24.22 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 2.0 110.78 179.932 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.01 171.87 14.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.489 2.126 . . . . 0.58999999999999997 112.276 -179.957 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 19.5 Cg_exo -66.86 -174.72 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.803 2.335 . . . . 1.6100000000000001 113.182 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.35 -177.81 49.67 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.4 -0.818 . . . . 0.97999999999999998 112.852 -179.794 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.14 116.4 35.65 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.391 0.139 . . . . 2.04 110.681 179.866 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 31.7 Cg_exo -62.76 142.75 90.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.595 2.197 . . . . 0.54000000000000004 112.374 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 14.6 p -145.95 104.42 4.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 1.6799999999999999 111.976 -179.476 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.9 Cg_exo -50.26 113.24 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.532 2.155 . . . . 0.64000000000000001 112.751 -179.963 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -63.86 -46.49 84.72 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.774 -0.825 . . . . 2.1699999999999999 108.774 178.977 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.29 151.25 50.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.28 -1.327 . . . . 0.84999999999999998 108.321 179.016 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' CG2' HG12 ' A' ' 95' ' ' ILE . 4.4 pt -143.17 70.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.399 -0.52 . . . . 1.5700000000000001 111.567 -179.104 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -72.44 146.88 46.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.613 -0.721 . . . . 1.46 110.468 179.864 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -65.99 61.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.764 0.792 . . . . 2.9100000000000001 112.387 -179.413 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 15' ' ' ARG . 0.9 OUTLIER 167.82 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.758 -0.655 . . . . 1.3300000000000001 110.509 179.09 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.4 126.12 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.472 -0.566 . . . . 1.28 109.472 179.27 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.545 ' CG1' ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -116.77 120.57 65.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.189 0.44 . . . . 1.49 112.189 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 97.6 m -91.63 142.34 27.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.692 -0.231 . . . . 1.1399999999999999 110.892 179.303 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -140.4 156.03 46.53 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.146 0.904 . . . . 1.3100000000000001 112.992 -179.641 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 1.8 tppp? -145.15 159.11 43.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.316 -1.311 . . . . 2.3100000000000001 109.59 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 40.0 p90 -155.66 -176.45 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.13 0.49 . . . . 0.40000000000000002 112.086 -179.879 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.95 133.37 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.569 -0.741 . . . . 1.1100000000000001 111.685 -179.664 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.568 ' HG2' ' HH ' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -70.64 141.56 87.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 2.5600000000000001 109.686 179.35 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.46 ' N ' ' HD2' ' A' ' 24' ' ' LYS . 6.3 Cg_endo -48.62 175.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.095 1.863 . . . . 1.1100000000000001 111.431 179.705 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.7 -25.66 4.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.33 0.493 . . . . 2.77 112.33 -179.367 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -106.45 -70.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.005 0.372 . . . . 1.6899999999999999 112.005 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 3.2 p 52.08 41.18 29.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.649 0.261 . . . . 1.3500000000000001 110.36 -179.313 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.87 -91.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.861 -0.685 . . . . 1.01 112.232 -179.805 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.73 35.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.077 -1.209 . . . . 0.97999999999999998 110.077 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -117.39 172.31 7.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.898 -0.651 . . . . 0.98999999999999999 111.635 -178.464 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -123.86 -3.45 8.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.852 -0.613 . . . . 2.6899999999999999 111.519 179.828 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 33' ' ' ILE . 16.2 mt 64.01 155.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 110.505 -0.183 . . . . 1.71 110.505 -179.908 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 p -139.56 8.27 2.38 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.482 0.549 . . . . 1.6599999999999999 112.482 -179.522 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 0.2 OUTLIER 178.49 149.39 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.826 0.346 . . . . 1.97 111.923 -179.994 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' HH ' ' HG2' ' A' ' 24' ' ' LYS . 1.8 m-85 -126.38 119.83 28.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.983 -0.553 . . . . 1.23 110.101 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.84 116.15 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.73 0.3 . . . . 1.76 111.471 -179.585 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -106.44 104.48 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.303 0.573 . . . . 1.6100000000000001 110.671 179.588 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 4.8 mt-10 -73.52 157.33 36.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.284 -0.871 . . . . 1.6699999999999999 110.38 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.23 137.41 53.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 2.4399999999999999 111.466 -179.569 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -113.9 120.2 39.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 1.79 110.726 179.656 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.837 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.71 77.7 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 1.5900000000000001 110.552 179.846 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 52.8 mt -53.3 145.16 27.33 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.637 -0.71 . . . . 1.4299999999999999 111.151 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -93.42 27.03 19.26 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.903 -1.29 . . . . 1.47 112.708 0.174 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -153.6 81.89 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.781 0.324 . . . . 2.6600000000000001 111.861 -179.835 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.75 -152.83 10.44 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.942 -0.647 . . . . 1.6200000000000001 111.968 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.15 29.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.027 0.413 . . . . 3.0600000000000001 111.759 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 69.1 m95 41.06 101.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.832 0.678 . . . . 1.0600000000000001 112.832 179.422 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.434 ' N ' ' HB3' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -131.48 117.97 19.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 1.8400000000000001 110.045 179.085 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -43.5 106.54 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.935 0.398 . . . . 1.77 111.484 -179.503 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.04 -36.54 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 1.4099999999999999 111.285 -179.867 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 8.3 p-10 -69.58 -173.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.336 -0.393 . . . . 2.0099999999999998 110.958 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 4.0 t80 176.93 -22.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.515 -0.766 . . . . 2.6400000000000001 111.799 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.99 35.78 0.8 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.075 0.398 . . . . 2.0299999999999998 112.075 -179.497 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.51 122.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 1.8700000000000001 111.294 179.594 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 HG12 ' CD1' ' A' ' 61' ' ' PHE . 35.2 mt -114.27 68.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 1.3700000000000001 110.987 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 2.1499999999999999 111.158 -179.892 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -70.2 166.53 19.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.99 0.424 . . . . 1.54 110.759 -179.948 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -78.83 1.69 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.904 -0.589 . . . . 1.75 111.537 179.873 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 7.1 tt0 -98.56 100.14 11.35 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.966 -0.383 . . . . 2.0499999999999998 109.966 179.608 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CG ' ' N ' ' A' ' 62' ' ' THR . 60.8 t80 -136.81 164.45 28.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.238 0.542 . . . . 0.56999999999999995 111.648 -179.502 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 5.6 m -125.55 125.14 42.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.463 -0.79 . . . . 1.1399999999999999 110.398 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' HB ' HG21 ' A' ' 18' ' ' VAL . 9.1 t -87.53 91.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.214 0.531 . . . . 1.72 110.747 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.2 p -85.52 -157.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.375 -0.829 . . . . 1.6399999999999999 110.825 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.78 9.19 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.578 -0.82 . . . . 0.95999999999999996 112.086 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.545 ' CD1' ' CG1' ' A' ' 18' ' ' VAL . 27.8 mt -75.61 164.98 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 2.02 111.025 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 1.8 m -115.27 101.59 9.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.557 . . . . 1.55 110.363 179.756 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 7.6 tt0 -49.25 150.15 1.84 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.489 -0.323 . . . . 1.9099999999999999 111.179 -179.748 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 20.2 m-20 70.92 46.73 0.46 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.983 -0.553 . . . . 1.8700000000000001 110.676 -179.625 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.83 121.42 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.034 -0.53 . . . . 1.2 111.139 -179.927 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 95' ' ' ILE . . . -74.86 117.41 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.055 -0.35 . . . . 1.1100000000000001 110.055 179.477 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' OH ' ' HB ' ' A' ' 67' ' ' THR . 78.2 m-85 -113.78 128.95 56.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 1.0800000000000001 113.014 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -95.41 146.4 24.43 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.469 -0.937 . . . . 1.5 108.469 178.271 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.535 ' CE2' ' CD1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -123.85 108.94 13.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.376 1.621 . . . . 0.79000000000000004 115.376 -178.177 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.71 133.8 41.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.133 -0.94 . . . . 2.6899999999999999 109.374 178.304 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -117.01 125.36 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 119.141 -1.023 . . . . 1.5700000000000001 113.678 179.811 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 HG21 ' N ' ' A' ' 78' ' ' ALA . 37.0 mt -114.74 145.57 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 113.589 -1.642 . . . . 1.3200000000000001 108.03 178.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -154.34 125.39 7.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.858 -0.737 . . . . 1.1100000000000001 112.541 -179.521 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' ALA . 15.5 ptpt -79.85 156.14 27.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 2.3500000000000001 110.25 179.276 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.566 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 5.0 p30 -102.36 172.92 6.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 2.7000000000000002 112.185 -179.32 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -44.26 -46.73 9.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.949 -1.023 . . . . 1.3400000000000001 111.963 179.72 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.559 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -65.64 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 1.4299999999999999 111.887 -179.273 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.22 -21.56 21.98 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.532 -0.842 . . . . 1.3799999999999999 112.208 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -49.18 154.03 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.989 -0.374 . . . . 1.49 109.989 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 85' ' ' ILE . 4.1 tp -108.58 115.78 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.255 0.465 . . . . 1.48 112.255 -179.38 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 24.1 p -69.72 113.84 20.23 Favored Pre-proline 0 C--O 1.235 0.34 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.583 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.19 150.25 14.6 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.319 2.013 . . . . 1.25 113.005 -178.905 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 10.7 Cg_exo -38.93 141.51 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.46 2.774 . . . . 1.2 113.961 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' GLU . 16.0 m -106.01 110.6 22.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.957 -1.02 . . . . 1.76 109.698 179.054 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tp10 -5.12 116.08 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 124.815 1.322 . . . . 1.77 113.471 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 81.2 Cg_exo -51.05 142.29 35.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.451 2.1 . . . . 1.01 114.554 -179.14 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 152.15 37.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.345 -0.983 . . . . 1.55 108.345 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.89 145.73 0.31 Allowed 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.343 0.402 . . . . 1.6299999999999999 110.978 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -78.8 121.48 24.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.993 -0.549 . . . . 1.0900000000000001 111.07 -179.416 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 4.1 mp -100.77 114.94 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.266 -0.425 . . . . 1.1299999999999999 111.175 -179.995 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.0 m -51.47 -44.21 62.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.919 -0.582 . . . . 1.1299999999999999 110.655 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 50.3 t 62.43 67.94 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 116.17 -0.468 . . . . 1.5700000000000001 110.958 179.651 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.77 -84.61 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 3.7000000000000002 111.132 -179.973 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.999 ' OD1' HG11 ' A' ' 101' ' ' VAL . 2.7 p30 -122.58 -0.67 9.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 2.1400000000000001 111.109 179.719 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.49 26.1 1.08 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.991 0.424 . . . . 2.0600000000000001 111.236 -179.969 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.999 HG11 ' OD1' ' A' ' 99' ' ' ASP . 14.9 p -156.14 24.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 3.0800000000000001 110.815 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' OE2' ' N ' ' A' ' 99' ' ' ASP . 2.4 mp0 -126.65 -41.49 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 4.5800000000000001 110.88 -179.693 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.251 -0.88 . . . . 3.79 111.158 -179.818 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 111.677 0.251 . . . . 3.1699999999999999 111.677 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.27 59.32 6.95 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.416 2.077 . . . . 2.0600000000000001 112.364 -179.855 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.448 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 5.5 tt -46.64 149.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 1.26 111.475 -179.977 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -129.78 124.99 22.02 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.787 -0.642 . . . . 2.0 111.194 179.699 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 161.76 35.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.427 2.084 . . . . 0.58999999999999997 111.976 179.793 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.06 170.39 2.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.592 2.195 . . . . 1.6100000000000001 112.783 -179.677 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 167.66 49.94 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.695 -0.684 . . . . 0.97999999999999998 112.882 -179.749 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 tmtt? -51.43 119.37 12.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.505 -0.183 . . . . 2.04 110.505 179.806 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.435 ' CG ' HG21 ' A' ' 76' ' ' VAL . 16.5 Cg_exo -70.06 152.8 67.91 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.398 2.066 . . . . 0.54000000000000004 111.491 179.909 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 p -151.96 121.22 3.42 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.243 0.46 . . . . 1.6799999999999999 112.243 -179.068 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.2 Cg_exo -65.75 111.95 2.07 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.552 2.168 . . . . 0.64000000000000001 112.192 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER -76.45 -33.09 58.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 2.1699999999999999 110.625 179.711 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.56 126.02 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.84999999999999998 110.113 179.891 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -114.9 128.11 72.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 1.5700000000000001 111.606 -179.605 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -115.18 44.51 1.81 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.784 -0.644 . . . . 1.46 112.099 -179.318 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.8 mtm180 55.64 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.138 0.792 . . . . 2.9100000000000001 113.138 178.749 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m170 -75.8 -29.89 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 1.3300000000000001 110.934 -179.441 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.4 p -134.27 128.84 34.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.656 -0.498 . . . . 1.28 109.656 179.419 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 74' ' ' PHE . 3.6 m -115.44 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.452 -0.499 . . . . 1.49 111.215 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 13.4 m -119.72 114.76 22.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.334 -0.394 . . . . 1.1399999999999999 111.779 -178.997 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.506 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.04 158.0 40.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.686 0.755 . . . . 1.3100000000000001 111.154 178.879 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -138.18 -179.2 5.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.652 -1.158 . . . . 2.3100000000000001 109.591 179.813 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 24.7 p90 -162.08 175.46 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.328 0.585 . . . . 0.40000000000000002 112.24 179.521 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.18 175.21 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.315 -0.857 . . . . 1.1100000000000001 110.699 179.807 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 141.47 24.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.41 -0.359 . . . . 2.5600000000000001 110.476 179.883 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 11.1 Cg_endo -54.48 -176.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.7 2.267 . . . . 1.1100000000000001 112.464 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.23 -27.25 4.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 2.77 111.948 -179.77 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -113.84 -69.54 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.95 0.352 . . . . 1.6899999999999999 111.95 -179.556 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 46.0 p 52.59 48.27 22.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.919 0.39 . . . . 1.3500000000000001 110.227 -179.359 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.78 -101.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.657 -0.782 . . . . 1.01 112.03 -179.837 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.63 31.77 2.1 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.516 -1.034 . . . . 0.97999999999999998 110.516 179.22 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.6 m-85 -107.44 -172.76 2.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.836 -0.682 . . . . 0.98999999999999999 111.92 -178.806 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' CE ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.25 7.08 1.34 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.923 -1.035 . . . . 2.6899999999999999 111.832 179.187 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' CG2' ' CE1' ' A' ' 36' ' ' TYR . 2.1 mt 52.25 115.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.26 0.552 . . . . 1.71 112.329 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -117.12 22.76 12.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 1.6599999999999999 111.357 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.69 113.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.226 0.454 . . . . 1.97 112.226 -179.865 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 43.2 m-85 -97.45 138.08 35.43 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.095 -0.335 . . . . 1.23 110.095 178.884 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 HG23 ' CB ' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -125.77 111.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.894 0.378 . . . . 1.76 110.67 179.485 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -99.37 115.8 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.152 -0.476 . . . . 1.6100000000000001 111.364 -179.644 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 2.2 mt-10 -76.51 142.65 40.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.714 -0.675 . . . . 1.6699999999999999 110.32 179.7 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.474 ' HD3' ' CE1' ' A' ' 72' ' ' TYR . 27.5 ttmt -106.11 146.02 30.72 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 120.749 0.309 . . . . 2.4399999999999999 110.642 -179.577 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.507 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -129.8 100.77 5.6 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.547 -0.461 . . . . 1.79 110.483 178.931 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -70.6 78.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.618 -0.719 . . . . 1.5900000000000001 110.689 -179.927 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 81.2 mt -50.44 154.88 1.98 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 1.4299999999999999 111.02 -179.932 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.91 27.57 13.36 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.76 -1.35 . . . . 1.47 112.759 0.349 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -126.33 -79.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.574 0.225 . . . . 2.6600000000000001 110.996 -179.922 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 1.6200000000000001 112.907 179.845 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.27 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 3.0600000000000001 110.552 179.95 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.507 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 62.2 m95 43.93 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 1.0600000000000001 111.635 179.94 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -121.25 127.91 51.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 1.8400000000000001 110.602 179.915 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.449 ' CB ' HG23 ' A' ' 37' ' ' ILE . 0.7 OUTLIER -52.32 90.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.347 . . . . 1.77 110.627 -179.992 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' CB ' ' CG1' ' A' ' 63' ' ' VAL . . . -60.2 -46.06 91.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 1.4099999999999999 110.635 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 10.9 p-10 -64.99 102.01 0.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 2.0099999999999998 111.587 -179.828 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -15.65 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.085 -0.507 . . . . 2.6400000000000001 110.664 179.27 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 p -86.62 -155.82 0.28 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.38 -0.373 . . . . 2.0299999999999998 110.471 179.913 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.22 107.77 15.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.333 . . . . 1.8700000000000001 111.618 -179.708 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 6.9 mm -79.53 143.11 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.635 -0.505 . . . . 1.3700000000000001 109.635 178.989 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -145.34 -68.02 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.33 . . . . 2.1499999999999999 111.716 -179.843 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -54.93 -18.32 4.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 1.54 112.228 -179.731 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER 91.29 -18.45 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.877 0.871 . . . . 1.75 110.803 -179.58 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -88.92 85.26 6.69 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.555 -0.905 . . . . 2.0499999999999998 108.555 178.836 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 50.2 t80 -114.47 165.2 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.484 0.659 . . . . 0.56999999999999995 111.694 -178.61 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.53 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 91.9 m -123.4 116.99 24.16 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.893 -1.049 . . . . 1.1399999999999999 110.025 178.994 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' A' ' 51' ' ' ALA . 48.8 t -83.9 86.54 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.117 -0.492 . . . . 1.72 111.375 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.56 134.41 35.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.734 . . . . 1.6399999999999999 110.509 179.81 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.85 -14.3 2.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.83 . . . . 0.95999999999999996 112.919 -179.847 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.493 HD22 ' CG1' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -53.31 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.881 0.372 . . . . 2.02 110.609 179.94 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.2 m -148.75 142.3 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.55 111.11 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 1.286 ' OE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.0 137.27 58.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.9099999999999999 111.193 179.879 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 97' ' ' CYS . 21.1 t70 70.09 49.33 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 1.8700000000000001 111.221 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.87 120.51 2.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.873 0.368 . . . . 1.2 111.49 179.916 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -71.58 132.63 44.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 1.1100000000000001 109.983 179.239 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.519 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 14.7 m-85 -127.52 122.11 32.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 1.0800000000000001 113.014 -178.662 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.89 138.12 43.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.603 -0.888 . . . . 1.5 108.603 178.502 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.519 ' CZ ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.21 115.39 14.12 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.41 1.263 . . . . 0.79000000000000004 114.41 -178.702 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -93.32 167.77 11.52 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.806 -0.442 . . . . 2.6899999999999999 109.806 178.395 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 8' ' ' PRO . 28.5 t -122.43 121.18 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 113.706 1.002 . . . . 1.5700000000000001 113.706 -179.531 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 78' ' ' ALA . 70.1 mt -120.46 143.46 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.967 -1.494 . . . . 1.3200000000000001 106.967 178.007 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.425 ' N ' HG21 ' A' ' 77' ' ' ILE . . . -164.61 132.09 3.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.701 1.0 . . . . 1.1100000000000001 113.701 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.61 105.95 14.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.709 -0.848 . . . . 2.3500000000000001 108.709 178.245 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.589 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 3.3 m120 -40.1 -93.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.69 . . . . 2.7000000000000002 112.712 -178.721 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -131.93 -41.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.178 -0.327 . . . . 1.3400000000000001 111.643 -179.426 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.46 31.67 1.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 1.4299999999999999 111.796 -179.684 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 77.84 -2.35 64.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.477 -0.868 . . . . 1.3799999999999999 112.994 179.971 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -60.64 83.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 1.49 110.256 179.728 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 83' ' ' GLY . 0.6 OUTLIER -59.92 110.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 1.48 111.904 -179.325 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.0 p -70.64 118.13 61.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.101 -0.704 . . . . 0.81000000000000005 109.101 179.205 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 3.1 Cg_endo -47.15 172.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.623 2.215 . . . . 1.25 112.615 -179.192 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 17.0 Cg_endo -56.66 132.28 50.77 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.799 2.333 . . . . 1.2 112.46 -179.847 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.416 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m -105.99 98.14 7.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 1.76 111.155 -179.985 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mt-10 15.55 106.53 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 124.394 1.078 . . . . 1.77 113.858 179.58 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.493 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.1 Cg_exo -54.84 126.11 21.36 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.439 2.092 . . . . 1.01 113.89 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.77 147.64 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.431 -0.581 . . . . 1.55 109.431 178.996 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.77 143.48 0.08 Allowed 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 124.181 0.926 . . . . 1.6299999999999999 111.779 179.951 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.446 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -78.01 109.83 12.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 1.0900000000000001 109.901 179.712 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.4 HD13 ' HG2' ' A' ' 10' ' ' PRO . 4.8 mp -91.53 109.46 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 1.1299999999999999 111.485 -179.444 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 98.8 m -45.96 -28.54 1.17 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.27 -0.423 . . . . 1.1299999999999999 110.77 179.677 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.76 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 87.0 m 52.6 80.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 1.5700000000000001 110.172 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 1.286 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.2 -79.74 0.62 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.947 0.403 . . . . 3.7000000000000002 111.686 -179.394 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.852 ' OD1' ' HB ' ' A' ' 101' ' ' VAL . 2.6 p30 -112.44 22.23 14.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.01 -0.541 . . . . 2.1400000000000001 111.402 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 p30 51.88 21.68 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 2.0600000000000001 111.675 -179.767 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.852 ' HB ' ' OD1' ' A' ' 99' ' ' ASP . 15.2 t -119.63 -15.06 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 3.0800000000000001 111.07 179.536 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.878 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 42.87 55.21 4.47 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.032 0.444 . . . . 4.5800000000000001 111.541 179.891 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.209 -0.901 . . . . 3.79 111.162 -179.986 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.717 0.294 . . . . 3.1699999999999999 111.128 . . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.04 132.92 20.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.702 2.268 . . . . 2.0600000000000001 111.84 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 2.6 tt -130.84 142.3 43.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 1.26 111.31 -179.897 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.022 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -122.11 129.77 24.98 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 2.0 110.294 179.88 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 154.28 15.41 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.424 2.083 . . . . 0.58999999999999997 112.809 -179.628 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.522 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 78.2 Cg_exo -46.02 152.12 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.187 2.592 . . . . 1.6100000000000001 113.485 -179.854 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.36 -171.35 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.432 -0.804 . . . . 0.97999999999999998 113.103 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.7 tttt -77.07 129.39 78.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.457 -0.201 . . . . 2.04 110.457 179.824 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -78.48 128.43 8.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.608 2.206 . . . . 0.54000000000000004 112.896 -179.555 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.59 116.21 17.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.6799999999999999 111.103 179.713 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.1 Cg_exo -62.91 128.52 23.3 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.707 2.271 . . . . 0.64000000000000001 113.605 -179.467 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 21' ' ' LYS . 1.6 mp -93.63 -27.79 16.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 2.1699999999999999 109.693 179.059 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.42 151.16 32.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.715 -0.675 . . . . 0.84999999999999998 110.229 179.836 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 1.193 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -149.08 111.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 1.5700000000000001 111.503 -179.794 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.333 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -106.46 56.72 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.68 -0.691 . . . . 1.46 111.171 -179.956 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.955 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER 56.27 -69.97 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.881 0.738 . . . . 2.9100000000000001 112.853 179.016 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m-70 -83.99 -20.28 33.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 1.3300000000000001 111.82 -179.33 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.7 p -126.01 112.25 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 1.28 111.745 -179.603 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.502 HG13 ' CE2' ' A' ' 74' ' ' PHE . 95.2 t -106.39 120.55 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 1.49 110.478 179.606 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.417 ' OG1' ' CG2' ' A' ' 62' ' ' THR . 19.8 m -104.34 128.16 52.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 1.1399999999999999 111.843 -179.16 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -137.45 160.41 39.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.722 0.772 . . . . 1.3100000000000001 111.8 178.964 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' N ' HD13 ' A' ' 11' ' ' LEU . 8.6 tptm -142.57 139.19 31.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.514 -1.221 . . . . 2.3100000000000001 109.861 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 14.5 p90 -126.55 -174.86 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.40000000000000002 111.555 -179.714 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 171.81 8.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 1.1100000000000001 111.475 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 2.2 tptm -116.2 124.47 29.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.924 -0.58 . . . . 2.5600000000000001 110.06 179.842 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 6.5 Cg_endo -46.98 175.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.719 2.28 . . . . 1.1100000000000001 112.725 -179.908 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.54 3.35 5.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.77 110.846 179.718 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.022 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 3.7 t80 -121.87 -74.04 0.63 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.557 0.206 . . . . 1.6899999999999999 111.557 -179.558 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 1.006 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 16.6 p 41.29 56.75 3.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.524 0.202 . . . . 1.3500000000000001 111.254 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.13 -102.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.04 -0.527 . . . . 1.01 113.418 -179.717 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.68 28.85 3.2 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.968 -0.853 . . . . 0.97999999999999998 110.968 179.232 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -110.42 -176.19 2.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.356 -0.422 . . . . 0.98999999999999999 111.14 -179.138 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -137.89 1.01 2.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.976 -0.556 . . . . 2.6899999999999999 112.218 179.685 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 HG23 ' CE1' ' A' ' 36' ' ' TYR . 8.3 mt 57.51 116.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-O 121.071 0.462 . . . . 1.71 111.088 -179.749 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -103.16 10.84 37.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.435 0.532 . . . . 1.6599999999999999 112.435 -179.12 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -179.01 156.85 0.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.961 0.41 . . . . 1.97 111.898 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.479 ' CE1' HG23 ' A' ' 33' ' ' ILE . 28.5 m-85 -126.21 112.48 15.81 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.893 -0.594 . . . . 1.23 110.84 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -94.55 99.79 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 1.76 110.718 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -92.26 113.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 1.6100000000000001 110.488 179.861 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -81.5 144.73 31.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.605 -0.725 . . . . 1.6699999999999999 110.911 -179.784 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -111.79 139.13 47.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 2.4399999999999999 110.917 179.893 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 15.7 ttm180 -106.97 110.83 23.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.438 . . . . 1.79 110.382 179.405 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -82.66 91.21 6.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 110.307 179.866 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -68.0 154.53 93.62 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.519 -0.764 . . . . 1.4299999999999999 110.983 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.05 4.41 66.12 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.685 -1.381 . . . . 1.47 112.999 0.255 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -78.86 -68.03 0.69 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 2.6600000000000001 110.451 179.896 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 88.06 177.14 47.68 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.769 -0.729 . . . . 1.6200000000000001 113.016 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.47 -28.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.699 0.285 . . . . 3.0600000000000001 110.718 179.938 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 51.4 m95 63.31 87.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 1.0600000000000001 111.138 179.894 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.45 141.47 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.8400000000000001 111.116 -179.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -58.5 117.64 4.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 1.77 110.747 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.428 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -86.95 -49.59 7.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 1.4099999999999999 111.267 -179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -42.41 -54.18 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 2.0099999999999998 112.101 -179.707 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 t80 46.59 44.24 13.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.686 0.279 . . . . 2.6400000000000001 111.347 -179.87 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 t -152.5 -84.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 2.0299999999999998 111.156 179.924 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -178.13 110.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 1.8700000000000001 110.556 179.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.481 HG12 ' CD2' ' A' ' 61' ' ' PHE . 11.2 mt -108.74 80.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 1.3700000000000001 111.103 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -64.7 -65.69 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 2.1499999999999999 110.961 -179.962 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.43 160.16 30.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.989 -0.374 . . . . 1.54 109.989 179.737 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -74.16 -3.57 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.304 -0.407 . . . . 1.75 111.556 -179.87 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -100.0 101.34 12.4 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.801 0.334 . . . . 2.0499999999999998 110.151 179.853 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 62' ' ' THR . 50.3 t80 -135.07 162.97 30.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.258 0.551 . . . . 0.56999999999999995 111.719 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.568 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 51.6 m -122.58 109.94 14.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.52 -0.764 . . . . 1.1399999999999999 110.354 179.167 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG11 ' CB ' ' A' ' 51' ' ' ALA . 98.9 t -81.79 93.96 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.74 -0.664 . . . . 1.72 111.002 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.0 p -98.79 144.56 27.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 1.6399999999999999 110.872 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.44 -9.31 5.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.672 -0.775 . . . . 0.95999999999999996 112.986 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.03 0.443 . . . . 2.02 111.063 -179.93 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 m -129.27 131.8 47.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 1.55 110.442 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.31 150.27 35.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.306 -0.406 . . . . 1.9099999999999999 111.104 -179.758 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t0 62.75 48.56 4.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 1.8700000000000001 110.814 -179.999 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.02 126.13 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.498 . . . . 1.2 111.319 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 43' ' ' LEU . . . -71.52 134.57 46.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.242 -0.436 . . . . 1.1100000000000001 110.604 179.694 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -133.02 130.82 39.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 1.0800000000000001 112.414 -179.19 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' HB2' ' CH2' ' A' ' 48' ' ' TRP . 2.0 mt-10 -105.94 148.42 27.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.791 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.502 ' CE2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.59 117.89 13.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.717 1.377 . . . . 0.79000000000000004 114.717 -179.228 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -104.56 158.33 16.56 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.931 -0.766 . . . . 2.6899999999999999 108.931 177.663 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 99.3 t -115.19 109.93 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.584 -0.846 . . . . 1.5700000000000001 113.02 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.446 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 68.3 mt -105.37 157.18 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.021 -1.474 . . . . 1.3200000000000001 107.021 177.723 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -176.88 136.28 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.054 -1.058 . . . . 1.1100000000000001 112.684 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.0 ptpp? -75.63 -150.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.106 -0.701 . . . . 2.3500000000000001 109.106 178.846 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.541 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 25.4 p30 -147.43 -107.33 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.212 -0.595 . . . . 2.7000000000000002 111.291 -179.723 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -127.47 -43.04 1.62 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.709 0.686 . . . . 1.3400000000000001 110.423 179.847 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.94 -9.9 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 1.4299999999999999 111.749 179.803 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.81 -18.84 28.84 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.475 -0.869 . . . . 1.3799999999999999 112.398 -179.743 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.82 158.29 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.58 0.229 . . . . 1.49 110.72 179.959 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 6.3 tp -114.79 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.352 . . . . 1.48 111.649 -179.931 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -77.83 122.7 85.99 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 109.719 -0.474 . . . . 0.81000000000000005 109.719 179.328 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -41.47 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.353 2.702 . . . . 1.25 113.649 -179.419 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 1.1 Cg_endo -83.56 129.67 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.361 2.707 . . . . 1.2 112.469 -179.91 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.402 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 78.2 p -85.19 125.06 32.53 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.994 -0.372 . . . . 1.76 109.994 179.349 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -17.65 106.89 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 124.696 1.248 . . . . 1.77 113.497 -179.476 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 54.4 Cg_exo -45.25 152.53 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.503 2.135 . . . . 1.01 113.302 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.436 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -83.76 144.04 29.59 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.421 -0.808 . . . . 1.55 109.005 179.063 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -34.93 146.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.213 0.946 . . . . 1.6299999999999999 111.73 -179.624 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . . . -76.66 125.31 29.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.694 -0.684 . . . . 1.0900000000000001 110.69 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 mp -109.56 115.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 1.1299999999999999 110.956 179.72 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.0 m -48.2 -30.61 4.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.981 -0.554 . . . . 1.1299999999999999 111.262 -179.642 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 57.2 m 51.88 72.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 1.5700000000000001 110.212 -179.779 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.73 -80.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 3.7000000000000002 111.421 -179.485 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.448 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 20.7 p-10 -114.73 27.95 9.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.667 -0.697 . . . . 2.1400000000000001 110.819 -179.734 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.333 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.18 25.3 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.085 0.469 . . . . 2.0600000000000001 111.091 -179.323 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 47.0 t -127.4 -11.87 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.829 -0.623 . . . . 3.0800000000000001 111.496 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.84 29.69 4.55 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.96 0.409 . . . . 4.5800000000000001 111.024 179.732 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.249 -0.882 . . . . 3.79 111.019 -179.983 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 120.405 0.145 . . . . 3.1699999999999999 111.16 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.448 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 89.1 Cg_endo -85.4 -165.62 0.29 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.661 2.241 . . . . 2.0600000000000001 112.466 -179.905 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HD12 ' CB ' ' A' ' 86' ' ' SER . 7.0 tt -161.16 151.22 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 1.26 111.506 -179.972 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 1.24 ' OD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -140.55 130.77 13.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 2.0 110.132 179.757 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 166.94 17.2 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.437 2.091 . . . . 0.58999999999999997 112.843 -179.592 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.488 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 24.1 Cg_endo -61.74 -175.86 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.111 2.541 . . . . 1.6100000000000001 113.404 -179.489 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.45 168.61 36.68 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.578 -0.737 . . . . 0.97999999999999998 112.445 179.938 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -59.32 130.56 87.35 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.724 0.262 . . . . 2.04 110.353 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.4 Cg_exo -79.46 153.99 24.09 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.523 2.149 . . . . 0.54000000000000004 112.86 -179.413 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 10.7 p -140.34 116.35 7.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 1.6799999999999999 110.351 179.977 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 19' ' ' THR . 14.2 Cg_exo -66.81 91.54 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.953 1.769 . . . . 0.64000000000000001 113.191 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.47 ' CD1' ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER -46.75 -42.77 17.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.293 0.568 . . . . 2.1699999999999999 110.283 179.449 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' O ' HG21 ' A' ' 13' ' ' ILE . 2.0 t30 -134.58 153.21 52.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.216 -0.902 . . . . 0.84999999999999998 109.278 179.631 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' CG2' HG13 ' A' ' 18' ' ' VAL . 2.6 pt -140.4 94.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.48 . . . . 1.5700000000000001 111.235 -179.543 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -91.63 55.61 2.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.677 -0.692 . . . . 1.46 112.282 -179.202 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 2.5 mtm180 53.58 -71.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.678 0.992 . . . . 2.9100000000000001 113.678 178.638 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.6 m170 -84.8 -32.61 23.27 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.281 0.474 . . . . 1.3300000000000001 112.281 -178.726 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.432 ' CB ' ' HA ' ' A' ' 64' ' ' SER . 19.9 p -126.4 101.7 6.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.673 0.273 . . . . 1.28 111.075 -179.714 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.547 ' CG1' ' CD2' ' A' ' 66' ' ' LEU . 32.5 m -98.72 138.28 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.378 . . . . 1.49 110.423 179.505 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 91.1 m -101.13 119.95 39.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.74 0.644 . . . . 1.1399999999999999 112.74 -179.099 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -129.95 150.81 51.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.794 0.806 . . . . 1.3100000000000001 111.834 178.221 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.49 159.2 42.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.719 -1.128 . . . . 2.3100000000000001 109.364 179.607 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -141.93 -176.87 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.087 0.773 . . . . 0.40000000000000002 113.087 -178.922 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 -158.13 0.27 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.774 -1.103 . . . . 1.1100000000000001 110.643 179.387 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.71 148.84 71.69 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.417 -0.356 . . . . 2.5600000000000001 110.738 179.606 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 80.7 Cg_exo -49.1 -173.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.983 2.455 . . . . 1.1100000000000001 113.084 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.78 -29.79 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 2.77 111.649 -179.834 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.24 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 t80 -129.4 -69.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.961 0.356 . . . . 1.6899999999999999 111.961 -179.563 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.852 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 16.1 p 58.49 46.16 15.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 1.3500000000000001 110.566 -179.308 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.22 -98.51 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.929 -0.653 . . . . 1.01 112.551 179.905 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.36 22.85 2.87 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.336 -0.706 . . . . 0.97999999999999998 111.336 179.354 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -103.29 -176.12 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 0.98999999999999999 111.206 -179.178 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -134.89 5.69 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 2.6899999999999999 111.437 179.482 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.486 HG22 ' CE1' ' A' ' 36' ' ' TYR . 12.1 mt 57.55 97.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-O 121.151 0.5 . . . . 1.71 110.868 -179.725 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -104.63 29.44 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.52 -0.764 . . . . 1.6599999999999999 111.306 -179.424 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.83 116.77 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.917 0.389 . . . . 1.97 111.996 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.488 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 48.2 m-85 -110.42 107.46 17.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 1.23 110.3 179.267 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.444 HG23 ' CB ' ' A' ' 50' ' ' LYS . 1.6 mm -90.92 116.47 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.658 0.266 . . . . 1.76 111.075 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.74 118.27 35.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.31 -0.404 . . . . 1.6100000000000001 111.811 -179.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 2.8 mm-40 -96.9 135.03 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.422 -0.584 . . . . 1.6699999999999999 109.422 178.901 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.32 145.75 39.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 2.4399999999999999 112.229 -179.269 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.2 ttm180 -117.86 103.42 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.295 -0.866 . . . . 1.79 110.233 179.46 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.691 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -73.05 92.7 1.7 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.031 0.443 . . . . 1.5900000000000001 110.9 -179.771 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' CB ' ' A' ' 94' ' ' ALA . 27.5 mt -70.82 149.42 95.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.786 -0.643 . . . . 1.4299999999999999 110.692 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.5 -18.1 18.52 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.845 -1.315 . . . . 1.47 113.01 0.423 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -52.22 -90.95 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.062 -0.255 . . . . 2.6600000000000001 110.672 -179.717 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' CA ' ' CG ' ' A' ' 41' ' ' ARG . . . 88.06 123.36 1.94 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.318 -0.944 . . . . 1.6200000000000001 113.305 179.52 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' NE ' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.94 17.22 0.67 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.858 0.318 . . . . 3.0600000000000001 111.858 179.678 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.5 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 69.0 m95 28.66 98.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.953 0.723 . . . . 1.0600000000000001 112.953 179.901 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.427 HD21 ' NE ' ' A' ' 47' ' ' ARG . 1.1 mp -135.65 133.48 38.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 1.8400000000000001 111.214 179.929 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' CB ' HG23 ' A' ' 37' ' ' ILE . 9.8 ptmm? -51.11 106.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 1.77 111.112 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.39 -56.84 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 1.4099999999999999 110.714 179.819 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 9.4 p-10 -57.66 113.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 2.0099999999999998 110.571 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.21 24.0 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 2.6400000000000001 111.224 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 t -125.56 -82.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 2.0299999999999998 110.77 -179.935 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.95 141.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 1.8700000000000001 110.56 179.947 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 30.9 mt -125.56 79.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 1.3700000000000001 111.19 -179.651 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.84 -66.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 2.1499999999999999 110.923 179.998 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -179.72 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.481 -0.327 . . . . 1.54 110.424 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 30.1 p30 -96.69 10.05 39.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 1.75 111.618 179.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -111.28 95.84 5.76 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.757 -0.46 . . . . 2.0499999999999998 109.757 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.531 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 76.6 t80 -128.26 164.83 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.196 0.522 . . . . 0.56999999999999995 111.531 -179.26 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.9 m -127.38 124.03 37.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.578 -0.737 . . . . 1.1399999999999999 110.333 179.253 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -81.36 82.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.17 0.509 . . . . 1.72 109.941 179.694 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HA ' ' CB ' ' A' ' 17' ' ' THR . 33.2 t -68.27 -39.05 82.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.403 -0.817 . . . . 1.6399999999999999 111.514 -179.18 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.68 62.22 0.47 Allowed Glycine 0 C--N 1.321 -0.301 0 C-N-CA 120.811 -0.709 . . . . 0.95999999999999996 111.69 179.733 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -131.66 149.19 52.58 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.385 -0.598 . . . . 2.02 109.385 -179.118 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.405 ' N ' HD11 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -105.23 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 1.55 111.87 -179.207 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HB2' ' NE2' ' A' ' 16' ' ' HIS . 19.7 tt0 -103.75 165.14 11.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 1.9099999999999999 111.28 -179.46 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.65 68.91 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.993 -0.549 . . . . 1.8700000000000001 111.125 179.826 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . 176.87 110.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 1.2 110.882 179.904 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . . . -63.05 110.2 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.21 0.529 . . . . 1.1100000000000001 110.641 -179.866 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 82.7 m-85 -103.75 125.54 50.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 1.0800000000000001 112.728 -178.999 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HG3' HD13 ' A' ' 43' ' ' LEU . 20.1 mt-10 -103.36 137.2 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.863 -1.162 . . . . 1.5 107.863 177.704 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.571 ' CE2' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -129.61 116.97 19.66 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.307 1.595 . . . . 0.79000000000000004 115.307 -178.717 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -102.21 177.8 4.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.579 -1.267 . . . . 2.6899999999999999 107.579 176.856 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -145.14 111.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 118.969 -1.093 . . . . 1.5700000000000001 112.753 -179.835 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.449 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 25.1 mt -92.99 142.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.691 -1.226 . . . . 1.3200000000000001 107.691 177.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -154.1 120.7 5.51 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.746 . . . . 1.1100000000000001 111.945 -178.951 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.706 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -56.3 -100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.367 -0.533 . . . . 2.3500000000000001 109.969 179.633 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.536 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 18.6 p30 171.41 -111.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.935 -0.765 . . . . 2.7000000000000002 108.935 179.65 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -135.09 5.54 3.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.054 0.843 . . . . 1.3400000000000001 111.53 179.015 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.94 0.02 7.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.736 -0.211 . . . . 1.4299999999999999 111.236 179.956 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.82 61.16 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 120.334 -0.936 . . . . 1.3799999999999999 113.186 179.864 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.87 114.35 6.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 1.49 110.335 179.866 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -72.77 121.3 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 1.48 112.255 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.432 ' CB ' HD12 ' A' ' 2' ' ' ILE . 1.3 p -89.36 127.0 56.65 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 109.674 -0.491 . . . . 0.81000000000000005 109.674 179.264 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -32.97 155.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.547 2.832 . . . . 1.25 113.844 -179.16 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 14.6 Cg_exo -68.06 120.97 7.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.698 2.265 . . . . 1.2 112.685 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.75 133.07 54.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.351 -0.611 . . . . 1.76 109.351 179.167 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -31.53 116.58 0.37 Allowed Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 123.682 0.614 . . . . 1.77 112.425 -179.305 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.481 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 68.6 Cg_exo -40.67 169.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.011 2.474 . . . . 1.01 114.252 -179.565 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.08 141.46 35.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.73 -1.123 . . . . 1.55 109.729 179.834 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -41.85 130.54 3.37 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.71 0.631 . . . . 1.6299999999999999 111.078 179.606 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.453 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -59.88 133.97 56.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.861 -0.609 . . . . 1.0900000000000001 111.552 -179.557 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CD1' ' CE2' ' A' ' 74' ' ' PHE . 3.5 mp -116.79 113.19 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 1.1299999999999999 110.71 179.507 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.1 m -53.42 -16.0 1.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.056 0.761 . . . . 1.1299999999999999 113.056 -179.106 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 p 42.08 64.9 0.98 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.254 0.55 . . . . 1.5700000000000001 111.127 -179.644 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' CD ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -86.28 -90.28 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.399 -0.819 . . . . 3.7000000000000002 111.429 -179.492 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.407 ' OD1' ' CG1' ' A' ' 101' ' ' VAL . 2.2 p30 -133.19 31.29 3.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.846 0.355 . . . . 2.1400000000000001 110.713 -179.748 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 26.0 t0 38.44 28.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.019 -0.537 . . . . 2.0600000000000001 112.249 -179.617 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.407 ' CG1' ' OD1' ' A' ' 99' ' ' ASP . 12.7 p -163.19 24.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.187 -0.461 . . . . 3.0800000000000001 111.189 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.253 ' HG3' ' OD2' ' A' ' 99' ' ' ASP . 6.6 mt-10 -116.78 -25.22 7.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.355 . . . . 4.5800000000000001 111.413 -179.716 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.21 -0.9 . . . . 3.79 110.896 179.889 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.367 0.127 . . . . 3.1699999999999999 111.113 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.95 -155.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.459 2.106 . . . . 2.0600000000000001 112.087 179.83 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.45 ' CD1' ' O ' ' A' ' 84' ' ' ALA . 1.6 tt -172.73 144.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.97 -0.559 . . . . 1.26 111.012 179.637 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.36 122.7 26.67 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.13 -0.486 . . . . 2.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 59.6 Cg_endo -71.57 155.88 58.63 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.036 1.824 . . . . 0.58999999999999997 112.181 -179.751 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -59.73 172.75 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.317 2.011 . . . . 1.6100000000000001 112.242 -179.757 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.55 168.58 51.05 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.93 -0.652 . . . . 0.97999999999999998 113.031 -179.693 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 5.6 tttt -63.17 141.13 97.75 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.026 -0.361 . . . . 2.04 110.026 179.663 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' HG2' ' A' ' 7' ' ' LYS . 3.6 Cg_exo -83.4 142.08 10.41 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.417 2.078 . . . . 0.54000000000000004 112.589 -179.729 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.74 118.33 6.11 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 1.6799999999999999 110.588 179.749 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.6 Cg_exo -67.0 123.02 10.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.196 1.931 . . . . 0.64000000000000001 113.521 -179.439 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -34.38 20.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.901 -0.778 . . . . 2.1699999999999999 108.901 178.701 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 143.48 35.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.794 -1.094 . . . . 0.84999999999999998 109.047 179.386 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' CG2' HG12 ' A' ' 18' ' ' VAL . 2.6 pt -136.94 102.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.026 0.441 . . . . 1.5700000000000001 112.044 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.72 59.17 1.47 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.756 -0.656 . . . . 1.46 111.115 -179.999 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 51.53 -74.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.553 -0.748 . . . . 2.9100000000000001 112.273 179.045 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' THR . 7.2 m-70 -79.69 -45.85 18.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 1.3300000000000001 110.894 -179.944 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -99.12 104.61 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.28 111.061 -179.905 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.459 ' CG2' ' CD2' ' A' ' 66' ' ' LEU . 61.7 t -101.22 118.95 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 1.49 110.219 179.761 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 27.3 m -95.29 117.72 30.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.979 -0.555 . . . . 1.1399999999999999 112.12 -179.117 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -134.37 159.49 40.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.447 0.641 . . . . 1.3100000000000001 111.165 178.541 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.64 148.21 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.911 -1.04 . . . . 2.3100000000000001 109.692 -179.987 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 1.2 p90 -116.46 -111.06 0.35 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.487 -0.485 . . . . 0.40000000000000002 112.078 -179.994 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -157.48 -159.55 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.993 -0.442 . . . . 1.1100000000000001 111.196 -179.189 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' HD3' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.73 132.61 24.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 2.5600000000000001 110.61 179.981 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.3 Cg_endo -57.04 -175.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.432 2.088 . . . . 1.1100000000000001 112.102 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.51 -43.19 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.955 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -97.03 -66.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 1.6899999999999999 112.047 -179.32 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 27.8 p 55.18 32.0 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 1.3500000000000001 110.493 -179.345 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.14 -94.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.481 -0.866 . . . . 1.01 111.866 -179.824 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.89 41.68 1.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.513 -1.035 . . . . 0.97999999999999998 110.513 179.261 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.471 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 6.4 m-85 -121.7 -179.15 4.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.181 -0.51 . . . . 0.98999999999999999 111.752 -178.859 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -133.13 -32.96 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 2.6899999999999999 111.998 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 4.0 mt 80.98 107.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.083 0.468 . . . . 1.71 110.821 -179.542 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -102.7 12.32 36.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.686 -0.688 . . . . 1.6599999999999999 111.69 -179.546 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -178.23 137.09 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.485 0.55 . . . . 1.97 112.485 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CE1' HG23 ' A' ' 33' ' ' ILE . 55.2 m-85 -112.6 151.17 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.819 . . . . 1.23 109.637 178.684 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.73 123.98 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.74 0.305 . . . . 1.76 111.055 -179.529 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.75 101.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 1.6100000000000001 111.36 -179.959 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -74.54 144.61 43.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.34 -0.615 . . . . 1.6699999999999999 109.34 179.267 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.431 ' CG ' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -122.02 145.73 47.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.133 0.492 . . . . 2.4399999999999999 111.6 -179.226 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.8 ttm180 -133.57 94.32 3.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.789 -0.641 . . . . 1.79 111.056 -179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.696 ' CG ' ' HH ' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -57.43 164.67 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.409 -0.96 . . . . 1.5900000000000001 108.409 179.121 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 35.2 mt -142.25 129.97 11.48 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.227 -0.589 . . . . 1.4299999999999999 111.067 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.79 33.83 3.92 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.08 -1.217 . . . . 1.47 113.653 0.743 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -112.12 51.92 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 2.6600000000000001 111.202 179.895 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -60.65 -178.58 2.14 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.773 -0.727 . . . . 1.6200000000000001 112.815 -179.998 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.74 -28.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.585 0.217 . . . . 3.0600000000000001 111.585 -179.968 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 24.3 m95 65.42 72.59 0.42 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.792 0.329 . . . . 1.0600000000000001 111.251 -179.981 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.6 mp -119.86 133.84 55.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 1.8400000000000001 110.605 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 86.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 1.77 110.787 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -53.22 -41.62 65.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 1.4099999999999999 111.175 -179.668 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . 5.4 t30 -44.37 -90.59 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.309 -0.405 . . . . 2.0099999999999998 111.427 -179.768 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 t80 73.1 39.55 0.61 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.724 0.297 . . . . 2.6400000000000001 110.712 -179.609 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -157.13 24.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 2.0299999999999998 111.551 -179.911 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.85 121.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.82 0.343 . . . . 1.8700000000000001 111.219 179.611 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.605 ' CD1' ' CD1' ' A' ' 61' ' ' PHE . 38.9 mm -108.5 75.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 1.3700000000000001 110.972 179.58 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -48.66 -67.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.731 0.301 . . . . 2.1499999999999999 111.001 -179.995 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.38 163.43 21.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.54 110.158 179.635 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 34.1 p30 -76.89 -1.09 26.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.369 -0.378 . . . . 1.75 111.73 -179.829 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -104.52 98.35 8.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.865 0.364 . . . . 2.0499999999999998 110.051 179.711 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.605 ' CD1' ' CD1' ' A' ' 56' ' ' ILE . 64.6 t80 -128.84 164.72 22.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.56999999999999995 111.439 -179.39 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 51.1 m -128.76 106.85 9.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.319 -0.855 . . . . 1.1399999999999999 110.826 179.302 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 27.0 m -61.77 134.92 26.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.72 110.868 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.72 133.45 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 1.6399999999999999 111.502 -179.524 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.25 21.83 4.33 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.95999999999999996 112.293 179.917 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' HG ' ' CD2' ' A' ' 72' ' ' TYR . 3.0 mp -79.69 176.65 9.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.185 0.517 . . . . 2.02 111.749 -179.504 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 134.27 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.394 -0.821 . . . . 1.55 110.124 179.419 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 mt-10 -73.73 174.2 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 1.9099999999999999 111.736 -179.501 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 6.2 t70 52.83 27.44 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.905 -0.588 . . . . 1.8700000000000001 110.973 -179.962 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.33 126.02 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 1.2 110.871 179.803 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -66.03 127.87 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.362 -0.381 . . . . 1.1100000000000001 110.607 179.78 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.696 ' HH ' ' CG ' ' A' ' 42' ' ' ASP . 3.6 m-85 -115.91 125.71 52.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 1.0800000000000001 112.014 -179.087 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.2 tt0 -106.33 148.41 28.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.873 -0.788 . . . . 1.5 108.873 179.001 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -139.93 118.76 12.47 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.79000000000000004 115.032 -178.718 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -100.35 178.06 4.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.004 -0.544 . . . . 2.6899999999999999 109.831 178.102 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 75.4 t -134.68 122.07 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 113.245 0.831 . . . . 1.5700000000000001 113.245 -179.53 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 91.9 mt -122.56 142.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.147 -1.427 . . . . 1.3200000000000001 107.147 178.188 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 36' ' ' TYR . . . -169.31 134.35 1.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.49 1.292 . . . . 1.1100000000000001 114.49 -178.836 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -83.75 136.93 33.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.887 -1.153 . . . . 2.3500000000000001 107.887 177.529 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 5.9 m-20 -76.69 -92.5 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.468 0.544 . . . . 2.7000000000000002 112.468 -178.566 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -126.31 -40.96 1.93 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.444 0.535 . . . . 1.3400000000000001 112.444 -178.99 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.471 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -100.43 36.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.339 0.496 . . . . 1.4299999999999999 112.339 -179.078 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.96 -0.67 57.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 1.3799999999999999 113.486 179.575 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -63.11 85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.032 0.416 . . . . 1.49 110.176 179.677 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -64.41 121.39 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.169 0.509 . . . . 1.48 111.98 -179.26 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 22.9 p -78.31 123.94 85.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.81000000000000005 109.311 179.159 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.54 171.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.872 2.381 . . . . 1.25 113.172 -179.211 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 14.4 Cg_exo -67.53 112.79 2.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 1.2 112.862 -179.596 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -74.36 132.58 42.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 1.76 110.037 179.367 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.7 mm-40 -31.01 113.75 0.33 Allowed Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 123.761 0.663 . . . . 1.77 112.355 -179.599 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HG3' ' CZ ' ' A' ' 75' ' ' ARG . 44.1 Cg_exo -56.07 138.63 83.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 1.01 113.057 -179.658 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -69.94 146.49 51.13 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.279 -0.638 . . . . 1.55 109.279 179.193 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -35.76 139.43 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.094 0.871 . . . . 1.6299999999999999 111.843 -179.865 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -75.65 108.86 8.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 1.0900000000000001 111.175 -179.709 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mp -91.29 114.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.197 -0.456 . . . . 1.1299999999999999 111.122 -179.712 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 97.5 m -36.22 -32.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.214 -0.448 . . . . 1.1299999999999999 111.862 -179.96 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 69' ' ' ASP . 9.3 m 51.28 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.428 -0.351 . . . . 1.5700000000000001 110.117 179.773 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.99 -90.92 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 3.7000000000000002 111.669 -179.317 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.855 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.7 OUTLIER -105.71 6.59 32.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.805 0.298 . . . . 2.1400000000000001 111.805 -179.609 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 53.5 t0 58.79 17.8 5.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.862 0.319 . . . . 2.0600000000000001 111.862 179.755 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.855 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 3.6 p -111.77 -20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.347 -0.388 . . . . 3.0800000000000001 110.27 179.52 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.503 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.2 mm-40 40.28 51.56 2.77 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.205 -0.452 . . . . 4.5800000000000001 111.861 179.498 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.162 -0.923 . . . . 3.79 111.111 179.974 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.692 0.282 . . . . 3.1699999999999999 111.303 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.83 172.69 3.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.044 2.496 . . . . 2.0600000000000001 112.009 179.919 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.477 ' CD1' ' ND2' ' A' ' 80' ' ' ASN . 6.9 tt -161.27 145.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 1.26 111.041 -179.867 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.81 114.26 19.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 2.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.75 154.61 54.16 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.395 2.063 . . . . 0.58999999999999997 112.007 179.907 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.81 174.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.692 2.261 . . . . 1.6100000000000001 112.826 -179.708 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.77 171.48 44.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.993 -0.622 . . . . 0.97999999999999998 112.658 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -63.64 135.9 96.48 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 110.49 -0.189 . . . . 2.04 110.49 179.802 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 3.0 Cg_endo -80.9 129.76 7.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.457 2.104 . . . . 0.54000000000000004 112.861 -179.697 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 7.9 p -132.83 106.01 12.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.917 -0.583 . . . . 1.6799999999999999 110.793 179.613 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.5 Cg_exo -49.03 131.76 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.334 2.022 . . . . 0.64000000000000001 113.691 -179.069 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.75 -39.92 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.861 -0.792 . . . . 2.1699999999999999 108.861 178.689 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -136.35 150.37 48.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.406 -1.27 . . . . 0.84999999999999998 108.607 179.576 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 13' ' ' ILE . 1.9 pt -143.44 83.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.262 -0.575 . . . . 1.5700000000000001 112.516 -179.157 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.23 159.73 29.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.729 -0.669 . . . . 1.46 110.507 179.476 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -17.37 7.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.9100000000000001 111.961 -179.554 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.408 ' O ' ' CG2' ' A' ' 17' ' ' THR . 10.7 m-70 -141.91 34.39 1.57 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.973 0.36 . . . . 1.3300000000000001 111.973 -179.754 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 179.66 120.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.648 -0.251 . . . . 1.28 110.387 179.714 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.438 ' HB ' HG21 ' A' ' 63' ' ' VAL . 95.2 t -117.86 111.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.18 0.514 . . . . 1.49 112.045 -179.317 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 92.4 m -85.21 142.28 29.54 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.004 -0.543 . . . . 1.1399999999999999 110.266 179.154 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.79 161.13 41.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.428 0.633 . . . . 1.3100000000000001 112.298 -179.857 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -149.3 144.37 26.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.878 -1.056 . . . . 2.3100000000000001 110.49 179.742 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.4 p90 -138.23 -173.38 3.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.431 . . . . 0.40000000000000002 110.734 -179.973 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 -166.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 1.1100000000000001 110.381 179.534 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -132.23 155.61 81.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.786 0.327 . . . . 2.5600000000000001 110.942 179.907 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.456 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.6 Cg_exo -69.25 163.41 37.96 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.097 . . . . 1.1100000000000001 111.835 179.802 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.96 -0.66 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 2.77 111.493 179.652 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -128.6 -70.34 0.68 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.658 0.266 . . . . 1.6899999999999999 111.644 -179.805 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 30.4 p 48.83 57.43 6.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.598 -0.274 . . . . 1.3500000000000001 110.733 -179.575 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.46 -92.17 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.301 -0.476 . . . . 1.01 112.799 -179.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -145.96 32.66 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.236 -1.146 . . . . 0.97999999999999998 110.236 179.177 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -119.44 -179.04 3.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.953 -0.624 . . . . 0.98999999999999999 111.374 -178.716 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.08 3.75 2.92 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.249 -0.432 . . . . 2.6899999999999999 112.164 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 33' ' ' ILE . 10.1 mt 60.05 154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.752 0.31 . . . . 1.71 110.635 -179.935 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.3 p -145.2 15.14 1.49 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.002 0.371 . . . . 1.6599999999999999 112.002 -179.646 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 9.1 t -177.65 133.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 1.97 111.214 -179.915 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.422 ' O ' ' HB ' ' A' ' 56' ' ' ILE . 25.9 m-85 -109.58 105.18 14.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 1.23 110.642 179.592 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -84.91 152.02 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.019 -0.537 . . . . 1.76 111.039 -179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 2.5 t -131.53 111.76 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 1.6100000000000001 110.568 179.65 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -87.12 143.88 27.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.006 -0.368 . . . . 1.6699999999999999 110.006 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 141.24 51.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.122 0.487 . . . . 2.4399999999999999 112.23 -179.0 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 23.0 ttp180 -112.02 112.14 23.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.741 -0.663 . . . . 1.79 109.614 178.932 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 1.368 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.9 96.99 4.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 1.5900000000000001 110.887 -179.594 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' CD2' ' HG2' ' A' ' 41' ' ' ARG . 7.6 mt -80.26 154.1 74.45 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 1.4299999999999999 110.785 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.61 12.32 51.47 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.691 -1.379 . . . . 1.47 112.89 0.192 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -77.96 -82.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.402 . . . . 2.6600000000000001 110.632 179.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 123.8 143.2 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.864 -0.684 . . . . 1.6200000000000001 112.484 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 1.368 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 171.83 55.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.466 0.174 . . . . 3.0600000000000001 111.158 -179.847 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.582 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 14.1 m95 -36.97 107.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.378 -0.374 . . . . 1.0600000000000001 111.725 -179.994 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 136.89 28.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.049 0.452 . . . . 1.8400000000000001 111.065 179.976 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.22 104.33 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 1.77 111.173 -179.921 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.01 87.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.037 0.446 . . . . 1.4099999999999999 110.259 179.557 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.492 ' OD1' ' CE2' ' A' ' 61' ' ' PHE . 1.9 t30 -68.35 116.98 9.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.788 -0.642 . . . . 2.0099999999999998 110.189 179.639 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -114.31 46.69 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 2.6400000000000001 111.117 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 t -150.12 -83.91 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.409 -0.36 . . . . 2.0299999999999998 110.962 -179.958 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.78 147.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 1.8700000000000001 110.777 -179.961 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.499 HG12 ' CD2' ' A' ' 61' ' ' PHE . 14.3 mt -142.0 75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 1.3700000000000001 111.31 -179.827 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.76 -53.06 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 2.1499999999999999 110.718 179.835 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -80.29 161.58 25.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.127 179.684 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 45.2 p-10 -81.45 6.08 15.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 1.75 111.918 -179.756 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -106.58 104.31 13.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.591 -0.522 . . . . 2.0499999999999998 109.591 179.413 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 62' ' ' THR . 63.9 t80 -137.77 163.81 30.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.56999999999999995 112.184 -179.255 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 65.5 m -122.2 107.15 11.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.628 -0.715 . . . . 1.1399999999999999 111.358 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 18' ' ' VAL . 2.2 m -72.05 94.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.759 -0.655 . . . . 1.72 110.436 179.57 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -100.44 155.62 17.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.589 0.709 . . . . 1.6399999999999999 111.068 179.989 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.0 22.67 3.81 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.664 -1.153 . . . . 0.95999999999999996 112.314 179.793 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -172.49 4.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.898 0.38 . . . . 2.02 110.932 -179.753 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -148.28 116.11 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 1.55 110.654 179.998 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' OE2' ' CG1' ' A' ' 101' ' ' VAL . 1.7 tt0 -41.53 137.86 1.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.096 -0.502 . . . . 1.9099999999999999 111.563 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t70 75.69 47.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 1.8700000000000001 111.085 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.6 121.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 1.2 110.983 179.778 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -72.0 127.42 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 1.1100000000000001 111.086 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 55.3 m-85 -124.35 127.28 47.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.503 -0.771 . . . . 1.0800000000000001 112.307 -179.225 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.473 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 3.1 tp10 -99.8 147.41 25.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.036 -0.727 . . . . 1.5 109.036 178.812 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 72' ' ' TYR . 15.0 m-85 -137.18 116.95 13.07 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.969 1.47 . . . . 0.79000000000000004 114.969 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.582 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -107.43 171.05 7.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.963 -0.755 . . . . 2.6899999999999999 108.963 177.587 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.454 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 77.0 t -126.24 108.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.951 0.723 . . . . 1.5700000000000001 112.951 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 88' ' ' PRO . 31.4 mt -102.83 139.19 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.528 -1.286 . . . . 1.3200000000000001 107.528 177.946 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -153.76 129.75 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.64 -0.824 . . . . 1.1100000000000001 112.064 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 40.8 mttt -78.75 -178.22 5.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 2.3500000000000001 110.486 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.481 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 3.5 m-80 -129.02 172.58 11.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.003 -0.544 . . . . 2.7000000000000002 110.812 179.839 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -44.1 -28.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.719 -0.673 . . . . 1.3400000000000001 111.785 179.658 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.14 34.77 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.136 0.421 . . . . 1.4299999999999999 112.136 -179.439 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 42.68 37.81 2.87 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.67 -0.776 . . . . 1.3799999999999999 113.02 179.611 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.01 8.24 8.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.287 0.477 . . . . 1.49 112.287 -179.956 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 35.7 97.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 113.496 0.924 . . . . 1.48 113.496 179.738 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -75.73 116.64 57.13 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.53 -0.915 . . . . 0.81000000000000005 108.53 178.461 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -35.16 158.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.405 2.737 . . . . 1.25 113.39 -178.843 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HG3' ' CD1' ' A' ' 77' ' ' ILE . 12.6 Cg_exo -68.06 142.77 57.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.627 2.218 . . . . 1.2 112.23 179.871 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLU . 50.5 m -92.25 118.64 31.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.958 -0.565 . . . . 1.76 110.125 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 42.5 mt-10 -19.66 104.94 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.021 0.929 . . . . 1.77 113.151 -179.461 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 55.5 Cg_exo -39.98 161.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.608 2.205 . . . . 1.01 113.246 -179.471 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.431 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -97.04 143.51 27.81 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.501 -0.772 . . . . 1.55 109.339 179.175 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' O ' HD13 ' A' ' 95' ' ' ILE . 2.6 m-20 -35.31 129.01 0.54 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.027 0.83 . . . . 1.6299999999999999 112.077 -179.286 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -50.19 133.06 23.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 1.0900000000000001 111.397 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.497 HD11 ' CE2' ' A' ' 74' ' ' PHE . 3.2 mp -113.24 106.76 21.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 1.1299999999999999 111.686 -179.789 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.7 m -52.54 -23.02 5.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.233 -0.44 . . . . 1.1299999999999999 110.841 179.688 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 60.29 38.35 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.5700000000000001 110.235 -179.834 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -132.97 -38.42 0.98 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 3.7000000000000002 111.946 -179.635 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 3.9 p-10 -49.0 -26.27 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 2.1400000000000001 111.624 -179.405 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -8.07 55.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.115 -0.493 . . . . 2.0600000000000001 111.531 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 98' ' ' ARG . 11.8 p -124.67 4.96 4.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.852 -0.613 . . . . 3.0800000000000001 109.873 179.026 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -149.49 -80.34 0.13 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.919 0.39 . . . . 4.5800000000000001 111.029 -179.999 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.276 -0.869 . . . . 3.79 111.059 -179.991 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 1' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.729 0.299 . . . . 3.1699999999999999 111.27 . . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.474 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 86.7 Cg_endo -78.25 -26.11 6.53 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.637 2.225 . . . . 2.0600000000000001 112.463 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.486 HG22 HD11 ' A' ' 2' ' ' ILE . 5.2 tt 52.61 146.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 124.019 0.824 . . . . 1.26 112.439 -179.775 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.981 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -141.93 123.59 8.91 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.43 -179.962 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.08 166.92 28.43 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.321 2.014 . . . . 0.58999999999999997 112.256 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.2 Cg_exo -52.24 173.96 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.667 2.245 . . . . 1.6100000000000001 112.749 -179.626 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.56 39.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.071 -0.585 . . . . 0.97999999999999998 112.78 -179.831 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -65.44 118.12 47.44 Favored Pre-proline 0 CA--C 1.532 0.254 0 O-C-N 123.043 -0.092 . . . . 2.04 110.772 179.879 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 15.5 Cg_exo -69.77 127.94 15.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.418 2.079 . . . . 0.54000000000000004 112.731 -179.68 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 8.4 p -131.96 113.6 14.97 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.74 -0.664 . . . . 1.6799999999999999 111.405 -179.491 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 71.5 Cg_exo -47.32 112.1 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.52 2.146 . . . . 0.64000000000000001 113.193 -179.61 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -74.12 -35.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.736 -0.838 . . . . 2.1699999999999999 108.736 179.174 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 3.9 t30 -143.91 153.29 42.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.486 -1.234 . . . . 0.84999999999999998 107.718 178.621 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.424 ' CG2' HG12 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -142.93 141.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.809 -0.756 . . . . 1.5700000000000001 113.019 -178.793 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.94 136.44 33.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.21 -0.904 . . . . 1.46 109.863 179.263 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -42.68 -24.83 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.005 0.743 . . . . 2.9100000000000001 113.005 -179.023 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -118.11 -12.98 9.96 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.744 -0.598 . . . . 1.3300000000000001 112.517 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -153.46 125.6 7.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.246 -0.279 . . . . 1.28 110.246 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.555 ' CG2' ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -118.64 145.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 1.49 111.81 -179.809 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 12' ' ' ASN . 9.0 m -111.36 127.72 55.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.04 -0.527 . . . . 1.1399999999999999 111.072 -179.745 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.06 139.27 52.09 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.865 0.841 . . . . 1.3100000000000001 111.355 178.769 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HG3' ' N ' ' A' ' 22' ' ' TRP . 15.6 tptp -121.67 155.49 35.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.124 -1.398 . . . . 2.3100000000000001 108.973 179.632 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.6 p90 -152.55 -174.48 4.92 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.213 -0.595 . . . . 0.40000000000000002 111.966 -179.729 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.77 168.2 10.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.052 -0.522 . . . . 1.1100000000000001 112.046 -179.389 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -97.76 141.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.775 -0.648 . . . . 2.5600000000000001 110.434 179.888 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' CB ' ' CG2' ' A' ' 28' ' ' THR . 88.8 Cg_exo -47.38 176.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.346 2.031 . . . . 1.1100000000000001 112.246 179.958 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -121.18 -29.54 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.418 -0.355 . . . . 2.77 111.799 -179.7 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 10.8 t80 -113.77 -71.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.986 0.365 . . . . 1.6899999999999999 111.986 -179.376 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.981 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 47.7 p 50.48 43.92 27.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 1.3500000000000001 110.985 -179.593 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.18 -91.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.814 -0.707 . . . . 1.01 112.49 179.89 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.27 32.6 1.04 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.637 -0.985 . . . . 0.97999999999999998 110.637 179.561 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.471 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -112.08 175.14 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.007 -0.596 . . . . 0.98999999999999999 111.147 -179.076 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 18.1 ttpt -126.17 -17.71 5.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.061 -0.518 . . . . 2.6899999999999999 112.015 -179.799 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 33' ' ' ILE . 35.9 mt 70.84 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.685 0.279 . . . . 1.71 110.713 -179.589 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -126.77 25.46 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 1.6599999999999999 111.671 -179.619 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.6 t -178.75 127.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 1.97 111.259 179.903 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.432 ' CE1' HG23 ' A' ' 33' ' ' ILE . 5.5 m-85 -114.36 95.46 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 1.23 111.172 -179.916 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mt -87.32 112.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 1.76 111.003 -179.972 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 p -102.58 116.68 46.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 1.6100000000000001 111.103 -179.69 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -81.12 154.92 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 1.6699999999999999 109.857 179.502 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttt -127.94 146.57 50.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.187 0.518 . . . . 2.4399999999999999 111.494 -179.759 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 10.3 ttp180 -116.08 108.19 15.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 1.79 110.045 179.472 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.826 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.97 87.3 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.881 -0.6 . . . . 1.5900000000000001 110.54 -179.836 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD13 ' CB ' ' A' ' 94' ' ' ALA . 33.1 mt -65.07 153.95 87.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 1.4299999999999999 110.879 -179.88 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.62 24.49 20.2 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.846 -1.314 . . . . 1.47 112.976 0.386 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -154.8 70.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.781 0.324 . . . . 2.6600000000000001 111.592 -179.936 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.41 -161.59 35.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.676 -0.773 . . . . 1.6200000000000001 112.019 179.606 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.406 ' HD3' HD21 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -160.03 26.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.296 . . . . 3.0600000000000001 111.166 -179.991 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 38.5 m95 42.71 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.205 -0.452 . . . . 1.0600000000000001 111.544 179.828 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -132.27 130.41 40.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 1.8400000000000001 111.202 -179.961 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -54.96 88.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 1.77 110.787 179.989 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.427 ' CB ' HG12 ' A' ' 63' ' ' VAL . . . -52.5 -54.59 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 1.4099999999999999 110.907 179.979 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 5.4 p-10 -62.47 128.81 37.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 2.0099999999999998 110.814 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.71 -2.36 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 2.6400000000000001 111.714 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -168.8 1.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.815 0.341 . . . . 2.0299999999999998 110.941 179.939 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.77 115.97 26.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 1.8700000000000001 111.18 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.508 HG12 ' CD1' ' A' ' 61' ' ' PHE . 54.5 mt -99.27 60.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 1.3700000000000001 110.59 179.711 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -43.38 -64.48 0.63 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.242 -0.435 . . . . 2.1499999999999999 111.648 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -72.57 171.52 12.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 1.54 110.533 179.847 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -89.49 11.76 18.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.75 111.412 179.978 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -110.66 100.07 8.91 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 110.099 -0.334 . . . . 2.0499999999999998 110.099 179.446 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CD1' HG12 ' A' ' 56' ' ' ILE . 61.3 t80 -131.66 164.75 25.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.139 0.495 . . . . 0.56999999999999995 111.715 -179.465 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 2.1 m -124.76 123.46 40.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.657 -0.702 . . . . 1.1399999999999999 110.744 179.631 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' CB ' ' A' ' 51' ' ' ALA . 16.5 t -83.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.171 0.51 . . . . 1.72 111.189 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 134.98 36.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 1.6399999999999999 110.701 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.09 -16.28 4.45 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.552 -0.749 . . . . 0.95999999999999996 111.469 -179.295 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' CD2' ' CG1' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -51.38 172.16 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.805 0.335 . . . . 2.02 110.649 179.656 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.4 m -137.27 152.8 50.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.184 -0.462 . . . . 1.55 111.057 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 2.5 tt0 -61.1 155.49 20.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.9099999999999999 111.197 179.943 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 97' ' ' CYS . 60.2 m-20 47.36 60.62 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 1.8700000000000001 111.55 179.952 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.34 116.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.688 0.28 . . . . 1.2 111.375 179.646 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 43' ' ' LEU . . . -71.66 125.4 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.677 -0.49 . . . . 1.1100000000000001 109.677 179.234 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 44.1 m-85 -117.28 124.37 48.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.066 0.765 . . . . 1.0800000000000001 113.066 -178.869 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.46 135.1 44.68 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.496 -0.928 . . . . 1.5 108.496 178.208 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.555 ' CZ ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.46 111.28 12.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.082 1.142 . . . . 0.79000000000000004 114.082 -178.337 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.7 ptp180 -91.27 146.67 23.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 2.6899999999999999 109.694 178.471 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 98.7 t -106.13 110.09 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.919 0.711 . . . . 1.5700000000000001 112.919 -179.297 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 85.0 mt -106.59 154.54 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.805 -1.183 . . . . 1.3200000000000001 107.805 177.991 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -167.63 120.87 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.203 -0.999 . . . . 1.1100000000000001 113.145 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.8 ptpt -72.41 156.94 38.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.556 -0.535 . . . . 2.3500000000000001 109.556 178.795 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' ND2' ' CD1' ' A' ' 2' ' ' ILE . 2.6 m-80 -100.86 170.87 8.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.533 0.682 . . . . 2.7000000000000002 112.406 -178.842 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -39.2 -58.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 1.3400000000000001 112.112 179.716 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.4 ' HB1' ' CE1' ' A' ' 31' ' ' PHE . . . -61.51 -12.94 17.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 1.4299999999999999 112.296 -179.686 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 -14.61 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.536 -0.84 . . . . 1.3799999999999999 112.176 -179.733 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.46 155.96 1.38 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 110.171 -0.307 . . . . 1.49 110.171 179.709 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -107.71 117.37 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.29 0.478 . . . . 1.48 112.29 -179.399 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.0 p -79.88 111.43 21.58 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.667 -0.697 . . . . 0.81000000000000005 109.581 179.051 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.74 160.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.004 2.469 . . . . 1.25 112.932 -179.782 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 41.0 Cg_endo -68.77 134.79 31.08 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.675 2.25 . . . . 1.2 112.853 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 90' ' ' GLU . 19.8 m -90.84 111.07 22.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 1.76 109.919 179.28 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -4.12 108.33 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.717 1.207 . . . . 1.77 113.573 -179.677 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 84.3 Cg_exo -41.8 131.31 4.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.677 2.251 . . . . 1.01 113.712 -179.711 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.412 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.21 148.21 48.76 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.884 -0.598 . . . . 1.55 109.468 178.959 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -33.07 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.386 1.054 . . . . 1.6299999999999999 112.409 -179.999 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.454 ' CB ' HD13 ' A' ' 43' ' ' LEU . . . -77.46 106.61 9.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 1.0900000000000001 110.372 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 74' ' ' PHE . 5.0 mp -85.69 108.66 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.743 0.306 . . . . 1.1299999999999999 110.571 -179.923 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.9 m -42.53 -40.07 2.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.959 0.409 . . . . 1.1299999999999999 111.027 179.956 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 69' ' ' ASP . 94.0 m 60.84 75.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.5700000000000001 111.415 179.31 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -108.88 -79.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 3.7000000000000002 110.109 179.605 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.287 ' CG ' HG21 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -126.03 0.22 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.703 -0.681 . . . . 2.1400000000000001 111.314 179.471 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.63 17.97 1.34 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.676 0.621 . . . . 2.0600000000000001 112.676 179.629 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.287 HG21 ' CG ' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -129.85 -0.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 111.624 0.231 . . . . 3.0800000000000001 111.624 179.556 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -122.29 -14.97 7.79 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.04 0.385 . . . . 4.5800000000000001 112.04 -179.514 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 3.79 111.135 -179.904 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.431 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.574 0.226 . . . . 3.1699999999999999 111.319 . . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 7.8 Cg_exo -73.24 138.83 28.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.703 2.268 . . . . 2.0600000000000001 111.244 179.78 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.441 HG12 ' N ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -129.38 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.01 0.433 . . . . 1.26 111.854 -179.443 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 4.2 m-20 -134.56 127.24 18.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.0 110.127 179.69 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 86' ' ' SER . 74.5 Cg_endo -73.26 163.08 38.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.239 1.959 . . . . 0.58999999999999997 112.444 -179.714 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 37.0 Cg_exo -57.8 178.19 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.779 2.319 . . . . 1.6100000000000001 112.782 -179.732 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.89 174.56 43.02 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.913 -0.66 . . . . 0.97999999999999998 112.819 -179.988 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 130.66 91.78 Favored Pre-proline 0 N--CA 1.462 0.152 0 CA-C-N 116.64 0.22 . . . . 2.04 110.415 179.813 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.0 Cg_exo -72.7 138.37 29.02 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.386 2.057 . . . . 0.54000000000000004 113.124 -179.287 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 p -140.93 116.74 7.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.819 -0.628 . . . . 1.6799999999999999 110.534 179.535 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.7 Cg_exo -58.91 138.36 85.21 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.546 2.164 . . . . 0.64000000000000001 113.973 -179.207 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -104.17 -33.13 8.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.525 -0.761 . . . . 2.1699999999999999 109.064 178.649 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.23 153.29 41.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.051 -0.977 . . . . 0.84999999999999998 109.498 179.557 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 13' ' ' ILE . 0.8 OUTLIER -148.62 108.68 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.124 0.487 . . . . 1.5700000000000001 111.929 -179.549 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 1.092 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -105.41 53.04 0.72 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.679 -0.691 . . . . 1.46 111.212 -179.924 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 1.084 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.26 -73.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.98 0.8 . . . . 2.9100000000000001 112.548 179.239 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' THR . 9.0 m-70 -70.64 -29.49 65.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.269 -0.423 . . . . 1.3300000000000001 111.598 -179.349 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -128.78 126.2 39.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.759 0.314 . . . . 1.28 111.332 -179.815 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 74' ' ' PHE . 87.4 t -113.06 128.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 1.49 110.802 179.836 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.2 m -102.41 124.1 47.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 1.1399999999999999 111.461 -179.392 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.14 162.09 34.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.535 0.683 . . . . 1.3100000000000001 111.585 179.384 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.35 151.64 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.97 -1.014 . . . . 2.3100000000000001 110.536 -179.635 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 11.1 p90 -136.88 -173.58 3.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.022 0.439 . . . . 0.40000000000000002 111.463 -179.948 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.91 173.52 8.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 1.1100000000000001 111.088 179.922 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -100.47 149.54 36.18 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.451 -0.34 . . . . 2.5600000000000001 110.631 179.857 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 9.6 Cg_endo -53.12 -162.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.938 2.426 . . . . 1.1100000000000001 113.036 -179.652 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -146.37 -48.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.77 111.139 -179.67 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.413 ' O ' ' OG1' ' A' ' 28' ' ' THR . 6.2 t80 -95.03 -72.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.479 -0.328 . . . . 1.6899999999999999 111.35 -179.846 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 27' ' ' TYR . 13.6 p 69.39 -45.14 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.055 0.761 . . . . 1.3500000000000001 113.055 -179.7 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.57 -22.32 10.16 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.269 -0.967 . . . . 1.01 112.302 -179.889 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.74 -26.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.496 -1.442 . . . . 0.97999999999999998 109.496 -179.241 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 8.8 m-85 -60.9 -175.31 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.275 -0.963 . . . . 0.98999999999999999 110.366 179.13 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 24.33 0.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.136 -0.484 . . . . 2.6899999999999999 111.098 179.584 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG23 ' CE1' ' A' ' 36' ' ' TYR . 7.0 mt 42.97 98.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.136 0.493 . . . . 1.71 112.195 179.845 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 p -94.59 14.13 21.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 1.6599999999999999 111.282 179.755 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.7 t 176.68 122.86 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.797 0.332 . . . . 1.97 111.568 -179.939 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 33' ' ' ILE . 1.4 m-85 -106.86 117.28 33.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 1.23 110.226 179.502 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' OD1' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -97.28 135.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.654 -0.248 . . . . 1.76 110.959 -179.624 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 t -112.99 113.49 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.755 0.312 . . . . 1.6100000000000001 111.249 179.84 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -87.57 127.52 35.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 1.6699999999999999 110.158 179.474 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.441 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 3.9 pttm -106.56 147.31 29.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 2.4399999999999999 111.724 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.478 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.3 ttp180 -129.13 117.48 20.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.59 -0.732 . . . . 1.79 110.428 179.455 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.936 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.77 123.92 25.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 1.5900000000000001 110.178 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.479 ' CD1' ' CB ' ' A' ' 94' ' ' ALA . 4.2 mt -113.99 150.23 43.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 1.4299999999999999 111.479 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 8.8 Cg_endo -88.71 33.01 7.61 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.994 -1.253 . . . . 1.47 112.499 0.308 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.419 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 m-80 -154.17 98.82 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 2.6600000000000001 110.852 -179.989 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.936 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . 177.28 -168.69 40.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.752 . . . . 1.6200000000000001 112.179 -179.953 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.34 166.19 32.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.442 . . . . 3.0600000000000001 111.37 179.877 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 73.2 m95 -68.47 120.12 14.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.574 -0.739 . . . . 1.0600000000000001 111.894 -179.536 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -143.38 129.39 19.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 1.8400000000000001 110.585 179.79 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -50.54 92.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.77 110.805 -179.778 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -62.68 -52.76 62.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 1.4099999999999999 110.871 179.893 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 4.6 p-10 -59.22 157.01 11.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.801 -0.636 . . . . 2.0099999999999998 111.261 -179.891 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -165.52 28.81 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.702 -0.681 . . . . 2.6400000000000001 110.716 179.558 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 p -128.71 36.56 4.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.459 -0.337 . . . . 2.0299999999999998 111.234 -179.761 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.14 99.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.8700000000000001 110.896 179.962 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 61' ' ' PHE . 15.8 mt -90.63 93.7 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.503 . . . . 1.3700000000000001 111.467 -179.842 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.83 -55.09 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 2.1499999999999999 111.197 -179.974 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.05 173.11 12.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 1.54 110.511 179.871 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 35.1 p30 -84.66 -2.12 57.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.75 111.502 179.98 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -104.17 102.07 11.8 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.162 -0.31 . . . . 2.0499999999999998 110.162 179.741 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 52' ' ' ASN . 44.8 t80 -135.22 164.85 26.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.286 -0.415 . . . . 0.56999999999999995 111.329 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 93.1 m -121.04 114.09 20.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.978 -0.556 . . . . 1.1399999999999999 111.529 -179.925 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' A' ' 74' ' ' PHE . 6.8 m -76.72 91.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.723 -0.671 . . . . 1.72 111.424 179.752 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 p -93.01 178.73 5.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 1.6399999999999999 110.896 179.932 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.9 10.89 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.806 -0.712 . . . . 0.95999999999999996 112.478 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.3 mt -104.58 -161.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 2.02 111.168 -179.837 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -141.15 146.85 37.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.044 -0.525 . . . . 1.55 111.159 -179.892 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.14 149.19 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 1.9099999999999999 110.916 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.36 43.97 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 1.8700000000000001 110.733 -179.977 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -162.96 125.01 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 1.2 111.439 -179.833 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.4 137.24 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 1.1100000000000001 110.256 179.521 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -132.3 119.4 20.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.598 0.592 . . . . 1.0800000000000001 112.598 -179.198 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -98.41 147.31 24.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.602 -0.888 . . . . 1.5 108.602 178.531 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.74 115.48 11.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.648 1.351 . . . . 0.79000000000000004 114.648 -178.632 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.473 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 ptt85 -104.84 167.95 9.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.6 -0.889 . . . . 2.6899999999999999 108.6 177.674 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -134.28 129.8 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 119.472 -0.891 . . . . 1.5700000000000001 113.386 -179.654 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.46 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 76.5 mt -118.63 151.89 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.376 -1.284 . . . . 1.3200000000000001 108.045 178.366 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -158.09 130.83 7.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.646 -0.822 . . . . 1.1100000000000001 112.676 -179.543 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.18 63.88 8.26 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.566 0.698 . . . . 2.3500000000000001 109.537 178.831 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.488 ' HB3' ' CB ' ' A' ' 31' ' ' PHE . 4.3 m-20 9.22 -104.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.302 -1.772 . . . . 2.7000000000000002 114.201 -179.949 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.446 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.57 -44.68 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 122.014 -0.429 . . . . 1.3400000000000001 111.859 -179.66 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.82 45.07 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.068 0.396 . . . . 1.4299999999999999 112.068 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.41 1.35 60.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.378 -0.915 . . . . 1.3799999999999999 113.276 179.622 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.431 ' CB ' HD13 ' A' ' 2' ' ' ILE . . . -63.06 88.05 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.675 -0.491 . . . . 1.49 109.675 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -59.35 112.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.399 0.618 . . . . 1.48 112.516 -178.824 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 49.5 p -85.55 111.7 39.01 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.941 -1.027 . . . . 0.81000000000000005 108.973 178.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -38.32 157.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.9 2.4 . . . . 1.25 112.879 -179.053 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 18.4 Cg_endo -60.66 132.06 40.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.803 2.335 . . . . 1.2 113.081 -179.709 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -89.02 108.27 19.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.411 -0.813 . . . . 1.76 109.498 179.155 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -6.24 120.93 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.803 1.314 . . . . 1.77 113.674 -179.492 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 50.4 Cg_exo -54.58 143.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.383 2.056 . . . . 1.01 113.307 -179.695 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.75 146.77 35.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.048 -0.723 . . . . 1.55 109.048 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -33.41 131.23 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.175 0.922 . . . . 1.6299999999999999 112.238 -179.849 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -70.67 116.53 11.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 1.0900000000000001 111.232 -179.843 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 13' ' ' ILE . 4.9 mp -99.86 120.15 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.822 0.344 . . . . 1.1299999999999999 111.16 179.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.5 m -46.99 -36.51 7.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 1.1299999999999999 111.127 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 92.8 m 60.39 88.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.5700000000000001 110.498 179.932 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 -81.94 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 3.7000000000000002 110.953 -179.678 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.406 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -108.25 5.99 26.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.825 -0.625 . . . . 2.1400000000000001 111.325 179.751 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 1.092 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.4 OUTLIER 44.39 27.91 0.26 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.23 0.538 . . . . 2.0600000000000001 112.225 179.943 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 1.204 HG11 ' OD1' ' A' ' 99' ' ' ASP . 11.8 p -168.9 30.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.492 -0.776 . . . . 3.0800000000000001 110.338 179.583 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 1.406 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -119.7 -32.14 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 4.5800000000000001 111.259 -179.794 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.232 -0.889 . . . . 3.79 111.199 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.736 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.7 tt . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.845 0.355 . . . . 0.68 110.982 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.17 120.11 25.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 2.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 159.24 54.07 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.141 1.894 . . . . 0.5 111.696 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.8 Cg_endo -52.43 172.93 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.71 112.502 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 164.8 52.63 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.999 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.91 123.92 61.78 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.463 -0.199 . . . . 1.52 110.463 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.589 ' CG ' HG23 ' A' ' 76' ' ' VAL . 21.7 Cg_exo -67.3 133.89 31.87 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.345 2.03 . . . . 0.44 112.713 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.3 p -131.47 117.54 16.66 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.006 -0.543 . . . . 1.09 110.794 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.9 Cg_exo -67.66 125.99 14.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.464 2.109 . . . . 0.64 113.801 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.22 -31.84 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -142.48 145.82 34.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.075 -0.966 . . . . 0.72 109.48 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 96.36 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.166 0.508 . . . . 0.96 111.573 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.54 156.58 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 1.46 110.814 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -50.67 -22.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 2.42 112.043 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -139.06 12.18 2.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.254 0.464 . . . . 1.02 112.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.85 106.32 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.68 111.326 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 13' ' ' ILE . 96.0 t -100.59 117.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 0.8 110.629 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.699 ' C ' HD13 ' A' ' 20' ' ' LEU . 18.1 m -98.33 125.05 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.802 -0.636 . . . . 0.35 111.632 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.47 154.75 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.821 0.82 . . . . 0.52 112.163 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.61 164.39 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.369 -1.287 . . . . 1.84 109.11 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 7.0 p90 -141.98 -175.14 4.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.165 0.507 . . . . 0.4 112.117 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.94 128.38 47.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.83 110.895 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -59.46 146.68 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 2.11 110.815 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.542 ' HG2' HD12 ' A' ' 33' ' ' ILE . 53.4 Cg_exo -52.47 171.39 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.89 112.682 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.67 -18.49 6.57 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 2.77 112.137 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -127.17 -71.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 121.003 -0.279 . . . . 1.37 111.581 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.4 p 55.88 47.37 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.91 110.987 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.14 0.01 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.889 -0.672 . . . . 1.01 112.515 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.19 38.03 1.2 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 109.796 -1.322 . . . . 0.98 109.796 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -126.29 -179.53 4.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.685 -0.758 . . . . 0.87 111.033 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -133.66 -1.07 3.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.302 0.482 . . . . 2.26 112.302 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 25' ' ' PRO . 19.9 mt 61.98 132.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.785 0.326 . . . . 1.71 110.952 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.429 HG22 ' HD2' ' A' ' 32' ' ' LYS . 4.1 p -128.63 39.75 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.15 111.193 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.9 t 172.29 134.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 1.58 110.658 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -122.94 83.82 2.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.76 111.313 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.469 HG23 HD21 ' A' ' 52' ' ' ASN . 0.8 OUTLIER -74.56 162.7 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 1.14 110.417 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -150.75 126.51 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.63 110.474 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' HD12 ' A' ' 77' ' ' ILE . 3.7 mt-10 -93.62 137.67 32.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 1.67 110.949 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -107.06 141.54 38.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.889 -0.596 . . . . 1.97 110.839 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -110.97 116.66 31.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.44 110.69 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -84.67 87.39 7.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.809 -0.632 . . . . 1.59 110.025 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 4.3 mt -75.33 154.42 86.05 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.084 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -89.33 34.02 7.12 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.862 -1.308 . . . . 1.43 113.044 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -155.02 64.06 0.64 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.303 . . . . 2.66 111.288 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.01 -163.2 22.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.887 -0.673 . . . . 1.12 112.446 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -170.86 30.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.677 0.251 . . . . 2.41 111.677 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.553 ' CE3' ' CD ' ' A' ' 75' ' ' ARG . 48.8 m95 52.49 109.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.925 0.342 . . . . 0.65 111.925 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.706 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -137.7 117.38 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.28 111.244 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -53.31 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 1.3 110.874 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -65.78 -55.11 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.193 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 p-10 -50.84 149.02 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 2.01 111.215 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.36 24.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 2.08 110.786 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 m -122.52 25.7 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 1.89 111.153 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.36 106.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 1.87 110.648 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 73.3 mt -97.28 84.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.474 . . . . 0.69 110.774 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.9 -40.1 65.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 1.6 111.563 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 139.92 30.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.527 -0.306 . . . . 1.54 110.225 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 27.5 p-10 -72.63 62.64 0.56 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.248 0.547 . . . . 1.75 111.19 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE2' ' CB ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -166.81 91.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 2.05 108.872 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.0 t80 -126.95 165.13 19.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.176 0.512 . . . . 0.48 111.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.671 HG23 ' OG1' ' A' ' 19' ' ' THR . 4.2 m -123.93 121.14 34.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.505 -0.771 . . . . 0.42 110.76 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.0 t -86.35 105.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.19 0.519 . . . . 1.08 111.43 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 p -99.18 -157.17 0.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 1.33 110.73 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.65 17.75 42.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.9 112.42 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' CD1' HG23 ' A' ' 18' ' ' VAL . 17.7 mt -81.68 -163.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.36 . . . . 1.47 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -144.52 154.82 43.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.996 -0.547 . . . . 1.06 110.567 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 157.96 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 1.91 110.765 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t0 51.87 50.3 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 1.87 110.746 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -156.83 124.58 5.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.49 111.245 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.72 124.39 26.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.391 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 58.8 m-85 -123.96 129.57 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.078 0.466 . . . . 0.56 111.897 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 7.6 tt0 -104.15 150.18 24.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.956 -0.757 . . . . 1.5 108.956 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.844 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -141.21 119.65 12.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.893 1.442 . . . . 0.6 114.893 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -106.41 161.74 14.31 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.223 -0.658 . . . . 2.11 109.223 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' CG ' ' A' ' 8' ' ' PRO . 85.0 t -117.21 109.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.054 -0.658 . . . . 0.6 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 87.0 mt -97.15 139.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.619 -1.252 . . . . 0.7 107.619 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -155.05 140.68 17.97 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.572 -0.851 . . . . 0.6 112.691 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 mttt -86.53 -174.63 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.449 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.736 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.6 p30 -130.36 162.66 28.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 2.19 110.761 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.18 -26.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.08 112.22 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.93 -18.68 42.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.554 0.576 . . . . 1.06 112.554 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.27 -20.43 25.78 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.407 -0.901 . . . . 0.93 112.033 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.68 166.68 0.64 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.828 -0.434 . . . . 1.38 109.828 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -117.56 103.39 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.563 0.579 . . . . 0.79 112.563 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 1.2 p -63.03 122.46 75.26 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 108.962 -0.755 . . . . 0.59 108.962 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.9 Cg_endo -42.54 162.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.016 2.477 . . . . 0.85 113.098 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 33.6 Cg_endo -64.1 135.62 48.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.826 2.351 . . . . 0.76 112.747 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -78.35 124.84 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.91 -0.586 . . . . 1.28 109.555 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 4.6 mt-10 -24.85 99.59 0.08 OUTLIER Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 123.732 0.813 . . . . 1.77 113.074 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 93.7 Cg_exo -32.35 154.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.425 2.75 . . . . 0.55 114.02 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -94.07 143.85 26.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.419 -0.809 . . . . 1.23 109.388 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 58.3 m-20 -34.27 138.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.217 0.948 . . . . 1.63 111.916 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 43' ' ' LEU . . . -75.16 117.51 17.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.41 111.339 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.742 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.1 mp -102.58 122.88 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.241 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.6 m -51.51 -25.03 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 0.44 111.248 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.742 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.7 m 57.75 49.06 12.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 1.1 110.204 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -146.82 -39.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.693 -0.685 . . . . 3.0 111.603 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -46.21 -26.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 2.14 111.73 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 2.06 111.92 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.889 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.944 0.402 . . . . 0.68 111.002 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.1 t0 -128.65 128.44 23.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.333 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 66.6 Cg_endo -71.22 157.33 57.49 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.317 2.011 . . . . 0.5 112.633 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 51.0 Cg_exo -54.63 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.71 112.34 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.17 -153.9 5.85 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.954 -0.641 . . . . 0.66 112.753 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.7 ttpt -95.13 141.28 23.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.697 -0.112 . . . . 1.52 110.697 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.583 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.8 Cg_endo -86.79 143.89 7.25 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.071 2.514 . . . . 0.44 112.285 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -159.48 125.07 2.3 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.685 -0.234 . . . . 1.09 111.577 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.613 ' CG ' HD11 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -70.92 97.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.235 1.957 . . . . 0.64 112.714 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.7 mp -60.62 -30.4 69.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.228 0.537 . . . . 1.64 109.982 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -146.73 157.33 43.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.342 -0.844 . . . . 0.72 109.443 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -143.39 105.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.103 0.478 . . . . 0.96 111.415 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -91.62 47.71 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.74 -0.663 . . . . 1.46 111.652 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.51 -73.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.876 0.735 . . . . 2.42 112.07 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' THR . 16.0 m170 -81.35 -31.83 33.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 1.02 111.718 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -125.2 105.21 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.717 0.294 . . . . 0.68 110.832 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.92 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 6.6 m -92.02 156.22 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.44 -0.346 . . . . 0.8 110.713 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.6 m -123.76 113.03 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.708 -0.223 . . . . 0.35 111.594 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -127.06 149.31 49.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.52 111.265 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.309 ' CB ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -138.49 166.25 24.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.716 -1.129 . . . . 1.84 109.847 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.512 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 8.8 p90 -141.42 -122.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.372 -0.377 . . . . 0.4 110.852 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.53 136.47 10.53 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.499 0.59 . . . . 0.83 111.174 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -51.8 140.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.55 -0.295 . . . . 2.11 110.631 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.672 ' HB2' HG23 ' A' ' 28' ' ' THR . 6.7 Cg_endo -48.93 -174.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.932 2.422 . . . . 0.89 112.473 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -120.88 -34.08 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -115.78 -69.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.317 0.488 . . . . 1.37 112.317 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 25' ' ' PRO . 32.2 p 53.65 30.16 10.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.91 110.068 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.96 -101.39 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.643 -0.789 . . . . 1.01 111.928 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.41 30.96 2.73 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.633 -0.987 . . . . 0.98 110.633 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -110.9 -171.62 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.065 -0.567 . . . . 0.87 111.541 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -139.94 21.8 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.769 -0.651 . . . . 2.26 111.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.061 HG21 ' CE1' ' A' ' 36' ' ' TYR . 15.8 mm 67.45 -69.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 1.71 110.878 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.612 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 75.97 9.66 3.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.945 -0.57 . . . . 1.15 112.402 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.5 t 168.16 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.765 0.317 . . . . 1.58 111.686 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.061 ' CE1' HG21 ' A' ' 33' ' ' ILE . 38.4 m-85 -120.26 95.09 4.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.76 110.554 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.4 mt -70.13 152.12 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.409 -0.36 . . . . 1.14 111.347 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.2 t -124.63 104.43 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.63 111.27 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 1.058 ' CD ' ' HB3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -76.43 115.44 16.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 1.67 110.168 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.469 ' HD3' ' CG1' ' A' ' 63' ' ' VAL . 5.5 mtmt -93.32 149.74 21.0 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.469 0.652 . . . . 1.97 112.484 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 8.2 ttm180 -135.02 86.18 2.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.92 -1.036 . . . . 1.44 108.969 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -64.69 87.94 0.06 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.62 -0.718 . . . . 1.59 109.703 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -67.95 146.56 98.31 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.976 -0.556 . . . . 0.9 111.517 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.89 39.43 4.52 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.854 -1.311 . . . . 1.43 112.34 0.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -144.72 43.02 1.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 2.66 111.597 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.03 -176.7 46.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.632 -0.794 . . . . 1.12 112.339 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -167.88 30.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.641 0.258 . . . . 2.41 111.167 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 1.058 ' HB3' ' CD ' ' A' ' 39' ' ' GLU . 24.5 m95 46.99 87.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.65 111.192 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.61 135.98 49.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.998 0.428 . . . . 1.28 111.487 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 15.9 ptmt -65.19 79.32 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 1.3 111.023 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -65.7 -43.82 88.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.555 . . . . 0.86 111.87 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.9 p-10 -42.02 -56.6 2.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.64 -0.255 . . . . 2.01 111.591 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER 75.21 -49.94 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.984 0.364 . . . . 2.08 111.984 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -173.7 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.954 0.407 . . . . 1.89 111.193 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.37 107.0 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.949 -0.569 . . . . 1.87 111.339 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 36' ' ' TYR . 29.4 mt -86.35 87.84 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.69 110.919 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.7 mt -74.23 -45.15 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 1.6 111.438 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.49 149.66 22.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.99 -0.374 . . . . 1.54 109.99 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.1 p30 -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 1.75 111.302 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.309 ' OE1' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tp10 -101.35 93.92 5.66 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.929 -0.767 . . . . 2.05 108.929 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 62' ' ' THR . 66.3 t80 -118.6 164.76 14.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.974 -0.557 . . . . 0.48 111.805 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 84.2 m -121.94 119.53 31.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.42 110.564 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 20' ' ' LEU . 57.8 t -80.76 125.61 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 1.08 111.724 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -119.8 163.33 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 1.33 110.558 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.18 57.72 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.9 112.138 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.811 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.0 mp -53.0 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.808 0.337 . . . . 1.47 110.313 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.9 m -143.77 152.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.41 . . . . 1.06 110.57 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -69.01 151.77 46.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 1.91 111.181 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.5 OUTLIER 54.7 51.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.149 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.77 122.6 3.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.49 111.332 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.86 134.76 47.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.383 -0.371 . . . . 0.36 110.335 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.9 m-85 -128.26 119.79 25.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.782 0.66 . . . . 0.56 112.782 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 91' ' ' PRO . 1.3 tt0 -106.38 136.63 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.261 -0.644 . . . . 1.5 109.261 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.77 119.39 19.21 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.414 1.264 . . . . 0.6 114.414 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -95.97 162.92 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 2.11 109.907 178.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 8' ' ' PRO . 61.8 t -113.95 128.56 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.243 0.544 . . . . 0.6 112.206 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.593 HD11 ' HG3' ' A' ' 88' ' ' PRO . 34.4 mt -130.74 141.42 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.578 -1.267 . . . . 0.7 107.578 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -157.09 127.28 6.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.81 -0.756 . . . . 0.6 112.763 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.6 mttt -75.64 -157.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.687 -0.405 . . . . 1.98 110.072 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.889 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.7 p30 -159.26 162.99 36.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 2.19 111.515 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -38.54 -43.79 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.323 -0.853 . . . . 1.08 112.816 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -66.14 -23.94 66.57 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.133 0.42 . . . . 1.06 112.133 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.9 -8.19 36.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.698 -0.763 . . . . 0.93 112.208 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.631 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -56.8 -164.23 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.667 0.234 . . . . 1.38 110.377 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.681 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -148.7 111.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.382 0.512 . . . . 0.79 112.382 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.6 p -70.84 110.73 7.71 Favored Pre-proline 0 C--O 1.235 0.337 0 N-CA-C 107.233 -1.395 . . . . 0.59 107.233 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.38 171.9 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.499 2.133 . . . . 0.85 113.816 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.593 ' HG3' HD11 ' A' ' 77' ' ' ILE . 76.5 Cg_exo -50.42 145.0 22.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.338 2.692 . . . . 0.76 113.594 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -125.19 102.42 7.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 1.28 110.729 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.0 mm-40 12.63 108.64 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.737 1.215 . . . . 1.77 113.881 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 51.6 Cg_exo -56.05 143.67 82.54 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.437 2.092 . . . . 0.55 113.272 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.473 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -70.55 139.26 51.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.874 -0.787 . . . . 1.23 108.874 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -37.14 133.9 0.61 Allowed 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 124.254 0.971 . . . . 1.63 111.517 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.85 118.56 8.54 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.41 111.144 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.893 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -98.11 111.15 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.677 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -49.36 -25.83 2.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.319 -0.4 . . . . 0.44 110.595 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.548 ' H ' HG22 ' A' ' 95' ' ' ILE . 99.6 m 49.02 81.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 1.1 110.845 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 -85.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.35 . . . . 3.0 110.593 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.58 17.83 21.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.039 -0.528 . . . . 2.14 110.879 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 3.7 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.061 0.458 . . . . 2.06 111.251 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 86' ' ' SER . 5.5 tt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 0.68 110.741 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.7 t70 -138.59 119.87 10.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.0 -0.545 . . . . 2.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.51 163.04 40.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.245 1.963 . . . . 0.5 112.014 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 40.5 Cg_exo -57.71 -169.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.701 2.268 . . . . 0.71 112.75 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.56 -177.19 50.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.87 -0.681 . . . . 0.66 112.685 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.9 tttt -73.35 133.65 80.56 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.277 0.085 . . . . 1.52 110.962 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.619 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.6 Cg_exo -76.81 130.61 11.61 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.688 2.259 . . . . 0.44 112.071 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.02 105.97 6.2 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.545 -0.298 . . . . 1.09 111.759 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.2 Cg_exo -44.28 131.31 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.206 1.937 . . . . 0.64 112.794 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.011 HD21 ' CB ' ' A' ' 21' ' ' LYS . 1.6 mt -90.27 -31.78 16.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.239 -1.023 . . . . 1.64 108.239 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -149.7 160.82 43.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 0.72 108.35 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.881 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.39 97.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.569 -0.453 . . . . 0.96 111.598 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -87.56 49.11 1.75 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.723 -0.671 . . . . 1.46 111.708 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.76 -74.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.874 0.734 . . . . 2.42 112.335 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.5 m-70 -72.2 -39.52 68.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.365 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 44.8 p -125.71 118.05 24.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.37 . . . . 0.68 110.163 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.01 HG13 HD12 ' A' ' 66' ' ' LEU . 5.9 m -107.61 135.96 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.442 0.639 . . . . 0.8 112.368 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.531 ' N ' HG23 ' A' ' 62' ' ' THR . 23.0 m -90.59 144.16 26.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.35 109.771 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.761 HD11 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.52 158.95 44.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.52 111.586 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.011 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -150.82 146.36 26.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.543 -0.753 . . . . 1.84 110.792 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.518 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.0 p90 -136.18 -176.24 4.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.4 111.064 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.7 155.9 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.83 110.973 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 150.83 80.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.11 110.699 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HG2' HD12 ' A' ' 33' ' ' ILE . 92.1 Cg_exo -43.94 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.969 2.446 . . . . 0.89 113.236 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -22.38 8.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.01 -0.541 . . . . 2.77 111.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.79 -65.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.059 0.392 . . . . 1.37 112.059 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 14.9 p 57.73 46.07 17.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.91 110.155 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.51 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.6 -0.809 . . . . 1.01 111.828 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.17 25.71 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.902 -0.879 . . . . 0.98 110.902 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -103.68 -176.88 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.87 111.641 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.54 1.0 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 2.26 111.792 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.669 HG21 ' CE1' ' A' ' 36' ' ' TYR . 22.9 mt 60.26 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.125 0.488 . . . . 1.71 110.952 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -140.34 23.69 2.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 1.15 111.711 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.33 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.741 0.645 . . . . 1.58 112.741 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 33' ' ' ILE . 24.0 m-85 -105.3 85.91 2.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.031 -0.729 . . . . 0.76 109.031 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.485 HG23 HD21 ' A' ' 52' ' ' ASN . 0.4 OUTLIER -80.98 120.87 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 1.14 111.266 -179.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -112.04 129.21 67.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.06 -0.518 . . . . 0.63 110.681 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -90.43 136.25 33.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.303 -0.408 . . . . 1.67 111.17 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 3.8 pttt -98.6 150.12 22.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.989 -0.55 . . . . 1.97 110.585 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 6.5 ttp180 -134.69 109.03 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.388 -0.369 . . . . 1.44 110.888 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -78.59 101.2 7.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 1.59 110.608 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 94' ' ' ALA . 3.8 mt -88.27 153.41 51.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.9 111.062 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.35 17.33 42.28 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.793 -1.336 . . . . 1.43 112.739 0.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -138.21 81.01 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.931 0.396 . . . . 2.66 111.189 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.91 -167.3 19.44 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.898 -0.668 . . . . 1.12 112.258 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.75 159.06 37.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 2.41 110.945 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.794 ' O ' HD22 ' A' ' 49' ' ' LEU . 64.8 m95 -65.01 122.17 16.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.793 -0.639 . . . . 0.65 111.166 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -150.68 140.63 21.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.439 . . . . 1.28 110.635 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -44.09 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.363 -0.38 . . . . 1.3 111.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 40' ' ' LYS . . . -70.81 -40.89 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.86 110.889 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.637 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.4 p-10 -68.8 -44.34 73.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.842 -0.617 . . . . 2.01 111.287 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 54.85 22.63 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 2.08 110.706 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -136.42 -157.01 0.75 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 1.89 110.724 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.92 88.55 2.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.746 0.308 . . . . 1.87 111.163 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.81 HD12 ' CD1' ' A' ' 61' ' ' PHE . 16.4 mm -70.39 63.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.69 110.731 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.86 -56.78 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 1.6 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.622 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -87.13 159.73 18.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 1.54 109.409 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.9 p30 -77.98 1.45 20.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.155 0.428 . . . . 1.75 112.155 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.43 95.18 6.31 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.902 -0.407 . . . . 2.05 109.902 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CD1' HD12 ' A' ' 56' ' ' ILE . 80.8 t80 -130.99 162.82 28.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.391 0.615 . . . . 0.48 111.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.69 HG23 ' C ' ' A' ' 18' ' ' VAL . 89.9 m -129.69 122.42 28.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.844 -1.071 . . . . 0.42 108.803 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 18' ' ' VAL . 33.5 m -80.18 108.97 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.204 0.526 . . . . 1.08 111.832 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -98.63 135.26 40.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.522 -0.763 . . . . 1.33 110.436 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.55 -8.44 7.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.586 -0.816 . . . . 0.9 112.681 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.01 HD12 HG13 ' A' ' 18' ' ' VAL . 33.6 mt -57.88 -162.29 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.847 0.323 . . . . 1.47 110.146 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -148.02 160.68 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.857 0.36 . . . . 1.06 111.222 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 tt0 -83.82 144.5 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 1.91 110.975 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' CYS . 23.8 t0 63.97 59.13 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 1.87 110.862 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.76 124.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.49 111.429 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.65 129.84 40.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.401 . . . . 0.36 110.31 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 50.7 m-85 -123.96 118.81 27.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.56 112.103 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -101.95 139.47 37.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.234 -0.654 . . . . 1.5 109.234 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.94 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.4 122.62 19.28 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.147 1.166 . . . . 0.6 114.147 -179.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.821 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.73 152.4 19.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.02 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' CG ' ' A' ' 8' ' ' PRO . 97.2 t -111.44 101.57 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.589 0.589 . . . . 0.6 112.589 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 85' ' ' ILE . 53.3 mt -98.55 155.36 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.629 -1.248 . . . . 0.7 107.629 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.19 137.67 2.48 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.898 -1.121 . . . . 0.6 113.253 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.4 mttt -78.39 -159.3 0.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 1.98 109.482 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.737 HD21 ' HB3' ' A' ' 84' ' ' ALA . 33.1 p30 -139.5 -130.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.79 -0.448 . . . . 2.19 109.79 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -110.83 -7.66 14.59 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.402 0.546 . . . . 1.08 111.12 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.66 3.56 22.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.865 0.32 . . . . 1.06 111.865 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.95 50.94 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.4 -0.905 . . . . 0.93 112.77 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -58.68 126.41 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.35 . . . . 1.38 110.426 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 79' ' ' LYS . 3.2 tp -85.87 110.9 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.247 -0.433 . . . . 0.79 111.669 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.554 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 p -68.52 124.71 90.61 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 109.393 -0.595 . . . . 0.59 109.393 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -37.68 162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.252 2.634 . . . . 0.85 113.206 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . 7.4 Cg_exo -71.79 145.96 47.15 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.699 2.266 . . . . 0.76 112.724 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 90' ' ' GLU . 12.4 m -99.05 106.33 18.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.555 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.4 mt-10 -1.46 107.27 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.828 1.251 . . . . 1.77 114.017 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 92.4 Cg_exo -38.49 149.2 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.782 2.321 . . . . 0.55 113.145 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.89 137.32 33.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.697 -0.853 . . . . 1.23 108.697 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -37.13 129.83 0.88 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.155 0.909 . . . . 1.63 111.805 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.22 119.12 7.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 0.41 110.963 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 13' ' ' ILE . 4.2 mp -97.56 111.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.44 110.473 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.1 m -45.68 -29.73 1.35 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.294 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.455 ' H ' HG22 ' A' ' 95' ' ' ILE . 63.0 m 48.05 70.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.1 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 1.3 ptp180 -103.29 -99.56 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.459 -0.337 . . . . 3.0 111.268 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -97.82 20.66 11.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 2.14 111.008 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 38.3 t0 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 2.06 111.156 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.684 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.4 tt . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 110.412 -0.218 . . . . 0.68 110.412 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.7 m-20 -136.93 126.17 15.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.826 -0.35 . . . . 2.0 111.92 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 33.2 Cg_exo -58.61 171.79 1.79 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.563 2.175 . . . . 0.5 112.015 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 52.4 Cg_endo -69.09 -178.6 2.16 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.59 2.193 . . . . 0.71 112.36 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.78 174.35 54.82 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.897 -0.668 . . . . 0.66 112.585 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.6 tptm -61.83 119.06 44.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 110.707 -0.109 . . . . 1.52 110.707 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.483 ' CG ' HG23 ' A' ' 76' ' ' VAL . 12.6 Cg_exo -70.4 146.47 56.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.161 . . . . 0.44 112.453 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -143.51 112.78 5.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.015 -0.539 . . . . 1.09 111.4 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.721 ' HG2' HD11 ' A' ' 95' ' ' ILE . 34.3 Cg_exo -62.69 107.93 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.727 2.285 . . . . 0.64 113.876 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -62.68 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.658 -0.867 . . . . 1.64 108.658 178.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -132.79 151.16 52.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.439 -1.255 . . . . 0.72 108.514 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -141.91 99.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.091 -0.644 . . . . 0.96 112.266 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -90.04 134.66 34.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 1.46 110.301 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -33.88 -30.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.867 1.062 . . . . 2.42 113.867 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 5.0 m-70 -116.51 -24.16 7.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.663 0.616 . . . . 1.02 112.663 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 75.0 p -136.54 132.32 35.06 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.747 -0.464 . . . . 0.68 109.747 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.129 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -123.28 142.78 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.886 -0.726 . . . . 0.8 112.453 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.615 ' C ' HD13 ' A' ' 20' ' ' LEU . 54.0 m -103.87 124.63 49.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.35 111.994 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.771 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.2 151.56 50.75 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 121.687 0.755 . . . . 0.52 111.744 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.606 ' HB3' HD11 ' A' ' 11' ' ' LEU . 15.8 tptm -134.43 153.64 51.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.508 -1.224 . . . . 1.84 109.702 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 22.8 p90 -143.1 -176.35 4.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.266 0.555 . . . . 0.4 112.182 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.4 -159.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.83 110.953 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.44 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -128.13 141.66 41.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 2.11 110.094 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.895 ' HG2' HD11 ' A' ' 33' ' ' ILE . 84.1 Cg_exo -42.65 168.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.228 1.952 . . . . 0.89 112.222 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -107.89 -30.3 8.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 2.77 111.724 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -119.24 -69.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.854 0.316 . . . . 1.37 111.854 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 25' ' ' PRO . 18.6 p 50.92 45.34 27.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 0.91 110.444 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.4 -93.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.068 -0.587 . . . . 1.01 112.683 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.28 36.18 0.7 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.515 -1.034 . . . . 0.98 110.515 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.85 -172.81 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.908 -0.646 . . . . 0.87 111.577 -178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.02 23.03 4.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 2.26 112.132 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.895 HD11 ' HG2' ' A' ' 25' ' ' PRO . 45.5 mm 68.82 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 111.903 0.334 . . . . 1.71 111.903 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.632 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.7 p 87.67 -16.93 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.128 0.571 . . . . 1.15 112.34 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 34.3 t 177.86 169.44 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.848 0.356 . . . . 1.58 111.861 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 54.1 m-85 -140.19 105.12 4.97 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 116.075 -0.511 . . . . 0.76 111.403 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.493 HG21 ' HD3' ' A' ' 50' ' ' LYS . 4.9 mt -89.37 91.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.038 -0.528 . . . . 1.14 110.839 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -82.76 123.39 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.022 0.439 . . . . 0.63 110.748 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 77' ' ' ILE . 14.7 mt-10 -97.83 156.68 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.699 . . . . 1.67 111.345 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.16 139.74 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 1.97 110.62 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HD3' HD23 ' A' ' 43' ' ' LEU . 2.4 ttm180 -121.02 113.68 20.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.181 -0.463 . . . . 1.44 110.568 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.542 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -71.48 86.93 0.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 1.59 109.654 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -70.35 142.39 89.47 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.949 -0.569 . . . . 0.9 110.759 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.96 47.85 1.94 Allowed 'Cis proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.182 -1.174 . . . . 1.43 112.869 0.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.58 60.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.679 0.276 . . . . 2.66 111.546 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -114.79 -177.48 18.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.636 -0.792 . . . . 1.12 112.325 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.6 24.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 2.41 111.123 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 54.0 m95 51.77 95.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.65 111.332 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD13 ' HG2' ' A' ' 47' ' ' ARG . 1.2 mp -118.23 137.7 52.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 1.28 110.328 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HD3' HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -45.3 93.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 1.3 111.689 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -70.09 -40.52 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.86 110.306 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -63.66 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.01 110.481 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 68.96 41.08 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 2.08 110.803 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 t -154.37 -72.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.993 -0.549 . . . . 1.89 110.972 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t30 175.48 136.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.87 110.659 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 52' ' ' ASN . 8.1 mt -140.69 79.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.69 110.967 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 57' ' ' LEU . 8.5 tp -68.62 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.6 110.825 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.59 169.66 17.86 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.305 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -80.67 -2.0 44.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.293 -0.412 . . . . 1.75 111.672 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.87 102.55 13.62 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.853 0.358 . . . . 2.05 110.33 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.688 ' HB2' HG23 ' A' ' 56' ' ' ILE . 66.5 t80 -139.02 164.05 30.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.48 111.872 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 54.0 m -127.12 128.43 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.451 -0.795 . . . . 0.42 109.795 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 18' ' ' VAL . 29.7 m -91.62 128.7 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 120.221 -0.591 . . . . 1.08 112.168 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -110.81 127.01 55.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.546 -0.752 . . . . 1.33 109.821 179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.72 -13.04 1.97 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.521 -0.847 . . . . 0.9 112.59 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.129 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -52.08 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.013 0.435 . . . . 1.47 110.553 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -152.53 157.07 40.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 1.06 110.601 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 4.4 mt-10 -76.76 143.76 39.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 1.91 110.675 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 65.87 38.04 5.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.214 -0.448 . . . . 1.87 110.929 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -151.41 117.3 5.5 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.565 -0.289 . . . . 0.49 111.731 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -75.25 121.31 21.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.655 -0.498 . . . . 0.36 109.655 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 75.7 m-85 -116.15 131.77 56.85 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.56 112.696 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.775 ' HB2' HD11 ' A' ' 43' ' ' LEU . 1.2 tt0 -105.83 142.46 35.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.239 -1.022 . . . . 1.5 108.239 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -126.92 114.98 18.58 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.247 1.203 . . . . 0.6 114.247 -178.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -93.5 144.87 24.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.313 -0.858 . . . . 2.11 110.229 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' CG ' ' A' ' 8' ' ' PRO . 52.9 t -106.7 119.77 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.6 112.368 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.71 HD11 ' HD3' ' A' ' 88' ' ' PRO . 5.9 mt -110.1 165.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.978 -1.119 . . . . 0.7 107.978 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -179.3 130.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.965 -0.694 . . . . 0.6 112.345 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.4 pttm -81.26 -158.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.969 -0.752 . . . . 1.98 108.969 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.684 ' ND2' HD11 ' A' ' 2' ' ' ILE . 17.6 m-80 -155.78 167.62 29.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 2.19 112.029 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.26 -53.25 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 1.08 111.864 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.32 -5.84 25.76 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.313 0.486 . . . . 1.06 112.313 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.94 63.31 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.39 -0.91 . . . . 0.93 112.714 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 124.84 22.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 1.38 110.157 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -92.4 110.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.649 0.611 . . . . 0.79 112.649 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 4.5 p -74.89 120.28 80.84 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 88.3 Cg_endo -70.95 172.97 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.574 2.182 . . . . 0.85 112.961 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HD3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -36.93 121.56 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.395 2.73 . . . . 0.76 112.819 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' GLU . 5.1 p -107.88 104.23 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.037 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 21.6 mt-10 18.36 110.48 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.505 1.122 . . . . 1.77 113.809 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 34.5 Cg_exo -63.38 155.79 60.04 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.496 2.13 . . . . 0.55 114.374 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -84.5 146.11 27.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.903 -1.044 . . . . 1.23 108.839 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -32.23 143.96 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.256 0.972 . . . . 1.63 112.478 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -79.64 114.32 18.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.428 -0.805 . . . . 0.41 110.326 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.937 HG12 HG21 ' A' ' 13' ' ' ILE . 3.8 mp -99.37 110.17 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.452 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 63.0 m -45.19 -39.79 6.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.044 -0.526 . . . . 0.44 111.224 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 69' ' ' ASP . 90.9 m 54.96 106.8 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.1 110.448 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -141.87 -75.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.987 0.423 . . . . 3.0 110.957 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -122.86 3.09 9.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.577 . . . . 2.14 111.496 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.766 0.317 . . . . 2.06 111.444 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.68 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.81 0.338 . . . . 0.68 111.16 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.64 132.8 24.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 2.0 110.318 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.86 162.38 18.54 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.157 . . . . 0.5 112.451 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 71.4 Cg_exo -53.11 177.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.906 2.404 . . . . 0.71 112.611 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.17 -175.58 50.15 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.043 -0.598 . . . . 0.66 113.128 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 tmtp? -69.69 123.29 88.27 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.974 0.11 . . . . 1.52 110.848 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 10.7 Cg_exo -75.47 128.12 10.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.669 2.246 . . . . 0.44 112.741 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 3.8 t -134.15 115.63 13.03 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.375 -0.375 . . . . 1.09 111.439 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 22.0 Cg_exo -61.98 108.11 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.224 1.949 . . . . 0.64 113.448 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.57 -41.18 93.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.46 0.648 . . . . 1.64 109.298 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -136.66 154.73 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.891 -1.05 . . . . 0.72 109.379 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.866 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -143.32 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.904 0.383 . . . . 0.96 111.22 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.836 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -101.71 56.86 0.82 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.023 -0.535 . . . . 1.46 112.266 -179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.254 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.74 -74.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.614 -0.721 . . . . 2.42 112.754 178.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' THR . 18.0 m170 -78.28 -35.28 48.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.072 0.397 . . . . 1.02 112.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 p -126.09 117.47 23.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.853 0.359 . . . . 0.68 110.98 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.3 m -110.29 141.8 24.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.137 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.754 ' C ' HD13 ' A' ' 20' ' ' LEU . 55.2 m -107.33 127.99 54.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.57 . . . . 0.35 111.768 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.811 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -133.25 156.38 47.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.371 0.605 . . . . 0.52 111.377 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.046 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -138.14 142.93 40.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.079 -0.964 . . . . 1.84 109.973 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 42.8 p90 -137.8 163.29 31.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.144 0.497 . . . . 0.4 111.885 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.88 164.93 24.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.83 110.318 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.82 157.15 35.13 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 2.11 110.873 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 76.9 Cg_exo -50.34 -173.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.233 . . . . 0.89 112.658 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.11 -25.57 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.897 -0.592 . . . . 2.77 111.829 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -129.05 -69.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.057 0.391 . . . . 1.37 112.057 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.488 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.5 p 59.45 50.79 7.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.346 . . . . 0.91 110.725 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.82 -98.86 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.163 -0.541 . . . . 1.01 112.64 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.05 32.74 1.66 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 109.735 -1.346 . . . . 0.98 109.735 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.95 -169.98 1.58 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.62 -0.79 . . . . 0.87 111.262 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 34' ' ' THR . 1.9 pttt -142.2 24.1 1.98 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 2.26 112.008 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.897 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mm 66.44 -69.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.7 0.286 . . . . 1.71 110.902 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.6 p 87.33 -20.72 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.188 0.595 . . . . 1.15 112.058 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.796 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.8 t -177.25 165.31 2.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 1.58 111.464 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.897 ' CE1' HG21 ' A' ' 33' ' ' ILE . 54.1 m-85 -133.75 109.1 8.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.76 111.073 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.33 156.26 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.22 -0.289 . . . . 1.14 110.22 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 7.1 t -135.06 124.31 42.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.63 111.807 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CD ' HD12 ' A' ' 77' ' ' ILE . 6.9 mt-10 -96.51 131.56 42.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -98.34 138.99 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.038 0.447 . . . . 1.97 111.964 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -122.14 109.65 14.79 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.825 -0.625 . . . . 1.44 110.374 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD2' ' NE ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -77.15 95.67 4.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 1.59 110.578 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -65.49 151.62 94.01 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.9 111.106 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -88.79 4.12 69.96 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.803 -1.332 . . . . 1.43 113.212 0.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -77.18 -84.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.672 0.272 . . . . 2.66 110.502 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.76 161.61 12.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.639 -0.791 . . . . 1.12 113.326 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' NE ' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 168.72 55.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 2.41 110.008 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.9 m95 -36.78 120.48 0.71 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.838 -0.619 . . . . 0.65 112.544 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -155.49 131.1 9.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 1.28 110.008 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 1.8 ptpt -52.11 117.41 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 1.3 110.84 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -101.87 -41.32 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.131 -0.486 . . . . 0.86 111.268 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' CB ' HD11 ' A' ' 56' ' ' ILE . 16.9 p-10 -44.79 -48.27 10.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.373 -0.376 . . . . 2.01 111.376 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.74 29.73 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.259 -0.428 . . . . 2.08 111.329 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -133.39 -170.11 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 1.89 110.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -99.69 89.29 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 1.87 111.181 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 36' ' ' TYR . 36.4 mt -86.78 72.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.69 110.768 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 57' ' ' LEU . 9.7 tp -63.08 -38.31 90.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.6 111.455 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 56' ' ' ILE . 21.8 pt-20 -100.6 160.49 14.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.379 . . . . 1.54 110.528 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -74.25 -7.92 54.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.211 -0.45 . . . . 1.75 111.323 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.046 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.3 tp10 -90.55 97.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.322 -0.621 . . . . 2.05 109.322 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 58.4 t80 -135.79 165.35 25.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.48 111.985 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 94.3 m -123.21 123.37 40.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.325 -0.852 . . . . 0.42 110.281 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.811 HG23 HD21 ' A' ' 20' ' ' LEU . 17.3 t -82.02 119.62 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 1.08 111.71 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.26 145.36 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.663 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.03 -19.35 5.48 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.746 -0.74 . . . . 0.9 112.171 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.742 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -55.9 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.666 0.27 . . . . 1.47 110.46 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -157.88 143.58 17.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.848 0.356 . . . . 1.06 110.765 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 mt-10 -51.92 129.88 27.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.063 -0.517 . . . . 1.91 111.127 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.61 66.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.073 -0.512 . . . . 1.87 111.397 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -175.5 118.44 0.16 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.468 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.54 129.73 40.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.36 109.519 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.607 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 73.3 m-85 -128.87 124.46 35.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.053 0.76 . . . . 0.56 113.053 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 10.5 mt-10 -103.52 142.36 34.41 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.498 -0.927 . . . . 1.5 108.498 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -133.15 111.98 11.36 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.478 1.288 . . . . 0.6 114.478 -178.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.01 157.39 16.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.495 -0.928 . . . . 2.11 108.495 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -125.21 124.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.535 -0.866 . . . . 0.6 112.878 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.447 HD12 ' CD ' ' A' ' 39' ' ' GLU . 63.6 mt -108.03 139.71 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.407 -1.331 . . . . 0.7 107.407 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -149.18 117.52 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.529 -0.869 . . . . 0.6 112.603 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.4 ptpt -71.57 -172.73 0.82 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.191 -0.459 . . . . 1.98 110.149 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.68 ' ND2' HD11 ' A' ' 2' ' ' ILE . 5.1 m-80 -135.09 168.08 19.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.263 0.554 . . . . 2.19 111.915 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.59 -44.04 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 1.08 111.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.69 -18.0 58.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.998 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 113.68 -16.75 21.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.551 -0.833 . . . . 0.93 112.1 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 123.46 8.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.663 0.268 . . . . 1.38 110.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 85' ' ' ILE . 3.3 tp -87.91 109.81 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.694 0.627 . . . . 0.79 112.694 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 12.7 p -68.58 107.34 1.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 107.811 -1.181 . . . . 0.59 107.811 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.0 Cg_endo -45.98 155.41 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.091 . . . . 0.85 112.841 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 2.3 Cg_endo -45.18 128.76 9.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.372 2.714 . . . . 0.76 113.483 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 1.1 p -97.43 109.14 21.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.364 -0.835 . . . . 1.28 109.862 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 7.6 mt-10 1.72 119.22 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.093 0 O-C-N 124.858 1.349 . . . . 1.77 113.927 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.7 Cg_exo -62.18 139.97 81.0 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.051 . . . . 0.55 113.768 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.89 144.3 57.18 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.063 -0.718 . . . . 1.23 109.063 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -40.43 134.2 1.75 Allowed 'General case' 0 C--N 1.333 -0.11 0 O-C-N 124.006 0.816 . . . . 1.63 111.633 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.68 127.09 29.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.41 111.255 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.636 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -109.4 114.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.478 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.499 HG21 ' NH1' ' A' ' 98' ' ' ARG . 65.2 m -48.13 -39.04 19.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.929 0.395 . . . . 0.44 111.03 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 78.9 m 60.29 65.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.246 -0.434 . . . . 1.1 110.881 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.658 ' HD3' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -107.63 -89.53 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.784 0.326 . . . . 3.0 110.52 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.658 ' OD2' ' HD3' ' A' ' 98' ' ' ARG . 3.6 p30 -102.27 12.82 36.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.412 -0.358 . . . . 2.14 110.635 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.254 ' OD1' ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.864 0.364 . . . . 2.06 111.189 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.567 HD12 ' HB1' ' A' ' 84' ' ' ALA . 2.7 tt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.883 0.373 . . . . 0.68 110.874 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.406 ' N ' HG12 ' A' ' 2' ' ' ILE . 3.5 m-20 -135.39 128.53 18.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.618 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 157.02 43.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.394 2.062 . . . . 0.5 112.161 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.55 -164.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.801 2.334 . . . . 0.71 113.228 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.94 -175.41 44.02 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.423 -0.808 . . . . 0.66 112.799 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.2 tttt -78.08 134.64 63.41 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 110.382 -0.229 . . . . 1.52 110.382 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CG ' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_exo -79.04 147.04 20.72 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.652 2.234 . . . . 0.44 112.83 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.2 p -138.69 115.06 8.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.625 -0.716 . . . . 1.09 110.647 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.7 Cg_exo -63.34 112.74 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.201 1.934 . . . . 0.64 113.149 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER -76.9 -40.37 47.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.305 0.574 . . . . 1.64 109.848 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -132.22 114.01 13.95 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.233 -0.894 . . . . 0.72 109.215 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.588 HG21 HG12 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -113.0 126.26 70.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.73 0.641 . . . . 0.96 112.73 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -116.63 144.7 44.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.339 -0.846 . . . . 1.46 109.674 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -52.29 -18.36 1.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.94 0.719 . . . . 2.42 112.94 -178.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 17' ' ' THR . 3.1 m-70 -124.33 -7.75 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.543 0.571 . . . . 1.02 112.543 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 64' ' ' SER . 77.8 p -161.0 124.7 3.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.408 -0.219 . . . . 0.68 110.408 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.079 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -113.88 156.79 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.253 -0.579 . . . . 0.8 112.066 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 HD12 ' A' ' 11' ' ' LEU . 6.5 m -125.2 123.01 38.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.1 -0.5 . . . . 0.35 110.943 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.64 162.13 30.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.731 0.777 . . . . 0.52 112.454 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -136.1 159.01 43.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.502 -1.226 . . . . 1.84 109.762 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 19.7 p90 -149.4 -175.8 5.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.4 112.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.39 -173.99 4.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.617 -0.72 . . . . 0.83 112.072 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -120.94 140.58 31.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.289 -0.869 . . . . 2.11 110.272 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 33' ' ' ILE . 83.9 Cg_exo -46.07 175.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.43 2.087 . . . . 0.89 112.578 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -21.01 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 2.77 111.687 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.52 -68.71 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.991 0.367 . . . . 1.37 111.991 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 25' ' ' PRO . 66.2 p 51.79 49.62 20.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.91 110.496 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.75 -94.11 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.057 -0.592 . . . . 1.01 112.825 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.32 43.27 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.472 -1.051 . . . . 0.98 110.472 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -122.32 -168.97 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.458 . . . . 0.87 111.487 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.35 20.68 1.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.619 0.6 . . . . 2.26 112.619 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 35' ' ' SER . 3.6 mp 59.61 -85.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.927 -0.309 . . . . 1.71 110.483 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 77.59 30.84 0.47 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.982 0.364 . . . . 1.15 111.982 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 160.95 146.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.368 -0.378 . . . . 1.58 110.362 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' ILE . 93.1 m-85 -140.1 117.12 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.022 0.439 . . . . 0.76 111.679 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 23.9 mt -85.43 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 1.14 110.346 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 74' ' ' PHE . 2.1 t -109.53 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.158 0.429 . . . . 0.63 112.158 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.718 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 4.6 mm-40 -64.22 132.59 50.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.382 -0.599 . . . . 1.67 109.382 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -114.75 134.53 55.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 1.97 111.718 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.0 ttm180 -113.92 111.9 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.599 -0.728 . . . . 1.44 110.007 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.823 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.96 108.7 13.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 1.59 110.902 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 41' ' ' ARG . 1.2 mm? -84.34 143.68 42.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.436 -0.347 . . . . 0.9 110.985 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 63.5 Cg_endo -98.43 45.34 2.67 Favored 'Cis proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.36 -1.1 . . . . 1.43 112.755 0.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 m-80 -153.1 58.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 2.66 111.306 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -116.05 167.57 12.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.848 -0.691 . . . . 1.12 112.762 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.35 27.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.001 0.429 . . . . 2.41 110.615 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.578 ' O ' HD22 ' A' ' 49' ' ' LEU . 72.3 m95 53.23 110.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.65 111.638 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.609 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -143.32 118.4 10.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.233 -0.44 . . . . 1.28 110.459 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.718 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 7.2 ptpt -49.69 118.0 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.181 0.515 . . . . 1.3 111.2 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -102.37 -40.29 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.86 110.956 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.8 p-10 -40.28 -48.27 2.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 2.01 111.765 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 43.19 44.02 4.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.721 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.1 p -162.46 158.49 23.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 1.89 110.912 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.8 105.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 1.87 110.681 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 36' ' ' TYR . 53.5 mt -100.19 63.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.69 110.261 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.94 -76.22 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.566 -0.743 . . . . 1.6 111.821 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -64.82 170.02 4.6 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.772 0.32 . . . . 1.54 110.147 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 43.7 p30 -88.8 13.4 12.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.403 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 49.3 tt0 -111.55 107.3 16.42 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' HB2' HG23 ' A' ' 56' ' ' ILE . 58.6 t80 -142.49 164.97 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.48 112.049 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 18' ' ' VAL . 30.5 m -125.02 122.9 38.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.581 -0.736 . . . . 0.42 110.8 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 18' ' ' VAL . 3.7 m -91.53 96.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 120.24 -0.584 . . . . 1.08 110.714 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.565 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -82.85 -165.28 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 1.33 110.885 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.89 20.44 59.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.685 -0.769 . . . . 0.9 112.371 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.079 ' CD1' HG13 ' A' ' 18' ' ' VAL . 69.9 mt -74.28 -176.58 2.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.848 0.356 . . . . 1.47 110.75 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 m -132.68 154.9 49.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 1.06 110.875 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 22.9 tt0 -88.28 160.22 17.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 1.91 110.906 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.874 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 52.33 43.59 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 1.87 110.858 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.45 120.7 3.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.49 111.33 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.36 132.68 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.36 110.107 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 48.3 m-85 -125.69 118.97 26.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.681 0.622 . . . . 0.56 112.681 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.744 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 5.1 mt-10 -99.45 142.95 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.46 -0.941 . . . . 1.5 108.46 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.996 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -125.81 115.1 19.49 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.289 1.218 . . . . 0.6 114.289 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 2.5 ttp85 -94.91 139.49 31.26 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.341 -0.845 . . . . 2.11 109.537 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' CG ' ' A' ' 8' ' ' PRO . 80.6 t -106.98 138.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.71 0.767 . . . . 0.6 112.349 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 86' ' ' SER . 29.0 mt -134.66 156.64 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -168.42 121.07 0.84 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.652 -1.219 . . . . 0.6 112.987 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mmtt -61.91 -173.33 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.003 -0.679 . . . . 1.98 109.725 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 5.4 m120 -136.8 161.2 36.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.033 0.444 . . . . 2.19 110.908 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -36.87 -30.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.155 0.798 . . . . 1.08 113.155 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.626 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.73 24.37 13.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.979 0.733 . . . . 1.06 112.979 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.17 -11.1 51.1 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.561 -0.828 . . . . 0.93 113.222 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -53.82 102.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.946 0.373 . . . . 1.38 110.217 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -70.0 104.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.444 0.535 . . . . 0.79 112.444 -179.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.5 p -65.96 111.74 7.21 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.777 -0.823 . . . . 0.59 108.777 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 72.6 Cg_exo -48.8 -179.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.236 2.624 . . . . 0.85 114.311 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 68.1 Cg_exo -52.61 144.17 43.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.404 2.736 . . . . 0.76 113.544 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 10.9 m -123.04 122.05 37.55 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.906 -0.588 . . . . 1.28 110.505 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -18.53 102.47 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.161 0.985 . . . . 1.77 113.36 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 76.2 Cg_exo -48.42 169.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.043 2.495 . . . . 0.55 114.93 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.88 142.28 28.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.178 -1.374 . . . . 1.23 109.784 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -44.85 133.61 6.11 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.77 0.669 . . . . 1.63 110.457 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.07 119.65 11.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.984 -0.553 . . . . 0.41 111.754 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 10' ' ' PRO . 4.0 mp -97.37 109.55 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.408 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 13.6 m -46.89 -37.63 9.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.379 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 3.0 m 52.76 88.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.371 . . . . 1.1 110.227 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -134.75 -91.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.63 -0.259 . . . . 3.0 111.113 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -91.45 -6.1 53.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.625 -0.261 . . . . 2.14 111.421 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.973 0.416 . . . . 2.06 111.122 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.391 -0.226 . . . . 0.68 110.391 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.7 142.31 45.06 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 2.0 111.53 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.401 ' CA ' ' HB2' ' A' ' 86' ' ' SER . 87.0 Cg_endo -83.44 161.79 14.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.84 2.36 . . . . 0.5 112.276 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.53 177.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.597 2.198 . . . . 0.71 112.625 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -81.01 -176.69 51.06 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.036 -0.602 . . . . 0.66 113.309 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.0 tmtm? -66.64 127.32 93.34 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 122.197 0.199 . . . . 1.52 110.79 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 4.9 Cg_exo -80.34 135.9 10.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.532 2.155 . . . . 0.44 112.797 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -137.11 114.0 9.79 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.786 -0.643 . . . . 1.09 110.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 69.3 Cg_exo -48.52 135.02 26.9 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.144 1.896 . . . . 0.64 113.123 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -99.06 -30.37 12.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 1.64 110.061 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.99 121.61 4.45 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.319 -0.855 . . . . 0.72 109.356 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.013 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.37 132.68 61.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.828 0.677 . . . . 0.96 112.828 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.88 151.46 46.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.879 -1.055 . . . . 1.46 109.68 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG2' ' CA ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -57.74 -18.1 19.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.339 -0.391 . . . . 2.42 111.706 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 17' ' ' THR . 4.5 m-70 -131.44 18.75 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.811 0.3 . . . . 1.02 111.811 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -178.56 114.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 0.68 111.422 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 13' ' ' ILE . 81.3 t -104.82 135.13 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.001 -0.545 . . . . 0.8 110.178 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.775 ' C ' HD13 ' A' ' 20' ' ' LEU . 61.6 m -111.52 132.27 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.35 110.661 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -140.83 143.19 34.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.96 0.886 . . . . 0.52 111.766 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -123.79 134.92 53.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.955 -1.475 . . . . 1.84 109.51 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 35.7 p90 -126.4 172.0 10.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 0.4 111.196 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.454 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -83.83 -157.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.762 -0.654 . . . . 0.83 110.84 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.75 159.31 69.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.47 -0.332 . . . . 2.11 110.607 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 28' ' ' THR . 55.4 Cg_endo -70.38 169.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.104 1.87 . . . . 0.89 111.815 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.33 -19.84 11.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.196 0.443 . . . . 2.77 112.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -112.74 -74.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.343 0.498 . . . . 1.37 112.343 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 25' ' ' PRO . 11.9 p 47.31 57.76 5.5 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.527 0.203 . . . . 0.91 110.704 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.75 -95.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.966 -0.635 . . . . 1.01 112.384 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -148.69 27.56 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.693 -0.963 . . . . 0.98 110.693 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.22 -177.56 3.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.471 . . . . 0.87 111.477 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -134.88 5.24 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 2.26 111.319 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 35' ' ' SER . 22.8 mt 60.53 145.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 1.71 110.605 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -133.31 18.27 4.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.842 0.312 . . . . 1.15 111.842 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.519 ' H ' HG22 ' A' ' 33' ' ' ILE . 47.9 t -179.96 151.23 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.168 0.509 . . . . 1.58 111.971 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.3 m-85 -134.4 100.31 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.736 . . . . 0.76 110.002 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.43 114.62 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 1.14 111.008 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -103.61 106.28 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.35 0.595 . . . . 0.63 110.596 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 25.2 mt-10 -75.31 154.92 37.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.251 -0.886 . . . . 1.67 111.212 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 2.7 pttt -117.07 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.134 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 2.8 ttm180 -112.85 101.65 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 1.44 109.788 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -68.54 141.47 55.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.848 -0.614 . . . . 1.59 110.622 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.516 HD12 ' HB1' ' A' ' 94' ' ' ALA . 6.9 mt -126.87 153.71 76.12 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.9 111.252 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.4 Cg_endo -81.8 24.08 8.27 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.962 -1.266 . . . . 1.43 113.616 0.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.407 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -154.46 100.25 2.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.363 . . . . 2.66 110.903 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -165.9 167.9 39.42 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.84 -0.695 . . . . 1.12 112.419 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.631 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -133.14 148.43 52.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 2.41 111.188 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 72.1 m95 -55.45 105.88 0.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.65 111.227 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.631 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -134.2 122.54 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 1.28 110.354 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -44.47 118.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 1.3 111.346 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -103.84 -9.83 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.86 111.993 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.58 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.6 p-10 -77.71 -54.72 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.201 -0.2 . . . . 2.01 111.467 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 38.34 35.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.999 0.37 . . . . 2.08 111.999 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 26.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.442 -0.345 . . . . 1.89 111.42 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.24 130.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.378 . . . . 1.87 111.211 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 36' ' ' TYR . 48.1 mt -129.99 84.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.69 110.633 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.34 -43.79 76.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 1.6 111.985 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.45 154.74 17.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.834 0.349 . . . . 1.54 110.866 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -72.81 -4.59 32.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 1.75 111.672 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -96.86 98.2 9.92 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.167 -0.679 . . . . 2.05 109.167 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 52' ' ' ASN . 69.8 t80 -128.48 164.53 22.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.452 0.644 . . . . 0.48 112.146 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -125.76 114.87 19.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.077 -0.965 . . . . 0.42 110.783 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 38' ' ' VAL . 14.3 t -77.66 109.09 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 1.08 110.817 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.77 151.45 26.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 1.33 111.055 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.93 4.57 10.27 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.574 -0.739 . . . . 0.9 112.396 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -68.54 -167.19 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.947 0.403 . . . . 1.47 110.918 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -150.25 139.32 21.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 1.06 110.76 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE1' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -58.86 130.45 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.91 111.063 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t0 76.16 49.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 1.87 111.277 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.03 127.42 4.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.49 111.356 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.24 134.23 41.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.134 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -133.2 125.2 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.798 0.666 . . . . 0.56 112.798 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.12 150.06 22.88 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.04 -0.726 . . . . 1.5 109.04 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.899 ' CE2' HG11 ' A' ' 18' ' ' VAL . 1.4 m-85 -134.71 117.24 15.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.146 1.165 . . . . 0.6 114.146 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 88' ' ' PRO . 24.1 ttm-85 -111.82 159.5 18.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.132 -0.94 . . . . 2.11 109.412 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -136.88 144.83 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.982 0.896 . . . . 0.6 112.803 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 86' ' ' SER . 22.8 mt -130.32 145.19 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.828 -1.533 . . . . 0.7 107.655 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -145.87 130.62 18.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.586 -0.846 . . . . 0.6 112.575 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -91.77 123.96 35.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 1.98 111.308 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.4 p-10 -66.28 -174.82 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.851 . . . . 2.19 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -65.68 -26.04 67.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.844 -0.616 . . . . 1.08 112.063 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.657 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -88.19 1.47 54.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.435 0.531 . . . . 1.06 112.435 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.8 79.76 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.369 -0.919 . . . . 0.93 113.078 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -77.31 68.08 3.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.239 0.543 . . . . 1.38 109.616 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -27.47 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 114.695 1.369 . . . . 0.79 114.695 -178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.879 ' O ' HG23 ' A' ' 77' ' ' ILE . 10.7 p -75.29 106.81 3.2 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.491 -1.67 . . . . 0.59 106.491 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 9.8 Cg_endo -50.32 169.08 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.88 2.387 . . . . 0.85 114.605 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 72.6 Cg_exo -31.04 136.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.251 3.3 . . . . 0.76 114.078 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 2.8 p -122.01 103.2 8.65 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.589 -0.732 . . . . 1.28 109.972 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -1.8 120.16 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.014 1.326 . . . . 1.77 113.872 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 4.6 Cg_exo -76.77 163.5 31.35 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.268 1.978 . . . . 0.55 113.882 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 2.0 t -90.97 146.71 23.64 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.002 -0.999 . . . . 1.23 109.401 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -38.75 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 O-C-N 123.72 0.637 . . . . 1.63 111.596 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -87.43 120.92 29.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.033 -0.53 . . . . 0.41 111.532 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -98.55 114.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 38.2 m -47.89 -28.68 2.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.839 -0.618 . . . . 0.44 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.869 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 m 50.14 60.6 3.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 1.1 110.973 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.702 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -95.41 -74.17 0.56 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.933 0.397 . . . . 3.0 111.147 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.483 ' CA ' ' HG2' ' A' ' 15' ' ' ARG . 7.2 p-10 -131.08 20.0 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.974 -0.557 . . . . 2.14 111.633 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.4 t0 . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 112.649 0.611 . . . . 2.06 112.649 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.9 tt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.882 0.373 . . . . 0.68 111.274 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 23.9 m-20 -132.22 129.97 21.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 2.0 110.475 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.22 157.98 15.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.532 2.155 . . . . 0.5 112.604 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 4.5 Cg_endo -48.35 -177.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.122 2.548 . . . . 0.71 113.514 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 168.78 29.26 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.53 -0.759 . . . . 0.66 112.957 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -53.39 128.13 50.18 Favored Pre-proline 0 CA--C 1.53 0.197 0 O-C-N 122.987 -0.126 . . . . 1.52 110.811 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 11.8 Cg_exo -74.98 113.95 3.91 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.506 2.137 . . . . 0.44 112.701 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -104.72 107.76 59.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 1.09 110.652 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 27.2 Cg_exo -61.7 105.71 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.525 2.15 . . . . 0.64 113.789 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -63.22 -32.92 74.44 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.89 -0.782 . . . . 1.64 108.89 178.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -142.99 143.92 32.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.878 -1.055 . . . . 0.72 109.061 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.059 HG22 HG13 ' A' ' 18' ' ' VAL . 3.2 pt -138.74 81.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.146 0.424 . . . . 0.96 112.146 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.257 HG22 ' OD1' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -79.97 151.44 30.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 1.46 110.237 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -56.48 -20.67 21.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.982 -0.554 . . . . 2.42 111.877 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 17' ' ' THR . 0.3 OUTLIER -125.86 11.4 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.252 0.464 . . . . 1.02 112.252 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -169.85 115.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.68 110.709 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 13' ' ' ILE . 24.9 t -109.83 119.51 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.061 0.458 . . . . 0.8 111.232 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.73 ' C ' HD13 ' A' ' 20' ' ' LEU . 11.0 m -99.8 124.77 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.675 -0.693 . . . . 0.35 110.811 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.18 150.33 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.805 0.812 . . . . 0.52 112.315 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.86 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.35 154.35 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.313 -1.312 . . . . 1.84 109.798 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.4 p90 -142.21 -176.05 4.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.278 0.561 . . . . 0.4 112.397 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.65 24.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.44 -0.8 . . . . 0.83 111.154 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 4.0 tmmm? -84.91 139.21 37.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 2.11 110.758 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.691 ' CB ' HG23 ' A' ' 28' ' ' THR . 93.0 Cg_exo -43.84 160.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.216 1.944 . . . . 0.89 111.837 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -106.94 -15.92 14.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.77 111.749 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 -70.62 0.7 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.863 0.32 . . . . 1.37 111.863 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 25' ' ' PRO . 14.4 p 50.59 54.78 10.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.971 0.415 . . . . 0.91 110.382 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.33 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.927 -0.579 . . . . 1.01 112.55 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.66 24.06 2.77 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.35 -0.7 . . . . 0.98 111.35 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -92.04 -176.64 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 0.87 111.923 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 13.6 ttpt -130.87 -13.48 3.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.646 -0.706 . . . . 2.26 112.209 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.625 HD11 HG21 ' A' ' 28' ' ' THR . 11.4 mt 64.1 132.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.701 -0.481 . . . . 1.71 109.701 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -124.42 11.82 8.69 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.575 0.583 . . . . 1.15 112.575 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 146.35 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.999 0.428 . . . . 1.58 112.138 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.506 ' O ' HD12 ' A' ' 56' ' ' ILE . 51.1 m-85 -118.52 122.16 42.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.717 -0.674 . . . . 0.76 109.972 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -107.85 129.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.765 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -119.28 130.22 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.63 110.584 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.5 mt-10 -94.54 136.66 34.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.442 -0.799 . . . . 1.67 110.668 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -99.94 159.36 15.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 1.97 111.112 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.832 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -140.73 105.29 4.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.543 . . . . 1.44 110.546 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.704 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -75.11 80.41 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.59 110.97 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 41' ' ' ARG . 1.2 mm? -65.63 155.82 84.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.9 110.763 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -91.81 36.7 5.99 Favored 'Cis proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.063 -1.224 . . . . 1.43 112.639 0.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.18 57.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.923 0.392 . . . . 2.66 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.704 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -127.05 172.79 18.51 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.973 -0.632 . . . . 1.12 112.156 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.62 51.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.217 0.532 . . . . 2.41 111.348 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.712 ' O ' HD22 ' A' ' 49' ' ' LEU . 50.5 m95 -60.94 124.05 19.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.391 -0.822 . . . . 0.65 110.527 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -154.95 124.05 6.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.841 0.353 . . . . 1.28 111.295 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -50.95 115.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.3 110.537 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -99.26 -35.22 10.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.86 111.545 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.686 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.1 p-10 -53.54 -62.5 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.316 . . . . 2.01 111.85 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 3.5 t80 80.05 -51.39 0.37 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.544 0.211 . . . . 2.08 111.259 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -64.04 -171.31 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.886 0.374 . . . . 1.89 110.975 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -97.2 106.13 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 1.87 110.814 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.4 mt -92.42 74.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 0.69 111.268 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -73.65 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.6 111.018 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.51 174.12 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.54 110.189 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 44.4 p30 -92.86 17.38 10.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.267 -0.424 . . . . 1.75 111.452 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.69 103.01 9.28 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 59.1 t80 -134.68 164.18 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.068 0.461 . . . . 0.48 111.537 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.661 HG23 ' OG1' ' A' ' 19' ' ' THR . 17.3 m -122.03 119.68 32.12 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.672 -0.694 . . . . 0.42 111.152 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG23 HD21 ' A' ' 20' ' ' LEU . 22.3 t -86.92 97.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 1.08 110.995 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.28 150.74 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.665 -0.698 . . . . 1.33 110.951 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.57 7.45 8.92 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.711 -0.677 . . . . 0.9 112.338 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 72' ' ' TYR . 4.4 mm? -51.81 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.018 0.437 . . . . 1.47 110.928 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 m -142.71 111.01 6.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.813 -0.631 . . . . 1.06 110.112 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -42.0 138.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.91 111.869 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.79 56.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.897 -0.592 . . . . 1.87 111.583 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.44 123.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.49 111.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.12 134.43 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.36 110.536 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' HD12 ' A' ' 66' ' ' LEU . 49.4 m-85 -130.6 118.89 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.317 0.488 . . . . 0.56 112.317 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.72 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.08 143.09 30.69 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.311 -0.626 . . . . 1.5 109.311 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.57 119.89 13.86 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.486 1.291 . . . . 0.6 114.486 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -108.06 173.57 6.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.444 -0.947 . . . . 2.11 108.444 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.85 113.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 114.116 1.154 . . . . 0.6 114.116 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 37' ' ' ILE . 41.6 mt -97.32 154.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 106.479 -1.674 . . . . 0.7 106.479 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.16 128.27 1.29 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.434 -0.906 . . . . 0.6 111.656 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 85' ' ' ILE . 20.6 mttt -63.57 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.047 -0.723 . . . . 1.98 109.047 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.758 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.1 m-80 -146.01 -94.21 0.09 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.66 -0.416 . . . . 2.19 110.925 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -137.15 -42.28 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 1.08 110.952 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.18 30.45 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.06 111.996 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.16 -12.37 58.34 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.541 -0.838 . . . . 0.93 113.353 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.518 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -53.11 115.75 2.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.973 0.386 . . . . 1.38 110.894 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -87.78 104.37 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.034 0.445 . . . . 0.79 111.519 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.65 119.76 71.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 109.803 -0.443 . . . . 0.59 109.803 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.24 162.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.177 2.585 . . . . 0.85 113.122 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 36.7 Cg_endo -66.26 142.3 66.19 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.695 2.263 . . . . 0.76 112.409 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.8 m -94.59 105.32 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 1.28 110.332 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 tt0 -4.27 115.27 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 124.705 1.202 . . . . 1.77 113.681 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.2 Cg_exo -56.2 141.8 87.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.125 1.883 . . . . 0.55 113.6 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 15.7 m -72.31 143.17 48.79 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.753 -0.832 . . . . 1.23 108.753 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.0 m-20 -41.12 137.27 1.36 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.768 0.668 . . . . 1.63 110.752 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -62.85 117.76 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.036 -0.529 . . . . 0.41 111.779 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' SG ' ' A' ' 97' ' ' CYS . 3.9 mp -92.35 110.82 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.615 -0.72 . . . . 0.44 110.422 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.488 HG21 ' NH1' ' A' ' 98' ' ' ARG . 26.0 m -46.95 -39.04 11.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.919 0.39 . . . . 0.44 110.655 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 95' ' ' ILE . 99.1 m 61.46 89.13 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.504 . . . . 1.1 110.91 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.4 -82.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 3.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 11.7 p-10 -96.02 30.28 2.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.752 -0.658 . . . . 2.14 110.653 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.257 ' OD1' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 2.06 112.036 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.559 0.219 . . . . 0.68 110.657 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.74 151.57 68.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 2.0 111.773 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.71 164.62 12.1 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.907 2.405 . . . . 0.5 112.043 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.33 -164.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.501 2.134 . . . . 0.71 112.637 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.34 -153.59 27.95 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.939 -0.648 . . . . 0.66 113.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -90.09 125.05 61.7 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.407 0.146 . . . . 1.52 111.008 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 23.3 Cg_exo -66.52 130.89 24.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.489 2.126 . . . . 0.44 112.327 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.05 98.42 17.38 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.163 -0.471 . . . . 1.09 111.19 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.9 Cg_exo -47.14 130.41 16.58 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.64 113.081 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 21' ' ' LYS . 2.2 mt -90.71 -30.75 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.055 -0.721 . . . . 1.64 109.055 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -151.49 119.65 6.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.167 -0.924 . . . . 0.72 109.218 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -117.39 122.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.96 112.448 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.94 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -124.52 160.5 28.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.831 . . . . 1.46 110.237 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -59.02 -13.97 8.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.394 0.516 . . . . 2.42 112.394 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -140.44 23.9 2.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.285 0.476 . . . . 1.02 112.285 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -175.98 113.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.841 0.353 . . . . 0.68 110.232 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 44.7 t -116.24 99.28 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.153 0.427 . . . . 0.8 112.153 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.802 ' OG1' HG23 ' A' ' 62' ' ' THR . 46.1 m -83.66 144.85 29.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.35 110.68 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -148.55 163.97 35.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.649 0.737 . . . . 0.52 112.499 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 11' ' ' LEU . 28.4 tptp -145.58 137.86 25.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.595 -1.184 . . . . 1.84 109.601 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 37.4 p90 -133.81 177.93 7.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.183 0.516 . . . . 0.4 111.709 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.3 -163.95 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.83 110.838 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -128.68 140.38 38.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.901 -0.59 . . . . 2.11 110.185 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HG2' HD11 ' A' ' 33' ' ' ILE . 95.9 Cg_exo -39.05 161.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.166 . . . . 0.89 112.2 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.44 -43.22 5.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -108.91 -70.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.482 0.549 . . . . 1.37 112.482 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 19.5 p 55.77 40.78 30.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.429 . . . . 0.91 109.951 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.67 -100.21 0.02 OUTLIER Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.804 -0.635 . . . . 1.01 112.53 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.35 27.62 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.295 -0.722 . . . . 0.98 111.295 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -111.85 -171.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.87 111.267 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.29 35.3 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 2.26 111.24 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 25' ' ' PRO . 2.9 mm 59.44 158.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.465 -0.334 . . . . 1.71 110.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 33' ' ' ILE . 81.1 p -138.87 1.74 2.1 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.656 0.613 . . . . 1.15 112.656 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 33' ' ' ILE . 10.0 t 168.59 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.7 0.286 . . . . 1.58 111.539 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.771 ' O ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -99.82 87.06 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.76 111.113 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.541 HG21 ' HD2' ' A' ' 50' ' ' LYS . 1.1 mp -73.74 120.47 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 1.14 110.796 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 63' ' ' VAL . 14.0 t -94.15 107.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.111 0.481 . . . . 0.63 111.563 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.82 139.24 31.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 1.67 110.616 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.711 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -108.12 138.93 43.54 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.904 0.383 . . . . 1.97 111.568 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -119.12 97.41 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.564 -0.902 . . . . 1.44 108.564 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.862 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -65.48 97.16 0.28 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.403 -0.817 . . . . 1.59 110.603 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -69.3 148.01 97.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.9 110.837 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -93.93 32.22 11.17 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.966 -1.264 . . . . 1.43 112.861 0.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.79 64.63 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.754 0.311 . . . . 2.66 111.547 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.862 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -95.85 -174.77 36.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 1.12 112.032 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 26.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 2.41 110.777 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.8 m95 41.38 88.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.099 0.476 . . . . 0.65 111.202 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 137.86 54.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.28 111.27 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 37' ' ' ILE . 1.4 mtmt -53.89 129.14 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 1.3 110.4 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -110.29 -31.55 7.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.86 110.645 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.692 ' HB3' HD11 ' A' ' 56' ' ' ILE . 10.7 p-10 -57.18 -43.31 82.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 2.01 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.87 25.08 10.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 2.08 110.766 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -169.77 3.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 1.89 110.956 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -94.9 116.08 28.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.87 110.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 36' ' ' TYR . 27.1 mt -105.71 90.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.54 . . . . 0.69 110.636 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.497 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.6 mt -74.62 -61.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.6 111.336 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -75.02 159.16 32.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.934 0.397 . . . . 1.54 110.621 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -74.85 -3.22 30.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 1.75 111.039 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 1.7 tt0 -100.46 103.53 14.89 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.413 -0.588 . . . . 2.05 109.413 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.9 t80 -140.19 165.35 27.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.48 111.779 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' OG1' ' A' ' 19' ' ' THR . 8.1 m -121.29 114.78 21.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.42 111.391 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 38' ' ' VAL . 56.6 t -84.71 90.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.143 0.497 . . . . 1.08 111.041 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.67 151.69 19.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.33 111.0 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.34 14.65 7.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.9 112.354 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 72' ' ' TYR . 3.6 mm? -58.25 -179.67 0.06 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.132 0.491 . . . . 1.47 111.357 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 m -133.37 109.23 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.589 -0.732 . . . . 1.06 110.199 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.91 135.7 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.087 -0.506 . . . . 1.91 111.816 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 97' ' ' CYS . 9.5 m-20 65.64 62.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.87 111.215 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.7 114.74 0.17 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.509 -0.314 . . . . 0.49 111.588 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.18 135.34 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.731 -0.47 . . . . 0.36 109.731 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 33.3 m-85 -128.61 121.51 28.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.162 0.801 . . . . 0.56 113.162 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' HD21 ' A' ' 43' ' ' LEU . 1.1 mt-10 -99.3 133.7 43.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.618 -1.253 . . . . 1.5 107.618 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.756 ' HE2' HG11 ' A' ' 18' ' ' VAL . 7.8 m-85 -117.94 114.87 23.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.138 1.532 . . . . 0.6 115.138 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -100.72 135.34 42.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.193 -0.912 . . . . 2.11 108.998 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -108.24 127.39 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 119.288 -0.965 . . . . 0.6 111.721 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.741 HG23 ' O ' ' A' ' 86' ' ' SER . 94.1 mt -115.52 143.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.811 -1.086 . . . . 0.7 108.126 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.11 134.45 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.833 -0.747 . . . . 0.6 112.395 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -84.85 -178.6 6.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.28 -0.568 . . . . 1.98 110.626 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.521 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.3 p-10 -127.84 -173.23 2.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.36 -0.836 . . . . 2.19 110.104 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -69.66 -11.96 61.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.041 -0.527 . . . . 1.08 112.095 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -104.01 -4.23 23.6 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.228 0.455 . . . . 1.06 112.228 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.98 87.93 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.452 -0.88 . . . . 0.93 113.291 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -76.57 71.98 3.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.341 0.591 . . . . 1.38 109.951 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.9 tt -36.56 123.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.96 1.096 . . . . 0.79 113.96 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.6 p -76.2 107.81 5.12 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.372 -1.344 . . . . 0.59 107.372 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 14.6 Cg_endo -55.18 171.4 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.592 2.194 . . . . 0.85 113.454 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 77' ' ' ILE . 48.0 Cg_exo -31.95 122.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.973 3.115 . . . . 0.76 113.317 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 4.1 p -106.85 103.82 13.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 1.28 110.121 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 9.98 113.85 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 125.045 1.466 . . . . 1.77 113.416 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 15.4 Cg_exo -68.31 162.39 40.67 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.88 1.72 . . . . 0.55 114.292 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.82 152.75 18.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.153 -0.93 . . . . 1.23 109.345 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -33.75 156.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.112 0.882 . . . . 1.63 112.294 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -90.64 103.3 16.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.41 111.363 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.709 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.0 mp -82.81 110.24 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.44 111.497 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 90.8 m -48.74 -35.37 14.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.13 0.491 . . . . 0.44 110.612 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.506 ' SG ' HG22 ' A' ' 95' ' ' ILE . 91.7 m 56.93 79.6 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.673 -0.694 . . . . 1.1 111.046 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -87.68 0.47 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.506 -0.315 . . . . 3.0 111.381 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -111.17 0.43 16.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.426 -0.352 . . . . 2.14 111.666 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.94 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.907 0.385 . . . . 2.06 111.215 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 80' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.68 111.434 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 5.1 m-20 -122.02 142.97 37.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 2.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.53 168.64 17.84 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.569 2.179 . . . . 0.5 112.402 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 174.29 2.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.654 2.236 . . . . 0.71 112.898 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -72.4 177.12 40.61 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.66 112.493 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.0 tttt -60.77 127.53 87.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.533 -0.173 . . . . 1.52 110.533 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' HG13 ' A' ' 76' ' ' VAL . 7.0 Cg_exo -74.29 156.89 46.13 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.352 2.035 . . . . 0.44 112.074 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -152.47 114.56 2.85 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.415 -0.357 . . . . 1.09 111.677 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 25.6 Cg_exo -61.44 111.31 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.691 2.26 . . . . 0.64 113.405 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.58 -33.85 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.661 -0.866 . . . . 1.64 108.661 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.871 -1.059 . . . . 0.72 108.995 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.002 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -133.98 105.3 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.96 112.041 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 151.23 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.7 -0.682 . . . . 1.46 110.35 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -60.29 -16.06 30.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.422 . . . . 2.42 111.439 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 17' ' ' THR . 6.1 m-70 -132.29 16.96 4.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.48 0.181 . . . . 1.02 111.464 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -176.27 106.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.946 0.403 . . . . 0.68 110.917 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.002 HG13 HG22 ' A' ' 13' ' ' ILE . 49.7 t -102.57 117.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.966 -0.561 . . . . 0.8 110.971 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.33 128.9 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.35 111.571 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -139.77 156.47 46.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.935 0.874 . . . . 0.52 112.412 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.932 ' HG2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -124.71 -170.45 2.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.04 -1.437 . . . . 1.84 109.219 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.7 p90 -179.83 161.14 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.4 111.836 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -80.77 168.06 19.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.83 111.797 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.27 141.42 32.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.53 -0.759 . . . . 2.11 110.236 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 28' ' ' THR . 4.5 Cg_endo -46.51 166.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.369 2.046 . . . . 0.89 111.716 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -102.93 -55.62 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.238 -0.437 . . . . 2.77 111.518 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -113.15 61.92 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.567 -0.288 . . . . 1.37 111.331 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.49 ' O ' ' CE2' ' A' ' 31' ' ' PHE . 44.4 p -57.68 -25.08 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.709 0.29 . . . . 0.91 110.452 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.09 -65.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.579 -0.819 . . . . 1.01 111.886 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 40.09 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.991 -1.244 . . . . 0.98 109.991 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -137.87 -176.92 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.087 -0.557 . . . . 0.87 111.024 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -144.3 15.21 1.66 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.5 0.556 . . . . 2.26 112.5 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.608 ' C ' HG23 ' A' ' 34' ' ' THR . 5.1 mp 64.22 -74.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 111.905 0.335 . . . . 1.71 111.905 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 79.53 21.43 0.6 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.573 -0.285 . . . . 1.15 111.696 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.595 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 169.96 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.924 -0.126 . . . . 1.58 111.232 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.8 m-85 -118.06 128.71 55.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.94 0.4 . . . . 0.76 112.001 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -119.4 120.67 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.513 -0.312 . . . . 1.14 110.433 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -105.69 140.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.879 0.371 . . . . 0.63 110.813 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' CD ' HD11 ' A' ' 77' ' ' ILE . 2.6 mt-10 -101.96 135.52 43.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.259 0.552 . . . . 1.67 111.966 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.837 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 mtmp? -101.26 139.19 37.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.273 -0.876 . . . . 1.97 111.336 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.556 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 7.6 ptt180 -132.63 115.65 15.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.454 0.645 . . . . 1.44 109.84 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -75.65 113.11 12.72 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.123 -0.944 . . . . 1.59 111.053 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 2.5 mm? -73.58 161.04 80.76 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.9 110.412 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 80.6 Cg_endo -83.8 14.89 33.18 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 124.115 -1.202 . . . . 1.43 113.427 0.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.65 -77.81 0.51 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.938 -0.393 . . . . 2.66 109.938 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' A' ' 41' ' ' ARG . . . 92.22 130.81 5.26 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.633 -0.794 . . . . 1.12 113.206 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.615 HH11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.47 1.68 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.64 0.237 . . . . 2.41 111.64 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.593 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 40.4 m95 44.31 94.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.205 0.202 . . . . 0.65 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.615 HD22 HH11 ' A' ' 47' ' ' ARG . 1.4 mp -123.62 135.55 54.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.955 0.407 . . . . 1.28 111.615 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HD2' HG21 ' A' ' 37' ' ' ILE . 9.7 mtmt -62.99 82.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 1.3 110.662 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.837 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -49.11 -53.94 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.231 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -60.31 138.28 57.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 2.01 111.06 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -136.77 23.07 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 2.08 111.031 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 t -120.73 -83.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 1.89 110.72 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 178.48 120.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 1.87 110.86 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.0 mt -107.02 98.99 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.69 110.986 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -76.68 -68.25 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 1.6 111.087 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -74.85 -179.12 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 1.54 110.65 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.9 OUTLIER -86.93 -2.91 58.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 1.75 111.482 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.932 ' CD ' ' HG2' ' A' ' 21' ' ' LYS . 9.0 tp10 -97.42 101.86 13.49 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.749 0.309 . . . . 2.05 110.179 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CG ' HD13 ' A' ' 56' ' ' ILE . 40.3 t80 -135.81 165.49 25.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.055 0.455 . . . . 0.48 111.584 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.7 m -122.21 120.69 34.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.758 -0.655 . . . . 0.42 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.653 ' CG2' HD21 ' A' ' 20' ' ' LEU . 4.8 t -85.77 112.07 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.995 -0.548 . . . . 1.08 111.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -173.38 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 1.33 110.944 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.8 9.58 71.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.747 . . . . 0.9 112.847 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG23 ' A' ' 18' ' ' VAL . 1.6 mt -61.72 -177.19 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 1.47 110.83 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 72' ' ' TYR . 3.8 t -138.93 11.49 2.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.026 0.38 . . . . 1.06 112.026 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 56.9 159.31 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.006 0.432 . . . . 1.91 111.382 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 90.5 m-20 45.76 66.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 1.87 111.368 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 174.76 119.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.067 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.83 132.82 55.12 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.205 -0.598 . . . . 0.36 110.281 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 67' ' ' THR . 25.0 m-85 -130.34 121.0 25.2 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.003 0.742 . . . . 0.56 113.003 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 92' ' ' SER . 2.4 tt0 -102.66 141.05 36.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.516 -0.55 . . . . 1.5 109.516 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.777 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.65 128.01 26.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.126 1.158 . . . . 0.6 114.126 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.593 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -111.32 160.98 16.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.31 -0.626 . . . . 2.11 109.31 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -121.3 112.32 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.057 -0.657 . . . . 0.6 111.955 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.945 HG22 ' O ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -105.05 179.81 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.237 -0.892 . . . . 0.7 108.852 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -179.37 -162.59 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.106 0.479 . . . . 0.6 111.395 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.7 mttt -136.85 -171.53 2.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.275 -1.009 . . . . 1.98 108.275 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.865 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.8 p-10 -135.72 156.62 48.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.056 0.455 . . . . 2.19 110.54 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.35 -29.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.601 -0.727 . . . . 1.08 112.084 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -77.07 -24.5 51.88 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.815 0.672 . . . . 1.06 112.815 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.29 -11.5 26.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.431 -0.89 . . . . 0.93 112.341 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.865 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . . . -59.89 -156.63 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.958 -0.386 . . . . 1.38 109.958 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -145.15 114.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.059 0.762 . . . . 0.79 113.059 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.945 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 p -64.71 109.91 3.43 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.59 107.028 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 12.3 Cg_endo -54.48 147.63 46.8 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.159 1.906 . . . . 0.85 112.767 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.927 ' HA ' HG23 ' A' ' 77' ' ' ILE . 47.8 Cg_exo -37.22 120.53 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.378 2.719 . . . . 0.76 113.666 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.54 ' OG ' HG13 ' A' ' 76' ' ' VAL . 28.2 p -87.21 101.98 14.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.05 -0.523 . . . . 1.28 110.128 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.8 tt0 0.41 111.05 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.991 1.316 . . . . 1.77 114.292 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 51.9 Cg_exo -48.61 167.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.156 1.904 . . . . 0.55 113.19 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -105.91 143.88 33.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.064 -0.971 . . . . 1.23 109.038 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.579 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -28.36 144.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.187 0.929 . . . . 1.63 112.555 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.67 111.02 15.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.41 110.911 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.784 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.2 mp -88.8 120.29 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.7 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.7 m -57.82 -13.02 3.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.812 -0.631 . . . . 0.44 112.408 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.784 ' H ' HG22 ' A' ' 95' ' ' ILE . 26.4 p 43.77 70.62 0.3 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.887 0.375 . . . . 1.1 111.287 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -101.1 -87.95 0.38 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.982 -0.554 . . . . 3.0 111.187 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.38 8.61 7.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 2.14 111.485 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.9 t0 . . . . . 0 C--N 1.334 -0.108 0 CA-C-O 120.844 0.354 . . . . 2.06 110.93 -179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.97 HD11 ' ND2' ' A' ' 80' ' ' ASN . 7.3 tt . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 121.464 0.65 . . . . 0.68 112.341 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -134.22 119.71 14.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 2.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.8 171.35 18.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.501 2.134 . . . . 0.5 112.79 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 45.6 Cg_exo -56.72 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.805 2.337 . . . . 0.71 112.556 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 -171.33 39.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.85 -0.691 . . . . 0.66 112.576 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 33.8 tttt -73.76 128.96 85.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.369 0.128 . . . . 1.52 110.825 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 20.4 Cg_exo -69.19 143.92 55.24 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.44 112.713 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.19 97.41 5.23 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.586 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.3 Cg_exo -50.14 128.82 23.51 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.252 1.968 . . . . 0.64 113.493 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 21' ' ' LYS . 2.8 mm? -83.97 -35.43 23.97 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.184 -1.043 . . . . 1.64 108.184 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -139.83 144.48 37.32 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.583 -1.19 . . . . 0.72 107.891 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -136.35 102.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.778 0.659 . . . . 0.96 112.778 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -106.42 144.3 33.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.33 -0.85 . . . . 1.46 110.173 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -46.33 -23.69 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.693 -0.685 . . . . 2.42 112.78 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 17' ' ' THR . 7.8 m170 -125.9 -1.59 7.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.505 0.557 . . . . 1.02 112.505 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' HIS . 1.8 p -157.91 115.23 2.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.943 0.401 . . . . 0.68 110.487 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 HG22 ' A' ' 13' ' ' ILE . 57.9 t -119.0 114.57 45.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.8 112.032 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 12.7 m -83.34 146.82 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.35 109.928 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.28 160.17 43.38 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.847 0.684 . . . . 0.52 112.847 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.725 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.49 147.92 32.69 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.854 -1.066 . . . . 1.84 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.4 p90 -142.68 -177.8 5.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.4 111.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 176.62 7.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.83 112.049 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -115.95 143.33 30.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.742 -0.663 . . . . 2.11 110.899 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 73.5 Cg_exo -51.55 -179.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.531 2.154 . . . . 0.89 112.426 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.157 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 3.1 pm0 -125.69 -35.27 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 2.77 111.927 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -106.73 -69.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.173 0.434 . . . . 1.37 112.173 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 40.9 p 56.2 40.42 30.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.91 110.426 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.22 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.873 -0.68 . . . . 1.01 112.109 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.34 35.0 1.59 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.362 -1.095 . . . . 0.98 110.362 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.663 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 3.1 m-85 -113.16 -178.11 3.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.812 -0.694 . . . . 0.87 111.71 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 1.41 2.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.697 -0.683 . . . . 2.26 112.224 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 79' ' ' LYS . 7.3 mt 57.97 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.117 0.484 . . . . 1.71 111.769 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -132.79 6.97 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.021 -0.536 . . . . 1.15 111.997 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -179.41 142.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.865 0.364 . . . . 1.58 111.474 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 35.6 m-85 -113.85 109.6 18.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.844 -0.617 . . . . 0.76 111.423 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -89.29 104.6 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.14 110.63 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -99.3 119.0 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.63 111.209 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -80.12 163.08 24.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.649 -0.705 . . . . 1.67 111.236 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -118.82 168.07 11.11 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.658 -0.701 . . . . 1.97 109.285 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.94 87.05 0.98 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.793 -0.763 . . . . 1.44 111.386 177.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.842 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -66.51 85.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 1.59 110.963 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -61.94 159.4 36.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.595 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.9 Cg_exo -80.83 21.67 9.18 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.261 -1.141 . . . . 1.43 113.703 0.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.403 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 67.2 m-80 -132.41 -85.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.027 -0.269 . . . . 2.66 110.536 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.94 -164.7 0.02 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.073 -0.584 . . . . 1.12 112.945 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.51 145.07 3.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 2.41 110.491 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 53.7 m95 -65.58 77.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.638 -0.71 . . . . 0.65 111.786 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -112.78 156.65 22.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.998 -0.547 . . . . 1.28 109.855 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -50.25 90.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.689 0.281 . . . . 1.3 111.24 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB2' ' CB ' ' A' ' 40' ' ' LYS . . . -60.2 -31.63 70.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.29 0.567 . . . . 0.86 109.514 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.776 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.9 p-10 -91.69 -145.41 0.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.289 -0.868 . . . . 2.01 110.492 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 175.85 -33.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.86 0.362 . . . . 2.08 110.194 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -91.92 171.53 9.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.89 110.738 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.63 105.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.87 111.086 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 52' ' ' ASN . 14.4 mt -87.98 53.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.69 110.306 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.3 tm? -44.2 -54.6 5.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.978 -0.556 . . . . 1.6 111.233 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -84.07 158.95 21.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.089 -0.505 . . . . 1.54 109.974 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.481 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 12.4 p30 -80.37 4.68 17.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.43 -0.35 . . . . 1.75 111.587 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -98.38 94.34 6.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.013 -0.736 . . . . 2.05 109.013 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 74.3 t80 -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.142 0.496 . . . . 0.48 112.052 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.507 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 10.9 m -133.74 109.62 9.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.42 110.954 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.74 HG21 ' CE1' ' A' ' 74' ' ' PHE . 27.8 m -67.42 114.31 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 1.08 111.238 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -117.42 129.44 55.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.892 -0.594 . . . . 1.33 111.21 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.21 6.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.9 112.857 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.33 -158.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 1.47 110.548 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.6 m -138.04 147.78 44.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.496 -0.32 . . . . 1.06 110.181 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -82.5 142.01 32.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 1.91 111.332 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t0 65.94 60.08 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.547 . . . . 1.87 111.36 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.66 128.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 0.49 110.919 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.81 143.53 50.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.806 0.336 . . . . 0.36 110.422 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 2.0 m-85 -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.529 0.566 . . . . 0.56 112.529 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.793 ' OE1' ' HB2' ' A' ' 94' ' ' ALA . 6.5 tp10 -101.54 140.55 35.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.018 -0.734 . . . . 1.5 109.018 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.74 ' CE1' HG21 ' A' ' 63' ' ' VAL . 8.6 m-85 -123.82 110.54 15.02 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.668 0.988 . . . . 0.6 113.668 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 ttm180 -90.32 159.83 16.43 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.636 -0.711 . . . . 2.11 109.962 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 47.8 t -130.7 120.7 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.536 0.939 . . . . 0.6 113.536 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.6 mt -123.33 153.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.703 -1.591 . . . . 0.7 106.703 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -173.21 123.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.417 -1.313 . . . . 0.6 113.937 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 33' ' ' ILE . 18.4 mttt -68.21 158.8 32.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.97 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -99.8 -91.35 0.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.843 -0.743 . . . . 2.19 111.805 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -133.89 -42.63 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.276 0.472 . . . . 1.08 112.276 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.663 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -95.05 40.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.33 0.493 . . . . 1.06 112.33 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.73 8.72 41.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.93 113.196 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.75 92.66 4.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.0 0.4 . . . . 1.38 109.947 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -62.71 107.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.28 0.474 . . . . 0.79 112.28 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 8.3 p -62.89 121.92 71.46 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.005 -0.739 . . . . 0.59 109.005 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.59 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.266 . . . . 0.85 112.624 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 4.2 Cg_exo -73.3 155.37 51.34 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.822 2.348 . . . . 0.76 112.829 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.26 135.34 53.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.626 -0.715 . . . . 1.28 110.304 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.4 tt0 -35.24 110.89 0.42 Allowed Pre-proline 0 N--CA 1.469 0.503 0 O-C-N 124.0 0.812 . . . . 1.77 111.848 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 75.3 Cg_exo -50.96 145.46 24.55 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.827 2.351 . . . . 0.55 114.4 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.62 149.86 41.76 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.608 -0.886 . . . . 1.23 108.608 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -34.12 155.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.076 0.86 . . . . 1.63 112.093 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -89.31 110.82 21.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.41 111.847 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.664 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.2 mp -88.22 112.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.44 111.167 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.486 HG21 ' NH1' ' A' ' 98' ' ' ARG . 85.6 m -42.77 -29.9 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.004 0.43 . . . . 0.44 110.87 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.531 ' H ' HG22 ' A' ' 95' ' ' ILE . 84.7 m 51.07 69.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 1.1 110.439 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.486 ' NH1' HG21 ' A' ' 96' ' ' THR . 1.5 ptp85 -111.87 -87.51 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 3.0 110.824 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 1.2 p30 -123.49 0.27 8.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.111 -0.495 . . . . 2.14 110.884 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.2 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 2.06 111.71 -179.886 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.9 tt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.818 0.342 . . . . 0.68 110.89 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 28' ' ' THR . 9.8 m-20 -130.12 135.08 26.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 2.0 110.193 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -83.3 175.16 8.5 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.558 2.172 . . . . 0.5 112.837 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -65.18 171.64 8.71 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.914 2.409 . . . . 0.71 112.676 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.74 173.04 53.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.007 -0.616 . . . . 0.66 112.831 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -63.9 123.23 81.12 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.498 0.149 . . . . 1.52 110.677 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 34.8 Cg_exo -65.27 131.1 27.25 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.453 2.102 . . . . 0.44 112.699 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 108.01 20.74 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.007 -0.542 . . . . 1.09 110.575 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 39.0 Cg_exo -58.94 115.07 2.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.471 2.114 . . . . 0.64 113.976 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -77.71 -38.43 47.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.885 -0.783 . . . . 1.64 108.885 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -133.73 145.36 49.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.8 -1.091 . . . . 0.72 108.701 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.071 HG22 HG13 ' A' ' 18' ' ' VAL . 1.7 pt -141.0 97.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.598 0.592 . . . . 0.96 112.598 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.96 147.7 23.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.643 -0.708 . . . . 1.46 109.34 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -53.5 -18.28 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.226 0.454 . . . . 2.42 112.226 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.463 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 2.5 m-70 -126.78 -4.22 6.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.272 0.471 . . . . 1.02 112.272 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 116.46 5.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.873 0.368 . . . . 0.68 111.107 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 13' ' ' ILE . 66.6 t -105.25 134.41 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.009 0.433 . . . . 0.8 111.167 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 m -111.96 122.47 47.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.35 110.669 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.98 149.23 52.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.753 0.787 . . . . 0.52 112.203 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.936 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 7.0 tptt -133.09 139.01 46.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.427 -1.261 . . . . 1.84 109.704 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.9 p90 -128.64 -174.98 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.056 0.455 . . . . 0.4 111.881 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.23 179.33 5.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.83 112.044 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -107.88 138.68 20.13 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 2.11 110.221 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 28' ' ' THR . 79.9 Cg_exo -44.21 171.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.418 2.079 . . . . 0.89 112.613 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -110.89 -25.06 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 2.77 111.992 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.51 -69.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.158 0.429 . . . . 1.37 112.158 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 25' ' ' PRO . 64.4 p 51.37 56.22 8.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.91 110.704 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.12 -93.46 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.966 -0.561 . . . . 1.01 112.844 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.02 32.95 1.05 Allowed Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.008 -1.237 . . . . 0.98 110.008 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.99 179.54 3.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.738 -0.731 . . . . 0.87 111.009 -178.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.34 -3.17 3.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.179 -0.464 . . . . 2.26 112.185 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.1 mt 61.27 138.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.921 0.391 . . . . 1.71 110.606 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -140.78 24.72 2.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 1.15 111.525 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.2 m -166.51 102.69 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 1.58 111.618 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 33.8 m-85 -98.12 115.64 28.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.76 110.454 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -104.63 112.71 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.14 111.199 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -101.54 114.59 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 0.63 110.74 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -79.6 151.24 30.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.522 -0.763 . . . . 1.67 110.347 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -121.27 140.13 52.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.168 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.699 ' O ' HD22 ' A' ' 43' ' ' LEU . 9.5 ttp180 -121.73 116.4 24.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.44 110.371 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -76.57 102.69 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 1.59 110.798 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.6 mm? -88.65 156.83 50.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.531 -0.304 . . . . 0.9 110.738 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -91.54 36.27 6.24 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.152 -1.187 . . . . 1.43 112.377 0.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.47 83.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 2.66 111.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -155.74 -164.82 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.207 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.627 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.77 172.57 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 2.41 111.279 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.651 ' O ' HD22 ' A' ' 49' ' ' LEU . 68.4 m95 -78.8 118.36 20.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.57 -0.741 . . . . 0.65 112.212 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -147.37 127.03 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.28 110.649 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.24 99.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 1.3 111.625 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.31 -38.37 89.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.246 0.546 . . . . 0.86 110.338 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.5 p-10 -70.4 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.01 110.963 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 172.44 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.76 0.314 . . . . 2.08 110.461 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -81.33 -159.77 0.29 Allowed 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.35 -0.386 . . . . 1.89 110.641 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -102.94 97.83 7.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 1.87 111.05 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 36' ' ' TYR . 28.8 mt -81.25 87.94 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.69 111.127 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.45 -53.74 9.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 1.6 111.074 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.64 164.82 21.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.54 110.562 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -81.21 4.55 19.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.46 . . . . 1.75 111.644 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.936 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.9 tp10 -106.93 96.21 6.27 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 120.802 0.335 . . . . 2.05 110.179 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 67.3 t80 -124.43 164.36 19.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.48 111.298 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.0 m -132.14 114.06 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.42 110.959 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.484 HG23 HD21 ' A' ' 66' ' ' LEU . 24.6 m -76.21 133.05 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.08 111.064 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 133.01 49.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.973 -0.558 . . . . 1.33 110.949 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.89 -2.16 4.76 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.683 -0.77 . . . . 0.9 113.145 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -58.38 -173.67 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.975 0.417 . . . . 1.47 111.232 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -139.76 141.61 36.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.806 -0.634 . . . . 1.06 110.634 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 6.6 mt-10 -64.57 146.51 54.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.095 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 5.9 m-20 63.83 57.36 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 1.87 111.344 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.03 124.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.706 0.289 . . . . 0.49 111.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -66.4 138.07 57.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.522 -0.308 . . . . 0.36 110.172 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.71 117.57 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.448 0.536 . . . . 0.56 112.448 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.646 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.72 144.2 28.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.906 -0.776 . . . . 1.5 108.906 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.796 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -135.59 115.39 12.98 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.24 1.2 . . . . 0.6 114.24 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.2 ptp180 -105.59 177.97 4.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.987 -1.116 . . . . 2.11 107.987 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -154.24 126.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 122.257 1.027 . . . . 0.6 113.225 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' SER . 11.3 mt -105.45 152.99 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.7 106.958 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.11 135.92 8.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.01 -1.076 . . . . 0.6 112.762 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HG2' HD12 ' A' ' 85' ' ' ILE . 5.5 mttt -80.16 -169.63 2.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.526 -0.761 . . . . 1.98 110.384 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.739 ' ND2' HD12 ' A' ' 2' ' ' ILE . 3.7 p30 -135.54 171.74 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.195 0.522 . . . . 2.19 111.336 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.94 -25.07 1.22 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.754 . . . . 1.08 111.859 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.15 -20.67 28.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.267 0.469 . . . . 1.06 112.267 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 79' ' ' LYS . . . 110.32 -18.37 28.02 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.279 -0.962 . . . . 0.93 112.319 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.685 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -62.09 144.35 55.41 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 110.203 -0.295 . . . . 1.38 110.203 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -94.17 117.8 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.79 112.008 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.1 p -78.77 127.94 78.54 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.549 -0.75 . . . . 0.59 110.259 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -34.69 159.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.592 2.861 . . . . 0.85 114.076 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 6.2 Cg_exo -74.28 138.74 25.37 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.06 2.507 . . . . 0.76 112.555 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.531 ' OG ' HG13 ' A' ' 76' ' ' VAL . 79.1 p -88.76 130.47 35.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.132 -0.485 . . . . 1.28 110.016 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -34.53 122.51 0.55 Allowed Pre-proline 0 N--CA 1.469 0.478 0 O-C-N 123.743 0.652 . . . . 1.77 112.338 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 33.7 Cg_exo -55.97 145.58 73.39 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.456 2.104 . . . . 0.55 113.345 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.12 149.12 35.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.606 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -36.0 142.26 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.829 0.705 . . . . 1.63 112.128 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.09 112.69 14.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.41 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -93.11 118.16 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.252 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 98' ' ' ARG . 88.7 m -48.51 -37.83 18.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.202 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 69' ' ' ASP . 66.9 m 55.49 90.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.809 0.338 . . . . 1.1 110.767 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -143.65 -86.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 3.0 110.378 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.847 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -107.8 -11.09 15.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 2.14 110.849 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.209 -0.45 . . . . 2.06 111.716 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.787 HD11 ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.74 0.305 . . . . 0.68 111.245 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -128.65 148.45 68.47 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0 111.551 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.38 160.12 14.94 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.98 2.453 . . . . 0.5 112.937 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.4 Cg_endo -54.64 -176.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.898 2.399 . . . . 0.71 112.378 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -176.45 51.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.901 -0.666 . . . . 0.66 112.492 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -74.13 128.05 86.93 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.412 -0.218 . . . . 1.52 110.412 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 14.2 Cg_exo -72.28 126.72 11.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.297 1.998 . . . . 0.44 112.872 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.73 105.99 50.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.613 -0.721 . . . . 1.09 109.502 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.6 Cg_exo -43.12 92.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.364 2.043 . . . . 0.64 113.98 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.453 HD23 ' CG2' ' A' ' 19' ' ' THR . 1.9 tp -57.74 -29.45 64.77 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.315 -0.857 . . . . 1.64 109.335 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -159.99 153.35 22.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.161 -0.927 . . . . 0.72 108.966 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.136 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 1.4 pt -142.72 141.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.361 0.6 . . . . 0.96 112.446 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.633 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -138.56 142.91 39.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.154 -0.93 . . . . 1.46 109.886 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -44.92 -24.47 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.609 0.596 . . . . 2.42 112.609 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -125.19 -6.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.402 0.519 . . . . 1.02 112.402 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.11 111.09 5.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.68 110.92 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 HG22 ' A' ' 13' ' ' ILE . 69.6 t -106.1 122.02 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.8 111.514 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.8 m -99.38 135.47 40.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.35 110.825 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -137.7 143.36 41.23 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.662 0.744 . . . . 0.52 111.338 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -126.81 149.59 49.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.66 -1.155 . . . . 1.84 110.011 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.1 p90 -143.61 -175.69 4.67 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.279 0.561 . . . . 0.4 112.367 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.63 -174.03 4.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 0.83 111.428 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 137.3 21.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 2.11 109.941 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 28' ' ' THR . 6.2 Cg_exo -36.12 153.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.245 2.63 . . . . 0.89 112.736 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.06 -40.31 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 2.77 111.862 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -130.98 -63.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 1.37 111.804 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 25' ' ' PRO . 6.1 p 52.31 45.22 28.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.91 110.793 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.25 -112.11 0.91 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.188 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.44 28.35 5.3 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.408 -1.077 . . . . 0.98 110.408 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -114.07 173.97 6.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.159 -0.52 . . . . 0.87 110.991 -178.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.72 10.4 2.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.26 111.759 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.6 mt 59.33 116.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.942 0.401 . . . . 1.71 111.103 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -109.25 28.81 8.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 1.15 111.425 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 174.3 106.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.747 0.308 . . . . 1.58 111.329 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 33' ' ' ILE . 57.7 m-85 -94.38 124.74 38.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.76 110.969 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.4 mm -97.23 142.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 1.14 109.594 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.86 94.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.754 -0.378 . . . . 0.63 111.994 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 3.0 mt-10 -68.13 137.85 55.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.244 -0.651 . . . . 1.67 109.244 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.1 134.67 53.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 1.97 111.589 -179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HG2' HD12 ' A' ' 43' ' ' LEU . 8.7 ttp180 -108.6 104.46 13.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.78 -0.646 . . . . 1.44 109.895 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.28 82.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 1.59 110.665 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 41' ' ' ARG . 3.6 mp -50.56 155.83 1.73 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 0.9 111.088 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.34 32.71 7.58 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.653 -1.395 . . . . 1.43 112.836 0.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 -77.24 0.38 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.79 0.328 . . . . 2.66 111.108 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . 51.16 -175.2 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.82 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.92 30.54 0.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.962 0.41 . . . . 2.41 110.646 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 71.2 m95 45.25 96.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.65 111.59 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.448 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -131.01 123.55 29.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.841 -0.618 . . . . 1.28 110.217 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 10.8 ptpt -48.42 137.92 10.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.3 110.967 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -123.66 -36.51 2.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.86 111.553 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB3' HD11 ' A' ' 56' ' ' ILE . 2.5 p-10 -41.75 -62.56 0.87 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.509 -0.314 . . . . 2.01 111.696 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 t80 45.91 30.22 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.507 -0.315 . . . . 2.08 111.39 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.41 30.36 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 1.89 111.284 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 45.74 95.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.44 -0.345 . . . . 1.87 111.337 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 61' ' ' PHE . 7.5 mt -86.32 90.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.69 111.246 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.67 -44.13 67.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.158 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -100.13 153.36 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.92 0.39 . . . . 1.54 110.658 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 20.9 p-10 -66.3 -10.46 42.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 1.75 111.527 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HG3' ' CG ' ' A' ' 21' ' ' LYS . 2.9 tt0 -93.77 99.19 11.63 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.938 -0.764 . . . . 2.05 108.938 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.695 ' CG ' HD13 ' A' ' 56' ' ' ILE . 81.6 t80 -129.35 162.61 27.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.947 -0.701 . . . . 0.48 112.596 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 71.8 m -125.16 114.52 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.198 -0.91 . . . . 0.42 111.222 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.633 HG23 HD21 ' A' ' 20' ' ' LEU . 48.7 t -80.73 120.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.841 -0.618 . . . . 1.08 110.958 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -117.28 162.33 18.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.243 0.544 . . . . 1.33 110.988 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.26 -2.22 31.19 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.381 -0.827 . . . . 0.9 112.903 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -67.17 -176.1 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.077 0.465 . . . . 1.47 110.732 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.474 HG22 ' OH ' ' A' ' 72' ' ' TYR . 1.7 t -140.55 144.11 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.745 -0.661 . . . . 1.06 110.453 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.465 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 tt0 -64.55 144.28 57.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.25 -0.432 . . . . 1.91 110.782 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.4 t0 71.76 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.87 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.61 122.56 0.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.497 -0.32 . . . . 0.49 111.51 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.04 132.11 43.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.36 109.96 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.474 ' OH ' HG22 ' A' ' 67' ' ' THR . 52.1 m-85 -128.72 123.26 32.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.392 0.515 . . . . 0.56 112.392 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -101.7 144.15 30.76 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.699 -0.852 . . . . 1.5 108.699 178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -130.51 114.93 16.11 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.27 1.582 . . . . 0.6 115.27 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 21.4 ttm-85 -99.7 157.51 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.361 -0.977 . . . . 2.11 108.361 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.881 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -135.05 128.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.232 -0.987 . . . . 0.6 112.819 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 86' ' ' SER . 57.0 mt -117.96 156.04 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.094 -1.412 . . . . 0.7 107.371 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.45 116.78 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 118.896 -1.122 . . . . 0.6 112.657 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 1.6 mmtp -59.13 -177.83 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.077 -0.649 . . . . 1.98 109.552 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.787 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.1 m120 -130.61 163.3 27.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.093 0.473 . . . . 2.19 111.498 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.2 -26.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.141 0.793 . . . . 1.08 113.141 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -102.84 11.57 37.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.907 0.706 . . . . 1.06 112.907 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 88.56 -2.16 84.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.266 -0.969 . . . . 0.93 113.273 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -68.97 120.53 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.139 0.47 . . . . 1.38 109.887 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -79.81 102.05 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.603 -0.439 . . . . 0.79 111.88 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.5 p -61.81 111.3 4.23 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.369 -0.604 . . . . 0.59 109.369 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -40.81 173.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.676 2.918 . . . . 0.85 114.608 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.07 128.88 24.07 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.098 2.532 . . . . 0.76 112.824 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.881 ' OG ' HG13 ' A' ' 76' ' ' VAL . 3.8 p -97.89 119.03 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.811 -0.631 . . . . 1.28 109.957 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -20.24 119.8 0.1 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.009 0.924 . . . . 1.77 112.673 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 27.8 Cg_exo -63.39 156.51 55.75 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.655 2.237 . . . . 0.55 114.385 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.487 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.67 149.73 25.11 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.022 -0.99 . . . . 1.23 109.316 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -37.44 158.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.869 0.731 . . . . 1.63 111.771 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -91.08 108.08 19.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.41 111.053 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.767 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -90.93 114.35 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.541 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 85.4 m -52.4 -31.16 32.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.1 m 57.04 93.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.34 . . . . 1.1 110.113 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -143.87 -86.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.501 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.67 -2.52 24.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 2.14 111.716 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.136 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.301 0 N-CA-C 112.564 0.579 . . . . 2.06 112.564 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 86' ' ' SER . 11.8 tt . . . . . 0 CA--C 1.521 -0.15 0 CA-C-O 120.95 0.405 . . . . 0.68 111.135 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 2' ' ' ILE . 79.0 m-20 -137.7 127.3 15.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.76 154.2 34.21 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.256 1.971 . . . . 0.5 112.054 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.65 -179.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.717 2.278 . . . . 0.71 113.098 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.81 -157.15 3.69 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.66 112.749 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -91.41 134.08 30.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.7 -0.111 . . . . 1.52 110.7 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.0 Cg_exo -77.44 132.44 12.33 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.647 2.232 . . . . 0.44 112.157 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.1 123.29 10.33 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.445 -0.343 . . . . 1.09 111.538 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.631 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.8 Cg_exo -68.39 129.83 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.282 1.988 . . . . 0.64 112.822 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.379 -0.6 . . . . 1.64 109.379 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.65 100.89 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.72 109.609 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.742 HG21 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -98.68 140.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.92 -0.582 . . . . 0.96 112.071 -179.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -135.74 144.26 45.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.534 -0.757 . . . . 1.46 111.001 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 1.8 mtp180 -33.05 -47.97 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.58 0.956 . . . . 2.42 113.58 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -106.73 -14.49 15.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.338 0.866 . . . . 1.02 113.338 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' HD22 ' A' ' 66' ' ' LEU . 15.3 p -147.77 129.51 15.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.65 -0.42 . . . . 0.68 111.42 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.99 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -117.1 152.49 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.641 -0.423 . . . . 0.8 110.604 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.543 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.1 m -119.39 118.84 32.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.35 111.168 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.808 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.28 155.63 47.98 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.428 0.632 . . . . 0.52 111.288 179.176 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.61 159.64 42.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.031 -0.986 . . . . 1.84 109.905 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.48 ' N ' ' HD3' ' A' ' 21' ' ' LYS . 11.8 p90 -137.93 -171.83 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.4 111.756 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.6 -171.93 3.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.83 111.591 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -124.22 139.71 33.35 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 2.11 111.0 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 28' ' ' THR . 16.8 Cg_endo -58.65 179.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.89 112.106 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.17 0.29 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.156 0.428 . . . . 2.77 112.156 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -132.56 -72.6 0.52 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 121.082 -0.247 . . . . 1.37 111.126 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 25' ' ' PRO . 6.0 p 42.77 55.28 4.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.614 0.245 . . . . 0.91 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.54 1.3 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.217 -0.516 . . . . 1.01 112.671 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.57 30.29 5.8 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.444 -1.063 . . . . 0.98 110.444 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.517 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.38 177.91 4.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.971 -0.614 . . . . 0.87 111.531 -178.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 -2.14 3.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.715 -0.675 . . . . 2.26 111.941 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.713 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.9 mt 55.75 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-O 121.007 0.432 . . . . 1.71 110.746 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -106.18 17.82 22.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 1.15 111.651 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.67 138.98 0.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.804 0.335 . . . . 1.58 111.594 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 56' ' ' ILE . 48.3 m-85 -120.25 141.94 49.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.115 -0.493 . . . . 0.76 110.342 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' A' ' 50' ' ' LYS . 10.9 mm -108.17 156.24 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 1.14 110.767 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.452 -0.34 . . . . 0.63 111.123 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt-10 -77.85 120.81 23.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 1.67 109.574 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -106.33 148.84 27.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.362 0.601 . . . . 1.97 111.961 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 3.2 ttp180 -131.06 111.42 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.158 -0.928 . . . . 1.44 109.557 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.3 79.88 1.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.611 -0.722 . . . . 1.59 110.528 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.728 HD12 ' HB1' ' A' ' 94' ' ' ALA . 16.0 mt -63.54 142.66 97.96 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.9 110.858 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -93.64 13.42 47.9 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.059 -1.226 . . . . 1.43 112.765 0.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -130.44 86.77 2.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.751 0.31 . . . . 2.66 111.007 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.52 173.17 44.37 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.584 -0.817 . . . . 1.12 112.718 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.677 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -135.16 143.2 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 2.41 110.589 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 83.2 m95 -50.02 103.43 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.65 111.234 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.677 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -133.79 141.57 47.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.488 -0.323 . . . . 1.28 110.603 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' A' ' 37' ' ' ILE . 46.2 mtpt -44.87 104.7 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.872 0.368 . . . . 1.3 111.36 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -69.98 -51.04 35.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.079 -0.51 . . . . 0.86 110.655 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.72 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -53.22 -64.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 2.01 109.872 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 t80 62.33 38.23 13.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.405 -0.361 . . . . 2.08 111.487 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -160.44 -89.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.71 -0.223 . . . . 1.89 111.495 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.732 HD21 HD22 ' A' ' 57' ' ' LEU . 4.3 t-20 -158.87 141.21 14.01 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.913 0.387 . . . . 1.87 110.688 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 61' ' ' PHE . 41.7 mt -139.28 65.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.69 110.729 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.732 HD22 HD21 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -48.71 -63.28 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.6 111.2 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -82.74 160.72 22.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.936 0.398 . . . . 1.54 110.527 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.469 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -72.25 -7.25 48.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.958 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 2.9 tt0 -97.41 97.91 9.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.79 -0.448 . . . . 2.05 109.79 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.85 ' HB2' HG23 ' A' ' 56' ' ' ILE . 62.4 t80 -129.82 165.2 22.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.0 -0.546 . . . . 0.48 111.354 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 18' ' ' VAL . 43.9 m -122.03 121.75 37.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.962 -0.563 . . . . 0.42 110.508 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.947 HG13 ' HB1' ' A' ' 51' ' ' ALA . 25.1 t -80.61 100.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.952 -0.567 . . . . 1.08 111.56 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.542 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -94.29 138.16 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.78 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.3 -13.11 4.63 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.869 -0.681 . . . . 0.9 112.385 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.99 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -55.74 -173.83 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.708 0.29 . . . . 1.47 110.462 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 m -152.01 163.71 38.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 1.06 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 tt0 -74.97 123.42 25.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 1.91 110.887 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.4 t0 75.11 65.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.043 -0.526 . . . . 1.87 111.498 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.6 113.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.899 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.46 133.73 53.06 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.766 -0.374 . . . . 0.36 110.202 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 29.3 m-85 -126.29 118.11 24.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.21 -0.45 . . . . 0.56 112.191 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.15 141.45 34.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 1.5 109.933 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.61 115.81 10.44 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.366 1.247 . . . . 0.6 114.366 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 6.0 ptt85 -97.63 163.75 12.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.927 -0.768 . . . . 2.11 108.927 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' CG ' ' A' ' 8' ' ' PRO . 48.7 t -116.94 133.82 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.778 0.659 . . . . 0.6 112.778 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 88' ' ' PRO . 40.6 mt -132.98 165.62 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.726 -1.213 . . . . 0.7 107.726 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 77' ' ' ILE . . . 177.07 134.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.908 -0.717 . . . . 0.6 112.107 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.4 ptpt -67.17 -99.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.653 -0.819 . . . . 1.98 109.289 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.63 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER 170.43 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 110.497 -0.186 . . . . 2.19 110.497 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.66 -42.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.029 -0.419 . . . . 1.08 110.729 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.08 -10.27 59.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.574 . . . . 1.06 112.237 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.21 -11.29 40.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.178 -1.01 . . . . 0.93 112.501 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.86 115.87 4.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.112 -0.329 . . . . 1.38 110.112 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.9 tp -72.81 122.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.374 0.509 . . . . 0.79 112.374 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.686 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.6 p -89.36 131.74 39.52 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.959 -0.386 . . . . 0.59 109.959 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 74.3 Cg_exo -41.11 173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.571 2.847 . . . . 0.85 114.311 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 77' ' ' ILE . 87.9 Cg_endo -87.56 172.79 5.63 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.235 2.623 . . . . 0.76 113.727 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -130.57 125.29 33.8 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.165 -0.925 . . . . 1.28 109.561 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -19.98 114.63 0.11 Allowed Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.228 0.955 . . . . 1.77 113.224 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 87.1 Cg_exo -47.7 144.02 11.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.699 2.266 . . . . 0.55 113.653 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.67 143.12 46.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.422 -0.808 . . . . 1.23 108.83 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -31.69 135.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.294 0.996 . . . . 1.63 112.568 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.25 99.78 1.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.623 -0.717 . . . . 0.41 109.718 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -77.46 109.4 11.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 0.44 110.946 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 59.5 m -49.12 -25.67 2.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.065 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' H ' HG22 ' A' ' 95' ' ' ILE . 80.4 m 52.43 38.39 25.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 1.1 110.744 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 1.033 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 17.2 ptp180 -71.98 -47.53 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 3.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 1.033 ' OD1' ' HG3' ' A' ' 98' ' ' ARG . 20.1 p-10 -161.34 33.98 0.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.468 -0.787 . . . . 2.14 110.284 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 2.06 111.61 -179.136 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.933 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.5 tt . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.975 0.416 . . . . 0.68 111.753 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.141 ' OD2' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.82 114.53 13.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 2.0 110.458 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.24 171.73 13.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.996 1.797 . . . . 0.5 112.126 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 34.5 Cg_exo -59.24 179.32 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.839 2.359 . . . . 0.71 112.789 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -86.91 171.44 42.85 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.094 -0.574 . . . . 0.66 113.051 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 tttt -59.72 125.14 79.25 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 110.326 -0.25 . . . . 1.52 110.326 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 19.4 Cg_exo -71.53 143.74 43.32 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.44 113.035 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.24 105.45 7.89 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 1.09 110.537 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 31.7 Cg_exo -54.11 128.76 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.277 1.985 . . . . 0.64 113.676 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 21' ' ' LYS . 1.3 mm? -95.81 -26.68 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.697 -0.683 . . . . 1.64 109.531 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -152.52 152.41 31.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.737 -0.665 . . . . 0.72 110.478 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.59 111.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.94 0.4 . . . . 0.96 110.287 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -109.16 69.0 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.841 0.682 . . . . 1.46 112.841 -178.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 1.7 mtp180 28.1 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 2.42 113.147 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.7 OUTLIER 176.69 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.213 0.53 . . . . 1.02 109.596 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 p -112.25 93.7 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.68 110.708 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.881 HG11 ' CE1' ' A' ' 74' ' ' PHE . 48.0 t -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.558 -0.746 . . . . 0.8 110.789 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 56.0 m -90.13 144.27 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.35 111.9 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.62 165.65 32.72 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.962 -1.017 . . . . 0.52 111.903 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.757 ' HB3' HD21 ' A' ' 11' ' ' LEU . 15.6 tptm -143.47 138.72 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.744 -1.117 . . . . 1.84 110.13 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.0 p90 -125.83 -176.56 3.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.4 111.962 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -100.71 116.98 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.528 -0.76 . . . . 0.83 110.972 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 144.21 49.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.523 -0.308 . . . . 2.11 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HG3' HD12 ' A' ' 33' ' ' ILE . 58.2 Cg_endo -70.19 169.92 18.32 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.614 2.209 . . . . 0.89 112.412 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.32 -45.8 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 2.77 111.048 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.141 ' C ' ' OD2' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -89.75 66.06 6.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.846 -0.342 . . . . 1.37 111.286 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.541 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 61.5 p -95.88 50.9 1.22 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.631 -0.507 . . . . 0.91 109.631 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.16 -93.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.74 -0.663 . . . . 1.01 112.303 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.32 26.81 2.79 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.22 -0.752 . . . . 0.98 111.22 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.535 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -118.28 -175.5 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.143 0.497 . . . . 0.87 111.41 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 5.48 2.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.579 -0.737 . . . . 2.26 111.876 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.1 mt 60.91 134.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.081 0.467 . . . . 1.71 110.654 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 p -108.1 2.37 22.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.15 112.087 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' ILE . 8.7 t -176.63 -176.12 0.7 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.58 111.85 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.7 m-85 -149.45 100.36 3.0 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.76 109.664 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mt -84.65 121.87 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.943 -0.303 . . . . 1.14 111.304 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.17 103.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.161 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 18.5 mt-10 -74.74 133.74 41.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.659 -0.497 . . . . 1.67 109.659 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.633 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -116.88 147.68 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 1.97 111.853 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 16.0 ttp180 -123.66 114.44 19.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.79 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -77.42 78.67 3.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.022 -0.535 . . . . 1.59 110.655 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.6 mt -52.78 154.27 5.05 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.9 110.827 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.19 0.35 34.38 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.688 -1.38 . . . . 1.43 113.213 0.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -97.64 -85.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.28 . . . . 2.66 111.11 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.31 175.98 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.697 -0.763 . . . . 1.12 112.581 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD3' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -164.2 30.1 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.097 0.475 . . . . 2.41 110.309 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 57.8 m95 50.21 94.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.65 110.984 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -127.64 126.67 42.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 1.28 110.622 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -42.14 93.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 1.3 111.522 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -54.71 -51.31 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.86 110.971 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -65.08 114.45 4.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.943 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.35 16.13 7.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 2.08 111.198 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -136.72 -160.15 1.03 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 1.89 110.981 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -98.77 113.48 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.87 111.134 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 52' ' ' ASN . 20.3 mm -87.56 59.03 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.69 110.854 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.4 tp -43.59 -57.87 2.93 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.91 0.386 . . . . 1.6 110.613 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 pt-20 -79.0 165.94 22.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -88.11 15.65 7.16 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.995 0.368 . . . . 1.75 111.995 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.7 111.6 18.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.372 -0.603 . . . . 2.05 109.372 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.717 ' CG ' HD12 ' A' ' 56' ' ' ILE . 73.7 t80 -139.73 163.36 32.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.48 112.051 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.2 m -114.03 106.13 14.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.06 -0.973 . . . . 0.42 110.668 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 51' ' ' ALA . 90.8 t -66.8 82.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.44 -0.8 . . . . 1.08 111.312 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -88.03 -175.3 5.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 1.33 110.936 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 23.93 72.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.9 112.782 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 63' ' ' VAL . 14.0 mt -97.1 -162.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 1.47 111.021 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 68' ' ' GLU . 52.0 m -138.0 159.4 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 1.06 111.025 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 67' ' ' THR . 23.8 tt0 -90.13 148.34 23.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 1.91 111.109 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.4 40.69 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.87 111.224 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -155.37 131.45 10.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.49 110.845 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.86 135.41 45.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.483 -0.326 . . . . 0.36 110.361 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 30.5 m-85 -130.89 124.79 31.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.399 0.518 . . . . 0.56 112.399 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.4 tt0 -102.97 139.24 38.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.631 -0.878 . . . . 1.5 108.631 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.881 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.08 118.85 13.15 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.26 1.578 . . . . 0.6 115.26 -178.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -105.22 179.67 4.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.283 -1.006 . . . . 2.11 108.283 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.2 OUTLIER -144.43 121.3 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.439 -0.905 . . . . 0.6 113.328 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 88' ' ' PRO . 61.7 mt -106.99 152.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.138 -1.43 . . . . 0.7 107.138 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -163.92 115.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.029 -1.068 . . . . 0.6 112.809 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -62.29 -175.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.85 -0.74 . . . . 1.98 109.644 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.933 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.1 m-80 -120.9 -114.13 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.569 -0.453 . . . . 2.19 111.572 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.93 -38.38 2.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.412 0.551 . . . . 1.08 111.361 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -92.19 23.46 3.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 1.06 111.588 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.83 0.74 89.87 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.628 -0.796 . . . . 0.93 113.311 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.94 112.83 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.987 0.394 . . . . 1.38 110.635 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.817 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -79.66 112.41 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.071 0.397 . . . . 0.79 112.071 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 5.4 p -71.59 121.45 84.44 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 120.433 -0.507 . . . . 0.59 109.81 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.51 164.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.827 2.352 . . . . 0.85 112.609 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HG3' HD11 ' A' ' 77' ' ' ILE . 3.8 Cg_exo -76.47 130.22 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.892 2.395 . . . . 0.76 112.895 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.608 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -76.88 131.71 38.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.28 109.482 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.447 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 10.8 mt-10 -32.98 119.57 0.43 Allowed Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 123.689 0.618 . . . . 1.77 112.349 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 52.4 Cg_exo -52.4 150.43 20.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.465 2.11 . . . . 0.55 113.197 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 142.57 29.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.475 -0.784 . . . . 1.23 109.207 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.658 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.74 140.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.07 0.856 . . . . 1.63 112.142 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -74.08 112.3 10.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.773 -0.648 . . . . 0.41 110.699 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -98.8 117.75 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.44 111.369 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 70' ' ' ALA . 48.3 m -48.38 -28.33 3.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.327 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 95' ' ' ILE . 3.1 m 55.6 59.2 4.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.44 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 1.051 ' HD2' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.9 -42.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.252 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 1.051 ' OD1' ' HD2' ' A' ' 98' ' ' ARG . 7.7 p-10 -116.05 22.65 12.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.761 -0.654 . . . . 2.14 111.428 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 4.8 p-10 . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.841 0.829 . . . . 2.06 111.314 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 2' ' ' ILE . 2.0 tt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.861 0.362 . . . . 0.68 111.049 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 28' ' ' THR . 71.4 m-20 -107.71 123.25 38.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.62 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.67 172.75 10.02 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.241 1.961 . . . . 0.5 112.276 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.9 Cg_endo -61.39 171.15 4.5 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.839 2.359 . . . . 0.71 112.68 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 -177.66 30.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.947 -0.644 . . . . 0.66 112.671 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tptt -68.5 118.47 60.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.253 -0.277 . . . . 1.52 110.253 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 21.8 Cg_exo -67.51 122.91 10.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.387 2.058 . . . . 0.44 111.733 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.76 112.69 28.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.518 -0.31 . . . . 1.09 111.303 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.6 Cg_exo -61.88 120.27 7.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.547 2.164 . . . . 0.64 113.5 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -84.56 -31.83 24.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 1.64 109.665 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -143.22 145.78 33.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.72 109.635 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.064 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -144.07 96.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.7 0.63 . . . . 0.96 112.7 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.105 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -82.87 158.65 22.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.225 -0.658 . . . . 1.46 109.225 178.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -60.61 -13.23 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.068 0.396 . . . . 2.42 112.068 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . 2.1 m-70 -139.08 25.55 2.49 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.952 0.353 . . . . 1.02 111.952 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -176.95 116.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.696 0.284 . . . . 0.68 110.922 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.064 HG13 HG22 ' A' ' 13' ' ' ILE . 86.4 t -105.38 137.26 35.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.392 . . . . 0.8 111.114 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.635 ' C ' HD13 ' A' ' 20' ' ' LEU . 16.6 m -117.91 122.37 43.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.552 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.757 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.33 152.67 51.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.739 0.78 . . . . 0.52 112.07 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 11' ' ' LEU . 9.5 tptt -133.35 155.03 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.411 -1.268 . . . . 1.84 109.707 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 20.9 p90 -145.34 -177.54 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 0.4 112.176 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.75 159.48 15.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.83 111.357 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -88.23 137.52 30.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.012 -0.54 . . . . 2.11 110.238 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' ILE . 2.6 Cg_endo -41.27 160.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.595 2.197 . . . . 0.89 111.929 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.74 -29.6 11.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.498 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -122.85 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 1.37 111.562 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 46.54 54.44 8.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.809 0.337 . . . . 0.91 110.863 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 37.79 -131.83 1.34 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.803 -0.635 . . . . 1.01 113.128 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 29.87 9.12 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.178 -1.169 . . . . 0.98 110.178 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -96.49 175.3 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.679 -0.761 . . . . 0.87 111.286 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -136.89 0.2 2.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.551 . . . . 2.26 112.255 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.449 HD11 ' HG3' ' A' ' 25' ' ' PRO . 27.7 mt 60.69 138.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 121.007 0.432 . . . . 1.71 111.004 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 p -120.2 -11.91 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.202 0.445 . . . . 1.15 112.202 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.61 138.51 2.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 1.58 111.54 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.0 m-85 -105.08 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.76 110.855 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -82.17 165.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.764 -0.458 . . . . 1.14 109.764 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -157.46 137.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.563 0.697 . . . . 0.63 111.164 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG3' HD12 ' A' ' 77' ' ' ILE . 6.1 mt-10 -105.35 134.53 48.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.767 -1.106 . . . . 1.67 110.185 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -103.79 146.97 27.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 1.97 111.194 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.7 ttm180 -119.44 113.96 21.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 1.44 110.581 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 92.79 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.316 -0.856 . . . . 1.59 109.69 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD11 ' HG3' ' A' ' 73' ' ' GLU . 7.8 mt -76.73 150.65 81.93 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.9 111.23 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -88.54 -2.22 62.59 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.741 -1.358 . . . . 1.43 113.038 0.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -123.67 79.46 1.7 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.886 0.374 . . . . 2.66 110.993 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.59 -166.16 10.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.797 -0.716 . . . . 1.12 112.377 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.634 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -157.95 151.25 23.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 2.41 110.898 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.714 ' O ' HD22 ' A' ' 49' ' ' LEU . 59.2 m95 -64.35 116.76 6.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.88 -0.6 . . . . 0.65 110.406 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.68 136.66 25.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.831 0.348 . . . . 1.28 111.206 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -44.82 110.09 0.21 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.3 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.78 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -84.85 -37.3 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.86 110.633 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.61 ' CB ' HD11 ' A' ' 56' ' ' ILE . 10.6 p-10 -82.43 178.6 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.569 . . . . 2.01 110.475 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 178.92 36.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 2.08 111.035 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.56 32.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 1.89 111.285 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.77 121.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.87 110.956 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 36' ' ' TYR . 22.3 mt -116.28 76.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.69 111.083 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.2 mt -59.43 -66.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.6 111.463 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 168.24 9.08 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.874 0.369 . . . . 1.54 110.674 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.8 m120 -86.61 8.06 23.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.077 -0.51 . . . . 1.75 111.419 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.84 103.88 12.74 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.694 0.283 . . . . 2.05 110.35 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' ILE . 65.1 t80 -135.16 163.12 30.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.48 111.677 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.1 m -122.93 117.23 25.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.644 -0.707 . . . . 0.42 111.216 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 51' ' ' ALA . 47.8 t -83.31 101.92 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.037 -0.529 . . . . 1.08 110.942 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 p -94.15 162.91 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.366 0.603 . . . . 1.33 110.997 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.49 7.35 24.38 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.969 -1.014 . . . . 0.9 111.983 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.3 mm? -54.33 168.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.264 0.554 . . . . 1.47 111.449 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -139.26 98.88 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.245 -0.889 . . . . 1.06 109.284 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.5 tm-20 -37.24 139.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.5 0.556 . . . . 1.91 112.5 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.18 42.34 0.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.726 -0.67 . . . . 1.87 110.827 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.27 124.48 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.49 111.532 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.79 137.77 54.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.945 -0.391 . . . . 0.36 109.945 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 30.6 m-85 -129.43 124.18 33.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.419 0.526 . . . . 0.56 112.419 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.847 ' HG3' HD11 ' A' ' 43' ' ' LEU . 12.0 mt-10 -100.96 141.72 33.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.473 -0.566 . . . . 1.5 109.473 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.46 ' HD2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.29 114.81 11.85 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.712 1.375 . . . . 0.6 114.712 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HD3' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.29 151.89 22.16 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.345 -0.613 . . . . 2.11 109.345 177.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -114.61 118.05 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.622 -0.831 . . . . 0.6 112.922 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' A' ' 88' ' ' PRO . 66.7 mt -103.41 136.45 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.993 -1.484 . . . . 0.7 106.993 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -151.33 139.28 19.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.502 -0.879 . . . . 0.6 111.965 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.721 ' HG2' HD12 ' A' ' 85' ' ' ILE . 19.5 mttp -66.8 -133.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.727 -0.789 . . . . 1.98 109.625 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.566 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -167.55 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.127 0.422 . . . . 2.19 110.153 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -154.15 -42.14 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.824 0.345 . . . . 1.08 110.754 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.38 -2.57 58.68 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.514 0.561 . . . . 1.06 112.514 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.09 62.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.249 -0.977 . . . . 0.93 113.332 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.25 81.16 3.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.155 0.502 . . . . 1.38 109.895 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.721 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -40.2 119.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 114.397 1.258 . . . . 0.79 114.397 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 3.8 p -73.06 109.36 6.08 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 106.765 -1.568 . . . . 0.59 106.765 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 9.4 Cg_endo -49.72 162.98 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.652 2.235 . . . . 0.85 113.799 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' A' ' 77' ' ' ILE . 53.2 Cg_exo -40.42 128.56 2.4 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.714 2.942 . . . . 0.76 114.53 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.538 ' OG ' HG13 ' A' ' 76' ' ' VAL . 78.2 p -102.19 100.88 11.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.127 -0.942 . . . . 1.28 110.268 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER 11.8 115.84 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 125.037 1.335 . . . . 1.77 114.387 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.535 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 6.5 Cg_exo -67.21 135.16 36.16 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.02 1.813 . . . . 0.55 113.011 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.33 144.05 56.18 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.339 -0.615 . . . . 1.23 109.339 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' HD12 ' A' ' 95' ' ' ILE . 8.8 m-20 -40.25 149.31 0.07 Allowed 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.66 0.6 . . . . 1.63 111.235 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -76.06 119.17 19.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.945 -0.571 . . . . 0.41 111.812 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.625 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -99.52 118.73 46.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.695 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 m -50.03 -38.0 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 0.44 111.124 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 2.8 m 62.23 43.96 8.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 1.1 110.503 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.558 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 1.4 ptp85 -84.96 -91.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.64 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.558 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 20.2 p-10 -113.46 28.19 8.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.541 -0.299 . . . . 2.14 110.406 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.105 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.228 0.537 . . . . 2.06 110.895 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 tt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.737 0.303 . . . . 0.68 111.057 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.12 131.71 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 2.0 110.654 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.73 168.6 15.81 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.589 2.193 . . . . 0.5 112.385 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 73.0 Cg_exo -49.12 179.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.453 2.102 . . . . 0.71 112.182 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.21 -167.17 42.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.66 112.815 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.69 114.21 22.93 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.642 -0.133 . . . . 1.52 110.642 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 13.3 Cg_exo -70.49 131.32 19.98 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.423 2.082 . . . . 0.44 112.494 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -142.55 106.92 5.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 1.09 111.66 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 78.3 Cg_exo -36.18 141.74 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.991 2.461 . . . . 0.64 112.79 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.14 -30.83 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.507 -0.553 . . . . 1.64 109.507 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.06 97.81 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 0.72 109.988 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.815 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -94.69 133.23 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.997 0.74 . . . . 0.96 112.997 -179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.735 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -127.85 137.86 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.95 -1.023 . . . . 1.46 110.092 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.735 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.35 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.006 1.113 . . . . 2.42 114.006 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.1 m170 -120.16 -22.33 6.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.641 0.608 . . . . 1.02 112.641 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' HD22 ' A' ' 66' ' ' LEU . 13.6 p -134.44 130.33 36.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.25 -0.278 . . . . 0.68 110.25 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.104 HG13 HD23 ' A' ' 66' ' ' LEU . 4.5 m -124.91 141.34 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.142 0.496 . . . . 0.8 112.103 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.3 m -106.95 151.64 25.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.35 109.788 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.51 152.02 37.32 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.532 0.682 . . . . 0.52 112.021 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.71 147.46 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.581 -1.19 . . . . 1.84 109.675 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 26.4 p90 -146.69 -174.0 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.4 111.282 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -164.79 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.83 110.784 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.426 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -137.08 139.87 29.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 2.11 110.858 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HB3' HG23 ' A' ' 28' ' ' THR . 93.3 Cg_exo -41.24 158.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.415 2.076 . . . . 0.89 111.952 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -112.49 -21.67 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.284 -0.417 . . . . 2.77 111.651 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -129.33 -71.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.049 -0.26 . . . . 1.37 111.66 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.5 p 51.26 45.42 27.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.91 110.37 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.79 -124.36 4.96 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.881 -0.6 . . . . 1.01 112.446 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.46 36.64 3.95 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.099 -1.201 . . . . 0.98 110.099 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.577 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -105.28 177.58 4.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.639 -0.781 . . . . 0.87 111.929 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 7.81 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.85 -0.613 . . . . 2.26 111.869 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.475 HD11 ' HG2' ' A' ' 25' ' ' PRO . 12.7 mt 59.18 146.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 121.077 0.465 . . . . 1.71 111.251 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 p -114.14 -31.99 6.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.021 -0.536 . . . . 1.15 112.44 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 135.43 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.947 0.351 . . . . 1.58 111.947 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.5 m-85 -88.74 89.34 7.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.76 111.263 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt -78.77 109.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 1.14 110.641 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.1 p -106.48 127.19 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.63 111.208 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.628 ' OE2' HD12 ' A' ' 77' ' ' ILE . 27.1 mt-10 -92.65 149.53 21.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.83 -0.623 . . . . 1.67 110.404 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.828 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.73 157.97 21.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.05 0.452 . . . . 1.97 110.975 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CZ ' ' CZ2' ' A' ' 48' ' ' TRP . 12.9 ttp180 -133.52 112.71 11.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.438 -0.801 . . . . 1.44 109.576 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.88 107.13 6.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 1.59 110.868 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.704 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -89.38 147.79 38.99 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 121.077 -0.249 . . . . 0.9 110.627 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -93.17 15.94 44.35 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.8 -1.333 . . . . 1.43 112.493 0.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.18 93.68 2.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.856 0.36 . . . . 2.66 110.966 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.21 -167.94 35.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.938 -0.648 . . . . 1.12 112.365 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -157.55 171.44 20.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.719 0.295 . . . . 2.41 111.211 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 62.3 m95 -70.06 121.78 18.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.65 111.941 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.54 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -142.06 137.62 31.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 1.28 110.598 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -46.94 92.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.4 . . . . 1.3 111.484 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.846 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -57.95 -61.45 2.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.86 110.232 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.816 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -74.32 132.8 42.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.501 -0.772 . . . . 2.01 110.266 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.57 35.49 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.167 -0.47 . . . . 2.08 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -142.28 -68.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.89 110.873 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 176.03 153.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.87 110.847 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.816 HD11 ' CB ' ' A' ' 52' ' ' ASN . 13.6 mt -148.78 62.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.69 110.596 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 57' ' ' LEU . 7.7 tp -54.29 -60.51 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.986 -0.552 . . . . 1.6 111.21 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -73.39 166.4 23.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.486 -0.325 . . . . 1.54 110.587 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 36.1 p30 -83.88 8.36 15.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 1.75 112.009 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -114.42 107.77 15.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.776 ' HB2' HG23 ' A' ' 56' ' ' ILE . 39.9 t80 -141.94 165.51 27.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.471 . . . . 0.48 111.832 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 33.4 m -119.52 121.49 39.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.698 -0.683 . . . . 0.42 111.059 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.846 HG13 ' HB1' ' A' ' 51' ' ' ALA . 15.0 t -86.05 109.05 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.287 -0.415 . . . . 1.08 111.189 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.03 132.16 44.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.981 -0.554 . . . . 1.33 110.841 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.03 -12.75 2.84 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.757 -0.735 . . . . 0.9 112.721 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.104 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -57.45 -171.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 1.47 110.667 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -160.59 155.14 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 1.06 110.629 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 12.9 mt-10 -66.97 144.11 56.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 1.91 111.101 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.929 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 62.44 43.79 7.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 1.87 111.443 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 115.65 3.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.869 0.366 . . . . 0.49 111.787 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.25 130.74 42.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.36 109.954 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 51.8 m-85 -124.15 118.97 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt-10 -99.04 145.14 27.41 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.364 -0.606 . . . . 1.5 109.364 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.93 119.41 14.87 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.319 1.229 . . . . 0.6 114.319 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.577 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.99 142.99 26.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.845 -0.616 . . . . 2.11 109.623 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 8' ' ' PRO . 51.5 t -99.79 107.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.59 0.589 . . . . 0.6 112.59 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.628 HD12 ' OE2' ' A' ' 39' ' ' GLU . 11.0 mt -106.76 151.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.536 -1.283 . . . . 0.7 107.536 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -177.18 140.93 0.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.835 -0.746 . . . . 0.6 111.816 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.763 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mtmt -74.97 -155.64 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.101 -0.64 . . . . 1.98 109.424 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -139.67 -80.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.85 0.357 . . . . 2.19 110.603 -179.272 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -159.73 -41.77 0.05 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.098 -0.501 . . . . 1.08 110.377 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.14 -13.67 60.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.955 -0.566 . . . . 1.06 111.93 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.79 58.49 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.424 -0.893 . . . . 0.93 113.0 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -51.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.032 0.416 . . . . 1.38 110.389 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.763 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER 128.88 112.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.734 1.272 . . . . 0.79 112.495 178.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -75.74 110.53 10.99 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 107.834 -1.173 . . . . 0.59 107.834 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 11.1 Cg_endo -52.8 165.07 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.341 2.027 . . . . 0.85 112.629 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 9.5 Cg_endo -51.56 135.37 48.09 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.132 2.554 . . . . 0.76 113.155 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -105.51 107.21 18.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.757 -0.656 . . . . 1.28 110.756 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 8.49 104.39 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.818 1.247 . . . . 1.77 114.013 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 73.4 Cg_exo -49.58 126.4 16.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.673 2.249 . . . . 0.55 113.579 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.426 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -57.51 149.31 21.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.006 -0.739 . . . . 1.23 109.006 178.754 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.85 149.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.729 0.643 . . . . 1.63 111.27 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . -78.89 115.36 18.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.496 -0.775 . . . . 0.41 110.13 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -89.41 107.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.075 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 91.1 m -44.05 -38.94 3.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.846 -0.615 . . . . 0.44 111.58 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' ASP . 71.2 m 54.07 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.998 -0.371 . . . . 1.1 109.998 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -88.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.881 0.372 . . . . 3.0 111.466 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -96.21 -10.59 27.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.298 -0.41 . . . . 2.14 111.226 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 t0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 2.06 110.977 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.687 HD11 ' OD1' ' A' ' 80' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.744 0.307 . . . . 0.68 110.799 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.101 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.11 121.41 15.62 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 2.0 111.058 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.92 156.6 52.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.428 2.085 . . . . 0.5 112.211 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.4 Cg_endo -52.44 -175.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.948 2.432 . . . . 0.71 112.58 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.69 168.41 43.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.66 112.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -56.23 125.29 64.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.63 -0.137 . . . . 1.52 110.63 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.5 Cg_exo -73.96 133.81 18.8 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.268 1.978 . . . . 0.44 111.242 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -136.23 111.07 9.96 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.318 0.488 . . . . 1.09 112.318 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 95' ' ' ILE . 27.4 Cg_exo -58.68 94.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.458 2.105 . . . . 0.64 113.296 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.64 -36.8 62.45 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.254 0.549 . . . . 1.64 109.753 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -138.53 152.55 48.32 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.286 -0.87 . . . . 0.72 109.582 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.927 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -141.34 97.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.411 . . . . 0.96 111.509 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -90.02 45.02 1.24 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.82 -0.627 . . . . 1.46 112.428 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 16.5 mtp180 56.73 -73.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.514 0.561 . . . . 2.42 112.514 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 14' ' ' THR . 10.0 m170 -76.92 -32.45 57.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 1.02 110.832 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.2 p -127.78 113.09 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.68 109.865 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HD13 ' A' ' 66' ' ' LEU . 10.3 m -110.9 119.15 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.634 0.73 . . . . 0.8 111.833 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.1 m -83.99 142.92 30.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.35 110.637 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.52 164.51 33.2 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.121 0.888 . . . . 0.52 111.76 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -158.09 152.56 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.449 -0.796 . . . . 1.84 110.808 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.5 p90 -140.57 -174.42 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.047 0.451 . . . . 0.4 111.76 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.92 -174.82 3.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.83 111.407 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tmtt? -119.42 138.02 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.11 110.533 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 28' ' ' THR . 77.9 Cg_exo -50.19 173.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.416 2.078 . . . . 0.89 112.11 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.8 -19.2 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 2.77 111.803 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.4 t80 -123.79 -70.92 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.22 0.452 . . . . 1.37 112.22 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 1.101 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 70.7 p 51.72 52.0 15.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.065 0.459 . . . . 0.91 110.078 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.7 -106.27 0.06 OUTLIER Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.689 -0.687 . . . . 1.01 112.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.39 37.39 2.14 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.468 -1.053 . . . . 0.98 110.468 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.3 m-85 -117.82 -178.58 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.094 -0.553 . . . . 0.87 111.583 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -140.66 -0.38 1.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.583 -0.735 . . . . 2.26 112.375 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CE1' ' A' ' 36' ' ' TYR . 11.8 mt 56.34 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.976 0.417 . . . . 1.71 111.437 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' SER . 31.1 p -114.25 23.72 12.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 1.15 111.605 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 46.1 t 178.55 135.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 1.58 111.352 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.818 ' CE1' HG21 ' A' ' 33' ' ' ILE . 49.9 m-85 -121.62 102.22 8.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.979 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -79.58 140.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.066 -0.346 . . . . 1.14 110.066 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.92 105.35 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.477 -0.329 . . . . 0.63 111.885 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 80.1 mt-10 -75.59 150.34 38.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.92 -0.77 . . . . 1.67 108.92 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.747 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -131.57 145.91 51.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.97 112.202 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 16.2 ttp180 -121.0 105.09 10.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.177 -0.919 . . . . 1.44 109.595 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.837 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 82.9 0.45 Allowed 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.861 -0.608 . . . . 1.59 110.491 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.52 HD21 ' OE1' ' A' ' 73' ' ' GLU . 3.1 mt -61.02 149.68 80.91 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.785 -0.643 . . . . 0.9 110.904 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.29 18.9 26.59 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.096 -1.21 . . . . 1.43 113.067 0.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -150.74 83.13 1.34 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.668 0.27 . . . . 2.66 111.386 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -103.83 -169.16 25.31 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.827 -0.701 . . . . 1.12 112.518 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -139.77 8.84 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.735 0.272 . . . . 2.41 111.735 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 19.5 m95 52.52 72.26 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.65 110.959 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -120.63 137.77 54.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 1.28 110.943 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.34 98.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 1.3 111.228 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.747 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.25 -51.11 71.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.86 110.498 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.7 p-10 -60.8 131.51 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 2.01 110.937 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 30.4 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 2.08 110.978 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t -138.89 -161.06 1.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 1.89 110.701 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.91 114.5 28.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.384 . . . . 1.87 111.186 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 36' ' ' TYR . 33.6 mt -100.86 80.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.69 110.852 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.19 -59.72 4.08 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.191 -0.459 . . . . 1.6 111.52 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -77.31 167.07 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.909 0.385 . . . . 1.54 110.695 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 53.3 p30 -84.01 4.93 27.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 1.75 111.615 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.17 100.69 10.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.702 -0.481 . . . . 2.05 109.702 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 56' ' ' ILE . 75.4 t80 -131.66 163.02 29.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.234 0.54 . . . . 0.48 112.2 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.45 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 42.8 m -131.61 124.54 30.17 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.254 -0.884 . . . . 0.42 110.01 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 HD11 ' A' ' 20' ' ' LEU . 7.4 t -82.81 94.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.072 0.463 . . . . 1.08 111.209 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -89.02 165.09 14.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.661 -0.699 . . . . 1.33 111.078 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.5 8.46 83.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.9 112.705 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.031 HD13 HG13 ' A' ' 18' ' ' VAL . 4.7 mt -58.82 -175.02 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.982 0.42 . . . . 1.47 110.775 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -131.5 133.23 44.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 1.06 110.471 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.3 tt0 -71.13 149.92 45.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.149 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.846 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 66.19 38.17 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 1.87 110.788 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.1 116.74 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.49 111.535 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.02 131.94 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.36 110.129 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 53.5 m-85 -125.33 127.15 46.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.658 0.614 . . . . 0.56 112.658 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' OE1' HD21 ' A' ' 43' ' ' LEU . 4.7 mt-10 -108.45 134.04 51.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.974 -1.121 . . . . 1.5 107.974 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.906 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.17 121.64 25.23 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.753 1.39 . . . . 0.6 114.753 -178.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' CA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -97.08 167.9 10.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.077 -0.51 . . . . 2.11 109.828 178.15 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' CG ' ' A' ' 8' ' ' PRO . 71.6 t -116.3 145.41 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.397 0.617 . . . . 0.6 111.974 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.772 HD11 ' HG3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -141.45 152.91 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -166.8 124.84 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.533 -0.867 . . . . 0.6 112.457 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.55 95.92 7.28 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.067 -0.653 . . . . 1.98 109.898 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.687 ' OD1' HD11 ' A' ' 2' ' ' ILE . 1.3 m120 -40.34 156.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 2.19 111.667 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -20.77 -47.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.193 1.183 . . . . 1.08 114.193 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.45 48.63 0.87 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.933 0.716 . . . . 1.06 112.933 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.83 37.65 9.45 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.4 -0.905 . . . . 0.93 113.248 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -78.3 1.02 23.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.88 0.371 . . . . 1.38 111.202 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 37.24 111.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 114.972 1.471 . . . . 0.79 114.972 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -93.27 111.45 51.98 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 113.909 -1.496 . . . . 0.59 107.022 177.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.3 Cg_endo -45.67 172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.026 2.484 . . . . 0.85 113.656 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.772 ' HG3' HD11 ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.32 92.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.085 2.524 . . . . 0.76 113.141 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -58.65 105.33 0.29 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.941 -0.572 . . . . 1.28 110.035 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.1 tt0 4.83 117.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.15 1.38 . . . . 1.77 114.346 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 48.5 Cg_exo -42.62 170.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.943 2.429 . . . . 0.55 114.03 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -102.19 139.1 38.26 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 114.944 -1.025 . . . . 1.23 109.355 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -38.08 127.54 1.3 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.273 0.983 . . . . 1.63 111.282 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -58.26 131.14 49.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.507 -0.769 . . . . 0.41 111.384 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -117.38 108.0 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.933 -0.576 . . . . 0.44 110.961 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.2 m -46.64 -37.23 7.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.44 110.824 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 59.7 m 59.85 37.71 21.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 1.1 110.777 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.16 -39.78 16.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 3.0 112.036 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' HA ' ' NE ' ' A' ' 15' ' ' ARG . 17.8 p-10 -156.09 24.65 0.37 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.382 -0.372 . . . . 2.14 111.457 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.6 p30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 2.06 112.088 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.769 0.318 . . . . 0.68 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 68.2 m-20 -122.52 134.86 25.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 2.0 110.462 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.55 160.7 10.9 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.593 2.195 . . . . 0.5 113.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 77.1 Cg_exo -52.53 167.61 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.058 2.506 . . . . 0.71 113.125 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.32 -179.88 38.47 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.37 -0.832 . . . . 0.66 112.226 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -66.9 124.21 88.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 O-C-N 122.846 -0.208 . . . . 1.52 110.688 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.6 Cg_exo -70.64 135.65 28.84 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.355 2.037 . . . . 0.44 112.178 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -130.41 115.44 17.28 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.288 -0.414 . . . . 1.09 111.214 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.5 Cg_exo -70.42 114.45 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.209 1.94 . . . . 0.64 113.575 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.703 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.84 -33.56 57.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.497 -0.927 . . . . 1.64 108.497 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -140.5 151.2 44.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.754 -1.112 . . . . 0.72 109.043 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.012 HG22 HG13 ' A' ' 18' ' ' VAL . 4.2 pt -140.87 97.59 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.489 0.551 . . . . 0.96 112.489 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.251 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -85.7 140.28 30.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 1.46 110.007 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -24.48 1.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 2.42 112.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 3.2 m80 -120.44 -1.75 10.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.393 0.516 . . . . 1.02 112.393 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 16' ' ' HIS . 17.2 p -160.5 119.61 2.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.601 0.239 . . . . 0.68 110.672 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.012 HG13 HG22 ' A' ' 13' ' ' ILE . 46.5 t -102.97 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.474 . . . . 0.8 111.668 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.7 m -109.85 121.82 46.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.819 -0.628 . . . . 0.35 111.405 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.762 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.94 161.8 35.04 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.676 0.75 . . . . 0.52 112.139 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -138.6 151.54 47.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.574 -1.194 . . . . 1.84 110.295 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.7 p90 -136.77 -178.05 5.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.264 0.554 . . . . 0.4 112.073 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.61 -154.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.417 -0.81 . . . . 0.83 110.395 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -155.08 127.16 3.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.748 -0.381 . . . . 2.11 111.727 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -46.32 179.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.181 2.587 . . . . 0.89 112.772 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -122.36 -10.06 8.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 2.77 111.971 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -116.76 -72.65 0.68 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.615 -0.434 . . . . 1.37 112.107 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 25' ' ' PRO . 68.6 p 49.63 47.03 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.1 0.476 . . . . 0.91 110.364 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.12 -93.39 0.01 OUTLIER Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.615 -0.721 . . . . 1.01 112.306 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.35 32.99 1.48 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.265 -1.134 . . . . 0.98 110.265 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.702 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.96 -172.8 2.46 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.752 -0.724 . . . . 0.87 111.314 -178.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 8.1 ptmt -145.33 39.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 2.26 111.077 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.126 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.4 mp 62.48 -81.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 1.71 110.492 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.418 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 2.9 p 59.6 29.59 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.15 111.493 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 172.23 94.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 1.58 111.4 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.126 ' CE1' HG21 ' A' ' 33' ' ' ILE . 58.6 m-85 -102.61 81.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.76 111.172 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -72.53 110.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.461 -0.495 . . . . 1.14 110.359 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.28 81.55 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -52.78 138.75 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.457 -0.572 . . . . 1.67 109.457 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.7 153.62 26.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.371 0.605 . . . . 1.97 112.152 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.39 98.52 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.054 -0.975 . . . . 1.44 110.201 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -75.2 76.74 2.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.875 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 73' ' ' GLU . 12.3 mt -57.27 138.26 80.65 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.9 111.131 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -92.2 17.36 42.15 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 124.009 -1.246 . . . . 1.43 112.763 0.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 42' ' ' ASP . 1.6 p-10 -121.84 53.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.51 -0.314 . . . . 2.66 111.398 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -104.35 173.89 21.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.507 -0.854 . . . . 1.12 112.329 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 1.018 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -165.92 42.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 2.41 110.997 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.569 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 20.8 m95 40.85 69.26 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.958 -0.565 . . . . 0.65 111.855 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.018 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -101.29 121.32 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.765 0.317 . . . . 1.28 110.389 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.94 92.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.454 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -62.61 -46.39 88.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.86 110.438 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.63 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.1 p-10 -62.57 127.11 29.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 2.01 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.73 -17.34 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 2.08 111.113 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -110.63 145.93 37.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 1.89 110.814 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -55.8 111.43 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 1.87 110.915 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 58' ' ' GLU . 19.7 mm -75.63 90.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.315 -0.402 . . . . 0.69 110.871 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.51 -38.23 65.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.965 0.412 . . . . 1.6 110.457 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -99.73 154.33 18.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 1.54 109.589 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 26.1 p-10 -75.3 -0.71 20.6 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.093 0.405 . . . . 1.75 112.093 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.655 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 2.5 tp10 -100.73 105.47 16.81 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.44 -0.578 . . . . 2.05 109.44 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.658 ' CD1' HD12 ' A' ' 56' ' ' ILE . 58.2 t80 -137.15 165.99 24.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.346 0.594 . . . . 0.48 111.922 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -133.06 100.4 4.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.205 -0.907 . . . . 0.42 110.843 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 14.9 m -57.29 142.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 1.08 111.04 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.497 ' OG ' HG22 ' A' ' 17' ' ' THR . 7.5 t -136.12 154.17 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.72 0.772 . . . . 1.33 111.131 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.16 -5.9 19.61 Favored Glycine 0 C--N 1.313 -0.711 0 CA-C-N 114.48 -1.236 . . . . 0.9 112.3 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.795 HD23 HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -62.85 -175.52 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.834 0.349 . . . . 1.47 110.815 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 m -149.35 130.66 14.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.435 . . . . 1.06 110.634 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 5.8 tt0 -50.92 149.35 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 1.91 111.085 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.84 48.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.87 110.793 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.2 130.81 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.49 111.625 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.82 135.13 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.36 110.243 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -131.8 121.77 24.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.926 0.393 . . . . 0.56 111.99 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' A' ' 43' ' ' LEU . 2.7 mt-10 -97.3 137.74 35.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.86 -0.792 . . . . 1.5 108.86 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.902 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -122.21 106.76 11.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.42 1.267 . . . . 0.6 114.42 -179.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -104.49 143.47 32.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.136 -0.938 . . . . 2.11 108.927 178.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.484 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -116.51 136.33 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.958 -0.697 . . . . 0.6 112.001 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.751 ' O ' HD12 ' A' ' 37' ' ' ILE . 33.9 mt -117.21 153.17 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.907 -1.042 . . . . 0.7 108.513 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -146.35 117.4 7.77 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.371 -0.531 . . . . 0.6 111.735 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 23.0 ptmt -86.89 14.75 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.15 0.796 . . . . 1.98 113.15 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 2.6 m-80 43.51 -179.91 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.074 1.138 . . . . 2.19 114.074 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -57.61 -50.26 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.972 -1.467 . . . . 1.08 112.372 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.702 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -88.79 34.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.584 0.587 . . . . 1.06 112.584 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.1 39.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.544 -0.836 . . . . 0.93 113.045 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.11 94.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 1.38 109.257 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.4 tp -61.04 107.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.294 0.85 . . . . 0.79 113.294 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.2 p -87.52 108.5 20.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.978 -1.119 . . . . 0.59 107.978 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.5 Cg_endo -42.01 172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.125 2.55 . . . . 0.85 113.883 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 54.1 Cg_exo -51.81 129.04 28.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.9 2.4 . . . . 0.76 112.466 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 15.2 m -99.94 106.12 17.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.334 -0.394 . . . . 1.28 110.419 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 1.92 117.69 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.243 0 O-C-N 124.696 1.248 . . . . 1.77 113.355 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.569 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 9.1 Cg_exo -69.29 160.59 49.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.803 1.669 . . . . 0.55 113.915 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -87.28 141.1 28.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.779 -1.193 . . . . 1.23 107.779 178.034 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.839 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -32.12 138.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.042 0.839 . . . . 1.63 112.201 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -67.53 101.25 0.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.158 -0.473 . . . . 0.41 111.063 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.6 mp -84.2 115.03 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.926 0.393 . . . . 0.44 111.053 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 23.8 m -52.45 -23.52 6.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.875 -0.602 . . . . 0.44 110.6 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.638 ' H ' HG22 ' A' ' 95' ' ' ILE . 7.6 m 50.12 84.34 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.089 0.471 . . . . 1.1 109.875 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -132.35 -87.36 0.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.716 -0.675 . . . . 3.0 110.979 -179.234 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 26.7 p-10 -93.28 21.9 5.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.125 -0.489 . . . . 2.14 110.631 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.251 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.273 0.559 . . . . 2.06 111.54 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.884 0.373 . . . . 0.68 111.422 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 18.0 m-20 -111.61 130.45 23.11 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 2.0 110.186 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.72 162.43 24.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.412 2.075 . . . . 0.5 112.38 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' N ' ' HG3' ' A' ' 25' ' ' PRO . 53.7 Cg_exo -54.39 178.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.929 2.419 . . . . 0.71 113.37 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.69 161.02 30.59 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.66 112.517 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.4 tttt -53.23 132.53 51.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 110.244 -0.28 . . . . 1.52 110.244 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HG3' HG23 ' A' ' 76' ' ' VAL . 4.5 Cg_exo -82.01 136.89 9.44 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.445 2.097 . . . . 0.44 112.396 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -130.87 121.23 18.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.09 110.849 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.7 Cg_exo -65.71 100.71 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.439 2.093 . . . . 0.64 113.417 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.685 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.95 -35.01 72.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.869 -0.789 . . . . 1.64 108.869 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -142.07 151.45 42.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.661 -1.154 . . . . 0.72 108.339 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.053 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -139.84 113.61 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.129 -0.629 . . . . 0.96 112.301 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.002 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.61 151.27 23.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.65 -0.705 . . . . 1.46 109.865 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HB2' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -64.29 -10.52 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.61 0.596 . . . . 2.42 112.61 -179.187 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 17' ' ' THR . 12.4 m80 -135.07 20.09 3.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.273 . . . . 1.02 111.323 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 168.13 114.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.68 109.956 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 ' CD1' ' A' ' 66' ' ' LEU . 14.5 m -108.4 146.68 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.594 -0.442 . . . . 0.8 110.632 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.533 ' C ' HD13 ' A' ' 20' ' ' LEU . 4.1 m -110.58 120.21 41.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.35 111.979 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.867 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -132.36 171.1 14.16 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.662 0.744 . . . . 0.52 111.804 178.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.67 173.22 16.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.024 -0.989 . . . . 1.84 109.123 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 3.1 p90 -138.37 -168.36 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.595 0.591 . . . . 0.4 112.595 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 24' ' ' LYS . . . -96.67 -13.41 22.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.83 113.416 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.464 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 74.34 149.84 0.13 Allowed Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 110.121 -0.325 . . . . 2.11 110.121 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 20.0 Cg_exo -65.96 -167.35 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.33 2.02 . . . . 0.89 113.047 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -148.74 -45.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 2.77 110.787 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.1 77.16 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.37 111.283 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 22.6 p -92.47 46.73 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.91 109.95 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.16 -98.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.546 -0.835 . . . . 1.01 111.653 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.2 29.48 2.92 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.578 -1.009 . . . . 0.98 110.578 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -117.38 174.39 6.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.091 -0.555 . . . . 0.87 111.071 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -0.58 4.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 2.26 111.457 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 23.3 mt 63.25 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.178 -0.304 . . . . 1.71 110.178 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -107.69 -15.25 14.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.715 0.635 . . . . 1.15 112.715 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -167.43 158.58 11.68 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.397 0.518 . . . . 1.58 112.397 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -117.36 131.4 56.79 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.76 110.014 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 5.6 mt -104.84 132.49 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.852 -0.613 . . . . 1.14 111.023 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 63' ' ' VAL . 5.1 t -110.33 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.265 -0.425 . . . . 0.63 111.278 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 14.0 mt-10 -85.42 131.2 34.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.532 -0.544 . . . . 1.67 109.532 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -102.32 129.26 48.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 1.97 111.854 -179.209 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 5.4 ttp180 -105.9 92.59 4.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.634 -0.712 . . . . 1.44 109.488 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -62.96 146.75 52.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.54 . . . . 1.59 109.574 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 10.0 mt -127.12 131.0 23.65 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.871 -0.332 . . . . 0.9 110.808 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 6.7 Cg_endo -88.5 38.98 3.14 Favored 'Cis proline' 0 C--N 1.352 0.726 0 C-N-CA 124.542 -1.024 . . . . 1.43 113.026 0.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -114.2 56.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.314 . . . . 2.66 110.607 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . -62.17 169.61 13.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.792 -0.718 . . . . 1.12 113.262 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.51 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.657 0.265 . . . . 2.41 111.628 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 68.5 m95 63.17 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.248 -0.279 . . . . 0.65 110.248 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.34 121.58 11.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.838 0.351 . . . . 1.28 110.796 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 6.2 ptpt -51.03 111.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 1.3 111.105 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -100.92 -11.94 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.896 -0.593 . . . . 0.86 111.258 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 56' ' ' ILE . 6.1 p-10 -74.21 -60.94 2.04 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.654 -0.418 . . . . 2.01 111.871 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 4.8 t80 78.37 -51.32 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.549 0.214 . . . . 2.08 111.409 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -173.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.036 0.446 . . . . 1.89 111.47 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -102.0 80.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.786 -0.643 . . . . 1.87 110.764 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.565 HD11 ' CB ' ' A' ' 52' ' ' ASN . 70.3 mt -71.11 103.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.69 110.733 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.36 -50.82 2.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.6 111.665 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -56.66 -20.26 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.137 0.421 . . . . 1.54 112.137 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.2 p-10 89.17 -25.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.71 0.804 . . . . 1.75 111.65 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -81.93 86.56 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.751 -0.833 . . . . 2.05 108.751 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 62' ' ' THR . 55.0 t80 -120.8 165.56 14.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.328 0.585 . . . . 0.48 111.998 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 18' ' ' VAL . 54.9 m -123.7 122.26 37.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.37 -0.832 . . . . 0.42 110.84 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 20' ' ' LEU . 9.6 t -81.91 95.7 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.159 0.504 . . . . 1.08 110.834 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 17' ' ' THR . 41.3 t -83.26 -158.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.495 -0.775 . . . . 1.33 110.74 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 57.72 19.62 36.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.511 -0.852 . . . . 0.9 112.248 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.037 ' CD1' HG13 ' A' ' 18' ' ' VAL . 68.7 mt -75.12 -176.97 3.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 1.47 110.607 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -144.59 144.29 31.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 1.06 110.68 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 22.2 tt0 -70.67 146.92 49.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 1.91 110.971 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.2 t0 60.4 41.23 16.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.551 . . . . 1.87 111.16 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -150.69 124.67 9.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.732 0.301 . . . . 0.49 111.347 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.056 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 68.8 m-85 -126.86 126.15 42.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.143 0.794 . . . . 0.56 113.143 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -100.01 137.72 38.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.219 -0.66 . . . . 1.5 109.219 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.993 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.89 116.88 23.64 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.486 0.921 . . . . 0.6 113.486 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -102.25 145.76 28.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.855 -0.612 . . . . 2.11 110.967 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG23 ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -105.94 104.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.479 0.548 . . . . 0.6 112.479 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.445 HG12 ' CA ' ' A' ' 88' ' ' PRO . 30.2 mt -105.03 147.77 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.9 -1.519 . . . . 0.7 106.9 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -166.04 144.04 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.16 -1.016 . . . . 0.6 112.74 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.02 -172.35 4.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 1.98 110.136 179.123 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 50.0 p30 -126.09 -128.52 0.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.391 -0.368 . . . . 2.19 110.279 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -116.06 -28.15 6.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.158 0.89 . . . . 1.08 111.24 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -82.02 4.75 21.66 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.179 0.437 . . . . 1.06 112.179 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.13 78.73 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.425 -0.893 . . . . 0.93 113.303 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -75.8 161.98 28.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.118 0.459 . . . . 1.38 110.448 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.9 tp -115.26 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 0.79 112.629 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 2.0 p -74.48 113.72 26.76 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.262 -0.644 . . . . 0.59 109.262 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.35 163.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.749 2.3 . . . . 0.85 113.041 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' CA ' HG12 ' A' ' 77' ' ' ILE . 28.1 Cg_endo -63.99 144.96 89.18 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.826 2.351 . . . . 0.76 113.126 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.0 m -98.99 127.17 44.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.593 -0.73 . . . . 1.28 109.963 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt0 -20.97 98.33 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 O-C-N 124.587 1.179 . . . . 1.77 113.067 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 42.0 Cg_exo -35.67 166.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.57 2.847 . . . . 0.55 115.574 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.514 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 1.5 m -93.32 141.49 28.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.02 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -39.87 139.42 0.65 Allowed 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 123.731 0.644 . . . . 1.63 111.412 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.37 102.23 2.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.017 -0.538 . . . . 0.41 109.923 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 13' ' ' ILE . 4.4 mp -84.26 111.74 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.941 0.401 . . . . 0.44 111.226 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 98' ' ' ARG . 66.8 m -47.63 -30.11 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.44 111.254 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.471 ' H ' HG22 ' A' ' 95' ' ' ILE . 79.2 m 49.6 89.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 1.1 110.323 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.77 -85.95 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 3.0 111.28 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.506 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.5 p-10 -101.72 2.37 38.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 2.14 111.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.053 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 112.359 0.503 . . . . 2.06 112.359 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.761 HD12 ' OD1' ' A' ' 80' ' ' ASN . 4.9 tt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.067 0.461 . . . . 0.68 111.312 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.325 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -133.86 128.17 19.65 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.615 -0.721 . . . . 2.0 109.875 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.62 176.37 9.17 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.42 2.08 . . . . 0.5 112.379 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 21.0 Cg_exo -65.39 178.29 2.17 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.809 2.339 . . . . 0.71 112.729 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.06 172.49 55.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.988 -0.625 . . . . 0.66 112.614 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.642 ' NZ ' ' OE2' ' A' ' 90' ' ' GLU . 10.0 tttp -58.66 120.44 45.49 Favored Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.021 -0.105 . . . . 1.52 110.722 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.761 ' CG ' HG23 ' A' ' 76' ' ' VAL . 22.2 Cg_exo -67.58 127.09 15.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.077 . . . . 0.44 112.802 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.6 p -133.18 107.46 12.37 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 115.821 -0.627 . . . . 1.09 111.158 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.1 Cg_exo -37.67 142.58 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.827 2.352 . . . . 0.64 113.292 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 19' ' ' THR . 0.5 OUTLIER -97.71 -44.63 6.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.747 -1.115 . . . . 1.64 108.372 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -148.11 155.61 41.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.997 -1.456 . . . . 0.72 109.061 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.01 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -143.85 100.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.436 -0.505 . . . . 0.96 111.69 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.252 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -98.87 50.13 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.943 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.831 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.68 -70.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.998 0.811 . . . . 2.42 112.075 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 8.4 m170 -77.41 -26.85 52.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 1.02 111.255 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -125.23 112.12 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.819 0.343 . . . . 0.68 111.148 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 13' ' ' ILE . 72.9 t -107.23 110.68 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.086 -0.506 . . . . 0.8 111.171 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 79.4 m -88.43 149.19 23.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.35 110.678 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.88 154.71 38.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.533 0.682 . . . . 0.52 112.148 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -143.86 144.83 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.737 -1.12 . . . . 1.84 110.171 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 10.9 p90 -140.57 -172.31 3.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 0.4 111.545 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.73 159.36 14.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.319 0.581 . . . . 0.83 112.337 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.4 139.59 28.36 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.32 -0.854 . . . . 2.11 110.057 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -44.85 169.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.336 2.024 . . . . 0.89 111.869 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -119.04 -4.87 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.099 0.407 . . . . 2.77 112.099 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.747 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.5 t80 -141.42 -73.89 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 1.37 111.933 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 1.325 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.8 p 79.6 -39.28 0.2 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.225 0.61 . . . . 0.91 112.315 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.7 -82.81 0.33 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.498 -0.858 . . . . 1.01 111.554 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.18 27.57 0.79 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.114 -1.194 . . . . 0.98 110.114 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.523 ' CE2' ' OD1' ' A' ' 80' ' ' ASN . 1.7 m-85 -116.94 -177.07 3.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.705 -0.748 . . . . 0.87 111.404 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.56 -3.06 2.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.652 -0.704 . . . . 2.26 111.923 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' HG3' ' A' ' 25' ' ' PRO . 15.0 mt 60.76 140.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 120.8 0.334 . . . . 1.71 110.506 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -123.96 6.74 8.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.359 0.503 . . . . 1.15 112.359 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 178.0 162.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.134 0.492 . . . . 1.58 111.965 179.867 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.722 ' O ' HD12 ' A' ' 56' ' ' ILE . 42.5 m-85 -128.76 101.11 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.411 -0.813 . . . . 0.76 110.3 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.8 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -87.62 122.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.623 -0.262 . . . . 1.14 110.888 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.6 p -110.84 128.61 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.044 0.449 . . . . 0.63 110.815 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mt-10 -90.0 136.17 33.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.91 -0.586 . . . . 1.67 112.227 -179.24 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -99.8 132.43 45.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.419 0.896 . . . . 1.97 113.419 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 7.5 ttm180 -115.4 107.61 15.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.484 . . . . 1.44 110.077 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 90.6 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.869 -0.605 . . . . 1.59 111.015 -179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -66.05 150.22 96.9 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.45 -0.341 . . . . 0.9 110.611 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.78 -9.25 47.24 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.086 -1.214 . . . . 1.43 112.794 0.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -60.26 -61.98 2.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.907 0.384 . . . . 2.66 110.725 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 85.36 142.92 6.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.916 -0.659 . . . . 1.12 112.839 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 176.3 64.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 2.41 110.692 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 80.9 m95 -33.89 98.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.446 -0.797 . . . . 0.65 111.881 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -125.23 139.52 53.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.189 0.519 . . . . 1.28 112.271 -179.326 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HD2' HG21 ' A' ' 37' ' ' ILE . 4.2 mtmt -57.33 86.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.549 -0.751 . . . . 1.3 110.868 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -59.31 -51.98 67.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.86 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.806 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.0 p-10 -61.49 150.94 34.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.01 111.189 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.88 27.67 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.786 -0.643 . . . . 2.08 110.544 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -130.68 30.41 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.89 110.727 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.52 111.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 1.87 110.734 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 52' ' ' ASN . 19.6 mt -101.32 71.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.69 111.275 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -50.84 -80.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.489 . . . . 1.6 110.85 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.97 168.63 5.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.996 -0.372 . . . . 1.54 109.996 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -88.81 47.11 1.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.992 0.425 . . . . 1.75 111.533 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -144.32 101.28 3.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 2.05 109.308 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' A' ' 56' ' ' ILE . 77.0 t80 -134.53 165.22 25.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.48 112.135 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 85.1 m -131.27 116.59 17.82 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.42 110.861 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 18' ' ' VAL . 7.2 m -77.42 110.06 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.08 111.045 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.24 126.18 51.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.059 -0.518 . . . . 1.33 111.098 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.97 -1.31 2.8 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.539 -0.839 . . . . 0.9 113.659 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -51.77 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.189 0.519 . . . . 1.47 111.302 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.1 m -135.45 117.02 14.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.631 -0.713 . . . . 1.06 110.7 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 1.4 tt0 -47.3 132.53 12.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.061 -0.518 . . . . 1.91 111.32 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 6.3 t0 73.77 67.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 1.87 111.243 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 177.27 124.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.49 111.064 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.37 130.81 43.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.36 110.454 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 38.4 m-85 -126.07 122.93 37.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.56 112.017 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.2 tt0 -107.22 141.32 38.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.282 -0.636 . . . . 1.5 109.282 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.55 125.16 16.8 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.153 1.168 . . . . 0.6 114.153 -179.24 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.775 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -100.38 165.83 11.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.034 -0.53 . . . . 2.11 109.78 178.592 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.761 HG23 ' CG ' ' A' ' 8' ' ' PRO . 46.9 t -122.95 114.08 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 113.557 0.947 . . . . 0.6 113.557 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 56.6 mt -108.11 154.85 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.562 -1.644 . . . . 0.7 106.562 177.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -167.39 131.27 1.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.955 -1.098 . . . . 0.6 113.473 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -83.67 143.32 30.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.655 -0.702 . . . . 1.98 109.288 178.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.761 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -78.89 -106.71 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.077 -0.511 . . . . 2.19 111.902 -178.952 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.01 -28.36 2.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.783 0.72 . . . . 1.08 112.622 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.85 20.78 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.429 0.529 . . . . 1.06 112.429 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 87.72 -17.04 47.49 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.378 -0.915 . . . . 0.93 112.772 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.339 . . . . 1.38 110.414 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.4 tt -77.81 112.18 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.494 . . . . 0.79 112.005 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.5 p -66.06 122.11 79.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.854 -0.612 . . . . 0.59 109.896 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -35.04 158.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.415 2.744 . . . . 0.85 113.45 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 12.0 Cg_exo -71.22 148.21 55.23 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.871 2.381 . . . . 0.76 112.423 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.42 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 3.0 m -97.32 129.49 44.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 1.28 109.748 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.642 ' OE2' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -30.8 111.67 0.29 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.805 0.691 . . . . 1.77 112.372 -179.476 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.7 Cg_exo -37.93 148.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.762 2.308 . . . . 0.55 113.629 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.423 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.66 139.66 31.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.062 -0.972 . . . . 1.23 109.457 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.646 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -32.72 139.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.28 0.988 . . . . 1.63 112.363 -179.75 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -75.47 109.93 9.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.558 -0.746 . . . . 0.41 110.731 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.1 mp -92.54 115.77 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.029 0.443 . . . . 0.44 111.225 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 86.1 m -47.22 -30.81 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.535 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.536 ' H ' HG22 ' A' ' 95' ' ' ILE . 91.5 m 54.19 62.39 2.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.91 0.386 . . . . 1.1 110.182 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -97.71 -86.84 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 3.0 111.623 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -116.83 28.33 8.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 2.14 110.662 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.252 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 2.06 111.543 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' CG ' ' A' ' 80' ' ' ASN . 2.0 tt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.917 0.389 . . . . 0.68 111.842 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -117.42 137.0 23.69 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.055 -0.52 . . . . 2.0 110.419 179.534 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 160.14 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.443 2.096 . . . . 0.5 112.418 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 172.3 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.822 2.348 . . . . 0.71 112.98 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.88 174.21 20.69 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.66 112.817 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -66.63 138.08 95.36 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 110.544 -0.169 . . . . 1.52 110.544 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.2 Cg_exo -77.87 139.32 17.43 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.818 2.345 . . . . 0.44 112.502 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.9 p -145.9 126.37 7.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.33 -0.395 . . . . 1.09 111.456 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.695 ' CG ' HD11 ' A' ' 95' ' ' ILE . 16.9 Cg_exo -66.87 141.21 58.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.76 2.307 . . . . 0.64 113.757 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.4 mm? -107.32 -36.17 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.627 -0.879 . . . . 1.64 108.627 178.379 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -139.36 150.73 45.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.614 -1.176 . . . . 0.72 108.297 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.929 HG21 HG12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -143.86 101.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.259 -0.576 . . . . 0.96 112.068 -179.279 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -93.89 56.89 2.37 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 115.881 -0.599 . . . . 1.46 110.863 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 47.84 -74.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.024 0.827 . . . . 2.42 112.886 179.389 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -73.99 -37.8 64.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.99 0.367 . . . . 1.02 111.99 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HB3' ' A' ' 64' ' ' SER . 72.3 p -122.46 110.27 15.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.718 0.294 . . . . 0.68 111.02 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 4.1 m -99.29 152.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.8 111.288 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.595 ' C ' HD13 ' A' ' 20' ' ' LEU . 13.9 m -118.21 123.92 46.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.35 111.32 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.52 162.74 32.27 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.413 0.625 . . . . 0.52 111.336 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.963 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -151.3 158.46 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 1.84 110.12 179.384 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.6 p90 -137.42 -167.82 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.4 111.316 -179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.11 -166.59 1.45 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.354 0.597 . . . . 0.83 112.367 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' HG2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -114.59 141.45 26.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.148 -0.933 . . . . 2.11 110.228 -179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' THR . 12.1 Cg_endo -55.35 172.63 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.247 1.965 . . . . 0.89 112.186 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.26 -39.17 2.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 2.77 111.106 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 1.8 t80 -120.28 71.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 1.37 111.478 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 25' ' ' PRO . 73.8 p -91.01 44.24 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.501 -0.318 . . . . 0.91 110.539 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.07 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.704 -0.76 . . . . 1.01 112.501 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.95 49.26 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.987 -1.245 . . . . 0.98 109.987 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.57 177.45 7.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.984 -0.608 . . . . 0.87 110.929 -178.208 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -138.53 6.31 2.5 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.09 0.404 . . . . 2.26 112.09 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.5 mt 58.52 150.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 120.851 0.358 . . . . 1.71 111.042 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -131.73 15.09 4.87 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.0 0.37 . . . . 1.15 112.0 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.616 ' H ' HG22 ' A' ' 33' ' ' ILE . 42.3 t 179.25 124.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 1.58 111.092 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.768 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.8 m-85 -105.38 88.21 2.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.76 111.195 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.483 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.4 mm -69.39 151.96 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.95 -0.3 . . . . 1.14 110.323 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.17 103.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.272 0.558 . . . . 0.63 110.782 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.51 161.92 29.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.367 -0.833 . . . . 1.67 110.04 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -136.41 153.35 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 1.97 111.391 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 23.7 ttm180 -134.69 121.33 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 1.44 110.801 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.818 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.56 91.62 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.593 . . . . 1.59 110.859 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -56.3 152.52 23.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.9 110.53 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.37 30.4 11.85 Favored 'Cis proline' 0 C--N 1.348 0.533 0 C-N-CA 123.911 -1.287 . . . . 1.43 112.573 0.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.99 99.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.368 . . . . 2.66 111.139 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.818 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -135.35 -123.12 2.29 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.685 -0.769 . . . . 1.12 112.89 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -135.03 -169.83 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.431 0.158 . . . . 2.41 110.716 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 4.4 m95 -136.33 49.67 2.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.65 110.946 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.5 148.3 25.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.28 111.231 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 37' ' ' ILE . 8.2 ptmm? -79.16 89.61 4.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.127 -0.488 . . . . 1.3 110.875 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -49.02 -41.83 36.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.01 0.433 . . . . 0.86 110.575 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.606 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 21.4 t-20 -60.46 100.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.796 -0.638 . . . . 2.01 110.159 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -104.86 28.66 6.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 2.08 111.321 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.3 t -130.47 -70.64 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.344 . . . . 1.89 111.005 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 170.58 153.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 1.87 110.588 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 61' ' ' PHE . 16.8 mt -142.09 56.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.69 111.253 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 tp -48.46 -38.24 19.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 1.6 110.747 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.721 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -92.77 166.74 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 1.54 110.161 179.67 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 56.6 p30 -89.22 15.12 9.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.496 -0.32 . . . . 1.75 111.651 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.963 ' OE1' ' HB3' ' A' ' 21' ' ' LYS . 19.7 tp10 -122.71 99.56 6.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 56' ' ' ILE . 26.1 t80 -131.71 166.6 21.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.007 0.432 . . . . 0.48 111.424 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' VAL . 21.6 m -117.58 120.67 38.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.42 111.076 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 20' ' ' LEU . 12.5 t -84.14 104.29 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.16 0.505 . . . . 1.08 111.507 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.774 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -94.5 -168.64 1.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.461 -0.79 . . . . 1.33 110.404 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.44 11.82 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.572 -0.823 . . . . 0.9 112.893 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.01 ' CD1' HG13 ' A' ' 18' ' ' VAL . 16.2 mt -69.18 -159.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.927 -0.397 . . . . 1.47 109.927 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.7 m -147.69 147.73 30.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.902 0.382 . . . . 1.06 110.594 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.1 mt-10 -81.78 145.82 30.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 1.91 110.988 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t0 67.65 39.4 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 1.87 111.058 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.95 122.91 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.49 111.452 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -68.78 133.22 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.36 109.884 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.43 ' HA ' HD22 ' A' ' 43' ' ' LEU . 35.6 m-85 -124.38 127.37 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.691 0.626 . . . . 0.56 112.691 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' CG ' HD21 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -98.05 138.24 35.66 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.178 -1.045 . . . . 1.5 108.178 178.225 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.42 108.7 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.523 -1.271 . . . . 0.6 113.937 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -88.67 159.72 17.7 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.112 -0.329 . . . . 2.11 110.112 179.041 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.649 HG23 ' CG ' ' A' ' 8' ' ' PRO . 64.6 t -121.2 122.84 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.427 0.632 . . . . 0.6 112.585 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 39.5 mt -117.06 155.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.719 -1.215 . . . . 0.7 107.719 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -172.4 138.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.378 -0.929 . . . . 0.6 112.178 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 33' ' ' ILE . 5.2 ptpt -84.57 176.53 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 1.98 110.766 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.739 ' CG ' HD12 ' A' ' 2' ' ' ILE . 2.4 p-10 -124.57 163.61 21.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.871 -0.604 . . . . 2.19 111.208 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.82 -25.53 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 1.08 111.906 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -77.22 -12.39 59.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.897 0.332 . . . . 1.06 111.897 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 -17.75 57.68 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.49 -0.862 . . . . 0.93 112.425 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -57.33 -162.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.54 0.209 . . . . 1.38 110.492 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -145.0 105.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.79 112.001 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -63.44 119.56 54.55 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.59 108.734 179.175 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.6 Cg_endo -48.98 159.25 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.89 2.393 . . . . 0.85 113.242 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 24.0 Cg_endo -62.56 150.78 86.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.907 2.405 . . . . 0.76 113.264 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 m -106.53 132.8 52.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.805 . . . . 1.28 109.651 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 13.7 tt0 -30.25 111.91 0.29 Allowed Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.867 0.73 . . . . 1.77 112.325 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.49 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 71.7 Cg_exo -45.66 139.57 10.15 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.787 2.324 . . . . 0.55 114.324 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -53.75 144.54 17.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.834 -0.802 . . . . 1.23 108.834 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 4.7 m-20 -14.62 -89.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.743 1.902 . . . . 1.63 113.793 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . 158.43 106.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.967 0.907 . . . . 0.41 109.239 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.929 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -98.04 112.99 31.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.756 -0.378 . . . . 0.44 111.956 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.4 m -47.44 -32.53 5.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.276 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 55.65 82.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.839 -0.618 . . . . 1.1 110.163 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -88.19 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.743 -0.662 . . . . 3.0 111.392 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -124.77 9.02 8.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.478 -0.328 . . . . 2.14 111.568 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.3 t0 . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.969 0.414 . . . . 2.06 110.893 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.446 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.914 0.387 . . . . 0.68 111.22 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.3 m-20 -128.87 132.09 24.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.077 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 158.1 53.15 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.368 2.045 . . . . 0.5 112.4 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 9.9 Cg_endo -52.03 175.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.943 2.429 . . . . 0.71 112.763 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.91 168.62 49.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.024 -0.608 . . . . 0.66 112.665 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -59.73 121.89 61.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 110.461 -0.199 . . . . 1.52 110.461 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.653 ' CG ' HG23 ' A' ' 76' ' ' VAL . 32.1 Cg_exo -62.17 147.85 94.29 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.426 2.084 . . . . 0.44 112.451 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -151.52 110.48 2.97 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.954 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.5 Cg_exo -59.63 127.34 23.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.613 2.209 . . . . 0.64 113.52 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -94.16 -26.37 16.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.373 -0.831 . . . . 1.64 109.081 178.512 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 7.5 t30 -145.85 149.53 34.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.696 -0.684 . . . . 0.72 109.897 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.051 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.56 103.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.415 . . . . 0.96 111.132 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.218 ' CA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.48 60.42 0.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.883 -0.599 . . . . 1.46 111.544 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.166 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 59.12 -70.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.671 0.607 . . . . 2.42 112.445 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.0 m170 -87.31 -27.18 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.185 -0.461 . . . . 1.02 111.762 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.8 p -111.86 103.47 11.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.68 111.424 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.051 HG13 HG22 ' A' ' 13' ' ' ILE . 86.9 t -102.07 95.73 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.8 111.038 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 78.3 m -80.96 142.52 33.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.248 -0.433 . . . . 0.35 111.636 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.731 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -154.85 164.77 38.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.43 -0.805 . . . . 0.52 112.009 -179.702 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.846 ' HB3' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.47 176.14 10.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.107 -0.951 . . . . 1.84 109.302 178.448 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.8 p90 -158.01 -177.54 6.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.275 0.56 . . . . 0.4 112.303 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.28 178.65 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.147 -0.933 . . . . 0.83 110.65 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 157.07 40.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.403 -0.362 . . . . 2.11 110.21 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' A' ' 28' ' ' THR . 37.1 Cg_exo -56.45 -157.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.506 2.138 . . . . 0.89 112.443 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -26.19 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.32 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -134.24 -67.73 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.856 0.317 . . . . 1.37 111.856 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' HG2' ' A' ' 25' ' ' PRO . 2.8 p 65.31 34.63 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.91 110.515 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.39 -95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.53 -0.843 . . . . 1.01 111.813 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.65 28.85 1.46 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.526 -1.029 . . . . 0.98 110.526 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HE1' ' HB2' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -107.01 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.193 -0.503 . . . . 0.87 111.591 -178.947 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -133.41 -0.41 3.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.66 -0.7 . . . . 2.26 111.706 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 35' ' ' SER . 2.9 mt 60.89 129.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 120.932 0.396 . . . . 1.71 110.901 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -116.71 25.99 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.442 -0.345 . . . . 1.15 111.63 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.564 ' H ' HG22 ' A' ' 33' ' ' ILE . 1.7 m 172.09 164.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 1.58 111.169 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.769 ' O ' HD12 ' A' ' 56' ' ' ILE . 40.7 m-85 -142.36 106.18 4.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.504 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -87.35 94.62 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 1.14 111.039 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -86.42 114.58 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.63 110.75 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 2.0 mm-40 -86.0 156.79 20.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.634 -0.712 . . . . 1.67 110.922 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.719 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -122.62 142.99 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 1.97 111.316 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -119.03 114.01 21.84 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.037 -0.529 . . . . 1.44 110.584 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.763 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.7 102.08 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.59 110.492 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 94' ' ' ALA . 46.8 mt -80.09 156.12 74.52 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.583 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 89.1 Cg_endo -86.26 28.64 9.63 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.88 -1.3 . . . . 1.43 113.489 0.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.3 -86.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.636 0.255 . . . . 2.66 110.555 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 117.43 170.69 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.456 -0.878 . . . . 1.12 113.208 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.763 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 1.0 OUTLIER 176.68 -35.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.407 . . . . 2.41 110.566 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 34.0 m95 62.92 81.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.65 111.406 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -122.54 128.67 51.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.759 -0.655 . . . . 1.28 110.234 179.786 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -55.11 87.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.76 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.719 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -51.4 -47.56 62.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.86 111.226 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' HB2' HD11 ' A' ' 56' ' ' ILE . 2.0 t30 -44.79 -79.2 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 2.01 110.983 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 84.46 -43.12 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.181 0.437 . . . . 2.08 112.181 179.624 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.2 m -67.02 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 1.89 111.28 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 140.13 1.05 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 1.87 110.798 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 36' ' ' TYR . 51.4 mt -130.16 67.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.69 110.982 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.09 -65.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.463 . . . . 1.6 110.751 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -74.42 179.27 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.549 . . . . 1.54 110.115 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 5.3 p-10 -93.7 13.24 22.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.398 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.846 ' CD ' ' HB3' ' A' ' 21' ' ' LYS . 16.1 tp10 -117.63 105.48 12.08 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.981 -0.377 . . . . 2.05 109.981 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.691 ' HB2' HG23 ' A' ' 56' ' ' ILE . 37.3 t80 -137.51 165.99 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.48 111.156 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.51 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -122.53 120.42 33.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.42 111.372 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 51' ' ' ALA . 5.5 t -83.17 85.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 1.08 111.029 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -86.98 -169.78 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.618 -0.719 . . . . 1.33 110.632 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.22 25.1 46.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.9 112.411 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.682 ' CD1' HG23 ' A' ' 18' ' ' VAL . 44.1 mt -77.63 -178.04 5.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.47 111.104 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 134.14 54.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 1.06 110.496 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.68 152.09 28.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 1.91 111.223 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 1.1 t70 66.73 60.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 1.87 110.985 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 178.13 130.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.49 111.359 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 128.63 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.36 110.194 179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 44.9 m-85 -124.21 124.92 43.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.846 0.684 . . . . 0.56 112.846 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 19.8 mt-10 -100.03 141.12 33.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.798 -0.815 . . . . 1.5 108.798 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.701 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -130.88 120.8 24.17 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.358 1.244 . . . . 0.6 114.358 -178.704 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -105.47 169.85 8.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.746 -0.661 . . . . 2.11 109.778 178.493 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' CG ' ' A' ' 8' ' ' PRO . 61.2 t -125.54 105.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.428 0.899 . . . . 0.6 113.428 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 88' ' ' PRO . 44.3 mt -100.59 130.57 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 106.934 -1.506 . . . . 0.7 106.934 177.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.91 147.74 21.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.452 -0.899 . . . . 0.6 113.046 -178.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mttt -77.31 -167.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 1.98 110.345 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 49.7 p30 -129.78 -119.5 0.23 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.475 -0.565 . . . . 2.19 109.475 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.02 1.14 5.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.49 1.041 . . . . 1.08 111.71 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . . . -112.01 4.32 18.02 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.597 0.221 . . . . 1.06 111.597 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.84 -11.76 64.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.344 -0.932 . . . . 0.93 112.929 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.96 177.03 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.936 0.368 . . . . 1.38 110.394 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -130.88 101.31 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.79 111.989 -179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -57.57 118.35 24.91 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.553 -0.906 . . . . 0.59 108.553 178.817 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.0 Cg_endo -42.8 171.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.896 2.397 . . . . 0.85 113.313 -178.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HG3' HD11 ' A' ' 77' ' ' ILE . 6.7 Cg_exo -71.3 130.73 17.9 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.778 2.318 . . . . 0.76 112.778 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -87.86 108.26 19.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.765 -0.652 . . . . 1.28 109.932 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -10.3 115.3 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.458 1.103 . . . . 1.77 113.401 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 89.2 Cg_exo -47.91 163.34 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.736 2.291 . . . . 0.55 114.217 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.38 151.99 19.95 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 1.23 109.48 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.57 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -32.33 140.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 124.3 1.0 . . . . 1.63 112.455 179.914 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.01 113.08 16.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.767 -0.651 . . . . 0.41 111.138 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.3 mp -97.57 116.29 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.44 110.828 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.6 m -46.17 -26.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.885 -0.598 . . . . 0.44 111.47 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 95' ' ' ILE . 34.2 m 47.34 78.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.571 -0.286 . . . . 1.1 111.273 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -121.87 -79.55 0.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.096 0.474 . . . . 3.0 110.99 179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.66 26.33 8.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.52 -0.764 . . . . 2.14 110.451 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.218 ' OD1' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.002 -0.545 . . . . 2.06 111.225 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.669 HD11 ' OD1' ' A' ' 80' ' ' ASN . 2.0 tt . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.735 0.302 . . . . 0.68 111.064 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' ILE . 13.1 m-20 -136.77 133.48 18.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 2.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.67 174.95 9.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.665 2.243 . . . . 0.5 112.439 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 24.5 Cg_exo -63.97 -164.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.9 2.4 . . . . 0.71 113.175 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -102.38 -151.89 24.0 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.675 -0.693 . . . . 0.66 112.852 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -88.24 125.24 64.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.056 -0.085 . . . . 1.52 110.791 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_exo -80.09 141.79 14.95 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.763 2.308 . . . . 0.44 112.314 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.23 116.11 4.7 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.077 -0.511 . . . . 1.09 111.463 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' A' ' 95' ' ' ILE . 23.0 Cg_exo -62.0 104.22 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.577 2.185 . . . . 0.64 113.081 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.634 HD12 HG22 ' A' ' 19' ' ' THR . 0.3 OUTLIER -64.99 -35.05 79.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.48 0.657 . . . . 1.64 109.601 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -140.3 153.49 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.941 -1.027 . . . . 0.72 108.77 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.812 HG21 HG12 ' A' ' 95' ' ' ILE . 1.2 pt -144.88 108.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.704 -0.399 . . . . 0.96 111.882 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -101.48 59.89 0.89 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.106 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 49.34 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.951 0.782 . . . . 2.42 112.59 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 14' ' ' THR . 31.8 m170 -82.27 -34.72 28.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.231 -0.441 . . . . 1.02 111.609 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -119.05 106.19 12.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.883 0.373 . . . . 0.68 110.923 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.921 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 10.3 m -104.57 154.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.8 111.163 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.634 HG22 HD12 ' A' ' 11' ' ' LEU . 3.4 m -123.07 123.63 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.35 111.259 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -131.2 159.58 37.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.52 111.714 179.212 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 11' ' ' LEU . 2.0 tppt? -140.83 157.24 45.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.814 -1.085 . . . . 1.84 109.776 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 25.5 p90 -149.12 -176.1 5.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.294 0.568 . . . . 0.4 112.264 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -94.49 121.87 36.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.399 -0.819 . . . . 0.83 110.7 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 150.12 96.41 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 121.0 -0.28 . . . . 2.11 110.576 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 33' ' ' ILE . 77.6 Cg_exo -43.52 173.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.89 112.823 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -26.16 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.145 0.424 . . . . 2.77 112.145 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.4 t80 -124.45 -70.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.178 0.436 . . . . 1.37 112.178 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.537 HG21 HD11 ' A' ' 33' ' ' ILE . 20.0 p 56.04 55.01 7.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.713 0.292 . . . . 0.91 110.655 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.82 -93.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.055 -0.521 . . . . 1.01 112.657 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.54 34.48 0.89 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.127 -1.589 . . . . 0.98 109.127 178.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -113.63 142.99 45.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.275 -0.963 . . . . 0.87 111.54 -178.318 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -92.25 -8.18 46.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.112 -0.495 . . . . 2.26 111.459 179.606 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 71.47 -75.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 1.71 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.1 p 72.96 18.34 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.838 0.31 . . . . 1.15 111.838 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 179.85 145.8 0.21 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.073 0.463 . . . . 1.58 112.121 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.701 ' O ' HD12 ' A' ' 56' ' ' ILE . 89.6 m-85 -133.05 104.14 6.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.859 -0.61 . . . . 0.76 111.083 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' A' ' 79' ' ' LYS . 15.3 mt -78.66 93.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 1.14 110.463 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.5 p -91.08 106.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.63 111.384 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.4 mm-40 -71.29 167.13 20.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.372 -0.831 . . . . 1.67 111.143 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.804 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.74 151.99 49.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 1.97 111.399 -179.716 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.3 ttm180 -138.49 104.61 5.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 1.44 109.904 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.35 105.84 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.59 111.027 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.94 151.06 81.84 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.9 110.641 179.742 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -92.87 22.15 30.1 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.987 -1.256 . . . . 1.43 112.576 0.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.64 75.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 2.66 111.274 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -131.67 177.46 18.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 1.12 112.415 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.69 -148.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.595 -0.15 . . . . 2.41 110.595 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 16.1 m95 -136.71 74.27 1.48 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.996 0.427 . . . . 0.65 110.981 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.654 HD23 ' HG3' ' A' ' 47' ' ' ARG . 1.5 mm? -110.81 137.16 48.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.829 -0.623 . . . . 1.28 110.795 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 14.9 ptmt -52.54 92.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.06 -0.518 . . . . 1.3 111.837 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -54.15 -49.11 70.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.456 0.646 . . . . 0.86 109.867 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' HD11 ' A' ' 56' ' ' ILE . 3.1 t30 -44.43 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.1 -0.955 . . . . 2.01 110.822 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.7 43.09 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 2.08 110.774 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -152.35 -71.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 1.89 111.119 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 179.24 143.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.888 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 36' ' ' TYR . 37.2 mt -149.14 64.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.69 110.975 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -46.22 -69.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 1.6 111.345 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.56 179.57 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.502 -0.317 . . . . 1.54 110.741 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -86.53 10.62 14.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.699 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -107.98 104.32 13.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.551 -0.537 . . . . 2.05 109.551 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.594 ' HB2' HG23 ' A' ' 56' ' ' ILE . 43.6 t80 -131.13 164.27 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.391 0.615 . . . . 0.48 111.84 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' VAL . 98.6 m -127.91 115.74 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.966 -1.016 . . . . 0.42 109.506 179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.57 HG22 ' HE2' ' A' ' 61' ' ' PHE . 15.4 t -76.09 111.6 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.042 0.448 . . . . 1.08 111.701 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 140.23 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.637 -0.71 . . . . 1.33 110.706 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.07 7.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 0.9 112.569 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -50.94 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.963 0.411 . . . . 1.47 111.042 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -142.43 154.69 44.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 1.06 110.568 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.97 143.74 47.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 1.91 110.937 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 67.43 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 1.87 111.418 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.53 124.66 0.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.746 0.307 . . . . 0.49 111.564 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.98 137.53 51.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.147 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 34.5 m-85 -131.78 118.83 20.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.291 0.848 . . . . 0.56 113.291 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.1 mm-40 -100.59 140.5 34.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.157 -0.683 . . . . 1.5 109.157 178.308 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 2.2 m-85 -123.06 106.72 11.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.419 1.266 . . . . 0.6 114.419 -178.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -76.08 151.81 36.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.643 -0.708 . . . . 2.11 110.292 178.602 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 t -125.42 118.3 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.092 0.473 . . . . 0.6 112.242 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 65.4 mt -124.69 163.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.849 -0.797 . . . . 0.7 108.849 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -163.13 127.64 2.99 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.826 -0.749 . . . . 0.6 112.124 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.44 24.4 1.66 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.622 0.601 . . . . 1.98 112.622 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.669 ' OD1' HD11 ' A' ' 2' ' ' ILE . 2.8 m120 44.4 -173.31 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.502 0.668 . . . . 2.19 112.643 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -63.7 -37.07 85.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.299 -0.864 . . . . 1.08 112.347 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.06 33.71 3.17 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.964 0.728 . . . . 1.06 112.964 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' LYS . . . 65.24 9.89 44.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.255 -0.974 . . . . 0.93 113.37 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -66.4 103.17 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.177 -0.675 . . . . 1.38 109.177 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -60.32 110.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.678 0.752 . . . . 0.79 112.579 -178.486 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 41.1 p -87.88 110.87 38.53 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.651 -1.159 . . . . 0.59 108.673 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -35.03 160.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.641 2.894 . . . . 0.85 113.609 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 24.1 Cg_exo -62.46 150.52 87.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.78 2.32 . . . . 0.76 112.8 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.0 m -120.88 108.9 14.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.587 -0.733 . . . . 1.28 109.8 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -6.0 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 124.534 1.146 . . . . 1.77 113.317 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 48' ' ' TRP . 56.7 Cg_exo -50.4 135.63 39.69 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.508 2.139 . . . . 0.55 113.763 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -53.48 152.13 5.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.648 -0.871 . . . . 1.23 108.648 178.804 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -41.87 154.72 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.769 0.668 . . . . 1.63 110.616 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -85.41 114.16 22.25 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.658 -0.701 . . . . 0.41 110.03 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -92.94 113.15 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.084 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.6 m -51.13 -27.07 7.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.678 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.475 ' H ' HG22 ' A' ' 95' ' ' ILE . 76.6 m 53.22 84.82 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.1 110.539 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -97.38 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.547 -0.297 . . . . 3.0 111.499 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.611 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -93.21 0.67 57.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.651 0.241 . . . . 2.14 111.651 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 1.4 p30 . . . . . 0 C--O 1.231 0.13 0 N-CA-C 112.016 0.376 . . . . 2.06 112.016 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.681 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.5 tt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.873 0.368 . . . . 0.68 110.844 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.267 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.62 127.65 18.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 2.0 110.596 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 154.62 31.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.405 2.07 . . . . 0.5 112.186 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 1.9 Cg_endo -45.68 176.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.897 2.398 . . . . 0.71 112.79 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.65 170.64 50.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.896 -0.668 . . . . 0.66 112.649 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.2 tttp -56.59 128.62 75.19 Favored Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 110.185 -0.302 . . . . 1.52 110.185 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' HG12 ' A' ' 76' ' ' VAL . 6.2 Cg_exo -80.35 133.56 9.72 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.628 2.219 . . . . 0.44 112.109 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 p -126.85 117.27 22.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 1.09 110.948 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' THR . 25.3 Cg_exo -63.03 93.05 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.479 2.119 . . . . 0.64 113.032 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 19' ' ' THR . 1.8 mt -52.85 -42.08 64.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.636 0.732 . . . . 1.64 109.14 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -132.44 151.69 51.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.626 -1.17 . . . . 0.72 108.456 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.672 HG21 HG12 ' A' ' 95' ' ' ILE . 2.3 pt -142.84 100.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.386 -0.525 . . . . 0.96 112.346 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.77 144.19 27.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 1.46 110.211 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -47.63 -24.34 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.389 0.514 . . . . 2.42 112.389 -179.091 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 17' ' ' THR . 6.7 m-70 -130.37 30.76 4.69 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.904 -0.318 . . . . 1.02 111.633 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER 172.2 111.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 0.68 110.62 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 66' ' ' LEU . 4.4 m -111.21 133.34 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.8 110.375 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.2 m -102.99 111.47 23.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.35 111.996 -178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.807 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.17 143.53 48.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.52 111.235 178.646 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -131.92 144.24 50.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.746 -1.116 . . . . 1.84 110.206 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 27.4 p90 -129.15 -177.1 4.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.362 0.601 . . . . 0.4 112.304 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.14 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.83 111.162 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -84.4 140.09 38.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 2.11 110.251 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.467 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.7 Cg_endo -44.63 172.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.668 2.245 . . . . 0.89 112.236 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.55 -29.03 9.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 2.77 111.479 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.2 t80 -130.44 -69.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.877 0.325 . . . . 1.37 111.877 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . 1.267 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.4 p 52.43 48.67 22.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.154 0.502 . . . . 0.91 110.495 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.51 -94.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.681 -0.691 . . . . 1.01 112.77 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.69 35.57 0.93 Allowed Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.891 -0.884 . . . . 0.98 110.891 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -116.85 -172.16 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.276 -0.462 . . . . 0.87 111.152 -178.982 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.4 ptmt -147.23 26.24 1.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 2.26 111.476 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.891 HG22 ' H ' ' A' ' 35' ' ' SER . 1.5 mp 65.71 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 1.71 110.676 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.594 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.68 -12.12 1.0 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.318 0.488 . . . . 1.15 112.318 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.891 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -169.72 102.63 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.56 0.219 . . . . 1.58 111.32 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 47.8 m-85 -80.0 147.96 31.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.205 -0.295 . . . . 0.76 110.205 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.481 HG22 ' CB ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -129.39 111.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.319 . . . . 1.14 111.115 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.41 99.14 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.69 0.281 . . . . 0.63 111.392 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -75.63 128.34 35.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.978 -0.378 . . . . 1.67 109.978 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -109.16 131.28 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.252 0.464 . . . . 1.97 112.252 -179.425 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.18 111.56 24.22 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.789 -1.189 . . . . 1.44 107.789 177.976 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' N ' ' HA3' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.69 81.54 2.05 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.269 -0.878 . . . . 1.59 111.088 -179.034 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -53.54 155.87 5.0 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.825 -0.625 . . . . 0.9 110.694 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 5.8 Cg_exo -79.13 1.64 33.22 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.027 -1.239 . . . . 1.43 113.029 0.301 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -104.5 -75.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 2.66 110.881 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . 50.22 179.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.831 -0.7 . . . . 1.12 112.957 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.9 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.49 32.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 2.41 110.905 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.541 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 65.5 m95 40.34 97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.705 -0.68 . . . . 0.65 112.203 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -133.52 128.99 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.28 110.679 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 37' ' ' ILE . 1.1 ptmm? -56.68 83.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 1.3 111.494 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.554 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -67.26 -38.86 85.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.86 110.244 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' HD11 ' A' ' 56' ' ' ILE . 14.2 p-10 -36.82 -44.42 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.515 -0.766 . . . . 2.01 111.71 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.13 43.47 2.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.115 -0.493 . . . . 2.08 111.785 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -152.79 -175.45 5.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 1.89 111.622 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.1 89.28 5.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.87 110.641 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.747 HD13 ' CG ' ' A' ' 61' ' ' PHE . 25.2 mt -85.43 75.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.69 111.251 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 57' ' ' LEU . 4.5 mt -58.0 -61.97 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 1.6 111.223 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.2 163.13 27.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 1.54 110.27 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 20.2 p30 -80.5 2.7 24.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.281 -0.418 . . . . 1.75 111.675 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 21.1 tt0 -102.13 101.54 11.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.586 -0.524 . . . . 2.05 109.586 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CG ' HD13 ' A' ' 56' ' ' ILE . 70.2 t80 -135.27 164.38 27.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.48 111.506 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 92.9 m -124.31 123.49 40.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.42 110.36 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.704 HG23 HD21 ' A' ' 20' ' ' LEU . 6.7 t -79.94 94.53 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 116.063 -0.517 . . . . 1.08 110.49 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.6 p -86.61 -171.18 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.494 -0.775 . . . . 1.33 110.811 -179.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.82 9.75 53.45 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.449 -0.881 . . . . 0.9 112.525 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.061 ' CD1' HG13 ' A' ' 18' ' ' VAL . 13.8 mt -60.85 -179.34 0.13 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.827 0.313 . . . . 1.47 110.407 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -137.13 128.11 27.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 1.06 110.809 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.17 155.5 13.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.91 111.133 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 97' ' ' CYS . 3.5 t70 53.37 46.07 27.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 1.87 110.959 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.58 118.71 2.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.402 -0.363 . . . . 0.49 111.371 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -70.29 133.64 47.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.114 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -129.92 126.44 37.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.605 0.595 . . . . 0.56 112.605 -178.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.9 mt-10 -102.85 143.36 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.143 -1.058 . . . . 1.5 108.143 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.999 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.69 115.93 12.58 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.16 1.541 . . . . 0.6 115.16 -178.89 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.36 169.22 9.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.171 -1.418 . . . . 2.11 107.171 176.778 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 89' ' ' SER . 0.7 OUTLIER -134.75 112.54 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 118.867 -1.133 . . . . 0.6 113.323 -179.836 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' ILE . 79.0 mt -102.73 145.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.227 -1.397 . . . . 0.7 107.227 177.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.78 119.88 2.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.72 -0.792 . . . . 0.6 111.898 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -59.07 -161.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.461 -0.496 . . . . 1.98 109.954 179.523 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.681 ' ND2' HD11 ' A' ' 2' ' ' ILE . 6.1 m-80 -150.91 165.72 32.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.249 0.547 . . . . 2.19 110.885 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.25 -29.57 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.282 -0.872 . . . . 1.08 112.656 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.54 11.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.36 2.2 53.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.623 -0.799 . . . . 0.93 113.294 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.615 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -64.63 102.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.088 0.444 . . . . 1.38 109.914 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -68.23 114.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 113.023 0.749 . . . . 0.79 113.023 -178.798 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.433 ' N ' HD12 ' A' ' 85' ' ' ILE . 14.2 p -78.94 115.0 48.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.29 -0.868 . . . . 0.59 109.927 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.11 155.85 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.16 1.907 . . . . 0.85 111.881 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 15.0 Cg_endo -58.69 126.85 22.45 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 122.807 2.338 . . . . 0.76 113.443 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.52 ' HB3' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -78.64 132.46 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.92 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -22.42 107.34 0.12 Allowed Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 124.168 0.917 . . . . 1.77 113.33 -179.414 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 86.8 Cg_exo -45.3 142.87 5.82 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.825 2.35 . . . . 0.55 113.26 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -79.48 150.38 31.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.758 -0.46 . . . . 1.23 109.758 179.029 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -37.16 151.2 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.143 0.902 . . . . 1.63 111.656 179.814 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -80.5 113.8 18.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.364 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.672 HG12 HG21 ' A' ' 13' ' ' ILE . 4.3 mp -96.6 112.77 29.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.917 0.389 . . . . 0.44 111.468 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 84.5 m -54.4 -36.13 63.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.074 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 61.0 93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.38 . . . . 1.1 110.27 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -140.07 -84.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.418 . . . . 3.0 111.788 -179.625 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.806 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -108.16 -9.53 15.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 2.14 111.94 -179.631 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 2.06 111.075 179.76 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.501 HD11 ' ND2' ' A' ' 80' ' ' ASN . 9.0 tt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.68 111.475 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' ILE . 91.7 m-20 -129.82 132.63 24.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 2.0 110.548 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.59 171.12 16.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.494 2.129 . . . . 0.5 112.66 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.523 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 12.4 Cg_endo -55.7 171.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.043 2.495 . . . . 0.71 112.837 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -93.97 113.6 4.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.049 -0.596 . . . . 0.66 113.083 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 10.87 109.15 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 124.572 1.149 . . . . 1.52 113.767 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.46 ' CG ' HG23 ' A' ' 76' ' ' VAL . 19.9 Cg_exo -68.8 139.08 42.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.787 2.325 . . . . 0.44 112.96 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.02 112.21 10.37 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.038 -0.528 . . . . 1.09 111.508 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.9 Cg_exo -64.89 112.39 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.829 2.352 . . . . 0.64 113.696 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.72 -35.85 72.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.854 -0.795 . . . . 1.64 108.854 178.7 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -135.93 135.97 40.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.774 -1.103 . . . . 0.72 108.895 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -134.27 70.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.269 0.47 . . . . 0.96 112.269 -178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 156.96 34.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.46 110.151 179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.69 -8.65 36.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.887 -0.325 . . . . 2.42 111.464 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.414 ' O ' HG23 ' A' ' 17' ' ' THR . 11.1 m-70 -128.88 18.2 6.16 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.507 0.194 . . . . 1.02 111.357 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 177.23 124.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.806 0.336 . . . . 0.68 110.925 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 23.1 t -114.28 113.81 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.8 111.104 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 17.4 m -100.26 127.4 46.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.984 -0.553 . . . . 0.35 111.23 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -138.07 150.3 46.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.745 0.783 . . . . 0.52 111.976 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.087 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -132.52 147.36 52.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.425 -1.262 . . . . 1.84 109.337 179.596 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.523 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 8.3 p90 -132.47 -175.75 3.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.236 0.541 . . . . 0.4 112.375 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.466 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.85 177.31 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.332 -0.849 . . . . 0.83 111.329 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -98.16 139.4 21.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.625 -0.716 . . . . 2.11 110.25 179.733 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.816 ' HB2' HG23 ' A' ' 28' ' ' THR . 2.9 Cg_endo -47.52 178.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.89 112.039 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -113.15 -15.44 12.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 2.77 112.081 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -139.15 -66.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.313 0.486 . . . . 1.37 112.313 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.816 HG23 ' HB2' ' A' ' 25' ' ' PRO . 54.4 p 54.57 45.03 27.77 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.91 110.532 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.46 -93.99 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.738 -0.744 . . . . 1.01 112.379 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.68 42.19 0.8 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.662 -1.375 . . . . 0.98 109.662 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -127.98 -177.32 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.997 -0.602 . . . . 0.87 111.298 -178.211 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.69 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.5 OUTLIER -136.54 19.97 3.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.338 -0.392 . . . . 2.26 111.747 -179.456 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.059 HG23 ' HB1' ' A' ' 78' ' ' ALA . 3.5 mp 64.15 -74.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.282 . . . . 1.71 111.279 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.69 HG22 ' HD2' ' A' ' 32' ' ' LYS . 2.5 p 58.05 32.39 21.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 1.15 111.132 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.602 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t 170.72 110.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.58 110.845 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.661 ' O ' HD12 ' A' ' 56' ' ' ILE . 23.4 m-85 -111.75 87.8 2.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.971 0.415 . . . . 0.76 111.061 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.678 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -79.03 88.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.78 -0.645 . . . . 1.14 111.43 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.27 127.58 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.8 -0.444 . . . . 0.63 109.8 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.9 143.73 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.812 -0.631 . . . . 1.67 111.563 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.683 ' HD3' HG11 ' A' ' 63' ' ' VAL . 3.5 mtmp? -98.35 148.38 23.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 1.97 110.871 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -144.77 86.58 1.81 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 1.44 110.604 179.126 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 1.173 ' OD2' ' O ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -48.51 150.02 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.125 -0.489 . . . . 1.59 110.725 179.236 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 42' ' ' ASP . 1.8 mm? -123.78 101.11 36.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.033 -0.667 . . . . 0.9 111.291 179.022 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 6.3 Cg_endo -87.57 -136.56 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.053 -1.228 . . . . 1.43 110.212 -0.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.173 ' O ' ' OD2' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 42.63 42.22 2.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.783 0.325 . . . . 2.66 111.441 179.708 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -118.23 148.26 18.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.183 -1.008 . . . . 1.12 113.861 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.818 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.91 122.17 9.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.432 -0.581 . . . . 2.41 109.432 179.44 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 40.9 m95 -43.81 94.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.65 111.149 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -119.32 130.88 55.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.849 -0.614 . . . . 1.28 110.712 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.678 ' HE3' HG21 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.67 69.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 1.3 110.819 179.938 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -47.74 -38.82 16.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.86 111.355 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.554 ' HB3' HD11 ' A' ' 56' ' ' ILE . 5.3 p-10 -51.28 -58.65 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 2.01 111.616 -179.574 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER 80.0 -51.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.585 0.231 . . . . 2.08 111.221 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -169.93 0.19 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.806 0.336 . . . . 1.89 111.111 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -98.27 107.5 19.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.87 111.014 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 36' ' ' TYR . 24.0 mt -87.13 75.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.69 110.728 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 34' ' ' THR . 1.9 mt -52.52 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.289 -179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 175.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.677 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 51.1 p30 -94.1 21.89 6.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.889 -0.596 . . . . 1.75 111.157 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.087 ' OE2' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -125.43 109.49 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 2.05 110.196 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CG ' HD13 ' A' ' 56' ' ' ILE . 64.5 t80 -136.45 164.61 27.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.48 111.669 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.9 m -127.26 117.37 22.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.612 -0.722 . . . . 0.42 110.783 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HD3' ' A' ' 40' ' ' LYS . 6.6 t -82.05 118.77 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.08 111.158 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -173.42 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 1.33 110.89 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.54 28.36 73.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.639 -0.791 . . . . 0.9 112.281 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' CD1' HG23 ' A' ' 18' ' ' VAL . 7.3 mt -82.04 174.25 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 1.47 111.318 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -125.38 99.25 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.686 . . . . 1.06 110.224 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 42.9 tt0 -43.74 148.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 1.91 111.728 -179.505 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 35.0 t0 75.41 65.48 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.87 111.059 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 171.49 127.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.49 111.006 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.55 136.3 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.068 -0.345 . . . . 0.36 110.068 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 37.3 m-85 -133.31 121.95 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.293 0.849 . . . . 0.56 113.293 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 11.8 mt-10 -102.58 131.96 48.98 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.391 -0.596 . . . . 1.5 109.391 178.512 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -124.87 118.99 27.55 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.673 0.99 . . . . 0.6 113.673 -178.77 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' NH1' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -94.67 144.73 25.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 2.11 110.381 178.97 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 5' ' ' PRO . 86.8 t -98.23 115.82 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.357 -0.537 . . . . 0.6 110.845 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 2.3 mt -110.29 167.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.542 -0.911 . . . . 0.7 108.542 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 1.059 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.14 -174.41 4.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -117.32 -77.75 0.57 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.157 0.503 . . . . 1.98 110.535 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER 125.79 140.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.196 1.798 . . . . 2.19 109.93 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -32.75 -44.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.217 0.821 . . . . 1.08 113.217 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -107.75 49.53 0.8 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.489 0.552 . . . . 1.06 112.489 -179.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.56 40.93 5.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.662 -0.78 . . . . 0.93 113.314 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB3' ' CB ' ' A' ' 80' ' ' ASN . . . -89.1 24.46 2.12 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.554 0.216 . . . . 1.38 111.227 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp 18.5 112.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 115.373 1.62 . . . . 0.79 115.373 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.671 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -85.64 111.81 40.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.66 -0.867 . . . . 0.59 108.66 177.957 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 28.6 Cg_endo -60.98 167.26 9.16 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.209 1.94 . . . . 0.85 112.523 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 75' ' ' ARG . 9.7 Cg_endo -53.8 136.31 65.32 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.052 2.501 . . . . 0.76 113.269 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.34 112.71 24.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.966 -0.561 . . . . 1.28 110.794 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 5.96 100.18 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.019 1.328 . . . . 1.77 114.435 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 82.7 Cg_exo -46.29 145.8 5.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.8 2.333 . . . . 0.55 113.358 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -78.19 143.9 36.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.074 -0.713 . . . . 1.23 109.074 179.068 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -30.93 148.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.298 0.999 . . . . 1.63 112.016 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -81.75 103.82 11.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.347 -0.388 . . . . 0.41 110.794 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.3 mp -83.86 116.01 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.537 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 98' ' ' ARG . 48.2 m -56.21 -30.41 62.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.401 . . . . 0.44 110.425 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.431 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 53.62 61.31 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 1.1 111.148 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -101.73 -77.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.04 0.448 . . . . 3.0 110.309 179.895 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 15' ' ' ARG . 2.2 p-10 -126.08 -0.13 7.17 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.616 -0.72 . . . . 2.14 111.244 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 CA--C 1.516 -0.33 0 CA-C-O 121.108 0.48 . . . . 2.06 112.167 -179.942 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.501 HG13 ' ND2' ' A' ' 80' ' ' ASN . 9.9 tt . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 112.803 0.668 . . . . 0.68 112.803 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.343 ' OD2' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.57 120.71 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.853 179.693 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.41 170.44 20.28 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.202 1.935 . . . . 0.5 112.398 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 7.1 Cg_endo -54.48 -171.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.754 2.303 . . . . 0.71 113.21 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.07 166.64 22.37 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.867 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.6 tptm -49.03 122.72 11.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.059 -0.348 . . . . 1.52 110.059 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.5 Cg_exo -77.41 128.77 9.81 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.242 1.961 . . . . 0.44 112.401 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -120.12 112.85 34.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 1.09 111.1 -179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.3 Cg_exo -60.59 124.74 15.67 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.142 1.894 . . . . 0.64 113.223 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.635 HD11 ' CB ' ' A' ' 21' ' ' LYS . 1.4 mp -89.76 -29.42 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.83 -0.623 . . . . 1.64 109.809 179.118 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.421 ' O ' ' HB ' ' A' ' 19' ' ' THR . 5.9 t-20 -152.45 110.14 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.783 . . . . 0.72 110.226 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.731 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.8 131.74 66.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.394 0.616 . . . . 0.96 112.151 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -119.55 157.53 28.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.309 -0.86 . . . . 1.46 110.125 179.914 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.48 -9.07 16.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.325 0.491 . . . . 2.42 112.325 -179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 17' ' ' THR . 1.5 m-70 -135.38 17.47 3.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.793 0.294 . . . . 1.02 111.793 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.832 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER 171.31 117.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.509 -0.182 . . . . 0.68 110.509 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.076 ' CG1' HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -104.14 165.0 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 120.592 -0.443 . . . . 0.8 111.64 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.6 m -140.87 123.9 16.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.35 111.251 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.778 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.55 159.56 41.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.664 0.745 . . . . 0.52 112.007 179.225 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.635 ' CB ' HD11 ' A' ' 11' ' ' LEU . 24.0 tptp -139.1 136.36 35.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.407 -1.27 . . . . 1.84 109.803 179.722 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.0 p90 -123.35 -177.93 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.281 0.562 . . . . 0.4 112.336 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.93 161.08 16.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.201 -0.909 . . . . 0.83 111.042 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -90.06 135.96 29.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 2.11 110.715 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HG3' HD11 ' A' ' 33' ' ' ILE . 11.5 Cg_endo -56.12 171.77 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.455 2.103 . . . . 0.89 112.005 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -50.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.658 0.265 . . . . 2.77 111.208 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.343 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.2 t80 -98.92 71.09 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 1.37 111.74 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.8 p -94.27 48.72 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.91 110.131 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.02 -94.92 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.967 -0.561 . . . . 1.01 112.344 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.55 33.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.936 -0.865 . . . . 0.98 110.936 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.58 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -118.66 175.76 5.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.253 -0.473 . . . . 0.87 111.299 -178.964 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.73 3.88 3.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.068 -0.514 . . . . 2.26 111.505 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.1 mt 59.75 144.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 120.96 0.409 . . . . 1.71 111.864 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -129.51 -5.11 4.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.946 -0.57 . . . . 1.15 112.258 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.27 143.86 3.68 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.919 0.34 . . . . 1.58 111.919 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 33' ' ' ILE . 33.7 m-85 -116.3 113.1 22.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.76 110.269 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 50' ' ' LYS . 2.7 mt -92.12 119.59 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.799 0.333 . . . . 1.14 110.987 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.29 93.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.442 0.534 . . . . 0.63 112.442 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.97 ' OE1' ' CA ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -72.93 146.33 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.147 -0.686 . . . . 1.67 109.147 178.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.35 141.62 51.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.215 0.531 . . . . 1.97 112.025 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.7 ttm180 -104.64 106.55 17.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.389 -0.823 . . . . 1.44 109.464 179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 1.052 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.84 91.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.475 -0.784 . . . . 1.59 111.071 -179.379 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 94' ' ' ALA . 13.7 mt -75.96 146.0 78.45 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.112 -0.495 . . . . 0.9 110.328 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.78 27.85 15.27 Favored 'Cis proline' 0 C--N 1.347 0.467 0 C-N-CA 123.801 -1.333 . . . . 1.43 112.88 0.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -88.73 -73.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.761 0.315 . . . . 2.66 111.169 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 100.27 152.58 26.54 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.624 -0.798 . . . . 1.12 112.778 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 1.052 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 170.91 -31.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.303 . . . . 2.41 111.181 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.908 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 61.4 m95 58.62 75.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.361 . . . . 0.65 111.375 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.97 ' CA ' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mm? -117.42 130.91 56.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 1.28 110.341 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' CB ' HG22 ' A' ' 37' ' ' ILE . 5.2 ptmm? -52.69 97.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.926 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.94 -41.05 86.46 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.194 -0.669 . . . . 0.86 109.194 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 17.5 t-20 -58.56 164.35 2.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.061 -0.972 . . . . 2.01 110.405 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.37 31.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.471 . . . . 2.08 110.801 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.1 37.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.89 110.91 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 61.57 153.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 1.87 110.757 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.677 HD13 ' CG ' ' A' ' 61' ' ' PHE . 47.9 mt -147.23 60.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.69 110.44 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 tm? -46.03 -50.66 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 1.6 111.841 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -87.23 160.19 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.422 . . . . 1.54 111.048 -179.656 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.3 m-20 -76.27 -1.15 25.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.89 -0.596 . . . . 1.75 111.694 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.865 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -102.54 103.92 14.29 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.745 -0.465 . . . . 2.05 109.745 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.677 ' CG ' HD13 ' A' ' 56' ' ' ILE . 43.6 t80 -140.22 166.4 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.124 0.488 . . . . 0.48 111.9 -178.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 18' ' ' VAL . 95.4 m -117.23 119.42 35.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.42 110.797 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.8 t -82.12 99.31 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.204 0.526 . . . . 1.08 111.297 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 1.1 p -81.56 -157.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.533 -0.758 . . . . 1.33 111.207 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 54.03 45.54 71.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.727 -0.749 . . . . 0.9 112.154 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 18' ' ' VAL . 9.8 mt -87.61 -176.85 5.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.167 0.508 . . . . 1.47 111.205 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -153.36 115.04 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.717 . . . . 1.06 110.332 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 132.83 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 1.91 111.236 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.33 60.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 1.87 111.089 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -169.92 119.12 0.61 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.49 111.652 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.3 125.97 28.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.631 -0.507 . . . . 0.36 109.631 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 55.0 m-85 -121.95 122.18 38.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.4 0.518 . . . . 0.56 112.4 -178.878 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -101.18 131.95 46.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.312 -0.996 . . . . 1.5 108.312 178.386 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.95 ' CE2' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.2 109.69 19.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.157 1.54 . . . . 0.6 115.157 -177.849 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 ttp180 -97.72 124.54 42.1 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.681 -1.6 . . . . 2.11 106.681 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -105.87 119.64 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 119.103 -1.039 . . . . 0.6 113.716 -178.476 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' A' ' 88' ' ' PRO . 80.8 mt -101.41 163.78 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.537 -1.653 . . . . 0.7 106.537 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 77' ' ' ILE . . . -174.32 123.15 0.3 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.022 -1.071 . . . . 0.6 112.755 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 85' ' ' ILE . 21.9 mttt -60.8 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.002 -0.74 . . . . 1.98 109.002 178.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' A' ' 2' ' ' ILE . 36.3 m-20 -138.38 -101.95 0.18 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.514 -0.474 . . . . 2.19 111.387 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.32 -41.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 1.08 111.598 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . . . -101.97 40.96 1.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 1.06 111.962 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.91 9.6 53.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.579 -0.82 . . . . 0.93 113.154 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.81 87.3 4.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 1.38 110.322 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.712 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -58.76 111.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.79 111.682 -179.378 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -73.57 119.05 73.94 Favored Pre-proline 0 C--O 1.238 0.454 0 N-CA-C 109.454 -0.573 . . . . 0.59 109.454 179.562 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.8 Cg_endo -43.4 166.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.677 2.251 . . . . 0.85 112.461 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 77' ' ' ILE . 23.9 Cg_exo -64.36 149.21 90.54 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.676 2.251 . . . . 0.76 112.571 -179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.596 ' HB2' HG13 ' A' ' 76' ' ' VAL . 5.8 m -103.12 125.4 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.263 179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 62.9 mt-10 -22.07 117.45 0.15 Allowed Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 124.094 0.871 . . . . 1.77 112.793 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 66.1 Cg_exo -45.27 165.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.981 2.454 . . . . 0.55 114.513 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -100.82 146.36 27.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.339 -1.3 . . . . 1.23 109.166 178.764 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.761 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -37.09 130.66 0.83 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.864 0.728 . . . . 1.63 111.644 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.92 101.33 0.65 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.879 -0.6 . . . . 0.41 110.854 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.827 HD13 ' CZ ' ' A' ' 74' ' ' PHE . 4.8 mp -82.22 113.55 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.462 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -51.64 -28.06 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.44 111.159 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.468 ' H ' HG22 ' A' ' 95' ' ' ILE . 60.7 m 55.24 76.07 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.505 -0.316 . . . . 1.1 110.841 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -134.43 -87.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 3.0 111.073 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.652 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -103.14 -3.06 26.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 2.14 111.356 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.333 -0.13 0 CA-C-O 120.888 0.375 . . . . 2.06 111.415 -179.769 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.501 HD12 ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.052 0.453 . . . . 0.68 111.685 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.927 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -114.06 135.56 22.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.65 . . . . 2.0 109.937 179.395 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.36 174.04 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.672 2.248 . . . . 0.5 113.101 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.68 174.6 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.119 2.546 . . . . 0.71 113.462 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.08 169.67 42.37 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.297 -0.865 . . . . 0.66 112.627 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 65.4 tttt -58.57 127.28 81.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 110.581 -0.155 . . . . 1.52 110.581 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.0 Cg_exo -76.79 149.38 29.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.502 2.135 . . . . 0.44 113.078 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -144.16 113.4 5.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.284 -0.871 . . . . 1.09 110.015 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.7 Cg_exo -49.0 94.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.283 1.989 . . . . 0.64 113.553 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.66 -27.73 63.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.268 -0.878 . . . . 1.64 110.135 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 13' ' ' ILE . 10.9 t-20 -161.41 161.33 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.72 109.91 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.771 ' CG2' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.84 115.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.96 111.301 179.731 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -104.48 47.62 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.793 -0.64 . . . . 1.46 110.79 -179.908 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.81 -70.63 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.746 -0.661 . . . . 2.42 111.516 179.473 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' THR . 1.5 m-70 -82.79 -22.98 34.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 1.02 111.289 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.16 102.9 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.578 -0.283 . . . . 0.68 111.224 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -93.66 120.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.8 110.816 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.625 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.6 126.42 44.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.35 111.346 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.47 139.88 50.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.948 0.88 . . . . 0.52 111.69 178.437 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -116.97 172.78 7.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.192 -1.367 . . . . 1.84 109.317 179.681 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.52 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 46.0 p90 -168.34 165.51 12.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.126 -0.63 . . . . 0.4 112.503 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 156.07 23.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.963 -1.017 . . . . 0.83 110.685 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.98 156.46 52.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.725 -0.472 . . . . 2.11 109.725 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.15 -170.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.371 2.048 . . . . 0.89 111.954 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.53 13.21 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.883 0.327 . . . . 2.77 111.883 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.768 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 3.6 t80 -168.91 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.572 0.582 . . . . 1.37 112.572 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.927 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 52.0 p 53.8 38.81 29.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.003 0.43 . . . . 0.91 110.074 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.64 -125.15 4.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.852 -0.613 . . . . 1.01 112.175 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.45 4.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.451 -1.859 . . . . 0.98 108.451 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.608 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -112.99 -165.78 1.02 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.888 -1.156 . . . . 0.87 111.607 -178.03 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' C ' HD12 ' A' ' 33' ' ' ILE . 1.1 pttt -163.84 38.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 2.26 112.084 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.799 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.8 mp 66.29 -61.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.94 0.719 . . . . 1.71 112.94 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.4 p 83.08 -38.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.631 0.772 . . . . 1.15 111.856 -178.672 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -167.61 140.08 3.23 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.832 0.348 . . . . 1.58 111.406 -179.565 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.799 ' CE1' HG21 ' A' ' 33' ' ' ILE . 52.7 m-85 -99.6 139.94 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.76 110.218 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.97 98.1 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.671 -0.24 . . . . 1.14 111.05 -179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -91.69 126.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.133 0.492 . . . . 0.63 110.862 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.37 152.28 19.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.532 -0.758 . . . . 1.67 110.675 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.766 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 6.4 ptpt -116.14 144.14 44.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 1.97 111.521 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 1.1 ttt180 -119.38 104.86 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.979 179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.72 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.65 89.1 2.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.741 -0.663 . . . . 1.59 110.556 -179.863 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -67.09 144.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.686 . . . . 0.9 110.895 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -95.24 27.92 17.96 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.052 -1.229 . . . . 1.43 112.807 0.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.68 42.6 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 2.66 111.368 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -95.13 150.66 19.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.828 . . . . 1.12 112.224 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' CD ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.45 29.0 4.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 2.41 110.935 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.9 m95 51.36 100.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.999 -0.546 . . . . 0.65 111.133 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 ' CD ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -127.67 141.84 51.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.967 -0.561 . . . . 1.28 110.558 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 49.5 mtpt -49.36 91.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.3 110.95 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -65.26 -48.21 74.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.86 110.754 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.8 p-10 -74.28 114.61 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.95 -0.568 . . . . 2.01 110.746 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.54 30.34 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 2.08 110.913 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -138.02 21.2 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.89 111.352 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.15 144.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 1.87 111.174 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.584 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.0 mt -134.87 112.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.082 -0.508 . . . . 0.69 111.009 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -94.58 -47.75 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 1.6 110.862 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.57 157.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.891 -0.411 . . . . 1.54 109.891 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -73.53 -3.76 29.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.417 -0.356 . . . . 1.75 111.521 -179.924 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 tt0 -97.76 96.15 8.04 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.421 -0.585 . . . . 2.05 109.421 179.309 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.56 ' CG ' HD13 ' A' ' 56' ' ' ILE . 72.3 t80 -121.68 163.86 18.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.48 111.57 -178.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 59.9 m -132.19 112.67 12.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.42 111.06 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.648 HG13 ' HB1' ' A' ' 51' ' ' ALA . 4.6 t -74.73 113.43 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 1.08 110.872 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.96 136.49 44.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.705 -0.679 . . . . 1.33 111.012 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.3 9.16 6.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.9 112.714 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.5 mm? -51.19 -177.6 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.05 0.452 . . . . 1.47 110.954 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.439 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 58.9 m -143.7 96.7 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 1.06 110.0 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 2.3 tt0 -40.56 139.17 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.526 . . . . 1.91 111.839 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER 75.57 33.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.913 -0.585 . . . . 1.87 110.902 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.37 136.34 13.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.358 -0.383 . . . . 0.49 111.212 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -80.89 132.13 35.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.36 110.701 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' OH ' ' HB ' ' A' ' 67' ' ' THR . 46.9 m-85 -127.31 130.67 49.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.56 111.94 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 3.7 mt-10 -104.65 148.81 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.596 -0.52 . . . . 1.5 109.596 178.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.982 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.19 116.08 10.87 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.821 1.415 . . . . 0.6 114.821 -179.264 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.8 ptp180 -109.99 178.65 4.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.455 -0.943 . . . . 2.11 108.455 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.66 133.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.678 1.228 . . . . 0.6 114.198 179.15 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -115.17 152.72 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 112.599 -2.092 . . . . 0.7 106.964 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -160.26 147.56 16.17 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.229 -0.989 . . . . 0.6 112.146 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HG2' HD12 ' A' ' 85' ' ' ILE . 13.0 mmtp -68.81 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 1.98 110.442 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -156.08 -66.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.843 0.83 . . . . 2.19 111.513 -179.249 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . 179.52 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.351 -0.84 . . . . 1.08 110.879 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.69 -4.01 57.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 1.06 112.192 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.83 -16.2 40.07 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.317 -0.944 . . . . 0.93 112.506 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -68.18 149.99 48.87 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.797 -0.446 . . . . 1.38 109.797 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.1 tp -102.41 112.21 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.381 0.511 . . . . 0.79 112.381 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -68.33 123.73 88.17 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.59 109.936 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -38.57 162.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.26 2.64 . . . . 0.85 113.394 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.47 ' N ' HG23 ' A' ' 77' ' ' ILE . 21.0 Cg_exo -67.95 170.84 13.41 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.227 2.618 . . . . 0.76 112.927 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -128.4 127.32 42.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.363 -0.835 . . . . 1.28 109.474 179.173 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.2 tt0 -27.06 129.58 0.19 Allowed Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 123.89 0.743 . . . . 1.77 112.597 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.0 Cg_exo -62.33 169.84 7.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.385 2.057 . . . . 0.55 113.765 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.34 136.62 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.754 -1.112 . . . . 1.23 109.042 179.109 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -37.68 135.34 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.006 0.817 . . . . 1.63 111.584 -179.748 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.07 132.33 51.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.41 111.415 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.4 mp -118.39 119.73 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.44 110.917 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m -48.07 -30.01 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.927 -0.579 . . . . 0.44 111.173 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.618 ' H ' HG22 ' A' ' 95' ' ' ILE . 15.4 m 55.45 36.79 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 1.1 111.032 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 3.0 110.941 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 41.3 p30 -106.3 23.99 13.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 2.14 110.547 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 49.3 t0 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.991 -0.55 . . . . 2.06 111.966 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.702 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.4 tt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.846 0.355 . . . . 0.68 111.278 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.907 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -126.34 133.16 24.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 2.0 110.055 179.451 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 94.4 Cg_endo -77.89 172.0 16.35 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.353 2.035 . . . . 0.5 112.655 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.535 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.7 Cg_endo -59.64 148.89 85.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.078 2.519 . . . . 0.71 112.623 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.64 161.81 4.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.66 112.092 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -58.01 132.67 83.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.982 -0.377 . . . . 1.52 109.982 179.757 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -79.26 127.91 7.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.493 2.129 . . . . 0.44 112.812 -179.409 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.21 110.38 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.863 -0.608 . . . . 1.09 110.379 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.659 ' HG2' HD11 ' A' ' 95' ' ' ILE . 33.6 Cg_exo -56.42 102.57 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.122 1.881 . . . . 0.64 113.599 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.265 HD11 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -66.82 -31.05 71.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.02 -0.733 . . . . 1.64 109.02 178.674 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 13' ' ' ILE . 15.9 t-20 -150.33 161.65 42.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.098 -0.956 . . . . 0.72 110.161 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.703 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.79 86.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.96 110.228 179.593 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -77.7 64.15 2.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 1.46 112.427 -179.1 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.473 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 19.84 47.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.447 0.906 . . . . 2.42 113.447 179.281 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.759 ' C ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER 165.31 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.582 -0.736 . . . . 1.02 110.395 179.239 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.96 89.5 3.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.68 109.713 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.954 HG11 ' CE2' ' A' ' 74' ' ' PHE . 75.3 t -78.68 114.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 0.8 110.046 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 HD12 ' A' ' 11' ' ' LEU . 6.1 m -96.68 109.22 21.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.35 112.527 -178.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.1 145.79 44.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.569 0.699 . . . . 0.52 111.463 178.81 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.445 ' HB2' ' CD ' ' A' ' 60' ' ' GLU . 7.3 tptp -134.07 143.39 48.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.733 -1.121 . . . . 1.84 109.508 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 13.6 p90 -132.68 -177.04 4.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.239 0.542 . . . . 0.4 111.983 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.59 -173.93 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.475 -0.784 . . . . 0.83 111.109 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -114.62 131.69 23.25 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 2.11 110.727 179.929 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' CB ' HG23 ' A' ' 28' ' ' THR . 3.0 Cg_exo -35.84 157.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.487 2.791 . . . . 0.89 112.809 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.29 -15.57 20.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 2.77 111.63 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.799 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.8 t80 -134.52 -72.01 0.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.324 0.49 . . . . 1.37 112.324 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.907 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 4.4 p 50.44 57.55 6.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.91 110.49 -179.148 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.84 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.748 -0.66 . . . . 1.01 112.52 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -155.25 32.8 0.65 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.376 -1.09 . . . . 0.98 110.376 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.98 -167.68 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -0.667 . . . . 0.87 111.649 -178.561 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 34' ' ' THR . 29.5 ttpt -144.04 20.44 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.607 -0.724 . . . . 2.26 111.581 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.873 HG22 ' H ' ' A' ' 35' ' ' SER . 1.6 mp 62.82 -77.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.623 0.249 . . . . 1.71 111.037 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.3 p 80.08 -7.9 1.59 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.607 0.595 . . . . 1.15 112.607 179.299 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -161.94 117.96 2.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.401 0.519 . . . . 1.58 112.401 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 33' ' ' ILE . 61.1 m-85 -103.7 146.22 28.91 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.32 -0.4 . . . . 0.76 110.414 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.454 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -137.11 107.47 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.553 -0.294 . . . . 1.14 110.219 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.45 117.72 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.63 111.387 -179.747 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 3.0 mm-40 -85.95 159.78 19.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.247 -0.888 . . . . 1.67 110.57 179.68 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 3.0 mtmp? -120.99 154.04 36.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.513 0.673 . . . . 1.97 111.804 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 10.5 ttm180 -128.67 96.2 4.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.223 -1.029 . . . . 1.44 108.223 177.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 83.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.109 -0.951 . . . . 1.59 110.053 -179.149 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 73' ' ' GLU . 19.1 mt -59.45 150.87 63.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.736 -179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.03 3.19 37.28 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.713 -1.37 . . . . 1.43 113.207 0.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.82 -89.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.116 -0.234 . . . . 2.66 111.019 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 158.38 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.818 -0.706 . . . . 1.12 113.036 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.612 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.57 24.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 2.41 110.988 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.542 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 31.7 m95 53.8 83.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 0.65 111.423 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.612 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -123.33 124.27 42.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.756 0.313 . . . . 1.28 110.667 179.855 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' HG22 ' A' ' 37' ' ' ILE . 15.5 ptmt -54.27 95.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 1.3 111.033 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -65.75 -35.47 80.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.109 0.48 . . . . 0.86 110.281 179.517 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.595 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 6.4 t-20 -66.09 120.58 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 2.01 110.546 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 23.7 14.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.072 -0.513 . . . . 2.08 110.501 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.25 130.4 22.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.6 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -43.15 114.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 1.87 111.861 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.683 HD13 ' CG ' ' A' ' 61' ' ' PHE . 55.2 mt -96.04 88.29 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.69 110.426 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.77 -64.87 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.48 -0.327 . . . . 1.6 111.198 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.08 165.91 12.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.435 -0.348 . . . . 1.54 110.418 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.54 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.4 p30 -90.47 15.5 10.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.194 -0.457 . . . . 1.75 111.357 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.445 ' CD ' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tp10 -116.42 95.65 5.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.696 -0.483 . . . . 2.05 109.696 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.683 ' CG ' HD13 ' A' ' 56' ' ' ILE . 93.6 t80 -118.14 162.85 17.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.299 0.571 . . . . 0.48 112.091 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 97.5 m -135.01 108.77 8.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.294 -0.866 . . . . 0.42 110.397 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.671 HG11 ' HD3' ' A' ' 40' ' ' LYS . 38.6 t -68.34 105.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.689 -0.687 . . . . 1.08 111.052 -179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 t -100.92 164.3 11.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.058 -0.519 . . . . 1.33 110.754 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.11 28.53 68.19 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.098 -0.801 . . . . 0.9 111.098 -179.417 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.88 HD22 HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -84.31 155.84 22.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.425 -0.388 . . . . 1.47 110.344 -179.521 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.614 ' N ' HD12 ' A' ' 66' ' ' LEU . 2.5 m -91.7 127.17 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 1.06 111.482 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 2.2 tt0 -76.95 163.32 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.208 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.81 43.21 5.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.832 -0.622 . . . . 1.87 111.002 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.41 122.99 1.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.009 -0.541 . . . . 0.49 110.736 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 116.55 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.008 0.432 . . . . 0.36 110.772 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 42.5 m-85 -110.05 132.48 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.824 -0.626 . . . . 0.56 112.139 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' HD11 ' A' ' 43' ' ' LEU . 6.9 mt-10 -102.08 134.28 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.193 -1.04 . . . . 1.5 108.193 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -128.82 118.92 23.56 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.215 1.561 . . . . 0.6 115.215 -178.588 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.01 -175.27 2.73 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.832 -1.173 . . . . 2.11 107.832 177.232 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -155.99 125.86 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.233 -0.987 . . . . 0.6 113.213 179.09 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 86' ' ' SER . 20.2 mt -103.33 150.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 113.644 -1.616 . . . . 0.7 107.9 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.35 120.99 2.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.025 -1.07 . . . . 0.6 113.254 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.0 mttp -66.6 -176.07 0.44 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.98 109.994 178.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.786 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.1 p30 -135.0 169.11 17.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.829 -0.623 . . . . 2.19 110.599 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -42.79 -27.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.693 -0.685 . . . . 1.08 112.155 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 -16.97 28.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.798 0.666 . . . . 1.06 112.798 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.27 -23.07 27.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.297 -0.954 . . . . 0.93 112.128 -179.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.786 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.05 115.43 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.999 -0.371 . . . . 1.38 109.999 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -72.62 110.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.578 0.584 . . . . 0.79 112.578 -179.061 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 77' ' ' ILE . 7.7 p -65.86 116.4 32.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.59 110.087 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.78 157.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.888 2.392 . . . . 0.85 112.844 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 31.7 Cg_endo -64.28 121.56 9.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.753 2.302 . . . . 0.76 113.34 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 76' ' ' VAL . 7.8 p -71.38 132.9 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 1.28 109.62 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 46.0 mt-10 -28.89 125.7 0.25 Allowed Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.868 0.73 . . . . 1.77 112.625 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 63.0 Cg_exo -54.12 174.15 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.541 2.161 . . . . 0.55 113.822 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -106.38 142.18 36.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 1.23 109.927 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.5 t0 -38.83 136.12 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.872 0.733 . . . . 1.63 111.051 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -68.28 103.34 1.57 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.487 -0.324 . . . . 0.41 111.479 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.8 mp -88.41 115.15 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.437 -0.347 . . . . 0.44 110.751 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' NH1' ' A' ' 98' ' ' ARG . 99.0 m -49.02 -35.94 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.44 111.408 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 66' ' ' LEU . 51.6 t 61.59 95.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.197 -0.297 . . . . 1.1 110.197 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' NH1' HG21 ' A' ' 96' ' ' THR . 0.0 OUTLIER -147.22 -86.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.271 0.471 . . . . 3.0 112.271 -179.26 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.819 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -104.56 7.09 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.192 0.441 . . . . 2.14 112.192 -179.308 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.413 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 112.484 0.549 . . . . 2.06 112.484 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.041 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.6 tt . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.76 0.314 . . . . 0.68 110.923 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 2' ' ' ILE . 17.4 m-20 -136.89 121.85 12.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.357 -0.383 . . . . 2.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.87 169.46 17.7 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.307 2.005 . . . . 0.5 111.716 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.7 Cg_endo -53.74 162.98 3.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.655 2.237 . . . . 0.71 112.542 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.69 170.74 27.37 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.934 -0.651 . . . . 0.66 112.66 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -55.93 127.19 68.19 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.639 -0.134 . . . . 1.52 110.639 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 6.1 Cg_exo -76.0 128.81 10.98 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.119 1.879 . . . . 0.44 112.199 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -130.5 110.19 16.22 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.216 -0.447 . . . . 1.09 111.462 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.0 Cg_exo -58.24 103.28 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.64 113.476 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -65.35 -29.68 70.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 1.64 109.629 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' HD13 ' A' ' 13' ' ' ILE . 19.2 t-20 -150.79 154.01 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.27 -0.877 . . . . 0.72 109.22 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.057 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -144.03 114.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.039 0.447 . . . . 0.96 112.018 -179.621 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -100.22 156.29 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.713 -0.676 . . . . 1.46 110.268 179.64 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -56.9 -23.24 43.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.349 -0.387 . . . . 2.42 110.995 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' THR . 75.9 m-70 -140.12 26.5 2.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 1.02 111.117 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -170.43 97.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.68 111.147 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.057 HG13 HG22 ' A' ' 13' ' ' ILE . 89.4 t -94.77 129.11 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.8 110.964 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.658 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.9 m -106.0 125.92 51.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.681 -0.69 . . . . 0.35 111.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.827 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.87 153.19 49.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.808 0.813 . . . . 0.52 111.895 179.424 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -128.35 -174.54 3.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.254 -1.339 . . . . 1.84 109.871 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 48.5 p90 179.98 160.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.42 . . . . 0.4 111.687 179.724 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.53 146.13 45.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.83 111.319 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -82.39 139.76 44.92 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 2.11 110.573 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 33' ' ' ILE . 93.9 Cg_exo -43.69 163.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.381 2.054 . . . . 0.89 112.066 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -121.55 -38.51 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.482 . . . . 2.77 111.282 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.93 -70.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.896 -0.321 . . . . 1.37 111.476 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 25' ' ' PRO . 21.1 p 46.75 41.3 10.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.215 0.531 . . . . 0.91 110.568 -179.598 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.9 -97.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.488 -0.778 . . . . 1.01 112.506 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.75 60.71 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.739 -0.944 . . . . 0.98 110.739 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 5.2 m-85 -130.45 -172.28 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.19 0.519 . . . . 0.87 112.023 -178.451 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 14.69 1.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.482 -0.781 . . . . 2.26 111.647 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.763 HD11 ' HG2' ' A' ' 25' ' ' PRO . 17.5 mt 56.61 153.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.401 0.62 . . . . 1.71 112.538 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 33' ' ' ILE . 2.9 p -127.98 55.74 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.273 -0.876 . . . . 1.15 110.566 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' THR . 0.2 OUTLIER 87.18 154.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.565 -0.743 . . . . 1.58 110.485 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 82.0 m-85 -105.99 156.64 18.18 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.277 0.561 . . . . 0.76 111.921 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 38' ' ' VAL . 4.1 mt -121.69 168.0 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.299 -0.864 . . . . 1.14 109.563 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 74' ' ' PHE . 4.7 t -146.03 99.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.982 0.364 . . . . 0.63 111.982 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 6.3 mt-10 -77.26 126.85 31.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.154 0.502 . . . . 1.67 110.27 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 2.5 mmtp -94.2 131.37 39.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.29 -0.868 . . . . 1.97 112.63 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.1 ttm180 -111.07 105.32 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.784 -0.45 . . . . 1.44 109.784 178.029 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 1.299 ' OD2' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.43 94.14 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.996 -0.547 . . . . 1.59 111.191 -179.611 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 94' ' ' ALA . 12.9 mt -79.23 153.34 76.88 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.99 -0.55 . . . . 0.9 110.557 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.18 29.74 7.34 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.123 -1.199 . . . . 1.43 113.149 0.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -100.8 -85.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.61 0.243 . . . . 2.66 111.312 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.89 162.78 11.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.663 -0.78 . . . . 1.12 112.78 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 1.299 ' HG2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 173.7 -32.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 2.41 111.522 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 40.6 m95 48.87 75.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.667 -0.242 . . . . 0.65 110.517 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.03 137.57 52.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.896 0.379 . . . . 1.28 111.809 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.8 ptmt -65.26 85.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.125 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -58.64 -37.64 76.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.86 111.179 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 t30 -47.26 -67.03 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.01 110.546 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.37 35.19 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.425 -0.352 . . . . 2.08 111.181 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 t -139.8 -78.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 1.89 111.014 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.22 142.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 1.87 111.027 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 61' ' ' PHE . 3.5 mt -144.98 74.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.69 111.016 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 57' ' ' LEU . 1.1 mt -68.16 -37.1 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.157 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -100.68 167.19 10.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 1.54 110.597 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -77.0 -9.94 59.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.499 . . . . 1.75 111.613 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG3' ' HG2' ' A' ' 21' ' ' LYS . 4.9 tt0 -96.3 102.43 14.22 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.833 0.349 . . . . 2.05 110.296 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.726 ' HB2' HG23 ' A' ' 56' ' ' ILE . 57.9 t80 -136.57 163.37 30.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.107 -0.497 . . . . 0.48 111.677 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 75.7 m -126.05 119.55 27.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.42 111.252 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 51' ' ' ALA . 12.1 t -83.88 102.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.08 111.009 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -102.38 168.15 9.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 1.33 111.012 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.25 12.04 52.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.787 -0.72 . . . . 0.9 112.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER -86.55 -174.1 4.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.778 0.289 . . . . 1.47 110.835 179.947 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 2.0 m -128.31 154.69 45.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 1.06 111.099 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 3.2 tm-20 -77.42 158.19 30.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 1.91 110.93 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.3 t70 56.54 59.98 3.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 1.87 110.943 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.32 123.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.49 111.144 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.48 129.79 39.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.36 110.453 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 51.5 m-85 -126.77 129.51 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.56 112.075 -179.142 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 3.5 mt-10 -107.78 144.99 34.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.814 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 119.43 14.09 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.543 1.312 . . . . 0.6 114.543 -178.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.85 146.59 26.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.466 -0.333 . . . . 2.11 110.366 178.434 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 57.1 t -93.98 119.54 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.6 110.935 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 87' ' ' PRO . 1.1 mt -118.99 144.39 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.271 -1.011 . . . . 0.7 108.271 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -178.57 142.52 0.23 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.6 111.959 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HE3' HD12 ' A' ' 85' ' ' ILE . 12.5 mttp -77.35 -178.64 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.152 -0.619 . . . . 1.98 109.677 179.015 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 1.041 ' ND2' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -112.69 -86.93 0.56 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.921 -0.581 . . . . 2.19 110.3 -179.899 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -155.19 -42.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.491 0.552 . . . . 1.08 112.491 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.64 46.14 0.98 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.658 0.614 . . . . 1.06 112.658 -178.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.14 -2.02 62.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.163 -1.017 . . . . 0.93 113.288 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.821 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.05 105.47 8.15 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.039 -0.726 . . . . 1.38 109.039 179.369 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt -97.31 111.0 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.548 0.944 . . . . 0.79 113.548 -178.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.75 111.38 6.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.411 -1.7 . . . . 0.59 106.411 177.435 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 73.0 Cg_endo -66.39 -99.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.814 1.676 . . . . 0.85 113.843 -177.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 87' ' ' PRO . 72.5 Cg_endo -106.73 134.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 CA-C-N 124.815 2.755 . . . . 0.76 114.168 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 29.3 m -109.22 88.51 2.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.254 -0.43 . . . . 1.28 110.181 178.585 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 18.88 100.53 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.541 1.136 . . . . 1.77 113.973 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 53.0 Cg_exo -51.17 145.72 25.39 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.479 2.119 . . . . 0.55 113.616 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 75.2 m -73.49 141.21 46.79 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.23 109.274 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.7 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -39.73 144.94 0.15 Allowed 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 124.035 0.834 . . . . 1.63 110.865 179.462 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.15 110.78 6.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.551 -0.46 . . . . 0.41 110.491 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.949 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -92.55 109.87 22.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.007 0.432 . . . . 0.44 111.333 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 33.8 m -45.43 -32.94 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.708 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.5 m 52.53 59.3 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.949 0.404 . . . . 1.1 110.379 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.817 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -90.47 -75.65 0.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 3.0 112.463 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.817 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.0 p-10 -119.75 30.56 6.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.121 -0.49 . . . . 2.14 111.754 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 53.0 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.076 0.465 . . . . 2.06 111.835 -179.448 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.677 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.3 tt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.871 0.367 . . . . 0.68 110.754 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -125.81 133.23 24.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 2.0 110.636 179.858 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.0 160.7 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.28 1.987 . . . . 0.5 112.097 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.0 176.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.665 2.243 . . . . 0.71 113.067 -179.488 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.78 171.44 53.56 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.882 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -63.52 118.29 42.86 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 110.19 -0.3 . . . . 1.52 110.19 179.585 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 31.5 Cg_exo -64.74 135.49 45.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.067 . . . . 0.44 112.801 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.45 103.65 11.31 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.036 -0.529 . . . . 1.09 111.693 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 33.1 Cg_exo -48.7 117.69 2.88 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.055 1.836 . . . . 0.64 112.366 179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -75.5 -32.72 60.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.1 -0.704 . . . . 1.64 109.1 178.86 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.81 157.48 43.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.878 -1.055 . . . . 0.72 108.914 179.43 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.856 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -140.34 97.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.513 . . . . 0.96 111.437 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -87.13 48.09 1.6 Allowed 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 115.635 -0.711 . . . . 1.46 112.279 -179.259 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.85 -75.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.678 0.621 . . . . 2.42 112.678 178.698 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.2 m-70 -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 1.02 111.614 -179.39 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.6 p -139.48 121.97 16.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.465 -0.334 . . . . 0.68 110.309 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.974 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 16.8 m -109.45 135.57 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.8 112.168 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 11' ' ' LEU . 18.9 m -93.6 140.19 29.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.68 -0.691 . . . . 0.35 109.942 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.92 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.96 152.54 38.8 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.657 0.598 . . . . 0.52 112.251 -179.854 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.435 ' CG ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -140.94 145.41 36.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.127 -0.942 . . . . 1.84 110.438 179.825 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.3 p90 -140.03 -176.91 4.76 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.058 0.456 . . . . 0.4 111.864 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.45 165.97 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.83 110.705 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.24 147.07 32.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 2.11 110.801 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.595 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.9 Cg_endo -42.77 167.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.032 2.488 . . . . 0.89 112.047 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.58 -28.47 8.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 2.77 111.759 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -123.15 -69.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 1.37 111.312 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.595 HG23 ' CB ' ' A' ' 25' ' ' PRO . 13.7 p 51.14 53.04 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.91 111.007 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.14 -92.26 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.789 -0.72 . . . . 1.01 112.31 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.96 32.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.776 -0.93 . . . . 0.98 110.776 179.379 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.1 -179.2 3.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.22 -0.49 . . . . 0.87 111.509 -178.787 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 11.36 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 2.26 111.398 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.6 mp 60.09 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.064 0.459 . . . . 1.71 110.897 -179.747 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 p -126.68 5.61 6.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 1.15 111.277 179.861 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.58 123.14 0.64 Allowed 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.746 0.308 . . . . 1.58 110.987 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.3 m-85 -100.88 92.4 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.76 110.575 179.561 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.482 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 5.8 mm -69.69 138.23 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.463 -0.335 . . . . 1.14 111.0 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.93 101.19 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.45 -0.341 . . . . 0.63 111.677 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -77.46 138.69 39.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.914 -0.772 . . . . 1.67 108.914 178.815 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -121.1 135.23 55.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 1.97 111.64 -179.45 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 20.0 ttm180 -114.17 113.28 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.605 -0.725 . . . . 1.44 110.455 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.16 112.98 11.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.59 110.502 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 41' ' ' ARG . 2.2 mm? -80.39 149.22 68.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.9 110.975 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.55 17.21 41.12 Favored 'Cis proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.885 -1.298 . . . . 1.43 112.66 0.069 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -151.08 93.16 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 2.66 111.372 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -144.07 -165.52 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 1.12 112.138 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 148.38 33.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 2.41 110.842 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 50.6 m95 -68.88 97.56 0.85 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.678 -0.692 . . . . 0.65 110.907 -179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -128.37 126.42 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.604 179.919 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 10.2 ptmm? -58.32 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.871 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -74.29 -35.23 63.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.953 0.406 . . . . 0.86 110.373 179.794 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 56' ' ' ILE . 11.4 p-10 -44.28 -47.75 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.849 -0.614 . . . . 2.01 111.386 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 41.27 30.03 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 2.08 111.982 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 -161.34 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.44 -0.345 . . . . 1.89 110.711 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.85 61.86 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.935 -179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 61' ' ' PHE . 2.4 mm -57.95 95.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.69 110.131 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.21 -8.03 9.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.017 0.377 . . . . 1.6 112.017 -179.536 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.28 9.14 23.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.157 0.428 . . . . 1.54 112.157 -179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 13.0 p30 53.05 21.26 2.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 1.75 111.59 -179.075 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.435 ' OE1' ' CG ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -130.85 78.67 1.85 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 178.902 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.875 ' CG ' HD12 ' A' ' 56' ' ' ILE . 82.3 t80 -120.03 164.63 15.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.519 0.676 . . . . 0.48 112.378 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 18' ' ' VAL . 48.8 m -124.43 120.86 33.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.765 -1.107 . . . . 0.42 109.972 178.937 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.92 HG23 HD11 ' A' ' 20' ' ' LEU . 21.3 t -76.26 100.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.962 -0.563 . . . . 1.08 111.307 -179.521 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.23 137.13 32.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.243 -0.89 . . . . 1.33 110.44 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.14 -17.41 4.33 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.787 -0.72 . . . . 0.9 111.945 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.92 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -52.05 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.676 0.274 . . . . 1.47 110.311 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -148.03 141.81 25.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.481 -0.327 . . . . 1.06 110.563 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 3.0 tt0 -57.49 139.26 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 1.91 110.967 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.885 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 67.86 61.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 1.87 111.06 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.29 120.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.443 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.74 135.56 51.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.159 -0.682 . . . . 0.36 109.159 179.078 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 33.1 m-85 -129.94 115.87 17.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.258 0.836 . . . . 0.56 113.258 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.792 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 7.8 mt-10 -99.27 134.18 42.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.5 107.917 178.087 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.42 118.34 14.24 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.901 1.074 . . . . 0.6 113.901 -179.066 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.46 172.98 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.028 -1.101 . . . . 2.11 108.028 177.945 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -138.78 116.22 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.927 . . . . 0.6 112.176 179.446 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 86' ' ' SER . 69.6 mt -99.2 142.15 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.784 -1.191 . . . . 0.7 107.784 178.3 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -148.91 116.08 6.09 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.433 -0.907 . . . . 0.6 112.729 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.696 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.6 mtpt -63.28 -167.66 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.638 -0.505 . . . . 1.98 109.638 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.761 HD21 ' HB3' ' A' ' 84' ' ' ALA . 22.5 p30 -143.95 169.86 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.267 0.556 . . . . 2.19 111.684 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.01 -30.18 0.99 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.315 -0.857 . . . . 1.08 111.941 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.85 -22.55 36.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.848 0.314 . . . . 1.06 111.848 -179.48 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.67 -21.54 18.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.368 -0.92 . . . . 0.93 111.935 -179.51 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -52.22 161.03 0.68 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.087 -0.338 . . . . 1.38 110.087 179.581 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.696 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -112.56 109.76 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.247 0.462 . . . . 0.79 112.247 -179.596 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.0 p -66.88 115.87 29.5 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 109.167 -0.679 . . . . 0.59 109.167 179.009 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -38.87 159.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.672 2.248 . . . . 0.85 112.812 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 28.4 Cg_endo -64.75 124.4 13.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.704 2.269 . . . . 0.76 112.976 -179.665 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.456 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.6 m -76.76 115.64 16.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 1.28 109.636 179.062 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -12.19 118.44 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.588 1.155 . . . . 1.77 113.534 -179.34 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' HD3' ' A' ' 75' ' ' ARG . 70.2 Cg_exo -52.26 131.68 40.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.575 2.184 . . . . 0.55 113.606 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.97 144.99 56.92 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.585 -0.895 . . . . 1.23 108.585 178.687 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.638 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.21 141.75 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.956 0.785 . . . . 1.63 112.352 -179.553 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -73.15 107.19 5.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.76 -0.655 . . . . 0.41 109.977 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -86.79 112.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.874 -179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.2 m -48.09 -32.32 6.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.656 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.441 ' H ' HG22 ' A' ' 95' ' ' ILE . 81.5 m 54.83 83.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.86 -0.609 . . . . 1.1 110.993 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 -91.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.314 -0.403 . . . . 3.0 110.269 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.44 17.86 16.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.846 0.355 . . . . 2.14 110.063 179.064 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 p30 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-N 116.04 -0.527 . . . . 2.06 111.436 -179.77 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.457 ' CG1' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 0.68 111.882 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.7 134.29 13.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 2.0 111.067 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.19 159.96 26.49 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.607 2.205 . . . . 0.5 112.719 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 51.1 Cg_exo -55.09 172.63 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.713 2.275 . . . . 0.71 112.491 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -62.8 -163.42 0.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.66 112.221 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 4.7 tttp -87.4 142.9 33.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.57 0.185 . . . . 1.52 110.532 179.849 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HG3' HG23 ' A' ' 76' ' ' VAL . 2.2 Cg_endo -83.24 132.5 6.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.659 2.239 . . . . 0.44 112.494 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.74 110.73 10.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 1.09 110.69 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.9 Cg_exo -59.54 139.93 91.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.117 1.878 . . . . 0.64 113.887 -179.152 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HG ' HG22 ' A' ' 19' ' ' THR . 0.1 OUTLIER -105.71 -26.83 11.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.957 -1.019 . . . . 1.64 109.162 178.971 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.469 ' C ' HD13 ' A' ' 13' ' ' ILE . 5.5 t-20 -161.79 158.01 25.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.72 110.452 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.4 95.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.127 0.489 . . . . 0.96 110.469 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.21 56.61 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 1.46 112.166 -179.258 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.518 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.07 -68.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.548 0.573 . . . . 2.42 112.548 178.371 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' THR . 24.4 m-70 -95.89 -7.25 37.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 1.02 111.883 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' SER . 6.6 p -133.0 98.73 4.37 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.721 -0.392 . . . . 0.68 111.762 -179.783 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 20' ' ' LEU . 84.6 t -86.62 141.84 13.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.242 -0.435 . . . . 0.8 109.945 179.356 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.777 HG22 ' HG ' ' A' ' 11' ' ' LEU . 88.0 m -123.89 115.53 21.44 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.872 0.693 . . . . 0.35 112.872 -178.708 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.54 150.03 51.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.639 0.733 . . . . 0.52 111.465 178.499 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.61 140.86 37.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.721 -1.127 . . . . 1.84 110.207 -179.417 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -131.25 -176.81 4.14 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.443 0.639 . . . . 0.4 112.47 -179.34 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.453 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -85.44 -162.5 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.592 -0.731 . . . . 0.83 111.026 179.839 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -122.44 153.07 62.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 2.11 111.005 -179.76 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.447 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 50.4 Cg_exo -55.81 179.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.771 2.314 . . . . 0.89 113.248 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.85 -28.59 4.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 2.77 111.914 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -124.81 -69.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.015 0.376 . . . . 1.37 112.015 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 4.1 p 51.61 49.8 20.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.91 110.648 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.27 -104.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.113 -0.565 . . . . 1.01 112.692 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.16 2.56 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 110.563 -1.015 . . . . 0.98 110.563 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CD2' ' OD1' ' A' ' 80' ' ' ASN . 1.2 m-85 -108.85 178.14 4.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.634 -0.783 . . . . 0.87 111.47 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.13 6.02 2.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.889 -0.596 . . . . 2.26 111.84 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 18.8 mt 60.02 134.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-O 121.126 0.488 . . . . 1.71 111.083 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.427 ' C ' ' HG ' ' A' ' 35' ' ' SER . 3.7 p -122.92 -3.65 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 1.15 112.201 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.427 ' HG ' ' C ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -168.63 116.1 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.103 0.408 . . . . 1.58 112.103 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 19.5 m-85 -90.52 142.15 28.04 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.849 0.356 . . . . 0.76 110.152 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 77' ' ' ILE . 3.3 mt -111.94 166.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.123 -0.49 . . . . 1.14 110.712 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 37' ' ' ILE . 2.8 t -141.44 101.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.442 -0.345 . . . . 0.63 111.386 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -75.93 137.9 40.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 1.67 109.677 179.279 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.845 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -115.62 152.54 32.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.14 0.495 . . . . 1.97 111.532 -179.426 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 9.2 ttm180 -143.04 118.8 10.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.634 -0.712 . . . . 1.44 110.62 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 1.08 ' OD1' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -62.35 -15.41 48.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.305 -0.407 . . . . 1.59 111.862 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 73' ' ' GLU . 77.5 mt 57.05 148.42 0.05 OUTLIER Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.771 -0.65 . . . . 0.9 111.755 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.86 13.22 46.17 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.744 -1.357 . . . . 1.43 112.4 -0.188 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -124.29 -67.9 0.89 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.383 -0.371 . . . . 2.66 110.418 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 1.08 ' CA ' ' OD1' ' A' ' 42' ' ' ASP . . . 42.04 -129.7 4.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.118 -0.563 . . . . 1.12 113.107 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.414 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 170.67 110.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 2.41 110.781 -179.863 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.4 m95 -52.0 104.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.648 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -142.75 136.29 28.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 1.28 111.106 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.2 ptmm? -52.61 119.08 4.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.167 -179.898 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.845 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -109.21 -29.51 8.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.86 110.619 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 15.1 p-10 -52.45 -50.21 63.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 2.01 111.174 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 51.77 24.95 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.396 -0.366 . . . . 2.08 110.808 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -159.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 1.89 110.719 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.36 59.36 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.87 111.134 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.57 HD13 ' CB ' ' A' ' 61' ' ' PHE . 15.4 mt -52.42 155.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.762 -0.459 . . . . 0.69 109.762 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -164.79 -36.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.81 0.671 . . . . 1.6 112.81 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.83 22.94 2.9 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.241 0.46 . . . . 1.54 112.241 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 17.9 p30 50.52 22.82 1.13 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.962 -0.563 . . . . 1.75 111.775 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -133.0 91.84 2.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.261 -1.014 . . . . 2.05 108.261 178.915 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CB ' HD13 ' A' ' 56' ' ' ILE . 72.1 t80 -122.31 165.55 16.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.245 0.545 . . . . 0.48 111.946 -178.385 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.518 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 24.6 m -129.24 107.05 9.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.404 -0.816 . . . . 0.42 111.124 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.1 t -67.47 108.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 1.08 110.718 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 17' ' ' THR . 4.6 p -110.15 144.24 39.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.658 -0.701 . . . . 1.33 110.966 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.67 10.54 14.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.686 -0.769 . . . . 0.9 112.902 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 3.7 mm? -52.58 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.105 0.452 . . . . 1.47 110.68 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -105.71 -18.56 14.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.06 110.955 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 68.0 141.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.894 0.378 . . . . 1.91 110.63 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.49 25.05 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 1.87 110.203 -179.367 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.09 141.58 25.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.878 -0.601 . . . . 0.49 110.693 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -80.81 132.41 35.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.36 110.9 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 49.5 m-85 -132.39 133.39 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.773 . . . . 0.56 112.154 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HB2' HD11 ' A' ' 43' ' ' LEU . 7.0 tt0 -106.21 143.75 33.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.173 -1.047 . . . . 1.5 108.173 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.529 ' HZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.83 117.96 16.48 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.066 1.506 . . . . 0.6 115.066 -178.337 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.9 156.52 17.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 2.11 109.895 177.815 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 8' ' ' PRO . 71.9 t -104.57 128.89 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.252 0.548 . . . . 0.6 111.498 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 37' ' ' ILE . 11.0 mt -132.85 155.74 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.551 -1.278 . . . . 0.7 107.551 179.131 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -176.86 131.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.467 -0.893 . . . . 0.6 112.799 -179.628 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 ptpt -87.92 111.73 21.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.738 -0.838 . . . . 1.98 108.738 178.407 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -46.39 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.851 1.056 . . . . 2.19 113.851 -177.933 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.15 -52.05 1.65 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.043 0.757 . . . . 1.08 113.043 -178.615 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -74.14 0.76 12.92 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.084 0.772 . . . . 1.06 113.084 -178.905 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.7 -17.6 38.9 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.184 -1.008 . . . . 0.93 112.259 -179.835 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.6 97.13 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 179.23 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.11 118.53 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.486 0.921 . . . . 0.79 113.486 -178.173 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.2 p -71.29 110.45 7.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 107.945 -1.132 . . . . 0.59 107.945 178.123 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -56.44 175.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.82 2.347 . . . . 0.85 114.324 -178.168 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 86.2 Cg_exo -45.79 135.78 13.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.621 2.881 . . . . 0.76 113.866 -179.373 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 m -119.84 95.55 4.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.036 -0.529 . . . . 1.28 111.416 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 20.96 105.83 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.996 1.11 . . . . 1.77 113.996 179.435 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.6 Cg_exo -60.66 136.86 69.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.531 2.154 . . . . 0.55 112.643 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -71.6 146.85 48.11 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.021 -0.536 . . . . 1.23 110.23 179.627 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -34.09 146.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.348 1.03 . . . . 1.63 112.159 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -81.56 118.13 22.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.784 -0.644 . . . . 0.41 110.947 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -108.59 119.47 58.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.44 111.503 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 53.1 m -52.21 -22.81 4.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.056 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.701 ' H ' HG22 ' A' ' 95' ' ' ILE . 1.9 m 57.93 58.0 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.235 0.541 . . . . 1.1 110.176 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -78.82 -132.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.433 -0.803 . . . . 3.0 110.759 -179.594 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 15' ' ' ARG . 2.6 p30 -93.41 35.81 1.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.175 0.443 . . . . 2.14 110.824 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.518 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 24.2 t0 . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.26 0.552 . . . . 2.06 112.312 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.732 HD12 ' OD1' ' A' ' 80' ' ' ASN . 1.6 tt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.888 0.375 . . . . 0.68 111.181 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.6 m-20 -130.41 138.61 33.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 2.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.27 161.91 13.2 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.854 2.369 . . . . 0.5 112.552 -179.916 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 12.3 Cg_endo -56.33 -174.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.062 2.508 . . . . 0.71 112.981 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 178.05 49.14 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.967 -0.56 . . . . 0.66 112.838 -179.77 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.9 122.81 85.28 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.198 -0.297 . . . . 1.52 110.198 179.648 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CG ' HG12 ' A' ' 76' ' ' VAL . 29.3 Cg_exo -67.66 141.78 56.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.44 112.816 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.55 108.01 7.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.7 -0.682 . . . . 1.09 110.848 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.544 ' CB ' HD23 ' A' ' 20' ' ' LEU . 24.4 Cg_exo -51.06 123.2 11.37 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.14 1.893 . . . . 0.64 113.048 -179.518 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -84.03 -31.67 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.084 -0.71 . . . . 1.64 109.084 178.41 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -151.11 147.97 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.879 -1.055 . . . . 0.72 108.934 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.969 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -132.58 98.39 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.96 111.441 -179.556 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.45 50.96 2.06 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.628 -0.714 . . . . 1.46 111.576 -179.719 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.77 -75.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.661 0.615 . . . . 2.42 112.661 178.933 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.3 m-70 -73.6 -24.92 60.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.333 0.494 . . . . 1.02 112.333 -179.132 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -137.59 122.09 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.226 -0.287 . . . . 0.68 110.226 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.969 ' HB ' HG22 ' A' ' 13' ' ' ILE . 12.6 m -111.64 121.92 65.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.625 0.726 . . . . 0.8 112.647 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 15.5 m -83.69 138.37 33.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.92 -1.037 . . . . 0.35 110.35 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.816 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -147.61 164.12 34.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.642 0.588 . . . . 0.52 111.724 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.929 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.31 178.93 6.84 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.648 -0.706 . . . . 1.84 110.352 179.437 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.513 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 47.6 p90 -172.31 167.18 5.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.393 0.616 . . . . 0.4 112.533 179.717 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.83 148.95 29.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.19 -0.914 . . . . 0.83 110.657 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.61 149.13 43.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.496 -0.32 . . . . 2.11 110.842 179.819 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 86.5 Cg_exo -44.65 176.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.024 2.483 . . . . 0.89 112.919 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -30.64 4.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.908 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -114.01 -71.72 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.143 0.423 . . . . 1.37 112.143 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 12.1 p 54.38 37.11 26.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.91 110.808 -179.451 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.38 -92.65 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.788 . . . . 1.01 112.229 179.996 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.3 27.38 1.54 Allowed Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.46 -0.656 . . . . 0.98 111.46 179.516 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -102.55 -177.27 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.87 111.567 -179.17 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.81 2.99 2.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.431 0.53 . . . . 2.26 112.431 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.7 mp 60.65 136.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.107 0.479 . . . . 1.71 111.436 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 p -124.7 9.64 8.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 1.15 111.779 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 t -179.29 138.39 0.14 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.831 0.348 . . . . 1.58 111.752 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.63 ' O ' HD12 ' A' ' 56' ' ' ILE . 32.8 m-85 -114.35 103.96 11.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.76 110.496 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.5 mm -79.83 128.36 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 1.14 110.883 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.98 111.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.832 0.308 . . . . 0.63 111.832 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.801 ' CD ' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -86.81 136.36 33.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 1.67 108.834 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.608 ' CD ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.54 143.78 50.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.338 0.59 . . . . 1.97 112.274 -179.001 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG3' ' HA3' ' A' ' 46' ' ' GLY . 20.3 ttp180 -110.53 108.5 18.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.151 -0.931 . . . . 1.44 109.905 179.426 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.954 ' OD2' ' NH2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.83 92.69 3.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.698 -0.683 . . . . 1.59 109.839 179.809 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.852 HD11 ' HG2' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -68.17 142.86 95.37 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.9 111.172 -179.405 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -94.2 16.25 41.64 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.047 -1.231 . . . . 1.43 112.793 0.109 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.37 67.78 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.579 -0.282 . . . . 2.66 111.642 -179.616 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -110.57 176.54 18.93 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.571 -0.823 . . . . 1.12 112.681 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.954 ' NH2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -151.58 19.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 111.246 -179.827 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 82.2 m95 49.74 98.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.65 111.106 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -143.14 155.29 44.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 1.28 110.851 179.198 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -71.84 116.83 12.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.089 0.471 . . . . 1.3 111.563 -179.427 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -93.14 -39.79 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.86 110.609 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.638 ' CB ' HD11 ' A' ' 56' ' ' ILE . 13.9 p-10 -49.92 -48.62 51.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 2.01 111.049 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.05 30.43 0.59 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 2.08 111.297 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 m -139.29 -164.64 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 1.89 111.153 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -95.86 107.7 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 1.87 111.022 -179.854 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.638 HD11 ' CB ' ' A' ' 52' ' ' ASN . 44.1 mt -108.48 65.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.69 110.704 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mt -47.66 -66.75 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.475 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.15 162.47 27.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.933 0.397 . . . . 1.54 110.555 179.975 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.7 p30 -75.9 -2.39 30.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.894 -0.594 . . . . 1.75 111.659 -179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 58' ' ' GLU . 16.7 tt0 -93.48 99.55 12.01 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.457 -0.571 . . . . 2.05 109.457 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 73.0 t80 -134.51 164.58 27.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.316 0.579 . . . . 0.48 112.024 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.8 m -124.3 124.86 43.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.246 -0.888 . . . . 0.42 109.974 179.32 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 20' ' ' LEU . 9.9 t -80.55 96.07 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.098 0.475 . . . . 1.08 111.365 -179.442 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.25 132.51 35.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 1.33 110.83 179.936 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.82 -25.65 2.93 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.529 -0.76 . . . . 0.9 111.325 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.708 ' CD2' HG13 ' A' ' 18' ' ' VAL . 6.9 mp -49.14 158.29 0.37 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.958 0.408 . . . . 1.47 110.928 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -124.91 144.14 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 1.06 110.805 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -60.21 143.73 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 1.91 111.16 -179.844 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER 69.87 44.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 1.87 111.213 179.891 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.41 122.2 4.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.858 0.361 . . . . 0.49 111.808 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -74.81 128.84 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.36 109.861 179.168 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 47.0 m-85 -125.13 125.14 43.26 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.082 0.771 . . . . 0.56 113.082 -178.701 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.852 ' HG2' HD11 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -102.37 137.94 39.96 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.885 -1.154 . . . . 1.5 107.885 178.013 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.887 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -142.75 126.58 17.13 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.208 1.558 . . . . 0.6 115.208 -178.781 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -106.02 -173.04 2.2 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.954 -1.128 . . . . 2.11 107.954 177.384 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.603 HG12 ' CG ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -151.34 117.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 118.989 -1.084 . . . . 0.6 113.336 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.801 HD12 ' CD ' ' A' ' 39' ' ' GLU . 65.4 mt -100.18 146.11 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.7 106.832 177.288 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -158.33 135.69 10.15 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.75 -0.78 . . . . 0.6 112.286 -178.847 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.1 mttp -73.6 -152.38 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 178.792 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.732 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -147.29 -108.91 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.452 -0.499 . . . . 2.19 110.724 179.576 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.36 -12.06 4.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.978 0.808 . . . . 1.08 112.5 179.617 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.1 -1.07 26.03 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.754 0.279 . . . . 1.06 111.754 -179.911 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.88 43.63 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.427 -0.892 . . . . 0.93 112.481 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.28 153.61 11.88 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.744 -0.268 . . . . 1.38 110.316 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -113.63 106.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.069 0.462 . . . . 0.79 111.681 -179.725 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -65.42 127.44 92.95 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 115.93 -0.577 . . . . 0.59 109.738 179.585 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -41.35 168.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.88 2.387 . . . . 0.85 113.365 -179.321 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HG3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -75.74 121.35 6.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.254 2.636 . . . . 0.76 112.6 -179.744 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.588 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -66.79 132.84 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.998 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -33.6 121.71 0.48 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 122.869 0.468 . . . . 1.77 112.169 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 56.3 Cg_exo -52.98 155.31 11.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.94 2.426 . . . . 0.55 113.977 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.94 149.72 21.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 1.23 109.832 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -42.47 148.26 0.23 Allowed 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 124.21 0.944 . . . . 1.63 111.222 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.786 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . . . -75.24 124.23 26.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.825 -0.625 . . . . 0.41 111.62 -179.636 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.659 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -102.99 109.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.517 179.483 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.6 m -46.63 -28.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.44 111.004 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.641 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 52.04 83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.1 110.515 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -131.79 -87.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 3.0 111.278 -179.873 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.525 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.5 p-10 -98.59 9.88 42.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.337 -0.392 . . . . 2.14 111.304 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.4 p30 . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.999 0.428 . . . . 2.06 111.252 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.899 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.2 tt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.78 0.324 . . . . 0.68 110.722 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.12 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -129.0 119.39 19.82 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 2.0 110.537 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.9 161.89 37.46 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.164 1.909 . . . . 0.5 111.983 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.96 167.0 18.87 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.645 2.23 . . . . 0.71 113.158 -179.312 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.68 154.96 25.87 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.789 -0.641 . . . . 0.66 112.94 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 2.6 tttt -53.65 138.83 51.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 1.52 110.103 179.704 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.513 ' CG ' HG23 ' A' ' 76' ' ' VAL . 4.2 Cg_exo -80.63 115.35 3.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.448 2.098 . . . . 0.44 111.901 179.652 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.5 p -109.29 109.74 60.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.538 -0.301 . . . . 1.09 110.649 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 72.9 Cg_exo -41.66 125.0 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.341 2.027 . . . . 0.64 113.123 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -89.59 -33.26 16.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.49 -0.777 . . . . 1.64 109.61 179.833 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' O ' ' HB ' ' A' ' 19' ' ' THR . 4.9 t-20 -158.35 111.1 2.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.72 109.565 179.22 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.037 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -102.74 140.07 22.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.357 0.598 . . . . 0.96 112.4 -179.229 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.917 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -136.42 141.59 43.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.299 -0.864 . . . . 1.46 110.197 179.777 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -43.14 -24.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.155 0.798 . . . . 2.42 113.155 -179.239 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.406 ' O ' HG23 ' A' ' 17' ' ' THR . 11.0 m170 -122.73 -0.15 9.17 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.784 -0.572 . . . . 1.02 112.497 -179.589 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -161.27 120.29 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.68 110.95 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 13' ' ' ILE . 61.2 t -108.16 128.31 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.168 -0.469 . . . . 0.8 111.176 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.884 ' C ' HD13 ' A' ' 20' ' ' LEU . 21.7 m -106.48 133.43 51.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.35 110.938 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.884 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -136.34 147.0 47.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.681 0.753 . . . . 0.52 112.033 179.493 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -130.25 131.12 45.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.473 -1.24 . . . . 1.84 109.646 179.682 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 6.5 p90 -118.01 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.003 0.43 . . . . 0.4 111.946 -179.565 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.32 177.94 4.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.721 -0.672 . . . . 0.83 112.052 -179.498 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.27 142.17 25.83 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.34 -0.845 . . . . 2.11 110.266 179.801 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 78.3 Cg_exo -51.86 -161.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.888 2.392 . . . . 0.89 113.595 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.3 -43.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.267 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.032 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.7 t80 -111.2 -70.66 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.453 -0.34 . . . . 1.37 111.885 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' THR . . . . . 1.12 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 p 55.16 43.84 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.922 -0.399 . . . . 0.91 109.922 -179.243 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.37 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.733 -0.667 . . . . 1.01 112.769 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.95 37.87 0.81 Allowed Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 109.872 -1.291 . . . . 0.98 109.872 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -117.65 -179.27 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.631 -0.785 . . . . 0.87 111.055 -178.67 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -6.77 4.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 2.26 112.29 -179.744 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 79' ' ' LYS . 11.9 mt 62.26 142.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 1.71 110.648 -179.642 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -138.93 42.66 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.3 . . . . 1.15 111.428 -179.57 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.31 165.45 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.416 -0.356 . . . . 1.58 110.69 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 61.2 m-85 -153.53 74.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.76 110.889 179.839 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.484 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.6 mt -57.42 133.52 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 1.14 110.865 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 61' ' ' PHE . 2.5 t -105.1 104.79 17.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.342 -0.39 . . . . 0.63 111.302 179.999 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.948 ' OE2' ' O ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -78.98 130.12 35.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.686 -0.487 . . . . 1.67 109.686 179.394 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.812 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.67 143.92 43.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.886 0.374 . . . . 1.97 110.983 -179.877 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 4.1 ttm180 -117.36 105.38 12.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.944 -0.571 . . . . 1.44 110.575 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.745 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.59 98.56 3.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 1.59 110.907 -179.742 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.6 mt -83.2 154.7 66.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.9 110.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.33 37.96 5.76 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.056 -1.227 . . . . 1.43 112.835 0.297 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 45' ' ' ASN . 1.9 p-10 -167.19 79.46 0.2 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 2.66 111.305 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -152.92 -169.71 18.42 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.932 -0.576 . . . . 1.12 111.85 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.776 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.2 159.75 42.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.138 0.494 . . . . 2.41 111.278 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.948 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 70.0 m95 -64.52 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.65 111.017 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.776 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -116.69 128.49 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.351 -0.386 . . . . 1.28 111.086 -179.813 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.89 117.57 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 1.3 111.234 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.812 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -95.86 -33.72 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.86 110.811 179.702 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.3 p-10 -47.64 -59.12 3.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 2.01 111.558 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.41 37.76 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 2.08 111.181 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -145.44 20.37 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.89 111.422 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.71 116.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.999 0.428 . . . . 1.87 111.262 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.73 HD12 ' CD1' ' A' ' 61' ' ' PHE . 15.4 mm -105.4 85.04 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.69 111.324 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.12 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 1.6 110.45 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.22 176.72 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 1.54 110.35 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -95.74 32.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 1.75 111.746 -179.616 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -131.58 97.85 4.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.727 -0.471 . . . . 2.05 109.727 179.513 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CD1' HD12 ' A' ' 56' ' ' ILE . 83.3 t80 -133.29 163.16 29.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.259 0.552 . . . . 0.48 111.927 -179.345 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.528 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 46.0 m -130.25 112.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.175 -0.92 . . . . 0.42 110.824 179.152 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.701 HG23 HD21 ' A' ' 20' ' ' LEU . 5.0 t -72.06 119.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.08 111.05 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.78 142.47 46.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.923 -0.58 . . . . 1.33 110.992 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.18 5.44 6.17 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.786 -0.721 . . . . 0.9 112.798 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -71.92 -172.54 0.86 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.071 0.435 . . . . 1.47 110.929 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -142.12 147.26 36.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 1.06 111.017 -179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 5.8 tt0 -63.82 138.53 58.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 1.91 111.455 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.14 57.68 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 1.87 111.008 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.62 118.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.182 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.34 123.73 22.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.36 110.464 179.563 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 37.8 m-85 -119.12 127.93 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.583 0.586 . . . . 0.56 112.583 -178.875 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.2 tt0 -104.32 145.88 29.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.9 -0.778 . . . . 1.5 108.9 178.641 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -142.45 130.04 21.41 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.228 1.195 . . . . 0.6 114.228 -179.186 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -115.67 -178.85 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.684 -0.689 . . . . 2.11 109.814 178.312 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG23 ' CG ' ' A' ' 8' ' ' PRO . 39.5 t -132.56 110.35 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.132 -0.627 . . . . 0.6 112.632 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 39' ' ' GLU . 59.2 mt -105.48 142.17 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.067 -1.457 . . . . 0.7 107.067 177.514 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -150.66 -171.23 3.87 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.765 -0.774 . . . . 0.6 111.655 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 33' ' ' ILE . 7.1 mttt -129.78 -175.38 3.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 1.98 109.705 179.419 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.899 ' ND2' HD11 ' A' ' 2' ' ' ILE . 4.4 m-80 -132.9 162.07 32.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.978 0.418 . . . . 2.19 111.464 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.36 -28.69 0.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 1.08 112.544 -179.706 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -85.87 -7.6 58.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.709 0.633 . . . . 1.06 112.709 -179.125 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 102.91 -16.71 54.09 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.241 -0.981 . . . . 0.93 112.458 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.18 161.92 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 1.38 109.93 179.731 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -115.73 98.5 6.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.79 111.583 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -54.09 116.58 10.69 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 179.237 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.58 168.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.938 2.425 . . . . 0.85 113.072 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 22.5 Cg_exo -65.15 121.54 9.03 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.937 2.425 . . . . 0.76 113.281 -179.651 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -78.35 124.2 27.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.663 -0.699 . . . . 1.28 109.233 179.021 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 mm-40 -22.68 117.97 0.17 Allowed Pre-proline 0 N--CA 1.479 0.986 0 O-C-N 124.015 0.822 . . . . 1.77 113.084 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.4 Cg_exo -60.28 163.72 14.18 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.881 2.387 . . . . 0.55 113.999 -179.233 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.451 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.94 147.78 24.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.207 -0.906 . . . . 1.23 109.661 179.317 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -36.73 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 124.016 0.823 . . . . 1.63 111.86 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -87.9 111.16 21.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.969 -0.559 . . . . 0.41 111.494 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.552 HG22 ' SG ' ' A' ' 97' ' ' CYS . 4.5 mp -84.06 110.56 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.44 110.516 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -46.09 -38.35 7.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.014 0.435 . . . . 0.44 110.645 179.781 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 95' ' ' ILE . 70.8 m 59.37 68.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 1.1 110.189 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -103.64 -77.61 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 3.0 111.288 -179.265 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.469 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 33.8 p30 -138.49 17.81 2.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.884 -0.598 . . . . 2.14 111.034 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.917 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.376 0.608 . . . . 2.06 111.653 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.961 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.1 tt . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.762 0.315 . . . . 0.68 111.45 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -117.84 133.82 23.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 2.0 111.148 -179.653 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.0 146.15 12.71 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.482 2.121 . . . . 0.5 112.176 179.75 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 77.6 Cg_exo -46.41 159.7 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.282 2.655 . . . . 0.71 114.011 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.39 -158.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.136 -0.938 . . . . 0.66 112.802 179.734 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.24 124.62 69.88 Favored Pre-proline 0 C--O 1.233 0.193 0 N-CA-C 110.684 -0.117 . . . . 1.52 110.684 179.728 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HD3' ' A' ' 7' ' ' LYS . 5.5 Cg_exo -74.13 117.12 4.88 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.472 2.114 . . . . 0.44 111.633 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 111.84 26.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.189 -0.46 . . . . 1.09 110.438 -179.827 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 80.5 Cg_exo -33.84 145.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.839 2.359 . . . . 0.64 113.581 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.28 HD12 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -107.76 -41.74 4.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.402 -1.272 . . . . 1.64 108.932 -179.941 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.435 ' O ' ' HB ' ' A' ' 19' ' ' THR . 4.8 t-20 -164.35 107.77 0.93 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.497 -1.229 . . . . 0.72 110.135 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.995 HG22 HG13 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -88.56 102.27 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.6 -0.727 . . . . 0.96 111.877 -179.75 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -91.51 43.53 1.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.453 -0.794 . . . . 1.46 111.079 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.454 ' C ' ' HG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER 55.61 -74.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.591 -0.731 . . . . 2.42 112.287 179.269 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-70 -74.27 -27.67 60.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 1.02 111.053 -179.251 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -129.08 104.09 7.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.007 -0.542 . . . . 0.68 109.621 179.312 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 13' ' ' ILE . 73.8 t -89.44 114.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.949 -0.568 . . . . 0.8 111.548 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 70.4 m -88.41 148.81 24.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.931 0.396 . . . . 0.35 111.425 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.68 158.7 42.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.44 -0.8 . . . . 0.52 111.269 179.628 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.044 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.0 142.16 28.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.84 110.225 179.593 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 11.6 p90 -125.05 -174.06 2.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.871 0.367 . . . . 0.4 111.941 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -94.25 -23.04 18.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.984 -0.553 . . . . 0.83 112.47 -179.352 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER 75.39 166.03 0.13 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.403 -179.387 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 59.8 Cg_endo -70.59 -173.85 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.89 112.785 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -129.71 -40.11 1.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 2.77 111.359 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -93.58 -70.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.938 -0.305 . . . . 1.37 111.268 -179.858 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 7.4 p 58.43 42.44 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.91 110.907 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.601 -0.809 . . . . 1.01 112.337 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.15 30.5 2.53 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.478 -1.049 . . . . 0.98 110.478 179.164 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -114.55 171.57 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -0.659 . . . . 0.87 111.097 -178.845 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 4.15 3.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.183 -0.462 . . . . 2.26 111.75 179.44 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.3 mt 55.01 117.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 CA-C-O 121.362 0.601 . . . . 1.71 112.21 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 p -98.38 -11.53 22.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.47 -0.787 . . . . 1.15 110.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.68 138.01 4.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.807 0.337 . . . . 1.58 111.562 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 33' ' ' ILE . 93.1 m-85 -108.21 115.25 29.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.76 110.945 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -95.77 106.46 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.337 -0.392 . . . . 1.14 110.66 179.65 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.65 135.88 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.41 0.624 . . . . 0.63 111.475 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 4.9 mt-10 -91.13 143.9 26.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.872 -1.058 . . . . 1.67 110.845 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.896 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -108.57 151.58 25.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.007 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.547 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -132.11 102.82 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 1.44 110.527 179.709 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.83 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -77.17 96.28 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.341 -0.39 . . . . 1.59 110.548 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.3 mm? -75.12 147.31 83.18 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.9 110.687 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -90.38 3.66 68.12 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.942 -1.274 . . . . 1.43 113.226 0.304 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -125.38 74.67 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 2.66 110.913 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -136.96 -177.76 15.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.686 . . . . 1.12 112.644 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 140.82 17.52 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.034 0.445 . . . . 2.41 110.698 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.522 ' NE1' ' CZ ' ' A' ' 41' ' ' ARG . 64.6 m95 -55.11 104.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.625 -0.716 . . . . 0.65 110.818 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -136.77 117.36 13.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 1.28 110.67 179.958 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HB3' HG22 ' A' ' 37' ' ' ILE . 3.1 ptmm? -45.45 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.942 -0.572 . . . . 1.3 111.339 -179.661 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.9 -17.49 61.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.86 111.244 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.705 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.9 p-10 -81.94 113.05 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 2.01 110.817 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.69 25.44 11.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.206 -0.452 . . . . 2.08 110.659 179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -125.9 -160.91 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 1.89 110.806 -179.989 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -106.04 88.5 2.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 1.87 111.177 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 61' ' ' PHE . 12.8 mt -75.74 62.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.69 111.065 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.29 -75.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.988 -0.551 . . . . 1.6 111.095 -179.894 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -179.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 1.54 110.721 179.822 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 33.3 p30 -93.98 17.01 13.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.75 111.361 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.28 ' OE2' HD12 ' A' ' 11' ' ' LEU . 3.1 tp10 -118.34 108.29 14.9 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.897 -0.409 . . . . 2.05 109.897 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.765 ' HB2' HG23 ' A' ' 56' ' ' ILE . 61.7 t80 -141.12 165.56 27.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.097 0.475 . . . . 0.48 111.379 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 12.0 m -127.37 115.74 19.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.703 -0.681 . . . . 0.42 110.769 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 51' ' ' ALA . 22.6 t -75.42 139.16 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.67 -0.696 . . . . 1.08 111.382 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.5 p -124.11 -171.08 2.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.738 -0.664 . . . . 1.33 110.607 179.598 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.88 90.09 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.59 -0.732 . . . . 0.9 112.479 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 3.6 mp -71.23 163.91 26.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.336 0.589 . . . . 1.47 111.839 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -128.73 112.19 13.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 1.06 109.809 179.464 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 7.8 tt0 -41.23 150.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.557 . . . . 1.91 112.453 -179.09 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.845 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 73.18 39.84 0.58 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.398 -0.819 . . . . 1.87 110.782 -179.867 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.39 135.16 7.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.49 111.352 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.69 129.41 37.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.191 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.708 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 49.4 m-85 -124.34 118.21 26.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.063 0.394 . . . . 0.56 112.063 -179.5 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.4 mt-10 -101.39 135.4 42.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 1.5 109.139 179.072 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -130.53 122.1 26.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.895 1.443 . . . . 0.6 114.895 -178.857 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -104.54 154.48 19.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.505 -0.924 . . . . 2.11 108.505 177.254 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -114.24 119.13 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 119.323 -0.951 . . . . 0.6 113.41 -179.243 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 86' ' ' SER . 61.3 mt -111.25 150.64 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.018 -1.446 . . . . 0.7 107.423 178.323 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.14 127.54 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.066 -1.053 . . . . 0.6 113.278 -179.642 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.19 80.12 9.32 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.733 -0.839 . . . . 1.98 108.733 178.185 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 18.1 m-20 -17.1 -92.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 113.88 -1.509 . . . . 2.19 114.339 -178.931 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -128.61 -48.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.051 0.759 . . . . 1.08 113.051 -179.101 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.93 43.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.264 0.468 . . . . 1.06 112.264 -178.819 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 76.43 -3.13 55.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.462 -0.875 . . . . 0.93 113.246 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.961 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -58.93 85.98 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.111 0.455 . . . . 1.38 109.946 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -66.47 117.2 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.086 -0.506 . . . . 0.79 112.344 -179.083 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.2 t -80.69 110.61 17.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 107.669 -1.234 . . . . 0.59 107.669 178.346 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.45 162.79 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.403 2.069 . . . . 0.85 113.185 -178.407 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 75' ' ' ARG . 63.4 Cg_exo -36.18 91.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.32 2.68 . . . . 0.76 113.288 -179.728 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 76' ' ' VAL . 52.9 p -73.13 99.0 2.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.657 -0.417 . . . . 1.28 110.707 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 mt-10 18.61 107.66 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 124.688 1.242 . . . . 1.77 113.917 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 98.5 Cg_exo -44.87 177.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.498 2.132 . . . . 0.55 113.741 179.483 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -113.15 140.52 47.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.225 -1.352 . . . . 1.23 108.764 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.736 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -36.94 134.42 0.52 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.638 0.586 . . . . 1.63 111.634 -179.925 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.18 107.92 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.41 110.966 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -91.05 112.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.878 0.37 . . . . 0.44 110.882 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.1 m -59.03 -23.79 62.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.892 -0.594 . . . . 0.44 111.174 -179.77 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.454 ' HG ' ' C ' ' A' ' 15' ' ' ARG . 18.9 t 56.02 101.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.14 0.495 . . . . 1.1 110.218 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -77.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 3.0 109.638 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -106.35 21.36 17.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.267 -0.879 . . . . 2.14 110.099 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.1 p30 . . . . . 0 C--O 1.231 0.101 0 CA-C-N 115.983 -0.553 . . . . 2.06 111.03 -179.639 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.623 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.7 tt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.928 0.394 . . . . 0.68 111.406 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.88 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.46 128.24 28.64 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.423 179.798 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.45 173.1 14.77 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.5 112.926 -179.54 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 33.7 Cg_exo -58.91 177.46 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.052 2.501 . . . . 0.71 113.172 -179.577 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.62 22.13 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.66 112.734 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -85.48 122.3 73.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.301 0.096 . . . . 1.52 111.102 -179.897 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 4.2 Cg_exo -76.95 134.08 14.34 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.498 2.132 . . . . 0.44 111.69 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 9.3 t -141.09 120.07 8.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.951 0.352 . . . . 1.09 111.951 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.61 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.3 Cg_exo -65.78 102.21 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.683 2.256 . . . . 0.64 112.92 -179.956 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -60.21 -45.27 93.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.847 -0.797 . . . . 1.64 108.847 179.046 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -125.17 138.27 54.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.741 -1.118 . . . . 0.72 108.426 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -133.64 99.05 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.094 -0.642 . . . . 0.96 112.203 -179.331 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.39 148.97 23.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.46 110.079 179.346 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -60.93 -13.66 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.979 0.363 . . . . 2.42 111.979 -179.412 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.677 ' O ' HG23 ' A' ' 17' ' ' THR . 1.9 m-70 -134.68 31.45 3.37 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.673 0.273 . . . . 1.02 111.656 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 64' ' ' SER . 0.3 OUTLIER 162.14 125.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.627 -0.508 . . . . 0.68 109.627 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.028 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.8 m -120.4 149.41 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.269 -0.572 . . . . 0.8 111.492 179.774 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.633 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 m -120.73 123.44 42.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.35 111.046 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.881 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -129.56 161.71 29.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.808 0.813 . . . . 0.52 112.48 179.647 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.934 ' HG2' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -133.55 168.78 18.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.212 -1.358 . . . . 1.84 110.153 179.853 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.6 p90 -158.03 172.38 18.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.426 . . . . 0.4 111.304 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.12 139.77 30.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.877 -0.601 . . . . 0.83 111.964 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -79.04 140.93 57.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 2.11 109.733 179.274 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' THR . 10.5 Cg_endo -53.14 -175.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.215 1.943 . . . . 0.89 111.619 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.3 -37.56 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.379 . . . . 2.77 111.55 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.88 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 5.5 t80 -95.03 -71.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.551 -0.295 . . . . 1.37 111.579 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.877 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 68.9 p 49.59 43.76 24.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.971 0.415 . . . . 0.91 110.509 -179.448 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.24 -93.89 0.01 OUTLIER Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.996 -0.547 . . . . 1.01 112.614 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -142.48 39.71 1.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.057 -0.817 . . . . 0.98 111.057 179.537 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -124.5 176.99 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.529 -0.336 . . . . 0.87 110.909 -179.05 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.75 3.59 3.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.27 -0.423 . . . . 2.26 111.775 179.66 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.7 mt 58.77 117.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 121.091 0.472 . . . . 1.71 111.241 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.414 ' C ' ' HG ' ' A' ' 35' ' ' SER . 1.5 p -102.73 11.19 37.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.658 . . . . 1.15 111.731 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -168.62 170.92 9.18 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.037 0.446 . . . . 1.58 111.502 -179.92 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.6 m-85 -154.06 75.47 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.534 -0.757 . . . . 0.76 109.917 179.578 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -50.14 144.11 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.564 -0.744 . . . . 1.14 111.497 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.879 HG11 HG21 ' A' ' 63' ' ' VAL . 3.6 t -129.23 107.01 14.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.348 -0.387 . . . . 0.63 111.407 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -93.2 149.03 21.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.092 -0.504 . . . . 1.67 110.431 179.735 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -115.49 139.62 49.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.196 0.522 . . . . 1.97 112.116 179.737 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -112.37 96.34 5.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.185 -0.916 . . . . 1.44 108.622 178.304 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.769 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -67.89 105.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 1.59 110.798 -179.136 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' HD2' ' A' ' 41' ' ' ARG . 10.6 mt -76.73 150.72 81.99 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.857 -0.61 . . . . 0.9 111.147 -179.807 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -87.89 9.05 64.13 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.756 -1.352 . . . . 1.43 113.179 0.281 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -80.5 -88.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 2.66 110.49 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . 115.72 175.37 18.13 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.647 -0.787 . . . . 1.12 113.568 179.258 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.8 -25.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.267 0.227 . . . . 2.41 111.381 -179.923 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 85.4 m95 50.81 87.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.793 0.33 . . . . 0.65 111.065 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -125.77 127.96 46.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.365 . . . . 1.28 111.018 179.589 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 50' ' ' LYS . 16.8 ptmt -54.16 109.86 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 1.3 110.905 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . . . -81.77 -35.95 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.86 110.709 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.522 ' CG ' HD11 ' A' ' 56' ' ' ILE . 1.2 t30 -48.36 -62.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 2.01 110.661 179.976 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 51.61 37.18 19.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 2.08 111.101 179.761 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 t -145.02 -82.91 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 1.89 110.811 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 172.85 120.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 1.87 111.192 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.858 HD12 ' CD1' ' A' ' 61' ' ' PHE . 8.2 mm -103.46 69.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.69 110.8 179.756 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -53.98 -46.48 71.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 1.6 110.259 179.912 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.702 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pt-20 -99.61 154.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 1.54 109.996 179.571 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -68.21 -9.55 47.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.468 -0.333 . . . . 1.75 111.414 179.98 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.934 ' OE1' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tp10 -93.59 98.61 11.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.836 -0.431 . . . . 2.05 109.836 179.711 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.858 ' CD1' HD12 ' A' ' 56' ' ' ILE . 70.4 t80 -133.98 164.01 28.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.103 0.478 . . . . 0.48 111.566 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.531 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 19.2 m -117.38 116.44 27.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.626 -0.716 . . . . 0.42 110.808 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.881 HG23 HD21 ' A' ' 20' ' ' LEU . 65.1 t -86.53 96.38 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.0 0.428 . . . . 1.08 110.471 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 17' ' ' THR . 1.2 p -85.59 158.54 20.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.33 110.373 179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.5 -8.4 8.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.347 -0.842 . . . . 0.9 111.793 -179.304 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 18' ' ' VAL . 3.3 mm? -44.7 171.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.096 0.474 . . . . 1.47 111.356 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.6 m -147.59 123.86 10.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.868 -0.605 . . . . 1.06 110.714 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.1 mt-10 -48.43 137.14 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 1.91 111.191 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER 61.12 46.77 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 1.87 111.523 179.905 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -156.81 122.51 4.78 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.49 111.526 179.791 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.57 135.71 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.36 110.086 179.318 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CD1' ' NZ ' ' A' ' 40' ' ' LYS . 42.5 m-85 -131.56 126.71 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.769 0.655 . . . . 0.56 112.769 -178.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.8 mt-10 -106.56 139.28 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.868 -0.789 . . . . 1.5 108.868 178.354 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.028 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.65 114.99 19.41 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.367 1.247 . . . . 0.6 114.367 -178.52 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.3 ttp85 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.119 -0.492 . . . . 2.11 111.247 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 89' ' ' SER . 58.6 t -100.16 134.39 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.32 0.581 . . . . 0.6 111.0 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -132.48 149.55 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.563 -1.273 . . . . 0.7 107.563 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -171.3 141.26 1.56 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.079 -1.048 . . . . 0.6 112.526 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.2 mttt -82.1 -123.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 1.98 110.65 179.634 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.623 ' ND2' HD12 ' A' ' 2' ' ' ILE . 54.5 p30 -170.02 -122.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.394 0.543 . . . . 2.19 109.583 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -129.0 -1.16 5.24 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.432 1.014 . . . . 1.08 112.085 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.13 -1.32 14.42 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.894 0.331 . . . . 1.06 111.894 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.75 -19.53 41.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.014 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.588 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -61.41 158.53 14.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.949 -0.389 . . . . 1.38 109.949 179.742 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.7 tt -120.99 118.18 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.09 0.774 . . . . 0.79 113.09 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -74.02 111.93 14.56 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 107.205 -1.406 . . . . 0.59 107.205 177.835 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.444 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 18.7 Cg_endo -57.86 170.82 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.149 2.566 . . . . 0.85 114.557 -178.051 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 7.6 Cg_exo -32.48 142.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.385 3.39 . . . . 0.76 113.821 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.9 m -131.24 104.74 7.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.518 -0.764 . . . . 1.28 110.243 179.185 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 3.6 110.27 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.872 1.269 . . . . 1.77 113.568 -179.974 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.515 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 23.9 Cg_exo -63.71 153.19 76.78 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.55 114.421 -179.3 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.96 145.94 44.28 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.945 -1.025 . . . . 1.23 109.491 179.023 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -34.71 154.5 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 O-C-N 124.135 0.897 . . . . 1.63 112.207 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.21 111.23 19.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.48 179.252 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.826 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -94.2 111.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.914 -0.314 . . . . 0.44 111.391 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' ALA . 12.4 m -48.37 -30.53 5.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.72 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.683 ' SG ' HD12 ' A' ' 66' ' ' LEU . 82.5 m 49.85 86.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.065 -0.516 . . . . 1.1 111.088 179.678 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 -84.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.34 -0.391 . . . . 3.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -11.61 20.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.059 -0.519 . . . . 2.14 111.011 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.417 -0.356 . . . . 2.06 111.562 179.642 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 80' ' ' ASN . 1.2 tt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.84 0.352 . . . . 0.68 110.714 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -130.56 131.89 23.63 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 2.0 110.738 179.83 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 162.43 28.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.435 2.09 . . . . 0.5 112.509 -179.914 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.2 Cg_endo -57.09 -179.56 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.01 2.474 . . . . 0.71 112.554 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.29 -161.83 8.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.869 -0.681 . . . . 0.66 112.813 -179.794 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.94 118.88 70.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.559 -0.163 . . . . 1.52 110.559 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 36.7 Cg_exo -62.52 133.77 44.44 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.54 2.16 . . . . 0.44 112.74 -179.84 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.0 104.91 9.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.02 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 47.0 Cg_exo -51.01 99.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.261 1.974 . . . . 0.64 113.206 -179.594 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mt -55.56 -37.21 67.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.054 -0.721 . . . . 1.64 109.054 179.065 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 25.7 t-20 -136.5 153.72 50.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.765 -1.107 . . . . 0.72 108.648 179.007 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.278 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 3.6 pt -143.78 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.402 -0.519 . . . . 0.96 112.208 -179.004 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.625 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -94.7 137.91 33.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 1.46 110.117 179.412 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -40.47 -26.11 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.359 0.874 . . . . 2.42 113.359 -178.9 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -115.53 -19.96 10.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.53 -0.468 . . . . 1.02 111.966 -179.848 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' HD22 ' A' ' 66' ' ' LEU . 49.9 p -147.8 122.26 9.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.555 0.216 . . . . 0.68 110.659 -179.843 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 ' CD2' ' A' ' 66' ' ' LEU . 17.7 m -111.04 125.59 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.954 0.353 . . . . 0.8 111.954 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 47.2 m -87.05 144.53 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.35 110.035 179.083 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.758 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -143.91 151.45 39.83 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.82 0.7 . . . . 0.52 112.521 -179.885 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.878 ' HB2' HD11 ' A' ' 11' ' ' LEU . 19.3 tptp -144.66 148.15 33.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.765 -1.107 . . . . 1.84 110.091 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.2 p90 -140.87 -176.51 4.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.4 112.248 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.44 -159.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.384 -0.825 . . . . 0.83 111.068 179.956 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -130.83 142.42 45.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.158 179.952 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.76 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 88.2 Cg_exo -43.96 171.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.349 2.033 . . . . 0.89 112.458 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.76 ' OE1' ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -106.92 -42.16 5.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 2.77 112.059 -179.608 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -118.03 -70.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.218 0.451 . . . . 1.37 112.218 -179.419 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.4 p 60.31 46.23 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.91 110.454 -179.253 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.71 -109.63 0.35 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.814 -0.708 . . . . 1.01 112.193 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.69 31.9 3.45 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.525 -1.03 . . . . 0.98 110.525 179.108 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.38 -177.59 3.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.098 -0.551 . . . . 0.87 111.468 -178.908 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 15.38 1.44 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 2.26 111.743 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 ' CZ ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER 61.05 152.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.551 0.215 . . . . 1.71 111.27 179.699 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -140.5 8.26 2.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.548 0.573 . . . . 1.15 112.548 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 t -178.06 125.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 1.58 110.979 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.691 ' O ' HD12 ' A' ' 56' ' ' ILE . 7.7 m-85 -108.64 98.14 7.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.76 111.553 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.653 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -91.21 124.72 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 1.14 110.157 179.477 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -110.18 119.1 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.63 111.538 -179.507 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.91 137.45 43.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.402 -0.817 . . . . 1.67 109.397 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HD2' ' CD1' ' A' ' 72' ' ' TYR . 3.9 ttpm? -104.1 146.32 28.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.344 -0.389 . . . . 1.97 110.348 -179.226 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' HG2' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.75 86.55 2.46 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.05 0.452 . . . . 1.44 110.579 179.711 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.857 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -62.36 86.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.509 -0.769 . . . . 1.59 110.612 -179.828 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD12 ' CB ' ' A' ' 94' ' ' ALA . 76.5 mt -66.36 149.02 98.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.974 -0.557 . . . . 0.9 111.049 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -93.23 27.38 18.68 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.893 -1.295 . . . . 1.43 112.719 0.337 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -136.25 45.16 2.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.512 -0.313 . . . . 2.66 111.369 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -87.28 179.0 48.03 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.474 -0.87 . . . . 1.12 112.344 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.79 31.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 2.41 110.952 -179.727 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 53.4 m95 45.32 74.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.65 111.236 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.3 mp -109.31 133.08 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 1.28 111.016 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.653 ' HD2' HG21 ' A' ' 37' ' ' ILE . 8.4 mtmm -50.17 98.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.046 -0.524 . . . . 1.3 110.79 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -64.73 -53.56 45.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.86 110.772 -179.993 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.7 p-10 -71.0 129.12 38.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.873 179.843 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -124.62 34.92 4.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.077 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 m -130.41 -84.93 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 1.89 110.923 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.37 118.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 1.87 110.964 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.9 mt -109.04 74.34 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.69 110.968 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -56.74 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 1.6 111.001 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.94 -178.48 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.547 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.9 p30 -92.56 2.88 56.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 1.75 111.672 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -102.98 101.82 11.83 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.524 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HB2' HG23 ' A' ' 56' ' ' ILE . 72.8 t80 -135.06 163.92 28.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.48 111.44 -179.454 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 80.2 m -125.63 125.22 42.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.42 110.387 179.345 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.758 ' CG2' HD11 ' A' ' 20' ' ' LEU . 17.0 t -83.43 90.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.208 0.527 . . . . 1.08 111.691 -179.355 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -92.46 137.9 31.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 1.33 110.623 179.784 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.83 -5.61 7.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.9 112.456 -179.642 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.018 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -48.91 -179.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.121 0.486 . . . . 1.47 111.591 179.807 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -141.19 118.72 11.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 1.06 110.132 179.795 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -45.59 155.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 1.91 111.483 -179.561 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.0 m-20 52.87 55.03 9.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 1.87 111.175 -179.884 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.71 121.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.49 111.296 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.15 138.03 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.92 -0.4 . . . . 0.36 109.92 179.481 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.8 m-85 -128.83 112.97 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.713 1.005 . . . . 0.56 113.713 -178.37 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.6 tt0 -102.35 134.7 45.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.234 -1.024 . . . . 1.5 108.234 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.35 125.89 19.06 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.819 1.415 . . . . 0.6 114.819 -178.644 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -103.62 165.49 11.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.257 -0.883 . . . . 2.11 109.025 178.202 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -131.68 122.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 113.487 0.921 . . . . 0.6 113.487 179.688 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 86' ' ' SER . 29.4 mt -106.59 147.91 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.667 -1.606 . . . . 0.7 107.486 177.996 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -159.16 112.78 2.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.152 -1.019 . . . . 0.6 112.688 -179.412 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 mttp -56.21 -175.87 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.31 -0.626 . . . . 1.98 109.31 178.64 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.5 m120 -133.52 170.78 15.01 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.858 -0.337 . . . . 2.19 110.559 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.1 -27.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.58 0.585 . . . . 1.08 112.58 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -106.6 14.68 26.7 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 1.06 112.852 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.96 -18.07 46.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.465 -0.874 . . . . 0.93 112.947 179.659 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.5 105.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 1.38 110.903 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -68.98 97.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.79 111.65 -179.462 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' ILE . 21.5 p -60.38 111.54 4.17 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 120.203 -0.599 . . . . 0.59 109.939 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.18 146.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.758 2.305 . . . . 0.85 112.683 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 1.6 Cg_endo -46.52 140.57 11.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.691 2.26 . . . . 0.76 112.807 -179.665 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 90' ' ' GLU . 2.0 m -96.42 108.67 21.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.811 . . . . 1.28 110.386 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -2.95 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.715 1.206 . . . . 1.77 113.748 -179.935 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 78.3 Cg_exo -46.73 139.36 13.93 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.328 2.019 . . . . 0.55 113.28 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -76.27 147.41 38.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.893 -0.594 . . . . 1.23 109.51 179.338 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -39.08 147.1 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.967 0.792 . . . . 1.63 111.577 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.79 117.22 18.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.719 -0.673 . . . . 0.41 111.261 -179.71 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.711 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -95.48 113.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.597 179.408 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.431 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 84.5 m -51.82 -32.96 33.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 0.44 111.036 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 69' ' ' ASP . 3.6 m 54.57 89.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.138 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -129.21 -78.0 0.56 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.223 0.535 . . . . 3.0 110.69 -179.803 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.19 0.98 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.49 -0.777 . . . . 2.14 111.052 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.278 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.784 0.326 . . . . 2.06 111.244 -179.706 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.457 HD12 ' OD1' ' A' ' 80' ' ' ASN . 2.8 tt . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.955 0.407 . . . . 0.68 111.238 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.12 125.95 20.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 2.0 110.497 179.982 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 161.18 41.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.357 2.038 . . . . 0.5 112.324 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.42 -173.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.792 2.328 . . . . 0.71 112.969 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -78.02 -154.13 6.84 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.66 113.017 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -94.36 141.83 24.05 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.293 0.092 . . . . 1.52 110.932 -179.83 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.662 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.4 Cg_endo -83.34 127.11 4.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.901 2.401 . . . . 0.44 112.411 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.99 102.75 10.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.09 110.97 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.9 Cg_exo -37.05 140.13 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.818 2.345 . . . . 0.64 112.88 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.39 -28.76 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.151 -179.769 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -160.45 109.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.797 -0.638 . . . . 0.72 109.911 179.775 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.747 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -106.6 148.51 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.714 1.005 . . . . 0.96 113.714 -178.883 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.437 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -141.38 165.88 26.29 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.197 -0.91 . . . . 1.46 110.867 179.382 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.19 ' HD2' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -42.69 -41.72 3.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.241 -0.891 . . . . 2.42 112.865 -179.44 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.5 m-70 -132.87 27.46 4.27 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.938 0.718 . . . . 1.02 112.938 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.693 ' N ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -166.3 112.74 0.85 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.499 -0.48 . . . . 0.68 111.354 179.04 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.032 HG13 HD22 ' A' ' 66' ' ' LEU . 1.7 m -110.61 127.64 67.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 C-N-CA 120.156 -0.618 . . . . 0.8 111.82 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.5 m -97.81 144.61 27.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.307 -0.627 . . . . 0.35 109.307 179.161 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.86 152.98 39.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.413 0.625 . . . . 0.52 112.323 -179.732 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -133.24 137.71 46.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.007 -0.997 . . . . 1.84 110.238 179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.7 p90 -138.0 178.25 7.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 0.4 111.062 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.443 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.0 -167.78 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.83 110.899 179.816 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.15 161.58 60.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.849 0.357 . . . . 2.11 111.129 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.652 ' HB2' HG23 ' A' ' 28' ' ' THR . 31.4 Cg_exo -59.66 -177.67 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.878 2.386 . . . . 0.89 113.192 -179.568 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.17 7.51 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.536 179.761 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.685 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 20.8 t80 -142.84 -67.37 0.37 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.369 . . . . 1.37 110.858 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' PRO . 50.8 p 48.23 44.92 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 0.91 110.776 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.61 -102.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 1.01 112.254 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.05 26.68 4.18 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.204 -0.759 . . . . 0.98 111.204 179.234 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -115.03 -174.57 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.87 111.055 -179.34 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.8 ttpt -145.04 25.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 2.26 110.833 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.856 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.2 mm 60.77 148.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 1.71 110.712 -179.897 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -135.46 17.93 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.266 -0.424 . . . . 1.15 111.025 179.792 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.654 ' H ' HG22 ' A' ' 33' ' ' ILE . 7.1 t 170.55 160.34 0.07 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.156 0.503 . . . . 1.58 111.383 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 33' ' ' ILE . 37.8 m-85 -137.41 78.49 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 0.76 109.946 179.428 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.818 HG21 ' HE2' ' A' ' 50' ' ' LYS . 12.7 mt -80.66 118.26 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 1.14 111.663 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.586 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -100.19 127.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.266 179.732 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -84.5 131.96 34.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.67 111.375 -179.583 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.666 ' HD3' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -95.23 140.59 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.719 -0.673 . . . . 1.97 112.659 -179.435 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.7 ttt180 -127.34 104.57 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 1.44 110.098 178.527 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.679 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.48 84.96 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 1.59 110.681 -179.79 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.01 154.7 2.41 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.485 -0.779 . . . . 0.9 110.828 -179.96 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.89 15.35 36.5 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 123.875 -1.302 . . . . 1.43 112.951 0.376 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -117.61 -77.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 2.66 111.111 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . 52.87 -178.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.63 -0.795 . . . . 1.12 112.006 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -163.94 29.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 2.41 111.257 -179.823 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 61.1 m95 47.5 93.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.65 110.92 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.581 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -129.14 131.74 47.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.692 -0.403 . . . . 1.28 111.29 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.818 ' HE2' HG21 ' A' ' 37' ' ' ILE . 17.7 ptpt -63.19 74.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.824 -0.626 . . . . 1.3 111.389 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -55.64 -43.11 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.86 110.26 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.547 ' HB2' HD11 ' A' ' 56' ' ' ILE . 16.5 p-10 -42.07 -46.51 4.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.987 -0.551 . . . . 2.01 111.253 179.713 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.65 36.84 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 2.08 110.997 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -144.35 -162.99 1.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 1.89 110.624 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -111.58 88.69 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 1.87 110.828 -179.906 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 61' ' ' PHE . 10.2 mm -70.52 67.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.69 111.1 179.861 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.19 -58.88 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 1.6 110.363 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.8 pm0 -76.88 160.67 29.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.173 -0.677 . . . . 1.54 109.173 179.055 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.6 p30 -84.16 10.28 10.64 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.561 -0.456 . . . . 1.75 112.057 -179.651 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.02 98.79 7.01 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.605 . . . . 2.05 109.365 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 56' ' ' ILE . 81.2 t80 -130.02 163.65 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.447 0.641 . . . . 0.48 112.251 -179.041 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 25.7 m -117.15 114.91 24.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.42 110.872 179.232 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HD3' ' A' ' 40' ' ' LYS . 44.8 t -81.65 84.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.777 -0.647 . . . . 1.08 110.739 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.677 ' HB3' HG22 ' A' ' 17' ' ' THR . 51.8 p -83.37 -179.78 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.72 . . . . 1.33 110.673 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.18 -20.83 34.58 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.581 -0.819 . . . . 0.9 112.446 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.032 HD22 HG13 ' A' ' 18' ' ' VAL . 1.3 pp -51.95 179.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.683 0.278 . . . . 1.47 110.482 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 3.0 m -140.55 127.56 20.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 1.06 111.247 -179.482 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -54.52 157.34 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.11 0.481 . . . . 1.91 111.477 -179.877 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.4 OUTLIER 68.84 47.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 1.87 110.649 -179.605 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.9 123.78 0.43 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.49 111.594 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.05 134.16 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.659 -0.497 . . . . 0.36 109.659 179.11 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 43.0 m-85 -127.37 118.22 23.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.819 0.674 . . . . 0.56 112.819 -178.677 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -103.53 139.18 39.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.348 -0.612 . . . . 1.5 109.348 178.709 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.02 127.24 19.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.63 1.344 . . . . 0.6 114.63 -179.438 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -96.59 163.23 13.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.492 -0.777 . . . . 2.11 109.344 178.184 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.662 HG23 ' HG3' ' A' ' 8' ' ' PRO . 60.6 t -115.52 123.5 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 112.807 0.669 . . . . 0.6 112.807 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.05 155.61 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 114.79 -1.095 . . . . 0.7 109.248 179.023 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -165.52 127.77 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.884 -0.726 . . . . 0.6 111.931 179.02 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mttt -77.85 -157.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 1.98 110.358 179.828 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -155.64 162.88 40.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.336 0.589 . . . . 2.19 111.415 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.11 -41.17 1.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 1.08 112.784 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -70.34 -14.12 62.44 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.411 0.523 . . . . 1.06 112.411 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.83 59.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.435 -0.888 . . . . 0.93 112.108 -179.201 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -66.56 170.02 6.83 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.004 -0.369 . . . . 1.38 110.004 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -119.02 120.25 63.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.512 0.56 . . . . 0.79 112.512 -179.294 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.2 p -81.64 118.8 73.58 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.076 -1.083 . . . . 0.59 108.076 178.344 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.47 158.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.761 2.307 . . . . 0.85 113.08 -178.863 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.0 Cg_endo -67.59 162.53 38.74 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.82 2.347 . . . . 0.76 113.896 -179.208 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 m -114.14 135.26 54.23 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.099 -0.955 . . . . 1.28 109.839 179.29 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -19.69 106.71 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 124.497 1.123 . . . . 1.77 113.48 -179.445 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.483 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 87.6 Cg_exo -43.83 141.79 3.95 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.55 113.222 -179.944 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -76.11 147.13 38.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.626 -0.715 . . . . 1.23 109.817 179.418 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -37.21 146.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 O-C-N 124.207 0.942 . . . . 1.63 111.797 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.78 108.91 11.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.932 -0.576 . . . . 0.41 110.66 179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -86.23 113.44 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.44 110.72 179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 92.6 m -50.89 -46.32 60.53 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.44 110.033 179.748 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 69' ' ' ASP . 2.3 m 57.53 107.76 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.685 -0.689 . . . . 1.1 109.697 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.942 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -140.6 -85.35 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.975 0.417 . . . . 3.0 110.474 -179.602 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.942 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 12.2 p-10 -106.65 32.18 4.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 2.14 109.183 179.245 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.437 ' OD1' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.192 -0.913 . . . . 2.06 111.356 -179.126 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 86' ' ' SER . 13.3 tt . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 121.688 0.756 . . . . 0.68 112.794 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -135.62 109.59 10.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.277 -0.874 . . . . 2.0 110.053 179.903 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.65 153.23 79.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.272 1.981 . . . . 0.5 112.271 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.64 179.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.889 2.392 . . . . 0.71 112.976 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -77.22 -178.22 47.16 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.909 -0.587 . . . . 0.66 113.088 -179.644 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.6 tttt -69.28 136.11 88.95 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.448 0.166 . . . . 1.52 111.276 -179.875 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HG3' HG23 ' A' ' 76' ' ' VAL . 5.1 Cg_exo -75.72 131.34 13.38 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.521 2.148 . . . . 0.44 112.201 179.665 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 21' ' ' LYS . 2.5 p -132.5 100.06 15.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.09 110.797 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 17.3 Cg_exo -52.63 122.66 11.3 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.025 1.816 . . . . 0.64 113.697 -179.234 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -82.95 -31.73 27.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.551 -0.907 . . . . 1.64 108.551 178.347 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.59 138.16 37.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.979 -1.009 . . . . 0.72 108.634 179.2 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.03 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.43 94.92 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.306 -0.558 . . . . 0.96 112.308 -179.139 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 163.12 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.46 110.133 179.264 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -61.46 -21.38 64.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.36 -0.382 . . . . 2.42 111.944 -179.42 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 17' ' ' THR . 37.4 m170 -126.34 16.02 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 1.02 111.471 179.542 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 ' C ' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -158.68 159.28 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.68 109.826 179.683 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.03 HG13 HG22 ' A' ' 13' ' ' ILE . 82.5 t -156.2 91.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.924 -0.311 . . . . 0.8 111.563 -179.161 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 30.9 m -79.07 145.47 33.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.35 110.363 179.432 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -149.13 161.8 41.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.736 0.779 . . . . 0.52 112.898 -179.072 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.225 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -141.18 142.03 34.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.32 -1.309 . . . . 1.84 109.249 179.213 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 14.7 p90 -137.88 -174.28 3.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.73 0.3 . . . . 0.4 111.145 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -95.63 163.4 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.83 111.267 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -111.56 145.1 31.93 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.108 -0.496 . . . . 2.11 110.077 179.874 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HB2' HG23 ' A' ' 28' ' ' THR . 5.2 Cg_exo -77.82 162.61 29.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.31 2.007 . . . . 0.89 112.169 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -112.78 -22.62 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 2.77 111.192 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -85.01 -72.61 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 1.37 111.137 -179.839 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' HB2' ' A' ' 25' ' ' PRO . 31.7 p 41.4 45.56 2.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.67 -0.241 . . . . 0.91 111.497 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.25 -92.53 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.703 -0.76 . . . . 1.01 112.409 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -153.14 43.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.187 -1.165 . . . . 0.98 110.187 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -123.72 -176.43 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.527 . . . . 0.87 111.368 -178.519 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 21.5 tttt -123.63 -20.28 5.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.084 -0.507 . . . . 2.26 111.975 -179.53 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt 68.51 112.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.688 -0.486 . . . . 1.71 109.688 -178.998 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -114.07 33.13 5.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.917 0.339 . . . . 1.15 111.917 -179.211 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.09 144.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.278 0.473 . . . . 1.58 112.278 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.884 ' O ' HD12 ' A' ' 56' ' ' ILE . 57.0 m-85 -127.48 85.15 2.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.678 . . . . 0.76 110.282 179.243 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -79.76 105.02 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 1.14 111.487 -179.795 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -96.07 138.34 21.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.991 -0.744 . . . . 0.63 108.991 179.065 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 50' ' ' LYS . 6.0 mt-10 -96.76 152.36 18.75 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.052 0.22 . . . . 1.67 110.492 -179.782 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' A' ' 72' ' ' TYR . 8.8 ttpp -108.42 155.46 20.54 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.417 -0.356 . . . . 1.97 110.651 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.611 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -134.08 103.6 5.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.733 -0.387 . . . . 1.44 110.085 178.993 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HA ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -79.98 83.15 5.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 1.59 110.349 -179.741 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.4 mt -61.24 159.67 28.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.077 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.1 Cg_endo -82.63 24.47 9.08 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 124.561 -1.016 . . . . 1.43 113.775 0.715 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -142.11 -80.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.844 0.354 . . . . 2.66 110.631 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 38.31 -161.9 0.01 OUTLIER Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.925 -0.579 . . . . 1.12 113.7 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -158.44 145.75 17.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.592 -0.522 . . . . 2.41 109.592 179.676 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.611 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 74.7 m95 -63.61 78.59 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.08 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -116.54 106.29 13.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.796 -0.638 . . . . 1.28 111.001 -179.615 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER 20.4 -151.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.82 1.325 . . . . 1.3 113.924 179.303 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.09 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . 175.98 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.001 -0.437 . . . . 0.86 110.451 -179.451 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.618 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.28 -38.04 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 2.01 110.81 -179.969 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 57.75 34.57 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.948 0.351 . . . . 2.08 111.948 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 11.2 t -170.23 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.797 0.295 . . . . 1.89 111.797 179.691 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 5.9 t30 -165.52 125.64 1.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 1.87 110.412 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 36' ' ' TYR . 25.5 mt -109.86 75.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.69 110.977 -179.916 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.4 tm? -53.22 -70.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 1.6 110.947 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -71.2 170.4 13.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.137 -0.32 . . . . 1.54 110.137 179.639 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 46.8 p-10 -84.69 6.1 25.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 1.75 111.874 -179.807 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.225 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -115.06 105.57 13.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.134 -0.691 . . . . 2.05 109.134 179.121 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.861 ' HB2' HG23 ' A' ' 56' ' ' ILE . 55.9 t80 -136.7 164.17 28.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.331 0.493 . . . . 0.48 112.331 -178.813 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 91.6 m -115.71 105.64 12.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.42 111.647 179.673 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.09 HG13 ' HB1' ' A' ' 51' ' ' ALA . 73.9 t -75.44 118.79 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.475 -0.784 . . . . 1.08 111.012 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.0 p -123.65 155.0 38.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 1.33 111.371 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.36 -4.03 8.24 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.9 112.862 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 18' ' ' VAL . 6.6 mp -65.81 165.94 11.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.105 0.479 . . . . 1.47 111.866 -179.592 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -121.49 127.38 50.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 1.06 110.347 179.72 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -48.97 145.25 4.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.486 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 97' ' ' CYS . 18.8 t0 68.22 54.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 1.87 111.527 179.576 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.77 120.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.49 111.335 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.56 135.86 53.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.467 -0.333 . . . . 0.36 110.236 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HD2' ' A' ' 40' ' ' LYS . 20.7 m-85 -128.06 123.47 34.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.433 0.901 . . . . 0.56 113.433 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -106.19 140.72 38.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.378 -0.971 . . . . 1.5 108.378 178.119 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.51 129.02 28.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 -178.482 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.82 146.2 28.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.031 -0.531 . . . . 2.11 110.142 178.282 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HB ' ' A' ' 38' ' ' VAL . 44.8 t -99.71 108.78 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.28 -0.568 . . . . 0.6 112.427 -179.568 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.49 HG12 ' CA ' ' A' ' 88' ' ' PRO . 77.1 mt -101.5 150.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.579 -1.267 . . . . 0.7 107.579 177.768 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -161.51 145.13 12.69 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.073 -1.051 . . . . 0.6 112.505 -179.642 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.4 ptpt -92.66 -161.23 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.555 . . . . 1.98 110.402 179.545 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.8 p-10 -150.46 165.92 31.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.989 0.423 . . . . 2.19 111.233 -179.274 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.47 -26.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 1.08 112.251 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.15 -20.34 21.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.969 0.359 . . . . 1.06 111.969 -179.382 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.62 -1.45 60.04 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.702 -0.761 . . . . 0.93 112.81 -179.684 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -73.1 76.84 1.24 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.991 0.424 . . . . 1.38 110.421 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -34.24 125.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.79 113.879 -178.922 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.518 ' HB3' HD11 ' A' ' 2' ' ' ILE . 14.0 p -90.6 124.97 61.07 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.05 -0.977 . . . . 0.59 109.596 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -40.55 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.852 2.368 . . . . 0.85 112.832 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.49 ' CA ' HG12 ' A' ' 77' ' ' ILE . 8.0 Cg_exo -72.21 149.35 51.46 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.804 2.336 . . . . 0.76 112.885 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m -95.2 129.11 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 1.28 109.733 179.349 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.5 tp10 -20.17 103.15 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.991 0 O-C-N 124.494 1.121 . . . . 1.77 112.886 -179.575 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 36.5 Cg_exo -38.12 150.04 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.806 2.337 . . . . 0.55 114.041 -179.443 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.21 145.6 26.32 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.336 -0.847 . . . . 1.23 109.054 178.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -35.12 151.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 124.229 0.956 . . . . 1.63 111.894 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -84.69 121.12 27.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.41 111.251 -179.536 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.8 mp -103.6 112.12 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.44 111.169 179.888 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 88.0 m -42.82 -34.11 0.88 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.965 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.6 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 51.4 82.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 1.1 110.586 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 -81.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.112 0.482 . . . . 3.0 110.761 -179.733 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -117.79 -11.38 10.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.738 -0.664 . . . . 2.14 111.24 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 111.782 0.29 . . . . 2.06 111.782 -179.931 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 86' ' ' SER . 6.8 tt . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.065 0.46 . . . . 0.68 111.199 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.95 130.09 23.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.829 -0.623 . . . . 2.0 110.023 179.644 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.59 173.86 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.189 1.926 . . . . 0.5 112.739 -179.453 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 53.1 Cg_exo -54.98 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.201 2.601 . . . . 0.71 113.419 -179.401 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.15 -163.41 39.18 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.759 -0.655 . . . . 0.66 112.773 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.3 tmtt? -78.63 114.83 46.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 110.549 -0.167 . . . . 1.52 110.549 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.682 ' HG2' HG12 ' A' ' 76' ' ' VAL . 20.4 Cg_exo -72.17 149.56 52.1 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.969 2.446 . . . . 0.44 113.487 -179.26 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -146.97 107.99 3.97 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.629 -0.714 . . . . 1.09 111.201 179.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG3' HD22 ' A' ' 20' ' ' LEU . 38.7 Cg_exo -59.06 94.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.508 2.139 . . . . 0.64 113.041 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -51.25 -46.02 62.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.503 0.668 . . . . 1.64 109.454 179.244 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -122.3 150.27 42.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.959 -1.018 . . . . 0.72 108.408 178.619 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.816 ' HB ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -144.07 80.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.29 -0.564 . . . . 0.96 111.956 -179.219 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.08 156.53 35.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.46 110.288 179.594 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -61.4 -11.84 11.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -179.043 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.792 ' O ' HG23 ' A' ' 17' ' ' THR . 2.8 m80 -140.07 20.19 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.811 -0.356 . . . . 1.02 111.581 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER 179.14 109.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.68 110.383 179.742 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 ' CD1' ' A' ' 66' ' ' LEU . 25.9 m -108.6 126.16 65.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 0.8 111.364 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.7 m -96.61 137.76 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 0.35 111.054 179.709 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -139.56 164.25 30.4 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.061 0.85 . . . . 0.52 112.426 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.692 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -152.48 153.7 34.04 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.933 -1.031 . . . . 1.84 110.519 179.614 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 31.7 p90 -146.93 -171.5 3.78 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.533 0.568 . . . . 0.4 112.533 -179.462 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.31 -158.37 0.18 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.584 -0.735 . . . . 0.83 110.834 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -142.75 139.21 16.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 2.11 110.475 -179.963 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HB3' HG23 ' A' ' 28' ' ' THR . 84.3 Cg_exo -34.42 148.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.124 2.549 . . . . 0.89 112.778 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.726 ' CA ' ' OE1' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -98.48 11.67 37.51 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 2.77 111.802 -179.592 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -169.95 -66.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.37 111.753 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.2 p 52.05 47.6 24.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.008 0.432 . . . . 0.91 110.197 -179.307 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.29 -108.65 0.23 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.802 -0.713 . . . . 1.01 112.31 -179.758 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.39 29.56 4.03 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.784 -0.926 . . . . 0.98 110.784 179.176 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -114.74 -174.48 2.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.13 -0.535 . . . . 0.87 110.814 -178.967 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.0 pttt -143.08 32.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 2.26 111.594 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.838 HG21 ' CE1' ' A' ' 36' ' ' TYR . 7.7 mm 65.56 -71.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 1.71 111.365 179.861 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.59 -10.18 1.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.634 0.605 . . . . 1.15 112.634 179.63 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.808 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t -179.65 140.93 0.15 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.763 -0.375 . . . . 1.58 111.995 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.838 ' CE1' HG21 ' A' ' 33' ' ' ILE . 69.2 m-85 -116.59 138.73 51.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.76 110.852 179.409 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 5.0 mt -116.43 129.32 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.446 -0.343 . . . . 1.14 110.423 179.707 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.57 113.52 44.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.814 0.34 . . . . 0.63 111.813 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 50.8 mt-10 -83.02 132.85 35.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 1.67 110.151 179.271 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.664 ' CE ' HD23 ' A' ' 66' ' ' LEU . 2.1 tttp -95.42 128.14 42.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 113.554 0.946 . . . . 1.97 113.554 -178.426 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -108.52 95.16 5.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.873 -0.603 . . . . 1.44 110.196 178.539 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 1.099 ' OD2' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -64.17 142.17 58.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.15 -0.477 . . . . 1.59 109.753 179.619 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 94' ' ' ALA . 29.9 mt -123.71 133.11 24.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.754 -0.378 . . . . 0.9 110.919 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 66.8 Cg_endo -90.96 47.7 1.32 Allowed 'Cis proline' 0 C--N 1.351 0.689 0 C-N-CA 124.28 -1.134 . . . . 1.43 113.125 0.495 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 42' ' ' ASP . 1.7 m120 -127.13 57.5 1.47 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 2.66 110.801 -179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -42.65 160.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.044 -0.526 . . . . 1.12 113.42 -179.634 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 1.099 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 5.4 ptm180 -179.86 -32.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.041 0.385 . . . . 2.41 112.041 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 64.0 m95 61.41 81.53 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.296 -0.631 . . . . 0.65 109.296 -179.12 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -118.57 135.92 54.15 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.386 0.513 . . . . 1.28 112.386 -178.739 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtpm? -46.96 94.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.3 111.015 179.782 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -80.45 -42.29 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.551 -179.665 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.695 ' CB ' HD11 ' A' ' 56' ' ' ILE . 8.0 p-10 -54.21 -58.76 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.639 -0.255 . . . . 2.01 111.319 -179.678 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 39.56 49.27 1.96 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.053 0.39 . . . . 2.08 112.053 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -161.22 26.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.729 0.27 . . . . 1.89 111.729 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 t30 58.32 113.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 1.87 111.225 179.67 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' HB2' ' A' ' 61' ' ' PHE . 28.1 mt -109.94 71.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.69 110.827 179.587 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 34' ' ' THR . 4.9 mt -50.39 -59.57 3.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 1.6 111.3 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.7 pt-20 -86.93 158.91 19.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.917 0.389 . . . . 1.54 110.334 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 4.7 p-10 -69.99 -7.93 44.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.024 -0.535 . . . . 1.75 111.772 -179.764 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -98.22 105.07 17.17 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.443 -0.577 . . . . 2.05 109.443 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.805 ' HB2' HG23 ' A' ' 56' ' ' ILE . 53.2 t80 -142.47 165.42 27.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.48 111.711 -179.002 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.5 m -120.96 121.37 37.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.42 111.074 179.778 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 20' ' ' LEU . 14.5 t -81.7 110.8 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.113 -0.494 . . . . 1.08 111.637 -179.654 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 47.6 t -97.38 -159.54 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.858 -0.61 . . . . 1.33 110.495 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 61.19 23.48 62.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.64 -0.79 . . . . 0.9 112.114 -179.863 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.039 ' CD1' HG13 ' A' ' 18' ' ' VAL . 14.2 mt -76.03 169.8 17.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 1.47 110.944 -179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 2.1 m -134.17 141.32 47.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 1.06 110.564 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 15' ' ' ARG . 29.8 mt-10 -75.12 144.41 42.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.128 -0.487 . . . . 1.91 111.215 -179.783 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.9 t0 67.82 40.32 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.87 110.849 179.89 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . -155.53 115.34 3.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.49 111.42 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.72 130.34 42.69 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.49 -0.559 . . . . 0.36 109.49 179.082 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD1' ' HD3' ' A' ' 40' ' ' LYS . 57.8 m-85 -124.89 119.44 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.871 1.064 . . . . 0.56 113.871 -177.968 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 5.8 mt-10 -102.66 139.97 37.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.684 -1.228 . . . . 1.5 107.684 177.631 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.91 122.07 23.79 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.028 1.492 . . . . 0.6 115.028 -178.574 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 19.9 ttm-85 -94.93 143.81 26.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 114.509 -1.223 . . . . 2.11 109.086 178.087 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -121.06 120.1 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 119.121 -1.031 . . . . 0.6 112.538 179.458 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -110.58 165.42 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.861 -1.518 . . . . 0.7 107.689 178.537 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -165.81 149.23 7.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 118.934 -1.106 . . . . 0.6 112.376 -179.839 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.692 ' HG2' HD12 ' A' ' 85' ' ' ILE . 4.0 mttt -99.12 -177.61 3.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.308 -0.406 . . . . 1.98 109.973 179.097 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.701 ' OD1' HD12 ' A' ' 2' ' ' ILE . 7.8 p-10 -136.41 166.72 22.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.06 -0.518 . . . . 2.19 110.907 -179.682 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.756 -0.656 . . . . 1.08 112.482 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -89.08 -20.28 24.52 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.654 0.613 . . . . 1.06 112.654 -179.25 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.09 57.95 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.423 -0.894 . . . . 0.93 112.603 -179.59 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 2' ' ' ILE . . . -74.23 77.89 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.964 0.411 . . . . 1.38 110.297 179.74 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.692 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -36.23 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.79 113.285 -179.152 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.706 ' HB3' HD11 ' A' ' 2' ' ' ILE . 33.8 p -62.93 117.66 34.71 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.599 -0.728 . . . . 0.59 109.415 178.718 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -35.32 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.363 2.709 . . . . 0.85 113.398 -179.342 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' N ' HG23 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -59.22 168.28 4.99 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.219 2.613 . . . . 0.76 113.499 -179.612 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.509 ' HB2' HG13 ' A' ' 76' ' ' VAL . 19.9 m -124.61 129.62 50.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.084 -0.962 . . . . 1.28 109.706 178.983 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -25.03 118.57 0.21 Allowed Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.688 0.795 . . . . 1.77 112.604 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 51.5 Cg_exo -55.53 154.68 23.87 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.363 2.042 . . . . 0.55 114.249 -179.211 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -84.78 146.43 27.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.08 -0.963 . . . . 1.23 109.092 178.961 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -40.31 146.81 0.12 Allowed 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.623 0.577 . . . . 1.63 111.428 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -76.14 122.13 23.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.659 . . . . 0.41 110.671 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.816 HG21 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mp -102.28 109.09 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.632 -179.565 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 76.0 m -48.18 -36.11 13.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.087 -179.897 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.3 m 50.65 98.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 1.1 111.173 179.782 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -72.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.152 -0.476 . . . . 3.0 110.513 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -141.52 10.91 2.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.769 -0.65 . . . . 2.14 111.726 179.677 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.083 0.468 . . . . 2.06 111.624 -179.787 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.713 HD12 ' OD1' ' A' ' 80' ' ' ASN . 3.1 tt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.186 0.517 . . . . 0.68 111.88 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -125.99 136.51 28.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.436 -0.802 . . . . 2.0 109.55 179.262 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.21 161.37 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.192 1.928 . . . . 0.5 112.429 -179.616 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.0 Cg_exo -54.22 164.5 2.69 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.864 2.376 . . . . 0.71 113.108 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.45 169.17 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.511 -0.768 . . . . 0.66 112.229 179.803 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -68.55 126.61 92.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.066 -0.346 . . . . 1.52 110.066 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 32.9 Cg_exo -62.85 153.19 74.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.28 1.987 . . . . 0.44 113.422 -179.289 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.79 96.19 3.6 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 1.09 109.641 179.368 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 86.2 Cg_exo -40.36 118.84 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.178 1.919 . . . . 0.64 113.224 -179.129 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.949 ' CD2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -84.99 -26.84 26.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.509 -0.923 . . . . 1.64 108.509 178.844 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.624 ' C ' HD13 ' A' ' 13' ' ' ILE . 18.3 t-20 -147.87 153.08 38.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.642 -1.244 . . . . 0.72 107.642 178.169 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.849 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.51 134.72 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.118 -0.633 . . . . 0.96 112.225 -179.133 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -145.92 146.93 31.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.958 -0.565 . . . . 1.46 111.251 179.435 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.489 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -24.62 -48.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.541 -1.209 . . . . 2.42 114.002 -179.336 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.671 ' HA ' HD12 ' A' ' 66' ' ' LEU . 29.3 m-70 -128.78 22.03 5.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.675 0.621 . . . . 1.02 112.675 -179.016 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' HIS . 38.7 p -162.49 114.42 1.62 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 0.68 109.995 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 HD21 ' A' ' 66' ' ' LEU . 5.3 m -128.83 121.6 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.953 0.882 . . . . 0.8 113.025 -179.405 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.1 m -82.33 148.91 28.03 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.184 -0.916 . . . . 0.35 110.686 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.71 147.73 27.7 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 124.337 1.023 . . . . 0.52 111.189 179.721 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.208 ' HD3' ' OE1' ' A' ' 60' ' ' GLU . 19.3 tptm -129.54 151.86 49.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.275 -0.875 . . . . 1.84 110.718 179.793 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 49.1 p90 -150.36 -179.04 6.88 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.057 0.455 . . . . 0.4 112.17 179.801 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.78 162.15 13.16 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.83 111.597 -179.417 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.13 152.85 38.22 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.421 -0.354 . . . . 2.11 110.891 179.802 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 11.7 Cg_endo -55.1 141.28 80.03 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.013 2.475 . . . . 0.89 113.524 -179.501 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -7.28 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 2.77 112.095 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -134.1 -67.11 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.883 -0.327 . . . . 1.37 111.677 -179.877 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t 35.85 49.59 0.58 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.302 0.573 . . . . 0.91 111.838 -179.201 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.47 -123.06 8.08 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.574 -0.739 . . . . 1.01 112.416 179.995 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.64 31.84 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.952 -0.859 . . . . 0.98 110.952 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.4 OUTLIER -103.47 -170.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.351 0.596 . . . . 0.87 112.238 -178.875 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' THR . 9.5 ttpt -145.84 24.74 1.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.069 -0.969 . . . . 2.26 110.744 179.856 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.039 HG21 ' CE1' ' A' ' 36' ' ' TYR . 24.2 mm 66.49 -70.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.248 -0.433 . . . . 1.71 111.119 179.918 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 83.36 -11.52 0.91 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.909 -0.587 . . . . 1.15 112.232 179.684 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 6.9 t -178.98 140.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.321 . . . . 1.58 111.807 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 33' ' ' ILE . 59.2 m-85 -119.65 139.84 51.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.126 0.489 . . . . 0.76 111.11 179.596 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.3 mt -116.97 130.84 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 1.14 110.088 179.367 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 56' ' ' ILE . 31.9 t -104.68 109.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.63 112.293 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' CB ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -81.87 107.93 14.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.557 -0.534 . . . . 1.67 109.557 178.979 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 2.3 ptmt -97.46 151.53 19.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.322 -179.368 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 43' ' ' LEU . 12.2 ttp180 -139.01 120.29 14.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.123 -0.49 . . . . 1.44 111.366 -179.905 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -82.86 90.76 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 1.59 109.616 179.432 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -83.82 150.61 59.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.04 -0.527 . . . . 0.9 111.414 -179.228 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -94.01 28.35 17.24 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.003 -1.249 . . . . 1.43 112.705 0.081 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -139.69 69.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 2.66 110.941 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.42 -169.88 30.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.814 -0.708 . . . . 1.12 112.297 179.986 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' NE ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.05 168.28 25.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 2.41 111.223 179.971 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.649 ' O ' HD22 ' A' ' 49' ' ' LEU . 70.7 m95 -69.71 118.43 12.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.715 -0.675 . . . . 0.65 111.393 -179.764 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.649 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -147.38 127.55 13.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 1.28 110.705 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -65.27 83.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3 111.368 -179.737 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.765 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -60.6 -38.67 85.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.86 110.434 179.672 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 3.9 t-20 -40.13 -84.47 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.91 -0.586 . . . . 2.01 111.197 -179.997 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 t80 60.22 15.7 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.036 0.384 . . . . 2.08 112.036 179.568 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -122.75 22.42 9.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 1.89 110.939 179.826 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.99 133.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.936 0.398 . . . . 1.87 111.224 179.834 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 61' ' ' PHE . 13.2 mt -129.38 74.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.69 110.857 179.993 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -56.69 16.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 1.6 111.057 -179.957 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.28 160.53 15.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 1.54 110.808 179.967 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.7 m-20 -70.46 -8.4 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 1.75 111.525 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 1.208 ' OE1' ' HD3' ' A' ' 21' ' ' LYS . 14.7 tp10 -93.13 96.11 9.84 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.732 -0.47 . . . . 2.05 109.732 179.68 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.713 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.1 t80 -131.65 165.9 22.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.48 111.576 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.0 m -121.92 121.96 38.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.801 -0.636 . . . . 0.42 111.256 179.636 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.929 ' CG2' HD11 ' A' ' 20' ' ' LEU . 7.5 t -81.16 74.57 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.197 0.522 . . . . 1.08 110.294 -179.961 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 83.2 p -78.66 164.39 24.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.326 -0.852 . . . . 1.33 110.91 -179.589 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -9.97 64.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.586 -0.816 . . . . 0.9 113.009 179.922 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.061 HD21 HG13 ' A' ' 18' ' ' VAL . 4.4 pp -60.89 166.1 3.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 117.244 0.522 . . . . 1.47 110.694 -179.977 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -104.64 157.94 16.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.06 111.185 -179.478 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HG2' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.85 167.24 10.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.939 -0.573 . . . . 1.91 112.413 -179.289 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 2.2 t70 73.27 55.94 0.11 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.542 -0.753 . . . . 1.87 111.214 179.887 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 43' ' ' LEU . . . 165.58 138.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.49 110.363 179.818 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -56.87 133.85 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.36 110.393 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.485 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 2.3 m-85 -126.35 116.68 21.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.56 111.898 -178.852 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 43' ' ' LEU . 2.2 mt-10 -106.13 145.85 30.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.93 -0.577 . . . . 1.5 109.495 179.027 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.009 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.98 115.52 10.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.348 1.24 . . . . 0.6 114.348 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD3' ' CB ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -98.9 -178.45 3.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.794 -0.817 . . . . 2.11 108.794 177.922 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -150.48 130.7 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 119.309 -0.956 . . . . 0.6 112.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.759 HG22 HD11 ' A' ' 85' ' ' ILE . 55.6 mt -114.7 151.91 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.45 -1.25 . . . . 0.7 108.593 178.916 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.89 136.54 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.62 -0.832 . . . . 0.6 112.771 -179.662 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.58 -158.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.576 . . . . 1.98 109.912 179.228 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' A' ' 2' ' ' ILE . 2.8 p-10 -160.34 176.31 11.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 2.19 111.82 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.068 -0.969 . . . . 1.08 112.169 179.796 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -94.22 -20.33 19.93 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.91 0.337 . . . . 1.06 111.91 -179.453 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.7 61.16 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.48 -0.867 . . . . 0.93 112.981 -179.974 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 85.93 0.26 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 1.38 110.391 179.77 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.759 HD11 HG22 ' A' ' 77' ' ' ILE . 5.3 tp -46.32 122.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.658 0.614 . . . . 0.79 112.658 -179.116 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' ILE . 26.7 p -82.31 120.98 78.17 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.297 -0.865 . . . . 0.59 109.258 178.889 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.4 Cg_exo -38.54 163.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.904 2.403 . . . . 0.85 113.219 -179.495 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.619 ' HG3' HD11 ' A' ' 77' ' ' ILE . 4.2 Cg_exo -75.1 118.1 5.12 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.781 2.321 . . . . 0.76 112.72 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 3.3 t -68.5 137.84 54.73 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.822 -0.626 . . . . 1.28 109.968 179.516 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -32.68 125.74 0.39 Allowed Pre-proline 0 N--CA 1.47 0.525 0 O-C-N 124.027 0.829 . . . . 1.77 112.347 -179.451 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.6 Cg_exo -60.98 134.12 51.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.543 2.162 . . . . 0.55 113.206 -179.679 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.445 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.46 153.43 38.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.742 -0.663 . . . . 1.23 109.955 179.193 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -30.42 145.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.387 1.054 . . . . 1.63 112.652 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.56 112.24 20.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.702 -0.681 . . . . 0.41 109.718 179.376 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.8 mp -97.77 113.89 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.813 -179.276 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 71.7 m -46.36 -28.89 1.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.128 0.49 . . . . 0.44 110.025 179.153 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.599 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER 45.27 55.44 6.4 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.634 -0.712 . . . . 1.1 111.266 179.555 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -79.88 -93.59 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.714 -0.394 . . . . 3.0 110.97 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.93 39.22 2.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 2.14 109.707 179.829 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 15' ' ' ARG . 28.1 t0 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.866 -0.606 . . . . 2.06 111.192 -178.558 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 ' CB ' ' A' ' 84' ' ' ALA . 5.0 tt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.973 0.416 . . . . 0.68 111.975 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 2' ' ' ILE . 73.1 m-20 -139.67 130.71 14.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.651 . . . . 2.0 110.226 179.496 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.21 164.07 29.63 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.262 1.975 . . . . 0.5 112.511 -179.654 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 11.9 Cg_endo -56.52 177.25 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.155 2.57 . . . . 0.71 113.219 -179.579 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.05 171.88 54.54 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.828 -0.624 . . . . 0.66 112.375 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.59 127.73 89.06 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.227 -0.286 . . . . 1.52 110.227 179.718 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HG3' HG12 ' A' ' 76' ' ' VAL . 14.8 Cg_exo -73.67 150.04 44.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.566 2.178 . . . . 0.44 112.874 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -146.24 106.08 4.13 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 115.839 -0.619 . . . . 1.09 110.98 179.717 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -59.89 111.45 0.98 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.346 2.031 . . . . 0.64 113.305 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -71.64 -39.35 70.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.643 -0.873 . . . . 1.64 108.643 178.791 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.65 148.99 51.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.591 -1.186 . . . . 0.72 108.572 179.119 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.795 HD12 ' CG2' ' A' ' 95' ' ' ILE . 4.4 pt -142.78 89.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.989 0.423 . . . . 0.96 111.539 -179.253 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -79.58 149.01 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 1.46 110.785 -179.866 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.901 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -40.41 -35.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.083 0.772 . . . . 2.42 113.083 -179.212 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' THR . 3.4 m-70 -135.25 31.62 3.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 1.02 111.437 -179.332 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -178.62 108.54 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.68 110.226 179.578 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 66' ' ' LEU . 9.5 m -112.82 143.38 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.415 -0.514 . . . . 0.8 111.159 -179.91 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 53.2 m -106.72 136.82 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.438 -0.346 . . . . 0.35 110.817 179.565 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.04 160.81 37.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.094 0.871 . . . . 0.52 112.569 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.706 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -148.4 147.11 28.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.909 -1.041 . . . . 1.84 110.456 179.465 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 30.3 p90 -137.68 -175.12 3.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.133 0.492 . . . . 0.4 111.927 -179.575 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.86 16.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.577 -0.738 . . . . 0.83 110.908 179.725 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.97 147.39 33.8 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.408 179.621 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 28' ' ' THR . 35.1 Cg_endo -63.72 173.08 4.94 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.325 2.017 . . . . 0.89 112.325 179.941 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -123.79 13.49 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.627 -179.853 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -144.01 -73.91 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 1.37 111.919 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.5 p 43.63 56.81 4.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.878 0.371 . . . . 0.91 110.811 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.16 -100.4 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.543 . . . . 1.01 112.483 -179.528 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.8 34.33 1.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.009 -1.237 . . . . 0.98 110.009 179.152 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -116.11 -168.01 1.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.664 -0.768 . . . . 0.87 111.388 -178.717 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.21 45.74 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.621 -0.718 . . . . 2.26 111.305 -179.958 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.812 HG22 ' H ' ' A' ' 35' ' ' SER . 12.2 mm 52.98 -87.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.086 179.731 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 74.39 23.58 1.96 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.564 0.579 . . . . 1.15 112.564 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.812 ' H ' HG22 ' A' ' 33' ' ' ILE . 4.3 t 168.91 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.937 0.347 . . . . 1.58 111.937 179.562 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 56' ' ' ILE . 18.4 m-85 -102.61 93.52 5.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.76 110.831 179.498 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.0 mt -85.9 114.68 26.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.747 0.308 . . . . 1.14 110.922 179.96 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' ARG . 14.4 t -89.27 121.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.278 -0.419 . . . . 0.63 111.737 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -95.16 129.86 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 1.67 109.895 179.214 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -110.21 140.13 44.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.217 0.532 . . . . 1.97 111.968 -179.416 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HG3' ' HA2' ' A' ' 46' ' ' GLY . 13.0 ttm180 -111.9 112.63 24.43 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.366 -0.834 . . . . 1.44 109.616 179.047 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -81.8 101.22 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.601 -0.727 . . . . 1.59 110.644 -179.594 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -76.67 155.53 83.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.48 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -87.57 9.06 63.62 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.142 -1.191 . . . . 1.43 113.287 0.519 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.77 -74.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 2.66 110.195 179.75 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 98.06 155.96 29.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.735 . . . . 1.12 113.915 179.018 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 161.26 62.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 122.928 0.491 . . . . 2.41 109.799 -179.939 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 80.9 m95 -28.79 105.08 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.469 0.708 . . . . 0.65 112.593 -179.422 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.66 130.66 42.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.986 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 2.5 ptmm? -56.19 91.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 1.3 111.481 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.821 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.36 -55.41 31.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.1 0.476 . . . . 0.86 110.142 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.647 ' CB ' HD11 ' A' ' 56' ' ' ILE . 9.1 p-10 -44.58 112.55 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.717 . . . . 2.01 111.023 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.56 43.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.08 111.598 -179.604 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 t -168.18 172.2 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 1.89 111.221 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 115.37 18.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 1.87 110.869 179.946 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 36' ' ' TYR . 35.6 mt -96.63 89.53 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.69 110.929 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 34' ' ' THR . 2.5 mt -61.22 -79.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.6 111.253 -179.798 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 172.18 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.54 110.726 -179.995 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.2 p30 -88.15 12.35 13.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 1.75 111.687 -179.851 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 53.5 tt0 -109.49 108.9 19.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.278 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE1' ' O ' ' A' ' 62' ' ' THR . 55.4 t80 -145.0 165.08 29.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.48 112.055 -178.874 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.566 ' O ' ' CE1' ' A' ' 61' ' ' PHE . 99.5 m -119.22 112.89 20.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.671 -0.695 . . . . 0.42 110.26 179.497 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.957 ' CG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -79.76 89.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.762 -0.654 . . . . 1.08 110.51 -179.495 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.798 ' CB ' HG22 ' A' ' 17' ' ' THR . 25.4 t -88.05 -178.07 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.908 . . . . 1.33 110.929 -179.49 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 84.01 7.17 85.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.687 -0.768 . . . . 0.9 112.79 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.8 pp -84.61 172.07 11.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.186 0.493 . . . . 1.47 110.887 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 68' ' ' GLU . 1.7 m -121.41 173.3 7.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 1.06 111.376 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 67' ' ' THR . 2.7 tt0 -91.86 170.52 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 1.91 111.202 -179.93 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.814 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 47.03 35.26 3.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 1.87 111.194 179.831 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.7 114.84 6.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.49 111.395 -179.832 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.19 123.47 20.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.672 -0.492 . . . . 0.36 109.672 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 58.0 m-85 -116.99 121.85 42.57 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.357 0.873 . . . . 0.56 113.357 -178.361 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.4 tt0 -102.85 136.76 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.829 -1.175 . . . . 1.5 107.829 177.832 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.26 126.53 21.39 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.933 1.457 . . . . 0.6 114.933 -178.519 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -101.0 -177.16 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.846 -1.07 . . . . 2.11 108.423 177.756 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -147.89 106.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 119.656 -0.818 . . . . 0.6 112.655 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.465 HD11 ' HG3' ' A' ' 88' ' ' PRO . 42.7 mt -88.07 154.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 177.455 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.18 126.72 4.28 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.927 -1.109 . . . . 0.6 113.198 -179.144 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.1 mttt -76.6 -159.87 0.13 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.71 . . . . 1.98 109.394 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.5 m-80 -149.82 176.94 10.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.056 0.455 . . . . 2.19 111.338 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.6 -26.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 1.08 111.682 179.773 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.26 10.36 29.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.427 0.528 . . . . 1.06 112.427 -179.571 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.46 -14.61 57.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.349 -0.929 . . . . 0.93 112.853 179.875 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.42 102.51 0.03 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.813 0.34 . . . . 1.38 111.258 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.0 tp -69.98 101.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.79 111.819 -179.623 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.1 p -69.56 126.35 92.54 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 109.502 -0.555 . . . . 0.59 109.502 179.371 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -39.2 160.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.716 2.278 . . . . 0.85 112.446 -179.53 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.5 Cg_exo -67.53 124.61 12.21 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.684 2.256 . . . . 0.76 113.054 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.792 ' HB2' HG13 ' A' ' 76' ' ' VAL . 3.2 m -70.99 130.47 41.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.776 -0.647 . . . . 1.28 109.44 179.17 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -31.99 124.34 0.37 Allowed Pre-proline 0 N--CA 1.474 0.727 0 N-CA-C 112.538 0.57 . . . . 1.77 112.538 -179.316 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 32.2 Cg_exo -59.39 147.6 90.47 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.833 2.355 . . . . 0.55 113.387 -179.559 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.15 147.59 28.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.695 -0.684 . . . . 1.23 109.885 179.291 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.63 137.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 124.186 0.929 . . . . 1.63 111.736 -179.921 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -66.38 120.49 13.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.655 . . . . 0.41 110.789 179.88 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.795 ' CG2' HD12 ' A' ' 13' ' ' ILE . 4.0 mp -100.42 109.54 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.44 111.337 -179.886 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -45.79 -48.88 15.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.32 -179.702 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 64.65 86.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.446 . . . . 1.1 110.42 -179.952 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.31 -86.24 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 3.0 111.071 -179.758 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.568 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 14.7 p30 -105.43 14.59 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.162 -0.472 . . . . 2.14 111.097 179.886 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 C--N 1.333 -0.123 0 CA-C-O 121.023 0.44 . . . . 2.06 110.606 -179.827 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.74 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.68 111.52 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' ILE . 8.1 t70 -126.49 129.06 24.22 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 2.0 110.78 179.932 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.01 171.87 14.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.489 2.126 . . . . 0.5 112.276 -179.957 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -66.86 -174.72 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.803 2.335 . . . . 0.71 113.182 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.35 -177.81 49.67 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.4 -0.818 . . . . 0.66 112.852 -179.794 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.14 116.4 35.65 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.391 0.139 . . . . 1.52 110.681 179.866 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 31.7 Cg_exo -62.76 142.75 90.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.595 2.197 . . . . 0.44 112.374 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.6 p -145.95 104.42 4.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 1.09 111.976 -179.476 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.9 Cg_exo -50.26 113.24 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.532 2.155 . . . . 0.64 112.751 -179.963 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -63.86 -46.49 84.72 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.774 -0.825 . . . . 1.64 108.774 178.977 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -129.29 151.25 50.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.28 -1.327 . . . . 0.72 108.321 179.016 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' HB ' HG21 ' A' ' 95' ' ' ILE . 4.4 pt -143.17 70.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.399 -0.52 . . . . 0.96 111.567 -179.104 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -72.44 146.88 46.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.613 -0.721 . . . . 1.46 110.468 179.864 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -65.99 61.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.764 0.792 . . . . 2.42 112.387 -179.413 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.416 ' N ' ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 167.82 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.758 -0.655 . . . . 1.02 110.509 179.09 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -146.4 126.12 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.472 -0.566 . . . . 0.68 109.472 179.27 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -116.77 120.57 65.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.189 0.44 . . . . 0.8 112.189 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.587 ' OG1' HG23 ' A' ' 62' ' ' THR . 97.6 m -91.63 142.34 27.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.692 -0.231 . . . . 0.35 110.892 179.303 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -140.4 156.03 46.53 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.146 0.904 . . . . 0.52 112.992 -179.641 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 1.8 tppp? -145.15 159.11 43.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.316 -1.311 . . . . 1.84 109.59 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 40.0 p90 -155.66 -176.45 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.13 0.49 . . . . 0.4 112.086 -179.879 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.95 133.37 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.569 -0.741 . . . . 0.83 111.685 -179.664 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -70.64 141.56 87.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 2.11 109.686 179.35 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 6.3 Cg_endo -48.62 175.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.095 1.863 . . . . 0.89 111.431 179.705 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.7 -25.66 4.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.33 0.493 . . . . 2.77 112.33 -179.367 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -106.45 -70.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.005 0.372 . . . . 1.37 112.005 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.475 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 3.2 p 52.08 41.18 29.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.649 0.261 . . . . 0.91 110.36 -179.313 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.87 -91.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.861 -0.685 . . . . 1.01 112.232 -179.805 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.73 35.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.077 -1.209 . . . . 0.98 110.077 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -117.39 172.31 7.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.898 -0.651 . . . . 0.87 111.635 -178.464 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -123.86 -3.45 8.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.852 -0.613 . . . . 2.26 111.519 179.828 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 64.01 155.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 110.505 -0.183 . . . . 1.71 110.505 -179.908 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 4.6 p -139.56 8.27 2.38 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.482 0.549 . . . . 1.15 112.482 -179.522 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.44 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 178.49 149.39 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.826 0.346 . . . . 1.58 111.923 -179.994 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.8 m-85 -126.38 119.83 28.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.983 -0.553 . . . . 0.76 110.101 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.84 116.15 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.73 0.3 . . . . 1.14 111.471 -179.585 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -106.44 104.48 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.303 0.573 . . . . 0.63 110.671 179.588 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 4.8 mt-10 -73.52 157.33 36.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.284 -0.871 . . . . 1.67 110.38 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -118.23 137.41 53.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.97 111.466 -179.569 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -113.9 120.2 39.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 1.44 110.726 179.656 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.837 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.71 77.7 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 1.59 110.552 179.846 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 52.8 mt -53.3 145.16 27.33 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.637 -0.71 . . . . 0.9 111.151 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -93.42 27.03 19.26 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.903 -1.29 . . . . 1.43 112.708 0.174 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -153.6 81.89 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.781 0.324 . . . . 2.66 111.861 -179.835 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.75 -152.83 10.44 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.942 -0.647 . . . . 1.12 111.968 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.853 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -167.15 29.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.027 0.413 . . . . 2.41 111.759 179.894 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 69.1 m95 41.06 101.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.832 0.678 . . . . 0.65 112.832 179.422 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -131.48 117.97 19.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 1.28 110.045 179.085 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -43.5 106.54 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.935 0.398 . . . . 1.3 111.484 -179.503 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -73.04 -36.54 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.86 111.285 -179.867 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.687 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.3 p-10 -69.58 -173.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.336 -0.393 . . . . 2.01 110.958 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 4.0 t80 176.93 -22.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.515 -0.766 . . . . 2.08 111.799 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.99 35.78 0.8 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.075 0.398 . . . . 1.89 112.075 -179.497 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.51 122.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 1.87 111.294 179.594 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 52' ' ' ASN . 35.2 mt -114.27 68.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.69 110.987 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 1.6 111.158 -179.892 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 1.7 pm0 -70.2 166.53 19.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.99 0.424 . . . . 1.54 110.759 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -78.83 1.69 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.904 -0.589 . . . . 1.75 111.537 179.873 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 7.1 tt0 -98.56 100.14 11.35 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.966 -0.383 . . . . 2.05 109.966 179.608 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.8 t80 -136.81 164.45 28.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.238 0.542 . . . . 0.48 111.648 -179.502 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.6 m -125.55 125.14 42.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.463 -0.79 . . . . 0.42 110.398 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' LEU . 9.1 t -87.53 91.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.214 0.531 . . . . 1.08 110.747 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 17' ' ' THR . 24.2 p -85.52 -157.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.375 -0.829 . . . . 1.33 110.825 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.78 9.19 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.578 -0.82 . . . . 0.9 112.086 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.026 ' CD1' HG13 ' A' ' 18' ' ' VAL . 27.8 mt -75.61 164.98 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 1.47 111.025 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.424 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 1.8 m -115.27 101.59 9.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.557 . . . . 1.06 110.363 179.756 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 7.6 tt0 -49.25 150.15 1.84 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.489 -0.323 . . . . 1.91 111.179 -179.748 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 20.2 m-20 70.92 46.73 0.46 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.983 -0.553 . . . . 1.87 110.676 -179.625 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -167.83 121.42 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.034 -0.53 . . . . 0.49 111.139 -179.927 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.86 117.41 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.055 -0.35 . . . . 0.36 110.055 179.477 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 78.2 m-85 -113.78 128.95 56.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 5.8 mt-10 -95.41 146.4 24.43 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.469 -0.937 . . . . 1.5 108.469 178.271 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -123.85 108.94 13.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.376 1.621 . . . . 0.6 115.376 -178.177 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' CZ ' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.71 133.8 41.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.133 -0.94 . . . . 2.11 109.374 178.304 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -117.01 125.36 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 119.141 -1.023 . . . . 0.6 113.678 179.811 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 86' ' ' SER . 37.0 mt -114.74 145.57 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 113.589 -1.642 . . . . 0.7 108.03 178.546 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -154.34 125.39 7.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.858 -0.737 . . . . 0.6 112.541 -179.521 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 85' ' ' ILE . 15.5 ptpt -79.85 156.14 27.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.25 179.276 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.74 ' ND2' HD12 ' A' ' 2' ' ' ILE . 5.0 p30 -102.36 172.92 6.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 2.19 112.185 -179.32 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.26 -46.73 9.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.949 -1.023 . . . . 1.08 111.963 179.72 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -65.64 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 1.06 111.887 -179.273 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.22 -21.56 21.98 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.532 -0.842 . . . . 0.93 112.208 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.633 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -49.18 154.03 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.989 -0.374 . . . . 1.38 109.989 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tp -108.58 115.78 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.255 0.465 . . . . 0.79 112.255 -179.38 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' ILE . 24.1 p -69.72 113.84 20.23 Favored Pre-proline 0 C--O 1.235 0.34 0 N-CA-C 108.033 -1.099 . . . . 0.59 108.033 178.583 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.19 150.25 14.6 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.319 2.013 . . . . 0.85 113.005 -178.905 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' CA ' HG12 ' A' ' 77' ' ' ILE . 10.7 Cg_exo -38.93 141.51 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.46 2.774 . . . . 0.76 113.961 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' GLU . 16.0 m -106.01 110.6 22.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.957 -1.02 . . . . 1.28 109.698 179.054 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tp10 -5.12 116.08 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 124.815 1.322 . . . . 1.77 113.471 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 81.2 Cg_exo -51.05 142.29 35.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.451 2.1 . . . . 0.55 114.554 -179.14 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.418 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -75.56 152.15 37.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 178.427 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.89 145.73 0.31 Allowed 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.343 0.402 . . . . 1.63 110.978 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -78.8 121.48 24.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.993 -0.549 . . . . 0.41 111.07 -179.416 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.587 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.1 mp -100.77 114.94 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.175 -179.995 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.0 m -51.47 -44.21 62.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.919 -0.582 . . . . 0.44 110.655 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 50.3 t 62.43 67.94 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 116.17 -0.468 . . . . 1.1 110.958 179.651 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.77 -84.61 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 3.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.58 -0.67 9.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 2.14 111.109 179.719 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.991 0.424 . . . . 2.06 111.236 -179.969 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.448 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 5.5 tt . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 121.023 0.44 . . . . 0.68 111.475 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -129.78 124.99 22.02 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.787 -0.642 . . . . 2.0 111.194 179.699 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 161.76 35.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.427 2.084 . . . . 0.5 111.976 179.793 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 18.2 Cg_endo -59.06 170.39 2.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.592 2.195 . . . . 0.71 112.783 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -70.55 167.66 49.94 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.695 -0.684 . . . . 0.66 112.882 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 tmtt? -51.43 119.37 12.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.505 -0.183 . . . . 1.52 110.505 179.806 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' CG ' HG23 ' A' ' 76' ' ' VAL . 16.5 Cg_exo -70.06 152.8 67.91 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.398 2.066 . . . . 0.44 111.491 179.909 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.1 p -151.96 121.22 3.42 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.243 0.46 . . . . 1.09 112.243 -179.068 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.2 Cg_exo -65.75 111.95 2.07 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.552 2.168 . . . . 0.64 112.192 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.671 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.45 -33.09 58.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 1.64 110.625 179.711 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' HB ' ' A' ' 19' ' ' THR . 3.2 t-20 -148.56 126.02 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.72 110.113 179.891 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.872 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -114.9 128.11 72.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.96 111.606 -179.605 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -115.18 44.51 1.81 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.784 -0.644 . . . . 1.46 112.099 -179.318 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.8 mtm180 55.64 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.138 0.792 . . . . 2.42 113.138 178.749 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m170 -75.8 -29.89 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 1.02 110.934 -179.441 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.497 ' HA ' HD22 ' A' ' 66' ' ' LEU . 60.4 p -134.27 128.84 34.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.656 -0.498 . . . . 0.68 109.656 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.023 HG13 ' CD2' ' A' ' 66' ' ' LEU . 3.6 m -115.44 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.452 -0.499 . . . . 0.8 111.215 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 13.4 m -119.72 114.76 22.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.334 -0.394 . . . . 0.35 111.779 -178.997 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.04 158.0 40.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.686 0.755 . . . . 0.52 111.154 178.879 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CG ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.18 -179.2 5.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.652 -1.158 . . . . 1.84 109.591 179.813 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 24.7 p90 -162.08 175.46 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.328 0.585 . . . . 0.4 112.24 179.521 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -88.18 175.21 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.315 -0.857 . . . . 0.83 110.699 179.807 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 141.47 24.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.41 -0.359 . . . . 2.11 110.476 179.883 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' THR . 11.1 Cg_endo -54.48 -176.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.7 2.267 . . . . 0.89 112.464 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.23 -27.25 4.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 2.77 111.948 -179.77 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -113.84 -69.54 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.95 0.352 . . . . 1.37 111.95 -179.556 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.0 p 52.59 48.27 22.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.919 0.39 . . . . 0.91 110.227 -179.359 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.78 -101.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.657 -0.782 . . . . 1.01 112.03 -179.837 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.63 31.77 2.1 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.516 -1.034 . . . . 0.98 110.516 179.22 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.6 m-85 -107.44 -172.76 2.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.836 -0.682 . . . . 0.87 111.92 -178.806 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.25 7.08 1.34 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.923 -1.035 . . . . 2.26 111.832 179.187 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.013 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.1 mt 52.25 115.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.26 0.552 . . . . 1.71 112.329 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -117.12 22.76 12.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 1.15 111.357 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER 175.69 113.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.226 0.454 . . . . 1.58 112.226 -179.865 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 33' ' ' ILE . 43.2 m-85 -97.45 138.08 35.43 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.095 -0.335 . . . . 0.76 110.095 178.884 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -125.77 111.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.894 0.378 . . . . 1.14 110.67 179.485 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -99.37 115.8 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.364 -179.644 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.2 mt-10 -76.51 142.65 40.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.714 -0.675 . . . . 1.67 110.32 179.7 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.65 ' HE3' ' HB2' ' A' ' 51' ' ' ALA . 27.5 ttmt -106.11 146.02 30.72 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 120.749 0.309 . . . . 1.97 110.642 -179.577 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -129.8 100.77 5.6 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.547 -0.461 . . . . 1.44 110.483 178.931 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -70.6 78.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.618 -0.719 . . . . 1.59 110.689 -179.927 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.665 HD12 ' HB1' ' A' ' 94' ' ' ALA . 81.2 mt -50.44 154.88 1.98 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 0.9 111.02 -179.932 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.91 27.57 13.36 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.76 -1.35 . . . . 1.43 112.759 0.349 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.33 -79.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.574 0.225 . . . . 2.66 110.996 -179.922 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 1.12 112.907 179.845 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.27 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 2.41 110.552 179.95 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 62.2 m95 43.93 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.65 111.635 179.94 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -121.25 127.91 51.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 1.28 110.602 179.915 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -52.32 90.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.347 . . . . 1.3 110.627 -179.992 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.797 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -60.2 -46.06 91.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.86 110.635 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.814 ' HB2' HD11 ' A' ' 56' ' ' ILE . 10.9 p-10 -64.99 102.01 0.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 2.01 111.587 -179.828 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -15.65 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.085 -0.507 . . . . 2.08 110.664 179.27 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 p -86.62 -155.82 0.28 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.38 -0.373 . . . . 1.89 110.471 179.913 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -115.22 107.77 15.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.333 . . . . 1.87 111.618 -179.708 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 52' ' ' ASN . 6.9 mm -79.53 143.11 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.635 -0.505 . . . . 0.69 109.635 178.989 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -145.34 -68.02 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.33 . . . . 1.6 111.716 -179.843 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -54.93 -18.32 4.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 1.54 112.228 -179.731 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER 91.29 -18.45 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.877 0.871 . . . . 1.75 110.803 -179.58 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -88.92 85.26 6.69 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.555 -0.905 . . . . 2.05 108.555 178.836 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.737 ' CD1' HD12 ' A' ' 56' ' ' ILE . 50.2 t80 -114.47 165.2 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.484 0.659 . . . . 0.48 111.694 -178.61 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 91.9 m -123.4 116.99 24.16 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.893 -1.049 . . . . 0.42 110.025 178.994 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.797 HG13 ' CB ' ' A' ' 51' ' ' ALA . 48.8 t -83.9 86.54 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.117 -0.492 . . . . 1.08 111.375 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.56 134.41 35.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.734 . . . . 1.33 110.509 179.81 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.85 -14.3 2.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.83 . . . . 0.9 112.919 -179.847 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.023 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -53.31 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.47 110.609 179.94 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.2 m -148.75 142.3 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.06 111.11 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 1.282 ' OE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.0 137.27 58.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.193 179.879 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 97' ' ' CYS . 21.1 t70 70.09 49.33 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 1.87 111.221 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.87 120.51 2.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.873 0.368 . . . . 0.49 111.49 179.916 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.58 132.63 44.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.36 109.983 179.239 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.7 m-85 -127.52 122.11 32.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.662 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.89 138.12 43.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.603 -0.888 . . . . 1.5 108.603 178.502 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.21 115.39 14.12 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.41 1.263 . . . . 0.6 114.41 -178.702 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.32 167.77 11.52 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.806 -0.442 . . . . 2.11 109.806 178.395 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' CG ' ' A' ' 8' ' ' PRO . 28.5 t -122.43 121.18 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 113.706 1.002 . . . . 0.6 113.706 -179.531 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 86' ' ' SER . 70.1 mt -120.46 143.46 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.967 -1.494 . . . . 0.7 106.967 178.007 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -164.61 132.09 3.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.701 1.0 . . . . 0.6 113.701 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.61 105.95 14.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.709 -0.848 . . . . 1.98 108.709 178.245 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 3.3 m120 -40.1 -93.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.69 . . . . 2.19 112.712 -178.721 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -131.93 -41.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.178 -0.327 . . . . 1.08 111.643 -179.426 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -93.46 31.67 1.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 1.06 111.796 -179.684 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 77.84 -2.35 64.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.477 -0.868 . . . . 0.93 112.994 179.971 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -60.64 83.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 1.38 110.256 179.728 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.92 110.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.79 111.904 -179.325 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 77' ' ' ILE . 5.0 p -70.64 118.13 61.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.101 -0.704 . . . . 0.59 109.101 179.205 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 3.1 Cg_endo -47.15 172.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.623 2.215 . . . . 0.85 112.615 -179.192 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 17.0 Cg_endo -56.66 132.28 50.77 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.799 2.333 . . . . 0.76 112.46 -179.847 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m -105.99 98.14 7.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 1.28 111.155 -179.985 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mt-10 15.55 106.53 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 124.394 1.078 . . . . 1.77 113.858 179.58 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.1 Cg_exo -54.84 126.11 21.36 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.439 2.092 . . . . 0.55 113.89 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.425 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -54.77 147.64 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.431 -0.581 . . . . 1.23 109.431 178.996 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -36.77 143.48 0.08 Allowed 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 124.181 0.926 . . . . 1.63 111.779 179.951 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -78.01 109.83 12.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.41 109.901 179.712 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.82 HG12 HG21 ' A' ' 13' ' ' ILE . 4.8 mp -91.53 109.46 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.485 -179.444 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 98.8 m -45.96 -28.54 1.17 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.77 179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.76 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 87.0 m 52.6 80.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 1.1 110.172 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 1.282 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.2 -79.74 0.62 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.947 0.403 . . . . 3.0 111.686 -179.394 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -112.44 22.23 14.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.01 -0.541 . . . . 2.14 111.402 -179.824 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 2.06 111.675 -179.767 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.496 HD12 ' OD1' ' A' ' 80' ' ' ASN . 2.6 tt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.842 0.353 . . . . 0.68 111.31 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.039 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -122.11 129.77 24.98 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 2.0 110.294 179.88 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 154.28 15.41 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.424 2.083 . . . . 0.5 112.809 -179.628 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 78.2 Cg_exo -46.02 152.12 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.187 2.592 . . . . 0.71 113.485 -179.854 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.36 -171.35 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.432 -0.804 . . . . 0.66 113.103 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.7 tttt -77.07 129.39 78.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.457 -0.201 . . . . 1.52 110.457 179.824 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 2.7 Cg_exo -78.48 128.43 8.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.608 2.206 . . . . 0.44 112.896 -179.555 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -130.59 116.21 17.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.09 111.103 179.713 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.1 Cg_exo -62.91 128.52 23.3 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.707 2.271 . . . . 0.64 113.605 -179.467 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.6 mp -93.63 -27.79 16.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 1.64 109.693 179.059 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -150.42 151.16 32.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.715 -0.675 . . . . 0.72 110.229 179.836 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.193 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -149.08 111.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 0.96 111.503 -179.794 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.338 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -106.46 56.72 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.68 -0.691 . . . . 1.46 111.171 -179.956 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.955 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER 56.27 -69.97 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.881 0.738 . . . . 2.42 112.853 179.016 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m-70 -83.99 -20.28 33.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 1.02 111.82 -179.33 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 64' ' ' SER . 49.7 p -126.01 112.25 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.68 111.745 -179.603 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.004 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -106.39 120.55 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.8 110.478 179.606 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.706 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -104.34 128.16 52.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.35 111.843 -179.16 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.45 160.41 39.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.722 0.772 . . . . 0.52 111.8 178.964 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.822 ' HB3' HD11 ' A' ' 11' ' ' LEU . 8.6 tptm -142.57 139.19 31.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.514 -1.221 . . . . 1.84 109.861 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 14.5 p90 -126.55 -174.86 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.4 111.555 -179.714 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 171.81 8.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.83 111.475 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tptm -116.2 124.47 29.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.924 -0.58 . . . . 2.11 110.06 179.842 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.58 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 6.5 Cg_endo -46.98 175.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.719 2.28 . . . . 0.89 112.725 -179.908 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.54 3.35 5.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.77 110.846 179.718 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.039 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 3.7 t80 -121.87 -74.04 0.63 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.557 0.206 . . . . 1.37 111.557 -179.558 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' THR . . . . . 1.006 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 16.6 p 41.29 56.75 3.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.524 0.202 . . . . 0.91 111.254 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.13 -102.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.04 -0.527 . . . . 1.01 113.418 -179.717 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.68 28.85 3.2 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.968 -0.853 . . . . 0.98 110.968 179.232 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -110.42 -176.19 2.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.356 -0.422 . . . . 0.87 111.14 -179.138 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -137.89 1.01 2.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.976 -0.556 . . . . 2.26 112.218 179.685 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.596 HG21 ' CE1' ' A' ' 36' ' ' TYR . 8.3 mt 57.51 116.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-O 121.071 0.462 . . . . 1.71 111.088 -179.749 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -103.16 10.84 37.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.435 0.532 . . . . 1.15 112.435 -179.12 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -179.01 156.85 0.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.961 0.41 . . . . 1.58 111.898 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 28.5 m-85 -126.21 112.48 15.81 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.893 -0.594 . . . . 0.76 110.84 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.5 OUTLIER -94.55 99.79 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 1.14 110.718 -179.85 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.654 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -92.26 113.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 0.63 110.488 179.861 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.3 mp0 -81.5 144.73 31.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.605 -0.725 . . . . 1.67 110.911 -179.784 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -111.79 139.13 47.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 1.97 110.917 179.893 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 15.7 ttm180 -106.97 110.83 23.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.438 . . . . 1.44 110.382 179.405 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -82.66 91.21 6.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.715 -0.675 . . . . 1.59 110.307 179.866 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -68.0 154.53 93.62 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.519 -0.764 . . . . 0.9 110.983 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.05 4.41 66.12 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.685 -1.381 . . . . 1.43 112.999 0.255 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -78.86 -68.03 0.69 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 2.66 110.451 179.896 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 88.06 177.14 47.68 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.769 -0.729 . . . . 1.12 113.016 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.663 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 164.47 -28.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 110.718 179.938 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 51.4 m95 63.31 87.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 0.65 111.138 179.894 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.663 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.45 141.47 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.116 -179.834 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -58.5 117.64 4.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 1.3 110.747 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -86.95 -49.59 7.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.86 111.267 -179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.896 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -42.41 -54.18 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 2.01 112.101 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 t80 46.59 44.24 13.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.686 0.279 . . . . 2.08 111.347 -179.87 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 t -152.5 -84.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 1.89 111.156 179.924 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -178.13 110.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 1.87 110.556 179.967 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 52' ' ' ASN . 11.2 mt -108.74 80.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.69 111.103 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.8 tm? -64.7 -65.69 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 1.6 110.961 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.43 160.16 30.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.989 -0.374 . . . . 1.54 109.989 179.737 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -74.16 -3.57 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.304 -0.407 . . . . 1.75 111.556 -179.87 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -100.0 101.34 12.4 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.801 0.334 . . . . 2.05 110.151 179.853 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.683 ' HB2' HG23 ' A' ' 56' ' ' ILE . 50.3 t80 -135.07 162.97 30.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.258 0.551 . . . . 0.48 111.719 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 19' ' ' THR . 51.6 m -122.58 109.94 14.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.52 -0.764 . . . . 0.42 110.354 179.167 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' CB ' ' A' ' 51' ' ' ALA . 98.9 t -81.79 93.96 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.74 -0.664 . . . . 1.08 111.002 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.745 ' HB3' HG22 ' A' ' 17' ' ' THR . 3.0 p -98.79 144.56 27.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 1.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.44 -9.31 5.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.672 -0.775 . . . . 0.9 112.986 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -54.83 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.03 0.443 . . . . 1.47 111.063 -179.93 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 m -129.27 131.8 47.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 1.06 110.442 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.3 mt-10 -61.31 150.27 35.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.306 -0.406 . . . . 1.91 111.104 -179.758 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t0 62.75 48.56 4.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 1.87 110.814 -179.999 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.02 126.13 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.498 . . . . 0.49 111.319 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.758 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -71.52 134.57 46.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.604 179.694 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 46.1 m-85 -133.02 130.82 39.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.56 112.414 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -105.94 148.42 27.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.791 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.891 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.59 117.89 13.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.717 1.377 . . . . 0.6 114.717 -179.228 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -104.56 158.33 16.56 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.931 -0.766 . . . . 2.11 108.931 177.663 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 38' ' ' VAL . 99.3 t -115.19 109.93 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.584 -0.846 . . . . 0.6 113.02 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.483 HD12 ' CD ' ' A' ' 39' ' ' GLU . 68.3 mt -105.37 157.18 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.021 -1.474 . . . . 0.7 107.021 177.723 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -176.88 136.28 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.054 -1.058 . . . . 0.6 112.684 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.0 ptpp? -75.63 -150.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.106 -0.701 . . . . 1.98 109.106 178.846 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.496 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -147.43 -107.33 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.212 -0.595 . . . . 2.19 111.291 -179.723 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -127.47 -43.04 1.62 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.709 0.686 . . . . 1.08 110.423 179.847 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.94 -9.9 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 1.06 111.749 179.803 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.81 -18.84 28.84 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.475 -0.869 . . . . 0.93 112.398 -179.743 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -52.82 158.29 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.58 0.229 . . . . 1.38 110.72 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 6.3 tp -114.79 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.352 . . . . 0.79 111.649 -179.931 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -77.83 122.7 85.99 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 109.719 -0.474 . . . . 0.59 109.719 179.328 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -41.47 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.353 2.702 . . . . 0.85 113.649 -179.419 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' CA ' HG12 ' A' ' 77' ' ' ILE . 1.1 Cg_endo -83.56 129.67 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.361 2.707 . . . . 0.76 112.469 -179.91 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 78.2 p -85.19 125.06 32.53 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.994 -0.372 . . . . 1.28 109.994 179.349 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -17.65 106.89 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 124.696 1.248 . . . . 1.77 113.497 -179.476 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 54.4 Cg_exo -45.25 152.53 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.503 2.135 . . . . 0.55 113.302 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.436 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -83.76 144.04 29.59 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.421 -0.808 . . . . 1.23 109.005 179.063 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -34.93 146.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.213 0.946 . . . . 1.63 111.73 -179.624 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -76.66 125.31 29.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.694 -0.684 . . . . 0.41 110.69 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.1 mp -109.56 115.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.44 110.956 179.72 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.0 m -48.2 -30.61 4.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.44 111.262 -179.642 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.498 ' H ' HG22 ' A' ' 95' ' ' ILE . 57.2 m 51.88 72.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 1.1 110.212 -179.779 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.73 -80.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 3.0 111.421 -179.485 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -114.73 27.95 9.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.667 -0.697 . . . . 2.14 110.819 -179.734 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.338 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.085 0.469 . . . . 2.06 111.091 -179.323 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.672 HD11 ' HB3' ' A' ' 86' ' ' SER . 7.0 tt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.97 0.414 . . . . 0.68 111.506 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 1.24 ' OD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -140.55 130.77 13.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 2.0 110.132 179.757 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 166.94 17.2 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.437 2.091 . . . . 0.5 112.843 -179.592 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.1 Cg_endo -61.74 -175.86 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.111 2.541 . . . . 0.71 113.404 -179.489 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.45 168.61 36.68 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.578 -0.737 . . . . 0.66 112.445 179.938 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.3 tttt -59.32 130.56 87.35 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.724 0.262 . . . . 1.52 110.353 179.808 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.4 Cg_exo -79.46 153.99 24.09 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.523 2.149 . . . . 0.44 112.86 -179.413 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.34 116.35 7.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 1.09 110.351 179.977 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' THR . 14.2 Cg_exo -66.81 91.54 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.953 1.769 . . . . 0.64 113.191 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER -46.75 -42.77 17.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.293 0.568 . . . . 1.64 110.283 179.449 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -134.58 153.21 52.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.216 -0.902 . . . . 0.72 109.278 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -140.4 94.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.48 . . . . 0.96 111.235 -179.543 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -91.63 55.61 2.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.677 -0.692 . . . . 1.46 112.282 -179.202 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 2.5 mtm180 53.58 -71.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.678 0.992 . . . . 2.42 113.678 178.638 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 12.6 m170 -84.8 -32.61 23.27 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.281 0.474 . . . . 1.02 112.281 -178.726 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 64' ' ' SER . 19.9 p -126.4 101.7 6.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.673 0.273 . . . . 0.68 111.075 -179.714 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.069 HG13 ' CD2' ' A' ' 66' ' ' LEU . 32.5 m -98.72 138.28 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.378 . . . . 0.8 110.423 179.505 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 91.1 m -101.13 119.95 39.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.74 0.644 . . . . 0.35 112.74 -179.099 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.95 150.81 51.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.794 0.806 . . . . 0.52 111.834 178.221 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.49 159.2 42.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.719 -1.128 . . . . 1.84 109.364 179.607 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -141.93 -176.87 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.087 0.773 . . . . 0.4 113.087 -178.922 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 -158.13 0.27 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.774 -1.103 . . . . 0.83 110.643 179.387 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.71 148.84 71.69 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.417 -0.356 . . . . 2.11 110.738 179.606 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 80.7 Cg_exo -49.1 -173.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.983 2.455 . . . . 0.89 113.084 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.78 -29.79 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 2.77 111.649 -179.834 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 1.24 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 t80 -129.4 -69.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.961 0.356 . . . . 1.37 111.961 -179.563 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.865 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 16.1 p 58.49 46.16 15.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.91 110.566 -179.308 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.22 -98.51 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.929 -0.653 . . . . 1.01 112.551 179.905 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.36 22.85 2.87 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.336 -0.706 . . . . 0.98 111.336 179.354 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -103.29 -176.12 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 0.87 111.206 -179.178 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -134.89 5.69 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 2.26 111.437 179.482 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.646 HG21 ' CE1' ' A' ' 36' ' ' TYR . 12.1 mt 57.55 97.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-O 121.151 0.5 . . . . 1.71 110.868 -179.725 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -104.63 29.44 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.52 -0.764 . . . . 1.15 111.306 -179.424 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.83 116.77 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.917 0.389 . . . . 1.58 111.996 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.2 m-85 -110.42 107.46 17.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.76 110.3 179.267 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 1.6 mm -90.92 116.47 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.658 0.266 . . . . 1.14 111.075 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 56' ' ' ILE . 3.2 t -90.74 118.27 35.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.31 -0.404 . . . . 0.63 111.811 -179.762 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.8 mm-40 -96.9 135.03 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.422 -0.584 . . . . 1.67 109.422 178.901 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.636 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -112.32 145.75 39.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 1.97 112.229 -179.269 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.2 ttm180 -117.86 103.42 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.295 -0.866 . . . . 1.44 110.233 179.46 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -73.05 92.7 1.7 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.031 0.443 . . . . 1.59 110.9 -179.771 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.753 HD11 ' HG3' ' A' ' 73' ' ' GLU . 27.5 mt -70.82 149.42 95.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.786 -0.643 . . . . 0.9 110.692 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.5 -18.1 18.52 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.845 -1.315 . . . . 1.43 113.01 0.423 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -52.22 -90.95 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.062 -0.255 . . . . 2.66 110.672 -179.717 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' HA3' ' CG ' ' A' ' 41' ' ' ARG . . . 88.06 123.36 1.94 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.318 -0.944 . . . . 1.12 113.305 179.52 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.658 ' NE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.94 17.22 0.67 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.858 0.318 . . . . 2.41 111.858 179.678 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 69.0 m95 28.66 98.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.953 0.723 . . . . 0.65 112.953 179.901 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.658 HD22 ' NE ' ' A' ' 47' ' ' ARG . 1.1 mp -135.65 133.48 38.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 1.28 111.214 179.929 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 9.8 ptmm? -51.11 106.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 1.3 111.112 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.636 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.39 -56.84 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.86 110.714 179.819 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 9.4 p-10 -57.66 113.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 2.01 110.571 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.21 24.0 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 2.08 111.224 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 t -125.56 -82.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 1.89 110.77 -179.935 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.95 141.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 1.87 110.56 179.947 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.638 HD13 ' CG ' ' A' ' 61' ' ' PHE . 30.9 mt -125.56 79.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 0.69 111.19 -179.651 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.84 -66.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 1.6 110.923 179.998 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -179.72 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.481 -0.327 . . . . 1.54 110.424 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 30.1 p30 -96.69 10.05 39.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 1.75 111.618 179.861 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -111.28 95.84 5.76 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.757 -0.46 . . . . 2.05 109.757 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.638 ' CG ' HD13 ' A' ' 56' ' ' ILE . 76.6 t80 -128.26 164.83 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.196 0.522 . . . . 0.48 111.531 -179.26 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.9 m -127.38 124.03 37.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.578 -0.737 . . . . 0.42 110.333 179.253 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 20' ' ' LEU . 4.4 t -81.36 82.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.17 0.509 . . . . 1.08 109.941 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 17' ' ' THR . 33.2 t -68.27 -39.05 82.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.403 -0.817 . . . . 1.33 111.514 -179.18 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.68 62.22 0.47 Allowed Glycine 0 C--N 1.321 -0.301 0 C-N-CA 120.811 -0.709 . . . . 0.9 111.69 179.733 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.069 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -131.66 149.19 52.58 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.385 -0.598 . . . . 1.47 109.385 -179.118 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -105.23 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 1.06 111.87 -179.207 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 67' ' ' THR . 19.7 tt0 -103.75 165.14 11.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 1.91 111.28 -179.46 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 47.65 68.91 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.993 -0.549 . . . . 1.87 111.125 179.826 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . 176.87 110.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.49 110.882 179.904 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -63.05 110.2 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.21 0.529 . . . . 0.36 110.641 -179.866 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 82.7 m-85 -103.75 125.54 50.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.56 112.728 -178.999 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.753 ' HG3' HD11 ' A' ' 43' ' ' LEU . 20.1 mt-10 -103.36 137.2 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.863 -1.162 . . . . 1.5 107.863 177.704 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.013 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.61 116.97 19.66 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.307 1.595 . . . . 0.6 115.307 -178.717 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -102.21 177.8 4.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.579 -1.267 . . . . 2.11 107.579 176.856 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.579 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -145.14 111.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 118.969 -1.093 . . . . 0.6 112.753 -179.835 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' A' ' 39' ' ' GLU . 25.1 mt -92.99 142.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.691 -1.226 . . . . 0.7 107.691 177.944 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -154.1 120.7 5.51 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.746 . . . . 0.6 111.945 -178.951 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -56.3 -100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.367 -0.533 . . . . 1.98 109.969 179.633 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 18.6 p30 171.41 -111.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.935 -0.765 . . . . 2.19 108.935 179.65 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -135.09 5.54 3.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.054 0.843 . . . . 1.08 111.53 179.015 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.94 0.02 7.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.736 -0.211 . . . . 1.06 111.236 179.956 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.82 61.16 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 120.334 -0.936 . . . . 0.93 113.186 179.864 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -67.87 114.35 6.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 1.38 110.335 179.866 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -72.77 121.3 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 0.79 112.255 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.672 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.3 p -89.36 127.0 56.65 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 109.674 -0.491 . . . . 0.59 109.674 179.264 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -32.97 155.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.547 2.832 . . . . 0.85 113.844 -179.16 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.6 Cg_exo -68.06 120.97 7.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.698 2.265 . . . . 0.76 112.685 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.579 ' OG ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -62.75 133.07 54.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.351 -0.611 . . . . 1.28 109.351 179.167 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -31.53 116.58 0.37 Allowed Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 123.682 0.614 . . . . 1.77 112.425 -179.305 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 68.6 Cg_exo -40.67 169.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.011 2.474 . . . . 0.55 114.252 -179.565 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -103.08 141.46 35.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.73 -1.123 . . . . 1.23 109.729 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -41.85 130.54 3.37 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.71 0.631 . . . . 1.63 111.078 179.606 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -59.88 133.97 56.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.861 -0.609 . . . . 0.41 111.552 -179.557 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 13' ' ' ILE . 3.5 mp -116.79 113.19 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.71 179.507 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.1 m -53.42 -16.0 1.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.056 0.761 . . . . 0.44 113.056 -179.106 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 p 42.08 64.9 0.98 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.254 0.55 . . . . 1.1 111.127 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -90.28 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.399 -0.819 . . . . 3.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -133.19 31.29 3.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.846 0.355 . . . . 2.14 110.713 -179.748 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 26.0 t0 . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 116.019 -0.537 . . . . 2.06 112.249 -179.617 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.769 0.319 . . . . 0.68 111.012 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.36 122.7 26.67 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.13 -0.486 . . . . 2.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 59.6 Cg_endo -71.57 155.88 58.63 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.036 1.824 . . . . 0.5 112.181 -179.751 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 30.9 Cg_exo -59.73 172.75 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.317 2.011 . . . . 0.71 112.242 -179.757 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.55 168.58 51.05 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.93 -0.652 . . . . 0.66 113.031 -179.693 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 5.6 tttt -63.17 141.13 97.75 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.026 -0.361 . . . . 1.52 110.026 179.663 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.629 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.6 Cg_exo -83.4 142.08 10.41 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.417 2.078 . . . . 0.44 112.589 -179.729 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -143.74 118.33 6.11 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 1.09 110.588 179.749 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.6 Cg_exo -67.0 123.02 10.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.196 1.931 . . . . 0.64 113.521 -179.439 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -34.38 20.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.901 -0.778 . . . . 1.64 108.901 178.701 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -140.48 143.48 35.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.794 -1.094 . . . . 0.72 109.047 179.386 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -136.94 102.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.026 0.441 . . . . 0.96 112.044 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.72 59.17 1.47 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.756 -0.656 . . . . 1.46 111.115 -179.999 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 51.53 -74.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.553 -0.748 . . . . 2.42 112.273 179.045 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' THR . 7.2 m-70 -79.69 -45.85 18.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 1.02 110.894 -179.944 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 64' ' ' SER . 1.4 p -99.12 104.61 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 0.68 111.061 -179.905 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 61.7 t -101.22 118.95 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.8 110.219 179.761 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.501 ' C ' HD13 ' A' ' 20' ' ' LEU . 27.3 m -95.29 117.72 30.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.979 -0.555 . . . . 0.35 112.12 -179.117 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.794 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.37 159.49 40.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.447 0.641 . . . . 0.52 111.165 178.541 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.64 148.21 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.911 -1.04 . . . . 1.84 109.692 -179.987 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 1.2 p90 -116.46 -111.06 0.35 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.487 -0.485 . . . . 0.4 112.078 -179.994 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -157.48 -159.55 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.993 -0.442 . . . . 0.83 111.196 -179.189 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HD3' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.73 132.61 24.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 2.11 110.61 179.981 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.3 Cg_endo -57.04 -175.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.432 2.088 . . . . 0.89 112.102 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.51 -43.19 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.955 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -97.03 -66.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 1.37 112.047 -179.32 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.482 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 27.8 p 55.18 32.0 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.91 110.493 -179.345 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.14 -94.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.481 -0.866 . . . . 1.01 111.866 -179.824 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.89 41.68 1.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.513 -1.035 . . . . 0.98 110.513 179.261 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 6.4 m-85 -121.7 -179.15 4.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.181 -0.51 . . . . 0.87 111.752 -178.859 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 1.9 tttt -133.13 -32.96 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 2.26 111.998 -179.972 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.76 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.0 mt 80.98 107.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.083 0.468 . . . . 1.71 110.821 -179.542 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -102.7 12.32 36.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.686 -0.688 . . . . 1.15 111.69 -179.546 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -178.23 137.09 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.485 0.55 . . . . 1.58 112.485 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.76 ' CE1' HG21 ' A' ' 33' ' ' ILE . 55.2 m-85 -112.6 151.17 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.819 . . . . 0.76 109.637 178.684 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.73 123.98 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.74 0.305 . . . . 1.14 111.055 -179.529 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG21 ' HD2' ' A' ' 61' ' ' PHE . 1.4 t -103.75 101.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.63 111.36 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -74.54 144.61 43.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.34 -0.615 . . . . 1.67 109.34 179.267 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.02 145.73 47.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.133 0.492 . . . . 1.97 111.6 -179.226 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.8 ttm180 -133.57 94.32 3.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.789 -0.641 . . . . 1.44 111.056 -179.963 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.483 ' OD1' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -57.43 164.67 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.409 -0.96 . . . . 1.59 108.409 179.121 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 94' ' ' ALA . 35.2 mt -142.25 129.97 11.48 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.227 -0.589 . . . . 0.9 111.067 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.79 33.83 3.92 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.08 -1.217 . . . . 1.43 113.653 0.743 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -112.12 51.92 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 2.66 111.202 179.895 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -60.65 -178.58 2.14 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.773 -0.727 . . . . 1.12 112.815 -179.998 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.74 -28.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.585 0.217 . . . . 2.41 111.585 -179.968 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 24.3 m95 65.42 72.59 0.42 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.792 0.329 . . . . 0.65 111.251 -179.981 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.6 mp -119.86 133.84 55.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 1.28 110.605 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 86.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 1.3 110.787 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -53.22 -41.62 65.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.86 111.175 -179.668 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.715 ' CG ' HD11 ' A' ' 56' ' ' ILE . 2.6 t-20 -44.37 -90.59 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.309 -0.405 . . . . 2.01 111.427 -179.768 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 t80 73.1 39.55 0.61 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.724 0.297 . . . . 2.08 110.712 -179.609 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -157.13 24.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.89 111.551 -179.911 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 t30 63.85 121.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.82 0.343 . . . . 1.87 111.219 179.611 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.841 HD12 ' CG ' ' A' ' 61' ' ' PHE . 38.9 mm -108.5 75.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.69 110.972 179.58 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.66 -67.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.731 0.301 . . . . 1.6 111.001 -179.995 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pm0 -82.38 163.43 21.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.54 110.158 179.635 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 34.1 p30 -76.89 -1.09 26.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.369 -0.378 . . . . 1.75 111.73 -179.829 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -104.52 98.35 8.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.865 0.364 . . . . 2.05 110.051 179.711 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.841 ' CG ' HD12 ' A' ' 56' ' ' ILE . 64.6 t80 -128.84 164.72 22.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.48 111.439 -179.39 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 51.1 m -128.76 106.85 9.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.319 -0.855 . . . . 0.42 110.826 179.302 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 18' ' ' VAL . 27.0 m -61.77 134.92 26.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.08 110.868 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -130.72 133.45 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 1.33 111.502 -179.524 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.25 21.83 4.33 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.9 112.293 179.917 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.714 HD22 HG23 ' A' ' 18' ' ' VAL . 3.0 mp -79.69 176.65 9.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.185 0.517 . . . . 1.47 111.749 -179.504 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 134.27 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.394 -0.821 . . . . 1.06 110.124 179.419 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 mt-10 -73.73 174.2 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 1.91 111.736 -179.501 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 6.2 t70 52.83 27.44 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.905 -0.588 . . . . 1.87 110.973 -179.962 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.33 126.02 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.49 110.871 179.803 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' CB ' HD12 ' A' ' 43' ' ' LEU . . . -66.03 127.87 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.362 -0.381 . . . . 0.36 110.607 179.78 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 3.6 m-85 -115.91 125.71 52.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.56 112.014 -179.087 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.2 tt0 -106.33 148.41 28.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.873 -0.788 . . . . 1.5 108.873 179.001 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.93 118.76 12.47 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.6 115.032 -178.718 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -100.35 178.06 4.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.004 -0.544 . . . . 2.11 109.831 178.102 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 ' HG3' ' A' ' 8' ' ' PRO . 75.4 t -134.68 122.07 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 113.245 0.831 . . . . 0.6 113.245 -179.53 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 91.9 mt -122.56 142.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.147 -1.427 . . . . 0.7 107.147 178.188 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -169.31 134.35 1.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.49 1.292 . . . . 0.6 114.49 -178.836 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -83.75 136.93 33.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.887 -1.153 . . . . 1.98 107.887 177.529 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 5.9 m-20 -76.69 -92.5 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.468 0.544 . . . . 2.19 112.468 -178.566 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -126.31 -40.96 1.93 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.444 0.535 . . . . 1.08 112.444 -178.99 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.741 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -100.43 36.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.339 0.496 . . . . 1.06 112.339 -179.078 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.96 -0.67 57.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.93 113.486 179.575 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.11 85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.032 0.416 . . . . 1.38 110.176 179.677 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -64.41 121.39 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.169 0.509 . . . . 0.79 111.98 -179.26 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 22.9 p -78.31 123.94 85.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.59 109.311 179.159 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.7 Cg_endo -48.54 171.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.872 2.381 . . . . 0.85 113.172 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB2' ' NH1' ' A' ' 75' ' ' ARG . 14.4 Cg_exo -67.53 112.79 2.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.76 112.862 -179.596 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -74.36 132.58 42.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 1.28 110.037 179.367 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.7 mm-40 -31.01 113.75 0.33 Allowed Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 123.761 0.663 . . . . 1.77 112.355 -179.599 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 75' ' ' ARG . 44.1 Cg_exo -56.07 138.63 83.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.55 113.057 -179.658 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -69.94 146.49 51.13 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.279 -0.638 . . . . 1.23 109.279 179.193 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.6 m-20 -35.76 139.43 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.094 0.871 . . . . 1.63 111.843 -179.865 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -75.65 108.86 8.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.41 111.175 -179.709 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 13' ' ' ILE . 5.0 mp -91.29 114.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.122 -179.712 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 97.5 m -36.22 -32.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.214 -0.448 . . . . 0.44 111.862 -179.96 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.557 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 m 51.28 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.428 -0.351 . . . . 1.1 110.117 179.773 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.99 -90.92 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 3.0 111.669 -179.317 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.634 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -105.71 6.59 32.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.805 0.298 . . . . 2.14 111.805 -179.609 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 53.5 t0 . . . . . 0 C--N 1.331 -0.218 0 N-CA-C 111.862 0.319 . . . . 2.06 111.862 179.755 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.887 HD11 ' ND2' ' A' ' 80' ' ' ASN . 6.9 tt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.766 0.317 . . . . 0.68 111.041 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.81 114.26 19.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 2.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.75 154.61 54.16 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.395 2.063 . . . . 0.5 112.007 179.907 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.81 174.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.692 2.261 . . . . 0.71 112.826 -179.708 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.77 171.48 44.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.993 -0.622 . . . . 0.66 112.658 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -63.64 135.9 96.48 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 110.49 -0.189 . . . . 1.52 110.49 179.802 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_endo -80.9 129.76 7.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.457 2.104 . . . . 0.44 112.861 -179.697 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -132.83 106.01 12.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.917 -0.583 . . . . 1.09 110.793 179.613 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.5 Cg_exo -49.03 131.76 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.334 2.022 . . . . 0.64 113.691 -179.069 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -86.75 -39.92 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.64 108.861 178.689 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -136.35 150.37 48.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.406 -1.27 . . . . 0.72 108.607 179.576 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 1.9 pt -143.44 83.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.262 -0.575 . . . . 0.96 112.516 -179.157 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.23 159.73 29.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.729 -0.669 . . . . 1.46 110.507 179.476 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -17.37 7.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.42 111.961 -179.554 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' THR . 10.7 m-70 -141.91 34.39 1.57 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.973 0.36 . . . . 1.02 111.973 -179.754 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 179.66 120.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.648 -0.251 . . . . 0.68 110.387 179.714 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -117.86 111.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.18 0.514 . . . . 0.8 112.045 -179.317 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 92.4 m -85.21 142.28 29.54 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.004 -0.543 . . . . 0.35 110.266 179.154 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.79 161.13 41.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.428 0.633 . . . . 0.52 112.298 -179.857 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -149.3 144.37 26.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.878 -1.056 . . . . 1.84 110.49 179.742 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.4 p90 -138.23 -173.38 3.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.431 . . . . 0.4 110.734 -179.973 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 -166.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.83 110.381 179.534 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -132.23 155.61 81.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.786 0.327 . . . . 2.11 110.942 179.907 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 28' ' ' THR . 14.6 Cg_exo -69.25 163.41 37.96 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.097 . . . . 0.89 111.835 179.802 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.96 -0.66 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 2.77 111.493 179.652 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -128.6 -70.34 0.68 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.658 0.266 . . . . 1.37 111.644 -179.805 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 25' ' ' PRO . 30.4 p 48.83 57.43 6.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.598 -0.274 . . . . 0.91 110.733 -179.575 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.46 -92.17 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.301 -0.476 . . . . 1.01 112.799 -179.733 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -145.96 32.66 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.236 -1.146 . . . . 0.98 110.236 179.177 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -119.44 -179.04 3.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.953 -0.624 . . . . 0.87 111.374 -178.716 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.08 3.75 2.92 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.249 -0.432 . . . . 2.26 112.164 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mt 60.05 154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.752 0.31 . . . . 1.71 110.635 -179.935 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 33' ' ' ILE . 8.3 p -145.2 15.14 1.49 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.002 0.371 . . . . 1.15 112.002 -179.646 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -177.65 133.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 1.58 111.214 -179.915 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.9 m-85 -109.58 105.18 14.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.76 110.642 179.592 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.554 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.3 mt -84.91 152.02 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.019 -0.537 . . . . 1.14 111.039 -179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 75' ' ' ARG . 2.5 t -131.53 111.76 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.63 110.568 179.65 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -87.12 143.88 27.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.006 -0.368 . . . . 1.67 110.006 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.34 141.24 51.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.122 0.487 . . . . 1.97 112.23 -179.0 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 23.0 ttp180 -112.02 112.14 23.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.741 -0.663 . . . . 1.44 109.614 178.932 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 1.368 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.9 96.99 4.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 1.59 110.887 -179.594 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 7.6 mt -80.26 154.1 74.45 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.9 110.785 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.61 12.32 51.47 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.691 -1.379 . . . . 1.43 112.89 0.192 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -77.96 -82.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.402 . . . . 2.66 110.632 179.845 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 123.8 143.2 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.864 -0.684 . . . . 1.12 112.484 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 1.368 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 171.83 55.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.466 0.174 . . . . 2.41 111.158 -179.847 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.624 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 14.1 m95 -36.97 107.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.378 -0.374 . . . . 0.65 111.725 -179.994 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -143.47 136.89 28.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.049 0.452 . . . . 1.28 111.065 179.976 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' HE2' HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.22 104.33 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 1.3 111.173 -179.921 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.42 -47.01 87.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.037 0.446 . . . . 0.86 110.259 179.557 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.599 ' ND2' ' CE2' ' A' ' 61' ' ' PHE . 6.7 t-20 -68.35 116.98 9.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.788 -0.642 . . . . 2.01 110.189 179.639 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -114.31 46.69 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 2.08 111.117 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 t -150.12 -83.91 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.409 -0.36 . . . . 1.89 110.962 -179.958 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.78 147.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 1.87 110.777 -179.961 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.705 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.3 mt -142.0 75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.69 111.31 -179.827 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.4 tm? -59.76 -53.06 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 1.6 110.718 179.835 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.4 pt-20 -80.29 161.58 25.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.127 179.684 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 45.2 p-10 -81.45 6.08 15.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 1.75 111.918 -179.756 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 22.1 tt0 -106.58 104.31 13.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.591 -0.522 . . . . 2.05 109.591 179.413 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.705 ' CG ' HD13 ' A' ' 56' ' ' ILE . 63.9 t80 -137.77 163.81 30.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.48 112.184 -179.255 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 65.5 m -122.2 107.15 11.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.628 -0.715 . . . . 0.42 111.358 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 18' ' ' VAL . 2.2 m -72.05 94.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.759 -0.655 . . . . 1.08 110.436 179.57 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -100.44 155.62 17.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.589 0.709 . . . . 1.33 111.068 179.989 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.0 22.67 3.81 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.664 -1.153 . . . . 0.9 112.314 179.793 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -85.8 -172.49 4.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.898 0.38 . . . . 1.47 110.932 -179.753 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -148.28 116.11 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 1.06 110.654 179.998 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 97' ' ' CYS . 1.7 tt0 -41.53 137.86 1.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.096 -0.502 . . . . 1.91 111.563 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t70 75.69 47.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.085 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.6 121.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.49 110.983 179.778 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.0 127.42 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.36 111.086 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 55.3 m-85 -124.35 127.28 47.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.503 -0.771 . . . . 0.56 112.307 -179.225 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 3.1 tp10 -99.8 147.41 25.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.036 -0.727 . . . . 1.5 109.036 178.812 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 95' ' ' ILE . 15.0 m-85 -137.18 116.95 13.07 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.969 1.47 . . . . 0.6 114.969 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.624 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -107.43 171.05 7.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.963 -0.755 . . . . 2.11 108.963 177.587 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 8' ' ' PRO . 77.0 t -126.24 108.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.951 0.723 . . . . 0.6 112.951 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.596 HD11 ' HG3' ' A' ' 88' ' ' PRO . 31.4 mt -102.83 139.19 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.528 -1.286 . . . . 0.7 107.528 177.946 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -153.76 129.75 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.64 -0.824 . . . . 0.6 112.064 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 40.8 mttt -78.75 -178.22 5.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.486 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.887 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.5 m-80 -129.02 172.58 11.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.003 -0.544 . . . . 2.19 110.812 179.839 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.1 -28.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.719 -0.673 . . . . 1.08 111.785 179.658 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -112.14 34.77 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.439 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 42.68 37.81 2.87 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.67 -0.776 . . . . 0.93 113.02 179.611 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.01 8.24 8.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.287 0.477 . . . . 1.38 112.287 -179.956 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER 35.7 97.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 113.496 0.924 . . . . 0.79 113.496 179.738 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -75.73 116.64 57.13 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.53 -0.915 . . . . 0.59 108.53 178.461 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -35.16 158.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.405 2.737 . . . . 0.85 113.39 -178.843 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.596 ' HG3' HD11 ' A' ' 77' ' ' ILE . 12.6 Cg_exo -68.06 142.77 57.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.627 2.218 . . . . 0.76 112.23 179.871 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 50.5 m -92.25 118.64 31.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.958 -0.565 . . . . 1.28 110.125 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 42.5 mt-10 -19.66 104.94 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.021 0.929 . . . . 1.77 113.151 -179.461 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.475 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 55.5 Cg_exo -39.98 161.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.608 2.205 . . . . 0.55 113.246 -179.471 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.46 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -97.04 143.51 27.81 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.501 -0.772 . . . . 1.23 109.339 179.175 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 2.6 m-20 -35.31 129.01 0.54 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.027 0.83 . . . . 1.63 112.077 -179.286 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -50.19 133.06 23.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.41 111.397 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.743 HD13 ' HE2' ' A' ' 74' ' ' PHE . 3.2 mp -113.24 106.76 21.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.44 111.686 -179.789 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.7 m -52.54 -23.02 5.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.841 179.688 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.452 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 60.29 38.35 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.1 110.235 -179.834 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -132.97 -38.42 0.98 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 3.0 111.946 -179.635 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.429 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 3.9 p-10 -49.0 -26.27 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 2.14 111.624 -179.405 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 116.115 -0.493 . . . . 2.06 111.531 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.916 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.2 tt . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.596 0.712 . . . . 0.68 112.439 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.981 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -141.93 123.59 8.91 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.43 -179.962 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.08 166.92 28.43 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.321 2.014 . . . . 0.5 112.256 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.2 Cg_exo -52.24 173.96 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.667 2.245 . . . . 0.71 112.749 -179.626 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.56 39.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.071 -0.585 . . . . 0.66 112.78 -179.831 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 tptm -65.44 118.12 47.44 Favored Pre-proline 0 CA--C 1.532 0.254 0 O-C-N 123.043 -0.092 . . . . 1.52 110.772 179.879 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.688 ' CG ' HG23 ' A' ' 76' ' ' VAL . 15.5 Cg_exo -69.77 127.94 15.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.418 2.079 . . . . 0.44 112.731 -179.68 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -131.96 113.6 14.97 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.74 -0.664 . . . . 1.09 111.405 -179.491 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 71.5 Cg_exo -47.32 112.1 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.52 2.146 . . . . 0.64 113.193 -179.61 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -74.12 -35.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.736 -0.838 . . . . 1.64 108.736 179.174 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 22.9 t-20 -143.91 153.29 42.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.486 -1.234 . . . . 0.72 107.718 178.621 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.824 HG21 HG12 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -142.93 141.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.809 -0.756 . . . . 0.96 113.019 -178.793 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -139.94 136.44 33.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.21 -0.904 . . . . 1.46 109.863 179.263 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -42.68 -24.83 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.005 0.743 . . . . 2.42 113.005 -179.023 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -118.11 -12.98 9.96 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.744 -0.598 . . . . 1.02 112.517 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -153.46 125.6 7.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.246 -0.279 . . . . 0.68 110.246 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -118.64 145.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.8 111.81 -179.809 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.701 ' OG1' HG23 ' A' ' 62' ' ' THR . 9.0 m -111.36 127.72 55.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.04 -0.527 . . . . 0.35 111.072 -179.745 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.776 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.06 139.27 52.09 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.865 0.841 . . . . 0.52 111.355 178.769 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -121.67 155.49 35.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.124 -1.398 . . . . 1.84 108.973 179.632 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.538 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.6 p90 -152.55 -174.48 4.92 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.213 -0.595 . . . . 0.4 111.966 -179.729 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.77 168.2 10.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.052 -0.522 . . . . 0.83 112.046 -179.389 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -97.76 141.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.775 -0.648 . . . . 2.11 110.434 179.888 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HB2' HG23 ' A' ' 28' ' ' THR . 88.8 Cg_exo -47.38 176.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.346 2.031 . . . . 0.89 112.246 179.958 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -121.18 -29.54 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.418 -0.355 . . . . 2.77 111.799 -179.7 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 10.8 t80 -113.77 -71.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.986 0.365 . . . . 1.37 111.986 -179.376 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.981 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 47.7 p 50.48 43.92 27.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 0.91 110.985 -179.593 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.18 -91.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.814 -0.707 . . . . 1.01 112.49 179.89 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.27 32.6 1.04 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.637 -0.985 . . . . 0.98 110.637 179.561 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -112.08 175.14 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.007 -0.596 . . . . 0.87 111.147 -179.076 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 18.1 ttpt -126.17 -17.71 5.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.061 -0.518 . . . . 2.26 112.015 -179.799 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 35.9 mt 70.84 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.685 0.279 . . . . 1.71 110.713 -179.589 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -126.77 25.46 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 1.15 111.671 -179.619 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.6 t -178.75 127.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 1.58 111.259 179.903 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.547 ' O ' HD12 ' A' ' 56' ' ' ILE . 5.5 m-85 -114.36 95.46 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.76 111.172 -179.916 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.61 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.3 mt -87.32 112.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 1.14 111.003 -179.972 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -102.58 116.68 46.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.63 111.103 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -81.12 154.92 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 1.67 109.857 179.502 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 23.0 pttt -127.94 146.57 50.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.187 0.518 . . . . 1.97 111.494 -179.759 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 10.3 ttp180 -116.08 108.19 15.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 1.44 110.045 179.472 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.826 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.97 87.3 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.881 -0.6 . . . . 1.59 110.54 -179.836 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.605 HD11 ' OE1' ' A' ' 73' ' ' GLU . 33.1 mt -65.07 153.95 87.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.879 -179.88 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.62 24.49 20.2 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.846 -1.314 . . . . 1.43 112.976 0.386 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -154.8 70.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.781 0.324 . . . . 2.66 111.592 -179.936 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.41 -161.59 35.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.676 -0.773 . . . . 1.12 112.019 179.606 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -160.03 26.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.296 . . . . 2.41 111.166 -179.991 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 38.5 m95 42.71 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.544 179.828 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.463 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -132.27 130.41 40.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 1.28 111.202 -179.961 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HE3' HG21 ' A' ' 37' ' ' ILE . 3.3 ptmt -54.96 88.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 1.3 110.787 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.675 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -52.5 -54.59 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.86 110.907 179.979 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.663 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.4 p-10 -62.47 128.81 37.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.814 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.71 -2.36 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 2.08 111.714 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -168.8 1.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.815 0.341 . . . . 1.89 110.941 179.939 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.77 115.97 26.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 1.87 111.18 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.663 HD11 ' CB ' ' A' ' 52' ' ' ASN . 54.5 mt -99.27 60.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.59 179.711 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -43.38 -64.48 0.63 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.242 -0.435 . . . . 1.6 111.648 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -72.57 171.52 12.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 1.54 110.533 179.847 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.478 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -89.49 11.76 18.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.75 111.412 179.978 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -110.66 100.07 8.91 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 110.099 -0.334 . . . . 2.05 110.099 179.446 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CG ' HD13 ' A' ' 56' ' ' ILE . 61.3 t80 -131.66 164.75 25.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.139 0.495 . . . . 0.48 111.715 -179.465 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.701 HG23 ' OG1' ' A' ' 19' ' ' THR . 2.1 m -124.76 123.46 40.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.657 -0.702 . . . . 0.42 110.744 179.631 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.675 HG13 ' CB ' ' A' ' 51' ' ' ALA . 16.5 t -83.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.171 0.51 . . . . 1.08 111.189 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 134.98 36.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 1.33 110.701 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.09 -16.28 4.45 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.552 -0.749 . . . . 0.9 111.469 -179.295 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.857 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -51.38 172.16 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.805 0.335 . . . . 1.47 110.649 179.656 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.4 m -137.27 152.8 50.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.057 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 2.5 tt0 -61.1 155.49 20.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.91 111.197 179.943 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 97' ' ' CYS . 60.2 m-20 47.36 60.62 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 1.87 111.55 179.952 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.34 116.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.688 0.28 . . . . 0.49 111.375 179.646 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.66 125.4 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.677 -0.49 . . . . 0.36 109.677 179.234 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 44.1 m-85 -117.28 124.37 48.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.066 0.765 . . . . 0.56 113.066 -178.869 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.605 ' OE1' HD11 ' A' ' 43' ' ' LEU . 1.6 mt-10 -102.46 135.1 44.68 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.496 -0.928 . . . . 1.5 108.496 178.208 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 1.085 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.46 111.28 12.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.082 1.142 . . . . 0.6 114.082 -178.337 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.585 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 ptp180 -91.27 146.67 23.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 2.11 109.694 178.471 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.688 HG23 ' CG ' ' A' ' 8' ' ' PRO . 98.7 t -106.13 110.09 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.919 0.711 . . . . 0.6 112.919 -179.297 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' A' ' 39' ' ' GLU . 85.0 mt -106.59 154.54 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.805 -1.183 . . . . 0.7 107.805 177.991 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.63 120.87 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.203 -0.999 . . . . 0.6 113.145 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.8 ptpt -72.41 156.94 38.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.556 -0.535 . . . . 1.98 109.556 178.795 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.916 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -100.86 170.87 8.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.533 0.682 . . . . 2.19 112.406 -178.842 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.2 -58.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 1.08 112.112 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -12.94 17.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 1.06 112.296 -179.686 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 -14.61 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.536 -0.84 . . . . 0.93 112.176 -179.733 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -51.46 155.96 1.38 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 110.171 -0.307 . . . . 1.38 110.171 179.709 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -107.71 117.37 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.29 0.478 . . . . 0.79 112.29 -179.399 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.0 p -79.88 111.43 21.58 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.667 -0.697 . . . . 0.59 109.581 179.051 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.74 160.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.004 2.469 . . . . 0.85 112.932 -179.782 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' CB ' ' HD3' ' A' ' 75' ' ' ARG . 41.0 Cg_endo -68.77 134.79 31.08 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.675 2.25 . . . . 0.76 112.853 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 90' ' ' GLU . 19.8 m -90.84 111.07 22.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 1.28 109.919 179.28 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -4.12 108.33 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.717 1.207 . . . . 1.77 113.573 -179.677 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 84.3 Cg_exo -41.8 131.31 4.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.677 2.251 . . . . 0.55 113.712 -179.711 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.21 148.21 48.76 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.884 -0.598 . . . . 1.23 109.468 178.959 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -33.07 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.386 1.054 . . . . 1.63 112.409 -179.999 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.46 106.61 9.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.41 110.372 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.824 HG12 HG21 ' A' ' 13' ' ' ILE . 5.0 mp -85.69 108.66 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.743 0.306 . . . . 0.44 110.571 -179.923 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.9 m -42.53 -40.07 2.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.959 0.409 . . . . 0.44 111.027 179.956 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 15' ' ' ARG . 94.0 m 60.84 75.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.1 111.415 179.31 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -108.88 -79.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 3.0 110.109 179.605 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -126.03 0.22 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.703 -0.681 . . . . 2.14 111.314 179.471 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.463 0.193 0 N-CA-C 112.676 0.621 . . . . 2.06 112.676 179.629 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.573 HD12 ' HB1' ' A' ' 84' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.01 0.433 . . . . 0.68 111.854 . . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' ILE . 4.2 m-20 -134.56 127.24 18.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.0 110.127 179.69 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.26 163.08 38.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.239 1.959 . . . . 0.5 112.444 -179.714 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 37.0 Cg_exo -57.8 178.19 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.779 2.319 . . . . 0.71 112.782 -179.732 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.89 174.56 43.02 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.913 -0.66 . . . . 0.66 112.819 -179.988 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -68.63 130.66 91.78 Favored Pre-proline 0 N--CA 1.462 0.152 0 CA-C-N 116.64 0.22 . . . . 1.52 110.415 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HG3' HG12 ' A' ' 76' ' ' VAL . 17.0 Cg_exo -72.7 138.37 29.02 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.386 2.057 . . . . 0.44 113.124 -179.287 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.93 116.74 7.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.534 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.7 Cg_exo -58.91 138.36 85.21 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.546 2.164 . . . . 0.64 113.973 -179.207 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.605 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.3 mm? -104.17 -33.13 8.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.525 -0.761 . . . . 1.64 109.064 178.649 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -144.23 153.29 41.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.051 -0.977 . . . . 0.72 109.498 179.557 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.13 HG22 HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -148.62 108.68 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.124 0.487 . . . . 0.96 111.929 -179.549 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.092 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -105.41 53.04 0.72 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.679 -0.691 . . . . 1.46 111.212 -179.924 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 1.104 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.26 -73.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.98 0.8 . . . . 2.42 112.548 179.239 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' THR . 9.0 m-70 -70.64 -29.49 65.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.269 -0.423 . . . . 1.02 111.598 -179.349 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 64' ' ' SER . 62.3 p -128.78 126.2 39.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.759 0.314 . . . . 0.68 111.332 -179.815 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 13' ' ' ILE . 87.4 t -113.06 128.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.8 110.802 179.836 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 14.2 m -102.41 124.1 47.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.35 111.461 -179.392 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.815 HD11 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -137.14 162.09 34.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.535 0.683 . . . . 0.52 111.585 179.384 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.35 151.64 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.97 -1.014 . . . . 1.84 110.536 -179.635 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 11.1 p90 -136.88 -173.58 3.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.022 0.439 . . . . 0.4 111.463 -179.948 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.91 173.52 8.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.83 111.088 179.922 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 149.54 36.18 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.451 -0.34 . . . . 2.11 110.631 179.857 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.12 -162.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.938 2.426 . . . . 0.89 113.036 -179.652 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -146.37 -48.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.77 111.139 -179.67 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -95.03 -72.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.479 -0.328 . . . . 1.37 111.35 -179.846 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 p 69.39 -45.14 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.055 0.761 . . . . 0.91 113.055 -179.7 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.57 -22.32 10.16 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.269 -0.967 . . . . 1.01 112.302 -179.889 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.74 -26.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.496 -1.442 . . . . 0.98 109.496 -179.241 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 8.8 m-85 -60.9 -175.31 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.275 -0.963 . . . . 0.87 110.366 179.13 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 24.33 0.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.136 -0.484 . . . . 2.26 111.098 179.584 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 7.0 mt 42.97 98.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.136 0.493 . . . . 1.71 112.195 179.845 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' SER . 3.0 p -94.59 14.13 21.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 1.15 111.282 179.755 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' THR . 28.7 t 176.68 122.86 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.797 0.332 . . . . 1.58 111.568 -179.939 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.838 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.4 m-85 -106.86 117.28 33.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.76 110.226 179.502 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.613 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -97.28 135.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.654 -0.248 . . . . 1.14 110.959 -179.624 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 t -112.99 113.49 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.755 0.312 . . . . 0.63 111.249 179.84 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 5.3 mt-10 -87.57 127.52 35.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 1.67 110.158 179.474 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.893 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 3.9 pttm -106.56 147.31 29.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 1.97 111.724 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.3 ttp180 -129.13 117.48 20.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.59 -0.732 . . . . 1.44 110.428 179.455 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.947 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.77 123.92 25.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 1.59 110.178 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 94' ' ' ALA . 4.2 mt -113.99 150.23 43.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.9 111.479 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 8.8 Cg_endo -88.71 33.01 7.61 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.994 -1.253 . . . . 1.43 112.499 0.308 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.41 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 m-80 -154.17 98.82 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 2.66 110.852 -179.989 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.947 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . 177.28 -168.69 40.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.752 . . . . 1.12 112.179 -179.953 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -152.34 166.19 32.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.442 . . . . 2.41 111.37 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 73.2 m95 -68.47 120.12 14.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.574 -0.739 . . . . 0.65 111.894 -179.536 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.667 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -143.38 129.39 19.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 1.28 110.585 179.79 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.613 ' HD2' HG21 ' A' ' 37' ' ' ILE . 11.6 mtmm -50.54 92.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.3 110.805 -179.778 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.68 -52.76 62.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.86 110.871 179.893 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.73 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.6 p-10 -59.22 157.01 11.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.801 -0.636 . . . . 2.01 111.261 -179.891 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -165.52 28.81 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.702 -0.681 . . . . 2.08 110.716 179.558 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 p -128.71 36.56 4.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.459 -0.337 . . . . 1.89 111.234 -179.761 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.14 99.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.87 110.896 179.962 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.8 mt -90.63 93.7 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.503 . . . . 0.69 111.467 -179.842 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.9 tm? -76.83 -55.09 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.6 111.197 -179.974 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.05 173.11 12.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 1.54 110.511 179.871 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 35.1 p30 -84.66 -2.12 57.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.75 111.502 179.98 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -104.17 102.07 11.8 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.162 -0.31 . . . . 2.05 110.162 179.741 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 56' ' ' ILE . 44.8 t80 -135.22 164.85 26.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.286 -0.415 . . . . 0.48 111.329 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 93.1 m -121.04 114.09 20.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.978 -0.556 . . . . 0.42 111.529 -179.925 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.815 HG22 HD11 ' A' ' 20' ' ' LEU . 6.8 m -76.72 91.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.723 -0.671 . . . . 1.08 111.424 179.752 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.692 ' HB2' HG22 ' A' ' 17' ' ' THR . 13.9 p -93.01 178.73 5.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 1.33 110.896 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.9 10.89 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.806 -0.712 . . . . 0.9 112.478 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 ' CD1' HG23 ' A' ' 18' ' ' VAL . 15.3 mt -104.58 -161.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 1.47 111.168 -179.837 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -141.15 146.85 37.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.044 -0.525 . . . . 1.06 111.159 -179.892 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.14 149.19 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 1.91 110.916 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.36 43.97 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 1.87 110.733 -179.977 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -162.96 125.01 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.49 111.439 -179.833 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -67.4 137.24 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.36 110.256 179.521 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 36.0 m-85 -132.3 119.4 20.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.598 0.592 . . . . 0.56 112.598 -179.198 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -98.41 147.31 24.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.602 -0.888 . . . . 1.5 108.602 178.531 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.74 115.48 11.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.648 1.351 . . . . 0.6 114.648 -178.632 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 ptt85 -104.84 167.95 9.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 177.674 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -134.28 129.8 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 119.472 -0.891 . . . . 0.6 113.386 -179.654 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 86' ' ' SER . 76.5 mt -118.63 151.89 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.376 -1.284 . . . . 0.7 108.045 178.366 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -158.09 130.83 7.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.646 -0.822 . . . . 0.6 112.676 -179.543 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.18 63.88 8.26 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.566 0.698 . . . . 1.98 109.537 178.831 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 4.3 m-20 9.22 -104.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.302 -1.772 . . . . 2.19 114.201 -179.949 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.57 -44.68 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 122.014 -0.429 . . . . 1.08 111.859 -179.66 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.615 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -105.82 45.07 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.068 0.396 . . . . 1.06 112.068 -179.371 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.41 1.35 60.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.378 -0.915 . . . . 0.93 113.276 179.622 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.06 88.05 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.675 -0.491 . . . . 1.38 109.675 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.35 112.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.399 0.618 . . . . 0.79 112.516 -178.824 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' ILE . 49.5 p -85.55 111.7 39.01 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.941 -1.027 . . . . 0.59 108.973 178.958 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.4 Cg_exo -38.32 157.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.9 2.4 . . . . 0.85 112.879 -179.053 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' CA ' HG12 ' A' ' 77' ' ' ILE . 18.4 Cg_endo -60.66 132.06 40.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.803 2.335 . . . . 0.76 113.081 -179.709 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -89.02 108.27 19.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.411 -0.813 . . . . 1.28 109.498 179.155 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -6.24 120.93 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.803 1.314 . . . . 1.77 113.674 -179.492 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 50.4 Cg_exo -54.58 143.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.383 2.056 . . . . 0.55 113.307 -179.695 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.75 146.77 35.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.509 ' O ' HD12 ' A' ' 95' ' ' ILE . 4.1 m-20 -33.41 131.23 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.175 0.922 . . . . 1.63 112.238 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -70.67 116.53 11.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.41 111.232 -179.843 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -99.86 120.15 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.44 111.16 179.959 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.5 m -46.99 -36.51 7.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.44 111.127 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 60.39 88.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.1 110.498 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 -81.94 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 3.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.5 OUTLIER -108.25 5.99 26.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.825 -0.625 . . . . 2.14 111.325 179.751 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 1.104 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 121.23 0.538 . . . . 2.06 112.225 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.76 0.314 . . . . 2.74 111.183 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -92.64 -166.93 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.054 2.503 . . . . 2.06 112.488 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.736 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.7 tt -148.47 144.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.68 110.982 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.17 120.11 25.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 2.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 159.24 54.07 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.141 1.894 . . . . 0.5 111.696 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.8 Cg_endo -52.43 172.93 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.71 112.502 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 164.8 52.63 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.999 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.91 123.92 61.78 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.463 -0.199 . . . . 1.52 110.463 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.589 ' CG ' HG23 ' A' ' 76' ' ' VAL . 21.7 Cg_exo -67.3 133.89 31.87 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.345 2.03 . . . . 0.44 112.713 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.3 p -131.47 117.54 16.66 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.006 -0.543 . . . . 1.09 110.794 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.9 Cg_exo -67.66 125.99 14.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.464 2.109 . . . . 0.64 113.801 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.22 -31.84 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -142.48 145.82 34.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.075 -0.966 . . . . 0.72 109.48 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 96.36 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.166 0.508 . . . . 0.96 111.573 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.54 156.58 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 1.46 110.814 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -50.67 -22.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 2.42 112.043 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -139.06 12.18 2.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.254 0.464 . . . . 1.02 112.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.85 106.32 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.68 111.326 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 13' ' ' ILE . 96.0 t -100.59 117.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 0.8 110.629 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.699 ' C ' HD13 ' A' ' 20' ' ' LEU . 18.1 m -98.33 125.05 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.802 -0.636 . . . . 0.35 111.632 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.47 154.75 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.821 0.82 . . . . 0.52 112.163 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.61 164.39 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.369 -1.287 . . . . 1.84 109.11 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 7.0 p90 -141.98 -175.14 4.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.165 0.507 . . . . 0.4 112.117 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.94 128.38 47.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.83 110.895 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -59.46 146.68 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 2.11 110.815 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.542 ' HG2' HD12 ' A' ' 33' ' ' ILE . 53.4 Cg_exo -52.47 171.39 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.89 112.682 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.67 -18.49 6.57 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 2.77 112.137 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -127.17 -71.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 121.003 -0.279 . . . . 1.37 111.581 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.4 p 55.88 47.37 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.91 110.987 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.14 0.01 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.889 -0.672 . . . . 1.01 112.515 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.19 38.03 1.2 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 109.796 -1.322 . . . . 0.98 109.796 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -126.29 -179.53 4.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.685 -0.758 . . . . 0.87 111.033 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -133.66 -1.07 3.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.302 0.482 . . . . 2.26 112.302 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 25' ' ' PRO . 19.9 mt 61.98 132.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.785 0.326 . . . . 1.71 110.952 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.429 HG22 ' HD2' ' A' ' 32' ' ' LYS . 4.1 p -128.63 39.75 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.15 111.193 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.9 t 172.29 134.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 1.58 110.658 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -122.94 83.82 2.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.76 111.313 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.469 HG23 HD21 ' A' ' 52' ' ' ASN . 0.8 OUTLIER -74.56 162.7 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 1.14 110.417 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -150.75 126.51 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.63 110.474 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' HD12 ' A' ' 77' ' ' ILE . 3.7 mt-10 -93.62 137.67 32.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 1.67 110.949 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -107.06 141.54 38.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.889 -0.596 . . . . 1.97 110.839 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -110.97 116.66 31.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.44 110.69 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -84.67 87.39 7.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.809 -0.632 . . . . 1.59 110.025 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 4.3 mt -75.33 154.42 86.05 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.084 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -89.33 34.02 7.12 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.862 -1.308 . . . . 1.43 113.044 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -155.02 64.06 0.64 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.303 . . . . 2.66 111.288 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.01 -163.2 22.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.887 -0.673 . . . . 1.12 112.446 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -170.86 30.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.677 0.251 . . . . 2.41 111.677 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.553 ' CE3' ' CD ' ' A' ' 75' ' ' ARG . 48.8 m95 52.49 109.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.925 0.342 . . . . 0.65 111.925 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.706 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -137.7 117.38 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.28 111.244 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -53.31 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 1.3 110.874 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -65.78 -55.11 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.193 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 p-10 -50.84 149.02 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 2.01 111.215 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.36 24.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 2.08 110.786 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 m -122.52 25.7 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 1.89 111.153 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.36 106.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 1.87 110.648 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 73.3 mt -97.28 84.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.474 . . . . 0.69 110.774 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.9 -40.1 65.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 1.6 111.563 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 139.92 30.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.527 -0.306 . . . . 1.54 110.225 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 27.5 p-10 -72.63 62.64 0.56 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.248 0.547 . . . . 1.75 111.19 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE2' ' CB ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -166.81 91.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 2.05 108.872 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.0 t80 -126.95 165.13 19.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.176 0.512 . . . . 0.48 111.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.671 HG23 ' OG1' ' A' ' 19' ' ' THR . 4.2 m -123.93 121.14 34.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.505 -0.771 . . . . 0.42 110.76 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.0 t -86.35 105.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.19 0.519 . . . . 1.08 111.43 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 p -99.18 -157.17 0.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 1.33 110.73 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.65 17.75 42.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.9 112.42 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' CD1' HG23 ' A' ' 18' ' ' VAL . 17.7 mt -81.68 -163.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.36 . . . . 1.47 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -144.52 154.82 43.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.996 -0.547 . . . . 1.06 110.567 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 157.96 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 1.91 110.765 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t0 51.87 50.3 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 1.87 110.746 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -156.83 124.58 5.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.49 111.245 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.72 124.39 26.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.391 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 58.8 m-85 -123.96 129.57 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.078 0.466 . . . . 0.56 111.897 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 7.6 tt0 -104.15 150.18 24.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.956 -0.757 . . . . 1.5 108.956 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.844 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -141.21 119.65 12.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.893 1.442 . . . . 0.6 114.893 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -106.41 161.74 14.31 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.223 -0.658 . . . . 2.11 109.223 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' CG ' ' A' ' 8' ' ' PRO . 85.0 t -117.21 109.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.054 -0.658 . . . . 0.6 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 87.0 mt -97.15 139.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.619 -1.252 . . . . 0.7 107.619 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -155.05 140.68 17.97 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.572 -0.851 . . . . 0.6 112.691 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 mttt -86.53 -174.63 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.449 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.736 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.6 p30 -130.36 162.66 28.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 2.19 110.761 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.18 -26.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.08 112.22 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.93 -18.68 42.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.554 0.576 . . . . 1.06 112.554 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.27 -20.43 25.78 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.407 -0.901 . . . . 0.93 112.033 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.68 166.68 0.64 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.828 -0.434 . . . . 1.38 109.828 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -117.56 103.39 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.563 0.579 . . . . 0.79 112.563 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 1.2 p -63.03 122.46 75.26 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 108.962 -0.755 . . . . 0.59 108.962 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.9 Cg_endo -42.54 162.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.016 2.477 . . . . 0.85 113.098 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 33.6 Cg_endo -64.1 135.62 48.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.826 2.351 . . . . 0.76 112.747 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -78.35 124.84 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.91 -0.586 . . . . 1.28 109.555 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 4.6 mt-10 -24.85 99.59 0.08 OUTLIER Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 123.732 0.813 . . . . 1.77 113.074 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 93.7 Cg_exo -32.35 154.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.425 2.75 . . . . 0.55 114.02 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -94.07 143.85 26.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.419 -0.809 . . . . 1.23 109.388 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 58.3 m-20 -34.27 138.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.217 0.948 . . . . 1.63 111.916 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 43' ' ' LEU . . . -75.16 117.51 17.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.41 111.339 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.742 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.1 mp -102.58 122.88 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.241 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.6 m -51.51 -25.03 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 0.44 111.248 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.742 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.7 m 57.75 49.06 12.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 1.1 110.204 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.893 ' O ' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -146.82 -39.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.693 -0.685 . . . . 3.0 111.603 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -46.21 -26.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 2.14 111.73 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -6.09 38.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 2.06 111.92 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.893 HG12 ' O ' ' A' ' 98' ' ' ARG . 11.4 p -119.98 -1.21 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 2.8 110.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 103' ' ' ALA . 1.9 pp20? -140.58 -50.13 0.45 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.865 -0.334 . . . . 4.58 111.297 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.221 -0.895 . . . . 3.79 111.154 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.669 0.271 . . . . 2.74 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.91 -159.03 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.128 2.552 . . . . 2.06 111.883 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.889 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -170.01 145.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.68 111.002 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.1 t0 -128.65 128.44 23.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.333 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 66.6 Cg_endo -71.22 157.33 57.49 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.317 2.011 . . . . 0.5 112.633 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 51.0 Cg_exo -54.63 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.71 112.34 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.17 -153.9 5.85 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.954 -0.641 . . . . 0.66 112.753 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.7 ttpt -95.13 141.28 23.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.697 -0.112 . . . . 1.52 110.697 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.8 Cg_endo -86.79 143.89 7.25 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.071 2.514 . . . . 0.44 112.285 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -159.48 125.07 2.3 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.685 -0.234 . . . . 1.09 111.577 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.613 ' CG ' HD11 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -70.92 97.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.235 1.957 . . . . 0.64 112.714 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.7 mp -60.62 -30.4 69.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.228 0.537 . . . . 1.64 109.982 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -146.73 157.33 43.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.342 -0.844 . . . . 0.72 109.443 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -143.39 105.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.103 0.478 . . . . 0.96 111.415 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -91.62 47.71 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.74 -0.663 . . . . 1.46 111.652 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.51 -73.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.876 0.735 . . . . 2.42 112.07 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' THR . 16.0 m170 -81.35 -31.83 33.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 1.02 111.718 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -125.2 105.21 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.717 0.294 . . . . 0.68 110.832 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.92 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 6.6 m -92.02 156.22 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.44 -0.346 . . . . 0.8 110.713 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.6 m -123.76 113.03 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.708 -0.223 . . . . 0.35 111.594 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -127.06 149.31 49.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.52 111.265 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.309 ' CB ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -138.49 166.25 24.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.716 -1.129 . . . . 1.84 109.847 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.512 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 8.8 p90 -141.42 -122.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.372 -0.377 . . . . 0.4 110.852 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.53 136.47 10.53 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.499 0.59 . . . . 0.83 111.174 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -51.8 140.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.55 -0.295 . . . . 2.11 110.631 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.672 ' HB2' HG23 ' A' ' 28' ' ' THR . 6.7 Cg_endo -48.93 -174.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.932 2.422 . . . . 0.89 112.473 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -120.88 -34.08 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -115.78 -69.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.317 0.488 . . . . 1.37 112.317 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 25' ' ' PRO . 32.2 p 53.65 30.16 10.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.91 110.068 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.96 -101.39 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.643 -0.789 . . . . 1.01 111.928 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.41 30.96 2.73 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.633 -0.987 . . . . 0.98 110.633 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -110.9 -171.62 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.065 -0.567 . . . . 0.87 111.541 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -139.94 21.8 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.769 -0.651 . . . . 2.26 111.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.061 HG21 ' CE1' ' A' ' 36' ' ' TYR . 15.8 mm 67.45 -69.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 1.71 110.878 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.612 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 75.97 9.66 3.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.945 -0.57 . . . . 1.15 112.402 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.5 t 168.16 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.765 0.317 . . . . 1.58 111.686 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.061 ' CE1' HG21 ' A' ' 33' ' ' ILE . 38.4 m-85 -120.26 95.09 4.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.76 110.554 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.4 mt -70.13 152.12 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.409 -0.36 . . . . 1.14 111.347 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.2 t -124.63 104.43 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.63 111.27 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 1.058 ' CD ' ' HB3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -76.43 115.44 16.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 1.67 110.168 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.469 ' HD3' ' CG1' ' A' ' 63' ' ' VAL . 5.5 mtmt -93.32 149.74 21.0 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.469 0.652 . . . . 1.97 112.484 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 8.2 ttm180 -135.02 86.18 2.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.92 -1.036 . . . . 1.44 108.969 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -64.69 87.94 0.06 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.62 -0.718 . . . . 1.59 109.703 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -67.95 146.56 98.31 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.976 -0.556 . . . . 0.9 111.517 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.89 39.43 4.52 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.854 -1.311 . . . . 1.43 112.34 0.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -144.72 43.02 1.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 2.66 111.597 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.03 -176.7 46.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.632 -0.794 . . . . 1.12 112.339 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -167.88 30.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.641 0.258 . . . . 2.41 111.167 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 1.058 ' HB3' ' CD ' ' A' ' 39' ' ' GLU . 24.5 m95 46.99 87.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.65 111.192 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.61 135.98 49.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.998 0.428 . . . . 1.28 111.487 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 15.9 ptmt -65.19 79.32 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 1.3 111.023 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -65.7 -43.82 88.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.555 . . . . 0.86 111.87 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.9 p-10 -42.02 -56.6 2.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.64 -0.255 . . . . 2.01 111.591 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER 75.21 -49.94 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.984 0.364 . . . . 2.08 111.984 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -173.7 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.954 0.407 . . . . 1.89 111.193 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.37 107.0 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.949 -0.569 . . . . 1.87 111.339 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 36' ' ' TYR . 29.4 mt -86.35 87.84 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.69 110.919 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.7 mt -74.23 -45.15 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 1.6 111.438 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.49 149.66 22.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.99 -0.374 . . . . 1.54 109.99 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.1 p30 -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 1.75 111.302 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.309 ' OE1' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tp10 -101.35 93.92 5.66 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.929 -0.767 . . . . 2.05 108.929 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 62' ' ' THR . 66.3 t80 -118.6 164.76 14.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.974 -0.557 . . . . 0.48 111.805 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 84.2 m -121.94 119.53 31.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.42 110.564 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 20' ' ' LEU . 57.8 t -80.76 125.61 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 1.08 111.724 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -119.8 163.33 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 1.33 110.558 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.18 57.72 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.9 112.138 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.811 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.0 mp -53.0 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.808 0.337 . . . . 1.47 110.313 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.9 m -143.77 152.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.41 . . . . 1.06 110.57 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -69.01 151.77 46.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 1.91 111.181 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.5 OUTLIER 54.7 51.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.149 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.77 122.6 3.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.49 111.332 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.86 134.76 47.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.383 -0.371 . . . . 0.36 110.335 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.9 m-85 -128.26 119.79 25.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.782 0.66 . . . . 0.56 112.782 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 91' ' ' PRO . 1.3 tt0 -106.38 136.63 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.261 -0.644 . . . . 1.5 109.261 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.77 119.39 19.21 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.414 1.264 . . . . 0.6 114.414 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -95.97 162.92 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 2.11 109.907 178.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 8' ' ' PRO . 61.8 t -113.95 128.56 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.243 0.544 . . . . 0.6 112.206 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.593 HD11 ' HG3' ' A' ' 88' ' ' PRO . 34.4 mt -130.74 141.42 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.578 -1.267 . . . . 0.7 107.578 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -157.09 127.28 6.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.81 -0.756 . . . . 0.6 112.763 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.6 mttt -75.64 -157.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.687 -0.405 . . . . 1.98 110.072 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.889 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.7 p30 -159.26 162.99 36.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 2.19 111.515 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -38.54 -43.79 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.323 -0.853 . . . . 1.08 112.816 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -66.14 -23.94 66.57 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.133 0.42 . . . . 1.06 112.133 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.9 -8.19 36.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.698 -0.763 . . . . 0.93 112.208 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.631 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -56.8 -164.23 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.667 0.234 . . . . 1.38 110.377 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.681 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -148.7 111.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.382 0.512 . . . . 0.79 112.382 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.6 p -70.84 110.73 7.71 Favored Pre-proline 0 C--O 1.235 0.337 0 N-CA-C 107.233 -1.395 . . . . 0.59 107.233 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.38 171.9 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.499 2.133 . . . . 0.85 113.816 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.593 ' HG3' HD11 ' A' ' 77' ' ' ILE . 76.5 Cg_exo -50.42 145.0 22.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.338 2.692 . . . . 0.76 113.594 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -125.19 102.42 7.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 1.28 110.729 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.0 mm-40 12.63 108.64 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.737 1.215 . . . . 1.77 113.881 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 51.6 Cg_exo -56.05 143.67 82.54 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.437 2.092 . . . . 0.55 113.272 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.473 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -70.55 139.26 51.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.874 -0.787 . . . . 1.23 108.874 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -37.14 133.9 0.61 Allowed 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 124.254 0.971 . . . . 1.63 111.517 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.85 118.56 8.54 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.41 111.144 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.893 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -98.11 111.15 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.677 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -49.36 -25.83 2.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.319 -0.4 . . . . 0.44 110.595 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.548 ' H ' HG22 ' A' ' 95' ' ' ILE . 99.6 m 49.02 81.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 1.1 110.845 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 -85.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.35 . . . . 3.0 110.593 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.864 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.2 p-10 -108.58 17.83 21.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.039 -0.528 . . . . 2.14 110.879 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 3.7 p-10 47.18 26.55 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.061 0.458 . . . . 2.06 111.251 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 99' ' ' ASP . 67.2 t -119.77 -19.44 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 2.8 111.079 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 44.42 82.37 0.03 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 4.58 111.607 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.161 -0.923 . . . . 3.79 111.02 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.748 0.309 . . . . 2.74 111.055 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -90.33 69.32 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.831 2.354 . . . . 2.06 112.338 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 86' ' ' SER . 5.5 tt -50.22 149.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.68 110.741 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.7 t70 -138.59 119.87 10.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.0 -0.545 . . . . 2.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.51 163.04 40.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.245 1.963 . . . . 0.5 112.014 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 40.5 Cg_exo -57.71 -169.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.701 2.268 . . . . 0.71 112.75 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.56 -177.19 50.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.87 -0.681 . . . . 0.66 112.685 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.9 tttt -73.35 133.65 80.56 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.277 0.085 . . . . 1.52 110.962 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.6 Cg_exo -76.81 130.61 11.61 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.688 2.259 . . . . 0.44 112.071 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.02 105.97 6.2 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.545 -0.298 . . . . 1.09 111.759 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.2 Cg_exo -44.28 131.31 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.206 1.937 . . . . 0.64 112.794 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.011 HD21 ' CB ' ' A' ' 21' ' ' LYS . 1.6 mt -90.27 -31.78 16.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.239 -1.023 . . . . 1.64 108.239 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -149.7 160.82 43.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 0.72 108.35 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.881 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.39 97.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.569 -0.453 . . . . 0.96 111.598 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -87.56 49.11 1.75 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.723 -0.671 . . . . 1.46 111.708 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.76 -74.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.874 0.734 . . . . 2.42 112.335 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.5 m-70 -72.2 -39.52 68.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.365 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 44.8 p -125.71 118.05 24.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.37 . . . . 0.68 110.163 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.01 HG13 HD12 ' A' ' 66' ' ' LEU . 5.9 m -107.61 135.96 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.442 0.639 . . . . 0.8 112.368 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.531 ' N ' HG23 ' A' ' 62' ' ' THR . 23.0 m -90.59 144.16 26.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.35 109.771 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.761 HD11 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.52 158.95 44.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.52 111.586 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.011 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -150.82 146.36 26.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.543 -0.753 . . . . 1.84 110.792 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.518 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.0 p90 -136.18 -176.24 4.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.4 111.064 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.7 155.9 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.83 110.973 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 150.83 80.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.11 110.699 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HG2' HD12 ' A' ' 33' ' ' ILE . 92.1 Cg_exo -43.94 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.969 2.446 . . . . 0.89 113.236 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -22.38 8.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.01 -0.541 . . . . 2.77 111.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.79 -65.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.059 0.392 . . . . 1.37 112.059 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 14.9 p 57.73 46.07 17.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.91 110.155 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.51 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.6 -0.809 . . . . 1.01 111.828 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.17 25.71 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.902 -0.879 . . . . 0.98 110.902 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -103.68 -176.88 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.87 111.641 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.54 1.0 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 2.26 111.792 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.669 HG21 ' CE1' ' A' ' 36' ' ' TYR . 22.9 mt 60.26 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.125 0.488 . . . . 1.71 110.952 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -140.34 23.69 2.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 1.15 111.711 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.33 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.741 0.645 . . . . 1.58 112.741 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 33' ' ' ILE . 24.0 m-85 -105.3 85.91 2.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.031 -0.729 . . . . 0.76 109.031 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.485 HG23 HD21 ' A' ' 52' ' ' ASN . 0.4 OUTLIER -80.98 120.87 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 1.14 111.266 -179.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -112.04 129.21 67.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.06 -0.518 . . . . 0.63 110.681 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -90.43 136.25 33.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.303 -0.408 . . . . 1.67 111.17 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 3.8 pttt -98.6 150.12 22.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.989 -0.55 . . . . 1.97 110.585 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 6.5 ttp180 -134.69 109.03 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.388 -0.369 . . . . 1.44 110.888 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -78.59 101.2 7.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 1.59 110.608 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 94' ' ' ALA . 3.8 mt -88.27 153.41 51.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.9 111.062 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.35 17.33 42.28 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.793 -1.336 . . . . 1.43 112.739 0.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -138.21 81.01 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.931 0.396 . . . . 2.66 111.189 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.91 -167.3 19.44 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.898 -0.668 . . . . 1.12 112.258 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.75 159.06 37.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 2.41 110.945 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.794 ' O ' HD22 ' A' ' 49' ' ' LEU . 64.8 m95 -65.01 122.17 16.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.793 -0.639 . . . . 0.65 111.166 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -150.68 140.63 21.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.439 . . . . 1.28 110.635 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -44.09 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.363 -0.38 . . . . 1.3 111.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 40' ' ' LYS . . . -70.81 -40.89 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.86 110.889 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.637 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.4 p-10 -68.8 -44.34 73.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.842 -0.617 . . . . 2.01 111.287 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 54.85 22.63 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 2.08 110.706 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -136.42 -157.01 0.75 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 1.89 110.724 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.92 88.55 2.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.746 0.308 . . . . 1.87 111.163 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.81 HD12 ' CD1' ' A' ' 61' ' ' PHE . 16.4 mm -70.39 63.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.69 110.731 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.86 -56.78 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 1.6 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.622 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -87.13 159.73 18.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 1.54 109.409 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.9 p30 -77.98 1.45 20.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.155 0.428 . . . . 1.75 112.155 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.43 95.18 6.31 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.902 -0.407 . . . . 2.05 109.902 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CD1' HD12 ' A' ' 56' ' ' ILE . 80.8 t80 -130.99 162.82 28.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.391 0.615 . . . . 0.48 111.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.69 HG23 ' C ' ' A' ' 18' ' ' VAL . 89.9 m -129.69 122.42 28.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.844 -1.071 . . . . 0.42 108.803 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 18' ' ' VAL . 33.5 m -80.18 108.97 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.204 0.526 . . . . 1.08 111.832 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -98.63 135.26 40.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.522 -0.763 . . . . 1.33 110.436 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.55 -8.44 7.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.586 -0.816 . . . . 0.9 112.681 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.01 HD12 HG13 ' A' ' 18' ' ' VAL . 33.6 mt -57.88 -162.29 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.847 0.323 . . . . 1.47 110.146 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -148.02 160.68 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.857 0.36 . . . . 1.06 111.222 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 tt0 -83.82 144.5 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 1.91 110.975 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' CYS . 23.8 t0 63.97 59.13 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 1.87 110.862 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.76 124.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.49 111.429 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.65 129.84 40.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.401 . . . . 0.36 110.31 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 50.7 m-85 -123.96 118.81 27.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.56 112.103 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -101.95 139.47 37.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.234 -0.654 . . . . 1.5 109.234 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.94 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.4 122.62 19.28 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.147 1.166 . . . . 0.6 114.147 -179.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.821 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.73 152.4 19.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.02 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' CG ' ' A' ' 8' ' ' PRO . 97.2 t -111.44 101.57 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.589 0.589 . . . . 0.6 112.589 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 85' ' ' ILE . 53.3 mt -98.55 155.36 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.629 -1.248 . . . . 0.7 107.629 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.19 137.67 2.48 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.898 -1.121 . . . . 0.6 113.253 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.4 mttt -78.39 -159.3 0.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 1.98 109.482 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.737 HD21 ' HB3' ' A' ' 84' ' ' ALA . 33.1 p30 -139.5 -130.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.79 -0.448 . . . . 2.19 109.79 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -110.83 -7.66 14.59 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.402 0.546 . . . . 1.08 111.12 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.66 3.56 22.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.865 0.32 . . . . 1.06 111.865 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.95 50.94 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.4 -0.905 . . . . 0.93 112.77 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -58.68 126.41 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.35 . . . . 1.38 110.426 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 79' ' ' LYS . 3.2 tp -85.87 110.9 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.247 -0.433 . . . . 0.79 111.669 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.554 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 p -68.52 124.71 90.61 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 109.393 -0.595 . . . . 0.59 109.393 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -37.68 162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.252 2.634 . . . . 0.85 113.206 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . 7.4 Cg_exo -71.79 145.96 47.15 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.699 2.266 . . . . 0.76 112.724 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 90' ' ' GLU . 12.4 m -99.05 106.33 18.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.555 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.4 mt-10 -1.46 107.27 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.828 1.251 . . . . 1.77 114.017 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 92.4 Cg_exo -38.49 149.2 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.782 2.321 . . . . 0.55 113.145 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.89 137.32 33.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.697 -0.853 . . . . 1.23 108.697 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -37.13 129.83 0.88 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.155 0.909 . . . . 1.63 111.805 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.22 119.12 7.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 0.41 110.963 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 13' ' ' ILE . 4.2 mp -97.56 111.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.44 110.473 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.1 m -45.68 -29.73 1.35 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.294 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.455 ' H ' HG22 ' A' ' 95' ' ' ILE . 63.0 m 48.05 70.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.1 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 1.3 ptp180 -103.29 -99.56 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.459 -0.337 . . . . 3.0 111.268 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 2.5 p30 -97.82 20.66 11.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 2.14 111.008 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 38.3 t0 54.12 21.56 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 2.06 111.156 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 101' ' ' VAL . 7.6 p -125.9 -7.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 2.8 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.952 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 43.85 32.18 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.923 0.392 . . . . 4.58 111.588 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.203 -0.903 . . . . 3.79 111.087 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.562 0.22 . . . . 2.74 111.425 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.49 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 59.6 Cg_endo -91.37 -165.6 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.884 2.389 . . . . 2.06 112.373 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.684 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.4 tt -165.65 151.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.68 110.412 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.7 m-20 -136.93 126.17 15.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.826 -0.35 . . . . 2.0 111.92 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 33.2 Cg_exo -58.61 171.79 1.79 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.563 2.175 . . . . 0.5 112.015 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 52.4 Cg_endo -69.09 -178.6 2.16 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.59 2.193 . . . . 0.71 112.36 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.78 174.35 54.82 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.897 -0.668 . . . . 0.66 112.585 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.6 tptm -61.83 119.06 44.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 110.707 -0.109 . . . . 1.52 110.707 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' CG ' HG23 ' A' ' 76' ' ' VAL . 12.6 Cg_exo -70.4 146.47 56.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.161 . . . . 0.44 112.453 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -143.51 112.78 5.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.015 -0.539 . . . . 1.09 111.4 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.721 ' HG2' HD11 ' A' ' 95' ' ' ILE . 34.3 Cg_exo -62.69 107.93 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.727 2.285 . . . . 0.64 113.876 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -62.68 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.658 -0.867 . . . . 1.64 108.658 178.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -132.79 151.16 52.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.439 -1.255 . . . . 0.72 108.514 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -141.91 99.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.091 -0.644 . . . . 0.96 112.266 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -90.04 134.66 34.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 1.46 110.301 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -33.88 -30.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.867 1.062 . . . . 2.42 113.867 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 5.0 m-70 -116.51 -24.16 7.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.663 0.616 . . . . 1.02 112.663 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 75.0 p -136.54 132.32 35.06 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.747 -0.464 . . . . 0.68 109.747 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.129 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -123.28 142.78 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.886 -0.726 . . . . 0.8 112.453 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.615 ' C ' HD13 ' A' ' 20' ' ' LEU . 54.0 m -103.87 124.63 49.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.35 111.994 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.771 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.2 151.56 50.75 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 121.687 0.755 . . . . 0.52 111.744 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.606 ' HB3' HD11 ' A' ' 11' ' ' LEU . 15.8 tptm -134.43 153.64 51.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.508 -1.224 . . . . 1.84 109.702 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 22.8 p90 -143.1 -176.35 4.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.266 0.555 . . . . 0.4 112.182 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.4 -159.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.83 110.953 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -128.13 141.66 41.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 2.11 110.094 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.895 ' HG2' HD11 ' A' ' 33' ' ' ILE . 84.1 Cg_exo -42.65 168.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.228 1.952 . . . . 0.89 112.222 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -107.89 -30.3 8.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 2.77 111.724 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 1' ' ' PRO . 8.7 t80 -119.24 -69.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.854 0.316 . . . . 1.37 111.854 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 25' ' ' PRO . 18.6 p 50.92 45.34 27.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 0.91 110.444 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.4 -93.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.068 -0.587 . . . . 1.01 112.683 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.28 36.18 0.7 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.515 -1.034 . . . . 0.98 110.515 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.85 -172.81 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.908 -0.646 . . . . 0.87 111.577 -178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.02 23.03 4.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 2.26 112.132 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.895 HD11 ' HG2' ' A' ' 25' ' ' PRO . 45.5 mm 68.82 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 111.903 0.334 . . . . 1.71 111.903 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.632 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.7 p 87.67 -16.93 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.128 0.571 . . . . 1.15 112.34 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 34.3 t 177.86 169.44 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.848 0.356 . . . . 1.58 111.861 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 54.1 m-85 -140.19 105.12 4.97 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 116.075 -0.511 . . . . 0.76 111.403 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.493 HG21 ' HD3' ' A' ' 50' ' ' LYS . 4.9 mt -89.37 91.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.038 -0.528 . . . . 1.14 110.839 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -82.76 123.39 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.022 0.439 . . . . 0.63 110.748 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 77' ' ' ILE . 14.7 mt-10 -97.83 156.68 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.699 . . . . 1.67 111.345 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.16 139.74 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 1.97 110.62 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HD3' HD23 ' A' ' 43' ' ' LEU . 2.4 ttm180 -121.02 113.68 20.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.181 -0.463 . . . . 1.44 110.568 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.542 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -71.48 86.93 0.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 1.59 109.654 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -70.35 142.39 89.47 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.949 -0.569 . . . . 0.9 110.759 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.96 47.85 1.94 Allowed 'Cis proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.182 -1.174 . . . . 1.43 112.869 0.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.58 60.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.679 0.276 . . . . 2.66 111.546 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -114.79 -177.48 18.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.636 -0.792 . . . . 1.12 112.325 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.6 24.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 2.41 111.123 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 54.0 m95 51.77 95.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.65 111.332 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.456 HD13 ' HG2' ' A' ' 47' ' ' ARG . 1.2 mp -118.23 137.7 52.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 1.28 110.328 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HD3' HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -45.3 93.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 1.3 111.689 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -70.09 -40.52 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.86 110.306 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -63.66 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.01 110.481 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 68.96 41.08 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 2.08 110.803 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 t -154.37 -72.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.993 -0.549 . . . . 1.89 110.972 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.1 t30 175.48 136.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.87 110.659 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 52' ' ' ASN . 8.1 mt -140.69 79.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.69 110.967 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 57' ' ' LEU . 8.5 tp -68.62 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.6 110.825 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.59 169.66 17.86 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.305 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -80.67 -2.0 44.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.293 -0.412 . . . . 1.75 111.672 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.87 102.55 13.62 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.853 0.358 . . . . 2.05 110.33 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.688 ' HB2' HG23 ' A' ' 56' ' ' ILE . 66.5 t80 -139.02 164.05 30.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.48 111.872 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 54.0 m -127.12 128.43 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.451 -0.795 . . . . 0.42 109.795 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 18' ' ' VAL . 29.7 m -91.62 128.7 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 120.221 -0.591 . . . . 1.08 112.168 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -110.81 127.01 55.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.546 -0.752 . . . . 1.33 109.821 179.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.72 -13.04 1.97 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.521 -0.847 . . . . 0.9 112.59 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.129 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -52.08 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.013 0.435 . . . . 1.47 110.553 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -152.53 157.07 40.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 1.06 110.601 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 4.4 mt-10 -76.76 143.76 39.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 1.91 110.675 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 65.87 38.04 5.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.214 -0.448 . . . . 1.87 110.929 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -151.41 117.3 5.5 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.565 -0.289 . . . . 0.49 111.731 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -75.25 121.31 21.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.655 -0.498 . . . . 0.36 109.655 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 75.7 m-85 -116.15 131.77 56.85 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.56 112.696 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.775 ' HB2' HD11 ' A' ' 43' ' ' LEU . 1.2 tt0 -105.83 142.46 35.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.239 -1.022 . . . . 1.5 108.239 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -126.92 114.98 18.58 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.247 1.203 . . . . 0.6 114.247 -178.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -93.5 144.87 24.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.313 -0.858 . . . . 2.11 110.229 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' CG ' ' A' ' 8' ' ' PRO . 52.9 t -106.7 119.77 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.6 112.368 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.71 HD11 ' HD3' ' A' ' 88' ' ' PRO . 5.9 mt -110.1 165.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.978 -1.119 . . . . 0.7 107.978 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -179.3 130.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.965 -0.694 . . . . 0.6 112.345 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.4 pttm -81.26 -158.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.969 -0.752 . . . . 1.98 108.969 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.684 ' ND2' HD11 ' A' ' 2' ' ' ILE . 17.6 m-80 -155.78 167.62 29.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 2.19 112.029 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.26 -53.25 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 1.08 111.864 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.32 -5.84 25.76 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.313 0.486 . . . . 1.06 112.313 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.94 63.31 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.39 -0.91 . . . . 0.93 112.714 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 124.84 22.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 1.38 110.157 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -92.4 110.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.649 0.611 . . . . 0.79 112.649 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 4.5 p -74.89 120.28 80.84 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 88.3 Cg_endo -70.95 172.97 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.574 2.182 . . . . 0.85 112.961 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HD3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -36.93 121.56 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.395 2.73 . . . . 0.76 112.819 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' GLU . 5.1 p -107.88 104.23 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.037 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 21.6 mt-10 18.36 110.48 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.505 1.122 . . . . 1.77 113.809 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 34.5 Cg_exo -63.38 155.79 60.04 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.496 2.13 . . . . 0.55 114.374 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -84.5 146.11 27.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.903 -1.044 . . . . 1.23 108.839 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -32.23 143.96 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.256 0.972 . . . . 1.63 112.478 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -79.64 114.32 18.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.428 -0.805 . . . . 0.41 110.326 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.937 HG12 HG21 ' A' ' 13' ' ' ILE . 3.8 mp -99.37 110.17 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.452 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 63.0 m -45.19 -39.79 6.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.044 -0.526 . . . . 0.44 111.224 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 69' ' ' ASP . 90.9 m 54.96 106.8 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.1 110.448 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -141.87 -75.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.987 0.423 . . . . 3.0 110.957 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.177 ' OD2' ' CG1' ' A' ' 101' ' ' VAL . 3.1 p-10 -122.86 3.09 9.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.577 . . . . 2.14 111.496 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t0 53.2 22.59 2.71 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.766 0.317 . . . . 2.06 111.444 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.177 ' CG1' ' OD2' ' A' ' 99' ' ' ASP . 11.1 p -153.39 22.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 2.8 110.931 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.542 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 1.5 mt-10 -115.88 -24.69 8.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.289 -0.414 . . . . 4.58 111.331 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.227 -0.892 . . . . 3.79 111.183 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.721 0.296 . . . . 2.74 111.227 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 95.0 Cg_endo -78.16 68.12 7.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.619 2.212 . . . . 2.06 112.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.68 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -52.77 141.89 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.68 111.16 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.64 132.8 24.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 2.0 110.318 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.86 162.38 18.54 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.157 . . . . 0.5 112.451 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 71.4 Cg_exo -53.11 177.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.906 2.404 . . . . 0.71 112.611 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.17 -175.58 50.15 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.043 -0.598 . . . . 0.66 113.128 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 tmtp? -69.69 123.29 88.27 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.974 0.11 . . . . 1.52 110.848 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 10.7 Cg_exo -75.47 128.12 10.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.669 2.246 . . . . 0.44 112.741 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 3.8 t -134.15 115.63 13.03 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.375 -0.375 . . . . 1.09 111.439 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 22.0 Cg_exo -61.98 108.11 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.224 1.949 . . . . 0.64 113.448 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.57 -41.18 93.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.46 0.648 . . . . 1.64 109.298 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -136.66 154.73 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.891 -1.05 . . . . 0.72 109.379 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.866 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -143.32 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.904 0.383 . . . . 0.96 111.22 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.836 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -101.71 56.86 0.82 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.023 -0.535 . . . . 1.46 112.266 -179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.254 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.74 -74.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.614 -0.721 . . . . 2.42 112.754 178.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' THR . 18.0 m170 -78.28 -35.28 48.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.072 0.397 . . . . 1.02 112.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 p -126.09 117.47 23.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.853 0.359 . . . . 0.68 110.98 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.3 m -110.29 141.8 24.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.137 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.754 ' C ' HD13 ' A' ' 20' ' ' LEU . 55.2 m -107.33 127.99 54.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.57 . . . . 0.35 111.768 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.811 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -133.25 156.38 47.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.371 0.605 . . . . 0.52 111.377 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.046 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -138.14 142.93 40.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.079 -0.964 . . . . 1.84 109.973 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 42.8 p90 -137.8 163.29 31.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.144 0.497 . . . . 0.4 111.885 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.88 164.93 24.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.83 110.318 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.82 157.15 35.13 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 2.11 110.873 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 76.9 Cg_exo -50.34 -173.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.233 . . . . 0.89 112.658 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.11 -25.57 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.897 -0.592 . . . . 2.77 111.829 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.529 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 10.1 t80 -129.05 -69.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.057 0.391 . . . . 1.37 112.057 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.5 p 59.45 50.79 7.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.346 . . . . 0.91 110.725 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.82 -98.86 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.163 -0.541 . . . . 1.01 112.64 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.05 32.74 1.66 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 109.735 -1.346 . . . . 0.98 109.735 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.95 -169.98 1.58 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.62 -0.79 . . . . 0.87 111.262 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 34' ' ' THR . 1.9 pttt -142.2 24.1 1.98 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 2.26 112.008 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.897 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mm 66.44 -69.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.7 0.286 . . . . 1.71 110.902 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.6 p 87.33 -20.72 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.188 0.595 . . . . 1.15 112.058 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.796 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.8 t -177.25 165.31 2.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 1.58 111.464 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.897 ' CE1' HG21 ' A' ' 33' ' ' ILE . 54.1 m-85 -133.75 109.1 8.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.76 111.073 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.33 156.26 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.22 -0.289 . . . . 1.14 110.22 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 7.1 t -135.06 124.31 42.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.63 111.807 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CD ' HD12 ' A' ' 77' ' ' ILE . 6.9 mt-10 -96.51 131.56 42.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -98.34 138.99 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.038 0.447 . . . . 1.97 111.964 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -122.14 109.65 14.79 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.825 -0.625 . . . . 1.44 110.374 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD2' ' NE ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -77.15 95.67 4.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 1.59 110.578 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -65.49 151.62 94.01 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.9 111.106 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -88.79 4.12 69.96 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.803 -1.332 . . . . 1.43 113.212 0.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -77.18 -84.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.672 0.272 . . . . 2.66 110.502 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.76 161.61 12.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.639 -0.791 . . . . 1.12 113.326 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' NE ' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 168.72 55.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 2.41 110.008 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.9 m95 -36.78 120.48 0.71 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.838 -0.619 . . . . 0.65 112.544 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -155.49 131.1 9.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 1.28 110.008 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 1.8 ptpt -52.11 117.41 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 1.3 110.84 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -101.87 -41.32 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.131 -0.486 . . . . 0.86 111.268 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' CB ' HD11 ' A' ' 56' ' ' ILE . 16.9 p-10 -44.79 -48.27 10.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.373 -0.376 . . . . 2.01 111.376 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.74 29.73 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.259 -0.428 . . . . 2.08 111.329 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -133.39 -170.11 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 1.89 110.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -99.69 89.29 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 1.87 111.181 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 36' ' ' TYR . 36.4 mt -86.78 72.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.69 110.768 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 57' ' ' LEU . 9.7 tp -63.08 -38.31 90.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.6 111.455 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 56' ' ' ILE . 21.8 pt-20 -100.6 160.49 14.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.379 . . . . 1.54 110.528 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -74.25 -7.92 54.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.211 -0.45 . . . . 1.75 111.323 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.046 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.3 tp10 -90.55 97.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.322 -0.621 . . . . 2.05 109.322 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 58.4 t80 -135.79 165.35 25.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.48 111.985 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 94.3 m -123.21 123.37 40.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.325 -0.852 . . . . 0.42 110.281 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.811 HG23 HD21 ' A' ' 20' ' ' LEU . 17.3 t -82.02 119.62 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 1.08 111.71 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.26 145.36 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.663 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.03 -19.35 5.48 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.746 -0.74 . . . . 0.9 112.171 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.742 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -55.9 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.666 0.27 . . . . 1.47 110.46 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -157.88 143.58 17.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.848 0.356 . . . . 1.06 110.765 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 mt-10 -51.92 129.88 27.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.063 -0.517 . . . . 1.91 111.127 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.61 66.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.073 -0.512 . . . . 1.87 111.397 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -175.5 118.44 0.16 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.468 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.54 129.73 40.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.36 109.519 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.607 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 73.3 m-85 -128.87 124.46 35.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.053 0.76 . . . . 0.56 113.053 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 10.5 mt-10 -103.52 142.36 34.41 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.498 -0.927 . . . . 1.5 108.498 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -133.15 111.98 11.36 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.478 1.288 . . . . 0.6 114.478 -178.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.01 157.39 16.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.495 -0.928 . . . . 2.11 108.495 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -125.21 124.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.535 -0.866 . . . . 0.6 112.878 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.447 HD12 ' CD ' ' A' ' 39' ' ' GLU . 63.6 mt -108.03 139.71 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.407 -1.331 . . . . 0.7 107.407 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -149.18 117.52 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.529 -0.869 . . . . 0.6 112.603 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.4 ptpt -71.57 -172.73 0.82 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.191 -0.459 . . . . 1.98 110.149 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.68 ' ND2' HD11 ' A' ' 2' ' ' ILE . 5.1 m-80 -135.09 168.08 19.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.263 0.554 . . . . 2.19 111.915 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.59 -44.04 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 1.08 111.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.69 -18.0 58.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.998 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 113.68 -16.75 21.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.551 -0.833 . . . . 0.93 112.1 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 123.46 8.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.663 0.268 . . . . 1.38 110.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 85' ' ' ILE . 3.3 tp -87.91 109.81 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.694 0.627 . . . . 0.79 112.694 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 12.7 p -68.58 107.34 1.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 107.811 -1.181 . . . . 0.59 107.811 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.0 Cg_endo -45.98 155.41 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.091 . . . . 0.85 112.841 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 2.3 Cg_endo -45.18 128.76 9.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.372 2.714 . . . . 0.76 113.483 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 1.1 p -97.43 109.14 21.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.364 -0.835 . . . . 1.28 109.862 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 7.6 mt-10 1.72 119.22 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.093 0 O-C-N 124.858 1.349 . . . . 1.77 113.927 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.7 Cg_exo -62.18 139.97 81.0 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.051 . . . . 0.55 113.768 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.89 144.3 57.18 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.063 -0.718 . . . . 1.23 109.063 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -40.43 134.2 1.75 Allowed 'General case' 0 C--N 1.333 -0.11 0 O-C-N 124.006 0.816 . . . . 1.63 111.633 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.68 127.09 29.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.41 111.255 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.636 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -109.4 114.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.478 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.499 HG21 ' NH1' ' A' ' 98' ' ' ARG . 65.2 m -48.13 -39.04 19.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.929 0.395 . . . . 0.44 111.03 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 78.9 m 60.29 65.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.246 -0.434 . . . . 1.1 110.881 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.658 ' HD3' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -107.63 -89.53 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.784 0.326 . . . . 3.0 110.52 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.953 ' O ' HG23 ' A' ' 101' ' ' VAL . 3.6 p30 -102.27 12.82 36.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.412 -0.358 . . . . 2.14 110.635 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.254 ' OD1' ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER 48.96 25.06 0.97 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.864 0.364 . . . . 2.06 111.189 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 99' ' ' ASP . 15.7 t -131.43 -7.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 2.8 112.071 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.988 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 39.44 83.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.062 0.458 . . . . 4.58 112.186 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.236 -0.888 . . . . 3.79 111.157 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.459 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 111.665 0.246 . . . . 2.74 111.665 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 0' ' ' SER . 14.1 Cg_exo -69.11 -163.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.592 2.194 . . . . 2.06 112.053 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.567 HD12 ' HB1' ' A' ' 84' ' ' ALA . 2.7 tt -166.02 143.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.68 110.874 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' N ' HG12 ' A' ' 2' ' ' ILE . 3.5 m-20 -135.39 128.53 18.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.618 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 157.02 43.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.394 2.062 . . . . 0.5 112.161 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.55 -164.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.801 2.334 . . . . 0.71 113.228 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.94 -175.41 44.02 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.423 -0.808 . . . . 0.66 112.799 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.2 tttt -78.08 134.64 63.41 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 110.382 -0.229 . . . . 1.52 110.382 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CG ' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_exo -79.04 147.04 20.72 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.652 2.234 . . . . 0.44 112.83 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.2 p -138.69 115.06 8.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.625 -0.716 . . . . 1.09 110.647 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.7 Cg_exo -63.34 112.74 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.201 1.934 . . . . 0.64 113.149 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER -76.9 -40.37 47.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.305 0.574 . . . . 1.64 109.848 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -132.22 114.01 13.95 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.233 -0.894 . . . . 0.72 109.215 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.588 HG21 HG12 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -113.0 126.26 70.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.73 0.641 . . . . 0.96 112.73 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -116.63 144.7 44.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.339 -0.846 . . . . 1.46 109.674 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -52.29 -18.36 1.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.94 0.719 . . . . 2.42 112.94 -178.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 17' ' ' THR . 3.1 m-70 -124.33 -7.75 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.543 0.571 . . . . 1.02 112.543 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 64' ' ' SER . 77.8 p -161.0 124.7 3.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.408 -0.219 . . . . 0.68 110.408 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.079 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -113.88 156.79 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.253 -0.579 . . . . 0.8 112.066 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 HD12 ' A' ' 11' ' ' LEU . 6.5 m -125.2 123.01 38.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.1 -0.5 . . . . 0.35 110.943 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.64 162.13 30.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.731 0.777 . . . . 0.52 112.454 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -136.1 159.01 43.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.502 -1.226 . . . . 1.84 109.762 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 19.7 p90 -149.4 -175.8 5.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.4 112.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.39 -173.99 4.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.617 -0.72 . . . . 0.83 112.072 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -120.94 140.58 31.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.289 -0.869 . . . . 2.11 110.272 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 33' ' ' ILE . 83.9 Cg_exo -46.07 175.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.43 2.087 . . . . 0.89 112.578 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -21.01 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 2.77 111.687 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.52 -68.71 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.991 0.367 . . . . 1.37 111.991 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 25' ' ' PRO . 66.2 p 51.79 49.62 20.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.91 110.496 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.75 -94.11 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.057 -0.592 . . . . 1.01 112.825 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.32 43.27 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.472 -1.051 . . . . 0.98 110.472 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -122.32 -168.97 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.458 . . . . 0.87 111.487 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.35 20.68 1.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.619 0.6 . . . . 2.26 112.619 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 35' ' ' SER . 3.6 mp 59.61 -85.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.927 -0.309 . . . . 1.71 110.483 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 77.59 30.84 0.47 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.982 0.364 . . . . 1.15 111.982 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 160.95 146.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.368 -0.378 . . . . 1.58 110.362 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' ILE . 93.1 m-85 -140.1 117.12 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.022 0.439 . . . . 0.76 111.679 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 23.9 mt -85.43 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 1.14 110.346 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 74' ' ' PHE . 2.1 t -109.53 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.158 0.429 . . . . 0.63 112.158 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.718 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 4.6 mm-40 -64.22 132.59 50.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.382 -0.599 . . . . 1.67 109.382 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -114.75 134.53 55.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 1.97 111.718 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.0 ttm180 -113.92 111.9 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.599 -0.728 . . . . 1.44 110.007 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.823 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.96 108.7 13.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 1.59 110.902 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 41' ' ' ARG . 1.2 mm? -84.34 143.68 42.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.436 -0.347 . . . . 0.9 110.985 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 63.5 Cg_endo -98.43 45.34 2.67 Favored 'Cis proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.36 -1.1 . . . . 1.43 112.755 0.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 m-80 -153.1 58.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 2.66 111.306 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -116.05 167.57 12.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.848 -0.691 . . . . 1.12 112.762 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.35 27.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.001 0.429 . . . . 2.41 110.615 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.578 ' O ' HD22 ' A' ' 49' ' ' LEU . 72.3 m95 53.23 110.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.65 111.638 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.609 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -143.32 118.4 10.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.233 -0.44 . . . . 1.28 110.459 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.718 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 7.2 ptpt -49.69 118.0 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.181 0.515 . . . . 1.3 111.2 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -102.37 -40.29 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.86 110.956 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.8 p-10 -40.28 -48.27 2.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 2.01 111.765 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 43.19 44.02 4.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.721 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.1 p -162.46 158.49 23.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 1.89 110.912 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -63.8 105.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 1.87 110.681 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 36' ' ' TYR . 53.5 mt -100.19 63.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.69 110.261 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.94 -76.22 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.566 -0.743 . . . . 1.6 111.821 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -64.82 170.02 4.6 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.772 0.32 . . . . 1.54 110.147 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 43.7 p30 -88.8 13.4 12.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.403 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 49.3 tt0 -111.55 107.3 16.42 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' HB2' HG23 ' A' ' 56' ' ' ILE . 58.6 t80 -142.49 164.97 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.48 112.049 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 18' ' ' VAL . 30.5 m -125.02 122.9 38.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.581 -0.736 . . . . 0.42 110.8 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 18' ' ' VAL . 3.7 m -91.53 96.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 120.24 -0.584 . . . . 1.08 110.714 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.565 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -82.85 -165.28 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 1.33 110.885 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.89 20.44 59.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.685 -0.769 . . . . 0.9 112.371 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.079 ' CD1' HG13 ' A' ' 18' ' ' VAL . 69.9 mt -74.28 -176.58 2.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.848 0.356 . . . . 1.47 110.75 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 m -132.68 154.9 49.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 1.06 110.875 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 22.9 tt0 -88.28 160.22 17.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 1.91 110.906 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.874 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 52.33 43.59 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 1.87 110.858 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.45 120.7 3.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.49 111.33 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.36 132.68 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.36 110.107 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 48.3 m-85 -125.69 118.97 26.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.681 0.622 . . . . 0.56 112.681 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.744 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 5.1 mt-10 -99.45 142.95 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.46 -0.941 . . . . 1.5 108.46 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.996 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -125.81 115.1 19.49 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.289 1.218 . . . . 0.6 114.289 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 2.5 ttp85 -94.91 139.49 31.26 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.341 -0.845 . . . . 2.11 109.537 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' CG ' ' A' ' 8' ' ' PRO . 80.6 t -106.98 138.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.71 0.767 . . . . 0.6 112.349 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 86' ' ' SER . 29.0 mt -134.66 156.64 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -168.42 121.07 0.84 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.652 -1.219 . . . . 0.6 112.987 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mmtt -61.91 -173.33 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.003 -0.679 . . . . 1.98 109.725 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 5.4 m120 -136.8 161.2 36.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.033 0.444 . . . . 2.19 110.908 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -36.87 -30.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.155 0.798 . . . . 1.08 113.155 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.626 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.73 24.37 13.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.979 0.733 . . . . 1.06 112.979 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.17 -11.1 51.1 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.561 -0.828 . . . . 0.93 113.222 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -53.82 102.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.946 0.373 . . . . 1.38 110.217 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -70.0 104.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.444 0.535 . . . . 0.79 112.444 -179.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.5 p -65.96 111.74 7.21 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.777 -0.823 . . . . 0.59 108.777 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 72.6 Cg_exo -48.8 -179.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.236 2.624 . . . . 0.85 114.311 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 68.1 Cg_exo -52.61 144.17 43.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.404 2.736 . . . . 0.76 113.544 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 10.9 m -123.04 122.05 37.55 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.906 -0.588 . . . . 1.28 110.505 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -18.53 102.47 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.161 0.985 . . . . 1.77 113.36 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 76.2 Cg_exo -48.42 169.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.043 2.495 . . . . 0.55 114.93 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.88 142.28 28.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.178 -1.374 . . . . 1.23 109.784 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -44.85 133.61 6.11 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.77 0.669 . . . . 1.63 110.457 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.07 119.65 11.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.984 -0.553 . . . . 0.41 111.754 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 10' ' ' PRO . 4.0 mp -97.37 109.55 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.408 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 13.6 m -46.89 -37.63 9.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.379 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 3.0 m 52.76 88.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.371 . . . . 1.1 110.227 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -134.75 -91.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.63 -0.259 . . . . 3.0 111.113 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 101' ' ' VAL . 27.0 p30 -91.45 -6.1 53.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.625 -0.261 . . . . 2.14 111.421 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.31 24.66 14.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.973 0.416 . . . . 2.06 111.122 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 99' ' ' ASP . 37.1 t -114.91 -21.2 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.979 -0.555 . . . . 2.8 110.786 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.91 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 57.6 83.35 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.012 0.434 . . . . 4.58 111.103 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.208 -0.901 . . . . 3.79 111.101 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.719 0.295 . . . . 2.74 111.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 87.2 Cg_endo -87.81 122.51 1.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.919 2.413 . . . . 2.06 112.659 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -99.8 145.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.68 110.391 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.7 142.31 45.06 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 2.0 111.53 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' CA ' ' HB2' ' A' ' 86' ' ' SER . 87.0 Cg_endo -83.44 161.79 14.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.84 2.36 . . . . 0.5 112.276 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.53 177.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.597 2.198 . . . . 0.71 112.625 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -81.01 -176.69 51.06 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.036 -0.602 . . . . 0.66 113.309 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.0 tmtm? -66.64 127.32 93.34 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 122.197 0.199 . . . . 1.52 110.79 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 4.9 Cg_exo -80.34 135.9 10.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.532 2.155 . . . . 0.44 112.797 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -137.11 114.0 9.79 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.786 -0.643 . . . . 1.09 110.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 69.3 Cg_exo -48.52 135.02 26.9 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.144 1.896 . . . . 0.64 113.123 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -99.06 -30.37 12.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 1.64 110.061 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.99 121.61 4.45 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.319 -0.855 . . . . 0.72 109.356 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.013 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.37 132.68 61.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.828 0.677 . . . . 0.96 112.828 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.88 151.46 46.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.879 -1.055 . . . . 1.46 109.68 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG2' ' CA ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -57.74 -18.1 19.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.339 -0.391 . . . . 2.42 111.706 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 17' ' ' THR . 4.5 m-70 -131.44 18.75 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.811 0.3 . . . . 1.02 111.811 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -178.56 114.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 0.68 111.422 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 13' ' ' ILE . 81.3 t -104.82 135.13 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.001 -0.545 . . . . 0.8 110.178 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.775 ' C ' HD13 ' A' ' 20' ' ' LEU . 61.6 m -111.52 132.27 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.35 110.661 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -140.83 143.19 34.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.96 0.886 . . . . 0.52 111.766 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -123.79 134.92 53.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.955 -1.475 . . . . 1.84 109.51 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 35.7 p90 -126.4 172.0 10.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 0.4 111.196 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -83.83 -157.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.762 -0.654 . . . . 0.83 110.84 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.75 159.31 69.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.47 -0.332 . . . . 2.11 110.607 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 28' ' ' THR . 55.4 Cg_endo -70.38 169.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.104 1.87 . . . . 0.89 111.815 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.33 -19.84 11.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.196 0.443 . . . . 2.77 112.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.442 ' CE1' ' HG2' ' A' ' 1' ' ' PRO . 2.7 t80 -112.74 -74.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.343 0.498 . . . . 1.37 112.343 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 25' ' ' PRO . 11.9 p 47.31 57.76 5.5 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.527 0.203 . . . . 0.91 110.704 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.75 -95.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.966 -0.635 . . . . 1.01 112.384 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -148.69 27.56 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.693 -0.963 . . . . 0.98 110.693 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.22 -177.56 3.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.471 . . . . 0.87 111.477 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -134.88 5.24 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 2.26 111.319 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 35' ' ' SER . 22.8 mt 60.53 145.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 1.71 110.605 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -133.31 18.27 4.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.842 0.312 . . . . 1.15 111.842 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.519 ' H ' HG22 ' A' ' 33' ' ' ILE . 47.9 t -179.96 151.23 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.168 0.509 . . . . 1.58 111.971 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.3 m-85 -134.4 100.31 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.736 . . . . 0.76 110.002 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.43 114.62 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 1.14 111.008 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -103.61 106.28 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.35 0.595 . . . . 0.63 110.596 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 25.2 mt-10 -75.31 154.92 37.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.251 -0.886 . . . . 1.67 111.212 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 2.7 pttt -117.07 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.134 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 2.8 ttm180 -112.85 101.65 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 1.44 109.788 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -68.54 141.47 55.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.848 -0.614 . . . . 1.59 110.622 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.516 HD12 ' HB1' ' A' ' 94' ' ' ALA . 6.9 mt -126.87 153.71 76.12 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.9 111.252 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.4 Cg_endo -81.8 24.08 8.27 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.962 -1.266 . . . . 1.43 113.616 0.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.407 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -154.46 100.25 2.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.363 . . . . 2.66 110.903 179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -165.9 167.9 39.42 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.84 -0.695 . . . . 1.12 112.419 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.631 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -133.14 148.43 52.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 2.41 111.188 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 72.1 m95 -55.45 105.88 0.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.65 111.227 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -134.2 122.54 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 1.28 110.354 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -44.47 118.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 1.3 111.346 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -103.84 -9.83 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.86 111.993 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.58 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.6 p-10 -77.71 -54.72 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.201 -0.2 . . . . 2.01 111.467 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 38.34 35.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.999 0.37 . . . . 2.08 111.999 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 26.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.442 -0.345 . . . . 1.89 111.42 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.24 130.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.378 . . . . 1.87 111.211 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 36' ' ' TYR . 48.1 mt -129.99 84.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.69 110.633 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.34 -43.79 76.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 1.6 111.985 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.45 154.74 17.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.834 0.349 . . . . 1.54 110.866 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -72.81 -4.59 32.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 1.75 111.672 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -96.86 98.2 9.92 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.167 -0.679 . . . . 2.05 109.167 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 52' ' ' ASN . 69.8 t80 -128.48 164.53 22.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.452 0.644 . . . . 0.48 112.146 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -125.76 114.87 19.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.077 -0.965 . . . . 0.42 110.783 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 38' ' ' VAL . 14.3 t -77.66 109.09 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 1.08 110.817 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.77 151.45 26.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 1.33 111.055 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.93 4.57 10.27 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.574 -0.739 . . . . 0.9 112.396 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -68.54 -167.19 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.947 0.403 . . . . 1.47 110.918 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -150.25 139.32 21.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 1.06 110.76 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE1' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -58.86 130.45 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.91 111.063 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t0 76.16 49.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 1.87 111.277 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.03 127.42 4.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.49 111.356 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.24 134.23 41.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.134 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -133.2 125.2 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.798 0.666 . . . . 0.56 112.798 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.12 150.06 22.88 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.04 -0.726 . . . . 1.5 109.04 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.899 ' CE2' HG11 ' A' ' 18' ' ' VAL . 1.4 m-85 -134.71 117.24 15.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.146 1.165 . . . . 0.6 114.146 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 88' ' ' PRO . 24.1 ttm-85 -111.82 159.5 18.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.132 -0.94 . . . . 2.11 109.412 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -136.88 144.83 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.982 0.896 . . . . 0.6 112.803 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 86' ' ' SER . 22.8 mt -130.32 145.19 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.828 -1.533 . . . . 0.7 107.655 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -145.87 130.62 18.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.586 -0.846 . . . . 0.6 112.575 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -91.77 123.96 35.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 1.98 111.308 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.4 p-10 -66.28 -174.82 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.851 . . . . 2.19 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -65.68 -26.04 67.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.844 -0.616 . . . . 1.08 112.063 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.657 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -88.19 1.47 54.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.435 0.531 . . . . 1.06 112.435 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.8 79.76 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.369 -0.919 . . . . 0.93 113.078 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -77.31 68.08 3.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.239 0.543 . . . . 1.38 109.616 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -27.47 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 114.695 1.369 . . . . 0.79 114.695 -178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.879 ' O ' HG23 ' A' ' 77' ' ' ILE . 10.7 p -75.29 106.81 3.2 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.491 -1.67 . . . . 0.59 106.491 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 9.8 Cg_endo -50.32 169.08 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.88 2.387 . . . . 0.85 114.605 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 72.6 Cg_exo -31.04 136.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.251 3.3 . . . . 0.76 114.078 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 2.8 p -122.01 103.2 8.65 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.589 -0.732 . . . . 1.28 109.972 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -1.8 120.16 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.014 1.326 . . . . 1.77 113.872 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 4.6 Cg_exo -76.77 163.5 31.35 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.268 1.978 . . . . 0.55 113.882 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 2.0 t -90.97 146.71 23.64 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.002 -0.999 . . . . 1.23 109.401 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -38.75 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 O-C-N 123.72 0.637 . . . . 1.63 111.596 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -87.43 120.92 29.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.033 -0.53 . . . . 0.41 111.532 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -98.55 114.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 38.2 m -47.89 -28.68 2.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.839 -0.618 . . . . 0.44 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.869 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 m 50.14 60.6 3.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 1.1 110.973 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.702 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -95.41 -74.17 0.56 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.933 0.397 . . . . 3.0 111.147 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.625 ' O ' HG23 ' A' ' 101' ' ' VAL . 7.2 p-10 -131.08 20.0 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.974 -0.557 . . . . 2.14 111.633 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.4 t0 44.07 24.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.649 0.611 . . . . 2.06 112.649 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.677 ' O ' HG12 ' A' ' 101' ' ' VAL . 28.1 t -143.75 15.41 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 2.8 111.416 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 17.7 mm-40 -113.92 -17.47 12.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.346 . . . . 4.58 111.238 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.217 -0.897 . . . . 3.79 110.93 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.58 0.229 . . . . 2.74 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.06 -153.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.562 2.175 . . . . 2.06 111.967 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.9 tt -164.81 147.19 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.68 111.274 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 23.9 m-20 -132.22 129.97 21.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 2.0 110.475 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.22 157.98 15.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.532 2.155 . . . . 0.5 112.604 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 4.5 Cg_endo -48.35 -177.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.122 2.548 . . . . 0.71 113.514 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 168.78 29.26 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.53 -0.759 . . . . 0.66 112.957 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -53.39 128.13 50.18 Favored Pre-proline 0 CA--C 1.53 0.197 0 O-C-N 122.987 -0.126 . . . . 1.52 110.811 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 11.8 Cg_exo -74.98 113.95 3.91 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.506 2.137 . . . . 0.44 112.701 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -104.72 107.76 59.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 1.09 110.652 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 27.2 Cg_exo -61.7 105.71 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.525 2.15 . . . . 0.64 113.789 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -63.22 -32.92 74.44 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.89 -0.782 . . . . 1.64 108.89 178.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -142.99 143.92 32.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.878 -1.055 . . . . 0.72 109.061 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.059 HG22 HG13 ' A' ' 18' ' ' VAL . 3.2 pt -138.74 81.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.146 0.424 . . . . 0.96 112.146 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.257 HG22 ' OD1' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -79.97 151.44 30.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 1.46 110.237 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -56.48 -20.67 21.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.982 -0.554 . . . . 2.42 111.877 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 17' ' ' THR . 0.3 OUTLIER -125.86 11.4 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.252 0.464 . . . . 1.02 112.252 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -169.85 115.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.68 110.709 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 13' ' ' ILE . 24.9 t -109.83 119.51 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.061 0.458 . . . . 0.8 111.232 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.73 ' C ' HD13 ' A' ' 20' ' ' LEU . 11.0 m -99.8 124.77 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.675 -0.693 . . . . 0.35 110.811 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.18 150.33 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.805 0.812 . . . . 0.52 112.315 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.86 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.35 154.35 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.313 -1.312 . . . . 1.84 109.798 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.4 p90 -142.21 -176.05 4.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.278 0.561 . . . . 0.4 112.397 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.65 24.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.44 -0.8 . . . . 0.83 111.154 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 4.0 tmmm? -84.91 139.21 37.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 2.11 110.758 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.691 ' CB ' HG23 ' A' ' 28' ' ' THR . 93.0 Cg_exo -43.84 160.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.216 1.944 . . . . 0.89 111.837 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -106.94 -15.92 14.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.77 111.749 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 -70.62 0.7 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.863 0.32 . . . . 1.37 111.863 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 25' ' ' PRO . 14.4 p 50.59 54.78 10.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.971 0.415 . . . . 0.91 110.382 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.33 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.927 -0.579 . . . . 1.01 112.55 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.66 24.06 2.77 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.35 -0.7 . . . . 0.98 111.35 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -92.04 -176.64 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 0.87 111.923 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 13.6 ttpt -130.87 -13.48 3.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.646 -0.706 . . . . 2.26 112.209 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.625 HD11 HG21 ' A' ' 28' ' ' THR . 11.4 mt 64.1 132.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.701 -0.481 . . . . 1.71 109.701 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -124.42 11.82 8.69 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.575 0.583 . . . . 1.15 112.575 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 146.35 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.999 0.428 . . . . 1.58 112.138 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.506 ' O ' HD12 ' A' ' 56' ' ' ILE . 51.1 m-85 -118.52 122.16 42.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.717 -0.674 . . . . 0.76 109.972 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -107.85 129.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.765 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -119.28 130.22 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.63 110.584 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.5 mt-10 -94.54 136.66 34.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.442 -0.799 . . . . 1.67 110.668 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -99.94 159.36 15.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 1.97 111.112 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.832 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -140.73 105.29 4.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.543 . . . . 1.44 110.546 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.704 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -75.11 80.41 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.59 110.97 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 41' ' ' ARG . 1.2 mm? -65.63 155.82 84.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.9 110.763 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -91.81 36.7 5.99 Favored 'Cis proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.063 -1.224 . . . . 1.43 112.639 0.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.18 57.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.923 0.392 . . . . 2.66 111.11 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.704 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -127.05 172.79 18.51 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.973 -0.632 . . . . 1.12 112.156 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.62 51.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.217 0.532 . . . . 2.41 111.348 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.712 ' O ' HD22 ' A' ' 49' ' ' LEU . 50.5 m95 -60.94 124.05 19.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.391 -0.822 . . . . 0.65 110.527 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -154.95 124.05 6.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.841 0.353 . . . . 1.28 111.295 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -50.95 115.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.3 110.537 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -99.26 -35.22 10.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.86 111.545 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.686 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.1 p-10 -53.54 -62.5 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.316 . . . . 2.01 111.85 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 3.5 t80 80.05 -51.39 0.37 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.544 0.211 . . . . 2.08 111.259 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -64.04 -171.31 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.886 0.374 . . . . 1.89 110.975 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -97.2 106.13 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 1.87 110.814 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.4 mt -92.42 74.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 0.69 111.268 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -73.65 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.6 111.018 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.51 174.12 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.54 110.189 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 44.4 p30 -92.86 17.38 10.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.267 -0.424 . . . . 1.75 111.452 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.69 103.01 9.28 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 59.1 t80 -134.68 164.18 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.068 0.461 . . . . 0.48 111.537 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.661 HG23 ' OG1' ' A' ' 19' ' ' THR . 17.3 m -122.03 119.68 32.12 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.672 -0.694 . . . . 0.42 111.152 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG23 HD21 ' A' ' 20' ' ' LEU . 22.3 t -86.92 97.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 1.08 110.995 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.28 150.74 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.665 -0.698 . . . . 1.33 110.951 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.57 7.45 8.92 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.711 -0.677 . . . . 0.9 112.338 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 72' ' ' TYR . 4.4 mm? -51.81 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.018 0.437 . . . . 1.47 110.928 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 m -142.71 111.01 6.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.813 -0.631 . . . . 1.06 110.112 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -42.0 138.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.91 111.869 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.79 56.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.897 -0.592 . . . . 1.87 111.583 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.44 123.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.49 111.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.12 134.43 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.36 110.536 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' HD12 ' A' ' 66' ' ' LEU . 49.4 m-85 -130.6 118.89 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.317 0.488 . . . . 0.56 112.317 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.72 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.08 143.09 30.69 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.311 -0.626 . . . . 1.5 109.311 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.57 119.89 13.86 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.486 1.291 . . . . 0.6 114.486 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -108.06 173.57 6.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.444 -0.947 . . . . 2.11 108.444 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.85 113.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 114.116 1.154 . . . . 0.6 114.116 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 37' ' ' ILE . 41.6 mt -97.32 154.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 106.479 -1.674 . . . . 0.7 106.479 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.16 128.27 1.29 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.434 -0.906 . . . . 0.6 111.656 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 85' ' ' ILE . 20.6 mttt -63.57 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.047 -0.723 . . . . 1.98 109.047 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.758 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.1 m-80 -146.01 -94.21 0.09 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.66 -0.416 . . . . 2.19 110.925 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -137.15 -42.28 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 1.08 110.952 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.18 30.45 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.06 111.996 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.16 -12.37 58.34 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.541 -0.838 . . . . 0.93 113.353 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.518 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -53.11 115.75 2.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.973 0.386 . . . . 1.38 110.894 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -87.78 104.37 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.034 0.445 . . . . 0.79 111.519 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.65 119.76 71.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 109.803 -0.443 . . . . 0.59 109.803 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.24 162.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.177 2.585 . . . . 0.85 113.122 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 36.7 Cg_endo -66.26 142.3 66.19 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.695 2.263 . . . . 0.76 112.409 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.8 m -94.59 105.32 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 1.28 110.332 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 tt0 -4.27 115.27 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 124.705 1.202 . . . . 1.77 113.681 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.2 Cg_exo -56.2 141.8 87.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.125 1.883 . . . . 0.55 113.6 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 15.7 m -72.31 143.17 48.79 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.753 -0.832 . . . . 1.23 108.753 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.0 m-20 -41.12 137.27 1.36 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.768 0.668 . . . . 1.63 110.752 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -62.85 117.76 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.036 -0.529 . . . . 0.41 111.779 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' SG ' ' A' ' 97' ' ' CYS . 3.9 mp -92.35 110.82 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.615 -0.72 . . . . 0.44 110.422 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.161 ' HB ' ' OE2' ' A' ' 102' ' ' GLU . 26.0 m -46.95 -39.04 11.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.919 0.39 . . . . 0.44 110.655 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 95' ' ' ILE . 99.1 m 61.46 89.13 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.504 . . . . 1.1 110.91 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.4 -82.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 3.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.099 ' OD2' HG13 ' A' ' 101' ' ' VAL . 11.7 p-10 -96.02 30.28 2.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.752 -0.658 . . . . 2.14 110.653 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.257 ' OD1' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER 44.58 26.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 2.06 112.036 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.099 HG13 ' OD2' ' A' ' 99' ' ' ASP . 7.7 p -164.4 25.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.658 -0.701 . . . . 2.8 110.393 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.161 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 6.3 mm-40 31.88 54.39 0.29 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.656 -0.702 . . . . 4.58 112.646 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' CB ' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.252 -0.88 . . . . 3.79 111.143 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.435 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.674 0.273 . . . . 2.74 111.146 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 65.0 Cg_endo -74.35 -167.6 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.65 2.234 . . . . 2.06 112.552 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -155.63 149.72 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.68 110.657 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.74 151.57 68.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 2.0 111.773 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.71 164.62 12.1 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.907 2.405 . . . . 0.5 112.043 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.33 -164.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.501 2.134 . . . . 0.71 112.637 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.34 -153.59 27.95 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.939 -0.648 . . . . 0.66 113.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -90.09 125.05 61.7 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.407 0.146 . . . . 1.52 111.008 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 23.3 Cg_exo -66.52 130.89 24.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.489 2.126 . . . . 0.44 112.327 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.05 98.42 17.38 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.163 -0.471 . . . . 1.09 111.19 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.9 Cg_exo -47.14 130.41 16.58 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.64 113.081 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 21' ' ' LYS . 2.2 mt -90.71 -30.75 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.055 -0.721 . . . . 1.64 109.055 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -151.49 119.65 6.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.167 -0.924 . . . . 0.72 109.218 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -117.39 122.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.96 112.448 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.94 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -124.52 160.5 28.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.831 . . . . 1.46 110.237 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -59.02 -13.97 8.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.394 0.516 . . . . 2.42 112.394 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -140.44 23.9 2.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.285 0.476 . . . . 1.02 112.285 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -175.98 113.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.841 0.353 . . . . 0.68 110.232 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 44.7 t -116.24 99.28 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.153 0.427 . . . . 0.8 112.153 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.802 ' OG1' HG23 ' A' ' 62' ' ' THR . 46.1 m -83.66 144.85 29.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.35 110.68 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -148.55 163.97 35.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.649 0.737 . . . . 0.52 112.499 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 11' ' ' LEU . 28.4 tptp -145.58 137.86 25.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.595 -1.184 . . . . 1.84 109.601 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 37.4 p90 -133.81 177.93 7.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.183 0.516 . . . . 0.4 111.709 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.3 -163.95 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.83 110.838 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -128.68 140.38 38.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.901 -0.59 . . . . 2.11 110.185 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HG2' HD11 ' A' ' 33' ' ' ILE . 95.9 Cg_exo -39.05 161.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.166 . . . . 0.89 112.2 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.44 -43.22 5.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 3.5 t80 -108.91 -70.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.482 0.549 . . . . 1.37 112.482 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 19.5 p 55.77 40.78 30.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.429 . . . . 0.91 109.951 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' HB2' ' A' ' 0' ' ' SER . . . 44.67 -100.21 0.02 OUTLIER Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.804 -0.635 . . . . 1.01 112.53 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.35 27.62 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.295 -0.722 . . . . 0.98 111.295 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -111.85 -171.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.87 111.267 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.29 35.3 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 2.26 111.24 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 25' ' ' PRO . 2.9 mm 59.44 158.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.465 -0.334 . . . . 1.71 110.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 33' ' ' ILE . 81.1 p -138.87 1.74 2.1 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.656 0.613 . . . . 1.15 112.656 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 33' ' ' ILE . 10.0 t 168.59 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.7 0.286 . . . . 1.58 111.539 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.771 ' O ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -99.82 87.06 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.76 111.113 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.541 HG21 ' HD2' ' A' ' 50' ' ' LYS . 1.1 mp -73.74 120.47 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 1.14 110.796 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 63' ' ' VAL . 14.0 t -94.15 107.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.111 0.481 . . . . 0.63 111.563 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.82 139.24 31.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 1.67 110.616 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.711 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -108.12 138.93 43.54 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.904 0.383 . . . . 1.97 111.568 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -119.12 97.41 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.564 -0.902 . . . . 1.44 108.564 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.862 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -65.48 97.16 0.28 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.403 -0.817 . . . . 1.59 110.603 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -69.3 148.01 97.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.9 110.837 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -93.93 32.22 11.17 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.966 -1.264 . . . . 1.43 112.861 0.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.79 64.63 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.754 0.311 . . . . 2.66 111.547 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.862 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -95.85 -174.77 36.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 1.12 112.032 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 26.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 2.41 110.777 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.8 m95 41.38 88.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.099 0.476 . . . . 0.65 111.202 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 137.86 54.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.28 111.27 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 37' ' ' ILE . 1.4 mtmt -53.89 129.14 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 1.3 110.4 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -110.29 -31.55 7.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.86 110.645 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.692 ' HB3' HD11 ' A' ' 56' ' ' ILE . 10.7 p-10 -57.18 -43.31 82.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 2.01 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.87 25.08 10.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 2.08 110.766 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -169.77 3.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 1.89 110.956 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -94.9 116.08 28.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.87 110.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 36' ' ' TYR . 27.1 mt -105.71 90.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.54 . . . . 0.69 110.636 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.497 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.6 mt -74.62 -61.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.6 111.336 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -75.02 159.16 32.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.934 0.397 . . . . 1.54 110.621 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -74.85 -3.22 30.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 1.75 111.039 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 1.7 tt0 -100.46 103.53 14.89 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.413 -0.588 . . . . 2.05 109.413 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.9 t80 -140.19 165.35 27.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.48 111.779 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' OG1' ' A' ' 19' ' ' THR . 8.1 m -121.29 114.78 21.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.42 111.391 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 38' ' ' VAL . 56.6 t -84.71 90.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.143 0.497 . . . . 1.08 111.041 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.67 151.69 19.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.33 111.0 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.34 14.65 7.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.9 112.354 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 72' ' ' TYR . 3.6 mm? -58.25 -179.67 0.06 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.132 0.491 . . . . 1.47 111.357 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 m -133.37 109.23 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.589 -0.732 . . . . 1.06 110.199 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.91 135.7 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.087 -0.506 . . . . 1.91 111.816 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 97' ' ' CYS . 9.5 m-20 65.64 62.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.87 111.215 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.7 114.74 0.17 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.509 -0.314 . . . . 0.49 111.588 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.18 135.34 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.731 -0.47 . . . . 0.36 109.731 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 33.3 m-85 -128.61 121.51 28.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.162 0.801 . . . . 0.56 113.162 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' HD21 ' A' ' 43' ' ' LEU . 1.1 mt-10 -99.3 133.7 43.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.618 -1.253 . . . . 1.5 107.618 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.756 ' HE2' HG11 ' A' ' 18' ' ' VAL . 7.8 m-85 -117.94 114.87 23.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.138 1.532 . . . . 0.6 115.138 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -100.72 135.34 42.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.193 -0.912 . . . . 2.11 108.998 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -108.24 127.39 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 119.288 -0.965 . . . . 0.6 111.721 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.741 HG23 ' O ' ' A' ' 86' ' ' SER . 94.1 mt -115.52 143.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.811 -1.086 . . . . 0.7 108.126 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.11 134.45 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.833 -0.747 . . . . 0.6 112.395 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -84.85 -178.6 6.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.28 -0.568 . . . . 1.98 110.626 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.521 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.3 p-10 -127.84 -173.23 2.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.36 -0.836 . . . . 2.19 110.104 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -69.66 -11.96 61.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.041 -0.527 . . . . 1.08 112.095 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -104.01 -4.23 23.6 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.228 0.455 . . . . 1.06 112.228 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.98 87.93 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.452 -0.88 . . . . 0.93 113.291 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -76.57 71.98 3.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.341 0.591 . . . . 1.38 109.951 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.9 tt -36.56 123.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.96 1.096 . . . . 0.79 113.96 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.6 p -76.2 107.81 5.12 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.372 -1.344 . . . . 0.59 107.372 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 14.6 Cg_endo -55.18 171.4 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.592 2.194 . . . . 0.85 113.454 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 77' ' ' ILE . 48.0 Cg_exo -31.95 122.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.973 3.115 . . . . 0.76 113.317 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 4.1 p -106.85 103.82 13.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 1.28 110.121 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 9.98 113.85 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 125.045 1.466 . . . . 1.77 113.416 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 15.4 Cg_exo -68.31 162.39 40.67 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.88 1.72 . . . . 0.55 114.292 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.82 152.75 18.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.153 -0.93 . . . . 1.23 109.345 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -33.75 156.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.112 0.882 . . . . 1.63 112.294 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -90.64 103.3 16.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.41 111.363 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.709 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.0 mp -82.81 110.24 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.44 111.497 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 90.8 m -48.74 -35.37 14.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.13 0.491 . . . . 0.44 110.612 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.506 ' SG ' HG22 ' A' ' 95' ' ' ILE . 91.7 m 56.93 79.6 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.673 -0.694 . . . . 1.1 111.046 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -87.68 0.47 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.506 -0.315 . . . . 3.0 111.381 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.764 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.17 0.43 16.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.426 -0.352 . . . . 2.14 111.666 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.94 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 47.73 26.2 0.83 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.907 0.385 . . . . 2.06 111.215 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 99' ' ' ASP . 27.1 m -115.87 -19.01 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 116.032 -0.531 . . . . 2.8 110.953 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -135.01 -45.87 0.72 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.901 0.381 . . . . 4.58 110.773 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.224 -0.893 . . . . 3.79 110.928 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.733 0.302 . . . . 2.74 111.287 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 96.0 Cg_endo -92.11 170.91 2.68 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.086 2.524 . . . . 2.06 112.248 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -135.58 137.25 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.986 0.422 . . . . 0.68 111.434 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 5.1 m-20 -122.02 142.97 37.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 2.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.53 168.64 17.84 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.569 2.179 . . . . 0.5 112.402 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 174.29 2.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.654 2.236 . . . . 0.71 112.898 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -72.4 177.12 40.61 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.66 112.493 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.0 tttt -60.77 127.53 87.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.533 -0.173 . . . . 1.52 110.533 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' HG13 ' A' ' 76' ' ' VAL . 7.0 Cg_exo -74.29 156.89 46.13 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.352 2.035 . . . . 0.44 112.074 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -152.47 114.56 2.85 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.415 -0.357 . . . . 1.09 111.677 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 25.6 Cg_exo -61.44 111.31 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.691 2.26 . . . . 0.64 113.405 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.58 -33.85 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.661 -0.866 . . . . 1.64 108.661 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.871 -1.059 . . . . 0.72 108.995 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.002 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -133.98 105.3 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.96 112.041 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 151.23 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.7 -0.682 . . . . 1.46 110.35 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -60.29 -16.06 30.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.422 . . . . 2.42 111.439 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 17' ' ' THR . 6.1 m-70 -132.29 16.96 4.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.48 0.181 . . . . 1.02 111.464 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -176.27 106.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.946 0.403 . . . . 0.68 110.917 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.002 HG13 HG22 ' A' ' 13' ' ' ILE . 49.7 t -102.57 117.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.966 -0.561 . . . . 0.8 110.971 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.33 128.9 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.35 111.571 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -139.77 156.47 46.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.935 0.874 . . . . 0.52 112.412 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.932 ' HG2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -124.71 -170.45 2.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.04 -1.437 . . . . 1.84 109.219 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.7 p90 -179.83 161.14 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.4 111.836 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -80.77 168.06 19.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.83 111.797 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.27 141.42 32.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.53 -0.759 . . . . 2.11 110.236 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 28' ' ' THR . 4.5 Cg_endo -46.51 166.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.369 2.046 . . . . 0.89 111.716 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -102.93 -55.62 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.238 -0.437 . . . . 2.77 111.518 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CD1' ' HG2' ' A' ' 1' ' ' PRO . 2.8 t80 -113.15 61.92 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.567 -0.288 . . . . 1.37 111.331 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.49 ' O ' ' CE2' ' A' ' 31' ' ' PHE . 44.4 p -57.68 -25.08 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.709 0.29 . . . . 0.91 110.452 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.09 -65.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.579 -0.819 . . . . 1.01 111.886 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 40.09 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.991 -1.244 . . . . 0.98 109.991 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -137.87 -176.92 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.087 -0.557 . . . . 0.87 111.024 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -144.3 15.21 1.66 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.5 0.556 . . . . 2.26 112.5 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.608 ' C ' HG23 ' A' ' 34' ' ' THR . 5.1 mp 64.22 -74.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 111.905 0.335 . . . . 1.71 111.905 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 79.53 21.43 0.6 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.573 -0.285 . . . . 1.15 111.696 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.595 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 169.96 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.924 -0.126 . . . . 1.58 111.232 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.8 m-85 -118.06 128.71 55.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.94 0.4 . . . . 0.76 112.001 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -119.4 120.67 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.513 -0.312 . . . . 1.14 110.433 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -105.69 140.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.879 0.371 . . . . 0.63 110.813 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' CD ' HD11 ' A' ' 77' ' ' ILE . 2.6 mt-10 -101.96 135.52 43.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.259 0.552 . . . . 1.67 111.966 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.837 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 mtmp? -101.26 139.19 37.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.273 -0.876 . . . . 1.97 111.336 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.556 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 7.6 ptt180 -132.63 115.65 15.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.454 0.645 . . . . 1.44 109.84 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -75.65 113.11 12.72 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.123 -0.944 . . . . 1.59 111.053 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 2.5 mm? -73.58 161.04 80.76 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.9 110.412 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 80.6 Cg_endo -83.8 14.89 33.18 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 124.115 -1.202 . . . . 1.43 113.427 0.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.65 -77.81 0.51 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.938 -0.393 . . . . 2.66 109.938 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' A' ' 41' ' ' ARG . . . 92.22 130.81 5.26 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.633 -0.794 . . . . 1.12 113.206 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.615 HH11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.47 1.68 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.64 0.237 . . . . 2.41 111.64 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.593 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 40.4 m95 44.31 94.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.205 0.202 . . . . 0.65 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.615 HD22 HH11 ' A' ' 47' ' ' ARG . 1.4 mp -123.62 135.55 54.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.955 0.407 . . . . 1.28 111.615 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HD2' HG21 ' A' ' 37' ' ' ILE . 9.7 mtmt -62.99 82.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 1.3 110.662 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.837 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -49.11 -53.94 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.231 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -60.31 138.28 57.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 2.01 111.06 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -136.77 23.07 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 2.08 111.031 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 t -120.73 -83.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 1.89 110.72 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 178.48 120.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 1.87 110.86 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.0 mt -107.02 98.99 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.69 110.986 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -76.68 -68.25 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 1.6 111.087 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -74.85 -179.12 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 1.54 110.65 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.9 OUTLIER -86.93 -2.91 58.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 1.75 111.482 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.932 ' CD ' ' HG2' ' A' ' 21' ' ' LYS . 9.0 tp10 -97.42 101.86 13.49 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.749 0.309 . . . . 2.05 110.179 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CG ' HD13 ' A' ' 56' ' ' ILE . 40.3 t80 -135.81 165.49 25.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.055 0.455 . . . . 0.48 111.584 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.7 m -122.21 120.69 34.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.758 -0.655 . . . . 0.42 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.653 ' CG2' HD21 ' A' ' 20' ' ' LEU . 4.8 t -85.77 112.07 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.995 -0.548 . . . . 1.08 111.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -173.38 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 1.33 110.944 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.8 9.58 71.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.747 . . . . 0.9 112.847 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG23 ' A' ' 18' ' ' VAL . 1.6 mt -61.72 -177.19 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 1.47 110.83 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 72' ' ' TYR . 3.8 t -138.93 11.49 2.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.026 0.38 . . . . 1.06 112.026 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 56.9 159.31 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.006 0.432 . . . . 1.91 111.382 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 90.5 m-20 45.76 66.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 1.87 111.368 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 174.76 119.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.067 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.83 132.82 55.12 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.205 -0.598 . . . . 0.36 110.281 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 67' ' ' THR . 25.0 m-85 -130.34 121.0 25.2 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.003 0.742 . . . . 0.56 113.003 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 92' ' ' SER . 2.4 tt0 -102.66 141.05 36.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.516 -0.55 . . . . 1.5 109.516 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.777 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.65 128.01 26.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.126 1.158 . . . . 0.6 114.126 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.593 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -111.32 160.98 16.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.31 -0.626 . . . . 2.11 109.31 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -121.3 112.32 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.057 -0.657 . . . . 0.6 111.955 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.945 HG22 ' O ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -105.05 179.81 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.237 -0.892 . . . . 0.7 108.852 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -179.37 -162.59 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.106 0.479 . . . . 0.6 111.395 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.7 mttt -136.85 -171.53 2.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.275 -1.009 . . . . 1.98 108.275 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.865 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.8 p-10 -135.72 156.62 48.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.056 0.455 . . . . 2.19 110.54 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.35 -29.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.601 -0.727 . . . . 1.08 112.084 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -77.07 -24.5 51.88 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.815 0.672 . . . . 1.06 112.815 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.29 -11.5 26.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.431 -0.89 . . . . 0.93 112.341 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.865 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . . . -59.89 -156.63 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.958 -0.386 . . . . 1.38 109.958 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -145.15 114.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.059 0.762 . . . . 0.79 113.059 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.945 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 p -64.71 109.91 3.43 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.59 107.028 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 12.3 Cg_endo -54.48 147.63 46.8 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.159 1.906 . . . . 0.85 112.767 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.927 ' HA ' HG23 ' A' ' 77' ' ' ILE . 47.8 Cg_exo -37.22 120.53 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.378 2.719 . . . . 0.76 113.666 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.54 ' OG ' HG13 ' A' ' 76' ' ' VAL . 28.2 p -87.21 101.98 14.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.05 -0.523 . . . . 1.28 110.128 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.8 tt0 0.41 111.05 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.991 1.316 . . . . 1.77 114.292 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 51.9 Cg_exo -48.61 167.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.156 1.904 . . . . 0.55 113.19 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -105.91 143.88 33.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.064 -0.971 . . . . 1.23 109.038 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.579 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -28.36 144.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.187 0.929 . . . . 1.63 112.555 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.67 111.02 15.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.41 110.911 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.784 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.2 mp -88.8 120.29 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.7 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.7 m -57.82 -13.02 3.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.812 -0.631 . . . . 0.44 112.408 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.784 ' H ' HG22 ' A' ' 95' ' ' ILE . 26.4 p 43.77 70.62 0.3 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.887 0.375 . . . . 1.1 111.287 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -101.1 -87.95 0.38 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.982 -0.554 . . . . 3.0 111.187 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -126.38 8.61 7.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 2.14 111.485 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.9 t0 50.39 25.24 1.82 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.844 0.354 . . . . 2.06 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 101' ' ' VAL . 14.8 p -141.36 9.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 2.8 111.83 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 29.65 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.844 0.683 . . . . 4.58 112.844 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.219 -0.896 . . . . 3.79 111.048 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.653 0.263 . . . . 2.74 111.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.692 ' O ' HG22 ' A' ' 2' ' ' ILE . 72.3 Cg_endo -79.41 -28.94 3.29 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.455 2.104 . . . . 2.06 112.404 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.97 HD11 ' ND2' ' A' ' 80' ' ' ASN . 7.3 tt 53.9 146.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 124.047 0.842 . . . . 0.68 112.341 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -134.22 119.71 14.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 2.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.8 171.35 18.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.501 2.134 . . . . 0.5 112.79 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 45.6 Cg_exo -56.72 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.805 2.337 . . . . 0.71 112.556 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 -171.33 39.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.85 -0.691 . . . . 0.66 112.576 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 33.8 tttt -73.76 128.96 85.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.369 0.128 . . . . 1.52 110.825 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 20.4 Cg_exo -69.19 143.92 55.24 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.44 112.713 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.19 97.41 5.23 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.586 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.3 Cg_exo -50.14 128.82 23.51 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.252 1.968 . . . . 0.64 113.493 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 21' ' ' LYS . 2.8 mm? -83.97 -35.43 23.97 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.184 -1.043 . . . . 1.64 108.184 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -139.83 144.48 37.32 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.583 -1.19 . . . . 0.72 107.891 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -136.35 102.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.778 0.659 . . . . 0.96 112.778 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -106.42 144.3 33.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.33 -0.85 . . . . 1.46 110.173 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -46.33 -23.69 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.693 -0.685 . . . . 2.42 112.78 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 17' ' ' THR . 7.8 m170 -125.9 -1.59 7.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.505 0.557 . . . . 1.02 112.505 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' HIS . 1.8 p -157.91 115.23 2.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.943 0.401 . . . . 0.68 110.487 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 HG22 ' A' ' 13' ' ' ILE . 57.9 t -119.0 114.57 45.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.8 112.032 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 12.7 m -83.34 146.82 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.35 109.928 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.28 160.17 43.38 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.847 0.684 . . . . 0.52 112.847 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.725 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.49 147.92 32.69 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.854 -1.066 . . . . 1.84 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.4 p90 -142.68 -177.8 5.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.4 111.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 176.62 7.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.83 112.049 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -115.95 143.33 30.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.742 -0.663 . . . . 2.11 110.899 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 73.5 Cg_exo -51.55 -179.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.531 2.154 . . . . 0.89 112.426 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.157 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 3.1 pm0 -125.69 -35.27 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 2.77 111.927 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -106.73 -69.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.173 0.434 . . . . 1.37 112.173 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 40.9 p 56.2 40.42 30.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.91 110.426 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.22 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.873 -0.68 . . . . 1.01 112.109 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.34 35.0 1.59 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.362 -1.095 . . . . 0.98 110.362 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.663 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 3.1 m-85 -113.16 -178.11 3.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.812 -0.694 . . . . 0.87 111.71 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 1.41 2.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.697 -0.683 . . . . 2.26 112.224 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 79' ' ' LYS . 7.3 mt 57.97 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.117 0.484 . . . . 1.71 111.769 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -132.79 6.97 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.021 -0.536 . . . . 1.15 111.997 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -179.41 142.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.865 0.364 . . . . 1.58 111.474 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 35.6 m-85 -113.85 109.6 18.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.844 -0.617 . . . . 0.76 111.423 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -89.29 104.6 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.14 110.63 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -99.3 119.0 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.63 111.209 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -80.12 163.08 24.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.649 -0.705 . . . . 1.67 111.236 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -118.82 168.07 11.11 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.658 -0.701 . . . . 1.97 109.285 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.94 87.05 0.98 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.793 -0.763 . . . . 1.44 111.386 177.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.842 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -66.51 85.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 1.59 110.963 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -61.94 159.4 36.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.595 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.9 Cg_exo -80.83 21.67 9.18 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.261 -1.141 . . . . 1.43 113.703 0.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.403 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 67.2 m-80 -132.41 -85.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.027 -0.269 . . . . 2.66 110.536 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.94 -164.7 0.02 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.073 -0.584 . . . . 1.12 112.945 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.51 145.07 3.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 2.41 110.491 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 53.7 m95 -65.58 77.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.638 -0.71 . . . . 0.65 111.786 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -112.78 156.65 22.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.998 -0.547 . . . . 1.28 109.855 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -50.25 90.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.689 0.281 . . . . 1.3 111.24 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB2' ' CB ' ' A' ' 40' ' ' LYS . . . -60.2 -31.63 70.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.29 0.567 . . . . 0.86 109.514 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.776 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.9 p-10 -91.69 -145.41 0.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.289 -0.868 . . . . 2.01 110.492 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 175.85 -33.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.86 0.362 . . . . 2.08 110.194 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -91.92 171.53 9.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.89 110.738 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.63 105.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.87 111.086 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 52' ' ' ASN . 14.4 mt -87.98 53.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.69 110.306 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.3 tm? -44.2 -54.6 5.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.978 -0.556 . . . . 1.6 111.233 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -84.07 158.95 21.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.089 -0.505 . . . . 1.54 109.974 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.481 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 12.4 p30 -80.37 4.68 17.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.43 -0.35 . . . . 1.75 111.587 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -98.38 94.34 6.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.013 -0.736 . . . . 2.05 109.013 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 74.3 t80 -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.142 0.496 . . . . 0.48 112.052 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.507 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 10.9 m -133.74 109.62 9.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.42 110.954 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.74 HG21 ' CE1' ' A' ' 74' ' ' PHE . 27.8 m -67.42 114.31 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 1.08 111.238 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -117.42 129.44 55.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.892 -0.594 . . . . 1.33 111.21 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.21 6.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.9 112.857 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.33 -158.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 1.47 110.548 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.6 m -138.04 147.78 44.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.496 -0.32 . . . . 1.06 110.181 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -82.5 142.01 32.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 1.91 111.332 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t0 65.94 60.08 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.547 . . . . 1.87 111.36 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.66 128.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 0.49 110.919 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.81 143.53 50.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.806 0.336 . . . . 0.36 110.422 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 2.0 m-85 -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.529 0.566 . . . . 0.56 112.529 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.793 ' OE1' ' HB2' ' A' ' 94' ' ' ALA . 6.5 tp10 -101.54 140.55 35.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.018 -0.734 . . . . 1.5 109.018 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.74 ' CE1' HG21 ' A' ' 63' ' ' VAL . 8.6 m-85 -123.82 110.54 15.02 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.668 0.988 . . . . 0.6 113.668 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 ttm180 -90.32 159.83 16.43 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.636 -0.711 . . . . 2.11 109.962 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 47.8 t -130.7 120.7 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.536 0.939 . . . . 0.6 113.536 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.6 mt -123.33 153.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.703 -1.591 . . . . 0.7 106.703 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -173.21 123.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.417 -1.313 . . . . 0.6 113.937 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 33' ' ' ILE . 18.4 mttt -68.21 158.8 32.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.97 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -99.8 -91.35 0.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.843 -0.743 . . . . 2.19 111.805 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -133.89 -42.63 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.276 0.472 . . . . 1.08 112.276 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.663 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -95.05 40.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.33 0.493 . . . . 1.06 112.33 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.73 8.72 41.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.93 113.196 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.75 92.66 4.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.0 0.4 . . . . 1.38 109.947 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -62.71 107.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.28 0.474 . . . . 0.79 112.28 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 8.3 p -62.89 121.92 71.46 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.005 -0.739 . . . . 0.59 109.005 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.59 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.266 . . . . 0.85 112.624 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 4.2 Cg_exo -73.3 155.37 51.34 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.822 2.348 . . . . 0.76 112.829 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.26 135.34 53.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.626 -0.715 . . . . 1.28 110.304 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.4 tt0 -35.24 110.89 0.42 Allowed Pre-proline 0 N--CA 1.469 0.503 0 O-C-N 124.0 0.812 . . . . 1.77 111.848 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 75.3 Cg_exo -50.96 145.46 24.55 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.827 2.351 . . . . 0.55 114.4 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.62 149.86 41.76 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.608 -0.886 . . . . 1.23 108.608 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -34.12 155.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.076 0.86 . . . . 1.63 112.093 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -89.31 110.82 21.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.41 111.847 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.664 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.2 mp -88.22 112.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.44 111.167 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.486 HG21 ' NH1' ' A' ' 98' ' ' ARG . 85.6 m -42.77 -29.9 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.004 0.43 . . . . 0.44 110.87 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.531 ' H ' HG22 ' A' ' 95' ' ' ILE . 84.7 m 51.07 69.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 1.1 110.439 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 1.035 ' HD3' ' CD ' ' A' ' 102' ' ' GLU . 1.5 ptp85 -111.87 -87.51 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 3.0 110.824 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.303 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 1.2 p30 -123.49 0.27 8.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.111 -0.495 . . . . 2.14 110.884 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.2 t0 45.39 26.95 0.32 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 2.06 111.71 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.849 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 10.6 p -153.38 19.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 2.8 111.542 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.303 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -145.16 12.09 1.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.095 0.405 . . . . 4.58 112.095 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.012 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.232 -0.89 . . . . 3.79 111.097 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.719 0.295 . . . . 2.74 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.29 124.83 2.89 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.747 2.298 . . . . 2.06 112.615 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.9 tt -99.54 146.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.68 110.89 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 28' ' ' THR . 9.8 m-20 -130.12 135.08 26.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 2.0 110.193 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -83.3 175.16 8.5 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.558 2.172 . . . . 0.5 112.837 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -65.18 171.64 8.71 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.914 2.409 . . . . 0.71 112.676 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.74 173.04 53.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.007 -0.616 . . . . 0.66 112.831 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -63.9 123.23 81.12 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.498 0.149 . . . . 1.52 110.677 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 34.8 Cg_exo -65.27 131.1 27.25 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.453 2.102 . . . . 0.44 112.699 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 108.01 20.74 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.007 -0.542 . . . . 1.09 110.575 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 39.0 Cg_exo -58.94 115.07 2.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.471 2.114 . . . . 0.64 113.976 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -77.71 -38.43 47.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.885 -0.783 . . . . 1.64 108.885 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -133.73 145.36 49.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.8 -1.091 . . . . 0.72 108.701 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.071 HG22 HG13 ' A' ' 18' ' ' VAL . 1.7 pt -141.0 97.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.598 0.592 . . . . 0.96 112.598 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.96 147.7 23.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.643 -0.708 . . . . 1.46 109.34 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -53.5 -18.28 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.226 0.454 . . . . 2.42 112.226 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.463 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 2.5 m-70 -126.78 -4.22 6.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.272 0.471 . . . . 1.02 112.272 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 116.46 5.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.873 0.368 . . . . 0.68 111.107 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 13' ' ' ILE . 66.6 t -105.25 134.41 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.009 0.433 . . . . 0.8 111.167 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 m -111.96 122.47 47.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.35 110.669 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.98 149.23 52.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.753 0.787 . . . . 0.52 112.203 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.936 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 7.0 tptt -133.09 139.01 46.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.427 -1.261 . . . . 1.84 109.704 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.9 p90 -128.64 -174.98 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.056 0.455 . . . . 0.4 111.881 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.23 179.33 5.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.83 112.044 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -107.88 138.68 20.13 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 2.11 110.221 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 28' ' ' THR . 79.9 Cg_exo -44.21 171.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.418 2.079 . . . . 0.89 112.613 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -110.89 -25.06 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 2.77 111.992 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.51 -69.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.158 0.429 . . . . 1.37 112.158 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 25' ' ' PRO . 64.4 p 51.37 56.22 8.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.91 110.704 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.12 -93.46 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.966 -0.561 . . . . 1.01 112.844 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.02 32.95 1.05 Allowed Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.008 -1.237 . . . . 0.98 110.008 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.99 179.54 3.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.738 -0.731 . . . . 0.87 111.009 -178.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.34 -3.17 3.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.179 -0.464 . . . . 2.26 112.185 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.1 mt 61.27 138.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.921 0.391 . . . . 1.71 110.606 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -140.78 24.72 2.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 1.15 111.525 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.2 m -166.51 102.69 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 1.58 111.618 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 33.8 m-85 -98.12 115.64 28.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.76 110.454 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -104.63 112.71 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.14 111.199 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -101.54 114.59 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 0.63 110.74 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -79.6 151.24 30.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.522 -0.763 . . . . 1.67 110.347 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -121.27 140.13 52.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.168 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.699 ' O ' HD22 ' A' ' 43' ' ' LEU . 9.5 ttp180 -121.73 116.4 24.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.44 110.371 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -76.57 102.69 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 1.59 110.798 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.6 mm? -88.65 156.83 50.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.531 -0.304 . . . . 0.9 110.738 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -91.54 36.27 6.24 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.152 -1.187 . . . . 1.43 112.377 0.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.47 83.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 2.66 111.163 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -155.74 -164.82 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.207 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.627 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.77 172.57 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 2.41 111.279 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.651 ' O ' HD22 ' A' ' 49' ' ' LEU . 68.4 m95 -78.8 118.36 20.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.57 -0.741 . . . . 0.65 112.212 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -147.37 127.03 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.28 110.649 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.24 99.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 1.3 111.625 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.31 -38.37 89.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.246 0.546 . . . . 0.86 110.338 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.5 p-10 -70.4 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.01 110.963 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 172.44 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.76 0.314 . . . . 2.08 110.461 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -81.33 -159.77 0.29 Allowed 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.35 -0.386 . . . . 1.89 110.641 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -102.94 97.83 7.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 1.87 111.05 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 36' ' ' TYR . 28.8 mt -81.25 87.94 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.69 111.127 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.45 -53.74 9.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 1.6 111.074 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.64 164.82 21.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.54 110.562 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -81.21 4.55 19.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.46 . . . . 1.75 111.644 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.936 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.9 tp10 -106.93 96.21 6.27 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 120.802 0.335 . . . . 2.05 110.179 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 67.3 t80 -124.43 164.36 19.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.48 111.298 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.0 m -132.14 114.06 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.42 110.959 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.484 HG23 HD21 ' A' ' 66' ' ' LEU . 24.6 m -76.21 133.05 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.08 111.064 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 133.01 49.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.973 -0.558 . . . . 1.33 110.949 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.89 -2.16 4.76 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.683 -0.77 . . . . 0.9 113.145 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -58.38 -173.67 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.975 0.417 . . . . 1.47 111.232 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -139.76 141.61 36.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.806 -0.634 . . . . 1.06 110.634 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 6.6 mt-10 -64.57 146.51 54.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.095 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 5.9 m-20 63.83 57.36 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 1.87 111.344 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.03 124.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.706 0.289 . . . . 0.49 111.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -66.4 138.07 57.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.522 -0.308 . . . . 0.36 110.172 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.71 117.57 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.448 0.536 . . . . 0.56 112.448 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.646 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.72 144.2 28.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.906 -0.776 . . . . 1.5 108.906 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.796 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -135.59 115.39 12.98 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.24 1.2 . . . . 0.6 114.24 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.2 ptp180 -105.59 177.97 4.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.987 -1.116 . . . . 2.11 107.987 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -154.24 126.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 122.257 1.027 . . . . 0.6 113.225 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' SER . 11.3 mt -105.45 152.99 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.7 106.958 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.11 135.92 8.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.01 -1.076 . . . . 0.6 112.762 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HG2' HD12 ' A' ' 85' ' ' ILE . 5.5 mttt -80.16 -169.63 2.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.526 -0.761 . . . . 1.98 110.384 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.739 ' ND2' HD12 ' A' ' 2' ' ' ILE . 3.7 p30 -135.54 171.74 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.195 0.522 . . . . 2.19 111.336 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.94 -25.07 1.22 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.754 . . . . 1.08 111.859 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.15 -20.67 28.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.267 0.469 . . . . 1.06 112.267 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 79' ' ' LYS . . . 110.32 -18.37 28.02 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.279 -0.962 . . . . 0.93 112.319 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.685 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -62.09 144.35 55.41 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 110.203 -0.295 . . . . 1.38 110.203 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -94.17 117.8 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.79 112.008 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.1 p -78.77 127.94 78.54 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.549 -0.75 . . . . 0.59 110.259 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -34.69 159.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.592 2.861 . . . . 0.85 114.076 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 6.2 Cg_exo -74.28 138.74 25.37 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.06 2.507 . . . . 0.76 112.555 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.531 ' OG ' HG13 ' A' ' 76' ' ' VAL . 79.1 p -88.76 130.47 35.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.132 -0.485 . . . . 1.28 110.016 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -34.53 122.51 0.55 Allowed Pre-proline 0 N--CA 1.469 0.478 0 O-C-N 123.743 0.652 . . . . 1.77 112.338 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 33.7 Cg_exo -55.97 145.58 73.39 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.456 2.104 . . . . 0.55 113.345 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.12 149.12 35.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.606 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -36.0 142.26 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.829 0.705 . . . . 1.63 112.128 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.09 112.69 14.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.41 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -93.11 118.16 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.252 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 98' ' ' ARG . 88.7 m -48.51 -37.83 18.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.202 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 69' ' ' ASP . 66.9 m 55.49 90.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.809 0.338 . . . . 1.1 110.767 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -143.65 -86.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 3.0 110.378 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.147 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.8 -11.09 15.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 2.14 110.849 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.56 21.29 1.76 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.209 -0.45 . . . . 2.06 111.716 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.147 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.3 t -123.38 -11.09 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.338 -0.392 . . . . 2.8 111.302 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.76 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 1.3 mp0 -115.91 -14.84 11.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.586 0.231 . . . . 4.58 111.006 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.253 -0.88 . . . . 3.79 111.299 -179.881 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.818 0.342 . . . . 2.74 111.28 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.423 ' HD2' ' CE2' ' A' ' 27' ' ' TYR . 88.1 Cg_endo -90.69 72.16 1.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.07 2.514 . . . . 2.06 112.158 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.787 HD11 ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -56.37 135.51 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.68 111.245 -179.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -128.65 148.45 68.47 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0 111.551 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.38 160.12 14.94 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.98 2.453 . . . . 0.5 112.937 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.4 Cg_endo -54.64 -176.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.898 2.399 . . . . 0.71 112.378 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -176.45 51.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.901 -0.666 . . . . 0.66 112.492 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -74.13 128.05 86.93 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.412 -0.218 . . . . 1.52 110.412 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 14.2 Cg_exo -72.28 126.72 11.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.297 1.998 . . . . 0.44 112.872 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.73 105.99 50.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.613 -0.721 . . . . 1.09 109.502 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.6 Cg_exo -43.12 92.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.364 2.043 . . . . 0.64 113.98 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.453 HD23 ' CG2' ' A' ' 19' ' ' THR . 1.9 tp -57.74 -29.45 64.77 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.315 -0.857 . . . . 1.64 109.335 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -159.99 153.35 22.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.161 -0.927 . . . . 0.72 108.966 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.136 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 1.4 pt -142.72 141.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.361 0.6 . . . . 0.96 112.446 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.633 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -138.56 142.91 39.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.154 -0.93 . . . . 1.46 109.886 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -44.92 -24.47 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.609 0.596 . . . . 2.42 112.609 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -125.19 -6.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.402 0.519 . . . . 1.02 112.402 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.11 111.09 5.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.68 110.92 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 HG22 ' A' ' 13' ' ' ILE . 69.6 t -106.1 122.02 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.8 111.514 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.8 m -99.38 135.47 40.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.35 110.825 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -137.7 143.36 41.23 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.662 0.744 . . . . 0.52 111.338 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -126.81 149.59 49.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.66 -1.155 . . . . 1.84 110.011 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.1 p90 -143.61 -175.69 4.67 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.279 0.561 . . . . 0.4 112.367 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.63 -174.03 4.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 0.83 111.428 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 137.3 21.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 2.11 109.941 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 28' ' ' THR . 6.2 Cg_exo -36.12 153.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.245 2.63 . . . . 0.89 112.736 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.06 -40.31 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 2.77 111.862 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE2' ' HD2' ' A' ' 1' ' ' PRO . 23.2 t80 -130.98 -63.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 1.37 111.804 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 25' ' ' PRO . 6.1 p 52.31 45.22 28.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.91 110.793 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.25 -112.11 0.91 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.188 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.44 28.35 5.3 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.408 -1.077 . . . . 0.98 110.408 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -114.07 173.97 6.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.159 -0.52 . . . . 0.87 110.991 -178.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.72 10.4 2.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.26 111.759 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.6 mt 59.33 116.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.942 0.401 . . . . 1.71 111.103 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -109.25 28.81 8.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 1.15 111.425 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 174.3 106.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.747 0.308 . . . . 1.58 111.329 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 33' ' ' ILE . 57.7 m-85 -94.38 124.74 38.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.76 110.969 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.4 mm -97.23 142.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 1.14 109.594 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.86 94.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.754 -0.378 . . . . 0.63 111.994 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 3.0 mt-10 -68.13 137.85 55.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.244 -0.651 . . . . 1.67 109.244 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.1 134.67 53.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 1.97 111.589 -179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HG2' HD12 ' A' ' 43' ' ' LEU . 8.7 ttp180 -108.6 104.46 13.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.78 -0.646 . . . . 1.44 109.895 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.28 82.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 1.59 110.665 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 41' ' ' ARG . 3.6 mp -50.56 155.83 1.73 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 0.9 111.088 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.34 32.71 7.58 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.653 -1.395 . . . . 1.43 112.836 0.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 -77.24 0.38 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.79 0.328 . . . . 2.66 111.108 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . 51.16 -175.2 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.82 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.92 30.54 0.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.962 0.41 . . . . 2.41 110.646 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 71.2 m95 45.25 96.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.65 111.59 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.448 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -131.01 123.55 29.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.841 -0.618 . . . . 1.28 110.217 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 10.8 ptpt -48.42 137.92 10.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.3 110.967 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -123.66 -36.51 2.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.86 111.553 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB3' HD11 ' A' ' 56' ' ' ILE . 2.5 p-10 -41.75 -62.56 0.87 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.509 -0.314 . . . . 2.01 111.696 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 t80 45.91 30.22 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.507 -0.315 . . . . 2.08 111.39 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.41 30.36 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 1.89 111.284 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 45.74 95.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.44 -0.345 . . . . 1.87 111.337 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 61' ' ' PHE . 7.5 mt -86.32 90.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.69 111.246 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.67 -44.13 67.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.158 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -100.13 153.36 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.92 0.39 . . . . 1.54 110.658 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 20.9 p-10 -66.3 -10.46 42.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 1.75 111.527 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HG3' ' CG ' ' A' ' 21' ' ' LYS . 2.9 tt0 -93.77 99.19 11.63 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.938 -0.764 . . . . 2.05 108.938 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.695 ' CG ' HD13 ' A' ' 56' ' ' ILE . 81.6 t80 -129.35 162.61 27.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.947 -0.701 . . . . 0.48 112.596 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 71.8 m -125.16 114.52 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.198 -0.91 . . . . 0.42 111.222 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.633 HG23 HD21 ' A' ' 20' ' ' LEU . 48.7 t -80.73 120.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.841 -0.618 . . . . 1.08 110.958 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -117.28 162.33 18.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.243 0.544 . . . . 1.33 110.988 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.26 -2.22 31.19 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.381 -0.827 . . . . 0.9 112.903 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -67.17 -176.1 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.077 0.465 . . . . 1.47 110.732 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.474 HG22 ' OH ' ' A' ' 72' ' ' TYR . 1.7 t -140.55 144.11 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.745 -0.661 . . . . 1.06 110.453 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.465 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 tt0 -64.55 144.28 57.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.25 -0.432 . . . . 1.91 110.782 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.4 t0 71.76 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.87 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.61 122.56 0.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.497 -0.32 . . . . 0.49 111.51 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.04 132.11 43.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.36 109.96 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.474 ' OH ' HG22 ' A' ' 67' ' ' THR . 52.1 m-85 -128.72 123.26 32.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.392 0.515 . . . . 0.56 112.392 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -101.7 144.15 30.76 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.699 -0.852 . . . . 1.5 108.699 178.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -130.51 114.93 16.11 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.27 1.582 . . . . 0.6 115.27 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 21.4 ttm-85 -99.7 157.51 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.361 -0.977 . . . . 2.11 108.361 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.881 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -135.05 128.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.232 -0.987 . . . . 0.6 112.819 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 86' ' ' SER . 57.0 mt -117.96 156.04 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.094 -1.412 . . . . 0.7 107.371 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.45 116.78 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 118.896 -1.122 . . . . 0.6 112.657 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 1.6 mmtp -59.13 -177.83 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.077 -0.649 . . . . 1.98 109.552 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.787 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.1 m120 -130.61 163.3 27.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.093 0.473 . . . . 2.19 111.498 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.2 -26.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.141 0.793 . . . . 1.08 113.141 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -102.84 11.57 37.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.907 0.706 . . . . 1.06 112.907 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 88.56 -2.16 84.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.266 -0.969 . . . . 0.93 113.273 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -68.97 120.53 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.139 0.47 . . . . 1.38 109.887 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -79.81 102.05 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.603 -0.439 . . . . 0.79 111.88 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.5 p -61.81 111.3 4.23 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.369 -0.604 . . . . 0.59 109.369 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -40.81 173.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.676 2.918 . . . . 0.85 114.608 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.07 128.88 24.07 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.098 2.532 . . . . 0.76 112.824 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.881 ' OG ' HG13 ' A' ' 76' ' ' VAL . 3.8 p -97.89 119.03 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.811 -0.631 . . . . 1.28 109.957 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -20.24 119.8 0.1 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.009 0.924 . . . . 1.77 112.673 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 27.8 Cg_exo -63.39 156.51 55.75 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.655 2.237 . . . . 0.55 114.385 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.487 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.67 149.73 25.11 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.022 -0.99 . . . . 1.23 109.316 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -37.44 158.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.869 0.731 . . . . 1.63 111.771 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -91.08 108.08 19.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.41 111.053 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.767 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -90.93 114.35 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.541 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 85.4 m -52.4 -31.16 32.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.1 m 57.04 93.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.34 . . . . 1.1 110.113 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -143.87 -86.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.501 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.156 ' OD2' HG13 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -104.67 -2.52 24.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 2.14 111.716 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.136 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER 43.78 27.58 0.18 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 112.564 0.579 . . . . 2.06 112.564 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.156 HG13 ' OD2' ' A' ' 99' ' ' ASP . 5.5 p -156.39 21.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.319 0.581 . . . . 2.8 111.302 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.28 -38.88 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 4.58 110.012 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.252 -0.88 . . . . 3.79 111.051 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.62 0.248 . . . . 2.74 111.277 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.27 -166.57 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.737 2.291 . . . . 2.06 111.774 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.686 HD11 ' HB3' ' A' ' 86' ' ' SER . 11.8 tt -150.61 154.0 9.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.68 111.135 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 2' ' ' ILE . 79.0 m-20 -137.7 127.3 15.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.76 154.2 34.21 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.256 1.971 . . . . 0.5 112.054 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.65 -179.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.717 2.278 . . . . 0.71 113.098 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.81 -157.15 3.69 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.66 112.749 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -91.41 134.08 30.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.7 -0.111 . . . . 1.52 110.7 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.0 Cg_exo -77.44 132.44 12.33 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.647 2.232 . . . . 0.44 112.157 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.1 123.29 10.33 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.445 -0.343 . . . . 1.09 111.538 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.631 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.8 Cg_exo -68.39 129.83 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.282 1.988 . . . . 0.64 112.822 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.379 -0.6 . . . . 1.64 109.379 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -140.65 100.89 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.72 109.609 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.742 HG21 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -98.68 140.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.92 -0.582 . . . . 0.96 112.071 -179.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -135.74 144.26 45.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.534 -0.757 . . . . 1.46 111.001 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 1.8 mtp180 -33.05 -47.97 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.58 0.956 . . . . 2.42 113.58 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -106.73 -14.49 15.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.338 0.866 . . . . 1.02 113.338 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' HD22 ' A' ' 66' ' ' LEU . 15.3 p -147.77 129.51 15.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.65 -0.42 . . . . 0.68 111.42 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.99 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -117.1 152.49 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.641 -0.423 . . . . 0.8 110.604 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.543 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.1 m -119.39 118.84 32.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.35 111.168 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.808 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.28 155.63 47.98 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.428 0.632 . . . . 0.52 111.288 179.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.61 159.64 42.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.031 -0.986 . . . . 1.84 109.905 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' N ' ' HD3' ' A' ' 21' ' ' LYS . 11.8 p90 -137.93 -171.83 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.4 111.756 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.6 -171.93 3.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.83 111.591 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -124.22 139.71 33.35 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 2.11 111.0 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 28' ' ' THR . 16.8 Cg_endo -58.65 179.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.89 112.106 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.17 0.29 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.156 0.428 . . . . 2.77 112.156 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -132.56 -72.6 0.52 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 121.082 -0.247 . . . . 1.37 111.126 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 25' ' ' PRO . 6.0 p 42.77 55.28 4.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.614 0.245 . . . . 0.91 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.54 1.3 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.217 -0.516 . . . . 1.01 112.671 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.57 30.29 5.8 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.444 -1.063 . . . . 0.98 110.444 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.517 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.38 177.91 4.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.971 -0.614 . . . . 0.87 111.531 -178.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 -2.14 3.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.715 -0.675 . . . . 2.26 111.941 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.713 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.9 mt 55.75 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-O 121.007 0.432 . . . . 1.71 110.746 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -106.18 17.82 22.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 1.15 111.651 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.67 138.98 0.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.804 0.335 . . . . 1.58 111.594 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 56' ' ' ILE . 48.3 m-85 -120.25 141.94 49.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.115 -0.493 . . . . 0.76 110.342 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' A' ' 50' ' ' LYS . 10.9 mm -108.17 156.24 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 1.14 110.767 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.452 -0.34 . . . . 0.63 111.123 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt-10 -77.85 120.81 23.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 1.67 109.574 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -106.33 148.84 27.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.362 0.601 . . . . 1.97 111.961 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 3.2 ttp180 -131.06 111.42 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.158 -0.928 . . . . 1.44 109.557 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.3 79.88 1.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.611 -0.722 . . . . 1.59 110.528 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.728 HD12 ' HB1' ' A' ' 94' ' ' ALA . 16.0 mt -63.54 142.66 97.96 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.9 110.858 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -93.64 13.42 47.9 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.059 -1.226 . . . . 1.43 112.765 0.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.7 OUTLIER -130.44 86.77 2.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.751 0.31 . . . . 2.66 111.007 -179.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.52 173.17 44.37 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.584 -0.817 . . . . 1.12 112.718 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.677 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -135.16 143.2 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 2.41 110.589 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 83.2 m95 -50.02 103.43 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.65 111.234 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.677 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -133.79 141.57 47.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.488 -0.323 . . . . 1.28 110.603 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' A' ' 37' ' ' ILE . 46.2 mtpt -44.87 104.7 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.872 0.368 . . . . 1.3 111.36 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -69.98 -51.04 35.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.079 -0.51 . . . . 0.86 110.655 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.72 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -53.22 -64.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 2.01 109.872 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 t80 62.33 38.23 13.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.405 -0.361 . . . . 2.08 111.487 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -160.44 -89.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.71 -0.223 . . . . 1.89 111.495 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.732 HD21 HD22 ' A' ' 57' ' ' LEU . 4.3 t-20 -158.87 141.21 14.01 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.913 0.387 . . . . 1.87 110.688 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 61' ' ' PHE . 41.7 mt -139.28 65.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.69 110.729 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.732 HD22 HD21 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -48.71 -63.28 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.6 111.2 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -82.74 160.72 22.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.936 0.398 . . . . 1.54 110.527 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.469 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -72.25 -7.25 48.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.958 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 2.9 tt0 -97.41 97.91 9.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.79 -0.448 . . . . 2.05 109.79 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.85 ' HB2' HG23 ' A' ' 56' ' ' ILE . 62.4 t80 -129.82 165.2 22.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.0 -0.546 . . . . 0.48 111.354 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 18' ' ' VAL . 43.9 m -122.03 121.75 37.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.962 -0.563 . . . . 0.42 110.508 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.947 HG13 ' HB1' ' A' ' 51' ' ' ALA . 25.1 t -80.61 100.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.952 -0.567 . . . . 1.08 111.56 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.542 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -94.29 138.16 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.78 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.3 -13.11 4.63 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.869 -0.681 . . . . 0.9 112.385 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.99 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -55.74 -173.83 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.708 0.29 . . . . 1.47 110.462 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 m -152.01 163.71 38.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 1.06 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 tt0 -74.97 123.42 25.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 1.91 110.887 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.4 t0 75.11 65.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.043 -0.526 . . . . 1.87 111.498 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.6 113.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.899 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.46 133.73 53.06 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.766 -0.374 . . . . 0.36 110.202 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 29.3 m-85 -126.29 118.11 24.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.21 -0.45 . . . . 0.56 112.191 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.15 141.45 34.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 1.5 109.933 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.61 115.81 10.44 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.366 1.247 . . . . 0.6 114.366 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 6.0 ptt85 -97.63 163.75 12.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.927 -0.768 . . . . 2.11 108.927 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' CG ' ' A' ' 8' ' ' PRO . 48.7 t -116.94 133.82 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.778 0.659 . . . . 0.6 112.778 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 88' ' ' PRO . 40.6 mt -132.98 165.62 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.726 -1.213 . . . . 0.7 107.726 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 77' ' ' ILE . . . 177.07 134.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.908 -0.717 . . . . 0.6 112.107 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.4 ptpt -67.17 -99.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.653 -0.819 . . . . 1.98 109.289 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.63 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER 170.43 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 110.497 -0.186 . . . . 2.19 110.497 179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.66 -42.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.029 -0.419 . . . . 1.08 110.729 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.08 -10.27 59.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.574 . . . . 1.06 112.237 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.21 -11.29 40.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.178 -1.01 . . . . 0.93 112.501 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.86 115.87 4.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.112 -0.329 . . . . 1.38 110.112 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.9 tp -72.81 122.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.374 0.509 . . . . 0.79 112.374 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.686 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.6 p -89.36 131.74 39.52 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.959 -0.386 . . . . 0.59 109.959 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 74.3 Cg_exo -41.11 173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.571 2.847 . . . . 0.85 114.311 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 77' ' ' ILE . 87.9 Cg_endo -87.56 172.79 5.63 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.235 2.623 . . . . 0.76 113.727 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -130.57 125.29 33.8 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.165 -0.925 . . . . 1.28 109.561 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -19.98 114.63 0.11 Allowed Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.228 0.955 . . . . 1.77 113.224 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 87.1 Cg_exo -47.7 144.02 11.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.699 2.266 . . . . 0.55 113.653 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.67 143.12 46.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.422 -0.808 . . . . 1.23 108.83 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -31.69 135.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.294 0.996 . . . . 1.63 112.568 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.25 99.78 1.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.623 -0.717 . . . . 0.41 109.718 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -77.46 109.4 11.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 0.44 110.946 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 59.5 m -49.12 -25.67 2.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.065 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' H ' HG22 ' A' ' 95' ' ' ILE . 80.4 m 52.43 38.39 25.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 1.1 110.744 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 1.033 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 17.2 ptp180 -71.98 -47.53 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 3.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.294 ' OD2' HG21 ' A' ' 101' ' ' VAL . 20.1 p-10 -161.34 33.98 0.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.468 -0.787 . . . . 2.14 110.284 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 50.97 21.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 2.06 111.61 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.294 HG21 ' OD2' ' A' ' 99' ' ' ASP . 2.3 m -114.1 -26.57 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.936 -0.574 . . . . 2.8 110.101 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.73 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 40.62 64.77 0.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.033 -0.531 . . . . 4.58 111.549 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.195 -0.907 . . . . 3.79 111.066 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.444 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.582 0.23 . . . . 2.74 111.149 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 4.7 Cg_exo -79.0 169.91 18.65 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.718 2.279 . . . . 2.06 111.489 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.933 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.5 tt -171.03 140.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.416 . . . . 0.68 111.753 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.141 ' OD2' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.82 114.53 13.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 2.0 110.458 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.24 171.73 13.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.996 1.797 . . . . 0.5 112.126 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 34.5 Cg_exo -59.24 179.32 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.839 2.359 . . . . 0.71 112.789 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -86.91 171.44 42.85 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.094 -0.574 . . . . 0.66 113.051 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 tttt -59.72 125.14 79.25 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 110.326 -0.25 . . . . 1.52 110.326 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 19.4 Cg_exo -71.53 143.74 43.32 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.44 113.035 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.24 105.45 7.89 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 1.09 110.537 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 31.7 Cg_exo -54.11 128.76 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.277 1.985 . . . . 0.64 113.676 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 21' ' ' LYS . 1.3 mm? -95.81 -26.68 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.697 -0.683 . . . . 1.64 109.531 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -152.52 152.41 31.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.737 -0.665 . . . . 0.72 110.478 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.59 111.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.94 0.4 . . . . 0.96 110.287 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -109.16 69.0 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.841 0.682 . . . . 1.46 112.841 -178.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 1.7 mtp180 28.1 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 2.42 113.147 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.7 OUTLIER 176.69 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.213 0.53 . . . . 1.02 109.596 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 p -112.25 93.7 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.68 110.708 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.881 HG11 ' CE1' ' A' ' 74' ' ' PHE . 48.0 t -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.558 -0.746 . . . . 0.8 110.789 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 56.0 m -90.13 144.27 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.35 111.9 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.62 165.65 32.72 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.962 -1.017 . . . . 0.52 111.903 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.757 ' HB3' HD21 ' A' ' 11' ' ' LEU . 15.6 tptm -143.47 138.72 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.744 -1.117 . . . . 1.84 110.13 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.0 p90 -125.83 -176.56 3.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.4 111.962 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -100.71 116.98 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.528 -0.76 . . . . 0.83 110.972 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 144.21 49.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.523 -0.308 . . . . 2.11 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HG3' HD12 ' A' ' 33' ' ' ILE . 58.2 Cg_endo -70.19 169.92 18.32 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.614 2.209 . . . . 0.89 112.412 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.32 -45.8 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 2.77 111.048 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.141 ' C ' ' OD2' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -89.75 66.06 6.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.846 -0.342 . . . . 1.37 111.286 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.541 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 61.5 p -95.88 50.9 1.22 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.631 -0.507 . . . . 0.91 109.631 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.16 -93.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.74 -0.663 . . . . 1.01 112.303 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.32 26.81 2.79 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.22 -0.752 . . . . 0.98 111.22 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.535 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -118.28 -175.5 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.143 0.497 . . . . 0.87 111.41 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 5.48 2.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.579 -0.737 . . . . 2.26 111.876 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.1 mt 60.91 134.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.081 0.467 . . . . 1.71 110.654 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 p -108.1 2.37 22.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.15 112.087 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' ILE . 8.7 t -176.63 -176.12 0.7 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.58 111.85 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.7 m-85 -149.45 100.36 3.0 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.76 109.664 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mt -84.65 121.87 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.943 -0.303 . . . . 1.14 111.304 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.17 103.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.161 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 18.5 mt-10 -74.74 133.74 41.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.659 -0.497 . . . . 1.67 109.659 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.633 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -116.88 147.68 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 1.97 111.853 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 16.0 ttp180 -123.66 114.44 19.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.79 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -77.42 78.67 3.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.022 -0.535 . . . . 1.59 110.655 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.6 mt -52.78 154.27 5.05 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.9 110.827 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.19 0.35 34.38 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.688 -1.38 . . . . 1.43 113.213 0.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -97.64 -85.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.28 . . . . 2.66 111.11 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.31 175.98 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.697 -0.763 . . . . 1.12 112.581 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD3' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -164.2 30.1 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.097 0.475 . . . . 2.41 110.309 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 57.8 m95 50.21 94.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.65 110.984 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -127.64 126.67 42.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 1.28 110.622 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -42.14 93.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 1.3 111.522 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -54.71 -51.31 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.86 110.971 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -65.08 114.45 4.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.943 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.35 16.13 7.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 2.08 111.198 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -136.72 -160.15 1.03 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 1.89 110.981 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -98.77 113.48 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.87 111.134 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 52' ' ' ASN . 20.3 mm -87.56 59.03 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.69 110.854 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.4 tp -43.59 -57.87 2.93 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.91 0.386 . . . . 1.6 110.613 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 pt-20 -79.0 165.94 22.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -88.11 15.65 7.16 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.995 0.368 . . . . 1.75 111.995 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.7 111.6 18.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.372 -0.603 . . . . 2.05 109.372 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.717 ' CG ' HD12 ' A' ' 56' ' ' ILE . 73.7 t80 -139.73 163.36 32.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.48 112.051 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.2 m -114.03 106.13 14.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.06 -0.973 . . . . 0.42 110.668 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 51' ' ' ALA . 90.8 t -66.8 82.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.44 -0.8 . . . . 1.08 111.312 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -88.03 -175.3 5.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 1.33 110.936 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 23.93 72.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.9 112.782 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 63' ' ' VAL . 14.0 mt -97.1 -162.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 1.47 111.021 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 68' ' ' GLU . 52.0 m -138.0 159.4 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 1.06 111.025 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 67' ' ' THR . 23.8 tt0 -90.13 148.34 23.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 1.91 111.109 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.4 40.69 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.87 111.224 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -155.37 131.45 10.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.49 110.845 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.86 135.41 45.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.483 -0.326 . . . . 0.36 110.361 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 30.5 m-85 -130.89 124.79 31.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.399 0.518 . . . . 0.56 112.399 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.4 tt0 -102.97 139.24 38.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.631 -0.878 . . . . 1.5 108.631 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.881 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.08 118.85 13.15 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.26 1.578 . . . . 0.6 115.26 -178.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -105.22 179.67 4.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.283 -1.006 . . . . 2.11 108.283 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.2 OUTLIER -144.43 121.3 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.439 -0.905 . . . . 0.6 113.328 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 88' ' ' PRO . 61.7 mt -106.99 152.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.138 -1.43 . . . . 0.7 107.138 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -163.92 115.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.029 -1.068 . . . . 0.6 112.809 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -62.29 -175.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.85 -0.74 . . . . 1.98 109.644 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.933 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.1 m-80 -120.9 -114.13 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.569 -0.453 . . . . 2.19 111.572 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.93 -38.38 2.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.412 0.551 . . . . 1.08 111.361 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -92.19 23.46 3.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 1.06 111.588 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.83 0.74 89.87 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.628 -0.796 . . . . 0.93 113.311 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.94 112.83 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.987 0.394 . . . . 1.38 110.635 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.817 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -79.66 112.41 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.071 0.397 . . . . 0.79 112.071 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 5.4 p -71.59 121.45 84.44 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 120.433 -0.507 . . . . 0.59 109.81 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.51 164.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.827 2.352 . . . . 0.85 112.609 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HG3' HD11 ' A' ' 77' ' ' ILE . 3.8 Cg_exo -76.47 130.22 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.892 2.395 . . . . 0.76 112.895 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.608 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -76.88 131.71 38.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.28 109.482 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 10.8 mt-10 -32.98 119.57 0.43 Allowed Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 123.689 0.618 . . . . 1.77 112.349 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 52.4 Cg_exo -52.4 150.43 20.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.465 2.11 . . . . 0.55 113.197 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 142.57 29.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.475 -0.784 . . . . 1.23 109.207 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.658 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.74 140.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.07 0.856 . . . . 1.63 112.142 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -74.08 112.3 10.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.773 -0.648 . . . . 0.41 110.699 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -98.8 117.75 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.44 111.369 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.973 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 48.3 m -48.38 -28.33 3.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.327 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 95' ' ' ILE . 3.1 m 55.6 59.2 4.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.44 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 1.051 ' HD2' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.9 -42.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.252 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.284 ' OD1' ' HA ' ' A' ' 102' ' ' GLU . 7.7 p-10 -116.05 22.65 12.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.761 -0.654 . . . . 2.14 111.428 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 36.58 47.12 0.5 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.841 0.829 . . . . 2.06 111.314 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.949 HG12 ' O ' ' A' ' 99' ' ' ASP . 11.7 p 164.87 -25.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.072 -1.876 . . . . 2.8 109.511 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.284 ' HA ' ' OD1' ' A' ' 99' ' ' ASP . 3.0 mm-40 59.65 91.98 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.981 -0.554 . . . . 4.58 110.88 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' N ' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.202 -0.904 . . . . 3.79 111.215 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.755 0.312 . . . . 2.74 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -92.76 99.76 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.093 2.529 . . . . 2.06 112.544 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 2' ' ' ILE . 2.0 tt -93.17 127.78 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.68 111.049 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 28' ' ' THR . 71.4 m-20 -107.71 123.25 38.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.62 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.67 172.75 10.02 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.241 1.961 . . . . 0.5 112.276 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.9 Cg_endo -61.39 171.15 4.5 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.839 2.359 . . . . 0.71 112.68 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 -177.66 30.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.947 -0.644 . . . . 0.66 112.671 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tptt -68.5 118.47 60.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.253 -0.277 . . . . 1.52 110.253 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 21.8 Cg_exo -67.51 122.91 10.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.387 2.058 . . . . 0.44 111.733 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.76 112.69 28.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.518 -0.31 . . . . 1.09 111.303 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.6 Cg_exo -61.88 120.27 7.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.547 2.164 . . . . 0.64 113.5 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -84.56 -31.83 24.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 1.64 109.665 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -143.22 145.78 33.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.72 109.635 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.064 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -144.07 96.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.7 0.63 . . . . 0.96 112.7 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.105 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -82.87 158.65 22.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.225 -0.658 . . . . 1.46 109.225 178.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -60.61 -13.23 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.068 0.396 . . . . 2.42 112.068 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . 2.1 m-70 -139.08 25.55 2.49 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.952 0.353 . . . . 1.02 111.952 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -176.95 116.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.696 0.284 . . . . 0.68 110.922 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.064 HG13 HG22 ' A' ' 13' ' ' ILE . 86.4 t -105.38 137.26 35.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.392 . . . . 0.8 111.114 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.635 ' C ' HD13 ' A' ' 20' ' ' LEU . 16.6 m -117.91 122.37 43.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.552 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.757 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.33 152.67 51.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.739 0.78 . . . . 0.52 112.07 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 11' ' ' LEU . 9.5 tptt -133.35 155.03 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.411 -1.268 . . . . 1.84 109.707 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 20.9 p90 -145.34 -177.54 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 0.4 112.176 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.75 159.48 15.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.83 111.357 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -88.23 137.52 30.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.012 -0.54 . . . . 2.11 110.238 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' ILE . 2.6 Cg_endo -41.27 160.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.595 2.197 . . . . 0.89 111.929 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.74 -29.6 11.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.498 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -122.85 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 1.37 111.562 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 46.54 54.44 8.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.809 0.337 . . . . 0.91 110.863 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 37.79 -131.83 1.34 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.803 -0.635 . . . . 1.01 113.128 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 29.87 9.12 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.178 -1.169 . . . . 0.98 110.178 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -96.49 175.3 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.679 -0.761 . . . . 0.87 111.286 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -136.89 0.2 2.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.551 . . . . 2.26 112.255 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.449 HD11 ' HG3' ' A' ' 25' ' ' PRO . 27.7 mt 60.69 138.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 121.007 0.432 . . . . 1.71 111.004 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 p -120.2 -11.91 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.202 0.445 . . . . 1.15 112.202 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.61 138.51 2.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 1.58 111.54 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.0 m-85 -105.08 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.76 110.855 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -82.17 165.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.764 -0.458 . . . . 1.14 109.764 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -157.46 137.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.563 0.697 . . . . 0.63 111.164 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG3' HD12 ' A' ' 77' ' ' ILE . 6.1 mt-10 -105.35 134.53 48.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.767 -1.106 . . . . 1.67 110.185 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -103.79 146.97 27.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 1.97 111.194 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.7 ttm180 -119.44 113.96 21.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 1.44 110.581 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 92.79 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.316 -0.856 . . . . 1.59 109.69 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD11 ' HG3' ' A' ' 73' ' ' GLU . 7.8 mt -76.73 150.65 81.93 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.9 111.23 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -88.54 -2.22 62.59 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.741 -1.358 . . . . 1.43 113.038 0.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -123.67 79.46 1.7 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.886 0.374 . . . . 2.66 110.993 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.59 -166.16 10.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.797 -0.716 . . . . 1.12 112.377 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.634 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -157.95 151.25 23.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 2.41 110.898 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.714 ' O ' HD22 ' A' ' 49' ' ' LEU . 59.2 m95 -64.35 116.76 6.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.88 -0.6 . . . . 0.65 110.406 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.68 136.66 25.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.831 0.348 . . . . 1.28 111.206 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -44.82 110.09 0.21 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.3 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.78 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -84.85 -37.3 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.86 110.633 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.61 ' CB ' HD11 ' A' ' 56' ' ' ILE . 10.6 p-10 -82.43 178.6 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.569 . . . . 2.01 110.475 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 178.92 36.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 2.08 111.035 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.56 32.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 1.89 111.285 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.77 121.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.87 110.956 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 36' ' ' TYR . 22.3 mt -116.28 76.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.69 111.083 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.2 mt -59.43 -66.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.6 111.463 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 168.24 9.08 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.874 0.369 . . . . 1.54 110.674 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.8 m120 -86.61 8.06 23.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.077 -0.51 . . . . 1.75 111.419 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.84 103.88 12.74 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.694 0.283 . . . . 2.05 110.35 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' ILE . 65.1 t80 -135.16 163.12 30.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.48 111.677 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.1 m -122.93 117.23 25.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.644 -0.707 . . . . 0.42 111.216 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 51' ' ' ALA . 47.8 t -83.31 101.92 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.037 -0.529 . . . . 1.08 110.942 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 p -94.15 162.91 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.366 0.603 . . . . 1.33 110.997 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.49 7.35 24.38 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.969 -1.014 . . . . 0.9 111.983 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.3 mm? -54.33 168.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.264 0.554 . . . . 1.47 111.449 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -139.26 98.88 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.245 -0.889 . . . . 1.06 109.284 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.5 tm-20 -37.24 139.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.5 0.556 . . . . 1.91 112.5 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.18 42.34 0.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.726 -0.67 . . . . 1.87 110.827 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.27 124.48 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.49 111.532 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.79 137.77 54.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.945 -0.391 . . . . 0.36 109.945 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 30.6 m-85 -129.43 124.18 33.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.419 0.526 . . . . 0.56 112.419 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.847 ' HG3' HD11 ' A' ' 43' ' ' LEU . 12.0 mt-10 -100.96 141.72 33.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.473 -0.566 . . . . 1.5 109.473 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.46 ' HD2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.29 114.81 11.85 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.712 1.375 . . . . 0.6 114.712 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HD3' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.29 151.89 22.16 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.345 -0.613 . . . . 2.11 109.345 177.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -114.61 118.05 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.622 -0.831 . . . . 0.6 112.922 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' A' ' 88' ' ' PRO . 66.7 mt -103.41 136.45 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.993 -1.484 . . . . 0.7 106.993 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -151.33 139.28 19.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.502 -0.879 . . . . 0.6 111.965 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.721 ' HG2' HD12 ' A' ' 85' ' ' ILE . 19.5 mttp -66.8 -133.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.727 -0.789 . . . . 1.98 109.625 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.566 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -167.55 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.127 0.422 . . . . 2.19 110.153 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -154.15 -42.14 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.824 0.345 . . . . 1.08 110.754 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.38 -2.57 58.68 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.514 0.561 . . . . 1.06 112.514 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.09 62.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.249 -0.977 . . . . 0.93 113.332 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.25 81.16 3.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.155 0.502 . . . . 1.38 109.895 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.721 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -40.2 119.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 114.397 1.258 . . . . 0.79 114.397 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 3.8 p -73.06 109.36 6.08 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 106.765 -1.568 . . . . 0.59 106.765 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 9.4 Cg_endo -49.72 162.98 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.652 2.235 . . . . 0.85 113.799 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' A' ' 77' ' ' ILE . 53.2 Cg_exo -40.42 128.56 2.4 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.714 2.942 . . . . 0.76 114.53 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.538 ' OG ' HG13 ' A' ' 76' ' ' VAL . 78.2 p -102.19 100.88 11.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.127 -0.942 . . . . 1.28 110.268 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER 11.8 115.84 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 125.037 1.335 . . . . 1.77 114.387 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.535 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 6.5 Cg_exo -67.21 135.16 36.16 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.02 1.813 . . . . 0.55 113.011 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.33 144.05 56.18 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.339 -0.615 . . . . 1.23 109.339 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' HD12 ' A' ' 95' ' ' ILE . 8.8 m-20 -40.25 149.31 0.07 Allowed 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.66 0.6 . . . . 1.63 111.235 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -76.06 119.17 19.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.945 -0.571 . . . . 0.41 111.812 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.625 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -99.52 118.73 46.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.695 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 m -50.03 -38.0 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 0.44 111.124 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 2.8 m 62.23 43.96 8.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 1.1 110.503 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.558 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 1.4 ptp85 -84.96 -91.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.64 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.558 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 20.2 p-10 -113.46 28.19 8.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.541 -0.299 . . . . 2.14 110.406 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.105 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.41 25.61 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.228 0.537 . . . . 2.06 110.895 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 99' ' ' ASP . 3.4 m -112.65 -26.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.387 -0.824 . . . . 2.8 110.405 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.881 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.4 35.34 1.28 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.811 -0.631 . . . . 4.58 111.485 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB2' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.261 -0.876 . . . . 3.79 111.213 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.736 0.303 . . . . 2.74 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.48 150.1 21.82 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.175 2.583 . . . . 2.06 112.23 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 tt -131.93 132.13 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.365 -0.38 . . . . 0.68 111.057 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.12 131.71 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 2.0 110.654 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.73 168.6 15.81 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.589 2.193 . . . . 0.5 112.385 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 73.0 Cg_exo -49.12 179.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.453 2.102 . . . . 0.71 112.182 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.21 -167.17 42.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.66 112.815 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.69 114.21 22.93 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.642 -0.133 . . . . 1.52 110.642 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 13.3 Cg_exo -70.49 131.32 19.98 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.423 2.082 . . . . 0.44 112.494 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -142.55 106.92 5.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 1.09 111.66 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 78.3 Cg_exo -36.18 141.74 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.991 2.461 . . . . 0.64 112.79 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.14 -30.83 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.507 -0.553 . . . . 1.64 109.507 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.06 97.81 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 0.72 109.988 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.815 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -94.69 133.23 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.997 0.74 . . . . 0.96 112.997 -179.389 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.735 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -127.85 137.86 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.95 -1.023 . . . . 1.46 110.092 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.735 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.35 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.006 1.113 . . . . 2.42 114.006 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.1 m170 -120.16 -22.33 6.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.641 0.608 . . . . 1.02 112.641 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' HD22 ' A' ' 66' ' ' LEU . 13.6 p -134.44 130.33 36.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.25 -0.278 . . . . 0.68 110.25 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.104 HG13 HD23 ' A' ' 66' ' ' LEU . 4.5 m -124.91 141.34 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.142 0.496 . . . . 0.8 112.103 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.3 m -106.95 151.64 25.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.35 109.788 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.51 152.02 37.32 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.532 0.682 . . . . 0.52 112.021 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.71 147.46 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.581 -1.19 . . . . 1.84 109.675 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 26.4 p90 -146.69 -174.0 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.4 111.282 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -164.79 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.83 110.784 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -137.08 139.87 29.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 2.11 110.858 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HB3' HG23 ' A' ' 28' ' ' THR . 93.3 Cg_exo -41.24 158.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.415 2.076 . . . . 0.89 111.952 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -112.49 -21.67 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.284 -0.417 . . . . 2.77 111.651 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -129.33 -71.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.049 -0.26 . . . . 1.37 111.66 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.5 p 51.26 45.42 27.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.91 110.37 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.79 -124.36 4.96 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.881 -0.6 . . . . 1.01 112.446 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.46 36.64 3.95 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.099 -1.201 . . . . 0.98 110.099 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.577 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -105.28 177.58 4.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.639 -0.781 . . . . 0.87 111.929 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 7.81 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.85 -0.613 . . . . 2.26 111.869 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.475 HD11 ' HG2' ' A' ' 25' ' ' PRO . 12.7 mt 59.18 146.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 121.077 0.465 . . . . 1.71 111.251 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 p -114.14 -31.99 6.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.021 -0.536 . . . . 1.15 112.44 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 135.43 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.947 0.351 . . . . 1.58 111.947 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.5 m-85 -88.74 89.34 7.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.76 111.263 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt -78.77 109.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 1.14 110.641 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.1 p -106.48 127.19 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.63 111.208 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.628 ' OE2' HD12 ' A' ' 77' ' ' ILE . 27.1 mt-10 -92.65 149.53 21.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.83 -0.623 . . . . 1.67 110.404 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.828 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.73 157.97 21.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.05 0.452 . . . . 1.97 110.975 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CZ ' ' CZ2' ' A' ' 48' ' ' TRP . 12.9 ttp180 -133.52 112.71 11.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.438 -0.801 . . . . 1.44 109.576 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.88 107.13 6.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 1.59 110.868 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.704 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -89.38 147.79 38.99 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 121.077 -0.249 . . . . 0.9 110.627 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -93.17 15.94 44.35 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.8 -1.333 . . . . 1.43 112.493 0.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.18 93.68 2.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.856 0.36 . . . . 2.66 110.966 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.21 -167.94 35.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.938 -0.648 . . . . 1.12 112.365 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -157.55 171.44 20.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.719 0.295 . . . . 2.41 111.211 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 62.3 m95 -70.06 121.78 18.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.65 111.941 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.54 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -142.06 137.62 31.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 1.28 110.598 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -46.94 92.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.4 . . . . 1.3 111.484 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.846 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -57.95 -61.45 2.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.86 110.232 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.816 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -74.32 132.8 42.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.501 -0.772 . . . . 2.01 110.266 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.57 35.49 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.167 -0.47 . . . . 2.08 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -142.28 -68.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.89 110.873 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 176.03 153.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.87 110.847 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.816 HD11 ' CB ' ' A' ' 52' ' ' ASN . 13.6 mt -148.78 62.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.69 110.596 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 57' ' ' LEU . 7.7 tp -54.29 -60.51 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.986 -0.552 . . . . 1.6 111.21 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -73.39 166.4 23.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.486 -0.325 . . . . 1.54 110.587 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 36.1 p30 -83.88 8.36 15.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 1.75 112.009 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -114.42 107.77 15.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.776 ' HB2' HG23 ' A' ' 56' ' ' ILE . 39.9 t80 -141.94 165.51 27.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.471 . . . . 0.48 111.832 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 33.4 m -119.52 121.49 39.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.698 -0.683 . . . . 0.42 111.059 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.846 HG13 ' HB1' ' A' ' 51' ' ' ALA . 15.0 t -86.05 109.05 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.287 -0.415 . . . . 1.08 111.189 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.03 132.16 44.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.981 -0.554 . . . . 1.33 110.841 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.03 -12.75 2.84 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.757 -0.735 . . . . 0.9 112.721 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.104 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -57.45 -171.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 1.47 110.667 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -160.59 155.14 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 1.06 110.629 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 12.9 mt-10 -66.97 144.11 56.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 1.91 111.101 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.929 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 62.44 43.79 7.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 1.87 111.443 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 115.65 3.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.869 0.366 . . . . 0.49 111.787 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.25 130.74 42.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.36 109.954 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 51.8 m-85 -124.15 118.97 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt-10 -99.04 145.14 27.41 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.364 -0.606 . . . . 1.5 109.364 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.93 119.41 14.87 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.319 1.229 . . . . 0.6 114.319 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.577 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.99 142.99 26.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.845 -0.616 . . . . 2.11 109.623 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 8' ' ' PRO . 51.5 t -99.79 107.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.59 0.589 . . . . 0.6 112.59 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.628 HD12 ' OE2' ' A' ' 39' ' ' GLU . 11.0 mt -106.76 151.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.536 -1.283 . . . . 0.7 107.536 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -177.18 140.93 0.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.835 -0.746 . . . . 0.6 111.816 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.763 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mtmt -74.97 -155.64 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.101 -0.64 . . . . 1.98 109.424 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -139.67 -80.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.85 0.357 . . . . 2.19 110.603 -179.272 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -159.73 -41.77 0.05 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.098 -0.501 . . . . 1.08 110.377 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.14 -13.67 60.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.955 -0.566 . . . . 1.06 111.93 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.79 58.49 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.424 -0.893 . . . . 0.93 113.0 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -51.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.032 0.416 . . . . 1.38 110.389 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.763 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER 128.88 112.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.734 1.272 . . . . 0.79 112.495 178.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -75.74 110.53 10.99 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 107.834 -1.173 . . . . 0.59 107.834 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 11.1 Cg_endo -52.8 165.07 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.341 2.027 . . . . 0.85 112.629 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 9.5 Cg_endo -51.56 135.37 48.09 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.132 2.554 . . . . 0.76 113.155 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -105.51 107.21 18.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.757 -0.656 . . . . 1.28 110.756 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 8.49 104.39 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.818 1.247 . . . . 1.77 114.013 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 73.4 Cg_exo -49.58 126.4 16.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.673 2.249 . . . . 0.55 113.579 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.426 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -57.51 149.31 21.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.006 -0.739 . . . . 1.23 109.006 178.754 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.85 149.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.729 0.643 . . . . 1.63 111.27 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . -78.89 115.36 18.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.496 -0.775 . . . . 0.41 110.13 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -89.41 107.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.075 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 91.1 m -44.05 -38.94 3.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.846 -0.615 . . . . 0.44 111.58 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' ASP . 71.2 m 54.07 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.998 -0.371 . . . . 1.1 109.998 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -88.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.881 0.372 . . . . 3.0 111.466 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.717 ' OD2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.21 -10.59 27.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.298 -0.41 . . . . 2.14 111.226 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 t0 51.53 24.01 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 2.06 110.977 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.696 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.0 p -140.79 10.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 2.8 111.631 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.717 ' HG2' ' OD2' ' A' ' 99' ' ' ASP . 13.2 pt-20 -133.05 -44.62 0.86 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.872 0.368 . . . . 4.58 111.064 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.275 -0.869 . . . . 3.79 111.133 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.46 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 1.5 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 111.612 0.227 . . . . 2.74 111.612 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 0' ' ' SER . 96.4 Cg_endo -81.62 177.9 7.11 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.645 2.23 . . . . 2.06 112.561 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.687 HD11 ' OD1' ' A' ' 80' ' ' ASN . 3.7 tt -137.97 148.81 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.68 110.799 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.101 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.11 121.41 15.62 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 2.0 111.058 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.92 156.6 52.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.428 2.085 . . . . 0.5 112.211 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.4 Cg_endo -52.44 -175.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.948 2.432 . . . . 0.71 112.58 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.69 168.41 43.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.66 112.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -56.23 125.29 64.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.63 -0.137 . . . . 1.52 110.63 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.5 Cg_exo -73.96 133.81 18.8 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.268 1.978 . . . . 0.44 111.242 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -136.23 111.07 9.96 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.318 0.488 . . . . 1.09 112.318 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 95' ' ' ILE . 27.4 Cg_exo -58.68 94.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.458 2.105 . . . . 0.64 113.296 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.64 -36.8 62.45 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.254 0.549 . . . . 1.64 109.753 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -138.53 152.55 48.32 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.286 -0.87 . . . . 0.72 109.582 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.927 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -141.34 97.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.411 . . . . 0.96 111.509 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -90.02 45.02 1.24 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.82 -0.627 . . . . 1.46 112.428 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 16.5 mtp180 56.73 -73.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.514 0.561 . . . . 2.42 112.514 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 14' ' ' THR . 10.0 m170 -76.92 -32.45 57.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 1.02 110.832 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.2 p -127.78 113.09 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.68 109.865 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HD13 ' A' ' 66' ' ' LEU . 10.3 m -110.9 119.15 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.634 0.73 . . . . 0.8 111.833 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.1 m -83.99 142.92 30.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.35 110.637 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.52 164.51 33.2 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.121 0.888 . . . . 0.52 111.76 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -158.09 152.56 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.449 -0.796 . . . . 1.84 110.808 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.5 p90 -140.57 -174.42 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.047 0.451 . . . . 0.4 111.76 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.92 -174.82 3.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.83 111.407 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tmtt? -119.42 138.02 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.11 110.533 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 28' ' ' THR . 77.9 Cg_exo -50.19 173.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.416 2.078 . . . . 0.89 112.11 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.8 -19.2 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 2.77 111.803 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.4 t80 -123.79 -70.92 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.22 0.452 . . . . 1.37 112.22 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 1.101 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 70.7 p 51.72 52.0 15.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.065 0.459 . . . . 0.91 110.078 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 40.7 -106.27 0.06 OUTLIER Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.689 -0.687 . . . . 1.01 112.636 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.39 37.39 2.14 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.468 -1.053 . . . . 0.98 110.468 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.3 m-85 -117.82 -178.58 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.094 -0.553 . . . . 0.87 111.583 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -140.66 -0.38 1.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.583 -0.735 . . . . 2.26 112.375 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CE1' ' A' ' 36' ' ' TYR . 11.8 mt 56.34 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.976 0.417 . . . . 1.71 111.437 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' SER . 31.1 p -114.25 23.72 12.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 1.15 111.605 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 46.1 t 178.55 135.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 1.58 111.352 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.818 ' CE1' HG21 ' A' ' 33' ' ' ILE . 49.9 m-85 -121.62 102.22 8.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.979 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -79.58 140.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.066 -0.346 . . . . 1.14 110.066 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.92 105.35 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.477 -0.329 . . . . 0.63 111.885 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 80.1 mt-10 -75.59 150.34 38.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.92 -0.77 . . . . 1.67 108.92 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.747 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -131.57 145.91 51.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.97 112.202 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 16.2 ttp180 -121.0 105.09 10.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.177 -0.919 . . . . 1.44 109.595 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.837 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 82.9 0.45 Allowed 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.861 -0.608 . . . . 1.59 110.491 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.52 HD21 ' OE1' ' A' ' 73' ' ' GLU . 3.1 mt -61.02 149.68 80.91 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.785 -0.643 . . . . 0.9 110.904 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.29 18.9 26.59 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.096 -1.21 . . . . 1.43 113.067 0.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -150.74 83.13 1.34 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.668 0.27 . . . . 2.66 111.386 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -103.83 -169.16 25.31 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.827 -0.701 . . . . 1.12 112.518 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -139.77 8.84 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.735 0.272 . . . . 2.41 111.735 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 19.5 m95 52.52 72.26 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.65 110.959 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -120.63 137.77 54.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 1.28 110.943 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.34 98.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 1.3 111.228 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.747 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.25 -51.11 71.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.86 110.498 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.7 p-10 -60.8 131.51 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 2.01 110.937 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 30.4 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 2.08 110.978 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t -138.89 -161.06 1.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 1.89 110.701 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -100.91 114.5 28.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.384 . . . . 1.87 111.186 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 36' ' ' TYR . 33.6 mt -100.86 80.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.69 110.852 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.19 -59.72 4.08 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.191 -0.459 . . . . 1.6 111.52 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -77.31 167.07 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.909 0.385 . . . . 1.54 110.695 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 53.3 p30 -84.01 4.93 27.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 1.75 111.615 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.17 100.69 10.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.702 -0.481 . . . . 2.05 109.702 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 56' ' ' ILE . 75.4 t80 -131.66 163.02 29.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.234 0.54 . . . . 0.48 112.2 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.45 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 42.8 m -131.61 124.54 30.17 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.254 -0.884 . . . . 0.42 110.01 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 HD11 ' A' ' 20' ' ' LEU . 7.4 t -82.81 94.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.072 0.463 . . . . 1.08 111.209 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -89.02 165.09 14.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.661 -0.699 . . . . 1.33 111.078 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.5 8.46 83.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.9 112.705 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.031 HD13 HG13 ' A' ' 18' ' ' VAL . 4.7 mt -58.82 -175.02 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.982 0.42 . . . . 1.47 110.775 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -131.5 133.23 44.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 1.06 110.471 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.3 tt0 -71.13 149.92 45.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.149 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.846 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 66.19 38.17 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 1.87 110.788 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.1 116.74 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.49 111.535 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.02 131.94 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.36 110.129 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 53.5 m-85 -125.33 127.15 46.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.658 0.614 . . . . 0.56 112.658 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' OE1' HD21 ' A' ' 43' ' ' LEU . 4.7 mt-10 -108.45 134.04 51.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.974 -1.121 . . . . 1.5 107.974 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.906 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.17 121.64 25.23 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.753 1.39 . . . . 0.6 114.753 -178.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' CA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -97.08 167.9 10.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.077 -0.51 . . . . 2.11 109.828 178.15 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' CG ' ' A' ' 8' ' ' PRO . 71.6 t -116.3 145.41 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.397 0.617 . . . . 0.6 111.974 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.772 HD11 ' HG3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -141.45 152.91 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -166.8 124.84 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.533 -0.867 . . . . 0.6 112.457 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.55 95.92 7.28 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.067 -0.653 . . . . 1.98 109.898 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.687 ' OD1' HD11 ' A' ' 2' ' ' ILE . 1.3 m120 -40.34 156.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 2.19 111.667 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -20.77 -47.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.193 1.183 . . . . 1.08 114.193 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.45 48.63 0.87 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.933 0.716 . . . . 1.06 112.933 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.83 37.65 9.45 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.4 -0.905 . . . . 0.93 113.248 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -78.3 1.02 23.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.88 0.371 . . . . 1.38 111.202 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 37.24 111.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 114.972 1.471 . . . . 0.79 114.972 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -93.27 111.45 51.98 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 113.909 -1.496 . . . . 0.59 107.022 177.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.3 Cg_endo -45.67 172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.026 2.484 . . . . 0.85 113.656 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.772 ' HG3' HD11 ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.32 92.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.085 2.524 . . . . 0.76 113.141 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -58.65 105.33 0.29 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.941 -0.572 . . . . 1.28 110.035 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.1 tt0 4.83 117.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.15 1.38 . . . . 1.77 114.346 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 48.5 Cg_exo -42.62 170.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.943 2.429 . . . . 0.55 114.03 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -102.19 139.1 38.26 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 114.944 -1.025 . . . . 1.23 109.355 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -38.08 127.54 1.3 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.273 0.983 . . . . 1.63 111.282 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -58.26 131.14 49.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.507 -0.769 . . . . 0.41 111.384 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -117.38 108.0 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.933 -0.576 . . . . 0.44 110.961 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.2 m -46.64 -37.23 7.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.44 110.824 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 59.7 m 59.85 37.71 21.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 1.1 110.777 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.16 -39.78 16.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 3.0 112.036 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.363 ' CG ' HG22 ' A' ' 101' ' ' VAL . 17.8 p-10 -156.09 24.65 0.37 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.382 -0.372 . . . . 2.14 111.457 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.6 p30 51.91 19.81 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 2.06 112.088 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.363 HG22 ' CG ' ' A' ' 99' ' ' ASP . 15.7 m -114.73 -20.22 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 120.706 0.289 . . . . 2.8 110.711 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.87 55.27 7.12 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.949 0.404 . . . . 4.58 111.25 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.267 -0.873 . . . . 3.79 111.129 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.657 0.265 . . . . 2.74 111.131 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 98.5 Cg_endo -89.62 -174.6 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.899 2.399 . . . . 2.06 112.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt -158.12 140.49 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.68 111.074 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 68.2 m-20 -122.52 134.86 25.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 2.0 110.462 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.55 160.7 10.9 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.593 2.195 . . . . 0.5 113.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 77.1 Cg_exo -52.53 167.61 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.058 2.506 . . . . 0.71 113.125 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.32 -179.88 38.47 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.37 -0.832 . . . . 0.66 112.226 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -66.9 124.21 88.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 O-C-N 122.846 -0.208 . . . . 1.52 110.688 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.6 Cg_exo -70.64 135.65 28.84 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.355 2.037 . . . . 0.44 112.178 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -130.41 115.44 17.28 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.288 -0.414 . . . . 1.09 111.214 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.5 Cg_exo -70.42 114.45 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.209 1.94 . . . . 0.64 113.575 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.703 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.84 -33.56 57.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.497 -0.927 . . . . 1.64 108.497 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -140.5 151.2 44.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.754 -1.112 . . . . 0.72 109.043 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.012 HG22 HG13 ' A' ' 18' ' ' VAL . 4.2 pt -140.87 97.59 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.489 0.551 . . . . 0.96 112.489 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.251 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -85.7 140.28 30.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 1.46 110.007 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -24.48 1.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 2.42 112.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 3.2 m80 -120.44 -1.75 10.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.393 0.516 . . . . 1.02 112.393 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 16' ' ' HIS . 17.2 p -160.5 119.61 2.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.601 0.239 . . . . 0.68 110.672 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.012 HG13 HG22 ' A' ' 13' ' ' ILE . 46.5 t -102.97 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.474 . . . . 0.8 111.668 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.7 m -109.85 121.82 46.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.819 -0.628 . . . . 0.35 111.405 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.762 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.94 161.8 35.04 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.676 0.75 . . . . 0.52 112.139 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -138.6 151.54 47.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.574 -1.194 . . . . 1.84 110.295 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.7 p90 -136.77 -178.05 5.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.264 0.554 . . . . 0.4 112.073 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.61 -154.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.417 -0.81 . . . . 0.83 110.395 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -155.08 127.16 3.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.748 -0.381 . . . . 2.11 111.727 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -46.32 179.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.181 2.587 . . . . 0.89 112.772 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -122.36 -10.06 8.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 2.77 111.971 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 5.6 t80 -116.76 -72.65 0.68 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.615 -0.434 . . . . 1.37 112.107 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 25' ' ' PRO . 68.6 p 49.63 47.03 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.1 0.476 . . . . 0.91 110.364 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.12 -93.39 0.01 OUTLIER Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.615 -0.721 . . . . 1.01 112.306 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.35 32.99 1.48 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.265 -1.134 . . . . 0.98 110.265 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.702 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.96 -172.8 2.46 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.752 -0.724 . . . . 0.87 111.314 -178.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 8.1 ptmt -145.33 39.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 2.26 111.077 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.126 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.4 mp 62.48 -81.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 1.71 110.492 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.418 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 2.9 p 59.6 29.59 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.15 111.493 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 172.23 94.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 1.58 111.4 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.126 ' CE1' HG21 ' A' ' 33' ' ' ILE . 58.6 m-85 -102.61 81.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.76 111.172 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -72.53 110.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.461 -0.495 . . . . 1.14 110.359 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.28 81.55 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -52.78 138.75 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.457 -0.572 . . . . 1.67 109.457 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.7 153.62 26.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.371 0.605 . . . . 1.97 112.152 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.39 98.52 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.054 -0.975 . . . . 1.44 110.201 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -75.2 76.74 2.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.875 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 73' ' ' GLU . 12.3 mt -57.27 138.26 80.65 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.9 111.131 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -92.2 17.36 42.15 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 124.009 -1.246 . . . . 1.43 112.763 0.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 42' ' ' ASP . 1.6 p-10 -121.84 53.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.51 -0.314 . . . . 2.66 111.398 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -104.35 173.89 21.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.507 -0.854 . . . . 1.12 112.329 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.018 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -165.92 42.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 2.41 110.997 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.569 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 20.8 m95 40.85 69.26 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.958 -0.565 . . . . 0.65 111.855 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.018 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -101.29 121.32 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.765 0.317 . . . . 1.28 110.389 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.94 92.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.454 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -62.61 -46.39 88.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.86 110.438 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.63 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.1 p-10 -62.57 127.11 29.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 2.01 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.73 -17.34 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 2.08 111.113 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -110.63 145.93 37.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 1.89 110.814 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -55.8 111.43 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 1.87 110.915 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 58' ' ' GLU . 19.7 mm -75.63 90.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.315 -0.402 . . . . 0.69 110.871 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.51 -38.23 65.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.965 0.412 . . . . 1.6 110.457 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -99.73 154.33 18.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 1.54 109.589 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 26.1 p-10 -75.3 -0.71 20.6 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.093 0.405 . . . . 1.75 112.093 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.655 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 2.5 tp10 -100.73 105.47 16.81 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.44 -0.578 . . . . 2.05 109.44 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.658 ' CD1' HD12 ' A' ' 56' ' ' ILE . 58.2 t80 -137.15 165.99 24.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.346 0.594 . . . . 0.48 111.922 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -133.06 100.4 4.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.205 -0.907 . . . . 0.42 110.843 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 14.9 m -57.29 142.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 1.08 111.04 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.497 ' OG ' HG22 ' A' ' 17' ' ' THR . 7.5 t -136.12 154.17 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.72 0.772 . . . . 1.33 111.131 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.16 -5.9 19.61 Favored Glycine 0 C--N 1.313 -0.711 0 CA-C-N 114.48 -1.236 . . . . 0.9 112.3 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.795 HD23 HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -62.85 -175.52 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.834 0.349 . . . . 1.47 110.815 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 m -149.35 130.66 14.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.435 . . . . 1.06 110.634 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 5.8 tt0 -50.92 149.35 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 1.91 111.085 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.84 48.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.87 110.793 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.2 130.81 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.49 111.625 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.82 135.13 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.36 110.243 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -131.8 121.77 24.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.926 0.393 . . . . 0.56 111.99 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' A' ' 43' ' ' LEU . 2.7 mt-10 -97.3 137.74 35.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.86 -0.792 . . . . 1.5 108.86 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.902 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -122.21 106.76 11.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.42 1.267 . . . . 0.6 114.42 -179.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -104.49 143.47 32.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.136 -0.938 . . . . 2.11 108.927 178.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.484 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -116.51 136.33 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.958 -0.697 . . . . 0.6 112.001 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.751 ' O ' HD12 ' A' ' 37' ' ' ILE . 33.9 mt -117.21 153.17 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.907 -1.042 . . . . 0.7 108.513 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -146.35 117.4 7.77 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.371 -0.531 . . . . 0.6 111.735 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 23.0 ptmt -86.89 14.75 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.15 0.796 . . . . 1.98 113.15 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 2.6 m-80 43.51 -179.91 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.074 1.138 . . . . 2.19 114.074 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -57.61 -50.26 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.972 -1.467 . . . . 1.08 112.372 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.702 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -88.79 34.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.584 0.587 . . . . 1.06 112.584 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.1 39.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.544 -0.836 . . . . 0.93 113.045 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.11 94.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 1.38 109.257 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.4 tp -61.04 107.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.294 0.85 . . . . 0.79 113.294 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.2 p -87.52 108.5 20.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.978 -1.119 . . . . 0.59 107.978 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.5 Cg_endo -42.01 172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.125 2.55 . . . . 0.85 113.883 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 54.1 Cg_exo -51.81 129.04 28.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.9 2.4 . . . . 0.76 112.466 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 15.2 m -99.94 106.12 17.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.334 -0.394 . . . . 1.28 110.419 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 1.92 117.69 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.243 0 O-C-N 124.696 1.248 . . . . 1.77 113.355 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 9.1 Cg_exo -69.29 160.59 49.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.803 1.669 . . . . 0.55 113.915 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -87.28 141.1 28.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.779 -1.193 . . . . 1.23 107.779 178.034 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.839 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -32.12 138.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.042 0.839 . . . . 1.63 112.201 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -67.53 101.25 0.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.158 -0.473 . . . . 0.41 111.063 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.6 mp -84.2 115.03 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.926 0.393 . . . . 0.44 111.053 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 23.8 m -52.45 -23.52 6.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.875 -0.602 . . . . 0.44 110.6 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.638 ' H ' HG22 ' A' ' 95' ' ' ILE . 7.6 m 50.12 84.34 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.089 0.471 . . . . 1.1 109.875 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.644 ' HD2' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -132.35 -87.36 0.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.716 -0.675 . . . . 3.0 110.979 -179.234 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.942 ' O ' HG12 ' A' ' 101' ' ' VAL . 26.7 p-10 -93.28 21.9 5.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.125 -0.489 . . . . 2.14 110.631 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.251 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER 43.07 29.93 0.23 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.273 0.559 . . . . 2.06 111.54 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.3 p -164.57 25.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 2.8 110.599 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.731 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 29.3 74.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.17 0.804 . . . . 4.58 113.17 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.651 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.178 -0.915 . . . . 3.79 111.111 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.756 0.312 . . . . 2.74 111.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.5 -151.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 2.06 111.545 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -166.69 131.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.68 111.422 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 18.0 m-20 -111.61 130.45 23.11 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 2.0 110.186 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.72 162.43 24.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.412 2.075 . . . . 0.5 112.38 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' N ' ' HG3' ' A' ' 25' ' ' PRO . 53.7 Cg_exo -54.39 178.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.929 2.419 . . . . 0.71 113.37 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.69 161.02 30.59 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.66 112.517 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.4 tttt -53.23 132.53 51.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 110.244 -0.28 . . . . 1.52 110.244 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HG3' HG23 ' A' ' 76' ' ' VAL . 4.5 Cg_exo -82.01 136.89 9.44 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.445 2.097 . . . . 0.44 112.396 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -130.87 121.23 18.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.09 110.849 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.7 Cg_exo -65.71 100.71 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.439 2.093 . . . . 0.64 113.417 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.95 -35.01 72.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.869 -0.789 . . . . 1.64 108.869 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -142.07 151.45 42.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.661 -1.154 . . . . 0.72 108.339 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.053 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -139.84 113.61 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.129 -0.629 . . . . 0.96 112.301 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.002 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.61 151.27 23.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.65 -0.705 . . . . 1.46 109.865 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HB2' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -64.29 -10.52 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.61 0.596 . . . . 2.42 112.61 -179.187 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 17' ' ' THR . 12.4 m80 -135.07 20.09 3.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.273 . . . . 1.02 111.323 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 168.13 114.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.68 109.956 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 ' CD1' ' A' ' 66' ' ' LEU . 14.5 m -108.4 146.68 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.594 -0.442 . . . . 0.8 110.632 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.533 ' C ' HD13 ' A' ' 20' ' ' LEU . 4.1 m -110.58 120.21 41.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.35 111.979 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.867 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -132.36 171.1 14.16 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.662 0.744 . . . . 0.52 111.804 178.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.67 173.22 16.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.024 -0.989 . . . . 1.84 109.123 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 3.1 p90 -138.37 -168.36 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.595 0.591 . . . . 0.4 112.595 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 24' ' ' LYS . . . -96.67 -13.41 22.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.83 113.416 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.464 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 74.34 149.84 0.13 Allowed Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 110.121 -0.325 . . . . 2.11 110.121 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 20.0 Cg_exo -65.96 -167.35 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.33 2.02 . . . . 0.89 113.047 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -148.74 -45.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 2.77 110.787 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.1 77.16 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.37 111.283 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 22.6 p -92.47 46.73 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.91 109.95 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.16 -98.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.546 -0.835 . . . . 1.01 111.653 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.2 29.48 2.92 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.578 -1.009 . . . . 0.98 110.578 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -117.38 174.39 6.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.091 -0.555 . . . . 0.87 111.071 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -0.58 4.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 2.26 111.457 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 23.3 mt 63.25 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.178 -0.304 . . . . 1.71 110.178 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -107.69 -15.25 14.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.715 0.635 . . . . 1.15 112.715 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -167.43 158.58 11.68 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.397 0.518 . . . . 1.58 112.397 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -117.36 131.4 56.79 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.76 110.014 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 5.6 mt -104.84 132.49 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.852 -0.613 . . . . 1.14 111.023 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 63' ' ' VAL . 5.1 t -110.33 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.265 -0.425 . . . . 0.63 111.278 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 14.0 mt-10 -85.42 131.2 34.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.532 -0.544 . . . . 1.67 109.532 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -102.32 129.26 48.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 1.97 111.854 -179.209 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 5.4 ttp180 -105.9 92.59 4.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.634 -0.712 . . . . 1.44 109.488 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -62.96 146.75 52.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.54 . . . . 1.59 109.574 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 10.0 mt -127.12 131.0 23.65 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.871 -0.332 . . . . 0.9 110.808 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 6.7 Cg_endo -88.5 38.98 3.14 Favored 'Cis proline' 0 C--N 1.352 0.726 0 C-N-CA 124.542 -1.024 . . . . 1.43 113.026 0.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -114.2 56.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.314 . . . . 2.66 110.607 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . -62.17 169.61 13.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.792 -0.718 . . . . 1.12 113.262 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.51 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.657 0.265 . . . . 2.41 111.628 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 68.5 m95 63.17 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.248 -0.279 . . . . 0.65 110.248 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.34 121.58 11.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.838 0.351 . . . . 1.28 110.796 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 6.2 ptpt -51.03 111.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 1.3 111.105 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -100.92 -11.94 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.896 -0.593 . . . . 0.86 111.258 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 56' ' ' ILE . 6.1 p-10 -74.21 -60.94 2.04 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.654 -0.418 . . . . 2.01 111.871 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 4.8 t80 78.37 -51.32 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.549 0.214 . . . . 2.08 111.409 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -173.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.036 0.446 . . . . 1.89 111.47 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -102.0 80.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.786 -0.643 . . . . 1.87 110.764 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.565 HD11 ' CB ' ' A' ' 52' ' ' ASN . 70.3 mt -71.11 103.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.69 110.733 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.36 -50.82 2.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.6 111.665 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -56.66 -20.26 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.137 0.421 . . . . 1.54 112.137 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.2 p-10 89.17 -25.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.71 0.804 . . . . 1.75 111.65 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -81.93 86.56 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.751 -0.833 . . . . 2.05 108.751 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 62' ' ' THR . 55.0 t80 -120.8 165.56 14.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.328 0.585 . . . . 0.48 111.998 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 18' ' ' VAL . 54.9 m -123.7 122.26 37.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.37 -0.832 . . . . 0.42 110.84 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 20' ' ' LEU . 9.6 t -81.91 95.7 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.159 0.504 . . . . 1.08 110.834 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 17' ' ' THR . 41.3 t -83.26 -158.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.495 -0.775 . . . . 1.33 110.74 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 57.72 19.62 36.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.511 -0.852 . . . . 0.9 112.248 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.037 ' CD1' HG13 ' A' ' 18' ' ' VAL . 68.7 mt -75.12 -176.97 3.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 1.47 110.607 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -144.59 144.29 31.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 1.06 110.68 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 22.2 tt0 -70.67 146.92 49.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 1.91 110.971 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.2 t0 60.4 41.23 16.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.551 . . . . 1.87 111.16 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -150.69 124.67 9.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.732 0.301 . . . . 0.49 111.347 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.056 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 68.8 m-85 -126.86 126.15 42.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.143 0.794 . . . . 0.56 113.143 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -100.01 137.72 38.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.219 -0.66 . . . . 1.5 109.219 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.993 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.89 116.88 23.64 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.486 0.921 . . . . 0.6 113.486 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -102.25 145.76 28.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.855 -0.612 . . . . 2.11 110.967 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG23 ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -105.94 104.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.479 0.548 . . . . 0.6 112.479 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.445 HG12 ' CA ' ' A' ' 88' ' ' PRO . 30.2 mt -105.03 147.77 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.9 -1.519 . . . . 0.7 106.9 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -166.04 144.04 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.16 -1.016 . . . . 0.6 112.74 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.02 -172.35 4.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 1.98 110.136 179.123 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 50.0 p30 -126.09 -128.52 0.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.391 -0.368 . . . . 2.19 110.279 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -116.06 -28.15 6.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.158 0.89 . . . . 1.08 111.24 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -82.02 4.75 21.66 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.179 0.437 . . . . 1.06 112.179 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.13 78.73 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.425 -0.893 . . . . 0.93 113.303 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -75.8 161.98 28.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.118 0.459 . . . . 1.38 110.448 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.9 tp -115.26 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 0.79 112.629 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 2.0 p -74.48 113.72 26.76 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.262 -0.644 . . . . 0.59 109.262 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.35 163.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.749 2.3 . . . . 0.85 113.041 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' CA ' HG12 ' A' ' 77' ' ' ILE . 28.1 Cg_endo -63.99 144.96 89.18 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.826 2.351 . . . . 0.76 113.126 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.0 m -98.99 127.17 44.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.593 -0.73 . . . . 1.28 109.963 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt0 -20.97 98.33 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 O-C-N 124.587 1.179 . . . . 1.77 113.067 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 42.0 Cg_exo -35.67 166.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.57 2.847 . . . . 0.55 115.574 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.514 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 1.5 m -93.32 141.49 28.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.02 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -39.87 139.42 0.65 Allowed 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 123.731 0.644 . . . . 1.63 111.412 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.37 102.23 2.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.017 -0.538 . . . . 0.41 109.923 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 13' ' ' ILE . 4.4 mp -84.26 111.74 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.941 0.401 . . . . 0.44 111.226 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 98' ' ' ARG . 66.8 m -47.63 -30.11 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.44 111.254 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.471 ' H ' HG22 ' A' ' 95' ' ' ILE . 79.2 m 49.6 89.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 1.1 110.323 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.77 -85.95 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 3.0 111.28 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.072 ' OD1' ' HB2' ' A' ' 102' ' ' GLU . 4.5 p-10 -101.72 2.37 38.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 2.14 111.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.053 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 43.4 29.2 0.22 Allowed 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.359 0.503 . . . . 2.06 112.359 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.7 p -162.62 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.781 -0.645 . . . . 2.8 110.507 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.072 ' HB2' ' OD1' ' A' ' 99' ' ' ASP . 1.4 mt-10 -137.96 -43.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.61 . . . . 4.58 110.966 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.28 -0.867 . . . . 3.79 111.212 -179.968 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.748 0.309 . . . . 2.74 111.322 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -90.89 156.21 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.098 2.532 . . . . 2.06 112.472 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.761 HD12 ' OD1' ' A' ' 80' ' ' ASN . 4.9 tt -113.36 151.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.067 0.461 . . . . 0.68 111.312 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.325 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -133.86 128.17 19.65 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.615 -0.721 . . . . 2.0 109.875 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.62 176.37 9.17 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.42 2.08 . . . . 0.5 112.379 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 21.0 Cg_exo -65.39 178.29 2.17 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.809 2.339 . . . . 0.71 112.729 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.06 172.49 55.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.988 -0.625 . . . . 0.66 112.614 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' NZ ' ' OE2' ' A' ' 90' ' ' GLU . 10.0 tttp -58.66 120.44 45.49 Favored Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.021 -0.105 . . . . 1.52 110.722 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.761 ' CG ' HG23 ' A' ' 76' ' ' VAL . 22.2 Cg_exo -67.58 127.09 15.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.077 . . . . 0.44 112.802 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.6 p -133.18 107.46 12.37 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 115.821 -0.627 . . . . 1.09 111.158 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.1 Cg_exo -37.67 142.58 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.827 2.352 . . . . 0.64 113.292 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 19' ' ' THR . 0.5 OUTLIER -97.71 -44.63 6.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.747 -1.115 . . . . 1.64 108.372 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -148.11 155.61 41.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.997 -1.456 . . . . 0.72 109.061 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.01 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -143.85 100.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.436 -0.505 . . . . 0.96 111.69 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.252 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -98.87 50.13 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.943 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.831 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.68 -70.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.998 0.811 . . . . 2.42 112.075 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 8.4 m170 -77.41 -26.85 52.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 1.02 111.255 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -125.23 112.12 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.819 0.343 . . . . 0.68 111.148 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 13' ' ' ILE . 72.9 t -107.23 110.68 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.086 -0.506 . . . . 0.8 111.171 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 79.4 m -88.43 149.19 23.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.35 110.678 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.88 154.71 38.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.533 0.682 . . . . 0.52 112.148 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -143.86 144.83 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.737 -1.12 . . . . 1.84 110.171 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 10.9 p90 -140.57 -172.31 3.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 0.4 111.545 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.73 159.36 14.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.319 0.581 . . . . 0.83 112.337 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.4 139.59 28.36 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.32 -0.854 . . . . 2.11 110.057 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -44.85 169.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.336 2.024 . . . . 0.89 111.869 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -119.04 -4.87 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.099 0.407 . . . . 2.77 112.099 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.747 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.5 t80 -141.42 -73.89 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 1.37 111.933 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 1.325 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.8 p 79.6 -39.28 0.2 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.225 0.61 . . . . 0.91 112.315 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.7 -82.81 0.33 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.498 -0.858 . . . . 1.01 111.554 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.18 27.57 0.79 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.114 -1.194 . . . . 0.98 110.114 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.523 ' CE2' ' OD1' ' A' ' 80' ' ' ASN . 1.7 m-85 -116.94 -177.07 3.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.705 -0.748 . . . . 0.87 111.404 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.56 -3.06 2.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.652 -0.704 . . . . 2.26 111.923 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' HG3' ' A' ' 25' ' ' PRO . 15.0 mt 60.76 140.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 120.8 0.334 . . . . 1.71 110.506 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -123.96 6.74 8.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.359 0.503 . . . . 1.15 112.359 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 178.0 162.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.134 0.492 . . . . 1.58 111.965 179.867 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.722 ' O ' HD12 ' A' ' 56' ' ' ILE . 42.5 m-85 -128.76 101.11 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.411 -0.813 . . . . 0.76 110.3 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.8 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -87.62 122.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.623 -0.262 . . . . 1.14 110.888 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.6 p -110.84 128.61 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.044 0.449 . . . . 0.63 110.815 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mt-10 -90.0 136.17 33.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.91 -0.586 . . . . 1.67 112.227 -179.24 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -99.8 132.43 45.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.419 0.896 . . . . 1.97 113.419 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 7.5 ttm180 -115.4 107.61 15.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.484 . . . . 1.44 110.077 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 90.6 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.869 -0.605 . . . . 1.59 111.015 -179.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -66.05 150.22 96.9 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.45 -0.341 . . . . 0.9 110.611 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.78 -9.25 47.24 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.086 -1.214 . . . . 1.43 112.794 0.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -60.26 -61.98 2.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.907 0.384 . . . . 2.66 110.725 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 85.36 142.92 6.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.916 -0.659 . . . . 1.12 112.839 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 176.3 64.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 2.41 110.692 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 80.9 m95 -33.89 98.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.446 -0.797 . . . . 0.65 111.881 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -125.23 139.52 53.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.189 0.519 . . . . 1.28 112.271 -179.326 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HD2' HG21 ' A' ' 37' ' ' ILE . 4.2 mtmt -57.33 86.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.549 -0.751 . . . . 1.3 110.868 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -59.31 -51.98 67.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.86 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.806 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.0 p-10 -61.49 150.94 34.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.01 111.189 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.88 27.67 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.786 -0.643 . . . . 2.08 110.544 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -130.68 30.41 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.89 110.727 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.52 111.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 1.87 110.734 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 52' ' ' ASN . 19.6 mt -101.32 71.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.69 111.275 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -50.84 -80.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.489 . . . . 1.6 110.85 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.97 168.63 5.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.996 -0.372 . . . . 1.54 109.996 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -88.81 47.11 1.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.992 0.425 . . . . 1.75 111.533 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -144.32 101.28 3.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 2.05 109.308 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' A' ' 56' ' ' ILE . 77.0 t80 -134.53 165.22 25.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.48 112.135 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 85.1 m -131.27 116.59 17.82 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.42 110.861 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 18' ' ' VAL . 7.2 m -77.42 110.06 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.08 111.045 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.24 126.18 51.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.059 -0.518 . . . . 1.33 111.098 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.97 -1.31 2.8 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.539 -0.839 . . . . 0.9 113.659 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -51.77 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.189 0.519 . . . . 1.47 111.302 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.1 m -135.45 117.02 14.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.631 -0.713 . . . . 1.06 110.7 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 1.4 tt0 -47.3 132.53 12.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.061 -0.518 . . . . 1.91 111.32 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 6.3 t0 73.77 67.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 1.87 111.243 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 177.27 124.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.49 111.064 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.37 130.81 43.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.36 110.454 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 38.4 m-85 -126.07 122.93 37.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.56 112.017 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.2 tt0 -107.22 141.32 38.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.282 -0.636 . . . . 1.5 109.282 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.55 125.16 16.8 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.153 1.168 . . . . 0.6 114.153 -179.24 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.775 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -100.38 165.83 11.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.034 -0.53 . . . . 2.11 109.78 178.592 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.761 HG23 ' CG ' ' A' ' 8' ' ' PRO . 46.9 t -122.95 114.08 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 113.557 0.947 . . . . 0.6 113.557 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 56.6 mt -108.11 154.85 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.562 -1.644 . . . . 0.7 106.562 177.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -167.39 131.27 1.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.955 -1.098 . . . . 0.6 113.473 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -83.67 143.32 30.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.655 -0.702 . . . . 1.98 109.288 178.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.761 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -78.89 -106.71 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.077 -0.511 . . . . 2.19 111.902 -178.952 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.01 -28.36 2.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.783 0.72 . . . . 1.08 112.622 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.85 20.78 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.429 0.529 . . . . 1.06 112.429 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 87.72 -17.04 47.49 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.378 -0.915 . . . . 0.93 112.772 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.339 . . . . 1.38 110.414 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.4 tt -77.81 112.18 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.494 . . . . 0.79 112.005 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.5 p -66.06 122.11 79.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.854 -0.612 . . . . 0.59 109.896 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -35.04 158.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.415 2.744 . . . . 0.85 113.45 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 12.0 Cg_exo -71.22 148.21 55.23 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.871 2.381 . . . . 0.76 112.423 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.42 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 3.0 m -97.32 129.49 44.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 1.28 109.748 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.642 ' OE2' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -30.8 111.67 0.29 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.805 0.691 . . . . 1.77 112.372 -179.476 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.7 Cg_exo -37.93 148.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.762 2.308 . . . . 0.55 113.629 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.423 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.66 139.66 31.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.062 -0.972 . . . . 1.23 109.457 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.646 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -32.72 139.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.28 0.988 . . . . 1.63 112.363 -179.75 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -75.47 109.93 9.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.558 -0.746 . . . . 0.41 110.731 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.1 mp -92.54 115.77 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.029 0.443 . . . . 0.44 111.225 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 86.1 m -47.22 -30.81 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.535 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.536 ' H ' HG22 ' A' ' 95' ' ' ILE . 91.5 m 54.19 62.39 2.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.91 0.386 . . . . 1.1 110.182 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -97.71 -86.84 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 3.0 111.623 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -116.83 28.33 8.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 2.14 110.662 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.252 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 49.05 22.86 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 2.06 111.543 -179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.98 -20.96 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 116.244 -0.434 . . . . 2.8 110.849 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.093 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.61 43.31 6.45 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.092 0.472 . . . . 4.58 111.458 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.179 -0.915 . . . . 3.79 111.27 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.421 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.429 0.157 . . . . 2.74 111.362 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.457 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 1.1 Cg_endo -82.72 53.04 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.883 2.388 . . . . 2.06 111.765 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' CG ' ' A' ' 80' ' ' ASN . 2.0 tt -49.43 136.14 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.68 111.842 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -117.42 137.0 23.69 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.055 -0.52 . . . . 2.0 110.419 179.534 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 160.14 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.443 2.096 . . . . 0.5 112.418 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 172.3 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.822 2.348 . . . . 0.71 112.98 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.88 174.21 20.69 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.66 112.817 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -66.63 138.08 95.36 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 110.544 -0.169 . . . . 1.52 110.544 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.2 Cg_exo -77.87 139.32 17.43 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.818 2.345 . . . . 0.44 112.502 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.9 p -145.9 126.37 7.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.33 -0.395 . . . . 1.09 111.456 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.695 ' CG ' HD11 ' A' ' 95' ' ' ILE . 16.9 Cg_exo -66.87 141.21 58.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.76 2.307 . . . . 0.64 113.757 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.4 mm? -107.32 -36.17 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.627 -0.879 . . . . 1.64 108.627 178.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -139.36 150.73 45.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.614 -1.176 . . . . 0.72 108.297 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.929 HG21 HG12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -143.86 101.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.259 -0.576 . . . . 0.96 112.068 -179.279 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -93.89 56.89 2.37 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 115.881 -0.599 . . . . 1.46 110.863 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 47.84 -74.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.024 0.827 . . . . 2.42 112.886 179.389 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -73.99 -37.8 64.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.99 0.367 . . . . 1.02 111.99 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HB3' ' A' ' 64' ' ' SER . 72.3 p -122.46 110.27 15.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.718 0.294 . . . . 0.68 111.02 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 4.1 m -99.29 152.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.8 111.288 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.595 ' C ' HD13 ' A' ' 20' ' ' LEU . 13.9 m -118.21 123.92 46.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.35 111.32 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.52 162.74 32.27 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.413 0.625 . . . . 0.52 111.336 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.963 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -151.3 158.46 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 1.84 110.12 179.384 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.6 p90 -137.42 -167.82 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.4 111.316 -179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.11 -166.59 1.45 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.354 0.597 . . . . 0.83 112.367 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' HG2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -114.59 141.45 26.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.148 -0.933 . . . . 2.11 110.228 -179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' THR . 12.1 Cg_endo -55.35 172.63 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.247 1.965 . . . . 0.89 112.186 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.26 -39.17 2.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 2.77 111.106 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 1' ' ' PRO . 1.8 t80 -120.28 71.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 1.37 111.478 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 25' ' ' PRO . 73.8 p -91.01 44.24 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.501 -0.318 . . . . 0.91 110.539 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.07 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.704 -0.76 . . . . 1.01 112.501 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.95 49.26 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.987 -1.245 . . . . 0.98 109.987 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.57 177.45 7.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.984 -0.608 . . . . 0.87 110.929 -178.208 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -138.53 6.31 2.5 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.09 0.404 . . . . 2.26 112.09 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.5 mt 58.52 150.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 120.851 0.358 . . . . 1.71 111.042 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -131.73 15.09 4.87 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.0 0.37 . . . . 1.15 112.0 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.616 ' H ' HG22 ' A' ' 33' ' ' ILE . 42.3 t 179.25 124.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 1.58 111.092 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.768 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.8 m-85 -105.38 88.21 2.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.76 111.195 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.483 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.4 mm -69.39 151.96 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.95 -0.3 . . . . 1.14 110.323 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.17 103.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.272 0.558 . . . . 0.63 110.782 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.51 161.92 29.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.367 -0.833 . . . . 1.67 110.04 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -136.41 153.35 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 1.97 111.391 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 23.7 ttm180 -134.69 121.33 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 1.44 110.801 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.818 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.56 91.62 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.593 . . . . 1.59 110.859 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -56.3 152.52 23.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.9 110.53 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.37 30.4 11.85 Favored 'Cis proline' 0 C--N 1.348 0.533 0 C-N-CA 123.911 -1.287 . . . . 1.43 112.573 0.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.99 99.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.368 . . . . 2.66 111.139 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.818 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -135.35 -123.12 2.29 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.685 -0.769 . . . . 1.12 112.89 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -135.03 -169.83 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.431 0.158 . . . . 2.41 110.716 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 4.4 m95 -136.33 49.67 2.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.65 110.946 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.5 148.3 25.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.28 111.231 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 37' ' ' ILE . 8.2 ptmm? -79.16 89.61 4.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.127 -0.488 . . . . 1.3 110.875 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -49.02 -41.83 36.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.01 0.433 . . . . 0.86 110.575 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.606 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 21.4 t-20 -60.46 100.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.796 -0.638 . . . . 2.01 110.159 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -104.86 28.66 6.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 2.08 111.321 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.3 t -130.47 -70.64 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.344 . . . . 1.89 111.005 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 170.58 153.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 1.87 110.588 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 61' ' ' PHE . 16.8 mt -142.09 56.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.69 111.253 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 tp -48.46 -38.24 19.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 1.6 110.747 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.721 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -92.77 166.74 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 1.54 110.161 179.67 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 56.6 p30 -89.22 15.12 9.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.496 -0.32 . . . . 1.75 111.651 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.963 ' OE1' ' HB3' ' A' ' 21' ' ' LYS . 19.7 tp10 -122.71 99.56 6.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 56' ' ' ILE . 26.1 t80 -131.71 166.6 21.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.007 0.432 . . . . 0.48 111.424 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' VAL . 21.6 m -117.58 120.67 38.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.42 111.076 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 20' ' ' LEU . 12.5 t -84.14 104.29 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.16 0.505 . . . . 1.08 111.507 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.774 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -94.5 -168.64 1.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.461 -0.79 . . . . 1.33 110.404 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.44 11.82 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.572 -0.823 . . . . 0.9 112.893 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.01 ' CD1' HG13 ' A' ' 18' ' ' VAL . 16.2 mt -69.18 -159.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.927 -0.397 . . . . 1.47 109.927 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.7 m -147.69 147.73 30.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.902 0.382 . . . . 1.06 110.594 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.1 mt-10 -81.78 145.82 30.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 1.91 110.988 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t0 67.65 39.4 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 1.87 111.058 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.95 122.91 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.49 111.452 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -68.78 133.22 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.36 109.884 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.43 ' HA ' HD22 ' A' ' 43' ' ' LEU . 35.6 m-85 -124.38 127.37 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.691 0.626 . . . . 0.56 112.691 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' CG ' HD21 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -98.05 138.24 35.66 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.178 -1.045 . . . . 1.5 108.178 178.225 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.42 108.7 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.523 -1.271 . . . . 0.6 113.937 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -88.67 159.72 17.7 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.112 -0.329 . . . . 2.11 110.112 179.041 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.649 HG23 ' CG ' ' A' ' 8' ' ' PRO . 64.6 t -121.2 122.84 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.427 0.632 . . . . 0.6 112.585 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 39.5 mt -117.06 155.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.719 -1.215 . . . . 0.7 107.719 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -172.4 138.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.378 -0.929 . . . . 0.6 112.178 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 33' ' ' ILE . 5.2 ptpt -84.57 176.53 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 1.98 110.766 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.739 ' CG ' HD12 ' A' ' 2' ' ' ILE . 2.4 p-10 -124.57 163.61 21.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.871 -0.604 . . . . 2.19 111.208 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.82 -25.53 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 1.08 111.906 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -77.22 -12.39 59.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.897 0.332 . . . . 1.06 111.897 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 -17.75 57.68 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.49 -0.862 . . . . 0.93 112.425 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -57.33 -162.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.54 0.209 . . . . 1.38 110.492 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -145.0 105.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.79 112.001 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -63.44 119.56 54.55 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.59 108.734 179.175 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.6 Cg_endo -48.98 159.25 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.89 2.393 . . . . 0.85 113.242 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 24.0 Cg_endo -62.56 150.78 86.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.907 2.405 . . . . 0.76 113.264 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 m -106.53 132.8 52.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.805 . . . . 1.28 109.651 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 13.7 tt0 -30.25 111.91 0.29 Allowed Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.867 0.73 . . . . 1.77 112.325 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.49 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 71.7 Cg_exo -45.66 139.57 10.15 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.787 2.324 . . . . 0.55 114.324 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -53.75 144.54 17.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.834 -0.802 . . . . 1.23 108.834 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 4.7 m-20 -14.62 -89.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.743 1.902 . . . . 1.63 113.793 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . 158.43 106.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.967 0.907 . . . . 0.41 109.239 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.929 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -98.04 112.99 31.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.756 -0.378 . . . . 0.44 111.956 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.4 m -47.44 -32.53 5.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.276 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 55.65 82.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.839 -0.618 . . . . 1.1 110.163 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -88.19 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.743 -0.662 . . . . 3.0 111.392 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.13 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 2.4 p30 -124.77 9.02 8.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.478 -0.328 . . . . 2.14 111.568 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.3 t0 50.46 26.14 2.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.969 0.414 . . . . 2.06 110.893 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 101' ' ' VAL . 14.6 p -142.54 14.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 2.8 111.667 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.13 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -136.29 -58.22 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.063 0.458 . . . . 4.58 110.328 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.336 -0.84 . . . . 3.79 111.196 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.551 0.215 . . . . 2.74 111.078 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.76 -167.01 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 2.06 112.318 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.446 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -158.26 145.78 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.68 111.22 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.3 m-20 -128.87 132.09 24.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.077 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 158.1 53.15 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.368 2.045 . . . . 0.5 112.4 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 9.9 Cg_endo -52.03 175.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.943 2.429 . . . . 0.71 112.763 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.91 168.62 49.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.024 -0.608 . . . . 0.66 112.665 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -59.73 121.89 61.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 110.461 -0.199 . . . . 1.52 110.461 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.653 ' CG ' HG23 ' A' ' 76' ' ' VAL . 32.1 Cg_exo -62.17 147.85 94.29 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.426 2.084 . . . . 0.44 112.451 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -151.52 110.48 2.97 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.954 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.5 Cg_exo -59.63 127.34 23.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.613 2.209 . . . . 0.64 113.52 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -94.16 -26.37 16.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.373 -0.831 . . . . 1.64 109.081 178.512 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 7.5 t30 -145.85 149.53 34.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.696 -0.684 . . . . 0.72 109.897 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.051 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.56 103.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.415 . . . . 0.96 111.132 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.218 ' CA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.48 60.42 0.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.883 -0.599 . . . . 1.46 111.544 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.166 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 59.12 -70.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.671 0.607 . . . . 2.42 112.445 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.0 m170 -87.31 -27.18 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.185 -0.461 . . . . 1.02 111.762 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.8 p -111.86 103.47 11.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.68 111.424 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.051 HG13 HG22 ' A' ' 13' ' ' ILE . 86.9 t -102.07 95.73 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.8 111.038 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 78.3 m -80.96 142.52 33.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.248 -0.433 . . . . 0.35 111.636 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.731 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -154.85 164.77 38.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.43 -0.805 . . . . 0.52 112.009 -179.702 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.846 ' HB3' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.47 176.14 10.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.107 -0.951 . . . . 1.84 109.302 178.448 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.8 p90 -158.01 -177.54 6.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.275 0.56 . . . . 0.4 112.303 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.28 178.65 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.147 -0.933 . . . . 0.83 110.65 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 157.07 40.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.403 -0.362 . . . . 2.11 110.21 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' A' ' 28' ' ' THR . 37.1 Cg_exo -56.45 -157.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.506 2.138 . . . . 0.89 112.443 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -26.19 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.32 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -134.24 -67.73 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.856 0.317 . . . . 1.37 111.856 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' HG2' ' A' ' 25' ' ' PRO . 2.8 p 65.31 34.63 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.91 110.515 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.39 -95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.53 -0.843 . . . . 1.01 111.813 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.65 28.85 1.46 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.526 -1.029 . . . . 0.98 110.526 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HE1' ' HB2' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -107.01 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.193 -0.503 . . . . 0.87 111.591 -178.947 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -133.41 -0.41 3.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.66 -0.7 . . . . 2.26 111.706 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 35' ' ' SER . 2.9 mt 60.89 129.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 120.932 0.396 . . . . 1.71 110.901 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -116.71 25.99 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.442 -0.345 . . . . 1.15 111.63 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.564 ' H ' HG22 ' A' ' 33' ' ' ILE . 1.7 m 172.09 164.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 1.58 111.169 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.769 ' O ' HD12 ' A' ' 56' ' ' ILE . 40.7 m-85 -142.36 106.18 4.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.504 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -87.35 94.62 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 1.14 111.039 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -86.42 114.58 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.63 110.75 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 2.0 mm-40 -86.0 156.79 20.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.634 -0.712 . . . . 1.67 110.922 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.719 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -122.62 142.99 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 1.97 111.316 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -119.03 114.01 21.84 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.037 -0.529 . . . . 1.44 110.584 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.763 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.7 102.08 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.59 110.492 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 94' ' ' ALA . 46.8 mt -80.09 156.12 74.52 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.583 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 89.1 Cg_endo -86.26 28.64 9.63 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.88 -1.3 . . . . 1.43 113.489 0.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.3 -86.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.636 0.255 . . . . 2.66 110.555 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 117.43 170.69 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.456 -0.878 . . . . 1.12 113.208 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.763 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 1.0 OUTLIER 176.68 -35.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.407 . . . . 2.41 110.566 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 34.0 m95 62.92 81.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.65 111.406 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -122.54 128.67 51.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.759 -0.655 . . . . 1.28 110.234 179.786 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -55.11 87.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.76 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.719 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -51.4 -47.56 62.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.86 111.226 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' HB2' HD11 ' A' ' 56' ' ' ILE . 2.0 t30 -44.79 -79.2 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 2.01 110.983 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 84.46 -43.12 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.181 0.437 . . . . 2.08 112.181 179.624 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.2 m -67.02 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 1.89 111.28 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 140.13 1.05 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 1.87 110.798 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 36' ' ' TYR . 51.4 mt -130.16 67.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.69 110.982 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.09 -65.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.463 . . . . 1.6 110.751 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -74.42 179.27 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.549 . . . . 1.54 110.115 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 5.3 p-10 -93.7 13.24 22.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.398 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.846 ' CD ' ' HB3' ' A' ' 21' ' ' LYS . 16.1 tp10 -117.63 105.48 12.08 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.981 -0.377 . . . . 2.05 109.981 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.691 ' HB2' HG23 ' A' ' 56' ' ' ILE . 37.3 t80 -137.51 165.99 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.48 111.156 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.51 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -122.53 120.42 33.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.42 111.372 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 51' ' ' ALA . 5.5 t -83.17 85.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 1.08 111.029 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -86.98 -169.78 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.618 -0.719 . . . . 1.33 110.632 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.22 25.1 46.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.9 112.411 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.682 ' CD1' HG23 ' A' ' 18' ' ' VAL . 44.1 mt -77.63 -178.04 5.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.47 111.104 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 134.14 54.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 1.06 110.496 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.68 152.09 28.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 1.91 111.223 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 1.1 t70 66.73 60.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 1.87 110.985 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 178.13 130.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.49 111.359 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 128.63 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.36 110.194 179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 44.9 m-85 -124.21 124.92 43.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.846 0.684 . . . . 0.56 112.846 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 19.8 mt-10 -100.03 141.12 33.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.798 -0.815 . . . . 1.5 108.798 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.701 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -130.88 120.8 24.17 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.358 1.244 . . . . 0.6 114.358 -178.704 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -105.47 169.85 8.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.746 -0.661 . . . . 2.11 109.778 178.493 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' CG ' ' A' ' 8' ' ' PRO . 61.2 t -125.54 105.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.428 0.899 . . . . 0.6 113.428 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 88' ' ' PRO . 44.3 mt -100.59 130.57 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 106.934 -1.506 . . . . 0.7 106.934 177.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.91 147.74 21.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.452 -0.899 . . . . 0.6 113.046 -178.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mttt -77.31 -167.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 1.98 110.345 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 49.7 p30 -129.78 -119.5 0.23 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.475 -0.565 . . . . 2.19 109.475 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.02 1.14 5.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.49 1.041 . . . . 1.08 111.71 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . . . -112.01 4.32 18.02 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.597 0.221 . . . . 1.06 111.597 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.84 -11.76 64.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.344 -0.932 . . . . 0.93 112.929 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.96 177.03 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.936 0.368 . . . . 1.38 110.394 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -130.88 101.31 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.79 111.989 -179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -57.57 118.35 24.91 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.553 -0.906 . . . . 0.59 108.553 178.817 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.0 Cg_endo -42.8 171.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.896 2.397 . . . . 0.85 113.313 -178.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HG3' HD11 ' A' ' 77' ' ' ILE . 6.7 Cg_exo -71.3 130.73 17.9 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.778 2.318 . . . . 0.76 112.778 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -87.86 108.26 19.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.765 -0.652 . . . . 1.28 109.932 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -10.3 115.3 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.458 1.103 . . . . 1.77 113.401 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 89.2 Cg_exo -47.91 163.34 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.736 2.291 . . . . 0.55 114.217 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.38 151.99 19.95 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 1.23 109.48 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.57 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -32.33 140.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 124.3 1.0 . . . . 1.63 112.455 179.914 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.01 113.08 16.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.767 -0.651 . . . . 0.41 111.138 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.3 mp -97.57 116.29 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.44 110.828 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.6 m -46.17 -26.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.885 -0.598 . . . . 0.44 111.47 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 95' ' ' ILE . 34.2 m 47.34 78.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.571 -0.286 . . . . 1.1 111.273 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -121.87 -79.55 0.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.096 0.474 . . . . 3.0 110.99 179.999 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.03 ' OD1' ' HB ' ' A' ' 101' ' ' VAL . 3.3 p30 -122.66 26.33 8.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.52 -0.764 . . . . 2.14 110.451 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.218 ' OD1' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.98 24.1 0.82 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.002 -0.545 . . . . 2.06 111.225 -179.237 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.03 ' HB ' ' OD1' ' A' ' 99' ' ' ASP . 58.9 t -123.77 -13.96 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 2.8 111.435 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.31 28.96 0.33 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.841 0.353 . . . . 4.58 111.468 179.841 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.31 -0.853 . . . . 3.79 111.095 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.68 0.276 . . . . 2.74 111.148 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.62 110.26 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.687 2.258 . . . . 2.06 112.332 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.669 HD11 ' OD1' ' A' ' 80' ' ' ASN . 2.0 tt -81.47 147.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.68 111.064 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' ILE . 13.1 m-20 -136.77 133.48 18.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 2.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.67 174.95 9.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.665 2.243 . . . . 0.5 112.439 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 24.5 Cg_exo -63.97 -164.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.9 2.4 . . . . 0.71 113.175 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -102.38 -151.89 24.0 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.675 -0.693 . . . . 0.66 112.852 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -88.24 125.24 64.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.056 -0.085 . . . . 1.52 110.791 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_exo -80.09 141.79 14.95 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.763 2.308 . . . . 0.44 112.314 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.23 116.11 4.7 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.077 -0.511 . . . . 1.09 111.463 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' A' ' 95' ' ' ILE . 23.0 Cg_exo -62.0 104.22 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.577 2.185 . . . . 0.64 113.081 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.634 HD12 HG22 ' A' ' 19' ' ' THR . 0.3 OUTLIER -64.99 -35.05 79.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.48 0.657 . . . . 1.64 109.601 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -140.3 153.49 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.941 -1.027 . . . . 0.72 108.77 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.812 HG21 HG12 ' A' ' 95' ' ' ILE . 1.2 pt -144.88 108.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.704 -0.399 . . . . 0.96 111.882 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -101.48 59.89 0.89 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.106 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 49.34 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.951 0.782 . . . . 2.42 112.59 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 14' ' ' THR . 31.8 m170 -82.27 -34.72 28.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.231 -0.441 . . . . 1.02 111.609 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -119.05 106.19 12.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.883 0.373 . . . . 0.68 110.923 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.921 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 10.3 m -104.57 154.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.8 111.163 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.634 HG22 HD12 ' A' ' 11' ' ' LEU . 3.4 m -123.07 123.63 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.35 111.259 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -131.2 159.58 37.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.52 111.714 179.212 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 11' ' ' LEU . 2.0 tppt? -140.83 157.24 45.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.814 -1.085 . . . . 1.84 109.776 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 25.5 p90 -149.12 -176.1 5.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.294 0.568 . . . . 0.4 112.264 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -94.49 121.87 36.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.399 -0.819 . . . . 0.83 110.7 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 150.12 96.41 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 121.0 -0.28 . . . . 2.11 110.576 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 33' ' ' ILE . 77.6 Cg_exo -43.52 173.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.89 112.823 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -26.16 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.145 0.424 . . . . 2.77 112.145 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.4 t80 -124.45 -70.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.178 0.436 . . . . 1.37 112.178 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.537 HG21 HD11 ' A' ' 33' ' ' ILE . 20.0 p 56.04 55.01 7.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.713 0.292 . . . . 0.91 110.655 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.82 -93.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.055 -0.521 . . . . 1.01 112.657 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.54 34.48 0.89 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.127 -1.589 . . . . 0.98 109.127 178.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -113.63 142.99 45.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.275 -0.963 . . . . 0.87 111.54 -178.318 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -92.25 -8.18 46.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.112 -0.495 . . . . 2.26 111.459 179.606 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 71.47 -75.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 1.71 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.1 p 72.96 18.34 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.838 0.31 . . . . 1.15 111.838 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 179.85 145.8 0.21 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.073 0.463 . . . . 1.58 112.121 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.701 ' O ' HD12 ' A' ' 56' ' ' ILE . 89.6 m-85 -133.05 104.14 6.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.859 -0.61 . . . . 0.76 111.083 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' A' ' 79' ' ' LYS . 15.3 mt -78.66 93.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 1.14 110.463 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.5 p -91.08 106.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.63 111.384 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.4 mm-40 -71.29 167.13 20.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.372 -0.831 . . . . 1.67 111.143 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.804 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.74 151.99 49.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 1.97 111.399 -179.716 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.3 ttm180 -138.49 104.61 5.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 1.44 109.904 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.35 105.84 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.59 111.027 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.94 151.06 81.84 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.9 110.641 179.742 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -92.87 22.15 30.1 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.987 -1.256 . . . . 1.43 112.576 0.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.64 75.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 2.66 111.274 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -131.67 177.46 18.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 1.12 112.415 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.69 -148.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.595 -0.15 . . . . 2.41 110.595 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 16.1 m95 -136.71 74.27 1.48 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.996 0.427 . . . . 0.65 110.981 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.654 HD23 ' HG3' ' A' ' 47' ' ' ARG . 1.5 mm? -110.81 137.16 48.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.829 -0.623 . . . . 1.28 110.795 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 14.9 ptmt -52.54 92.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.06 -0.518 . . . . 1.3 111.837 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -54.15 -49.11 70.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.456 0.646 . . . . 0.86 109.867 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' HD11 ' A' ' 56' ' ' ILE . 3.1 t30 -44.43 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.1 -0.955 . . . . 2.01 110.822 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.7 43.09 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 2.08 110.774 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -152.35 -71.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 1.89 111.119 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 179.24 143.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.888 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 36' ' ' TYR . 37.2 mt -149.14 64.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.69 110.975 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -46.22 -69.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 1.6 111.345 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.56 179.57 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.502 -0.317 . . . . 1.54 110.741 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -86.53 10.62 14.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.699 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -107.98 104.32 13.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.551 -0.537 . . . . 2.05 109.551 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.594 ' HB2' HG23 ' A' ' 56' ' ' ILE . 43.6 t80 -131.13 164.27 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.391 0.615 . . . . 0.48 111.84 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' VAL . 98.6 m -127.91 115.74 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.966 -1.016 . . . . 0.42 109.506 179.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.57 HG22 ' HE2' ' A' ' 61' ' ' PHE . 15.4 t -76.09 111.6 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.042 0.448 . . . . 1.08 111.701 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 140.23 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.637 -0.71 . . . . 1.33 110.706 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.07 7.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 0.9 112.569 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -50.94 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.963 0.411 . . . . 1.47 111.042 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -142.43 154.69 44.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 1.06 110.568 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.97 143.74 47.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 1.91 110.937 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 67.43 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 1.87 111.418 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.53 124.66 0.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.746 0.307 . . . . 0.49 111.564 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.98 137.53 51.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.147 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 34.5 m-85 -131.78 118.83 20.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.291 0.848 . . . . 0.56 113.291 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.1 mm-40 -100.59 140.5 34.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.157 -0.683 . . . . 1.5 109.157 178.308 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 2.2 m-85 -123.06 106.72 11.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.419 1.266 . . . . 0.6 114.419 -178.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -76.08 151.81 36.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.643 -0.708 . . . . 2.11 110.292 178.602 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 t -125.42 118.3 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.092 0.473 . . . . 0.6 112.242 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 65.4 mt -124.69 163.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.849 -0.797 . . . . 0.7 108.849 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -163.13 127.64 2.99 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.826 -0.749 . . . . 0.6 112.124 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.44 24.4 1.66 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.622 0.601 . . . . 1.98 112.622 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.669 ' OD1' HD11 ' A' ' 2' ' ' ILE . 2.8 m120 44.4 -173.31 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.502 0.668 . . . . 2.19 112.643 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -63.7 -37.07 85.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.299 -0.864 . . . . 1.08 112.347 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.06 33.71 3.17 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.964 0.728 . . . . 1.06 112.964 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' LYS . . . 65.24 9.89 44.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.255 -0.974 . . . . 0.93 113.37 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -66.4 103.17 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.177 -0.675 . . . . 1.38 109.177 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -60.32 110.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.678 0.752 . . . . 0.79 112.579 -178.486 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 41.1 p -87.88 110.87 38.53 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.651 -1.159 . . . . 0.59 108.673 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -35.03 160.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.641 2.894 . . . . 0.85 113.609 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 24.1 Cg_exo -62.46 150.52 87.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.78 2.32 . . . . 0.76 112.8 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.0 m -120.88 108.9 14.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.587 -0.733 . . . . 1.28 109.8 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -6.0 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 124.534 1.146 . . . . 1.77 113.317 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 48' ' ' TRP . 56.7 Cg_exo -50.4 135.63 39.69 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.508 2.139 . . . . 0.55 113.763 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -53.48 152.13 5.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.648 -0.871 . . . . 1.23 108.648 178.804 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -41.87 154.72 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.769 0.668 . . . . 1.63 110.616 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -85.41 114.16 22.25 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.658 -0.701 . . . . 0.41 110.03 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -92.94 113.15 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.084 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.6 m -51.13 -27.07 7.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.678 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.475 ' H ' HG22 ' A' ' 95' ' ' ILE . 76.6 m 53.22 84.82 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.1 110.539 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -97.38 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.547 -0.297 . . . . 3.0 111.499 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.878 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -93.21 0.67 57.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.651 0.241 . . . . 2.14 111.651 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 1.4 p30 52.52 21.63 1.86 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.016 0.376 . . . . 2.06 112.016 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.878 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -119.5 -13.04 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.649 -0.25 . . . . 2.8 110.972 179.57 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -162.55 27.99 0.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.784 0.326 . . . . 4.58 111.221 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.213 -0.899 . . . . 3.79 111.082 179.9 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.437 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.748 0.309 . . . . 2.74 111.014 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 0' ' ' SER . 94.0 Cg_endo -90.11 66.3 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.934 2.422 . . . . 2.06 112.439 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.681 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.5 tt -52.28 149.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.68 110.844 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.267 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.62 127.65 18.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 2.0 110.596 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 154.62 31.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.405 2.07 . . . . 0.5 112.186 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 1.9 Cg_endo -45.68 176.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.897 2.398 . . . . 0.71 112.79 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.65 170.64 50.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.896 -0.668 . . . . 0.66 112.649 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.2 tttp -56.59 128.62 75.19 Favored Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 110.185 -0.302 . . . . 1.52 110.185 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' HG12 ' A' ' 76' ' ' VAL . 6.2 Cg_exo -80.35 133.56 9.72 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.628 2.219 . . . . 0.44 112.109 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 p -126.85 117.27 22.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 1.09 110.948 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' THR . 25.3 Cg_exo -63.03 93.05 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.479 2.119 . . . . 0.64 113.032 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 19' ' ' THR . 1.8 mt -52.85 -42.08 64.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.636 0.732 . . . . 1.64 109.14 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -132.44 151.69 51.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.626 -1.17 . . . . 0.72 108.456 178.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.672 HG21 HG12 ' A' ' 95' ' ' ILE . 2.3 pt -142.84 100.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.386 -0.525 . . . . 0.96 112.346 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.77 144.19 27.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 1.46 110.211 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -47.63 -24.34 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.389 0.514 . . . . 2.42 112.389 -179.091 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 17' ' ' THR . 6.7 m-70 -130.37 30.76 4.69 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.904 -0.318 . . . . 1.02 111.633 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER 172.2 111.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 0.68 110.62 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 66' ' ' LEU . 4.4 m -111.21 133.34 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.8 110.375 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.2 m -102.99 111.47 23.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.35 111.996 -178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.807 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.17 143.53 48.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.52 111.235 178.646 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -131.92 144.24 50.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.746 -1.116 . . . . 1.84 110.206 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 27.4 p90 -129.15 -177.1 4.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.362 0.601 . . . . 0.4 112.304 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.14 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.83 111.162 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -84.4 140.09 38.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 2.11 110.251 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.7 Cg_endo -44.63 172.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.668 2.245 . . . . 0.89 112.236 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.55 -29.03 9.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 2.77 111.479 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.2 t80 -130.44 -69.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.877 0.325 . . . . 1.37 111.877 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . 1.267 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.4 p 52.43 48.67 22.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.154 0.502 . . . . 0.91 110.495 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.51 -94.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.681 -0.691 . . . . 1.01 112.77 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.69 35.57 0.93 Allowed Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.891 -0.884 . . . . 0.98 110.891 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -116.85 -172.16 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.276 -0.462 . . . . 0.87 111.152 -178.982 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.4 ptmt -147.23 26.24 1.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 2.26 111.476 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.891 HG22 ' H ' ' A' ' 35' ' ' SER . 1.5 mp 65.71 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 1.71 110.676 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.594 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.68 -12.12 1.0 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.318 0.488 . . . . 1.15 112.318 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.891 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -169.72 102.63 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.56 0.219 . . . . 1.58 111.32 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 47.8 m-85 -80.0 147.96 31.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.205 -0.295 . . . . 0.76 110.205 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.481 HG22 ' CB ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -129.39 111.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.319 . . . . 1.14 111.115 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.41 99.14 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.69 0.281 . . . . 0.63 111.392 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -75.63 128.34 35.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.978 -0.378 . . . . 1.67 109.978 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -109.16 131.28 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.252 0.464 . . . . 1.97 112.252 -179.425 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.18 111.56 24.22 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.789 -1.189 . . . . 1.44 107.789 177.976 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' N ' ' HA3' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.69 81.54 2.05 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.269 -0.878 . . . . 1.59 111.088 -179.034 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -53.54 155.87 5.0 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.825 -0.625 . . . . 0.9 110.694 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 5.8 Cg_exo -79.13 1.64 33.22 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.027 -1.239 . . . . 1.43 113.029 0.301 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -104.5 -75.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 2.66 110.881 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . 50.22 179.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.831 -0.7 . . . . 1.12 112.957 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.9 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.49 32.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 2.41 110.905 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.541 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 65.5 m95 40.34 97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.705 -0.68 . . . . 0.65 112.203 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -133.52 128.99 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.28 110.679 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 37' ' ' ILE . 1.1 ptmm? -56.68 83.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 1.3 111.494 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.554 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -67.26 -38.86 85.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.86 110.244 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' HD11 ' A' ' 56' ' ' ILE . 14.2 p-10 -36.82 -44.42 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.515 -0.766 . . . . 2.01 111.71 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.13 43.47 2.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.115 -0.493 . . . . 2.08 111.785 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -152.79 -175.45 5.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 1.89 111.622 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.1 89.28 5.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.87 110.641 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.747 HD13 ' CG ' ' A' ' 61' ' ' PHE . 25.2 mt -85.43 75.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.69 111.251 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 57' ' ' LEU . 4.5 mt -58.0 -61.97 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 1.6 111.223 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.2 163.13 27.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 1.54 110.27 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 20.2 p30 -80.5 2.7 24.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.281 -0.418 . . . . 1.75 111.675 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 21.1 tt0 -102.13 101.54 11.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.586 -0.524 . . . . 2.05 109.586 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CG ' HD13 ' A' ' 56' ' ' ILE . 70.2 t80 -135.27 164.38 27.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.48 111.506 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 92.9 m -124.31 123.49 40.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.42 110.36 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.704 HG23 HD21 ' A' ' 20' ' ' LEU . 6.7 t -79.94 94.53 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 116.063 -0.517 . . . . 1.08 110.49 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.6 p -86.61 -171.18 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.494 -0.775 . . . . 1.33 110.811 -179.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.82 9.75 53.45 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.449 -0.881 . . . . 0.9 112.525 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.061 ' CD1' HG13 ' A' ' 18' ' ' VAL . 13.8 mt -60.85 -179.34 0.13 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.827 0.313 . . . . 1.47 110.407 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -137.13 128.11 27.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 1.06 110.809 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.17 155.5 13.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.91 111.133 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 97' ' ' CYS . 3.5 t70 53.37 46.07 27.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 1.87 110.959 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.58 118.71 2.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.402 -0.363 . . . . 0.49 111.371 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -70.29 133.64 47.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.114 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -129.92 126.44 37.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.605 0.595 . . . . 0.56 112.605 -178.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.9 mt-10 -102.85 143.36 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.143 -1.058 . . . . 1.5 108.143 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.999 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.69 115.93 12.58 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.16 1.541 . . . . 0.6 115.16 -178.89 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.36 169.22 9.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.171 -1.418 . . . . 2.11 107.171 176.778 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 89' ' ' SER . 0.7 OUTLIER -134.75 112.54 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 118.867 -1.133 . . . . 0.6 113.323 -179.836 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' ILE . 79.0 mt -102.73 145.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.227 -1.397 . . . . 0.7 107.227 177.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.78 119.88 2.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.72 -0.792 . . . . 0.6 111.898 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -59.07 -161.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.461 -0.496 . . . . 1.98 109.954 179.523 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.681 ' ND2' HD11 ' A' ' 2' ' ' ILE . 6.1 m-80 -150.91 165.72 32.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.249 0.547 . . . . 2.19 110.885 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.25 -29.57 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.282 -0.872 . . . . 1.08 112.656 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.54 11.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.36 2.2 53.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.623 -0.799 . . . . 0.93 113.294 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.615 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -64.63 102.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.088 0.444 . . . . 1.38 109.914 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -68.23 114.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 113.023 0.749 . . . . 0.79 113.023 -178.798 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.433 ' N ' HD12 ' A' ' 85' ' ' ILE . 14.2 p -78.94 115.0 48.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.29 -0.868 . . . . 0.59 109.927 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.11 155.85 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.16 1.907 . . . . 0.85 111.881 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 15.0 Cg_endo -58.69 126.85 22.45 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 122.807 2.338 . . . . 0.76 113.443 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.52 ' HB3' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -78.64 132.46 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.92 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -22.42 107.34 0.12 Allowed Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 124.168 0.917 . . . . 1.77 113.33 -179.414 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 86.8 Cg_exo -45.3 142.87 5.82 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.825 2.35 . . . . 0.55 113.26 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -79.48 150.38 31.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.758 -0.46 . . . . 1.23 109.758 179.029 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -37.16 151.2 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.143 0.902 . . . . 1.63 111.656 179.814 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -80.5 113.8 18.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.364 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.672 HG12 HG21 ' A' ' 13' ' ' ILE . 4.3 mp -96.6 112.77 29.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.917 0.389 . . . . 0.44 111.468 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 84.5 m -54.4 -36.13 63.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.074 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 61.0 93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.38 . . . . 1.1 110.27 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -140.07 -84.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.418 . . . . 3.0 111.788 -179.625 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.532 ' CG ' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.16 -9.53 15.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 2.14 111.94 -179.631 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 54.22 27.92 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 2.06 111.075 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.532 HG12 ' CG ' ' A' ' 99' ' ' ASP . 8.6 p -135.36 5.27 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 2.8 111.842 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.1 pp20? -156.84 -41.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 111.649 0.24 . . . . 4.58 111.649 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.205 -0.902 . . . . 3.79 111.23 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.537 0.208 . . . . 2.74 111.204 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.03 150.35 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.766 2.311 . . . . 2.06 111.887 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.501 HD11 ' ND2' ' A' ' 80' ' ' ASN . 9.0 tt -118.07 150.91 20.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.032 0.444 . . . . 0.68 111.475 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' ILE . 91.7 m-20 -129.82 132.63 24.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 2.0 110.548 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.59 171.12 16.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.494 2.129 . . . . 0.5 112.66 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 12.4 Cg_endo -55.7 171.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.043 2.495 . . . . 0.71 112.837 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -93.97 113.6 4.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.049 -0.596 . . . . 0.66 113.083 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 10.87 109.15 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 124.572 1.149 . . . . 1.52 113.767 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.46 ' CG ' HG23 ' A' ' 76' ' ' VAL . 19.9 Cg_exo -68.8 139.08 42.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.787 2.325 . . . . 0.44 112.96 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.02 112.21 10.37 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.038 -0.528 . . . . 1.09 111.508 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.9 Cg_exo -64.89 112.39 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.829 2.352 . . . . 0.64 113.696 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.72 -35.85 72.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.854 -0.795 . . . . 1.64 108.854 178.7 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -135.93 135.97 40.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.774 -1.103 . . . . 0.72 108.895 179.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -134.27 70.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.269 0.47 . . . . 0.96 112.269 -178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 156.96 34.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.46 110.151 179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.69 -8.65 36.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.887 -0.325 . . . . 2.42 111.464 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.414 ' O ' HG23 ' A' ' 17' ' ' THR . 11.1 m-70 -128.88 18.2 6.16 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.507 0.194 . . . . 1.02 111.357 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 177.23 124.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.806 0.336 . . . . 0.68 110.925 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 23.1 t -114.28 113.81 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.8 111.104 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 17.4 m -100.26 127.4 46.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.984 -0.553 . . . . 0.35 111.23 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -138.07 150.3 46.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.745 0.783 . . . . 0.52 111.976 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.087 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -132.52 147.36 52.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.425 -1.262 . . . . 1.84 109.337 179.596 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.523 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 8.3 p90 -132.47 -175.75 3.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.236 0.541 . . . . 0.4 112.375 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.85 177.31 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.332 -0.849 . . . . 0.83 111.329 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -98.16 139.4 21.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.625 -0.716 . . . . 2.11 110.25 179.733 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.816 ' HB2' HG23 ' A' ' 28' ' ' THR . 2.9 Cg_endo -47.52 178.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.89 112.039 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -113.15 -15.44 12.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 2.77 112.081 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -139.15 -66.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.313 0.486 . . . . 1.37 112.313 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.816 HG23 ' HB2' ' A' ' 25' ' ' PRO . 54.4 p 54.57 45.03 27.77 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.91 110.532 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.46 -93.99 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.738 -0.744 . . . . 1.01 112.379 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.68 42.19 0.8 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.662 -1.375 . . . . 0.98 109.662 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -127.98 -177.32 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.997 -0.602 . . . . 0.87 111.298 -178.211 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.69 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.5 OUTLIER -136.54 19.97 3.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.338 -0.392 . . . . 2.26 111.747 -179.456 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.059 HG23 ' HB1' ' A' ' 78' ' ' ALA . 3.5 mp 64.15 -74.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.282 . . . . 1.71 111.279 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.69 HG22 ' HD2' ' A' ' 32' ' ' LYS . 2.5 p 58.05 32.39 21.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 1.15 111.132 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.602 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t 170.72 110.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.58 110.845 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.661 ' O ' HD12 ' A' ' 56' ' ' ILE . 23.4 m-85 -111.75 87.8 2.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.971 0.415 . . . . 0.76 111.061 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.678 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -79.03 88.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.78 -0.645 . . . . 1.14 111.43 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.27 127.58 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.8 -0.444 . . . . 0.63 109.8 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.9 143.73 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.812 -0.631 . . . . 1.67 111.563 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' HD3' HG11 ' A' ' 63' ' ' VAL . 3.5 mtmp? -98.35 148.38 23.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 1.97 110.871 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -144.77 86.58 1.81 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 1.44 110.604 179.126 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.173 ' OD2' ' O ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -48.51 150.02 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.125 -0.489 . . . . 1.59 110.725 179.236 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 42' ' ' ASP . 1.8 mm? -123.78 101.11 36.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.033 -0.667 . . . . 0.9 111.291 179.022 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 6.3 Cg_endo -87.57 -136.56 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.053 -1.228 . . . . 1.43 110.212 -0.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.173 ' O ' ' OD2' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 42.63 42.22 2.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.783 0.325 . . . . 2.66 111.441 179.708 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -118.23 148.26 18.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.183 -1.008 . . . . 1.12 113.861 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.818 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.91 122.17 9.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.432 -0.581 . . . . 2.41 109.432 179.44 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 40.9 m95 -43.81 94.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.65 111.149 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -119.32 130.88 55.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.849 -0.614 . . . . 1.28 110.712 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.678 ' HE3' HG21 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.67 69.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 1.3 110.819 179.938 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -47.74 -38.82 16.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.86 111.355 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.554 ' HB3' HD11 ' A' ' 56' ' ' ILE . 5.3 p-10 -51.28 -58.65 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 2.01 111.616 -179.574 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER 80.0 -51.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.585 0.231 . . . . 2.08 111.221 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -169.93 0.19 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.806 0.336 . . . . 1.89 111.111 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -98.27 107.5 19.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.87 111.014 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 36' ' ' TYR . 24.0 mt -87.13 75.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.69 110.728 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 34' ' ' THR . 1.9 mt -52.52 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.289 -179.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 175.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.677 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 51.1 p30 -94.1 21.89 6.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.889 -0.596 . . . . 1.75 111.157 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.087 ' OE2' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -125.43 109.49 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 2.05 110.196 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CG ' HD13 ' A' ' 56' ' ' ILE . 64.5 t80 -136.45 164.61 27.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.48 111.669 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.9 m -127.26 117.37 22.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.612 -0.722 . . . . 0.42 110.783 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HD3' ' A' ' 40' ' ' LYS . 6.6 t -82.05 118.77 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.08 111.158 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -173.42 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 1.33 110.89 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.54 28.36 73.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.639 -0.791 . . . . 0.9 112.281 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' CD1' HG23 ' A' ' 18' ' ' VAL . 7.3 mt -82.04 174.25 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 1.47 111.318 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -125.38 99.25 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.686 . . . . 1.06 110.224 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 42.9 tt0 -43.74 148.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 1.91 111.728 -179.505 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 35.0 t0 75.41 65.48 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.87 111.059 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 171.49 127.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.49 111.006 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.55 136.3 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.068 -0.345 . . . . 0.36 110.068 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 37.3 m-85 -133.31 121.95 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.293 0.849 . . . . 0.56 113.293 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 11.8 mt-10 -102.58 131.96 48.98 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.391 -0.596 . . . . 1.5 109.391 178.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -124.87 118.99 27.55 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.673 0.99 . . . . 0.6 113.673 -178.77 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' NH1' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -94.67 144.73 25.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 2.11 110.381 178.97 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 5' ' ' PRO . 86.8 t -98.23 115.82 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.357 -0.537 . . . . 0.6 110.845 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 2.3 mt -110.29 167.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.542 -0.911 . . . . 0.7 108.542 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 1.059 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.14 -174.41 4.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -117.32 -77.75 0.57 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.157 0.503 . . . . 1.98 110.535 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER 125.79 140.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.196 1.798 . . . . 2.19 109.93 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -32.75 -44.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.217 0.821 . . . . 1.08 113.217 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -107.75 49.53 0.8 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.489 0.552 . . . . 1.06 112.489 -179.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.56 40.93 5.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.662 -0.78 . . . . 0.93 113.314 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB3' ' CB ' ' A' ' 80' ' ' ASN . . . -89.1 24.46 2.12 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.554 0.216 . . . . 1.38 111.227 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp 18.5 112.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 115.373 1.62 . . . . 0.79 115.373 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.671 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -85.64 111.81 40.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.66 -0.867 . . . . 0.59 108.66 177.957 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 28.6 Cg_endo -60.98 167.26 9.16 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.209 1.94 . . . . 0.85 112.523 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 75' ' ' ARG . 9.7 Cg_endo -53.8 136.31 65.32 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.052 2.501 . . . . 0.76 113.269 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.34 112.71 24.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.966 -0.561 . . . . 1.28 110.794 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 5.96 100.18 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.019 1.328 . . . . 1.77 114.435 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 82.7 Cg_exo -46.29 145.8 5.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.8 2.333 . . . . 0.55 113.358 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -78.19 143.9 36.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.074 -0.713 . . . . 1.23 109.074 179.068 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -30.93 148.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.298 0.999 . . . . 1.63 112.016 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -81.75 103.82 11.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.347 -0.388 . . . . 0.41 110.794 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.3 mp -83.86 116.01 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.537 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 98' ' ' ARG . 48.2 m -56.21 -30.41 62.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.401 . . . . 0.44 110.425 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.431 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 53.62 61.31 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 1.1 111.148 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -101.73 -77.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.04 0.448 . . . . 3.0 110.309 179.895 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.059 ' OD2' ' HB3' ' A' ' 102' ' ' GLU . 2.2 p-10 -126.08 -0.13 7.17 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.616 -0.72 . . . . 2.14 111.244 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 p30 46.85 26.03 0.52 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.108 0.48 . . . . 2.06 112.167 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.2 p -170.35 30.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.595 -0.729 . . . . 2.8 110.28 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.059 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -123.18 -30.6 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.702 -0.681 . . . . 4.58 111.613 -179.843 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 3.79 111.106 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.44 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.619 0.247 . . . . 2.74 111.163 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.664 ' O ' HG22 ' A' ' 2' ' ' ILE . 5.6 Cg_exo -78.77 -38.18 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.808 2.339 . . . . 2.06 112.131 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 1' ' ' PRO . 9.9 tt 53.64 138.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 123.952 0.783 . . . . 0.68 112.803 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.343 ' OD2' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.57 120.71 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.853 179.693 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.41 170.44 20.28 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.202 1.935 . . . . 0.5 112.398 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 7.1 Cg_endo -54.48 -171.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.754 2.303 . . . . 0.71 113.21 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.07 166.64 22.37 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.867 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.6 tptm -49.03 122.72 11.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.059 -0.348 . . . . 1.52 110.059 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.5 Cg_exo -77.41 128.77 9.81 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.242 1.961 . . . . 0.44 112.401 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -120.12 112.85 34.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 1.09 111.1 -179.748 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.3 Cg_exo -60.59 124.74 15.67 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.142 1.894 . . . . 0.64 113.223 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.635 HD11 ' CB ' ' A' ' 21' ' ' LYS . 1.4 mp -89.76 -29.42 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.83 -0.623 . . . . 1.64 109.809 179.118 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.421 ' O ' ' HB ' ' A' ' 19' ' ' THR . 5.9 t-20 -152.45 110.14 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.783 . . . . 0.72 110.226 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.731 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.8 131.74 66.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.394 0.616 . . . . 0.96 112.151 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -119.55 157.53 28.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.309 -0.86 . . . . 1.46 110.125 179.914 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.48 -9.07 16.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.325 0.491 . . . . 2.42 112.325 -179.637 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 17' ' ' THR . 1.5 m-70 -135.38 17.47 3.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.793 0.294 . . . . 1.02 111.793 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.832 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER 171.31 117.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.509 -0.182 . . . . 0.68 110.509 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.076 ' CG1' HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -104.14 165.0 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 120.592 -0.443 . . . . 0.8 111.64 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.6 m -140.87 123.9 16.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.35 111.251 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.778 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.55 159.56 41.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.664 0.745 . . . . 0.52 112.007 179.225 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.635 ' CB ' HD11 ' A' ' 11' ' ' LEU . 24.0 tptp -139.1 136.36 35.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.407 -1.27 . . . . 1.84 109.803 179.722 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.0 p90 -123.35 -177.93 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.281 0.562 . . . . 0.4 112.336 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.93 161.08 16.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.201 -0.909 . . . . 0.83 111.042 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -90.06 135.96 29.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 2.11 110.715 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HG3' HD11 ' A' ' 33' ' ' ILE . 11.5 Cg_endo -56.12 171.77 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.455 2.103 . . . . 0.89 112.005 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -50.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.658 0.265 . . . . 2.77 111.208 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.343 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.2 t80 -98.92 71.09 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 1.37 111.74 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.8 p -94.27 48.72 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.91 110.131 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.02 -94.92 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.967 -0.561 . . . . 1.01 112.344 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.55 33.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.936 -0.865 . . . . 0.98 110.936 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.58 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -118.66 175.76 5.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.253 -0.473 . . . . 0.87 111.299 -178.964 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.73 3.88 3.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.068 -0.514 . . . . 2.26 111.505 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.1 mt 59.75 144.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 120.96 0.409 . . . . 1.71 111.864 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -129.51 -5.11 4.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.946 -0.57 . . . . 1.15 112.258 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.27 143.86 3.68 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.919 0.34 . . . . 1.58 111.919 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 33' ' ' ILE . 33.7 m-85 -116.3 113.1 22.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.76 110.269 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 50' ' ' LYS . 2.7 mt -92.12 119.59 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.799 0.333 . . . . 1.14 110.987 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.29 93.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.442 0.534 . . . . 0.63 112.442 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.97 ' OE1' ' CA ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -72.93 146.33 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.147 -0.686 . . . . 1.67 109.147 178.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.35 141.62 51.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.215 0.531 . . . . 1.97 112.025 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.7 ttm180 -104.64 106.55 17.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.389 -0.823 . . . . 1.44 109.464 179.197 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.052 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.84 91.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.475 -0.784 . . . . 1.59 111.071 -179.379 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 94' ' ' ALA . 13.7 mt -75.96 146.0 78.45 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.112 -0.495 . . . . 0.9 110.328 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.78 27.85 15.27 Favored 'Cis proline' 0 C--N 1.347 0.467 0 C-N-CA 123.801 -1.333 . . . . 1.43 112.88 0.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -88.73 -73.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.761 0.315 . . . . 2.66 111.169 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 100.27 152.58 26.54 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.624 -0.798 . . . . 1.12 112.778 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.052 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 170.91 -31.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.303 . . . . 2.41 111.181 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.908 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 61.4 m95 58.62 75.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.361 . . . . 0.65 111.375 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.97 ' CA ' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mm? -117.42 130.91 56.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 1.28 110.341 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' CB ' HG22 ' A' ' 37' ' ' ILE . 5.2 ptmm? -52.69 97.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.926 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.94 -41.05 86.46 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.194 -0.669 . . . . 0.86 109.194 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 17.5 t-20 -58.56 164.35 2.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.061 -0.972 . . . . 2.01 110.405 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.37 31.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.471 . . . . 2.08 110.801 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.1 37.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.89 110.91 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 61.57 153.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 1.87 110.757 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.677 HD13 ' CG ' ' A' ' 61' ' ' PHE . 47.9 mt -147.23 60.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.69 110.44 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 tm? -46.03 -50.66 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 1.6 111.841 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -87.23 160.19 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.422 . . . . 1.54 111.048 -179.656 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.3 m-20 -76.27 -1.15 25.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.89 -0.596 . . . . 1.75 111.694 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.865 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -102.54 103.92 14.29 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.745 -0.465 . . . . 2.05 109.745 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.677 ' CG ' HD13 ' A' ' 56' ' ' ILE . 43.6 t80 -140.22 166.4 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.124 0.488 . . . . 0.48 111.9 -178.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 18' ' ' VAL . 95.4 m -117.23 119.42 35.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.42 110.797 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.8 t -82.12 99.31 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.204 0.526 . . . . 1.08 111.297 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 1.1 p -81.56 -157.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.533 -0.758 . . . . 1.33 111.207 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 54.03 45.54 71.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.727 -0.749 . . . . 0.9 112.154 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 18' ' ' VAL . 9.8 mt -87.61 -176.85 5.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.167 0.508 . . . . 1.47 111.205 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -153.36 115.04 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.717 . . . . 1.06 110.332 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 132.83 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 1.91 111.236 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.33 60.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 1.87 111.089 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -169.92 119.12 0.61 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.49 111.652 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.3 125.97 28.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.631 -0.507 . . . . 0.36 109.631 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 55.0 m-85 -121.95 122.18 38.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.4 0.518 . . . . 0.56 112.4 -178.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -101.18 131.95 46.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.312 -0.996 . . . . 1.5 108.312 178.386 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.95 ' CE2' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.2 109.69 19.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.157 1.54 . . . . 0.6 115.157 -177.849 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 ttp180 -97.72 124.54 42.1 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.681 -1.6 . . . . 2.11 106.681 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -105.87 119.64 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 119.103 -1.039 . . . . 0.6 113.716 -178.476 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' A' ' 88' ' ' PRO . 80.8 mt -101.41 163.78 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.537 -1.653 . . . . 0.7 106.537 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 77' ' ' ILE . . . -174.32 123.15 0.3 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.022 -1.071 . . . . 0.6 112.755 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 85' ' ' ILE . 21.9 mttt -60.8 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.002 -0.74 . . . . 1.98 109.002 178.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' A' ' 2' ' ' ILE . 36.3 m-20 -138.38 -101.95 0.18 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.514 -0.474 . . . . 2.19 111.387 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.32 -41.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 1.08 111.598 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . . . -101.97 40.96 1.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 1.06 111.962 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.91 9.6 53.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.579 -0.82 . . . . 0.93 113.154 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.81 87.3 4.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 1.38 110.322 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.712 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -58.76 111.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.79 111.682 -179.378 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -73.57 119.05 73.94 Favored Pre-proline 0 C--O 1.238 0.454 0 N-CA-C 109.454 -0.573 . . . . 0.59 109.454 179.562 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.8 Cg_endo -43.4 166.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.677 2.251 . . . . 0.85 112.461 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 77' ' ' ILE . 23.9 Cg_exo -64.36 149.21 90.54 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.676 2.251 . . . . 0.76 112.571 -179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.596 ' HB2' HG13 ' A' ' 76' ' ' VAL . 5.8 m -103.12 125.4 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.263 179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 62.9 mt-10 -22.07 117.45 0.15 Allowed Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 124.094 0.871 . . . . 1.77 112.793 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 66.1 Cg_exo -45.27 165.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.981 2.454 . . . . 0.55 114.513 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -100.82 146.36 27.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.339 -1.3 . . . . 1.23 109.166 178.764 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.761 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -37.09 130.66 0.83 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.864 0.728 . . . . 1.63 111.644 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.92 101.33 0.65 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.879 -0.6 . . . . 0.41 110.854 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.827 HD13 ' CZ ' ' A' ' 74' ' ' PHE . 4.8 mp -82.22 113.55 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.462 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -51.64 -28.06 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.44 111.159 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.468 ' H ' HG22 ' A' ' 95' ' ' ILE . 60.7 m 55.24 76.07 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.505 -0.316 . . . . 1.1 110.841 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -134.43 -87.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 3.0 111.073 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.976 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.14 -3.06 26.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 2.14 111.356 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 49.72 25.75 1.61 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.888 0.375 . . . . 2.06 111.415 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.976 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 11.9 t -116.65 -22.76 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.947 -0.57 . . . . 2.8 110.643 179.393 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -117.31 -15.05 10.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 4.58 111.295 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.223 -0.894 . . . . 3.79 111.096 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.453 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.653 0.263 . . . . 2.74 111.131 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 7.9 Cg_exo -72.22 137.12 28.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.864 2.376 . . . . 2.06 111.675 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.501 HD12 ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -115.2 124.46 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.68 111.685 -179.737 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.927 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -114.06 135.56 22.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.65 . . . . 2.0 109.937 179.395 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.36 174.04 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.672 2.248 . . . . 0.5 113.101 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.68 174.6 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.119 2.546 . . . . 0.71 113.462 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.08 169.67 42.37 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.297 -0.865 . . . . 0.66 112.627 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 65.4 tttt -58.57 127.28 81.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 110.581 -0.155 . . . . 1.52 110.581 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.0 Cg_exo -76.79 149.38 29.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.502 2.135 . . . . 0.44 113.078 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -144.16 113.4 5.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.284 -0.871 . . . . 1.09 110.015 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.7 Cg_exo -49.0 94.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.283 1.989 . . . . 0.64 113.553 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.66 -27.73 63.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.268 -0.878 . . . . 1.64 110.135 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 13' ' ' ILE . 10.9 t-20 -161.41 161.33 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.72 109.91 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.771 ' CG2' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.84 115.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.96 111.301 179.731 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -104.48 47.62 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.793 -0.64 . . . . 1.46 110.79 -179.908 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.81 -70.63 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.746 -0.661 . . . . 2.42 111.516 179.473 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' THR . 1.5 m-70 -82.79 -22.98 34.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 1.02 111.289 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.16 102.9 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.578 -0.283 . . . . 0.68 111.224 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -93.66 120.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.8 110.816 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.625 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.6 126.42 44.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.35 111.346 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.47 139.88 50.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.948 0.88 . . . . 0.52 111.69 178.437 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -116.97 172.78 7.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.192 -1.367 . . . . 1.84 109.317 179.681 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.52 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 46.0 p90 -168.34 165.51 12.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.126 -0.63 . . . . 0.4 112.503 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 156.07 23.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.963 -1.017 . . . . 0.83 110.685 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.98 156.46 52.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.725 -0.472 . . . . 2.11 109.725 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.15 -170.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.371 2.048 . . . . 0.89 111.954 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.53 13.21 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.883 0.327 . . . . 2.77 111.883 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.768 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 3.6 t80 -168.91 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.572 0.582 . . . . 1.37 112.572 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.927 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 52.0 p 53.8 38.81 29.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.003 0.43 . . . . 0.91 110.074 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 42.64 -125.15 4.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.852 -0.613 . . . . 1.01 112.175 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.45 4.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.451 -1.859 . . . . 0.98 108.451 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.608 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -112.99 -165.78 1.02 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.888 -1.156 . . . . 0.87 111.607 -178.03 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' C ' HD12 ' A' ' 33' ' ' ILE . 1.1 pttt -163.84 38.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 2.26 112.084 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.799 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.8 mp 66.29 -61.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.94 0.719 . . . . 1.71 112.94 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.4 p 83.08 -38.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.631 0.772 . . . . 1.15 111.856 -178.672 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -167.61 140.08 3.23 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.832 0.348 . . . . 1.58 111.406 -179.565 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.799 ' CE1' HG21 ' A' ' 33' ' ' ILE . 52.7 m-85 -99.6 139.94 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.76 110.218 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.97 98.1 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.671 -0.24 . . . . 1.14 111.05 -179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -91.69 126.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.133 0.492 . . . . 0.63 110.862 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.37 152.28 19.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.532 -0.758 . . . . 1.67 110.675 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.766 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 6.4 ptpt -116.14 144.14 44.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 1.97 111.521 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 1.1 ttt180 -119.38 104.86 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.979 179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.72 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.65 89.1 2.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.741 -0.663 . . . . 1.59 110.556 -179.863 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -67.09 144.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.686 . . . . 0.9 110.895 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -95.24 27.92 17.96 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.052 -1.229 . . . . 1.43 112.807 0.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.68 42.6 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 2.66 111.368 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -95.13 150.66 19.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.828 . . . . 1.12 112.224 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' CD ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.45 29.0 4.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 2.41 110.935 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.9 m95 51.36 100.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.999 -0.546 . . . . 0.65 111.133 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 ' CD ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -127.67 141.84 51.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.967 -0.561 . . . . 1.28 110.558 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 49.5 mtpt -49.36 91.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.3 110.95 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -65.26 -48.21 74.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.86 110.754 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.8 p-10 -74.28 114.61 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.95 -0.568 . . . . 2.01 110.746 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.54 30.34 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 2.08 110.913 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -138.02 21.2 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.89 111.352 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.15 144.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 1.87 111.174 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.584 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.0 mt -134.87 112.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.082 -0.508 . . . . 0.69 111.009 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -94.58 -47.75 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 1.6 110.862 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.57 157.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.891 -0.411 . . . . 1.54 109.891 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -73.53 -3.76 29.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.417 -0.356 . . . . 1.75 111.521 -179.924 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 tt0 -97.76 96.15 8.04 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.421 -0.585 . . . . 2.05 109.421 179.309 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' CG ' HD13 ' A' ' 56' ' ' ILE . 72.3 t80 -121.68 163.86 18.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.48 111.57 -178.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 59.9 m -132.19 112.67 12.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.42 111.06 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.648 HG13 ' HB1' ' A' ' 51' ' ' ALA . 4.6 t -74.73 113.43 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 1.08 110.872 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.96 136.49 44.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.705 -0.679 . . . . 1.33 111.012 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.3 9.16 6.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.9 112.714 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.5 mm? -51.19 -177.6 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.05 0.452 . . . . 1.47 110.954 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.439 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 58.9 m -143.7 96.7 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 1.06 110.0 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 2.3 tt0 -40.56 139.17 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.526 . . . . 1.91 111.839 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER 75.57 33.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.913 -0.585 . . . . 1.87 110.902 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.37 136.34 13.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.358 -0.383 . . . . 0.49 111.212 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -80.89 132.13 35.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.36 110.701 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' OH ' ' HB ' ' A' ' 67' ' ' THR . 46.9 m-85 -127.31 130.67 49.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.56 111.94 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 3.7 mt-10 -104.65 148.81 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.596 -0.52 . . . . 1.5 109.596 178.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.982 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.19 116.08 10.87 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.821 1.415 . . . . 0.6 114.821 -179.264 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.8 ptp180 -109.99 178.65 4.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.455 -0.943 . . . . 2.11 108.455 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.66 133.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.678 1.228 . . . . 0.6 114.198 179.15 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -115.17 152.72 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 112.599 -2.092 . . . . 0.7 106.964 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -160.26 147.56 16.17 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.229 -0.989 . . . . 0.6 112.146 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HG2' HD12 ' A' ' 85' ' ' ILE . 13.0 mmtp -68.81 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 1.98 110.442 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -156.08 -66.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.843 0.83 . . . . 2.19 111.513 -179.249 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . 179.52 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.351 -0.84 . . . . 1.08 110.879 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.69 -4.01 57.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 1.06 112.192 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.83 -16.2 40.07 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.317 -0.944 . . . . 0.93 112.506 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -68.18 149.99 48.87 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.797 -0.446 . . . . 1.38 109.797 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.1 tp -102.41 112.21 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.381 0.511 . . . . 0.79 112.381 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -68.33 123.73 88.17 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.59 109.936 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -38.57 162.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.26 2.64 . . . . 0.85 113.394 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' N ' HG23 ' A' ' 77' ' ' ILE . 21.0 Cg_exo -67.95 170.84 13.41 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.227 2.618 . . . . 0.76 112.927 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -128.4 127.32 42.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.363 -0.835 . . . . 1.28 109.474 179.173 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.2 tt0 -27.06 129.58 0.19 Allowed Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 123.89 0.743 . . . . 1.77 112.597 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.0 Cg_exo -62.33 169.84 7.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.385 2.057 . . . . 0.55 113.765 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.34 136.62 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.754 -1.112 . . . . 1.23 109.042 179.109 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -37.68 135.34 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.006 0.817 . . . . 1.63 111.584 -179.748 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.07 132.33 51.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.41 111.415 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.4 mp -118.39 119.73 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.44 110.917 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m -48.07 -30.01 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.927 -0.579 . . . . 0.44 111.173 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.618 ' H ' HG22 ' A' ' 95' ' ' ILE . 15.4 m 55.45 36.79 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 1.1 111.032 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 3.0 110.941 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 41.3 p30 -106.3 23.99 13.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 2.14 110.547 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 49.3 t0 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.991 -0.55 . . . . 2.06 111.966 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.0 OUTLIER -107.18 -23.72 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.912 -0.403 . . . . 2.8 109.912 179.118 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.883 ' OE2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 37.69 96.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.745 -0.661 . . . . 4.58 112.013 179.759 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.228 -0.892 . . . . 3.79 111.193 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.745 0.307 . . . . 2.74 111.295 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.491 ' HD2' ' CE1' ' A' ' 27' ' ' TYR . 84.8 Cg_endo -86.29 137.98 5.41 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.895 2.396 . . . . 2.06 112.341 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.702 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.4 tt -106.04 145.94 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.68 111.278 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.907 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -126.34 133.16 24.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 2.0 110.055 179.451 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 94.4 Cg_endo -77.89 172.0 16.35 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.353 2.035 . . . . 0.5 112.655 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.535 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.7 Cg_endo -59.64 148.89 85.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.078 2.519 . . . . 0.71 112.623 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.64 161.81 4.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.66 112.092 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -58.01 132.67 83.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.982 -0.377 . . . . 1.52 109.982 179.757 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -79.26 127.91 7.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.493 2.129 . . . . 0.44 112.812 -179.409 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.21 110.38 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.863 -0.608 . . . . 1.09 110.379 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.659 ' HG2' HD11 ' A' ' 95' ' ' ILE . 33.6 Cg_exo -56.42 102.57 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.122 1.881 . . . . 0.64 113.599 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.265 HD11 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -66.82 -31.05 71.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.02 -0.733 . . . . 1.64 109.02 178.674 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 13' ' ' ILE . 15.9 t-20 -150.33 161.65 42.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.098 -0.956 . . . . 0.72 110.161 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.703 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.79 86.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.96 110.228 179.593 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -77.7 64.15 2.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 1.46 112.427 -179.1 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.473 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 19.84 47.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.447 0.906 . . . . 2.42 113.447 179.281 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.759 ' C ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER 165.31 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.582 -0.736 . . . . 1.02 110.395 179.239 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.96 89.5 3.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.68 109.713 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.954 HG11 ' CE2' ' A' ' 74' ' ' PHE . 75.3 t -78.68 114.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 0.8 110.046 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 HD12 ' A' ' 11' ' ' LEU . 6.1 m -96.68 109.22 21.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.35 112.527 -178.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.1 145.79 44.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.569 0.699 . . . . 0.52 111.463 178.81 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.445 ' HB2' ' CD ' ' A' ' 60' ' ' GLU . 7.3 tptp -134.07 143.39 48.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.733 -1.121 . . . . 1.84 109.508 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 13.6 p90 -132.68 -177.04 4.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.239 0.542 . . . . 0.4 111.983 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.59 -173.93 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.475 -0.784 . . . . 0.83 111.109 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -114.62 131.69 23.25 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 2.11 110.727 179.929 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' CB ' HG23 ' A' ' 28' ' ' THR . 3.0 Cg_exo -35.84 157.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.487 2.791 . . . . 0.89 112.809 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.29 -15.57 20.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 2.77 111.63 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.799 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.8 t80 -134.52 -72.01 0.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.324 0.49 . . . . 1.37 112.324 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.907 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 4.4 p 50.44 57.55 6.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.91 110.49 -179.148 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.84 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.748 -0.66 . . . . 1.01 112.52 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -155.25 32.8 0.65 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.376 -1.09 . . . . 0.98 110.376 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.98 -167.68 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -0.667 . . . . 0.87 111.649 -178.561 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 34' ' ' THR . 29.5 ttpt -144.04 20.44 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.607 -0.724 . . . . 2.26 111.581 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.873 HG22 ' H ' ' A' ' 35' ' ' SER . 1.6 mp 62.82 -77.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.623 0.249 . . . . 1.71 111.037 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.3 p 80.08 -7.9 1.59 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.607 0.595 . . . . 1.15 112.607 179.299 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -161.94 117.96 2.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.401 0.519 . . . . 1.58 112.401 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 33' ' ' ILE . 61.1 m-85 -103.7 146.22 28.91 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.32 -0.4 . . . . 0.76 110.414 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.454 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -137.11 107.47 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.553 -0.294 . . . . 1.14 110.219 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.45 117.72 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.63 111.387 -179.747 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 3.0 mm-40 -85.95 159.78 19.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.247 -0.888 . . . . 1.67 110.57 179.68 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 3.0 mtmp? -120.99 154.04 36.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.513 0.673 . . . . 1.97 111.804 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 10.5 ttm180 -128.67 96.2 4.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.223 -1.029 . . . . 1.44 108.223 177.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 83.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.109 -0.951 . . . . 1.59 110.053 -179.149 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 73' ' ' GLU . 19.1 mt -59.45 150.87 63.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.736 -179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.03 3.19 37.28 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.713 -1.37 . . . . 1.43 113.207 0.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.82 -89.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.116 -0.234 . . . . 2.66 111.019 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 158.38 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.818 -0.706 . . . . 1.12 113.036 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.612 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.57 24.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 2.41 110.988 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.542 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 31.7 m95 53.8 83.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 0.65 111.423 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.612 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -123.33 124.27 42.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.756 0.313 . . . . 1.28 110.667 179.855 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' HG22 ' A' ' 37' ' ' ILE . 15.5 ptmt -54.27 95.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 1.3 111.033 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -65.75 -35.47 80.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.109 0.48 . . . . 0.86 110.281 179.517 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.595 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 6.4 t-20 -66.09 120.58 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 2.01 110.546 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 23.7 14.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.072 -0.513 . . . . 2.08 110.501 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.25 130.4 22.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.6 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -43.15 114.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 1.87 111.861 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.683 HD13 ' CG ' ' A' ' 61' ' ' PHE . 55.2 mt -96.04 88.29 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.69 110.426 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.77 -64.87 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.48 -0.327 . . . . 1.6 111.198 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.08 165.91 12.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.435 -0.348 . . . . 1.54 110.418 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.54 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.4 p30 -90.47 15.5 10.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.194 -0.457 . . . . 1.75 111.357 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.445 ' CD ' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tp10 -116.42 95.65 5.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.696 -0.483 . . . . 2.05 109.696 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.683 ' CG ' HD13 ' A' ' 56' ' ' ILE . 93.6 t80 -118.14 162.85 17.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.299 0.571 . . . . 0.48 112.091 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 97.5 m -135.01 108.77 8.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.294 -0.866 . . . . 0.42 110.397 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.671 HG11 ' HD3' ' A' ' 40' ' ' LYS . 38.6 t -68.34 105.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.689 -0.687 . . . . 1.08 111.052 -179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 t -100.92 164.3 11.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.058 -0.519 . . . . 1.33 110.754 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.11 28.53 68.19 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.098 -0.801 . . . . 0.9 111.098 -179.417 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.88 HD22 HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -84.31 155.84 22.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.425 -0.388 . . . . 1.47 110.344 -179.521 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.614 ' N ' HD12 ' A' ' 66' ' ' LEU . 2.5 m -91.7 127.17 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 1.06 111.482 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 2.2 tt0 -76.95 163.32 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.208 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.81 43.21 5.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.832 -0.622 . . . . 1.87 111.002 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.41 122.99 1.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.009 -0.541 . . . . 0.49 110.736 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 116.55 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.008 0.432 . . . . 0.36 110.772 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 42.5 m-85 -110.05 132.48 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.824 -0.626 . . . . 0.56 112.139 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' HD11 ' A' ' 43' ' ' LEU . 6.9 mt-10 -102.08 134.28 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.193 -1.04 . . . . 1.5 108.193 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -128.82 118.92 23.56 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.215 1.561 . . . . 0.6 115.215 -178.588 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.01 -175.27 2.73 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.832 -1.173 . . . . 2.11 107.832 177.232 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -155.99 125.86 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.233 -0.987 . . . . 0.6 113.213 179.09 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 86' ' ' SER . 20.2 mt -103.33 150.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 113.644 -1.616 . . . . 0.7 107.9 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.35 120.99 2.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.025 -1.07 . . . . 0.6 113.254 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.0 mttp -66.6 -176.07 0.44 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.98 109.994 178.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.786 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.1 p30 -135.0 169.11 17.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.829 -0.623 . . . . 2.19 110.599 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -42.79 -27.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.693 -0.685 . . . . 1.08 112.155 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 -16.97 28.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.798 0.666 . . . . 1.06 112.798 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.27 -23.07 27.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.297 -0.954 . . . . 0.93 112.128 -179.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.786 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.05 115.43 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.999 -0.371 . . . . 1.38 109.999 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -72.62 110.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.578 0.584 . . . . 0.79 112.578 -179.061 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 77' ' ' ILE . 7.7 p -65.86 116.4 32.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.59 110.087 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.78 157.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.888 2.392 . . . . 0.85 112.844 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 31.7 Cg_endo -64.28 121.56 9.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.753 2.302 . . . . 0.76 113.34 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 76' ' ' VAL . 7.8 p -71.38 132.9 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 1.28 109.62 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 46.0 mt-10 -28.89 125.7 0.25 Allowed Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.868 0.73 . . . . 1.77 112.625 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 63.0 Cg_exo -54.12 174.15 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.541 2.161 . . . . 0.55 113.822 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -106.38 142.18 36.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 1.23 109.927 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.5 t0 -38.83 136.12 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.872 0.733 . . . . 1.63 111.051 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -68.28 103.34 1.57 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.487 -0.324 . . . . 0.41 111.479 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.8 mp -88.41 115.15 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.437 -0.347 . . . . 0.44 110.751 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' NH1' ' A' ' 98' ' ' ARG . 99.0 m -49.02 -35.94 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.44 111.408 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 66' ' ' LEU . 51.6 t 61.59 95.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.197 -0.297 . . . . 1.1 110.197 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HD2' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -147.22 -86.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.271 0.471 . . . . 3.0 112.271 -179.26 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.955 ' O ' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.56 7.09 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.192 0.441 . . . . 2.14 112.192 -179.308 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 43.09 27.72 0.12 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.484 0.549 . . . . 2.06 112.484 179.87 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 99' ' ' ASP . 6.2 p -158.32 25.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.356 0.598 . . . . 2.8 111.061 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.614 ' HG2' ' CG ' ' A' ' 99' ' ' ASP . 21.6 pt-20 -159.93 -44.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 4.58 110.9 179.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.212 -0.899 . . . . 3.79 111.146 179.958 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.616 0.246 . . . . 2.74 111.115 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.3 158.11 41.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.872 2.381 . . . . 2.06 112.264 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.041 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.6 tt -141.2 147.12 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.68 110.923 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 2' ' ' ILE . 17.4 m-20 -136.89 121.85 12.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.357 -0.383 . . . . 2.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.87 169.46 17.7 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.307 2.005 . . . . 0.5 111.716 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.7 Cg_endo -53.74 162.98 3.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.655 2.237 . . . . 0.71 112.542 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.69 170.74 27.37 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.934 -0.651 . . . . 0.66 112.66 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -55.93 127.19 68.19 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.639 -0.134 . . . . 1.52 110.639 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 6.1 Cg_exo -76.0 128.81 10.98 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.119 1.879 . . . . 0.44 112.199 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -130.5 110.19 16.22 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.216 -0.447 . . . . 1.09 111.462 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.0 Cg_exo -58.24 103.28 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.64 113.476 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -65.35 -29.68 70.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 1.64 109.629 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' HD13 ' A' ' 13' ' ' ILE . 19.2 t-20 -150.79 154.01 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.27 -0.877 . . . . 0.72 109.22 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.057 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -144.03 114.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.039 0.447 . . . . 0.96 112.018 -179.621 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -100.22 156.29 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.713 -0.676 . . . . 1.46 110.268 179.64 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -56.9 -23.24 43.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.349 -0.387 . . . . 2.42 110.995 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' THR . 75.9 m-70 -140.12 26.5 2.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 1.02 111.117 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -170.43 97.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.68 111.147 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.057 HG13 HG22 ' A' ' 13' ' ' ILE . 89.4 t -94.77 129.11 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.8 110.964 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.658 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.9 m -106.0 125.92 51.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.681 -0.69 . . . . 0.35 111.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.827 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.87 153.19 49.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.808 0.813 . . . . 0.52 111.895 179.424 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -128.35 -174.54 3.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.254 -1.339 . . . . 1.84 109.871 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 48.5 p90 179.98 160.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.42 . . . . 0.4 111.687 179.724 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.53 146.13 45.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.83 111.319 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -82.39 139.76 44.92 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 2.11 110.573 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 33' ' ' ILE . 93.9 Cg_exo -43.69 163.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.381 2.054 . . . . 0.89 112.066 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -121.55 -38.51 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.482 . . . . 2.77 111.282 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.93 -70.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.896 -0.321 . . . . 1.37 111.476 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 25' ' ' PRO . 21.1 p 46.75 41.3 10.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.215 0.531 . . . . 0.91 110.568 -179.598 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.9 -97.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.488 -0.778 . . . . 1.01 112.506 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.75 60.71 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.739 -0.944 . . . . 0.98 110.739 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 5.2 m-85 -130.45 -172.28 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.19 0.519 . . . . 0.87 112.023 -178.451 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 14.69 1.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.482 -0.781 . . . . 2.26 111.647 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.763 HD11 ' HG2' ' A' ' 25' ' ' PRO . 17.5 mt 56.61 153.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.401 0.62 . . . . 1.71 112.538 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 33' ' ' ILE . 2.9 p -127.98 55.74 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.273 -0.876 . . . . 1.15 110.566 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' THR . 0.2 OUTLIER 87.18 154.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.565 -0.743 . . . . 1.58 110.485 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 82.0 m-85 -105.99 156.64 18.18 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.277 0.561 . . . . 0.76 111.921 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 38' ' ' VAL . 4.1 mt -121.69 168.0 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.299 -0.864 . . . . 1.14 109.563 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 74' ' ' PHE . 4.7 t -146.03 99.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.982 0.364 . . . . 0.63 111.982 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 6.3 mt-10 -77.26 126.85 31.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.154 0.502 . . . . 1.67 110.27 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 2.5 mmtp -94.2 131.37 39.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.29 -0.868 . . . . 1.97 112.63 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.1 ttm180 -111.07 105.32 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.784 -0.45 . . . . 1.44 109.784 178.029 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.299 ' OD2' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.43 94.14 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.996 -0.547 . . . . 1.59 111.191 -179.611 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 94' ' ' ALA . 12.9 mt -79.23 153.34 76.88 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.99 -0.55 . . . . 0.9 110.557 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.18 29.74 7.34 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.123 -1.199 . . . . 1.43 113.149 0.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -100.8 -85.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.61 0.243 . . . . 2.66 111.312 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.89 162.78 11.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.663 -0.78 . . . . 1.12 112.78 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.299 ' HG2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 173.7 -32.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 2.41 111.522 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 40.6 m95 48.87 75.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.667 -0.242 . . . . 0.65 110.517 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.03 137.57 52.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.896 0.379 . . . . 1.28 111.809 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.8 ptmt -65.26 85.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.125 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -58.64 -37.64 76.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.86 111.179 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 t30 -47.26 -67.03 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.01 110.546 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.37 35.19 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.425 -0.352 . . . . 2.08 111.181 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 t -139.8 -78.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 1.89 111.014 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.22 142.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 1.87 111.027 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 61' ' ' PHE . 3.5 mt -144.98 74.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.69 111.016 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 57' ' ' LEU . 1.1 mt -68.16 -37.1 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.157 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -100.68 167.19 10.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 1.54 110.597 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -77.0 -9.94 59.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.499 . . . . 1.75 111.613 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG3' ' HG2' ' A' ' 21' ' ' LYS . 4.9 tt0 -96.3 102.43 14.22 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.833 0.349 . . . . 2.05 110.296 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.726 ' HB2' HG23 ' A' ' 56' ' ' ILE . 57.9 t80 -136.57 163.37 30.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.107 -0.497 . . . . 0.48 111.677 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 75.7 m -126.05 119.55 27.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.42 111.252 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 51' ' ' ALA . 12.1 t -83.88 102.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.08 111.009 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -102.38 168.15 9.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 1.33 111.012 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.25 12.04 52.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.787 -0.72 . . . . 0.9 112.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER -86.55 -174.1 4.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.778 0.289 . . . . 1.47 110.835 179.947 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 2.0 m -128.31 154.69 45.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 1.06 111.099 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 3.2 tm-20 -77.42 158.19 30.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 1.91 110.93 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.3 t70 56.54 59.98 3.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 1.87 110.943 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.32 123.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.49 111.144 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.48 129.79 39.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.36 110.453 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 51.5 m-85 -126.77 129.51 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.56 112.075 -179.142 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 3.5 mt-10 -107.78 144.99 34.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.814 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 119.43 14.09 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.543 1.312 . . . . 0.6 114.543 -178.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.85 146.59 26.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.466 -0.333 . . . . 2.11 110.366 178.434 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 57.1 t -93.98 119.54 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.6 110.935 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 87' ' ' PRO . 1.1 mt -118.99 144.39 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.271 -1.011 . . . . 0.7 108.271 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -178.57 142.52 0.23 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.6 111.959 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HE3' HD12 ' A' ' 85' ' ' ILE . 12.5 mttp -77.35 -178.64 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.152 -0.619 . . . . 1.98 109.677 179.015 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 1.041 ' ND2' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -112.69 -86.93 0.56 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.921 -0.581 . . . . 2.19 110.3 -179.899 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -155.19 -42.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.491 0.552 . . . . 1.08 112.491 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.64 46.14 0.98 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.658 0.614 . . . . 1.06 112.658 -178.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.14 -2.02 62.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.163 -1.017 . . . . 0.93 113.288 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.821 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.05 105.47 8.15 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.039 -0.726 . . . . 1.38 109.039 179.369 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt -97.31 111.0 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.548 0.944 . . . . 0.79 113.548 -178.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.75 111.38 6.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.411 -1.7 . . . . 0.59 106.411 177.435 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 73.0 Cg_endo -66.39 -99.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.814 1.676 . . . . 0.85 113.843 -177.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 87' ' ' PRO . 72.5 Cg_endo -106.73 134.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 CA-C-N 124.815 2.755 . . . . 0.76 114.168 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 29.3 m -109.22 88.51 2.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.254 -0.43 . . . . 1.28 110.181 178.585 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 18.88 100.53 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.541 1.136 . . . . 1.77 113.973 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 53.0 Cg_exo -51.17 145.72 25.39 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.479 2.119 . . . . 0.55 113.616 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 75.2 m -73.49 141.21 46.79 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.23 109.274 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.7 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -39.73 144.94 0.15 Allowed 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 124.035 0.834 . . . . 1.63 110.865 179.462 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.15 110.78 6.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.551 -0.46 . . . . 0.41 110.491 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.949 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -92.55 109.87 22.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.007 0.432 . . . . 0.44 111.333 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 33.8 m -45.43 -32.94 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.708 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.5 m 52.53 59.3 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.949 0.404 . . . . 1.1 110.379 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.817 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -90.47 -75.65 0.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 3.0 112.463 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.817 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.0 p-10 -119.75 30.56 6.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.121 -0.49 . . . . 2.14 111.754 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 53.0 t0 44.39 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.076 0.465 . . . . 2.06 111.835 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 99' ' ' ASP . 11.1 p -162.23 27.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 2.8 110.417 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -42.3 139.04 1.54 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.991 -0.549 . . . . 4.58 111.48 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 3.79 111.096 -179.954 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.802 0.334 . . . . 2.74 111.313 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -89.6 75.08 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.182 2.588 . . . . 2.06 112.363 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.677 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.3 tt -67.1 147.27 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.096 -0.502 . . . . 0.68 110.754 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -125.81 133.23 24.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 2.0 110.636 179.858 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.0 160.7 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.28 1.987 . . . . 0.5 112.097 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.0 176.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.665 2.243 . . . . 0.71 113.067 -179.488 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.78 171.44 53.56 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.882 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -63.52 118.29 42.86 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 110.19 -0.3 . . . . 1.52 110.19 179.585 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 31.5 Cg_exo -64.74 135.49 45.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.067 . . . . 0.44 112.801 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.45 103.65 11.31 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.036 -0.529 . . . . 1.09 111.693 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 33.1 Cg_exo -48.7 117.69 2.88 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.055 1.836 . . . . 0.64 112.366 179.903 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -75.5 -32.72 60.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.1 -0.704 . . . . 1.64 109.1 178.86 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.81 157.48 43.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.878 -1.055 . . . . 0.72 108.914 179.43 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.856 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -140.34 97.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.513 . . . . 0.96 111.437 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -87.13 48.09 1.6 Allowed 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 115.635 -0.711 . . . . 1.46 112.279 -179.259 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.85 -75.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.678 0.621 . . . . 2.42 112.678 178.698 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.2 m-70 -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 1.02 111.614 -179.39 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.6 p -139.48 121.97 16.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.465 -0.334 . . . . 0.68 110.309 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.974 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 16.8 m -109.45 135.57 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.8 112.168 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 11' ' ' LEU . 18.9 m -93.6 140.19 29.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.68 -0.691 . . . . 0.35 109.942 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.92 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.96 152.54 38.8 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.657 0.598 . . . . 0.52 112.251 -179.854 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.435 ' CG ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -140.94 145.41 36.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.127 -0.942 . . . . 1.84 110.438 179.825 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.3 p90 -140.03 -176.91 4.76 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.058 0.456 . . . . 0.4 111.864 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.45 165.97 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.83 110.705 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.24 147.07 32.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 2.11 110.801 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.9 Cg_endo -42.77 167.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.032 2.488 . . . . 0.89 112.047 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.58 -28.47 8.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 2.77 111.759 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -123.15 -69.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 1.37 111.312 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.595 HG23 ' CB ' ' A' ' 25' ' ' PRO . 13.7 p 51.14 53.04 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.91 111.007 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.14 -92.26 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.789 -0.72 . . . . 1.01 112.31 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.96 32.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.776 -0.93 . . . . 0.98 110.776 179.379 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.1 -179.2 3.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.22 -0.49 . . . . 0.87 111.509 -178.787 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 11.36 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 2.26 111.398 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.6 mp 60.09 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.064 0.459 . . . . 1.71 110.897 -179.747 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 p -126.68 5.61 6.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 1.15 111.277 179.861 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.58 123.14 0.64 Allowed 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.746 0.308 . . . . 1.58 110.987 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.3 m-85 -100.88 92.4 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.76 110.575 179.561 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.482 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 5.8 mm -69.69 138.23 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.463 -0.335 . . . . 1.14 111.0 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.93 101.19 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.45 -0.341 . . . . 0.63 111.677 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -77.46 138.69 39.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.914 -0.772 . . . . 1.67 108.914 178.815 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -121.1 135.23 55.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 1.97 111.64 -179.45 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 20.0 ttm180 -114.17 113.28 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.605 -0.725 . . . . 1.44 110.455 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.16 112.98 11.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.59 110.502 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 41' ' ' ARG . 2.2 mm? -80.39 149.22 68.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.9 110.975 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.55 17.21 41.12 Favored 'Cis proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.885 -1.298 . . . . 1.43 112.66 0.069 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -151.08 93.16 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 2.66 111.372 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -144.07 -165.52 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 1.12 112.138 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 148.38 33.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 2.41 110.842 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 50.6 m95 -68.88 97.56 0.85 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.678 -0.692 . . . . 0.65 110.907 -179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -128.37 126.42 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.604 179.919 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 10.2 ptmm? -58.32 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.871 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -74.29 -35.23 63.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.953 0.406 . . . . 0.86 110.373 179.794 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 56' ' ' ILE . 11.4 p-10 -44.28 -47.75 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.849 -0.614 . . . . 2.01 111.386 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 41.27 30.03 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 2.08 111.982 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 -161.34 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.44 -0.345 . . . . 1.89 110.711 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.85 61.86 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.935 -179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 61' ' ' PHE . 2.4 mm -57.95 95.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.69 110.131 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.21 -8.03 9.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.017 0.377 . . . . 1.6 112.017 -179.536 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.28 9.14 23.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.157 0.428 . . . . 1.54 112.157 -179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 13.0 p30 53.05 21.26 2.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 1.75 111.59 -179.075 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.435 ' OE1' ' CG ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -130.85 78.67 1.85 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 178.902 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.875 ' CG ' HD12 ' A' ' 56' ' ' ILE . 82.3 t80 -120.03 164.63 15.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.519 0.676 . . . . 0.48 112.378 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 18' ' ' VAL . 48.8 m -124.43 120.86 33.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.765 -1.107 . . . . 0.42 109.972 178.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.92 HG23 HD11 ' A' ' 20' ' ' LEU . 21.3 t -76.26 100.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.962 -0.563 . . . . 1.08 111.307 -179.521 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.23 137.13 32.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.243 -0.89 . . . . 1.33 110.44 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.14 -17.41 4.33 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.787 -0.72 . . . . 0.9 111.945 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.92 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -52.05 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.676 0.274 . . . . 1.47 110.311 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -148.03 141.81 25.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.481 -0.327 . . . . 1.06 110.563 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 3.0 tt0 -57.49 139.26 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 1.91 110.967 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.885 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 67.86 61.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 1.87 111.06 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.29 120.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.443 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.74 135.56 51.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.159 -0.682 . . . . 0.36 109.159 179.078 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 33.1 m-85 -129.94 115.87 17.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.258 0.836 . . . . 0.56 113.258 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.792 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 7.8 mt-10 -99.27 134.18 42.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.5 107.917 178.087 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.42 118.34 14.24 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.901 1.074 . . . . 0.6 113.901 -179.066 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.46 172.98 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.028 -1.101 . . . . 2.11 108.028 177.945 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -138.78 116.22 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.927 . . . . 0.6 112.176 179.446 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 86' ' ' SER . 69.6 mt -99.2 142.15 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.784 -1.191 . . . . 0.7 107.784 178.3 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -148.91 116.08 6.09 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.433 -0.907 . . . . 0.6 112.729 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.696 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.6 mtpt -63.28 -167.66 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.638 -0.505 . . . . 1.98 109.638 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.761 HD21 ' HB3' ' A' ' 84' ' ' ALA . 22.5 p30 -143.95 169.86 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.267 0.556 . . . . 2.19 111.684 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.01 -30.18 0.99 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.315 -0.857 . . . . 1.08 111.941 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.85 -22.55 36.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.848 0.314 . . . . 1.06 111.848 -179.48 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.67 -21.54 18.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.368 -0.92 . . . . 0.93 111.935 -179.51 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -52.22 161.03 0.68 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.087 -0.338 . . . . 1.38 110.087 179.581 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.696 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -112.56 109.76 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.247 0.462 . . . . 0.79 112.247 -179.596 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.0 p -66.88 115.87 29.5 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 109.167 -0.679 . . . . 0.59 109.167 179.009 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -38.87 159.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.672 2.248 . . . . 0.85 112.812 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 28.4 Cg_endo -64.75 124.4 13.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.704 2.269 . . . . 0.76 112.976 -179.665 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.456 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.6 m -76.76 115.64 16.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 1.28 109.636 179.062 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -12.19 118.44 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.588 1.155 . . . . 1.77 113.534 -179.34 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' HD3' ' A' ' 75' ' ' ARG . 70.2 Cg_exo -52.26 131.68 40.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.575 2.184 . . . . 0.55 113.606 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.97 144.99 56.92 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.585 -0.895 . . . . 1.23 108.585 178.687 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.638 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.21 141.75 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.956 0.785 . . . . 1.63 112.352 -179.553 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -73.15 107.19 5.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.76 -0.655 . . . . 0.41 109.977 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -86.79 112.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.874 -179.6 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.2 m -48.09 -32.32 6.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.656 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.441 ' H ' HG22 ' A' ' 95' ' ' ILE . 81.5 m 54.83 83.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.86 -0.609 . . . . 1.1 110.993 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 -91.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.314 -0.403 . . . . 3.0 110.269 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.966 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.8 p-10 -97.44 17.86 16.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.846 0.355 . . . . 2.14 110.063 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 p30 47.82 26.02 0.83 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.04 -0.527 . . . . 2.06 111.436 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 99' ' ' ASP . 23.5 t -119.99 -20.92 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 2.8 111.188 179.586 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.741 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 37.69 63.04 0.82 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.02 0.438 . . . . 4.58 112.089 179.933 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.227 -0.892 . . . . 3.79 111.21 179.855 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 1' ' ' PRO . 85.8 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.602 0.239 . . . . 2.74 111.112 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.571 ' O ' HG22 ' A' ' 2' ' ' ILE . 36.1 Cg_exo -60.37 -54.03 2.47 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.411 2.074 . . . . 2.06 111.761 179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER 57.31 142.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.519 -0.764 . . . . 0.68 111.882 179.754 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.7 134.29 13.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 2.0 111.067 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.19 159.96 26.49 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.607 2.205 . . . . 0.5 112.719 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 51.1 Cg_exo -55.09 172.63 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.713 2.275 . . . . 0.71 112.491 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -62.8 -163.42 0.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.66 112.221 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 4.7 tttp -87.4 142.9 33.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.57 0.185 . . . . 1.52 110.532 179.849 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HG3' HG23 ' A' ' 76' ' ' VAL . 2.2 Cg_endo -83.24 132.5 6.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.659 2.239 . . . . 0.44 112.494 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.74 110.73 10.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 1.09 110.69 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.9 Cg_exo -59.54 139.93 91.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.117 1.878 . . . . 0.64 113.887 -179.152 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HG ' HG22 ' A' ' 19' ' ' THR . 0.1 OUTLIER -105.71 -26.83 11.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.957 -1.019 . . . . 1.64 109.162 178.971 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.469 ' C ' HD13 ' A' ' 13' ' ' ILE . 5.5 t-20 -161.79 158.01 25.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.72 110.452 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.4 95.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.127 0.489 . . . . 0.96 110.469 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.21 56.61 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 1.46 112.166 -179.258 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.518 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.07 -68.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.548 0.573 . . . . 2.42 112.548 178.371 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' THR . 24.4 m-70 -95.89 -7.25 37.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 1.02 111.883 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' SER . 6.6 p -133.0 98.73 4.37 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.721 -0.392 . . . . 0.68 111.762 -179.783 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 20' ' ' LEU . 84.6 t -86.62 141.84 13.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.242 -0.435 . . . . 0.8 109.945 179.356 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.777 HG22 ' HG ' ' A' ' 11' ' ' LEU . 88.0 m -123.89 115.53 21.44 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.872 0.693 . . . . 0.35 112.872 -178.708 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.54 150.03 51.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.639 0.733 . . . . 0.52 111.465 178.499 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.61 140.86 37.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.721 -1.127 . . . . 1.84 110.207 -179.417 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -131.25 -176.81 4.14 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.443 0.639 . . . . 0.4 112.47 -179.34 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.453 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -85.44 -162.5 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.592 -0.731 . . . . 0.83 111.026 179.839 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -122.44 153.07 62.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 2.11 111.005 -179.76 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 50.4 Cg_exo -55.81 179.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.771 2.314 . . . . 0.89 113.248 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.85 -28.59 4.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 2.77 111.914 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -124.81 -69.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.015 0.376 . . . . 1.37 112.015 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 4.1 p 51.61 49.8 20.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.91 110.648 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.27 -104.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.113 -0.565 . . . . 1.01 112.692 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.16 2.56 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 110.563 -1.015 . . . . 0.98 110.563 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CD2' ' OD1' ' A' ' 80' ' ' ASN . 1.2 m-85 -108.85 178.14 4.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.634 -0.783 . . . . 0.87 111.47 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.13 6.02 2.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.889 -0.596 . . . . 2.26 111.84 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 18.8 mt 60.02 134.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-O 121.126 0.488 . . . . 1.71 111.083 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.427 ' C ' ' HG ' ' A' ' 35' ' ' SER . 3.7 p -122.92 -3.65 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 1.15 112.201 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.427 ' HG ' ' C ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -168.63 116.1 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.103 0.408 . . . . 1.58 112.103 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 19.5 m-85 -90.52 142.15 28.04 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.849 0.356 . . . . 0.76 110.152 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 77' ' ' ILE . 3.3 mt -111.94 166.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.123 -0.49 . . . . 1.14 110.712 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 37' ' ' ILE . 2.8 t -141.44 101.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.442 -0.345 . . . . 0.63 111.386 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -75.93 137.9 40.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 1.67 109.677 179.279 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.845 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -115.62 152.54 32.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.14 0.495 . . . . 1.97 111.532 -179.426 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 9.2 ttm180 -143.04 118.8 10.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.634 -0.712 . . . . 1.44 110.62 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.08 ' OD1' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -62.35 -15.41 48.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.305 -0.407 . . . . 1.59 111.862 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 73' ' ' GLU . 77.5 mt 57.05 148.42 0.05 OUTLIER Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.771 -0.65 . . . . 0.9 111.755 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.86 13.22 46.17 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.744 -1.357 . . . . 1.43 112.4 -0.188 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -124.29 -67.9 0.89 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.383 -0.371 . . . . 2.66 110.418 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 1.08 ' CA ' ' OD1' ' A' ' 42' ' ' ASP . . . 42.04 -129.7 4.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.118 -0.563 . . . . 1.12 113.107 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.414 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 170.67 110.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 2.41 110.781 -179.863 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.4 m95 -52.0 104.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.648 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -142.75 136.29 28.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 1.28 111.106 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.2 ptmm? -52.61 119.08 4.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.167 -179.898 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.845 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -109.21 -29.51 8.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.86 110.619 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 15.1 p-10 -52.45 -50.21 63.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 2.01 111.174 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 51.77 24.95 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.396 -0.366 . . . . 2.08 110.808 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -159.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 1.89 110.719 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.36 59.36 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.87 111.134 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.57 HD13 ' CB ' ' A' ' 61' ' ' PHE . 15.4 mt -52.42 155.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.762 -0.459 . . . . 0.69 109.762 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -164.79 -36.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.81 0.671 . . . . 1.6 112.81 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.83 22.94 2.9 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.241 0.46 . . . . 1.54 112.241 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 17.9 p30 50.52 22.82 1.13 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.962 -0.563 . . . . 1.75 111.775 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -133.0 91.84 2.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.261 -1.014 . . . . 2.05 108.261 178.915 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CB ' HD13 ' A' ' 56' ' ' ILE . 72.1 t80 -122.31 165.55 16.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.245 0.545 . . . . 0.48 111.946 -178.385 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.518 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 24.6 m -129.24 107.05 9.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.404 -0.816 . . . . 0.42 111.124 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.1 t -67.47 108.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 1.08 110.718 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 17' ' ' THR . 4.6 p -110.15 144.24 39.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.658 -0.701 . . . . 1.33 110.966 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.67 10.54 14.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.686 -0.769 . . . . 0.9 112.902 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 3.7 mm? -52.58 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.105 0.452 . . . . 1.47 110.68 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -105.71 -18.56 14.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.06 110.955 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 68.0 141.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.894 0.378 . . . . 1.91 110.63 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.49 25.05 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 1.87 110.203 -179.367 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.09 141.58 25.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.878 -0.601 . . . . 0.49 110.693 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -80.81 132.41 35.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.36 110.9 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 49.5 m-85 -132.39 133.39 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.773 . . . . 0.56 112.154 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HB2' HD11 ' A' ' 43' ' ' LEU . 7.0 tt0 -106.21 143.75 33.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.173 -1.047 . . . . 1.5 108.173 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.529 ' HZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.83 117.96 16.48 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.066 1.506 . . . . 0.6 115.066 -178.337 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.9 156.52 17.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 2.11 109.895 177.815 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 8' ' ' PRO . 71.9 t -104.57 128.89 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.252 0.548 . . . . 0.6 111.498 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 37' ' ' ILE . 11.0 mt -132.85 155.74 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.551 -1.278 . . . . 0.7 107.551 179.131 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -176.86 131.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.467 -0.893 . . . . 0.6 112.799 -179.628 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 ptpt -87.92 111.73 21.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.738 -0.838 . . . . 1.98 108.738 178.407 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -46.39 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.851 1.056 . . . . 2.19 113.851 -177.933 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.15 -52.05 1.65 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.043 0.757 . . . . 1.08 113.043 -178.615 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -74.14 0.76 12.92 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.084 0.772 . . . . 1.06 113.084 -178.905 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.7 -17.6 38.9 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.184 -1.008 . . . . 0.93 112.259 -179.835 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.6 97.13 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 179.23 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.11 118.53 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.486 0.921 . . . . 0.79 113.486 -178.173 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.2 p -71.29 110.45 7.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 107.945 -1.132 . . . . 0.59 107.945 178.123 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -56.44 175.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.82 2.347 . . . . 0.85 114.324 -178.168 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 86.2 Cg_exo -45.79 135.78 13.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.621 2.881 . . . . 0.76 113.866 -179.373 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 m -119.84 95.55 4.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.036 -0.529 . . . . 1.28 111.416 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 20.96 105.83 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.996 1.11 . . . . 1.77 113.996 179.435 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.6 Cg_exo -60.66 136.86 69.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.531 2.154 . . . . 0.55 112.643 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -71.6 146.85 48.11 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.021 -0.536 . . . . 1.23 110.23 179.627 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -34.09 146.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.348 1.03 . . . . 1.63 112.159 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -81.56 118.13 22.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.784 -0.644 . . . . 0.41 110.947 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -108.59 119.47 58.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.44 111.503 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 53.1 m -52.21 -22.81 4.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.056 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.701 ' H ' HG22 ' A' ' 95' ' ' ILE . 1.9 m 57.93 58.0 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.235 0.541 . . . . 1.1 110.176 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.632 ' NH1' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -78.82 -132.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.433 -0.803 . . . . 3.0 110.759 -179.594 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.981 ' OD1' ' CG1' ' A' ' 101' ' ' VAL . 2.6 p30 -93.41 35.81 1.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.175 0.443 . . . . 2.14 110.824 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.518 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 24.2 t0 34.44 32.38 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.26 0.552 . . . . 2.06 112.312 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.981 ' CG1' ' OD1' ' A' ' 99' ' ' ASP . 9.9 p -169.84 27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.857 -0.61 . . . . 2.8 111.449 179.742 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -113.06 -19.93 11.69 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.728 -0.389 . . . . 4.58 111.279 179.848 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.632 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.221 -0.895 . . . . 3.79 111.048 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.691 0.281 . . . . 2.74 111.203 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.4 Cg_exo -78.17 122.05 5.55 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.977 2.451 . . . . 2.06 111.937 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.732 HD12 ' OD1' ' A' ' 80' ' ' ASN . 1.6 tt -113.33 145.95 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.68 111.181 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.6 m-20 -130.41 138.61 33.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 2.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.27 161.91 13.2 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.854 2.369 . . . . 0.5 112.552 -179.916 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 12.3 Cg_endo -56.33 -174.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.062 2.508 . . . . 0.71 112.981 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 178.05 49.14 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.967 -0.56 . . . . 0.66 112.838 -179.77 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.9 122.81 85.28 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.198 -0.297 . . . . 1.52 110.198 179.648 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CG ' HG12 ' A' ' 76' ' ' VAL . 29.3 Cg_exo -67.66 141.78 56.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.44 112.816 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.55 108.01 7.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.7 -0.682 . . . . 1.09 110.848 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.544 ' CB ' HD23 ' A' ' 20' ' ' LEU . 24.4 Cg_exo -51.06 123.2 11.37 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.14 1.893 . . . . 0.64 113.048 -179.518 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -84.03 -31.67 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.084 -0.71 . . . . 1.64 109.084 178.41 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -151.11 147.97 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.879 -1.055 . . . . 0.72 108.934 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.969 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -132.58 98.39 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.96 111.441 -179.556 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.45 50.96 2.06 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.628 -0.714 . . . . 1.46 111.576 -179.719 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.77 -75.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.661 0.615 . . . . 2.42 112.661 178.933 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.3 m-70 -73.6 -24.92 60.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.333 0.494 . . . . 1.02 112.333 -179.132 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -137.59 122.09 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.226 -0.287 . . . . 0.68 110.226 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.969 ' HB ' HG22 ' A' ' 13' ' ' ILE . 12.6 m -111.64 121.92 65.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.625 0.726 . . . . 0.8 112.647 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 15.5 m -83.69 138.37 33.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.92 -1.037 . . . . 0.35 110.35 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.816 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -147.61 164.12 34.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.642 0.588 . . . . 0.52 111.724 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.929 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.31 178.93 6.84 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.648 -0.706 . . . . 1.84 110.352 179.437 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.513 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 47.6 p90 -172.31 167.18 5.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.393 0.616 . . . . 0.4 112.533 179.717 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.83 148.95 29.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.19 -0.914 . . . . 0.83 110.657 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.61 149.13 43.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.496 -0.32 . . . . 2.11 110.842 179.819 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 86.5 Cg_exo -44.65 176.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.024 2.483 . . . . 0.89 112.919 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -30.64 4.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.908 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -114.01 -71.72 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.143 0.423 . . . . 1.37 112.143 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 12.1 p 54.38 37.11 26.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.91 110.808 -179.451 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 50.38 -92.65 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.788 . . . . 1.01 112.229 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.3 27.38 1.54 Allowed Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.46 -0.656 . . . . 0.98 111.46 179.516 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -102.55 -177.27 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.87 111.567 -179.17 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.81 2.99 2.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.431 0.53 . . . . 2.26 112.431 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.7 mp 60.65 136.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.107 0.479 . . . . 1.71 111.436 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 p -124.7 9.64 8.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 1.15 111.779 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 t -179.29 138.39 0.14 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.831 0.348 . . . . 1.58 111.752 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.63 ' O ' HD12 ' A' ' 56' ' ' ILE . 32.8 m-85 -114.35 103.96 11.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.76 110.496 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.5 mm -79.83 128.36 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 1.14 110.883 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.98 111.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.832 0.308 . . . . 0.63 111.832 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.801 ' CD ' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -86.81 136.36 33.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 1.67 108.834 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.608 ' CD ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.54 143.78 50.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.338 0.59 . . . . 1.97 112.274 -179.001 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG3' ' HA3' ' A' ' 46' ' ' GLY . 20.3 ttp180 -110.53 108.5 18.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.151 -0.931 . . . . 1.44 109.905 179.426 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.954 ' OD2' ' NH2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.83 92.69 3.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.698 -0.683 . . . . 1.59 109.839 179.809 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.852 HD11 ' HG2' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -68.17 142.86 95.37 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.9 111.172 -179.405 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -94.2 16.25 41.64 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.047 -1.231 . . . . 1.43 112.793 0.109 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.37 67.78 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.579 -0.282 . . . . 2.66 111.642 -179.616 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -110.57 176.54 18.93 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.571 -0.823 . . . . 1.12 112.681 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.954 ' NH2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -151.58 19.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 111.246 -179.827 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 82.2 m95 49.74 98.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.65 111.106 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -143.14 155.29 44.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 1.28 110.851 179.198 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -71.84 116.83 12.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.089 0.471 . . . . 1.3 111.563 -179.427 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -93.14 -39.79 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.86 110.609 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.638 ' CB ' HD11 ' A' ' 56' ' ' ILE . 13.9 p-10 -49.92 -48.62 51.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 2.01 111.049 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.05 30.43 0.59 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 2.08 111.297 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 m -139.29 -164.64 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 1.89 111.153 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -95.86 107.7 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 1.87 111.022 -179.854 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.638 HD11 ' CB ' ' A' ' 52' ' ' ASN . 44.1 mt -108.48 65.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.69 110.704 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mt -47.66 -66.75 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.475 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.15 162.47 27.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.933 0.397 . . . . 1.54 110.555 179.975 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.7 p30 -75.9 -2.39 30.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.894 -0.594 . . . . 1.75 111.659 -179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 58' ' ' GLU . 16.7 tt0 -93.48 99.55 12.01 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.457 -0.571 . . . . 2.05 109.457 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 73.0 t80 -134.51 164.58 27.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.316 0.579 . . . . 0.48 112.024 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.8 m -124.3 124.86 43.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.246 -0.888 . . . . 0.42 109.974 179.32 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 20' ' ' LEU . 9.9 t -80.55 96.07 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.098 0.475 . . . . 1.08 111.365 -179.442 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.25 132.51 35.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 1.33 110.83 179.936 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.82 -25.65 2.93 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.529 -0.76 . . . . 0.9 111.325 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.708 ' CD2' HG13 ' A' ' 18' ' ' VAL . 6.9 mp -49.14 158.29 0.37 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.958 0.408 . . . . 1.47 110.928 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -124.91 144.14 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 1.06 110.805 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -60.21 143.73 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 1.91 111.16 -179.844 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER 69.87 44.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 1.87 111.213 179.891 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.41 122.2 4.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.858 0.361 . . . . 0.49 111.808 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -74.81 128.84 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.36 109.861 179.168 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 47.0 m-85 -125.13 125.14 43.26 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.082 0.771 . . . . 0.56 113.082 -178.701 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.852 ' HG2' HD11 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -102.37 137.94 39.96 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.885 -1.154 . . . . 1.5 107.885 178.013 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.887 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -142.75 126.58 17.13 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.208 1.558 . . . . 0.6 115.208 -178.781 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -106.02 -173.04 2.2 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.954 -1.128 . . . . 2.11 107.954 177.384 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.603 HG12 ' CG ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -151.34 117.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 118.989 -1.084 . . . . 0.6 113.336 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.801 HD12 ' CD ' ' A' ' 39' ' ' GLU . 65.4 mt -100.18 146.11 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.7 106.832 177.288 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -158.33 135.69 10.15 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.75 -0.78 . . . . 0.6 112.286 -178.847 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.1 mttp -73.6 -152.38 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 178.792 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.732 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -147.29 -108.91 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.452 -0.499 . . . . 2.19 110.724 179.576 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.36 -12.06 4.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.978 0.808 . . . . 1.08 112.5 179.617 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.1 -1.07 26.03 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.754 0.279 . . . . 1.06 111.754 -179.911 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.88 43.63 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.427 -0.892 . . . . 0.93 112.481 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.28 153.61 11.88 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.744 -0.268 . . . . 1.38 110.316 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -113.63 106.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.069 0.462 . . . . 0.79 111.681 -179.725 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -65.42 127.44 92.95 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 115.93 -0.577 . . . . 0.59 109.738 179.585 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -41.35 168.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.88 2.387 . . . . 0.85 113.365 -179.321 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HG3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -75.74 121.35 6.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.254 2.636 . . . . 0.76 112.6 -179.744 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.588 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -66.79 132.84 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.998 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -33.6 121.71 0.48 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 122.869 0.468 . . . . 1.77 112.169 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 56.3 Cg_exo -52.98 155.31 11.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.94 2.426 . . . . 0.55 113.977 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.94 149.72 21.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 1.23 109.832 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -42.47 148.26 0.23 Allowed 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 124.21 0.944 . . . . 1.63 111.222 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.786 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . . . -75.24 124.23 26.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.825 -0.625 . . . . 0.41 111.62 -179.636 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.659 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -102.99 109.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.517 179.483 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.6 m -46.63 -28.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.44 111.004 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.641 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 52.04 83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.1 110.515 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -131.79 -87.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 3.0 111.278 -179.873 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.945 ' O ' HG23 ' A' ' 101' ' ' VAL . 3.5 p-10 -98.59 9.88 42.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.337 -0.392 . . . . 2.14 111.304 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.4 p30 44.92 27.97 0.32 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.999 0.428 . . . . 2.06 111.252 -179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 99' ' ' ASP . 47.8 t -130.29 -4.78 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.926 -0.579 . . . . 2.8 111.932 -179.834 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.39 43.75 6.38 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.051 0.453 . . . . 4.58 111.614 179.681 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.233 -0.889 . . . . 3.79 110.979 179.882 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.454 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.603 0.24 . . . . 2.74 111.403 . . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 0' ' ' SER . 10.6 Cg_exo -71.83 -179.42 3.8 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 2.06 112.128 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.899 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.2 tt -156.11 141.42 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.939 -0.573 . . . . 0.68 110.722 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.12 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -129.0 119.39 19.82 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 2.0 110.537 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.9 161.89 37.46 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.164 1.909 . . . . 0.5 111.983 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.96 167.0 18.87 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.645 2.23 . . . . 0.71 113.158 -179.312 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.68 154.96 25.87 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.789 -0.641 . . . . 0.66 112.94 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 2.6 tttt -53.65 138.83 51.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 1.52 110.103 179.704 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.513 ' CG ' HG23 ' A' ' 76' ' ' VAL . 4.2 Cg_exo -80.63 115.35 3.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.448 2.098 . . . . 0.44 111.901 179.652 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.5 p -109.29 109.74 60.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.538 -0.301 . . . . 1.09 110.649 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 72.9 Cg_exo -41.66 125.0 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.341 2.027 . . . . 0.64 113.123 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -89.59 -33.26 16.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.49 -0.777 . . . . 1.64 109.61 179.833 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' O ' ' HB ' ' A' ' 19' ' ' THR . 4.9 t-20 -158.35 111.1 2.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.72 109.565 179.22 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.037 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -102.74 140.07 22.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.357 0.598 . . . . 0.96 112.4 -179.229 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.917 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -136.42 141.59 43.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.299 -0.864 . . . . 1.46 110.197 179.777 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -43.14 -24.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.155 0.798 . . . . 2.42 113.155 -179.239 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.406 ' O ' HG23 ' A' ' 17' ' ' THR . 11.0 m170 -122.73 -0.15 9.17 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.784 -0.572 . . . . 1.02 112.497 -179.589 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -161.27 120.29 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.68 110.95 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 13' ' ' ILE . 61.2 t -108.16 128.31 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.168 -0.469 . . . . 0.8 111.176 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.884 ' C ' HD13 ' A' ' 20' ' ' LEU . 21.7 m -106.48 133.43 51.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.35 110.938 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.884 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -136.34 147.0 47.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.681 0.753 . . . . 0.52 112.033 179.493 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -130.25 131.12 45.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.473 -1.24 . . . . 1.84 109.646 179.682 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 6.5 p90 -118.01 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.003 0.43 . . . . 0.4 111.946 -179.565 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.32 177.94 4.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.721 -0.672 . . . . 0.83 112.052 -179.498 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.27 142.17 25.83 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.34 -0.845 . . . . 2.11 110.266 179.801 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 78.3 Cg_exo -51.86 -161.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.888 2.392 . . . . 0.89 113.595 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.3 -43.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.267 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.032 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.7 t80 -111.2 -70.66 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.453 -0.34 . . . . 1.37 111.885 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' THR . . . . . 1.12 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 p 55.16 43.84 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.922 -0.399 . . . . 0.91 109.922 -179.243 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.37 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.733 -0.667 . . . . 1.01 112.769 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.95 37.87 0.81 Allowed Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 109.872 -1.291 . . . . 0.98 109.872 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -117.65 -179.27 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.631 -0.785 . . . . 0.87 111.055 -178.67 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -6.77 4.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 2.26 112.29 -179.744 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 79' ' ' LYS . 11.9 mt 62.26 142.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 1.71 110.648 -179.642 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -138.93 42.66 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.3 . . . . 1.15 111.428 -179.57 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.31 165.45 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.416 -0.356 . . . . 1.58 110.69 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 61.2 m-85 -153.53 74.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.76 110.889 179.839 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.484 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.6 mt -57.42 133.52 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 1.14 110.865 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 61' ' ' PHE . 2.5 t -105.1 104.79 17.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.342 -0.39 . . . . 0.63 111.302 179.999 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.948 ' OE2' ' O ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -78.98 130.12 35.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.686 -0.487 . . . . 1.67 109.686 179.394 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.812 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.67 143.92 43.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.886 0.374 . . . . 1.97 110.983 -179.877 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 4.1 ttm180 -117.36 105.38 12.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.944 -0.571 . . . . 1.44 110.575 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.745 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.59 98.56 3.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 1.59 110.907 -179.742 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.6 mt -83.2 154.7 66.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.9 110.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.33 37.96 5.76 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.056 -1.227 . . . . 1.43 112.835 0.297 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 45' ' ' ASN . 1.9 p-10 -167.19 79.46 0.2 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 2.66 111.305 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -152.92 -169.71 18.42 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.932 -0.576 . . . . 1.12 111.85 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.776 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.2 159.75 42.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.138 0.494 . . . . 2.41 111.278 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.948 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 70.0 m95 -64.52 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.65 111.017 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.776 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -116.69 128.49 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.351 -0.386 . . . . 1.28 111.086 -179.813 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.89 117.57 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 1.3 111.234 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.812 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -95.86 -33.72 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.86 110.811 179.702 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.3 p-10 -47.64 -59.12 3.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 2.01 111.558 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.41 37.76 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 2.08 111.181 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -145.44 20.37 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.89 111.422 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 57.71 116.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.999 0.428 . . . . 1.87 111.262 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.73 HD12 ' CD1' ' A' ' 61' ' ' PHE . 15.4 mm -105.4 85.04 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.69 111.324 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.12 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 1.6 110.45 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.22 176.72 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 1.54 110.35 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -95.74 32.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 1.75 111.746 -179.616 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -131.58 97.85 4.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.727 -0.471 . . . . 2.05 109.727 179.513 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CD1' HD12 ' A' ' 56' ' ' ILE . 83.3 t80 -133.29 163.16 29.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.259 0.552 . . . . 0.48 111.927 -179.345 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.528 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 46.0 m -130.25 112.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.175 -0.92 . . . . 0.42 110.824 179.152 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.701 HG23 HD21 ' A' ' 20' ' ' LEU . 5.0 t -72.06 119.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.08 111.05 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.78 142.47 46.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.923 -0.58 . . . . 1.33 110.992 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.18 5.44 6.17 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.786 -0.721 . . . . 0.9 112.798 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -71.92 -172.54 0.86 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.071 0.435 . . . . 1.47 110.929 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -142.12 147.26 36.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 1.06 111.017 -179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 5.8 tt0 -63.82 138.53 58.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 1.91 111.455 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.14 57.68 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 1.87 111.008 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.62 118.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.182 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.34 123.73 22.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.36 110.464 179.563 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 37.8 m-85 -119.12 127.93 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.583 0.586 . . . . 0.56 112.583 -178.875 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.2 tt0 -104.32 145.88 29.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.9 -0.778 . . . . 1.5 108.9 178.641 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -142.45 130.04 21.41 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.228 1.195 . . . . 0.6 114.228 -179.186 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -115.67 -178.85 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.684 -0.689 . . . . 2.11 109.814 178.312 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG23 ' CG ' ' A' ' 8' ' ' PRO . 39.5 t -132.56 110.35 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.132 -0.627 . . . . 0.6 112.632 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 39' ' ' GLU . 59.2 mt -105.48 142.17 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.067 -1.457 . . . . 0.7 107.067 177.514 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -150.66 -171.23 3.87 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.765 -0.774 . . . . 0.6 111.655 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 33' ' ' ILE . 7.1 mttt -129.78 -175.38 3.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 1.98 109.705 179.419 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.899 ' ND2' HD11 ' A' ' 2' ' ' ILE . 4.4 m-80 -132.9 162.07 32.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.978 0.418 . . . . 2.19 111.464 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.36 -28.69 0.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 1.08 112.544 -179.706 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -85.87 -7.6 58.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.709 0.633 . . . . 1.06 112.709 -179.125 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 102.91 -16.71 54.09 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.241 -0.981 . . . . 0.93 112.458 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.18 161.92 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 1.38 109.93 179.731 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -115.73 98.5 6.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.79 111.583 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -54.09 116.58 10.69 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 179.237 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.58 168.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.938 2.425 . . . . 0.85 113.072 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 22.5 Cg_exo -65.15 121.54 9.03 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.937 2.425 . . . . 0.76 113.281 -179.651 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -78.35 124.2 27.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.663 -0.699 . . . . 1.28 109.233 179.021 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 mm-40 -22.68 117.97 0.17 Allowed Pre-proline 0 N--CA 1.479 0.986 0 O-C-N 124.015 0.822 . . . . 1.77 113.084 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.4 Cg_exo -60.28 163.72 14.18 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.881 2.387 . . . . 0.55 113.999 -179.233 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.451 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.94 147.78 24.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.207 -0.906 . . . . 1.23 109.661 179.317 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -36.73 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 124.016 0.823 . . . . 1.63 111.86 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -87.9 111.16 21.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.969 -0.559 . . . . 0.41 111.494 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.552 HG22 ' SG ' ' A' ' 97' ' ' CYS . 4.5 mp -84.06 110.56 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.44 110.516 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -46.09 -38.35 7.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.014 0.435 . . . . 0.44 110.645 179.781 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 95' ' ' ILE . 70.8 m 59.37 68.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 1.1 110.189 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -103.64 -77.61 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 3.0 111.288 -179.265 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.394 ' CG ' ' HG2' ' A' ' 102' ' ' GLU . 33.8 p30 -138.49 17.81 2.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.884 -0.598 . . . . 2.14 111.034 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.917 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 44.2 30.18 0.42 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.376 0.608 . . . . 2.06 111.653 -179.919 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.96 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.3 p -170.94 33.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.06 -0.973 . . . . 2.8 110.172 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.394 ' HG2' ' CG ' ' A' ' 99' ' ' ASP . 7.1 mm-40 -113.97 -25.18 8.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.434 -0.803 . . . . 4.58 110.896 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.337 -0.839 . . . . 3.79 111.238 -179.95 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.441 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.682 0.277 . . . . 2.74 111.278 . . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.478 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 88.8 Cg_endo -93.57 52.37 0.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.092 2.528 . . . . 2.06 112.365 -179.945 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.961 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.1 tt -43.13 142.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.68 111.45 -179.833 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -117.84 133.82 23.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 2.0 111.148 -179.653 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.0 146.15 12.71 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.482 2.121 . . . . 0.5 112.176 179.75 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 77.6 Cg_exo -46.41 159.7 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.282 2.655 . . . . 0.71 114.011 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.39 -158.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.136 -0.938 . . . . 0.66 112.802 179.734 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.24 124.62 69.88 Favored Pre-proline 0 C--O 1.233 0.193 0 N-CA-C 110.684 -0.117 . . . . 1.52 110.684 179.728 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HD3' ' A' ' 7' ' ' LYS . 5.5 Cg_exo -74.13 117.12 4.88 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.472 2.114 . . . . 0.44 111.633 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 111.84 26.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.189 -0.46 . . . . 1.09 110.438 -179.827 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 80.5 Cg_exo -33.84 145.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.839 2.359 . . . . 0.64 113.581 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.28 HD12 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -107.76 -41.74 4.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.402 -1.272 . . . . 1.64 108.932 -179.941 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.435 ' O ' ' HB ' ' A' ' 19' ' ' THR . 4.8 t-20 -164.35 107.77 0.93 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.497 -1.229 . . . . 0.72 110.135 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.995 HG22 HG13 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -88.56 102.27 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.6 -0.727 . . . . 0.96 111.877 -179.75 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -91.51 43.53 1.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.453 -0.794 . . . . 1.46 111.079 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.454 ' C ' ' HG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER 55.61 -74.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.591 -0.731 . . . . 2.42 112.287 179.269 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-70 -74.27 -27.67 60.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 1.02 111.053 -179.251 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -129.08 104.09 7.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.007 -0.542 . . . . 0.68 109.621 179.312 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 13' ' ' ILE . 73.8 t -89.44 114.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.949 -0.568 . . . . 0.8 111.548 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 70.4 m -88.41 148.81 24.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.931 0.396 . . . . 0.35 111.425 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.68 158.7 42.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.44 -0.8 . . . . 0.52 111.269 179.628 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.044 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.0 142.16 28.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.84 110.225 179.593 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 11.6 p90 -125.05 -174.06 2.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.871 0.367 . . . . 0.4 111.941 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -94.25 -23.04 18.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.984 -0.553 . . . . 0.83 112.47 -179.352 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER 75.39 166.03 0.13 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.403 -179.387 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 59.8 Cg_endo -70.59 -173.85 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.89 112.785 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -129.71 -40.11 1.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 2.77 111.359 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 1' ' ' PRO . 28.2 t80 -93.58 -70.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.938 -0.305 . . . . 1.37 111.268 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 7.4 p 58.43 42.44 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.91 110.907 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.601 -0.809 . . . . 1.01 112.337 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.15 30.5 2.53 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.478 -1.049 . . . . 0.98 110.478 179.164 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -114.55 171.57 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -0.659 . . . . 0.87 111.097 -178.845 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 4.15 3.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.183 -0.462 . . . . 2.26 111.75 179.44 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.3 mt 55.01 117.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 CA-C-O 121.362 0.601 . . . . 1.71 112.21 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 p -98.38 -11.53 22.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.47 -0.787 . . . . 1.15 110.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.68 138.01 4.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.807 0.337 . . . . 1.58 111.562 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 33' ' ' ILE . 93.1 m-85 -108.21 115.25 29.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.76 110.945 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -95.77 106.46 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.337 -0.392 . . . . 1.14 110.66 179.65 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.65 135.88 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.41 0.624 . . . . 0.63 111.475 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 4.9 mt-10 -91.13 143.9 26.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.872 -1.058 . . . . 1.67 110.845 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.896 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -108.57 151.58 25.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.007 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.547 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -132.11 102.82 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 1.44 110.527 179.709 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.83 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -77.17 96.28 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.341 -0.39 . . . . 1.59 110.548 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.3 mm? -75.12 147.31 83.18 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.9 110.687 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -90.38 3.66 68.12 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.942 -1.274 . . . . 1.43 113.226 0.304 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -125.38 74.67 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 2.66 110.913 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -136.96 -177.76 15.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.686 . . . . 1.12 112.644 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 140.82 17.52 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.034 0.445 . . . . 2.41 110.698 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' NE1' ' CZ ' ' A' ' 41' ' ' ARG . 64.6 m95 -55.11 104.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.625 -0.716 . . . . 0.65 110.818 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -136.77 117.36 13.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 1.28 110.67 179.958 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HB3' HG22 ' A' ' 37' ' ' ILE . 3.1 ptmm? -45.45 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.942 -0.572 . . . . 1.3 111.339 -179.661 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.9 -17.49 61.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.86 111.244 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.705 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.9 p-10 -81.94 113.05 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 2.01 110.817 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.69 25.44 11.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.206 -0.452 . . . . 2.08 110.659 179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -125.9 -160.91 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 1.89 110.806 -179.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -106.04 88.5 2.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 1.87 111.177 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 61' ' ' PHE . 12.8 mt -75.74 62.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.69 111.065 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.29 -75.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.988 -0.551 . . . . 1.6 111.095 -179.894 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -179.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 1.54 110.721 179.822 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 33.3 p30 -93.98 17.01 13.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.75 111.361 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.28 ' OE2' HD12 ' A' ' 11' ' ' LEU . 3.1 tp10 -118.34 108.29 14.9 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.897 -0.409 . . . . 2.05 109.897 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.765 ' HB2' HG23 ' A' ' 56' ' ' ILE . 61.7 t80 -141.12 165.56 27.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.097 0.475 . . . . 0.48 111.379 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 12.0 m -127.37 115.74 19.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.703 -0.681 . . . . 0.42 110.769 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 51' ' ' ALA . 22.6 t -75.42 139.16 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.67 -0.696 . . . . 1.08 111.382 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.5 p -124.11 -171.08 2.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.738 -0.664 . . . . 1.33 110.607 179.598 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.88 90.09 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.59 -0.732 . . . . 0.9 112.479 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 3.6 mp -71.23 163.91 26.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.336 0.589 . . . . 1.47 111.839 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -128.73 112.19 13.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 1.06 109.809 179.464 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 7.8 tt0 -41.23 150.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.557 . . . . 1.91 112.453 -179.09 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.845 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 73.18 39.84 0.58 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.398 -0.819 . . . . 1.87 110.782 -179.867 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.39 135.16 7.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.49 111.352 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.69 129.41 37.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.191 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.708 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 49.4 m-85 -124.34 118.21 26.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.063 0.394 . . . . 0.56 112.063 -179.5 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.4 mt-10 -101.39 135.4 42.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 1.5 109.139 179.072 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -130.53 122.1 26.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.895 1.443 . . . . 0.6 114.895 -178.857 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -104.54 154.48 19.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.505 -0.924 . . . . 2.11 108.505 177.254 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -114.24 119.13 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 119.323 -0.951 . . . . 0.6 113.41 -179.243 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 86' ' ' SER . 61.3 mt -111.25 150.64 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.018 -1.446 . . . . 0.7 107.423 178.323 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.14 127.54 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.066 -1.053 . . . . 0.6 113.278 -179.642 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.19 80.12 9.32 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.733 -0.839 . . . . 1.98 108.733 178.185 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 18.1 m-20 -17.1 -92.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 113.88 -1.509 . . . . 2.19 114.339 -178.931 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -128.61 -48.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.051 0.759 . . . . 1.08 113.051 -179.101 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.93 43.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.264 0.468 . . . . 1.06 112.264 -178.819 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 76.43 -3.13 55.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.462 -0.875 . . . . 0.93 113.246 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.961 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -58.93 85.98 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.111 0.455 . . . . 1.38 109.946 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -66.47 117.2 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.086 -0.506 . . . . 0.79 112.344 -179.083 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.2 t -80.69 110.61 17.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 107.669 -1.234 . . . . 0.59 107.669 178.346 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.45 162.79 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.403 2.069 . . . . 0.85 113.185 -178.407 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 75' ' ' ARG . 63.4 Cg_exo -36.18 91.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.32 2.68 . . . . 0.76 113.288 -179.728 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 76' ' ' VAL . 52.9 p -73.13 99.0 2.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.657 -0.417 . . . . 1.28 110.707 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 mt-10 18.61 107.66 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 124.688 1.242 . . . . 1.77 113.917 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 98.5 Cg_exo -44.87 177.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.498 2.132 . . . . 0.55 113.741 179.483 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -113.15 140.52 47.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.225 -1.352 . . . . 1.23 108.764 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.736 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -36.94 134.42 0.52 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.638 0.586 . . . . 1.63 111.634 -179.925 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.18 107.92 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.41 110.966 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -91.05 112.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.878 0.37 . . . . 0.44 110.882 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.1 m -59.03 -23.79 62.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.892 -0.594 . . . . 0.44 111.174 -179.77 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.454 ' HG ' ' C ' ' A' ' 15' ' ' ARG . 18.9 t 56.02 101.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.14 0.495 . . . . 1.1 110.218 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -77.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 3.0 109.638 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.928 ' O ' HG23 ' A' ' 101' ' ' VAL . 20.7 p-10 -106.35 21.36 17.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.267 -0.879 . . . . 2.14 110.099 179.019 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.1 p30 47.25 27.79 0.91 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.983 -0.553 . . . . 2.06 111.03 -179.639 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 99' ' ' ASP . 57.7 t -119.46 -21.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.576 -0.738 . . . . 2.8 111.355 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.788 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 42.75 85.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.081 0.467 . . . . 4.58 111.703 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.238 -0.887 . . . . 3.79 111.17 179.957 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.775 0.321 . . . . 2.74 111.256 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.495 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 94.4 Cg_endo -85.13 72.47 4.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.846 2.364 . . . . 2.06 112.345 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.623 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.7 tt -57.56 124.53 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.68 111.406 -179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.88 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.46 128.24 28.64 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.423 179.798 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.45 173.1 14.77 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.5 112.926 -179.54 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 33.7 Cg_exo -58.91 177.46 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.052 2.501 . . . . 0.71 113.172 -179.577 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.62 22.13 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.66 112.734 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -85.48 122.3 73.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.301 0.096 . . . . 1.52 111.102 -179.897 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 4.2 Cg_exo -76.95 134.08 14.34 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.498 2.132 . . . . 0.44 111.69 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 9.3 t -141.09 120.07 8.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.951 0.352 . . . . 1.09 111.951 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.61 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.3 Cg_exo -65.78 102.21 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.683 2.256 . . . . 0.64 112.92 -179.956 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -60.21 -45.27 93.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.847 -0.797 . . . . 1.64 108.847 179.046 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -125.17 138.27 54.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.741 -1.118 . . . . 0.72 108.426 178.718 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -133.64 99.05 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.094 -0.642 . . . . 0.96 112.203 -179.331 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.39 148.97 23.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.46 110.079 179.346 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -60.93 -13.66 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.979 0.363 . . . . 2.42 111.979 -179.412 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.677 ' O ' HG23 ' A' ' 17' ' ' THR . 1.9 m-70 -134.68 31.45 3.37 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.673 0.273 . . . . 1.02 111.656 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 64' ' ' SER . 0.3 OUTLIER 162.14 125.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.627 -0.508 . . . . 0.68 109.627 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.028 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.8 m -120.4 149.41 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.269 -0.572 . . . . 0.8 111.492 179.774 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.633 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 m -120.73 123.44 42.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.35 111.046 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.881 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -129.56 161.71 29.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.808 0.813 . . . . 0.52 112.48 179.647 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.934 ' HG2' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -133.55 168.78 18.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.212 -1.358 . . . . 1.84 110.153 179.853 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.6 p90 -158.03 172.38 18.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.426 . . . . 0.4 111.304 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.12 139.77 30.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.877 -0.601 . . . . 0.83 111.964 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -79.04 140.93 57.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 2.11 109.733 179.274 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' THR . 10.5 Cg_endo -53.14 -175.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.215 1.943 . . . . 0.89 111.619 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.3 -37.56 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.379 . . . . 2.77 111.55 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.88 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 5.5 t80 -95.03 -71.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.551 -0.295 . . . . 1.37 111.579 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.877 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 68.9 p 49.59 43.76 24.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.971 0.415 . . . . 0.91 110.509 -179.448 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.24 -93.89 0.01 OUTLIER Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.996 -0.547 . . . . 1.01 112.614 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -142.48 39.71 1.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.057 -0.817 . . . . 0.98 111.057 179.537 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -124.5 176.99 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.529 -0.336 . . . . 0.87 110.909 -179.05 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.75 3.59 3.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.27 -0.423 . . . . 2.26 111.775 179.66 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.7 mt 58.77 117.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 121.091 0.472 . . . . 1.71 111.241 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.414 ' C ' ' HG ' ' A' ' 35' ' ' SER . 1.5 p -102.73 11.19 37.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.658 . . . . 1.15 111.731 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -168.62 170.92 9.18 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.037 0.446 . . . . 1.58 111.502 -179.92 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.6 m-85 -154.06 75.47 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.534 -0.757 . . . . 0.76 109.917 179.578 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -50.14 144.11 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.564 -0.744 . . . . 1.14 111.497 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.879 HG11 HG21 ' A' ' 63' ' ' VAL . 3.6 t -129.23 107.01 14.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.348 -0.387 . . . . 0.63 111.407 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -93.2 149.03 21.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.092 -0.504 . . . . 1.67 110.431 179.735 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -115.49 139.62 49.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.196 0.522 . . . . 1.97 112.116 179.737 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -112.37 96.34 5.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.185 -0.916 . . . . 1.44 108.622 178.304 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.769 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -67.89 105.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 1.59 110.798 -179.136 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' HD2' ' A' ' 41' ' ' ARG . 10.6 mt -76.73 150.72 81.99 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.857 -0.61 . . . . 0.9 111.147 -179.807 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -87.89 9.05 64.13 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.756 -1.352 . . . . 1.43 113.179 0.281 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -80.5 -88.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 2.66 110.49 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . 115.72 175.37 18.13 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.647 -0.787 . . . . 1.12 113.568 179.258 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.8 -25.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.267 0.227 . . . . 2.41 111.381 -179.923 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 85.4 m95 50.81 87.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.793 0.33 . . . . 0.65 111.065 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -125.77 127.96 46.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.365 . . . . 1.28 111.018 179.589 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 50' ' ' LYS . 16.8 ptmt -54.16 109.86 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 1.3 110.905 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . . . -81.77 -35.95 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.86 110.709 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' CG ' HD11 ' A' ' 56' ' ' ILE . 1.2 t30 -48.36 -62.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 2.01 110.661 179.976 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 51.61 37.18 19.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 2.08 111.101 179.761 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 t -145.02 -82.91 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 1.89 110.811 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 172.85 120.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 1.87 111.192 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.858 HD12 ' CD1' ' A' ' 61' ' ' PHE . 8.2 mm -103.46 69.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.69 110.8 179.756 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -53.98 -46.48 71.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 1.6 110.259 179.912 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.702 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pt-20 -99.61 154.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 1.54 109.996 179.571 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -68.21 -9.55 47.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.468 -0.333 . . . . 1.75 111.414 179.98 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.934 ' OE1' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tp10 -93.59 98.61 11.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.836 -0.431 . . . . 2.05 109.836 179.711 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.858 ' CD1' HD12 ' A' ' 56' ' ' ILE . 70.4 t80 -133.98 164.01 28.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.103 0.478 . . . . 0.48 111.566 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.531 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 19.2 m -117.38 116.44 27.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.626 -0.716 . . . . 0.42 110.808 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.881 HG23 HD21 ' A' ' 20' ' ' LEU . 65.1 t -86.53 96.38 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.0 0.428 . . . . 1.08 110.471 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 17' ' ' THR . 1.2 p -85.59 158.54 20.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.33 110.373 179.799 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.5 -8.4 8.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.347 -0.842 . . . . 0.9 111.793 -179.304 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 18' ' ' VAL . 3.3 mm? -44.7 171.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.096 0.474 . . . . 1.47 111.356 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.6 m -147.59 123.86 10.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.868 -0.605 . . . . 1.06 110.714 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.1 mt-10 -48.43 137.14 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 1.91 111.191 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER 61.12 46.77 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 1.87 111.523 179.905 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -156.81 122.51 4.78 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.49 111.526 179.791 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.57 135.71 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.36 110.086 179.318 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CD1' ' NZ ' ' A' ' 40' ' ' LYS . 42.5 m-85 -131.56 126.71 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.769 0.655 . . . . 0.56 112.769 -178.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.8 mt-10 -106.56 139.28 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.868 -0.789 . . . . 1.5 108.868 178.354 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.028 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.65 114.99 19.41 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.367 1.247 . . . . 0.6 114.367 -178.52 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.3 ttp85 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.119 -0.492 . . . . 2.11 111.247 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 89' ' ' SER . 58.6 t -100.16 134.39 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.32 0.581 . . . . 0.6 111.0 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -132.48 149.55 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.563 -1.273 . . . . 0.7 107.563 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -171.3 141.26 1.56 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.079 -1.048 . . . . 0.6 112.526 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.2 mttt -82.1 -123.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 1.98 110.65 179.634 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.623 ' ND2' HD12 ' A' ' 2' ' ' ILE . 54.5 p30 -170.02 -122.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.394 0.543 . . . . 2.19 109.583 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -129.0 -1.16 5.24 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.432 1.014 . . . . 1.08 112.085 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.13 -1.32 14.42 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.894 0.331 . . . . 1.06 111.894 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.75 -19.53 41.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.014 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.588 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -61.41 158.53 14.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.949 -0.389 . . . . 1.38 109.949 179.742 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.7 tt -120.99 118.18 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.09 0.774 . . . . 0.79 113.09 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -74.02 111.93 14.56 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 107.205 -1.406 . . . . 0.59 107.205 177.835 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.444 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 18.7 Cg_endo -57.86 170.82 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.149 2.566 . . . . 0.85 114.557 -178.051 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 7.6 Cg_exo -32.48 142.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.385 3.39 . . . . 0.76 113.821 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.9 m -131.24 104.74 7.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.518 -0.764 . . . . 1.28 110.243 179.185 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 3.6 110.27 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.872 1.269 . . . . 1.77 113.568 -179.974 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.515 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 23.9 Cg_exo -63.71 153.19 76.78 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.55 114.421 -179.3 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.96 145.94 44.28 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.945 -1.025 . . . . 1.23 109.491 179.023 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -34.71 154.5 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 O-C-N 124.135 0.897 . . . . 1.63 112.207 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.21 111.23 19.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.48 179.252 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.826 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -94.2 111.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.914 -0.314 . . . . 0.44 111.391 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' ALA . 12.4 m -48.37 -30.53 5.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.72 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.683 ' SG ' HD12 ' A' ' 66' ' ' LEU . 82.5 m 49.85 86.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.065 -0.516 . . . . 1.1 111.088 179.678 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 -84.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.34 -0.391 . . . . 3.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -99.92 -11.61 20.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.059 -0.519 . . . . 2.14 111.011 179.469 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 57.55 20.06 5.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.417 -0.356 . . . . 2.06 111.562 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.68 -2.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.671 -0.24 . . . . 2.8 111.446 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.1 -69.13 0.51 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.973 0.416 . . . . 4.58 110.436 -179.828 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.203 -0.903 . . . . 3.79 111.623 179.745 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.476 0.179 . . . . 2.74 111.041 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.41 175.48 9.58 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.506 2.137 . . . . 2.06 112.439 -179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 80' ' ' ASN . 1.2 tt -143.12 144.62 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.68 110.714 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -130.56 131.89 23.63 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 2.0 110.738 179.83 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 162.43 28.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.435 2.09 . . . . 0.5 112.509 -179.914 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.2 Cg_endo -57.09 -179.56 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.01 2.474 . . . . 0.71 112.554 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.29 -161.83 8.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.869 -0.681 . . . . 0.66 112.813 -179.794 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.94 118.88 70.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.559 -0.163 . . . . 1.52 110.559 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 36.7 Cg_exo -62.52 133.77 44.44 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.54 2.16 . . . . 0.44 112.74 -179.84 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.0 104.91 9.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.02 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 47.0 Cg_exo -51.01 99.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.261 1.974 . . . . 0.64 113.206 -179.594 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mt -55.56 -37.21 67.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.054 -0.721 . . . . 1.64 109.054 179.065 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 25.7 t-20 -136.5 153.72 50.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.765 -1.107 . . . . 0.72 108.648 179.007 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.278 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 3.6 pt -143.78 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.402 -0.519 . . . . 0.96 112.208 -179.004 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.625 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -94.7 137.91 33.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 1.46 110.117 179.412 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -40.47 -26.11 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.359 0.874 . . . . 2.42 113.359 -178.9 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -115.53 -19.96 10.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.53 -0.468 . . . . 1.02 111.966 -179.848 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' HD22 ' A' ' 66' ' ' LEU . 49.9 p -147.8 122.26 9.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.555 0.216 . . . . 0.68 110.659 -179.843 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 ' CD2' ' A' ' 66' ' ' LEU . 17.7 m -111.04 125.59 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.954 0.353 . . . . 0.8 111.954 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 47.2 m -87.05 144.53 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.35 110.035 179.083 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.758 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -143.91 151.45 39.83 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.82 0.7 . . . . 0.52 112.521 -179.885 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.878 ' HB2' HD11 ' A' ' 11' ' ' LEU . 19.3 tptp -144.66 148.15 33.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.765 -1.107 . . . . 1.84 110.091 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.2 p90 -140.87 -176.51 4.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.4 112.248 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.44 -159.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.384 -0.825 . . . . 0.83 111.068 179.956 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -130.83 142.42 45.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.158 179.952 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.76 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 88.2 Cg_exo -43.96 171.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.349 2.033 . . . . 0.89 112.458 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.76 ' OE1' ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -106.92 -42.16 5.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 2.77 112.059 -179.608 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -118.03 -70.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.218 0.451 . . . . 1.37 112.218 -179.419 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.4 p 60.31 46.23 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.91 110.454 -179.253 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.71 -109.63 0.35 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.814 -0.708 . . . . 1.01 112.193 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.69 31.9 3.45 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.525 -1.03 . . . . 0.98 110.525 179.108 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.38 -177.59 3.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.098 -0.551 . . . . 0.87 111.468 -178.908 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 15.38 1.44 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 2.26 111.743 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 ' CZ ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER 61.05 152.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.551 0.215 . . . . 1.71 111.27 179.699 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -140.5 8.26 2.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.548 0.573 . . . . 1.15 112.548 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 t -178.06 125.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 1.58 110.979 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.691 ' O ' HD12 ' A' ' 56' ' ' ILE . 7.7 m-85 -108.64 98.14 7.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.76 111.553 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.653 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -91.21 124.72 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 1.14 110.157 179.477 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -110.18 119.1 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.63 111.538 -179.507 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.91 137.45 43.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.402 -0.817 . . . . 1.67 109.397 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HD2' ' CD1' ' A' ' 72' ' ' TYR . 3.9 ttpm? -104.1 146.32 28.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.344 -0.389 . . . . 1.97 110.348 -179.226 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' HG2' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.75 86.55 2.46 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.05 0.452 . . . . 1.44 110.579 179.711 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.857 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -62.36 86.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.509 -0.769 . . . . 1.59 110.612 -179.828 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD12 ' CB ' ' A' ' 94' ' ' ALA . 76.5 mt -66.36 149.02 98.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.974 -0.557 . . . . 0.9 111.049 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -93.23 27.38 18.68 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.893 -1.295 . . . . 1.43 112.719 0.337 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -136.25 45.16 2.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.512 -0.313 . . . . 2.66 111.369 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -87.28 179.0 48.03 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.474 -0.87 . . . . 1.12 112.344 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.79 31.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 2.41 110.952 -179.727 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 53.4 m95 45.32 74.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.65 111.236 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.3 mp -109.31 133.08 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 1.28 111.016 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.653 ' HD2' HG21 ' A' ' 37' ' ' ILE . 8.4 mtmm -50.17 98.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.046 -0.524 . . . . 1.3 110.79 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -64.73 -53.56 45.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.86 110.772 -179.993 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.7 p-10 -71.0 129.12 38.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.873 179.843 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -124.62 34.92 4.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.077 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 m -130.41 -84.93 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 1.89 110.923 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.37 118.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 1.87 110.964 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.9 mt -109.04 74.34 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.69 110.968 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -56.74 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 1.6 111.001 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.94 -178.48 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.547 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.9 p30 -92.56 2.88 56.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 1.75 111.672 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -102.98 101.82 11.83 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.524 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HB2' HG23 ' A' ' 56' ' ' ILE . 72.8 t80 -135.06 163.92 28.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.48 111.44 -179.454 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 80.2 m -125.63 125.22 42.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.42 110.387 179.345 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.758 ' CG2' HD11 ' A' ' 20' ' ' LEU . 17.0 t -83.43 90.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.208 0.527 . . . . 1.08 111.691 -179.355 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -92.46 137.9 31.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 1.33 110.623 179.784 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.83 -5.61 7.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.9 112.456 -179.642 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.018 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -48.91 -179.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.121 0.486 . . . . 1.47 111.591 179.807 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -141.19 118.72 11.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 1.06 110.132 179.795 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -45.59 155.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 1.91 111.483 -179.561 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.0 m-20 52.87 55.03 9.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 1.87 111.175 -179.884 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.71 121.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.49 111.296 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.15 138.03 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.92 -0.4 . . . . 0.36 109.92 179.481 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.8 m-85 -128.83 112.97 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.713 1.005 . . . . 0.56 113.713 -178.37 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.6 tt0 -102.35 134.7 45.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.234 -1.024 . . . . 1.5 108.234 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.35 125.89 19.06 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.819 1.415 . . . . 0.6 114.819 -178.644 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -103.62 165.49 11.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.257 -0.883 . . . . 2.11 109.025 178.202 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -131.68 122.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 113.487 0.921 . . . . 0.6 113.487 179.688 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 86' ' ' SER . 29.4 mt -106.59 147.91 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.667 -1.606 . . . . 0.7 107.486 177.996 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -159.16 112.78 2.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.152 -1.019 . . . . 0.6 112.688 -179.412 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 mttp -56.21 -175.87 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.31 -0.626 . . . . 1.98 109.31 178.64 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.5 m120 -133.52 170.78 15.01 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.858 -0.337 . . . . 2.19 110.559 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.1 -27.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.58 0.585 . . . . 1.08 112.58 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -106.6 14.68 26.7 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 1.06 112.852 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.96 -18.07 46.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.465 -0.874 . . . . 0.93 112.947 179.659 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.5 105.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 1.38 110.903 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -68.98 97.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.79 111.65 -179.462 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' ILE . 21.5 p -60.38 111.54 4.17 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 120.203 -0.599 . . . . 0.59 109.939 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.18 146.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.758 2.305 . . . . 0.85 112.683 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 1.6 Cg_endo -46.52 140.57 11.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.691 2.26 . . . . 0.76 112.807 -179.665 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 90' ' ' GLU . 2.0 m -96.42 108.67 21.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.811 . . . . 1.28 110.386 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -2.95 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.715 1.206 . . . . 1.77 113.748 -179.935 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 78.3 Cg_exo -46.73 139.36 13.93 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.328 2.019 . . . . 0.55 113.28 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -76.27 147.41 38.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.893 -0.594 . . . . 1.23 109.51 179.338 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -39.08 147.1 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.967 0.792 . . . . 1.63 111.577 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.79 117.22 18.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.719 -0.673 . . . . 0.41 111.261 -179.71 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.711 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -95.48 113.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.597 179.408 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.431 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 84.5 m -51.82 -32.96 33.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 0.44 111.036 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 69' ' ' ASP . 3.6 m 54.57 89.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.138 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.431 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -129.21 -78.0 0.56 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.223 0.535 . . . . 3.0 110.69 -179.803 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.151 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -126.19 0.98 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.49 -0.777 . . . . 2.14 111.052 179.717 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.278 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 49.43 24.22 1.04 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.784 0.326 . . . . 2.06 111.244 -179.706 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.151 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 53.5 t -132.37 0.64 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.317 -0.402 . . . . 2.8 112.016 179.876 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.007 ' HG2' ' OD1' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -119.75 -4.53 10.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.694 0.283 . . . . 4.58 111.21 179.702 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.247 -0.883 . . . . 3.79 111.069 179.797 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.454 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 111.52 0.193 . . . . 2.74 111.52 . . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 0' ' ' SER . 13.0 Cg_exo -71.1 -175.94 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.536 2.158 . . . . 2.06 111.85 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.457 HD12 ' OD1' ' A' ' 80' ' ' ASN . 2.8 tt -160.75 144.82 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.955 0.407 . . . . 0.68 111.238 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.12 125.95 20.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 2.0 110.497 179.982 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 161.18 41.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.357 2.038 . . . . 0.5 112.324 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.42 -173.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.792 2.328 . . . . 0.71 112.969 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -78.02 -154.13 6.84 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.66 113.017 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -94.36 141.83 24.05 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.293 0.092 . . . . 1.52 110.932 -179.83 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.662 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.4 Cg_endo -83.34 127.11 4.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.901 2.401 . . . . 0.44 112.411 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.99 102.75 10.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.09 110.97 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.9 Cg_exo -37.05 140.13 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.818 2.345 . . . . 0.64 112.88 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.39 -28.76 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.151 -179.769 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -160.45 109.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.797 -0.638 . . . . 0.72 109.911 179.775 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.747 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -106.6 148.51 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.714 1.005 . . . . 0.96 113.714 -178.883 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.437 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -141.38 165.88 26.29 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.197 -0.91 . . . . 1.46 110.867 179.382 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.19 ' HD2' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -42.69 -41.72 3.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.241 -0.891 . . . . 2.42 112.865 -179.44 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.5 m-70 -132.87 27.46 4.27 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.938 0.718 . . . . 1.02 112.938 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.693 ' N ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -166.3 112.74 0.85 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.499 -0.48 . . . . 0.68 111.354 179.04 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.032 HG13 HD22 ' A' ' 66' ' ' LEU . 1.7 m -110.61 127.64 67.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 C-N-CA 120.156 -0.618 . . . . 0.8 111.82 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.5 m -97.81 144.61 27.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.307 -0.627 . . . . 0.35 109.307 179.161 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.86 152.98 39.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.413 0.625 . . . . 0.52 112.323 -179.732 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -133.24 137.71 46.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.007 -0.997 . . . . 1.84 110.238 179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.7 p90 -138.0 178.25 7.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 0.4 111.062 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.443 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.0 -167.78 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.83 110.899 179.816 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.15 161.58 60.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.849 0.357 . . . . 2.11 111.129 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.652 ' HB2' HG23 ' A' ' 28' ' ' THR . 31.4 Cg_exo -59.66 -177.67 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.878 2.386 . . . . 0.89 113.192 -179.568 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.17 7.51 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.536 179.761 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.685 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 20.8 t80 -142.84 -67.37 0.37 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.369 . . . . 1.37 110.858 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' PRO . 50.8 p 48.23 44.92 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 0.91 110.776 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.61 -102.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 1.01 112.254 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.05 26.68 4.18 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.204 -0.759 . . . . 0.98 111.204 179.234 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -115.03 -174.57 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.87 111.055 -179.34 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.8 ttpt -145.04 25.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 2.26 110.833 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.856 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.2 mm 60.77 148.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 1.71 110.712 -179.897 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -135.46 17.93 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.266 -0.424 . . . . 1.15 111.025 179.792 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.654 ' H ' HG22 ' A' ' 33' ' ' ILE . 7.1 t 170.55 160.34 0.07 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.156 0.503 . . . . 1.58 111.383 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 33' ' ' ILE . 37.8 m-85 -137.41 78.49 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 0.76 109.946 179.428 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.818 HG21 ' HE2' ' A' ' 50' ' ' LYS . 12.7 mt -80.66 118.26 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 1.14 111.663 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -100.19 127.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.266 179.732 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -84.5 131.96 34.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.67 111.375 -179.583 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.666 ' HD3' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -95.23 140.59 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.719 -0.673 . . . . 1.97 112.659 -179.435 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.7 ttt180 -127.34 104.57 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 1.44 110.098 178.527 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.679 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.48 84.96 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 1.59 110.681 -179.79 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.01 154.7 2.41 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.485 -0.779 . . . . 0.9 110.828 -179.96 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.89 15.35 36.5 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 123.875 -1.302 . . . . 1.43 112.951 0.376 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -117.61 -77.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 2.66 111.111 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . 52.87 -178.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.63 -0.795 . . . . 1.12 112.006 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -163.94 29.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 2.41 111.257 -179.823 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 61.1 m95 47.5 93.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.65 110.92 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -129.14 131.74 47.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.692 -0.403 . . . . 1.28 111.29 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.818 ' HE2' HG21 ' A' ' 37' ' ' ILE . 17.7 ptpt -63.19 74.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.824 -0.626 . . . . 1.3 111.389 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -55.64 -43.11 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.86 110.26 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.547 ' HB2' HD11 ' A' ' 56' ' ' ILE . 16.5 p-10 -42.07 -46.51 4.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.987 -0.551 . . . . 2.01 111.253 179.713 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.65 36.84 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 2.08 110.997 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -144.35 -162.99 1.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 1.89 110.624 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -111.58 88.69 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 1.87 110.828 -179.906 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 61' ' ' PHE . 10.2 mm -70.52 67.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.69 111.1 179.861 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.19 -58.88 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 1.6 110.363 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.8 pm0 -76.88 160.67 29.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.173 -0.677 . . . . 1.54 109.173 179.055 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.6 p30 -84.16 10.28 10.64 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.561 -0.456 . . . . 1.75 112.057 -179.651 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.02 98.79 7.01 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.605 . . . . 2.05 109.365 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 56' ' ' ILE . 81.2 t80 -130.02 163.65 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.447 0.641 . . . . 0.48 112.251 -179.041 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 25.7 m -117.15 114.91 24.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.42 110.872 179.232 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HD3' ' A' ' 40' ' ' LYS . 44.8 t -81.65 84.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.777 -0.647 . . . . 1.08 110.739 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.677 ' HB3' HG22 ' A' ' 17' ' ' THR . 51.8 p -83.37 -179.78 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.72 . . . . 1.33 110.673 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.18 -20.83 34.58 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.581 -0.819 . . . . 0.9 112.446 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.032 HD22 HG13 ' A' ' 18' ' ' VAL . 1.3 pp -51.95 179.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.683 0.278 . . . . 1.47 110.482 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 3.0 m -140.55 127.56 20.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 1.06 111.247 -179.482 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -54.52 157.34 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.11 0.481 . . . . 1.91 111.477 -179.877 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.4 OUTLIER 68.84 47.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 1.87 110.649 -179.605 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.9 123.78 0.43 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.49 111.594 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.05 134.16 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.659 -0.497 . . . . 0.36 109.659 179.11 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 43.0 m-85 -127.37 118.22 23.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.819 0.674 . . . . 0.56 112.819 -178.677 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -103.53 139.18 39.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.348 -0.612 . . . . 1.5 109.348 178.709 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.02 127.24 19.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.63 1.344 . . . . 0.6 114.63 -179.438 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -96.59 163.23 13.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.492 -0.777 . . . . 2.11 109.344 178.184 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.662 HG23 ' HG3' ' A' ' 8' ' ' PRO . 60.6 t -115.52 123.5 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 112.807 0.669 . . . . 0.6 112.807 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.05 155.61 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 114.79 -1.095 . . . . 0.7 109.248 179.023 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -165.52 127.77 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.884 -0.726 . . . . 0.6 111.931 179.02 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mttt -77.85 -157.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 1.98 110.358 179.828 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -155.64 162.88 40.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.336 0.589 . . . . 2.19 111.415 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.11 -41.17 1.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 1.08 112.784 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -70.34 -14.12 62.44 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.411 0.523 . . . . 1.06 112.411 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.83 59.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.435 -0.888 . . . . 0.93 112.108 -179.201 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -66.56 170.02 6.83 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.004 -0.369 . . . . 1.38 110.004 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -119.02 120.25 63.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.512 0.56 . . . . 0.79 112.512 -179.294 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.2 p -81.64 118.8 73.58 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.076 -1.083 . . . . 0.59 108.076 178.344 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.47 158.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.761 2.307 . . . . 0.85 113.08 -178.863 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.0 Cg_endo -67.59 162.53 38.74 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.82 2.347 . . . . 0.76 113.896 -179.208 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 m -114.14 135.26 54.23 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.099 -0.955 . . . . 1.28 109.839 179.29 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -19.69 106.71 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 124.497 1.123 . . . . 1.77 113.48 -179.445 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.483 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 87.6 Cg_exo -43.83 141.79 3.95 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.55 113.222 -179.944 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -76.11 147.13 38.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.626 -0.715 . . . . 1.23 109.817 179.418 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -37.21 146.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 O-C-N 124.207 0.942 . . . . 1.63 111.797 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.78 108.91 11.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.932 -0.576 . . . . 0.41 110.66 179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -86.23 113.44 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.44 110.72 179.856 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 92.6 m -50.89 -46.32 60.53 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.44 110.033 179.748 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 69' ' ' ASP . 2.3 m 57.53 107.76 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.685 -0.689 . . . . 1.1 109.697 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.942 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -140.6 -85.35 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.975 0.417 . . . . 3.0 110.474 -179.602 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.97 ' O ' HG23 ' A' ' 101' ' ' VAL . 12.2 p-10 -106.65 32.18 4.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 2.14 109.183 179.245 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.437 ' OD1' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER 47.93 24.17 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.192 -0.913 . . . . 2.06 111.356 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 99' ' ' ASP . 21.0 t -123.87 -17.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 2.8 111.444 179.502 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.775 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 39.35 95.22 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.945 0.403 . . . . 4.58 111.772 179.97 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.344 -0.836 . . . . 3.79 111.065 179.911 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.678 0.275 . . . . 2.74 111.049 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.674 ' O ' HG22 ' A' ' 2' ' ' ILE . 14.5 Cg_exo -70.98 -41.52 2.68 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.878 2.385 . . . . 2.06 111.808 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 1' ' ' PRO . 13.3 tt 52.87 150.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 124.114 0.884 . . . . 0.68 112.794 179.861 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -135.62 109.59 10.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.277 -0.874 . . . . 2.0 110.053 179.903 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.65 153.23 79.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.272 1.981 . . . . 0.5 112.271 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.64 179.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.889 2.392 . . . . 0.71 112.976 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -77.22 -178.22 47.16 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.909 -0.587 . . . . 0.66 113.088 -179.644 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.6 tttt -69.28 136.11 88.95 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.448 0.166 . . . . 1.52 111.276 -179.875 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HG3' HG23 ' A' ' 76' ' ' VAL . 5.1 Cg_exo -75.72 131.34 13.38 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.521 2.148 . . . . 0.44 112.201 179.665 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 21' ' ' LYS . 2.5 p -132.5 100.06 15.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.09 110.797 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 17.3 Cg_exo -52.63 122.66 11.3 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.025 1.816 . . . . 0.64 113.697 -179.234 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -82.95 -31.73 27.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.551 -0.907 . . . . 1.64 108.551 178.347 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -138.59 138.16 37.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.979 -1.009 . . . . 0.72 108.634 179.2 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.03 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.43 94.92 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.306 -0.558 . . . . 0.96 112.308 -179.139 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 163.12 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.46 110.133 179.264 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -61.46 -21.38 64.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.36 -0.382 . . . . 2.42 111.944 -179.42 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 17' ' ' THR . 37.4 m170 -126.34 16.02 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 1.02 111.471 179.542 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 ' C ' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -158.68 159.28 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.68 109.826 179.683 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.03 HG13 HG22 ' A' ' 13' ' ' ILE . 82.5 t -156.2 91.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.924 -0.311 . . . . 0.8 111.563 -179.161 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 30.9 m -79.07 145.47 33.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.35 110.363 179.432 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -149.13 161.8 41.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.736 0.779 . . . . 0.52 112.898 -179.072 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.225 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -141.18 142.03 34.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.32 -1.309 . . . . 1.84 109.249 179.213 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 14.7 p90 -137.88 -174.28 3.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.73 0.3 . . . . 0.4 111.145 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -95.63 163.4 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.83 111.267 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -111.56 145.1 31.93 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.108 -0.496 . . . . 2.11 110.077 179.874 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HB2' HG23 ' A' ' 28' ' ' THR . 5.2 Cg_exo -77.82 162.61 29.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.31 2.007 . . . . 0.89 112.169 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -112.78 -22.62 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 2.77 111.192 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -85.01 -72.61 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 1.37 111.137 -179.839 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' HB2' ' A' ' 25' ' ' PRO . 31.7 p 41.4 45.56 2.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.67 -0.241 . . . . 0.91 111.497 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.25 -92.53 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.703 -0.76 . . . . 1.01 112.409 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -153.14 43.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.187 -1.165 . . . . 0.98 110.187 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -123.72 -176.43 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.527 . . . . 0.87 111.368 -178.519 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 21.5 tttt -123.63 -20.28 5.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.084 -0.507 . . . . 2.26 111.975 -179.53 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt 68.51 112.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.688 -0.486 . . . . 1.71 109.688 -178.998 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -114.07 33.13 5.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.917 0.339 . . . . 1.15 111.917 -179.211 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.09 144.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.278 0.473 . . . . 1.58 112.278 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.884 ' O ' HD12 ' A' ' 56' ' ' ILE . 57.0 m-85 -127.48 85.15 2.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.678 . . . . 0.76 110.282 179.243 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -79.76 105.02 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 1.14 111.487 -179.795 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -96.07 138.34 21.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.991 -0.744 . . . . 0.63 108.991 179.065 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 50' ' ' LYS . 6.0 mt-10 -96.76 152.36 18.75 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.052 0.22 . . . . 1.67 110.492 -179.782 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' A' ' 72' ' ' TYR . 8.8 ttpp -108.42 155.46 20.54 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.417 -0.356 . . . . 1.97 110.651 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.611 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -134.08 103.6 5.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.733 -0.387 . . . . 1.44 110.085 178.993 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HA ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -79.98 83.15 5.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 1.59 110.349 -179.741 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.4 mt -61.24 159.67 28.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.077 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.1 Cg_endo -82.63 24.47 9.08 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 124.561 -1.016 . . . . 1.43 113.775 0.715 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -142.11 -80.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.844 0.354 . . . . 2.66 110.631 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 38.31 -161.9 0.01 OUTLIER Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.925 -0.579 . . . . 1.12 113.7 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -158.44 145.75 17.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.592 -0.522 . . . . 2.41 109.592 179.676 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.611 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 74.7 m95 -63.61 78.59 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.08 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -116.54 106.29 13.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.796 -0.638 . . . . 1.28 111.001 -179.615 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER 20.4 -151.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.82 1.325 . . . . 1.3 113.924 179.303 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.09 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . 175.98 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.001 -0.437 . . . . 0.86 110.451 -179.451 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.618 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.28 -38.04 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 2.01 110.81 -179.969 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 57.75 34.57 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.948 0.351 . . . . 2.08 111.948 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 11.2 t -170.23 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.797 0.295 . . . . 1.89 111.797 179.691 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 5.9 t30 -165.52 125.64 1.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 1.87 110.412 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 36' ' ' TYR . 25.5 mt -109.86 75.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.69 110.977 -179.916 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.4 tm? -53.22 -70.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 1.6 110.947 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -71.2 170.4 13.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.137 -0.32 . . . . 1.54 110.137 179.639 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 46.8 p-10 -84.69 6.1 25.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 1.75 111.874 -179.807 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.225 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -115.06 105.57 13.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.134 -0.691 . . . . 2.05 109.134 179.121 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.861 ' HB2' HG23 ' A' ' 56' ' ' ILE . 55.9 t80 -136.7 164.17 28.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.331 0.493 . . . . 0.48 112.331 -178.813 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 91.6 m -115.71 105.64 12.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.42 111.647 179.673 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.09 HG13 ' HB1' ' A' ' 51' ' ' ALA . 73.9 t -75.44 118.79 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.475 -0.784 . . . . 1.08 111.012 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.0 p -123.65 155.0 38.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 1.33 111.371 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.36 -4.03 8.24 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.9 112.862 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 18' ' ' VAL . 6.6 mp -65.81 165.94 11.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.105 0.479 . . . . 1.47 111.866 -179.592 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -121.49 127.38 50.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 1.06 110.347 179.72 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -48.97 145.25 4.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.486 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 97' ' ' CYS . 18.8 t0 68.22 54.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 1.87 111.527 179.576 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.77 120.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.49 111.335 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.56 135.86 53.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.467 -0.333 . . . . 0.36 110.236 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HD2' ' A' ' 40' ' ' LYS . 20.7 m-85 -128.06 123.47 34.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.433 0.901 . . . . 0.56 113.433 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -106.19 140.72 38.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.378 -0.971 . . . . 1.5 108.378 178.119 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.51 129.02 28.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 -178.482 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.82 146.2 28.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.031 -0.531 . . . . 2.11 110.142 178.282 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HB ' ' A' ' 38' ' ' VAL . 44.8 t -99.71 108.78 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.28 -0.568 . . . . 0.6 112.427 -179.568 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.49 HG12 ' CA ' ' A' ' 88' ' ' PRO . 77.1 mt -101.5 150.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.579 -1.267 . . . . 0.7 107.579 177.768 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -161.51 145.13 12.69 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.073 -1.051 . . . . 0.6 112.505 -179.642 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.4 ptpt -92.66 -161.23 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.555 . . . . 1.98 110.402 179.545 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.8 p-10 -150.46 165.92 31.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.989 0.423 . . . . 2.19 111.233 -179.274 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.47 -26.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 1.08 112.251 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.15 -20.34 21.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.969 0.359 . . . . 1.06 111.969 -179.382 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.62 -1.45 60.04 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.702 -0.761 . . . . 0.93 112.81 -179.684 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -73.1 76.84 1.24 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.991 0.424 . . . . 1.38 110.421 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -34.24 125.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.79 113.879 -178.922 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.518 ' HB3' HD11 ' A' ' 2' ' ' ILE . 14.0 p -90.6 124.97 61.07 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.05 -0.977 . . . . 0.59 109.596 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -40.55 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.852 2.368 . . . . 0.85 112.832 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.49 ' CA ' HG12 ' A' ' 77' ' ' ILE . 8.0 Cg_exo -72.21 149.35 51.46 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.804 2.336 . . . . 0.76 112.885 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m -95.2 129.11 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 1.28 109.733 179.349 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.5 tp10 -20.17 103.15 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.991 0 O-C-N 124.494 1.121 . . . . 1.77 112.886 -179.575 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 36.5 Cg_exo -38.12 150.04 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.806 2.337 . . . . 0.55 114.041 -179.443 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.21 145.6 26.32 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.336 -0.847 . . . . 1.23 109.054 178.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -35.12 151.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 124.229 0.956 . . . . 1.63 111.894 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -84.69 121.12 27.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.41 111.251 -179.536 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.8 mp -103.6 112.12 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.44 111.169 179.888 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 88.0 m -42.82 -34.11 0.88 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.965 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.6 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 51.4 82.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 1.1 110.586 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 -81.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.112 0.482 . . . . 3.0 110.761 -179.733 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.245 ' CG ' ' HG3' ' A' ' 102' ' ' GLU . 2.4 p30 -117.79 -11.38 10.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.738 -0.664 . . . . 2.14 111.24 179.588 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 58.25 16.5 4.02 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.782 0.29 . . . . 2.06 111.782 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.646 ' O ' HG12 ' A' ' 101' ' ' VAL . 86.4 t -136.45 6.95 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.926 0.393 . . . . 2.8 111.148 179.627 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.245 ' HG3' ' CG ' ' A' ' 99' ' ' ASP . 6.1 mt-10 -126.02 -0.2 7.21 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.287 -0.258 . . . . 4.58 111.12 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.142 -0.932 . . . . 3.79 111.135 179.717 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.446 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.642 0.258 . . . . 2.74 111.261 . . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 91.9 Cg_endo -83.77 -167.75 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.723 2.282 . . . . 2.06 112.282 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 86' ' ' SER . 6.8 tt -155.59 146.36 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.68 111.199 179.807 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.95 130.09 23.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.829 -0.623 . . . . 2.0 110.023 179.644 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.59 173.86 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.189 1.926 . . . . 0.5 112.739 -179.453 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 53.1 Cg_exo -54.98 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.201 2.601 . . . . 0.71 113.419 -179.401 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.15 -163.41 39.18 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.759 -0.655 . . . . 0.66 112.773 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.3 tmtt? -78.63 114.83 46.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 110.549 -0.167 . . . . 1.52 110.549 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.682 ' HG2' HG12 ' A' ' 76' ' ' VAL . 20.4 Cg_exo -72.17 149.56 52.1 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.969 2.446 . . . . 0.44 113.487 -179.26 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -146.97 107.99 3.97 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.629 -0.714 . . . . 1.09 111.201 179.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG3' HD22 ' A' ' 20' ' ' LEU . 38.7 Cg_exo -59.06 94.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.508 2.139 . . . . 0.64 113.041 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -51.25 -46.02 62.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.503 0.668 . . . . 1.64 109.454 179.244 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -122.3 150.27 42.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.959 -1.018 . . . . 0.72 108.408 178.619 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.816 ' HB ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -144.07 80.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.29 -0.564 . . . . 0.96 111.956 -179.219 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.08 156.53 35.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.46 110.288 179.594 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -61.4 -11.84 11.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -179.043 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.792 ' O ' HG23 ' A' ' 17' ' ' THR . 2.8 m80 -140.07 20.19 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.811 -0.356 . . . . 1.02 111.581 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER 179.14 109.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.68 110.383 179.742 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 ' CD1' ' A' ' 66' ' ' LEU . 25.9 m -108.6 126.16 65.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 0.8 111.364 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.7 m -96.61 137.76 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 0.35 111.054 179.709 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -139.56 164.25 30.4 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.061 0.85 . . . . 0.52 112.426 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.692 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -152.48 153.7 34.04 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.933 -1.031 . . . . 1.84 110.519 179.614 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 31.7 p90 -146.93 -171.5 3.78 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.533 0.568 . . . . 0.4 112.533 -179.462 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.31 -158.37 0.18 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.584 -0.735 . . . . 0.83 110.834 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -142.75 139.21 16.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 2.11 110.475 -179.963 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HB3' HG23 ' A' ' 28' ' ' THR . 84.3 Cg_exo -34.42 148.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.124 2.549 . . . . 0.89 112.778 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.726 ' CA ' ' OE1' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -98.48 11.67 37.51 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 2.77 111.802 -179.592 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -169.95 -66.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.37 111.753 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.2 p 52.05 47.6 24.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.008 0.432 . . . . 0.91 110.197 -179.307 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.29 -108.65 0.23 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.802 -0.713 . . . . 1.01 112.31 -179.758 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.39 29.56 4.03 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.784 -0.926 . . . . 0.98 110.784 179.176 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -114.74 -174.48 2.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.13 -0.535 . . . . 0.87 110.814 -178.967 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.0 pttt -143.08 32.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 2.26 111.594 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.838 HG21 ' CE1' ' A' ' 36' ' ' TYR . 7.7 mm 65.56 -71.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 1.71 111.365 179.861 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.59 -10.18 1.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.634 0.605 . . . . 1.15 112.634 179.63 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.808 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t -179.65 140.93 0.15 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.763 -0.375 . . . . 1.58 111.995 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.838 ' CE1' HG21 ' A' ' 33' ' ' ILE . 69.2 m-85 -116.59 138.73 51.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.76 110.852 179.409 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 5.0 mt -116.43 129.32 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.446 -0.343 . . . . 1.14 110.423 179.707 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.57 113.52 44.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.814 0.34 . . . . 0.63 111.813 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 50.8 mt-10 -83.02 132.85 35.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 1.67 110.151 179.271 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.664 ' CE ' HD23 ' A' ' 66' ' ' LEU . 2.1 tttp -95.42 128.14 42.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 113.554 0.946 . . . . 1.97 113.554 -178.426 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -108.52 95.16 5.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.873 -0.603 . . . . 1.44 110.196 178.539 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.099 ' OD2' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -64.17 142.17 58.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.15 -0.477 . . . . 1.59 109.753 179.619 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 94' ' ' ALA . 29.9 mt -123.71 133.11 24.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.754 -0.378 . . . . 0.9 110.919 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 66.8 Cg_endo -90.96 47.7 1.32 Allowed 'Cis proline' 0 C--N 1.351 0.689 0 C-N-CA 124.28 -1.134 . . . . 1.43 113.125 0.495 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 42' ' ' ASP . 1.7 m120 -127.13 57.5 1.47 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 2.66 110.801 -179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -42.65 160.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.044 -0.526 . . . . 1.12 113.42 -179.634 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.099 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 5.4 ptm180 -179.86 -32.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.041 0.385 . . . . 2.41 112.041 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 64.0 m95 61.41 81.53 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.296 -0.631 . . . . 0.65 109.296 -179.12 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -118.57 135.92 54.15 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.386 0.513 . . . . 1.28 112.386 -178.739 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtpm? -46.96 94.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.3 111.015 179.782 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -80.45 -42.29 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.551 -179.665 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.695 ' CB ' HD11 ' A' ' 56' ' ' ILE . 8.0 p-10 -54.21 -58.76 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.639 -0.255 . . . . 2.01 111.319 -179.678 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 39.56 49.27 1.96 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.053 0.39 . . . . 2.08 112.053 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -161.22 26.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.729 0.27 . . . . 1.89 111.729 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.3 t30 58.32 113.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 1.87 111.225 179.67 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' HB2' ' A' ' 61' ' ' PHE . 28.1 mt -109.94 71.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.69 110.827 179.587 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 34' ' ' THR . 4.9 mt -50.39 -59.57 3.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 1.6 111.3 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.7 pt-20 -86.93 158.91 19.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.917 0.389 . . . . 1.54 110.334 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 4.7 p-10 -69.99 -7.93 44.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.024 -0.535 . . . . 1.75 111.772 -179.764 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -98.22 105.07 17.17 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.443 -0.577 . . . . 2.05 109.443 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.805 ' HB2' HG23 ' A' ' 56' ' ' ILE . 53.2 t80 -142.47 165.42 27.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.48 111.711 -179.002 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.5 m -120.96 121.37 37.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.42 111.074 179.778 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 20' ' ' LEU . 14.5 t -81.7 110.8 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.113 -0.494 . . . . 1.08 111.637 -179.654 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 47.6 t -97.38 -159.54 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.858 -0.61 . . . . 1.33 110.495 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 61.19 23.48 62.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.64 -0.79 . . . . 0.9 112.114 -179.863 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.039 ' CD1' HG13 ' A' ' 18' ' ' VAL . 14.2 mt -76.03 169.8 17.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 1.47 110.944 -179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 2.1 m -134.17 141.32 47.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 1.06 110.564 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 15' ' ' ARG . 29.8 mt-10 -75.12 144.41 42.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.128 -0.487 . . . . 1.91 111.215 -179.783 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.9 t0 67.82 40.32 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.87 110.849 179.89 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . -155.53 115.34 3.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.49 111.42 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.72 130.34 42.69 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.49 -0.559 . . . . 0.36 109.49 179.082 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD1' ' HD3' ' A' ' 40' ' ' LYS . 57.8 m-85 -124.89 119.44 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.871 1.064 . . . . 0.56 113.871 -177.968 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 5.8 mt-10 -102.66 139.97 37.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.684 -1.228 . . . . 1.5 107.684 177.631 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.91 122.07 23.79 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.028 1.492 . . . . 0.6 115.028 -178.574 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 19.9 ttm-85 -94.93 143.81 26.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 114.509 -1.223 . . . . 2.11 109.086 178.087 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -121.06 120.1 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 119.121 -1.031 . . . . 0.6 112.538 179.458 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -110.58 165.42 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.861 -1.518 . . . . 0.7 107.689 178.537 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -165.81 149.23 7.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 118.934 -1.106 . . . . 0.6 112.376 -179.839 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.692 ' HG2' HD12 ' A' ' 85' ' ' ILE . 4.0 mttt -99.12 -177.61 3.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.308 -0.406 . . . . 1.98 109.973 179.097 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.701 ' OD1' HD12 ' A' ' 2' ' ' ILE . 7.8 p-10 -136.41 166.72 22.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.06 -0.518 . . . . 2.19 110.907 -179.682 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.756 -0.656 . . . . 1.08 112.482 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -89.08 -20.28 24.52 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.654 0.613 . . . . 1.06 112.654 -179.25 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.09 57.95 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.423 -0.894 . . . . 0.93 112.603 -179.59 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 2' ' ' ILE . . . -74.23 77.89 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.964 0.411 . . . . 1.38 110.297 179.74 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.692 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -36.23 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.79 113.285 -179.152 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.706 ' HB3' HD11 ' A' ' 2' ' ' ILE . 33.8 p -62.93 117.66 34.71 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.599 -0.728 . . . . 0.59 109.415 178.718 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -35.32 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.363 2.709 . . . . 0.85 113.398 -179.342 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' N ' HG23 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -59.22 168.28 4.99 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.219 2.613 . . . . 0.76 113.499 -179.612 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.509 ' HB2' HG13 ' A' ' 76' ' ' VAL . 19.9 m -124.61 129.62 50.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.084 -0.962 . . . . 1.28 109.706 178.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -25.03 118.57 0.21 Allowed Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.688 0.795 . . . . 1.77 112.604 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 51.5 Cg_exo -55.53 154.68 23.87 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.363 2.042 . . . . 0.55 114.249 -179.211 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -84.78 146.43 27.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.08 -0.963 . . . . 1.23 109.092 178.961 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -40.31 146.81 0.12 Allowed 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.623 0.577 . . . . 1.63 111.428 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -76.14 122.13 23.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.659 . . . . 0.41 110.671 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.816 HG21 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mp -102.28 109.09 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.632 -179.565 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 76.0 m -48.18 -36.11 13.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.087 -179.897 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.3 m 50.65 98.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 1.1 111.173 179.782 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -72.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.152 -0.476 . . . . 3.0 110.513 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.713 ' O ' HG12 ' A' ' 101' ' ' VAL . 6.4 p-10 -141.52 10.91 2.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.769 -0.65 . . . . 2.14 111.726 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 38.72 31.63 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.083 0.468 . . . . 2.06 111.624 -179.787 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 99' ' ' ASP . 14.2 p -159.29 24.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.676 -0.693 . . . . 2.8 110.928 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 -42.44 0.27 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.408 -0.36 . . . . 4.58 111.512 -179.776 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.161 -0.924 . . . . 3.79 111.207 179.99 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.744 0.307 . . . . 2.74 111.47 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.05 -164.7 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.449 2.766 . . . . 2.06 111.944 179.889 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.713 HD12 ' OD1' ' A' ' 80' ' ' ASN . 3.1 tt -164.36 150.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.186 0.517 . . . . 0.68 111.88 179.624 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -125.99 136.51 28.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.436 -0.802 . . . . 2.0 109.55 179.262 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.21 161.37 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.192 1.928 . . . . 0.5 112.429 -179.616 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.0 Cg_exo -54.22 164.5 2.69 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.864 2.376 . . . . 0.71 113.108 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.45 169.17 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.511 -0.768 . . . . 0.66 112.229 179.803 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -68.55 126.61 92.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.066 -0.346 . . . . 1.52 110.066 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 32.9 Cg_exo -62.85 153.19 74.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.28 1.987 . . . . 0.44 113.422 -179.289 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.79 96.19 3.6 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 1.09 109.641 179.368 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 86.2 Cg_exo -40.36 118.84 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.178 1.919 . . . . 0.64 113.224 -179.129 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.949 ' CD2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -84.99 -26.84 26.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.509 -0.923 . . . . 1.64 108.509 178.844 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.624 ' C ' HD13 ' A' ' 13' ' ' ILE . 18.3 t-20 -147.87 153.08 38.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.642 -1.244 . . . . 0.72 107.642 178.169 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.849 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.51 134.72 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.118 -0.633 . . . . 0.96 112.225 -179.133 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -145.92 146.93 31.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.958 -0.565 . . . . 1.46 111.251 179.435 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.489 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -24.62 -48.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.541 -1.209 . . . . 2.42 114.002 -179.336 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.671 ' HA ' HD12 ' A' ' 66' ' ' LEU . 29.3 m-70 -128.78 22.03 5.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.675 0.621 . . . . 1.02 112.675 -179.016 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' HIS . 38.7 p -162.49 114.42 1.62 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 0.68 109.995 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 HD21 ' A' ' 66' ' ' LEU . 5.3 m -128.83 121.6 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.953 0.882 . . . . 0.8 113.025 -179.405 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.1 m -82.33 148.91 28.03 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.184 -0.916 . . . . 0.35 110.686 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.71 147.73 27.7 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 124.337 1.023 . . . . 0.52 111.189 179.721 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.208 ' HD3' ' OE1' ' A' ' 60' ' ' GLU . 19.3 tptm -129.54 151.86 49.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.275 -0.875 . . . . 1.84 110.718 179.793 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 49.1 p90 -150.36 -179.04 6.88 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.057 0.455 . . . . 0.4 112.17 179.801 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.78 162.15 13.16 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.83 111.597 -179.417 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.13 152.85 38.22 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.421 -0.354 . . . . 2.11 110.891 179.802 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 11.7 Cg_endo -55.1 141.28 80.03 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.013 2.475 . . . . 0.89 113.524 -179.501 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -7.28 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 2.77 112.095 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -134.1 -67.11 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.883 -0.327 . . . . 1.37 111.677 -179.877 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t 35.85 49.59 0.58 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.302 0.573 . . . . 0.91 111.838 -179.201 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.47 -123.06 8.08 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.574 -0.739 . . . . 1.01 112.416 179.995 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.64 31.84 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.952 -0.859 . . . . 0.98 110.952 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.4 OUTLIER -103.47 -170.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.351 0.596 . . . . 0.87 112.238 -178.875 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' THR . 9.5 ttpt -145.84 24.74 1.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.069 -0.969 . . . . 2.26 110.744 179.856 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.039 HG21 ' CE1' ' A' ' 36' ' ' TYR . 24.2 mm 66.49 -70.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.248 -0.433 . . . . 1.71 111.119 179.918 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 83.36 -11.52 0.91 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.909 -0.587 . . . . 1.15 112.232 179.684 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 6.9 t -178.98 140.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.321 . . . . 1.58 111.807 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 33' ' ' ILE . 59.2 m-85 -119.65 139.84 51.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.126 0.489 . . . . 0.76 111.11 179.596 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.3 mt -116.97 130.84 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 1.14 110.088 179.367 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 56' ' ' ILE . 31.9 t -104.68 109.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.63 112.293 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' CB ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -81.87 107.93 14.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.557 -0.534 . . . . 1.67 109.557 178.979 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 2.3 ptmt -97.46 151.53 19.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.322 -179.368 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 43' ' ' LEU . 12.2 ttp180 -139.01 120.29 14.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.123 -0.49 . . . . 1.44 111.366 -179.905 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -82.86 90.76 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 1.59 109.616 179.432 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -83.82 150.61 59.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.04 -0.527 . . . . 0.9 111.414 -179.228 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -94.01 28.35 17.24 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.003 -1.249 . . . . 1.43 112.705 0.081 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -139.69 69.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 2.66 110.941 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.42 -169.88 30.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.814 -0.708 . . . . 1.12 112.297 179.986 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' NE ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.05 168.28 25.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 2.41 111.223 179.971 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.649 ' O ' HD22 ' A' ' 49' ' ' LEU . 70.7 m95 -69.71 118.43 12.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.715 -0.675 . . . . 0.65 111.393 -179.764 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.649 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -147.38 127.55 13.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 1.28 110.705 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -65.27 83.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3 111.368 -179.737 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.765 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -60.6 -38.67 85.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.86 110.434 179.672 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 61' ' ' PHE . 3.9 t-20 -40.13 -84.47 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.91 -0.586 . . . . 2.01 111.197 -179.997 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 t80 60.22 15.7 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.036 0.384 . . . . 2.08 112.036 179.568 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -122.75 22.42 9.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 1.89 110.939 179.826 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.99 133.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.936 0.398 . . . . 1.87 111.224 179.834 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 61' ' ' PHE . 13.2 mt -129.38 74.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.69 110.857 179.993 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -56.69 16.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 1.6 111.057 -179.957 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.28 160.53 15.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 1.54 110.808 179.967 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.7 m-20 -70.46 -8.4 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 1.75 111.525 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 1.208 ' OE1' ' HD3' ' A' ' 21' ' ' LYS . 14.7 tp10 -93.13 96.11 9.84 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.732 -0.47 . . . . 2.05 109.732 179.68 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.713 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.1 t80 -131.65 165.9 22.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.48 111.576 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.0 m -121.92 121.96 38.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.801 -0.636 . . . . 0.42 111.256 179.636 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.929 ' CG2' HD11 ' A' ' 20' ' ' LEU . 7.5 t -81.16 74.57 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.197 0.522 . . . . 1.08 110.294 -179.961 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 83.2 p -78.66 164.39 24.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.326 -0.852 . . . . 1.33 110.91 -179.589 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -9.97 64.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.586 -0.816 . . . . 0.9 113.009 179.922 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.061 HD21 HG13 ' A' ' 18' ' ' VAL . 4.4 pp -60.89 166.1 3.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 117.244 0.522 . . . . 1.47 110.694 -179.977 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -104.64 157.94 16.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.06 111.185 -179.478 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HG2' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.85 167.24 10.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.939 -0.573 . . . . 1.91 112.413 -179.289 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 2.2 t70 73.27 55.94 0.11 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.542 -0.753 . . . . 1.87 111.214 179.887 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 43' ' ' LEU . . . 165.58 138.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.49 110.363 179.818 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -56.87 133.85 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.36 110.393 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.485 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 2.3 m-85 -126.35 116.68 21.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.56 111.898 -178.852 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 43' ' ' LEU . 2.2 mt-10 -106.13 145.85 30.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.93 -0.577 . . . . 1.5 109.495 179.027 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.009 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.98 115.52 10.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.348 1.24 . . . . 0.6 114.348 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD3' ' CB ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -98.9 -178.45 3.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.794 -0.817 . . . . 2.11 108.794 177.922 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -150.48 130.7 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 119.309 -0.956 . . . . 0.6 112.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.759 HG22 HD11 ' A' ' 85' ' ' ILE . 55.6 mt -114.7 151.91 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.45 -1.25 . . . . 0.7 108.593 178.916 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.89 136.54 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.62 -0.832 . . . . 0.6 112.771 -179.662 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.58 -158.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.576 . . . . 1.98 109.912 179.228 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' A' ' 2' ' ' ILE . 2.8 p-10 -160.34 176.31 11.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 2.19 111.82 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.068 -0.969 . . . . 1.08 112.169 179.796 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -94.22 -20.33 19.93 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.91 0.337 . . . . 1.06 111.91 -179.453 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.7 61.16 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.48 -0.867 . . . . 0.93 112.981 -179.974 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 85.93 0.26 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 1.38 110.391 179.77 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.759 HD11 HG22 ' A' ' 77' ' ' ILE . 5.3 tp -46.32 122.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.658 0.614 . . . . 0.79 112.658 -179.116 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' ILE . 26.7 p -82.31 120.98 78.17 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.297 -0.865 . . . . 0.59 109.258 178.889 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.4 Cg_exo -38.54 163.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.904 2.403 . . . . 0.85 113.219 -179.495 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.619 ' HG3' HD11 ' A' ' 77' ' ' ILE . 4.2 Cg_exo -75.1 118.1 5.12 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.781 2.321 . . . . 0.76 112.72 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 3.3 t -68.5 137.84 54.73 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.822 -0.626 . . . . 1.28 109.968 179.516 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -32.68 125.74 0.39 Allowed Pre-proline 0 N--CA 1.47 0.525 0 O-C-N 124.027 0.829 . . . . 1.77 112.347 -179.451 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.6 Cg_exo -60.98 134.12 51.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.543 2.162 . . . . 0.55 113.206 -179.679 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.445 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.46 153.43 38.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.742 -0.663 . . . . 1.23 109.955 179.193 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -30.42 145.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.387 1.054 . . . . 1.63 112.652 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.56 112.24 20.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.702 -0.681 . . . . 0.41 109.718 179.376 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.8 mp -97.77 113.89 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.813 -179.276 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 71.7 m -46.36 -28.89 1.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.128 0.49 . . . . 0.44 110.025 179.153 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.599 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER 45.27 55.44 6.4 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.634 -0.712 . . . . 1.1 111.266 179.555 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -79.88 -93.59 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.714 -0.394 . . . . 3.0 110.97 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.93 39.22 2.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 2.14 109.707 179.829 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 15' ' ' ARG . 28.1 t0 47.73 22.38 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.866 -0.606 . . . . 2.06 111.192 -178.558 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.15 -26.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.928 -0.578 . . . . 2.8 110.06 179.405 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 50.4 54.07 11.8 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.869 -0.605 . . . . 4.58 110.774 -179.939 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.24 -0.886 . . . . 3.79 111.098 -179.862 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.599 0.237 . . . . 2.74 111.239 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -84.24 160.5 13.23 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.809 2.339 . . . . 2.06 111.762 179.677 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 ' CB ' ' A' ' 84' ' ' ALA . 5.0 tt -167.7 150.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.973 0.416 . . . . 0.68 111.975 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 2' ' ' ILE . 73.1 m-20 -139.67 130.71 14.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.651 . . . . 2.0 110.226 179.496 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.21 164.07 29.63 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.262 1.975 . . . . 0.5 112.511 -179.654 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 11.9 Cg_endo -56.52 177.25 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.155 2.57 . . . . 0.71 113.219 -179.579 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.05 171.88 54.54 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.828 -0.624 . . . . 0.66 112.375 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.59 127.73 89.06 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.227 -0.286 . . . . 1.52 110.227 179.718 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HG3' HG12 ' A' ' 76' ' ' VAL . 14.8 Cg_exo -73.67 150.04 44.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.566 2.178 . . . . 0.44 112.874 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -146.24 106.08 4.13 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 115.839 -0.619 . . . . 1.09 110.98 179.717 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -59.89 111.45 0.98 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.346 2.031 . . . . 0.64 113.305 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -71.64 -39.35 70.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.643 -0.873 . . . . 1.64 108.643 178.791 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.65 148.99 51.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.591 -1.186 . . . . 0.72 108.572 179.119 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.795 HD12 ' CG2' ' A' ' 95' ' ' ILE . 4.4 pt -142.78 89.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.989 0.423 . . . . 0.96 111.539 -179.253 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -79.58 149.01 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 1.46 110.785 -179.866 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.901 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -40.41 -35.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.083 0.772 . . . . 2.42 113.083 -179.212 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' THR . 3.4 m-70 -135.25 31.62 3.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 1.02 111.437 -179.332 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -178.62 108.54 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.68 110.226 179.578 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 66' ' ' LEU . 9.5 m -112.82 143.38 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.415 -0.514 . . . . 0.8 111.159 -179.91 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 53.2 m -106.72 136.82 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.438 -0.346 . . . . 0.35 110.817 179.565 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.04 160.81 37.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.094 0.871 . . . . 0.52 112.569 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.706 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -148.4 147.11 28.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.909 -1.041 . . . . 1.84 110.456 179.465 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 30.3 p90 -137.68 -175.12 3.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.133 0.492 . . . . 0.4 111.927 -179.575 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.86 16.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.577 -0.738 . . . . 0.83 110.908 179.725 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.97 147.39 33.8 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.408 179.621 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 28' ' ' THR . 35.1 Cg_endo -63.72 173.08 4.94 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.325 2.017 . . . . 0.89 112.325 179.941 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -123.79 13.49 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.627 -179.853 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -144.01 -73.91 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 1.37 111.919 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.5 p 43.63 56.81 4.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.878 0.371 . . . . 0.91 110.811 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.16 -100.4 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.543 . . . . 1.01 112.483 -179.528 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.8 34.33 1.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.009 -1.237 . . . . 0.98 110.009 179.152 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -116.11 -168.01 1.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.664 -0.768 . . . . 0.87 111.388 -178.717 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.21 45.74 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.621 -0.718 . . . . 2.26 111.305 -179.958 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.812 HG22 ' H ' ' A' ' 35' ' ' SER . 12.2 mm 52.98 -87.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.086 179.731 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 74.39 23.58 1.96 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.564 0.579 . . . . 1.15 112.564 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.812 ' H ' HG22 ' A' ' 33' ' ' ILE . 4.3 t 168.91 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.937 0.347 . . . . 1.58 111.937 179.562 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 56' ' ' ILE . 18.4 m-85 -102.61 93.52 5.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.76 110.831 179.498 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.0 mt -85.9 114.68 26.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.747 0.308 . . . . 1.14 110.922 179.96 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' ARG . 14.4 t -89.27 121.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.278 -0.419 . . . . 0.63 111.737 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -95.16 129.86 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 1.67 109.895 179.214 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -110.21 140.13 44.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.217 0.532 . . . . 1.97 111.968 -179.416 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HG3' ' HA2' ' A' ' 46' ' ' GLY . 13.0 ttm180 -111.9 112.63 24.43 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.366 -0.834 . . . . 1.44 109.616 179.047 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -81.8 101.22 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.601 -0.727 . . . . 1.59 110.644 -179.594 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -76.67 155.53 83.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.48 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -87.57 9.06 63.62 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.142 -1.191 . . . . 1.43 113.287 0.519 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.77 -74.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 2.66 110.195 179.75 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 98.06 155.96 29.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.735 . . . . 1.12 113.915 179.018 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 161.26 62.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 122.928 0.491 . . . . 2.41 109.799 -179.939 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 80.9 m95 -28.79 105.08 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.469 0.708 . . . . 0.65 112.593 -179.422 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.66 130.66 42.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.986 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 2.5 ptmm? -56.19 91.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 1.3 111.481 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.821 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.36 -55.41 31.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.1 0.476 . . . . 0.86 110.142 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.647 ' CB ' HD11 ' A' ' 56' ' ' ILE . 9.1 p-10 -44.58 112.55 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.717 . . . . 2.01 111.023 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.56 43.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.08 111.598 -179.604 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 t -168.18 172.2 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 1.89 111.221 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 115.37 18.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 1.87 110.869 179.946 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 36' ' ' TYR . 35.6 mt -96.63 89.53 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.69 110.929 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 34' ' ' THR . 2.5 mt -61.22 -79.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.6 111.253 -179.798 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 172.18 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.54 110.726 -179.995 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.2 p30 -88.15 12.35 13.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 1.75 111.687 -179.851 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 53.5 tt0 -109.49 108.9 19.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.278 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE1' ' O ' ' A' ' 62' ' ' THR . 55.4 t80 -145.0 165.08 29.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.48 112.055 -178.874 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.566 ' O ' ' CE1' ' A' ' 61' ' ' PHE . 99.5 m -119.22 112.89 20.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.671 -0.695 . . . . 0.42 110.26 179.497 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.957 ' CG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -79.76 89.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.762 -0.654 . . . . 1.08 110.51 -179.495 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.798 ' CB ' HG22 ' A' ' 17' ' ' THR . 25.4 t -88.05 -178.07 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.908 . . . . 1.33 110.929 -179.49 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 84.01 7.17 85.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.687 -0.768 . . . . 0.9 112.79 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.8 pp -84.61 172.07 11.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.186 0.493 . . . . 1.47 110.887 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 68' ' ' GLU . 1.7 m -121.41 173.3 7.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 1.06 111.376 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 67' ' ' THR . 2.7 tt0 -91.86 170.52 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 1.91 111.202 -179.93 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.814 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 47.03 35.26 3.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 1.87 111.194 179.831 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.7 114.84 6.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.49 111.395 -179.832 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.19 123.47 20.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.672 -0.492 . . . . 0.36 109.672 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 58.0 m-85 -116.99 121.85 42.57 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.357 0.873 . . . . 0.56 113.357 -178.361 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.4 tt0 -102.85 136.76 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.829 -1.175 . . . . 1.5 107.829 177.832 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.26 126.53 21.39 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.933 1.457 . . . . 0.6 114.933 -178.519 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -101.0 -177.16 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.846 -1.07 . . . . 2.11 108.423 177.756 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -147.89 106.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 119.656 -0.818 . . . . 0.6 112.655 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.465 HD11 ' HG3' ' A' ' 88' ' ' PRO . 42.7 mt -88.07 154.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 177.455 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.18 126.72 4.28 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.927 -1.109 . . . . 0.6 113.198 -179.144 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.1 mttt -76.6 -159.87 0.13 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.71 . . . . 1.98 109.394 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.5 m-80 -149.82 176.94 10.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.056 0.455 . . . . 2.19 111.338 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.6 -26.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 1.08 111.682 179.773 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.26 10.36 29.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.427 0.528 . . . . 1.06 112.427 -179.571 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.46 -14.61 57.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.349 -0.929 . . . . 0.93 112.853 179.875 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.42 102.51 0.03 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.813 0.34 . . . . 1.38 111.258 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.0 tp -69.98 101.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.79 111.819 -179.623 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.1 p -69.56 126.35 92.54 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 109.502 -0.555 . . . . 0.59 109.502 179.371 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -39.2 160.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.716 2.278 . . . . 0.85 112.446 -179.53 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.5 Cg_exo -67.53 124.61 12.21 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.684 2.256 . . . . 0.76 113.054 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.792 ' HB2' HG13 ' A' ' 76' ' ' VAL . 3.2 m -70.99 130.47 41.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.776 -0.647 . . . . 1.28 109.44 179.17 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -31.99 124.34 0.37 Allowed Pre-proline 0 N--CA 1.474 0.727 0 N-CA-C 112.538 0.57 . . . . 1.77 112.538 -179.316 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 32.2 Cg_exo -59.39 147.6 90.47 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.833 2.355 . . . . 0.55 113.387 -179.559 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.15 147.59 28.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.695 -0.684 . . . . 1.23 109.885 179.291 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.63 137.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 124.186 0.929 . . . . 1.63 111.736 -179.921 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -66.38 120.49 13.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.655 . . . . 0.41 110.789 179.88 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.795 ' CG2' HD12 ' A' ' 13' ' ' ILE . 4.0 mp -100.42 109.54 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.44 111.337 -179.886 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -45.79 -48.88 15.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.32 -179.702 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 64.65 86.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.446 . . . . 1.1 110.42 -179.952 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.31 -86.24 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 3.0 111.071 -179.758 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.707 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 14.7 p30 -105.43 14.59 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.162 -0.472 . . . . 2.14 111.097 179.886 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.5 t0 50.35 26.76 2.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.023 0.44 . . . . 2.06 110.606 -179.827 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.707 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.8 p -125.02 -9.63 6.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.688 -0.687 . . . . 2.8 111.607 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 55.0 mt-10 -144.21 -78.07 0.21 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.759 0.314 . . . . 4.58 111.213 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.92 . . . . 3.79 110.94 -179.92 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.731 0.301 . . . . 2.74 111.461 . . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 0' ' ' SER . 1.3 Cg_endo -85.25 57.49 4.7 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.248 2.632 . . . . 2.06 112.047 -179.918 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.74 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.3 tt -44.33 148.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.68 111.52 -179.926 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' ILE . 8.1 t70 -126.49 129.06 24.22 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 2.0 110.78 179.932 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.01 171.87 14.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.489 2.126 . . . . 0.5 112.276 -179.957 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -66.86 -174.72 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.803 2.335 . . . . 0.71 113.182 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.35 -177.81 49.67 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.4 -0.818 . . . . 0.66 112.852 -179.794 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.14 116.4 35.65 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.391 0.139 . . . . 1.52 110.681 179.866 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 31.7 Cg_exo -62.76 142.75 90.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.595 2.197 . . . . 0.44 112.374 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.6 p -145.95 104.42 4.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 1.09 111.976 -179.476 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.9 Cg_exo -50.26 113.24 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.532 2.155 . . . . 0.64 112.751 -179.963 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -63.86 -46.49 84.72 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.774 -0.825 . . . . 1.64 108.774 178.977 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -129.29 151.25 50.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.28 -1.327 . . . . 0.72 108.321 179.016 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' HB ' HG21 ' A' ' 95' ' ' ILE . 4.4 pt -143.17 70.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.399 -0.52 . . . . 0.96 111.567 -179.104 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -72.44 146.88 46.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.613 -0.721 . . . . 1.46 110.468 179.864 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -65.99 61.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.764 0.792 . . . . 2.42 112.387 -179.413 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.416 ' N ' ' SG ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 167.82 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.758 -0.655 . . . . 1.02 110.509 179.09 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -146.4 126.12 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.472 -0.566 . . . . 0.68 109.472 179.27 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -116.77 120.57 65.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.189 0.44 . . . . 0.8 112.189 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.587 ' OG1' HG23 ' A' ' 62' ' ' THR . 97.6 m -91.63 142.34 27.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.692 -0.231 . . . . 0.35 110.892 179.303 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -140.4 156.03 46.53 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.146 0.904 . . . . 0.52 112.992 -179.641 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 1.8 tppp? -145.15 159.11 43.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.316 -1.311 . . . . 1.84 109.59 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 40.0 p90 -155.66 -176.45 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.13 0.49 . . . . 0.4 112.086 -179.879 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.95 133.37 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.569 -0.741 . . . . 0.83 111.685 -179.664 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -70.64 141.56 87.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 2.11 109.686 179.35 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 6.3 Cg_endo -48.62 175.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.095 1.863 . . . . 0.89 111.431 179.705 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.7 -25.66 4.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.33 0.493 . . . . 2.77 112.33 -179.367 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -106.45 -70.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.005 0.372 . . . . 1.37 112.005 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.475 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 3.2 p 52.08 41.18 29.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.649 0.261 . . . . 0.91 110.36 -179.313 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.87 -91.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.861 -0.685 . . . . 1.01 112.232 -179.805 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.73 35.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.077 -1.209 . . . . 0.98 110.077 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -117.39 172.31 7.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.898 -0.651 . . . . 0.87 111.635 -178.464 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -123.86 -3.45 8.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.852 -0.613 . . . . 2.26 111.519 179.828 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 64.01 155.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 110.505 -0.183 . . . . 1.71 110.505 -179.908 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 4.6 p -139.56 8.27 2.38 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.482 0.549 . . . . 1.15 112.482 -179.522 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.44 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 178.49 149.39 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.826 0.346 . . . . 1.58 111.923 -179.994 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.8 m-85 -126.38 119.83 28.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.983 -0.553 . . . . 0.76 110.101 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.84 116.15 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.73 0.3 . . . . 1.14 111.471 -179.585 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -106.44 104.48 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.303 0.573 . . . . 0.63 110.671 179.588 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 4.8 mt-10 -73.52 157.33 36.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.284 -0.871 . . . . 1.67 110.38 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -118.23 137.41 53.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.97 111.466 -179.569 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -113.9 120.2 39.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 1.44 110.726 179.656 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.837 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.71 77.7 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 1.59 110.552 179.846 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 52.8 mt -53.3 145.16 27.33 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.637 -0.71 . . . . 0.9 111.151 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -93.42 27.03 19.26 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.903 -1.29 . . . . 1.43 112.708 0.174 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -153.6 81.89 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.781 0.324 . . . . 2.66 111.861 -179.835 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.75 -152.83 10.44 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.942 -0.647 . . . . 1.12 111.968 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.853 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -167.15 29.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.027 0.413 . . . . 2.41 111.759 179.894 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 69.1 m95 41.06 101.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.832 0.678 . . . . 0.65 112.832 179.422 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -131.48 117.97 19.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 1.28 110.045 179.085 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -43.5 106.54 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.935 0.398 . . . . 1.3 111.484 -179.503 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -73.04 -36.54 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.86 111.285 -179.867 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.687 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.3 p-10 -69.58 -173.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.336 -0.393 . . . . 2.01 110.958 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 4.0 t80 176.93 -22.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.515 -0.766 . . . . 2.08 111.799 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.99 35.78 0.8 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.075 0.398 . . . . 1.89 112.075 -179.497 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.51 122.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 1.87 111.294 179.594 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 52' ' ' ASN . 35.2 mt -114.27 68.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.69 110.987 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 1.6 111.158 -179.892 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 1.7 pm0 -70.2 166.53 19.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.99 0.424 . . . . 1.54 110.759 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -78.83 1.69 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.904 -0.589 . . . . 1.75 111.537 179.873 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 7.1 tt0 -98.56 100.14 11.35 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.966 -0.383 . . . . 2.05 109.966 179.608 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.8 t80 -136.81 164.45 28.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.238 0.542 . . . . 0.48 111.648 -179.502 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.6 m -125.55 125.14 42.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.463 -0.79 . . . . 0.42 110.398 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' LEU . 9.1 t -87.53 91.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.214 0.531 . . . . 1.08 110.747 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 17' ' ' THR . 24.2 p -85.52 -157.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.375 -0.829 . . . . 1.33 110.825 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.78 9.19 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.578 -0.82 . . . . 0.9 112.086 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.026 ' CD1' HG13 ' A' ' 18' ' ' VAL . 27.8 mt -75.61 164.98 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 1.47 111.025 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.424 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 1.8 m -115.27 101.59 9.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.557 . . . . 1.06 110.363 179.756 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 7.6 tt0 -49.25 150.15 1.84 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.489 -0.323 . . . . 1.91 111.179 -179.748 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 20.2 m-20 70.92 46.73 0.46 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.983 -0.553 . . . . 1.87 110.676 -179.625 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -167.83 121.42 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.034 -0.53 . . . . 0.49 111.139 -179.927 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.86 117.41 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.055 -0.35 . . . . 0.36 110.055 179.477 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 78.2 m-85 -113.78 128.95 56.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 5.8 mt-10 -95.41 146.4 24.43 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.469 -0.937 . . . . 1.5 108.469 178.271 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -123.85 108.94 13.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.376 1.621 . . . . 0.6 115.376 -178.177 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' CZ ' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.71 133.8 41.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.133 -0.94 . . . . 2.11 109.374 178.304 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -117.01 125.36 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 119.141 -1.023 . . . . 0.6 113.678 179.811 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 86' ' ' SER . 37.0 mt -114.74 145.57 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 113.589 -1.642 . . . . 0.7 108.03 178.546 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -154.34 125.39 7.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.858 -0.737 . . . . 0.6 112.541 -179.521 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 85' ' ' ILE . 15.5 ptpt -79.85 156.14 27.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.25 179.276 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.74 ' ND2' HD12 ' A' ' 2' ' ' ILE . 5.0 p30 -102.36 172.92 6.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 2.19 112.185 -179.32 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.26 -46.73 9.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.949 -1.023 . . . . 1.08 111.963 179.72 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -65.64 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 1.06 111.887 -179.273 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.22 -21.56 21.98 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.532 -0.842 . . . . 0.93 112.208 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.633 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -49.18 154.03 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.989 -0.374 . . . . 1.38 109.989 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tp -108.58 115.78 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.255 0.465 . . . . 0.79 112.255 -179.38 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' ILE . 24.1 p -69.72 113.84 20.23 Favored Pre-proline 0 C--O 1.235 0.34 0 N-CA-C 108.033 -1.099 . . . . 0.59 108.033 178.583 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.19 150.25 14.6 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.319 2.013 . . . . 0.85 113.005 -178.905 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' CA ' HG12 ' A' ' 77' ' ' ILE . 10.7 Cg_exo -38.93 141.51 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.46 2.774 . . . . 0.76 113.961 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' GLU . 16.0 m -106.01 110.6 22.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.957 -1.02 . . . . 1.28 109.698 179.054 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tp10 -5.12 116.08 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 124.815 1.322 . . . . 1.77 113.471 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 81.2 Cg_exo -51.05 142.29 35.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.451 2.1 . . . . 0.55 114.554 -179.14 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.418 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -75.56 152.15 37.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 178.427 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.89 145.73 0.31 Allowed 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.343 0.402 . . . . 1.63 110.978 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -78.8 121.48 24.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.993 -0.549 . . . . 0.41 111.07 -179.416 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.587 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.1 mp -100.77 114.94 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.175 -179.995 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.0 m -51.47 -44.21 62.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.919 -0.582 . . . . 0.44 110.655 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 50.3 t 62.43 67.94 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 116.17 -0.468 . . . . 1.1 110.958 179.651 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.77 -84.61 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 3.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 2.7 p30 -122.58 -0.67 9.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 2.14 111.109 179.719 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.49 26.1 1.08 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.991 0.424 . . . . 2.06 111.236 -179.969 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 101' ' ' VAL . 14.9 p -156.14 24.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 2.8 110.815 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' OE2' ' N ' ' A' ' 99' ' ' ASP . 2.4 mp0 -126.65 -41.49 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 4.58 110.88 -179.693 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.251 -0.88 . . . . 3.79 111.158 -179.818 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 111.677 0.251 . . . . 2.74 111.677 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.27 59.32 6.95 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.416 2.077 . . . . 2.06 112.364 -179.855 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.448 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 5.5 tt -46.64 149.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.68 111.475 -179.977 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -129.78 124.99 22.02 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.787 -0.642 . . . . 2.0 111.194 179.699 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 161.76 35.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.427 2.084 . . . . 0.5 111.976 179.793 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 18.2 Cg_endo -59.06 170.39 2.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.592 2.195 . . . . 0.71 112.783 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -70.55 167.66 49.94 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.695 -0.684 . . . . 0.66 112.882 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 tmtt? -51.43 119.37 12.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.505 -0.183 . . . . 1.52 110.505 179.806 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' CG ' HG23 ' A' ' 76' ' ' VAL . 16.5 Cg_exo -70.06 152.8 67.91 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.398 2.066 . . . . 0.44 111.491 179.909 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.1 p -151.96 121.22 3.42 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.243 0.46 . . . . 1.09 112.243 -179.068 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.2 Cg_exo -65.75 111.95 2.07 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.552 2.168 . . . . 0.64 112.192 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.671 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.45 -33.09 58.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 1.64 110.625 179.711 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' HB ' ' A' ' 19' ' ' THR . 3.2 t-20 -148.56 126.02 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.72 110.113 179.891 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.872 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -114.9 128.11 72.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.96 111.606 -179.605 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -115.18 44.51 1.81 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.784 -0.644 . . . . 1.46 112.099 -179.318 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.8 mtm180 55.64 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.138 0.792 . . . . 2.42 113.138 178.749 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m170 -75.8 -29.89 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 1.02 110.934 -179.441 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.497 ' HA ' HD22 ' A' ' 66' ' ' LEU . 60.4 p -134.27 128.84 34.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.656 -0.498 . . . . 0.68 109.656 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.023 HG13 ' CD2' ' A' ' 66' ' ' LEU . 3.6 m -115.44 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.452 -0.499 . . . . 0.8 111.215 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 13.4 m -119.72 114.76 22.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.334 -0.394 . . . . 0.35 111.779 -178.997 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.04 158.0 40.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.686 0.755 . . . . 0.52 111.154 178.879 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CG ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.18 -179.2 5.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.652 -1.158 . . . . 1.84 109.591 179.813 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 24.7 p90 -162.08 175.46 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.328 0.585 . . . . 0.4 112.24 179.521 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -88.18 175.21 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.315 -0.857 . . . . 0.83 110.699 179.807 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 141.47 24.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.41 -0.359 . . . . 2.11 110.476 179.883 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' THR . 11.1 Cg_endo -54.48 -176.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.7 2.267 . . . . 0.89 112.464 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.23 -27.25 4.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 2.77 111.948 -179.77 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -113.84 -69.54 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.95 0.352 . . . . 1.37 111.95 -179.556 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.0 p 52.59 48.27 22.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.919 0.39 . . . . 0.91 110.227 -179.359 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.78 -101.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.657 -0.782 . . . . 1.01 112.03 -179.837 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.63 31.77 2.1 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.516 -1.034 . . . . 0.98 110.516 179.22 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.6 m-85 -107.44 -172.76 2.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.836 -0.682 . . . . 0.87 111.92 -178.806 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.25 7.08 1.34 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.923 -1.035 . . . . 2.26 111.832 179.187 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.013 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.1 mt 52.25 115.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.26 0.552 . . . . 1.71 112.329 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -117.12 22.76 12.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 1.15 111.357 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER 175.69 113.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.226 0.454 . . . . 1.58 112.226 -179.865 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 33' ' ' ILE . 43.2 m-85 -97.45 138.08 35.43 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.095 -0.335 . . . . 0.76 110.095 178.884 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -125.77 111.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.894 0.378 . . . . 1.14 110.67 179.485 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -99.37 115.8 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.364 -179.644 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.2 mt-10 -76.51 142.65 40.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.714 -0.675 . . . . 1.67 110.32 179.7 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.65 ' HE3' ' HB2' ' A' ' 51' ' ' ALA . 27.5 ttmt -106.11 146.02 30.72 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 120.749 0.309 . . . . 1.97 110.642 -179.577 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -129.8 100.77 5.6 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.547 -0.461 . . . . 1.44 110.483 178.931 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -70.6 78.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.618 -0.719 . . . . 1.59 110.689 -179.927 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.665 HD12 ' HB1' ' A' ' 94' ' ' ALA . 81.2 mt -50.44 154.88 1.98 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 0.9 111.02 -179.932 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.91 27.57 13.36 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.76 -1.35 . . . . 1.43 112.759 0.349 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -126.33 -79.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.574 0.225 . . . . 2.66 110.996 -179.922 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 1.12 112.907 179.845 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.27 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 2.41 110.552 179.95 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 62.2 m95 43.93 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.65 111.635 179.94 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -121.25 127.91 51.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 1.28 110.602 179.915 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -52.32 90.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.347 . . . . 1.3 110.627 -179.992 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.797 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -60.2 -46.06 91.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.86 110.635 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.814 ' HB2' HD11 ' A' ' 56' ' ' ILE . 10.9 p-10 -64.99 102.01 0.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 2.01 111.587 -179.828 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -15.65 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.085 -0.507 . . . . 2.08 110.664 179.27 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 p -86.62 -155.82 0.28 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.38 -0.373 . . . . 1.89 110.471 179.913 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -115.22 107.77 15.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.333 . . . . 1.87 111.618 -179.708 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 52' ' ' ASN . 6.9 mm -79.53 143.11 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.635 -0.505 . . . . 0.69 109.635 178.989 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -145.34 -68.02 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.33 . . . . 1.6 111.716 -179.843 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -54.93 -18.32 4.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 1.54 112.228 -179.731 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER 91.29 -18.45 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.877 0.871 . . . . 1.75 110.803 -179.58 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -88.92 85.26 6.69 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.555 -0.905 . . . . 2.05 108.555 178.836 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.737 ' CD1' HD12 ' A' ' 56' ' ' ILE . 50.2 t80 -114.47 165.2 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.484 0.659 . . . . 0.48 111.694 -178.61 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 91.9 m -123.4 116.99 24.16 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.893 -1.049 . . . . 0.42 110.025 178.994 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.797 HG13 ' CB ' ' A' ' 51' ' ' ALA . 48.8 t -83.9 86.54 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.117 -0.492 . . . . 1.08 111.375 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.56 134.41 35.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.734 . . . . 1.33 110.509 179.81 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.85 -14.3 2.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.83 . . . . 0.9 112.919 -179.847 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.023 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -53.31 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.47 110.609 179.94 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.2 m -148.75 142.3 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.06 111.11 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 1.282 ' OE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.0 137.27 58.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.193 179.879 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 97' ' ' CYS . 21.1 t70 70.09 49.33 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 1.87 111.221 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.87 120.51 2.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.873 0.368 . . . . 0.49 111.49 179.916 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.58 132.63 44.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.36 109.983 179.239 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.7 m-85 -127.52 122.11 32.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.662 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.89 138.12 43.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.603 -0.888 . . . . 1.5 108.603 178.502 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.21 115.39 14.12 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.41 1.263 . . . . 0.6 114.41 -178.702 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.32 167.77 11.52 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.806 -0.442 . . . . 2.11 109.806 178.395 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' CG ' ' A' ' 8' ' ' PRO . 28.5 t -122.43 121.18 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 113.706 1.002 . . . . 0.6 113.706 -179.531 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 86' ' ' SER . 70.1 mt -120.46 143.46 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.967 -1.494 . . . . 0.7 106.967 178.007 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -164.61 132.09 3.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.701 1.0 . . . . 0.6 113.701 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.61 105.95 14.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.709 -0.848 . . . . 1.98 108.709 178.245 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 3.3 m120 -40.1 -93.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.69 . . . . 2.19 112.712 -178.721 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -131.93 -41.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.178 -0.327 . . . . 1.08 111.643 -179.426 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -93.46 31.67 1.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 1.06 111.796 -179.684 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 77.84 -2.35 64.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.477 -0.868 . . . . 0.93 112.994 179.971 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -60.64 83.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 1.38 110.256 179.728 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.92 110.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.79 111.904 -179.325 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 77' ' ' ILE . 5.0 p -70.64 118.13 61.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.101 -0.704 . . . . 0.59 109.101 179.205 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 3.1 Cg_endo -47.15 172.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.623 2.215 . . . . 0.85 112.615 -179.192 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 17.0 Cg_endo -56.66 132.28 50.77 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.799 2.333 . . . . 0.76 112.46 -179.847 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m -105.99 98.14 7.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 1.28 111.155 -179.985 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mt-10 15.55 106.53 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 124.394 1.078 . . . . 1.77 113.858 179.58 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.1 Cg_exo -54.84 126.11 21.36 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.439 2.092 . . . . 0.55 113.89 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.425 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -54.77 147.64 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.431 -0.581 . . . . 1.23 109.431 178.996 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -36.77 143.48 0.08 Allowed 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 124.181 0.926 . . . . 1.63 111.779 179.951 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -78.01 109.83 12.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.41 109.901 179.712 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.82 HG12 HG21 ' A' ' 13' ' ' ILE . 4.8 mp -91.53 109.46 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.485 -179.444 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 98.8 m -45.96 -28.54 1.17 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.77 179.677 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.76 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 87.0 m 52.6 80.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 1.1 110.172 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 1.282 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.2 -79.74 0.62 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.947 0.403 . . . . 3.0 111.686 -179.394 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.87 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.6 p30 -112.44 22.23 14.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.01 -0.541 . . . . 2.14 111.402 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 p30 51.88 21.68 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 2.06 111.675 -179.767 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 99' ' ' ASP . 15.2 t -119.63 -15.06 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 2.8 111.07 179.536 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.874 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 42.87 55.21 4.47 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.032 0.444 . . . . 4.58 111.541 179.891 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.209 -0.901 . . . . 3.79 111.162 -179.986 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.717 0.294 . . . . 2.74 111.128 . . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.04 132.92 20.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.702 2.268 . . . . 2.06 111.84 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.496 HD12 ' OD1' ' A' ' 80' ' ' ASN . 2.6 tt -130.84 142.3 43.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.68 111.31 -179.897 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.039 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -122.11 129.77 24.98 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 2.0 110.294 179.88 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 154.28 15.41 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.424 2.083 . . . . 0.5 112.809 -179.628 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 78.2 Cg_exo -46.02 152.12 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.187 2.592 . . . . 0.71 113.485 -179.854 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.36 -171.35 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.432 -0.804 . . . . 0.66 113.103 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.7 tttt -77.07 129.39 78.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.457 -0.201 . . . . 1.52 110.457 179.824 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 2.7 Cg_exo -78.48 128.43 8.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.608 2.206 . . . . 0.44 112.896 -179.555 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -130.59 116.21 17.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.09 111.103 179.713 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.1 Cg_exo -62.91 128.52 23.3 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.707 2.271 . . . . 0.64 113.605 -179.467 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.6 mp -93.63 -27.79 16.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 1.64 109.693 179.059 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -150.42 151.16 32.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.715 -0.675 . . . . 0.72 110.229 179.836 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.193 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -149.08 111.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 0.96 111.503 -179.794 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.338 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -106.46 56.72 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.68 -0.691 . . . . 1.46 111.171 -179.956 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.955 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER 56.27 -69.97 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.881 0.738 . . . . 2.42 112.853 179.016 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m-70 -83.99 -20.28 33.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 1.02 111.82 -179.33 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 64' ' ' SER . 49.7 p -126.01 112.25 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.68 111.745 -179.603 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.004 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -106.39 120.55 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.8 110.478 179.606 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.706 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -104.34 128.16 52.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.35 111.843 -179.16 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.45 160.41 39.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.722 0.772 . . . . 0.52 111.8 178.964 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.822 ' HB3' HD11 ' A' ' 11' ' ' LEU . 8.6 tptm -142.57 139.19 31.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.514 -1.221 . . . . 1.84 109.861 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 14.5 p90 -126.55 -174.86 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.4 111.555 -179.714 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 171.81 8.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.83 111.475 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tptm -116.2 124.47 29.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.924 -0.58 . . . . 2.11 110.06 179.842 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.58 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 6.5 Cg_endo -46.98 175.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.719 2.28 . . . . 0.89 112.725 -179.908 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.54 3.35 5.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.77 110.846 179.718 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.039 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 3.7 t80 -121.87 -74.04 0.63 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.557 0.206 . . . . 1.37 111.557 -179.558 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' THR . . . . . 1.006 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 16.6 p 41.29 56.75 3.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.524 0.202 . . . . 0.91 111.254 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.13 -102.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.04 -0.527 . . . . 1.01 113.418 -179.717 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.68 28.85 3.2 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.968 -0.853 . . . . 0.98 110.968 179.232 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -110.42 -176.19 2.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.356 -0.422 . . . . 0.87 111.14 -179.138 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -137.89 1.01 2.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.976 -0.556 . . . . 2.26 112.218 179.685 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.596 HG21 ' CE1' ' A' ' 36' ' ' TYR . 8.3 mt 57.51 116.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-O 121.071 0.462 . . . . 1.71 111.088 -179.749 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -103.16 10.84 37.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.435 0.532 . . . . 1.15 112.435 -179.12 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -179.01 156.85 0.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.961 0.41 . . . . 1.58 111.898 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 28.5 m-85 -126.21 112.48 15.81 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.893 -0.594 . . . . 0.76 110.84 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.5 OUTLIER -94.55 99.79 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 1.14 110.718 -179.85 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.654 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -92.26 113.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 0.63 110.488 179.861 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.3 mp0 -81.5 144.73 31.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.605 -0.725 . . . . 1.67 110.911 -179.784 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -111.79 139.13 47.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 1.97 110.917 179.893 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 15.7 ttm180 -106.97 110.83 23.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.438 . . . . 1.44 110.382 179.405 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -82.66 91.21 6.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.715 -0.675 . . . . 1.59 110.307 179.866 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -68.0 154.53 93.62 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.519 -0.764 . . . . 0.9 110.983 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.05 4.41 66.12 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.685 -1.381 . . . . 1.43 112.999 0.255 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -78.86 -68.03 0.69 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 2.66 110.451 179.896 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 88.06 177.14 47.68 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.769 -0.729 . . . . 1.12 113.016 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.663 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 164.47 -28.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 110.718 179.938 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 51.4 m95 63.31 87.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 0.65 111.138 179.894 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.663 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.45 141.47 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.116 -179.834 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -58.5 117.64 4.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 1.3 110.747 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -86.95 -49.59 7.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.86 111.267 -179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.896 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -42.41 -54.18 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 2.01 112.101 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 t80 46.59 44.24 13.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.686 0.279 . . . . 2.08 111.347 -179.87 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 t -152.5 -84.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 1.89 111.156 179.924 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -178.13 110.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 1.87 110.556 179.967 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 52' ' ' ASN . 11.2 mt -108.74 80.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.69 111.103 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.8 tm? -64.7 -65.69 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 1.6 110.961 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.43 160.16 30.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.989 -0.374 . . . . 1.54 109.989 179.737 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -74.16 -3.57 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.304 -0.407 . . . . 1.75 111.556 -179.87 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -100.0 101.34 12.4 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.801 0.334 . . . . 2.05 110.151 179.853 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.683 ' HB2' HG23 ' A' ' 56' ' ' ILE . 50.3 t80 -135.07 162.97 30.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.258 0.551 . . . . 0.48 111.719 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 19' ' ' THR . 51.6 m -122.58 109.94 14.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.52 -0.764 . . . . 0.42 110.354 179.167 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' CB ' ' A' ' 51' ' ' ALA . 98.9 t -81.79 93.96 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.74 -0.664 . . . . 1.08 111.002 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.745 ' HB3' HG22 ' A' ' 17' ' ' THR . 3.0 p -98.79 144.56 27.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 1.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.44 -9.31 5.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.672 -0.775 . . . . 0.9 112.986 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -54.83 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.03 0.443 . . . . 1.47 111.063 -179.93 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 m -129.27 131.8 47.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 1.06 110.442 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.3 mt-10 -61.31 150.27 35.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.306 -0.406 . . . . 1.91 111.104 -179.758 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t0 62.75 48.56 4.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 1.87 110.814 -179.999 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.02 126.13 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.498 . . . . 0.49 111.319 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.758 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -71.52 134.57 46.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.604 179.694 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 46.1 m-85 -133.02 130.82 39.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.56 112.414 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -105.94 148.42 27.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.791 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.891 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.59 117.89 13.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.717 1.377 . . . . 0.6 114.717 -179.228 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -104.56 158.33 16.56 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.931 -0.766 . . . . 2.11 108.931 177.663 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 38' ' ' VAL . 99.3 t -115.19 109.93 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.584 -0.846 . . . . 0.6 113.02 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.483 HD12 ' CD ' ' A' ' 39' ' ' GLU . 68.3 mt -105.37 157.18 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.021 -1.474 . . . . 0.7 107.021 177.723 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -176.88 136.28 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.054 -1.058 . . . . 0.6 112.684 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.0 ptpp? -75.63 -150.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.106 -0.701 . . . . 1.98 109.106 178.846 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.496 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -147.43 -107.33 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.212 -0.595 . . . . 2.19 111.291 -179.723 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -127.47 -43.04 1.62 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.709 0.686 . . . . 1.08 110.423 179.847 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.94 -9.9 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 1.06 111.749 179.803 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.81 -18.84 28.84 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.475 -0.869 . . . . 0.93 112.398 -179.743 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 79' ' ' LYS . . . -52.82 158.29 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.58 0.229 . . . . 1.38 110.72 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 6.3 tp -114.79 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.352 . . . . 0.79 111.649 -179.931 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -77.83 122.7 85.99 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 109.719 -0.474 . . . . 0.59 109.719 179.328 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -41.47 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.353 2.702 . . . . 0.85 113.649 -179.419 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' CA ' HG12 ' A' ' 77' ' ' ILE . 1.1 Cg_endo -83.56 129.67 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.361 2.707 . . . . 0.76 112.469 -179.91 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 78.2 p -85.19 125.06 32.53 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.994 -0.372 . . . . 1.28 109.994 179.349 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -17.65 106.89 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 124.696 1.248 . . . . 1.77 113.497 -179.476 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 54.4 Cg_exo -45.25 152.53 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.503 2.135 . . . . 0.55 113.302 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.436 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -83.76 144.04 29.59 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.421 -0.808 . . . . 1.23 109.005 179.063 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -34.93 146.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.213 0.946 . . . . 1.63 111.73 -179.624 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -76.66 125.31 29.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.694 -0.684 . . . . 0.41 110.69 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.1 mp -109.56 115.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.44 110.956 179.72 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.0 m -48.2 -30.61 4.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.44 111.262 -179.642 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.498 ' H ' HG22 ' A' ' 95' ' ' ILE . 57.2 m 51.88 72.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 1.1 110.212 -179.779 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.73 -80.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 3.0 111.421 -179.485 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.87 ' O ' HG23 ' A' ' 101' ' ' VAL . 20.7 p-10 -114.73 27.95 9.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.667 -0.697 . . . . 2.14 110.819 -179.734 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.338 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.18 25.3 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.085 0.469 . . . . 2.06 111.091 -179.323 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 99' ' ' ASP . 47.0 t -127.4 -11.87 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.829 -0.623 . . . . 2.8 111.496 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER 50.84 29.69 4.55 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.96 0.409 . . . . 4.58 111.024 179.732 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.249 -0.882 . . . . 3.79 111.019 -179.983 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 120.405 0.145 . . . . 2.74 111.16 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 89.1 Cg_endo -85.4 -165.62 0.29 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.661 2.241 . . . . 2.06 112.466 -179.905 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.672 HD11 ' HB3' ' A' ' 86' ' ' SER . 7.0 tt -161.16 151.22 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.68 111.506 -179.972 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 1.24 ' OD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -140.55 130.77 13.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 2.0 110.132 179.757 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 166.94 17.2 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.437 2.091 . . . . 0.5 112.843 -179.592 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.1 Cg_endo -61.74 -175.86 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.111 2.541 . . . . 0.71 113.404 -179.489 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.45 168.61 36.68 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.578 -0.737 . . . . 0.66 112.445 179.938 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.3 tttt -59.32 130.56 87.35 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.724 0.262 . . . . 1.52 110.353 179.808 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.4 Cg_exo -79.46 153.99 24.09 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.523 2.149 . . . . 0.44 112.86 -179.413 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.34 116.35 7.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 1.09 110.351 179.977 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' THR . 14.2 Cg_exo -66.81 91.54 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.953 1.769 . . . . 0.64 113.191 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER -46.75 -42.77 17.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.293 0.568 . . . . 1.64 110.283 179.449 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -134.58 153.21 52.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.216 -0.902 . . . . 0.72 109.278 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -140.4 94.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.48 . . . . 0.96 111.235 -179.543 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -91.63 55.61 2.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.677 -0.692 . . . . 1.46 112.282 -179.202 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 2.5 mtm180 53.58 -71.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.678 0.992 . . . . 2.42 113.678 178.638 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 12.6 m170 -84.8 -32.61 23.27 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.281 0.474 . . . . 1.02 112.281 -178.726 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 64' ' ' SER . 19.9 p -126.4 101.7 6.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.673 0.273 . . . . 0.68 111.075 -179.714 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.069 HG13 ' CD2' ' A' ' 66' ' ' LEU . 32.5 m -98.72 138.28 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.378 . . . . 0.8 110.423 179.505 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 91.1 m -101.13 119.95 39.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.74 0.644 . . . . 0.35 112.74 -179.099 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.95 150.81 51.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.794 0.806 . . . . 0.52 111.834 178.221 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.49 159.2 42.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.719 -1.128 . . . . 1.84 109.364 179.607 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -141.93 -176.87 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.087 0.773 . . . . 0.4 113.087 -178.922 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 -158.13 0.27 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.774 -1.103 . . . . 0.83 110.643 179.387 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.71 148.84 71.69 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.417 -0.356 . . . . 2.11 110.738 179.606 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 80.7 Cg_exo -49.1 -173.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.983 2.455 . . . . 0.89 113.084 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.78 -29.79 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 2.77 111.649 -179.834 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 1.24 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 t80 -129.4 -69.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.961 0.356 . . . . 1.37 111.961 -179.563 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.865 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 16.1 p 58.49 46.16 15.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.91 110.566 -179.308 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.22 -98.51 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.929 -0.653 . . . . 1.01 112.551 179.905 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.36 22.85 2.87 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.336 -0.706 . . . . 0.98 111.336 179.354 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -103.29 -176.12 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 0.87 111.206 -179.178 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -134.89 5.69 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 2.26 111.437 179.482 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.646 HG21 ' CE1' ' A' ' 36' ' ' TYR . 12.1 mt 57.55 97.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-O 121.151 0.5 . . . . 1.71 110.868 -179.725 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -104.63 29.44 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.52 -0.764 . . . . 1.15 111.306 -179.424 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.83 116.77 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.917 0.389 . . . . 1.58 111.996 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.2 m-85 -110.42 107.46 17.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.76 110.3 179.267 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 1.6 mm -90.92 116.47 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.658 0.266 . . . . 1.14 111.075 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 56' ' ' ILE . 3.2 t -90.74 118.27 35.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.31 -0.404 . . . . 0.63 111.811 -179.762 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.8 mm-40 -96.9 135.03 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.422 -0.584 . . . . 1.67 109.422 178.901 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.636 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -112.32 145.75 39.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 1.97 112.229 -179.269 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.2 ttm180 -117.86 103.42 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.295 -0.866 . . . . 1.44 110.233 179.46 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -73.05 92.7 1.7 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.031 0.443 . . . . 1.59 110.9 -179.771 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.753 HD11 ' HG3' ' A' ' 73' ' ' GLU . 27.5 mt -70.82 149.42 95.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.786 -0.643 . . . . 0.9 110.692 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.5 -18.1 18.52 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.845 -1.315 . . . . 1.43 113.01 0.423 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -52.22 -90.95 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.062 -0.255 . . . . 2.66 110.672 -179.717 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' HA3' ' CG ' ' A' ' 41' ' ' ARG . . . 88.06 123.36 1.94 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.318 -0.944 . . . . 1.12 113.305 179.52 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.658 ' NE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.94 17.22 0.67 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.858 0.318 . . . . 2.41 111.858 179.678 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 69.0 m95 28.66 98.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.953 0.723 . . . . 0.65 112.953 179.901 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.658 HD22 ' NE ' ' A' ' 47' ' ' ARG . 1.1 mp -135.65 133.48 38.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 1.28 111.214 179.929 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 9.8 ptmm? -51.11 106.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 1.3 111.112 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.636 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.39 -56.84 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.86 110.714 179.819 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 9.4 p-10 -57.66 113.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 2.01 110.571 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.21 24.0 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 2.08 111.224 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 t -125.56 -82.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 1.89 110.77 -179.935 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.95 141.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 1.87 110.56 179.947 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.638 HD13 ' CG ' ' A' ' 61' ' ' PHE . 30.9 mt -125.56 79.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 0.69 111.19 -179.651 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.84 -66.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 1.6 110.923 179.998 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -179.72 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.481 -0.327 . . . . 1.54 110.424 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 30.1 p30 -96.69 10.05 39.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 1.75 111.618 179.861 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -111.28 95.84 5.76 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.757 -0.46 . . . . 2.05 109.757 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.638 ' CG ' HD13 ' A' ' 56' ' ' ILE . 76.6 t80 -128.26 164.83 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.196 0.522 . . . . 0.48 111.531 -179.26 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.9 m -127.38 124.03 37.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.578 -0.737 . . . . 0.42 110.333 179.253 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 20' ' ' LEU . 4.4 t -81.36 82.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.17 0.509 . . . . 1.08 109.941 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 17' ' ' THR . 33.2 t -68.27 -39.05 82.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.403 -0.817 . . . . 1.33 111.514 -179.18 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.68 62.22 0.47 Allowed Glycine 0 C--N 1.321 -0.301 0 C-N-CA 120.811 -0.709 . . . . 0.9 111.69 179.733 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.069 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -131.66 149.19 52.58 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.385 -0.598 . . . . 1.47 109.385 -179.118 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -105.23 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 1.06 111.87 -179.207 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 67' ' ' THR . 19.7 tt0 -103.75 165.14 11.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 1.91 111.28 -179.46 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 47.65 68.91 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.993 -0.549 . . . . 1.87 111.125 179.826 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . 176.87 110.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.49 110.882 179.904 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -63.05 110.2 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.21 0.529 . . . . 0.36 110.641 -179.866 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 82.7 m-85 -103.75 125.54 50.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.56 112.728 -178.999 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.753 ' HG3' HD11 ' A' ' 43' ' ' LEU . 20.1 mt-10 -103.36 137.2 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.863 -1.162 . . . . 1.5 107.863 177.704 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.013 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.61 116.97 19.66 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.307 1.595 . . . . 0.6 115.307 -178.717 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -102.21 177.8 4.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.579 -1.267 . . . . 2.11 107.579 176.856 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.579 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -145.14 111.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 118.969 -1.093 . . . . 0.6 112.753 -179.835 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' A' ' 39' ' ' GLU . 25.1 mt -92.99 142.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.691 -1.226 . . . . 0.7 107.691 177.944 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -154.1 120.7 5.51 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.746 . . . . 0.6 111.945 -178.951 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -56.3 -100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.367 -0.533 . . . . 1.98 109.969 179.633 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 18.6 p30 171.41 -111.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.935 -0.765 . . . . 2.19 108.935 179.65 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -135.09 5.54 3.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.054 0.843 . . . . 1.08 111.53 179.015 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.94 0.02 7.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.736 -0.211 . . . . 1.06 111.236 179.956 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.82 61.16 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 120.334 -0.936 . . . . 0.93 113.186 179.864 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -67.87 114.35 6.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 1.38 110.335 179.866 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -72.77 121.3 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 0.79 112.255 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.672 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.3 p -89.36 127.0 56.65 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 109.674 -0.491 . . . . 0.59 109.674 179.264 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -32.97 155.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.547 2.832 . . . . 0.85 113.844 -179.16 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.6 Cg_exo -68.06 120.97 7.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.698 2.265 . . . . 0.76 112.685 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.579 ' OG ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -62.75 133.07 54.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.351 -0.611 . . . . 1.28 109.351 179.167 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -31.53 116.58 0.37 Allowed Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 123.682 0.614 . . . . 1.77 112.425 -179.305 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 68.6 Cg_exo -40.67 169.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.011 2.474 . . . . 0.55 114.252 -179.565 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -103.08 141.46 35.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.73 -1.123 . . . . 1.23 109.729 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -41.85 130.54 3.37 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.71 0.631 . . . . 1.63 111.078 179.606 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -59.88 133.97 56.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.861 -0.609 . . . . 0.41 111.552 -179.557 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 13' ' ' ILE . 3.5 mp -116.79 113.19 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.71 179.507 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.1 m -53.42 -16.0 1.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.056 0.761 . . . . 0.44 113.056 -179.106 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 p 42.08 64.9 0.98 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.254 0.55 . . . . 1.1 111.127 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HD2' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -86.28 -90.28 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.399 -0.819 . . . . 3.0 111.429 -179.492 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.407 ' OD1' ' CG1' ' A' ' 101' ' ' VAL . 2.2 p30 -133.19 31.29 3.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.846 0.355 . . . . 2.14 110.713 -179.748 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 26.0 t0 38.44 28.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.019 -0.537 . . . . 2.06 112.249 -179.617 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.407 ' CG1' ' OD1' ' A' ' 99' ' ' ASP . 12.7 p -163.19 24.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.187 -0.461 . . . . 2.8 111.189 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.24 ' HG3' ' OD2' ' A' ' 99' ' ' ASP . 6.6 mt-10 -116.78 -25.22 7.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.355 . . . . 4.58 111.413 -179.716 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.21 -0.9 . . . . 3.79 110.896 179.889 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.367 0.127 . . . . 2.74 111.113 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.95 -155.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.459 2.106 . . . . 2.06 112.087 179.83 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt -172.73 144.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.97 -0.559 . . . . 0.68 111.012 179.637 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.36 122.7 26.67 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.13 -0.486 . . . . 2.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 59.6 Cg_endo -71.57 155.88 58.63 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.036 1.824 . . . . 0.5 112.181 -179.751 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 30.9 Cg_exo -59.73 172.75 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.317 2.011 . . . . 0.71 112.242 -179.757 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.55 168.58 51.05 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.93 -0.652 . . . . 0.66 113.031 -179.693 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 5.6 tttt -63.17 141.13 97.75 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.026 -0.361 . . . . 1.52 110.026 179.663 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.629 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.6 Cg_exo -83.4 142.08 10.41 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.417 2.078 . . . . 0.44 112.589 -179.729 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -143.74 118.33 6.11 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 1.09 110.588 179.749 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.6 Cg_exo -67.0 123.02 10.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.196 1.931 . . . . 0.64 113.521 -179.439 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -34.38 20.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.901 -0.778 . . . . 1.64 108.901 178.701 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -140.48 143.48 35.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.794 -1.094 . . . . 0.72 109.047 179.386 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -136.94 102.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.026 0.441 . . . . 0.96 112.044 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.72 59.17 1.47 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.756 -0.656 . . . . 1.46 111.115 -179.999 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 51.53 -74.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.553 -0.748 . . . . 2.42 112.273 179.045 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' THR . 7.2 m-70 -79.69 -45.85 18.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 1.02 110.894 -179.944 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 64' ' ' SER . 1.4 p -99.12 104.61 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 0.68 111.061 -179.905 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 61.7 t -101.22 118.95 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.8 110.219 179.761 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.501 ' C ' HD13 ' A' ' 20' ' ' LEU . 27.3 m -95.29 117.72 30.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.979 -0.555 . . . . 0.35 112.12 -179.117 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.794 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.37 159.49 40.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.447 0.641 . . . . 0.52 111.165 178.541 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.64 148.21 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.911 -1.04 . . . . 1.84 109.692 -179.987 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 1.2 p90 -116.46 -111.06 0.35 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.487 -0.485 . . . . 0.4 112.078 -179.994 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -157.48 -159.55 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.993 -0.442 . . . . 0.83 111.196 -179.189 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HD3' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.73 132.61 24.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 2.11 110.61 179.981 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.3 Cg_endo -57.04 -175.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.432 2.088 . . . . 0.89 112.102 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.51 -43.19 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.955 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -97.03 -66.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 1.37 112.047 -179.32 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.482 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 27.8 p 55.18 32.0 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.91 110.493 -179.345 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.14 -94.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.481 -0.866 . . . . 1.01 111.866 -179.824 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.89 41.68 1.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.513 -1.035 . . . . 0.98 110.513 179.261 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 6.4 m-85 -121.7 -179.15 4.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.181 -0.51 . . . . 0.87 111.752 -178.859 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 1.9 tttt -133.13 -32.96 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 2.26 111.998 -179.972 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.76 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.0 mt 80.98 107.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.083 0.468 . . . . 1.71 110.821 -179.542 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -102.7 12.32 36.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.686 -0.688 . . . . 1.15 111.69 -179.546 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -178.23 137.09 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.485 0.55 . . . . 1.58 112.485 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.76 ' CE1' HG21 ' A' ' 33' ' ' ILE . 55.2 m-85 -112.6 151.17 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.819 . . . . 0.76 109.637 178.684 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.73 123.98 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.74 0.305 . . . . 1.14 111.055 -179.529 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG21 ' HD2' ' A' ' 61' ' ' PHE . 1.4 t -103.75 101.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.63 111.36 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -74.54 144.61 43.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.34 -0.615 . . . . 1.67 109.34 179.267 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.02 145.73 47.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.133 0.492 . . . . 1.97 111.6 -179.226 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.8 ttm180 -133.57 94.32 3.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.789 -0.641 . . . . 1.44 111.056 -179.963 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.483 ' OD1' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -57.43 164.67 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.409 -0.96 . . . . 1.59 108.409 179.121 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 94' ' ' ALA . 35.2 mt -142.25 129.97 11.48 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.227 -0.589 . . . . 0.9 111.067 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.79 33.83 3.92 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.08 -1.217 . . . . 1.43 113.653 0.743 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -112.12 51.92 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 2.66 111.202 179.895 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -60.65 -178.58 2.14 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.773 -0.727 . . . . 1.12 112.815 -179.998 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.74 -28.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.585 0.217 . . . . 2.41 111.585 -179.968 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 24.3 m95 65.42 72.59 0.42 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.792 0.329 . . . . 0.65 111.251 -179.981 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.6 mp -119.86 133.84 55.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 1.28 110.605 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 86.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 1.3 110.787 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -53.22 -41.62 65.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.86 111.175 -179.668 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.715 ' CG ' HD11 ' A' ' 56' ' ' ILE . 2.6 t-20 -44.37 -90.59 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.309 -0.405 . . . . 2.01 111.427 -179.768 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 t80 73.1 39.55 0.61 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.724 0.297 . . . . 2.08 110.712 -179.609 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -157.13 24.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.89 111.551 -179.911 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 t30 63.85 121.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.82 0.343 . . . . 1.87 111.219 179.611 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.841 HD12 ' CG ' ' A' ' 61' ' ' PHE . 38.9 mm -108.5 75.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.69 110.972 179.58 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.66 -67.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.731 0.301 . . . . 1.6 111.001 -179.995 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pm0 -82.38 163.43 21.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.54 110.158 179.635 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 34.1 p30 -76.89 -1.09 26.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.369 -0.378 . . . . 1.75 111.73 -179.829 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -104.52 98.35 8.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.865 0.364 . . . . 2.05 110.051 179.711 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.841 ' CG ' HD12 ' A' ' 56' ' ' ILE . 64.6 t80 -128.84 164.72 22.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.48 111.439 -179.39 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 51.1 m -128.76 106.85 9.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.319 -0.855 . . . . 0.42 110.826 179.302 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 18' ' ' VAL . 27.0 m -61.77 134.92 26.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.08 110.868 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -130.72 133.45 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 1.33 111.502 -179.524 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.25 21.83 4.33 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.9 112.293 179.917 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.714 HD22 HG23 ' A' ' 18' ' ' VAL . 3.0 mp -79.69 176.65 9.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.185 0.517 . . . . 1.47 111.749 -179.504 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 134.27 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.394 -0.821 . . . . 1.06 110.124 179.419 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 mt-10 -73.73 174.2 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 1.91 111.736 -179.501 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 6.2 t70 52.83 27.44 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.905 -0.588 . . . . 1.87 110.973 -179.962 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.33 126.02 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.49 110.871 179.803 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' CB ' HD12 ' A' ' 43' ' ' LEU . . . -66.03 127.87 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.362 -0.381 . . . . 0.36 110.607 179.78 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 3.6 m-85 -115.91 125.71 52.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.56 112.014 -179.087 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.2 tt0 -106.33 148.41 28.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.873 -0.788 . . . . 1.5 108.873 179.001 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.93 118.76 12.47 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.6 115.032 -178.718 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -100.35 178.06 4.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.004 -0.544 . . . . 2.11 109.831 178.102 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 ' HG3' ' A' ' 8' ' ' PRO . 75.4 t -134.68 122.07 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 113.245 0.831 . . . . 0.6 113.245 -179.53 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 91.9 mt -122.56 142.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.147 -1.427 . . . . 0.7 107.147 178.188 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -169.31 134.35 1.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.49 1.292 . . . . 0.6 114.49 -178.836 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -83.75 136.93 33.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.887 -1.153 . . . . 1.98 107.887 177.529 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 5.9 m-20 -76.69 -92.5 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.468 0.544 . . . . 2.19 112.468 -178.566 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -126.31 -40.96 1.93 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.444 0.535 . . . . 1.08 112.444 -178.99 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.741 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -100.43 36.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.339 0.496 . . . . 1.06 112.339 -179.078 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.96 -0.67 57.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.93 113.486 179.575 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.11 85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.032 0.416 . . . . 1.38 110.176 179.677 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -64.41 121.39 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.169 0.509 . . . . 0.79 111.98 -179.26 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 22.9 p -78.31 123.94 85.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.59 109.311 179.159 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.7 Cg_endo -48.54 171.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.872 2.381 . . . . 0.85 113.172 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB2' ' NH1' ' A' ' 75' ' ' ARG . 14.4 Cg_exo -67.53 112.79 2.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.76 112.862 -179.596 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -74.36 132.58 42.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 1.28 110.037 179.367 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.7 mm-40 -31.01 113.75 0.33 Allowed Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 123.761 0.663 . . . . 1.77 112.355 -179.599 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 75' ' ' ARG . 44.1 Cg_exo -56.07 138.63 83.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.55 113.057 -179.658 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -69.94 146.49 51.13 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.279 -0.638 . . . . 1.23 109.279 179.193 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.6 m-20 -35.76 139.43 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.094 0.871 . . . . 1.63 111.843 -179.865 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -75.65 108.86 8.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.41 111.175 -179.709 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 13' ' ' ILE . 5.0 mp -91.29 114.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.122 -179.712 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 97.5 m -36.22 -32.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.214 -0.448 . . . . 0.44 111.862 -179.96 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.557 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 m 51.28 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.428 -0.351 . . . . 1.1 110.117 179.773 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.99 -90.92 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 3.0 111.669 -179.317 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.855 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.7 OUTLIER -105.71 6.59 32.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.805 0.298 . . . . 2.14 111.805 -179.609 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 53.5 t0 58.79 17.8 5.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.862 0.319 . . . . 2.06 111.862 179.755 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.855 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 3.6 p -111.77 -20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.347 -0.388 . . . . 2.8 110.27 179.52 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.499 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.2 mm-40 40.28 51.56 2.77 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.205 -0.452 . . . . 4.58 111.861 179.498 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.162 -0.923 . . . . 3.79 111.111 179.974 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.692 0.282 . . . . 2.74 111.303 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.83 172.69 3.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.044 2.496 . . . . 2.06 112.009 179.919 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.887 HD11 ' ND2' ' A' ' 80' ' ' ASN . 6.9 tt -161.27 145.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.68 111.041 -179.867 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.81 114.26 19.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 2.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.75 154.61 54.16 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.395 2.063 . . . . 0.5 112.007 179.907 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.81 174.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.692 2.261 . . . . 0.71 112.826 -179.708 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.77 171.48 44.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.993 -0.622 . . . . 0.66 112.658 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -63.64 135.9 96.48 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 110.49 -0.189 . . . . 1.52 110.49 179.802 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_endo -80.9 129.76 7.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.457 2.104 . . . . 0.44 112.861 -179.697 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -132.83 106.01 12.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.917 -0.583 . . . . 1.09 110.793 179.613 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.5 Cg_exo -49.03 131.76 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.334 2.022 . . . . 0.64 113.691 -179.069 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -86.75 -39.92 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.64 108.861 178.689 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -136.35 150.37 48.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.406 -1.27 . . . . 0.72 108.607 179.576 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 1.9 pt -143.44 83.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.262 -0.575 . . . . 0.96 112.516 -179.157 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.23 159.73 29.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.729 -0.669 . . . . 1.46 110.507 179.476 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -17.37 7.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.42 111.961 -179.554 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' THR . 10.7 m-70 -141.91 34.39 1.57 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.973 0.36 . . . . 1.02 111.973 -179.754 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 179.66 120.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.648 -0.251 . . . . 0.68 110.387 179.714 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -117.86 111.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.18 0.514 . . . . 0.8 112.045 -179.317 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 92.4 m -85.21 142.28 29.54 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.004 -0.543 . . . . 0.35 110.266 179.154 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.79 161.13 41.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.428 0.633 . . . . 0.52 112.298 -179.857 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -149.3 144.37 26.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.878 -1.056 . . . . 1.84 110.49 179.742 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.4 p90 -138.23 -173.38 3.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.431 . . . . 0.4 110.734 -179.973 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 -166.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.83 110.381 179.534 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -132.23 155.61 81.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.786 0.327 . . . . 2.11 110.942 179.907 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 28' ' ' THR . 14.6 Cg_exo -69.25 163.41 37.96 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.097 . . . . 0.89 111.835 179.802 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.96 -0.66 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 2.77 111.493 179.652 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -128.6 -70.34 0.68 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.658 0.266 . . . . 1.37 111.644 -179.805 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 25' ' ' PRO . 30.4 p 48.83 57.43 6.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.598 -0.274 . . . . 0.91 110.733 -179.575 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.46 -92.17 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.301 -0.476 . . . . 1.01 112.799 -179.733 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -145.96 32.66 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.236 -1.146 . . . . 0.98 110.236 179.177 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -119.44 -179.04 3.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.953 -0.624 . . . . 0.87 111.374 -178.716 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.08 3.75 2.92 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.249 -0.432 . . . . 2.26 112.164 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mt 60.05 154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.752 0.31 . . . . 1.71 110.635 -179.935 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 33' ' ' ILE . 8.3 p -145.2 15.14 1.49 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.002 0.371 . . . . 1.15 112.002 -179.646 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -177.65 133.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 1.58 111.214 -179.915 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.9 m-85 -109.58 105.18 14.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.76 110.642 179.592 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.554 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.3 mt -84.91 152.02 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.019 -0.537 . . . . 1.14 111.039 -179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 75' ' ' ARG . 2.5 t -131.53 111.76 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.63 110.568 179.65 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -87.12 143.88 27.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.006 -0.368 . . . . 1.67 110.006 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.34 141.24 51.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.122 0.487 . . . . 1.97 112.23 -179.0 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 23.0 ttp180 -112.02 112.14 23.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.741 -0.663 . . . . 1.44 109.614 178.932 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 1.368 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.9 96.99 4.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 1.59 110.887 -179.594 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 7.6 mt -80.26 154.1 74.45 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.9 110.785 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.61 12.32 51.47 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.691 -1.379 . . . . 1.43 112.89 0.192 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -77.96 -82.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.402 . . . . 2.66 110.632 179.845 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 123.8 143.2 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.864 -0.684 . . . . 1.12 112.484 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.368 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 171.83 55.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.466 0.174 . . . . 2.41 111.158 -179.847 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.624 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 14.1 m95 -36.97 107.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.378 -0.374 . . . . 0.65 111.725 -179.994 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -143.47 136.89 28.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.049 0.452 . . . . 1.28 111.065 179.976 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' HE2' HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.22 104.33 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 1.3 111.173 -179.921 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.42 -47.01 87.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.037 0.446 . . . . 0.86 110.259 179.557 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.599 ' ND2' ' CE2' ' A' ' 61' ' ' PHE . 6.7 t-20 -68.35 116.98 9.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.788 -0.642 . . . . 2.01 110.189 179.639 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -114.31 46.69 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 2.08 111.117 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 t -150.12 -83.91 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.409 -0.36 . . . . 1.89 110.962 -179.958 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.78 147.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 1.87 110.777 -179.961 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.705 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.3 mt -142.0 75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.69 111.31 -179.827 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.4 tm? -59.76 -53.06 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 1.6 110.718 179.835 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.4 pt-20 -80.29 161.58 25.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.127 179.684 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 45.2 p-10 -81.45 6.08 15.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 1.75 111.918 -179.756 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 22.1 tt0 -106.58 104.31 13.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.591 -0.522 . . . . 2.05 109.591 179.413 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.705 ' CG ' HD13 ' A' ' 56' ' ' ILE . 63.9 t80 -137.77 163.81 30.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.48 112.184 -179.255 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 65.5 m -122.2 107.15 11.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.628 -0.715 . . . . 0.42 111.358 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 18' ' ' VAL . 2.2 m -72.05 94.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.759 -0.655 . . . . 1.08 110.436 179.57 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -100.44 155.62 17.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.589 0.709 . . . . 1.33 111.068 179.989 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.0 22.67 3.81 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.664 -1.153 . . . . 0.9 112.314 179.793 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -85.8 -172.49 4.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.898 0.38 . . . . 1.47 110.932 -179.753 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -148.28 116.11 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 1.06 110.654 179.998 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.611 ' OE2' HG11 ' A' ' 101' ' ' VAL . 1.7 tt0 -41.53 137.86 1.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.096 -0.502 . . . . 1.91 111.563 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t70 75.69 47.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.085 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.6 121.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.49 110.983 179.778 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.0 127.42 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.36 111.086 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 55.3 m-85 -124.35 127.28 47.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.503 -0.771 . . . . 0.56 112.307 -179.225 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 3.1 tp10 -99.8 147.41 25.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.036 -0.727 . . . . 1.5 109.036 178.812 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 95' ' ' ILE . 15.0 m-85 -137.18 116.95 13.07 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.969 1.47 . . . . 0.6 114.969 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.624 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -107.43 171.05 7.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.963 -0.755 . . . . 2.11 108.963 177.587 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 8' ' ' PRO . 77.0 t -126.24 108.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.951 0.723 . . . . 0.6 112.951 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.596 HD11 ' HG3' ' A' ' 88' ' ' PRO . 31.4 mt -102.83 139.19 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.528 -1.286 . . . . 0.7 107.528 177.946 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -153.76 129.75 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.64 -0.824 . . . . 0.6 112.064 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 40.8 mttt -78.75 -178.22 5.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.486 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.887 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.5 m-80 -129.02 172.58 11.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.003 -0.544 . . . . 2.19 110.812 179.839 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.1 -28.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.719 -0.673 . . . . 1.08 111.785 179.658 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -112.14 34.77 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.439 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 42.68 37.81 2.87 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.67 -0.776 . . . . 0.93 113.02 179.611 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.01 8.24 8.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.287 0.477 . . . . 1.38 112.287 -179.956 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER 35.7 97.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 113.496 0.924 . . . . 0.79 113.496 179.738 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -75.73 116.64 57.13 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.53 -0.915 . . . . 0.59 108.53 178.461 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -35.16 158.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.405 2.737 . . . . 0.85 113.39 -178.843 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.596 ' HG3' HD11 ' A' ' 77' ' ' ILE . 12.6 Cg_exo -68.06 142.77 57.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.627 2.218 . . . . 0.76 112.23 179.871 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 50.5 m -92.25 118.64 31.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.958 -0.565 . . . . 1.28 110.125 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 42.5 mt-10 -19.66 104.94 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.021 0.929 . . . . 1.77 113.151 -179.461 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.475 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 55.5 Cg_exo -39.98 161.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.608 2.205 . . . . 0.55 113.246 -179.471 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.46 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -97.04 143.51 27.81 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.501 -0.772 . . . . 1.23 109.339 179.175 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 2.6 m-20 -35.31 129.01 0.54 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.027 0.83 . . . . 1.63 112.077 -179.286 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -50.19 133.06 23.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.41 111.397 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.743 HD13 ' HE2' ' A' ' 74' ' ' PHE . 3.2 mp -113.24 106.76 21.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.44 111.686 -179.789 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.7 m -52.54 -23.02 5.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.841 179.688 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.452 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 60.29 38.35 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.1 110.235 -179.834 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.713 ' O ' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -132.97 -38.42 0.98 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 3.0 111.946 -179.635 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.429 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 3.9 p-10 -49.0 -26.27 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 2.14 111.624 -179.405 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -8.07 55.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.115 -0.493 . . . . 2.06 111.531 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 98' ' ' ARG . 11.8 p -124.67 4.96 4.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.852 -0.613 . . . . 2.8 109.873 179.026 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 3.4 mm-40 -149.49 -80.34 0.13 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.919 0.39 . . . . 4.58 111.029 -179.999 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.276 -0.869 . . . . 3.79 111.059 -179.991 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 1' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.729 0.299 . . . . 2.74 111.27 . . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.666 ' O ' HG22 ' A' ' 2' ' ' ILE . 86.7 Cg_endo -78.25 -26.11 6.53 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.637 2.225 . . . . 2.06 112.463 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.916 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.2 tt 52.61 146.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 124.019 0.824 . . . . 0.68 112.439 -179.775 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.981 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -141.93 123.59 8.91 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.43 -179.962 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.08 166.92 28.43 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.321 2.014 . . . . 0.5 112.256 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.2 Cg_exo -52.24 173.96 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.667 2.245 . . . . 0.71 112.749 -179.626 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.56 39.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.071 -0.585 . . . . 0.66 112.78 -179.831 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 tptm -65.44 118.12 47.44 Favored Pre-proline 0 CA--C 1.532 0.254 0 O-C-N 123.043 -0.092 . . . . 1.52 110.772 179.879 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.688 ' CG ' HG23 ' A' ' 76' ' ' VAL . 15.5 Cg_exo -69.77 127.94 15.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.418 2.079 . . . . 0.44 112.731 -179.68 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -131.96 113.6 14.97 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.74 -0.664 . . . . 1.09 111.405 -179.491 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 71.5 Cg_exo -47.32 112.1 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.52 2.146 . . . . 0.64 113.193 -179.61 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -74.12 -35.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.736 -0.838 . . . . 1.64 108.736 179.174 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 22.9 t-20 -143.91 153.29 42.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.486 -1.234 . . . . 0.72 107.718 178.621 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.824 HG21 HG12 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -142.93 141.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.809 -0.756 . . . . 0.96 113.019 -178.793 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -139.94 136.44 33.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.21 -0.904 . . . . 1.46 109.863 179.263 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -42.68 -24.83 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.005 0.743 . . . . 2.42 113.005 -179.023 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -118.11 -12.98 9.96 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.744 -0.598 . . . . 1.02 112.517 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -153.46 125.6 7.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.246 -0.279 . . . . 0.68 110.246 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -118.64 145.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.8 111.81 -179.809 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.701 ' OG1' HG23 ' A' ' 62' ' ' THR . 9.0 m -111.36 127.72 55.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.04 -0.527 . . . . 0.35 111.072 -179.745 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.776 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.06 139.27 52.09 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.865 0.841 . . . . 0.52 111.355 178.769 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -121.67 155.49 35.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.124 -1.398 . . . . 1.84 108.973 179.632 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.538 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.6 p90 -152.55 -174.48 4.92 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.213 -0.595 . . . . 0.4 111.966 -179.729 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.77 168.2 10.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.052 -0.522 . . . . 0.83 112.046 -179.389 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -97.76 141.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.775 -0.648 . . . . 2.11 110.434 179.888 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HB2' HG23 ' A' ' 28' ' ' THR . 88.8 Cg_exo -47.38 176.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.346 2.031 . . . . 0.89 112.246 179.958 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -121.18 -29.54 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.418 -0.355 . . . . 2.77 111.799 -179.7 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 10.8 t80 -113.77 -71.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.986 0.365 . . . . 1.37 111.986 -179.376 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.981 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 47.7 p 50.48 43.92 27.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 0.91 110.985 -179.593 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.18 -91.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.814 -0.707 . . . . 1.01 112.49 179.89 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.27 32.6 1.04 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.637 -0.985 . . . . 0.98 110.637 179.561 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -112.08 175.14 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.007 -0.596 . . . . 0.87 111.147 -179.076 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 18.1 ttpt -126.17 -17.71 5.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.061 -0.518 . . . . 2.26 112.015 -179.799 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 35.9 mt 70.84 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.685 0.279 . . . . 1.71 110.713 -179.589 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -126.77 25.46 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 1.15 111.671 -179.619 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.6 t -178.75 127.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 1.58 111.259 179.903 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.547 ' O ' HD12 ' A' ' 56' ' ' ILE . 5.5 m-85 -114.36 95.46 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.76 111.172 -179.916 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.61 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.3 mt -87.32 112.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 1.14 111.003 -179.972 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -102.58 116.68 46.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.63 111.103 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -81.12 154.92 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 1.67 109.857 179.502 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 23.0 pttt -127.94 146.57 50.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.187 0.518 . . . . 1.97 111.494 -179.759 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 10.3 ttp180 -116.08 108.19 15.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 1.44 110.045 179.472 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.826 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.97 87.3 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.881 -0.6 . . . . 1.59 110.54 -179.836 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.605 HD11 ' OE1' ' A' ' 73' ' ' GLU . 33.1 mt -65.07 153.95 87.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.879 -179.88 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.62 24.49 20.2 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.846 -1.314 . . . . 1.43 112.976 0.386 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -154.8 70.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.781 0.324 . . . . 2.66 111.592 -179.936 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.41 -161.59 35.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.676 -0.773 . . . . 1.12 112.019 179.606 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -160.03 26.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.296 . . . . 2.41 111.166 -179.991 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 38.5 m95 42.71 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.544 179.828 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.463 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -132.27 130.41 40.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 1.28 111.202 -179.961 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HE3' HG21 ' A' ' 37' ' ' ILE . 3.3 ptmt -54.96 88.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 1.3 110.787 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.675 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -52.5 -54.59 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.86 110.907 179.979 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.663 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.4 p-10 -62.47 128.81 37.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.814 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.71 -2.36 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 2.08 111.714 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -168.8 1.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.815 0.341 . . . . 1.89 110.941 179.939 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.77 115.97 26.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 1.87 111.18 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.663 HD11 ' CB ' ' A' ' 52' ' ' ASN . 54.5 mt -99.27 60.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.59 179.711 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -43.38 -64.48 0.63 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.242 -0.435 . . . . 1.6 111.648 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -72.57 171.52 12.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 1.54 110.533 179.847 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -89.49 11.76 18.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.75 111.412 179.978 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -110.66 100.07 8.91 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 110.099 -0.334 . . . . 2.05 110.099 179.446 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CG ' HD13 ' A' ' 56' ' ' ILE . 61.3 t80 -131.66 164.75 25.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.139 0.495 . . . . 0.48 111.715 -179.465 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.701 HG23 ' OG1' ' A' ' 19' ' ' THR . 2.1 m -124.76 123.46 40.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.657 -0.702 . . . . 0.42 110.744 179.631 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.675 HG13 ' CB ' ' A' ' 51' ' ' ALA . 16.5 t -83.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.171 0.51 . . . . 1.08 111.189 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 134.98 36.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 1.33 110.701 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.09 -16.28 4.45 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.552 -0.749 . . . . 0.9 111.469 -179.295 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.857 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -51.38 172.16 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.805 0.335 . . . . 1.47 110.649 179.656 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.4 m -137.27 152.8 50.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.057 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 2.5 tt0 -61.1 155.49 20.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.91 111.197 179.943 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 97' ' ' CYS . 60.2 m-20 47.36 60.62 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 1.87 111.55 179.952 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.34 116.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.688 0.28 . . . . 0.49 111.375 179.646 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.66 125.4 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.677 -0.49 . . . . 0.36 109.677 179.234 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 44.1 m-85 -117.28 124.37 48.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.066 0.765 . . . . 0.56 113.066 -178.869 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.605 ' OE1' HD11 ' A' ' 43' ' ' LEU . 1.6 mt-10 -102.46 135.1 44.68 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.496 -0.928 . . . . 1.5 108.496 178.208 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 1.085 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.46 111.28 12.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.082 1.142 . . . . 0.6 114.082 -178.337 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.585 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 ptp180 -91.27 146.67 23.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 2.11 109.694 178.471 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG23 ' CG ' ' A' ' 8' ' ' PRO . 98.7 t -106.13 110.09 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.919 0.711 . . . . 0.6 112.919 -179.297 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' A' ' 39' ' ' GLU . 85.0 mt -106.59 154.54 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.805 -1.183 . . . . 0.7 107.805 177.991 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.63 120.87 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.203 -0.999 . . . . 0.6 113.145 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.8 ptpt -72.41 156.94 38.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.556 -0.535 . . . . 1.98 109.556 178.795 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.916 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -100.86 170.87 8.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.533 0.682 . . . . 2.19 112.406 -178.842 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.2 -58.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 1.08 112.112 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -12.94 17.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 1.06 112.296 -179.686 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 -14.61 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.536 -0.84 . . . . 0.93 112.176 -179.733 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -51.46 155.96 1.38 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 110.171 -0.307 . . . . 1.38 110.171 179.709 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -107.71 117.37 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.29 0.478 . . . . 0.79 112.29 -179.399 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.0 p -79.88 111.43 21.58 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.667 -0.697 . . . . 0.59 109.581 179.051 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.74 160.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.004 2.469 . . . . 0.85 112.932 -179.782 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' CB ' ' HD3' ' A' ' 75' ' ' ARG . 41.0 Cg_endo -68.77 134.79 31.08 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.675 2.25 . . . . 0.76 112.853 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 90' ' ' GLU . 19.8 m -90.84 111.07 22.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 1.28 109.919 179.28 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -4.12 108.33 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.717 1.207 . . . . 1.77 113.573 -179.677 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 84.3 Cg_exo -41.8 131.31 4.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.677 2.251 . . . . 0.55 113.712 -179.711 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.21 148.21 48.76 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.884 -0.598 . . . . 1.23 109.468 178.959 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -33.07 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.386 1.054 . . . . 1.63 112.409 -179.999 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.46 106.61 9.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.41 110.372 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.824 HG12 HG21 ' A' ' 13' ' ' ILE . 5.0 mp -85.69 108.66 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.743 0.306 . . . . 0.44 110.571 -179.923 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.9 m -42.53 -40.07 2.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.959 0.409 . . . . 0.44 111.027 179.956 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 15' ' ' ARG . 94.0 m 60.84 75.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.1 111.415 179.31 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -108.88 -79.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 3.0 110.109 179.605 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.358 ' OD2' HG23 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -126.03 0.22 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.703 -0.681 . . . . 2.14 111.314 179.471 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.63 17.97 1.34 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.676 0.621 . . . . 2.06 112.676 179.629 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 1.358 HG23 ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -129.85 -0.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 111.624 0.231 . . . . 2.8 111.624 179.556 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -122.29 -14.97 7.79 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.04 0.385 . . . . 4.58 112.04 -179.514 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 3.79 111.135 -179.904 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.428 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.574 0.226 . . . . 2.74 111.319 . . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 7.8 Cg_exo -73.24 138.83 28.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.703 2.268 . . . . 2.06 111.244 179.78 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.573 HD12 ' HB1' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -129.38 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.01 0.433 . . . . 0.68 111.854 -179.443 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' ILE . 4.2 m-20 -134.56 127.24 18.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.0 110.127 179.69 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.26 163.08 38.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.239 1.959 . . . . 0.5 112.444 -179.714 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 37.0 Cg_exo -57.8 178.19 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.779 2.319 . . . . 0.71 112.782 -179.732 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.89 174.56 43.02 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.913 -0.66 . . . . 0.66 112.819 -179.988 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -68.63 130.66 91.78 Favored Pre-proline 0 N--CA 1.462 0.152 0 CA-C-N 116.64 0.22 . . . . 1.52 110.415 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HG3' HG12 ' A' ' 76' ' ' VAL . 17.0 Cg_exo -72.7 138.37 29.02 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.386 2.057 . . . . 0.44 113.124 -179.287 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.93 116.74 7.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.534 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.7 Cg_exo -58.91 138.36 85.21 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.546 2.164 . . . . 0.64 113.973 -179.207 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.605 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.3 mm? -104.17 -33.13 8.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.525 -0.761 . . . . 1.64 109.064 178.649 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -144.23 153.29 41.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.051 -0.977 . . . . 0.72 109.498 179.557 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.13 HG22 HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -148.62 108.68 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.124 0.487 . . . . 0.96 111.929 -179.549 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.092 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -105.41 53.04 0.72 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.679 -0.691 . . . . 1.46 111.212 -179.924 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 1.104 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.26 -73.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.98 0.8 . . . . 2.42 112.548 179.239 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' THR . 9.0 m-70 -70.64 -29.49 65.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.269 -0.423 . . . . 1.02 111.598 -179.349 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 64' ' ' SER . 62.3 p -128.78 126.2 39.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.759 0.314 . . . . 0.68 111.332 -179.815 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 13' ' ' ILE . 87.4 t -113.06 128.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.8 110.802 179.836 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 14.2 m -102.41 124.1 47.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.35 111.461 -179.392 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.815 HD11 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -137.14 162.09 34.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.535 0.683 . . . . 0.52 111.585 179.384 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.35 151.64 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.97 -1.014 . . . . 1.84 110.536 -179.635 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 11.1 p90 -136.88 -173.58 3.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.022 0.439 . . . . 0.4 111.463 -179.948 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.91 173.52 8.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.83 111.088 179.922 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 149.54 36.18 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.451 -0.34 . . . . 2.11 110.631 179.857 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.12 -162.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.938 2.426 . . . . 0.89 113.036 -179.652 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -146.37 -48.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.77 111.139 -179.67 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -95.03 -72.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.479 -0.328 . . . . 1.37 111.35 -179.846 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 p 69.39 -45.14 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.055 0.761 . . . . 0.91 113.055 -179.7 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.57 -22.32 10.16 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.269 -0.967 . . . . 1.01 112.302 -179.889 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.74 -26.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.496 -1.442 . . . . 0.98 109.496 -179.241 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 8.8 m-85 -60.9 -175.31 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.275 -0.963 . . . . 0.87 110.366 179.13 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 24.33 0.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.136 -0.484 . . . . 2.26 111.098 179.584 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 7.0 mt 42.97 98.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.136 0.493 . . . . 1.71 112.195 179.845 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' SER . 3.0 p -94.59 14.13 21.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 1.15 111.282 179.755 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' THR . 28.7 t 176.68 122.86 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.797 0.332 . . . . 1.58 111.568 -179.939 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.838 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.4 m-85 -106.86 117.28 33.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.76 110.226 179.502 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.613 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -97.28 135.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.654 -0.248 . . . . 1.14 110.959 -179.624 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 t -112.99 113.49 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.755 0.312 . . . . 0.63 111.249 179.84 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 5.3 mt-10 -87.57 127.52 35.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 1.67 110.158 179.474 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.893 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 3.9 pttm -106.56 147.31 29.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 1.97 111.724 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.3 ttp180 -129.13 117.48 20.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.59 -0.732 . . . . 1.44 110.428 179.455 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.947 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.77 123.92 25.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 1.59 110.178 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 94' ' ' ALA . 4.2 mt -113.99 150.23 43.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.9 111.479 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 8.8 Cg_endo -88.71 33.01 7.61 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.994 -1.253 . . . . 1.43 112.499 0.308 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.41 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 m-80 -154.17 98.82 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 2.66 110.852 -179.989 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.947 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . 177.28 -168.69 40.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.752 . . . . 1.12 112.179 -179.953 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -152.34 166.19 32.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.442 . . . . 2.41 111.37 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 73.2 m95 -68.47 120.12 14.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.574 -0.739 . . . . 0.65 111.894 -179.536 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.667 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -143.38 129.39 19.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 1.28 110.585 179.79 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.613 ' HD2' HG21 ' A' ' 37' ' ' ILE . 11.6 mtmm -50.54 92.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.3 110.805 -179.778 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.68 -52.76 62.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.86 110.871 179.893 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.73 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.6 p-10 -59.22 157.01 11.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.801 -0.636 . . . . 2.01 111.261 -179.891 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -165.52 28.81 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.702 -0.681 . . . . 2.08 110.716 179.558 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 p -128.71 36.56 4.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.459 -0.337 . . . . 1.89 111.234 -179.761 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.14 99.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.87 110.896 179.962 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.8 mt -90.63 93.7 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.503 . . . . 0.69 111.467 -179.842 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.9 tm? -76.83 -55.09 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.6 111.197 -179.974 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.05 173.11 12.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 1.54 110.511 179.871 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 35.1 p30 -84.66 -2.12 57.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.75 111.502 179.98 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -104.17 102.07 11.8 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.162 -0.31 . . . . 2.05 110.162 179.741 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 56' ' ' ILE . 44.8 t80 -135.22 164.85 26.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.286 -0.415 . . . . 0.48 111.329 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 93.1 m -121.04 114.09 20.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.978 -0.556 . . . . 0.42 111.529 -179.925 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.815 HG22 HD11 ' A' ' 20' ' ' LEU . 6.8 m -76.72 91.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.723 -0.671 . . . . 1.08 111.424 179.752 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.692 ' HB2' HG22 ' A' ' 17' ' ' THR . 13.9 p -93.01 178.73 5.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 1.33 110.896 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.9 10.89 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.806 -0.712 . . . . 0.9 112.478 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' CD1' HG23 ' A' ' 18' ' ' VAL . 15.3 mt -104.58 -161.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 1.47 111.168 -179.837 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -141.15 146.85 37.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.044 -0.525 . . . . 1.06 111.159 -179.892 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.14 149.19 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 1.91 110.916 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.36 43.97 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 1.87 110.733 -179.977 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -162.96 125.01 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.49 111.439 -179.833 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -67.4 137.24 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.36 110.256 179.521 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 36.0 m-85 -132.3 119.4 20.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.598 0.592 . . . . 0.56 112.598 -179.198 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -98.41 147.31 24.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.602 -0.888 . . . . 1.5 108.602 178.531 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.74 115.48 11.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.648 1.351 . . . . 0.6 114.648 -178.632 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 ptt85 -104.84 167.95 9.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 177.674 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -134.28 129.8 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 119.472 -0.891 . . . . 0.6 113.386 -179.654 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 86' ' ' SER . 76.5 mt -118.63 151.89 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.376 -1.284 . . . . 0.7 108.045 178.366 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -158.09 130.83 7.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.646 -0.822 . . . . 0.6 112.676 -179.543 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.18 63.88 8.26 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.566 0.698 . . . . 1.98 109.537 178.831 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 4.3 m-20 9.22 -104.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.302 -1.772 . . . . 2.19 114.201 -179.949 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.57 -44.68 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 122.014 -0.429 . . . . 1.08 111.859 -179.66 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.615 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -105.82 45.07 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.068 0.396 . . . . 1.06 112.068 -179.371 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.41 1.35 60.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.378 -0.915 . . . . 0.93 113.276 179.622 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.06 88.05 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.675 -0.491 . . . . 1.38 109.675 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.35 112.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.399 0.618 . . . . 0.79 112.516 -178.824 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' ILE . 49.5 p -85.55 111.7 39.01 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.941 -1.027 . . . . 0.59 108.973 178.958 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.4 Cg_exo -38.32 157.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.9 2.4 . . . . 0.85 112.879 -179.053 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' CA ' HG12 ' A' ' 77' ' ' ILE . 18.4 Cg_endo -60.66 132.06 40.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.803 2.335 . . . . 0.76 113.081 -179.709 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -89.02 108.27 19.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.411 -0.813 . . . . 1.28 109.498 179.155 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -6.24 120.93 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.803 1.314 . . . . 1.77 113.674 -179.492 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 50.4 Cg_exo -54.58 143.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.383 2.056 . . . . 0.55 113.307 -179.695 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.75 146.77 35.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.509 ' O ' HD12 ' A' ' 95' ' ' ILE . 4.1 m-20 -33.41 131.23 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.175 0.922 . . . . 1.63 112.238 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -70.67 116.53 11.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.41 111.232 -179.843 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -99.86 120.15 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.44 111.16 179.959 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.5 m -46.99 -36.51 7.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.44 111.127 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 60.39 88.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.1 110.498 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 -81.94 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 3.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.406 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -108.25 5.99 26.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.825 -0.625 . . . . 2.14 111.325 179.751 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 1.104 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 44.39 27.91 0.26 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.23 0.538 . . . . 2.06 112.225 179.943 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 99' ' ' ASP . 11.8 p -168.9 30.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.492 -0.776 . . . . 2.8 110.338 179.583 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 1.406 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -119.7 -32.14 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 4.58 111.259 -179.794 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.232 -0.889 . . . . 3.79 111.199 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.736 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.7 tt . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.845 0.355 . . . . 0.68 110.982 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.17 120.11 25.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 2.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 159.24 54.07 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.141 1.894 . . . . 0.5 111.696 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.8 Cg_endo -52.43 172.93 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.71 112.502 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 164.8 52.63 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.999 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.91 123.92 61.78 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.463 -0.199 . . . . 1.52 110.463 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.589 ' CG ' HG23 ' A' ' 76' ' ' VAL . 21.7 Cg_exo -67.3 133.89 31.87 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.345 2.03 . . . . 0.44 112.713 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.3 p -131.47 117.54 16.66 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.006 -0.543 . . . . 1.09 110.794 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.9 Cg_exo -67.66 125.99 14.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.464 2.109 . . . . 0.64 113.801 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.22 -31.84 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.48 145.82 34.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.075 -0.966 . . . . 0.72 109.48 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 96.36 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.166 0.508 . . . . 0.96 111.573 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.54 156.58 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 1.46 110.814 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -50.67 -22.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 2.42 112.043 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 67' ' ' THR . 1.5 m-70 -139.06 12.18 2.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.254 0.464 . . . . 1.02 112.254 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.85 106.32 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.68 111.326 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 13' ' ' ILE . 96.0 t -100.59 117.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 0.8 110.629 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.699 ' C ' HD13 ' A' ' 20' ' ' LEU . 18.1 m -98.33 125.05 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.802 -0.636 . . . . 0.35 111.632 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.47 154.75 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.821 0.82 . . . . 0.52 112.163 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.61 164.39 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.369 -1.287 . . . . 1.84 109.11 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 7.0 p90 -141.98 -175.14 4.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.165 0.507 . . . . 0.4 112.117 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.94 128.38 47.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.83 110.895 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -59.46 146.68 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 2.11 110.815 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.542 ' HG2' HD12 ' A' ' 33' ' ' ILE . 53.4 Cg_exo -52.47 171.39 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.89 112.682 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.67 -18.49 6.57 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 2.77 112.137 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -127.17 -71.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 121.003 -0.279 . . . . 1.37 111.581 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.4 p 55.88 47.37 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.91 110.987 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.14 0.01 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.889 -0.672 . . . . 1.01 112.515 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.19 38.03 1.2 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 109.796 -1.322 . . . . 0.98 109.796 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -126.29 -179.53 4.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.685 -0.758 . . . . 0.87 111.033 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -133.66 -1.07 3.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.302 0.482 . . . . 2.26 112.302 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 25' ' ' PRO . 19.9 mt 61.98 132.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.785 0.326 . . . . 1.71 110.952 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.429 HG22 ' HD2' ' A' ' 32' ' ' LYS . 4.1 p -128.63 39.75 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.15 111.193 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.9 t 172.29 134.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 1.58 110.658 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -122.94 83.82 2.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.76 111.313 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.469 HG23 HD21 ' A' ' 52' ' ' ASN . 0.8 OUTLIER -74.56 162.7 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 1.14 110.417 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -150.75 126.51 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.63 110.474 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' HD12 ' A' ' 77' ' ' ILE . 3.7 mt-10 -93.62 137.67 32.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 1.67 110.949 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -107.06 141.54 38.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.889 -0.596 . . . . 1.97 110.839 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -110.97 116.66 31.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.44 110.69 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -84.67 87.39 7.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.809 -0.632 . . . . 1.59 110.025 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 4.3 mt -75.33 154.42 86.05 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.084 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 66.8 Cg_endo -89.33 34.02 7.12 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.862 -1.308 . . . . 1.43 113.044 0.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.4 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p30 -155.02 64.06 0.64 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.303 . . . . 2.66 111.288 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.01 -163.2 22.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.887 -0.673 . . . . 1.12 112.446 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -170.86 30.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.677 0.251 . . . . 2.41 111.677 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.553 ' CE3' ' CD ' ' A' ' 75' ' ' ARG . 48.8 m95 52.49 109.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.925 0.342 . . . . 0.65 111.925 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.706 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -137.7 117.38 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.28 111.244 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -53.31 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 1.3 110.874 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -65.78 -55.11 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.193 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 p-10 -50.84 149.02 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 2.01 111.215 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.36 24.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 2.08 110.786 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 m -122.52 25.7 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 1.89 111.153 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.36 106.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 1.87 110.648 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 73.3 mt -97.28 84.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.474 . . . . 0.69 110.774 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.9 -40.1 65.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 1.6 111.563 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 139.92 30.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.527 -0.306 . . . . 1.54 110.225 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 27.5 p-10 -72.63 62.64 0.56 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.248 0.547 . . . . 1.75 111.19 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE2' ' CB ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -166.81 91.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 2.05 108.872 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.0 t80 -126.95 165.13 19.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.176 0.512 . . . . 0.48 111.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.671 HG23 ' OG1' ' A' ' 19' ' ' THR . 4.2 m -123.93 121.14 34.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.505 -0.771 . . . . 0.42 110.76 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.0 t -86.35 105.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.19 0.519 . . . . 1.08 111.43 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 p -99.18 -157.17 0.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 1.33 110.73 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.65 17.75 42.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.9 112.42 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.42 ' CD1' HG23 ' A' ' 18' ' ' VAL . 17.7 mt -81.68 -163.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.36 . . . . 1.47 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 94.9 m -144.52 154.82 43.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.996 -0.547 . . . . 1.06 110.567 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 157.96 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 1.91 110.765 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t0 51.87 50.3 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 1.87 110.746 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -156.83 124.58 5.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.49 111.245 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.72 124.39 26.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.391 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 58.8 m-85 -123.96 129.57 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.078 0.466 . . . . 0.56 111.897 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 7.6 tt0 -104.15 150.18 24.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.956 -0.757 . . . . 1.5 108.956 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.844 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -141.21 119.65 12.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.893 1.442 . . . . 0.6 114.893 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -106.41 161.74 14.31 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.223 -0.658 . . . . 2.11 109.223 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' CG ' ' A' ' 8' ' ' PRO . 85.0 t -117.21 109.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.054 -0.658 . . . . 0.6 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 87.0 mt -97.15 139.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.619 -1.252 . . . . 0.7 107.619 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -155.05 140.68 17.97 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.572 -0.851 . . . . 0.6 112.691 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 mttt -86.53 -174.63 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.449 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.736 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.6 p30 -130.36 162.66 28.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 2.19 110.761 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.18 -26.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.08 112.22 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.93 -18.68 42.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.554 0.576 . . . . 1.06 112.554 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.27 -20.43 25.78 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.407 -0.901 . . . . 0.93 112.033 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.68 166.68 0.64 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.828 -0.434 . . . . 1.38 109.828 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -117.56 103.39 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.563 0.579 . . . . 0.79 112.563 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 1.2 p -63.03 122.46 75.26 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 108.962 -0.755 . . . . 0.59 108.962 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.9 Cg_endo -42.54 162.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.016 2.477 . . . . 0.85 113.098 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 33.6 Cg_endo -64.1 135.62 48.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.826 2.351 . . . . 0.76 112.747 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -78.35 124.84 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.91 -0.586 . . . . 1.28 109.555 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 4.6 mt-10 -24.85 99.59 0.08 OUTLIER Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 123.732 0.813 . . . . 1.77 113.074 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 93.7 Cg_exo -32.35 154.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.425 2.75 . . . . 0.55 114.02 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -94.07 143.85 26.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.419 -0.809 . . . . 1.23 109.388 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 58.3 m-20 -34.27 138.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.217 0.948 . . . . 1.63 111.916 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 43' ' ' LEU . . . -75.16 117.51 17.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.41 111.339 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.742 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.1 mp -102.58 122.88 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.241 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.6 m -51.51 -25.03 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 0.44 111.248 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.742 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.7 m 57.75 49.06 12.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 1.1 110.204 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -146.82 -39.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.693 -0.685 . . . . 3.0 111.603 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -46.21 -26.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 2.14 111.73 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 2.06 111.92 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.889 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.944 0.402 . . . . 0.68 111.002 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.1 t0 -128.65 128.44 23.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.333 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 66.6 Cg_endo -71.22 157.33 57.49 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.317 2.011 . . . . 0.5 112.633 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 51.0 Cg_exo -54.63 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.71 112.34 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.17 -153.9 5.85 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.954 -0.641 . . . . 0.66 112.753 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.7 ttpt -95.13 141.28 23.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.697 -0.112 . . . . 1.52 110.697 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.583 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.8 Cg_endo -86.79 143.89 7.25 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.071 2.514 . . . . 0.44 112.285 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -159.48 125.07 2.3 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.685 -0.234 . . . . 1.09 111.577 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.613 ' CG ' HD11 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -70.92 97.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.235 1.957 . . . . 0.64 112.714 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.7 mp -60.62 -30.4 69.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.228 0.537 . . . . 1.64 109.982 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -146.73 157.33 43.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.342 -0.844 . . . . 0.72 109.443 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -143.39 105.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.103 0.478 . . . . 0.96 111.415 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -91.62 47.71 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.74 -0.663 . . . . 1.46 111.652 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.51 -73.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.876 0.735 . . . . 2.42 112.07 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' THR . 16.0 m170 -81.35 -31.83 33.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 1.02 111.718 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -125.2 105.21 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.717 0.294 . . . . 0.68 110.832 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.92 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 6.6 m -92.02 156.22 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.44 -0.346 . . . . 0.8 110.713 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.6 m -123.76 113.03 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.708 -0.223 . . . . 0.35 111.594 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -127.06 149.31 49.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.52 111.265 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.309 ' CB ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -138.49 166.25 24.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.716 -1.129 . . . . 1.84 109.847 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.512 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 8.8 p90 -141.42 -122.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.372 -0.377 . . . . 0.4 110.852 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.53 136.47 10.53 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.499 0.59 . . . . 0.83 111.174 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -51.8 140.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.55 -0.295 . . . . 2.11 110.631 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.672 ' HB2' HG23 ' A' ' 28' ' ' THR . 6.7 Cg_endo -48.93 -174.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.932 2.422 . . . . 0.89 112.473 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -120.88 -34.08 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -115.78 -69.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.317 0.488 . . . . 1.37 112.317 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 25' ' ' PRO . 32.2 p 53.65 30.16 10.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.91 110.068 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.96 -101.39 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.643 -0.789 . . . . 1.01 111.928 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.41 30.96 2.73 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.633 -0.987 . . . . 0.98 110.633 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -110.9 -171.62 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.065 -0.567 . . . . 0.87 111.541 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -139.94 21.8 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.769 -0.651 . . . . 2.26 111.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.061 HG21 ' CE1' ' A' ' 36' ' ' TYR . 15.8 mm 67.45 -69.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 1.71 110.878 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.612 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 75.97 9.66 3.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.945 -0.57 . . . . 1.15 112.402 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.5 t 168.16 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.765 0.317 . . . . 1.58 111.686 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.061 ' CE1' HG21 ' A' ' 33' ' ' ILE . 38.4 m-85 -120.26 95.09 4.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.76 110.554 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.4 mt -70.13 152.12 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.409 -0.36 . . . . 1.14 111.347 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.2 t -124.63 104.43 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.63 111.27 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 1.058 ' CD ' ' HB3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -76.43 115.44 16.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 1.67 110.168 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.469 ' HD3' ' CG1' ' A' ' 63' ' ' VAL . 5.5 mtmt -93.32 149.74 21.0 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.469 0.652 . . . . 1.97 112.484 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 8.2 ttm180 -135.02 86.18 2.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.92 -1.036 . . . . 1.44 108.969 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -64.69 87.94 0.06 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.62 -0.718 . . . . 1.59 109.703 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -67.95 146.56 98.31 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.976 -0.556 . . . . 0.9 111.517 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.89 39.43 4.52 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.854 -1.311 . . . . 1.43 112.34 0.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -144.72 43.02 1.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 2.66 111.597 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.03 -176.7 46.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.632 -0.794 . . . . 1.12 112.339 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -167.88 30.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.641 0.258 . . . . 2.41 111.167 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 1.058 ' HB3' ' CD ' ' A' ' 39' ' ' GLU . 24.5 m95 46.99 87.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.65 111.192 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.61 135.98 49.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.998 0.428 . . . . 1.28 111.487 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 15.9 ptmt -65.19 79.32 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 1.3 111.023 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -65.7 -43.82 88.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.555 . . . . 0.86 111.87 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.9 p-10 -42.02 -56.6 2.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.64 -0.255 . . . . 2.01 111.591 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER 75.21 -49.94 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.984 0.364 . . . . 2.08 111.984 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -173.7 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.954 0.407 . . . . 1.89 111.193 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.37 107.0 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.949 -0.569 . . . . 1.87 111.339 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 36' ' ' TYR . 29.4 mt -86.35 87.84 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.69 110.919 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.7 mt -74.23 -45.15 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 1.6 111.438 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.49 149.66 22.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.99 -0.374 . . . . 1.54 109.99 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.1 p30 -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 1.75 111.302 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.309 ' OE1' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tp10 -101.35 93.92 5.66 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.929 -0.767 . . . . 2.05 108.929 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 62' ' ' THR . 66.3 t80 -118.6 164.76 14.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.974 -0.557 . . . . 0.48 111.805 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 84.2 m -121.94 119.53 31.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.42 110.564 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 20' ' ' LEU . 57.8 t -80.76 125.61 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 1.08 111.724 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -119.8 163.33 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 1.33 110.558 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.18 57.72 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.9 112.138 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.811 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.0 mp -53.0 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.808 0.337 . . . . 1.47 110.313 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.9 m -143.77 152.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.41 . . . . 1.06 110.57 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -69.01 151.77 46.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 1.91 111.181 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.5 OUTLIER 54.7 51.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.149 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.77 122.6 3.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.49 111.332 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.86 134.76 47.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.383 -0.371 . . . . 0.36 110.335 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.562 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.9 m-85 -128.26 119.79 25.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.782 0.66 . . . . 0.56 112.782 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 91' ' ' PRO . 1.3 tt0 -106.38 136.63 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.261 -0.644 . . . . 1.5 109.261 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.77 119.39 19.21 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.414 1.264 . . . . 0.6 114.414 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -95.97 162.92 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 2.11 109.907 178.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 8' ' ' PRO . 61.8 t -113.95 128.56 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.243 0.544 . . . . 0.6 112.206 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.593 HD11 ' HG3' ' A' ' 88' ' ' PRO . 34.4 mt -130.74 141.42 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.578 -1.267 . . . . 0.7 107.578 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.575 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -157.09 127.28 6.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.81 -0.756 . . . . 0.6 112.763 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.6 mttt -75.64 -157.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.687 -0.405 . . . . 1.98 110.072 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.889 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.7 p30 -159.26 162.99 36.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 2.19 111.515 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -38.54 -43.79 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.323 -0.853 . . . . 1.08 112.816 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -66.14 -23.94 66.57 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.133 0.42 . . . . 1.06 112.133 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.9 -8.19 36.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.698 -0.763 . . . . 0.93 112.208 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.631 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -56.8 -164.23 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.667 0.234 . . . . 1.38 110.377 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.681 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -148.7 111.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.382 0.512 . . . . 0.79 112.382 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.6 p -70.84 110.73 7.71 Favored Pre-proline 0 C--O 1.235 0.337 0 N-CA-C 107.233 -1.395 . . . . 0.59 107.233 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.38 171.9 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.499 2.133 . . . . 0.85 113.816 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.593 ' HG3' HD11 ' A' ' 77' ' ' ILE . 76.5 Cg_exo -50.42 145.0 22.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.338 2.692 . . . . 0.76 113.594 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -125.19 102.42 7.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 1.28 110.729 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.0 mm-40 12.63 108.64 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.737 1.215 . . . . 1.77 113.881 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 51.6 Cg_exo -56.05 143.67 82.54 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.437 2.092 . . . . 0.55 113.272 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.473 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -70.55 139.26 51.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.874 -0.787 . . . . 1.23 108.874 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -37.14 133.9 0.61 Allowed 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 124.254 0.971 . . . . 1.63 111.517 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.85 118.56 8.54 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.41 111.144 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.893 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -98.11 111.15 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.677 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -49.36 -25.83 2.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.319 -0.4 . . . . 0.44 110.595 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.548 ' H ' HG22 ' A' ' 95' ' ' ILE . 99.6 m 49.02 81.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 1.1 110.845 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 -85.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.35 . . . . 3.0 110.593 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -108.58 17.83 21.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.039 -0.528 . . . . 2.14 110.879 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 3.7 p-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.061 0.458 . . . . 2.06 111.251 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 86' ' ' SER . 5.5 tt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.98 0.419 . . . . 0.68 110.741 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.7 t70 -138.59 119.87 10.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.0 -0.545 . . . . 2.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.51 163.04 40.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.245 1.963 . . . . 0.5 112.014 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 40.5 Cg_exo -57.71 -169.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.701 2.268 . . . . 0.71 112.75 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.56 -177.19 50.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.87 -0.681 . . . . 0.66 112.685 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.9 tttt -73.35 133.65 80.56 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.277 0.085 . . . . 1.52 110.962 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.619 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.6 Cg_exo -76.81 130.61 11.61 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.688 2.259 . . . . 0.44 112.071 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.02 105.97 6.2 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.545 -0.298 . . . . 1.09 111.759 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.2 Cg_exo -44.28 131.31 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.206 1.937 . . . . 0.64 112.794 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.011 HD21 ' CB ' ' A' ' 21' ' ' LYS . 1.6 mt -90.27 -31.78 16.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.239 -1.023 . . . . 1.64 108.239 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.7 160.82 43.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 0.72 108.35 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.881 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.39 97.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.569 -0.453 . . . . 0.96 111.598 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -87.56 49.11 1.75 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.723 -0.671 . . . . 1.46 111.708 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.76 -74.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.874 0.734 . . . . 2.42 112.335 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.5 m-70 -72.2 -39.52 68.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.365 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 44.8 p -125.71 118.05 24.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.37 . . . . 0.68 110.163 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.01 HG13 HD12 ' A' ' 66' ' ' LEU . 5.9 m -107.61 135.96 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.442 0.639 . . . . 0.8 112.368 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.531 ' N ' HG23 ' A' ' 62' ' ' THR . 23.0 m -90.59 144.16 26.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.35 109.771 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.761 HD11 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.52 158.95 44.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.52 111.586 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.011 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -150.82 146.36 26.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.543 -0.753 . . . . 1.84 110.792 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.518 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.0 p90 -136.18 -176.24 4.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.4 111.064 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.7 155.9 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.83 110.973 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 150.83 80.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.11 110.699 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HG2' HD12 ' A' ' 33' ' ' ILE . 92.1 Cg_exo -43.94 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.969 2.446 . . . . 0.89 113.236 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -22.38 8.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.01 -0.541 . . . . 2.77 111.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.79 -65.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.059 0.392 . . . . 1.37 112.059 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 14.9 p 57.73 46.07 17.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.91 110.155 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.51 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.6 -0.809 . . . . 1.01 111.828 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.17 25.71 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.902 -0.879 . . . . 0.98 110.902 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -103.68 -176.88 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.87 111.641 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.54 1.0 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 2.26 111.792 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.669 HG21 ' CE1' ' A' ' 36' ' ' TYR . 22.9 mt 60.26 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.125 0.488 . . . . 1.71 110.952 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -140.34 23.69 2.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 1.15 111.711 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.33 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.741 0.645 . . . . 1.58 112.741 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 33' ' ' ILE . 24.0 m-85 -105.3 85.91 2.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.031 -0.729 . . . . 0.76 109.031 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.485 HG23 HD21 ' A' ' 52' ' ' ASN . 0.4 OUTLIER -80.98 120.87 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 1.14 111.266 -179.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -112.04 129.21 67.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.06 -0.518 . . . . 0.63 110.681 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -90.43 136.25 33.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.303 -0.408 . . . . 1.67 111.17 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 3.8 pttt -98.6 150.12 22.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.989 -0.55 . . . . 1.97 110.585 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 6.5 ttp180 -134.69 109.03 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.388 -0.369 . . . . 1.44 110.888 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -78.59 101.2 7.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 1.59 110.608 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 94' ' ' ALA . 3.8 mt -88.27 153.41 51.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.9 111.062 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.35 17.33 42.28 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.793 -1.336 . . . . 1.43 112.739 0.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -138.21 81.01 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.931 0.396 . . . . 2.66 111.189 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.91 -167.3 19.44 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.898 -0.668 . . . . 1.12 112.258 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.75 159.06 37.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 2.41 110.945 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.794 ' O ' HD22 ' A' ' 49' ' ' LEU . 64.8 m95 -65.01 122.17 16.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.793 -0.639 . . . . 0.65 111.166 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -150.68 140.63 21.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.439 . . . . 1.28 110.635 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -44.09 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.363 -0.38 . . . . 1.3 111.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 40' ' ' LYS . . . -70.81 -40.89 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.86 110.889 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.637 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.4 p-10 -68.8 -44.34 73.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.842 -0.617 . . . . 2.01 111.287 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 54.85 22.63 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 2.08 110.706 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -136.42 -157.01 0.75 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 1.89 110.724 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.92 88.55 2.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.746 0.308 . . . . 1.87 111.163 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.81 HD12 ' CD1' ' A' ' 61' ' ' PHE . 16.4 mm -70.39 63.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.69 110.731 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.86 -56.78 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 1.6 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.622 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -87.13 159.73 18.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 1.54 109.409 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.9 p30 -77.98 1.45 20.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.155 0.428 . . . . 1.75 112.155 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.43 95.18 6.31 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.902 -0.407 . . . . 2.05 109.902 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CD1' HD12 ' A' ' 56' ' ' ILE . 80.8 t80 -130.99 162.82 28.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.391 0.615 . . . . 0.48 111.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.69 HG23 ' C ' ' A' ' 18' ' ' VAL . 89.9 m -129.69 122.42 28.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.844 -1.071 . . . . 0.42 108.803 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 18' ' ' VAL . 33.5 m -80.18 108.97 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.204 0.526 . . . . 1.08 111.832 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -98.63 135.26 40.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.522 -0.763 . . . . 1.33 110.436 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.55 -8.44 7.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.586 -0.816 . . . . 0.9 112.681 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.01 HD12 HG13 ' A' ' 18' ' ' VAL . 33.6 mt -57.88 -162.29 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.847 0.323 . . . . 1.47 110.146 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -148.02 160.68 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.857 0.36 . . . . 1.06 111.222 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 tt0 -83.82 144.5 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 1.91 110.975 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' CYS . 23.8 t0 63.97 59.13 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 1.87 110.862 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.76 124.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.49 111.429 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.65 129.84 40.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.401 . . . . 0.36 110.31 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 50.7 m-85 -123.96 118.81 27.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.56 112.103 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -101.95 139.47 37.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.234 -0.654 . . . . 1.5 109.234 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.94 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.4 122.62 19.28 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.147 1.166 . . . . 0.6 114.147 -179.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.821 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.73 152.4 19.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.02 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' CG ' ' A' ' 8' ' ' PRO . 97.2 t -111.44 101.57 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.589 0.589 . . . . 0.6 112.589 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 85' ' ' ILE . 53.3 mt -98.55 155.36 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.629 -1.248 . . . . 0.7 107.629 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.19 137.67 2.48 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.898 -1.121 . . . . 0.6 113.253 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.4 mttt -78.39 -159.3 0.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 1.98 109.482 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.737 HD21 ' HB3' ' A' ' 84' ' ' ALA . 33.1 p30 -139.5 -130.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.79 -0.448 . . . . 2.19 109.79 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -110.83 -7.66 14.59 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.402 0.546 . . . . 1.08 111.12 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.66 3.56 22.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.865 0.32 . . . . 1.06 111.865 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.95 50.94 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.4 -0.905 . . . . 0.93 112.77 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -58.68 126.41 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.35 . . . . 1.38 110.426 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 79' ' ' LYS . 3.2 tp -85.87 110.9 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.247 -0.433 . . . . 0.79 111.669 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.554 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 p -68.52 124.71 90.61 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 109.393 -0.595 . . . . 0.59 109.393 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -37.68 162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.252 2.634 . . . . 0.85 113.206 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . 7.4 Cg_exo -71.79 145.96 47.15 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.699 2.266 . . . . 0.76 112.724 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 90' ' ' GLU . 12.4 m -99.05 106.33 18.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.555 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.4 mt-10 -1.46 107.27 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.828 1.251 . . . . 1.77 114.017 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 92.4 Cg_exo -38.49 149.2 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.782 2.321 . . . . 0.55 113.145 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.89 137.32 33.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.697 -0.853 . . . . 1.23 108.697 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -37.13 129.83 0.88 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.155 0.909 . . . . 1.63 111.805 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.22 119.12 7.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 0.41 110.963 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 13' ' ' ILE . 4.2 mp -97.56 111.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.44 110.473 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.1 m -45.68 -29.73 1.35 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.294 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.455 ' H ' HG22 ' A' ' 95' ' ' ILE . 63.0 m 48.05 70.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.1 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 1.3 ptp180 -103.29 -99.56 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.459 -0.337 . . . . 3.0 111.268 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -97.82 20.66 11.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 2.14 111.008 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 38.3 t0 . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 2.06 111.156 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.684 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.4 tt . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 110.412 -0.218 . . . . 0.68 110.412 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.7 m-20 -136.93 126.17 15.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.826 -0.35 . . . . 2.0 111.92 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 33.2 Cg_exo -58.61 171.79 1.79 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.563 2.175 . . . . 0.5 112.015 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 52.4 Cg_endo -69.09 -178.6 2.16 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.59 2.193 . . . . 0.71 112.36 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.78 174.35 54.82 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.897 -0.668 . . . . 0.66 112.585 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.6 tptm -61.83 119.06 44.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 110.707 -0.109 . . . . 1.52 110.707 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.483 ' CG ' HG23 ' A' ' 76' ' ' VAL . 12.6 Cg_exo -70.4 146.47 56.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.161 . . . . 0.44 112.453 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -143.51 112.78 5.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.015 -0.539 . . . . 1.09 111.4 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.721 ' HG2' HD11 ' A' ' 95' ' ' ILE . 34.3 Cg_exo -62.69 107.93 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.727 2.285 . . . . 0.64 113.876 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -62.68 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.658 -0.867 . . . . 1.64 108.658 178.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -132.79 151.16 52.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.439 -1.255 . . . . 0.72 108.514 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -141.91 99.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.091 -0.644 . . . . 0.96 112.266 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -90.04 134.66 34.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 1.46 110.301 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -33.88 -30.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.867 1.062 . . . . 2.42 113.867 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 5.0 m-70 -116.51 -24.16 7.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.663 0.616 . . . . 1.02 112.663 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 75.0 p -136.54 132.32 35.06 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.747 -0.464 . . . . 0.68 109.747 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.129 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -123.28 142.78 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.886 -0.726 . . . . 0.8 112.453 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.615 ' C ' HD13 ' A' ' 20' ' ' LEU . 54.0 m -103.87 124.63 49.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.35 111.994 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.771 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.2 151.56 50.75 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 121.687 0.755 . . . . 0.52 111.744 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.606 ' HB3' HD11 ' A' ' 11' ' ' LEU . 15.8 tptm -134.43 153.64 51.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.508 -1.224 . . . . 1.84 109.702 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 22.8 p90 -143.1 -176.35 4.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.266 0.555 . . . . 0.4 112.182 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.4 -159.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.83 110.953 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.44 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -128.13 141.66 41.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 2.11 110.094 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.895 ' HG2' HD11 ' A' ' 33' ' ' ILE . 84.1 Cg_exo -42.65 168.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.228 1.952 . . . . 0.89 112.222 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -107.89 -30.3 8.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 2.77 111.724 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -119.24 -69.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.854 0.316 . . . . 1.37 111.854 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 25' ' ' PRO . 18.6 p 50.92 45.34 27.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 0.91 110.444 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.4 -93.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.068 -0.587 . . . . 1.01 112.683 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.28 36.18 0.7 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.515 -1.034 . . . . 0.98 110.515 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.85 -172.81 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.908 -0.646 . . . . 0.87 111.577 -178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.02 23.03 4.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 2.26 112.132 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.895 HD11 ' HG2' ' A' ' 25' ' ' PRO . 45.5 mm 68.82 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 111.903 0.334 . . . . 1.71 111.903 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.632 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.7 p 87.67 -16.93 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.128 0.571 . . . . 1.15 112.34 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 34.3 t 177.86 169.44 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.848 0.356 . . . . 1.58 111.861 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 54.1 m-85 -140.19 105.12 4.97 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 116.075 -0.511 . . . . 0.76 111.403 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.493 HG21 ' HD3' ' A' ' 50' ' ' LYS . 4.9 mt -89.37 91.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.038 -0.528 . . . . 1.14 110.839 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -82.76 123.39 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.022 0.439 . . . . 0.63 110.748 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 77' ' ' ILE . 14.7 mt-10 -97.83 156.68 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.699 . . . . 1.67 111.345 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.16 139.74 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 1.97 110.62 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HD3' HD23 ' A' ' 43' ' ' LEU . 2.4 ttm180 -121.02 113.68 20.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.181 -0.463 . . . . 1.44 110.568 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.542 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -71.48 86.93 0.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 1.59 109.654 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -70.35 142.39 89.47 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.949 -0.569 . . . . 0.9 110.759 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.96 47.85 1.94 Allowed 'Cis proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.182 -1.174 . . . . 1.43 112.869 0.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -158.58 60.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.679 0.276 . . . . 2.66 111.546 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -114.79 -177.48 18.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.636 -0.792 . . . . 1.12 112.325 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.6 24.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 2.41 111.123 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 54.0 m95 51.77 95.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.65 111.332 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD13 ' HG2' ' A' ' 47' ' ' ARG . 1.2 mp -118.23 137.7 52.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 1.28 110.328 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HD3' HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -45.3 93.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 1.3 111.689 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -70.09 -40.52 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.86 110.306 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -63.66 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.01 110.481 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 68.96 41.08 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 2.08 110.803 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 t -154.37 -72.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.993 -0.549 . . . . 1.89 110.972 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 175.48 136.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.87 110.659 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 52' ' ' ASN . 8.1 mt -140.69 79.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.69 110.967 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 57' ' ' LEU . 8.5 tp -68.62 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.6 110.825 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.59 169.66 17.86 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.305 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -80.67 -2.0 44.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.293 -0.412 . . . . 1.75 111.672 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.87 102.55 13.62 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.853 0.358 . . . . 2.05 110.33 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.688 ' HB2' HG23 ' A' ' 56' ' ' ILE . 66.5 t80 -139.02 164.05 30.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.48 111.872 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 54.0 m -127.12 128.43 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.451 -0.795 . . . . 0.42 109.795 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 18' ' ' VAL . 29.7 m -91.62 128.7 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 120.221 -0.591 . . . . 1.08 112.168 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -110.81 127.01 55.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.546 -0.752 . . . . 1.33 109.821 179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.72 -13.04 1.97 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.521 -0.847 . . . . 0.9 112.59 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.129 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -52.08 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.013 0.435 . . . . 1.47 110.553 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -152.53 157.07 40.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 1.06 110.601 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 4.4 mt-10 -76.76 143.76 39.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 1.91 110.675 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 65.87 38.04 5.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.214 -0.448 . . . . 1.87 110.929 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -151.41 117.3 5.5 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.565 -0.289 . . . . 0.49 111.731 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -75.25 121.31 21.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.655 -0.498 . . . . 0.36 109.655 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 75.7 m-85 -116.15 131.77 56.85 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.56 112.696 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.775 ' HB2' HD11 ' A' ' 43' ' ' LEU . 1.2 tt0 -105.83 142.46 35.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.239 -1.022 . . . . 1.5 108.239 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -126.92 114.98 18.58 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.247 1.203 . . . . 0.6 114.247 -178.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -93.5 144.87 24.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.313 -0.858 . . . . 2.11 110.229 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' CG ' ' A' ' 8' ' ' PRO . 52.9 t -106.7 119.77 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.6 112.368 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.71 HD11 ' HD3' ' A' ' 88' ' ' PRO . 5.9 mt -110.1 165.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.978 -1.119 . . . . 0.7 107.978 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -179.3 130.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.965 -0.694 . . . . 0.6 112.345 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.4 pttm -81.26 -158.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.969 -0.752 . . . . 1.98 108.969 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.684 ' ND2' HD11 ' A' ' 2' ' ' ILE . 17.6 m-80 -155.78 167.62 29.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 2.19 112.029 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.26 -53.25 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 1.08 111.864 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.32 -5.84 25.76 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.313 0.486 . . . . 1.06 112.313 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.94 63.31 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.39 -0.91 . . . . 0.93 112.714 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 124.84 22.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 1.38 110.157 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -92.4 110.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.649 0.611 . . . . 0.79 112.649 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 4.5 p -74.89 120.28 80.84 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 88.3 Cg_endo -70.95 172.97 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.574 2.182 . . . . 0.85 112.961 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HD3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -36.93 121.56 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.395 2.73 . . . . 0.76 112.819 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' GLU . 5.1 p -107.88 104.23 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.037 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 21.6 mt-10 18.36 110.48 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.505 1.122 . . . . 1.77 113.809 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 34.5 Cg_exo -63.38 155.79 60.04 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.496 2.13 . . . . 0.55 114.374 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -84.5 146.11 27.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.903 -1.044 . . . . 1.23 108.839 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -32.23 143.96 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.256 0.972 . . . . 1.63 112.478 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -79.64 114.32 18.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.428 -0.805 . . . . 0.41 110.326 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.937 HG12 HG21 ' A' ' 13' ' ' ILE . 3.8 mp -99.37 110.17 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.452 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 63.0 m -45.19 -39.79 6.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.044 -0.526 . . . . 0.44 111.224 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 69' ' ' ASP . 90.9 m 54.96 106.8 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.1 110.448 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -141.87 -75.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.987 0.423 . . . . 3.0 110.957 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -122.86 3.09 9.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.577 . . . . 2.14 111.496 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.766 0.317 . . . . 2.06 111.444 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.68 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.81 0.338 . . . . 0.68 111.16 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.64 132.8 24.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 2.0 110.318 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.86 162.38 18.54 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.157 . . . . 0.5 112.451 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 71.4 Cg_exo -53.11 177.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.906 2.404 . . . . 0.71 112.611 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.17 -175.58 50.15 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.043 -0.598 . . . . 0.66 113.128 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 tmtp? -69.69 123.29 88.27 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.974 0.11 . . . . 1.52 110.848 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 10.7 Cg_exo -75.47 128.12 10.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.669 2.246 . . . . 0.44 112.741 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 3.8 t -134.15 115.63 13.03 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.375 -0.375 . . . . 1.09 111.439 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 22.0 Cg_exo -61.98 108.11 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.224 1.949 . . . . 0.64 113.448 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.57 -41.18 93.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.46 0.648 . . . . 1.64 109.298 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -136.66 154.73 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.891 -1.05 . . . . 0.72 109.379 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.866 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -143.32 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.904 0.383 . . . . 0.96 111.22 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.836 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -101.71 56.86 0.82 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.023 -0.535 . . . . 1.46 112.266 -179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.254 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.74 -74.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.614 -0.721 . . . . 2.42 112.754 178.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' THR . 18.0 m170 -78.28 -35.28 48.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.072 0.397 . . . . 1.02 112.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 p -126.09 117.47 23.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.853 0.359 . . . . 0.68 110.98 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.3 m -110.29 141.8 24.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.137 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.754 ' C ' HD13 ' A' ' 20' ' ' LEU . 55.2 m -107.33 127.99 54.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.57 . . . . 0.35 111.768 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.811 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -133.25 156.38 47.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.371 0.605 . . . . 0.52 111.377 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.046 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -138.14 142.93 40.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.079 -0.964 . . . . 1.84 109.973 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 42.8 p90 -137.8 163.29 31.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.144 0.497 . . . . 0.4 111.885 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.88 164.93 24.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.83 110.318 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.82 157.15 35.13 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 2.11 110.873 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 76.9 Cg_exo -50.34 -173.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.233 . . . . 0.89 112.658 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.11 -25.57 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.897 -0.592 . . . . 2.77 111.829 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -129.05 -69.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.057 0.391 . . . . 1.37 112.057 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.488 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.5 p 59.45 50.79 7.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.346 . . . . 0.91 110.725 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.82 -98.86 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.163 -0.541 . . . . 1.01 112.64 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.05 32.74 1.66 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 109.735 -1.346 . . . . 0.98 109.735 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.95 -169.98 1.58 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.62 -0.79 . . . . 0.87 111.262 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 34' ' ' THR . 1.9 pttt -142.2 24.1 1.98 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 2.26 112.008 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.897 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mm 66.44 -69.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.7 0.286 . . . . 1.71 110.902 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.6 p 87.33 -20.72 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.188 0.595 . . . . 1.15 112.058 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.796 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.8 t -177.25 165.31 2.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 1.58 111.464 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.897 ' CE1' HG21 ' A' ' 33' ' ' ILE . 54.1 m-85 -133.75 109.1 8.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.76 111.073 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.33 156.26 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.22 -0.289 . . . . 1.14 110.22 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 7.1 t -135.06 124.31 42.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.63 111.807 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CD ' HD12 ' A' ' 77' ' ' ILE . 6.9 mt-10 -96.51 131.56 42.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -98.34 138.99 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.038 0.447 . . . . 1.97 111.964 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -122.14 109.65 14.79 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.825 -0.625 . . . . 1.44 110.374 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD2' ' NE ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -77.15 95.67 4.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 1.59 110.578 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -65.49 151.62 94.01 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.9 111.106 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -88.79 4.12 69.96 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.803 -1.332 . . . . 1.43 113.212 0.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -77.18 -84.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.672 0.272 . . . . 2.66 110.502 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.76 161.61 12.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.639 -0.791 . . . . 1.12 113.326 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' NE ' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 168.72 55.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 2.41 110.008 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.9 m95 -36.78 120.48 0.71 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.838 -0.619 . . . . 0.65 112.544 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -155.49 131.1 9.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 1.28 110.008 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 1.8 ptpt -52.11 117.41 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 1.3 110.84 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -101.87 -41.32 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.131 -0.486 . . . . 0.86 111.268 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' CB ' HD11 ' A' ' 56' ' ' ILE . 16.9 p-10 -44.79 -48.27 10.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.373 -0.376 . . . . 2.01 111.376 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.74 29.73 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.259 -0.428 . . . . 2.08 111.329 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -133.39 -170.11 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 1.89 110.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -99.69 89.29 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 1.87 111.181 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 36' ' ' TYR . 36.4 mt -86.78 72.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.69 110.768 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 57' ' ' LEU . 9.7 tp -63.08 -38.31 90.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.6 111.455 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 56' ' ' ILE . 21.8 pt-20 -100.6 160.49 14.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.379 . . . . 1.54 110.528 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -74.25 -7.92 54.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.211 -0.45 . . . . 1.75 111.323 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.046 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.3 tp10 -90.55 97.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.322 -0.621 . . . . 2.05 109.322 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 58.4 t80 -135.79 165.35 25.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.48 111.985 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 94.3 m -123.21 123.37 40.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.325 -0.852 . . . . 0.42 110.281 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.811 HG23 HD21 ' A' ' 20' ' ' LEU . 17.3 t -82.02 119.62 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 1.08 111.71 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.26 145.36 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.663 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.03 -19.35 5.48 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.746 -0.74 . . . . 0.9 112.171 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.742 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -55.9 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.666 0.27 . . . . 1.47 110.46 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -157.88 143.58 17.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.848 0.356 . . . . 1.06 110.765 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 mt-10 -51.92 129.88 27.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.063 -0.517 . . . . 1.91 111.127 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.61 66.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.073 -0.512 . . . . 1.87 111.397 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -175.5 118.44 0.16 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.468 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.54 129.73 40.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.36 109.519 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.607 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 73.3 m-85 -128.87 124.46 35.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.053 0.76 . . . . 0.56 113.053 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.543 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 10.5 mt-10 -103.52 142.36 34.41 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.498 -0.927 . . . . 1.5 108.498 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -133.15 111.98 11.36 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.478 1.288 . . . . 0.6 114.478 -178.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.01 157.39 16.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.495 -0.928 . . . . 2.11 108.495 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -125.21 124.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.535 -0.866 . . . . 0.6 112.878 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.447 HD12 ' CD ' ' A' ' 39' ' ' GLU . 63.6 mt -108.03 139.71 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.407 -1.331 . . . . 0.7 107.407 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -149.18 117.52 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.529 -0.869 . . . . 0.6 112.603 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.4 ptpt -71.57 -172.73 0.82 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.191 -0.459 . . . . 1.98 110.149 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.68 ' ND2' HD11 ' A' ' 2' ' ' ILE . 5.1 m-80 -135.09 168.08 19.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.263 0.554 . . . . 2.19 111.915 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.59 -44.04 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 1.08 111.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.69 -18.0 58.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.998 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 113.68 -16.75 21.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.551 -0.833 . . . . 0.93 112.1 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 123.46 8.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.663 0.268 . . . . 1.38 110.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 85' ' ' ILE . 3.3 tp -87.91 109.81 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.694 0.627 . . . . 0.79 112.694 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 12.7 p -68.58 107.34 1.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 107.811 -1.181 . . . . 0.59 107.811 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.0 Cg_endo -45.98 155.41 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.091 . . . . 0.85 112.841 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 2.3 Cg_endo -45.18 128.76 9.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.372 2.714 . . . . 0.76 113.483 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 1.1 p -97.43 109.14 21.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.364 -0.835 . . . . 1.28 109.862 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 7.6 mt-10 1.72 119.22 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.093 0 O-C-N 124.858 1.349 . . . . 1.77 113.927 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.7 Cg_exo -62.18 139.97 81.0 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.051 . . . . 0.55 113.768 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.89 144.3 57.18 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.063 -0.718 . . . . 1.23 109.063 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -40.43 134.2 1.75 Allowed 'General case' 0 C--N 1.333 -0.11 0 O-C-N 124.006 0.816 . . . . 1.63 111.633 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.68 127.09 29.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.41 111.255 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.636 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -109.4 114.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.478 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.499 HG21 ' NH1' ' A' ' 98' ' ' ARG . 65.2 m -48.13 -39.04 19.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.929 0.395 . . . . 0.44 111.03 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 78.9 m 60.29 65.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.246 -0.434 . . . . 1.1 110.881 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.658 ' HD3' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -107.63 -89.53 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.784 0.326 . . . . 3.0 110.52 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.658 ' OD2' ' HD3' ' A' ' 98' ' ' ARG . 3.6 p30 -102.27 12.82 36.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.412 -0.358 . . . . 2.14 110.635 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.254 ' OD1' ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.864 0.364 . . . . 2.06 111.189 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.567 HD12 ' HB1' ' A' ' 84' ' ' ALA . 2.7 tt . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.883 0.373 . . . . 0.68 110.874 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.406 ' N ' HG12 ' A' ' 2' ' ' ILE . 3.5 m-20 -135.39 128.53 18.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.618 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 157.02 43.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.394 2.062 . . . . 0.5 112.161 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.55 -164.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.801 2.334 . . . . 0.71 113.228 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.94 -175.41 44.02 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.423 -0.808 . . . . 0.66 112.799 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.2 tttt -78.08 134.64 63.41 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 110.382 -0.229 . . . . 1.52 110.382 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CG ' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_exo -79.04 147.04 20.72 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.652 2.234 . . . . 0.44 112.83 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.2 p -138.69 115.06 8.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.625 -0.716 . . . . 1.09 110.647 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.7 Cg_exo -63.34 112.74 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.201 1.934 . . . . 0.64 113.149 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER -76.9 -40.37 47.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.305 0.574 . . . . 1.64 109.848 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.22 114.01 13.95 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.233 -0.894 . . . . 0.72 109.215 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.588 HG21 HG12 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -113.0 126.26 70.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.73 0.641 . . . . 0.96 112.73 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -116.63 144.7 44.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.339 -0.846 . . . . 1.46 109.674 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -52.29 -18.36 1.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.94 0.719 . . . . 2.42 112.94 -178.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 17' ' ' THR . 3.1 m-70 -124.33 -7.75 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.543 0.571 . . . . 1.02 112.543 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 64' ' ' SER . 77.8 p -161.0 124.7 3.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.408 -0.219 . . . . 0.68 110.408 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.079 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -113.88 156.79 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.253 -0.579 . . . . 0.8 112.066 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 HD12 ' A' ' 11' ' ' LEU . 6.5 m -125.2 123.01 38.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.1 -0.5 . . . . 0.35 110.943 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.64 162.13 30.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.731 0.777 . . . . 0.52 112.454 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -136.1 159.01 43.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.502 -1.226 . . . . 1.84 109.762 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 19.7 p90 -149.4 -175.8 5.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.4 112.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.39 -173.99 4.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.617 -0.72 . . . . 0.83 112.072 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -120.94 140.58 31.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.289 -0.869 . . . . 2.11 110.272 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 33' ' ' ILE . 83.9 Cg_exo -46.07 175.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.43 2.087 . . . . 0.89 112.578 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -21.01 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 2.77 111.687 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.52 -68.71 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.991 0.367 . . . . 1.37 111.991 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 25' ' ' PRO . 66.2 p 51.79 49.62 20.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.91 110.496 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.75 -94.11 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.057 -0.592 . . . . 1.01 112.825 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.32 43.27 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.472 -1.051 . . . . 0.98 110.472 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -122.32 -168.97 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.458 . . . . 0.87 111.487 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.35 20.68 1.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.619 0.6 . . . . 2.26 112.619 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 35' ' ' SER . 3.6 mp 59.61 -85.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.927 -0.309 . . . . 1.71 110.483 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 77.59 30.84 0.47 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.982 0.364 . . . . 1.15 111.982 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 160.95 146.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.368 -0.378 . . . . 1.58 110.362 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' ILE . 93.1 m-85 -140.1 117.12 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.022 0.439 . . . . 0.76 111.679 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 23.9 mt -85.43 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 1.14 110.346 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 74' ' ' PHE . 2.1 t -109.53 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.158 0.429 . . . . 0.63 112.158 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.718 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 4.6 mm-40 -64.22 132.59 50.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.382 -0.599 . . . . 1.67 109.382 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -114.75 134.53 55.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 1.97 111.718 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.0 ttm180 -113.92 111.9 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.599 -0.728 . . . . 1.44 110.007 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.823 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.96 108.7 13.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 1.59 110.902 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 41' ' ' ARG . 1.2 mm? -84.34 143.68 42.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.436 -0.347 . . . . 0.9 110.985 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 63.5 Cg_endo -98.43 45.34 2.67 Favored 'Cis proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.36 -1.1 . . . . 1.43 112.755 0.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 m-80 -153.1 58.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 2.66 111.306 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -116.05 167.57 12.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.848 -0.691 . . . . 1.12 112.762 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.35 27.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.001 0.429 . . . . 2.41 110.615 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.578 ' O ' HD22 ' A' ' 49' ' ' LEU . 72.3 m95 53.23 110.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.65 111.638 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.609 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -143.32 118.4 10.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.233 -0.44 . . . . 1.28 110.459 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.718 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 7.2 ptpt -49.69 118.0 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.181 0.515 . . . . 1.3 111.2 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -102.37 -40.29 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.86 110.956 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.8 p-10 -40.28 -48.27 2.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 2.01 111.765 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 43.19 44.02 4.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.721 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.1 p -162.46 158.49 23.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 1.89 110.912 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' ND2' ' OG ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -63.8 105.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 1.87 110.681 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 36' ' ' TYR . 53.5 mt -100.19 63.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.69 110.261 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.94 -76.22 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.566 -0.743 . . . . 1.6 111.821 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -64.82 170.02 4.6 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.772 0.32 . . . . 1.54 110.147 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 43.7 p30 -88.8 13.4 12.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.403 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 49.3 tt0 -111.55 107.3 16.42 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' HB2' HG23 ' A' ' 56' ' ' ILE . 58.6 t80 -142.49 164.97 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.48 112.049 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 18' ' ' VAL . 30.5 m -125.02 122.9 38.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.581 -0.736 . . . . 0.42 110.8 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 18' ' ' VAL . 3.7 m -91.53 96.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 120.24 -0.584 . . . . 1.08 110.714 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.565 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -82.85 -165.28 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 1.33 110.885 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.89 20.44 59.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.685 -0.769 . . . . 0.9 112.371 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.079 ' CD1' HG13 ' A' ' 18' ' ' VAL . 69.9 mt -74.28 -176.58 2.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.848 0.356 . . . . 1.47 110.75 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.415 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 m -132.68 154.9 49.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 1.06 110.875 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 22.9 tt0 -88.28 160.22 17.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 1.91 110.906 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.874 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 52.33 43.59 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 1.87 110.858 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.45 120.7 3.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.49 111.33 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.36 132.68 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.36 110.107 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 48.3 m-85 -125.69 118.97 26.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.681 0.622 . . . . 0.56 112.681 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.744 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 5.1 mt-10 -99.45 142.95 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.46 -0.941 . . . . 1.5 108.46 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.996 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -125.81 115.1 19.49 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.289 1.218 . . . . 0.6 114.289 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 2.5 ttp85 -94.91 139.49 31.26 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.341 -0.845 . . . . 2.11 109.537 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' CG ' ' A' ' 8' ' ' PRO . 80.6 t -106.98 138.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.71 0.767 . . . . 0.6 112.349 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 86' ' ' SER . 29.0 mt -134.66 156.64 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -168.42 121.07 0.84 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.652 -1.219 . . . . 0.6 112.987 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mmtt -61.91 -173.33 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.003 -0.679 . . . . 1.98 109.725 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 5.4 m120 -136.8 161.2 36.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.033 0.444 . . . . 2.19 110.908 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -36.87 -30.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.155 0.798 . . . . 1.08 113.155 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.626 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.73 24.37 13.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.979 0.733 . . . . 1.06 112.979 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.17 -11.1 51.1 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.561 -0.828 . . . . 0.93 113.222 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -53.82 102.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.946 0.373 . . . . 1.38 110.217 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -70.0 104.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.444 0.535 . . . . 0.79 112.444 -179.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.5 p -65.96 111.74 7.21 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.777 -0.823 . . . . 0.59 108.777 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 72.6 Cg_exo -48.8 -179.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.236 2.624 . . . . 0.85 114.311 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 68.1 Cg_exo -52.61 144.17 43.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.404 2.736 . . . . 0.76 113.544 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 10.9 m -123.04 122.05 37.55 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.906 -0.588 . . . . 1.28 110.505 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -18.53 102.47 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.161 0.985 . . . . 1.77 113.36 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 76.2 Cg_exo -48.42 169.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.043 2.495 . . . . 0.55 114.93 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.88 142.28 28.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.178 -1.374 . . . . 1.23 109.784 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -44.85 133.61 6.11 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.77 0.669 . . . . 1.63 110.457 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.07 119.65 11.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.984 -0.553 . . . . 0.41 111.754 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 10' ' ' PRO . 4.0 mp -97.37 109.55 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.408 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 13.6 m -46.89 -37.63 9.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.379 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 3.0 m 52.76 88.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.371 . . . . 1.1 110.227 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -134.75 -91.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.63 -0.259 . . . . 3.0 111.113 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -91.45 -6.1 53.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.625 -0.261 . . . . 2.14 111.421 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.973 0.416 . . . . 2.06 111.122 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 N-CA-C 110.391 -0.226 . . . . 0.68 110.391 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.7 142.31 45.06 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 2.0 111.53 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.401 ' CA ' ' HB2' ' A' ' 86' ' ' SER . 87.0 Cg_endo -83.44 161.79 14.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.84 2.36 . . . . 0.5 112.276 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.53 177.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.597 2.198 . . . . 0.71 112.625 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -81.01 -176.69 51.06 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.036 -0.602 . . . . 0.66 113.309 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.0 tmtm? -66.64 127.32 93.34 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 122.197 0.199 . . . . 1.52 110.79 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 4.9 Cg_exo -80.34 135.9 10.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.532 2.155 . . . . 0.44 112.797 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -137.11 114.0 9.79 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.786 -0.643 . . . . 1.09 110.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 69.3 Cg_exo -48.52 135.02 26.9 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.144 1.896 . . . . 0.64 113.123 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -99.06 -30.37 12.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 1.64 110.061 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.99 121.61 4.45 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.319 -0.855 . . . . 0.72 109.356 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.013 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.37 132.68 61.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.828 0.677 . . . . 0.96 112.828 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.88 151.46 46.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.879 -1.055 . . . . 1.46 109.68 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG2' ' CA ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -57.74 -18.1 19.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.339 -0.391 . . . . 2.42 111.706 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 17' ' ' THR . 4.5 m-70 -131.44 18.75 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.811 0.3 . . . . 1.02 111.811 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -178.56 114.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 0.68 111.422 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 13' ' ' ILE . 81.3 t -104.82 135.13 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.001 -0.545 . . . . 0.8 110.178 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.775 ' C ' HD13 ' A' ' 20' ' ' LEU . 61.6 m -111.52 132.27 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.35 110.661 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -140.83 143.19 34.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.96 0.886 . . . . 0.52 111.766 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -123.79 134.92 53.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.955 -1.475 . . . . 1.84 109.51 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 35.7 p90 -126.4 172.0 10.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 0.4 111.196 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.454 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -83.83 -157.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.762 -0.654 . . . . 0.83 110.84 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.75 159.31 69.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.47 -0.332 . . . . 2.11 110.607 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 28' ' ' THR . 55.4 Cg_endo -70.38 169.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.104 1.87 . . . . 0.89 111.815 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.33 -19.84 11.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.196 0.443 . . . . 2.77 112.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -112.74 -74.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.343 0.498 . . . . 1.37 112.343 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 25' ' ' PRO . 11.9 p 47.31 57.76 5.5 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.527 0.203 . . . . 0.91 110.704 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.75 -95.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.966 -0.635 . . . . 1.01 112.384 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -148.69 27.56 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.693 -0.963 . . . . 0.98 110.693 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.22 -177.56 3.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.471 . . . . 0.87 111.477 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -134.88 5.24 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 2.26 111.319 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 35' ' ' SER . 22.8 mt 60.53 145.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 1.71 110.605 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -133.31 18.27 4.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.842 0.312 . . . . 1.15 111.842 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.519 ' H ' HG22 ' A' ' 33' ' ' ILE . 47.9 t -179.96 151.23 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.168 0.509 . . . . 1.58 111.971 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.3 m-85 -134.4 100.31 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.736 . . . . 0.76 110.002 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.43 114.62 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 1.14 111.008 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -103.61 106.28 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.35 0.595 . . . . 0.63 110.596 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 25.2 mt-10 -75.31 154.92 37.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.251 -0.886 . . . . 1.67 111.212 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 2.7 pttt -117.07 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.134 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 2.8 ttm180 -112.85 101.65 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 1.44 109.788 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -68.54 141.47 55.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.848 -0.614 . . . . 1.59 110.622 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.516 HD12 ' HB1' ' A' ' 94' ' ' ALA . 6.9 mt -126.87 153.71 76.12 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.9 111.252 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.4 Cg_endo -81.8 24.08 8.27 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.962 -1.266 . . . . 1.43 113.616 0.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.407 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 1.4 p30 -154.46 100.25 2.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.363 . . . . 2.66 110.903 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -165.9 167.9 39.42 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.84 -0.695 . . . . 1.12 112.419 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.631 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -133.14 148.43 52.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 2.41 111.188 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 72.1 m95 -55.45 105.88 0.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.65 111.227 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.631 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -134.2 122.54 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 1.28 110.354 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -44.47 118.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 1.3 111.346 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -103.84 -9.83 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.86 111.993 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.58 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.6 p-10 -77.71 -54.72 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.201 -0.2 . . . . 2.01 111.467 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 38.34 35.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.999 0.37 . . . . 2.08 111.999 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 26.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.442 -0.345 . . . . 1.89 111.42 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.24 130.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.378 . . . . 1.87 111.211 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 36' ' ' TYR . 48.1 mt -129.99 84.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.69 110.633 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.34 -43.79 76.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 1.6 111.985 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.45 154.74 17.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.834 0.349 . . . . 1.54 110.866 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -72.81 -4.59 32.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 1.75 111.672 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -96.86 98.2 9.92 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.167 -0.679 . . . . 2.05 109.167 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 52' ' ' ASN . 69.8 t80 -128.48 164.53 22.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.452 0.644 . . . . 0.48 112.146 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -125.76 114.87 19.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.077 -0.965 . . . . 0.42 110.783 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 38' ' ' VAL . 14.3 t -77.66 109.09 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 1.08 110.817 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.77 151.45 26.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 1.33 111.055 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.93 4.57 10.27 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.574 -0.739 . . . . 0.9 112.396 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -68.54 -167.19 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.947 0.403 . . . . 1.47 110.918 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -150.25 139.32 21.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 1.06 110.76 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE1' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -58.86 130.45 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.91 111.063 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t0 76.16 49.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 1.87 111.277 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.03 127.42 4.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.49 111.356 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.24 134.23 41.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.134 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -133.2 125.2 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.798 0.666 . . . . 0.56 112.798 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.12 150.06 22.88 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.04 -0.726 . . . . 1.5 109.04 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.899 ' CE2' HG11 ' A' ' 18' ' ' VAL . 1.4 m-85 -134.71 117.24 15.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.146 1.165 . . . . 0.6 114.146 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 88' ' ' PRO . 24.1 ttm-85 -111.82 159.5 18.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.132 -0.94 . . . . 2.11 109.412 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -136.88 144.83 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.982 0.896 . . . . 0.6 112.803 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 86' ' ' SER . 22.8 mt -130.32 145.19 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.828 -1.533 . . . . 0.7 107.655 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -145.87 130.62 18.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.586 -0.846 . . . . 0.6 112.575 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -91.77 123.96 35.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 1.98 111.308 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.4 p-10 -66.28 -174.82 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.851 . . . . 2.19 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -65.68 -26.04 67.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.844 -0.616 . . . . 1.08 112.063 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.657 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -88.19 1.47 54.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.435 0.531 . . . . 1.06 112.435 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.8 79.76 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.369 -0.919 . . . . 0.93 113.078 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -77.31 68.08 3.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.239 0.543 . . . . 1.38 109.616 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -27.47 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 114.695 1.369 . . . . 0.79 114.695 -178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.879 ' O ' HG23 ' A' ' 77' ' ' ILE . 10.7 p -75.29 106.81 3.2 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.491 -1.67 . . . . 0.59 106.491 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 9.8 Cg_endo -50.32 169.08 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.88 2.387 . . . . 0.85 114.605 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 72.6 Cg_exo -31.04 136.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.251 3.3 . . . . 0.76 114.078 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 2.8 p -122.01 103.2 8.65 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.589 -0.732 . . . . 1.28 109.972 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -1.8 120.16 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.014 1.326 . . . . 1.77 113.872 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 4.6 Cg_exo -76.77 163.5 31.35 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.268 1.978 . . . . 0.55 113.882 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 2.0 t -90.97 146.71 23.64 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.002 -0.999 . . . . 1.23 109.401 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -38.75 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 O-C-N 123.72 0.637 . . . . 1.63 111.596 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -87.43 120.92 29.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.033 -0.53 . . . . 0.41 111.532 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -98.55 114.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 38.2 m -47.89 -28.68 2.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.839 -0.618 . . . . 0.44 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.869 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 m 50.14 60.6 3.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 1.1 110.973 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.702 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -95.41 -74.17 0.56 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.933 0.397 . . . . 3.0 111.147 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.483 ' CA ' ' HG2' ' A' ' 15' ' ' ARG . 7.2 p-10 -131.08 20.0 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.974 -0.557 . . . . 2.14 111.633 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.4 t0 . . . . . 0 N--CA 1.467 0.385 0 N-CA-C 112.649 0.611 . . . . 2.06 112.649 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.9 tt . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.882 0.373 . . . . 0.68 111.274 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 23.9 m-20 -132.22 129.97 21.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 2.0 110.475 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.22 157.98 15.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.532 2.155 . . . . 0.5 112.604 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 4.5 Cg_endo -48.35 -177.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.122 2.548 . . . . 0.71 113.514 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 168.78 29.26 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.53 -0.759 . . . . 0.66 112.957 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -53.39 128.13 50.18 Favored Pre-proline 0 CA--C 1.53 0.197 0 O-C-N 122.987 -0.126 . . . . 1.52 110.811 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 11.8 Cg_exo -74.98 113.95 3.91 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.506 2.137 . . . . 0.44 112.701 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -104.72 107.76 59.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 1.09 110.652 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 27.2 Cg_exo -61.7 105.71 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.525 2.15 . . . . 0.64 113.789 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -63.22 -32.92 74.44 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.89 -0.782 . . . . 1.64 108.89 178.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.99 143.92 32.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.878 -1.055 . . . . 0.72 109.061 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.059 HG22 HG13 ' A' ' 18' ' ' VAL . 3.2 pt -138.74 81.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.146 0.424 . . . . 0.96 112.146 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.257 HG22 ' OD1' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -79.97 151.44 30.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 1.46 110.237 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -56.48 -20.67 21.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.982 -0.554 . . . . 2.42 111.877 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 17' ' ' THR . 0.3 OUTLIER -125.86 11.4 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.252 0.464 . . . . 1.02 112.252 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -169.85 115.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.68 110.709 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 13' ' ' ILE . 24.9 t -109.83 119.51 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.061 0.458 . . . . 0.8 111.232 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.73 ' C ' HD13 ' A' ' 20' ' ' LEU . 11.0 m -99.8 124.77 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.675 -0.693 . . . . 0.35 110.811 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.18 150.33 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.805 0.812 . . . . 0.52 112.315 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.86 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.35 154.35 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.313 -1.312 . . . . 1.84 109.798 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.4 p90 -142.21 -176.05 4.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.278 0.561 . . . . 0.4 112.397 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.65 24.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.44 -0.8 . . . . 0.83 111.154 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 4.0 tmmm? -84.91 139.21 37.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 2.11 110.758 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.691 ' CB ' HG23 ' A' ' 28' ' ' THR . 93.0 Cg_exo -43.84 160.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.216 1.944 . . . . 0.89 111.837 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -106.94 -15.92 14.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.77 111.749 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 -70.62 0.7 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.863 0.32 . . . . 1.37 111.863 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 25' ' ' PRO . 14.4 p 50.59 54.78 10.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.971 0.415 . . . . 0.91 110.382 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.33 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.927 -0.579 . . . . 1.01 112.55 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.66 24.06 2.77 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.35 -0.7 . . . . 0.98 111.35 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -92.04 -176.64 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 0.87 111.923 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 13.6 ttpt -130.87 -13.48 3.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.646 -0.706 . . . . 2.26 112.209 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.625 HD11 HG21 ' A' ' 28' ' ' THR . 11.4 mt 64.1 132.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.701 -0.481 . . . . 1.71 109.701 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -124.42 11.82 8.69 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.575 0.583 . . . . 1.15 112.575 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 146.35 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.999 0.428 . . . . 1.58 112.138 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.506 ' O ' HD12 ' A' ' 56' ' ' ILE . 51.1 m-85 -118.52 122.16 42.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.717 -0.674 . . . . 0.76 109.972 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -107.85 129.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.765 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -119.28 130.22 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.63 110.584 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.5 mt-10 -94.54 136.66 34.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.442 -0.799 . . . . 1.67 110.668 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -99.94 159.36 15.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 1.97 111.112 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.832 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -140.73 105.29 4.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.543 . . . . 1.44 110.546 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.704 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -75.11 80.41 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.59 110.97 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 41' ' ' ARG . 1.2 mm? -65.63 155.82 84.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.9 110.763 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -91.81 36.7 5.99 Favored 'Cis proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.063 -1.224 . . . . 1.43 112.639 0.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -162.18 57.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.923 0.392 . . . . 2.66 111.11 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.704 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -127.05 172.79 18.51 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.973 -0.632 . . . . 1.12 112.156 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.62 51.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.217 0.532 . . . . 2.41 111.348 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.712 ' O ' HD22 ' A' ' 49' ' ' LEU . 50.5 m95 -60.94 124.05 19.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.391 -0.822 . . . . 0.65 110.527 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -154.95 124.05 6.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.841 0.353 . . . . 1.28 111.295 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -50.95 115.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.3 110.537 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -99.26 -35.22 10.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.86 111.545 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.686 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.1 p-10 -53.54 -62.5 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.316 . . . . 2.01 111.85 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 3.5 t80 80.05 -51.39 0.37 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.544 0.211 . . . . 2.08 111.259 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -64.04 -171.31 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.886 0.374 . . . . 1.89 110.975 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.2 106.13 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 1.87 110.814 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.4 mt -92.42 74.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 0.69 111.268 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -73.65 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.6 111.018 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.51 174.12 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.54 110.189 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 44.4 p30 -92.86 17.38 10.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.267 -0.424 . . . . 1.75 111.452 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.69 103.01 9.28 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 59.1 t80 -134.68 164.18 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.068 0.461 . . . . 0.48 111.537 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.661 HG23 ' OG1' ' A' ' 19' ' ' THR . 17.3 m -122.03 119.68 32.12 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.672 -0.694 . . . . 0.42 111.152 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.635 HG23 HD21 ' A' ' 20' ' ' LEU . 22.3 t -86.92 97.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 1.08 110.995 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.28 150.74 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.665 -0.698 . . . . 1.33 110.951 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.57 7.45 8.92 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.711 -0.677 . . . . 0.9 112.338 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 72' ' ' TYR . 4.4 mm? -51.81 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.018 0.437 . . . . 1.47 110.928 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 m -142.71 111.01 6.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.813 -0.631 . . . . 1.06 110.112 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -42.0 138.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.91 111.869 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.79 56.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.897 -0.592 . . . . 1.87 111.583 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.44 123.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.49 111.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.12 134.43 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.36 110.536 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' HD12 ' A' ' 66' ' ' LEU . 49.4 m-85 -130.6 118.89 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.317 0.488 . . . . 0.56 112.317 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.72 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.08 143.09 30.69 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.311 -0.626 . . . . 1.5 109.311 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.57 119.89 13.86 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.486 1.291 . . . . 0.6 114.486 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -108.06 173.57 6.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.444 -0.947 . . . . 2.11 108.444 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.85 113.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 114.116 1.154 . . . . 0.6 114.116 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 37' ' ' ILE . 41.6 mt -97.32 154.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 106.479 -1.674 . . . . 0.7 106.479 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.16 128.27 1.29 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.434 -0.906 . . . . 0.6 111.656 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 85' ' ' ILE . 20.6 mttt -63.57 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.047 -0.723 . . . . 1.98 109.047 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.758 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.1 m-80 -146.01 -94.21 0.09 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.66 -0.416 . . . . 2.19 110.925 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -137.15 -42.28 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 1.08 110.952 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.18 30.45 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.06 111.996 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.16 -12.37 58.34 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.541 -0.838 . . . . 0.93 113.353 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.518 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -53.11 115.75 2.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.973 0.386 . . . . 1.38 110.894 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -87.78 104.37 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.034 0.445 . . . . 0.79 111.519 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.65 119.76 71.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 109.803 -0.443 . . . . 0.59 109.803 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.24 162.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.177 2.585 . . . . 0.85 113.122 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 36.7 Cg_endo -66.26 142.3 66.19 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.695 2.263 . . . . 0.76 112.409 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.8 m -94.59 105.32 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 1.28 110.332 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 tt0 -4.27 115.27 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 124.705 1.202 . . . . 1.77 113.681 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.527 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.2 Cg_exo -56.2 141.8 87.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.125 1.883 . . . . 0.55 113.6 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 15.7 m -72.31 143.17 48.79 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.753 -0.832 . . . . 1.23 108.753 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.0 m-20 -41.12 137.27 1.36 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.768 0.668 . . . . 1.63 110.752 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -62.85 117.76 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.036 -0.529 . . . . 0.41 111.779 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' SG ' ' A' ' 97' ' ' CYS . 3.9 mp -92.35 110.82 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.615 -0.72 . . . . 0.44 110.422 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.488 HG21 ' NH1' ' A' ' 98' ' ' ARG . 26.0 m -46.95 -39.04 11.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.919 0.39 . . . . 0.44 110.655 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 95' ' ' ILE . 99.1 m 61.46 89.13 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.504 . . . . 1.1 110.91 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.4 -82.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 3.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.568 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 11.7 p-10 -96.02 30.28 2.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.752 -0.658 . . . . 2.14 110.653 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.257 ' OD1' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 2.06 112.036 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.559 0.219 . . . . 0.68 110.657 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.74 151.57 68.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 2.0 111.773 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.71 164.62 12.1 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.907 2.405 . . . . 0.5 112.043 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.33 -164.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.501 2.134 . . . . 0.71 112.637 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.34 -153.59 27.95 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.939 -0.648 . . . . 0.66 113.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -90.09 125.05 61.7 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.407 0.146 . . . . 1.52 111.008 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 23.3 Cg_exo -66.52 130.89 24.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.489 2.126 . . . . 0.44 112.327 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.05 98.42 17.38 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.163 -0.471 . . . . 1.09 111.19 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.9 Cg_exo -47.14 130.41 16.58 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.64 113.081 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 21' ' ' LYS . 2.2 mt -90.71 -30.75 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.055 -0.721 . . . . 1.64 109.055 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.49 119.65 6.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.167 -0.924 . . . . 0.72 109.218 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -117.39 122.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.96 112.448 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.94 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -124.52 160.5 28.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.831 . . . . 1.46 110.237 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -59.02 -13.97 8.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.394 0.516 . . . . 2.42 112.394 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -140.44 23.9 2.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.285 0.476 . . . . 1.02 112.285 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -175.98 113.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.841 0.353 . . . . 0.68 110.232 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 44.7 t -116.24 99.28 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.153 0.427 . . . . 0.8 112.153 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.802 ' OG1' HG23 ' A' ' 62' ' ' THR . 46.1 m -83.66 144.85 29.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.35 110.68 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -148.55 163.97 35.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.649 0.737 . . . . 0.52 112.499 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 11' ' ' LEU . 28.4 tptp -145.58 137.86 25.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.595 -1.184 . . . . 1.84 109.601 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 37.4 p90 -133.81 177.93 7.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.183 0.516 . . . . 0.4 111.709 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.3 -163.95 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.83 110.838 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -128.68 140.38 38.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.901 -0.59 . . . . 2.11 110.185 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HG2' HD11 ' A' ' 33' ' ' ILE . 95.9 Cg_exo -39.05 161.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.166 . . . . 0.89 112.2 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.44 -43.22 5.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -108.91 -70.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.482 0.549 . . . . 1.37 112.482 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 19.5 p 55.77 40.78 30.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.429 . . . . 0.91 109.951 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.67 -100.21 0.02 OUTLIER Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.804 -0.635 . . . . 1.01 112.53 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.35 27.62 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.295 -0.722 . . . . 0.98 111.295 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -111.85 -171.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.87 111.267 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.29 35.3 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 2.26 111.24 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 25' ' ' PRO . 2.9 mm 59.44 158.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.465 -0.334 . . . . 1.71 110.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 33' ' ' ILE . 81.1 p -138.87 1.74 2.1 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.656 0.613 . . . . 1.15 112.656 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 33' ' ' ILE . 10.0 t 168.59 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.7 0.286 . . . . 1.58 111.539 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.771 ' O ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -99.82 87.06 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.76 111.113 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.541 HG21 ' HD2' ' A' ' 50' ' ' LYS . 1.1 mp -73.74 120.47 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 1.14 110.796 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 63' ' ' VAL . 14.0 t -94.15 107.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.111 0.481 . . . . 0.63 111.563 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.82 139.24 31.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 1.67 110.616 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.711 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -108.12 138.93 43.54 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.904 0.383 . . . . 1.97 111.568 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -119.12 97.41 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.564 -0.902 . . . . 1.44 108.564 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.862 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -65.48 97.16 0.28 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.403 -0.817 . . . . 1.59 110.603 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -69.3 148.01 97.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.9 110.837 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -93.93 32.22 11.17 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.966 -1.264 . . . . 1.43 112.861 0.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.79 64.63 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.754 0.311 . . . . 2.66 111.547 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.862 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -95.85 -174.77 36.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 1.12 112.032 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 26.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 2.41 110.777 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.8 m95 41.38 88.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.099 0.476 . . . . 0.65 111.202 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 137.86 54.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.28 111.27 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 37' ' ' ILE . 1.4 mtmt -53.89 129.14 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 1.3 110.4 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -110.29 -31.55 7.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.86 110.645 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.692 ' HB3' HD11 ' A' ' 56' ' ' ILE . 10.7 p-10 -57.18 -43.31 82.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 2.01 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.87 25.08 10.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 2.08 110.766 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -169.77 3.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 1.89 110.956 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -94.9 116.08 28.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.87 110.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 36' ' ' TYR . 27.1 mt -105.71 90.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.54 . . . . 0.69 110.636 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.497 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.6 mt -74.62 -61.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.6 111.336 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -75.02 159.16 32.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.934 0.397 . . . . 1.54 110.621 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -74.85 -3.22 30.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 1.75 111.039 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 1.7 tt0 -100.46 103.53 14.89 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.413 -0.588 . . . . 2.05 109.413 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.9 t80 -140.19 165.35 27.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.48 111.779 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' OG1' ' A' ' 19' ' ' THR . 8.1 m -121.29 114.78 21.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.42 111.391 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 38' ' ' VAL . 56.6 t -84.71 90.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.143 0.497 . . . . 1.08 111.041 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.67 151.69 19.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.33 111.0 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.34 14.65 7.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.9 112.354 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 72' ' ' TYR . 3.6 mm? -58.25 -179.67 0.06 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.132 0.491 . . . . 1.47 111.357 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 m -133.37 109.23 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.589 -0.732 . . . . 1.06 110.199 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.91 135.7 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.087 -0.506 . . . . 1.91 111.816 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 97' ' ' CYS . 9.5 m-20 65.64 62.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.87 111.215 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.7 114.74 0.17 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.509 -0.314 . . . . 0.49 111.588 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.18 135.34 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.731 -0.47 . . . . 0.36 109.731 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 33.3 m-85 -128.61 121.51 28.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.162 0.801 . . . . 0.56 113.162 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' HD21 ' A' ' 43' ' ' LEU . 1.1 mt-10 -99.3 133.7 43.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.618 -1.253 . . . . 1.5 107.618 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.756 ' HE2' HG11 ' A' ' 18' ' ' VAL . 7.8 m-85 -117.94 114.87 23.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.138 1.532 . . . . 0.6 115.138 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -100.72 135.34 42.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.193 -0.912 . . . . 2.11 108.998 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -108.24 127.39 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 119.288 -0.965 . . . . 0.6 111.721 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.741 HG23 ' O ' ' A' ' 86' ' ' SER . 94.1 mt -115.52 143.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.811 -1.086 . . . . 0.7 108.126 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.11 134.45 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.833 -0.747 . . . . 0.6 112.395 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -84.85 -178.6 6.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.28 -0.568 . . . . 1.98 110.626 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.521 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.3 p-10 -127.84 -173.23 2.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.36 -0.836 . . . . 2.19 110.104 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -69.66 -11.96 61.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.041 -0.527 . . . . 1.08 112.095 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -104.01 -4.23 23.6 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.228 0.455 . . . . 1.06 112.228 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.98 87.93 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.452 -0.88 . . . . 0.93 113.291 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -76.57 71.98 3.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.341 0.591 . . . . 1.38 109.951 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.9 tt -36.56 123.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.96 1.096 . . . . 0.79 113.96 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.6 p -76.2 107.81 5.12 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.372 -1.344 . . . . 0.59 107.372 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 14.6 Cg_endo -55.18 171.4 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.592 2.194 . . . . 0.85 113.454 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 77' ' ' ILE . 48.0 Cg_exo -31.95 122.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.973 3.115 . . . . 0.76 113.317 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 4.1 p -106.85 103.82 13.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 1.28 110.121 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 9.98 113.85 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 125.045 1.466 . . . . 1.77 113.416 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 15.4 Cg_exo -68.31 162.39 40.67 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.88 1.72 . . . . 0.55 114.292 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.82 152.75 18.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.153 -0.93 . . . . 1.23 109.345 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -33.75 156.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.112 0.882 . . . . 1.63 112.294 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -90.64 103.3 16.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.41 111.363 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.709 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.0 mp -82.81 110.24 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.44 111.497 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 90.8 m -48.74 -35.37 14.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.13 0.491 . . . . 0.44 110.612 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.506 ' SG ' HG22 ' A' ' 95' ' ' ILE . 91.7 m 56.93 79.6 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.673 -0.694 . . . . 1.1 111.046 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -87.68 0.47 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.506 -0.315 . . . . 3.0 111.381 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -111.17 0.43 16.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.426 -0.352 . . . . 2.14 111.666 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.94 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.907 0.385 . . . . 2.06 111.215 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 80' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.986 0.422 . . . . 0.68 111.434 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 5.1 m-20 -122.02 142.97 37.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 2.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.53 168.64 17.84 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.569 2.179 . . . . 0.5 112.402 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 174.29 2.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.654 2.236 . . . . 0.71 112.898 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -72.4 177.12 40.61 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.66 112.493 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.0 tttt -60.77 127.53 87.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.533 -0.173 . . . . 1.52 110.533 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' HG13 ' A' ' 76' ' ' VAL . 7.0 Cg_exo -74.29 156.89 46.13 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.352 2.035 . . . . 0.44 112.074 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -152.47 114.56 2.85 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.415 -0.357 . . . . 1.09 111.677 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 25.6 Cg_exo -61.44 111.31 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.691 2.26 . . . . 0.64 113.405 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.58 -33.85 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.661 -0.866 . . . . 1.64 108.661 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.871 -1.059 . . . . 0.72 108.995 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.002 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -133.98 105.3 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.96 112.041 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 151.23 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.7 -0.682 . . . . 1.46 110.35 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -60.29 -16.06 30.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.422 . . . . 2.42 111.439 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 17' ' ' THR . 6.1 m-70 -132.29 16.96 4.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.48 0.181 . . . . 1.02 111.464 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -176.27 106.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.946 0.403 . . . . 0.68 110.917 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.002 HG13 HG22 ' A' ' 13' ' ' ILE . 49.7 t -102.57 117.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.966 -0.561 . . . . 0.8 110.971 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.33 128.9 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.35 111.571 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -139.77 156.47 46.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.935 0.874 . . . . 0.52 112.412 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.932 ' HG2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -124.71 -170.45 2.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.04 -1.437 . . . . 1.84 109.219 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.7 p90 -179.83 161.14 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.4 111.836 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -80.77 168.06 19.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.83 111.797 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.27 141.42 32.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.53 -0.759 . . . . 2.11 110.236 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 28' ' ' THR . 4.5 Cg_endo -46.51 166.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.369 2.046 . . . . 0.89 111.716 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -102.93 -55.62 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.238 -0.437 . . . . 2.77 111.518 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -113.15 61.92 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.567 -0.288 . . . . 1.37 111.331 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.49 ' O ' ' CE2' ' A' ' 31' ' ' PHE . 44.4 p -57.68 -25.08 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.709 0.29 . . . . 0.91 110.452 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.09 -65.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.579 -0.819 . . . . 1.01 111.886 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 40.09 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.991 -1.244 . . . . 0.98 109.991 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -137.87 -176.92 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.087 -0.557 . . . . 0.87 111.024 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -144.3 15.21 1.66 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.5 0.556 . . . . 2.26 112.5 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.608 ' C ' HG23 ' A' ' 34' ' ' THR . 5.1 mp 64.22 -74.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 111.905 0.335 . . . . 1.71 111.905 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 79.53 21.43 0.6 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.573 -0.285 . . . . 1.15 111.696 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.595 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 169.96 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.924 -0.126 . . . . 1.58 111.232 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.8 m-85 -118.06 128.71 55.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.94 0.4 . . . . 0.76 112.001 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -119.4 120.67 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.513 -0.312 . . . . 1.14 110.433 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -105.69 140.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.879 0.371 . . . . 0.63 110.813 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' CD ' HD11 ' A' ' 77' ' ' ILE . 2.6 mt-10 -101.96 135.52 43.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.259 0.552 . . . . 1.67 111.966 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.837 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 mtmp? -101.26 139.19 37.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.273 -0.876 . . . . 1.97 111.336 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.556 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 7.6 ptt180 -132.63 115.65 15.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.454 0.645 . . . . 1.44 109.84 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -75.65 113.11 12.72 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.123 -0.944 . . . . 1.59 111.053 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 2.5 mm? -73.58 161.04 80.76 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.9 110.412 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 80.6 Cg_endo -83.8 14.89 33.18 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 124.115 -1.202 . . . . 1.43 113.427 0.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -98.65 -77.81 0.51 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.938 -0.393 . . . . 2.66 109.938 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' A' ' 41' ' ' ARG . . . 92.22 130.81 5.26 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.633 -0.794 . . . . 1.12 113.206 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.615 HH11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.47 1.68 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.64 0.237 . . . . 2.41 111.64 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.593 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 40.4 m95 44.31 94.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.205 0.202 . . . . 0.65 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.615 HD22 HH11 ' A' ' 47' ' ' ARG . 1.4 mp -123.62 135.55 54.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.955 0.407 . . . . 1.28 111.615 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HD2' HG21 ' A' ' 37' ' ' ILE . 9.7 mtmt -62.99 82.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 1.3 110.662 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.837 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -49.11 -53.94 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.231 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -60.31 138.28 57.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 2.01 111.06 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -136.77 23.07 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 2.08 111.031 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 t -120.73 -83.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 1.89 110.72 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 178.48 120.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 1.87 110.86 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.0 mt -107.02 98.99 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.69 110.986 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -76.68 -68.25 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 1.6 111.087 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -74.85 -179.12 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 1.54 110.65 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.9 OUTLIER -86.93 -2.91 58.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 1.75 111.482 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.932 ' CD ' ' HG2' ' A' ' 21' ' ' LYS . 9.0 tp10 -97.42 101.86 13.49 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.749 0.309 . . . . 2.05 110.179 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CG ' HD13 ' A' ' 56' ' ' ILE . 40.3 t80 -135.81 165.49 25.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.055 0.455 . . . . 0.48 111.584 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.7 m -122.21 120.69 34.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.758 -0.655 . . . . 0.42 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.653 ' CG2' HD21 ' A' ' 20' ' ' LEU . 4.8 t -85.77 112.07 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.995 -0.548 . . . . 1.08 111.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -173.38 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 1.33 110.944 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.8 9.58 71.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.747 . . . . 0.9 112.847 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG23 ' A' ' 18' ' ' VAL . 1.6 mt -61.72 -177.19 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 1.47 110.83 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 72' ' ' TYR . 3.8 t -138.93 11.49 2.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.026 0.38 . . . . 1.06 112.026 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 56.9 159.31 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.006 0.432 . . . . 1.91 111.382 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 90.5 m-20 45.76 66.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 1.87 111.368 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 174.76 119.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.067 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.83 132.82 55.12 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.205 -0.598 . . . . 0.36 110.281 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 67' ' ' THR . 25.0 m-85 -130.34 121.0 25.2 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.003 0.742 . . . . 0.56 113.003 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 92' ' ' SER . 2.4 tt0 -102.66 141.05 36.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.516 -0.55 . . . . 1.5 109.516 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.777 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.65 128.01 26.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.126 1.158 . . . . 0.6 114.126 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.593 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -111.32 160.98 16.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.31 -0.626 . . . . 2.11 109.31 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -121.3 112.32 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.057 -0.657 . . . . 0.6 111.955 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.945 HG22 ' O ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -105.05 179.81 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.237 -0.892 . . . . 0.7 108.852 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -179.37 -162.59 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.106 0.479 . . . . 0.6 111.395 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.7 mttt -136.85 -171.53 2.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.275 -1.009 . . . . 1.98 108.275 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.865 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.8 p-10 -135.72 156.62 48.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.056 0.455 . . . . 2.19 110.54 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.35 -29.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.601 -0.727 . . . . 1.08 112.084 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -77.07 -24.5 51.88 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.815 0.672 . . . . 1.06 112.815 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.29 -11.5 26.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.431 -0.89 . . . . 0.93 112.341 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.865 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . . . -59.89 -156.63 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.958 -0.386 . . . . 1.38 109.958 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -145.15 114.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.059 0.762 . . . . 0.79 113.059 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.945 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 p -64.71 109.91 3.43 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.59 107.028 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 12.3 Cg_endo -54.48 147.63 46.8 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.159 1.906 . . . . 0.85 112.767 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.927 ' HA ' HG23 ' A' ' 77' ' ' ILE . 47.8 Cg_exo -37.22 120.53 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.378 2.719 . . . . 0.76 113.666 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.54 ' OG ' HG13 ' A' ' 76' ' ' VAL . 28.2 p -87.21 101.98 14.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.05 -0.523 . . . . 1.28 110.128 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.8 tt0 0.41 111.05 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.991 1.316 . . . . 1.77 114.292 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 51.9 Cg_exo -48.61 167.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.156 1.904 . . . . 0.55 113.19 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -105.91 143.88 33.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.064 -0.971 . . . . 1.23 109.038 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.579 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -28.36 144.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.187 0.929 . . . . 1.63 112.555 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.67 111.02 15.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.41 110.911 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.784 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.2 mp -88.8 120.29 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.7 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.7 m -57.82 -13.02 3.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.812 -0.631 . . . . 0.44 112.408 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.784 ' H ' HG22 ' A' ' 95' ' ' ILE . 26.4 p 43.77 70.62 0.3 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.887 0.375 . . . . 1.1 111.287 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -101.1 -87.95 0.38 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.982 -0.554 . . . . 3.0 111.187 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.38 8.61 7.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 2.14 111.485 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.9 t0 . . . . . 0 C--N 1.334 -0.108 0 CA-C-O 120.844 0.354 . . . . 2.06 110.93 -179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.97 HD11 ' ND2' ' A' ' 80' ' ' ASN . 7.3 tt . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 121.464 0.65 . . . . 0.68 112.341 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -134.22 119.71 14.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 2.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.8 171.35 18.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.501 2.134 . . . . 0.5 112.79 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 45.6 Cg_exo -56.72 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.805 2.337 . . . . 0.71 112.556 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 -171.33 39.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.85 -0.691 . . . . 0.66 112.576 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 33.8 tttt -73.76 128.96 85.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.369 0.128 . . . . 1.52 110.825 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 20.4 Cg_exo -69.19 143.92 55.24 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.44 112.713 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.19 97.41 5.23 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.586 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.3 Cg_exo -50.14 128.82 23.51 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.252 1.968 . . . . 0.64 113.493 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 21' ' ' LYS . 2.8 mm? -83.97 -35.43 23.97 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.184 -1.043 . . . . 1.64 108.184 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.48 37.32 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.583 -1.19 . . . . 0.72 107.891 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -136.35 102.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.778 0.659 . . . . 0.96 112.778 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -106.42 144.3 33.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.33 -0.85 . . . . 1.46 110.173 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -46.33 -23.69 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.693 -0.685 . . . . 2.42 112.78 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 17' ' ' THR . 7.8 m170 -125.9 -1.59 7.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.505 0.557 . . . . 1.02 112.505 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' HIS . 1.8 p -157.91 115.23 2.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.943 0.401 . . . . 0.68 110.487 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 HG22 ' A' ' 13' ' ' ILE . 57.9 t -119.0 114.57 45.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.8 112.032 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 12.7 m -83.34 146.82 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.35 109.928 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.28 160.17 43.38 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.847 0.684 . . . . 0.52 112.847 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.725 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.49 147.92 32.69 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.854 -1.066 . . . . 1.84 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.4 p90 -142.68 -177.8 5.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.4 111.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 176.62 7.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.83 112.049 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -115.95 143.33 30.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.742 -0.663 . . . . 2.11 110.899 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 73.5 Cg_exo -51.55 -179.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.531 2.154 . . . . 0.89 112.426 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.157 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 3.1 pm0 -125.69 -35.27 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 2.77 111.927 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -106.73 -69.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.173 0.434 . . . . 1.37 112.173 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 40.9 p 56.2 40.42 30.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.91 110.426 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.22 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.873 -0.68 . . . . 1.01 112.109 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.34 35.0 1.59 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.362 -1.095 . . . . 0.98 110.362 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.663 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 3.1 m-85 -113.16 -178.11 3.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.812 -0.694 . . . . 0.87 111.71 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 1.41 2.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.697 -0.683 . . . . 2.26 112.224 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 79' ' ' LYS . 7.3 mt 57.97 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.117 0.484 . . . . 1.71 111.769 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -132.79 6.97 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.021 -0.536 . . . . 1.15 111.997 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -179.41 142.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.865 0.364 . . . . 1.58 111.474 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 35.6 m-85 -113.85 109.6 18.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.844 -0.617 . . . . 0.76 111.423 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -89.29 104.6 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.14 110.63 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -99.3 119.0 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.63 111.209 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -80.12 163.08 24.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.649 -0.705 . . . . 1.67 111.236 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -118.82 168.07 11.11 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.658 -0.701 . . . . 1.97 109.285 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.94 87.05 0.98 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.793 -0.763 . . . . 1.44 111.386 177.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.842 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -66.51 85.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 1.59 110.963 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -61.94 159.4 36.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.595 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.9 Cg_exo -80.83 21.67 9.18 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.261 -1.141 . . . . 1.43 113.703 0.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.403 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 67.2 m-80 -132.41 -85.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.027 -0.269 . . . . 2.66 110.536 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.94 -164.7 0.02 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.073 -0.584 . . . . 1.12 112.945 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.51 145.07 3.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 2.41 110.491 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 53.7 m95 -65.58 77.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.638 -0.71 . . . . 0.65 111.786 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -112.78 156.65 22.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.998 -0.547 . . . . 1.28 109.855 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -50.25 90.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.689 0.281 . . . . 1.3 111.24 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB2' ' CB ' ' A' ' 40' ' ' LYS . . . -60.2 -31.63 70.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.29 0.567 . . . . 0.86 109.514 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.776 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.9 p-10 -91.69 -145.41 0.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.289 -0.868 . . . . 2.01 110.492 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 175.85 -33.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.86 0.362 . . . . 2.08 110.194 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -91.92 171.53 9.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.89 110.738 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.63 105.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.87 111.086 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 52' ' ' ASN . 14.4 mt -87.98 53.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.69 110.306 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.3 tm? -44.2 -54.6 5.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.978 -0.556 . . . . 1.6 111.233 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -84.07 158.95 21.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.089 -0.505 . . . . 1.54 109.974 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.481 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 12.4 p30 -80.37 4.68 17.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.43 -0.35 . . . . 1.75 111.587 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -98.38 94.34 6.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.013 -0.736 . . . . 2.05 109.013 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 74.3 t80 -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.142 0.496 . . . . 0.48 112.052 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.507 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 10.9 m -133.74 109.62 9.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.42 110.954 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.74 HG21 ' CE1' ' A' ' 74' ' ' PHE . 27.8 m -67.42 114.31 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 1.08 111.238 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -117.42 129.44 55.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.892 -0.594 . . . . 1.33 111.21 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.21 6.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.9 112.857 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.33 -158.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 1.47 110.548 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.6 m -138.04 147.78 44.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.496 -0.32 . . . . 1.06 110.181 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -82.5 142.01 32.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 1.91 111.332 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t0 65.94 60.08 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.547 . . . . 1.87 111.36 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.66 128.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 0.49 110.919 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.81 143.53 50.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.806 0.336 . . . . 0.36 110.422 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 2.0 m-85 -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.529 0.566 . . . . 0.56 112.529 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.793 ' OE1' ' HB2' ' A' ' 94' ' ' ALA . 6.5 tp10 -101.54 140.55 35.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.018 -0.734 . . . . 1.5 109.018 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.74 ' CE1' HG21 ' A' ' 63' ' ' VAL . 8.6 m-85 -123.82 110.54 15.02 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.668 0.988 . . . . 0.6 113.668 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 ttm180 -90.32 159.83 16.43 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.636 -0.711 . . . . 2.11 109.962 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 47.8 t -130.7 120.7 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.536 0.939 . . . . 0.6 113.536 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.6 mt -123.33 153.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.703 -1.591 . . . . 0.7 106.703 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -173.21 123.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.417 -1.313 . . . . 0.6 113.937 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 33' ' ' ILE . 18.4 mttt -68.21 158.8 32.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.97 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -99.8 -91.35 0.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.843 -0.743 . . . . 2.19 111.805 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -133.89 -42.63 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.276 0.472 . . . . 1.08 112.276 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.663 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -95.05 40.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.33 0.493 . . . . 1.06 112.33 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.73 8.72 41.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.93 113.196 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.75 92.66 4.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.0 0.4 . . . . 1.38 109.947 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -62.71 107.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.28 0.474 . . . . 0.79 112.28 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 8.3 p -62.89 121.92 71.46 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.005 -0.739 . . . . 0.59 109.005 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.59 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.266 . . . . 0.85 112.624 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 4.2 Cg_exo -73.3 155.37 51.34 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.822 2.348 . . . . 0.76 112.829 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.26 135.34 53.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.626 -0.715 . . . . 1.28 110.304 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.4 tt0 -35.24 110.89 0.42 Allowed Pre-proline 0 N--CA 1.469 0.503 0 O-C-N 124.0 0.812 . . . . 1.77 111.848 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 75.3 Cg_exo -50.96 145.46 24.55 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.827 2.351 . . . . 0.55 114.4 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.62 149.86 41.76 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.608 -0.886 . . . . 1.23 108.608 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -34.12 155.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.076 0.86 . . . . 1.63 112.093 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -89.31 110.82 21.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.41 111.847 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.664 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.2 mp -88.22 112.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.44 111.167 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.486 HG21 ' NH1' ' A' ' 98' ' ' ARG . 85.6 m -42.77 -29.9 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.004 0.43 . . . . 0.44 110.87 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.531 ' H ' HG22 ' A' ' 95' ' ' ILE . 84.7 m 51.07 69.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 1.1 110.439 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.486 ' NH1' HG21 ' A' ' 96' ' ' THR . 1.5 ptp85 -111.87 -87.51 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 3.0 110.824 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.537 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 1.2 p30 -123.49 0.27 8.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.111 -0.495 . . . . 2.14 110.884 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.2 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 2.06 111.71 -179.886 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.9 tt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.818 0.342 . . . . 0.68 110.89 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 28' ' ' THR . 9.8 m-20 -130.12 135.08 26.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 2.0 110.193 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -83.3 175.16 8.5 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.558 2.172 . . . . 0.5 112.837 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -65.18 171.64 8.71 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.914 2.409 . . . . 0.71 112.676 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.74 173.04 53.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.007 -0.616 . . . . 0.66 112.831 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -63.9 123.23 81.12 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.498 0.149 . . . . 1.52 110.677 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 34.8 Cg_exo -65.27 131.1 27.25 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.453 2.102 . . . . 0.44 112.699 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 108.01 20.74 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.007 -0.542 . . . . 1.09 110.575 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 39.0 Cg_exo -58.94 115.07 2.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.471 2.114 . . . . 0.64 113.976 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -77.71 -38.43 47.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.885 -0.783 . . . . 1.64 108.885 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.73 145.36 49.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.8 -1.091 . . . . 0.72 108.701 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.071 HG22 HG13 ' A' ' 18' ' ' VAL . 1.7 pt -141.0 97.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.598 0.592 . . . . 0.96 112.598 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.96 147.7 23.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.643 -0.708 . . . . 1.46 109.34 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -53.5 -18.28 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.226 0.454 . . . . 2.42 112.226 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.463 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 2.5 m-70 -126.78 -4.22 6.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.272 0.471 . . . . 1.02 112.272 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 116.46 5.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.873 0.368 . . . . 0.68 111.107 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 13' ' ' ILE . 66.6 t -105.25 134.41 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.009 0.433 . . . . 0.8 111.167 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 m -111.96 122.47 47.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.35 110.669 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.98 149.23 52.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.753 0.787 . . . . 0.52 112.203 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.936 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 7.0 tptt -133.09 139.01 46.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.427 -1.261 . . . . 1.84 109.704 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.9 p90 -128.64 -174.98 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.056 0.455 . . . . 0.4 111.881 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.23 179.33 5.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.83 112.044 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -107.88 138.68 20.13 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 2.11 110.221 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 28' ' ' THR . 79.9 Cg_exo -44.21 171.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.418 2.079 . . . . 0.89 112.613 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -110.89 -25.06 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 2.77 111.992 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.51 -69.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.158 0.429 . . . . 1.37 112.158 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 25' ' ' PRO . 64.4 p 51.37 56.22 8.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.91 110.704 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.12 -93.46 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.966 -0.561 . . . . 1.01 112.844 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.02 32.95 1.05 Allowed Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.008 -1.237 . . . . 0.98 110.008 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.99 179.54 3.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.738 -0.731 . . . . 0.87 111.009 -178.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.34 -3.17 3.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.179 -0.464 . . . . 2.26 112.185 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.1 mt 61.27 138.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.921 0.391 . . . . 1.71 110.606 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -140.78 24.72 2.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 1.15 111.525 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.2 m -166.51 102.69 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 1.58 111.618 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 33.8 m-85 -98.12 115.64 28.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.76 110.454 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -104.63 112.71 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.14 111.199 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -101.54 114.59 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 0.63 110.74 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -79.6 151.24 30.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.522 -0.763 . . . . 1.67 110.347 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -121.27 140.13 52.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.168 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.699 ' O ' HD22 ' A' ' 43' ' ' LEU . 9.5 ttp180 -121.73 116.4 24.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.44 110.371 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -76.57 102.69 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 1.59 110.798 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.6 mm? -88.65 156.83 50.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.531 -0.304 . . . . 0.9 110.738 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -91.54 36.27 6.24 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.152 -1.187 . . . . 1.43 112.377 0.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -165.47 83.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 2.66 111.163 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -155.74 -164.82 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.207 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.627 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.77 172.57 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 2.41 111.279 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.651 ' O ' HD22 ' A' ' 49' ' ' LEU . 68.4 m95 -78.8 118.36 20.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.57 -0.741 . . . . 0.65 112.212 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -147.37 127.03 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.28 110.649 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.24 99.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 1.3 111.625 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.31 -38.37 89.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.246 0.546 . . . . 0.86 110.338 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.5 p-10 -70.4 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.01 110.963 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 172.44 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.76 0.314 . . . . 2.08 110.461 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -81.33 -159.77 0.29 Allowed 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.35 -0.386 . . . . 1.89 110.641 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.94 97.83 7.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 1.87 111.05 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 36' ' ' TYR . 28.8 mt -81.25 87.94 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.69 111.127 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.45 -53.74 9.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 1.6 111.074 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.64 164.82 21.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.54 110.562 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -81.21 4.55 19.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.46 . . . . 1.75 111.644 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.936 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.9 tp10 -106.93 96.21 6.27 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 120.802 0.335 . . . . 2.05 110.179 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 67.3 t80 -124.43 164.36 19.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.48 111.298 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.0 m -132.14 114.06 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.42 110.959 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.484 HG23 HD21 ' A' ' 66' ' ' LEU . 24.6 m -76.21 133.05 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.08 111.064 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 133.01 49.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.973 -0.558 . . . . 1.33 110.949 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.89 -2.16 4.76 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.683 -0.77 . . . . 0.9 113.145 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -58.38 -173.67 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.975 0.417 . . . . 1.47 111.232 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -139.76 141.61 36.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.806 -0.634 . . . . 1.06 110.634 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 6.6 mt-10 -64.57 146.51 54.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.095 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 5.9 m-20 63.83 57.36 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 1.87 111.344 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.03 124.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.706 0.289 . . . . 0.49 111.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -66.4 138.07 57.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.522 -0.308 . . . . 0.36 110.172 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.71 117.57 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.448 0.536 . . . . 0.56 112.448 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.646 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.72 144.2 28.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.906 -0.776 . . . . 1.5 108.906 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.796 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -135.59 115.39 12.98 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.24 1.2 . . . . 0.6 114.24 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.2 ptp180 -105.59 177.97 4.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.987 -1.116 . . . . 2.11 107.987 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.531 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -154.24 126.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 122.257 1.027 . . . . 0.6 113.225 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' SER . 11.3 mt -105.45 152.99 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.7 106.958 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.11 135.92 8.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.01 -1.076 . . . . 0.6 112.762 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HG2' HD12 ' A' ' 85' ' ' ILE . 5.5 mttt -80.16 -169.63 2.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.526 -0.761 . . . . 1.98 110.384 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.739 ' ND2' HD12 ' A' ' 2' ' ' ILE . 3.7 p30 -135.54 171.74 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.195 0.522 . . . . 2.19 111.336 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.94 -25.07 1.22 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.754 . . . . 1.08 111.859 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.15 -20.67 28.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.267 0.469 . . . . 1.06 112.267 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 79' ' ' LYS . . . 110.32 -18.37 28.02 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.279 -0.962 . . . . 0.93 112.319 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.685 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -62.09 144.35 55.41 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 110.203 -0.295 . . . . 1.38 110.203 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -94.17 117.8 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.79 112.008 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.1 p -78.77 127.94 78.54 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.549 -0.75 . . . . 0.59 110.259 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -34.69 159.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.592 2.861 . . . . 0.85 114.076 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 6.2 Cg_exo -74.28 138.74 25.37 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.06 2.507 . . . . 0.76 112.555 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.531 ' OG ' HG13 ' A' ' 76' ' ' VAL . 79.1 p -88.76 130.47 35.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.132 -0.485 . . . . 1.28 110.016 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -34.53 122.51 0.55 Allowed Pre-proline 0 N--CA 1.469 0.478 0 O-C-N 123.743 0.652 . . . . 1.77 112.338 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 33.7 Cg_exo -55.97 145.58 73.39 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.456 2.104 . . . . 0.55 113.345 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.12 149.12 35.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.606 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -36.0 142.26 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.829 0.705 . . . . 1.63 112.128 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.09 112.69 14.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.41 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -93.11 118.16 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.252 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 98' ' ' ARG . 88.7 m -48.51 -37.83 18.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.202 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 69' ' ' ASP . 66.9 m 55.49 90.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.809 0.338 . . . . 1.1 110.767 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -143.65 -86.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 3.0 110.378 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.847 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -107.8 -11.09 15.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 2.14 110.849 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.209 -0.45 . . . . 2.06 111.716 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.787 HD11 ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.74 0.305 . . . . 0.68 111.245 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -128.65 148.45 68.47 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0 111.551 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.38 160.12 14.94 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.98 2.453 . . . . 0.5 112.937 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.4 Cg_endo -54.64 -176.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.898 2.399 . . . . 0.71 112.378 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -176.45 51.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.901 -0.666 . . . . 0.66 112.492 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -74.13 128.05 86.93 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.412 -0.218 . . . . 1.52 110.412 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 14.2 Cg_exo -72.28 126.72 11.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.297 1.998 . . . . 0.44 112.872 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.73 105.99 50.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.613 -0.721 . . . . 1.09 109.502 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.6 Cg_exo -43.12 92.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.364 2.043 . . . . 0.64 113.98 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.453 HD23 ' CG2' ' A' ' 19' ' ' THR . 1.9 tp -57.74 -29.45 64.77 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.315 -0.857 . . . . 1.64 109.335 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -159.99 153.35 22.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.161 -0.927 . . . . 0.72 108.966 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.136 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 1.4 pt -142.72 141.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.361 0.6 . . . . 0.96 112.446 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.633 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -138.56 142.91 39.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.154 -0.93 . . . . 1.46 109.886 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -44.92 -24.47 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.609 0.596 . . . . 2.42 112.609 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -125.19 -6.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.402 0.519 . . . . 1.02 112.402 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.11 111.09 5.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.68 110.92 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 HG22 ' A' ' 13' ' ' ILE . 69.6 t -106.1 122.02 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.8 111.514 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.8 m -99.38 135.47 40.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.35 110.825 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -137.7 143.36 41.23 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.662 0.744 . . . . 0.52 111.338 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -126.81 149.59 49.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.66 -1.155 . . . . 1.84 110.011 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.1 p90 -143.61 -175.69 4.67 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.279 0.561 . . . . 0.4 112.367 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.63 -174.03 4.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 0.83 111.428 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 137.3 21.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 2.11 109.941 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 28' ' ' THR . 6.2 Cg_exo -36.12 153.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.245 2.63 . . . . 0.89 112.736 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.06 -40.31 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 2.77 111.862 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -130.98 -63.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 1.37 111.804 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 25' ' ' PRO . 6.1 p 52.31 45.22 28.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.91 110.793 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.25 -112.11 0.91 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.188 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.44 28.35 5.3 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.408 -1.077 . . . . 0.98 110.408 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -114.07 173.97 6.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.159 -0.52 . . . . 0.87 110.991 -178.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.72 10.4 2.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.26 111.759 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.63 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.6 mt 59.33 116.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.942 0.401 . . . . 1.71 111.103 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -109.25 28.81 8.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 1.15 111.425 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 174.3 106.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.747 0.308 . . . . 1.58 111.329 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 33' ' ' ILE . 57.7 m-85 -94.38 124.74 38.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.76 110.969 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.4 mm -97.23 142.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 1.14 109.594 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.86 94.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.754 -0.378 . . . . 0.63 111.994 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 3.0 mt-10 -68.13 137.85 55.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.244 -0.651 . . . . 1.67 109.244 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.1 134.67 53.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 1.97 111.589 -179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HG2' HD12 ' A' ' 43' ' ' LEU . 8.7 ttp180 -108.6 104.46 13.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.78 -0.646 . . . . 1.44 109.895 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.28 82.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 1.59 110.665 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 41' ' ' ARG . 3.6 mp -50.56 155.83 1.73 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 0.9 111.088 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.34 32.71 7.58 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.653 -1.395 . . . . 1.43 112.836 0.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 -77.24 0.38 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.79 0.328 . . . . 2.66 111.108 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . 51.16 -175.2 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.82 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.92 30.54 0.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.962 0.41 . . . . 2.41 110.646 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 71.2 m95 45.25 96.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.65 111.59 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.448 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -131.01 123.55 29.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.841 -0.618 . . . . 1.28 110.217 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 10.8 ptpt -48.42 137.92 10.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.3 110.967 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -123.66 -36.51 2.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.86 111.553 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB3' HD11 ' A' ' 56' ' ' ILE . 2.5 p-10 -41.75 -62.56 0.87 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.509 -0.314 . . . . 2.01 111.696 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 t80 45.91 30.22 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.507 -0.315 . . . . 2.08 111.39 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.41 30.36 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 1.89 111.284 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.74 95.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.44 -0.345 . . . . 1.87 111.337 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 61' ' ' PHE . 7.5 mt -86.32 90.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.69 111.246 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.67 -44.13 67.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.158 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -100.13 153.36 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.92 0.39 . . . . 1.54 110.658 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 20.9 p-10 -66.3 -10.46 42.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 1.75 111.527 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HG3' ' CG ' ' A' ' 21' ' ' LYS . 2.9 tt0 -93.77 99.19 11.63 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.938 -0.764 . . . . 2.05 108.938 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.695 ' CG ' HD13 ' A' ' 56' ' ' ILE . 81.6 t80 -129.35 162.61 27.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.947 -0.701 . . . . 0.48 112.596 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 71.8 m -125.16 114.52 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.198 -0.91 . . . . 0.42 111.222 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.633 HG23 HD21 ' A' ' 20' ' ' LEU . 48.7 t -80.73 120.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.841 -0.618 . . . . 1.08 110.958 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -117.28 162.33 18.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.243 0.544 . . . . 1.33 110.988 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.26 -2.22 31.19 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.381 -0.827 . . . . 0.9 112.903 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -67.17 -176.1 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.077 0.465 . . . . 1.47 110.732 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.474 HG22 ' OH ' ' A' ' 72' ' ' TYR . 1.7 t -140.55 144.11 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.745 -0.661 . . . . 1.06 110.453 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.465 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 tt0 -64.55 144.28 57.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.25 -0.432 . . . . 1.91 110.782 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.4 t0 71.76 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.87 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.61 122.56 0.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.497 -0.32 . . . . 0.49 111.51 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.04 132.11 43.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.36 109.96 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.474 ' OH ' HG22 ' A' ' 67' ' ' THR . 52.1 m-85 -128.72 123.26 32.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.392 0.515 . . . . 0.56 112.392 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -101.7 144.15 30.76 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.699 -0.852 . . . . 1.5 108.699 178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -130.51 114.93 16.11 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.27 1.582 . . . . 0.6 115.27 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 21.4 ttm-85 -99.7 157.51 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.361 -0.977 . . . . 2.11 108.361 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.881 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -135.05 128.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.232 -0.987 . . . . 0.6 112.819 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 86' ' ' SER . 57.0 mt -117.96 156.04 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.094 -1.412 . . . . 0.7 107.371 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.45 116.78 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 118.896 -1.122 . . . . 0.6 112.657 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 1.6 mmtp -59.13 -177.83 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.077 -0.649 . . . . 1.98 109.552 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.787 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.1 m120 -130.61 163.3 27.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.093 0.473 . . . . 2.19 111.498 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.2 -26.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.141 0.793 . . . . 1.08 113.141 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -102.84 11.57 37.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.907 0.706 . . . . 1.06 112.907 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 88.56 -2.16 84.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.266 -0.969 . . . . 0.93 113.273 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -68.97 120.53 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.139 0.47 . . . . 1.38 109.887 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -79.81 102.05 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.603 -0.439 . . . . 0.79 111.88 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.5 p -61.81 111.3 4.23 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.369 -0.604 . . . . 0.59 109.369 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -40.81 173.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.676 2.918 . . . . 0.85 114.608 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.07 128.88 24.07 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.098 2.532 . . . . 0.76 112.824 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.881 ' OG ' HG13 ' A' ' 76' ' ' VAL . 3.8 p -97.89 119.03 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.811 -0.631 . . . . 1.28 109.957 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -20.24 119.8 0.1 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.009 0.924 . . . . 1.77 112.673 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 27.8 Cg_exo -63.39 156.51 55.75 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.655 2.237 . . . . 0.55 114.385 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.487 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.67 149.73 25.11 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.022 -0.99 . . . . 1.23 109.316 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -37.44 158.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.869 0.731 . . . . 1.63 111.771 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -91.08 108.08 19.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.41 111.053 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.767 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -90.93 114.35 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.541 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 85.4 m -52.4 -31.16 32.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.1 m 57.04 93.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.34 . . . . 1.1 110.113 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -143.87 -86.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.501 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.67 -2.52 24.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 2.14 111.716 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.136 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.517 -0.301 0 N-CA-C 112.564 0.579 . . . . 2.06 112.564 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.773 HD12 ' ND2' ' A' ' 80' ' ' ASN . 11.8 tt . . . . . 0 CA--C 1.521 -0.15 0 CA-C-O 120.95 0.405 . . . . 0.68 111.135 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 2' ' ' ILE . 79.0 m-20 -137.7 127.3 15.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.76 154.2 34.21 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.256 1.971 . . . . 0.5 112.054 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.65 -179.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.717 2.278 . . . . 0.71 113.098 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.81 -157.15 3.69 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.66 112.749 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -91.41 134.08 30.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.7 -0.111 . . . . 1.52 110.7 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.0 Cg_exo -77.44 132.44 12.33 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.647 2.232 . . . . 0.44 112.157 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.1 123.29 10.33 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.445 -0.343 . . . . 1.09 111.538 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.631 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.8 Cg_exo -68.39 129.83 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.282 1.988 . . . . 0.64 112.822 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.379 -0.6 . . . . 1.64 109.379 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.65 100.89 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.72 109.609 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.742 HG21 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -98.68 140.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.92 -0.582 . . . . 0.96 112.071 -179.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -135.74 144.26 45.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.534 -0.757 . . . . 1.46 111.001 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 1.8 mtp180 -33.05 -47.97 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.58 0.956 . . . . 2.42 113.58 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -106.73 -14.49 15.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.338 0.866 . . . . 1.02 113.338 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' HD22 ' A' ' 66' ' ' LEU . 15.3 p -147.77 129.51 15.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.65 -0.42 . . . . 0.68 111.42 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.99 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -117.1 152.49 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.641 -0.423 . . . . 0.8 110.604 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.543 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.1 m -119.39 118.84 32.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.35 111.168 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.808 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.28 155.63 47.98 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.428 0.632 . . . . 0.52 111.288 179.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.61 159.64 42.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.031 -0.986 . . . . 1.84 109.905 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.48 ' N ' ' HD3' ' A' ' 21' ' ' LYS . 11.8 p90 -137.93 -171.83 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.4 111.756 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.6 -171.93 3.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.83 111.591 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -124.22 139.71 33.35 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 2.11 111.0 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 28' ' ' THR . 16.8 Cg_endo -58.65 179.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.89 112.106 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.17 0.29 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.156 0.428 . . . . 2.77 112.156 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -132.56 -72.6 0.52 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 121.082 -0.247 . . . . 1.37 111.126 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 25' ' ' PRO . 6.0 p 42.77 55.28 4.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.614 0.245 . . . . 0.91 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.54 1.3 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.217 -0.516 . . . . 1.01 112.671 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.57 30.29 5.8 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.444 -1.063 . . . . 0.98 110.444 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.38 177.91 4.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.971 -0.614 . . . . 0.87 111.531 -178.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 -2.14 3.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.715 -0.675 . . . . 2.26 111.941 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.713 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.9 mt 55.75 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-O 121.007 0.432 . . . . 1.71 110.746 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -106.18 17.82 22.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 1.15 111.651 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.67 138.98 0.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.804 0.335 . . . . 1.58 111.594 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 56' ' ' ILE . 48.3 m-85 -120.25 141.94 49.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.115 -0.493 . . . . 0.76 110.342 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' A' ' 50' ' ' LYS . 10.9 mm -108.17 156.24 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 1.14 110.767 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.452 -0.34 . . . . 0.63 111.123 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt-10 -77.85 120.81 23.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 1.67 109.574 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -106.33 148.84 27.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.362 0.601 . . . . 1.97 111.961 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.473 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 3.2 ttp180 -131.06 111.42 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.158 -0.928 . . . . 1.44 109.557 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.3 79.88 1.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.611 -0.722 . . . . 1.59 110.528 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.728 HD12 ' HB1' ' A' ' 94' ' ' ALA . 16.0 mt -63.54 142.66 97.96 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.9 110.858 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -93.64 13.42 47.9 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.059 -1.226 . . . . 1.43 112.765 0.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -130.44 86.77 2.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.751 0.31 . . . . 2.66 111.007 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.52 173.17 44.37 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.584 -0.817 . . . . 1.12 112.718 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.677 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -135.16 143.2 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 2.41 110.589 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 83.2 m95 -50.02 103.43 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.65 111.234 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.677 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -133.79 141.57 47.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.488 -0.323 . . . . 1.28 110.603 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' A' ' 37' ' ' ILE . 46.2 mtpt -44.87 104.7 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.872 0.368 . . . . 1.3 111.36 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -69.98 -51.04 35.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.079 -0.51 . . . . 0.86 110.655 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.72 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -53.22 -64.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 2.01 109.872 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 t80 62.33 38.23 13.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.405 -0.361 . . . . 2.08 111.487 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -160.44 -89.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.71 -0.223 . . . . 1.89 111.495 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.732 HD21 HD22 ' A' ' 57' ' ' LEU . 4.3 t-20 -158.87 141.21 14.01 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.913 0.387 . . . . 1.87 110.688 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 61' ' ' PHE . 41.7 mt -139.28 65.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.69 110.729 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.732 HD22 HD21 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -48.71 -63.28 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.6 111.2 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -82.74 160.72 22.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.936 0.398 . . . . 1.54 110.527 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.469 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -72.25 -7.25 48.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.958 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 2.9 tt0 -97.41 97.91 9.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.79 -0.448 . . . . 2.05 109.79 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.85 ' HB2' HG23 ' A' ' 56' ' ' ILE . 62.4 t80 -129.82 165.2 22.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.0 -0.546 . . . . 0.48 111.354 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 18' ' ' VAL . 43.9 m -122.03 121.75 37.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.962 -0.563 . . . . 0.42 110.508 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.947 HG13 ' HB1' ' A' ' 51' ' ' ALA . 25.1 t -80.61 100.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.952 -0.567 . . . . 1.08 111.56 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.542 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -94.29 138.16 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.78 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.3 -13.11 4.63 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.869 -0.681 . . . . 0.9 112.385 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.99 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -55.74 -173.83 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.708 0.29 . . . . 1.47 110.462 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 m -152.01 163.71 38.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 1.06 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 tt0 -74.97 123.42 25.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 1.91 110.887 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.4 t0 75.11 65.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.043 -0.526 . . . . 1.87 111.498 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.6 113.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.899 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.46 133.73 53.06 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.766 -0.374 . . . . 0.36 110.202 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 29.3 m-85 -126.29 118.11 24.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.21 -0.45 . . . . 0.56 112.191 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.15 141.45 34.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 1.5 109.933 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.61 115.81 10.44 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.366 1.247 . . . . 0.6 114.366 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 6.0 ptt85 -97.63 163.75 12.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.927 -0.768 . . . . 2.11 108.927 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' CG ' ' A' ' 8' ' ' PRO . 48.7 t -116.94 133.82 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.778 0.659 . . . . 0.6 112.778 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 88' ' ' PRO . 40.6 mt -132.98 165.62 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.726 -1.213 . . . . 0.7 107.726 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 77' ' ' ILE . . . 177.07 134.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.908 -0.717 . . . . 0.6 112.107 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.4 ptpt -67.17 -99.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.653 -0.819 . . . . 1.98 109.289 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.773 ' ND2' HD12 ' A' ' 2' ' ' ILE . 6.1 p30 170.43 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 110.497 -0.186 . . . . 2.19 110.497 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.66 -42.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.029 -0.419 . . . . 1.08 110.729 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.08 -10.27 59.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.574 . . . . 1.06 112.237 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.21 -11.29 40.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.178 -1.01 . . . . 0.93 112.501 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.674 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -62.86 115.87 4.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.112 -0.329 . . . . 1.38 110.112 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.9 tp -72.81 122.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.374 0.509 . . . . 0.79 112.374 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.686 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.6 p -89.36 131.74 39.52 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.959 -0.386 . . . . 0.59 109.959 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 74.3 Cg_exo -41.11 173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.571 2.847 . . . . 0.85 114.311 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 77' ' ' ILE . 87.9 Cg_endo -87.56 172.79 5.63 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.235 2.623 . . . . 0.76 113.727 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -130.57 125.29 33.8 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.165 -0.925 . . . . 1.28 109.561 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -19.98 114.63 0.11 Allowed Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.228 0.955 . . . . 1.77 113.224 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 87.1 Cg_exo -47.7 144.02 11.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.699 2.266 . . . . 0.55 113.653 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.67 143.12 46.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.422 -0.808 . . . . 1.23 108.83 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -31.69 135.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.294 0.996 . . . . 1.63 112.568 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.25 99.78 1.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.623 -0.717 . . . . 0.41 109.718 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -77.46 109.4 11.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 0.44 110.946 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 59.5 m -49.12 -25.67 2.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.065 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' H ' HG22 ' A' ' 95' ' ' ILE . 80.4 m 52.43 38.39 25.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 1.1 110.744 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 1.033 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 17.2 ptp180 -71.98 -47.53 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 3.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 1.033 ' OD1' ' HG3' ' A' ' 98' ' ' ARG . 20.1 p-10 -161.34 33.98 0.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.468 -0.787 . . . . 2.14 110.284 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 2.06 111.61 -179.136 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.933 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.5 tt . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.975 0.416 . . . . 0.68 111.753 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.141 ' OD2' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.82 114.53 13.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 2.0 110.458 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.24 171.73 13.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.996 1.797 . . . . 0.5 112.126 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 34.5 Cg_exo -59.24 179.32 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.839 2.359 . . . . 0.71 112.789 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -86.91 171.44 42.85 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.094 -0.574 . . . . 0.66 113.051 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 tttt -59.72 125.14 79.25 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 110.326 -0.25 . . . . 1.52 110.326 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 19.4 Cg_exo -71.53 143.74 43.32 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.44 113.035 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.24 105.45 7.89 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 1.09 110.537 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 31.7 Cg_exo -54.11 128.76 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.277 1.985 . . . . 0.64 113.676 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 21' ' ' LYS . 1.3 mm? -95.81 -26.68 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.697 -0.683 . . . . 1.64 109.531 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -152.52 152.41 31.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.737 -0.665 . . . . 0.72 110.478 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.59 111.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.94 0.4 . . . . 0.96 110.287 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -109.16 69.0 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.841 0.682 . . . . 1.46 112.841 -178.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 1.7 mtp180 28.1 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 2.42 113.147 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.2 m-70 176.69 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.213 0.53 . . . . 1.02 109.596 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 p -112.25 93.7 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.68 110.708 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.881 HG11 ' CE1' ' A' ' 74' ' ' PHE . 48.0 t -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.558 -0.746 . . . . 0.8 110.789 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 56.0 m -90.13 144.27 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.35 111.9 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.62 165.65 32.72 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.962 -1.017 . . . . 0.52 111.903 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.757 ' HB3' HD21 ' A' ' 11' ' ' LEU . 15.6 tptm -143.47 138.72 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.744 -1.117 . . . . 1.84 110.13 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.0 p90 -125.83 -176.56 3.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.4 111.962 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -100.71 116.98 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.528 -0.76 . . . . 0.83 110.972 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 144.21 49.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.523 -0.308 . . . . 2.11 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HG3' HD12 ' A' ' 33' ' ' ILE . 58.2 Cg_endo -70.19 169.92 18.32 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.614 2.209 . . . . 0.89 112.412 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.32 -45.8 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 2.77 111.048 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.141 ' C ' ' OD2' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -89.75 66.06 6.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.846 -0.342 . . . . 1.37 111.286 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.541 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 61.5 p -95.88 50.9 1.22 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.631 -0.507 . . . . 0.91 109.631 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.16 -93.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.74 -0.663 . . . . 1.01 112.303 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.32 26.81 2.79 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.22 -0.752 . . . . 0.98 111.22 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.535 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -118.28 -175.5 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.143 0.497 . . . . 0.87 111.41 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 5.48 2.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.579 -0.737 . . . . 2.26 111.876 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.1 mt 60.91 134.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.081 0.467 . . . . 1.71 110.654 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 p -108.1 2.37 22.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.15 112.087 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.445 ' CB ' ' ND2' ' A' ' 55' ' ' ASN . 8.7 t -176.63 -176.12 0.7 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.58 111.85 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.7 m-85 -149.45 100.36 3.0 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.76 109.664 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mt -84.65 121.87 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.943 -0.303 . . . . 1.14 111.304 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.17 103.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.161 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 18.5 mt-10 -74.74 133.74 41.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.659 -0.497 . . . . 1.67 109.659 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.633 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -116.88 147.68 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 1.97 111.853 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 16.0 ttp180 -123.66 114.44 19.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.79 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -77.42 78.67 3.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.022 -0.535 . . . . 1.59 110.655 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.6 mt -52.78 154.27 5.05 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.9 110.827 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.19 0.35 34.38 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.688 -1.38 . . . . 1.43 113.213 0.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -97.64 -85.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.28 . . . . 2.66 111.11 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.31 175.98 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.697 -0.763 . . . . 1.12 112.581 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD3' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -164.2 30.1 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.097 0.475 . . . . 2.41 110.309 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 57.8 m95 50.21 94.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.65 110.984 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -127.64 126.67 42.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 1.28 110.622 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -42.14 93.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 1.3 111.522 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -54.71 -51.31 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.86 110.971 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -65.08 114.45 4.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.943 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.35 16.13 7.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 2.08 111.198 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -136.72 -160.15 1.03 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 1.89 110.981 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.445 ' ND2' ' CB ' ' A' ' 35' ' ' SER . 1.7 t-20 -98.77 113.48 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.87 111.134 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 52' ' ' ASN . 20.3 mm -87.56 59.03 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.69 110.854 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.4 tp -43.59 -57.87 2.93 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.91 0.386 . . . . 1.6 110.613 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 pt-20 -79.0 165.94 22.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -88.11 15.65 7.16 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.995 0.368 . . . . 1.75 111.995 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.7 111.6 18.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.372 -0.603 . . . . 2.05 109.372 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.717 ' CG ' HD12 ' A' ' 56' ' ' ILE . 73.7 t80 -139.73 163.36 32.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.48 112.051 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.2 m -114.03 106.13 14.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.06 -0.973 . . . . 0.42 110.668 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 51' ' ' ALA . 90.8 t -66.8 82.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.44 -0.8 . . . . 1.08 111.312 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -88.03 -175.3 5.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 1.33 110.936 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 23.93 72.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.9 112.782 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 63' ' ' VAL . 14.0 mt -97.1 -162.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 1.47 111.021 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 52.0 m -138.0 159.4 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 1.06 111.025 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 67' ' ' THR . 23.8 tt0 -90.13 148.34 23.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 1.91 111.109 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.4 40.69 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.87 111.224 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -155.37 131.45 10.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.49 110.845 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.86 135.41 45.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.483 -0.326 . . . . 0.36 110.361 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 30.5 m-85 -130.89 124.79 31.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.399 0.518 . . . . 0.56 112.399 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.4 tt0 -102.97 139.24 38.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.631 -0.878 . . . . 1.5 108.631 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.881 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.08 118.85 13.15 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.26 1.578 . . . . 0.6 115.26 -178.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -105.22 179.67 4.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.283 -1.006 . . . . 2.11 108.283 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.2 OUTLIER -144.43 121.3 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.439 -0.905 . . . . 0.6 113.328 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 88' ' ' PRO . 61.7 mt -106.99 152.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.138 -1.43 . . . . 0.7 107.138 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -163.92 115.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.029 -1.068 . . . . 0.6 112.809 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -62.29 -175.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.85 -0.74 . . . . 1.98 109.644 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.933 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.1 m-80 -120.9 -114.13 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.569 -0.453 . . . . 2.19 111.572 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.93 -38.38 2.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.412 0.551 . . . . 1.08 111.361 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -92.19 23.46 3.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 1.06 111.588 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.83 0.74 89.87 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.628 -0.796 . . . . 0.93 113.311 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.94 112.83 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.987 0.394 . . . . 1.38 110.635 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.817 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -79.66 112.41 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.071 0.397 . . . . 0.79 112.071 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 5.4 p -71.59 121.45 84.44 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 120.433 -0.507 . . . . 0.59 109.81 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.51 164.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.827 2.352 . . . . 0.85 112.609 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HG3' HD11 ' A' ' 77' ' ' ILE . 3.8 Cg_exo -76.47 130.22 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.892 2.395 . . . . 0.76 112.895 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.608 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -76.88 131.71 38.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.28 109.482 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.447 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 10.8 mt-10 -32.98 119.57 0.43 Allowed Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 123.689 0.618 . . . . 1.77 112.349 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 52.4 Cg_exo -52.4 150.43 20.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.465 2.11 . . . . 0.55 113.197 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 142.57 29.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.475 -0.784 . . . . 1.23 109.207 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.658 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.74 140.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.07 0.856 . . . . 1.63 112.142 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -74.08 112.3 10.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.773 -0.648 . . . . 0.41 110.699 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -98.8 117.75 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.44 111.369 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 70' ' ' ALA . 48.3 m -48.38 -28.33 3.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.327 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 95' ' ' ILE . 3.1 m 55.6 59.2 4.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.44 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 1.051 ' HD2' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.9 -42.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.252 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 1.051 ' OD1' ' HD2' ' A' ' 98' ' ' ARG . 7.7 p-10 -116.05 22.65 12.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.761 -0.654 . . . . 2.14 111.428 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 4.8 p-10 . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.841 0.829 . . . . 2.06 111.314 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 2' ' ' ILE . 2.0 tt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.861 0.362 . . . . 0.68 111.049 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 28' ' ' THR . 71.4 m-20 -107.71 123.25 38.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.62 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.67 172.75 10.02 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.241 1.961 . . . . 0.5 112.276 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.9 Cg_endo -61.39 171.15 4.5 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.839 2.359 . . . . 0.71 112.68 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 -177.66 30.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.947 -0.644 . . . . 0.66 112.671 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tptt -68.5 118.47 60.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.253 -0.277 . . . . 1.52 110.253 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 21.8 Cg_exo -67.51 122.91 10.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.387 2.058 . . . . 0.44 111.733 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.76 112.69 28.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.518 -0.31 . . . . 1.09 111.303 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.6 Cg_exo -61.88 120.27 7.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.547 2.164 . . . . 0.64 113.5 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -84.56 -31.83 24.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 1.64 109.665 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.22 145.78 33.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.72 109.635 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.064 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -144.07 96.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.7 0.63 . . . . 0.96 112.7 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.105 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -82.87 158.65 22.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.225 -0.658 . . . . 1.46 109.225 178.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -60.61 -13.23 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.068 0.396 . . . . 2.42 112.068 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . 2.1 m-70 -139.08 25.55 2.49 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.952 0.353 . . . . 1.02 111.952 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -176.95 116.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.696 0.284 . . . . 0.68 110.922 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.064 HG13 HG22 ' A' ' 13' ' ' ILE . 86.4 t -105.38 137.26 35.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.392 . . . . 0.8 111.114 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.635 ' C ' HD13 ' A' ' 20' ' ' LEU . 16.6 m -117.91 122.37 43.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.552 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.757 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.33 152.67 51.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.739 0.78 . . . . 0.52 112.07 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 11' ' ' LEU . 9.5 tptt -133.35 155.03 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.411 -1.268 . . . . 1.84 109.707 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 20.9 p90 -145.34 -177.54 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 0.4 112.176 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.75 159.48 15.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.83 111.357 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -88.23 137.52 30.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.012 -0.54 . . . . 2.11 110.238 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' ILE . 2.6 Cg_endo -41.27 160.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.595 2.197 . . . . 0.89 111.929 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.74 -29.6 11.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.498 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -122.85 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 1.37 111.562 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 46.54 54.44 8.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.809 0.337 . . . . 0.91 110.863 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 37.79 -131.83 1.34 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.803 -0.635 . . . . 1.01 113.128 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 29.87 9.12 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.178 -1.169 . . . . 0.98 110.178 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -96.49 175.3 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.679 -0.761 . . . . 0.87 111.286 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -136.89 0.2 2.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.551 . . . . 2.26 112.255 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.449 HD11 ' HG3' ' A' ' 25' ' ' PRO . 27.7 mt 60.69 138.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 121.007 0.432 . . . . 1.71 111.004 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 p -120.2 -11.91 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.202 0.445 . . . . 1.15 112.202 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.61 138.51 2.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 1.58 111.54 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.0 m-85 -105.08 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.76 110.855 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -82.17 165.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.764 -0.458 . . . . 1.14 109.764 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -157.46 137.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.563 0.697 . . . . 0.63 111.164 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG3' HD12 ' A' ' 77' ' ' ILE . 6.1 mt-10 -105.35 134.53 48.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.767 -1.106 . . . . 1.67 110.185 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -103.79 146.97 27.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 1.97 111.194 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.7 ttm180 -119.44 113.96 21.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 1.44 110.581 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 92.79 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.316 -0.856 . . . . 1.59 109.69 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD11 ' HG3' ' A' ' 73' ' ' GLU . 7.8 mt -76.73 150.65 81.93 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.9 111.23 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -88.54 -2.22 62.59 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.741 -1.358 . . . . 1.43 113.038 0.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -123.67 79.46 1.7 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.886 0.374 . . . . 2.66 110.993 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.59 -166.16 10.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.797 -0.716 . . . . 1.12 112.377 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.634 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -157.95 151.25 23.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 2.41 110.898 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.714 ' O ' HD22 ' A' ' 49' ' ' LEU . 59.2 m95 -64.35 116.76 6.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.88 -0.6 . . . . 0.65 110.406 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.68 136.66 25.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.831 0.348 . . . . 1.28 111.206 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -44.82 110.09 0.21 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.3 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.78 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -84.85 -37.3 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.86 110.633 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.61 ' CB ' HD11 ' A' ' 56' ' ' ILE . 10.6 p-10 -82.43 178.6 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.569 . . . . 2.01 110.475 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 178.92 36.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 2.08 111.035 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.56 32.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 1.89 111.285 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.77 121.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.87 110.956 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 36' ' ' TYR . 22.3 mt -116.28 76.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.69 111.083 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.2 mt -59.43 -66.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.6 111.463 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 168.24 9.08 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.874 0.369 . . . . 1.54 110.674 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 3.2 m-20 -86.61 8.06 23.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.077 -0.51 . . . . 1.75 111.419 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.84 103.88 12.74 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.694 0.283 . . . . 2.05 110.35 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' ILE . 65.1 t80 -135.16 163.12 30.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.48 111.677 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.1 m -122.93 117.23 25.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.644 -0.707 . . . . 0.42 111.216 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 51' ' ' ALA . 47.8 t -83.31 101.92 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.037 -0.529 . . . . 1.08 110.942 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 p -94.15 162.91 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.366 0.603 . . . . 1.33 110.997 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.49 7.35 24.38 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.969 -1.014 . . . . 0.9 111.983 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.3 mm? -54.33 168.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.264 0.554 . . . . 1.47 111.449 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -139.26 98.88 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.245 -0.889 . . . . 1.06 109.284 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.5 tm-20 -37.24 139.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.5 0.556 . . . . 1.91 112.5 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.18 42.34 0.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.726 -0.67 . . . . 1.87 110.827 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.27 124.48 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.49 111.532 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.79 137.77 54.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.945 -0.391 . . . . 0.36 109.945 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 30.6 m-85 -129.43 124.18 33.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.419 0.526 . . . . 0.56 112.419 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.847 ' HG3' HD11 ' A' ' 43' ' ' LEU . 12.0 mt-10 -100.96 141.72 33.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.473 -0.566 . . . . 1.5 109.473 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.46 ' HD2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.29 114.81 11.85 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.712 1.375 . . . . 0.6 114.712 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HD3' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.29 151.89 22.16 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.345 -0.613 . . . . 2.11 109.345 177.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -114.61 118.05 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.622 -0.831 . . . . 0.6 112.922 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' A' ' 88' ' ' PRO . 66.7 mt -103.41 136.45 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.993 -1.484 . . . . 0.7 106.993 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -151.33 139.28 19.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.502 -0.879 . . . . 0.6 111.965 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.721 ' HG2' HD12 ' A' ' 85' ' ' ILE . 19.5 mttp -66.8 -133.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.727 -0.789 . . . . 1.98 109.625 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.566 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -167.55 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.127 0.422 . . . . 2.19 110.153 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -154.15 -42.14 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.824 0.345 . . . . 1.08 110.754 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.38 -2.57 58.68 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.514 0.561 . . . . 1.06 112.514 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.09 62.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.249 -0.977 . . . . 0.93 113.332 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.25 81.16 3.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.155 0.502 . . . . 1.38 109.895 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.721 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -40.2 119.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 114.397 1.258 . . . . 0.79 114.397 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 3.8 p -73.06 109.36 6.08 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 106.765 -1.568 . . . . 0.59 106.765 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 9.4 Cg_endo -49.72 162.98 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.652 2.235 . . . . 0.85 113.799 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' A' ' 77' ' ' ILE . 53.2 Cg_exo -40.42 128.56 2.4 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.714 2.942 . . . . 0.76 114.53 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.538 ' OG ' HG13 ' A' ' 76' ' ' VAL . 78.2 p -102.19 100.88 11.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.127 -0.942 . . . . 1.28 110.268 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER 11.8 115.84 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 125.037 1.335 . . . . 1.77 114.387 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.535 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 6.5 Cg_exo -67.21 135.16 36.16 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.02 1.813 . . . . 0.55 113.011 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.33 144.05 56.18 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.339 -0.615 . . . . 1.23 109.339 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' HD12 ' A' ' 95' ' ' ILE . 8.8 m-20 -40.25 149.31 0.07 Allowed 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.66 0.6 . . . . 1.63 111.235 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -76.06 119.17 19.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.945 -0.571 . . . . 0.41 111.812 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.625 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -99.52 118.73 46.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.695 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 m -50.03 -38.0 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 0.44 111.124 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 2.8 m 62.23 43.96 8.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 1.1 110.503 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.558 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 1.4 ptp85 -84.96 -91.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.64 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.558 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 20.2 p-10 -113.46 28.19 8.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.541 -0.299 . . . . 2.14 110.406 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.105 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.228 0.537 . . . . 2.06 110.895 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 tt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.737 0.303 . . . . 0.68 111.057 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.12 131.71 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 2.0 110.654 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.73 168.6 15.81 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.589 2.193 . . . . 0.5 112.385 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 73.0 Cg_exo -49.12 179.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.453 2.102 . . . . 0.71 112.182 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.21 -167.17 42.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.66 112.815 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.69 114.21 22.93 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.642 -0.133 . . . . 1.52 110.642 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 13.3 Cg_exo -70.49 131.32 19.98 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.423 2.082 . . . . 0.44 112.494 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -142.55 106.92 5.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 1.09 111.66 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 78.3 Cg_exo -36.18 141.74 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.991 2.461 . . . . 0.64 112.79 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.14 -30.83 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.507 -0.553 . . . . 1.64 109.507 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.06 97.81 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 0.72 109.988 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.815 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -94.69 133.23 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.997 0.74 . . . . 0.96 112.997 -179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.735 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -127.85 137.86 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.95 -1.023 . . . . 1.46 110.092 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.735 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.35 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.006 1.113 . . . . 2.42 114.006 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.1 m170 -120.16 -22.33 6.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.641 0.608 . . . . 1.02 112.641 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' HD22 ' A' ' 66' ' ' LEU . 13.6 p -134.44 130.33 36.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.25 -0.278 . . . . 0.68 110.25 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.104 HG13 HD23 ' A' ' 66' ' ' LEU . 4.5 m -124.91 141.34 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.142 0.496 . . . . 0.8 112.103 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.3 m -106.95 151.64 25.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.35 109.788 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.51 152.02 37.32 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.532 0.682 . . . . 0.52 112.021 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.71 147.46 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.581 -1.19 . . . . 1.84 109.675 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 26.4 p90 -146.69 -174.0 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.4 111.282 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -164.79 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.83 110.784 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.426 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -137.08 139.87 29.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 2.11 110.858 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HB3' HG23 ' A' ' 28' ' ' THR . 93.3 Cg_exo -41.24 158.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.415 2.076 . . . . 0.89 111.952 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -112.49 -21.67 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.284 -0.417 . . . . 2.77 111.651 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -129.33 -71.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.049 -0.26 . . . . 1.37 111.66 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.5 p 51.26 45.42 27.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.91 110.37 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.79 -124.36 4.96 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.881 -0.6 . . . . 1.01 112.446 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.46 36.64 3.95 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.099 -1.201 . . . . 0.98 110.099 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.577 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -105.28 177.58 4.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.639 -0.781 . . . . 0.87 111.929 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 7.81 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.85 -0.613 . . . . 2.26 111.869 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.475 HD11 ' HG2' ' A' ' 25' ' ' PRO . 12.7 mt 59.18 146.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 121.077 0.465 . . . . 1.71 111.251 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 p -114.14 -31.99 6.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.021 -0.536 . . . . 1.15 112.44 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 135.43 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.947 0.351 . . . . 1.58 111.947 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.5 m-85 -88.74 89.34 7.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.76 111.263 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt -78.77 109.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 1.14 110.641 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.1 p -106.48 127.19 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.63 111.208 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.628 ' OE2' HD12 ' A' ' 77' ' ' ILE . 27.1 mt-10 -92.65 149.53 21.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.83 -0.623 . . . . 1.67 110.404 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.828 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.73 157.97 21.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.05 0.452 . . . . 1.97 110.975 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CZ ' ' CZ2' ' A' ' 48' ' ' TRP . 12.9 ttp180 -133.52 112.71 11.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.438 -0.801 . . . . 1.44 109.576 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.88 107.13 6.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 1.59 110.868 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.704 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -89.38 147.79 38.99 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 121.077 -0.249 . . . . 0.9 110.627 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -93.17 15.94 44.35 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.8 -1.333 . . . . 1.43 112.493 0.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.18 93.68 2.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.856 0.36 . . . . 2.66 110.966 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.21 -167.94 35.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.938 -0.648 . . . . 1.12 112.365 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -157.55 171.44 20.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.719 0.295 . . . . 2.41 111.211 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 62.3 m95 -70.06 121.78 18.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.65 111.941 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.54 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -142.06 137.62 31.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 1.28 110.598 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -46.94 92.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.4 . . . . 1.3 111.484 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.846 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -57.95 -61.45 2.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.86 110.232 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.816 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -74.32 132.8 42.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.501 -0.772 . . . . 2.01 110.266 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.57 35.49 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.167 -0.47 . . . . 2.08 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -142.28 -68.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.89 110.873 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 176.03 153.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.87 110.847 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.816 HD11 ' CB ' ' A' ' 52' ' ' ASN . 13.6 mt -148.78 62.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.69 110.596 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 57' ' ' LEU . 7.7 tp -54.29 -60.51 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.986 -0.552 . . . . 1.6 111.21 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -73.39 166.4 23.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.486 -0.325 . . . . 1.54 110.587 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 36.1 p30 -83.88 8.36 15.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 1.75 112.009 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -114.42 107.77 15.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.776 ' HB2' HG23 ' A' ' 56' ' ' ILE . 39.9 t80 -141.94 165.51 27.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.471 . . . . 0.48 111.832 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 33.4 m -119.52 121.49 39.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.698 -0.683 . . . . 0.42 111.059 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.846 HG13 ' HB1' ' A' ' 51' ' ' ALA . 15.0 t -86.05 109.05 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.287 -0.415 . . . . 1.08 111.189 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.03 132.16 44.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.981 -0.554 . . . . 1.33 110.841 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.03 -12.75 2.84 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.757 -0.735 . . . . 0.9 112.721 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.104 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -57.45 -171.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 1.47 110.667 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -160.59 155.14 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 1.06 110.629 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 12.9 mt-10 -66.97 144.11 56.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 1.91 111.101 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.929 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 62.44 43.79 7.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 1.87 111.443 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 115.65 3.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.869 0.366 . . . . 0.49 111.787 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.25 130.74 42.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.36 109.954 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 51.8 m-85 -124.15 118.97 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt-10 -99.04 145.14 27.41 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.364 -0.606 . . . . 1.5 109.364 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.93 119.41 14.87 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.319 1.229 . . . . 0.6 114.319 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.577 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.99 142.99 26.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.845 -0.616 . . . . 2.11 109.623 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 8' ' ' PRO . 51.5 t -99.79 107.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.59 0.589 . . . . 0.6 112.59 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.628 HD12 ' OE2' ' A' ' 39' ' ' GLU . 11.0 mt -106.76 151.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.536 -1.283 . . . . 0.7 107.536 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -177.18 140.93 0.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.835 -0.746 . . . . 0.6 111.816 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.763 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mtmt -74.97 -155.64 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.101 -0.64 . . . . 1.98 109.424 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -139.67 -80.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.85 0.357 . . . . 2.19 110.603 -179.272 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -159.73 -41.77 0.05 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.098 -0.501 . . . . 1.08 110.377 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.14 -13.67 60.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.955 -0.566 . . . . 1.06 111.93 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.79 58.49 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.424 -0.893 . . . . 0.93 113.0 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -51.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.032 0.416 . . . . 1.38 110.389 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.763 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER 128.88 112.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.734 1.272 . . . . 0.79 112.495 178.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -75.74 110.53 10.99 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 107.834 -1.173 . . . . 0.59 107.834 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 11.1 Cg_endo -52.8 165.07 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.341 2.027 . . . . 0.85 112.629 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 9.5 Cg_endo -51.56 135.37 48.09 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.132 2.554 . . . . 0.76 113.155 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -105.51 107.21 18.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.757 -0.656 . . . . 1.28 110.756 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 8.49 104.39 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.818 1.247 . . . . 1.77 114.013 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 73.4 Cg_exo -49.58 126.4 16.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.673 2.249 . . . . 0.55 113.579 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.426 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -57.51 149.31 21.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.006 -0.739 . . . . 1.23 109.006 178.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.85 149.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.729 0.643 . . . . 1.63 111.27 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . -78.89 115.36 18.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.496 -0.775 . . . . 0.41 110.13 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -89.41 107.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.075 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 91.1 m -44.05 -38.94 3.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.846 -0.615 . . . . 0.44 111.58 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' ASP . 71.2 m 54.07 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.998 -0.371 . . . . 1.1 109.998 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -88.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.881 0.372 . . . . 3.0 111.466 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -96.21 -10.59 27.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.298 -0.41 . . . . 2.14 111.226 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 t0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 2.06 110.977 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.687 HD11 ' OD1' ' A' ' 80' ' ' ASN . 3.7 tt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.744 0.307 . . . . 0.68 110.799 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.101 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.11 121.41 15.62 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 2.0 111.058 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.92 156.6 52.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.428 2.085 . . . . 0.5 112.211 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.4 Cg_endo -52.44 -175.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.948 2.432 . . . . 0.71 112.58 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.69 168.41 43.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.66 112.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -56.23 125.29 64.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.63 -0.137 . . . . 1.52 110.63 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.5 Cg_exo -73.96 133.81 18.8 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.268 1.978 . . . . 0.44 111.242 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -136.23 111.07 9.96 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.318 0.488 . . . . 1.09 112.318 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 95' ' ' ILE . 27.4 Cg_exo -58.68 94.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.458 2.105 . . . . 0.64 113.296 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.64 -36.8 62.45 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.254 0.549 . . . . 1.64 109.753 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.53 152.55 48.32 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.286 -0.87 . . . . 0.72 109.582 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.927 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -141.34 97.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.411 . . . . 0.96 111.509 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -90.02 45.02 1.24 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.82 -0.627 . . . . 1.46 112.428 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 16.5 mtp180 56.73 -73.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.514 0.561 . . . . 2.42 112.514 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 14' ' ' THR . 10.0 m170 -76.92 -32.45 57.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 1.02 110.832 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.2 p -127.78 113.09 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.68 109.865 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HD13 ' A' ' 66' ' ' LEU . 10.3 m -110.9 119.15 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.634 0.73 . . . . 0.8 111.833 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.1 m -83.99 142.92 30.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.35 110.637 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.52 164.51 33.2 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.121 0.888 . . . . 0.52 111.76 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -158.09 152.56 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.449 -0.796 . . . . 1.84 110.808 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.5 p90 -140.57 -174.42 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.047 0.451 . . . . 0.4 111.76 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.92 -174.82 3.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.83 111.407 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tmtt? -119.42 138.02 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.11 110.533 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 28' ' ' THR . 77.9 Cg_exo -50.19 173.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.416 2.078 . . . . 0.89 112.11 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.8 -19.2 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 2.77 111.803 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.4 t80 -123.79 -70.92 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.22 0.452 . . . . 1.37 112.22 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 1.101 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 70.7 p 51.72 52.0 15.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.065 0.459 . . . . 0.91 110.078 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.7 -106.27 0.06 OUTLIER Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.689 -0.687 . . . . 1.01 112.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.39 37.39 2.14 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.468 -1.053 . . . . 0.98 110.468 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.3 m-85 -117.82 -178.58 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.094 -0.553 . . . . 0.87 111.583 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -140.66 -0.38 1.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.583 -0.735 . . . . 2.26 112.375 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CE1' ' A' ' 36' ' ' TYR . 11.8 mt 56.34 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.976 0.417 . . . . 1.71 111.437 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' SER . 31.1 p -114.25 23.72 12.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 1.15 111.605 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 46.1 t 178.55 135.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 1.58 111.352 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.818 ' CE1' HG21 ' A' ' 33' ' ' ILE . 49.9 m-85 -121.62 102.22 8.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.979 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -79.58 140.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.066 -0.346 . . . . 1.14 110.066 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.92 105.35 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.477 -0.329 . . . . 0.63 111.885 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 80.1 mt-10 -75.59 150.34 38.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.92 -0.77 . . . . 1.67 108.92 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.747 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -131.57 145.91 51.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.97 112.202 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 16.2 ttp180 -121.0 105.09 10.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.177 -0.919 . . . . 1.44 109.595 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.837 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 82.9 0.45 Allowed 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.861 -0.608 . . . . 1.59 110.491 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.52 HD21 ' OE1' ' A' ' 73' ' ' GLU . 3.1 mt -61.02 149.68 80.91 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.785 -0.643 . . . . 0.9 110.904 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.29 18.9 26.59 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.096 -1.21 . . . . 1.43 113.067 0.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.74 83.13 1.34 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.668 0.27 . . . . 2.66 111.386 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -103.83 -169.16 25.31 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.827 -0.701 . . . . 1.12 112.518 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -139.77 8.84 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.735 0.272 . . . . 2.41 111.735 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 19.5 m95 52.52 72.26 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.65 110.959 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -120.63 137.77 54.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 1.28 110.943 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.34 98.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 1.3 111.228 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.747 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.25 -51.11 71.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.86 110.498 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.7 p-10 -60.8 131.51 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 2.01 110.937 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 30.4 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 2.08 110.978 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t -138.89 -161.06 1.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 1.89 110.701 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.91 114.5 28.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.384 . . . . 1.87 111.186 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 36' ' ' TYR . 33.6 mt -100.86 80.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.69 110.852 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.19 -59.72 4.08 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.191 -0.459 . . . . 1.6 111.52 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -77.31 167.07 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.909 0.385 . . . . 1.54 110.695 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 53.3 p30 -84.01 4.93 27.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 1.75 111.615 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.17 100.69 10.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.702 -0.481 . . . . 2.05 109.702 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 56' ' ' ILE . 75.4 t80 -131.66 163.02 29.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.234 0.54 . . . . 0.48 112.2 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.45 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 42.8 m -131.61 124.54 30.17 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.254 -0.884 . . . . 0.42 110.01 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 HD11 ' A' ' 20' ' ' LEU . 7.4 t -82.81 94.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.072 0.463 . . . . 1.08 111.209 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -89.02 165.09 14.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.661 -0.699 . . . . 1.33 111.078 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.5 8.46 83.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.9 112.705 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.031 HD13 HG13 ' A' ' 18' ' ' VAL . 4.7 mt -58.82 -175.02 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.982 0.42 . . . . 1.47 110.775 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -131.5 133.23 44.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 1.06 110.471 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.3 tt0 -71.13 149.92 45.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.149 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.846 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 66.19 38.17 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 1.87 110.788 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.1 116.74 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.49 111.535 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.02 131.94 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.36 110.129 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 53.5 m-85 -125.33 127.15 46.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.658 0.614 . . . . 0.56 112.658 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' OE1' HD21 ' A' ' 43' ' ' LEU . 4.7 mt-10 -108.45 134.04 51.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.974 -1.121 . . . . 1.5 107.974 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.906 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.17 121.64 25.23 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.753 1.39 . . . . 0.6 114.753 -178.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.504 ' CA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -97.08 167.9 10.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.077 -0.51 . . . . 2.11 109.828 178.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' CG ' ' A' ' 8' ' ' PRO . 71.6 t -116.3 145.41 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.397 0.617 . . . . 0.6 111.974 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.772 HD11 ' HG3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -141.45 152.91 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -166.8 124.84 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.533 -0.867 . . . . 0.6 112.457 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.55 95.92 7.28 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.067 -0.653 . . . . 1.98 109.898 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.687 ' OD1' HD11 ' A' ' 2' ' ' ILE . 1.3 m120 -40.34 156.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 2.19 111.667 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -20.77 -47.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.193 1.183 . . . . 1.08 114.193 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.45 48.63 0.87 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.933 0.716 . . . . 1.06 112.933 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.83 37.65 9.45 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.4 -0.905 . . . . 0.93 113.248 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -78.3 1.02 23.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.88 0.371 . . . . 1.38 111.202 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 37.24 111.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 114.972 1.471 . . . . 0.79 114.972 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -93.27 111.45 51.98 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 113.909 -1.496 . . . . 0.59 107.022 177.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.3 Cg_endo -45.67 172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.026 2.484 . . . . 0.85 113.656 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.772 ' HG3' HD11 ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.32 92.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.085 2.524 . . . . 0.76 113.141 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -58.65 105.33 0.29 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.941 -0.572 . . . . 1.28 110.035 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.1 tt0 4.83 117.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.15 1.38 . . . . 1.77 114.346 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 48.5 Cg_exo -42.62 170.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.943 2.429 . . . . 0.55 114.03 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -102.19 139.1 38.26 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 114.944 -1.025 . . . . 1.23 109.355 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -38.08 127.54 1.3 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.273 0.983 . . . . 1.63 111.282 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -58.26 131.14 49.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.507 -0.769 . . . . 0.41 111.384 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -117.38 108.0 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.933 -0.576 . . . . 0.44 110.961 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.2 m -46.64 -37.23 7.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.44 110.824 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 59.7 m 59.85 37.71 21.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 1.1 110.777 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.16 -39.78 16.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 3.0 112.036 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' HA ' ' NE ' ' A' ' 15' ' ' ARG . 17.8 p-10 -156.09 24.65 0.37 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.382 -0.372 . . . . 2.14 111.457 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.6 p30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 2.06 112.088 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.769 0.318 . . . . 0.68 111.074 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 68.2 m-20 -122.52 134.86 25.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 2.0 110.462 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.55 160.7 10.9 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.593 2.195 . . . . 0.5 113.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 77.1 Cg_exo -52.53 167.61 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.058 2.506 . . . . 0.71 113.125 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.32 -179.88 38.47 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.37 -0.832 . . . . 0.66 112.226 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -66.9 124.21 88.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 O-C-N 122.846 -0.208 . . . . 1.52 110.688 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.6 Cg_exo -70.64 135.65 28.84 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.355 2.037 . . . . 0.44 112.178 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -130.41 115.44 17.28 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.288 -0.414 . . . . 1.09 111.214 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.5 Cg_exo -70.42 114.45 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.209 1.94 . . . . 0.64 113.575 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.703 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.84 -33.56 57.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.497 -0.927 . . . . 1.64 108.497 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -140.5 151.2 44.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.754 -1.112 . . . . 0.72 109.043 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.012 HG22 HG13 ' A' ' 18' ' ' VAL . 4.2 pt -140.87 97.59 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.489 0.551 . . . . 0.96 112.489 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.251 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -85.7 140.28 30.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 1.46 110.007 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -24.48 1.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 2.42 112.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 12.2 m170 -120.44 -1.75 10.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.393 0.516 . . . . 1.02 112.393 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 16' ' ' HIS . 17.2 p -160.5 119.61 2.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.601 0.239 . . . . 0.68 110.672 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.012 HG13 HG22 ' A' ' 13' ' ' ILE . 46.5 t -102.97 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.474 . . . . 0.8 111.668 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.7 m -109.85 121.82 46.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.819 -0.628 . . . . 0.35 111.405 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.762 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.94 161.8 35.04 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.676 0.75 . . . . 0.52 112.139 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -138.6 151.54 47.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.574 -1.194 . . . . 1.84 110.295 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.7 p90 -136.77 -178.05 5.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.264 0.554 . . . . 0.4 112.073 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.61 -154.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.417 -0.81 . . . . 0.83 110.395 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -155.08 127.16 3.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.748 -0.381 . . . . 2.11 111.727 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -46.32 179.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.181 2.587 . . . . 0.89 112.772 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -122.36 -10.06 8.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 2.77 111.971 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -116.76 -72.65 0.68 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.615 -0.434 . . . . 1.37 112.107 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 25' ' ' PRO . 68.6 p 49.63 47.03 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.1 0.476 . . . . 0.91 110.364 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.12 -93.39 0.01 OUTLIER Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.615 -0.721 . . . . 1.01 112.306 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.35 32.99 1.48 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.265 -1.134 . . . . 0.98 110.265 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.702 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.96 -172.8 2.46 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.752 -0.724 . . . . 0.87 111.314 -178.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 8.1 ptmt -145.33 39.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 2.26 111.077 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.126 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.4 mp 62.48 -81.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 1.71 110.492 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.418 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 2.9 p 59.6 29.59 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.15 111.493 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 172.23 94.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 1.58 111.4 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.126 ' CE1' HG21 ' A' ' 33' ' ' ILE . 58.6 m-85 -102.61 81.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.76 111.172 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -72.53 110.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.461 -0.495 . . . . 1.14 110.359 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.28 81.55 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -52.78 138.75 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.457 -0.572 . . . . 1.67 109.457 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.7 153.62 26.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.371 0.605 . . . . 1.97 112.152 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.39 98.52 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.054 -0.975 . . . . 1.44 110.201 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -75.2 76.74 2.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.875 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 73' ' ' GLU . 12.3 mt -57.27 138.26 80.65 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.9 111.131 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -92.2 17.36 42.15 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 124.009 -1.246 . . . . 1.43 112.763 0.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.6 p30 -121.84 53.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.51 -0.314 . . . . 2.66 111.398 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -104.35 173.89 21.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.507 -0.854 . . . . 1.12 112.329 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 1.018 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -165.92 42.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 2.41 110.997 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.569 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 20.8 m95 40.85 69.26 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.958 -0.565 . . . . 0.65 111.855 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.018 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -101.29 121.32 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.765 0.317 . . . . 1.28 110.389 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.94 92.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.454 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -62.61 -46.39 88.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.86 110.438 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.63 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.1 p-10 -62.57 127.11 29.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 2.01 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.73 -17.34 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 2.08 111.113 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -110.63 145.93 37.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 1.89 110.814 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.8 111.43 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 1.87 110.915 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 58' ' ' GLU . 19.7 mm -75.63 90.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.315 -0.402 . . . . 0.69 110.871 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.51 -38.23 65.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.965 0.412 . . . . 1.6 110.457 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -99.73 154.33 18.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 1.54 109.589 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 26.1 p-10 -75.3 -0.71 20.6 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.093 0.405 . . . . 1.75 112.093 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.655 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 2.5 tp10 -100.73 105.47 16.81 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.44 -0.578 . . . . 2.05 109.44 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.658 ' CD1' HD12 ' A' ' 56' ' ' ILE . 58.2 t80 -137.15 165.99 24.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.346 0.594 . . . . 0.48 111.922 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -133.06 100.4 4.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.205 -0.907 . . . . 0.42 110.843 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 14.9 m -57.29 142.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 1.08 111.04 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.497 ' OG ' HG22 ' A' ' 17' ' ' THR . 7.5 t -136.12 154.17 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.72 0.772 . . . . 1.33 111.131 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.16 -5.9 19.61 Favored Glycine 0 C--N 1.313 -0.711 0 CA-C-N 114.48 -1.236 . . . . 0.9 112.3 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.795 HD23 HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -62.85 -175.52 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.834 0.349 . . . . 1.47 110.815 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 m -149.35 130.66 14.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.435 . . . . 1.06 110.634 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 5.8 tt0 -50.92 149.35 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 1.91 111.085 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.84 48.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.87 110.793 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.2 130.81 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.49 111.625 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.82 135.13 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.36 110.243 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -131.8 121.77 24.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.926 0.393 . . . . 0.56 111.99 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' A' ' 43' ' ' LEU . 2.7 mt-10 -97.3 137.74 35.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.86 -0.792 . . . . 1.5 108.86 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.902 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -122.21 106.76 11.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.42 1.267 . . . . 0.6 114.42 -179.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -104.49 143.47 32.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.136 -0.938 . . . . 2.11 108.927 178.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.484 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -116.51 136.33 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.958 -0.697 . . . . 0.6 112.001 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.751 ' O ' HD12 ' A' ' 37' ' ' ILE . 33.9 mt -117.21 153.17 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.907 -1.042 . . . . 0.7 108.513 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -146.35 117.4 7.77 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.371 -0.531 . . . . 0.6 111.735 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 23.0 ptmt -86.89 14.75 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.15 0.796 . . . . 1.98 113.15 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 2.6 m-80 43.51 -179.91 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.074 1.138 . . . . 2.19 114.074 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -57.61 -50.26 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.972 -1.467 . . . . 1.08 112.372 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.702 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -88.79 34.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.584 0.587 . . . . 1.06 112.584 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.1 39.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.544 -0.836 . . . . 0.93 113.045 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.11 94.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 1.38 109.257 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.4 tp -61.04 107.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.294 0.85 . . . . 0.79 113.294 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.2 p -87.52 108.5 20.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.978 -1.119 . . . . 0.59 107.978 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.5 Cg_endo -42.01 172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.125 2.55 . . . . 0.85 113.883 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 54.1 Cg_exo -51.81 129.04 28.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.9 2.4 . . . . 0.76 112.466 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 15.2 m -99.94 106.12 17.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.334 -0.394 . . . . 1.28 110.419 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 1.92 117.69 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.243 0 O-C-N 124.696 1.248 . . . . 1.77 113.355 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.569 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 9.1 Cg_exo -69.29 160.59 49.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.803 1.669 . . . . 0.55 113.915 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -87.28 141.1 28.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.779 -1.193 . . . . 1.23 107.779 178.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.839 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -32.12 138.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.042 0.839 . . . . 1.63 112.201 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -67.53 101.25 0.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.158 -0.473 . . . . 0.41 111.063 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.6 mp -84.2 115.03 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.926 0.393 . . . . 0.44 111.053 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 23.8 m -52.45 -23.52 6.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.875 -0.602 . . . . 0.44 110.6 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.638 ' H ' HG22 ' A' ' 95' ' ' ILE . 7.6 m 50.12 84.34 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.089 0.471 . . . . 1.1 109.875 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -132.35 -87.36 0.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.716 -0.675 . . . . 3.0 110.979 -179.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 26.7 p-10 -93.28 21.9 5.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.125 -0.489 . . . . 2.14 110.631 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.251 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.273 0.559 . . . . 2.06 111.54 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.884 0.373 . . . . 0.68 111.422 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 18.0 m-20 -111.61 130.45 23.11 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 2.0 110.186 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.72 162.43 24.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.412 2.075 . . . . 0.5 112.38 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' N ' ' HG3' ' A' ' 25' ' ' PRO . 53.7 Cg_exo -54.39 178.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.929 2.419 . . . . 0.71 113.37 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.69 161.02 30.59 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.66 112.517 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.4 tttt -53.23 132.53 51.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 110.244 -0.28 . . . . 1.52 110.244 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HG3' HG23 ' A' ' 76' ' ' VAL . 4.5 Cg_exo -82.01 136.89 9.44 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.445 2.097 . . . . 0.44 112.396 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -130.87 121.23 18.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.09 110.849 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.7 Cg_exo -65.71 100.71 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.439 2.093 . . . . 0.64 113.417 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.685 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.95 -35.01 72.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.869 -0.789 . . . . 1.64 108.869 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -142.07 151.45 42.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.661 -1.154 . . . . 0.72 108.339 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.053 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -139.84 113.61 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.129 -0.629 . . . . 0.96 112.301 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.002 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.61 151.27 23.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.65 -0.705 . . . . 1.46 109.865 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HB2' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -64.29 -10.52 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.61 0.596 . . . . 2.42 112.61 -179.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 17' ' ' THR . 6.6 m-70 -135.07 20.09 3.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.273 . . . . 1.02 111.323 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 168.13 114.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.68 109.956 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 ' CD1' ' A' ' 66' ' ' LEU . 14.5 m -108.4 146.68 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.594 -0.442 . . . . 0.8 110.632 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.533 ' C ' HD13 ' A' ' 20' ' ' LEU . 4.1 m -110.58 120.21 41.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.35 111.979 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.867 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -132.36 171.1 14.16 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.662 0.744 . . . . 0.52 111.804 178.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.67 173.22 16.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.024 -0.989 . . . . 1.84 109.123 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 3.1 p90 -138.37 -168.36 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.595 0.591 . . . . 0.4 112.595 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 24' ' ' LYS . . . -96.67 -13.41 22.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.83 113.416 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.464 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 74.34 149.84 0.13 Allowed Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 110.121 -0.325 . . . . 2.11 110.121 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 20.0 Cg_exo -65.96 -167.35 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.33 2.02 . . . . 0.89 113.047 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -148.74 -45.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 2.77 110.787 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.1 77.16 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.37 111.283 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 22.6 p -92.47 46.73 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.91 109.95 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.16 -98.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.546 -0.835 . . . . 1.01 111.653 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.2 29.48 2.92 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.578 -1.009 . . . . 0.98 110.578 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -117.38 174.39 6.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.091 -0.555 . . . . 0.87 111.071 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -0.58 4.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 2.26 111.457 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 23.3 mt 63.25 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.178 -0.304 . . . . 1.71 110.178 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -107.69 -15.25 14.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.715 0.635 . . . . 1.15 112.715 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -167.43 158.58 11.68 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.397 0.518 . . . . 1.58 112.397 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -117.36 131.4 56.79 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.76 110.014 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 5.6 mt -104.84 132.49 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.852 -0.613 . . . . 1.14 111.023 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 63' ' ' VAL . 5.1 t -110.33 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.265 -0.425 . . . . 0.63 111.278 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 14.0 mt-10 -85.42 131.2 34.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.532 -0.544 . . . . 1.67 109.532 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -102.32 129.26 48.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 1.97 111.854 -179.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 5.4 ttp180 -105.9 92.59 4.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.634 -0.712 . . . . 1.44 109.488 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -62.96 146.75 52.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.54 . . . . 1.59 109.574 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 10.0 mt -127.12 131.0 23.65 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.871 -0.332 . . . . 0.9 110.808 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 6.7 Cg_endo -88.5 38.98 3.14 Favored 'Cis proline' 0 C--N 1.352 0.726 0 C-N-CA 124.542 -1.024 . . . . 1.43 113.026 0.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -114.2 56.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.314 . . . . 2.66 110.607 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . -62.17 169.61 13.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.792 -0.718 . . . . 1.12 113.262 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.51 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.657 0.265 . . . . 2.41 111.628 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 68.5 m95 63.17 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.248 -0.279 . . . . 0.65 110.248 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.34 121.58 11.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.838 0.351 . . . . 1.28 110.796 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 6.2 ptpt -51.03 111.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 1.3 111.105 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -100.92 -11.94 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.896 -0.593 . . . . 0.86 111.258 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 56' ' ' ILE . 6.1 p-10 -74.21 -60.94 2.04 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.654 -0.418 . . . . 2.01 111.871 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 4.8 t80 78.37 -51.32 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.549 0.214 . . . . 2.08 111.409 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -173.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.036 0.446 . . . . 1.89 111.47 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.0 80.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.786 -0.643 . . . . 1.87 110.764 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.565 HD11 ' CB ' ' A' ' 52' ' ' ASN . 70.3 mt -71.11 103.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.69 110.733 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.36 -50.82 2.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.6 111.665 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -56.66 -20.26 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.137 0.421 . . . . 1.54 112.137 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.2 p-10 89.17 -25.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.71 0.804 . . . . 1.75 111.65 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -81.93 86.56 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.751 -0.833 . . . . 2.05 108.751 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 62' ' ' THR . 55.0 t80 -120.8 165.56 14.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.328 0.585 . . . . 0.48 111.998 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 18' ' ' VAL . 54.9 m -123.7 122.26 37.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.37 -0.832 . . . . 0.42 110.84 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 20' ' ' LEU . 9.6 t -81.91 95.7 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.159 0.504 . . . . 1.08 110.834 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 17' ' ' THR . 41.3 t -83.26 -158.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.495 -0.775 . . . . 1.33 110.74 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 57.72 19.62 36.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.511 -0.852 . . . . 0.9 112.248 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.037 ' CD1' HG13 ' A' ' 18' ' ' VAL . 68.7 mt -75.12 -176.97 3.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 1.47 110.607 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -144.59 144.29 31.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 1.06 110.68 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 22.2 tt0 -70.67 146.92 49.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 1.91 110.971 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.2 t0 60.4 41.23 16.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.551 . . . . 1.87 111.16 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -150.69 124.67 9.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.732 0.301 . . . . 0.49 111.347 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.056 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 68.8 m-85 -126.86 126.15 42.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.143 0.794 . . . . 0.56 113.143 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -100.01 137.72 38.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.219 -0.66 . . . . 1.5 109.219 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.993 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.89 116.88 23.64 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.486 0.921 . . . . 0.6 113.486 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -102.25 145.76 28.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.855 -0.612 . . . . 2.11 110.967 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.594 HG23 ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -105.94 104.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.479 0.548 . . . . 0.6 112.479 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.445 HG12 ' CA ' ' A' ' 88' ' ' PRO . 30.2 mt -105.03 147.77 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.9 -1.519 . . . . 0.7 106.9 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -166.04 144.04 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.16 -1.016 . . . . 0.6 112.74 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.02 -172.35 4.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 1.98 110.136 179.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 50.0 p30 -126.09 -128.52 0.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.391 -0.368 . . . . 2.19 110.279 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -116.06 -28.15 6.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.158 0.89 . . . . 1.08 111.24 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -82.02 4.75 21.66 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.179 0.437 . . . . 1.06 112.179 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.13 78.73 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.425 -0.893 . . . . 0.93 113.303 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -75.8 161.98 28.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.118 0.459 . . . . 1.38 110.448 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.9 tp -115.26 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 0.79 112.629 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 2.0 p -74.48 113.72 26.76 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.262 -0.644 . . . . 0.59 109.262 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.35 163.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.749 2.3 . . . . 0.85 113.041 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' CA ' HG12 ' A' ' 77' ' ' ILE . 28.1 Cg_endo -63.99 144.96 89.18 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.826 2.351 . . . . 0.76 113.126 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.0 m -98.99 127.17 44.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.593 -0.73 . . . . 1.28 109.963 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt0 -20.97 98.33 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 O-C-N 124.587 1.179 . . . . 1.77 113.067 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 42.0 Cg_exo -35.67 166.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.57 2.847 . . . . 0.55 115.574 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.514 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 1.5 m -93.32 141.49 28.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.02 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -39.87 139.42 0.65 Allowed 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 123.731 0.644 . . . . 1.63 111.412 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.37 102.23 2.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.017 -0.538 . . . . 0.41 109.923 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 13' ' ' ILE . 4.4 mp -84.26 111.74 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.941 0.401 . . . . 0.44 111.226 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 98' ' ' ARG . 66.8 m -47.63 -30.11 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.44 111.254 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.471 ' H ' HG22 ' A' ' 95' ' ' ILE . 79.2 m 49.6 89.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 1.1 110.323 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.77 -85.95 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 3.0 111.28 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.506 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.5 p-10 -101.72 2.37 38.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 2.14 111.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.053 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 112.359 0.503 . . . . 2.06 112.359 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.761 HD12 ' OD1' ' A' ' 80' ' ' ASN . 4.9 tt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.067 0.461 . . . . 0.68 111.312 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.325 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -133.86 128.17 19.65 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.615 -0.721 . . . . 2.0 109.875 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.62 176.37 9.17 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.42 2.08 . . . . 0.5 112.379 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 21.0 Cg_exo -65.39 178.29 2.17 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.809 2.339 . . . . 0.71 112.729 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.06 172.49 55.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.988 -0.625 . . . . 0.66 112.614 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.642 ' NZ ' ' OE2' ' A' ' 90' ' ' GLU . 10.0 tttp -58.66 120.44 45.49 Favored Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.021 -0.105 . . . . 1.52 110.722 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.761 ' CG ' HG23 ' A' ' 76' ' ' VAL . 22.2 Cg_exo -67.58 127.09 15.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.077 . . . . 0.44 112.802 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.6 p -133.18 107.46 12.37 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 115.821 -0.627 . . . . 1.09 111.158 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.1 Cg_exo -37.67 142.58 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.827 2.352 . . . . 0.64 113.292 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 19' ' ' THR . 0.5 OUTLIER -97.71 -44.63 6.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.747 -1.115 . . . . 1.64 108.372 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -148.11 155.61 41.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.997 -1.456 . . . . 0.72 109.061 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.01 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -143.85 100.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.436 -0.505 . . . . 0.96 111.69 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.252 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -98.87 50.13 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.943 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.831 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.68 -70.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.998 0.811 . . . . 2.42 112.075 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 8.4 m170 -77.41 -26.85 52.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 1.02 111.255 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -125.23 112.12 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.819 0.343 . . . . 0.68 111.148 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 13' ' ' ILE . 72.9 t -107.23 110.68 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.086 -0.506 . . . . 0.8 111.171 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 79.4 m -88.43 149.19 23.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.35 110.678 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.88 154.71 38.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.533 0.682 . . . . 0.52 112.148 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -143.86 144.83 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.737 -1.12 . . . . 1.84 110.171 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 10.9 p90 -140.57 -172.31 3.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 0.4 111.545 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.73 159.36 14.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.319 0.581 . . . . 0.83 112.337 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.4 139.59 28.36 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.32 -0.854 . . . . 2.11 110.057 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -44.85 169.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.336 2.024 . . . . 0.89 111.869 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -119.04 -4.87 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.099 0.407 . . . . 2.77 112.099 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.747 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.5 t80 -141.42 -73.89 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 1.37 111.933 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 1.325 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.8 p 79.6 -39.28 0.2 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.225 0.61 . . . . 0.91 112.315 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.7 -82.81 0.33 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.498 -0.858 . . . . 1.01 111.554 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.18 27.57 0.79 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.114 -1.194 . . . . 0.98 110.114 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.523 ' CE2' ' OD1' ' A' ' 80' ' ' ASN . 1.7 m-85 -116.94 -177.07 3.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.705 -0.748 . . . . 0.87 111.404 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.56 -3.06 2.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.652 -0.704 . . . . 2.26 111.923 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' HG3' ' A' ' 25' ' ' PRO . 15.0 mt 60.76 140.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 120.8 0.334 . . . . 1.71 110.506 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -123.96 6.74 8.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.359 0.503 . . . . 1.15 112.359 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 178.0 162.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.134 0.492 . . . . 1.58 111.965 179.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.722 ' O ' HD12 ' A' ' 56' ' ' ILE . 42.5 m-85 -128.76 101.11 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.411 -0.813 . . . . 0.76 110.3 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.8 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -87.62 122.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.623 -0.262 . . . . 1.14 110.888 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.6 p -110.84 128.61 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.044 0.449 . . . . 0.63 110.815 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mt-10 -90.0 136.17 33.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.91 -0.586 . . . . 1.67 112.227 -179.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -99.8 132.43 45.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.419 0.896 . . . . 1.97 113.419 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 7.5 ttm180 -115.4 107.61 15.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.484 . . . . 1.44 110.077 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 90.6 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.869 -0.605 . . . . 1.59 111.015 -179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -66.05 150.22 96.9 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.45 -0.341 . . . . 0.9 110.611 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.78 -9.25 47.24 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.086 -1.214 . . . . 1.43 112.794 0.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -60.26 -61.98 2.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.907 0.384 . . . . 2.66 110.725 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 85.36 142.92 6.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.916 -0.659 . . . . 1.12 112.839 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 176.3 64.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 2.41 110.692 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 80.9 m95 -33.89 98.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.446 -0.797 . . . . 0.65 111.881 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -125.23 139.52 53.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.189 0.519 . . . . 1.28 112.271 -179.326 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HD2' HG21 ' A' ' 37' ' ' ILE . 4.2 mtmt -57.33 86.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.549 -0.751 . . . . 1.3 110.868 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -59.31 -51.98 67.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.86 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.806 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.0 p-10 -61.49 150.94 34.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.01 111.189 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.88 27.67 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.786 -0.643 . . . . 2.08 110.544 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -130.68 30.41 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.89 110.727 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.52 111.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 1.87 110.734 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 52' ' ' ASN . 19.6 mt -101.32 71.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.69 111.275 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -50.84 -80.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.489 . . . . 1.6 110.85 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.97 168.63 5.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.996 -0.372 . . . . 1.54 109.996 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -88.81 47.11 1.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.992 0.425 . . . . 1.75 111.533 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -144.32 101.28 3.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 2.05 109.308 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' A' ' 56' ' ' ILE . 77.0 t80 -134.53 165.22 25.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.48 112.135 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 85.1 m -131.27 116.59 17.82 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.42 110.861 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 18' ' ' VAL . 7.2 m -77.42 110.06 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.08 111.045 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.24 126.18 51.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.059 -0.518 . . . . 1.33 111.098 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.97 -1.31 2.8 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.539 -0.839 . . . . 0.9 113.659 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -51.77 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.189 0.519 . . . . 1.47 111.302 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.1 m -135.45 117.02 14.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.631 -0.713 . . . . 1.06 110.7 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 1.4 tt0 -47.3 132.53 12.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.061 -0.518 . . . . 1.91 111.32 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 6.3 t0 73.77 67.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 1.87 111.243 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 177.27 124.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.49 111.064 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.37 130.81 43.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.36 110.454 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 38.4 m-85 -126.07 122.93 37.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.56 112.017 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.2 tt0 -107.22 141.32 38.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.282 -0.636 . . . . 1.5 109.282 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.55 125.16 16.8 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.153 1.168 . . . . 0.6 114.153 -179.24 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.775 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -100.38 165.83 11.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.034 -0.53 . . . . 2.11 109.78 178.592 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.761 HG23 ' CG ' ' A' ' 8' ' ' PRO . 46.9 t -122.95 114.08 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 113.557 0.947 . . . . 0.6 113.557 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 56.6 mt -108.11 154.85 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.562 -1.644 . . . . 0.7 106.562 177.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -167.39 131.27 1.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.955 -1.098 . . . . 0.6 113.473 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -83.67 143.32 30.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.655 -0.702 . . . . 1.98 109.288 178.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.761 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -78.89 -106.71 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.077 -0.511 . . . . 2.19 111.902 -178.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.01 -28.36 2.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.783 0.72 . . . . 1.08 112.622 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.85 20.78 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.429 0.529 . . . . 1.06 112.429 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 87.72 -17.04 47.49 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.378 -0.915 . . . . 0.93 112.772 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.339 . . . . 1.38 110.414 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.4 tt -77.81 112.18 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.494 . . . . 0.79 112.005 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.5 p -66.06 122.11 79.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.854 -0.612 . . . . 0.59 109.896 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -35.04 158.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.415 2.744 . . . . 0.85 113.45 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 12.0 Cg_exo -71.22 148.21 55.23 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.871 2.381 . . . . 0.76 112.423 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.42 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 3.0 m -97.32 129.49 44.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 1.28 109.748 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.642 ' OE2' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -30.8 111.67 0.29 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.805 0.691 . . . . 1.77 112.372 -179.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.7 Cg_exo -37.93 148.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.762 2.308 . . . . 0.55 113.629 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.423 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.66 139.66 31.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.062 -0.972 . . . . 1.23 109.457 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.646 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -32.72 139.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.28 0.988 . . . . 1.63 112.363 -179.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -75.47 109.93 9.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.558 -0.746 . . . . 0.41 110.731 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.1 mp -92.54 115.77 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.029 0.443 . . . . 0.44 111.225 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 86.1 m -47.22 -30.81 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.535 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.536 ' H ' HG22 ' A' ' 95' ' ' ILE . 91.5 m 54.19 62.39 2.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.91 0.386 . . . . 1.1 110.182 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -97.71 -86.84 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 3.0 111.623 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -116.83 28.33 8.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 2.14 110.662 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.252 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 2.06 111.543 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' CG ' ' A' ' 80' ' ' ASN . 2.0 tt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.917 0.389 . . . . 0.68 111.842 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -117.42 137.0 23.69 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.055 -0.52 . . . . 2.0 110.419 179.534 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 160.14 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.443 2.096 . . . . 0.5 112.418 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 172.3 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.822 2.348 . . . . 0.71 112.98 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.88 174.21 20.69 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.66 112.817 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -66.63 138.08 95.36 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 110.544 -0.169 . . . . 1.52 110.544 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.2 Cg_exo -77.87 139.32 17.43 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.818 2.345 . . . . 0.44 112.502 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.9 p -145.9 126.37 7.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.33 -0.395 . . . . 1.09 111.456 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.695 ' CG ' HD11 ' A' ' 95' ' ' ILE . 16.9 Cg_exo -66.87 141.21 58.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.76 2.307 . . . . 0.64 113.757 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.4 mm? -107.32 -36.17 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.627 -0.879 . . . . 1.64 108.627 178.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -139.36 150.73 45.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.614 -1.176 . . . . 0.72 108.297 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.929 HG21 HG12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -143.86 101.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.259 -0.576 . . . . 0.96 112.068 -179.279 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -93.89 56.89 2.37 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 115.881 -0.599 . . . . 1.46 110.863 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 47.84 -74.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.024 0.827 . . . . 2.42 112.886 179.389 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -73.99 -37.8 64.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.99 0.367 . . . . 1.02 111.99 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HB3' ' A' ' 64' ' ' SER . 72.3 p -122.46 110.27 15.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.718 0.294 . . . . 0.68 111.02 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 4.1 m -99.29 152.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.8 111.288 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.595 ' C ' HD13 ' A' ' 20' ' ' LEU . 13.9 m -118.21 123.92 46.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.35 111.32 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.52 162.74 32.27 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.413 0.625 . . . . 0.52 111.336 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.963 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -151.3 158.46 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 1.84 110.12 179.384 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.6 p90 -137.42 -167.82 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.4 111.316 -179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.11 -166.59 1.45 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.354 0.597 . . . . 0.83 112.367 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' HG2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -114.59 141.45 26.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.148 -0.933 . . . . 2.11 110.228 -179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' THR . 12.1 Cg_endo -55.35 172.63 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.247 1.965 . . . . 0.89 112.186 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.26 -39.17 2.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 2.77 111.106 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.402 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 1.8 t80 -120.28 71.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 1.37 111.478 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 25' ' ' PRO . 73.8 p -91.01 44.24 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.501 -0.318 . . . . 0.91 110.539 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.07 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.704 -0.76 . . . . 1.01 112.501 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.95 49.26 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.987 -1.245 . . . . 0.98 109.987 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.57 177.45 7.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.984 -0.608 . . . . 0.87 110.929 -178.208 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -138.53 6.31 2.5 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.09 0.404 . . . . 2.26 112.09 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.5 mt 58.52 150.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 120.851 0.358 . . . . 1.71 111.042 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -131.73 15.09 4.87 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.0 0.37 . . . . 1.15 112.0 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.616 ' H ' HG22 ' A' ' 33' ' ' ILE . 42.3 t 179.25 124.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 1.58 111.092 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.768 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.8 m-85 -105.38 88.21 2.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.76 111.195 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.483 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.4 mm -69.39 151.96 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.95 -0.3 . . . . 1.14 110.323 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.17 103.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.272 0.558 . . . . 0.63 110.782 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.51 161.92 29.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.367 -0.833 . . . . 1.67 110.04 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -136.41 153.35 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 1.97 111.391 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 23.7 ttm180 -134.69 121.33 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 1.44 110.801 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.818 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.56 91.62 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.593 . . . . 1.59 110.859 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.61 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -56.3 152.52 23.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.9 110.53 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.37 30.4 11.85 Favored 'Cis proline' 0 C--N 1.348 0.533 0 C-N-CA 123.911 -1.287 . . . . 1.43 112.573 0.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.99 99.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.368 . . . . 2.66 111.139 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.818 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -135.35 -123.12 2.29 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.685 -0.769 . . . . 1.12 112.89 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -135.03 -169.83 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.431 0.158 . . . . 2.41 110.716 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 4.4 m95 -136.33 49.67 2.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.65 110.946 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.5 148.3 25.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.28 111.231 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 37' ' ' ILE . 8.2 ptmm? -79.16 89.61 4.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.127 -0.488 . . . . 1.3 110.875 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -49.02 -41.83 36.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.01 0.433 . . . . 0.86 110.575 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.54 ' CB ' HD11 ' A' ' 56' ' ' ILE . 8.8 t30 -60.46 100.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.796 -0.638 . . . . 2.01 110.159 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -104.86 28.66 6.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 2.08 111.321 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.3 t -130.47 -70.64 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.344 . . . . 1.89 111.005 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 170.58 153.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 1.87 110.588 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 61' ' ' PHE . 16.8 mt -142.09 56.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.69 111.253 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 tp -48.46 -38.24 19.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 1.6 110.747 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.721 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -92.77 166.74 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 1.54 110.161 179.67 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 56.6 p30 -89.22 15.12 9.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.496 -0.32 . . . . 1.75 111.651 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.963 ' OE1' ' HB3' ' A' ' 21' ' ' LYS . 19.7 tp10 -122.71 99.56 6.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 56' ' ' ILE . 26.1 t80 -131.71 166.6 21.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.007 0.432 . . . . 0.48 111.424 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' VAL . 21.6 m -117.58 120.67 38.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.42 111.076 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 20' ' ' LEU . 12.5 t -84.14 104.29 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.16 0.505 . . . . 1.08 111.507 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.774 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -94.5 -168.64 1.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.461 -0.79 . . . . 1.33 110.404 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.44 11.82 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.572 -0.823 . . . . 0.9 112.893 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.01 ' CD1' HG13 ' A' ' 18' ' ' VAL . 16.2 mt -69.18 -159.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.927 -0.397 . . . . 1.47 109.927 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.7 m -147.69 147.73 30.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.902 0.382 . . . . 1.06 110.594 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.1 mt-10 -81.78 145.82 30.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 1.91 110.988 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t0 67.65 39.4 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 1.87 111.058 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.95 122.91 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.49 111.452 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -68.78 133.22 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.36 109.884 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.43 ' HA ' HD22 ' A' ' 43' ' ' LEU . 35.6 m-85 -124.38 127.37 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.691 0.626 . . . . 0.56 112.691 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.503 ' CG ' HD21 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -98.05 138.24 35.66 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.178 -1.045 . . . . 1.5 108.178 178.225 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.42 108.7 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.523 -1.271 . . . . 0.6 113.937 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -88.67 159.72 17.7 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.112 -0.329 . . . . 2.11 110.112 179.041 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.649 HG23 ' CG ' ' A' ' 8' ' ' PRO . 64.6 t -121.2 122.84 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.427 0.632 . . . . 0.6 112.585 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 39.5 mt -117.06 155.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.719 -1.215 . . . . 0.7 107.719 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -172.4 138.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.378 -0.929 . . . . 0.6 112.178 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 33' ' ' ILE . 5.2 ptpt -84.57 176.53 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 1.98 110.766 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.739 ' CG ' HD12 ' A' ' 2' ' ' ILE . 2.4 p-10 -124.57 163.61 21.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.871 -0.604 . . . . 2.19 111.208 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.82 -25.53 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 1.08 111.906 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -77.22 -12.39 59.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.897 0.332 . . . . 1.06 111.897 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 -17.75 57.68 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.49 -0.862 . . . . 0.93 112.425 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -57.33 -162.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.54 0.209 . . . . 1.38 110.492 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -145.0 105.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.79 112.001 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -63.44 119.56 54.55 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.59 108.734 179.175 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.6 Cg_endo -48.98 159.25 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.89 2.393 . . . . 0.85 113.242 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 24.0 Cg_endo -62.56 150.78 86.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.907 2.405 . . . . 0.76 113.264 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 m -106.53 132.8 52.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.805 . . . . 1.28 109.651 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 13.7 tt0 -30.25 111.91 0.29 Allowed Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.867 0.73 . . . . 1.77 112.325 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.49 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 71.7 Cg_exo -45.66 139.57 10.15 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.787 2.324 . . . . 0.55 114.324 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -53.75 144.54 17.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.834 -0.802 . . . . 1.23 108.834 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 4.7 m-20 -14.62 -89.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.743 1.902 . . . . 1.63 113.793 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . 158.43 106.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.967 0.907 . . . . 0.41 109.239 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.929 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -98.04 112.99 31.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.756 -0.378 . . . . 0.44 111.956 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.4 m -47.44 -32.53 5.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.276 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 55.65 82.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.839 -0.618 . . . . 1.1 110.163 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -88.19 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.743 -0.662 . . . . 3.0 111.392 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -124.77 9.02 8.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.478 -0.328 . . . . 2.14 111.568 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.3 t0 . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.969 0.414 . . . . 2.06 110.893 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.446 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.914 0.387 . . . . 0.68 111.22 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.3 m-20 -128.87 132.09 24.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.077 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 158.1 53.15 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.368 2.045 . . . . 0.5 112.4 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 9.9 Cg_endo -52.03 175.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.943 2.429 . . . . 0.71 112.763 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.91 168.62 49.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.024 -0.608 . . . . 0.66 112.665 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -59.73 121.89 61.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 110.461 -0.199 . . . . 1.52 110.461 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.653 ' CG ' HG23 ' A' ' 76' ' ' VAL . 32.1 Cg_exo -62.17 147.85 94.29 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.426 2.084 . . . . 0.44 112.451 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -151.52 110.48 2.97 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.954 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.5 Cg_exo -59.63 127.34 23.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.613 2.209 . . . . 0.64 113.52 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -94.16 -26.37 16.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.373 -0.831 . . . . 1.64 109.081 178.512 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 7.5 t30 -145.85 149.53 34.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.696 -0.684 . . . . 0.72 109.897 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.051 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.56 103.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.415 . . . . 0.96 111.132 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.218 ' CA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.48 60.42 0.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.883 -0.599 . . . . 1.46 111.544 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.166 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 59.12 -70.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.671 0.607 . . . . 2.42 112.445 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.0 m170 -87.31 -27.18 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.185 -0.461 . . . . 1.02 111.762 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.8 p -111.86 103.47 11.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.68 111.424 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.051 HG13 HG22 ' A' ' 13' ' ' ILE . 86.9 t -102.07 95.73 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.8 111.038 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 78.3 m -80.96 142.52 33.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.248 -0.433 . . . . 0.35 111.636 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.731 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -154.85 164.77 38.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.43 -0.805 . . . . 0.52 112.009 -179.702 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.846 ' HB3' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.47 176.14 10.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.107 -0.951 . . . . 1.84 109.302 178.448 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.8 p90 -158.01 -177.54 6.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.275 0.56 . . . . 0.4 112.303 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.28 178.65 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.147 -0.933 . . . . 0.83 110.65 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 157.07 40.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.403 -0.362 . . . . 2.11 110.21 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' A' ' 28' ' ' THR . 37.1 Cg_exo -56.45 -157.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.506 2.138 . . . . 0.89 112.443 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -26.19 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.32 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -134.24 -67.73 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.856 0.317 . . . . 1.37 111.856 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' HG2' ' A' ' 25' ' ' PRO . 2.8 p 65.31 34.63 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.91 110.515 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.39 -95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.53 -0.843 . . . . 1.01 111.813 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.65 28.85 1.46 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.526 -1.029 . . . . 0.98 110.526 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HE1' ' HB2' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -107.01 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.193 -0.503 . . . . 0.87 111.591 -178.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -133.41 -0.41 3.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.66 -0.7 . . . . 2.26 111.706 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 35' ' ' SER . 2.9 mt 60.89 129.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 120.932 0.396 . . . . 1.71 110.901 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -116.71 25.99 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.442 -0.345 . . . . 1.15 111.63 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.564 ' H ' HG22 ' A' ' 33' ' ' ILE . 1.7 m 172.09 164.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 1.58 111.169 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.769 ' O ' HD12 ' A' ' 56' ' ' ILE . 40.7 m-85 -142.36 106.18 4.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.504 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -87.35 94.62 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 1.14 111.039 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -86.42 114.58 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.63 110.75 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 2.0 mm-40 -86.0 156.79 20.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.634 -0.712 . . . . 1.67 110.922 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.719 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -122.62 142.99 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 1.97 111.316 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -119.03 114.01 21.84 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.037 -0.529 . . . . 1.44 110.584 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.763 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.7 102.08 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.59 110.492 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 94' ' ' ALA . 46.8 mt -80.09 156.12 74.52 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.583 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 89.1 Cg_endo -86.26 28.64 9.63 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.88 -1.3 . . . . 1.43 113.489 0.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.3 -86.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.636 0.255 . . . . 2.66 110.555 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 117.43 170.69 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.456 -0.878 . . . . 1.12 113.208 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.763 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 1.0 OUTLIER 176.68 -35.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.407 . . . . 2.41 110.566 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 34.0 m95 62.92 81.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.65 111.406 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -122.54 128.67 51.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.759 -0.655 . . . . 1.28 110.234 179.786 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -55.11 87.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.76 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.719 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -51.4 -47.56 62.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.86 111.226 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' HB2' HD11 ' A' ' 56' ' ' ILE . 2.0 t30 -44.79 -79.2 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 2.01 110.983 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 84.46 -43.12 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.181 0.437 . . . . 2.08 112.181 179.624 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.2 m -67.02 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 1.89 111.28 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 140.13 1.05 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 1.87 110.798 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 36' ' ' TYR . 51.4 mt -130.16 67.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.69 110.982 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.09 -65.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.463 . . . . 1.6 110.751 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -74.42 179.27 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.549 . . . . 1.54 110.115 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 5.3 p-10 -93.7 13.24 22.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.398 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.846 ' CD ' ' HB3' ' A' ' 21' ' ' LYS . 16.1 tp10 -117.63 105.48 12.08 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.981 -0.377 . . . . 2.05 109.981 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.691 ' HB2' HG23 ' A' ' 56' ' ' ILE . 37.3 t80 -137.51 165.99 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.48 111.156 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.51 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -122.53 120.42 33.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.42 111.372 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 51' ' ' ALA . 5.5 t -83.17 85.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 1.08 111.029 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -86.98 -169.78 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.618 -0.719 . . . . 1.33 110.632 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.22 25.1 46.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.9 112.411 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.682 ' CD1' HG23 ' A' ' 18' ' ' VAL . 44.1 mt -77.63 -178.04 5.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.47 111.104 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 134.14 54.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 1.06 110.496 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.68 152.09 28.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 1.91 111.223 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 1.1 t70 66.73 60.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 1.87 110.985 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 178.13 130.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.49 111.359 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 128.63 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.36 110.194 179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 44.9 m-85 -124.21 124.92 43.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.846 0.684 . . . . 0.56 112.846 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 19.8 mt-10 -100.03 141.12 33.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.798 -0.815 . . . . 1.5 108.798 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.701 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -130.88 120.8 24.17 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.358 1.244 . . . . 0.6 114.358 -178.704 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -105.47 169.85 8.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.746 -0.661 . . . . 2.11 109.778 178.493 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' CG ' ' A' ' 8' ' ' PRO . 61.2 t -125.54 105.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.428 0.899 . . . . 0.6 113.428 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 88' ' ' PRO . 44.3 mt -100.59 130.57 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 106.934 -1.506 . . . . 0.7 106.934 177.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.91 147.74 21.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.452 -0.899 . . . . 0.6 113.046 -178.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mttt -77.31 -167.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 1.98 110.345 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 49.7 p30 -129.78 -119.5 0.23 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.475 -0.565 . . . . 2.19 109.475 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.02 1.14 5.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.49 1.041 . . . . 1.08 111.71 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . . . -112.01 4.32 18.02 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.597 0.221 . . . . 1.06 111.597 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.84 -11.76 64.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.344 -0.932 . . . . 0.93 112.929 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.96 177.03 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.936 0.368 . . . . 1.38 110.394 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -130.88 101.31 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.79 111.989 -179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -57.57 118.35 24.91 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.553 -0.906 . . . . 0.59 108.553 178.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.0 Cg_endo -42.8 171.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.896 2.397 . . . . 0.85 113.313 -178.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HG3' HD11 ' A' ' 77' ' ' ILE . 6.7 Cg_exo -71.3 130.73 17.9 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.778 2.318 . . . . 0.76 112.778 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -87.86 108.26 19.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.765 -0.652 . . . . 1.28 109.932 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -10.3 115.3 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.458 1.103 . . . . 1.77 113.401 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 89.2 Cg_exo -47.91 163.34 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.736 2.291 . . . . 0.55 114.217 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.38 151.99 19.95 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 1.23 109.48 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.57 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -32.33 140.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 124.3 1.0 . . . . 1.63 112.455 179.914 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.01 113.08 16.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.767 -0.651 . . . . 0.41 111.138 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.3 mp -97.57 116.29 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.44 110.828 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.6 m -46.17 -26.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.885 -0.598 . . . . 0.44 111.47 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 95' ' ' ILE . 34.2 m 47.34 78.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.571 -0.286 . . . . 1.1 111.273 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -121.87 -79.55 0.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.096 0.474 . . . . 3.0 110.99 179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -122.66 26.33 8.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.52 -0.764 . . . . 2.14 110.451 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.218 ' OD1' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.002 -0.545 . . . . 2.06 111.225 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.669 HD11 ' OD1' ' A' ' 80' ' ' ASN . 2.0 tt . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.735 0.302 . . . . 0.68 111.064 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' ILE . 13.1 m-20 -136.77 133.48 18.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 2.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.67 174.95 9.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.665 2.243 . . . . 0.5 112.439 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 24.5 Cg_exo -63.97 -164.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.9 2.4 . . . . 0.71 113.175 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -102.38 -151.89 24.0 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.675 -0.693 . . . . 0.66 112.852 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -88.24 125.24 64.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.056 -0.085 . . . . 1.52 110.791 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_exo -80.09 141.79 14.95 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.763 2.308 . . . . 0.44 112.314 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.23 116.11 4.7 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.077 -0.511 . . . . 1.09 111.463 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' A' ' 95' ' ' ILE . 23.0 Cg_exo -62.0 104.22 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.577 2.185 . . . . 0.64 113.081 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.634 HD12 HG22 ' A' ' 19' ' ' THR . 0.3 OUTLIER -64.99 -35.05 79.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.48 0.657 . . . . 1.64 109.601 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.3 153.49 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.941 -1.027 . . . . 0.72 108.77 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.812 HG21 HG12 ' A' ' 95' ' ' ILE . 1.2 pt -144.88 108.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.704 -0.399 . . . . 0.96 111.882 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -101.48 59.89 0.89 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.106 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 49.34 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.951 0.782 . . . . 2.42 112.59 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 14' ' ' THR . 31.8 m170 -82.27 -34.72 28.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.231 -0.441 . . . . 1.02 111.609 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -119.05 106.19 12.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.883 0.373 . . . . 0.68 110.923 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.921 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 10.3 m -104.57 154.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.8 111.163 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.634 HG22 HD12 ' A' ' 11' ' ' LEU . 3.4 m -123.07 123.63 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.35 111.259 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -131.2 159.58 37.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.52 111.714 179.212 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 11' ' ' LEU . 2.0 tppt? -140.83 157.24 45.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.814 -1.085 . . . . 1.84 109.776 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 25.5 p90 -149.12 -176.1 5.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.294 0.568 . . . . 0.4 112.264 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -94.49 121.87 36.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.399 -0.819 . . . . 0.83 110.7 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 150.12 96.41 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 121.0 -0.28 . . . . 2.11 110.576 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 33' ' ' ILE . 77.6 Cg_exo -43.52 173.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.89 112.823 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -26.16 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.145 0.424 . . . . 2.77 112.145 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.4 t80 -124.45 -70.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.178 0.436 . . . . 1.37 112.178 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.537 HG21 HD11 ' A' ' 33' ' ' ILE . 20.0 p 56.04 55.01 7.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.713 0.292 . . . . 0.91 110.655 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.82 -93.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.055 -0.521 . . . . 1.01 112.657 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.54 34.48 0.89 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.127 -1.589 . . . . 0.98 109.127 178.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -113.63 142.99 45.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.275 -0.963 . . . . 0.87 111.54 -178.318 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -92.25 -8.18 46.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.112 -0.495 . . . . 2.26 111.459 179.606 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 71.47 -75.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 1.71 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.1 p 72.96 18.34 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.838 0.31 . . . . 1.15 111.838 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 179.85 145.8 0.21 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.073 0.463 . . . . 1.58 112.121 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.701 ' O ' HD12 ' A' ' 56' ' ' ILE . 89.6 m-85 -133.05 104.14 6.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.859 -0.61 . . . . 0.76 111.083 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' A' ' 79' ' ' LYS . 15.3 mt -78.66 93.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 1.14 110.463 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.5 p -91.08 106.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.63 111.384 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.4 mm-40 -71.29 167.13 20.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.372 -0.831 . . . . 1.67 111.143 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.804 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.74 151.99 49.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 1.97 111.399 -179.716 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.3 ttm180 -138.49 104.61 5.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 1.44 109.904 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.35 105.84 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.59 111.027 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.94 151.06 81.84 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.9 110.641 179.742 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -92.87 22.15 30.1 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.987 -1.256 . . . . 1.43 112.576 0.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -148.64 75.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 2.66 111.274 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -131.67 177.46 18.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 1.12 112.415 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.69 -148.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.595 -0.15 . . . . 2.41 110.595 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 16.1 m95 -136.71 74.27 1.48 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.996 0.427 . . . . 0.65 110.981 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.654 HD23 ' HG3' ' A' ' 47' ' ' ARG . 1.5 mm? -110.81 137.16 48.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.829 -0.623 . . . . 1.28 110.795 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 14.9 ptmt -52.54 92.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.06 -0.518 . . . . 1.3 111.837 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.804 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -54.15 -49.11 70.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.456 0.646 . . . . 0.86 109.867 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' HD11 ' A' ' 56' ' ' ILE . 3.1 t30 -44.43 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.1 -0.955 . . . . 2.01 110.822 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.7 43.09 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 2.08 110.774 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -152.35 -71.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 1.89 111.119 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 179.24 143.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.888 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 36' ' ' TYR . 37.2 mt -149.14 64.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.69 110.975 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -46.22 -69.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 1.6 111.345 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.56 179.57 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.502 -0.317 . . . . 1.54 110.741 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -86.53 10.62 14.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.699 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -107.98 104.32 13.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.551 -0.537 . . . . 2.05 109.551 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.594 ' HB2' HG23 ' A' ' 56' ' ' ILE . 43.6 t80 -131.13 164.27 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.391 0.615 . . . . 0.48 111.84 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' VAL . 98.6 m -127.91 115.74 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.966 -1.016 . . . . 0.42 109.506 179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.57 HG22 ' HE2' ' A' ' 61' ' ' PHE . 15.4 t -76.09 111.6 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.042 0.448 . . . . 1.08 111.701 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 140.23 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.637 -0.71 . . . . 1.33 110.706 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.07 7.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 0.9 112.569 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -50.94 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.963 0.411 . . . . 1.47 111.042 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -142.43 154.69 44.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 1.06 110.568 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.97 143.74 47.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 1.91 110.937 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 67.43 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 1.87 111.418 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.53 124.66 0.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.746 0.307 . . . . 0.49 111.564 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.98 137.53 51.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.147 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 34.5 m-85 -131.78 118.83 20.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.291 0.848 . . . . 0.56 113.291 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.1 mm-40 -100.59 140.5 34.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.157 -0.683 . . . . 1.5 109.157 178.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 2.2 m-85 -123.06 106.72 11.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.419 1.266 . . . . 0.6 114.419 -178.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -76.08 151.81 36.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.643 -0.708 . . . . 2.11 110.292 178.602 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 t -125.42 118.3 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.092 0.473 . . . . 0.6 112.242 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 65.4 mt -124.69 163.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.849 -0.797 . . . . 0.7 108.849 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -163.13 127.64 2.99 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.826 -0.749 . . . . 0.6 112.124 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.44 24.4 1.66 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.622 0.601 . . . . 1.98 112.622 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.669 ' OD1' HD11 ' A' ' 2' ' ' ILE . 2.8 m120 44.4 -173.31 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.502 0.668 . . . . 2.19 112.643 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -63.7 -37.07 85.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.299 -0.864 . . . . 1.08 112.347 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.06 33.71 3.17 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.964 0.728 . . . . 1.06 112.964 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' LYS . . . 65.24 9.89 44.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.255 -0.974 . . . . 0.93 113.37 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -66.4 103.17 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.177 -0.675 . . . . 1.38 109.177 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -60.32 110.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.678 0.752 . . . . 0.79 112.579 -178.486 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 41.1 p -87.88 110.87 38.53 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.651 -1.159 . . . . 0.59 108.673 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -35.03 160.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.641 2.894 . . . . 0.85 113.609 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 24.1 Cg_exo -62.46 150.52 87.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.78 2.32 . . . . 0.76 112.8 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.0 m -120.88 108.9 14.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.587 -0.733 . . . . 1.28 109.8 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -6.0 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 124.534 1.146 . . . . 1.77 113.317 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 48' ' ' TRP . 56.7 Cg_exo -50.4 135.63 39.69 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.508 2.139 . . . . 0.55 113.763 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -53.48 152.13 5.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.648 -0.871 . . . . 1.23 108.648 178.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -41.87 154.72 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.769 0.668 . . . . 1.63 110.616 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -85.41 114.16 22.25 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.658 -0.701 . . . . 0.41 110.03 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -92.94 113.15 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.084 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.6 m -51.13 -27.07 7.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.678 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.475 ' H ' HG22 ' A' ' 95' ' ' ILE . 76.6 m 53.22 84.82 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.1 110.539 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -97.38 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.547 -0.297 . . . . 3.0 111.499 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.611 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -93.21 0.67 57.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.651 0.241 . . . . 2.14 111.651 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 1.4 p30 . . . . . 0 C--O 1.231 0.13 0 N-CA-C 112.016 0.376 . . . . 2.06 112.016 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.681 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.5 tt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.873 0.368 . . . . 0.68 110.844 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.267 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.62 127.65 18.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 2.0 110.596 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 154.62 31.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.405 2.07 . . . . 0.5 112.186 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 1.9 Cg_endo -45.68 176.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.897 2.398 . . . . 0.71 112.79 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.65 170.64 50.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.896 -0.668 . . . . 0.66 112.649 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.2 tttp -56.59 128.62 75.19 Favored Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 110.185 -0.302 . . . . 1.52 110.185 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' HG12 ' A' ' 76' ' ' VAL . 6.2 Cg_exo -80.35 133.56 9.72 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.628 2.219 . . . . 0.44 112.109 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 p -126.85 117.27 22.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 1.09 110.948 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' THR . 25.3 Cg_exo -63.03 93.05 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.479 2.119 . . . . 0.64 113.032 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 19' ' ' THR . 1.8 mt -52.85 -42.08 64.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.636 0.732 . . . . 1.64 109.14 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.44 151.69 51.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.626 -1.17 . . . . 0.72 108.456 178.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.672 HG21 HG12 ' A' ' 95' ' ' ILE . 2.3 pt -142.84 100.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.386 -0.525 . . . . 0.96 112.346 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.77 144.19 27.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 1.46 110.211 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -47.63 -24.34 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.389 0.514 . . . . 2.42 112.389 -179.091 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 17' ' ' THR . 6.7 m-70 -130.37 30.76 4.69 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.904 -0.318 . . . . 1.02 111.633 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER 172.2 111.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 0.68 110.62 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 66' ' ' LEU . 4.4 m -111.21 133.34 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.8 110.375 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.2 m -102.99 111.47 23.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.35 111.996 -178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.807 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.17 143.53 48.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.52 111.235 178.646 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -131.92 144.24 50.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.746 -1.116 . . . . 1.84 110.206 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 27.4 p90 -129.15 -177.1 4.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.362 0.601 . . . . 0.4 112.304 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.14 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.83 111.162 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -84.4 140.09 38.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 2.11 110.251 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.467 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.7 Cg_endo -44.63 172.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.668 2.245 . . . . 0.89 112.236 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.55 -29.03 9.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 2.77 111.479 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.2 t80 -130.44 -69.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.877 0.325 . . . . 1.37 111.877 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 1.267 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.4 p 52.43 48.67 22.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.154 0.502 . . . . 0.91 110.495 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.51 -94.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.681 -0.691 . . . . 1.01 112.77 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.69 35.57 0.93 Allowed Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.891 -0.884 . . . . 0.98 110.891 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -116.85 -172.16 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.276 -0.462 . . . . 0.87 111.152 -178.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.4 ptmt -147.23 26.24 1.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 2.26 111.476 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.891 HG22 ' H ' ' A' ' 35' ' ' SER . 1.5 mp 65.71 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 1.71 110.676 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.594 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.68 -12.12 1.0 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.318 0.488 . . . . 1.15 112.318 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.891 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -169.72 102.63 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.56 0.219 . . . . 1.58 111.32 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 47.8 m-85 -80.0 147.96 31.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.205 -0.295 . . . . 0.76 110.205 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.481 HG22 ' CB ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -129.39 111.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.319 . . . . 1.14 111.115 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.41 99.14 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.69 0.281 . . . . 0.63 111.392 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -75.63 128.34 35.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.978 -0.378 . . . . 1.67 109.978 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -109.16 131.28 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.252 0.464 . . . . 1.97 112.252 -179.425 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.18 111.56 24.22 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.789 -1.189 . . . . 1.44 107.789 177.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' N ' ' HA3' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.69 81.54 2.05 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.269 -0.878 . . . . 1.59 111.088 -179.034 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -53.54 155.87 5.0 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.825 -0.625 . . . . 0.9 110.694 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 5.8 Cg_exo -79.13 1.64 33.22 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.027 -1.239 . . . . 1.43 113.029 0.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -104.5 -75.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 2.66 110.881 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . 50.22 179.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.831 -0.7 . . . . 1.12 112.957 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.9 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.49 32.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 2.41 110.905 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.541 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 65.5 m95 40.34 97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.705 -0.68 . . . . 0.65 112.203 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -133.52 128.99 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.28 110.679 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 37' ' ' ILE . 1.1 ptmm? -56.68 83.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 1.3 111.494 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.554 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -67.26 -38.86 85.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.86 110.244 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' HD11 ' A' ' 56' ' ' ILE . 14.2 p-10 -36.82 -44.42 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.515 -0.766 . . . . 2.01 111.71 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.13 43.47 2.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.115 -0.493 . . . . 2.08 111.785 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -152.79 -175.45 5.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 1.89 111.622 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.1 89.28 5.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.87 110.641 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.747 HD13 ' CG ' ' A' ' 61' ' ' PHE . 25.2 mt -85.43 75.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.69 111.251 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 57' ' ' LEU . 4.5 mt -58.0 -61.97 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 1.6 111.223 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.2 163.13 27.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 1.54 110.27 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 20.2 p30 -80.5 2.7 24.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.281 -0.418 . . . . 1.75 111.675 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 21.1 tt0 -102.13 101.54 11.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.586 -0.524 . . . . 2.05 109.586 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CG ' HD13 ' A' ' 56' ' ' ILE . 70.2 t80 -135.27 164.38 27.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.48 111.506 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 92.9 m -124.31 123.49 40.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.42 110.36 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.704 HG23 HD21 ' A' ' 20' ' ' LEU . 6.7 t -79.94 94.53 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 116.063 -0.517 . . . . 1.08 110.49 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.6 p -86.61 -171.18 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.494 -0.775 . . . . 1.33 110.811 -179.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.82 9.75 53.45 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.449 -0.881 . . . . 0.9 112.525 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.061 ' CD1' HG13 ' A' ' 18' ' ' VAL . 13.8 mt -60.85 -179.34 0.13 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.827 0.313 . . . . 1.47 110.407 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -137.13 128.11 27.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 1.06 110.809 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.17 155.5 13.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.91 111.133 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 97' ' ' CYS . 3.5 t70 53.37 46.07 27.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 1.87 110.959 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.58 118.71 2.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.402 -0.363 . . . . 0.49 111.371 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -70.29 133.64 47.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.114 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -129.92 126.44 37.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.605 0.595 . . . . 0.56 112.605 -178.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.9 mt-10 -102.85 143.36 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.143 -1.058 . . . . 1.5 108.143 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.999 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.69 115.93 12.58 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.16 1.541 . . . . 0.6 115.16 -178.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.36 169.22 9.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.171 -1.418 . . . . 2.11 107.171 176.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 89' ' ' SER . 0.7 OUTLIER -134.75 112.54 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 118.867 -1.133 . . . . 0.6 113.323 -179.836 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' ILE . 79.0 mt -102.73 145.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.227 -1.397 . . . . 0.7 107.227 177.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.78 119.88 2.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.72 -0.792 . . . . 0.6 111.898 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -59.07 -161.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.461 -0.496 . . . . 1.98 109.954 179.523 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.681 ' ND2' HD11 ' A' ' 2' ' ' ILE . 6.1 m-80 -150.91 165.72 32.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.249 0.547 . . . . 2.19 110.885 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.25 -29.57 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.282 -0.872 . . . . 1.08 112.656 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.54 11.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.36 2.2 53.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.623 -0.799 . . . . 0.93 113.294 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.615 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -64.63 102.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.088 0.444 . . . . 1.38 109.914 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -68.23 114.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 113.023 0.749 . . . . 0.79 113.023 -178.798 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.433 ' N ' HD12 ' A' ' 85' ' ' ILE . 14.2 p -78.94 115.0 48.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.29 -0.868 . . . . 0.59 109.927 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.11 155.85 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.16 1.907 . . . . 0.85 111.881 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 15.0 Cg_endo -58.69 126.85 22.45 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 122.807 2.338 . . . . 0.76 113.443 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.52 ' HB3' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -78.64 132.46 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -22.42 107.34 0.12 Allowed Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 124.168 0.917 . . . . 1.77 113.33 -179.414 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 86.8 Cg_exo -45.3 142.87 5.82 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.825 2.35 . . . . 0.55 113.26 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -79.48 150.38 31.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.758 -0.46 . . . . 1.23 109.758 179.029 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -37.16 151.2 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.143 0.902 . . . . 1.63 111.656 179.814 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -80.5 113.8 18.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.364 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.672 HG12 HG21 ' A' ' 13' ' ' ILE . 4.3 mp -96.6 112.77 29.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.917 0.389 . . . . 0.44 111.468 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 84.5 m -54.4 -36.13 63.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.074 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 61.0 93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.38 . . . . 1.1 110.27 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -140.07 -84.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.418 . . . . 3.0 111.788 -179.625 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.806 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -108.16 -9.53 15.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 2.14 111.94 -179.631 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 2.06 111.075 179.76 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.501 HD11 ' ND2' ' A' ' 80' ' ' ASN . 9.0 tt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.68 111.475 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' ILE . 91.7 m-20 -129.82 132.63 24.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 2.0 110.548 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.59 171.12 16.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.494 2.129 . . . . 0.5 112.66 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.523 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 12.4 Cg_endo -55.7 171.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.043 2.495 . . . . 0.71 112.837 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -93.97 113.6 4.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.049 -0.596 . . . . 0.66 113.083 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 10.87 109.15 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 124.572 1.149 . . . . 1.52 113.767 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.46 ' CG ' HG23 ' A' ' 76' ' ' VAL . 19.9 Cg_exo -68.8 139.08 42.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.787 2.325 . . . . 0.44 112.96 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.02 112.21 10.37 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.038 -0.528 . . . . 1.09 111.508 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.9 Cg_exo -64.89 112.39 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.829 2.352 . . . . 0.64 113.696 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.72 -35.85 72.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.854 -0.795 . . . . 1.64 108.854 178.7 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.93 135.97 40.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.774 -1.103 . . . . 0.72 108.895 179.099 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -134.27 70.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.269 0.47 . . . . 0.96 112.269 -178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 156.96 34.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.46 110.151 179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.69 -8.65 36.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.887 -0.325 . . . . 2.42 111.464 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.414 ' O ' HG23 ' A' ' 17' ' ' THR . 11.1 m-70 -128.88 18.2 6.16 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.507 0.194 . . . . 1.02 111.357 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 177.23 124.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.806 0.336 . . . . 0.68 110.925 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 23.1 t -114.28 113.81 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.8 111.104 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 17.4 m -100.26 127.4 46.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.984 -0.553 . . . . 0.35 111.23 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -138.07 150.3 46.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.745 0.783 . . . . 0.52 111.976 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.087 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -132.52 147.36 52.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.425 -1.262 . . . . 1.84 109.337 179.596 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.523 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 8.3 p90 -132.47 -175.75 3.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.236 0.541 . . . . 0.4 112.375 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.466 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.85 177.31 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.332 -0.849 . . . . 0.83 111.329 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -98.16 139.4 21.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.625 -0.716 . . . . 2.11 110.25 179.733 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.816 ' HB2' HG23 ' A' ' 28' ' ' THR . 2.9 Cg_endo -47.52 178.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.89 112.039 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -113.15 -15.44 12.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 2.77 112.081 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -139.15 -66.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.313 0.486 . . . . 1.37 112.313 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.816 HG23 ' HB2' ' A' ' 25' ' ' PRO . 54.4 p 54.57 45.03 27.77 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.91 110.532 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.46 -93.99 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.738 -0.744 . . . . 1.01 112.379 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.68 42.19 0.8 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.662 -1.375 . . . . 0.98 109.662 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -127.98 -177.32 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.997 -0.602 . . . . 0.87 111.298 -178.211 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.69 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.5 OUTLIER -136.54 19.97 3.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.338 -0.392 . . . . 2.26 111.747 -179.456 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.059 HG23 ' HB1' ' A' ' 78' ' ' ALA . 3.5 mp 64.15 -74.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.282 . . . . 1.71 111.279 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.69 HG22 ' HD2' ' A' ' 32' ' ' LYS . 2.5 p 58.05 32.39 21.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 1.15 111.132 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.602 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t 170.72 110.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.58 110.845 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.661 ' O ' HD12 ' A' ' 56' ' ' ILE . 23.4 m-85 -111.75 87.8 2.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.971 0.415 . . . . 0.76 111.061 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.678 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -79.03 88.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.78 -0.645 . . . . 1.14 111.43 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.27 127.58 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.8 -0.444 . . . . 0.63 109.8 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.9 143.73 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.812 -0.631 . . . . 1.67 111.563 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.683 ' HD3' HG11 ' A' ' 63' ' ' VAL . 3.5 mtmp? -98.35 148.38 23.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 1.97 110.871 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -144.77 86.58 1.81 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 1.44 110.604 179.126 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 1.173 ' OD2' ' O ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -48.51 150.02 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.125 -0.489 . . . . 1.59 110.725 179.236 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 42' ' ' ASP . 1.8 mm? -123.78 101.11 36.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.033 -0.667 . . . . 0.9 111.291 179.022 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 6.3 Cg_endo -87.57 -136.56 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.053 -1.228 . . . . 1.43 110.212 -0.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.173 ' O ' ' OD2' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 42.63 42.22 2.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.783 0.325 . . . . 2.66 111.441 179.708 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -118.23 148.26 18.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.183 -1.008 . . . . 1.12 113.861 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.818 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.91 122.17 9.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.432 -0.581 . . . . 2.41 109.432 179.44 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 40.9 m95 -43.81 94.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.65 111.149 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -119.32 130.88 55.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.849 -0.614 . . . . 1.28 110.712 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.678 ' HE3' HG21 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.67 69.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 1.3 110.819 179.938 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -47.74 -38.82 16.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.86 111.355 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.554 ' HB3' HD11 ' A' ' 56' ' ' ILE . 5.3 p-10 -51.28 -58.65 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 2.01 111.616 -179.574 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER 80.0 -51.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.585 0.231 . . . . 2.08 111.221 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -169.93 0.19 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.806 0.336 . . . . 1.89 111.111 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.27 107.5 19.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.87 111.014 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 36' ' ' TYR . 24.0 mt -87.13 75.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.69 110.728 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 34' ' ' THR . 1.9 mt -52.52 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.289 -179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 175.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.677 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 51.1 p30 -94.1 21.89 6.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.889 -0.596 . . . . 1.75 111.157 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.087 ' OE2' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -125.43 109.49 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 2.05 110.196 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CG ' HD13 ' A' ' 56' ' ' ILE . 64.5 t80 -136.45 164.61 27.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.48 111.669 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.9 m -127.26 117.37 22.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.612 -0.722 . . . . 0.42 110.783 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HD3' ' A' ' 40' ' ' LYS . 6.6 t -82.05 118.77 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.08 111.158 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -173.42 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 1.33 110.89 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.54 28.36 73.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.639 -0.791 . . . . 0.9 112.281 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' CD1' HG23 ' A' ' 18' ' ' VAL . 7.3 mt -82.04 174.25 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 1.47 111.318 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -125.38 99.25 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.686 . . . . 1.06 110.224 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 42.9 tt0 -43.74 148.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 1.91 111.728 -179.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 35.0 t0 75.41 65.48 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.87 111.059 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 171.49 127.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.49 111.006 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.55 136.3 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.068 -0.345 . . . . 0.36 110.068 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 37.3 m-85 -133.31 121.95 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.293 0.849 . . . . 0.56 113.293 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 11.8 mt-10 -102.58 131.96 48.98 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.391 -0.596 . . . . 1.5 109.391 178.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -124.87 118.99 27.55 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.673 0.99 . . . . 0.6 113.673 -178.77 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' NH1' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -94.67 144.73 25.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 2.11 110.381 178.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 5' ' ' PRO . 86.8 t -98.23 115.82 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.357 -0.537 . . . . 0.6 110.845 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 2.3 mt -110.29 167.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.542 -0.911 . . . . 0.7 108.542 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 1.059 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.14 -174.41 4.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -117.32 -77.75 0.57 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.157 0.503 . . . . 1.98 110.535 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER 125.79 140.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.196 1.798 . . . . 2.19 109.93 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -32.75 -44.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.217 0.821 . . . . 1.08 113.217 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -107.75 49.53 0.8 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.489 0.552 . . . . 1.06 112.489 -179.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.56 40.93 5.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.662 -0.78 . . . . 0.93 113.314 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB3' ' CB ' ' A' ' 80' ' ' ASN . . . -89.1 24.46 2.12 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.554 0.216 . . . . 1.38 111.227 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp 18.5 112.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 115.373 1.62 . . . . 0.79 115.373 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.671 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -85.64 111.81 40.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.66 -0.867 . . . . 0.59 108.66 177.957 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 28.6 Cg_endo -60.98 167.26 9.16 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.209 1.94 . . . . 0.85 112.523 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 75' ' ' ARG . 9.7 Cg_endo -53.8 136.31 65.32 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.052 2.501 . . . . 0.76 113.269 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.34 112.71 24.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.966 -0.561 . . . . 1.28 110.794 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 5.96 100.18 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.019 1.328 . . . . 1.77 114.435 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 82.7 Cg_exo -46.29 145.8 5.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.8 2.333 . . . . 0.55 113.358 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -78.19 143.9 36.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.074 -0.713 . . . . 1.23 109.074 179.068 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -30.93 148.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.298 0.999 . . . . 1.63 112.016 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -81.75 103.82 11.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.347 -0.388 . . . . 0.41 110.794 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.3 mp -83.86 116.01 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.537 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 98' ' ' ARG . 48.2 m -56.21 -30.41 62.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.401 . . . . 0.44 110.425 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.431 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 53.62 61.31 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 1.1 111.148 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -101.73 -77.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.04 0.448 . . . . 3.0 110.309 179.895 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 15' ' ' ARG . 2.2 p-10 -126.08 -0.13 7.17 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.616 -0.72 . . . . 2.14 111.244 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 CA--C 1.516 -0.33 0 CA-C-O 121.108 0.48 . . . . 2.06 112.167 -179.942 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.501 HG13 ' ND2' ' A' ' 80' ' ' ASN . 9.9 tt . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 112.803 0.668 . . . . 0.68 112.803 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.343 ' OD2' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.57 120.71 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.853 179.693 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.41 170.44 20.28 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.202 1.935 . . . . 0.5 112.398 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 7.1 Cg_endo -54.48 -171.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.754 2.303 . . . . 0.71 113.21 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.07 166.64 22.37 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.867 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.6 tptm -49.03 122.72 11.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.059 -0.348 . . . . 1.52 110.059 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.5 Cg_exo -77.41 128.77 9.81 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.242 1.961 . . . . 0.44 112.401 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -120.12 112.85 34.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 1.09 111.1 -179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.3 Cg_exo -60.59 124.74 15.67 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.142 1.894 . . . . 0.64 113.223 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.635 HD11 ' CB ' ' A' ' 21' ' ' LYS . 1.4 mp -89.76 -29.42 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.83 -0.623 . . . . 1.64 109.809 179.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.421 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -152.45 110.14 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.783 . . . . 0.72 110.226 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.731 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.8 131.74 66.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.394 0.616 . . . . 0.96 112.151 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -119.55 157.53 28.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.309 -0.86 . . . . 1.46 110.125 179.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.48 -9.07 16.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.325 0.491 . . . . 2.42 112.325 -179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 17' ' ' THR . 1.5 m-70 -135.38 17.47 3.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.793 0.294 . . . . 1.02 111.793 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.832 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER 171.31 117.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.509 -0.182 . . . . 0.68 110.509 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.076 ' CG1' HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -104.14 165.0 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 120.592 -0.443 . . . . 0.8 111.64 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.6 m -140.87 123.9 16.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.35 111.251 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.778 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.55 159.56 41.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.664 0.745 . . . . 0.52 112.007 179.225 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.635 ' CB ' HD11 ' A' ' 11' ' ' LEU . 24.0 tptp -139.1 136.36 35.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.407 -1.27 . . . . 1.84 109.803 179.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.0 p90 -123.35 -177.93 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.281 0.562 . . . . 0.4 112.336 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.93 161.08 16.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.201 -0.909 . . . . 0.83 111.042 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -90.06 135.96 29.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 2.11 110.715 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HG3' HD11 ' A' ' 33' ' ' ILE . 11.5 Cg_endo -56.12 171.77 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.455 2.103 . . . . 0.89 112.005 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -50.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.658 0.265 . . . . 2.77 111.208 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.343 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.2 t80 -98.92 71.09 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 1.37 111.74 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.8 p -94.27 48.72 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.91 110.131 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.02 -94.92 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.967 -0.561 . . . . 1.01 112.344 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.55 33.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.936 -0.865 . . . . 0.98 110.936 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.58 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -118.66 175.76 5.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.253 -0.473 . . . . 0.87 111.299 -178.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.73 3.88 3.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.068 -0.514 . . . . 2.26 111.505 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.513 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.1 mt 59.75 144.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 120.96 0.409 . . . . 1.71 111.864 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -129.51 -5.11 4.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.946 -0.57 . . . . 1.15 112.258 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.27 143.86 3.68 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.919 0.34 . . . . 1.58 111.919 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 33' ' ' ILE . 33.7 m-85 -116.3 113.1 22.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.76 110.269 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 50' ' ' LYS . 2.7 mt -92.12 119.59 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.799 0.333 . . . . 1.14 110.987 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.29 93.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.442 0.534 . . . . 0.63 112.442 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.97 ' OE1' ' CA ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -72.93 146.33 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.147 -0.686 . . . . 1.67 109.147 178.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.35 141.62 51.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.215 0.531 . . . . 1.97 112.025 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.7 ttm180 -104.64 106.55 17.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.389 -0.823 . . . . 1.44 109.464 179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 1.052 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.84 91.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.475 -0.784 . . . . 1.59 111.071 -179.379 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 94' ' ' ALA . 13.7 mt -75.96 146.0 78.45 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.112 -0.495 . . . . 0.9 110.328 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.78 27.85 15.27 Favored 'Cis proline' 0 C--N 1.347 0.467 0 C-N-CA 123.801 -1.333 . . . . 1.43 112.88 0.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -88.73 -73.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.761 0.315 . . . . 2.66 111.169 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 100.27 152.58 26.54 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.624 -0.798 . . . . 1.12 112.778 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 1.052 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 170.91 -31.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.303 . . . . 2.41 111.181 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.908 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 61.4 m95 58.62 75.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.361 . . . . 0.65 111.375 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.97 ' CA ' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mm? -117.42 130.91 56.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 1.28 110.341 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.541 ' CB ' HG22 ' A' ' 37' ' ' ILE . 5.2 ptmm? -52.69 97.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.926 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.94 -41.05 86.46 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.194 -0.669 . . . . 0.86 109.194 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 10.1 t30 -58.56 164.35 2.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.061 -0.972 . . . . 2.01 110.405 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.37 31.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.471 . . . . 2.08 110.801 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.1 37.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.89 110.91 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 61.57 153.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 1.87 110.757 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.677 HD13 ' CG ' ' A' ' 61' ' ' PHE . 47.9 mt -147.23 60.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.69 110.44 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 tm? -46.03 -50.66 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 1.6 111.841 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -87.23 160.19 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.422 . . . . 1.54 111.048 -179.656 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.3 m-20 -76.27 -1.15 25.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.89 -0.596 . . . . 1.75 111.694 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.865 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -102.54 103.92 14.29 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.745 -0.465 . . . . 2.05 109.745 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.677 ' CG ' HD13 ' A' ' 56' ' ' ILE . 43.6 t80 -140.22 166.4 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.124 0.488 . . . . 0.48 111.9 -178.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 18' ' ' VAL . 95.4 m -117.23 119.42 35.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.42 110.797 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.8 t -82.12 99.31 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.204 0.526 . . . . 1.08 111.297 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 1.1 p -81.56 -157.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.533 -0.758 . . . . 1.33 111.207 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.418 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 54.03 45.54 71.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.727 -0.749 . . . . 0.9 112.154 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 18' ' ' VAL . 9.8 mt -87.61 -176.85 5.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.167 0.508 . . . . 1.47 111.205 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -153.36 115.04 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.717 . . . . 1.06 110.332 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 132.83 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 1.91 111.236 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.33 60.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 1.87 111.089 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -169.92 119.12 0.61 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.49 111.652 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.3 125.97 28.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.631 -0.507 . . . . 0.36 109.631 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 55.0 m-85 -121.95 122.18 38.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.4 0.518 . . . . 0.56 112.4 -178.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -101.18 131.95 46.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.312 -0.996 . . . . 1.5 108.312 178.386 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.95 ' CE2' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.2 109.69 19.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.157 1.54 . . . . 0.6 115.157 -177.849 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 ttp180 -97.72 124.54 42.1 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.681 -1.6 . . . . 2.11 106.681 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -105.87 119.64 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 119.103 -1.039 . . . . 0.6 113.716 -178.476 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' A' ' 88' ' ' PRO . 80.8 mt -101.41 163.78 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.537 -1.653 . . . . 0.7 106.537 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 77' ' ' ILE . . . -174.32 123.15 0.3 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.022 -1.071 . . . . 0.6 112.755 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 85' ' ' ILE . 21.9 mttt -60.8 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.002 -0.74 . . . . 1.98 109.002 178.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' A' ' 2' ' ' ILE . 36.3 m-20 -138.38 -101.95 0.18 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.514 -0.474 . . . . 2.19 111.387 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.32 -41.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 1.08 111.598 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . . . -101.97 40.96 1.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 1.06 111.962 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.91 9.6 53.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.579 -0.82 . . . . 0.93 113.154 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.81 87.3 4.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 1.38 110.322 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.712 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -58.76 111.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.79 111.682 -179.378 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -73.57 119.05 73.94 Favored Pre-proline 0 C--O 1.238 0.454 0 N-CA-C 109.454 -0.573 . . . . 0.59 109.454 179.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.8 Cg_endo -43.4 166.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.677 2.251 . . . . 0.85 112.461 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 77' ' ' ILE . 23.9 Cg_exo -64.36 149.21 90.54 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.676 2.251 . . . . 0.76 112.571 -179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.596 ' HB2' HG13 ' A' ' 76' ' ' VAL . 5.8 m -103.12 125.4 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.263 179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 62.9 mt-10 -22.07 117.45 0.15 Allowed Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 124.094 0.871 . . . . 1.77 112.793 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 66.1 Cg_exo -45.27 165.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.981 2.454 . . . . 0.55 114.513 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -100.82 146.36 27.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.339 -1.3 . . . . 1.23 109.166 178.764 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.761 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -37.09 130.66 0.83 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.864 0.728 . . . . 1.63 111.644 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.92 101.33 0.65 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.879 -0.6 . . . . 0.41 110.854 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.827 HD13 ' CZ ' ' A' ' 74' ' ' PHE . 4.8 mp -82.22 113.55 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.462 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -51.64 -28.06 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.44 111.159 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.468 ' H ' HG22 ' A' ' 95' ' ' ILE . 60.7 m 55.24 76.07 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.505 -0.316 . . . . 1.1 110.841 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -134.43 -87.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 3.0 111.073 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.652 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -103.14 -3.06 26.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 2.14 111.356 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 C--N 1.333 -0.13 0 CA-C-O 120.888 0.375 . . . . 2.06 111.415 -179.769 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.501 HD12 ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.052 0.453 . . . . 0.68 111.685 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.927 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -114.06 135.56 22.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.65 . . . . 2.0 109.937 179.395 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.36 174.04 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.672 2.248 . . . . 0.5 113.101 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.68 174.6 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.119 2.546 . . . . 0.71 113.462 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.08 169.67 42.37 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.297 -0.865 . . . . 0.66 112.627 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 65.4 tttt -58.57 127.28 81.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 110.581 -0.155 . . . . 1.52 110.581 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.0 Cg_exo -76.79 149.38 29.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.502 2.135 . . . . 0.44 113.078 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -144.16 113.4 5.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.284 -0.871 . . . . 1.09 110.015 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.7 Cg_exo -49.0 94.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.283 1.989 . . . . 0.64 113.553 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.66 -27.73 63.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.268 -0.878 . . . . 1.64 110.135 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 13' ' ' ILE . 1.8 t30 -161.41 161.33 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.72 109.91 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.771 ' CG2' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.84 115.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.96 111.301 179.731 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -104.48 47.62 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.793 -0.64 . . . . 1.46 110.79 -179.908 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.81 -70.63 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.746 -0.661 . . . . 2.42 111.516 179.473 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' THR . 1.5 m-70 -82.79 -22.98 34.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 1.02 111.289 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.16 102.9 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.578 -0.283 . . . . 0.68 111.224 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -93.66 120.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.8 110.816 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.625 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.6 126.42 44.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.35 111.346 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.47 139.88 50.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.948 0.88 . . . . 0.52 111.69 178.437 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -116.97 172.78 7.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.192 -1.367 . . . . 1.84 109.317 179.681 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.52 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 46.0 p90 -168.34 165.51 12.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.126 -0.63 . . . . 0.4 112.503 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 156.07 23.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.963 -1.017 . . . . 0.83 110.685 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.98 156.46 52.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.725 -0.472 . . . . 2.11 109.725 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.15 -170.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.371 2.048 . . . . 0.89 111.954 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.53 13.21 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.883 0.327 . . . . 2.77 111.883 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.768 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 3.6 t80 -168.91 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.572 0.582 . . . . 1.37 112.572 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.927 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 52.0 p 53.8 38.81 29.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.003 0.43 . . . . 0.91 110.074 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.64 -125.15 4.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.852 -0.613 . . . . 1.01 112.175 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.45 4.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.451 -1.859 . . . . 0.98 108.451 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.608 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -112.99 -165.78 1.02 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.888 -1.156 . . . . 0.87 111.607 -178.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.515 ' C ' HD12 ' A' ' 33' ' ' ILE . 1.1 pttt -163.84 38.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 2.26 112.084 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.799 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.8 mp 66.29 -61.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.94 0.719 . . . . 1.71 112.94 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.4 p 83.08 -38.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.631 0.772 . . . . 1.15 111.856 -178.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -167.61 140.08 3.23 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.832 0.348 . . . . 1.58 111.406 -179.565 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.799 ' CE1' HG21 ' A' ' 33' ' ' ILE . 52.7 m-85 -99.6 139.94 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.76 110.218 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.97 98.1 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.671 -0.24 . . . . 1.14 111.05 -179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -91.69 126.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.133 0.492 . . . . 0.63 110.862 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.37 152.28 19.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.532 -0.758 . . . . 1.67 110.675 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.766 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 6.4 ptpt -116.14 144.14 44.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 1.97 111.521 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 1.1 ttt180 -119.38 104.86 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.979 179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.72 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.65 89.1 2.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.741 -0.663 . . . . 1.59 110.556 -179.863 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -67.09 144.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.686 . . . . 0.9 110.895 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -95.24 27.92 17.96 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.052 -1.229 . . . . 1.43 112.807 0.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.68 42.6 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 2.66 111.368 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -95.13 150.66 19.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.828 . . . . 1.12 112.224 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' CD ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.45 29.0 4.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 2.41 110.935 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.9 m95 51.36 100.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.999 -0.546 . . . . 0.65 111.133 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 ' CD ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -127.67 141.84 51.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.967 -0.561 . . . . 1.28 110.558 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 49.5 mtpt -49.36 91.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.3 110.95 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -65.26 -48.21 74.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.86 110.754 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.8 p-10 -74.28 114.61 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.95 -0.568 . . . . 2.01 110.746 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.54 30.34 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 2.08 110.913 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -138.02 21.2 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.89 111.352 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.15 144.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 1.87 111.174 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.584 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.0 mt -134.87 112.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.082 -0.508 . . . . 0.69 111.009 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -94.58 -47.75 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 1.6 110.862 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.57 157.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.891 -0.411 . . . . 1.54 109.891 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -73.53 -3.76 29.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.417 -0.356 . . . . 1.75 111.521 -179.924 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 tt0 -97.76 96.15 8.04 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.421 -0.585 . . . . 2.05 109.421 179.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.56 ' CG ' HD13 ' A' ' 56' ' ' ILE . 72.3 t80 -121.68 163.86 18.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.48 111.57 -178.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 59.9 m -132.19 112.67 12.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.42 111.06 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.648 HG13 ' HB1' ' A' ' 51' ' ' ALA . 4.6 t -74.73 113.43 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 1.08 110.872 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.96 136.49 44.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.705 -0.679 . . . . 1.33 111.012 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.3 9.16 6.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.9 112.714 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.5 mm? -51.19 -177.6 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.05 0.452 . . . . 1.47 110.954 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.439 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 58.9 m -143.7 96.7 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 1.06 110.0 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 2.3 tt0 -40.56 139.17 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.526 . . . . 1.91 111.839 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER 75.57 33.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.913 -0.585 . . . . 1.87 110.902 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.37 136.34 13.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.358 -0.383 . . . . 0.49 111.212 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -80.89 132.13 35.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.36 110.701 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.439 ' OH ' ' HB ' ' A' ' 67' ' ' THR . 46.9 m-85 -127.31 130.67 49.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.56 111.94 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 3.7 mt-10 -104.65 148.81 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.596 -0.52 . . . . 1.5 109.596 178.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.982 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.19 116.08 10.87 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.821 1.415 . . . . 0.6 114.821 -179.264 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.8 ptp180 -109.99 178.65 4.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.455 -0.943 . . . . 2.11 108.455 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.66 133.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.678 1.228 . . . . 0.6 114.198 179.15 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -115.17 152.72 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 112.599 -2.092 . . . . 0.7 106.964 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -160.26 147.56 16.17 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.229 -0.989 . . . . 0.6 112.146 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HG2' HD12 ' A' ' 85' ' ' ILE . 13.0 mmtp -68.81 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 1.98 110.442 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -156.08 -66.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.843 0.83 . . . . 2.19 111.513 -179.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . 179.52 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.351 -0.84 . . . . 1.08 110.879 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.69 -4.01 57.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 1.06 112.192 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.83 -16.2 40.07 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.317 -0.944 . . . . 0.93 112.506 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -68.18 149.99 48.87 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.797 -0.446 . . . . 1.38 109.797 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.1 tp -102.41 112.21 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.381 0.511 . . . . 0.79 112.381 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -68.33 123.73 88.17 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.59 109.936 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -38.57 162.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.26 2.64 . . . . 0.85 113.394 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.47 ' N ' HG23 ' A' ' 77' ' ' ILE . 21.0 Cg_exo -67.95 170.84 13.41 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.227 2.618 . . . . 0.76 112.927 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -128.4 127.32 42.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.363 -0.835 . . . . 1.28 109.474 179.173 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.2 tt0 -27.06 129.58 0.19 Allowed Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 123.89 0.743 . . . . 1.77 112.597 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.0 Cg_exo -62.33 169.84 7.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.385 2.057 . . . . 0.55 113.765 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.34 136.62 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.754 -1.112 . . . . 1.23 109.042 179.109 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -37.68 135.34 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.006 0.817 . . . . 1.63 111.584 -179.748 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.07 132.33 51.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.41 111.415 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.4 mp -118.39 119.73 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.44 110.917 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m -48.07 -30.01 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.927 -0.579 . . . . 0.44 111.173 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.618 ' H ' HG22 ' A' ' 95' ' ' ILE . 15.4 m 55.45 36.79 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 1.1 111.032 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 3.0 110.941 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 41.3 p30 -106.3 23.99 13.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 2.14 110.547 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 49.3 t0 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.991 -0.55 . . . . 2.06 111.966 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.702 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.4 tt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.846 0.355 . . . . 0.68 111.278 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.907 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -126.34 133.16 24.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 2.0 110.055 179.451 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 94.4 Cg_endo -77.89 172.0 16.35 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.353 2.035 . . . . 0.5 112.655 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.535 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.7 Cg_endo -59.64 148.89 85.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.078 2.519 . . . . 0.71 112.623 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.64 161.81 4.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.66 112.092 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -58.01 132.67 83.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.982 -0.377 . . . . 1.52 109.982 179.757 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -79.26 127.91 7.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.493 2.129 . . . . 0.44 112.812 -179.409 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.21 110.38 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.863 -0.608 . . . . 1.09 110.379 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.659 ' HG2' HD11 ' A' ' 95' ' ' ILE . 33.6 Cg_exo -56.42 102.57 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.122 1.881 . . . . 0.64 113.599 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.265 HD11 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -66.82 -31.05 71.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.02 -0.733 . . . . 1.64 109.02 178.674 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 13' ' ' ILE . 3.3 t30 -150.33 161.65 42.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.098 -0.956 . . . . 0.72 110.161 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.703 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.79 86.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.96 110.228 179.593 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -77.7 64.15 2.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 1.46 112.427 -179.1 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.473 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 19.84 47.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.447 0.906 . . . . 2.42 113.447 179.281 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.759 ' C ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER 165.31 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.582 -0.736 . . . . 1.02 110.395 179.239 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.96 89.5 3.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.68 109.713 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.954 HG11 ' CE2' ' A' ' 74' ' ' PHE . 75.3 t -78.68 114.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 0.8 110.046 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 HD12 ' A' ' 11' ' ' LEU . 6.1 m -96.68 109.22 21.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.35 112.527 -178.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.1 145.79 44.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.569 0.699 . . . . 0.52 111.463 178.81 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.445 ' HB2' ' CD ' ' A' ' 60' ' ' GLU . 7.3 tptp -134.07 143.39 48.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.733 -1.121 . . . . 1.84 109.508 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 13.6 p90 -132.68 -177.04 4.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.239 0.542 . . . . 0.4 111.983 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.59 -173.93 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.475 -0.784 . . . . 0.83 111.109 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -114.62 131.69 23.25 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 2.11 110.727 179.929 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' CB ' HG23 ' A' ' 28' ' ' THR . 3.0 Cg_exo -35.84 157.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.487 2.791 . . . . 0.89 112.809 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.29 -15.57 20.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 2.77 111.63 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.799 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.8 t80 -134.52 -72.01 0.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.324 0.49 . . . . 1.37 112.324 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.907 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 4.4 p 50.44 57.55 6.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.91 110.49 -179.148 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.84 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.748 -0.66 . . . . 1.01 112.52 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -155.25 32.8 0.65 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.376 -1.09 . . . . 0.98 110.376 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.98 -167.68 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -0.667 . . . . 0.87 111.649 -178.561 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 34' ' ' THR . 29.5 ttpt -144.04 20.44 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.607 -0.724 . . . . 2.26 111.581 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.873 HG22 ' H ' ' A' ' 35' ' ' SER . 1.6 mp 62.82 -77.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.623 0.249 . . . . 1.71 111.037 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.3 p 80.08 -7.9 1.59 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.607 0.595 . . . . 1.15 112.607 179.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -161.94 117.96 2.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.401 0.519 . . . . 1.58 112.401 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 33' ' ' ILE . 61.1 m-85 -103.7 146.22 28.91 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.32 -0.4 . . . . 0.76 110.414 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.454 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -137.11 107.47 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.553 -0.294 . . . . 1.14 110.219 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.45 117.72 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.63 111.387 -179.747 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 3.0 mm-40 -85.95 159.78 19.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.247 -0.888 . . . . 1.67 110.57 179.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 3.0 mtmp? -120.99 154.04 36.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.513 0.673 . . . . 1.97 111.804 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 10.5 ttm180 -128.67 96.2 4.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.223 -1.029 . . . . 1.44 108.223 177.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 83.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.109 -0.951 . . . . 1.59 110.053 -179.149 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 73' ' ' GLU . 19.1 mt -59.45 150.87 63.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.736 -179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.03 3.19 37.28 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.713 -1.37 . . . . 1.43 113.207 0.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.82 -89.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.116 -0.234 . . . . 2.66 111.019 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 158.38 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.818 -0.706 . . . . 1.12 113.036 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.612 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.57 24.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 2.41 110.988 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.542 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 31.7 m95 53.8 83.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 0.65 111.423 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.612 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -123.33 124.27 42.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.756 0.313 . . . . 1.28 110.667 179.855 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' HG22 ' A' ' 37' ' ' ILE . 15.5 ptmt -54.27 95.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 1.3 111.033 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -65.75 -35.47 80.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.109 0.48 . . . . 0.86 110.281 179.517 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.507 ' CG ' HD11 ' A' ' 56' ' ' ILE . 1.8 t30 -66.09 120.58 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 2.01 110.546 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 23.7 14.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.072 -0.513 . . . . 2.08 110.501 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.25 130.4 22.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.6 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.15 114.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 1.87 111.861 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.683 HD13 ' CG ' ' A' ' 61' ' ' PHE . 55.2 mt -96.04 88.29 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.69 110.426 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.77 -64.87 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.48 -0.327 . . . . 1.6 111.198 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.08 165.91 12.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.435 -0.348 . . . . 1.54 110.418 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.54 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.4 p30 -90.47 15.5 10.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.194 -0.457 . . . . 1.75 111.357 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.445 ' CD ' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tp10 -116.42 95.65 5.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.696 -0.483 . . . . 2.05 109.696 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.683 ' CG ' HD13 ' A' ' 56' ' ' ILE . 93.6 t80 -118.14 162.85 17.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.299 0.571 . . . . 0.48 112.091 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 97.5 m -135.01 108.77 8.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.294 -0.866 . . . . 0.42 110.397 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.671 HG11 ' HD3' ' A' ' 40' ' ' LYS . 38.6 t -68.34 105.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.689 -0.687 . . . . 1.08 111.052 -179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 t -100.92 164.3 11.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.058 -0.519 . . . . 1.33 110.754 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.11 28.53 68.19 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.098 -0.801 . . . . 0.9 111.098 -179.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.88 HD22 HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -84.31 155.84 22.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.425 -0.388 . . . . 1.47 110.344 -179.521 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.614 ' N ' HD12 ' A' ' 66' ' ' LEU . 2.5 m -91.7 127.17 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 1.06 111.482 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 2.2 tt0 -76.95 163.32 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.208 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.81 43.21 5.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.832 -0.622 . . . . 1.87 111.002 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.41 122.99 1.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.009 -0.541 . . . . 0.49 110.736 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 116.55 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.008 0.432 . . . . 0.36 110.772 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 42.5 m-85 -110.05 132.48 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.824 -0.626 . . . . 0.56 112.139 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' HD11 ' A' ' 43' ' ' LEU . 6.9 mt-10 -102.08 134.28 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.193 -1.04 . . . . 1.5 108.193 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -128.82 118.92 23.56 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.215 1.561 . . . . 0.6 115.215 -178.588 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.01 -175.27 2.73 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.832 -1.173 . . . . 2.11 107.832 177.232 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -155.99 125.86 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.233 -0.987 . . . . 0.6 113.213 179.09 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 86' ' ' SER . 20.2 mt -103.33 150.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 113.644 -1.616 . . . . 0.7 107.9 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.35 120.99 2.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.025 -1.07 . . . . 0.6 113.254 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.0 mttp -66.6 -176.07 0.44 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.98 109.994 178.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.786 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.1 p30 -135.0 169.11 17.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.829 -0.623 . . . . 2.19 110.599 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -42.79 -27.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.693 -0.685 . . . . 1.08 112.155 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 -16.97 28.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.798 0.666 . . . . 1.06 112.798 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.27 -23.07 27.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.297 -0.954 . . . . 0.93 112.128 -179.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.786 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.05 115.43 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.999 -0.371 . . . . 1.38 109.999 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -72.62 110.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.578 0.584 . . . . 0.79 112.578 -179.061 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 77' ' ' ILE . 7.7 p -65.86 116.4 32.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.59 110.087 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.78 157.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.888 2.392 . . . . 0.85 112.844 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 31.7 Cg_endo -64.28 121.56 9.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.753 2.302 . . . . 0.76 113.34 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 76' ' ' VAL . 7.8 p -71.38 132.9 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 1.28 109.62 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 46.0 mt-10 -28.89 125.7 0.25 Allowed Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.868 0.73 . . . . 1.77 112.625 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 63.0 Cg_exo -54.12 174.15 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.541 2.161 . . . . 0.55 113.822 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -106.38 142.18 36.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 1.23 109.927 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.5 t0 -38.83 136.12 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.872 0.733 . . . . 1.63 111.051 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -68.28 103.34 1.57 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.487 -0.324 . . . . 0.41 111.479 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.8 mp -88.41 115.15 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.437 -0.347 . . . . 0.44 110.751 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' NH1' ' A' ' 98' ' ' ARG . 99.0 m -49.02 -35.94 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.44 111.408 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 66' ' ' LEU . 51.6 t 61.59 95.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.197 -0.297 . . . . 1.1 110.197 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' NH1' HG21 ' A' ' 96' ' ' THR . 0.0 OUTLIER -147.22 -86.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.271 0.471 . . . . 3.0 112.271 -179.26 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.819 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -104.56 7.09 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.192 0.441 . . . . 2.14 112.192 -179.308 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.413 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 112.484 0.549 . . . . 2.06 112.484 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.883 HD11 ' OD1' ' A' ' 80' ' ' ASN . 2.6 tt . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.76 0.314 . . . . 0.68 110.923 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 2' ' ' ILE . 17.4 m-20 -136.89 121.85 12.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.357 -0.383 . . . . 2.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.87 169.46 17.7 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.307 2.005 . . . . 0.5 111.716 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.7 Cg_endo -53.74 162.98 3.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.655 2.237 . . . . 0.71 112.542 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.69 170.74 27.37 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.934 -0.651 . . . . 0.66 112.66 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -55.93 127.19 68.19 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.639 -0.134 . . . . 1.52 110.639 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 6.1 Cg_exo -76.0 128.81 10.98 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.119 1.879 . . . . 0.44 112.199 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -130.5 110.19 16.22 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.216 -0.447 . . . . 1.09 111.462 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.0 Cg_exo -58.24 103.28 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.64 113.476 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -65.35 -29.68 70.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 1.64 109.629 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' HD13 ' A' ' 13' ' ' ILE . 2.6 t30 -150.79 154.01 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.27 -0.877 . . . . 0.72 109.22 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.057 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -144.03 114.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.039 0.447 . . . . 0.96 112.018 -179.621 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -100.22 156.29 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.713 -0.676 . . . . 1.46 110.268 179.64 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -56.9 -23.24 43.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.349 -0.387 . . . . 2.42 110.995 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' THR . 75.9 m-70 -140.12 26.5 2.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 1.02 111.117 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -170.43 97.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.68 111.147 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.057 HG13 HG22 ' A' ' 13' ' ' ILE . 89.4 t -94.77 129.11 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.8 110.964 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.658 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.9 m -106.0 125.92 51.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.681 -0.69 . . . . 0.35 111.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.827 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.87 153.19 49.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.808 0.813 . . . . 0.52 111.895 179.424 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -128.35 -174.54 3.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.254 -1.339 . . . . 1.84 109.871 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 48.5 p90 179.98 160.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.42 . . . . 0.4 111.687 179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.53 146.13 45.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.83 111.319 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -82.39 139.76 44.92 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 2.11 110.573 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 33' ' ' ILE . 93.9 Cg_exo -43.69 163.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.381 2.054 . . . . 0.89 112.066 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -121.55 -38.51 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.482 . . . . 2.77 111.282 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.93 -70.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.896 -0.321 . . . . 1.37 111.476 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 25' ' ' PRO . 21.1 p 46.75 41.3 10.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.215 0.531 . . . . 0.91 110.568 -179.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.9 -97.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.488 -0.778 . . . . 1.01 112.506 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.75 60.71 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.739 -0.944 . . . . 0.98 110.739 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 5.2 m-85 -130.45 -172.28 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.19 0.519 . . . . 0.87 112.023 -178.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 14.69 1.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.482 -0.781 . . . . 2.26 111.647 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.763 HD11 ' HG2' ' A' ' 25' ' ' PRO . 17.5 mt 56.61 153.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.401 0.62 . . . . 1.71 112.538 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 33' ' ' ILE . 2.9 p -127.98 55.74 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.273 -0.876 . . . . 1.15 110.566 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' THR . 0.2 OUTLIER 87.18 154.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.565 -0.743 . . . . 1.58 110.485 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 82.0 m-85 -105.99 156.64 18.18 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.277 0.561 . . . . 0.76 111.921 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 38' ' ' VAL . 4.1 mt -121.69 168.0 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.299 -0.864 . . . . 1.14 109.563 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 74' ' ' PHE . 4.7 t -146.03 99.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.982 0.364 . . . . 0.63 111.982 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 6.3 mt-10 -77.26 126.85 31.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.154 0.502 . . . . 1.67 110.27 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 2.5 mmtp -94.2 131.37 39.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.29 -0.868 . . . . 1.97 112.63 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.1 ttm180 -111.07 105.32 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.784 -0.45 . . . . 1.44 109.784 178.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 1.299 ' OD2' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.43 94.14 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.996 -0.547 . . . . 1.59 111.191 -179.611 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 94' ' ' ALA . 12.9 mt -79.23 153.34 76.88 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.99 -0.55 . . . . 0.9 110.557 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.18 29.74 7.34 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.123 -1.199 . . . . 1.43 113.149 0.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -100.8 -85.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.61 0.243 . . . . 2.66 111.312 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.89 162.78 11.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.663 -0.78 . . . . 1.12 112.78 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 1.299 ' HG2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 173.7 -32.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 2.41 111.522 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 40.6 m95 48.87 75.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.667 -0.242 . . . . 0.65 110.517 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.03 137.57 52.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.896 0.379 . . . . 1.28 111.809 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.8 ptmt -65.26 85.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.125 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -58.64 -37.64 76.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.86 111.179 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 t30 -47.26 -67.03 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.01 110.546 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.37 35.19 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.425 -0.352 . . . . 2.08 111.181 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 t -139.8 -78.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 1.89 111.014 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.403 ' ND2' ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -179.22 142.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 1.87 111.027 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 61' ' ' PHE . 3.5 mt -144.98 74.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.69 111.016 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 57' ' ' LEU . 1.1 mt -68.16 -37.1 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.157 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -100.68 167.19 10.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 1.54 110.597 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -77.0 -9.94 59.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.499 . . . . 1.75 111.613 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG3' ' HG2' ' A' ' 21' ' ' LYS . 4.9 tt0 -96.3 102.43 14.22 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.833 0.349 . . . . 2.05 110.296 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.726 ' HB2' HG23 ' A' ' 56' ' ' ILE . 57.9 t80 -136.57 163.37 30.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.107 -0.497 . . . . 0.48 111.677 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 75.7 m -126.05 119.55 27.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.42 111.252 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 51' ' ' ALA . 12.1 t -83.88 102.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.08 111.009 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -102.38 168.15 9.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 1.33 111.012 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.25 12.04 52.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.787 -0.72 . . . . 0.9 112.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER -86.55 -174.1 4.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.778 0.289 . . . . 1.47 110.835 179.947 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 2.0 m -128.31 154.69 45.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 1.06 111.099 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 3.2 tm-20 -77.42 158.19 30.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 1.91 110.93 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.3 t70 56.54 59.98 3.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 1.87 110.943 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.32 123.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.49 111.144 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.48 129.79 39.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.36 110.453 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 51.5 m-85 -126.77 129.51 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.56 112.075 -179.142 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 3.5 mt-10 -107.78 144.99 34.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.814 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 119.43 14.09 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.543 1.312 . . . . 0.6 114.543 -178.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.85 146.59 26.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.466 -0.333 . . . . 2.11 110.366 178.434 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 57.1 t -93.98 119.54 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.6 110.935 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 87' ' ' PRO . 1.1 mt -118.99 144.39 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.271 -1.011 . . . . 0.7 108.271 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -178.57 142.52 0.23 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.6 111.959 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HE3' HD12 ' A' ' 85' ' ' ILE . 12.5 mttp -77.35 -178.64 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.152 -0.619 . . . . 1.98 109.677 179.015 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.883 ' OD1' HD11 ' A' ' 2' ' ' ILE . 4.4 m120 -112.69 -86.93 0.56 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.921 -0.581 . . . . 2.19 110.3 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -155.19 -42.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.491 0.552 . . . . 1.08 112.491 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.64 46.14 0.98 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.658 0.614 . . . . 1.06 112.658 -178.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.14 -2.02 62.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.163 -1.017 . . . . 0.93 113.288 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.821 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.05 105.47 8.15 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.039 -0.726 . . . . 1.38 109.039 179.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt -97.31 111.0 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.548 0.944 . . . . 0.79 113.548 -178.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.75 111.38 6.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.411 -1.7 . . . . 0.59 106.411 177.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 73.0 Cg_endo -66.39 -99.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.814 1.676 . . . . 0.85 113.843 -177.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 87' ' ' PRO . 72.5 Cg_endo -106.73 134.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 CA-C-N 124.815 2.755 . . . . 0.76 114.168 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 29.3 m -109.22 88.51 2.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.254 -0.43 . . . . 1.28 110.181 178.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 18.88 100.53 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.541 1.136 . . . . 1.77 113.973 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 53.0 Cg_exo -51.17 145.72 25.39 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.479 2.119 . . . . 0.55 113.616 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 75.2 m -73.49 141.21 46.79 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.23 109.274 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.7 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -39.73 144.94 0.15 Allowed 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 124.035 0.834 . . . . 1.63 110.865 179.462 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.15 110.78 6.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.551 -0.46 . . . . 0.41 110.491 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.949 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -92.55 109.87 22.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.007 0.432 . . . . 0.44 111.333 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 33.8 m -45.43 -32.94 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.708 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.5 m 52.53 59.3 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.949 0.404 . . . . 1.1 110.379 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.817 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -90.47 -75.65 0.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 3.0 112.463 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.817 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.0 p-10 -119.75 30.56 6.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.121 -0.49 . . . . 2.14 111.754 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 53.0 t0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 121.076 0.465 . . . . 2.06 111.835 -179.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.677 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.3 tt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.871 0.367 . . . . 0.68 110.754 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -125.81 133.23 24.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 2.0 110.636 179.858 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.0 160.7 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.28 1.987 . . . . 0.5 112.097 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.0 176.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.665 2.243 . . . . 0.71 113.067 -179.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.78 171.44 53.56 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.882 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -63.52 118.29 42.86 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 110.19 -0.3 . . . . 1.52 110.19 179.585 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 31.5 Cg_exo -64.74 135.49 45.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.067 . . . . 0.44 112.801 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.45 103.65 11.31 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.036 -0.529 . . . . 1.09 111.693 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 33.1 Cg_exo -48.7 117.69 2.88 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.055 1.836 . . . . 0.64 112.366 179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -75.5 -32.72 60.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.1 -0.704 . . . . 1.64 109.1 178.86 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.81 157.48 43.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.878 -1.055 . . . . 0.72 108.914 179.43 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.856 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -140.34 97.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.513 . . . . 0.96 111.437 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -87.13 48.09 1.6 Allowed 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 115.635 -0.711 . . . . 1.46 112.279 -179.259 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.85 -75.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.678 0.621 . . . . 2.42 112.678 178.698 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.2 m-70 -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 1.02 111.614 -179.39 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.6 p -139.48 121.97 16.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.465 -0.334 . . . . 0.68 110.309 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.974 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 16.8 m -109.45 135.57 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.8 112.168 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 11' ' ' LEU . 18.9 m -93.6 140.19 29.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.68 -0.691 . . . . 0.35 109.942 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.92 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.96 152.54 38.8 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.657 0.598 . . . . 0.52 112.251 -179.854 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.435 ' CG ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -140.94 145.41 36.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.127 -0.942 . . . . 1.84 110.438 179.825 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.3 p90 -140.03 -176.91 4.76 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.058 0.456 . . . . 0.4 111.864 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.45 165.97 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.83 110.705 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.24 147.07 32.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 2.11 110.801 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.595 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.9 Cg_endo -42.77 167.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.032 2.488 . . . . 0.89 112.047 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.58 -28.47 8.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 2.77 111.759 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -123.15 -69.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 1.37 111.312 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.595 HG23 ' CB ' ' A' ' 25' ' ' PRO . 13.7 p 51.14 53.04 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.91 111.007 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.14 -92.26 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.789 -0.72 . . . . 1.01 112.31 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.96 32.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.776 -0.93 . . . . 0.98 110.776 179.379 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.1 -179.2 3.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.22 -0.49 . . . . 0.87 111.509 -178.787 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 11.36 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 2.26 111.398 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.6 mp 60.09 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.064 0.459 . . . . 1.71 110.897 -179.747 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 p -126.68 5.61 6.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 1.15 111.277 179.861 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.58 123.14 0.64 Allowed 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.746 0.308 . . . . 1.58 110.987 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.3 m-85 -100.88 92.4 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.76 110.575 179.561 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.482 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 5.8 mm -69.69 138.23 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.463 -0.335 . . . . 1.14 111.0 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.93 101.19 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.45 -0.341 . . . . 0.63 111.677 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -77.46 138.69 39.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.914 -0.772 . . . . 1.67 108.914 178.815 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -121.1 135.23 55.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 1.97 111.64 -179.45 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 20.0 ttm180 -114.17 113.28 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.605 -0.725 . . . . 1.44 110.455 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.16 112.98 11.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.59 110.502 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 41' ' ' ARG . 2.2 mm? -80.39 149.22 68.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.9 110.975 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.55 17.21 41.12 Favored 'Cis proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.885 -1.298 . . . . 1.43 112.66 0.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -151.08 93.16 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 2.66 111.372 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -144.07 -165.52 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 1.12 112.138 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 148.38 33.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 2.41 110.842 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 50.6 m95 -68.88 97.56 0.85 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.678 -0.692 . . . . 0.65 110.907 -179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -128.37 126.42 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.604 179.919 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 10.2 ptmm? -58.32 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.871 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -74.29 -35.23 63.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.953 0.406 . . . . 0.86 110.373 179.794 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 56' ' ' ILE . 11.4 p-10 -44.28 -47.75 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.849 -0.614 . . . . 2.01 111.386 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 41.27 30.03 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 2.08 111.982 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 -161.34 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.44 -0.345 . . . . 1.89 110.711 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.85 61.86 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.935 -179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 61' ' ' PHE . 2.4 mm -57.95 95.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.69 110.131 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.21 -8.03 9.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.017 0.377 . . . . 1.6 112.017 -179.536 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.28 9.14 23.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.157 0.428 . . . . 1.54 112.157 -179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 13.0 p30 53.05 21.26 2.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 1.75 111.59 -179.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.435 ' OE1' ' CG ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -130.85 78.67 1.85 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 178.902 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.875 ' CG ' HD12 ' A' ' 56' ' ' ILE . 82.3 t80 -120.03 164.63 15.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.519 0.676 . . . . 0.48 112.378 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 18' ' ' VAL . 48.8 m -124.43 120.86 33.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.765 -1.107 . . . . 0.42 109.972 178.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.92 HG23 HD11 ' A' ' 20' ' ' LEU . 21.3 t -76.26 100.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.962 -0.563 . . . . 1.08 111.307 -179.521 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.23 137.13 32.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.243 -0.89 . . . . 1.33 110.44 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.14 -17.41 4.33 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.787 -0.72 . . . . 0.9 111.945 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.92 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -52.05 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.676 0.274 . . . . 1.47 110.311 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -148.03 141.81 25.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.481 -0.327 . . . . 1.06 110.563 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 3.0 tt0 -57.49 139.26 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 1.91 110.967 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.885 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 67.86 61.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 1.87 111.06 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.29 120.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.443 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.74 135.56 51.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.159 -0.682 . . . . 0.36 109.159 179.078 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 33.1 m-85 -129.94 115.87 17.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.258 0.836 . . . . 0.56 113.258 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.792 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 7.8 mt-10 -99.27 134.18 42.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.5 107.917 178.087 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.42 118.34 14.24 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.901 1.074 . . . . 0.6 113.901 -179.066 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.46 172.98 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.028 -1.101 . . . . 2.11 108.028 177.945 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -138.78 116.22 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.927 . . . . 0.6 112.176 179.446 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 86' ' ' SER . 69.6 mt -99.2 142.15 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.784 -1.191 . . . . 0.7 107.784 178.3 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -148.91 116.08 6.09 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.433 -0.907 . . . . 0.6 112.729 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.696 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.6 mtpt -63.28 -167.66 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.638 -0.505 . . . . 1.98 109.638 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.761 HD21 ' HB3' ' A' ' 84' ' ' ALA . 22.5 p30 -143.95 169.86 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.267 0.556 . . . . 2.19 111.684 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.01 -30.18 0.99 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.315 -0.857 . . . . 1.08 111.941 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.85 -22.55 36.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.848 0.314 . . . . 1.06 111.848 -179.48 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.67 -21.54 18.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.368 -0.92 . . . . 0.93 111.935 -179.51 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -52.22 161.03 0.68 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.087 -0.338 . . . . 1.38 110.087 179.581 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.696 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -112.56 109.76 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.247 0.462 . . . . 0.79 112.247 -179.596 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.0 p -66.88 115.87 29.5 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 109.167 -0.679 . . . . 0.59 109.167 179.009 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -38.87 159.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.672 2.248 . . . . 0.85 112.812 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 28.4 Cg_endo -64.75 124.4 13.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.704 2.269 . . . . 0.76 112.976 -179.665 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.456 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.6 m -76.76 115.64 16.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 1.28 109.636 179.062 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -12.19 118.44 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.588 1.155 . . . . 1.77 113.534 -179.34 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' HD3' ' A' ' 75' ' ' ARG . 70.2 Cg_exo -52.26 131.68 40.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.575 2.184 . . . . 0.55 113.606 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.97 144.99 56.92 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.585 -0.895 . . . . 1.23 108.585 178.687 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.638 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.21 141.75 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.956 0.785 . . . . 1.63 112.352 -179.553 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -73.15 107.19 5.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.76 -0.655 . . . . 0.41 109.977 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -86.79 112.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.874 -179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.2 m -48.09 -32.32 6.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.656 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.441 ' H ' HG22 ' A' ' 95' ' ' ILE . 81.5 m 54.83 83.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.86 -0.609 . . . . 1.1 110.993 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 -91.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.314 -0.403 . . . . 3.0 110.269 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.44 17.86 16.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.846 0.355 . . . . 2.14 110.063 179.064 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 p30 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-N 116.04 -0.527 . . . . 2.06 111.436 -179.77 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.457 ' CG1' ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 0.68 111.882 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.7 134.29 13.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 2.0 111.067 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.19 159.96 26.49 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.607 2.205 . . . . 0.5 112.719 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 51.1 Cg_exo -55.09 172.63 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.713 2.275 . . . . 0.71 112.491 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -62.8 -163.42 0.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.66 112.221 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 4.7 tttp -87.4 142.9 33.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.57 0.185 . . . . 1.52 110.532 179.849 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HG3' HG23 ' A' ' 76' ' ' VAL . 2.2 Cg_endo -83.24 132.5 6.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.659 2.239 . . . . 0.44 112.494 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.74 110.73 10.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 1.09 110.69 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.9 Cg_exo -59.54 139.93 91.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.117 1.878 . . . . 0.64 113.887 -179.152 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HG ' HG22 ' A' ' 19' ' ' THR . 0.1 OUTLIER -105.71 -26.83 11.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.957 -1.019 . . . . 1.64 109.162 178.971 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.469 ' C ' HD13 ' A' ' 13' ' ' ILE . 1.2 t30 -161.79 158.01 25.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.72 110.452 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.4 95.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.127 0.489 . . . . 0.96 110.469 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.21 56.61 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 1.46 112.166 -179.258 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.518 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.07 -68.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.548 0.573 . . . . 2.42 112.548 178.371 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' THR . 24.4 m-70 -95.89 -7.25 37.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 1.02 111.883 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' SER . 6.6 p -133.0 98.73 4.37 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.721 -0.392 . . . . 0.68 111.762 -179.783 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 20' ' ' LEU . 84.6 t -86.62 141.84 13.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.242 -0.435 . . . . 0.8 109.945 179.356 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.777 HG22 ' HG ' ' A' ' 11' ' ' LEU . 88.0 m -123.89 115.53 21.44 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.872 0.693 . . . . 0.35 112.872 -178.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.54 150.03 51.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.639 0.733 . . . . 0.52 111.465 178.499 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.61 140.86 37.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.721 -1.127 . . . . 1.84 110.207 -179.417 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -131.25 -176.81 4.14 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.443 0.639 . . . . 0.4 112.47 -179.34 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.453 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -85.44 -162.5 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.592 -0.731 . . . . 0.83 111.026 179.839 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -122.44 153.07 62.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 2.11 111.005 -179.76 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.447 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 50.4 Cg_exo -55.81 179.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.771 2.314 . . . . 0.89 113.248 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.85 -28.59 4.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 2.77 111.914 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -124.81 -69.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.015 0.376 . . . . 1.37 112.015 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 4.1 p 51.61 49.8 20.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.91 110.648 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.27 -104.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.113 -0.565 . . . . 1.01 112.692 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.16 2.56 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 110.563 -1.015 . . . . 0.98 110.563 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CD2' ' OD1' ' A' ' 80' ' ' ASN . 1.2 m-85 -108.85 178.14 4.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.634 -0.783 . . . . 0.87 111.47 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.13 6.02 2.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.889 -0.596 . . . . 2.26 111.84 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 18.8 mt 60.02 134.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-O 121.126 0.488 . . . . 1.71 111.083 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.427 ' C ' ' HG ' ' A' ' 35' ' ' SER . 3.7 p -122.92 -3.65 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 1.15 112.201 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.427 ' HG ' ' C ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -168.63 116.1 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.103 0.408 . . . . 1.58 112.103 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 19.5 m-85 -90.52 142.15 28.04 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.849 0.356 . . . . 0.76 110.152 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 77' ' ' ILE . 3.3 mt -111.94 166.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.123 -0.49 . . . . 1.14 110.712 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 37' ' ' ILE . 2.8 t -141.44 101.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.442 -0.345 . . . . 0.63 111.386 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -75.93 137.9 40.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 1.67 109.677 179.279 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.845 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -115.62 152.54 32.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.14 0.495 . . . . 1.97 111.532 -179.426 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 9.2 ttm180 -143.04 118.8 10.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.634 -0.712 . . . . 1.44 110.62 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 1.08 ' OD1' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -62.35 -15.41 48.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.305 -0.407 . . . . 1.59 111.862 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 73' ' ' GLU . 77.5 mt 57.05 148.42 0.05 OUTLIER Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.771 -0.65 . . . . 0.9 111.755 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.86 13.22 46.17 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.744 -1.357 . . . . 1.43 112.4 -0.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -124.29 -67.9 0.89 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.383 -0.371 . . . . 2.66 110.418 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 1.08 ' CA ' ' OD1' ' A' ' 42' ' ' ASP . . . 42.04 -129.7 4.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.118 -0.563 . . . . 1.12 113.107 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.414 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 170.67 110.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 2.41 110.781 -179.863 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.4 m95 -52.0 104.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.648 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -142.75 136.29 28.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 1.28 111.106 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.2 ptmm? -52.61 119.08 4.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.167 -179.898 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.845 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -109.21 -29.51 8.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.86 110.619 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 15.1 p-10 -52.45 -50.21 63.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 2.01 111.174 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 51.77 24.95 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.396 -0.366 . . . . 2.08 110.808 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -159.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 1.89 110.719 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.36 59.36 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.87 111.134 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.57 HD13 ' CB ' ' A' ' 61' ' ' PHE . 15.4 mt -52.42 155.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.762 -0.459 . . . . 0.69 109.762 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -164.79 -36.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.81 0.671 . . . . 1.6 112.81 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.83 22.94 2.9 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.241 0.46 . . . . 1.54 112.241 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 17.9 p30 50.52 22.82 1.13 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.962 -0.563 . . . . 1.75 111.775 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -133.0 91.84 2.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.261 -1.014 . . . . 2.05 108.261 178.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CB ' HD13 ' A' ' 56' ' ' ILE . 72.1 t80 -122.31 165.55 16.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.245 0.545 . . . . 0.48 111.946 -178.385 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.518 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 24.6 m -129.24 107.05 9.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.404 -0.816 . . . . 0.42 111.124 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.1 t -67.47 108.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 1.08 110.718 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 17' ' ' THR . 4.6 p -110.15 144.24 39.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.658 -0.701 . . . . 1.33 110.966 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.67 10.54 14.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.686 -0.769 . . . . 0.9 112.902 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 3.7 mm? -52.58 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.105 0.452 . . . . 1.47 110.68 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -105.71 -18.56 14.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.06 110.955 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 68.0 141.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.894 0.378 . . . . 1.91 110.63 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.49 25.05 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 1.87 110.203 -179.367 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.09 141.58 25.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.878 -0.601 . . . . 0.49 110.693 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -80.81 132.41 35.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.36 110.9 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 49.5 m-85 -132.39 133.39 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.773 . . . . 0.56 112.154 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HB2' HD11 ' A' ' 43' ' ' LEU . 7.0 tt0 -106.21 143.75 33.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.173 -1.047 . . . . 1.5 108.173 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.529 ' HZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.83 117.96 16.48 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.066 1.506 . . . . 0.6 115.066 -178.337 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.9 156.52 17.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 2.11 109.895 177.815 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 8' ' ' PRO . 71.9 t -104.57 128.89 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.252 0.548 . . . . 0.6 111.498 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 37' ' ' ILE . 11.0 mt -132.85 155.74 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.551 -1.278 . . . . 0.7 107.551 179.131 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -176.86 131.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.467 -0.893 . . . . 0.6 112.799 -179.628 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 ptpt -87.92 111.73 21.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.738 -0.838 . . . . 1.98 108.738 178.407 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -46.39 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.851 1.056 . . . . 2.19 113.851 -177.933 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.15 -52.05 1.65 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.043 0.757 . . . . 1.08 113.043 -178.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -74.14 0.76 12.92 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.084 0.772 . . . . 1.06 113.084 -178.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.7 -17.6 38.9 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.184 -1.008 . . . . 0.93 112.259 -179.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.6 97.13 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 179.23 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.11 118.53 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.486 0.921 . . . . 0.79 113.486 -178.173 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.2 p -71.29 110.45 7.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 107.945 -1.132 . . . . 0.59 107.945 178.123 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -56.44 175.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.82 2.347 . . . . 0.85 114.324 -178.168 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 86.2 Cg_exo -45.79 135.78 13.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.621 2.881 . . . . 0.76 113.866 -179.373 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 m -119.84 95.55 4.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.036 -0.529 . . . . 1.28 111.416 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 20.96 105.83 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.996 1.11 . . . . 1.77 113.996 179.435 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.6 Cg_exo -60.66 136.86 69.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.531 2.154 . . . . 0.55 112.643 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -71.6 146.85 48.11 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.021 -0.536 . . . . 1.23 110.23 179.627 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -34.09 146.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.348 1.03 . . . . 1.63 112.159 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -81.56 118.13 22.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.784 -0.644 . . . . 0.41 110.947 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -108.59 119.47 58.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.44 111.503 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 53.1 m -52.21 -22.81 4.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.056 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.701 ' H ' HG22 ' A' ' 95' ' ' ILE . 1.9 m 57.93 58.0 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.235 0.541 . . . . 1.1 110.176 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -78.82 -132.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.433 -0.803 . . . . 3.0 110.759 -179.594 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.49 ' HA ' ' HG2' ' A' ' 15' ' ' ARG . 2.6 p30 -93.41 35.81 1.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.175 0.443 . . . . 2.14 110.824 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.518 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 24.2 t0 . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.26 0.552 . . . . 2.06 112.312 -179.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.732 HD12 ' OD1' ' A' ' 80' ' ' ASN . 1.6 tt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.888 0.375 . . . . 0.68 111.181 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.6 m-20 -130.41 138.61 33.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 2.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.27 161.91 13.2 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.854 2.369 . . . . 0.5 112.552 -179.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 12.3 Cg_endo -56.33 -174.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.062 2.508 . . . . 0.71 112.981 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 178.05 49.14 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.967 -0.56 . . . . 0.66 112.838 -179.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.9 122.81 85.28 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.198 -0.297 . . . . 1.52 110.198 179.648 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CG ' HG12 ' A' ' 76' ' ' VAL . 29.3 Cg_exo -67.66 141.78 56.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.44 112.816 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.55 108.01 7.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.7 -0.682 . . . . 1.09 110.848 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.544 ' CB ' HD23 ' A' ' 20' ' ' LEU . 24.4 Cg_exo -51.06 123.2 11.37 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.14 1.893 . . . . 0.64 113.048 -179.518 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -84.03 -31.67 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.084 -0.71 . . . . 1.64 109.084 178.41 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.11 147.97 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.879 -1.055 . . . . 0.72 108.934 179.634 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.969 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -132.58 98.39 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.96 111.441 -179.556 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.45 50.96 2.06 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.628 -0.714 . . . . 1.46 111.576 -179.719 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.77 -75.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.661 0.615 . . . . 2.42 112.661 178.933 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.3 m-70 -73.6 -24.92 60.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.333 0.494 . . . . 1.02 112.333 -179.132 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -137.59 122.09 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.226 -0.287 . . . . 0.68 110.226 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.969 ' HB ' HG22 ' A' ' 13' ' ' ILE . 12.6 m -111.64 121.92 65.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.625 0.726 . . . . 0.8 112.647 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 15.5 m -83.69 138.37 33.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.92 -1.037 . . . . 0.35 110.35 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.816 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -147.61 164.12 34.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.642 0.588 . . . . 0.52 111.724 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.929 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.31 178.93 6.84 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.648 -0.706 . . . . 1.84 110.352 179.437 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.513 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 47.6 p90 -172.31 167.18 5.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.393 0.616 . . . . 0.4 112.533 179.717 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.83 148.95 29.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.19 -0.914 . . . . 0.83 110.657 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.61 149.13 43.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.496 -0.32 . . . . 2.11 110.842 179.819 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 86.5 Cg_exo -44.65 176.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.024 2.483 . . . . 0.89 112.919 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -30.64 4.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.908 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -114.01 -71.72 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.143 0.423 . . . . 1.37 112.143 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 12.1 p 54.38 37.11 26.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.91 110.808 -179.451 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.38 -92.65 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.788 . . . . 1.01 112.229 179.996 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.3 27.38 1.54 Allowed Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.46 -0.656 . . . . 0.98 111.46 179.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -102.55 -177.27 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.87 111.567 -179.17 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.81 2.99 2.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.431 0.53 . . . . 2.26 112.431 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.7 mp 60.65 136.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.107 0.479 . . . . 1.71 111.436 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 p -124.7 9.64 8.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 1.15 111.779 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 t -179.29 138.39 0.14 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.831 0.348 . . . . 1.58 111.752 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.63 ' O ' HD12 ' A' ' 56' ' ' ILE . 32.8 m-85 -114.35 103.96 11.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.76 110.496 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.5 mm -79.83 128.36 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 1.14 110.883 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.98 111.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.832 0.308 . . . . 0.63 111.832 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.801 ' CD ' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -86.81 136.36 33.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 1.67 108.834 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.608 ' CD ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.54 143.78 50.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.338 0.59 . . . . 1.97 112.274 -179.001 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG3' ' HA3' ' A' ' 46' ' ' GLY . 20.3 ttp180 -110.53 108.5 18.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.151 -0.931 . . . . 1.44 109.905 179.426 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.954 ' OD2' ' NH2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.83 92.69 3.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.698 -0.683 . . . . 1.59 109.839 179.809 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.852 HD11 ' HG2' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -68.17 142.86 95.37 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.9 111.172 -179.405 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -94.2 16.25 41.64 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.047 -1.231 . . . . 1.43 112.793 0.109 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.37 67.78 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.579 -0.282 . . . . 2.66 111.642 -179.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -110.57 176.54 18.93 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.571 -0.823 . . . . 1.12 112.681 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.954 ' NH2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -151.58 19.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 111.246 -179.827 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 82.2 m95 49.74 98.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.65 111.106 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -143.14 155.29 44.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 1.28 110.851 179.198 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -71.84 116.83 12.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.089 0.471 . . . . 1.3 111.563 -179.427 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -93.14 -39.79 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.86 110.609 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.638 ' CB ' HD11 ' A' ' 56' ' ' ILE . 13.9 p-10 -49.92 -48.62 51.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 2.01 111.049 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.05 30.43 0.59 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 2.08 111.297 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 m -139.29 -164.64 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 1.89 111.153 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.86 107.7 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 1.87 111.022 -179.854 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.638 HD11 ' CB ' ' A' ' 52' ' ' ASN . 44.1 mt -108.48 65.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.69 110.704 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mt -47.66 -66.75 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.475 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.15 162.47 27.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.933 0.397 . . . . 1.54 110.555 179.975 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.7 p30 -75.9 -2.39 30.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.894 -0.594 . . . . 1.75 111.659 -179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 58' ' ' GLU . 16.7 tt0 -93.48 99.55 12.01 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.457 -0.571 . . . . 2.05 109.457 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 73.0 t80 -134.51 164.58 27.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.316 0.579 . . . . 0.48 112.024 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.8 m -124.3 124.86 43.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.246 -0.888 . . . . 0.42 109.974 179.32 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 20' ' ' LEU . 9.9 t -80.55 96.07 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.098 0.475 . . . . 1.08 111.365 -179.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.25 132.51 35.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 1.33 110.83 179.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.82 -25.65 2.93 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.529 -0.76 . . . . 0.9 111.325 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.708 ' CD2' HG13 ' A' ' 18' ' ' VAL . 6.9 mp -49.14 158.29 0.37 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.958 0.408 . . . . 1.47 110.928 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -124.91 144.14 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 1.06 110.805 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -60.21 143.73 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 1.91 111.16 -179.844 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER 69.87 44.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 1.87 111.213 179.891 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.41 122.2 4.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.858 0.361 . . . . 0.49 111.808 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -74.81 128.84 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.36 109.861 179.168 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 47.0 m-85 -125.13 125.14 43.26 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.082 0.771 . . . . 0.56 113.082 -178.701 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.852 ' HG2' HD11 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -102.37 137.94 39.96 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.885 -1.154 . . . . 1.5 107.885 178.013 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.887 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -142.75 126.58 17.13 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.208 1.558 . . . . 0.6 115.208 -178.781 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -106.02 -173.04 2.2 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.954 -1.128 . . . . 2.11 107.954 177.384 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.603 HG12 ' CG ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -151.34 117.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 118.989 -1.084 . . . . 0.6 113.336 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.801 HD12 ' CD ' ' A' ' 39' ' ' GLU . 65.4 mt -100.18 146.11 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.7 106.832 177.288 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -158.33 135.69 10.15 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.75 -0.78 . . . . 0.6 112.286 -178.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.1 mttp -73.6 -152.38 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 178.792 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.732 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -147.29 -108.91 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.452 -0.499 . . . . 2.19 110.724 179.576 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.36 -12.06 4.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.978 0.808 . . . . 1.08 112.5 179.617 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.1 -1.07 26.03 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.754 0.279 . . . . 1.06 111.754 -179.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.88 43.63 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.427 -0.892 . . . . 0.93 112.481 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.28 153.61 11.88 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.744 -0.268 . . . . 1.38 110.316 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -113.63 106.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.069 0.462 . . . . 0.79 111.681 -179.725 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -65.42 127.44 92.95 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 115.93 -0.577 . . . . 0.59 109.738 179.585 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -41.35 168.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.88 2.387 . . . . 0.85 113.365 -179.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HG3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -75.74 121.35 6.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.254 2.636 . . . . 0.76 112.6 -179.744 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.588 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -66.79 132.84 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.998 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -33.6 121.71 0.48 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 122.869 0.468 . . . . 1.77 112.169 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 56.3 Cg_exo -52.98 155.31 11.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.94 2.426 . . . . 0.55 113.977 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.94 149.72 21.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 1.23 109.832 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -42.47 148.26 0.23 Allowed 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 124.21 0.944 . . . . 1.63 111.222 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.786 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . . . -75.24 124.23 26.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.825 -0.625 . . . . 0.41 111.62 -179.636 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.659 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -102.99 109.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.517 179.483 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.6 m -46.63 -28.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.44 111.004 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.641 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 52.04 83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.1 110.515 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -131.79 -87.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 3.0 111.278 -179.873 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.525 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 3.5 p-10 -98.59 9.88 42.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.337 -0.392 . . . . 2.14 111.304 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.4 p30 . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.999 0.428 . . . . 2.06 111.252 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.899 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.2 tt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.78 0.324 . . . . 0.68 110.722 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.12 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -129.0 119.39 19.82 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 2.0 110.537 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.9 161.89 37.46 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.164 1.909 . . . . 0.5 111.983 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.96 167.0 18.87 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.645 2.23 . . . . 0.71 113.158 -179.312 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.68 154.96 25.87 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.789 -0.641 . . . . 0.66 112.94 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 2.6 tttt -53.65 138.83 51.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 1.52 110.103 179.704 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.513 ' CG ' HG23 ' A' ' 76' ' ' VAL . 4.2 Cg_exo -80.63 115.35 3.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.448 2.098 . . . . 0.44 111.901 179.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.5 p -109.29 109.74 60.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.538 -0.301 . . . . 1.09 110.649 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 72.9 Cg_exo -41.66 125.0 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.341 2.027 . . . . 0.64 113.123 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -89.59 -33.26 16.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.49 -0.777 . . . . 1.64 109.61 179.833 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -158.35 111.1 2.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.72 109.565 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.037 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -102.74 140.07 22.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.357 0.598 . . . . 0.96 112.4 -179.229 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.917 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -136.42 141.59 43.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.299 -0.864 . . . . 1.46 110.197 179.777 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -43.14 -24.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.155 0.798 . . . . 2.42 113.155 -179.239 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.406 ' O ' HG23 ' A' ' 17' ' ' THR . 11.0 m170 -122.73 -0.15 9.17 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.784 -0.572 . . . . 1.02 112.497 -179.589 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -161.27 120.29 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.68 110.95 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 13' ' ' ILE . 61.2 t -108.16 128.31 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.168 -0.469 . . . . 0.8 111.176 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.884 ' C ' HD13 ' A' ' 20' ' ' LEU . 21.7 m -106.48 133.43 51.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.35 110.938 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.884 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -136.34 147.0 47.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.681 0.753 . . . . 0.52 112.033 179.493 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -130.25 131.12 45.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.473 -1.24 . . . . 1.84 109.646 179.682 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 6.5 p90 -118.01 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.003 0.43 . . . . 0.4 111.946 -179.565 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.32 177.94 4.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.721 -0.672 . . . . 0.83 112.052 -179.498 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.27 142.17 25.83 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.34 -0.845 . . . . 2.11 110.266 179.801 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 78.3 Cg_exo -51.86 -161.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.888 2.392 . . . . 0.89 113.595 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.3 -43.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.267 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.032 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.7 t80 -111.2 -70.66 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.453 -0.34 . . . . 1.37 111.885 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 1.12 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 p 55.16 43.84 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.922 -0.399 . . . . 0.91 109.922 -179.243 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.37 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.733 -0.667 . . . . 1.01 112.769 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.95 37.87 0.81 Allowed Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 109.872 -1.291 . . . . 0.98 109.872 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -117.65 -179.27 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.631 -0.785 . . . . 0.87 111.055 -178.67 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -6.77 4.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 2.26 112.29 -179.744 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 79' ' ' LYS . 11.9 mt 62.26 142.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 1.71 110.648 -179.642 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -138.93 42.66 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.3 . . . . 1.15 111.428 -179.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.31 165.45 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.416 -0.356 . . . . 1.58 110.69 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 61.2 m-85 -153.53 74.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.76 110.889 179.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.484 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.6 mt -57.42 133.52 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 1.14 110.865 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 61' ' ' PHE . 2.5 t -105.1 104.79 17.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.342 -0.39 . . . . 0.63 111.302 179.999 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.948 ' OE2' ' O ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -78.98 130.12 35.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.686 -0.487 . . . . 1.67 109.686 179.394 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.812 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.67 143.92 43.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.886 0.374 . . . . 1.97 110.983 -179.877 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 4.1 ttm180 -117.36 105.38 12.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.944 -0.571 . . . . 1.44 110.575 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.745 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.59 98.56 3.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 1.59 110.907 -179.742 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.6 mt -83.2 154.7 66.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.9 110.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.33 37.96 5.76 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.056 -1.227 . . . . 1.43 112.835 0.297 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -167.19 79.46 0.2 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 2.66 111.305 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -152.92 -169.71 18.42 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.932 -0.576 . . . . 1.12 111.85 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.776 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.2 159.75 42.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.138 0.494 . . . . 2.41 111.278 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.948 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 70.0 m95 -64.52 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.65 111.017 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.776 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -116.69 128.49 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.351 -0.386 . . . . 1.28 111.086 -179.813 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.89 117.57 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 1.3 111.234 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.812 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -95.86 -33.72 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.86 110.811 179.702 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.3 p-10 -47.64 -59.12 3.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 2.01 111.558 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.41 37.76 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 2.08 111.181 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -145.44 20.37 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.89 111.422 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.71 116.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.999 0.428 . . . . 1.87 111.262 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.73 HD12 ' CD1' ' A' ' 61' ' ' PHE . 15.4 mm -105.4 85.04 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.69 111.324 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.12 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 1.6 110.45 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.22 176.72 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 1.54 110.35 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -95.74 32.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 1.75 111.746 -179.616 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -131.58 97.85 4.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.727 -0.471 . . . . 2.05 109.727 179.513 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CD1' HD12 ' A' ' 56' ' ' ILE . 83.3 t80 -133.29 163.16 29.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.259 0.552 . . . . 0.48 111.927 -179.345 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.528 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 46.0 m -130.25 112.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.175 -0.92 . . . . 0.42 110.824 179.152 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.701 HG23 HD21 ' A' ' 20' ' ' LEU . 5.0 t -72.06 119.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.08 111.05 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.78 142.47 46.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.923 -0.58 . . . . 1.33 110.992 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.18 5.44 6.17 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.786 -0.721 . . . . 0.9 112.798 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -71.92 -172.54 0.86 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.071 0.435 . . . . 1.47 110.929 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -142.12 147.26 36.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 1.06 111.017 -179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 5.8 tt0 -63.82 138.53 58.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 1.91 111.455 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.14 57.68 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 1.87 111.008 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.62 118.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.182 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.34 123.73 22.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.36 110.464 179.563 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 37.8 m-85 -119.12 127.93 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.583 0.586 . . . . 0.56 112.583 -178.875 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.2 tt0 -104.32 145.88 29.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.9 -0.778 . . . . 1.5 108.9 178.641 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -142.45 130.04 21.41 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.228 1.195 . . . . 0.6 114.228 -179.186 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -115.67 -178.85 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.684 -0.689 . . . . 2.11 109.814 178.312 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG23 ' CG ' ' A' ' 8' ' ' PRO . 39.5 t -132.56 110.35 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.132 -0.627 . . . . 0.6 112.632 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 39' ' ' GLU . 59.2 mt -105.48 142.17 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.067 -1.457 . . . . 0.7 107.067 177.514 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -150.66 -171.23 3.87 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.765 -0.774 . . . . 0.6 111.655 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 33' ' ' ILE . 7.1 mttt -129.78 -175.38 3.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 1.98 109.705 179.419 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.899 ' ND2' HD11 ' A' ' 2' ' ' ILE . 4.4 m-80 -132.9 162.07 32.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.978 0.418 . . . . 2.19 111.464 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.36 -28.69 0.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 1.08 112.544 -179.706 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -85.87 -7.6 58.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.709 0.633 . . . . 1.06 112.709 -179.125 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 102.91 -16.71 54.09 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.241 -0.981 . . . . 0.93 112.458 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.18 161.92 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 1.38 109.93 179.731 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -115.73 98.5 6.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.79 111.583 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -54.09 116.58 10.69 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 179.237 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.58 168.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.938 2.425 . . . . 0.85 113.072 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 22.5 Cg_exo -65.15 121.54 9.03 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.937 2.425 . . . . 0.76 113.281 -179.651 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -78.35 124.2 27.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.663 -0.699 . . . . 1.28 109.233 179.021 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 mm-40 -22.68 117.97 0.17 Allowed Pre-proline 0 N--CA 1.479 0.986 0 O-C-N 124.015 0.822 . . . . 1.77 113.084 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.4 Cg_exo -60.28 163.72 14.18 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.881 2.387 . . . . 0.55 113.999 -179.233 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.451 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.94 147.78 24.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.207 -0.906 . . . . 1.23 109.661 179.317 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -36.73 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 124.016 0.823 . . . . 1.63 111.86 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -87.9 111.16 21.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.969 -0.559 . . . . 0.41 111.494 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.552 HG22 ' SG ' ' A' ' 97' ' ' CYS . 4.5 mp -84.06 110.56 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.44 110.516 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -46.09 -38.35 7.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.014 0.435 . . . . 0.44 110.645 179.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 95' ' ' ILE . 70.8 m 59.37 68.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 1.1 110.189 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -103.64 -77.61 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 3.0 111.288 -179.265 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.469 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 33.8 p30 -138.49 17.81 2.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.884 -0.598 . . . . 2.14 111.034 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.917 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.258 0 CA-C-O 121.376 0.608 . . . . 2.06 111.653 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.961 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.1 tt . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.762 0.315 . . . . 0.68 111.45 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -117.84 133.82 23.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 2.0 111.148 -179.653 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.0 146.15 12.71 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.482 2.121 . . . . 0.5 112.176 179.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 77.6 Cg_exo -46.41 159.7 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.282 2.655 . . . . 0.71 114.011 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.39 -158.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.136 -0.938 . . . . 0.66 112.802 179.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.24 124.62 69.88 Favored Pre-proline 0 C--O 1.233 0.193 0 N-CA-C 110.684 -0.117 . . . . 1.52 110.684 179.728 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HD3' ' A' ' 7' ' ' LYS . 5.5 Cg_exo -74.13 117.12 4.88 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.472 2.114 . . . . 0.44 111.633 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 111.84 26.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.189 -0.46 . . . . 1.09 110.438 -179.827 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 80.5 Cg_exo -33.84 145.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.839 2.359 . . . . 0.64 113.581 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.28 HD12 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -107.76 -41.74 4.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.402 -1.272 . . . . 1.64 108.932 -179.941 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.435 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -164.35 107.77 0.93 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.497 -1.229 . . . . 0.72 110.135 179.903 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.995 HG22 HG13 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -88.56 102.27 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.6 -0.727 . . . . 0.96 111.877 -179.75 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -91.51 43.53 1.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.453 -0.794 . . . . 1.46 111.079 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.454 ' C ' ' HG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER 55.61 -74.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.591 -0.731 . . . . 2.42 112.287 179.269 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-70 -74.27 -27.67 60.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 1.02 111.053 -179.251 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -129.08 104.09 7.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.007 -0.542 . . . . 0.68 109.621 179.312 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 13' ' ' ILE . 73.8 t -89.44 114.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.949 -0.568 . . . . 0.8 111.548 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 70.4 m -88.41 148.81 24.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.931 0.396 . . . . 0.35 111.425 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.68 158.7 42.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.44 -0.8 . . . . 0.52 111.269 179.628 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.044 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.0 142.16 28.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.84 110.225 179.593 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 11.6 p90 -125.05 -174.06 2.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.871 0.367 . . . . 0.4 111.941 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -94.25 -23.04 18.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.984 -0.553 . . . . 0.83 112.47 -179.352 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER 75.39 166.03 0.13 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.403 -179.387 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 59.8 Cg_endo -70.59 -173.85 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.89 112.785 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -129.71 -40.11 1.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 2.77 111.359 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -93.58 -70.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.938 -0.305 . . . . 1.37 111.268 -179.858 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 7.4 p 58.43 42.44 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.91 110.907 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.601 -0.809 . . . . 1.01 112.337 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.15 30.5 2.53 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.478 -1.049 . . . . 0.98 110.478 179.164 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -114.55 171.57 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -0.659 . . . . 0.87 111.097 -178.845 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 4.15 3.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.183 -0.462 . . . . 2.26 111.75 179.44 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.3 mt 55.01 117.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 CA-C-O 121.362 0.601 . . . . 1.71 112.21 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 p -98.38 -11.53 22.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.47 -0.787 . . . . 1.15 110.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.68 138.01 4.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.807 0.337 . . . . 1.58 111.562 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 33' ' ' ILE . 93.1 m-85 -108.21 115.25 29.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.76 110.945 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -95.77 106.46 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.337 -0.392 . . . . 1.14 110.66 179.65 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.65 135.88 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.41 0.624 . . . . 0.63 111.475 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 4.9 mt-10 -91.13 143.9 26.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.872 -1.058 . . . . 1.67 110.845 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.896 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -108.57 151.58 25.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.007 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.547 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -132.11 102.82 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 1.44 110.527 179.709 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.83 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -77.17 96.28 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.341 -0.39 . . . . 1.59 110.548 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.3 mm? -75.12 147.31 83.18 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.9 110.687 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -90.38 3.66 68.12 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.942 -1.274 . . . . 1.43 113.226 0.304 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -125.38 74.67 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 2.66 110.913 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -136.96 -177.76 15.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.686 . . . . 1.12 112.644 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 140.82 17.52 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.034 0.445 . . . . 2.41 110.698 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.522 ' NE1' ' CZ ' ' A' ' 41' ' ' ARG . 64.6 m95 -55.11 104.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.625 -0.716 . . . . 0.65 110.818 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -136.77 117.36 13.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 1.28 110.67 179.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HB3' HG22 ' A' ' 37' ' ' ILE . 3.1 ptmm? -45.45 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.942 -0.572 . . . . 1.3 111.339 -179.661 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.9 -17.49 61.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.86 111.244 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.705 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.9 p-10 -81.94 113.05 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 2.01 110.817 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.69 25.44 11.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.206 -0.452 . . . . 2.08 110.659 179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -125.9 -160.91 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 1.89 110.806 -179.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 88.5 2.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 1.87 111.177 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 61' ' ' PHE . 12.8 mt -75.74 62.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.69 111.065 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.29 -75.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.988 -0.551 . . . . 1.6 111.095 -179.894 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -179.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 1.54 110.721 179.822 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 33.3 p30 -93.98 17.01 13.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.75 111.361 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.28 ' OE2' HD12 ' A' ' 11' ' ' LEU . 3.1 tp10 -118.34 108.29 14.9 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.897 -0.409 . . . . 2.05 109.897 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.765 ' HB2' HG23 ' A' ' 56' ' ' ILE . 61.7 t80 -141.12 165.56 27.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.097 0.475 . . . . 0.48 111.379 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 12.0 m -127.37 115.74 19.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.703 -0.681 . . . . 0.42 110.769 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 51' ' ' ALA . 22.6 t -75.42 139.16 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.67 -0.696 . . . . 1.08 111.382 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.5 p -124.11 -171.08 2.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.738 -0.664 . . . . 1.33 110.607 179.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.88 90.09 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.59 -0.732 . . . . 0.9 112.479 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 3.6 mp -71.23 163.91 26.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.336 0.589 . . . . 1.47 111.839 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -128.73 112.19 13.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 1.06 109.809 179.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 7.8 tt0 -41.23 150.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.557 . . . . 1.91 112.453 -179.09 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.845 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 73.18 39.84 0.58 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.398 -0.819 . . . . 1.87 110.782 -179.867 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.39 135.16 7.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.49 111.352 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.69 129.41 37.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.191 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.708 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 49.4 m-85 -124.34 118.21 26.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.063 0.394 . . . . 0.56 112.063 -179.5 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.4 mt-10 -101.39 135.4 42.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 1.5 109.139 179.072 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -130.53 122.1 26.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.895 1.443 . . . . 0.6 114.895 -178.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -104.54 154.48 19.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.505 -0.924 . . . . 2.11 108.505 177.254 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -114.24 119.13 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 119.323 -0.951 . . . . 0.6 113.41 -179.243 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 86' ' ' SER . 61.3 mt -111.25 150.64 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.018 -1.446 . . . . 0.7 107.423 178.323 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.14 127.54 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.066 -1.053 . . . . 0.6 113.278 -179.642 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.19 80.12 9.32 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.733 -0.839 . . . . 1.98 108.733 178.185 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 18.1 m-20 -17.1 -92.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 113.88 -1.509 . . . . 2.19 114.339 -178.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -128.61 -48.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.051 0.759 . . . . 1.08 113.051 -179.101 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.93 43.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.264 0.468 . . . . 1.06 112.264 -178.819 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 76.43 -3.13 55.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.462 -0.875 . . . . 0.93 113.246 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.961 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -58.93 85.98 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.111 0.455 . . . . 1.38 109.946 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -66.47 117.2 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.086 -0.506 . . . . 0.79 112.344 -179.083 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.2 t -80.69 110.61 17.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 107.669 -1.234 . . . . 0.59 107.669 178.346 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.45 162.79 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.403 2.069 . . . . 0.85 113.185 -178.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 75' ' ' ARG . 63.4 Cg_exo -36.18 91.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.32 2.68 . . . . 0.76 113.288 -179.728 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 76' ' ' VAL . 52.9 p -73.13 99.0 2.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.657 -0.417 . . . . 1.28 110.707 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 mt-10 18.61 107.66 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 124.688 1.242 . . . . 1.77 113.917 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 98.5 Cg_exo -44.87 177.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.498 2.132 . . . . 0.55 113.741 179.483 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -113.15 140.52 47.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.225 -1.352 . . . . 1.23 108.764 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.736 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -36.94 134.42 0.52 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.638 0.586 . . . . 1.63 111.634 -179.925 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.18 107.92 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.41 110.966 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -91.05 112.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.878 0.37 . . . . 0.44 110.882 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.1 m -59.03 -23.79 62.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.892 -0.594 . . . . 0.44 111.174 -179.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.454 ' HG ' ' C ' ' A' ' 15' ' ' ARG . 18.9 t 56.02 101.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.14 0.495 . . . . 1.1 110.218 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -77.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 3.0 109.638 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -106.35 21.36 17.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.267 -0.879 . . . . 2.14 110.099 179.019 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.1 p30 . . . . . 0 C--O 1.231 0.101 0 CA-C-N 115.983 -0.553 . . . . 2.06 111.03 -179.639 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.623 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.7 tt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.928 0.394 . . . . 0.68 111.406 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.88 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.46 128.24 28.64 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.423 179.798 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.45 173.1 14.77 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.5 112.926 -179.54 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 33.7 Cg_exo -58.91 177.46 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.052 2.501 . . . . 0.71 113.172 -179.577 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.62 22.13 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.66 112.734 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -85.48 122.3 73.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.301 0.096 . . . . 1.52 111.102 -179.897 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 4.2 Cg_exo -76.95 134.08 14.34 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.498 2.132 . . . . 0.44 111.69 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 9.3 t -141.09 120.07 8.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.951 0.352 . . . . 1.09 111.951 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.61 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.3 Cg_exo -65.78 102.21 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.683 2.256 . . . . 0.64 112.92 -179.956 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -60.21 -45.27 93.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.847 -0.797 . . . . 1.64 108.847 179.046 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.17 138.27 54.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.741 -1.118 . . . . 0.72 108.426 178.718 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -133.64 99.05 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.094 -0.642 . . . . 0.96 112.203 -179.331 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.39 148.97 23.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.46 110.079 179.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -60.93 -13.66 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.979 0.363 . . . . 2.42 111.979 -179.412 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.677 ' O ' HG23 ' A' ' 17' ' ' THR . 1.9 m-70 -134.68 31.45 3.37 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.673 0.273 . . . . 1.02 111.656 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 64' ' ' SER . 0.3 OUTLIER 162.14 125.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.627 -0.508 . . . . 0.68 109.627 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.028 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.8 m -120.4 149.41 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.269 -0.572 . . . . 0.8 111.492 179.774 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.633 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 m -120.73 123.44 42.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.35 111.046 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.881 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -129.56 161.71 29.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.808 0.813 . . . . 0.52 112.48 179.647 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.934 ' HG2' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -133.55 168.78 18.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.212 -1.358 . . . . 1.84 110.153 179.853 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.6 p90 -158.03 172.38 18.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.426 . . . . 0.4 111.304 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.12 139.77 30.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.877 -0.601 . . . . 0.83 111.964 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -79.04 140.93 57.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 2.11 109.733 179.274 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' THR . 10.5 Cg_endo -53.14 -175.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.215 1.943 . . . . 0.89 111.619 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.3 -37.56 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.379 . . . . 2.77 111.55 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.88 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 5.5 t80 -95.03 -71.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.551 -0.295 . . . . 1.37 111.579 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.877 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 68.9 p 49.59 43.76 24.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.971 0.415 . . . . 0.91 110.509 -179.448 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.24 -93.89 0.01 OUTLIER Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.996 -0.547 . . . . 1.01 112.614 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -142.48 39.71 1.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.057 -0.817 . . . . 0.98 111.057 179.537 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -124.5 176.99 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.529 -0.336 . . . . 0.87 110.909 -179.05 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.75 3.59 3.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.27 -0.423 . . . . 2.26 111.775 179.66 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.7 mt 58.77 117.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 121.091 0.472 . . . . 1.71 111.241 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.414 ' C ' ' HG ' ' A' ' 35' ' ' SER . 1.5 p -102.73 11.19 37.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.658 . . . . 1.15 111.731 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -168.62 170.92 9.18 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.037 0.446 . . . . 1.58 111.502 -179.92 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.6 m-85 -154.06 75.47 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.534 -0.757 . . . . 0.76 109.917 179.578 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -50.14 144.11 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.564 -0.744 . . . . 1.14 111.497 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.879 HG11 HG21 ' A' ' 63' ' ' VAL . 3.6 t -129.23 107.01 14.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.348 -0.387 . . . . 0.63 111.407 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -93.2 149.03 21.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.092 -0.504 . . . . 1.67 110.431 179.735 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -115.49 139.62 49.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.196 0.522 . . . . 1.97 112.116 179.737 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -112.37 96.34 5.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.185 -0.916 . . . . 1.44 108.622 178.304 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.769 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -67.89 105.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 1.59 110.798 -179.136 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' HD2' ' A' ' 41' ' ' ARG . 10.6 mt -76.73 150.72 81.99 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.857 -0.61 . . . . 0.9 111.147 -179.807 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -87.89 9.05 64.13 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.756 -1.352 . . . . 1.43 113.179 0.281 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -80.5 -88.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 2.66 110.49 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . 115.72 175.37 18.13 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.647 -0.787 . . . . 1.12 113.568 179.258 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.8 -25.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.267 0.227 . . . . 2.41 111.381 -179.923 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 85.4 m95 50.81 87.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.793 0.33 . . . . 0.65 111.065 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -125.77 127.96 46.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.365 . . . . 1.28 111.018 179.589 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 50' ' ' LYS . 16.8 ptmt -54.16 109.86 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 1.3 110.905 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . . . -81.77 -35.95 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.86 110.709 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.522 ' CG ' HD11 ' A' ' 56' ' ' ILE . 1.2 t30 -48.36 -62.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 2.01 110.661 179.976 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 51.61 37.18 19.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 2.08 111.101 179.761 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 t -145.02 -82.91 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 1.89 110.811 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 172.85 120.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 1.87 111.192 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.858 HD12 ' CD1' ' A' ' 61' ' ' PHE . 8.2 mm -103.46 69.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.69 110.8 179.756 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -53.98 -46.48 71.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 1.6 110.259 179.912 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.702 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pt-20 -99.61 154.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 1.54 109.996 179.571 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -68.21 -9.55 47.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.468 -0.333 . . . . 1.75 111.414 179.98 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.934 ' OE1' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tp10 -93.59 98.61 11.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.836 -0.431 . . . . 2.05 109.836 179.711 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.858 ' CD1' HD12 ' A' ' 56' ' ' ILE . 70.4 t80 -133.98 164.01 28.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.103 0.478 . . . . 0.48 111.566 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.531 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 19.2 m -117.38 116.44 27.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.626 -0.716 . . . . 0.42 110.808 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.881 HG23 HD21 ' A' ' 20' ' ' LEU . 65.1 t -86.53 96.38 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.0 0.428 . . . . 1.08 110.471 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 17' ' ' THR . 1.2 p -85.59 158.54 20.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.33 110.373 179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.5 -8.4 8.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.347 -0.842 . . . . 0.9 111.793 -179.304 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 18' ' ' VAL . 3.3 mm? -44.7 171.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.096 0.474 . . . . 1.47 111.356 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.6 m -147.59 123.86 10.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.868 -0.605 . . . . 1.06 110.714 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.1 mt-10 -48.43 137.14 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 1.91 111.191 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER 61.12 46.77 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 1.87 111.523 179.905 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -156.81 122.51 4.78 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.49 111.526 179.791 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.57 135.71 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.36 110.086 179.318 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CD1' ' NZ ' ' A' ' 40' ' ' LYS . 42.5 m-85 -131.56 126.71 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.769 0.655 . . . . 0.56 112.769 -178.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.8 mt-10 -106.56 139.28 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.868 -0.789 . . . . 1.5 108.868 178.354 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.028 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.65 114.99 19.41 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.367 1.247 . . . . 0.6 114.367 -178.52 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.3 ttp85 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.119 -0.492 . . . . 2.11 111.247 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 89' ' ' SER . 58.6 t -100.16 134.39 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.32 0.581 . . . . 0.6 111.0 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -132.48 149.55 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.563 -1.273 . . . . 0.7 107.563 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -171.3 141.26 1.56 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.079 -1.048 . . . . 0.6 112.526 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.2 mttt -82.1 -123.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 1.98 110.65 179.634 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.623 ' ND2' HD12 ' A' ' 2' ' ' ILE . 54.5 p30 -170.02 -122.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.394 0.543 . . . . 2.19 109.583 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -129.0 -1.16 5.24 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.432 1.014 . . . . 1.08 112.085 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.13 -1.32 14.42 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.894 0.331 . . . . 1.06 111.894 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.75 -19.53 41.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.014 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.588 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -61.41 158.53 14.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.949 -0.389 . . . . 1.38 109.949 179.742 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.7 tt -120.99 118.18 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.09 0.774 . . . . 0.79 113.09 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -74.02 111.93 14.56 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 107.205 -1.406 . . . . 0.59 107.205 177.835 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.444 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 18.7 Cg_endo -57.86 170.82 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.149 2.566 . . . . 0.85 114.557 -178.051 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 7.6 Cg_exo -32.48 142.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.385 3.39 . . . . 0.76 113.821 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.9 m -131.24 104.74 7.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.518 -0.764 . . . . 1.28 110.243 179.185 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 3.6 110.27 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.872 1.269 . . . . 1.77 113.568 -179.974 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.515 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 23.9 Cg_exo -63.71 153.19 76.78 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.55 114.421 -179.3 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.96 145.94 44.28 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.945 -1.025 . . . . 1.23 109.491 179.023 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -34.71 154.5 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 O-C-N 124.135 0.897 . . . . 1.63 112.207 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.21 111.23 19.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.48 179.252 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.826 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -94.2 111.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.914 -0.314 . . . . 0.44 111.391 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' ALA . 12.4 m -48.37 -30.53 5.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.72 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.683 ' SG ' HD12 ' A' ' 66' ' ' LEU . 82.5 m 49.85 86.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.065 -0.516 . . . . 1.1 111.088 179.678 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 -84.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.34 -0.391 . . . . 3.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.92 -11.61 20.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.059 -0.519 . . . . 2.14 111.011 179.469 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.417 -0.356 . . . . 2.06 111.562 179.642 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 80' ' ' ASN . 1.2 tt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.84 0.352 . . . . 0.68 110.714 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -130.56 131.89 23.63 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 2.0 110.738 179.83 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 162.43 28.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.435 2.09 . . . . 0.5 112.509 -179.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.2 Cg_endo -57.09 -179.56 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.01 2.474 . . . . 0.71 112.554 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.29 -161.83 8.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.869 -0.681 . . . . 0.66 112.813 -179.794 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.94 118.88 70.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.559 -0.163 . . . . 1.52 110.559 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 36.7 Cg_exo -62.52 133.77 44.44 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.54 2.16 . . . . 0.44 112.74 -179.84 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.0 104.91 9.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.02 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 47.0 Cg_exo -51.01 99.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.261 1.974 . . . . 0.64 113.206 -179.594 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mt -55.56 -37.21 67.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.054 -0.721 . . . . 1.64 109.054 179.065 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 4.2 t30 -136.5 153.72 50.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.765 -1.107 . . . . 0.72 108.648 179.007 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.278 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 3.6 pt -143.78 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.402 -0.519 . . . . 0.96 112.208 -179.004 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.625 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -94.7 137.91 33.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 1.46 110.117 179.412 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -40.47 -26.11 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.359 0.874 . . . . 2.42 113.359 -178.9 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -115.53 -19.96 10.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.53 -0.468 . . . . 1.02 111.966 -179.848 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' HD22 ' A' ' 66' ' ' LEU . 49.9 p -147.8 122.26 9.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.555 0.216 . . . . 0.68 110.659 -179.843 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 ' CD2' ' A' ' 66' ' ' LEU . 17.7 m -111.04 125.59 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.954 0.353 . . . . 0.8 111.954 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 47.2 m -87.05 144.53 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.35 110.035 179.083 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.758 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -143.91 151.45 39.83 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.82 0.7 . . . . 0.52 112.521 -179.885 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.878 ' HB2' HD11 ' A' ' 11' ' ' LEU . 19.3 tptp -144.66 148.15 33.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.765 -1.107 . . . . 1.84 110.091 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.2 p90 -140.87 -176.51 4.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.4 112.248 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.44 -159.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.384 -0.825 . . . . 0.83 111.068 179.956 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -130.83 142.42 45.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.158 179.952 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.76 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 88.2 Cg_exo -43.96 171.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.349 2.033 . . . . 0.89 112.458 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.76 ' OE1' ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -106.92 -42.16 5.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 2.77 112.059 -179.608 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -118.03 -70.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.218 0.451 . . . . 1.37 112.218 -179.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.4 p 60.31 46.23 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.91 110.454 -179.253 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.71 -109.63 0.35 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.814 -0.708 . . . . 1.01 112.193 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.69 31.9 3.45 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.525 -1.03 . . . . 0.98 110.525 179.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.38 -177.59 3.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.098 -0.551 . . . . 0.87 111.468 -178.908 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 15.38 1.44 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 2.26 111.743 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 ' CZ ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER 61.05 152.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.551 0.215 . . . . 1.71 111.27 179.699 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -140.5 8.26 2.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.548 0.573 . . . . 1.15 112.548 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 t -178.06 125.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 1.58 110.979 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.691 ' O ' HD12 ' A' ' 56' ' ' ILE . 7.7 m-85 -108.64 98.14 7.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.76 111.553 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.653 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -91.21 124.72 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 1.14 110.157 179.477 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -110.18 119.1 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.63 111.538 -179.507 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.91 137.45 43.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.402 -0.817 . . . . 1.67 109.397 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HD2' ' CD1' ' A' ' 72' ' ' TYR . 3.9 ttpm? -104.1 146.32 28.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.344 -0.389 . . . . 1.97 110.348 -179.226 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' HG2' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.75 86.55 2.46 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.05 0.452 . . . . 1.44 110.579 179.711 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.857 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -62.36 86.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.509 -0.769 . . . . 1.59 110.612 -179.828 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.71 HD12 ' CB ' ' A' ' 94' ' ' ALA . 76.5 mt -66.36 149.02 98.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.974 -0.557 . . . . 0.9 111.049 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -93.23 27.38 18.68 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.893 -1.295 . . . . 1.43 112.719 0.337 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.25 45.16 2.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.512 -0.313 . . . . 2.66 111.369 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -87.28 179.0 48.03 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.474 -0.87 . . . . 1.12 112.344 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.79 31.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 2.41 110.952 -179.727 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 53.4 m95 45.32 74.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.65 111.236 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.3 mp -109.31 133.08 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 1.28 111.016 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.653 ' HD2' HG21 ' A' ' 37' ' ' ILE . 8.4 mtmm -50.17 98.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.046 -0.524 . . . . 1.3 110.79 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -64.73 -53.56 45.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.86 110.772 -179.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.7 p-10 -71.0 129.12 38.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.873 179.843 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -124.62 34.92 4.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.077 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 m -130.41 -84.93 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 1.89 110.923 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.37 118.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 1.87 110.964 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.9 mt -109.04 74.34 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.69 110.968 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -56.74 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 1.6 111.001 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.94 -178.48 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.547 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.9 p30 -92.56 2.88 56.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 1.75 111.672 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -102.98 101.82 11.83 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.524 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HB2' HG23 ' A' ' 56' ' ' ILE . 72.8 t80 -135.06 163.92 28.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.48 111.44 -179.454 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 80.2 m -125.63 125.22 42.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.42 110.387 179.345 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.758 ' CG2' HD11 ' A' ' 20' ' ' LEU . 17.0 t -83.43 90.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.208 0.527 . . . . 1.08 111.691 -179.355 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -92.46 137.9 31.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 1.33 110.623 179.784 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.83 -5.61 7.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.9 112.456 -179.642 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.018 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -48.91 -179.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.121 0.486 . . . . 1.47 111.591 179.807 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -141.19 118.72 11.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 1.06 110.132 179.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -45.59 155.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 1.91 111.483 -179.561 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.0 m-20 52.87 55.03 9.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 1.87 111.175 -179.884 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.71 121.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.49 111.296 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.15 138.03 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.92 -0.4 . . . . 0.36 109.92 179.481 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.8 m-85 -128.83 112.97 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.713 1.005 . . . . 0.56 113.713 -178.37 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.6 tt0 -102.35 134.7 45.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.234 -1.024 . . . . 1.5 108.234 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.35 125.89 19.06 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.819 1.415 . . . . 0.6 114.819 -178.644 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -103.62 165.49 11.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.257 -0.883 . . . . 2.11 109.025 178.202 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -131.68 122.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 113.487 0.921 . . . . 0.6 113.487 179.688 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 86' ' ' SER . 29.4 mt -106.59 147.91 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.667 -1.606 . . . . 0.7 107.486 177.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -159.16 112.78 2.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.152 -1.019 . . . . 0.6 112.688 -179.412 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 mttp -56.21 -175.87 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.31 -0.626 . . . . 1.98 109.31 178.64 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.5 m120 -133.52 170.78 15.01 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.858 -0.337 . . . . 2.19 110.559 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.1 -27.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.58 0.585 . . . . 1.08 112.58 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -106.6 14.68 26.7 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 1.06 112.852 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.96 -18.07 46.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.465 -0.874 . . . . 0.93 112.947 179.659 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.5 105.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 1.38 110.903 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -68.98 97.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.79 111.65 -179.462 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' ILE . 21.5 p -60.38 111.54 4.17 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 120.203 -0.599 . . . . 0.59 109.939 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.18 146.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.758 2.305 . . . . 0.85 112.683 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 1.6 Cg_endo -46.52 140.57 11.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.691 2.26 . . . . 0.76 112.807 -179.665 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 90' ' ' GLU . 2.0 m -96.42 108.67 21.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.811 . . . . 1.28 110.386 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -2.95 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.715 1.206 . . . . 1.77 113.748 -179.935 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 78.3 Cg_exo -46.73 139.36 13.93 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.328 2.019 . . . . 0.55 113.28 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -76.27 147.41 38.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.893 -0.594 . . . . 1.23 109.51 179.338 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -39.08 147.1 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.967 0.792 . . . . 1.63 111.577 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.79 117.22 18.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.719 -0.673 . . . . 0.41 111.261 -179.71 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.711 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -95.48 113.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.597 179.408 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.431 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 84.5 m -51.82 -32.96 33.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 0.44 111.036 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 69' ' ' ASP . 3.6 m 54.57 89.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.138 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -129.21 -78.0 0.56 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.223 0.535 . . . . 3.0 110.69 -179.803 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.19 0.98 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.49 -0.777 . . . . 2.14 111.052 179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.278 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.784 0.326 . . . . 2.06 111.244 -179.706 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.457 HD12 ' OD1' ' A' ' 80' ' ' ASN . 2.8 tt . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.955 0.407 . . . . 0.68 111.238 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.12 125.95 20.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 2.0 110.497 179.982 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 161.18 41.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.357 2.038 . . . . 0.5 112.324 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.42 -173.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.792 2.328 . . . . 0.71 112.969 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -78.02 -154.13 6.84 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.66 113.017 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -94.36 141.83 24.05 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.293 0.092 . . . . 1.52 110.932 -179.83 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.662 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.4 Cg_endo -83.34 127.11 4.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.901 2.401 . . . . 0.44 112.411 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.99 102.75 10.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.09 110.97 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.9 Cg_exo -37.05 140.13 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.818 2.345 . . . . 0.64 112.88 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.39 -28.76 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.151 -179.769 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.45 109.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.797 -0.638 . . . . 0.72 109.911 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.747 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -106.6 148.51 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.714 1.005 . . . . 0.96 113.714 -178.883 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.437 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -141.38 165.88 26.29 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.197 -0.91 . . . . 1.46 110.867 179.382 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.19 ' HD2' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -42.69 -41.72 3.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.241 -0.891 . . . . 2.42 112.865 -179.44 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.5 m-70 -132.87 27.46 4.27 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.938 0.718 . . . . 1.02 112.938 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.693 ' N ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -166.3 112.74 0.85 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.499 -0.48 . . . . 0.68 111.354 179.04 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.032 HG13 HD22 ' A' ' 66' ' ' LEU . 1.7 m -110.61 127.64 67.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 C-N-CA 120.156 -0.618 . . . . 0.8 111.82 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.5 m -97.81 144.61 27.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.307 -0.627 . . . . 0.35 109.307 179.161 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.86 152.98 39.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.413 0.625 . . . . 0.52 112.323 -179.732 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -133.24 137.71 46.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.007 -0.997 . . . . 1.84 110.238 179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.7 p90 -138.0 178.25 7.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 0.4 111.062 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.443 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.0 -167.78 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.83 110.899 179.816 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.15 161.58 60.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.849 0.357 . . . . 2.11 111.129 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.652 ' HB2' HG23 ' A' ' 28' ' ' THR . 31.4 Cg_exo -59.66 -177.67 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.878 2.386 . . . . 0.89 113.192 -179.568 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.17 7.51 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.536 179.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.685 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 20.8 t80 -142.84 -67.37 0.37 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.369 . . . . 1.37 110.858 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' PRO . 50.8 p 48.23 44.92 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 0.91 110.776 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.61 -102.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 1.01 112.254 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.05 26.68 4.18 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.204 -0.759 . . . . 0.98 111.204 179.234 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -115.03 -174.57 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.87 111.055 -179.34 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.8 ttpt -145.04 25.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 2.26 110.833 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.856 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.2 mm 60.77 148.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 1.71 110.712 -179.897 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -135.46 17.93 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.266 -0.424 . . . . 1.15 111.025 179.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.654 ' H ' HG22 ' A' ' 33' ' ' ILE . 7.1 t 170.55 160.34 0.07 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.156 0.503 . . . . 1.58 111.383 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 33' ' ' ILE . 37.8 m-85 -137.41 78.49 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 0.76 109.946 179.428 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.818 HG21 ' HE2' ' A' ' 50' ' ' LYS . 12.7 mt -80.66 118.26 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 1.14 111.663 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.586 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -100.19 127.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.266 179.732 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -84.5 131.96 34.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.67 111.375 -179.583 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.666 ' HD3' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -95.23 140.59 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.719 -0.673 . . . . 1.97 112.659 -179.435 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.7 ttt180 -127.34 104.57 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 1.44 110.098 178.527 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.679 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.48 84.96 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 1.59 110.681 -179.79 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.01 154.7 2.41 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.485 -0.779 . . . . 0.9 110.828 -179.96 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.89 15.35 36.5 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 123.875 -1.302 . . . . 1.43 112.951 0.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -117.61 -77.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 2.66 111.111 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . 52.87 -178.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.63 -0.795 . . . . 1.12 112.006 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -163.94 29.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 2.41 111.257 -179.823 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 61.1 m95 47.5 93.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.65 110.92 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.581 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -129.14 131.74 47.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.692 -0.403 . . . . 1.28 111.29 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.818 ' HE2' HG21 ' A' ' 37' ' ' ILE . 17.7 ptpt -63.19 74.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.824 -0.626 . . . . 1.3 111.389 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -55.64 -43.11 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.86 110.26 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.547 ' HB2' HD11 ' A' ' 56' ' ' ILE . 16.5 p-10 -42.07 -46.51 4.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.987 -0.551 . . . . 2.01 111.253 179.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.65 36.84 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 2.08 110.997 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -144.35 -162.99 1.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 1.89 110.624 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -111.58 88.69 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 1.87 110.828 -179.906 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 61' ' ' PHE . 10.2 mm -70.52 67.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.69 111.1 179.861 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.19 -58.88 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 1.6 110.363 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.8 pm0 -76.88 160.67 29.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.173 -0.677 . . . . 1.54 109.173 179.055 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.6 p30 -84.16 10.28 10.64 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.561 -0.456 . . . . 1.75 112.057 -179.651 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.02 98.79 7.01 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.605 . . . . 2.05 109.365 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 56' ' ' ILE . 81.2 t80 -130.02 163.65 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.447 0.641 . . . . 0.48 112.251 -179.041 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 25.7 m -117.15 114.91 24.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.42 110.872 179.232 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HD3' ' A' ' 40' ' ' LYS . 44.8 t -81.65 84.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.777 -0.647 . . . . 1.08 110.739 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.677 ' HB3' HG22 ' A' ' 17' ' ' THR . 51.8 p -83.37 -179.78 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.72 . . . . 1.33 110.673 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.18 -20.83 34.58 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.581 -0.819 . . . . 0.9 112.446 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.032 HD22 HG13 ' A' ' 18' ' ' VAL . 1.3 pp -51.95 179.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.683 0.278 . . . . 1.47 110.482 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 3.0 m -140.55 127.56 20.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 1.06 111.247 -179.482 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -54.52 157.34 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.11 0.481 . . . . 1.91 111.477 -179.877 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.4 OUTLIER 68.84 47.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 1.87 110.649 -179.605 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.9 123.78 0.43 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.49 111.594 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.05 134.16 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.659 -0.497 . . . . 0.36 109.659 179.11 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 43.0 m-85 -127.37 118.22 23.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.819 0.674 . . . . 0.56 112.819 -178.677 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -103.53 139.18 39.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.348 -0.612 . . . . 1.5 109.348 178.709 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.02 127.24 19.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.63 1.344 . . . . 0.6 114.63 -179.438 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -96.59 163.23 13.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.492 -0.777 . . . . 2.11 109.344 178.184 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.662 HG23 ' HG3' ' A' ' 8' ' ' PRO . 60.6 t -115.52 123.5 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 112.807 0.669 . . . . 0.6 112.807 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.05 155.61 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 114.79 -1.095 . . . . 0.7 109.248 179.023 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -165.52 127.77 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.884 -0.726 . . . . 0.6 111.931 179.02 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mttt -77.85 -157.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 1.98 110.358 179.828 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -155.64 162.88 40.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.336 0.589 . . . . 2.19 111.415 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.11 -41.17 1.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 1.08 112.784 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -70.34 -14.12 62.44 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.411 0.523 . . . . 1.06 112.411 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.83 59.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.435 -0.888 . . . . 0.93 112.108 -179.201 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -66.56 170.02 6.83 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.004 -0.369 . . . . 1.38 110.004 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -119.02 120.25 63.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.512 0.56 . . . . 0.79 112.512 -179.294 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.2 p -81.64 118.8 73.58 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.076 -1.083 . . . . 0.59 108.076 178.344 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.47 158.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.761 2.307 . . . . 0.85 113.08 -178.863 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.0 Cg_endo -67.59 162.53 38.74 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.82 2.347 . . . . 0.76 113.896 -179.208 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 m -114.14 135.26 54.23 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.099 -0.955 . . . . 1.28 109.839 179.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -19.69 106.71 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 124.497 1.123 . . . . 1.77 113.48 -179.445 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.483 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 87.6 Cg_exo -43.83 141.79 3.95 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.55 113.222 -179.944 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -76.11 147.13 38.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.626 -0.715 . . . . 1.23 109.817 179.418 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -37.21 146.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 O-C-N 124.207 0.942 . . . . 1.63 111.797 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.78 108.91 11.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.932 -0.576 . . . . 0.41 110.66 179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -86.23 113.44 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.44 110.72 179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 92.6 m -50.89 -46.32 60.53 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.44 110.033 179.748 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 69' ' ' ASP . 2.3 m 57.53 107.76 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.685 -0.689 . . . . 1.1 109.697 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.942 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -140.6 -85.35 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.975 0.417 . . . . 3.0 110.474 -179.602 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.942 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 12.2 p-10 -106.65 32.18 4.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 2.14 109.183 179.245 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.437 ' OD1' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.192 -0.913 . . . . 2.06 111.356 -179.126 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 86' ' ' SER . 13.3 tt . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 121.688 0.756 . . . . 0.68 112.794 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -135.62 109.59 10.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.277 -0.874 . . . . 2.0 110.053 179.903 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.65 153.23 79.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.272 1.981 . . . . 0.5 112.271 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.64 179.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.889 2.392 . . . . 0.71 112.976 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -77.22 -178.22 47.16 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.909 -0.587 . . . . 0.66 113.088 -179.644 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.6 tttt -69.28 136.11 88.95 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.448 0.166 . . . . 1.52 111.276 -179.875 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HG3' HG23 ' A' ' 76' ' ' VAL . 5.1 Cg_exo -75.72 131.34 13.38 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.521 2.148 . . . . 0.44 112.201 179.665 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 21' ' ' LYS . 2.5 p -132.5 100.06 15.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.09 110.797 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 17.3 Cg_exo -52.63 122.66 11.3 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.025 1.816 . . . . 0.64 113.697 -179.234 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -82.95 -31.73 27.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.551 -0.907 . . . . 1.64 108.551 178.347 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.59 138.16 37.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.979 -1.009 . . . . 0.72 108.634 179.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.03 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.43 94.92 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.306 -0.558 . . . . 0.96 112.308 -179.139 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 163.12 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.46 110.133 179.264 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -61.46 -21.38 64.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.36 -0.382 . . . . 2.42 111.944 -179.42 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 17' ' ' THR . 37.4 m170 -126.34 16.02 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 1.02 111.471 179.542 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 ' C ' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -158.68 159.28 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.68 109.826 179.683 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.03 HG13 HG22 ' A' ' 13' ' ' ILE . 82.5 t -156.2 91.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.924 -0.311 . . . . 0.8 111.563 -179.161 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 30.9 m -79.07 145.47 33.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.35 110.363 179.432 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -149.13 161.8 41.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.736 0.779 . . . . 0.52 112.898 -179.072 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.225 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -141.18 142.03 34.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.32 -1.309 . . . . 1.84 109.249 179.213 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 14.7 p90 -137.88 -174.28 3.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.73 0.3 . . . . 0.4 111.145 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -95.63 163.4 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.83 111.267 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -111.56 145.1 31.93 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.108 -0.496 . . . . 2.11 110.077 179.874 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HB2' HG23 ' A' ' 28' ' ' THR . 5.2 Cg_exo -77.82 162.61 29.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.31 2.007 . . . . 0.89 112.169 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -112.78 -22.62 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 2.77 111.192 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -85.01 -72.61 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 1.37 111.137 -179.839 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' HB2' ' A' ' 25' ' ' PRO . 31.7 p 41.4 45.56 2.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.67 -0.241 . . . . 0.91 111.497 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.25 -92.53 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.703 -0.76 . . . . 1.01 112.409 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -153.14 43.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.187 -1.165 . . . . 0.98 110.187 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -123.72 -176.43 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.527 . . . . 0.87 111.368 -178.519 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 21.5 tttt -123.63 -20.28 5.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.084 -0.507 . . . . 2.26 111.975 -179.53 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt 68.51 112.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.688 -0.486 . . . . 1.71 109.688 -178.998 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -114.07 33.13 5.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.917 0.339 . . . . 1.15 111.917 -179.211 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.09 144.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.278 0.473 . . . . 1.58 112.278 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.884 ' O ' HD12 ' A' ' 56' ' ' ILE . 57.0 m-85 -127.48 85.15 2.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.678 . . . . 0.76 110.282 179.243 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -79.76 105.02 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 1.14 111.487 -179.795 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -96.07 138.34 21.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.991 -0.744 . . . . 0.63 108.991 179.065 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 50' ' ' LYS . 6.0 mt-10 -96.76 152.36 18.75 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.052 0.22 . . . . 1.67 110.492 -179.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' A' ' 72' ' ' TYR . 8.8 ttpp -108.42 155.46 20.54 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.417 -0.356 . . . . 1.97 110.651 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.611 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -134.08 103.6 5.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.733 -0.387 . . . . 1.44 110.085 178.993 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HA ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -79.98 83.15 5.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 1.59 110.349 -179.741 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.4 mt -61.24 159.67 28.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.077 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.1 Cg_endo -82.63 24.47 9.08 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 124.561 -1.016 . . . . 1.43 113.775 0.715 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -142.11 -80.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.844 0.354 . . . . 2.66 110.631 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 38.31 -161.9 0.01 OUTLIER Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.925 -0.579 . . . . 1.12 113.7 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -158.44 145.75 17.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.592 -0.522 . . . . 2.41 109.592 179.676 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.611 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 74.7 m95 -63.61 78.59 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.08 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -116.54 106.29 13.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.796 -0.638 . . . . 1.28 111.001 -179.615 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER 20.4 -151.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.82 1.325 . . . . 1.3 113.924 179.303 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.09 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . 175.98 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.001 -0.437 . . . . 0.86 110.451 -179.451 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.618 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.28 -38.04 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 2.01 110.81 -179.969 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 57.75 34.57 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.948 0.351 . . . . 2.08 111.948 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 11.2 t -170.23 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.797 0.295 . . . . 1.89 111.797 179.691 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 10.1 t-20 -165.52 125.64 1.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 1.87 110.412 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 36' ' ' TYR . 25.5 mt -109.86 75.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.69 110.977 -179.916 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.4 tm? -53.22 -70.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 1.6 110.947 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -71.2 170.4 13.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.137 -0.32 . . . . 1.54 110.137 179.639 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 46.8 p-10 -84.69 6.1 25.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 1.75 111.874 -179.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.225 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -115.06 105.57 13.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.134 -0.691 . . . . 2.05 109.134 179.121 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.861 ' HB2' HG23 ' A' ' 56' ' ' ILE . 55.9 t80 -136.7 164.17 28.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.331 0.493 . . . . 0.48 112.331 -178.813 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 91.6 m -115.71 105.64 12.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.42 111.647 179.673 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.09 HG13 ' HB1' ' A' ' 51' ' ' ALA . 73.9 t -75.44 118.79 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.475 -0.784 . . . . 1.08 111.012 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.0 p -123.65 155.0 38.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 1.33 111.371 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.36 -4.03 8.24 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.9 112.862 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 18' ' ' VAL . 6.6 mp -65.81 165.94 11.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.105 0.479 . . . . 1.47 111.866 -179.592 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -121.49 127.38 50.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 1.06 110.347 179.72 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -48.97 145.25 4.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.486 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 97' ' ' CYS . 18.8 t0 68.22 54.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 1.87 111.527 179.576 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.77 120.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.49 111.335 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.56 135.86 53.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.467 -0.333 . . . . 0.36 110.236 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HD2' ' A' ' 40' ' ' LYS . 20.7 m-85 -128.06 123.47 34.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.433 0.901 . . . . 0.56 113.433 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -106.19 140.72 38.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.378 -0.971 . . . . 1.5 108.378 178.119 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.51 129.02 28.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 -178.482 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.82 146.2 28.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.031 -0.531 . . . . 2.11 110.142 178.282 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HB ' ' A' ' 38' ' ' VAL . 44.8 t -99.71 108.78 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.28 -0.568 . . . . 0.6 112.427 -179.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.49 HG12 ' CA ' ' A' ' 88' ' ' PRO . 77.1 mt -101.5 150.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.579 -1.267 . . . . 0.7 107.579 177.768 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -161.51 145.13 12.69 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.073 -1.051 . . . . 0.6 112.505 -179.642 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.4 ptpt -92.66 -161.23 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.555 . . . . 1.98 110.402 179.545 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.8 p-10 -150.46 165.92 31.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.989 0.423 . . . . 2.19 111.233 -179.274 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.47 -26.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 1.08 112.251 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.15 -20.34 21.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.969 0.359 . . . . 1.06 111.969 -179.382 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.62 -1.45 60.04 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.702 -0.761 . . . . 0.93 112.81 -179.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -73.1 76.84 1.24 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.991 0.424 . . . . 1.38 110.421 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -34.24 125.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.79 113.879 -178.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.518 ' HB3' HD11 ' A' ' 2' ' ' ILE . 14.0 p -90.6 124.97 61.07 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.05 -0.977 . . . . 0.59 109.596 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -40.55 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.852 2.368 . . . . 0.85 112.832 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.49 ' CA ' HG12 ' A' ' 77' ' ' ILE . 8.0 Cg_exo -72.21 149.35 51.46 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.804 2.336 . . . . 0.76 112.885 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m -95.2 129.11 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 1.28 109.733 179.349 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.5 tp10 -20.17 103.15 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.991 0 O-C-N 124.494 1.121 . . . . 1.77 112.886 -179.575 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 36.5 Cg_exo -38.12 150.04 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.806 2.337 . . . . 0.55 114.041 -179.443 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.21 145.6 26.32 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.336 -0.847 . . . . 1.23 109.054 178.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -35.12 151.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 124.229 0.956 . . . . 1.63 111.894 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -84.69 121.12 27.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.41 111.251 -179.536 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.8 mp -103.6 112.12 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.44 111.169 179.888 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 88.0 m -42.82 -34.11 0.88 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.965 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.6 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 51.4 82.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 1.1 110.586 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 -81.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.112 0.482 . . . . 3.0 110.761 -179.733 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -117.79 -11.38 10.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.738 -0.664 . . . . 2.14 111.24 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 . . . . . 0 CA--C 1.529 0.172 0 N-CA-C 111.782 0.29 . . . . 2.06 111.782 -179.931 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 86' ' ' SER . 6.8 tt . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 121.065 0.46 . . . . 0.68 111.199 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.95 130.09 23.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.829 -0.623 . . . . 2.0 110.023 179.644 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.59 173.86 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.189 1.926 . . . . 0.5 112.739 -179.453 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 53.1 Cg_exo -54.98 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.201 2.601 . . . . 0.71 113.419 -179.401 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.15 -163.41 39.18 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.759 -0.655 . . . . 0.66 112.773 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.3 tmtt? -78.63 114.83 46.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 110.549 -0.167 . . . . 1.52 110.549 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.682 ' HG2' HG12 ' A' ' 76' ' ' VAL . 20.4 Cg_exo -72.17 149.56 52.1 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.969 2.446 . . . . 0.44 113.487 -179.26 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -146.97 107.99 3.97 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.629 -0.714 . . . . 1.09 111.201 179.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG3' HD22 ' A' ' 20' ' ' LEU . 38.7 Cg_exo -59.06 94.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.508 2.139 . . . . 0.64 113.041 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -51.25 -46.02 62.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.503 0.668 . . . . 1.64 109.454 179.244 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -122.3 150.27 42.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.959 -1.018 . . . . 0.72 108.408 178.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.816 ' HB ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -144.07 80.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.29 -0.564 . . . . 0.96 111.956 -179.219 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.08 156.53 35.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.46 110.288 179.594 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -61.4 -11.84 11.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -179.043 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.792 ' O ' HG23 ' A' ' 17' ' ' THR . 2.3 m-70 -140.07 20.19 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.811 -0.356 . . . . 1.02 111.581 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER 179.14 109.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.68 110.383 179.742 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 ' CD1' ' A' ' 66' ' ' LEU . 25.9 m -108.6 126.16 65.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 0.8 111.364 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.7 m -96.61 137.76 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 0.35 111.054 179.709 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -139.56 164.25 30.4 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.061 0.85 . . . . 0.52 112.426 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.692 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -152.48 153.7 34.04 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.933 -1.031 . . . . 1.84 110.519 179.614 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 31.7 p90 -146.93 -171.5 3.78 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.533 0.568 . . . . 0.4 112.533 -179.462 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.31 -158.37 0.18 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.584 -0.735 . . . . 0.83 110.834 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -142.75 139.21 16.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 2.11 110.475 -179.963 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HB3' HG23 ' A' ' 28' ' ' THR . 84.3 Cg_exo -34.42 148.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.124 2.549 . . . . 0.89 112.778 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.726 ' CA ' ' OE1' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -98.48 11.67 37.51 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 2.77 111.802 -179.592 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -169.95 -66.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.37 111.753 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.2 p 52.05 47.6 24.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.008 0.432 . . . . 0.91 110.197 -179.307 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.29 -108.65 0.23 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.802 -0.713 . . . . 1.01 112.31 -179.758 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.39 29.56 4.03 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.784 -0.926 . . . . 0.98 110.784 179.176 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -114.74 -174.48 2.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.13 -0.535 . . . . 0.87 110.814 -178.967 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.0 pttt -143.08 32.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 2.26 111.594 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.838 HG21 ' CE1' ' A' ' 36' ' ' TYR . 7.7 mm 65.56 -71.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 1.71 111.365 179.861 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.59 -10.18 1.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.634 0.605 . . . . 1.15 112.634 179.63 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.808 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t -179.65 140.93 0.15 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.763 -0.375 . . . . 1.58 111.995 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.838 ' CE1' HG21 ' A' ' 33' ' ' ILE . 69.2 m-85 -116.59 138.73 51.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.76 110.852 179.409 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 5.0 mt -116.43 129.32 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.446 -0.343 . . . . 1.14 110.423 179.707 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.57 113.52 44.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.814 0.34 . . . . 0.63 111.813 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 50.8 mt-10 -83.02 132.85 35.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 1.67 110.151 179.271 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.664 ' CE ' HD23 ' A' ' 66' ' ' LEU . 2.1 tttp -95.42 128.14 42.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 113.554 0.946 . . . . 1.97 113.554 -178.426 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -108.52 95.16 5.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.873 -0.603 . . . . 1.44 110.196 178.539 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 1.099 ' OD2' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -64.17 142.17 58.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.15 -0.477 . . . . 1.59 109.753 179.619 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 94' ' ' ALA . 29.9 mt -123.71 133.11 24.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.754 -0.378 . . . . 0.9 110.919 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 66.8 Cg_endo -90.96 47.7 1.32 Allowed 'Cis proline' 0 C--N 1.351 0.689 0 C-N-CA 124.28 -1.134 . . . . 1.43 113.125 0.495 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 42' ' ' ASP . 1.7 m120 -127.13 57.5 1.47 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 2.66 110.801 -179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -42.65 160.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.044 -0.526 . . . . 1.12 113.42 -179.634 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 1.099 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 5.4 ptm180 -179.86 -32.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.041 0.385 . . . . 2.41 112.041 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 64.0 m95 61.41 81.53 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.296 -0.631 . . . . 0.65 109.296 -179.12 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -118.57 135.92 54.15 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.386 0.513 . . . . 1.28 112.386 -178.739 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtpm? -46.96 94.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.3 111.015 179.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -80.45 -42.29 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.551 -179.665 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.695 ' CB ' HD11 ' A' ' 56' ' ' ILE . 8.0 p-10 -54.21 -58.76 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.639 -0.255 . . . . 2.01 111.319 -179.678 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 39.56 49.27 1.96 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.053 0.39 . . . . 2.08 112.053 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -161.22 26.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.729 0.27 . . . . 1.89 111.729 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.32 113.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 1.87 111.225 179.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' HB2' ' A' ' 61' ' ' PHE . 28.1 mt -109.94 71.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.69 110.827 179.587 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 34' ' ' THR . 4.9 mt -50.39 -59.57 3.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 1.6 111.3 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.7 pt-20 -86.93 158.91 19.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.917 0.389 . . . . 1.54 110.334 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 4.7 p-10 -69.99 -7.93 44.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.024 -0.535 . . . . 1.75 111.772 -179.764 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -98.22 105.07 17.17 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.443 -0.577 . . . . 2.05 109.443 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.805 ' HB2' HG23 ' A' ' 56' ' ' ILE . 53.2 t80 -142.47 165.42 27.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.48 111.711 -179.002 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.5 m -120.96 121.37 37.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.42 111.074 179.778 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 20' ' ' LEU . 14.5 t -81.7 110.8 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.113 -0.494 . . . . 1.08 111.637 -179.654 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 47.6 t -97.38 -159.54 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.858 -0.61 . . . . 1.33 110.495 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 61.19 23.48 62.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.64 -0.79 . . . . 0.9 112.114 -179.863 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.039 ' CD1' HG13 ' A' ' 18' ' ' VAL . 14.2 mt -76.03 169.8 17.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 1.47 110.944 -179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 2.1 m -134.17 141.32 47.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 1.06 110.564 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 15' ' ' ARG . 29.8 mt-10 -75.12 144.41 42.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.128 -0.487 . . . . 1.91 111.215 -179.783 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.9 t0 67.82 40.32 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.87 110.849 179.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . -155.53 115.34 3.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.49 111.42 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.72 130.34 42.69 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.49 -0.559 . . . . 0.36 109.49 179.082 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD1' ' HD3' ' A' ' 40' ' ' LYS . 57.8 m-85 -124.89 119.44 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.871 1.064 . . . . 0.56 113.871 -177.968 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 5.8 mt-10 -102.66 139.97 37.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.684 -1.228 . . . . 1.5 107.684 177.631 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.91 122.07 23.79 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.028 1.492 . . . . 0.6 115.028 -178.574 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 19.9 ttm-85 -94.93 143.81 26.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 114.509 -1.223 . . . . 2.11 109.086 178.087 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -121.06 120.1 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 119.121 -1.031 . . . . 0.6 112.538 179.458 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -110.58 165.42 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.861 -1.518 . . . . 0.7 107.689 178.537 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -165.81 149.23 7.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 118.934 -1.106 . . . . 0.6 112.376 -179.839 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.692 ' HG2' HD12 ' A' ' 85' ' ' ILE . 4.0 mttt -99.12 -177.61 3.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.308 -0.406 . . . . 1.98 109.973 179.097 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.701 ' OD1' HD12 ' A' ' 2' ' ' ILE . 7.8 p-10 -136.41 166.72 22.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.06 -0.518 . . . . 2.19 110.907 -179.682 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.756 -0.656 . . . . 1.08 112.482 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -89.08 -20.28 24.52 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.654 0.613 . . . . 1.06 112.654 -179.25 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.09 57.95 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.423 -0.894 . . . . 0.93 112.603 -179.59 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 2' ' ' ILE . . . -74.23 77.89 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.964 0.411 . . . . 1.38 110.297 179.74 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.692 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -36.23 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.79 113.285 -179.152 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.706 ' HB3' HD11 ' A' ' 2' ' ' ILE . 33.8 p -62.93 117.66 34.71 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.599 -0.728 . . . . 0.59 109.415 178.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -35.32 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.363 2.709 . . . . 0.85 113.398 -179.342 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.515 ' N ' HG23 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -59.22 168.28 4.99 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.219 2.613 . . . . 0.76 113.499 -179.612 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.509 ' HB2' HG13 ' A' ' 76' ' ' VAL . 19.9 m -124.61 129.62 50.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.084 -0.962 . . . . 1.28 109.706 178.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -25.03 118.57 0.21 Allowed Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.688 0.795 . . . . 1.77 112.604 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 51.5 Cg_exo -55.53 154.68 23.87 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.363 2.042 . . . . 0.55 114.249 -179.211 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -84.78 146.43 27.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.08 -0.963 . . . . 1.23 109.092 178.961 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -40.31 146.81 0.12 Allowed 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.623 0.577 . . . . 1.63 111.428 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -76.14 122.13 23.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.659 . . . . 0.41 110.671 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.816 HG21 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mp -102.28 109.09 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.632 -179.565 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 76.0 m -48.18 -36.11 13.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.087 -179.897 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.3 m 50.65 98.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 1.1 111.173 179.782 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -72.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.152 -0.476 . . . . 3.0 110.513 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -141.52 10.91 2.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.769 -0.65 . . . . 2.14 111.726 179.677 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.083 0.468 . . . . 2.06 111.624 -179.787 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.713 HD12 ' OD1' ' A' ' 80' ' ' ASN . 3.1 tt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.186 0.517 . . . . 0.68 111.88 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -125.99 136.51 28.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.436 -0.802 . . . . 2.0 109.55 179.262 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.21 161.37 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.192 1.928 . . . . 0.5 112.429 -179.616 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.0 Cg_exo -54.22 164.5 2.69 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.864 2.376 . . . . 0.71 113.108 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.45 169.17 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.511 -0.768 . . . . 0.66 112.229 179.803 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -68.55 126.61 92.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.066 -0.346 . . . . 1.52 110.066 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 32.9 Cg_exo -62.85 153.19 74.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.28 1.987 . . . . 0.44 113.422 -179.289 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.79 96.19 3.6 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 1.09 109.641 179.368 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 86.2 Cg_exo -40.36 118.84 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.178 1.919 . . . . 0.64 113.224 -179.129 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.949 ' CD2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -84.99 -26.84 26.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.509 -0.923 . . . . 1.64 108.509 178.844 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.624 ' C ' HD13 ' A' ' 13' ' ' ILE . 2.0 t30 -147.87 153.08 38.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.642 -1.244 . . . . 0.72 107.642 178.169 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.849 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.51 134.72 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.118 -0.633 . . . . 0.96 112.225 -179.133 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -145.92 146.93 31.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.958 -0.565 . . . . 1.46 111.251 179.435 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.489 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -24.62 -48.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.541 -1.209 . . . . 2.42 114.002 -179.336 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.671 ' HA ' HD12 ' A' ' 66' ' ' LEU . 29.3 m-70 -128.78 22.03 5.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.675 0.621 . . . . 1.02 112.675 -179.016 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' HIS . 38.7 p -162.49 114.42 1.62 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 0.68 109.995 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 HD21 ' A' ' 66' ' ' LEU . 5.3 m -128.83 121.6 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.953 0.882 . . . . 0.8 113.025 -179.405 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.1 m -82.33 148.91 28.03 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.184 -0.916 . . . . 0.35 110.686 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.71 147.73 27.7 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 124.337 1.023 . . . . 0.52 111.189 179.721 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.208 ' HD3' ' OE1' ' A' ' 60' ' ' GLU . 19.3 tptm -129.54 151.86 49.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.275 -0.875 . . . . 1.84 110.718 179.793 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 49.1 p90 -150.36 -179.04 6.88 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.057 0.455 . . . . 0.4 112.17 179.801 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.78 162.15 13.16 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.83 111.597 -179.417 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.13 152.85 38.22 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.421 -0.354 . . . . 2.11 110.891 179.802 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 11.7 Cg_endo -55.1 141.28 80.03 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.013 2.475 . . . . 0.89 113.524 -179.501 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -7.28 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 2.77 112.095 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -134.1 -67.11 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.883 -0.327 . . . . 1.37 111.677 -179.877 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t 35.85 49.59 0.58 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.302 0.573 . . . . 0.91 111.838 -179.201 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.47 -123.06 8.08 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.574 -0.739 . . . . 1.01 112.416 179.995 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.64 31.84 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.952 -0.859 . . . . 0.98 110.952 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.4 OUTLIER -103.47 -170.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.351 0.596 . . . . 0.87 112.238 -178.875 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' THR . 9.5 ttpt -145.84 24.74 1.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.069 -0.969 . . . . 2.26 110.744 179.856 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.039 HG21 ' CE1' ' A' ' 36' ' ' TYR . 24.2 mm 66.49 -70.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.248 -0.433 . . . . 1.71 111.119 179.918 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 83.36 -11.52 0.91 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.909 -0.587 . . . . 1.15 112.232 179.684 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 6.9 t -178.98 140.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.321 . . . . 1.58 111.807 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 33' ' ' ILE . 59.2 m-85 -119.65 139.84 51.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.126 0.489 . . . . 0.76 111.11 179.596 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.3 mt -116.97 130.84 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 1.14 110.088 179.367 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 56' ' ' ILE . 31.9 t -104.68 109.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.63 112.293 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.43 ' CB ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -81.87 107.93 14.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.557 -0.534 . . . . 1.67 109.557 178.979 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 2.3 ptmt -97.46 151.53 19.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.322 -179.368 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 43' ' ' LEU . 12.2 ttp180 -139.01 120.29 14.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.123 -0.49 . . . . 1.44 111.366 -179.905 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -82.86 90.76 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 1.59 109.616 179.432 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -83.82 150.61 59.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.04 -0.527 . . . . 0.9 111.414 -179.228 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -94.01 28.35 17.24 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.003 -1.249 . . . . 1.43 112.705 0.081 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -139.69 69.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 2.66 110.941 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.42 -169.88 30.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.814 -0.708 . . . . 1.12 112.297 179.986 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' NE ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.05 168.28 25.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 2.41 111.223 179.971 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.649 ' O ' HD22 ' A' ' 49' ' ' LEU . 70.7 m95 -69.71 118.43 12.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.715 -0.675 . . . . 0.65 111.393 -179.764 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.649 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -147.38 127.55 13.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 1.28 110.705 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -65.27 83.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3 111.368 -179.737 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.765 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -60.6 -38.67 85.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.86 110.434 179.672 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' CE1' ' A' ' 61' ' ' PHE . 4.2 t30 -40.13 -84.47 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.91 -0.586 . . . . 2.01 111.197 -179.997 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 t80 60.22 15.7 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.036 0.384 . . . . 2.08 112.036 179.568 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -122.75 22.42 9.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 1.89 110.939 179.826 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.99 133.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.936 0.398 . . . . 1.87 111.224 179.834 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 61' ' ' PHE . 13.2 mt -129.38 74.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.69 110.857 179.993 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -56.69 16.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 1.6 111.057 -179.957 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.28 160.53 15.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 1.54 110.808 179.967 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.7 m-20 -70.46 -8.4 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 1.75 111.525 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 1.208 ' OE1' ' HD3' ' A' ' 21' ' ' LYS . 14.7 tp10 -93.13 96.11 9.84 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.732 -0.47 . . . . 2.05 109.732 179.68 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.713 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.1 t80 -131.65 165.9 22.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.48 111.576 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.0 m -121.92 121.96 38.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.801 -0.636 . . . . 0.42 111.256 179.636 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.929 ' CG2' HD11 ' A' ' 20' ' ' LEU . 7.5 t -81.16 74.57 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.197 0.522 . . . . 1.08 110.294 -179.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 83.2 p -78.66 164.39 24.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.326 -0.852 . . . . 1.33 110.91 -179.589 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -9.97 64.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.586 -0.816 . . . . 0.9 113.009 179.922 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.061 HD21 HG13 ' A' ' 18' ' ' VAL . 4.4 pp -60.89 166.1 3.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 117.244 0.522 . . . . 1.47 110.694 -179.977 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -104.64 157.94 16.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.06 111.185 -179.478 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HG2' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.85 167.24 10.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.939 -0.573 . . . . 1.91 112.413 -179.289 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 2.2 t70 73.27 55.94 0.11 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.542 -0.753 . . . . 1.87 111.214 179.887 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 43' ' ' LEU . . . 165.58 138.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.49 110.363 179.818 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -56.87 133.85 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.36 110.393 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.485 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 2.3 m-85 -126.35 116.68 21.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.56 111.898 -178.852 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 43' ' ' LEU . 2.2 mt-10 -106.13 145.85 30.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.93 -0.577 . . . . 1.5 109.495 179.027 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.009 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.98 115.52 10.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.348 1.24 . . . . 0.6 114.348 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD3' ' CB ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -98.9 -178.45 3.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.794 -0.817 . . . . 2.11 108.794 177.922 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -150.48 130.7 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 119.309 -0.956 . . . . 0.6 112.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.759 HG22 HD11 ' A' ' 85' ' ' ILE . 55.6 mt -114.7 151.91 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.45 -1.25 . . . . 0.7 108.593 178.916 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.89 136.54 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.62 -0.832 . . . . 0.6 112.771 -179.662 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.58 -158.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.576 . . . . 1.98 109.912 179.228 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' A' ' 2' ' ' ILE . 2.8 p-10 -160.34 176.31 11.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 2.19 111.82 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.068 -0.969 . . . . 1.08 112.169 179.796 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -94.22 -20.33 19.93 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.91 0.337 . . . . 1.06 111.91 -179.453 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.7 61.16 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.48 -0.867 . . . . 0.93 112.981 -179.974 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 85.93 0.26 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 1.38 110.391 179.77 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.759 HD11 HG22 ' A' ' 77' ' ' ILE . 5.3 tp -46.32 122.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.658 0.614 . . . . 0.79 112.658 -179.116 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' ILE . 26.7 p -82.31 120.98 78.17 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.297 -0.865 . . . . 0.59 109.258 178.889 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.4 Cg_exo -38.54 163.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.904 2.403 . . . . 0.85 113.219 -179.495 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.619 ' HG3' HD11 ' A' ' 77' ' ' ILE . 4.2 Cg_exo -75.1 118.1 5.12 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.781 2.321 . . . . 0.76 112.72 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 3.3 t -68.5 137.84 54.73 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.822 -0.626 . . . . 1.28 109.968 179.516 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -32.68 125.74 0.39 Allowed Pre-proline 0 N--CA 1.47 0.525 0 O-C-N 124.027 0.829 . . . . 1.77 112.347 -179.451 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.524 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.6 Cg_exo -60.98 134.12 51.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.543 2.162 . . . . 0.55 113.206 -179.679 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.445 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.46 153.43 38.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.742 -0.663 . . . . 1.23 109.955 179.193 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -30.42 145.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.387 1.054 . . . . 1.63 112.652 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.56 112.24 20.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.702 -0.681 . . . . 0.41 109.718 179.376 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.8 mp -97.77 113.89 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.813 -179.276 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 71.7 m -46.36 -28.89 1.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.128 0.49 . . . . 0.44 110.025 179.153 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.599 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER 45.27 55.44 6.4 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.634 -0.712 . . . . 1.1 111.266 179.555 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -79.88 -93.59 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.714 -0.394 . . . . 3.0 110.97 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.93 39.22 2.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 2.14 109.707 179.829 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 15' ' ' ARG . 28.1 t0 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.866 -0.606 . . . . 2.06 111.192 -178.558 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 ' CB ' ' A' ' 84' ' ' ALA . 5.0 tt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.973 0.416 . . . . 0.68 111.975 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 2' ' ' ILE . 73.1 m-20 -139.67 130.71 14.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.651 . . . . 2.0 110.226 179.496 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.21 164.07 29.63 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.262 1.975 . . . . 0.5 112.511 -179.654 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 11.9 Cg_endo -56.52 177.25 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.155 2.57 . . . . 0.71 113.219 -179.579 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.05 171.88 54.54 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.828 -0.624 . . . . 0.66 112.375 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.59 127.73 89.06 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.227 -0.286 . . . . 1.52 110.227 179.718 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HG3' HG12 ' A' ' 76' ' ' VAL . 14.8 Cg_exo -73.67 150.04 44.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.566 2.178 . . . . 0.44 112.874 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -146.24 106.08 4.13 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 115.839 -0.619 . . . . 1.09 110.98 179.717 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -59.89 111.45 0.98 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.346 2.031 . . . . 0.64 113.305 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -71.64 -39.35 70.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.643 -0.873 . . . . 1.64 108.643 178.791 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.65 148.99 51.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.591 -1.186 . . . . 0.72 108.572 179.119 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.795 HD12 ' CG2' ' A' ' 95' ' ' ILE . 4.4 pt -142.78 89.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.989 0.423 . . . . 0.96 111.539 -179.253 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -79.58 149.01 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 1.46 110.785 -179.866 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.901 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -40.41 -35.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.083 0.772 . . . . 2.42 113.083 -179.212 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' THR . 3.4 m-70 -135.25 31.62 3.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 1.02 111.437 -179.332 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -178.62 108.54 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.68 110.226 179.578 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 66' ' ' LEU . 9.5 m -112.82 143.38 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.415 -0.514 . . . . 0.8 111.159 -179.91 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 53.2 m -106.72 136.82 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.438 -0.346 . . . . 0.35 110.817 179.565 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.04 160.81 37.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.094 0.871 . . . . 0.52 112.569 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.706 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -148.4 147.11 28.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.909 -1.041 . . . . 1.84 110.456 179.465 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 30.3 p90 -137.68 -175.12 3.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.133 0.492 . . . . 0.4 111.927 -179.575 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.86 16.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.577 -0.738 . . . . 0.83 110.908 179.725 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.97 147.39 33.8 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.408 179.621 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 28' ' ' THR . 35.1 Cg_endo -63.72 173.08 4.94 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.325 2.017 . . . . 0.89 112.325 179.941 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -123.79 13.49 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.627 -179.853 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -144.01 -73.91 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 1.37 111.919 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.5 p 43.63 56.81 4.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.878 0.371 . . . . 0.91 110.811 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.16 -100.4 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.543 . . . . 1.01 112.483 -179.528 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.8 34.33 1.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.009 -1.237 . . . . 0.98 110.009 179.152 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -116.11 -168.01 1.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.664 -0.768 . . . . 0.87 111.388 -178.717 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.21 45.74 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.621 -0.718 . . . . 2.26 111.305 -179.958 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.812 HG22 ' H ' ' A' ' 35' ' ' SER . 12.2 mm 52.98 -87.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.086 179.731 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 74.39 23.58 1.96 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.564 0.579 . . . . 1.15 112.564 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.812 ' H ' HG22 ' A' ' 33' ' ' ILE . 4.3 t 168.91 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.937 0.347 . . . . 1.58 111.937 179.562 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 56' ' ' ILE . 18.4 m-85 -102.61 93.52 5.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.76 110.831 179.498 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.0 mt -85.9 114.68 26.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.747 0.308 . . . . 1.14 110.922 179.96 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' ARG . 14.4 t -89.27 121.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.278 -0.419 . . . . 0.63 111.737 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -95.16 129.86 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 1.67 109.895 179.214 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -110.21 140.13 44.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.217 0.532 . . . . 1.97 111.968 -179.416 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HG3' ' HA2' ' A' ' 46' ' ' GLY . 13.0 ttm180 -111.9 112.63 24.43 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.366 -0.834 . . . . 1.44 109.616 179.047 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -81.8 101.22 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.601 -0.727 . . . . 1.59 110.644 -179.594 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -76.67 155.53 83.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.48 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -87.57 9.06 63.62 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.142 -1.191 . . . . 1.43 113.287 0.519 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.77 -74.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 2.66 110.195 179.75 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 98.06 155.96 29.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.735 . . . . 1.12 113.915 179.018 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 161.26 62.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 122.928 0.491 . . . . 2.41 109.799 -179.939 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 80.9 m95 -28.79 105.08 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.469 0.708 . . . . 0.65 112.593 -179.422 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.66 130.66 42.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.986 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 2.5 ptmm? -56.19 91.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 1.3 111.481 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.821 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.36 -55.41 31.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.1 0.476 . . . . 0.86 110.142 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.647 ' CB ' HD11 ' A' ' 56' ' ' ILE . 9.1 p-10 -44.58 112.55 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.717 . . . . 2.01 111.023 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.56 43.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.08 111.598 -179.604 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 t -168.18 172.2 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 1.89 111.221 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 115.37 18.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 1.87 110.869 179.946 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 36' ' ' TYR . 35.6 mt -96.63 89.53 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.69 110.929 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 34' ' ' THR . 2.5 mt -61.22 -79.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.6 111.253 -179.798 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 172.18 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.54 110.726 -179.995 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.2 p30 -88.15 12.35 13.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 1.75 111.687 -179.851 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 53.5 tt0 -109.49 108.9 19.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.278 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE1' ' O ' ' A' ' 62' ' ' THR . 55.4 t80 -145.0 165.08 29.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.48 112.055 -178.874 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.566 ' O ' ' CE1' ' A' ' 61' ' ' PHE . 99.5 m -119.22 112.89 20.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.671 -0.695 . . . . 0.42 110.26 179.497 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.957 ' CG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -79.76 89.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.762 -0.654 . . . . 1.08 110.51 -179.495 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.798 ' CB ' HG22 ' A' ' 17' ' ' THR . 25.4 t -88.05 -178.07 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.908 . . . . 1.33 110.929 -179.49 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 84.01 7.17 85.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.687 -0.768 . . . . 0.9 112.79 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.8 pp -84.61 172.07 11.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.186 0.493 . . . . 1.47 110.887 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 68' ' ' GLU . 1.7 m -121.41 173.3 7.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 1.06 111.376 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 67' ' ' THR . 2.7 tt0 -91.86 170.52 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 1.91 111.202 -179.93 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.814 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 47.03 35.26 3.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 1.87 111.194 179.831 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.7 114.84 6.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.49 111.395 -179.832 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.19 123.47 20.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.672 -0.492 . . . . 0.36 109.672 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 58.0 m-85 -116.99 121.85 42.57 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.357 0.873 . . . . 0.56 113.357 -178.361 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.4 tt0 -102.85 136.76 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.829 -1.175 . . . . 1.5 107.829 177.832 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.26 126.53 21.39 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.933 1.457 . . . . 0.6 114.933 -178.519 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -101.0 -177.16 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.846 -1.07 . . . . 2.11 108.423 177.756 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -147.89 106.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 119.656 -0.818 . . . . 0.6 112.655 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.465 HD11 ' HG3' ' A' ' 88' ' ' PRO . 42.7 mt -88.07 154.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 177.455 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.18 126.72 4.28 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.927 -1.109 . . . . 0.6 113.198 -179.144 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.1 mttt -76.6 -159.87 0.13 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.71 . . . . 1.98 109.394 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.5 m-80 -149.82 176.94 10.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.056 0.455 . . . . 2.19 111.338 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.6 -26.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 1.08 111.682 179.773 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.26 10.36 29.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.427 0.528 . . . . 1.06 112.427 -179.571 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.46 -14.61 57.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.349 -0.929 . . . . 0.93 112.853 179.875 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.42 102.51 0.03 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.813 0.34 . . . . 1.38 111.258 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.0 tp -69.98 101.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.79 111.819 -179.623 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.1 p -69.56 126.35 92.54 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 109.502 -0.555 . . . . 0.59 109.502 179.371 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -39.2 160.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.716 2.278 . . . . 0.85 112.446 -179.53 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.5 Cg_exo -67.53 124.61 12.21 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.684 2.256 . . . . 0.76 113.054 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.792 ' HB2' HG13 ' A' ' 76' ' ' VAL . 3.2 m -70.99 130.47 41.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.776 -0.647 . . . . 1.28 109.44 179.17 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -31.99 124.34 0.37 Allowed Pre-proline 0 N--CA 1.474 0.727 0 N-CA-C 112.538 0.57 . . . . 1.77 112.538 -179.316 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 32.2 Cg_exo -59.39 147.6 90.47 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.833 2.355 . . . . 0.55 113.387 -179.559 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.15 147.59 28.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.695 -0.684 . . . . 1.23 109.885 179.291 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.63 137.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 124.186 0.929 . . . . 1.63 111.736 -179.921 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -66.38 120.49 13.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.655 . . . . 0.41 110.789 179.88 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.795 ' CG2' HD12 ' A' ' 13' ' ' ILE . 4.0 mp -100.42 109.54 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.44 111.337 -179.886 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -45.79 -48.88 15.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.32 -179.702 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 64.65 86.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.446 . . . . 1.1 110.42 -179.952 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.31 -86.24 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 3.0 111.071 -179.758 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.568 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 14.7 p30 -105.43 14.59 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.162 -0.472 . . . . 2.14 111.097 179.886 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 C--N 1.333 -0.123 0 CA-C-O 121.023 0.44 . . . . 2.06 110.606 -179.827 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.74 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.3 tt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.937 0.398 . . . . 0.68 111.52 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' ILE . 8.1 t70 -126.49 129.06 24.22 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 2.0 110.78 179.932 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.01 171.87 14.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.489 2.126 . . . . 0.5 112.276 -179.957 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -66.86 -174.72 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.803 2.335 . . . . 0.71 113.182 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.35 -177.81 49.67 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.4 -0.818 . . . . 0.66 112.852 -179.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.14 116.4 35.65 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.391 0.139 . . . . 1.52 110.681 179.866 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 31.7 Cg_exo -62.76 142.75 90.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.595 2.197 . . . . 0.44 112.374 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.6 p -145.95 104.42 4.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 1.09 111.976 -179.476 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.9 Cg_exo -50.26 113.24 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.532 2.155 . . . . 0.64 112.751 -179.963 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -63.86 -46.49 84.72 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.774 -0.825 . . . . 1.64 108.774 178.977 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.29 151.25 50.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.28 -1.327 . . . . 0.72 108.321 179.016 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.587 ' HB ' HG21 ' A' ' 95' ' ' ILE . 4.4 pt -143.17 70.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.399 -0.52 . . . . 0.96 111.567 -179.104 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -72.44 146.88 46.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.613 -0.721 . . . . 1.46 110.468 179.864 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -65.99 61.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.764 0.792 . . . . 2.42 112.387 -179.413 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 15' ' ' ARG . 0.9 OUTLIER 167.82 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.758 -0.655 . . . . 1.02 110.509 179.09 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -146.4 126.12 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.472 -0.566 . . . . 0.68 109.472 179.27 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -116.77 120.57 65.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.189 0.44 . . . . 0.8 112.189 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.587 ' OG1' HG23 ' A' ' 62' ' ' THR . 97.6 m -91.63 142.34 27.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.692 -0.231 . . . . 0.35 110.892 179.303 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -140.4 156.03 46.53 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.146 0.904 . . . . 0.52 112.992 -179.641 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 1.8 tppp? -145.15 159.11 43.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.316 -1.311 . . . . 1.84 109.59 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 40.0 p90 -155.66 -176.45 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.13 0.49 . . . . 0.4 112.086 -179.879 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.95 133.37 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.569 -0.741 . . . . 0.83 111.685 -179.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -70.64 141.56 87.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 2.11 109.686 179.35 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 6.3 Cg_endo -48.62 175.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.095 1.863 . . . . 0.89 111.431 179.705 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.7 -25.66 4.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.33 0.493 . . . . 2.77 112.33 -179.367 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -106.45 -70.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.005 0.372 . . . . 1.37 112.005 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.475 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 3.2 p 52.08 41.18 29.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.649 0.261 . . . . 0.91 110.36 -179.313 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.87 -91.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.861 -0.685 . . . . 1.01 112.232 -179.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.73 35.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.077 -1.209 . . . . 0.98 110.077 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -117.39 172.31 7.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.898 -0.651 . . . . 0.87 111.635 -178.464 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -123.86 -3.45 8.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.852 -0.613 . . . . 2.26 111.519 179.828 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 64.01 155.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 110.505 -0.183 . . . . 1.71 110.505 -179.908 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 4.6 p -139.56 8.27 2.38 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.482 0.549 . . . . 1.15 112.482 -179.522 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.44 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 178.49 149.39 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.826 0.346 . . . . 1.58 111.923 -179.994 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.8 m-85 -126.38 119.83 28.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.983 -0.553 . . . . 0.76 110.101 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.84 116.15 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.73 0.3 . . . . 1.14 111.471 -179.585 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -106.44 104.48 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.303 0.573 . . . . 0.63 110.671 179.588 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 4.8 mt-10 -73.52 157.33 36.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.284 -0.871 . . . . 1.67 110.38 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -118.23 137.41 53.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.97 111.466 -179.569 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.566 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -113.9 120.2 39.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 1.44 110.726 179.656 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.837 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.71 77.7 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 1.59 110.552 179.846 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 52.8 mt -53.3 145.16 27.33 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.637 -0.71 . . . . 0.9 111.151 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -93.42 27.03 19.26 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.903 -1.29 . . . . 1.43 112.708 0.174 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -153.6 81.89 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.781 0.324 . . . . 2.66 111.861 -179.835 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.75 -152.83 10.44 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.942 -0.647 . . . . 1.12 111.968 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.853 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -167.15 29.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.027 0.413 . . . . 2.41 111.759 179.894 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 69.1 m95 41.06 101.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.832 0.678 . . . . 0.65 112.832 179.422 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -131.48 117.97 19.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 1.28 110.045 179.085 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -43.5 106.54 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.935 0.398 . . . . 1.3 111.484 -179.503 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -73.04 -36.54 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.86 111.285 -179.867 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.687 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.3 p-10 -69.58 -173.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.336 -0.393 . . . . 2.01 110.958 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 4.0 t80 176.93 -22.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.515 -0.766 . . . . 2.08 111.799 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.99 35.78 0.8 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.075 0.398 . . . . 1.89 112.075 -179.497 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.51 122.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 1.87 111.294 179.594 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 52' ' ' ASN . 35.2 mt -114.27 68.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.69 110.987 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 1.6 111.158 -179.892 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 1.7 pm0 -70.2 166.53 19.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.99 0.424 . . . . 1.54 110.759 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -78.83 1.69 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.904 -0.589 . . . . 1.75 111.537 179.873 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 7.1 tt0 -98.56 100.14 11.35 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.966 -0.383 . . . . 2.05 109.966 179.608 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.8 t80 -136.81 164.45 28.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.238 0.542 . . . . 0.48 111.648 -179.502 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.6 m -125.55 125.14 42.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.463 -0.79 . . . . 0.42 110.398 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' LEU . 9.1 t -87.53 91.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.214 0.531 . . . . 1.08 110.747 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 17' ' ' THR . 24.2 p -85.52 -157.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.375 -0.829 . . . . 1.33 110.825 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.78 9.19 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.578 -0.82 . . . . 0.9 112.086 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.026 ' CD1' HG13 ' A' ' 18' ' ' VAL . 27.8 mt -75.61 164.98 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 1.47 111.025 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.424 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 1.8 m -115.27 101.59 9.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.557 . . . . 1.06 110.363 179.756 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 7.6 tt0 -49.25 150.15 1.84 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.489 -0.323 . . . . 1.91 111.179 -179.748 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 20.2 m-20 70.92 46.73 0.46 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.983 -0.553 . . . . 1.87 110.676 -179.625 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -167.83 121.42 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.034 -0.53 . . . . 0.49 111.139 -179.927 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.86 117.41 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.055 -0.35 . . . . 0.36 110.055 179.477 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 78.2 m-85 -113.78 128.95 56.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 5.8 mt-10 -95.41 146.4 24.43 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.469 -0.937 . . . . 1.5 108.469 178.271 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -123.85 108.94 13.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.376 1.621 . . . . 0.6 115.376 -178.177 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.466 ' CZ ' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.71 133.8 41.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.133 -0.94 . . . . 2.11 109.374 178.304 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -117.01 125.36 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 119.141 -1.023 . . . . 0.6 113.678 179.811 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 86' ' ' SER . 37.0 mt -114.74 145.57 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 113.589 -1.642 . . . . 0.7 108.03 178.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -154.34 125.39 7.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.858 -0.737 . . . . 0.6 112.541 -179.521 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 85' ' ' ILE . 15.5 ptpt -79.85 156.14 27.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.25 179.276 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.74 ' ND2' HD12 ' A' ' 2' ' ' ILE . 5.0 p30 -102.36 172.92 6.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 2.19 112.185 -179.32 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.26 -46.73 9.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.949 -1.023 . . . . 1.08 111.963 179.72 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -65.64 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 1.06 111.887 -179.273 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.22 -21.56 21.98 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.532 -0.842 . . . . 0.93 112.208 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.633 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -49.18 154.03 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.989 -0.374 . . . . 1.38 109.989 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tp -108.58 115.78 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.255 0.465 . . . . 0.79 112.255 -179.38 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' ILE . 24.1 p -69.72 113.84 20.23 Favored Pre-proline 0 C--O 1.235 0.34 0 N-CA-C 108.033 -1.099 . . . . 0.59 108.033 178.583 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.19 150.25 14.6 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.319 2.013 . . . . 0.85 113.005 -178.905 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' CA ' HG12 ' A' ' 77' ' ' ILE . 10.7 Cg_exo -38.93 141.51 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.46 2.774 . . . . 0.76 113.961 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' GLU . 16.0 m -106.01 110.6 22.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.957 -1.02 . . . . 1.28 109.698 179.054 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tp10 -5.12 116.08 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 124.815 1.322 . . . . 1.77 113.471 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 81.2 Cg_exo -51.05 142.29 35.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.451 2.1 . . . . 0.55 114.554 -179.14 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.418 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -75.56 152.15 37.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 178.427 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.89 145.73 0.31 Allowed 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.343 0.402 . . . . 1.63 110.978 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -78.8 121.48 24.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.993 -0.549 . . . . 0.41 111.07 -179.416 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.587 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.1 mp -100.77 114.94 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.175 -179.995 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.0 m -51.47 -44.21 62.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.919 -0.582 . . . . 0.44 110.655 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 50.3 t 62.43 67.94 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 116.17 -0.468 . . . . 1.1 110.958 179.651 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.77 -84.61 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 3.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -122.58 -0.67 9.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 2.14 111.109 179.719 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.991 0.424 . . . . 2.06 111.236 -179.969 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.448 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 5.5 tt . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 121.023 0.44 . . . . 0.68 111.475 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -129.78 124.99 22.02 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.787 -0.642 . . . . 2.0 111.194 179.699 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 161.76 35.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.427 2.084 . . . . 0.5 111.976 179.793 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 18.2 Cg_endo -59.06 170.39 2.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.592 2.195 . . . . 0.71 112.783 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -70.55 167.66 49.94 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.695 -0.684 . . . . 0.66 112.882 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 tmtt? -51.43 119.37 12.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.505 -0.183 . . . . 1.52 110.505 179.806 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.497 ' CG ' HG23 ' A' ' 76' ' ' VAL . 16.5 Cg_exo -70.06 152.8 67.91 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.398 2.066 . . . . 0.44 111.491 179.909 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.1 p -151.96 121.22 3.42 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.243 0.46 . . . . 1.09 112.243 -179.068 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.2 Cg_exo -65.75 111.95 2.07 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.552 2.168 . . . . 0.64 112.192 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.671 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.45 -33.09 58.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 1.64 110.625 179.711 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -148.56 126.02 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.72 110.113 179.891 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.872 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -114.9 128.11 72.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.96 111.606 -179.605 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -115.18 44.51 1.81 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.784 -0.644 . . . . 1.46 112.099 -179.318 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.8 mtm180 55.64 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.138 0.792 . . . . 2.42 113.138 178.749 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m170 -75.8 -29.89 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 1.02 110.934 -179.441 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.497 ' HA ' HD22 ' A' ' 66' ' ' LEU . 60.4 p -134.27 128.84 34.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.656 -0.498 . . . . 0.68 109.656 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.023 HG13 ' CD2' ' A' ' 66' ' ' LEU . 3.6 m -115.44 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.452 -0.499 . . . . 0.8 111.215 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 13.4 m -119.72 114.76 22.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.334 -0.394 . . . . 0.35 111.779 -178.997 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.04 158.0 40.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.686 0.755 . . . . 0.52 111.154 178.879 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CG ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.18 -179.2 5.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.652 -1.158 . . . . 1.84 109.591 179.813 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 24.7 p90 -162.08 175.46 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.328 0.585 . . . . 0.4 112.24 179.521 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -88.18 175.21 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.315 -0.857 . . . . 0.83 110.699 179.807 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 141.47 24.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.41 -0.359 . . . . 2.11 110.476 179.883 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' THR . 11.1 Cg_endo -54.48 -176.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.7 2.267 . . . . 0.89 112.464 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.23 -27.25 4.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 2.77 111.948 -179.77 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -113.84 -69.54 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.95 0.352 . . . . 1.37 111.95 -179.556 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.0 p 52.59 48.27 22.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.919 0.39 . . . . 0.91 110.227 -179.359 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.78 -101.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.657 -0.782 . . . . 1.01 112.03 -179.837 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.63 31.77 2.1 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.516 -1.034 . . . . 0.98 110.516 179.22 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.6 m-85 -107.44 -172.76 2.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.836 -0.682 . . . . 0.87 111.92 -178.806 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.25 7.08 1.34 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.923 -1.035 . . . . 2.26 111.832 179.187 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.013 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.1 mt 52.25 115.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.26 0.552 . . . . 1.71 112.329 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -117.12 22.76 12.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 1.15 111.357 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER 175.69 113.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.226 0.454 . . . . 1.58 112.226 -179.865 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 33' ' ' ILE . 43.2 m-85 -97.45 138.08 35.43 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.095 -0.335 . . . . 0.76 110.095 178.884 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -125.77 111.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.894 0.378 . . . . 1.14 110.67 179.485 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -99.37 115.8 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.364 -179.644 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.2 mt-10 -76.51 142.65 40.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.714 -0.675 . . . . 1.67 110.32 179.7 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.65 ' HE3' ' HB2' ' A' ' 51' ' ' ALA . 27.5 ttmt -106.11 146.02 30.72 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 120.749 0.309 . . . . 1.97 110.642 -179.577 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -129.8 100.77 5.6 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.547 -0.461 . . . . 1.44 110.483 178.931 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -70.6 78.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.618 -0.719 . . . . 1.59 110.689 -179.927 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.665 HD12 ' HB1' ' A' ' 94' ' ' ALA . 81.2 mt -50.44 154.88 1.98 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 0.9 111.02 -179.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.91 27.57 13.36 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.76 -1.35 . . . . 1.43 112.759 0.349 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -126.33 -79.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.574 0.225 . . . . 2.66 110.996 -179.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 1.12 112.907 179.845 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.27 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 2.41 110.552 179.95 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 62.2 m95 43.93 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.65 111.635 179.94 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -121.25 127.91 51.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 1.28 110.602 179.915 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -52.32 90.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.347 . . . . 1.3 110.627 -179.992 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.797 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -60.2 -46.06 91.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.86 110.635 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.814 ' HB2' HD11 ' A' ' 56' ' ' ILE . 10.9 p-10 -64.99 102.01 0.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 2.01 111.587 -179.828 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -15.65 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.085 -0.507 . . . . 2.08 110.664 179.27 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 p -86.62 -155.82 0.28 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.38 -0.373 . . . . 1.89 110.471 179.913 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.22 107.77 15.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.333 . . . . 1.87 111.618 -179.708 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 52' ' ' ASN . 6.9 mm -79.53 143.11 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.635 -0.505 . . . . 0.69 109.635 178.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -145.34 -68.02 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.33 . . . . 1.6 111.716 -179.843 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -54.93 -18.32 4.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 1.54 112.228 -179.731 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER 91.29 -18.45 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.877 0.871 . . . . 1.75 110.803 -179.58 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -88.92 85.26 6.69 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.555 -0.905 . . . . 2.05 108.555 178.836 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.737 ' CD1' HD12 ' A' ' 56' ' ' ILE . 50.2 t80 -114.47 165.2 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.484 0.659 . . . . 0.48 111.694 -178.61 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 91.9 m -123.4 116.99 24.16 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.893 -1.049 . . . . 0.42 110.025 178.994 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.797 HG13 ' CB ' ' A' ' 51' ' ' ALA . 48.8 t -83.9 86.54 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.117 -0.492 . . . . 1.08 111.375 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.56 134.41 35.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.734 . . . . 1.33 110.509 179.81 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.85 -14.3 2.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.83 . . . . 0.9 112.919 -179.847 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.023 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -53.31 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.47 110.609 179.94 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.2 m -148.75 142.3 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.06 111.11 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 1.282 ' OE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.0 137.27 58.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.193 179.879 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 97' ' ' CYS . 21.1 t70 70.09 49.33 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 1.87 111.221 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.87 120.51 2.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.873 0.368 . . . . 0.49 111.49 179.916 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.58 132.63 44.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.36 109.983 179.239 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.7 m-85 -127.52 122.11 32.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.662 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.89 138.12 43.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.603 -0.888 . . . . 1.5 108.603 178.502 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.21 115.39 14.12 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.41 1.263 . . . . 0.6 114.41 -178.702 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.32 167.77 11.52 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.806 -0.442 . . . . 2.11 109.806 178.395 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' CG ' ' A' ' 8' ' ' PRO . 28.5 t -122.43 121.18 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 113.706 1.002 . . . . 0.6 113.706 -179.531 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 86' ' ' SER . 70.1 mt -120.46 143.46 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.967 -1.494 . . . . 0.7 106.967 178.007 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -164.61 132.09 3.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.701 1.0 . . . . 0.6 113.701 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.61 105.95 14.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.709 -0.848 . . . . 1.98 108.709 178.245 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 3.3 m120 -40.1 -93.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.69 . . . . 2.19 112.712 -178.721 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -131.93 -41.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.178 -0.327 . . . . 1.08 111.643 -179.426 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -93.46 31.67 1.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 1.06 111.796 -179.684 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 77.84 -2.35 64.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.477 -0.868 . . . . 0.93 112.994 179.971 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -60.64 83.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 1.38 110.256 179.728 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.92 110.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.79 111.904 -179.325 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 77' ' ' ILE . 5.0 p -70.64 118.13 61.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.101 -0.704 . . . . 0.59 109.101 179.205 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 3.1 Cg_endo -47.15 172.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.623 2.215 . . . . 0.85 112.615 -179.192 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 17.0 Cg_endo -56.66 132.28 50.77 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.799 2.333 . . . . 0.76 112.46 -179.847 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m -105.99 98.14 7.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 1.28 111.155 -179.985 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mt-10 15.55 106.53 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 124.394 1.078 . . . . 1.77 113.858 179.58 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.1 Cg_exo -54.84 126.11 21.36 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.439 2.092 . . . . 0.55 113.89 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.425 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -54.77 147.64 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.431 -0.581 . . . . 1.23 109.431 178.996 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -36.77 143.48 0.08 Allowed 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 124.181 0.926 . . . . 1.63 111.779 179.951 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -78.01 109.83 12.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.41 109.901 179.712 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.82 HG12 HG21 ' A' ' 13' ' ' ILE . 4.8 mp -91.53 109.46 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.485 -179.444 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 98.8 m -45.96 -28.54 1.17 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.77 179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.76 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 87.0 m 52.6 80.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 1.1 110.172 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 1.282 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.2 -79.74 0.62 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.947 0.403 . . . . 3.0 111.686 -179.394 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -112.44 22.23 14.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.01 -0.541 . . . . 2.14 111.402 -179.824 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 p30 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 2.06 111.675 -179.767 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.659 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.6 tt . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.842 0.353 . . . . 0.68 111.31 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.039 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -122.11 129.77 24.98 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 2.0 110.294 179.88 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 154.28 15.41 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.424 2.083 . . . . 0.5 112.809 -179.628 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 78.2 Cg_exo -46.02 152.12 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.187 2.592 . . . . 0.71 113.485 -179.854 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.36 -171.35 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.432 -0.804 . . . . 0.66 113.103 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.7 tttt -77.07 129.39 78.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.457 -0.201 . . . . 1.52 110.457 179.824 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 2.7 Cg_exo -78.48 128.43 8.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.608 2.206 . . . . 0.44 112.896 -179.555 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -130.59 116.21 17.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.09 111.103 179.713 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.1 Cg_exo -62.91 128.52 23.3 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.707 2.271 . . . . 0.64 113.605 -179.467 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.6 mp -93.63 -27.79 16.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 1.64 109.693 179.059 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.42 151.16 32.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.715 -0.675 . . . . 0.72 110.229 179.836 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.193 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -149.08 111.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 0.96 111.503 -179.794 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.338 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -106.46 56.72 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.68 -0.691 . . . . 1.46 111.171 -179.956 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.955 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER 56.27 -69.97 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.881 0.738 . . . . 2.42 112.853 179.016 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m-70 -83.99 -20.28 33.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 1.02 111.82 -179.33 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 64' ' ' SER . 49.7 p -126.01 112.25 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.68 111.745 -179.603 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.004 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -106.39 120.55 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.8 110.478 179.606 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.706 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -104.34 128.16 52.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.35 111.843 -179.16 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.45 160.41 39.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.722 0.772 . . . . 0.52 111.8 178.964 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.822 ' HB3' HD11 ' A' ' 11' ' ' LEU . 8.6 tptm -142.57 139.19 31.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.514 -1.221 . . . . 1.84 109.861 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 14.5 p90 -126.55 -174.86 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.4 111.555 -179.714 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 171.81 8.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.83 111.475 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tptm -116.2 124.47 29.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.924 -0.58 . . . . 2.11 110.06 179.842 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.58 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 6.5 Cg_endo -46.98 175.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.719 2.28 . . . . 0.89 112.725 -179.908 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.54 3.35 5.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.77 110.846 179.718 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.039 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 3.7 t80 -121.87 -74.04 0.63 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.557 0.206 . . . . 1.37 111.557 -179.558 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 1.006 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 16.6 p 41.29 56.75 3.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.524 0.202 . . . . 0.91 111.254 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.13 -102.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.04 -0.527 . . . . 1.01 113.418 -179.717 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.68 28.85 3.2 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.968 -0.853 . . . . 0.98 110.968 179.232 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -110.42 -176.19 2.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.356 -0.422 . . . . 0.87 111.14 -179.138 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -137.89 1.01 2.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.976 -0.556 . . . . 2.26 112.218 179.685 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.596 HG21 ' CE1' ' A' ' 36' ' ' TYR . 8.3 mt 57.51 116.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-O 121.071 0.462 . . . . 1.71 111.088 -179.749 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -103.16 10.84 37.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.435 0.532 . . . . 1.15 112.435 -179.12 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -179.01 156.85 0.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.961 0.41 . . . . 1.58 111.898 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 28.5 m-85 -126.21 112.48 15.81 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.893 -0.594 . . . . 0.76 110.84 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.5 OUTLIER -94.55 99.79 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 1.14 110.718 -179.85 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.654 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -92.26 113.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 0.63 110.488 179.861 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.3 mp0 -81.5 144.73 31.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.605 -0.725 . . . . 1.67 110.911 -179.784 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -111.79 139.13 47.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 1.97 110.917 179.893 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 15.7 ttm180 -106.97 110.83 23.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.438 . . . . 1.44 110.382 179.405 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -82.66 91.21 6.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.715 -0.675 . . . . 1.59 110.307 179.866 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -68.0 154.53 93.62 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.519 -0.764 . . . . 0.9 110.983 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.05 4.41 66.12 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.685 -1.381 . . . . 1.43 112.999 0.255 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -78.86 -68.03 0.69 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 2.66 110.451 179.896 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 88.06 177.14 47.68 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.769 -0.729 . . . . 1.12 113.016 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.663 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 164.47 -28.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 110.718 179.938 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 51.4 m95 63.31 87.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 0.65 111.138 179.894 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.663 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.45 141.47 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.116 -179.834 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -58.5 117.64 4.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 1.3 110.747 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -86.95 -49.59 7.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.86 111.267 -179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.896 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -42.41 -54.18 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 2.01 112.101 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 t80 46.59 44.24 13.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.686 0.279 . . . . 2.08 111.347 -179.87 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 t -152.5 -84.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 1.89 111.156 179.924 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -178.13 110.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 1.87 110.556 179.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 52' ' ' ASN . 11.2 mt -108.74 80.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.69 111.103 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.8 tm? -64.7 -65.69 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 1.6 110.961 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.43 160.16 30.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.989 -0.374 . . . . 1.54 109.989 179.737 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -74.16 -3.57 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.304 -0.407 . . . . 1.75 111.556 -179.87 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -100.0 101.34 12.4 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.801 0.334 . . . . 2.05 110.151 179.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.683 ' HB2' HG23 ' A' ' 56' ' ' ILE . 50.3 t80 -135.07 162.97 30.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.258 0.551 . . . . 0.48 111.719 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 19' ' ' THR . 51.6 m -122.58 109.94 14.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.52 -0.764 . . . . 0.42 110.354 179.167 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' CB ' ' A' ' 51' ' ' ALA . 98.9 t -81.79 93.96 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.74 -0.664 . . . . 1.08 111.002 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.745 ' HB3' HG22 ' A' ' 17' ' ' THR . 3.0 p -98.79 144.56 27.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 1.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.44 -9.31 5.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.672 -0.775 . . . . 0.9 112.986 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -54.83 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.03 0.443 . . . . 1.47 111.063 -179.93 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 m -129.27 131.8 47.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 1.06 110.442 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.3 mt-10 -61.31 150.27 35.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.306 -0.406 . . . . 1.91 111.104 -179.758 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t0 62.75 48.56 4.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 1.87 110.814 -179.999 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.02 126.13 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.498 . . . . 0.49 111.319 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.758 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -71.52 134.57 46.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.604 179.694 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 46.1 m-85 -133.02 130.82 39.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.56 112.414 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -105.94 148.42 27.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.791 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.891 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.59 117.89 13.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.717 1.377 . . . . 0.6 114.717 -179.228 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -104.56 158.33 16.56 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.931 -0.766 . . . . 2.11 108.931 177.663 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 38' ' ' VAL . 99.3 t -115.19 109.93 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.584 -0.846 . . . . 0.6 113.02 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.483 HD12 ' CD ' ' A' ' 39' ' ' GLU . 68.3 mt -105.37 157.18 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.021 -1.474 . . . . 0.7 107.021 177.723 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -176.88 136.28 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.054 -1.058 . . . . 0.6 112.684 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.0 ptpp? -75.63 -150.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.106 -0.701 . . . . 1.98 109.106 178.846 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.755 HD21 ' HB3' ' A' ' 84' ' ' ALA . 25.4 p30 -147.43 -107.33 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.212 -0.595 . . . . 2.19 111.291 -179.723 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -127.47 -43.04 1.62 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.709 0.686 . . . . 1.08 110.423 179.847 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.94 -9.9 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 1.06 111.749 179.803 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.81 -18.84 28.84 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.475 -0.869 . . . . 0.93 112.398 -179.743 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.755 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -52.82 158.29 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.58 0.229 . . . . 1.38 110.72 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 6.3 tp -114.79 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.352 . . . . 0.79 111.649 -179.931 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -77.83 122.7 85.99 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 109.719 -0.474 . . . . 0.59 109.719 179.328 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -41.47 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.353 2.702 . . . . 0.85 113.649 -179.419 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' CA ' HG12 ' A' ' 77' ' ' ILE . 1.1 Cg_endo -83.56 129.67 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.361 2.707 . . . . 0.76 112.469 -179.91 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 78.2 p -85.19 125.06 32.53 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.994 -0.372 . . . . 1.28 109.994 179.349 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -17.65 106.89 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 124.696 1.248 . . . . 1.77 113.497 -179.476 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 54.4 Cg_exo -45.25 152.53 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.503 2.135 . . . . 0.55 113.302 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.436 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -83.76 144.04 29.59 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.421 -0.808 . . . . 1.23 109.005 179.063 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -34.93 146.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.213 0.946 . . . . 1.63 111.73 -179.624 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -76.66 125.31 29.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.694 -0.684 . . . . 0.41 110.69 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.1 mp -109.56 115.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.44 110.956 179.72 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.0 m -48.2 -30.61 4.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.44 111.262 -179.642 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.498 ' H ' HG22 ' A' ' 95' ' ' ILE . 57.2 m 51.88 72.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 1.1 110.212 -179.779 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.73 -80.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 3.0 111.421 -179.485 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -114.73 27.95 9.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.667 -0.697 . . . . 2.14 110.819 -179.734 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.338 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.085 0.469 . . . . 2.06 111.091 -179.323 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.672 HD11 ' HB3' ' A' ' 86' ' ' SER . 7.0 tt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.97 0.414 . . . . 0.68 111.506 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 1.24 ' OD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -140.55 130.77 13.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 2.0 110.132 179.757 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 166.94 17.2 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.437 2.091 . . . . 0.5 112.843 -179.592 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.1 Cg_endo -61.74 -175.86 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.111 2.541 . . . . 0.71 113.404 -179.489 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.45 168.61 36.68 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.578 -0.737 . . . . 0.66 112.445 179.938 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.3 tttt -59.32 130.56 87.35 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.724 0.262 . . . . 1.52 110.353 179.808 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.4 Cg_exo -79.46 153.99 24.09 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.523 2.149 . . . . 0.44 112.86 -179.413 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.34 116.35 7.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 1.09 110.351 179.977 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' THR . 14.2 Cg_exo -66.81 91.54 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.953 1.769 . . . . 0.64 113.191 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER -46.75 -42.77 17.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.293 0.568 . . . . 1.64 110.283 179.449 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -134.58 153.21 52.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.216 -0.902 . . . . 0.72 109.278 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -140.4 94.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.48 . . . . 0.96 111.235 -179.543 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -91.63 55.61 2.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.677 -0.692 . . . . 1.46 112.282 -179.202 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 2.5 mtm180 53.58 -71.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.678 0.992 . . . . 2.42 113.678 178.638 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 12.6 m170 -84.8 -32.61 23.27 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.281 0.474 . . . . 1.02 112.281 -178.726 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 64' ' ' SER . 19.9 p -126.4 101.7 6.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.673 0.273 . . . . 0.68 111.075 -179.714 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.069 HG13 ' CD2' ' A' ' 66' ' ' LEU . 32.5 m -98.72 138.28 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.378 . . . . 0.8 110.423 179.505 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 91.1 m -101.13 119.95 39.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.74 0.644 . . . . 0.35 112.74 -179.099 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.95 150.81 51.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.794 0.806 . . . . 0.52 111.834 178.221 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.49 159.2 42.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.719 -1.128 . . . . 1.84 109.364 179.607 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -141.93 -176.87 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.087 0.773 . . . . 0.4 113.087 -178.922 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 -158.13 0.27 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.774 -1.103 . . . . 0.83 110.643 179.387 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.71 148.84 71.69 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.417 -0.356 . . . . 2.11 110.738 179.606 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 80.7 Cg_exo -49.1 -173.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.983 2.455 . . . . 0.89 113.084 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.78 -29.79 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 2.77 111.649 -179.834 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 1.24 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 t80 -129.4 -69.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.961 0.356 . . . . 1.37 111.961 -179.563 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.865 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 16.1 p 58.49 46.16 15.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.91 110.566 -179.308 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.22 -98.51 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.929 -0.653 . . . . 1.01 112.551 179.905 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.36 22.85 2.87 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.336 -0.706 . . . . 0.98 111.336 179.354 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -103.29 -176.12 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 0.87 111.206 -179.178 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -134.89 5.69 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 2.26 111.437 179.482 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.646 HG21 ' CE1' ' A' ' 36' ' ' TYR . 12.1 mt 57.55 97.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-O 121.151 0.5 . . . . 1.71 110.868 -179.725 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -104.63 29.44 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.52 -0.764 . . . . 1.15 111.306 -179.424 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.83 116.77 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.917 0.389 . . . . 1.58 111.996 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.2 m-85 -110.42 107.46 17.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.76 110.3 179.267 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 1.6 mm -90.92 116.47 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.658 0.266 . . . . 1.14 111.075 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 56' ' ' ILE . 3.2 t -90.74 118.27 35.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.31 -0.404 . . . . 0.63 111.811 -179.762 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.8 mm-40 -96.9 135.03 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.422 -0.584 . . . . 1.67 109.422 178.901 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.636 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -112.32 145.75 39.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 1.97 112.229 -179.269 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.2 ttm180 -117.86 103.42 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.295 -0.866 . . . . 1.44 110.233 179.46 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -73.05 92.7 1.7 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.031 0.443 . . . . 1.59 110.9 -179.771 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.753 HD11 ' HG3' ' A' ' 73' ' ' GLU . 27.5 mt -70.82 149.42 95.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.786 -0.643 . . . . 0.9 110.692 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.5 -18.1 18.52 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.845 -1.315 . . . . 1.43 113.01 0.423 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -52.22 -90.95 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.062 -0.255 . . . . 2.66 110.672 -179.717 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' HA3' ' CG ' ' A' ' 41' ' ' ARG . . . 88.06 123.36 1.94 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.318 -0.944 . . . . 1.12 113.305 179.52 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.658 ' NE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.94 17.22 0.67 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.858 0.318 . . . . 2.41 111.858 179.678 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 69.0 m95 28.66 98.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.953 0.723 . . . . 0.65 112.953 179.901 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.658 HD22 ' NE ' ' A' ' 47' ' ' ARG . 1.1 mp -135.65 133.48 38.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 1.28 111.214 179.929 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 9.8 ptmm? -51.11 106.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 1.3 111.112 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.636 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.39 -56.84 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.86 110.714 179.819 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 9.4 p-10 -57.66 113.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 2.01 110.571 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.21 24.0 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 2.08 111.224 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 t -125.56 -82.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 1.89 110.77 -179.935 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.95 141.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 1.87 110.56 179.947 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.638 HD13 ' CG ' ' A' ' 61' ' ' PHE . 30.9 mt -125.56 79.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 0.69 111.19 -179.651 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.84 -66.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 1.6 110.923 179.998 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -179.72 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.481 -0.327 . . . . 1.54 110.424 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 30.1 p30 -96.69 10.05 39.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 1.75 111.618 179.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -111.28 95.84 5.76 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.757 -0.46 . . . . 2.05 109.757 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.638 ' CG ' HD13 ' A' ' 56' ' ' ILE . 76.6 t80 -128.26 164.83 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.196 0.522 . . . . 0.48 111.531 -179.26 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.9 m -127.38 124.03 37.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.578 -0.737 . . . . 0.42 110.333 179.253 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 20' ' ' LEU . 4.4 t -81.36 82.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.17 0.509 . . . . 1.08 109.941 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 17' ' ' THR . 33.2 t -68.27 -39.05 82.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.403 -0.817 . . . . 1.33 111.514 -179.18 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.68 62.22 0.47 Allowed Glycine 0 C--N 1.321 -0.301 0 C-N-CA 120.811 -0.709 . . . . 0.9 111.69 179.733 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.069 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -131.66 149.19 52.58 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.385 -0.598 . . . . 1.47 109.385 -179.118 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -105.23 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 1.06 111.87 -179.207 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 67' ' ' THR . 19.7 tt0 -103.75 165.14 11.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 1.91 111.28 -179.46 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 47.65 68.91 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.993 -0.549 . . . . 1.87 111.125 179.826 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . 176.87 110.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.49 110.882 179.904 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -63.05 110.2 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.21 0.529 . . . . 0.36 110.641 -179.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 82.7 m-85 -103.75 125.54 50.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.56 112.728 -178.999 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.753 ' HG3' HD11 ' A' ' 43' ' ' LEU . 20.1 mt-10 -103.36 137.2 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.863 -1.162 . . . . 1.5 107.863 177.704 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.013 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.61 116.97 19.66 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.307 1.595 . . . . 0.6 115.307 -178.717 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -102.21 177.8 4.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.579 -1.267 . . . . 2.11 107.579 176.856 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.579 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -145.14 111.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 118.969 -1.093 . . . . 0.6 112.753 -179.835 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' A' ' 39' ' ' GLU . 25.1 mt -92.99 142.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.691 -1.226 . . . . 0.7 107.691 177.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -154.1 120.7 5.51 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.746 . . . . 0.6 111.945 -178.951 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -56.3 -100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.367 -0.533 . . . . 1.98 109.969 179.633 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 18.6 p30 171.41 -111.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.935 -0.765 . . . . 2.19 108.935 179.65 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -135.09 5.54 3.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.054 0.843 . . . . 1.08 111.53 179.015 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.94 0.02 7.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.736 -0.211 . . . . 1.06 111.236 179.956 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.82 61.16 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 120.334 -0.936 . . . . 0.93 113.186 179.864 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -67.87 114.35 6.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 1.38 110.335 179.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -72.77 121.3 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 0.79 112.255 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.672 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.3 p -89.36 127.0 56.65 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 109.674 -0.491 . . . . 0.59 109.674 179.264 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -32.97 155.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.547 2.832 . . . . 0.85 113.844 -179.16 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.6 Cg_exo -68.06 120.97 7.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.698 2.265 . . . . 0.76 112.685 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.579 ' OG ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -62.75 133.07 54.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.351 -0.611 . . . . 1.28 109.351 179.167 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -31.53 116.58 0.37 Allowed Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 123.682 0.614 . . . . 1.77 112.425 -179.305 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 68.6 Cg_exo -40.67 169.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.011 2.474 . . . . 0.55 114.252 -179.565 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -103.08 141.46 35.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.73 -1.123 . . . . 1.23 109.729 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -41.85 130.54 3.37 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.71 0.631 . . . . 1.63 111.078 179.606 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -59.88 133.97 56.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.861 -0.609 . . . . 0.41 111.552 -179.557 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 13' ' ' ILE . 3.5 mp -116.79 113.19 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.71 179.507 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.1 m -53.42 -16.0 1.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.056 0.761 . . . . 0.44 113.056 -179.106 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 p 42.08 64.9 0.98 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.254 0.55 . . . . 1.1 111.127 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -90.28 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.399 -0.819 . . . . 3.0 111.429 -179.492 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -133.19 31.29 3.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.846 0.355 . . . . 2.14 110.713 -179.748 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 26.0 t0 . . . . . 0 N--CA 1.467 0.393 0 CA-C-N 116.019 -0.537 . . . . 2.06 112.249 -179.617 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.769 0.319 . . . . 0.68 111.012 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.36 122.7 26.67 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.13 -0.486 . . . . 2.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 59.6 Cg_endo -71.57 155.88 58.63 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.036 1.824 . . . . 0.5 112.181 -179.751 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 30.9 Cg_exo -59.73 172.75 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.317 2.011 . . . . 0.71 112.242 -179.757 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.55 168.58 51.05 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.93 -0.652 . . . . 0.66 113.031 -179.693 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 5.6 tttt -63.17 141.13 97.75 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.026 -0.361 . . . . 1.52 110.026 179.663 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.629 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.6 Cg_exo -83.4 142.08 10.41 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.417 2.078 . . . . 0.44 112.589 -179.729 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -143.74 118.33 6.11 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 1.09 110.588 179.749 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.6 Cg_exo -67.0 123.02 10.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.196 1.931 . . . . 0.64 113.521 -179.439 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -34.38 20.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.901 -0.778 . . . . 1.64 108.901 178.701 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 143.48 35.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.794 -1.094 . . . . 0.72 109.047 179.386 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -136.94 102.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.026 0.441 . . . . 0.96 112.044 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.72 59.17 1.47 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.756 -0.656 . . . . 1.46 111.115 -179.999 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 51.53 -74.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.553 -0.748 . . . . 2.42 112.273 179.045 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' THR . 7.2 m-70 -79.69 -45.85 18.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 1.02 110.894 -179.944 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 64' ' ' SER . 1.4 p -99.12 104.61 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 0.68 111.061 -179.905 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 61.7 t -101.22 118.95 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.8 110.219 179.761 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.501 ' C ' HD13 ' A' ' 20' ' ' LEU . 27.3 m -95.29 117.72 30.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.979 -0.555 . . . . 0.35 112.12 -179.117 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.794 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.37 159.49 40.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.447 0.641 . . . . 0.52 111.165 178.541 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.64 148.21 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.911 -1.04 . . . . 1.84 109.692 -179.987 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 1.2 p90 -116.46 -111.06 0.35 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.487 -0.485 . . . . 0.4 112.078 -179.994 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -157.48 -159.55 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.993 -0.442 . . . . 0.83 111.196 -179.189 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HD3' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.73 132.61 24.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 2.11 110.61 179.981 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.3 Cg_endo -57.04 -175.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.432 2.088 . . . . 0.89 112.102 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.51 -43.19 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.955 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -97.03 -66.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 1.37 112.047 -179.32 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.482 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 27.8 p 55.18 32.0 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.91 110.493 -179.345 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.14 -94.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.481 -0.866 . . . . 1.01 111.866 -179.824 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.89 41.68 1.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.513 -1.035 . . . . 0.98 110.513 179.261 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 6.4 m-85 -121.7 -179.15 4.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.181 -0.51 . . . . 0.87 111.752 -178.859 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 1.9 tttt -133.13 -32.96 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 2.26 111.998 -179.972 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.76 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.0 mt 80.98 107.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.083 0.468 . . . . 1.71 110.821 -179.542 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -102.7 12.32 36.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.686 -0.688 . . . . 1.15 111.69 -179.546 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.529 ' HG ' HD22 ' A' ' 55' ' ' ASN . 3.0 t -178.23 137.09 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.485 0.55 . . . . 1.58 112.485 -179.747 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.76 ' CE1' HG21 ' A' ' 33' ' ' ILE . 55.2 m-85 -112.6 151.17 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.819 . . . . 0.76 109.637 178.684 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.73 123.98 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.74 0.305 . . . . 1.14 111.055 -179.529 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 HG21 ' HD2' ' A' ' 61' ' ' PHE . 1.4 t -103.75 101.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.63 111.36 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -74.54 144.61 43.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.34 -0.615 . . . . 1.67 109.34 179.267 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.02 145.73 47.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.133 0.492 . . . . 1.97 111.6 -179.226 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.8 ttm180 -133.57 94.32 3.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.789 -0.641 . . . . 1.44 111.056 -179.963 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.483 ' OD1' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -57.43 164.67 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.409 -0.96 . . . . 1.59 108.409 179.121 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 94' ' ' ALA . 35.2 mt -142.25 129.97 11.48 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.227 -0.589 . . . . 0.9 111.067 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.79 33.83 3.92 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.08 -1.217 . . . . 1.43 113.653 0.743 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -112.12 51.92 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 2.66 111.202 179.895 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -60.65 -178.58 2.14 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.773 -0.727 . . . . 1.12 112.815 -179.998 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.74 -28.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.585 0.217 . . . . 2.41 111.585 -179.968 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 24.3 m95 65.42 72.59 0.42 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.792 0.329 . . . . 0.65 111.251 -179.981 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.6 mp -119.86 133.84 55.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 1.28 110.605 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 86.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 1.3 110.787 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -53.22 -41.62 65.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.86 111.175 -179.668 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.715 ' CG ' HD11 ' A' ' 56' ' ' ILE . 5.4 t30 -44.37 -90.59 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.309 -0.405 . . . . 2.01 111.427 -179.768 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 t80 73.1 39.55 0.61 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.724 0.297 . . . . 2.08 110.712 -179.609 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -157.13 24.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.89 111.551 -179.911 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.529 HD22 ' HG ' ' A' ' 35' ' ' SER . 1.9 t-20 63.85 121.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.82 0.343 . . . . 1.87 111.219 179.611 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.841 HD12 ' CG ' ' A' ' 61' ' ' PHE . 38.9 mm -108.5 75.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.69 110.972 179.58 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.66 -67.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.731 0.301 . . . . 1.6 111.001 -179.995 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pm0 -82.38 163.43 21.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.54 110.158 179.635 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 34.1 p30 -76.89 -1.09 26.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.369 -0.378 . . . . 1.75 111.73 -179.829 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -104.52 98.35 8.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.865 0.364 . . . . 2.05 110.051 179.711 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.841 ' CG ' HD12 ' A' ' 56' ' ' ILE . 64.6 t80 -128.84 164.72 22.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.48 111.439 -179.39 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 51.1 m -128.76 106.85 9.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.319 -0.855 . . . . 0.42 110.826 179.302 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 18' ' ' VAL . 27.0 m -61.77 134.92 26.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.08 110.868 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -130.72 133.45 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 1.33 111.502 -179.524 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.25 21.83 4.33 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.9 112.293 179.917 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.714 HD22 HG23 ' A' ' 18' ' ' VAL . 3.0 mp -79.69 176.65 9.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.185 0.517 . . . . 1.47 111.749 -179.504 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 134.27 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.394 -0.821 . . . . 1.06 110.124 179.419 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 mt-10 -73.73 174.2 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 1.91 111.736 -179.501 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 6.2 t70 52.83 27.44 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.905 -0.588 . . . . 1.87 110.973 -179.962 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.33 126.02 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.49 110.871 179.803 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' CB ' HD12 ' A' ' 43' ' ' LEU . . . -66.03 127.87 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.362 -0.381 . . . . 0.36 110.607 179.78 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 3.6 m-85 -115.91 125.71 52.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.56 112.014 -179.087 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.2 tt0 -106.33 148.41 28.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.873 -0.788 . . . . 1.5 108.873 179.001 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.93 118.76 12.47 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.6 115.032 -178.718 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -100.35 178.06 4.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.004 -0.544 . . . . 2.11 109.831 178.102 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 ' HG3' ' A' ' 8' ' ' PRO . 75.4 t -134.68 122.07 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 113.245 0.831 . . . . 0.6 113.245 -179.53 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 91.9 mt -122.56 142.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.147 -1.427 . . . . 0.7 107.147 178.188 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -169.31 134.35 1.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.49 1.292 . . . . 0.6 114.49 -178.836 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -83.75 136.93 33.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.887 -1.153 . . . . 1.98 107.887 177.529 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 5.9 m-20 -76.69 -92.5 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.468 0.544 . . . . 2.19 112.468 -178.566 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -126.31 -40.96 1.93 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.444 0.535 . . . . 1.08 112.444 -178.99 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.741 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -100.43 36.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.339 0.496 . . . . 1.06 112.339 -179.078 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.96 -0.67 57.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.93 113.486 179.575 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.11 85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.032 0.416 . . . . 1.38 110.176 179.677 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -64.41 121.39 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.169 0.509 . . . . 0.79 111.98 -179.26 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 22.9 p -78.31 123.94 85.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.59 109.311 179.159 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.7 Cg_endo -48.54 171.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.872 2.381 . . . . 0.85 113.172 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB2' ' NH1' ' A' ' 75' ' ' ARG . 14.4 Cg_exo -67.53 112.79 2.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.76 112.862 -179.596 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -74.36 132.58 42.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 1.28 110.037 179.367 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.7 mm-40 -31.01 113.75 0.33 Allowed Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 123.761 0.663 . . . . 1.77 112.355 -179.599 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 75' ' ' ARG . 44.1 Cg_exo -56.07 138.63 83.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.55 113.057 -179.658 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -69.94 146.49 51.13 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.279 -0.638 . . . . 1.23 109.279 179.193 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.6 m-20 -35.76 139.43 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.094 0.871 . . . . 1.63 111.843 -179.865 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -75.65 108.86 8.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.41 111.175 -179.709 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 13' ' ' ILE . 5.0 mp -91.29 114.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.122 -179.712 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 97.5 m -36.22 -32.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.214 -0.448 . . . . 0.44 111.862 -179.96 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.557 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 m 51.28 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.428 -0.351 . . . . 1.1 110.117 179.773 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.99 -90.92 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 3.0 111.669 -179.317 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.634 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -105.71 6.59 32.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.805 0.298 . . . . 2.14 111.805 -179.609 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 53.5 t0 . . . . . 0 C--N 1.331 -0.218 0 N-CA-C 111.862 0.319 . . . . 2.06 111.862 179.755 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.887 HD11 ' ND2' ' A' ' 80' ' ' ASN . 6.9 tt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.766 0.317 . . . . 0.68 111.041 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.81 114.26 19.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 2.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.75 154.61 54.16 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.395 2.063 . . . . 0.5 112.007 179.907 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.81 174.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.692 2.261 . . . . 0.71 112.826 -179.708 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.77 171.48 44.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.993 -0.622 . . . . 0.66 112.658 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -63.64 135.9 96.48 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 110.49 -0.189 . . . . 1.52 110.49 179.802 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_endo -80.9 129.76 7.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.457 2.104 . . . . 0.44 112.861 -179.697 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -132.83 106.01 12.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.917 -0.583 . . . . 1.09 110.793 179.613 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.5 Cg_exo -49.03 131.76 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.334 2.022 . . . . 0.64 113.691 -179.069 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -86.75 -39.92 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.64 108.861 178.689 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -136.35 150.37 48.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.406 -1.27 . . . . 0.72 108.607 179.576 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 1.9 pt -143.44 83.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.262 -0.575 . . . . 0.96 112.516 -179.157 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.23 159.73 29.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.729 -0.669 . . . . 1.46 110.507 179.476 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -17.37 7.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.42 111.961 -179.554 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' THR . 10.7 m-70 -141.91 34.39 1.57 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.973 0.36 . . . . 1.02 111.973 -179.754 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 179.66 120.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.648 -0.251 . . . . 0.68 110.387 179.714 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -117.86 111.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.18 0.514 . . . . 0.8 112.045 -179.317 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 92.4 m -85.21 142.28 29.54 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.004 -0.543 . . . . 0.35 110.266 179.154 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.79 161.13 41.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.428 0.633 . . . . 0.52 112.298 -179.857 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -149.3 144.37 26.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.878 -1.056 . . . . 1.84 110.49 179.742 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.4 p90 -138.23 -173.38 3.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.431 . . . . 0.4 110.734 -179.973 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 -166.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.83 110.381 179.534 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -132.23 155.61 81.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.786 0.327 . . . . 2.11 110.942 179.907 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 28' ' ' THR . 14.6 Cg_exo -69.25 163.41 37.96 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.097 . . . . 0.89 111.835 179.802 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.96 -0.66 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 2.77 111.493 179.652 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -128.6 -70.34 0.68 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.658 0.266 . . . . 1.37 111.644 -179.805 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 25' ' ' PRO . 30.4 p 48.83 57.43 6.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.598 -0.274 . . . . 0.91 110.733 -179.575 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.46 -92.17 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.301 -0.476 . . . . 1.01 112.799 -179.733 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -145.96 32.66 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.236 -1.146 . . . . 0.98 110.236 179.177 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -119.44 -179.04 3.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.953 -0.624 . . . . 0.87 111.374 -178.716 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.08 3.75 2.92 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.249 -0.432 . . . . 2.26 112.164 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mt 60.05 154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.752 0.31 . . . . 1.71 110.635 -179.935 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 33' ' ' ILE . 8.3 p -145.2 15.14 1.49 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.002 0.371 . . . . 1.15 112.002 -179.646 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -177.65 133.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 1.58 111.214 -179.915 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.9 m-85 -109.58 105.18 14.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.76 110.642 179.592 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.554 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.3 mt -84.91 152.02 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.019 -0.537 . . . . 1.14 111.039 -179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 75' ' ' ARG . 2.5 t -131.53 111.76 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.63 110.568 179.65 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -87.12 143.88 27.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.006 -0.368 . . . . 1.67 110.006 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.34 141.24 51.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.122 0.487 . . . . 1.97 112.23 -179.0 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 23.0 ttp180 -112.02 112.14 23.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.741 -0.663 . . . . 1.44 109.614 178.932 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 1.368 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.9 96.99 4.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 1.59 110.887 -179.594 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 7.6 mt -80.26 154.1 74.45 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.9 110.785 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.61 12.32 51.47 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.691 -1.379 . . . . 1.43 112.89 0.192 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -77.96 -82.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.402 . . . . 2.66 110.632 179.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 123.8 143.2 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.864 -0.684 . . . . 1.12 112.484 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 1.368 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 171.83 55.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.466 0.174 . . . . 2.41 111.158 -179.847 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.624 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 14.1 m95 -36.97 107.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.378 -0.374 . . . . 0.65 111.725 -179.994 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -143.47 136.89 28.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.049 0.452 . . . . 1.28 111.065 179.976 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.554 ' HE2' HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.22 104.33 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 1.3 111.173 -179.921 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.42 -47.01 87.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.037 0.446 . . . . 0.86 110.259 179.557 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.564 ' CB ' HD11 ' A' ' 56' ' ' ILE . 1.9 t30 -68.35 116.98 9.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.788 -0.642 . . . . 2.01 110.189 179.639 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -114.31 46.69 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 2.08 111.117 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 t -150.12 -83.91 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.409 -0.36 . . . . 1.89 110.962 -179.958 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.78 147.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 1.87 110.777 -179.961 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.705 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.3 mt -142.0 75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.69 111.31 -179.827 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.4 tm? -59.76 -53.06 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 1.6 110.718 179.835 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.4 pt-20 -80.29 161.58 25.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.127 179.684 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 45.2 p-10 -81.45 6.08 15.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 1.75 111.918 -179.756 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 22.1 tt0 -106.58 104.31 13.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.591 -0.522 . . . . 2.05 109.591 179.413 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.705 ' CG ' HD13 ' A' ' 56' ' ' ILE . 63.9 t80 -137.77 163.81 30.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.48 112.184 -179.255 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 65.5 m -122.2 107.15 11.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.628 -0.715 . . . . 0.42 111.358 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 18' ' ' VAL . 2.2 m -72.05 94.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.759 -0.655 . . . . 1.08 110.436 179.57 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -100.44 155.62 17.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.589 0.709 . . . . 1.33 111.068 179.989 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.0 22.67 3.81 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.664 -1.153 . . . . 0.9 112.314 179.793 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -85.8 -172.49 4.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.898 0.38 . . . . 1.47 110.932 -179.753 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -148.28 116.11 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 1.06 110.654 179.998 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 97' ' ' CYS . 1.7 tt0 -41.53 137.86 1.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.096 -0.502 . . . . 1.91 111.563 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t70 75.69 47.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.085 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.6 121.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.49 110.983 179.778 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.0 127.42 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.36 111.086 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 55.3 m-85 -124.35 127.28 47.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.503 -0.771 . . . . 0.56 112.307 -179.225 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 3.1 tp10 -99.8 147.41 25.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.036 -0.727 . . . . 1.5 109.036 178.812 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 95' ' ' ILE . 15.0 m-85 -137.18 116.95 13.07 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.969 1.47 . . . . 0.6 114.969 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.624 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -107.43 171.05 7.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.963 -0.755 . . . . 2.11 108.963 177.587 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 8' ' ' PRO . 77.0 t -126.24 108.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.951 0.723 . . . . 0.6 112.951 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.596 HD11 ' HG3' ' A' ' 88' ' ' PRO . 31.4 mt -102.83 139.19 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.528 -1.286 . . . . 0.7 107.528 177.946 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -153.76 129.75 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.64 -0.824 . . . . 0.6 112.064 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 40.8 mttt -78.75 -178.22 5.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.486 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.887 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.5 m-80 -129.02 172.58 11.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.003 -0.544 . . . . 2.19 110.812 179.839 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.1 -28.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.719 -0.673 . . . . 1.08 111.785 179.658 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -112.14 34.77 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.439 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 42.68 37.81 2.87 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.67 -0.776 . . . . 0.93 113.02 179.611 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.01 8.24 8.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.287 0.477 . . . . 1.38 112.287 -179.956 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER 35.7 97.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 113.496 0.924 . . . . 0.79 113.496 179.738 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -75.73 116.64 57.13 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.53 -0.915 . . . . 0.59 108.53 178.461 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -35.16 158.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.405 2.737 . . . . 0.85 113.39 -178.843 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.596 ' HG3' HD11 ' A' ' 77' ' ' ILE . 12.6 Cg_exo -68.06 142.77 57.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.627 2.218 . . . . 0.76 112.23 179.871 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 50.5 m -92.25 118.64 31.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.958 -0.565 . . . . 1.28 110.125 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 42.5 mt-10 -19.66 104.94 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.021 0.929 . . . . 1.77 113.151 -179.461 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.475 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 55.5 Cg_exo -39.98 161.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.608 2.205 . . . . 0.55 113.246 -179.471 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.46 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -97.04 143.51 27.81 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.501 -0.772 . . . . 1.23 109.339 179.175 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 2.6 m-20 -35.31 129.01 0.54 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.027 0.83 . . . . 1.63 112.077 -179.286 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -50.19 133.06 23.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.41 111.397 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.743 HD13 ' HE2' ' A' ' 74' ' ' PHE . 3.2 mp -113.24 106.76 21.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.44 111.686 -179.789 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.7 m -52.54 -23.02 5.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.841 179.688 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.452 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 60.29 38.35 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.1 110.235 -179.834 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -132.97 -38.42 0.98 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 3.0 111.946 -179.635 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.429 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 3.9 p-10 -49.0 -26.27 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 2.14 111.624 -179.405 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 116.115 -0.493 . . . . 2.06 111.531 179.821 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.916 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.2 tt . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.596 0.712 . . . . 0.68 112.439 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.981 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -141.93 123.59 8.91 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.43 -179.962 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.08 166.92 28.43 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.321 2.014 . . . . 0.5 112.256 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.2 Cg_exo -52.24 173.96 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.667 2.245 . . . . 0.71 112.749 -179.626 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.56 39.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.071 -0.585 . . . . 0.66 112.78 -179.831 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 tptm -65.44 118.12 47.44 Favored Pre-proline 0 CA--C 1.532 0.254 0 O-C-N 123.043 -0.092 . . . . 1.52 110.772 179.879 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.688 ' CG ' HG23 ' A' ' 76' ' ' VAL . 15.5 Cg_exo -69.77 127.94 15.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.418 2.079 . . . . 0.44 112.731 -179.68 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -131.96 113.6 14.97 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.74 -0.664 . . . . 1.09 111.405 -179.491 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 71.5 Cg_exo -47.32 112.1 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.52 2.146 . . . . 0.64 113.193 -179.61 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -74.12 -35.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.736 -0.838 . . . . 1.64 108.736 179.174 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 3.9 t30 -143.91 153.29 42.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.486 -1.234 . . . . 0.72 107.718 178.621 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.824 HG21 HG12 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -142.93 141.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.809 -0.756 . . . . 0.96 113.019 -178.793 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -139.94 136.44 33.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.21 -0.904 . . . . 1.46 109.863 179.263 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -42.68 -24.83 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.005 0.743 . . . . 2.42 113.005 -179.023 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -118.11 -12.98 9.96 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.744 -0.598 . . . . 1.02 112.517 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -153.46 125.6 7.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.246 -0.279 . . . . 0.68 110.246 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -118.64 145.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.8 111.81 -179.809 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.701 ' OG1' HG23 ' A' ' 62' ' ' THR . 9.0 m -111.36 127.72 55.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.04 -0.527 . . . . 0.35 111.072 -179.745 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.776 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.06 139.27 52.09 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.865 0.841 . . . . 0.52 111.355 178.769 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -121.67 155.49 35.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.124 -1.398 . . . . 1.84 108.973 179.632 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.538 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.6 p90 -152.55 -174.48 4.92 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.213 -0.595 . . . . 0.4 111.966 -179.729 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.77 168.2 10.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.052 -0.522 . . . . 0.83 112.046 -179.389 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -97.76 141.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.775 -0.648 . . . . 2.11 110.434 179.888 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HB2' HG23 ' A' ' 28' ' ' THR . 88.8 Cg_exo -47.38 176.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.346 2.031 . . . . 0.89 112.246 179.958 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -121.18 -29.54 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.418 -0.355 . . . . 2.77 111.799 -179.7 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 10.8 t80 -113.77 -71.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.986 0.365 . . . . 1.37 111.986 -179.376 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.981 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 47.7 p 50.48 43.92 27.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 0.91 110.985 -179.593 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.18 -91.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.814 -0.707 . . . . 1.01 112.49 179.89 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.27 32.6 1.04 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.637 -0.985 . . . . 0.98 110.637 179.561 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -112.08 175.14 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.007 -0.596 . . . . 0.87 111.147 -179.076 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 18.1 ttpt -126.17 -17.71 5.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.061 -0.518 . . . . 2.26 112.015 -179.799 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 35.9 mt 70.84 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.685 0.279 . . . . 1.71 110.713 -179.589 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -126.77 25.46 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 1.15 111.671 -179.619 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.6 t -178.75 127.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 1.58 111.259 179.903 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.547 ' O ' HD12 ' A' ' 56' ' ' ILE . 5.5 m-85 -114.36 95.46 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.76 111.172 -179.916 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.61 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.3 mt -87.32 112.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 1.14 111.003 -179.972 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -102.58 116.68 46.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.63 111.103 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -81.12 154.92 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 1.67 109.857 179.502 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 23.0 pttt -127.94 146.57 50.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.187 0.518 . . . . 1.97 111.494 -179.759 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 10.3 ttp180 -116.08 108.19 15.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 1.44 110.045 179.472 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.826 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.97 87.3 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.881 -0.6 . . . . 1.59 110.54 -179.836 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.605 HD11 ' OE1' ' A' ' 73' ' ' GLU . 33.1 mt -65.07 153.95 87.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.879 -179.88 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.62 24.49 20.2 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.846 -1.314 . . . . 1.43 112.976 0.386 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -154.8 70.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.781 0.324 . . . . 2.66 111.592 -179.936 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.41 -161.59 35.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.676 -0.773 . . . . 1.12 112.019 179.606 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -160.03 26.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.296 . . . . 2.41 111.166 -179.991 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 38.5 m95 42.71 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.544 179.828 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.463 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -132.27 130.41 40.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 1.28 111.202 -179.961 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HE3' HG21 ' A' ' 37' ' ' ILE . 3.3 ptmt -54.96 88.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 1.3 110.787 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.675 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -52.5 -54.59 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.86 110.907 179.979 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.663 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.4 p-10 -62.47 128.81 37.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.814 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.71 -2.36 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 2.08 111.714 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -168.8 1.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.815 0.341 . . . . 1.89 110.941 179.939 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.77 115.97 26.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 1.87 111.18 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.663 HD11 ' CB ' ' A' ' 52' ' ' ASN . 54.5 mt -99.27 60.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.59 179.711 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -43.38 -64.48 0.63 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.242 -0.435 . . . . 1.6 111.648 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -72.57 171.52 12.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 1.54 110.533 179.847 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.478 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -89.49 11.76 18.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.75 111.412 179.978 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -110.66 100.07 8.91 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 110.099 -0.334 . . . . 2.05 110.099 179.446 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CG ' HD13 ' A' ' 56' ' ' ILE . 61.3 t80 -131.66 164.75 25.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.139 0.495 . . . . 0.48 111.715 -179.465 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.701 HG23 ' OG1' ' A' ' 19' ' ' THR . 2.1 m -124.76 123.46 40.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.657 -0.702 . . . . 0.42 110.744 179.631 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.675 HG13 ' CB ' ' A' ' 51' ' ' ALA . 16.5 t -83.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.171 0.51 . . . . 1.08 111.189 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 134.98 36.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 1.33 110.701 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.09 -16.28 4.45 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.552 -0.749 . . . . 0.9 111.469 -179.295 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.857 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -51.38 172.16 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.805 0.335 . . . . 1.47 110.649 179.656 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.4 m -137.27 152.8 50.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.057 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 2.5 tt0 -61.1 155.49 20.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.91 111.197 179.943 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 97' ' ' CYS . 60.2 m-20 47.36 60.62 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 1.87 111.55 179.952 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.34 116.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.688 0.28 . . . . 0.49 111.375 179.646 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.66 125.4 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.677 -0.49 . . . . 0.36 109.677 179.234 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 44.1 m-85 -117.28 124.37 48.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.066 0.765 . . . . 0.56 113.066 -178.869 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.605 ' OE1' HD11 ' A' ' 43' ' ' LEU . 1.6 mt-10 -102.46 135.1 44.68 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.496 -0.928 . . . . 1.5 108.496 178.208 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 1.085 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.46 111.28 12.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.082 1.142 . . . . 0.6 114.082 -178.337 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.585 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 ptp180 -91.27 146.67 23.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 2.11 109.694 178.471 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.688 HG23 ' CG ' ' A' ' 8' ' ' PRO . 98.7 t -106.13 110.09 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.919 0.711 . . . . 0.6 112.919 -179.297 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' A' ' 39' ' ' GLU . 85.0 mt -106.59 154.54 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.805 -1.183 . . . . 0.7 107.805 177.991 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.63 120.87 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.203 -0.999 . . . . 0.6 113.145 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.8 ptpt -72.41 156.94 38.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.556 -0.535 . . . . 1.98 109.556 178.795 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.916 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -100.86 170.87 8.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.533 0.682 . . . . 2.19 112.406 -178.842 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.2 -58.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 1.08 112.112 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -12.94 17.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 1.06 112.296 -179.686 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 -14.61 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.536 -0.84 . . . . 0.93 112.176 -179.733 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -51.46 155.96 1.38 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 110.171 -0.307 . . . . 1.38 110.171 179.709 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -107.71 117.37 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.29 0.478 . . . . 0.79 112.29 -179.399 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.0 p -79.88 111.43 21.58 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.667 -0.697 . . . . 0.59 109.581 179.051 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.74 160.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.004 2.469 . . . . 0.85 112.932 -179.782 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.453 ' CB ' ' HD3' ' A' ' 75' ' ' ARG . 41.0 Cg_endo -68.77 134.79 31.08 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.675 2.25 . . . . 0.76 112.853 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 90' ' ' GLU . 19.8 m -90.84 111.07 22.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 1.28 109.919 179.28 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -4.12 108.33 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.717 1.207 . . . . 1.77 113.573 -179.677 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.519 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 84.3 Cg_exo -41.8 131.31 4.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.677 2.251 . . . . 0.55 113.712 -179.711 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.21 148.21 48.76 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.884 -0.598 . . . . 1.23 109.468 178.959 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -33.07 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.386 1.054 . . . . 1.63 112.409 -179.999 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.46 106.61 9.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.41 110.372 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.824 HG12 HG21 ' A' ' 13' ' ' ILE . 5.0 mp -85.69 108.66 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.743 0.306 . . . . 0.44 110.571 -179.923 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.9 m -42.53 -40.07 2.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.959 0.409 . . . . 0.44 111.027 179.956 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 15' ' ' ARG . 94.0 m 60.84 75.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.1 111.415 179.31 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -108.88 -79.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 3.0 110.109 179.605 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -126.03 0.22 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.703 -0.681 . . . . 2.14 111.314 179.471 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.463 0.193 0 N-CA-C 112.676 0.621 . . . . 2.06 112.676 179.629 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.573 HD12 ' HB1' ' A' ' 84' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 121.01 0.433 . . . . 0.68 111.854 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' ILE . 4.2 m-20 -134.56 127.24 18.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.0 110.127 179.69 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.26 163.08 38.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.239 1.959 . . . . 0.5 112.444 -179.714 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 37.0 Cg_exo -57.8 178.19 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.779 2.319 . . . . 0.71 112.782 -179.732 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.89 174.56 43.02 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.913 -0.66 . . . . 0.66 112.819 -179.988 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -68.63 130.66 91.78 Favored Pre-proline 0 N--CA 1.462 0.152 0 CA-C-N 116.64 0.22 . . . . 1.52 110.415 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HG3' HG12 ' A' ' 76' ' ' VAL . 17.0 Cg_exo -72.7 138.37 29.02 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.386 2.057 . . . . 0.44 113.124 -179.287 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.93 116.74 7.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.534 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.7 Cg_exo -58.91 138.36 85.21 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.546 2.164 . . . . 0.64 113.973 -179.207 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.605 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.3 mm? -104.17 -33.13 8.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.525 -0.761 . . . . 1.64 109.064 178.649 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.23 153.29 41.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.051 -0.977 . . . . 0.72 109.498 179.557 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.13 HG22 HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -148.62 108.68 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.124 0.487 . . . . 0.96 111.929 -179.549 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.092 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -105.41 53.04 0.72 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.679 -0.691 . . . . 1.46 111.212 -179.924 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 1.104 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.26 -73.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.98 0.8 . . . . 2.42 112.548 179.239 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' THR . 9.0 m-70 -70.64 -29.49 65.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.269 -0.423 . . . . 1.02 111.598 -179.349 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 64' ' ' SER . 62.3 p -128.78 126.2 39.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.759 0.314 . . . . 0.68 111.332 -179.815 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 13' ' ' ILE . 87.4 t -113.06 128.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.8 110.802 179.836 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 14.2 m -102.41 124.1 47.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.35 111.461 -179.392 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.815 HD11 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -137.14 162.09 34.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.535 0.683 . . . . 0.52 111.585 179.384 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.35 151.64 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.97 -1.014 . . . . 1.84 110.536 -179.635 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 11.1 p90 -136.88 -173.58 3.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.022 0.439 . . . . 0.4 111.463 -179.948 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.91 173.52 8.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.83 111.088 179.922 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 149.54 36.18 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.451 -0.34 . . . . 2.11 110.631 179.857 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.12 -162.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.938 2.426 . . . . 0.89 113.036 -179.652 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -146.37 -48.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.77 111.139 -179.67 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -95.03 -72.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.479 -0.328 . . . . 1.37 111.35 -179.846 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 p 69.39 -45.14 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.055 0.761 . . . . 0.91 113.055 -179.7 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.57 -22.32 10.16 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.269 -0.967 . . . . 1.01 112.302 -179.889 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.74 -26.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.496 -1.442 . . . . 0.98 109.496 -179.241 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 8.8 m-85 -60.9 -175.31 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.275 -0.963 . . . . 0.87 110.366 179.13 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 24.33 0.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.136 -0.484 . . . . 2.26 111.098 179.584 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 7.0 mt 42.97 98.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.136 0.493 . . . . 1.71 112.195 179.845 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' SER . 3.0 p -94.59 14.13 21.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 1.15 111.282 179.755 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' THR . 28.7 t 176.68 122.86 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.797 0.332 . . . . 1.58 111.568 -179.939 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.838 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.4 m-85 -106.86 117.28 33.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.76 110.226 179.502 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.613 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -97.28 135.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.654 -0.248 . . . . 1.14 110.959 -179.624 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 t -112.99 113.49 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.755 0.312 . . . . 0.63 111.249 179.84 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 5.3 mt-10 -87.57 127.52 35.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 1.67 110.158 179.474 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.893 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 3.9 pttm -106.56 147.31 29.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 1.97 111.724 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.3 ttp180 -129.13 117.48 20.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.59 -0.732 . . . . 1.44 110.428 179.455 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.947 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.77 123.92 25.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 1.59 110.178 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 94' ' ' ALA . 4.2 mt -113.99 150.23 43.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.9 111.479 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 8.8 Cg_endo -88.71 33.01 7.61 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.994 -1.253 . . . . 1.43 112.499 0.308 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.41 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 m-80 -154.17 98.82 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 2.66 110.852 -179.989 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.947 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . 177.28 -168.69 40.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.752 . . . . 1.12 112.179 -179.953 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -152.34 166.19 32.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.442 . . . . 2.41 111.37 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 73.2 m95 -68.47 120.12 14.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.574 -0.739 . . . . 0.65 111.894 -179.536 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.667 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -143.38 129.39 19.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 1.28 110.585 179.79 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.613 ' HD2' HG21 ' A' ' 37' ' ' ILE . 11.6 mtmm -50.54 92.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.3 110.805 -179.778 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.68 -52.76 62.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.86 110.871 179.893 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.73 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.6 p-10 -59.22 157.01 11.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.801 -0.636 . . . . 2.01 111.261 -179.891 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -165.52 28.81 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.702 -0.681 . . . . 2.08 110.716 179.558 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 p -128.71 36.56 4.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.459 -0.337 . . . . 1.89 111.234 -179.761 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.14 99.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.87 110.896 179.962 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.8 mt -90.63 93.7 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.503 . . . . 0.69 111.467 -179.842 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.9 tm? -76.83 -55.09 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.6 111.197 -179.974 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.05 173.11 12.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 1.54 110.511 179.871 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.485 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 35.1 p30 -84.66 -2.12 57.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.75 111.502 179.98 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -104.17 102.07 11.8 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.162 -0.31 . . . . 2.05 110.162 179.741 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 56' ' ' ILE . 44.8 t80 -135.22 164.85 26.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.286 -0.415 . . . . 0.48 111.329 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 93.1 m -121.04 114.09 20.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.978 -0.556 . . . . 0.42 111.529 -179.925 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.815 HG22 HD11 ' A' ' 20' ' ' LEU . 6.8 m -76.72 91.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.723 -0.671 . . . . 1.08 111.424 179.752 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.692 ' HB2' HG22 ' A' ' 17' ' ' THR . 13.9 p -93.01 178.73 5.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 1.33 110.896 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.9 10.89 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.806 -0.712 . . . . 0.9 112.478 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 ' CD1' HG23 ' A' ' 18' ' ' VAL . 15.3 mt -104.58 -161.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 1.47 111.168 -179.837 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -141.15 146.85 37.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.044 -0.525 . . . . 1.06 111.159 -179.892 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.14 149.19 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 1.91 110.916 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.36 43.97 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 1.87 110.733 -179.977 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -162.96 125.01 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.49 111.439 -179.833 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -67.4 137.24 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.36 110.256 179.521 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 36.0 m-85 -132.3 119.4 20.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.598 0.592 . . . . 0.56 112.598 -179.198 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -98.41 147.31 24.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.602 -0.888 . . . . 1.5 108.602 178.531 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.74 115.48 11.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.648 1.351 . . . . 0.6 114.648 -178.632 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 ptt85 -104.84 167.95 9.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 177.674 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -134.28 129.8 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 119.472 -0.891 . . . . 0.6 113.386 -179.654 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 86' ' ' SER . 76.5 mt -118.63 151.89 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.376 -1.284 . . . . 0.7 108.045 178.366 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -158.09 130.83 7.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.646 -0.822 . . . . 0.6 112.676 -179.543 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.18 63.88 8.26 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.566 0.698 . . . . 1.98 109.537 178.831 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 4.3 m-20 9.22 -104.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.302 -1.772 . . . . 2.19 114.201 -179.949 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.57 -44.68 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 122.014 -0.429 . . . . 1.08 111.859 -179.66 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.615 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -105.82 45.07 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.068 0.396 . . . . 1.06 112.068 -179.371 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.41 1.35 60.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.378 -0.915 . . . . 0.93 113.276 179.622 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.06 88.05 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.675 -0.491 . . . . 1.38 109.675 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.35 112.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.399 0.618 . . . . 0.79 112.516 -178.824 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' ILE . 49.5 p -85.55 111.7 39.01 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.941 -1.027 . . . . 0.59 108.973 178.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.4 Cg_exo -38.32 157.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.9 2.4 . . . . 0.85 112.879 -179.053 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.415 ' CA ' HG12 ' A' ' 77' ' ' ILE . 18.4 Cg_endo -60.66 132.06 40.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.803 2.335 . . . . 0.76 113.081 -179.709 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -89.02 108.27 19.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.411 -0.813 . . . . 1.28 109.498 179.155 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -6.24 120.93 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.803 1.314 . . . . 1.77 113.674 -179.492 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 50.4 Cg_exo -54.58 143.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.383 2.056 . . . . 0.55 113.307 -179.695 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.75 146.77 35.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.509 ' O ' HD12 ' A' ' 95' ' ' ILE . 4.1 m-20 -33.41 131.23 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.175 0.922 . . . . 1.63 112.238 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -70.67 116.53 11.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.41 111.232 -179.843 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -99.86 120.15 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.44 111.16 179.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.5 m -46.99 -36.51 7.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.44 111.127 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 60.39 88.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.1 110.498 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 -81.94 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 3.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.545 ' C ' ' OD1' ' A' ' 99' ' ' ASP . 0.5 OUTLIER -108.25 5.99 26.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.825 -0.625 . . . . 2.14 111.325 179.751 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 1.104 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 121.23 0.538 . . . . 2.06 112.225 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.76 0.314 . . . . 2.74 111.183 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -92.64 -166.93 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.054 2.503 . . . . 2.06 112.488 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.736 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.7 tt -148.47 144.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.007 -0.542 . . . . 0.68 110.982 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -125.17 120.11 25.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 2.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 159.24 54.07 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.141 1.894 . . . . 0.5 111.696 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.8 Cg_endo -52.43 172.93 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 0.71 112.502 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.55 164.8 52.63 Favored Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.723 -0.671 . . . . 0.66 112.999 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.91 123.92 61.78 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.463 -0.199 . . . . 1.52 110.463 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.589 ' CG ' HG23 ' A' ' 76' ' ' VAL . 21.7 Cg_exo -67.3 133.89 31.87 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.345 2.03 . . . . 0.44 112.713 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.3 p -131.47 117.54 16.66 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.006 -0.543 . . . . 1.09 110.794 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 11.9 Cg_exo -67.66 125.99 14.09 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.464 2.109 . . . . 0.64 113.801 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.3 OUTLIER -86.22 -31.84 21.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.485 -0.932 . . . . 1.64 108.485 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.48 145.82 34.11 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.075 -0.966 . . . . 0.72 109.48 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.005 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 96.36 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.166 0.508 . . . . 0.96 111.573 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.54 156.58 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.734 -0.666 . . . . 1.46 110.814 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -50.67 -22.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.862 -0.608 . . . . 2.42 112.043 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 67' ' ' THR . 1.5 m-70 -139.06 12.18 2.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.254 0.464 . . . . 1.02 112.254 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.85 106.32 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.401 . . . . 0.68 111.326 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.005 HG13 HG22 ' A' ' 13' ' ' ILE . 96.0 t -100.59 117.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.892 -0.595 . . . . 0.8 110.629 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.699 ' C ' HD13 ' A' ' 20' ' ' LEU . 18.1 m -98.33 125.05 43.3 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.802 -0.636 . . . . 0.35 111.632 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -139.47 154.75 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.821 0.82 . . . . 0.52 112.163 179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' HB3' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.61 164.39 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.369 -1.287 . . . . 1.84 109.11 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 7.0 p90 -141.98 -175.14 4.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.165 0.507 . . . . 0.4 112.117 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.94 128.38 47.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.572 -0.74 . . . . 0.83 110.895 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -59.46 146.68 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.454 -0.339 . . . . 2.11 110.815 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.542 ' HG2' HD12 ' A' ' 33' ' ' ILE . 53.4 Cg_exo -52.47 171.39 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.554 2.169 . . . . 0.89 112.682 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -122.67 -18.49 6.57 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 2.77 112.137 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -127.17 -71.0 0.69 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 121.003 -0.279 . . . . 1.37 111.581 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.48 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.4 p 55.88 47.37 20.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.66 -0.246 . . . . 0.91 110.987 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.14 0.01 OUTLIER Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.889 -0.672 . . . . 1.01 112.515 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.19 38.03 1.2 Allowed Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 109.796 -1.322 . . . . 0.98 109.796 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.693 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -126.29 -179.53 4.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.685 -0.758 . . . . 0.87 111.033 -178.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -133.66 -1.07 3.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.302 0.482 . . . . 2.26 112.302 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 25' ' ' PRO . 19.9 mt 61.98 132.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.785 0.326 . . . . 1.71 110.952 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.429 HG22 ' HD2' ' A' ' 32' ' ' LYS . 4.1 p -128.63 39.75 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.349 -0.387 . . . . 1.15 111.193 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 34' ' ' THR . 23.9 t 172.29 134.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 1.58 110.658 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -122.94 83.82 2.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.48 -0.327 . . . . 0.76 111.313 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.469 HG23 HD21 ' A' ' 52' ' ' ASN . 0.8 OUTLIER -74.56 162.7 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 1.14 110.417 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -150.75 126.51 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.072 0.463 . . . . 0.63 110.474 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' CG ' HD12 ' A' ' 77' ' ' ILE . 3.7 mt-10 -93.62 137.67 32.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.759 -0.655 . . . . 1.67 110.949 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -107.06 141.54 38.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.889 -0.596 . . . . 1.97 110.839 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 0.7 OUTLIER -110.97 116.66 31.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.44 110.69 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -84.67 87.39 7.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.809 -0.632 . . . . 1.59 110.025 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 4.3 mt -75.33 154.42 86.05 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.084 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 66.8 Cg_endo -89.33 34.02 7.12 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 123.862 -1.308 . . . . 1.43 113.044 0.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.4 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 p30 -155.02 64.06 0.64 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.737 0.303 . . . . 2.66 111.288 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -107.01 -163.2 22.09 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.887 -0.673 . . . . 1.12 112.446 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -170.86 30.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.677 0.251 . . . . 2.41 111.677 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.553 ' CE3' ' CD ' ' A' ' 75' ' ' ARG . 48.8 m95 52.49 109.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.925 0.342 . . . . 0.65 111.925 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.706 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -137.7 117.38 13.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 1.28 111.244 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -53.31 93.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.19 -0.459 . . . . 1.3 110.874 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.573 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -65.78 -55.11 18.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.193 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.5 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 1.2 p-10 -50.84 149.02 3.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 2.01 111.215 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -155.36 24.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.926 -0.579 . . . . 2.08 110.786 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.1 m -122.52 25.7 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 1.89 111.153 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.36 106.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.319 -0.401 . . . . 1.87 110.648 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 61' ' ' PHE . 73.3 mt -97.28 84.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.474 . . . . 0.69 110.774 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.9 -40.1 65.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.989 -0.55 . . . . 1.6 111.563 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 139.92 30.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.527 -0.306 . . . . 1.54 110.225 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 27.5 p-10 -72.63 62.64 0.56 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.248 0.547 . . . . 1.75 111.19 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE2' ' CB ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -166.81 91.17 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 2.05 108.872 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CG ' ' CD1' ' A' ' 56' ' ' ILE . 61.0 t80 -126.95 165.13 19.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.176 0.512 . . . . 0.48 111.886 -178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.671 HG23 ' OG1' ' A' ' 19' ' ' THR . 4.2 m -123.93 121.14 34.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.505 -0.771 . . . . 0.42 110.76 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.0 t -86.35 105.47 14.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.19 0.519 . . . . 1.08 111.43 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 p -99.18 -157.17 0.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 1.33 110.73 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.65 17.75 42.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.9 112.42 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.42 ' CD1' HG23 ' A' ' 18' ' ' VAL . 17.7 mt -81.68 -163.52 0.65 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.855 0.36 . . . . 1.47 110.765 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.467 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 94.9 m -144.52 154.82 43.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.996 -0.547 . . . . 1.06 110.567 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 157.96 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.154 -0.476 . . . . 1.91 110.765 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t0 51.87 50.3 18.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 1.87 110.746 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -156.83 124.58 5.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.235 -0.439 . . . . 0.49 111.245 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.72 124.39 26.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.199 -0.455 . . . . 0.36 110.391 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 58.8 m-85 -123.96 129.57 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.078 0.466 . . . . 0.56 111.897 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 7.6 tt0 -104.15 150.18 24.58 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.956 -0.757 . . . . 1.5 108.956 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.844 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -141.21 119.65 12.3 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.893 1.442 . . . . 0.6 114.893 -178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -106.41 161.74 14.31 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.223 -0.658 . . . . 2.11 109.223 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 HG23 ' CG ' ' A' ' 8' ' ' PRO . 85.0 t -117.21 109.29 27.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.054 -0.658 . . . . 0.6 112.343 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 87.0 mt -97.15 139.6 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.619 -1.252 . . . . 0.7 107.619 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -155.05 140.68 17.97 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.572 -0.851 . . . . 0.6 112.691 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 mttt -86.53 -174.63 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.449 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.736 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.6 p30 -130.36 162.66 28.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.963 0.411 . . . . 2.19 110.761 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.18 -26.94 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.08 112.22 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.93 -18.68 42.77 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.554 0.576 . . . . 1.06 112.554 -179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.27 -20.43 25.78 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.407 -0.901 . . . . 0.93 112.033 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.698 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.68 166.68 0.64 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.828 -0.434 . . . . 1.38 109.828 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -117.56 103.39 14.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 112.563 0.579 . . . . 0.79 112.563 -179.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.458 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 1.2 p -63.03 122.46 75.26 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 108.962 -0.755 . . . . 0.59 108.962 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.9 Cg_endo -42.54 162.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.016 2.477 . . . . 0.85 113.098 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 33.6 Cg_endo -64.1 135.62 48.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.826 2.351 . . . . 0.76 112.747 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -78.35 124.84 28.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.91 -0.586 . . . . 1.28 109.555 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.478 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 4.6 mt-10 -24.85 99.59 0.08 OUTLIER Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 123.732 0.813 . . . . 1.77 113.074 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 93.7 Cg_exo -32.35 154.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.425 2.75 . . . . 0.55 114.02 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -94.07 143.85 26.0 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.419 -0.809 . . . . 1.23 109.388 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 58.3 m-20 -34.27 138.07 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 O-C-N 124.217 0.948 . . . . 1.63 111.916 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB1' ' CD1' ' A' ' 43' ' ' LEU . . . -75.16 117.51 17.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.41 111.339 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.742 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.1 mp -102.58 122.88 55.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 0.44 111.241 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.6 m -51.51 -25.03 5.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 0.44 111.248 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.742 ' H ' HG22 ' A' ' 95' ' ' ILE . 90.7 m 57.75 49.06 12.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.075 0.464 . . . . 1.1 110.204 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.893 ' O ' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -146.82 -39.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.693 -0.685 . . . . 3.0 111.603 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 0.4 OUTLIER -46.21 -26.08 0.72 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.246 -0.434 . . . . 2.14 111.73 -179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -6.09 38.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 2.06 111.92 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.893 HG12 ' O ' ' A' ' 98' ' ' ARG . 11.4 p -119.98 -1.21 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.246 -0.434 . . . . 2.8 110.215 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 103' ' ' ALA . 1.9 pp20? -140.58 -50.13 0.45 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.865 -0.334 . . . . 4.58 111.297 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB3' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.221 -0.895 . . . . 3.79 111.154 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.669 0.271 . . . . 2.74 111.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.91 -159.03 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.128 2.552 . . . . 2.06 111.883 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.889 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -170.01 145.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.68 111.002 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.1 t0 -128.65 128.44 23.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.333 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 66.6 Cg_endo -71.22 157.33 57.49 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.317 2.011 . . . . 0.5 112.633 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 51.0 Cg_exo -54.63 -170.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.55 2.167 . . . . 0.71 112.34 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.17 -153.9 5.85 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.954 -0.641 . . . . 0.66 112.753 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.7 ttpt -95.13 141.28 23.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 110.697 -0.112 . . . . 1.52 110.697 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.583 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.8 Cg_endo -86.79 143.89 7.25 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.071 2.514 . . . . 0.44 112.285 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.8 p -159.48 125.07 2.3 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.685 -0.234 . . . . 1.09 111.577 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.613 ' CG ' HD11 ' A' ' 95' ' ' ILE . 7.3 Cg_exo -70.92 97.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.235 1.957 . . . . 0.64 112.714 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.7 mp -60.62 -30.4 69.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.228 0.537 . . . . 1.64 109.982 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -146.73 157.33 43.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.342 -0.844 . . . . 0.72 109.443 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.893 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -143.39 105.96 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.103 0.478 . . . . 0.96 111.415 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -91.62 47.71 1.39 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.74 -0.663 . . . . 1.46 111.652 -179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.51 -73.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 O-C-N 123.876 0.735 . . . . 2.42 112.07 179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' THR . 16.0 m170 -81.35 -31.83 33.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 1.02 111.718 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p -125.2 105.21 8.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.717 0.294 . . . . 0.68 110.832 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.92 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 6.6 m -92.02 156.22 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.44 -0.346 . . . . 0.8 110.713 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.6 m -123.76 113.03 18.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.708 -0.223 . . . . 0.35 111.594 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -127.06 149.31 49.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.52 111.265 178.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.309 ' CB ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -138.49 166.25 24.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.716 -1.129 . . . . 1.84 109.847 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.512 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 8.8 p90 -141.42 -122.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.372 -0.377 . . . . 0.4 110.852 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.53 136.47 10.53 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.499 0.59 . . . . 0.83 111.174 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -51.8 140.59 28.86 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.55 -0.295 . . . . 2.11 110.631 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.672 ' HB2' HG23 ' A' ' 28' ' ' THR . 6.7 Cg_endo -48.93 -174.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.932 2.422 . . . . 0.89 112.473 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -120.88 -34.08 3.62 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -115.78 -69.02 0.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.317 0.488 . . . . 1.37 112.317 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 25' ' ' PRO . 32.2 p 53.65 30.16 10.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.02 0.438 . . . . 0.91 110.068 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.96 -101.39 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.643 -0.789 . . . . 1.01 111.928 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.41 30.96 2.73 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.633 -0.987 . . . . 0.98 110.633 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -110.9 -171.62 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.065 -0.567 . . . . 0.87 111.541 -178.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.4 OUTLIER -139.94 21.8 2.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.769 -0.651 . . . . 2.26 111.381 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.061 HG21 ' CE1' ' A' ' 36' ' ' TYR . 15.8 mm 67.45 -69.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 1.71 110.878 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.612 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 75.97 9.66 3.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.945 -0.57 . . . . 1.15 112.402 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.5 t 168.16 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.765 0.317 . . . . 1.58 111.686 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.061 ' CE1' HG21 ' A' ' 33' ' ' ILE . 38.4 m-85 -120.26 95.09 4.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.76 110.554 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 4.4 mt -70.13 152.12 9.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.409 -0.36 . . . . 1.14 111.347 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 56' ' ' ILE . 2.2 t -124.63 104.43 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.221 -0.445 . . . . 0.63 111.27 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 1.058 ' CD ' ' HB3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -76.43 115.44 16.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.196 -0.456 . . . . 1.67 110.168 179.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.469 ' HD3' ' CG1' ' A' ' 63' ' ' VAL . 5.5 mtmt -93.32 149.74 21.0 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.469 0.652 . . . . 1.97 112.484 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 8.2 ttm180 -135.02 86.18 2.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.92 -1.036 . . . . 1.44 108.969 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.734 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -64.69 87.94 0.06 Allowed 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.62 -0.718 . . . . 1.59 109.703 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -67.95 146.56 98.31 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.976 -0.556 . . . . 0.9 111.517 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.89 39.43 4.52 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.854 -1.311 . . . . 1.43 112.34 0.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -144.72 43.02 1.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.803 0.335 . . . . 2.66 111.597 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.03 -176.7 46.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.632 -0.794 . . . . 1.12 112.339 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -167.88 30.24 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.641 0.258 . . . . 2.41 111.167 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 1.058 ' HB3' ' CD ' ' A' ' 39' ' ' GLU . 24.5 m95 46.99 87.99 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.471 -0.331 . . . . 0.65 111.192 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.61 135.98 49.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.998 0.428 . . . . 1.28 111.487 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 15.9 ptmt -65.19 79.32 0.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 1.3 111.023 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -65.7 -43.82 88.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.555 . . . . 0.86 111.87 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.9 p-10 -42.02 -56.6 2.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.64 -0.255 . . . . 2.01 111.591 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER 75.21 -49.94 0.65 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.984 0.364 . . . . 2.08 111.984 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -173.7 0.09 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.954 0.407 . . . . 1.89 111.193 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.37 107.0 19.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.949 -0.569 . . . . 1.87 111.339 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 36' ' ' TYR . 29.4 mt -86.35 87.84 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.69 110.919 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.7 mt -74.23 -45.15 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 1.6 111.438 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.49 149.66 22.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.99 -0.374 . . . . 1.54 109.99 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.1 p30 -70.36 -6.88 38.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 1.75 111.302 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.309 ' OE1' ' CB ' ' A' ' 21' ' ' LYS . 3.0 tp10 -101.35 93.92 5.66 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.929 -0.767 . . . . 2.05 108.929 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 62' ' ' THR . 66.3 t80 -118.6 164.76 14.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.974 -0.557 . . . . 0.48 111.805 -178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.486 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 84.2 m -121.94 119.53 31.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.539 -0.755 . . . . 0.42 110.564 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.636 HG23 HD21 ' A' ' 20' ' ' LEU . 57.8 t -80.76 125.61 39.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.907 -0.588 . . . . 1.08 111.724 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -119.8 163.33 17.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.619 -0.719 . . . . 1.33 110.558 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.18 57.72 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.585 -0.734 . . . . 0.9 112.138 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.811 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.0 mp -53.0 -176.31 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.808 0.337 . . . . 1.47 110.313 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.9 m -143.77 152.77 41.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.41 . . . . 1.06 110.57 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.1 OUTLIER -69.01 151.77 46.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 1.91 111.181 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.5 OUTLIER 54.7 51.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.149 179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.77 122.6 3.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.49 111.332 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.86 134.76 47.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.383 -0.371 . . . . 0.36 110.335 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.562 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 11.9 m-85 -128.26 119.79 25.86 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.782 0.66 . . . . 0.56 112.782 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 91' ' ' PRO . 1.3 tt0 -106.38 136.63 45.8 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.261 -0.644 . . . . 1.5 109.261 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -133.77 119.39 19.21 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.414 1.264 . . . . 0.6 114.414 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -95.97 162.92 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 2.11 109.907 178.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 8' ' ' PRO . 61.8 t -113.95 128.56 70.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.243 0.544 . . . . 0.6 112.206 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.593 HD11 ' HG3' ' A' ' 88' ' ' PRO . 34.4 mt -130.74 141.42 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 107.578 -1.267 . . . . 0.7 107.578 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.575 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -157.09 127.28 6.38 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.81 -0.756 . . . . 0.6 112.763 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.681 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.6 mttt -75.64 -157.02 0.07 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.687 -0.405 . . . . 1.98 110.072 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.889 ' ND2' HD12 ' A' ' 2' ' ' ILE . 33.7 p30 -159.26 162.99 36.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.228 0.537 . . . . 2.19 111.515 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -38.54 -43.79 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.323 -0.853 . . . . 1.08 112.816 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -66.14 -23.94 66.57 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 112.133 0.42 . . . . 1.06 112.133 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.9 -8.19 36.31 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.698 -0.763 . . . . 0.93 112.208 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.631 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -56.8 -164.23 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.132 0 CA-C-N 116.667 0.234 . . . . 1.38 110.377 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.681 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -148.7 111.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.382 0.512 . . . . 0.79 112.382 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.6 p -70.84 110.73 7.71 Favored Pre-proline 0 C--O 1.235 0.337 0 N-CA-C 107.233 -1.395 . . . . 0.59 107.233 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -53.38 171.9 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.499 2.133 . . . . 0.85 113.816 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.593 ' HG3' HD11 ' A' ' 77' ' ' ILE . 76.5 Cg_exo -50.42 145.0 22.75 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.338 2.692 . . . . 0.76 113.594 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -125.19 102.42 7.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.807 -0.633 . . . . 1.28 110.729 179.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.0 mm-40 12.63 108.64 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.737 1.215 . . . . 1.77 113.881 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 51.6 Cg_exo -56.05 143.67 82.54 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.437 2.092 . . . . 0.55 113.272 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.473 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -70.55 139.26 51.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.874 -0.787 . . . . 1.23 108.874 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -37.14 133.9 0.61 Allowed 'General case' 0 CA--C 1.522 -0.129 0 O-C-N 124.254 0.971 . . . . 1.63 111.517 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.85 118.56 8.54 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.41 111.144 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.893 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -98.11 111.15 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.677 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -49.36 -25.83 2.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.319 -0.4 . . . . 0.44 110.595 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.548 ' H ' HG22 ' A' ' 95' ' ' ILE . 99.6 m 49.02 81.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.314 -0.403 . . . . 1.1 110.845 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.83 -85.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.834 0.35 . . . . 3.0 110.593 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.864 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.2 p-10 -108.58 17.83 21.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.039 -0.528 . . . . 2.14 110.879 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.448 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 3.7 p-10 47.18 26.55 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.061 0.458 . . . . 2.06 111.251 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 99' ' ' ASP . 67.2 t -119.77 -19.44 5.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 2.8 111.079 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 44.42 82.37 0.03 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.054 0.454 . . . . 4.58 111.607 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.161 -0.923 . . . . 3.79 111.02 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.748 0.309 . . . . 2.74 111.055 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -90.33 69.32 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.831 2.354 . . . . 2.06 112.338 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 86' ' ' SER . 5.5 tt -50.22 149.95 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.98 0.419 . . . . 0.68 110.741 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.7 t70 -138.59 119.87 10.18 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.0 -0.545 . . . . 2.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.51 163.04 40.31 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.245 1.963 . . . . 0.5 112.014 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 40.5 Cg_exo -57.71 -169.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.701 2.268 . . . . 0.71 112.75 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.56 -177.19 50.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.87 -0.681 . . . . 0.66 112.685 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.9 tttt -73.35 133.65 80.56 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.277 0.085 . . . . 1.52 110.962 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.619 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.6 Cg_exo -76.81 130.61 11.61 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.688 2.259 . . . . 0.44 112.071 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -141.02 105.97 6.2 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.545 -0.298 . . . . 1.09 111.759 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.2 Cg_exo -44.28 131.31 9.01 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.206 1.937 . . . . 0.64 112.794 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.011 HD21 ' CB ' ' A' ' 21' ' ' LYS . 1.6 mt -90.27 -31.78 16.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.239 -1.023 . . . . 1.64 108.239 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -149.7 160.82 43.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.579 -1.191 . . . . 0.72 108.35 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.881 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -143.39 97.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.569 -0.453 . . . . 0.96 111.598 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -87.56 49.11 1.75 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.723 -0.671 . . . . 1.46 111.708 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.76 -74.97 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.874 0.734 . . . . 2.42 112.335 178.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.5 m-70 -72.2 -39.52 68.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.365 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 44.8 p -125.71 118.05 24.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.387 -0.37 . . . . 0.68 110.163 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.01 HG13 HD12 ' A' ' 66' ' ' LEU . 5.9 m -107.61 135.96 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.442 0.639 . . . . 0.8 112.368 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.531 ' N ' HG23 ' A' ' 62' ' ' THR . 23.0 m -90.59 144.16 26.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.588 -0.733 . . . . 0.35 109.771 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.761 HD11 HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.52 158.95 44.74 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.145 0.498 . . . . 0.52 111.586 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.011 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -150.82 146.36 26.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.543 -0.753 . . . . 1.84 110.792 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.518 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.0 p90 -136.18 -176.24 4.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.4 111.064 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.7 155.9 16.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.83 110.973 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 150.83 80.04 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 2.11 110.699 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.603 ' HG2' HD12 ' A' ' 33' ' ' ILE . 92.1 Cg_exo -43.94 175.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.969 2.446 . . . . 0.89 113.236 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -22.38 8.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.01 -0.541 . . . . 2.77 111.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.79 -65.0 0.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.059 0.392 . . . . 1.37 112.059 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.483 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 14.9 p 57.73 46.07 17.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.012 0.434 . . . . 0.91 110.155 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.51 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.6 -0.809 . . . . 1.01 111.828 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.17 25.71 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 110.902 -0.879 . . . . 0.98 110.902 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -103.68 -176.88 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.124 0.488 . . . . 0.87 111.641 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.54 1.0 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 2.26 111.792 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.669 HG21 ' CE1' ' A' ' 36' ' ' TYR . 22.9 mt 60.26 146.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-O 121.125 0.488 . . . . 1.71 110.952 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -140.34 23.69 2.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.966 -0.561 . . . . 1.15 111.711 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.33 122.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.741 0.645 . . . . 1.58 112.741 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 33' ' ' ILE . 24.0 m-85 -105.3 85.91 2.34 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.031 -0.729 . . . . 0.76 109.031 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.485 HG23 HD21 ' A' ' 52' ' ' ASN . 0.4 OUTLIER -80.98 120.87 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 1.14 111.266 -179.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -112.04 129.21 67.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.06 -0.518 . . . . 0.63 110.681 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -90.43 136.25 33.18 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.303 -0.408 . . . . 1.67 111.17 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 3.8 pttt -98.6 150.12 22.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.989 -0.55 . . . . 1.97 110.585 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 6.5 ttp180 -134.69 109.03 8.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.388 -0.369 . . . . 1.44 110.888 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.674 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -78.59 101.2 7.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 1.59 110.608 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.565 HD12 ' HB1' ' A' ' 94' ' ' ALA . 3.8 mt -88.27 153.41 51.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.143 -0.481 . . . . 0.9 111.062 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -90.35 17.33 42.28 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.793 -1.336 . . . . 1.43 112.739 0.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -138.21 81.01 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.931 0.396 . . . . 2.66 111.189 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -158.91 -167.3 19.44 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.898 -0.668 . . . . 1.12 112.258 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.44 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.75 159.06 37.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 2.41 110.945 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.794 ' O ' HD22 ' A' ' 49' ' ' LEU . 64.8 m95 -65.01 122.17 16.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.793 -0.639 . . . . 0.65 111.166 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.794 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -150.68 140.63 21.95 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.233 -0.439 . . . . 1.28 110.635 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -44.09 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.363 -0.38 . . . . 1.3 111.211 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.697 ' HB2' ' HB3' ' A' ' 40' ' ' LYS . . . -70.81 -40.89 72.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.86 110.889 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.637 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.4 p-10 -68.8 -44.34 73.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.842 -0.617 . . . . 2.01 111.287 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 54.85 22.63 4.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 2.08 110.706 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -136.42 -157.01 0.75 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.223 -0.444 . . . . 1.89 110.724 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -111.92 88.55 2.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.746 0.308 . . . . 1.87 111.163 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.81 HD12 ' CD1' ' A' ' 61' ' ' PHE . 16.4 mm -70.39 63.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.406 -0.361 . . . . 0.69 110.731 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 mt -47.86 -56.78 6.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.843 0.354 . . . . 1.6 110.819 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.622 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -87.13 159.73 18.79 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.409 -0.589 . . . . 1.54 109.409 179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.9 p30 -77.98 1.45 20.76 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.155 0.428 . . . . 1.75 112.155 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -101.43 95.18 6.31 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.902 -0.407 . . . . 2.05 109.902 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.81 ' CD1' HD12 ' A' ' 56' ' ' ILE . 80.8 t80 -130.99 162.82 28.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.391 0.615 . . . . 0.48 111.904 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.69 HG23 ' C ' ' A' ' 18' ' ' VAL . 89.9 m -129.69 122.42 28.93 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.844 -1.071 . . . . 0.42 108.803 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.88 ' CG2' HG22 ' A' ' 18' ' ' VAL . 33.5 m -80.18 108.97 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-O 121.204 0.526 . . . . 1.08 111.832 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -98.63 135.26 40.4 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.522 -0.763 . . . . 1.33 110.436 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.55 -8.44 7.37 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.586 -0.816 . . . . 0.9 112.681 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.01 HD12 HG13 ' A' ' 18' ' ' VAL . 33.6 mt -57.88 -162.29 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.847 0.323 . . . . 1.47 110.146 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -148.02 160.68 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.857 0.36 . . . . 1.06 111.222 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 tt0 -83.82 144.5 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 1.91 110.975 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' CYS . 23.8 t0 63.97 59.13 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 1.87 110.862 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.76 124.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.49 111.429 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.65 129.84 40.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.401 . . . . 0.36 110.31 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.421 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 50.7 m-85 -123.96 118.81 27.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.99 0.424 . . . . 0.56 112.103 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -101.95 139.47 37.53 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.234 -0.654 . . . . 1.5 109.234 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.94 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.4 122.62 19.28 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.147 1.166 . . . . 0.6 114.147 -179.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.821 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -97.73 152.4 19.17 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.02 178.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' CG ' ' A' ' 8' ' ' PRO . 97.2 t -111.44 101.57 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 112.589 0.589 . . . . 0.6 112.589 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 85' ' ' ILE . 53.3 mt -98.55 155.36 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 107.629 -1.248 . . . . 0.7 107.629 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.19 137.67 2.48 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 118.898 -1.121 . . . . 0.6 113.253 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.618 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.4 mttt -78.39 -159.3 0.16 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.611 -0.722 . . . . 1.98 109.482 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.737 HD21 ' HB3' ' A' ' 84' ' ' ALA . 33.1 p30 -139.5 -130.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.79 -0.448 . . . . 2.19 109.79 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -110.83 -7.66 14.59 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 118.402 0.546 . . . . 1.08 111.12 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -108.66 3.56 22.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 111.865 0.32 . . . . 1.06 111.865 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.56 -19.95 50.94 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.4 -0.905 . . . . 0.93 112.77 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.737 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -58.68 126.41 27.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.836 0.35 . . . . 1.38 110.426 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 79' ' ' LYS . 3.2 tp -85.87 110.9 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.247 -0.433 . . . . 0.79 111.669 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.554 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.6 p -68.52 124.71 90.61 Favored Pre-proline 0 C--O 1.241 0.623 0 N-CA-C 109.393 -0.595 . . . . 0.59 109.393 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -37.68 162.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.252 2.634 . . . . 0.85 113.206 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HG3' ' A' ' 75' ' ' ARG . 7.4 Cg_exo -71.79 145.96 47.15 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.699 2.266 . . . . 0.76 112.724 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 90' ' ' GLU . 12.4 m -99.05 106.33 18.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.644 -0.707 . . . . 1.28 110.555 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 89' ' ' SER . 4.4 mt-10 -1.46 107.27 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 124.828 1.251 . . . . 1.77 114.017 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 92.4 Cg_exo -38.49 149.2 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.782 2.321 . . . . 0.55 113.145 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.89 137.32 33.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.697 -0.853 . . . . 1.23 108.697 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -37.13 129.83 0.88 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.155 0.909 . . . . 1.63 111.805 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.806 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.22 119.12 7.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.751 -0.659 . . . . 0.41 110.963 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.649 HG12 HG21 ' A' ' 13' ' ' ILE . 4.2 mp -97.56 111.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.104 -0.498 . . . . 0.44 110.473 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 99.1 m -45.68 -29.73 1.35 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.294 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.455 ' H ' HG22 ' A' ' 95' ' ' ILE . 63.0 m 48.05 70.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.1 110.776 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 1.3 ptp180 -103.29 -99.56 0.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.459 -0.337 . . . . 3.0 111.268 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 2.5 p30 -97.82 20.66 11.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.749 0.309 . . . . 2.14 111.008 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 38.3 t0 54.12 21.56 3.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.413 -0.358 . . . . 2.06 111.156 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 101' ' ' VAL . 7.6 p -125.9 -7.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 2.8 111.564 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.952 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 43.85 32.18 0.57 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.923 0.392 . . . . 4.58 111.588 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.203 -0.903 . . . . 3.79 111.087 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.562 0.22 . . . . 2.74 111.425 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.49 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 59.6 Cg_endo -91.37 -165.6 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.884 2.389 . . . . 2.06 112.373 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.684 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.4 tt -165.65 151.36 2.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.51 . . . . 0.68 110.412 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.7 m-20 -136.93 126.17 15.39 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.826 -0.35 . . . . 2.0 111.92 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 89' ' ' SER . 33.2 Cg_exo -58.61 171.79 1.79 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.563 2.175 . . . . 0.5 112.015 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 52.4 Cg_endo -69.09 -178.6 2.16 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.59 2.193 . . . . 0.71 112.36 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.78 174.35 54.82 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.897 -0.668 . . . . 0.66 112.585 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.6 tptm -61.83 119.06 44.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 110.707 -0.109 . . . . 1.52 110.707 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' CG ' HG23 ' A' ' 76' ' ' VAL . 12.6 Cg_exo -70.4 146.47 56.31 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.542 2.161 . . . . 0.44 112.453 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -143.51 112.78 5.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.015 -0.539 . . . . 1.09 111.4 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.721 ' HG2' HD11 ' A' ' 95' ' ' ILE . 34.3 Cg_exo -62.69 107.93 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.727 2.285 . . . . 0.64 113.876 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -62.68 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.658 -0.867 . . . . 1.64 108.658 178.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -132.79 151.16 52.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.439 -1.255 . . . . 0.72 108.514 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.937 HG21 HG12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -141.91 99.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.091 -0.644 . . . . 0.96 112.266 -179.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.435 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -90.04 134.66 34.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.662 -0.699 . . . . 1.46 110.301 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -33.88 -30.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.867 1.062 . . . . 2.42 113.867 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 68' ' ' GLU . 5.0 m-70 -116.51 -24.16 7.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.663 0.616 . . . . 1.02 112.663 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 64' ' ' SER . 75.0 p -136.54 132.32 35.06 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.747 -0.464 . . . . 0.68 109.747 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.129 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -123.28 142.78 38.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.886 -0.726 . . . . 0.8 112.453 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.615 ' C ' HD13 ' A' ' 20' ' ' LEU . 54.0 m -103.87 124.63 49.29 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.641 -0.709 . . . . 0.35 111.994 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.771 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -135.2 151.56 50.75 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-O 121.687 0.755 . . . . 0.52 111.744 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.606 ' HB3' HD11 ' A' ' 11' ' ' LEU . 15.8 tptm -134.43 153.64 51.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.508 -1.224 . . . . 1.84 109.702 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 22.8 p90 -143.1 -176.35 4.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.266 0.555 . . . . 0.4 112.182 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.4 -159.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.83 110.953 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.44 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -128.13 141.66 41.98 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 2.11 110.094 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.895 ' HG2' HD11 ' A' ' 33' ' ' ILE . 84.1 Cg_exo -42.65 168.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.228 1.952 . . . . 0.89 112.222 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -107.89 -30.3 8.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.228 -0.442 . . . . 2.77 111.724 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 1' ' ' PRO . 8.7 t80 -119.24 -69.64 0.84 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.854 0.316 . . . . 1.37 111.854 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.675 HG23 ' CB ' ' A' ' 25' ' ' PRO . 18.6 p 50.92 45.34 27.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 0.91 110.444 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.4 -93.92 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 121.068 -0.587 . . . . 1.01 112.683 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.28 36.18 0.7 Allowed Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.515 -1.034 . . . . 0.98 110.515 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.85 -172.81 2.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.908 -0.646 . . . . 0.87 111.577 -178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.405 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.02 23.03 4.17 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 2.26 112.132 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.895 HD11 ' HG2' ' A' ' 25' ' ' PRO . 45.5 mm 68.82 -72.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 111.903 0.334 . . . . 1.71 111.903 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.632 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.7 p 87.67 -16.93 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.128 0.571 . . . . 1.15 112.34 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.819 ' H ' HG22 ' A' ' 33' ' ' ILE . 34.3 t 177.86 169.44 0.7 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.848 0.356 . . . . 1.58 111.861 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 54.1 m-85 -140.19 105.12 4.97 Favored 'General case' 0 C--N 1.335 -0.059 0 CA-C-N 116.075 -0.511 . . . . 0.76 111.403 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.493 HG21 ' HD3' ' A' ' 50' ' ' LYS . 4.9 mt -89.37 91.24 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.038 -0.528 . . . . 1.14 110.839 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -82.76 123.39 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.022 0.439 . . . . 0.63 110.748 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.63 ' OE1' HD12 ' A' ' 77' ' ' ILE . 14.7 mt-10 -97.83 156.68 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.699 . . . . 1.67 111.345 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.16 139.74 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 1.97 110.62 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.567 ' HD3' HD23 ' A' ' 43' ' ' LEU . 2.4 ttm180 -121.02 113.68 20.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.181 -0.463 . . . . 1.44 110.568 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.542 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -71.48 86.93 0.87 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.654 -0.498 . . . . 1.59 109.654 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.775 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -70.35 142.39 89.47 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.949 -0.569 . . . . 0.9 110.759 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -95.96 47.85 1.94 Allowed 'Cis proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.182 -1.174 . . . . 1.43 112.869 0.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -158.58 60.66 0.44 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.679 0.276 . . . . 2.66 111.546 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.542 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -114.79 -177.48 18.89 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.636 -0.792 . . . . 1.12 112.325 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.6 24.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.885 0.374 . . . . 2.41 111.123 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 54.0 m95 51.77 95.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.65 111.332 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.456 HD13 ' HG2' ' A' ' 47' ' ' ARG . 1.2 mp -118.23 137.7 52.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.34 -0.845 . . . . 1.28 110.328 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.493 ' HD3' HG21 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -45.3 93.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 1.3 111.689 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -70.09 -40.52 74.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.86 110.306 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.771 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -63.66 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.01 110.481 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.8 t80 68.96 41.08 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.876 0.369 . . . . 2.08 110.803 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 t -154.37 -72.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.993 -0.549 . . . . 1.89 110.972 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 175.48 136.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 1.87 110.659 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 52' ' ' ASN . 8.1 mt -140.69 79.09 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.69 110.967 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 57' ' ' LEU . 8.5 tp -68.62 -62.62 1.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 1.6 110.825 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -76.59 169.66 17.86 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.305 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -80.67 -2.0 44.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.293 -0.412 . . . . 1.75 111.672 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.87 102.55 13.62 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 120.853 0.358 . . . . 2.05 110.33 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.688 ' HB2' HG23 ' A' ' 56' ' ' ILE . 66.5 t80 -139.02 164.05 30.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.48 111.872 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.488 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 54.0 m -127.12 128.43 46.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.451 -0.795 . . . . 0.42 109.795 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.638 ' CG2' HG22 ' A' ' 18' ' ' VAL . 29.7 m -91.62 128.7 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 120.221 -0.591 . . . . 1.08 112.168 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -110.81 127.01 55.23 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.546 -0.752 . . . . 1.33 109.821 179.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 144.72 -13.04 1.97 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.521 -0.847 . . . . 0.9 112.59 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.129 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -52.08 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.013 0.435 . . . . 1.47 110.553 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -152.53 157.07 40.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.116 -0.493 . . . . 1.06 110.601 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 16' ' ' HIS . 4.4 mt-10 -76.76 143.76 39.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.094 -0.503 . . . . 1.91 110.675 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER 65.87 38.04 5.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.214 -0.448 . . . . 1.87 110.929 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -151.41 117.3 5.5 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.565 -0.289 . . . . 0.49 111.731 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -75.25 121.31 21.97 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.655 -0.498 . . . . 0.36 109.655 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 75.7 m-85 -116.15 131.77 56.85 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.696 0.628 . . . . 0.56 112.696 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.775 ' HB2' HD11 ' A' ' 43' ' ' LEU . 1.2 tt0 -105.83 142.46 35.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.239 -1.022 . . . . 1.5 108.239 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.992 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -126.92 114.98 18.58 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.247 1.203 . . . . 0.6 114.247 -178.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -93.5 144.87 24.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.313 -0.858 . . . . 2.11 110.229 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' CG ' ' A' ' 8' ' ' PRO . 52.9 t -106.7 119.77 56.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.188 0.518 . . . . 0.6 112.368 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.71 HD11 ' HD3' ' A' ' 88' ' ' PRO . 5.9 mt -110.1 165.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.978 -1.119 . . . . 0.7 107.978 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -179.3 130.66 0.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.965 -0.694 . . . . 0.6 112.345 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.4 pttm -81.26 -158.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.969 -0.752 . . . . 1.98 108.969 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.684 ' ND2' HD11 ' A' ' 2' ' ' ILE . 17.6 m-80 -155.78 167.62 29.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 2.19 112.029 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.26 -53.25 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.51 -0.768 . . . . 1.08 111.864 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.32 -5.84 25.76 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.313 0.486 . . . . 1.06 112.313 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.71 -0.94 63.31 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.39 -0.91 . . . . 0.93 112.714 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.31 124.84 22.29 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 1.38 110.157 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -92.4 110.48 22.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.649 0.611 . . . . 0.79 112.649 -179.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 4.5 p -74.89 120.28 80.84 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 108.812 -0.81 . . . . 0.59 108.812 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 88.3 Cg_endo -70.95 172.97 12.74 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.574 2.182 . . . . 0.85 112.961 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.71 ' HD3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -36.93 121.56 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.395 2.73 . . . . 0.76 112.819 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' GLU . 5.1 p -107.88 104.23 13.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.037 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 21.6 mt-10 18.36 110.48 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 124.505 1.122 . . . . 1.77 113.809 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 34.5 Cg_exo -63.38 155.79 60.04 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.496 2.13 . . . . 0.55 114.374 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -84.5 146.11 27.76 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.903 -1.044 . . . . 1.23 108.839 178.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -32.23 143.96 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.256 0.972 . . . . 1.63 112.478 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . . . -79.64 114.32 18.47 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.428 -0.805 . . . . 0.41 110.326 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.937 HG12 HG21 ' A' ' 13' ' ' ILE . 3.8 mp -99.37 110.17 26.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.452 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 63.0 m -45.19 -39.79 6.6 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.044 -0.526 . . . . 0.44 111.224 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 69' ' ' ASP . 90.9 m 54.96 106.8 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.1 110.448 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -141.87 -75.0 0.3 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.987 0.423 . . . . 3.0 110.957 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.177 ' OD2' ' CG1' ' A' ' 101' ' ' VAL . 3.1 p-10 -122.86 3.09 9.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.932 -0.577 . . . . 2.14 111.496 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.6 t0 53.2 22.59 2.71 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.766 0.317 . . . . 2.06 111.444 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.177 ' CG1' ' OD2' ' A' ' 99' ' ' ASP . 11.1 p -153.39 22.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.202 -0.454 . . . . 2.8 110.931 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.542 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 1.5 mt-10 -115.88 -24.69 8.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.289 -0.414 . . . . 4.58 111.331 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.227 -0.892 . . . . 3.79 111.183 -179.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.721 0.296 . . . . 2.74 111.227 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 95.0 Cg_endo -78.16 68.12 7.96 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.619 2.212 . . . . 2.06 112.137 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.68 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -52.77 141.89 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 0.68 111.16 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.64 132.8 24.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 2.0 110.318 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.86 162.38 18.54 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.535 2.157 . . . . 0.5 112.451 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 71.4 Cg_exo -53.11 177.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.906 2.404 . . . . 0.71 112.611 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.17 -175.58 50.15 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.043 -0.598 . . . . 0.66 113.128 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.1 tmtp? -69.69 123.29 88.27 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.974 0.11 . . . . 1.52 110.848 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 10.7 Cg_exo -75.47 128.12 10.88 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.669 2.246 . . . . 0.44 112.741 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD13 ' A' ' 11' ' ' LEU . 3.8 t -134.15 115.63 13.03 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.375 -0.375 . . . . 1.09 111.439 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 22.0 Cg_exo -61.98 108.11 0.62 Allowed 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.224 1.949 . . . . 0.64 113.448 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.688 HD11 ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.57 -41.18 93.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.46 0.648 . . . . 1.64 109.298 178.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -136.66 154.73 50.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.891 -1.05 . . . . 0.72 109.379 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.866 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -143.32 107.36 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.904 0.383 . . . . 0.96 111.22 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.836 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -101.71 56.86 0.82 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.023 -0.535 . . . . 1.46 112.266 -179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.254 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.74 -74.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.614 -0.721 . . . . 2.42 112.754 178.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 14' ' ' THR . 18.0 m170 -78.28 -35.28 48.21 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.072 0.397 . . . . 1.02 112.072 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.3 p -126.09 117.47 23.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.853 0.359 . . . . 0.68 110.98 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.017 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.3 m -110.29 141.8 24.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.0 -0.546 . . . . 0.8 111.137 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.754 ' C ' HD13 ' A' ' 20' ' ' LEU . 55.2 m -107.33 127.99 54.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.947 -0.57 . . . . 0.35 111.768 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.811 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -133.25 156.38 47.66 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.371 0.605 . . . . 0.52 111.377 178.557 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.046 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -138.14 142.93 40.12 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.079 -0.964 . . . . 1.84 109.973 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.508 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 42.8 p90 -137.8 163.29 31.76 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.144 0.497 . . . . 0.4 111.885 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.88 164.93 24.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.761 -0.654 . . . . 0.83 110.318 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.82 157.15 35.13 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.658 0.266 . . . . 2.11 110.873 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 76.9 Cg_exo -50.34 -173.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.649 2.233 . . . . 0.89 112.658 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.11 -25.57 4.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.897 -0.592 . . . . 2.77 111.829 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.529 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 10.1 t80 -129.05 -69.87 0.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.057 0.391 . . . . 1.37 112.057 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 11.5 p 59.45 50.79 7.18 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.828 0.346 . . . . 0.91 110.725 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.82 -98.86 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.163 -0.541 . . . . 1.01 112.64 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.05 32.74 1.66 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 109.735 -1.346 . . . . 0.98 109.735 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.95 -169.98 1.58 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.62 -0.79 . . . . 0.87 111.262 -178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HE2' HG22 ' A' ' 34' ' ' THR . 1.9 pttt -142.2 24.1 1.98 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.951 -0.568 . . . . 2.26 112.008 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.897 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mm 66.44 -69.25 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.7 0.286 . . . . 1.71 110.902 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 33' ' ' ILE . 1.6 p 87.33 -20.72 0.2 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.188 0.595 . . . . 1.15 112.058 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.796 ' H ' HG22 ' A' ' 33' ' ' ILE . 5.8 t -177.25 165.31 2.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 1.58 111.464 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.897 ' CE1' HG21 ' A' ' 33' ' ' ILE . 54.1 m-85 -133.75 109.1 8.9 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.127 -0.488 . . . . 0.76 111.073 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.33 156.26 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.22 -0.289 . . . . 1.14 110.22 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' LYS . 7.1 t -135.06 124.31 42.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.63 111.807 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CD ' HD12 ' A' ' 77' ' ' ILE . 6.9 mt-10 -96.51 131.56 42.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.174 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -98.34 138.99 34.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.038 0.447 . . . . 1.97 111.964 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.3 ttm180 -122.14 109.65 14.79 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.825 -0.625 . . . . 1.44 110.374 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.413 ' OD2' ' NE ' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -77.15 95.67 4.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 1.59 110.578 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -65.49 151.62 94.01 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 0.9 111.106 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -88.79 4.12 69.96 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 123.803 -1.332 . . . . 1.43 113.212 0.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -77.18 -84.28 0.07 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.672 0.272 . . . . 2.66 110.502 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.76 161.61 12.95 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.639 -0.791 . . . . 1.12 113.326 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' NE ' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 168.72 55.12 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.008 -0.367 . . . . 2.41 110.008 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.9 m95 -36.78 120.48 0.71 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.838 -0.619 . . . . 0.65 112.544 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -155.49 131.1 9.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 1.28 110.008 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 1.8 ptpt -52.11 117.41 2.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.976 0.417 . . . . 1.3 110.84 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -101.87 -41.32 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.131 -0.486 . . . . 0.86 111.268 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' CB ' HD11 ' A' ' 56' ' ' ILE . 16.9 p-10 -44.79 -48.27 10.92 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.373 -0.376 . . . . 2.01 111.376 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.74 29.73 0.73 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.259 -0.428 . . . . 2.08 111.329 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -133.39 -170.11 2.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 1.89 110.862 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -99.69 89.29 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 1.87 111.181 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 36' ' ' TYR . 36.4 mt -86.78 72.25 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.69 110.768 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 57' ' ' LEU . 9.7 tp -63.08 -38.31 90.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 1.6 111.455 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 56' ' ' ILE . 21.8 pt-20 -100.6 160.49 14.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.897 0.379 . . . . 1.54 110.528 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -74.25 -7.92 54.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.211 -0.45 . . . . 1.75 111.323 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.046 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.3 tp10 -90.55 97.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.322 -0.621 . . . . 2.05 109.322 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.511 ' CG ' ' N ' ' A' ' 62' ' ' THR . 58.4 t80 -135.79 165.35 25.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.48 111.985 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 94.3 m -123.21 123.37 40.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.325 -0.852 . . . . 0.42 110.281 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.811 HG23 HD21 ' A' ' 20' ' ' LEU . 17.3 t -82.02 119.62 31.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.219 -0.446 . . . . 1.08 111.71 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.26 145.36 36.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.663 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.03 -19.35 5.48 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.746 -0.74 . . . . 0.9 112.171 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.742 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -55.9 -176.38 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.666 0.27 . . . . 1.47 110.46 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.7 m -157.88 143.58 17.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.848 0.356 . . . . 1.06 110.765 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.3 mt-10 -51.92 129.88 27.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.063 -0.517 . . . . 1.91 111.127 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 71.61 66.51 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.073 -0.512 . . . . 1.87 111.397 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.607 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -175.5 118.44 0.16 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.468 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.54 129.73 40.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.519 -0.549 . . . . 0.36 109.519 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.607 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 73.3 m-85 -128.87 124.46 35.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.053 0.76 . . . . 0.56 113.053 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 10.5 mt-10 -103.52 142.36 34.41 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.498 -0.927 . . . . 1.5 108.498 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.017 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -133.15 111.98 11.36 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.478 1.288 . . . . 0.6 114.478 -178.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.52 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.01 157.39 16.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.495 -0.928 . . . . 2.11 108.495 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -125.21 124.57 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.535 -0.866 . . . . 0.6 112.878 -179.304 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.447 HD12 ' CD ' ' A' ' 39' ' ' GLU . 63.6 mt -108.03 139.71 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 107.407 -1.331 . . . . 0.7 107.407 177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -149.18 117.52 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.529 -0.869 . . . . 0.6 112.603 -178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.4 ptpt -71.57 -172.73 0.82 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.191 -0.459 . . . . 1.98 110.149 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.68 ' ND2' HD11 ' A' ' 2' ' ' ILE . 5.1 m-80 -135.09 168.08 19.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.263 0.554 . . . . 2.19 111.915 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -41.59 -44.04 2.93 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.288 -0.869 . . . . 1.08 111.828 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.69 -18.0 58.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.998 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 113.68 -16.75 21.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.551 -0.833 . . . . 0.93 112.1 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.01 123.46 8.24 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.663 0.268 . . . . 1.38 110.387 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.653 ' O ' HG23 ' A' ' 85' ' ' ILE . 3.3 tp -87.91 109.81 20.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.694 0.627 . . . . 0.79 112.694 -179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 12.7 p -68.58 107.34 1.92 Allowed Pre-proline 0 C--N 1.327 -0.392 0 N-CA-C 107.811 -1.181 . . . . 0.59 107.811 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.0 Cg_endo -45.98 155.41 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.091 . . . . 0.85 112.841 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 2.3 Cg_endo -45.18 128.76 9.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.372 2.714 . . . . 0.76 113.483 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 1.1 p -97.43 109.14 21.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.364 -0.835 . . . . 1.28 109.862 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 7.6 mt-10 1.72 119.22 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.093 0 O-C-N 124.858 1.349 . . . . 1.77 113.927 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.7 Cg_exo -62.18 139.97 81.0 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.376 2.051 . . . . 0.55 113.768 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.89 144.3 57.18 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.063 -0.718 . . . . 1.23 109.063 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -40.43 134.2 1.75 Allowed 'General case' 0 C--N 1.333 -0.11 0 O-C-N 124.006 0.816 . . . . 1.63 111.633 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -60.68 127.09 29.96 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.451 -0.795 . . . . 0.41 111.255 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.636 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -109.4 114.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.364 -0.38 . . . . 0.44 110.478 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.499 HG21 ' NH1' ' A' ' 98' ' ' ARG . 65.2 m -48.13 -39.04 19.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.929 0.395 . . . . 0.44 111.03 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 78.9 m 60.29 65.6 1.06 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.246 -0.434 . . . . 1.1 110.881 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.658 ' HD3' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -107.63 -89.53 0.45 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.784 0.326 . . . . 3.0 110.52 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.953 ' O ' HG23 ' A' ' 101' ' ' VAL . 3.6 p30 -102.27 12.82 36.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.412 -0.358 . . . . 2.14 110.635 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.254 ' OD1' ' N ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER 48.96 25.06 0.97 Allowed 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.864 0.364 . . . . 2.06 111.189 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 99' ' ' ASP . 15.7 t -131.43 -7.38 2.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.008 -0.542 . . . . 2.8 112.071 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.988 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 39.44 83.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.062 0.458 . . . . 4.58 112.186 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.236 -0.888 . . . . 3.79 111.157 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.459 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 111.665 0.246 . . . . 2.74 111.665 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 0' ' ' SER . 14.1 Cg_exo -69.11 -163.05 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.592 2.194 . . . . 2.06 112.053 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.567 HD12 ' HB1' ' A' ' 84' ' ' ALA . 2.7 tt -166.02 143.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.68 110.874 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' N ' HG12 ' A' ' 2' ' ' ILE . 3.5 m-20 -135.39 128.53 18.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.069 -0.514 . . . . 2.0 110.618 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 157.02 43.85 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.394 2.062 . . . . 0.5 112.161 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.55 -164.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.801 2.334 . . . . 0.71 113.228 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.94 -175.41 44.02 Favored Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.423 -0.808 . . . . 0.66 112.799 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.2 tttt -78.08 134.64 63.41 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 110.382 -0.229 . . . . 1.52 110.382 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' CG ' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_exo -79.04 147.04 20.72 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.652 2.234 . . . . 0.44 112.83 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.607 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.2 p -138.69 115.06 8.8 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.625 -0.716 . . . . 1.09 110.647 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.7 Cg_exo -63.34 112.74 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.201 1.934 . . . . 0.64 113.149 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.666 HD12 HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER -76.9 -40.37 47.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.305 0.574 . . . . 1.64 109.848 179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.22 114.01 13.95 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.233 -0.894 . . . . 0.72 109.215 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.588 HG21 HG12 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -113.0 126.26 70.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 112.73 0.641 . . . . 0.96 112.73 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -116.63 144.7 44.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.339 -0.846 . . . . 1.46 109.674 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -52.29 -18.36 1.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.94 0.719 . . . . 2.42 112.94 -178.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' O ' HG23 ' A' ' 17' ' ' THR . 3.1 m-70 -124.33 -7.75 7.58 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.543 0.571 . . . . 1.02 112.543 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.565 HG22 ' HB3' ' A' ' 64' ' ' SER . 77.8 p -161.0 124.7 3.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 110.408 -0.219 . . . . 0.68 110.408 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.079 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -113.88 156.79 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 120.253 -0.579 . . . . 0.8 112.066 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.666 HG22 HD12 ' A' ' 11' ' ' LEU . 6.5 m -125.2 123.01 38.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.1 -0.5 . . . . 0.35 110.943 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.724 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.64 162.13 30.07 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.731 0.777 . . . . 0.52 112.454 179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -136.1 159.01 43.03 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 114.502 -1.226 . . . . 1.84 109.762 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 19.7 p90 -149.4 -175.8 5.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.112 0.482 . . . . 0.4 112.08 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.39 -173.99 4.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.617 -0.72 . . . . 0.83 112.072 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -120.94 140.58 31.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.289 -0.869 . . . . 2.11 110.272 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 33' ' ' ILE . 83.9 Cg_exo -46.07 175.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.43 2.087 . . . . 0.89 112.578 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -21.01 7.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 2.77 111.687 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -130.52 -68.71 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.991 0.367 . . . . 1.37 111.991 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 25' ' ' PRO . 66.2 p 51.79 49.62 20.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.353 -0.385 . . . . 0.91 110.496 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.75 -94.11 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.057 -0.592 . . . . 1.01 112.825 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.32 43.27 0.78 Allowed Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.472 -1.051 . . . . 0.98 110.472 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -122.32 -168.97 1.81 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.284 -0.458 . . . . 0.87 111.487 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.35 20.68 1.37 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.619 0.6 . . . . 2.26 112.619 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.816 HG22 ' H ' ' A' ' 35' ' ' SER . 3.6 mp 59.61 -85.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 120.927 -0.309 . . . . 1.71 110.483 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.59 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 77.59 30.84 0.47 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.982 0.364 . . . . 1.15 111.982 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 160.95 146.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.368 -0.378 . . . . 1.58 110.362 179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.817 ' O ' HD12 ' A' ' 56' ' ' ILE . 93.1 m-85 -140.1 117.12 11.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.022 0.439 . . . . 0.76 111.679 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 23.9 mt -85.43 136.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.937 -0.574 . . . . 1.14 110.346 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.41 HG12 ' HB3' ' A' ' 74' ' ' PHE . 2.1 t -109.53 87.23 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.158 0.429 . . . . 0.63 112.158 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.718 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 4.6 mm-40 -64.22 132.59 50.76 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.382 -0.599 . . . . 1.67 109.382 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -114.75 134.53 55.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.121 0.486 . . . . 1.97 111.718 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HB2' ' CD2' ' A' ' 48' ' ' TRP . 3.0 ttm180 -113.92 111.9 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.599 -0.728 . . . . 1.44 110.007 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.823 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.96 108.7 13.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 1.59 110.902 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 ' HD3' ' A' ' 41' ' ' ARG . 1.2 mm? -84.34 143.68 42.29 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.436 -0.347 . . . . 0.9 110.985 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 63.5 Cg_endo -98.43 45.34 2.67 Favored 'Cis proline' 0 N--CA 1.458 -0.576 0 C-N-CA 124.36 -1.1 . . . . 1.43 112.755 0.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.408 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 7.7 m-80 -153.1 58.69 0.78 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.773 0.32 . . . . 2.66 111.306 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -116.05 167.57 12.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.848 -0.691 . . . . 1.12 112.762 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.35 27.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.001 0.429 . . . . 2.41 110.615 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.578 ' O ' HD22 ' A' ' 49' ' ' LEU . 72.3 m95 53.23 110.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.696 -0.684 . . . . 0.65 111.638 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.609 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -143.32 118.4 10.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.233 -0.44 . . . . 1.28 110.459 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.718 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 7.2 ptpt -49.69 118.0 2.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.181 0.515 . . . . 1.3 111.2 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -102.37 -40.29 6.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.86 110.956 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.717 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.8 p-10 -40.28 -48.27 2.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.061 -0.518 . . . . 2.01 111.765 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 43.19 44.02 4.22 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.721 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.1 p -162.46 158.49 23.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 1.89 110.912 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' ND2' ' OG ' ' A' ' 35' ' ' SER . 0.1 OUTLIER -63.8 105.77 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.098 -0.501 . . . . 1.87 110.681 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 36' ' ' TYR . 53.5 mt -100.19 63.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.135 0.493 . . . . 0.69 110.261 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -41.94 -76.22 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.566 -0.743 . . . . 1.6 111.821 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -64.82 170.02 4.6 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.772 0.32 . . . . 1.54 110.147 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 43.7 p30 -88.8 13.4 12.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.403 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 49.3 tt0 -111.55 107.3 16.42 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' HB2' HG23 ' A' ' 56' ' ' ILE . 58.6 t80 -142.49 164.97 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.19 0.519 . . . . 0.48 112.049 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 18' ' ' VAL . 30.5 m -125.02 122.9 38.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.581 -0.736 . . . . 0.42 110.8 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HG22 ' A' ' 18' ' ' VAL . 3.7 m -91.53 96.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 120.24 -0.584 . . . . 1.08 110.714 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.565 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -82.85 -165.28 1.02 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.687 -0.688 . . . . 1.33 110.885 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.89 20.44 59.92 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.685 -0.769 . . . . 0.9 112.371 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.079 ' CD1' HG13 ' A' ' 18' ' ' VAL . 69.9 mt -74.28 -176.58 2.69 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.848 0.356 . . . . 1.47 110.75 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.415 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 7.4 m -132.68 154.9 49.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 1.06 110.875 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 22.9 tt0 -88.28 160.22 17.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 1.91 110.906 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.874 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 52.33 43.59 30.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 1.87 110.858 -179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.45 120.7 3.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.49 111.33 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.36 132.68 46.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.36 110.107 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.528 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 48.3 m-85 -125.69 118.97 26.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.681 0.622 . . . . 0.56 112.681 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.744 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 5.1 mt-10 -99.45 142.95 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.46 -0.941 . . . . 1.5 108.46 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.996 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -125.81 115.1 19.49 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.289 1.218 . . . . 0.6 114.289 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 2.5 ttp85 -94.91 139.49 31.26 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.341 -0.845 . . . . 2.11 109.537 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG23 ' CG ' ' A' ' 8' ' ' PRO . 80.6 t -106.98 138.34 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.71 0.767 . . . . 0.6 112.349 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 86' ' ' SER . 29.0 mt -134.66 156.64 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -168.42 121.07 0.84 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 118.652 -1.219 . . . . 0.6 112.987 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mmtt -61.91 -173.33 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 120.003 -0.679 . . . . 1.98 109.725 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.659 ' HB2' ' HB3' ' A' ' 84' ' ' ALA . 5.4 m120 -136.8 161.2 36.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.033 0.444 . . . . 2.19 110.908 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -36.87 -30.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.155 0.798 . . . . 1.08 113.155 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.626 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.73 24.37 13.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.979 0.733 . . . . 1.06 112.979 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.17 -11.1 51.1 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.561 -0.828 . . . . 0.93 113.222 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.659 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -53.82 102.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.946 0.373 . . . . 1.38 110.217 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.676 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -70.0 104.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.444 0.535 . . . . 0.79 112.444 -179.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.5 p -65.96 111.74 7.21 Favored Pre-proline 0 C--O 1.238 0.472 0 N-CA-C 108.777 -0.823 . . . . 0.59 108.777 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.438 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 72.6 Cg_exo -48.8 -179.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.236 2.624 . . . . 0.85 114.311 -178.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . 68.1 Cg_exo -52.61 144.17 43.22 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.404 2.736 . . . . 0.76 113.544 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 10.9 m -123.04 122.05 37.55 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.906 -0.588 . . . . 1.28 110.505 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -18.53 102.47 0.06 OUTLIER Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.161 0.985 . . . . 1.77 113.36 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 76.2 Cg_exo -48.42 169.17 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.043 2.495 . . . . 0.55 114.93 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.88 142.28 28.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.178 -1.374 . . . . 1.23 109.784 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -44.85 133.61 6.11 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 123.77 0.669 . . . . 1.63 110.457 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.759 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.07 119.65 11.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.984 -0.553 . . . . 0.41 111.754 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 10' ' ' PRO . 4.0 mp -97.37 109.55 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.408 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 13.6 m -46.89 -37.63 9.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.363 -0.38 . . . . 0.44 111.379 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 3.0 m 52.76 88.33 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.371 . . . . 1.1 110.227 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -134.75 -91.65 0.32 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.63 -0.259 . . . . 3.0 111.113 -179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.417 ' O ' HG23 ' A' ' 101' ' ' VAL . 27.0 p30 -91.45 -6.1 53.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.625 -0.261 . . . . 2.14 111.421 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.31 24.66 14.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.973 0.416 . . . . 2.06 111.122 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 99' ' ' ASP . 37.1 t -114.91 -21.2 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.979 -0.555 . . . . 2.8 110.786 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.91 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 57.6 83.35 0.11 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.012 0.434 . . . . 4.58 111.103 179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.208 -0.901 . . . . 3.79 111.101 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.719 0.295 . . . . 2.74 111.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 87.2 Cg_endo -87.81 122.51 1.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.919 2.413 . . . . 2.06 112.659 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -99.8 145.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.262 -0.426 . . . . 0.68 110.391 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.7 142.31 45.06 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.819 0.342 . . . . 2.0 111.53 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' CA ' ' HB2' ' A' ' 86' ' ' SER . 87.0 Cg_endo -83.44 161.79 14.85 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.84 2.36 . . . . 0.5 112.276 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.53 177.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.597 2.198 . . . . 0.71 112.625 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -81.01 -176.69 51.06 Favored Glycine 0 CA--C 1.517 0.211 0 C-N-CA 121.036 -0.602 . . . . 0.66 113.309 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.0 tmtm? -66.64 127.32 93.34 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 122.197 0.199 . . . . 1.52 110.79 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 4.9 Cg_exo -80.34 135.9 10.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.532 2.155 . . . . 0.44 112.797 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -137.11 114.0 9.79 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 115.786 -0.643 . . . . 1.09 110.817 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 69.3 Cg_exo -48.52 135.02 26.9 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.144 1.896 . . . . 0.64 113.123 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -99.06 -30.37 12.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.391 -0.822 . . . . 1.64 110.061 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -156.99 121.61 4.45 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.319 -0.855 . . . . 0.72 109.356 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.013 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -113.37 132.68 61.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.828 0.677 . . . . 0.96 112.828 -179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.88 151.46 46.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.879 -1.055 . . . . 1.46 109.68 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.483 ' HG2' ' CA ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -57.74 -18.1 19.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.339 -0.391 . . . . 2.42 111.706 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.759 ' O ' HG23 ' A' ' 17' ' ' THR . 4.5 m-70 -131.44 18.75 4.81 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.811 0.3 . . . . 1.02 111.811 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -178.56 114.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 0.68 111.422 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 13' ' ' ILE . 81.3 t -104.82 135.13 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.001 -0.545 . . . . 0.8 110.178 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.775 ' C ' HD13 ' A' ' 20' ' ' LEU . 61.6 m -111.52 132.27 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.35 110.661 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.797 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -140.83 143.19 34.66 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.96 0.886 . . . . 0.52 111.766 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -123.79 134.92 53.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.955 -1.475 . . . . 1.84 109.51 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 35.7 p90 -126.4 172.0 10.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.049 0.452 . . . . 0.4 111.196 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.454 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -83.83 -157.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.762 -0.654 . . . . 0.83 110.84 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.75 159.31 69.37 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.47 -0.332 . . . . 2.11 110.607 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.534 ' HB2' HG23 ' A' ' 28' ' ' THR . 55.4 Cg_endo -70.38 169.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.104 1.87 . . . . 0.89 111.815 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.33 -19.84 11.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.196 0.443 . . . . 2.77 112.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.442 ' CE1' ' HG2' ' A' ' 1' ' ' PRO . 2.7 t80 -112.74 -74.84 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.343 0.498 . . . . 1.37 112.343 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 25' ' ' PRO . 11.9 p 47.31 57.76 5.5 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.527 0.203 . . . . 0.91 110.704 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.75 -95.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.966 -0.635 . . . . 1.01 112.384 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -148.69 27.56 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 110.693 -0.963 . . . . 0.98 110.693 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -104.22 -177.56 3.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.088 0.471 . . . . 0.87 111.477 -178.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -134.88 5.24 3.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.605 -0.725 . . . . 2.26 111.319 179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 35' ' ' SER . 22.8 mt 60.53 145.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 1.71 110.605 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -133.31 18.27 4.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.842 0.312 . . . . 1.15 111.842 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.519 ' H ' HG22 ' A' ' 33' ' ' ILE . 47.9 t -179.96 151.23 0.41 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.168 0.509 . . . . 1.58 111.971 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.864 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.3 m-85 -134.4 100.31 4.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.58 -0.736 . . . . 0.76 110.002 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.43 114.62 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 1.14 111.008 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -103.61 106.28 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.35 0.595 . . . . 0.63 110.596 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 25.2 mt-10 -75.31 154.92 37.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.251 -0.886 . . . . 1.67 111.212 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 2.7 pttt -117.07 134.36 54.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.134 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 2.8 ttm180 -112.85 101.65 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.878 -0.601 . . . . 1.44 109.788 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -68.54 141.47 55.51 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.848 -0.614 . . . . 1.59 110.622 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.516 HD12 ' HB1' ' A' ' 94' ' ' ALA . 6.9 mt -126.87 153.71 76.12 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.245 -0.434 . . . . 0.9 111.252 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.4 Cg_endo -81.8 24.08 8.27 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.962 -1.266 . . . . 1.43 113.616 0.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.407 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 1.4 p30 -154.46 100.25 2.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.363 . . . . 2.66 110.903 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -165.9 167.9 39.42 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.84 -0.695 . . . . 1.12 112.419 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.631 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -133.14 148.43 52.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 2.41 111.188 -179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CB ' ' A' ' 91' ' ' PRO . 72.1 m95 -55.45 105.88 0.2 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.156 -0.474 . . . . 0.65 111.227 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -134.2 122.54 22.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.846 -0.615 . . . . 1.28 110.354 179.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -44.47 118.2 1.48 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.911 0.386 . . . . 1.3 111.346 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -103.84 -9.83 18.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.86 111.993 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.58 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.6 p-10 -77.71 -54.72 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.201 -0.2 . . . . 2.01 111.467 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 38.34 35.89 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.999 0.37 . . . . 2.08 111.999 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.16 26.04 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.442 -0.345 . . . . 1.89 111.42 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.24 130.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.895 0.378 . . . . 1.87 111.211 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 36' ' ' TYR . 48.1 mt -129.99 84.01 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.004 -0.544 . . . . 0.69 110.633 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 tp -68.34 -43.79 76.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 1.6 111.985 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.45 154.74 17.29 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.834 0.349 . . . . 1.54 110.866 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -72.81 -4.59 32.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.083 -0.508 . . . . 1.75 111.672 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -96.86 98.2 9.92 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.167 -0.679 . . . . 2.05 109.167 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 52' ' ' ASN . 69.8 t80 -128.48 164.53 22.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.452 0.644 . . . . 0.48 112.146 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 4.2 m -125.76 114.87 19.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.077 -0.965 . . . . 0.42 110.783 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 38' ' ' VAL . 14.3 t -77.66 109.09 11.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.16 -0.473 . . . . 1.08 110.817 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.77 151.45 26.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.999 -0.546 . . . . 1.33 111.055 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.93 4.57 10.27 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.574 -0.739 . . . . 0.9 112.396 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.689 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -68.54 -167.19 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.947 0.403 . . . . 1.47 110.918 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -150.25 139.32 21.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.99 -0.55 . . . . 1.06 110.76 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.869 ' OE1' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -58.86 130.45 47.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 1.91 111.063 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t0 76.16 49.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 1.87 111.277 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.03 127.42 4.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.49 111.356 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -75.24 134.23 41.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.134 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -133.2 125.2 28.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.798 0.666 . . . . 0.56 112.798 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.12 150.06 22.88 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.04 -0.726 . . . . 1.5 109.04 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.899 ' CE2' HG11 ' A' ' 18' ' ' VAL . 1.4 m-85 -134.71 117.24 15.81 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.146 1.165 . . . . 0.6 114.146 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 88' ' ' PRO . 24.1 ttm-85 -111.82 159.5 18.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.132 -0.94 . . . . 2.11 109.412 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -136.88 144.83 31.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.982 0.896 . . . . 0.6 112.803 179.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.879 HG23 ' O ' ' A' ' 86' ' ' SER . 22.8 mt -130.32 145.19 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 113.828 -1.533 . . . . 0.7 107.655 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -145.87 130.62 18.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.586 -0.846 . . . . 0.6 112.575 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.7 OUTLIER -91.77 123.96 35.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.257 0.551 . . . . 1.98 111.308 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.506 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 5.4 p-10 -66.28 -174.82 0.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.851 . . . . 2.19 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -65.68 -26.04 67.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.844 -0.616 . . . . 1.08 112.063 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.657 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -88.19 1.47 54.34 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.435 0.531 . . . . 1.06 112.435 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.87 1.8 79.76 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.369 -0.919 . . . . 0.93 113.078 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -77.31 68.08 3.36 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.239 0.543 . . . . 1.38 109.616 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -27.47 120.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 114.695 1.369 . . . . 0.79 114.695 -178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.879 ' O ' HG23 ' A' ' 77' ' ' ILE . 10.7 p -75.29 106.81 3.2 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 106.491 -1.67 . . . . 0.59 106.491 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 9.8 Cg_endo -50.32 169.08 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.88 2.387 . . . . 0.85 114.605 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 72.6 Cg_exo -31.04 136.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.251 3.3 . . . . 0.76 114.078 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 2.8 p -122.01 103.2 8.65 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.589 -0.732 . . . . 1.28 109.972 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -1.8 120.16 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.014 1.326 . . . . 1.77 113.872 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 4.6 Cg_exo -76.77 163.5 31.35 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.268 1.978 . . . . 0.55 113.882 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.401 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 2.0 t -90.97 146.71 23.64 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.002 -0.999 . . . . 1.23 109.401 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -38.75 156.86 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 O-C-N 123.72 0.637 . . . . 1.63 111.596 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -87.43 120.92 29.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.033 -0.53 . . . . 0.41 111.532 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -98.55 114.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 38.2 m -47.89 -28.68 2.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.839 -0.618 . . . . 0.44 111.984 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.869 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 m 50.14 60.6 3.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.737 0.303 . . . . 1.1 110.973 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.702 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -95.41 -74.17 0.56 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.933 0.397 . . . . 3.0 111.147 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.625 ' O ' HG23 ' A' ' 101' ' ' VAL . 7.2 p-10 -131.08 20.0 4.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.974 -0.557 . . . . 2.14 111.633 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.47 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.4 t0 44.07 24.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.649 0.611 . . . . 2.06 112.649 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.677 ' O ' HG12 ' A' ' 101' ' ' VAL . 28.1 t -143.75 15.41 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.869 0.366 . . . . 2.8 111.416 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 17.7 mm-40 -113.92 -17.47 12.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.826 0.346 . . . . 4.58 111.238 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HB2' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.217 -0.897 . . . . 3.79 110.93 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.58 0.229 . . . . 2.74 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.06 -153.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.562 2.175 . . . . 2.06 111.967 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.758 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.9 tt -164.81 147.19 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.68 111.274 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 2' ' ' ILE . 23.9 m-20 -132.22 129.97 21.83 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.076 -0.511 . . . . 2.0 110.475 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.22 157.98 15.04 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.532 2.155 . . . . 0.5 112.604 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 4.5 Cg_endo -48.35 -177.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 123.122 2.548 . . . . 0.71 113.514 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 168.78 29.26 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.53 -0.759 . . . . 0.66 112.957 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -53.39 128.13 50.18 Favored Pre-proline 0 CA--C 1.53 0.197 0 O-C-N 122.987 -0.126 . . . . 1.52 110.811 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 11.8 Cg_exo -74.98 113.95 3.91 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.506 2.137 . . . . 0.44 112.701 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -104.72 107.76 59.13 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.265 -0.425 . . . . 1.09 110.652 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 27.2 Cg_exo -61.7 105.71 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.525 2.15 . . . . 0.64 113.789 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.86 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -63.22 -32.92 74.44 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.89 -0.782 . . . . 1.64 108.89 178.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.99 143.92 32.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.878 -1.055 . . . . 0.72 109.061 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.059 HG22 HG13 ' A' ' 18' ' ' VAL . 3.2 pt -138.74 81.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.146 0.424 . . . . 0.96 112.146 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.257 HG22 ' OD1' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -79.97 151.44 30.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.164 -0.471 . . . . 1.46 110.237 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -56.48 -20.67 21.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.982 -0.554 . . . . 2.42 111.877 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.729 ' O ' HG23 ' A' ' 17' ' ' THR . 0.3 OUTLIER -125.86 11.4 7.77 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.252 0.464 . . . . 1.02 112.252 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.9 OUTLIER -169.85 115.01 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.68 110.709 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 13' ' ' ILE . 24.9 t -109.83 119.51 59.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.061 0.458 . . . . 0.8 111.232 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.73 ' C ' HD13 ' A' ' 20' ' ' LEU . 11.0 m -99.8 124.77 45.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.675 -0.693 . . . . 0.35 110.811 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.18 150.33 48.98 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.805 0.812 . . . . 0.52 112.315 179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.86 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.35 154.35 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.313 -1.312 . . . . 1.84 109.798 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.4 p90 -142.21 -176.05 4.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.278 0.561 . . . . 0.4 112.397 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.47 146.65 24.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.44 -0.8 . . . . 0.83 111.154 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 4.0 tmmm? -84.91 139.21 37.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 2.11 110.758 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.691 ' CB ' HG23 ' A' ' 28' ' ' THR . 93.0 Cg_exo -43.84 160.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 122.216 1.944 . . . . 0.89 111.837 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -106.94 -15.92 14.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.77 111.749 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -127.58 -70.62 0.7 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.863 0.32 . . . . 1.37 111.863 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.691 HG23 ' CB ' ' A' ' 25' ' ' PRO . 14.4 p 50.59 54.78 10.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.971 0.415 . . . . 0.91 110.382 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.33 -103.54 0.04 OUTLIER Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.927 -0.579 . . . . 1.01 112.55 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.66 24.06 2.77 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.35 -0.7 . . . . 0.98 111.35 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -92.04 -176.64 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 0.87 111.923 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 13.6 ttpt -130.87 -13.48 3.63 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.646 -0.706 . . . . 2.26 112.209 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.625 HD11 HG21 ' A' ' 28' ' ' THR . 11.4 mt 64.1 132.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.701 -0.481 . . . . 1.71 109.701 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -124.42 11.82 8.69 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.575 0.583 . . . . 1.15 112.575 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 146.35 0.15 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.999 0.428 . . . . 1.58 112.138 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.506 ' O ' HD12 ' A' ' 56' ' ' ILE . 51.1 m-85 -118.52 122.16 42.0 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.717 -0.674 . . . . 0.76 109.972 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -107.85 129.65 61.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.765 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -119.28 130.22 74.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.63 110.584 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.5 mt-10 -94.54 136.66 34.59 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.442 -0.799 . . . . 1.67 110.668 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.628 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -99.94 159.36 15.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.938 -0.574 . . . . 1.97 111.112 -179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.832 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -140.73 105.29 4.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.004 -0.543 . . . . 1.44 110.546 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.704 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -75.11 80.41 2.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.59 110.97 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 41' ' ' ARG . 1.2 mm? -65.63 155.82 84.63 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.655 -0.702 . . . . 0.9 110.763 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -91.81 36.7 5.99 Favored 'Cis proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.063 -1.224 . . . . 1.43 112.639 0.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -162.18 57.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.923 0.392 . . . . 2.66 111.11 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.704 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -127.05 172.79 18.51 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.973 -0.632 . . . . 1.12 112.156 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 153.62 51.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.217 0.532 . . . . 2.41 111.348 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.712 ' O ' HD22 ' A' ' 49' ' ' LEU . 50.5 m95 -60.94 124.05 19.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.391 -0.822 . . . . 0.65 110.527 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.712 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -154.95 124.05 6.28 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.841 0.353 . . . . 1.28 111.295 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -50.95 115.71 1.65 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.3 110.537 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.628 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -99.26 -35.22 10.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.86 111.545 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.686 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.1 p-10 -53.54 -62.5 1.61 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.316 . . . . 2.01 111.85 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 3.5 t80 80.05 -51.39 0.37 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.544 0.211 . . . . 2.08 111.259 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.0 p -64.04 -171.31 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.886 0.374 . . . . 1.89 110.975 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.2 106.13 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 1.87 110.814 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.686 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.4 mt -92.42 74.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.98 -0.554 . . . . 0.69 111.268 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -73.65 0.05 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.18 -0.464 . . . . 1.6 111.018 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.51 174.12 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.366 -0.379 . . . . 1.54 110.189 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 44.4 p30 -92.86 17.38 10.65 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.267 -0.424 . . . . 1.75 111.452 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.69 103.01 9.28 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 59.1 t80 -134.68 164.18 28.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.068 0.461 . . . . 0.48 111.537 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.661 HG23 ' OG1' ' A' ' 19' ' ' THR . 17.3 m -122.03 119.68 32.12 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.672 -0.694 . . . . 0.42 111.152 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.635 HG23 HD21 ' A' ' 20' ' ' LEU . 22.3 t -86.92 97.24 6.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 1.08 110.995 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.28 150.74 20.01 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.665 -0.698 . . . . 1.33 110.951 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.57 7.45 8.92 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.711 -0.677 . . . . 0.9 112.338 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' CD2' ' A' ' 72' ' ' TYR . 4.4 mm? -51.81 -179.75 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.018 0.437 . . . . 1.47 110.928 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.9 m -142.71 111.01 6.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.813 -0.631 . . . . 1.06 110.112 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -42.0 138.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.91 111.869 -179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 65.79 56.11 0.92 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.897 -0.592 . . . . 1.87 111.583 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.44 123.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.49 111.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.12 134.43 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.36 110.536 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CD2' HD12 ' A' ' 66' ' ' LEU . 49.4 m-85 -130.6 118.89 21.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.317 0.488 . . . . 0.56 112.317 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.72 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -100.08 143.09 30.69 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.311 -0.626 . . . . 1.5 109.311 179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.723 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.57 119.89 13.86 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.486 1.291 . . . . 0.6 114.486 -179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -108.06 173.57 6.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.444 -0.947 . . . . 2.11 108.444 177.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -139.85 113.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 114.116 1.154 . . . . 0.6 114.116 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 37' ' ' ILE . 41.6 mt -97.32 154.57 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 106.479 -1.674 . . . . 0.7 106.479 176.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.16 128.27 1.29 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.434 -0.906 . . . . 0.6 111.656 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.522 ' HG2' HD12 ' A' ' 85' ' ' ILE . 20.6 mttt -63.57 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.047 -0.723 . . . . 1.98 109.047 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.758 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.1 m-80 -146.01 -94.21 0.09 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.66 -0.416 . . . . 2.19 110.925 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -137.15 -42.28 0.57 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.852 0.358 . . . . 1.08 110.952 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.18 30.45 3.46 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.065 -0.516 . . . . 1.06 111.996 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.16 -12.37 58.34 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.541 -0.838 . . . . 0.93 113.353 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.518 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -53.11 115.75 2.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.973 0.386 . . . . 1.38 110.894 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -87.78 104.37 14.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.034 0.445 . . . . 0.79 111.519 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.65 119.76 71.03 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 109.803 -0.443 . . . . 0.59 109.803 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -39.24 162.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.177 2.585 . . . . 0.85 113.122 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 36.7 Cg_endo -66.26 142.3 66.19 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.695 2.263 . . . . 0.76 112.409 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.44 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.8 m -94.59 105.32 17.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 1.28 110.332 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.437 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.5 tt0 -4.27 115.27 0.02 OUTLIER Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 124.705 1.202 . . . . 1.77 113.681 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.527 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.2 Cg_exo -56.2 141.8 87.67 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.125 1.883 . . . . 0.55 113.6 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 15.7 m -72.31 143.17 48.79 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.753 -0.832 . . . . 1.23 108.753 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.439 ' O ' HD12 ' A' ' 95' ' ' ILE . 6.0 m-20 -41.12 137.27 1.36 Allowed 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.768 0.668 . . . . 1.63 110.752 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.836 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -62.85 117.76 6.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.036 -0.529 . . . . 0.41 111.779 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.555 HG22 ' SG ' ' A' ' 97' ' ' CYS . 3.9 mp -92.35 110.82 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.615 -0.72 . . . . 0.44 110.422 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.161 ' HB ' ' OE2' ' A' ' 102' ' ' GLU . 26.0 m -46.95 -39.04 11.6 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.919 0.39 . . . . 0.44 110.655 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 95' ' ' ILE . 99.1 m 61.46 89.13 0.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.09 -0.504 . . . . 1.1 110.91 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.568 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.4 -82.45 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 3.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.099 ' OD2' HG13 ' A' ' 101' ' ' VAL . 11.7 p-10 -96.02 30.28 2.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.752 -0.658 . . . . 2.14 110.653 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.257 ' OD1' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER 44.58 26.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 2.06 112.036 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.099 HG13 ' OD2' ' A' ' 99' ' ' ASP . 7.7 p -164.4 25.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.658 -0.701 . . . . 2.8 110.393 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.161 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 6.3 mm-40 31.88 54.39 0.29 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.656 -0.702 . . . . 4.58 112.646 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' CB ' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.252 -0.88 . . . . 3.79 111.143 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.435 ' HB2' ' CA ' ' A' ' 29' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.674 0.273 . . . . 2.74 111.146 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 65.0 Cg_endo -74.35 -167.6 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.65 2.234 . . . . 2.06 112.552 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -155.63 149.72 11.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.68 110.657 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -138.74 151.57 68.89 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 2.0 111.773 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.71 164.62 12.1 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.907 2.405 . . . . 0.5 112.043 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.33 -164.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.501 2.134 . . . . 0.71 112.637 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.34 -153.59 27.95 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.939 -0.648 . . . . 0.66 113.228 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -90.09 125.05 61.7 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.407 0.146 . . . . 1.52 111.008 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' CD ' ' O ' ' A' ' 90' ' ' GLU . 23.3 Cg_exo -66.52 130.89 24.72 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.489 2.126 . . . . 0.44 112.327 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.05 98.42 17.38 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.163 -0.471 . . . . 1.09 111.19 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.9 Cg_exo -47.14 130.41 16.58 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.64 113.081 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.937 HD11 ' HB2' ' A' ' 21' ' ' LYS . 2.2 mt -90.71 -30.75 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.055 -0.721 . . . . 1.64 109.055 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.49 119.65 6.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.167 -0.924 . . . . 0.72 109.218 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -117.39 122.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.393 0.616 . . . . 0.96 112.448 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.94 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -124.52 160.5 28.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.373 -0.831 . . . . 1.46 110.237 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -59.02 -13.97 8.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.394 0.516 . . . . 2.42 112.394 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.784 ' O ' HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -140.44 23.9 2.3 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.285 0.476 . . . . 1.02 112.285 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.8 OUTLIER -175.98 113.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.841 0.353 . . . . 0.68 110.232 179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 44.7 t -116.24 99.28 8.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.153 0.427 . . . . 0.8 112.153 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.802 ' OG1' HG23 ' A' ' 62' ' ' THR . 46.1 m -83.66 144.85 29.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.35 110.68 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -148.55 163.97 35.63 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.649 0.737 . . . . 0.52 112.499 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.937 ' HB2' HD11 ' A' ' 11' ' ' LEU . 28.4 tptp -145.58 137.86 25.63 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.595 -1.184 . . . . 1.84 109.601 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 37.4 p90 -133.81 177.93 7.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.183 0.516 . . . . 0.4 111.709 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.3 -163.95 0.22 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.83 110.838 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -128.68 140.38 38.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.901 -0.59 . . . . 2.11 110.185 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HG2' HD11 ' A' ' 33' ' ' ILE . 95.9 Cg_exo -39.05 161.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.55 2.166 . . . . 0.89 112.2 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.44 -43.22 5.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.215 0.45 . . . . 2.77 112.215 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.437 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 3.5 t80 -108.91 -70.71 0.79 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.482 0.549 . . . . 1.37 112.482 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.505 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 19.5 p 55.77 40.78 30.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.0 0.429 . . . . 0.91 109.951 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' CA ' ' HB2' ' A' ' 0' ' ' SER . . . 44.67 -100.21 0.02 OUTLIER Glycine 0 CA--C 1.521 0.455 0 CA-C-N 115.804 -0.635 . . . . 1.01 112.53 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.35 27.62 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.295 -0.722 . . . . 0.98 111.295 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -111.85 -171.56 1.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.018 0.437 . . . . 0.87 111.267 -179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.29 35.3 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.831 -0.622 . . . . 2.26 111.24 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.718 HD11 ' HG2' ' A' ' 25' ' ' PRO . 2.9 mm 59.44 158.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.465 -0.334 . . . . 1.71 110.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 33' ' ' ILE . 81.1 p -138.87 1.74 2.1 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.656 0.613 . . . . 1.15 112.656 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.491 ' H ' HG22 ' A' ' 33' ' ' ILE . 10.0 t 168.59 125.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.7 0.286 . . . . 1.58 111.539 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.771 ' O ' HD12 ' A' ' 56' ' ' ILE . 36.9 m-85 -99.82 87.06 3.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.76 111.113 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.541 HG21 ' HD2' ' A' ' 50' ' ' LYS . 1.1 mp -73.74 120.47 22.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.41 -0.359 . . . . 1.14 110.796 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 63' ' ' VAL . 14.0 t -94.15 107.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.111 0.481 . . . . 0.63 111.563 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.82 139.24 31.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.675 -0.693 . . . . 1.67 110.616 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.711 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.0 OUTLIER -108.12 138.93 43.54 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.904 0.383 . . . . 1.97 111.568 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -119.12 97.41 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.564 -0.902 . . . . 1.44 108.564 177.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.862 ' OD1' ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -65.48 97.16 0.28 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.403 -0.817 . . . . 1.59 110.603 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -69.3 148.01 97.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.858 -0.61 . . . . 0.9 110.837 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -93.93 32.22 11.17 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.966 -1.264 . . . . 1.43 112.861 0.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.79 64.63 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.754 0.311 . . . . 2.66 111.547 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.862 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . -95.85 -174.77 36.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 1.12 112.032 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.14 26.78 0.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 2.41 110.777 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.592 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.8 m95 41.38 88.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.099 0.476 . . . . 0.65 111.202 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 137.86 54.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.733 -0.667 . . . . 1.28 111.27 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' HD2' HG21 ' A' ' 37' ' ' ILE . 1.4 mtmt -53.89 129.14 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 1.3 110.4 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -110.29 -31.55 7.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.126 0.489 . . . . 0.86 110.645 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.692 ' HB3' HD11 ' A' ' 56' ' ' ILE . 10.7 p-10 -57.18 -43.31 82.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.69 . . . . 2.01 110.894 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 56.87 25.08 10.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.166 -0.47 . . . . 2.08 110.766 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -169.77 3.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.219 -0.446 . . . . 1.89 110.956 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -94.9 116.08 28.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 1.87 110.974 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.771 HD12 ' O ' ' A' ' 36' ' ' TYR . 27.1 mt -105.71 90.08 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.013 -0.54 . . . . 0.69 110.636 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.497 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.6 mt -74.62 -61.3 1.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 1.6 111.336 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -75.02 159.16 32.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.934 0.397 . . . . 1.54 110.621 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -74.85 -3.22 30.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.544 . . . . 1.75 111.039 179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB2' ' HD3' ' A' ' 21' ' ' LYS . 1.7 tt0 -100.46 103.53 14.89 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.413 -0.588 . . . . 2.05 109.413 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.9 t80 -140.19 165.35 27.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.855 0.359 . . . . 0.48 111.779 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.802 HG23 ' OG1' ' A' ' 19' ' ' THR . 8.1 m -121.29 114.78 21.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.42 111.391 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 38' ' ' VAL . 56.6 t -84.71 90.88 2.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.143 0.497 . . . . 1.08 111.041 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.67 151.69 19.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.552 -0.749 . . . . 1.33 111.0 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.34 14.65 7.5 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.9 112.354 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 72' ' ' TYR . 3.6 mm? -58.25 -179.67 0.06 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.132 0.491 . . . . 1.47 111.357 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.1 m -133.37 109.23 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.589 -0.732 . . . . 1.06 110.199 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.91 135.7 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.087 -0.506 . . . . 1.91 111.816 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 97' ' ' CYS . 9.5 m-20 65.64 62.53 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.614 -0.721 . . . . 1.87 111.215 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.7 114.74 0.17 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.509 -0.314 . . . . 0.49 111.588 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.18 135.34 56.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.731 -0.47 . . . . 0.36 109.731 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 33.3 m-85 -128.61 121.51 28.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.162 0.801 . . . . 0.56 113.162 -178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' HB2' HD21 ' A' ' 43' ' ' LEU . 1.1 mt-10 -99.3 133.7 43.22 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.618 -1.253 . . . . 1.5 107.618 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.756 ' HE2' HG11 ' A' ' 18' ' ' VAL . 7.8 m-85 -117.94 114.87 23.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.138 1.532 . . . . 0.6 115.138 -177.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -100.72 135.34 42.32 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.193 -0.912 . . . . 2.11 108.998 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.567 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -108.24 127.39 64.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 119.288 -0.965 . . . . 0.6 111.721 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.741 HG23 ' O ' ' A' ' 86' ' ' SER . 94.1 mt -115.52 143.9 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 114.811 -1.086 . . . . 0.7 108.126 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.519 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.11 134.45 11.5 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 119.833 -0.747 . . . . 0.6 112.395 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -84.85 -178.6 6.89 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.28 -0.568 . . . . 1.98 110.626 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.521 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.3 p-10 -127.84 -173.23 2.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.36 -0.836 . . . . 2.19 110.104 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -69.66 -11.96 61.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.041 -0.527 . . . . 1.08 112.095 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.621 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -104.01 -4.23 23.6 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.228 0.455 . . . . 1.06 112.228 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.93 -0.98 87.93 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.452 -0.88 . . . . 0.93 113.291 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.558 ' O ' HD12 ' A' ' 2' ' ' ILE . . . -76.57 71.98 3.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.341 0.591 . . . . 1.38 109.951 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 1.9 tt -36.56 123.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.96 1.096 . . . . 0.79 113.96 -178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.741 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.6 p -76.2 107.81 5.12 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.372 -1.344 . . . . 0.59 107.372 177.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 14.6 Cg_endo -55.18 171.4 0.54 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.592 2.194 . . . . 0.85 113.454 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HA ' HG12 ' A' ' 77' ' ' ILE . 48.0 Cg_exo -31.95 122.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.973 3.115 . . . . 0.76 113.317 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 76' ' ' VAL . 4.1 p -106.85 103.82 13.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.205 -0.452 . . . . 1.28 110.121 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER 9.98 113.85 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 125.045 1.466 . . . . 1.77 113.416 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 15.4 Cg_exo -68.31 162.39 40.67 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.88 1.72 . . . . 0.55 114.292 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.82 152.75 18.2 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.153 -0.93 . . . . 1.23 109.345 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.41 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -33.75 156.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.112 0.882 . . . . 1.63 112.294 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -90.64 103.3 16.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.015 -0.539 . . . . 0.41 111.363 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.709 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.0 mp -82.81 110.24 17.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.44 111.497 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 90.8 m -48.74 -35.37 14.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.13 0.491 . . . . 0.44 110.612 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.506 ' SG ' HG22 ' A' ' 95' ' ' ILE . 91.7 m 56.93 79.6 0.18 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.673 -0.694 . . . . 1.1 111.046 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -87.68 0.47 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.506 -0.315 . . . . 3.0 111.381 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.764 ' O ' HG13 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -111.17 0.43 16.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.426 -0.352 . . . . 2.14 111.666 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.94 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 47.73 26.2 0.83 Allowed 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.907 0.385 . . . . 2.06 111.215 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 99' ' ' ASP . 27.1 m -115.87 -19.01 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 116.032 -0.531 . . . . 2.8 110.953 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -135.01 -45.87 0.72 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.901 0.381 . . . . 4.58 110.773 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.224 -0.893 . . . . 3.79 110.928 179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.733 0.302 . . . . 2.74 111.287 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 27' ' ' TYR . 96.0 Cg_endo -92.11 170.91 2.68 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.086 2.524 . . . . 2.06 112.248 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.568 HD12 ' OD1' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -135.58 137.25 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.986 0.422 . . . . 0.68 111.434 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 2' ' ' ILE . 5.1 m-20 -122.02 142.97 37.67 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 2.0 110.332 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.53 168.64 17.84 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.569 2.179 . . . . 0.5 112.402 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 174.29 2.39 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.654 2.236 . . . . 0.71 112.898 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -72.4 177.12 40.61 Favored Glycine 0 N--CA 1.452 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.66 112.493 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.0 tttt -60.77 127.53 87.4 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 110.533 -0.173 . . . . 1.52 110.533 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' HG13 ' A' ' 76' ' ' VAL . 7.0 Cg_exo -74.29 156.89 46.13 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.352 2.035 . . . . 0.44 112.074 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -152.47 114.56 2.85 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.415 -0.357 . . . . 1.09 111.677 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 25.6 Cg_exo -61.44 111.31 1.11 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.691 2.26 . . . . 0.64 113.405 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.58 -33.85 73.32 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.661 -0.866 . . . . 1.64 108.661 178.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.61 141.32 30.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.871 -1.059 . . . . 0.72 108.995 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.002 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -133.98 105.3 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.066 0.46 . . . . 0.96 112.041 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 151.23 20.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.7 -0.682 . . . . 1.46 110.35 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -60.29 -16.06 30.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.422 . . . . 2.42 111.439 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 17' ' ' THR . 6.1 m-70 -132.29 16.96 4.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.48 0.181 . . . . 1.02 111.464 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -176.27 106.97 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.946 0.403 . . . . 0.68 110.917 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.002 HG13 HG22 ' A' ' 13' ' ' ILE . 49.7 t -102.57 117.9 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.966 -0.561 . . . . 0.8 110.971 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.8 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.33 128.9 44.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.992 -0.549 . . . . 0.35 111.571 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -139.77 156.47 46.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.935 0.874 . . . . 0.52 112.412 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.932 ' HG2' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -124.71 -170.45 2.16 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.04 -1.437 . . . . 1.84 109.219 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.495 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 48.7 p90 -179.83 161.14 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.4 111.836 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -80.77 168.06 19.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.578 -0.737 . . . . 0.83 111.797 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.27 141.42 32.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.53 -0.759 . . . . 2.11 110.236 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 28' ' ' THR . 4.5 Cg_endo -46.51 166.63 0.07 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.369 2.046 . . . . 0.89 111.716 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -102.93 -55.62 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.238 -0.437 . . . . 2.77 111.518 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CD1' ' HG2' ' A' ' 1' ' ' PRO . 2.8 t80 -113.15 61.92 0.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.567 -0.288 . . . . 1.37 111.331 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.49 ' O ' ' CE2' ' A' ' 31' ' ' PHE . 44.4 p -57.68 -25.08 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.709 0.29 . . . . 0.91 110.452 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.09 -65.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.579 -0.819 . . . . 1.01 111.886 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.42 40.09 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.991 -1.244 . . . . 0.98 109.991 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -137.87 -176.92 4.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.087 -0.557 . . . . 0.87 111.024 -178.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -144.3 15.21 1.66 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.5 0.556 . . . . 2.26 112.5 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.608 ' C ' HG23 ' A' ' 34' ' ' THR . 5.1 mp 64.22 -74.63 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 111.905 0.335 . . . . 1.71 111.905 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 79.53 21.43 0.6 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.573 -0.285 . . . . 1.15 111.696 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.595 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 169.96 126.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.924 -0.126 . . . . 1.58 111.232 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.8 m-85 -118.06 128.71 55.02 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.94 0.4 . . . . 0.76 112.001 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -119.4 120.67 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.513 -0.312 . . . . 1.14 110.433 179.538 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -105.69 140.42 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.879 0.371 . . . . 0.63 110.813 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' CD ' HD11 ' A' ' 77' ' ' ILE . 2.6 mt-10 -101.96 135.52 43.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.259 0.552 . . . . 1.67 111.966 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.837 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 1.4 mtmp? -101.26 139.19 37.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.273 -0.876 . . . . 1.97 111.336 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.556 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 7.6 ptt180 -132.63 115.65 15.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.454 0.645 . . . . 1.44 109.84 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.615 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -75.65 113.11 12.72 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.123 -0.944 . . . . 1.59 111.053 -178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 2.5 mm? -73.58 161.04 80.76 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.955 -0.566 . . . . 0.9 110.412 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 80.6 Cg_endo -83.8 14.89 33.18 Favored 'Cis proline' 0 C--N 1.349 0.605 0 C-N-CA 124.115 -1.202 . . . . 1.43 113.427 0.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.431 ' ND2' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -98.65 -77.81 0.51 Allowed 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.938 -0.393 . . . . 2.66 109.938 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' CA ' ' HB2' ' A' ' 41' ' ' ARG . . . 92.22 130.81 5.26 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.633 -0.794 . . . . 1.12 113.206 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.615 HH11 HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.47 1.68 4.12 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.64 0.237 . . . . 2.41 111.64 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.593 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 40.4 m95 44.31 94.45 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.205 0.202 . . . . 0.65 111.028 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.615 HD22 HH11 ' A' ' 47' ' ' ARG . 1.4 mp -123.62 135.55 54.01 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.955 0.407 . . . . 1.28 111.615 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HD2' HG21 ' A' ' 37' ' ' ILE . 9.7 mtmt -62.99 82.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.95 -0.568 . . . . 1.3 110.662 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.837 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -49.11 -53.94 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.231 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 p-10 -60.31 138.28 57.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 2.01 111.06 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -136.77 23.07 3.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 2.08 111.031 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 t -120.73 -83.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.323 -0.399 . . . . 1.89 110.72 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 178.48 120.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 1.87 110.86 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.0 mt -107.02 98.99 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.69 110.986 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -76.68 -68.25 0.62 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 1.6 111.087 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -74.85 -179.12 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 1.54 110.65 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.495 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.9 OUTLIER -86.93 -2.91 58.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.169 -0.469 . . . . 1.75 111.482 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.932 ' CD ' ' HG2' ' A' ' 21' ' ' LYS . 9.0 tp10 -97.42 101.86 13.49 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.749 0.309 . . . . 2.05 110.179 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.693 ' CG ' HD13 ' A' ' 56' ' ' ILE . 40.3 t80 -135.81 165.49 25.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.055 0.455 . . . . 0.48 111.584 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.798 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.7 m -122.21 120.69 34.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.758 -0.655 . . . . 0.42 111.115 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.653 ' CG2' HD21 ' A' ' 20' ' ' LEU . 4.8 t -85.77 112.07 21.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.995 -0.548 . . . . 1.08 111.053 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -173.38 2.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.947 -0.57 . . . . 1.33 110.944 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.8 9.58 71.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.732 -0.747 . . . . 0.9 112.847 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.632 HD11 HG23 ' A' ' 18' ' ' VAL . 1.6 mt -61.72 -177.19 0.1 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.658 0.266 . . . . 1.47 110.83 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.698 HG22 ' OH ' ' A' ' 72' ' ' TYR . 3.8 t -138.93 11.49 2.64 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.026 0.38 . . . . 1.06 112.026 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 56.9 159.31 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.006 0.432 . . . . 1.91 111.382 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 90.5 m-20 45.76 66.49 0.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.091 -0.504 . . . . 1.87 111.368 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 174.76 119.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.251 -0.431 . . . . 0.49 111.067 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.83 132.82 55.12 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.205 -0.598 . . . . 0.36 110.281 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.698 ' OH ' HG22 ' A' ' 67' ' ' THR . 25.0 m-85 -130.34 121.0 25.2 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.003 0.742 . . . . 0.56 113.003 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 92' ' ' SER . 2.4 tt0 -102.66 141.05 36.12 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.516 -0.55 . . . . 1.5 109.516 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.777 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.65 128.01 26.38 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.126 1.158 . . . . 0.6 114.126 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.593 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -111.32 160.98 16.52 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.31 -0.626 . . . . 2.11 109.31 177.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.54 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -121.3 112.32 35.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.057 -0.657 . . . . 0.6 111.955 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.945 HG22 ' O ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -105.05 179.81 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.237 -0.892 . . . . 0.7 108.852 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -179.37 -162.59 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.106 0.479 . . . . 0.6 111.395 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' HD12 ' A' ' 85' ' ' ILE . 14.7 mttt -136.85 -171.53 2.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.275 -1.009 . . . . 1.98 108.275 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.865 ' OD1' ' HB3' ' A' ' 84' ' ' ALA . 8.8 p-10 -135.72 156.62 48.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.056 0.455 . . . . 2.19 110.54 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.598 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.35 -29.2 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.601 -0.727 . . . . 1.08 112.084 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.745 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -77.07 -24.5 51.88 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 112.815 0.672 . . . . 1.06 112.815 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.29 -11.5 26.37 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.431 -0.89 . . . . 0.93 112.341 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.865 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . . . -59.89 -156.63 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.125 0 N-CA-C 109.958 -0.386 . . . . 1.38 109.958 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -145.15 114.67 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.059 0.762 . . . . 0.79 113.059 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.945 ' O ' HG22 ' A' ' 77' ' ' ILE . 52.1 p -64.71 109.91 3.43 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.028 -1.471 . . . . 0.59 107.028 177.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 12.3 Cg_endo -54.48 147.63 46.8 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.159 1.906 . . . . 0.85 112.767 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.927 ' HA ' HG23 ' A' ' 77' ' ' ILE . 47.8 Cg_exo -37.22 120.53 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.378 2.719 . . . . 0.76 113.666 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.54 ' OG ' HG13 ' A' ' 76' ' ' VAL . 28.2 p -87.21 101.98 14.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.05 -0.523 . . . . 1.28 110.128 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.8 tt0 0.41 111.05 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 124.991 1.316 . . . . 1.77 114.292 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 51.9 Cg_exo -48.61 167.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.156 1.904 . . . . 0.55 113.19 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -105.91 143.88 33.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.064 -0.971 . . . . 1.23 109.038 179.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.579 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -28.36 144.34 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 124.187 0.929 . . . . 1.63 112.555 -179.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.658 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.67 111.02 15.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.0 -0.545 . . . . 0.41 110.911 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.784 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.2 mp -88.8 120.29 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.7 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.7 m -57.82 -13.02 3.57 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.812 -0.631 . . . . 0.44 112.408 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.784 ' H ' HG22 ' A' ' 95' ' ' ILE . 26.4 p 43.77 70.62 0.3 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.887 0.375 . . . . 1.1 111.287 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -101.1 -87.95 0.38 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.982 -0.554 . . . . 3.0 111.187 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.8 OUTLIER -126.38 8.61 7.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.305 -0.407 . . . . 2.14 111.485 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 38.9 t0 50.39 25.24 1.82 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.844 0.354 . . . . 2.06 110.93 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 101' ' ' VAL . 14.8 p -141.36 9.05 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 2.8 111.83 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 29.65 91.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.844 0.683 . . . . 4.58 112.844 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.219 -0.896 . . . . 3.79 111.048 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.653 0.263 . . . . 2.74 111.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.692 ' O ' HG22 ' A' ' 2' ' ' ILE . 72.3 Cg_endo -79.41 -28.94 3.29 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.455 2.104 . . . . 2.06 112.404 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.97 HD11 ' ND2' ' A' ' 80' ' ' ASN . 7.3 tt 53.9 146.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 O-C-N 124.047 0.842 . . . . 0.68 112.341 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -134.22 119.71 14.56 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.945 -0.571 . . . . 2.0 110.646 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.8 171.35 18.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.501 2.134 . . . . 0.5 112.79 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 45.6 Cg_exo -56.72 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.805 2.337 . . . . 0.71 112.556 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.29 -171.33 39.74 Favored Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.85 -0.691 . . . . 0.66 112.576 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 33.8 tttt -73.76 128.96 85.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.369 0.128 . . . . 1.52 110.825 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.517 ' HG3' ' CG2' ' A' ' 76' ' ' VAL . 20.4 Cg_exo -69.19 143.92 55.24 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.657 2.238 . . . . 0.44 112.713 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -144.19 97.41 5.23 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.586 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.3 Cg_exo -50.14 128.82 23.51 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.252 1.968 . . . . 0.64 113.493 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.725 HD21 ' CB ' ' A' ' 21' ' ' LYS . 2.8 mm? -83.97 -35.43 23.97 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.184 -1.043 . . . . 1.64 108.184 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.48 37.32 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.583 -1.19 . . . . 0.72 107.891 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -136.35 102.72 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 112.778 0.659 . . . . 0.96 112.778 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -106.42 144.3 33.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.33 -0.85 . . . . 1.46 110.173 179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.512 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -46.33 -23.69 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.693 -0.685 . . . . 2.42 112.78 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 17' ' ' THR . 7.8 m170 -125.9 -1.59 7.21 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.505 0.557 . . . . 1.02 112.505 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' HIS . 1.8 p -157.91 115.23 2.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.943 0.401 . . . . 0.68 110.487 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 HG22 ' A' ' 13' ' ' ILE . 57.9 t -119.0 114.57 45.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.051 -0.522 . . . . 0.8 112.032 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 12.7 m -83.34 146.82 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.197 -0.456 . . . . 0.35 109.928 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.28 160.17 43.38 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 112.847 0.684 . . . . 0.52 112.847 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.725 ' CB ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -145.49 147.92 32.69 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.854 -1.066 . . . . 1.84 110.173 179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.4 p90 -142.68 -177.8 5.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.015 0.436 . . . . 0.4 111.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 176.62 7.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.937 -0.574 . . . . 0.83 112.049 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -115.95 143.33 30.62 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.742 -0.663 . . . . 2.11 110.899 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 73.5 Cg_exo -51.55 -179.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.531 2.154 . . . . 0.89 112.426 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.157 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 3.1 pm0 -125.69 -35.27 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 2.77 111.927 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -106.73 -69.73 0.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.173 0.434 . . . . 1.37 112.173 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.463 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 40.9 p 56.2 40.42 30.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.026 0.441 . . . . 0.91 110.426 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.22 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.873 -0.68 . . . . 1.01 112.109 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.34 35.0 1.59 Allowed Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 110.362 -1.095 . . . . 0.98 110.362 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.663 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 3.1 m-85 -113.16 -178.11 3.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.812 -0.694 . . . . 0.87 111.71 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.16 1.41 2.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.697 -0.683 . . . . 2.26 112.224 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 79' ' ' LYS . 7.3 mt 57.97 145.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 CA-C-O 121.117 0.484 . . . . 1.71 111.769 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -132.79 6.97 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.021 -0.536 . . . . 1.15 111.997 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.414 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.6 OUTLIER -179.41 142.74 0.18 Allowed 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.865 0.364 . . . . 1.58 111.474 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.758 ' O ' HD12 ' A' ' 56' ' ' ILE . 35.6 m-85 -113.85 109.6 18.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.844 -0.617 . . . . 0.76 111.423 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -89.29 104.6 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 1.14 110.63 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.4 p -99.3 119.0 46.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.63 111.209 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -80.12 163.08 24.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.649 -0.705 . . . . 1.67 111.236 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.513 ' HG2' ' N ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -118.82 168.07 11.11 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 115.658 -0.701 . . . . 1.97 109.285 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -156.94 87.05 0.98 Allowed 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.793 -0.763 . . . . 1.44 111.386 177.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.842 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -66.51 85.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.512 . . . . 1.59 110.963 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -61.94 159.4 36.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.595 179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 3.9 Cg_exo -80.83 21.67 9.18 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.261 -1.141 . . . . 1.43 113.703 0.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.403 ' N ' ' HA ' ' A' ' 43' ' ' LEU . 67.2 m-80 -132.41 -85.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.027 -0.269 . . . . 2.66 110.536 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 41.94 -164.7 0.02 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.073 -0.584 . . . . 1.12 112.945 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.51 145.07 3.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.08 0.467 . . . . 2.41 110.491 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 53.7 m95 -65.58 77.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.638 -0.71 . . . . 0.65 111.786 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.449 ' HB2' ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -112.78 156.65 22.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.998 -0.547 . . . . 1.28 109.855 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -50.25 90.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.689 0.281 . . . . 1.3 111.24 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB2' ' CB ' ' A' ' 40' ' ' LYS . . . -60.2 -31.63 70.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.29 0.567 . . . . 0.86 109.514 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.776 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.9 p-10 -91.69 -145.41 0.2 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.289 -0.868 . . . . 2.01 110.492 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 175.85 -33.2 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.86 0.362 . . . . 2.08 110.194 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -91.92 171.53 9.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.064 -0.517 . . . . 1.89 110.738 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.63 105.06 1.77 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.87 111.086 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.776 HD11 ' CB ' ' A' ' 52' ' ' ASN . 14.4 mt -87.98 53.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.69 110.306 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.3 tm? -44.2 -54.6 5.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.978 -0.556 . . . . 1.6 111.233 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -84.07 158.95 21.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.089 -0.505 . . . . 1.54 109.974 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.481 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 12.4 p30 -80.37 4.68 17.18 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.43 -0.35 . . . . 1.75 111.587 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -98.38 94.34 6.68 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 109.013 -0.736 . . . . 2.05 109.013 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.528 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 74.3 t80 -126.05 164.83 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.142 0.496 . . . . 0.48 112.052 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.507 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 10.9 m -133.74 109.62 9.26 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.567 -0.742 . . . . 0.42 110.954 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.74 HG21 ' CE1' ' A' ' 74' ' ' PHE . 27.8 m -67.42 114.31 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.91 -0.586 . . . . 1.08 111.238 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -117.42 129.44 55.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.892 -0.594 . . . . 1.33 111.21 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.73 11.21 6.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.745 . . . . 0.9 112.857 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.33 -158.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.683 0.278 . . . . 1.47 110.548 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.6 m -138.04 147.78 44.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.496 -0.32 . . . . 1.06 110.181 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -82.5 142.01 32.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.963 0.411 . . . . 1.91 111.332 -179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 t0 65.94 60.08 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.547 . . . . 1.87 111.36 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.66 128.99 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.05 -0.523 . . . . 0.49 110.919 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -59.81 143.53 50.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.806 0.336 . . . . 0.36 110.422 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 2.0 m-85 -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.529 0.566 . . . . 0.56 112.529 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.793 ' OE1' ' HB2' ' A' ' 94' ' ' ALA . 6.5 tp10 -101.54 140.55 35.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.018 -0.734 . . . . 1.5 109.018 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.74 ' CE1' HG21 ' A' ' 63' ' ' VAL . 8.6 m-85 -123.82 110.54 15.02 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.668 0.988 . . . . 0.6 113.668 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.3 ttm180 -90.32 159.83 16.43 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.636 -0.711 . . . . 2.11 109.962 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 8' ' ' PRO . 47.8 t -130.7 120.7 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.536 0.939 . . . . 0.6 113.536 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 55.6 mt -123.33 153.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.703 -1.591 . . . . 0.7 106.703 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -173.21 123.1 0.39 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.417 -1.313 . . . . 0.6 113.937 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 33' ' ' ILE . 18.4 mttt -68.21 158.8 32.45 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.205 -1.035 . . . . 1.98 108.205 177.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.97 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -99.8 -91.35 0.29 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 119.843 -0.743 . . . . 2.19 111.805 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -133.89 -42.63 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.276 0.472 . . . . 1.08 112.276 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.663 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -95.05 40.46 1.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.33 0.493 . . . . 1.06 112.33 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.73 8.72 41.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.45 -0.881 . . . . 0.93 113.196 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.75 92.66 4.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.0 0.4 . . . . 1.38 109.947 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -62.71 107.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.28 0.474 . . . . 0.79 112.28 -179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 8.3 p -62.89 121.92 71.46 Favored Pre-proline 0 C--O 1.239 0.508 0 N-CA-C 109.005 -0.739 . . . . 0.59 109.005 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -45.59 174.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.266 . . . . 0.85 112.624 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 4.2 Cg_exo -73.3 155.37 51.34 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.822 2.348 . . . . 0.76 112.829 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -117.26 135.34 53.88 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.626 -0.715 . . . . 1.28 110.304 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.4 tt0 -35.24 110.89 0.42 Allowed Pre-proline 0 N--CA 1.469 0.503 0 O-C-N 124.0 0.812 . . . . 1.77 111.848 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 75.3 Cg_exo -50.96 145.46 24.55 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.827 2.351 . . . . 0.55 114.4 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.62 149.86 41.76 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.608 -0.886 . . . . 1.23 108.608 178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -34.12 155.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 O-C-N 124.076 0.86 . . . . 1.63 112.093 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.864 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -89.31 110.82 21.56 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.94 -0.573 . . . . 0.41 111.847 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.664 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.2 mp -88.22 112.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 0.44 111.167 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.486 HG21 ' NH1' ' A' ' 98' ' ' ARG . 85.6 m -42.77 -29.9 0.35 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.004 0.43 . . . . 0.44 110.87 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.531 ' H ' HG22 ' A' ' 95' ' ' ILE . 84.7 m 51.07 69.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.171 -0.468 . . . . 1.1 110.439 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 1.035 ' HD3' ' CD ' ' A' ' 102' ' ' GLU . 1.5 ptp85 -111.87 -87.51 0.54 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.067 -0.515 . . . . 3.0 110.824 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.303 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 1.2 p30 -123.49 0.27 8.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.111 -0.495 . . . . 2.14 110.884 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.2 t0 45.39 26.95 0.32 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.69 0.281 . . . . 2.06 111.71 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.849 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 10.6 p -153.38 19.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 2.8 111.542 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.303 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -145.16 12.09 1.37 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.095 0.405 . . . . 4.58 112.095 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.012 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.232 -0.89 . . . . 3.79 111.097 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.719 0.295 . . . . 2.74 111.215 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.29 124.83 2.89 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.747 2.298 . . . . 2.06 112.615 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.9 tt -99.54 146.03 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.68 110.89 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 28' ' ' THR . 9.8 m-20 -130.12 135.08 26.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 2.0 110.193 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -83.3 175.16 8.5 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.558 2.172 . . . . 0.5 112.837 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -65.18 171.64 8.71 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.914 2.409 . . . . 0.71 112.676 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.74 173.04 53.74 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.007 -0.616 . . . . 0.66 112.831 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -63.9 123.23 81.12 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.498 0.149 . . . . 1.52 110.677 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.524 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 34.8 Cg_exo -65.27 131.1 27.25 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.453 2.102 . . . . 0.44 112.699 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.63 108.01 20.74 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.007 -0.542 . . . . 1.09 110.575 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 39.0 Cg_exo -58.94 115.07 2.29 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.471 2.114 . . . . 0.64 113.976 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.65 HD11 ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -77.71 -38.43 47.32 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.885 -0.783 . . . . 1.64 108.885 178.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.73 145.36 49.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.8 -1.091 . . . . 0.72 108.701 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.071 HG22 HG13 ' A' ' 18' ' ' VAL . 1.7 pt -141.0 97.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.598 0.592 . . . . 0.96 112.598 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.96 147.7 23.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.643 -0.708 . . . . 1.46 109.34 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -53.5 -18.28 2.65 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.226 0.454 . . . . 2.42 112.226 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.463 ' N ' ' HD3' ' A' ' 15' ' ' ARG . 2.5 m-70 -126.78 -4.22 6.46 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.272 0.471 . . . . 1.02 112.272 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.87 116.46 5.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.873 0.368 . . . . 0.68 111.107 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 13' ' ' ILE . 66.6 t -105.25 134.41 46.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.009 0.433 . . . . 0.8 111.167 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.0 m -111.96 122.47 47.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.986 -0.552 . . . . 0.35 110.669 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.98 149.23 52.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.753 0.787 . . . . 0.52 112.203 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.936 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 7.0 tptt -133.09 139.01 46.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.427 -1.261 . . . . 1.84 109.704 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.517 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.9 p90 -128.64 -174.98 3.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.056 0.455 . . . . 0.4 111.881 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.23 179.33 5.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.703 -0.68 . . . . 0.83 112.044 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -107.88 138.68 20.13 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 2.11 110.221 179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.618 ' CB ' HG23 ' A' ' 28' ' ' THR . 79.9 Cg_exo -44.21 171.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.418 2.079 . . . . 0.89 112.613 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -110.89 -25.06 10.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.048 -0.524 . . . . 2.77 111.992 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -126.51 -69.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.158 0.429 . . . . 1.37 112.158 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' CB ' ' A' ' 25' ' ' PRO . 64.4 p 51.37 56.22 8.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 0.91 110.704 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.12 -93.46 0.01 OUTLIER Glycine 0 CA--C 1.522 0.522 0 CA-C-N 115.966 -0.561 . . . . 1.01 112.844 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.02 32.95 1.05 Allowed Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 110.008 -1.237 . . . . 0.98 110.008 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.66 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.99 179.54 3.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.738 -0.731 . . . . 0.87 111.009 -178.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.34 -3.17 3.45 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.179 -0.464 . . . . 2.26 112.185 179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.1 mt 61.27 138.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-O 120.921 0.391 . . . . 1.71 110.606 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -140.78 24.72 2.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.439 -0.346 . . . . 1.15 111.525 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.2 m -166.51 102.69 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.728 0.299 . . . . 1.58 111.618 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 33.8 m-85 -98.12 115.64 28.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.76 110.454 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -104.63 112.71 39.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.548 -0.296 . . . . 1.14 111.199 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.2 OUTLIER -101.54 114.59 41.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 0.63 110.74 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -79.6 151.24 30.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.522 -0.763 . . . . 1.67 110.347 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.71 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -121.27 140.13 52.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 1.97 111.168 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.699 ' O ' HD22 ' A' ' 43' ' ' LEU . 9.5 ttp180 -121.73 116.4 24.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.111 -0.495 . . . . 1.44 110.371 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -76.57 102.69 6.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 1.59 110.798 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.6 mm? -88.65 156.83 50.08 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.531 -0.304 . . . . 0.9 110.738 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -91.54 36.27 6.24 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.152 -1.187 . . . . 1.43 112.377 0.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -165.47 83.63 0.35 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.868 0.366 . . . . 2.66 111.163 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -155.74 -164.82 13.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.207 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.627 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.77 172.57 12.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.007 0.432 . . . . 2.41 111.279 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.651 ' O ' HD22 ' A' ' 49' ' ' LEU . 68.4 m95 -78.8 118.36 20.79 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.57 -0.741 . . . . 0.65 112.212 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -147.37 127.03 13.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.756 -0.656 . . . . 1.28 110.649 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.24 99.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.084 -0.507 . . . . 1.3 111.625 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.71 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.31 -38.37 89.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.246 0.546 . . . . 0.86 110.338 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 61' ' ' PHE . 10.5 p-10 -70.4 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.01 110.963 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 172.44 -29.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.76 0.314 . . . . 2.08 110.461 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 p -81.33 -159.77 0.29 Allowed 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.35 -0.386 . . . . 1.89 110.641 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.94 97.83 7.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.893 0.378 . . . . 1.87 111.05 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.813 HD12 ' O ' ' A' ' 36' ' ' TYR . 28.8 mt -81.25 87.94 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 0.69 111.127 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.9 tp -73.45 -53.74 9.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.21 -0.45 . . . . 1.6 111.074 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.64 164.82 21.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 1.54 110.562 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -81.21 4.55 19.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.46 . . . . 1.75 111.644 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.936 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 4.9 tp10 -106.93 96.21 6.27 Favored 'General case' 0 CA--C 1.522 -0.115 0 CA-C-O 120.802 0.335 . . . . 2.05 110.179 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 52' ' ' ASN . 67.3 t80 -124.43 164.36 19.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.48 111.298 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.48 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 89.0 m -132.14 114.06 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.872 -0.604 . . . . 0.42 110.959 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.484 HG23 HD21 ' A' ' 66' ' ' LEU . 24.6 m -76.21 133.05 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.08 111.064 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.69 133.01 49.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.973 -0.558 . . . . 1.33 110.949 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.89 -2.16 4.76 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.683 -0.77 . . . . 0.9 113.145 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.6 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -58.38 -173.67 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.975 0.417 . . . . 1.47 111.232 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 m -139.76 141.61 36.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.806 -0.634 . . . . 1.06 110.634 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 6.6 mt-10 -64.57 146.51 54.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.095 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' CYS . 5.9 m-20 63.83 57.36 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.003 -0.544 . . . . 1.87 111.344 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.03 124.2 0.62 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.706 0.289 . . . . 0.49 111.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -66.4 138.07 57.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.522 -0.308 . . . . 0.36 110.172 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.71 117.57 17.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.448 0.536 . . . . 0.56 112.448 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.646 ' HB2' HD21 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -98.72 144.2 28.23 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.906 -0.776 . . . . 1.5 108.906 178.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.796 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -135.59 115.39 12.98 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.24 1.2 . . . . 0.6 114.24 -179.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.2 ptp180 -105.59 177.97 4.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.987 -1.116 . . . . 2.11 107.987 177.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.531 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -154.24 126.09 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 122.257 1.027 . . . . 0.6 113.225 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' SER . 11.3 mt -105.45 152.99 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 CA-C-N 113.368 -1.742 . . . . 0.7 106.958 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.11 135.92 8.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.01 -1.076 . . . . 0.6 112.762 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HG2' HD12 ' A' ' 85' ' ' ILE . 5.5 mttt -80.16 -169.63 2.14 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.526 -0.761 . . . . 1.98 110.384 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.739 ' ND2' HD12 ' A' ' 2' ' ' ILE . 3.7 p30 -135.54 171.74 14.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.195 0.522 . . . . 2.19 111.336 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.94 -25.07 1.22 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.754 . . . . 1.08 111.859 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.15 -20.67 28.28 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.267 0.469 . . . . 1.06 112.267 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 79' ' ' LYS . . . 110.32 -18.37 28.02 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.279 -0.962 . . . . 0.93 112.319 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.685 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -62.09 144.35 55.41 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 110.203 -0.295 . . . . 1.38 110.203 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.601 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -94.17 117.8 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.79 112.008 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' ILE . 1.1 p -78.77 127.94 78.54 Favored Pre-proline 0 C--O 1.238 0.465 0 CA-C-N 115.549 -0.75 . . . . 0.59 110.259 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -34.69 159.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.592 2.861 . . . . 0.85 114.076 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 6.2 Cg_exo -74.28 138.74 25.37 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.06 2.507 . . . . 0.76 112.555 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.531 ' OG ' HG13 ' A' ' 76' ' ' VAL . 79.1 p -88.76 130.47 35.34 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.132 -0.485 . . . . 1.28 110.016 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -34.53 122.51 0.55 Allowed Pre-proline 0 N--CA 1.469 0.478 0 O-C-N 123.743 0.652 . . . . 1.77 112.338 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 33.7 Cg_exo -55.97 145.58 73.39 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.456 2.104 . . . . 0.55 113.345 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.12 149.12 35.7 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.606 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -36.0 142.26 0.08 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.829 0.705 . . . . 1.63 112.128 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.691 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.09 112.69 14.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.761 -0.654 . . . . 0.41 110.606 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -93.11 118.16 38.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.252 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.462 HG22 ' HG2' ' A' ' 98' ' ' ARG . 88.7 m -48.51 -37.83 18.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.202 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 69' ' ' ASP . 66.9 m 55.49 90.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.809 0.338 . . . . 1.1 110.767 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.462 ' HG2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -143.65 -86.67 0.13 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 3.0 110.378 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.147 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -107.8 -11.09 15.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.051 -0.522 . . . . 2.14 110.849 179.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 p30 52.56 21.29 1.76 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.209 -0.45 . . . . 2.06 111.716 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.147 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.3 t -123.38 -11.09 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.338 -0.392 . . . . 2.8 111.302 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.76 ' OE1' ' N ' ' A' ' 102' ' ' GLU . 1.3 mp0 -115.91 -14.84 11.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.586 0.231 . . . . 4.58 111.006 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.253 -0.88 . . . . 3.79 111.299 -179.881 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.818 0.342 . . . . 2.74 111.28 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.423 ' HD2' ' CE2' ' A' ' 27' ' ' TYR . 88.1 Cg_endo -90.69 72.16 1.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.07 2.514 . . . . 2.06 112.158 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.787 HD11 ' OD1' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -56.37 135.51 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.43 . . . . 0.68 111.245 -179.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -128.65 148.45 68.47 Favored Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 116.248 -0.433 . . . . 2.0 111.551 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -83.38 160.12 14.94 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.98 2.453 . . . . 0.5 112.937 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.4 Cg_endo -54.64 -176.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.898 2.399 . . . . 0.71 112.378 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.22 -176.45 51.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.901 -0.666 . . . . 0.66 112.492 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -74.13 128.05 86.93 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.412 -0.218 . . . . 1.52 110.412 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 14.2 Cg_exo -72.28 126.72 11.94 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.297 1.998 . . . . 0.44 112.872 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.73 105.99 50.8 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.613 -0.721 . . . . 1.09 109.502 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 19' ' ' THR . 86.6 Cg_exo -43.12 92.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.364 2.043 . . . . 0.64 113.98 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.453 HD23 ' CG2' ' A' ' 19' ' ' THR . 1.9 tp -57.74 -29.45 64.77 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.315 -0.857 . . . . 1.64 109.335 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -159.99 153.35 22.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.161 -0.927 . . . . 0.72 108.966 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.136 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 1.4 pt -142.72 141.12 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.361 0.6 . . . . 0.96 112.446 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.633 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -138.56 142.91 39.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.154 -0.93 . . . . 1.46 109.886 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -44.92 -24.47 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.609 0.596 . . . . 2.42 112.609 -179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -125.19 -6.76 7.12 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.402 0.519 . . . . 1.02 112.402 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.11 111.09 5.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.818 0.342 . . . . 0.68 110.92 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 HG22 ' A' ' 13' ' ' ILE . 69.6 t -106.1 122.02 59.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.8 111.514 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.8 m -99.38 135.47 40.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.35 110.825 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -137.7 143.36 41.23 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.662 0.744 . . . . 0.52 111.338 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -126.81 149.59 49.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.66 -1.155 . . . . 1.84 110.011 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.1 p90 -143.61 -175.69 4.67 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.279 0.561 . . . . 0.4 112.367 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.63 -174.03 4.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.398 -0.819 . . . . 0.83 111.428 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 137.3 21.13 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.084 -0.507 . . . . 2.11 109.941 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' HG23 ' A' ' 28' ' ' THR . 6.2 Cg_exo -36.12 153.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 123.245 2.63 . . . . 0.89 112.736 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -82.06 -40.31 22.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 2.77 111.862 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.423 ' CE2' ' HD2' ' A' ' 1' ' ' PRO . 23.2 t80 -130.98 -63.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 1.37 111.804 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.528 HG23 ' CB ' ' A' ' 25' ' ' PRO . 6.1 p 52.31 45.22 28.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.91 110.793 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.25 -112.11 0.91 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.773 -0.727 . . . . 1.01 112.188 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.44 28.35 5.3 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 110.408 -1.077 . . . . 0.98 110.408 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' CE1' ' CB ' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -114.07 173.97 6.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.159 -0.52 . . . . 0.87 110.991 -178.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.72 10.4 2.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.314 -0.403 . . . . 2.26 111.759 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.63 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.6 mt 59.33 116.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.942 0.401 . . . . 1.71 111.103 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 p -109.25 28.81 8.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 1.15 111.425 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.407 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 174.3 106.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.747 0.308 . . . . 1.58 111.329 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.63 ' CE1' HG21 ' A' ' 33' ' ' ILE . 57.7 m-85 -94.38 124.74 38.59 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.901 0.381 . . . . 0.76 110.969 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.4 mm -97.23 142.07 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.594 -0.521 . . . . 1.14 109.594 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.86 94.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.754 -0.378 . . . . 0.63 111.994 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 3.0 mt-10 -68.13 137.85 55.25 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.244 -0.651 . . . . 1.67 109.244 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.1 134.67 53.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 1.97 111.589 -179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.523 ' HG2' HD12 ' A' ' 43' ' ' LEU . 8.7 ttp180 -108.6 104.46 13.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.78 -0.646 . . . . 1.44 109.895 179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.28 82.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.853 -0.612 . . . . 1.59 110.665 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.523 HD12 ' HG2' ' A' ' 41' ' ' ARG . 3.6 mp -50.56 155.83 1.73 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 0.9 111.088 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -88.34 32.71 7.58 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.653 -1.395 . . . . 1.43 112.836 0.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 -77.24 0.38 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.79 0.328 . . . . 2.66 111.108 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . 51.16 -175.2 0.08 OUTLIER Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.913 -0.661 . . . . 1.12 112.82 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.92 30.54 0.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.962 0.41 . . . . 2.41 110.646 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.517 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 71.2 m95 45.25 96.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.863 -0.608 . . . . 0.65 111.59 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.448 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -131.01 123.55 29.0 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.841 -0.618 . . . . 1.28 110.217 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 10.8 ptpt -48.42 137.92 10.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.3 110.967 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -123.66 -36.51 2.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.86 111.553 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB3' HD11 ' A' ' 56' ' ' ILE . 2.5 p-10 -41.75 -62.56 0.87 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.509 -0.314 . . . . 2.01 111.696 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 t80 45.91 30.22 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.507 -0.315 . . . . 2.08 111.39 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.41 30.36 2.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.41 -0.359 . . . . 1.89 111.284 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.74 95.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.44 -0.345 . . . . 1.87 111.337 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 61' ' ' PHE . 7.5 mt -86.32 90.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.406 . . . . 0.69 111.246 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -70.67 -44.13 67.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.158 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -100.13 153.36 19.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.92 0.39 . . . . 1.54 110.658 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 20.9 p-10 -66.3 -10.46 42.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.947 -0.57 . . . . 1.75 111.527 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HG3' ' CG ' ' A' ' 21' ' ' LYS . 2.9 tt0 -93.77 99.19 11.63 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.938 -0.764 . . . . 2.05 108.938 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.695 ' CG ' HD13 ' A' ' 56' ' ' ILE . 81.6 t80 -129.35 162.61 27.6 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 119.947 -0.701 . . . . 0.48 112.596 -178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 71.8 m -125.16 114.52 19.12 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.198 -0.91 . . . . 0.42 111.222 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.633 HG23 HD21 ' A' ' 20' ' ' LEU . 48.7 t -80.73 120.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.841 -0.618 . . . . 1.08 110.958 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -117.28 162.33 18.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.243 0.544 . . . . 1.33 110.988 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.26 -2.22 31.19 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.381 -0.827 . . . . 0.9 112.903 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -67.17 -176.1 0.52 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.077 0.465 . . . . 1.47 110.732 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.474 HG22 ' OH ' ' A' ' 72' ' ' TYR . 1.7 t -140.55 144.11 35.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.745 -0.661 . . . . 1.06 110.453 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.465 ' CG ' ' HA ' ' A' ' 98' ' ' ARG . 7.6 tt0 -64.55 144.28 57.31 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.25 -0.432 . . . . 1.91 110.782 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.4 t0 71.76 54.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 1.87 110.904 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.61 122.56 0.62 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.497 -0.32 . . . . 0.49 111.51 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.04 132.11 43.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.36 109.96 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.474 ' OH ' HG22 ' A' ' 67' ' ' THR . 52.1 m-85 -128.72 123.26 32.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.392 0.515 . . . . 0.56 112.392 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -101.7 144.15 30.76 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.699 -0.852 . . . . 1.5 108.699 178.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -130.51 114.93 16.11 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.27 1.582 . . . . 0.6 115.27 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 21.4 ttm-85 -99.7 157.51 16.43 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.361 -0.977 . . . . 2.11 108.361 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.881 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -135.05 128.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.232 -0.987 . . . . 0.6 112.819 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 86' ' ' SER . 57.0 mt -117.96 156.04 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.094 -1.412 . . . . 0.7 107.371 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.45 116.78 0.82 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 118.896 -1.122 . . . . 0.6 112.657 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 1.6 mmtp -59.13 -177.83 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.077 -0.649 . . . . 1.98 109.552 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.787 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.1 m120 -130.61 163.3 27.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.093 0.473 . . . . 2.19 111.498 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.2 -26.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.141 0.793 . . . . 1.08 113.141 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' PHE . . . -102.84 11.57 37.34 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.907 0.706 . . . . 1.06 112.907 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 88.56 -2.16 84.49 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.266 -0.969 . . . . 0.93 113.273 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -68.97 120.53 14.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.139 0.47 . . . . 1.38 109.887 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -79.81 102.05 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.603 -0.439 . . . . 0.79 111.88 -179.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 77' ' ' ILE . 9.5 p -61.81 111.3 4.23 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 109.369 -0.604 . . . . 0.59 109.369 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -40.81 173.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.676 2.918 . . . . 0.85 114.608 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.07 128.88 24.07 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.098 2.532 . . . . 0.76 112.824 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.881 ' OG ' HG13 ' A' ' 76' ' ' VAL . 3.8 p -97.89 119.03 35.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.811 -0.631 . . . . 1.28 109.957 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -20.24 119.8 0.1 Allowed Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 124.009 0.924 . . . . 1.77 112.673 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 27.8 Cg_exo -63.39 156.51 55.75 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.655 2.237 . . . . 0.55 114.385 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.487 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.67 149.73 25.11 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.022 -0.99 . . . . 1.23 109.316 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -37.44 158.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.869 0.731 . . . . 1.63 111.771 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -91.08 108.08 19.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.747 -0.66 . . . . 0.41 111.053 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.767 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -90.93 114.35 28.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.36 -0.382 . . . . 0.44 111.541 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 85.4 m -52.4 -31.16 32.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.44 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 17.1 m 57.04 93.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.34 . . . . 1.1 110.113 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -143.87 -86.11 0.14 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.501 -179.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.156 ' OD2' HG13 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -104.67 -2.52 24.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 2.14 111.716 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.136 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER 43.78 27.58 0.18 Allowed 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 112.564 0.579 . . . . 2.06 112.564 179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.156 HG13 ' OD2' ' A' ' 99' ' ' ASP . 5.5 p -156.39 21.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.319 0.581 . . . . 2.8 111.302 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.45 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.28 -38.88 3.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 4.58 110.012 179.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.252 -0.88 . . . . 3.79 111.051 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.62 0.248 . . . . 2.74 111.277 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.27 -166.57 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.737 2.291 . . . . 2.06 111.774 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.773 HD12 ' ND2' ' A' ' 80' ' ' ASN . 11.8 tt -150.61 154.0 9.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.68 111.135 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' N ' HG12 ' A' ' 2' ' ' ILE . 79.0 m-20 -137.7 127.3 15.18 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.405 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.76 154.2 34.21 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.256 1.971 . . . . 0.5 112.054 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -56.65 -179.98 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.717 2.278 . . . . 0.71 113.098 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.81 -157.15 3.69 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.66 112.749 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -91.41 134.08 30.21 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.7 -0.111 . . . . 1.52 110.7 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.0 Cg_exo -77.44 132.44 12.33 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.647 2.232 . . . . 0.44 112.157 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.1 123.29 10.33 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.445 -0.343 . . . . 1.09 111.538 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.631 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.8 Cg_exo -68.39 129.83 19.88 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.282 1.988 . . . . 0.64 112.822 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 11' ' ' LEU . 0.8 OUTLIER -97.31 -35.74 10.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.379 -0.6 . . . . 1.64 109.379 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.65 100.89 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.72 109.609 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.742 HG21 HG12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -98.68 140.42 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.92 -0.582 . . . . 0.96 112.071 -179.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.422 ' CB ' ' O ' ' A' ' 17' ' ' THR . 0.3 OUTLIER -135.74 144.26 45.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.534 -0.757 . . . . 1.46 111.001 -179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 1.8 mtp180 -33.05 -47.97 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 113.58 0.956 . . . . 2.42 113.58 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -106.73 -14.49 15.0 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.338 0.866 . . . . 1.02 113.338 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.608 ' HA ' HD22 ' A' ' 66' ' ' LEU . 15.3 p -147.77 129.51 15.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.65 -0.42 . . . . 0.68 111.42 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.99 HG13 HD23 ' A' ' 66' ' ' LEU . 4.4 m -117.1 152.49 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.641 -0.423 . . . . 0.8 110.604 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.543 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.1 m -119.39 118.84 32.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.302 -0.408 . . . . 0.35 111.168 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.808 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.28 155.63 47.98 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.428 0.632 . . . . 0.52 111.288 179.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.61 159.64 42.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.031 -0.986 . . . . 1.84 109.905 179.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' N ' ' HD3' ' A' ' 21' ' ' LYS . 11.8 p90 -137.93 -171.83 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.4 111.756 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.6 -171.93 3.66 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.919 -0.582 . . . . 0.83 111.591 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -124.22 139.71 33.35 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.946 -0.57 . . . . 2.11 111.0 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 28' ' ' THR . 16.8 Cg_endo -58.65 179.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.546 2.164 . . . . 0.89 112.106 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -132.17 0.29 3.77 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.156 0.428 . . . . 2.77 112.156 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -132.56 -72.6 0.52 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 121.082 -0.247 . . . . 1.37 111.126 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 25' ' ' PRO . 6.0 p 42.77 55.28 4.38 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.614 0.245 . . . . 0.91 111.22 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.54 1.3 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.217 -0.516 . . . . 1.01 112.671 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.57 30.29 5.8 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 110.444 -1.063 . . . . 0.98 110.444 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -105.38 177.91 4.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.971 -0.614 . . . . 0.87 111.531 -178.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.55 -2.14 3.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.715 -0.675 . . . . 2.26 111.941 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.713 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.9 mt 55.75 106.16 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.055 0 CA-C-O 121.007 0.432 . . . . 1.71 110.746 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 p -106.18 17.82 22.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 1.15 111.651 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.67 138.98 0.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.804 0.335 . . . . 1.58 111.594 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 56' ' ' ILE . 48.3 m-85 -120.25 141.94 49.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.115 -0.493 . . . . 0.76 110.342 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' A' ' 50' ' ' LYS . 10.9 mm -108.17 156.24 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.117 -0.492 . . . . 1.14 110.767 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.34 106.06 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.452 -0.34 . . . . 0.63 111.123 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.1 mt-10 -77.85 120.81 23.26 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.574 -0.528 . . . . 1.67 109.574 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -106.33 148.84 27.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.362 0.601 . . . . 1.97 111.961 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.473 ' CZ ' ' NE1' ' A' ' 48' ' ' TRP . 3.2 ttp180 -131.06 111.42 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.158 -0.928 . . . . 1.44 109.557 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.3 79.88 1.84 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.611 -0.722 . . . . 1.59 110.528 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.728 HD12 ' HB1' ' A' ' 94' ' ' ALA . 16.0 mt -63.54 142.66 97.96 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.938 -0.574 . . . . 0.9 110.858 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -93.64 13.42 47.9 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.059 -1.226 . . . . 1.43 112.765 0.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -130.44 86.77 2.42 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.751 0.31 . . . . 2.66 111.007 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.52 173.17 44.37 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.584 -0.817 . . . . 1.12 112.718 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.677 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -135.16 143.2 46.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 2.41 110.589 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 83.2 m95 -50.02 103.43 0.05 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 0.65 111.234 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.677 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -133.79 141.57 47.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.488 -0.323 . . . . 1.28 110.603 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' A' ' 37' ' ' ILE . 46.2 mtpt -44.87 104.7 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.872 0.368 . . . . 1.3 111.36 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -69.98 -51.04 35.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.079 -0.51 . . . . 0.86 110.655 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.72 ' HB2' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -53.22 -64.5 0.8 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.042 -0.527 . . . . 2.01 109.872 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 t80 62.33 38.23 13.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.405 -0.361 . . . . 2.08 111.487 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 m -160.44 -89.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.71 -0.223 . . . . 1.89 111.495 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.732 HD21 HD22 ' A' ' 57' ' ' LEU . 4.3 t-20 -158.87 141.21 14.01 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.913 0.387 . . . . 1.87 110.688 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 61' ' ' PHE . 41.7 mt -139.28 65.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.69 110.729 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.732 HD22 HD21 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -48.71 -63.28 1.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 1.6 111.2 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -82.74 160.72 22.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.936 0.398 . . . . 1.54 110.527 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.469 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -72.25 -7.25 48.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.123 -0.49 . . . . 1.75 110.958 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 21' ' ' LYS . 2.9 tt0 -97.41 97.91 9.51 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 109.79 -0.448 . . . . 2.05 109.79 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.85 ' HB2' HG23 ' A' ' 56' ' ' ILE . 62.4 t80 -129.82 165.2 22.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.0 -0.546 . . . . 0.48 111.354 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 18' ' ' VAL . 43.9 m -122.03 121.75 37.72 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.962 -0.563 . . . . 0.42 110.508 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.947 HG13 ' HB1' ' A' ' 51' ' ' ALA . 25.1 t -80.61 100.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.952 -0.567 . . . . 1.08 111.56 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.542 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.3 OUTLIER -94.29 138.16 32.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.757 -0.656 . . . . 1.33 110.78 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.3 -13.11 4.63 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.869 -0.681 . . . . 0.9 112.385 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.99 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -55.74 -173.83 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.708 0.29 . . . . 1.47 110.462 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 m -152.01 163.71 38.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 1.06 110.931 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 tt0 -74.97 123.42 25.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.06 -0.518 . . . . 1.91 110.887 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.4 t0 75.11 65.98 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.043 -0.526 . . . . 1.87 111.498 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.6 113.8 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.899 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -64.46 133.73 53.06 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.766 -0.374 . . . . 0.36 110.202 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 29.3 m-85 -126.29 118.11 24.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.21 -0.45 . . . . 0.56 112.191 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -102.15 141.45 34.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.125 -0.489 . . . . 1.5 109.933 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.948 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.61 115.81 10.44 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.366 1.247 . . . . 0.6 114.366 -179.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 6.0 ptt85 -97.63 163.75 12.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.927 -0.768 . . . . 2.11 108.927 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' CG ' ' A' ' 8' ' ' PRO . 48.7 t -116.94 133.82 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 112.778 0.659 . . . . 0.6 112.778 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 88' ' ' PRO . 40.6 mt -132.98 165.62 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.726 -1.213 . . . . 0.7 107.726 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 77' ' ' ILE . . . 177.07 134.79 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.908 -0.717 . . . . 0.6 112.107 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.77 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.4 ptpt -67.17 -99.86 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 119.653 -0.819 . . . . 1.98 109.289 178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.773 ' ND2' HD12 ' A' ' 2' ' ' ILE . 6.1 p30 170.43 -97.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 110.497 -0.186 . . . . 2.19 110.497 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.66 -42.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 O-C-N 122.029 -0.419 . . . . 1.08 110.729 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.08 -10.27 59.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.936 -0.574 . . . . 1.06 112.237 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.21 -11.29 40.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.178 -1.01 . . . . 0.93 112.501 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.674 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -62.86 115.87 4.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 110.112 -0.329 . . . . 1.38 110.112 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.77 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.9 tp -72.81 122.48 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.374 0.509 . . . . 0.79 112.374 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.686 ' HB3' HD11 ' A' ' 2' ' ' ILE . 2.6 p -89.36 131.74 39.52 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 109.959 -0.386 . . . . 0.59 109.959 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HB3' ' HD2' ' A' ' 88' ' ' PRO . 74.3 Cg_exo -41.11 173.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.571 2.847 . . . . 0.85 114.311 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' A' ' 77' ' ' ILE . 87.9 Cg_endo -87.56 172.79 5.63 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.235 2.623 . . . . 0.76 113.727 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -130.57 125.29 33.8 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.165 -0.925 . . . . 1.28 109.561 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -19.98 114.63 0.11 Allowed Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.228 0.955 . . . . 1.77 113.224 -179.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 87.1 Cg_exo -47.7 144.02 11.65 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.699 2.266 . . . . 0.55 113.653 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -73.67 143.12 46.38 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.422 -0.808 . . . . 1.23 108.83 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.667 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -31.69 135.13 0.07 Allowed 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.294 0.996 . . . . 1.63 112.568 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.25 99.78 1.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.623 -0.717 . . . . 0.41 109.718 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -77.46 109.4 11.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 0.44 110.946 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 59.5 m -49.12 -25.67 2.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.065 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' H ' HG22 ' A' ' 95' ' ' ILE . 80.4 m 52.43 38.39 25.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 1.1 110.744 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 1.033 ' HG3' ' OD1' ' A' ' 99' ' ' ASP . 17.2 ptp180 -71.98 -47.53 51.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.536 . . . . 3.0 111.696 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.294 ' OD2' HG21 ' A' ' 101' ' ' VAL . 20.1 p-10 -161.34 33.98 0.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.468 -0.787 . . . . 2.14 110.284 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 50.97 21.41 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.737 -0.665 . . . . 2.06 111.61 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.294 HG21 ' OD2' ' A' ' 99' ' ' ASP . 2.3 m -114.1 -26.57 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.936 -0.574 . . . . 2.8 110.101 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.73 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 40.62 64.77 0.89 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.033 -0.531 . . . . 4.58 111.549 179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.195 -0.907 . . . . 3.79 111.066 -179.985 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.444 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.582 0.23 . . . . 2.74 111.149 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.444 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 4.7 Cg_exo -79.0 169.91 18.65 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.718 2.279 . . . . 2.06 111.489 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.933 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.5 tt -171.03 140.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.416 . . . . 0.68 111.753 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.141 ' OD2' ' C ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.82 114.53 13.07 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.823 -0.626 . . . . 2.0 110.458 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.24 171.73 13.38 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.996 1.797 . . . . 0.5 112.126 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.529 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 34.5 Cg_exo -59.24 179.32 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 122.839 2.359 . . . . 0.71 112.789 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -86.91 171.44 42.85 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.094 -0.574 . . . . 0.66 113.051 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 11.6 tttt -59.72 125.14 79.25 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 110.326 -0.25 . . . . 1.52 110.326 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 19.4 Cg_exo -71.53 143.74 43.32 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.441 2.094 . . . . 0.44 113.035 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.24 105.45 7.89 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 1.09 110.537 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 31.7 Cg_exo -54.11 128.76 31.16 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.277 1.985 . . . . 0.64 113.676 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 21' ' ' LYS . 1.3 mm? -95.81 -26.68 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.697 -0.683 . . . . 1.64 109.531 178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -152.52 152.41 31.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.737 -0.665 . . . . 0.72 110.478 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.602 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.59 111.06 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.94 0.4 . . . . 0.96 110.287 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -109.16 69.0 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.841 0.682 . . . . 1.46 112.841 -178.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 1.7 mtp180 28.1 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.75 0.82 . . . . 2.42 113.147 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.2 m-70 176.69 -40.93 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.213 0.53 . . . . 1.02 109.596 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 p -112.25 93.7 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.368 -0.833 . . . . 0.68 110.708 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.881 HG11 ' CE1' ' A' ' 74' ' ' PHE . 48.0 t -90.04 101.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.558 -0.746 . . . . 0.8 110.789 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 56.0 m -90.13 144.27 26.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.989 -0.55 . . . . 0.35 111.9 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -150.62 165.65 32.72 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.962 -1.017 . . . . 0.52 111.903 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.757 ' HB3' HD21 ' A' ' 11' ' ' LEU . 15.6 tptm -143.47 138.72 29.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.744 -1.117 . . . . 1.84 110.13 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.0 p90 -125.83 -176.56 3.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.184 0.516 . . . . 0.4 111.962 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -100.71 116.98 33.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.528 -0.76 . . . . 0.83 110.972 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 144.21 49.12 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.523 -0.308 . . . . 2.11 110.566 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.596 ' HG3' HD12 ' A' ' 33' ' ' ILE . 58.2 Cg_endo -70.19 169.92 18.32 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.614 2.209 . . . . 0.89 112.412 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -130.32 -45.8 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 2.77 111.048 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.141 ' C ' ' OD2' ' A' ' 3' ' ' ASP . 0.3 OUTLIER -89.75 66.06 6.98 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.846 -0.342 . . . . 1.37 111.286 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.541 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 61.5 p -95.88 50.9 1.22 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.631 -0.507 . . . . 0.91 109.631 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.16 -93.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.74 -0.663 . . . . 1.01 112.303 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.32 26.81 2.79 Favored Glycine 0 N--CA 1.452 -0.268 0 N-CA-C 111.22 -0.752 . . . . 0.98 111.22 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.535 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -118.28 -175.5 2.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.143 0.497 . . . . 0.87 111.41 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.8 5.48 2.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.579 -0.737 . . . . 2.26 111.876 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 36' ' ' TYR . 14.1 mt 60.91 134.84 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.081 0.467 . . . . 1.71 110.654 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 p -108.1 2.37 22.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.15 112.087 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.445 ' CB ' ' ND2' ' A' ' 55' ' ' ASN . 8.7 t -176.63 -176.12 0.7 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.076 0.465 . . . . 1.58 111.85 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.649 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 40.7 m-85 -149.45 100.36 3.0 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.76 109.664 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.6 mt -84.65 121.87 37.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.943 -0.303 . . . . 1.14 111.304 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.17 103.12 14.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.534 -0.303 . . . . 0.63 111.161 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 18.5 mt-10 -74.74 133.74 41.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.659 -0.497 . . . . 1.67 109.659 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.633 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.8 OUTLIER -116.88 147.68 41.97 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 1.97 111.853 -179.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.466 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 16.0 ttp180 -123.66 114.44 19.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.405 -0.816 . . . . 1.44 109.79 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.1 OUTLIER -77.42 78.67 3.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.022 -0.535 . . . . 1.59 110.655 -179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.6 mt -52.78 154.27 5.05 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.9 110.827 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.19 0.35 34.38 Favored 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.688 -1.38 . . . . 1.43 113.213 0.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -97.64 -85.38 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.687 0.28 . . . . 2.66 111.11 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.31 175.98 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.697 -0.763 . . . . 1.12 112.581 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HD3' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -164.2 30.1 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.097 0.475 . . . . 2.41 110.309 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 57.8 m95 50.21 94.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.737 -0.665 . . . . 0.65 110.984 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -127.64 126.67 42.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 1.28 110.622 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -42.14 93.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.342 -0.39 . . . . 1.3 111.522 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -54.71 -51.31 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.0 -0.546 . . . . 0.86 110.971 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -65.08 114.45 4.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.943 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -89.35 16.13 7.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 2.08 111.198 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -136.72 -160.15 1.03 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.832 0.349 . . . . 1.89 110.981 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.445 ' ND2' ' CB ' ' A' ' 35' ' ' SER . 1.7 t-20 -98.77 113.48 25.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.87 111.134 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 52' ' ' ASN . 20.3 mm -87.56 59.03 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.219 -0.446 . . . . 0.69 110.854 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.4 tp -43.59 -57.87 2.93 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.91 0.386 . . . . 1.6 110.613 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 pt-20 -79.0 165.94 22.9 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -88.11 15.65 7.16 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.995 0.368 . . . . 1.75 111.995 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.7 111.6 18.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.372 -0.603 . . . . 2.05 109.372 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.717 ' CG ' HD12 ' A' ' 56' ' ' ILE . 73.7 t80 -139.73 163.36 32.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.318 0.58 . . . . 0.48 112.051 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.2 m -114.03 106.13 14.05 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.06 -0.973 . . . . 0.42 110.668 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 51' ' ' ALA . 90.8 t -66.8 82.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-N 115.44 -0.8 . . . . 1.08 111.312 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p -88.03 -175.3 5.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 1.33 110.936 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.19 23.93 72.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.765 -0.731 . . . . 0.9 112.782 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD21 HG12 ' A' ' 63' ' ' VAL . 14.0 mt -97.1 -162.39 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 1.47 111.021 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 52.0 m -138.0 159.4 42.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 1.06 111.025 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 67' ' ' THR . 23.8 tt0 -90.13 148.34 23.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 1.91 111.109 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 68.4 40.69 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.87 111.224 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -155.37 131.45 10.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.49 110.845 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.86 135.41 45.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.483 -0.326 . . . . 0.36 110.361 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 30.5 m-85 -130.89 124.79 31.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.399 0.518 . . . . 0.56 112.399 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.4 tt0 -102.97 139.24 38.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.631 -0.878 . . . . 1.5 108.631 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.881 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.08 118.85 13.15 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.26 1.578 . . . . 0.6 115.26 -178.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -105.22 179.67 4.2 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.283 -1.006 . . . . 2.11 108.283 177.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.608 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.2 OUTLIER -144.43 121.3 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.439 -0.905 . . . . 0.6 113.328 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.458 HD11 ' HG3' ' A' ' 88' ' ' PRO . 61.7 mt -106.99 152.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 107.138 -1.43 . . . . 0.7 107.138 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -163.92 115.6 1.37 Allowed 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.029 -1.068 . . . . 0.6 112.809 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -62.29 -175.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.85 -0.74 . . . . 1.98 109.644 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.933 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.1 m-80 -120.9 -114.13 0.32 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.569 -0.453 . . . . 2.19 111.572 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.93 -38.38 2.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.412 0.551 . . . . 1.08 111.361 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -92.19 23.46 3.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 1.06 111.588 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.83 0.74 89.87 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.628 -0.796 . . . . 0.93 113.311 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.524 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.94 112.83 6.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.987 0.394 . . . . 1.38 110.635 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.817 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -79.66 112.41 17.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.071 0.397 . . . . 0.79 112.071 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 5.4 p -71.59 121.45 84.44 Favored Pre-proline 0 C--O 1.238 0.488 0 C-N-CA 120.433 -0.507 . . . . 0.59 109.81 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -40.51 164.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.827 2.352 . . . . 0.85 112.609 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HG3' HD11 ' A' ' 77' ' ' ILE . 3.8 Cg_exo -76.47 130.22 11.65 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.892 2.395 . . . . 0.76 112.895 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.608 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -76.88 131.71 38.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.934 -0.575 . . . . 1.28 109.482 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 10.8 mt-10 -32.98 119.57 0.43 Allowed Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 123.689 0.618 . . . . 1.77 112.349 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 52.4 Cg_exo -52.4 150.43 20.56 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.465 2.11 . . . . 0.55 113.197 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.44 142.57 29.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.475 -0.784 . . . . 1.23 109.207 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.658 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.74 140.82 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 124.07 0.856 . . . . 1.63 112.142 -179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -74.08 112.3 10.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.773 -0.648 . . . . 0.41 110.699 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.2 mp -98.8 117.75 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.44 111.369 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.973 ' CB ' ' OE2' ' A' ' 102' ' ' GLU . 48.3 m -48.38 -28.33 3.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.327 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 95' ' ' ILE . 3.1 m 55.6 59.2 4.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.429 -0.35 . . . . 1.1 110.44 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 1.051 ' HD2' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.9 -42.63 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 3.0 111.252 -179.769 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.284 ' OD1' ' HA ' ' A' ' 102' ' ' GLU . 7.7 p-10 -116.05 22.65 12.8 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.761 -0.654 . . . . 2.14 111.428 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' HB ' ' A' ' 101' ' ' VAL . 4.8 p-10 36.58 47.12 0.5 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.841 0.829 . . . . 2.06 111.314 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.949 HG12 ' O ' ' A' ' 99' ' ' ASP . 11.7 p 164.87 -25.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.072 -1.876 . . . . 2.8 109.511 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.284 ' HA ' ' OD1' ' A' ' 99' ' ' ASP . 3.0 mm-40 59.65 91.98 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.981 -0.554 . . . . 4.58 110.88 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' N ' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.202 -0.904 . . . . 3.79 111.215 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.755 0.312 . . . . 2.74 111.143 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -92.76 99.76 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.093 2.529 . . . . 2.06 112.544 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 2' ' ' ILE . 2.0 tt -93.17 127.78 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.68 111.049 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.618 ' O ' HG23 ' A' ' 28' ' ' THR . 71.4 m-20 -107.71 123.25 38.47 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.0 110.62 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.67 172.75 10.02 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.241 1.961 . . . . 0.5 112.276 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.9 Cg_endo -61.39 171.15 4.5 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.839 2.359 . . . . 0.71 112.68 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.2 -177.66 30.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.947 -0.644 . . . . 0.66 112.671 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.7 tptt -68.5 118.47 60.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.253 -0.277 . . . . 1.52 110.253 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 21.8 Cg_exo -67.51 122.91 10.18 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.387 2.058 . . . . 0.44 111.733 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -123.76 112.69 28.9 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.518 -0.31 . . . . 1.09 111.303 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.6 Cg_exo -61.88 120.27 7.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.547 2.164 . . . . 0.64 113.5 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -84.56 -31.83 24.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.969 -0.56 . . . . 1.64 109.665 179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.22 145.78 33.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.297 -0.865 . . . . 0.72 109.635 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.064 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -144.07 96.39 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.7 0.63 . . . . 0.96 112.7 -179.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.105 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -82.87 158.65 22.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.225 -0.658 . . . . 1.46 109.225 178.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.458 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -60.61 -13.23 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.068 0.396 . . . . 2.42 112.068 -179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . 2.1 m-70 -139.08 25.55 2.49 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.952 0.353 . . . . 1.02 111.952 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -176.95 116.69 0.1 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.696 0.284 . . . . 0.68 110.922 179.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.064 HG13 HG22 ' A' ' 13' ' ' ILE . 86.4 t -105.38 137.26 35.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.339 -0.392 . . . . 0.8 111.114 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.635 ' C ' HD13 ' A' ' 20' ' ' LEU . 16.6 m -117.91 122.37 43.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.552 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.757 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -132.33 152.67 51.31 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.739 0.78 . . . . 0.52 112.07 178.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' HD11 ' A' ' 11' ' ' LEU . 9.5 tptt -133.35 155.03 50.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.411 -1.268 . . . . 1.84 109.707 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 20.9 p90 -145.34 -177.54 5.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.096 0.474 . . . . 0.4 112.176 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.75 159.48 15.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.83 111.357 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.421 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -88.23 137.52 30.98 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.012 -0.54 . . . . 2.11 110.238 179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HG3' HD11 ' A' ' 33' ' ' ILE . 2.6 Cg_endo -41.27 160.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.595 2.197 . . . . 0.89 111.929 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.74 -29.6 11.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.161 -0.472 . . . . 2.77 111.498 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -122.85 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.634 0.254 . . . . 1.37 111.562 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' ASP . 0.2 OUTLIER 46.54 54.44 8.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.809 0.337 . . . . 0.91 110.863 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 37.79 -131.83 1.34 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.803 -0.635 . . . . 1.01 113.128 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 29.87 9.12 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.178 -1.169 . . . . 0.98 110.178 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -96.49 175.3 6.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.679 -0.761 . . . . 0.87 111.286 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -136.89 0.2 2.38 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.551 . . . . 2.26 112.255 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.449 HD11 ' HG3' ' A' ' 25' ' ' PRO . 27.7 mt 60.69 138.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-O 121.007 0.432 . . . . 1.71 111.004 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.7 p -120.2 -11.91 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.202 0.445 . . . . 1.15 112.202 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.61 138.51 2.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.711 0.291 . . . . 1.58 111.54 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.0 m-85 -105.08 98.72 8.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.294 -0.412 . . . . 0.76 110.855 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 38' ' ' VAL . 0.9 OUTLIER -82.17 165.11 2.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.764 -0.458 . . . . 1.14 109.764 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -157.46 137.11 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.563 0.697 . . . . 0.63 111.164 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG3' HD12 ' A' ' 77' ' ' ILE . 6.1 mt-10 -105.35 134.53 48.31 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.767 -1.106 . . . . 1.67 110.185 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.658 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -103.79 146.97 27.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.403 -0.362 . . . . 1.97 111.194 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.7 ttm180 -119.44 113.96 21.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.018 -0.537 . . . . 1.44 110.581 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.96 92.79 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.316 -0.856 . . . . 1.59 109.69 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD11 ' HG3' ' A' ' 73' ' ' GLU . 7.8 mt -76.73 150.65 81.93 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.9 111.23 -179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -88.54 -2.22 62.59 Favored 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 123.741 -1.358 . . . . 1.43 113.038 0.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -123.67 79.46 1.7 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.886 0.374 . . . . 2.66 110.993 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.59 -166.16 10.89 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.797 -0.716 . . . . 1.12 112.377 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.634 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -157.95 151.25 23.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.908 0.385 . . . . 2.41 110.898 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.714 ' O ' HD22 ' A' ' 49' ' ' LEU . 59.2 m95 -64.35 116.76 6.38 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.88 -0.6 . . . . 0.65 110.406 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.68 136.66 25.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.831 0.348 . . . . 1.28 111.206 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -44.82 110.09 0.21 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.094 -0.503 . . . . 1.3 111.3 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.78 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -84.85 -37.3 20.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.052 -0.522 . . . . 0.86 110.633 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.61 ' CB ' HD11 ' A' ' 56' ' ' ILE . 10.6 p-10 -82.43 178.6 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.949 -0.569 . . . . 2.01 110.475 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 t80 178.92 36.44 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.315 -0.402 . . . . 2.08 111.035 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.56 32.02 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.529 -0.305 . . . . 1.89 111.285 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.77 121.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 1.87 110.956 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.854 HD12 ' O ' ' A' ' 36' ' ' TYR . 22.3 mt -116.28 76.93 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.002 -0.545 . . . . 0.69 111.083 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.2 mt -59.43 -66.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.334 -0.394 . . . . 1.6 111.463 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 168.24 9.08 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.874 0.369 . . . . 1.54 110.674 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.512 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 3.2 m-20 -86.61 8.06 23.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.077 -0.51 . . . . 1.75 111.419 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -109.84 103.88 12.74 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.694 0.283 . . . . 2.05 110.35 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.599 ' CG ' HD13 ' A' ' 56' ' ' ILE . 65.1 t80 -135.16 163.12 30.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.48 111.677 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.464 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 9.1 m -122.93 117.23 25.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.644 -0.707 . . . . 0.42 111.216 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.78 HG13 ' CB ' ' A' ' 51' ' ' ALA . 47.8 t -83.31 101.92 8.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.037 -0.529 . . . . 1.08 110.942 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 p -94.15 162.91 13.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.366 0.603 . . . . 1.33 110.997 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.49 7.35 24.38 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.969 -1.014 . . . . 0.9 111.983 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.3 mm? -54.33 168.74 0.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.264 0.554 . . . . 1.47 111.449 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -139.26 98.88 3.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.245 -0.889 . . . . 1.06 109.284 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 2.5 tm-20 -37.24 139.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.5 0.556 . . . . 1.91 112.5 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 t0 76.18 42.34 0.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.726 -0.67 . . . . 1.87 110.827 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -167.27 124.48 1.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.345 -0.389 . . . . 0.49 111.532 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.79 137.77 54.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.945 -0.391 . . . . 0.36 109.945 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 30.6 m-85 -129.43 124.18 33.47 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.419 0.526 . . . . 0.56 112.419 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.847 ' HG3' HD11 ' A' ' 43' ' ' LEU . 12.0 mt-10 -100.96 141.72 33.44 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.473 -0.566 . . . . 1.5 109.473 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.46 ' HD2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.29 114.81 11.85 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.712 1.375 . . . . 0.6 114.712 -178.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HD3' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.29 151.89 22.16 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.345 -0.613 . . . . 2.11 109.345 177.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -114.61 118.05 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 119.622 -0.831 . . . . 0.6 112.922 -179.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' A' ' 88' ' ' PRO . 66.7 mt -103.41 136.45 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.993 -1.484 . . . . 0.7 106.993 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -151.33 139.28 19.98 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.502 -0.879 . . . . 0.6 111.965 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.721 ' HG2' HD12 ' A' ' 85' ' ' ILE . 19.5 mttp -66.8 -133.13 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.727 -0.789 . . . . 1.98 109.625 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.566 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.9 OUTLIER -167.55 -84.12 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.127 0.422 . . . . 2.19 110.153 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -154.15 -42.14 0.09 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.824 0.345 . . . . 1.08 110.754 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -88.38 -2.57 58.68 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.514 0.561 . . . . 1.06 112.514 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.09 62.65 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.249 -0.977 . . . . 0.93 113.332 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.25 81.16 3.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.155 0.502 . . . . 1.38 109.895 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.721 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -40.2 119.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 114.397 1.258 . . . . 0.79 114.397 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 3.8 p -73.06 109.36 6.08 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 106.765 -1.568 . . . . 0.59 106.765 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 9.4 Cg_endo -49.72 162.98 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.652 2.235 . . . . 0.85 113.799 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' A' ' 77' ' ' ILE . 53.2 Cg_exo -40.42 128.56 2.4 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.714 2.942 . . . . 0.76 114.53 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.538 ' OG ' HG13 ' A' ' 76' ' ' VAL . 78.2 p -102.19 100.88 11.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.127 -0.942 . . . . 1.28 110.268 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER 11.8 115.84 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 125.037 1.335 . . . . 1.77 114.387 179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.535 ' CB ' ' CH2' ' A' ' 48' ' ' TRP . 6.5 Cg_exo -67.21 135.16 36.16 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.02 1.813 . . . . 0.55 113.011 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.33 144.05 56.18 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.339 -0.615 . . . . 1.23 109.339 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' HD12 ' A' ' 95' ' ' ILE . 8.8 m-20 -40.25 149.31 0.07 Allowed 'General case' 0 N--CA 1.462 0.153 0 O-C-N 123.66 0.6 . . . . 1.63 111.235 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.845 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -76.06 119.17 19.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.945 -0.571 . . . . 0.41 111.812 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.625 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -99.52 118.73 46.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.695 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.9 m -50.03 -38.0 35.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.136 -0.484 . . . . 0.44 111.124 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 2.8 m 62.23 43.96 8.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.39 -0.368 . . . . 1.1 110.503 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.558 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 1.4 ptp85 -84.96 -91.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 3.0 111.64 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.558 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 20.2 p-10 -113.46 28.19 8.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.541 -0.299 . . . . 2.14 110.406 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.105 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.41 25.61 0.94 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.228 0.537 . . . . 2.06 110.895 -179.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 99' ' ' ASP . 3.4 m -112.65 -26.26 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 115.387 -0.824 . . . . 2.8 110.405 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.881 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.4 35.34 1.28 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.811 -0.631 . . . . 4.58 111.485 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB2' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.261 -0.876 . . . . 3.79 111.213 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 83.7 p . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.736 0.303 . . . . 2.74 111.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.48 150.1 21.82 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.175 2.583 . . . . 2.06 112.23 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 1.9 tt -131.93 132.13 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.365 -0.38 . . . . 0.68 111.057 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.12 131.71 23.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 2.0 110.654 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.73 168.6 15.81 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.589 2.193 . . . . 0.5 112.385 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 73.0 Cg_exo -49.12 179.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.453 2.102 . . . . 0.71 112.182 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.21 -167.17 42.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 0.66 112.815 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.69 114.21 22.93 Favored Pre-proline 0 C--N 1.332 -0.188 0 N-CA-C 110.642 -0.133 . . . . 1.52 110.642 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 13.3 Cg_exo -70.49 131.32 19.98 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.423 2.082 . . . . 0.44 112.494 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -142.55 106.92 5.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.53 . . . . 1.09 111.66 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 78.3 Cg_exo -36.18 141.74 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.991 2.461 . . . . 0.64 112.79 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.14 -30.83 8.19 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.507 -0.553 . . . . 1.64 109.507 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.06 97.81 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.611 -0.722 . . . . 0.72 109.988 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.815 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -94.69 133.23 36.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 112.997 0.74 . . . . 0.96 112.997 -179.389 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.735 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -127.85 137.86 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.95 -1.023 . . . . 1.46 110.092 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.735 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.35 -34.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.006 1.113 . . . . 2.42 114.006 -179.013 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 14' ' ' THR . 4.1 m170 -120.16 -22.33 6.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.641 0.608 . . . . 1.02 112.641 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.527 ' HA ' HD22 ' A' ' 66' ' ' LEU . 13.6 p -134.44 130.33 36.6 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 110.25 -0.278 . . . . 0.68 110.25 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.104 HG13 HD23 ' A' ' 66' ' ' LEU . 4.5 m -124.91 141.34 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.142 0.496 . . . . 0.8 112.103 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.3 m -106.95 151.64 25.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 0.35 109.788 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.51 152.02 37.32 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.532 0.682 . . . . 0.52 112.021 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.71 147.46 48.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.581 -1.19 . . . . 1.84 109.675 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.546 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 26.4 p90 -146.69 -174.0 4.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.841 0.353 . . . . 0.4 111.282 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -81.37 -164.79 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.83 110.784 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -137.08 139.87 29.65 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.158 -0.474 . . . . 2.11 110.858 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.586 ' HB3' HG23 ' A' ' 28' ' ' THR . 93.3 Cg_exo -41.24 158.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.415 2.076 . . . . 0.89 111.952 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -112.49 -21.67 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.284 -0.417 . . . . 2.77 111.651 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -129.33 -71.11 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.049 -0.26 . . . . 1.37 111.66 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.5 p 51.26 45.42 27.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.951 0.405 . . . . 0.91 110.37 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.79 -124.36 4.96 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.881 -0.6 . . . . 1.01 112.446 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.46 36.64 3.95 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.099 -1.201 . . . . 0.98 110.099 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.577 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -105.28 177.58 4.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.639 -0.781 . . . . 0.87 111.929 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.69 7.81 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.85 -0.613 . . . . 2.26 111.869 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.475 HD11 ' HG2' ' A' ' 25' ' ' PRO . 12.7 mt 59.18 146.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-O 121.077 0.465 . . . . 1.71 111.251 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.5 p -114.14 -31.99 6.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.021 -0.536 . . . . 1.15 112.44 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.64 135.43 1.51 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.947 0.351 . . . . 1.58 111.947 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.747 ' O ' HD12 ' A' ' 56' ' ' ILE . 60.5 m-85 -88.74 89.34 7.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.76 111.263 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mt -78.77 109.44 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 1.14 110.641 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.1 p -106.48 127.19 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.994 0.426 . . . . 0.63 111.208 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.628 ' OE2' HD12 ' A' ' 77' ' ' ILE . 27.1 mt-10 -92.65 149.53 21.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.83 -0.623 . . . . 1.67 110.404 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.828 ' CG ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -113.73 157.97 21.54 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.05 0.452 . . . . 1.97 110.975 179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.483 ' CZ ' ' CZ2' ' A' ' 48' ' ' TRP . 12.9 ttp180 -133.52 112.71 11.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.438 -0.801 . . . . 1.44 109.576 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.88 107.13 6.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 1.59 110.868 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.704 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -89.38 147.79 38.99 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 121.077 -0.249 . . . . 0.9 110.627 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -93.17 15.94 44.35 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.8 -1.333 . . . . 1.43 112.493 0.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.18 93.68 2.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.856 0.36 . . . . 2.66 110.966 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.21 -167.94 35.07 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.938 -0.648 . . . . 1.12 112.365 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -157.55 171.44 20.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.719 0.295 . . . . 2.41 111.211 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 62.3 m95 -70.06 121.78 18.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.65 111.941 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.54 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -142.06 137.62 31.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.79 -0.641 . . . . 1.28 110.598 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -46.94 92.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.321 -0.4 . . . . 1.3 111.484 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.846 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . -57.95 -61.45 2.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.156 -0.474 . . . . 0.86 110.232 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.816 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -74.32 132.8 42.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.501 -0.772 . . . . 2.01 110.266 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.57 35.49 4.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.167 -0.47 . . . . 2.08 110.939 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.7 t -142.28 -68.15 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 1.89 110.873 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 176.03 153.22 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 1.87 110.847 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.816 HD11 ' CB ' ' A' ' 52' ' ' ASN . 13.6 mt -148.78 62.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.851 -0.613 . . . . 0.69 110.596 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 57' ' ' LEU . 7.7 tp -54.29 -60.51 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.986 -0.552 . . . . 1.6 111.21 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -73.39 166.4 23.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.486 -0.325 . . . . 1.54 110.587 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 36.1 p30 -83.88 8.36 15.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 1.75 112.009 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -114.42 107.77 15.99 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.776 ' HB2' HG23 ' A' ' 56' ' ' ILE . 39.9 t80 -141.94 165.51 27.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.471 . . . . 0.48 111.832 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 33.4 m -119.52 121.49 39.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.698 -0.683 . . . . 0.42 111.059 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.846 HG13 ' HB1' ' A' ' 51' ' ' ALA . 15.0 t -86.05 109.05 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.287 -0.415 . . . . 1.08 111.189 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.03 132.16 44.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.981 -0.554 . . . . 1.33 110.841 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.03 -12.75 2.84 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.757 -0.735 . . . . 0.9 112.721 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.104 HD23 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -57.45 -171.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 1.47 110.667 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.0 m -160.59 155.14 23.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.136 -0.484 . . . . 1.06 110.629 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 12.9 mt-10 -66.97 144.11 56.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.292 -0.413 . . . . 1.91 111.101 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.929 ' OD1' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 62.44 43.79 7.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.969 -0.559 . . . . 1.87 111.443 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.35 115.65 3.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.869 0.366 . . . . 0.49 111.787 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.25 130.74 42.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.36 109.954 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 51.8 m-85 -124.15 118.97 28.1 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.1 mt-10 -99.04 145.14 27.41 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.364 -0.606 . . . . 1.5 109.364 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.935 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.93 119.41 14.87 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.319 1.229 . . . . 0.6 114.319 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.577 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.99 142.99 26.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.845 -0.616 . . . . 2.11 109.623 178.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 HG23 ' CG ' ' A' ' 8' ' ' PRO . 51.5 t -99.79 107.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.59 0.589 . . . . 0.6 112.59 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.628 HD12 ' OE2' ' A' ' 39' ' ' GLU . 11.0 mt -106.76 151.97 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.536 -1.283 . . . . 0.7 107.536 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -177.18 140.93 0.31 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.835 -0.746 . . . . 0.6 111.816 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.763 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mtmt -74.97 -155.64 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.101 -0.64 . . . . 1.98 109.424 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -139.67 -80.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.85 0.357 . . . . 2.19 110.603 -179.272 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -159.73 -41.77 0.05 Allowed 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.098 -0.501 . . . . 1.08 110.377 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.14 -13.67 60.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.955 -0.566 . . . . 1.06 111.93 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.9 1.79 58.49 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.424 -0.893 . . . . 0.93 113.0 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 85' ' ' ILE . . . -51.99 -83.93 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.032 0.416 . . . . 1.38 110.389 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.763 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.9 OUTLIER 128.88 112.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.734 1.272 . . . . 0.79 112.495 178.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.6 p -75.74 110.53 10.99 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 107.834 -1.173 . . . . 0.59 107.834 177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 11.1 Cg_endo -52.8 165.07 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.341 2.027 . . . . 0.85 112.629 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 9.5 Cg_endo -51.56 135.37 48.09 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 123.132 2.554 . . . . 0.76 113.155 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 p -105.51 107.21 18.08 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.757 -0.656 . . . . 1.28 110.756 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 8.49 104.39 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.818 1.247 . . . . 1.77 114.013 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 73.4 Cg_exo -49.58 126.4 16.11 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.673 2.249 . . . . 0.55 113.579 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.426 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -57.51 149.31 21.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.006 -0.739 . . . . 1.23 109.006 178.754 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -40.85 149.14 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.729 0.643 . . . . 1.63 111.27 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.704 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . -78.89 115.36 18.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.496 -0.775 . . . . 0.41 110.13 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.815 HG12 HG21 ' A' ' 13' ' ' ILE . 4.5 mp -89.41 107.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.075 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 91.1 m -44.05 -38.94 3.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.846 -0.615 . . . . 0.44 111.58 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 69' ' ' ASP . 71.2 m 54.07 101.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.998 -0.371 . . . . 1.1 109.998 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -88.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.881 0.372 . . . . 3.0 111.466 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.717 ' OD2' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -96.21 -10.59 27.71 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.298 -0.41 . . . . 2.14 111.226 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 t0 51.53 24.01 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.743 0.306 . . . . 2.06 110.977 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.696 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 12.0 p -140.79 10.69 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.274 -0.421 . . . . 2.8 111.631 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.717 ' HG2' ' OD2' ' A' ' 99' ' ' ASP . 13.2 pt-20 -133.05 -44.62 0.86 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.872 0.368 . . . . 4.58 111.064 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.275 -0.869 . . . . 3.79 111.133 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.46 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 1.5 t . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 111.612 0.227 . . . . 2.74 111.612 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 0' ' ' SER . 96.4 Cg_endo -81.62 177.9 7.11 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.645 2.23 . . . . 2.06 112.561 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.687 HD11 ' OD1' ' A' ' 80' ' ' ASN . 3.7 tt -137.97 148.81 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.988 -0.551 . . . . 0.68 110.799 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.101 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.11 121.41 15.62 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.378 -0.374 . . . . 2.0 111.058 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.92 156.6 52.33 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.428 2.085 . . . . 0.5 112.211 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 9.4 Cg_endo -52.44 -175.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.948 2.432 . . . . 0.71 112.58 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.69 168.41 43.63 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.767 -0.73 . . . . 0.66 112.294 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -56.23 125.29 64.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 110.63 -0.137 . . . . 1.52 110.63 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' CG ' HG23 ' A' ' 76' ' ' VAL . 6.5 Cg_exo -73.96 133.81 18.8 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.268 1.978 . . . . 0.44 111.242 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -136.23 111.07 9.96 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.318 0.488 . . . . 1.09 112.318 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HG2' HD11 ' A' ' 95' ' ' ILE . 27.4 Cg_exo -58.68 94.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.458 2.105 . . . . 0.64 113.296 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.64 -36.8 62.45 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.254 0.549 . . . . 1.64 109.753 179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -138.53 152.55 48.32 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.286 -0.87 . . . . 0.72 109.582 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.927 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -141.34 97.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.964 0.411 . . . . 0.96 111.509 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -90.02 45.02 1.24 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.82 -0.627 . . . . 1.46 112.428 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 97' ' ' CYS . 16.5 mtp180 56.73 -73.39 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.514 0.561 . . . . 2.42 112.514 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' A' ' 14' ' ' THR . 10.0 m170 -76.92 -32.45 57.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.929 0.395 . . . . 1.02 110.832 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.2 p -127.78 113.09 15.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.962 -0.563 . . . . 0.68 109.865 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HD13 ' A' ' 66' ' ' LEU . 10.3 m -110.9 119.15 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.634 0.73 . . . . 0.8 111.833 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 55.1 m -83.99 142.92 30.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.35 110.637 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -147.52 164.51 33.2 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.121 0.888 . . . . 0.52 111.76 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.815 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -158.09 152.56 24.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.449 -0.796 . . . . 1.84 110.808 179.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 15.5 p90 -140.57 -174.42 3.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.047 0.451 . . . . 0.4 111.76 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.92 -174.82 3.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.005 -0.543 . . . . 0.83 111.407 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tmtt? -119.42 138.02 26.03 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.11 110.533 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.606 ' HB2' HG23 ' A' ' 28' ' ' THR . 77.9 Cg_exo -50.19 173.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.416 2.078 . . . . 0.89 112.11 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.8 -19.2 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.391 -0.368 . . . . 2.77 111.803 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.4 t80 -123.79 -70.92 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.22 0.452 . . . . 1.37 112.22 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 1.101 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 70.7 p 51.72 52.0 15.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.065 0.459 . . . . 0.91 110.078 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 40.7 -106.27 0.06 OUTLIER Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.689 -0.687 . . . . 1.01 112.636 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.39 37.39 2.14 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.468 -1.053 . . . . 0.98 110.468 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.3 m-85 -117.82 -178.58 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.094 -0.553 . . . . 0.87 111.583 -178.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -140.66 -0.38 1.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.583 -0.735 . . . . 2.26 112.375 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CE1' ' A' ' 36' ' ' TYR . 11.8 mt 56.34 117.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.976 0.417 . . . . 1.71 111.437 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' SER . 31.1 p -114.25 23.72 12.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.342 -0.39 . . . . 1.15 111.605 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.429 ' O ' ' HB1' ' A' ' 78' ' ' ALA . 46.1 t 178.55 135.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.831 0.348 . . . . 1.58 111.352 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.818 ' CE1' HG21 ' A' ' 33' ' ' ILE . 49.9 m-85 -121.62 102.22 8.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.979 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.3 mt -79.58 140.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 110.066 -0.346 . . . . 1.14 110.066 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.92 105.35 18.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.477 -0.329 . . . . 0.63 111.885 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 80.1 mt-10 -75.59 150.34 38.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.92 -0.77 . . . . 1.67 108.92 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.747 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -131.57 145.91 51.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.219 0.533 . . . . 1.97 112.202 -179.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 16.2 ttp180 -121.0 105.09 10.32 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.177 -0.919 . . . . 1.44 109.595 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.837 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 82.9 0.45 Allowed 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.861 -0.608 . . . . 1.59 110.491 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.52 HD21 ' OE1' ' A' ' 73' ' ' GLU . 3.1 mt -61.02 149.68 80.91 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.785 -0.643 . . . . 0.9 110.904 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -85.29 18.9 26.59 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.096 -1.21 . . . . 1.43 113.067 0.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.74 83.13 1.34 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.668 0.27 . . . . 2.66 111.386 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -103.83 -169.16 25.31 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.827 -0.701 . . . . 1.12 112.518 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -139.77 8.84 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.735 0.272 . . . . 2.41 111.735 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 19.5 m95 52.52 72.26 0.42 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.675 0.274 . . . . 0.65 110.959 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -120.63 137.77 54.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.392 . . . . 1.28 110.943 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -54.34 98.14 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 1.3 111.228 -179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.747 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.25 -51.11 71.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.86 110.498 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' CB ' HD11 ' A' ' 56' ' ' ILE . 12.7 p-10 -60.8 131.51 50.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 2.01 110.937 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 30.4 7.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.327 -0.397 . . . . 2.08 110.978 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.1 t -138.89 -161.06 1.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.139 -0.482 . . . . 1.89 110.701 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.91 114.5 28.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.356 -0.384 . . . . 1.87 111.186 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 36' ' ' TYR . 33.6 mt -100.86 80.35 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.69 110.852 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.19 -59.72 4.08 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.191 -0.459 . . . . 1.6 111.52 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -77.31 167.07 22.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.909 0.385 . . . . 1.54 110.695 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 53.3 p30 -84.01 4.93 27.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.039 -0.528 . . . . 1.75 111.615 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.17 100.69 10.93 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.702 -0.481 . . . . 2.05 109.702 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 56' ' ' ILE . 75.4 t80 -131.66 163.02 29.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.234 0.54 . . . . 0.48 112.2 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.45 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 42.8 m -131.61 124.54 30.17 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.254 -0.884 . . . . 0.42 110.01 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 HD11 ' A' ' 20' ' ' LEU . 7.4 t -82.81 94.35 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.072 0.463 . . . . 1.08 111.209 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -89.02 165.09 14.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.661 -0.699 . . . . 1.33 111.078 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.5 8.46 83.13 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.9 112.705 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.031 HD13 HG13 ' A' ' 18' ' ' VAL . 4.7 mt -58.82 -175.02 0.02 OUTLIER 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.982 0.42 . . . . 1.47 110.775 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.8 m -131.5 133.23 44.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 1.06 110.471 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.3 tt0 -71.13 149.92 45.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.283 -0.417 . . . . 1.91 111.149 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.846 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 66.19 38.17 4.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 1.87 110.788 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -156.1 116.74 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.49 111.535 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.02 131.94 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.36 110.129 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.459 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 53.5 m-85 -125.33 127.15 46.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.658 0.614 . . . . 0.56 112.658 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' OE1' HD21 ' A' ' 43' ' ' LEU . 4.7 mt-10 -108.45 134.04 51.79 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.974 -1.121 . . . . 1.5 107.974 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.906 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.17 121.64 25.23 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.753 1.39 . . . . 0.6 114.753 -178.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.504 ' CA ' ' HA ' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -97.08 167.9 10.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.077 -0.51 . . . . 2.11 109.828 178.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' CG ' ' A' ' 8' ' ' PRO . 71.6 t -116.3 145.41 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.397 0.617 . . . . 0.6 111.974 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.772 HD11 ' HG3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -141.45 152.91 19.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 35' ' ' SER . . . -166.8 124.84 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.533 -0.867 . . . . 0.6 112.457 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -81.55 95.92 7.28 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.067 -0.653 . . . . 1.98 109.898 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.687 ' OD1' HD11 ' A' ' 2' ' ' ILE . 1.3 m120 -40.34 156.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.429 -0.805 . . . . 2.19 111.667 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -20.77 -47.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.193 1.183 . . . . 1.08 114.193 -179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -109.45 48.63 0.87 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.933 0.716 . . . . 1.06 112.933 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 46.83 37.65 9.45 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.4 -0.905 . . . . 0.93 113.248 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . . . -78.3 1.02 23.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.88 0.371 . . . . 1.38 111.202 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 37.24 111.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 114.972 1.471 . . . . 0.79 114.972 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.469 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -93.27 111.45 51.98 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 113.909 -1.496 . . . . 0.59 107.022 177.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.3 Cg_endo -45.67 172.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.026 2.484 . . . . 0.85 113.656 -178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.772 ' HG3' HD11 ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.32 92.63 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.085 2.524 . . . . 0.76 113.141 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -58.65 105.33 0.29 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.941 -0.572 . . . . 1.28 110.035 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.1 tt0 4.83 117.4 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.15 1.38 . . . . 1.77 114.346 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 48.5 Cg_exo -42.62 170.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.943 2.429 . . . . 0.55 114.03 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 74' ' ' PHE . 0.6 OUTLIER -102.19 139.1 38.26 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-N 114.944 -1.025 . . . . 1.23 109.355 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -38.08 127.54 1.3 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.273 0.983 . . . . 1.63 111.282 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -58.26 131.14 49.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.507 -0.769 . . . . 0.41 111.384 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.856 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -117.38 108.0 23.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.933 -0.576 . . . . 0.44 110.961 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.2 m -46.64 -37.23 7.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.845 0.355 . . . . 0.44 110.824 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 15' ' ' ARG . 59.7 m 59.85 37.71 21.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 1.1 110.777 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.16 -39.78 16.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.13 -0.487 . . . . 3.0 112.036 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.363 ' CG ' HG22 ' A' ' 101' ' ' VAL . 17.8 p-10 -156.09 24.65 0.37 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.382 -0.372 . . . . 2.14 111.457 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 13' ' ' ILE . 1.6 p30 51.91 19.81 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 2.06 112.088 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.363 HG22 ' CG ' ' A' ' 99' ' ' ASP . 15.7 m -114.73 -20.22 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 120.706 0.289 . . . . 2.8 110.711 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 45.87 55.27 7.12 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.949 0.404 . . . . 4.58 111.25 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.267 -0.873 . . . . 3.79 111.129 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.657 0.265 . . . . 2.74 111.131 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 98.5 Cg_endo -89.62 -174.6 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.899 2.399 . . . . 2.06 112.181 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt -158.12 140.49 5.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.68 111.074 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 68.2 m-20 -122.52 134.86 25.12 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 2.0 110.462 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.55 160.7 10.9 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.593 2.195 . . . . 0.5 113.026 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 77.1 Cg_exo -52.53 167.61 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.058 2.506 . . . . 0.71 113.125 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.32 -179.88 38.47 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.37 -0.832 . . . . 0.66 112.226 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -66.9 124.21 88.1 Favored Pre-proline 0 C--N 1.33 -0.245 0 O-C-N 122.846 -0.208 . . . . 1.52 110.688 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 17.6 Cg_exo -70.64 135.65 28.84 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.355 2.037 . . . . 0.44 112.178 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -130.41 115.44 17.28 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.288 -0.414 . . . . 1.09 111.214 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 6.5 Cg_exo -70.42 114.45 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.209 1.94 . . . . 0.64 113.575 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.703 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.84 -33.56 57.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.497 -0.927 . . . . 1.64 108.497 178.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -140.5 151.2 44.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.754 -1.112 . . . . 0.72 109.043 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.012 HG22 HG13 ' A' ' 18' ' ' VAL . 4.2 pt -140.87 97.59 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.489 0.551 . . . . 0.96 112.489 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.251 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -85.7 140.28 30.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 1.46 110.007 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -24.48 1.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.113 -0.494 . . . . 2.42 112.282 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.553 ' O ' HG23 ' A' ' 17' ' ' THR . 12.2 m170 -120.44 -1.75 10.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.393 0.516 . . . . 1.02 112.393 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 16' ' ' HIS . 17.2 p -160.5 119.61 2.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.601 0.239 . . . . 0.68 110.672 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.012 HG13 HG22 ' A' ' 13' ' ' ILE . 46.5 t -102.97 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.474 . . . . 0.8 111.668 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.7 m -109.85 121.82 46.11 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.819 -0.628 . . . . 0.35 111.405 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.762 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.94 161.8 35.04 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.676 0.75 . . . . 0.52 112.139 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -138.6 151.54 47.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.574 -1.194 . . . . 1.84 110.295 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.7 p90 -136.77 -178.05 5.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.264 0.554 . . . . 0.4 112.073 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.61 -154.01 0.37 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.417 -0.81 . . . . 0.83 110.395 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -155.08 127.16 3.87 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 120.748 -0.381 . . . . 2.11 111.727 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 5.7 Cg_endo -46.32 179.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.181 2.587 . . . . 0.89 112.772 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -122.36 -10.06 8.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.987 -0.551 . . . . 2.77 111.971 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' CD2' ' HG2' ' A' ' 1' ' ' PRO . 5.6 t80 -116.76 -72.65 0.68 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 120.615 -0.434 . . . . 1.37 112.107 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.465 HG23 ' HB2' ' A' ' 25' ' ' PRO . 68.6 p 49.63 47.03 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.1 0.476 . . . . 0.91 110.364 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.12 -93.39 0.01 OUTLIER Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.615 -0.721 . . . . 1.01 112.306 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -146.35 32.99 1.48 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.265 -1.134 . . . . 0.98 110.265 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.702 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.96 -172.8 2.46 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.752 -0.724 . . . . 0.87 111.314 -178.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HG3' ' CG2' ' A' ' 34' ' ' THR . 8.1 ptmt -145.33 39.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 2.26 111.077 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.126 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.4 mp 62.48 -81.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 1.71 110.492 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.418 ' CG2' ' HG3' ' A' ' 32' ' ' LYS . 2.9 p 59.6 29.59 19.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 1.15 111.493 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 172.23 94.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.92 0.39 . . . . 1.58 111.4 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.126 ' CE1' HG21 ' A' ' 33' ' ' ILE . 58.6 m-85 -102.61 81.07 1.99 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.76 111.172 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.751 HD12 ' O ' ' A' ' 77' ' ' ILE . 0.3 OUTLIER -72.53 110.59 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.461 -0.495 . . . . 1.14 110.359 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.28 81.55 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 111.991 0.367 . . . . 0.63 111.991 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -52.78 138.75 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.457 -0.572 . . . . 1.67 109.457 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -111.7 153.62 26.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.371 0.605 . . . . 1.97 112.152 -178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -128.39 98.52 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.054 -0.975 . . . . 1.44 110.201 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -75.2 76.74 2.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.818 -0.628 . . . . 1.59 110.875 -179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 73' ' ' GLU . 12.3 mt -57.27 138.26 80.65 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.9 111.131 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -92.2 17.36 42.15 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 124.009 -1.246 . . . . 1.43 112.763 0.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.6 p30 -121.84 53.01 1.22 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.51 -0.314 . . . . 2.66 111.398 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -104.35 173.89 21.64 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.507 -0.854 . . . . 1.12 112.329 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.018 ' HG2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -165.92 42.64 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 2.41 110.997 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.569 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 20.8 m95 40.85 69.26 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.958 -0.565 . . . . 0.65 111.855 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.018 HD23 ' HG2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -101.29 121.32 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.765 0.317 . . . . 1.28 110.389 179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.94 92.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 1.3 111.454 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -62.61 -46.39 88.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.86 110.438 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.63 ' HB2' HD11 ' A' ' 56' ' ' ILE . 12.1 p-10 -62.57 127.11 29.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.863 -0.608 . . . . 2.01 111.086 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.73 -17.34 20.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.965 -0.561 . . . . 2.08 111.113 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.7 m -110.63 145.93 37.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.89 0.376 . . . . 1.89 110.814 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.8 111.43 0.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 1.87 110.915 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 58' ' ' GLU . 19.7 mm -75.63 90.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.315 -0.402 . . . . 0.69 110.871 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.51 -38.23 65.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.965 0.412 . . . . 1.6 110.457 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.723 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -99.73 154.33 18.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 1.54 109.589 179.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 26.1 p-10 -75.3 -0.71 20.6 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.093 0.405 . . . . 1.75 112.093 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.655 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 2.5 tp10 -100.73 105.47 16.81 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.44 -0.578 . . . . 2.05 109.44 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.658 ' CD1' HD12 ' A' ' 56' ' ' ILE . 58.2 t80 -137.15 165.99 24.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.346 0.594 . . . . 0.48 111.922 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -133.06 100.4 4.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.205 -0.907 . . . . 0.42 110.843 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 14.9 m -57.29 142.59 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.581 . . . . 1.08 111.04 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.497 ' OG ' HG22 ' A' ' 17' ' ' THR . 7.5 t -136.12 154.17 51.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.72 0.772 . . . . 1.33 111.131 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.16 -5.9 19.61 Favored Glycine 0 C--N 1.313 -0.711 0 CA-C-N 114.48 -1.236 . . . . 0.9 112.3 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.795 HD23 HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -62.85 -175.52 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.834 0.349 . . . . 1.47 110.815 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 m -149.35 130.66 14.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.244 -0.435 . . . . 1.06 110.634 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 5.8 tt0 -50.92 149.35 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 1.91 111.085 -179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 67.84 48.82 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 1.87 110.793 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.2 130.81 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 0.49 111.625 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.82 135.13 41.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.36 110.243 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -131.8 121.77 24.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.926 0.393 . . . . 0.56 111.99 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.702 ' HG3' HD11 ' A' ' 43' ' ' LEU . 2.7 mt-10 -97.3 137.74 35.85 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.86 -0.792 . . . . 1.5 108.86 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.902 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -122.21 106.76 11.42 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.42 1.267 . . . . 0.6 114.42 -179.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 91' ' ' PRO . 0.2 OUTLIER -104.49 143.47 32.98 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.136 -0.938 . . . . 2.11 108.927 178.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.484 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -116.51 136.33 53.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 119.958 -0.697 . . . . 0.6 112.001 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.751 ' O ' HD12 ' A' ' 37' ' ' ILE . 33.9 mt -117.21 153.17 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.907 -1.042 . . . . 0.7 108.513 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -146.35 117.4 7.77 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.371 -0.531 . . . . 0.6 111.735 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 23.0 ptmt -86.89 14.75 6.75 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 113.15 0.796 . . . . 1.98 113.15 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 2.6 m-80 43.51 -179.91 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.074 1.138 . . . . 2.19 114.074 178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -57.61 -50.26 73.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 113.972 -1.467 . . . . 1.08 112.372 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.702 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -88.79 34.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.584 0.587 . . . . 1.06 112.584 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.08 18.1 39.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.544 -0.836 . . . . 0.93 113.045 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -69.11 94.73 0.68 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.257 -0.646 . . . . 1.38 109.257 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.4 tp -61.04 107.6 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 113.294 0.85 . . . . 0.79 113.294 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.2 p -87.52 108.5 20.33 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.978 -1.119 . . . . 0.59 107.978 178.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.479 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.5 Cg_endo -42.01 172.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.125 2.55 . . . . 0.85 113.883 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HB3' ' HG2' ' A' ' 75' ' ' ARG . 54.1 Cg_exo -51.81 129.04 28.66 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.9 2.4 . . . . 0.76 112.466 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 76' ' ' VAL . 15.2 m -99.94 106.12 17.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.334 -0.394 . . . . 1.28 110.419 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 1.92 117.69 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.243 0 O-C-N 124.696 1.248 . . . . 1.77 113.355 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 9.1 Cg_exo -69.29 160.59 49.24 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 121.803 1.669 . . . . 0.55 113.915 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.412 ' OG ' ' HG3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -87.28 141.1 28.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.779 -1.193 . . . . 1.23 107.779 178.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.839 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -32.12 138.0 0.05 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.042 0.839 . . . . 1.63 112.201 -179.508 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -67.53 101.25 0.97 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.158 -0.473 . . . . 0.41 111.063 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.839 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.6 mp -84.2 115.03 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.926 0.393 . . . . 0.44 111.053 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 23.8 m -52.45 -23.52 6.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.875 -0.602 . . . . 0.44 110.6 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.638 ' H ' HG22 ' A' ' 95' ' ' ILE . 7.6 m 50.12 84.34 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.089 0.471 . . . . 1.1 109.875 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.644 ' HD2' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -132.35 -87.36 0.45 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.716 -0.675 . . . . 3.0 110.979 -179.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.942 ' O ' HG12 ' A' ' 101' ' ' VAL . 26.7 p-10 -93.28 21.9 5.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.125 -0.489 . . . . 2.14 110.631 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.251 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER 43.07 29.93 0.23 Allowed 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.273 0.559 . . . . 2.06 111.54 -179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.942 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.3 p -164.57 25.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 2.8 110.599 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.731 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.1 OUTLIER 29.3 74.67 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.17 0.804 . . . . 4.58 113.17 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.651 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.178 -0.915 . . . . 3.79 111.111 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 61.0 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.756 0.312 . . . . 2.74 111.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.5 -151.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 2.06 111.545 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.516 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.4 tt -166.69 131.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.884 0.373 . . . . 0.68 111.422 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 18.0 m-20 -111.61 130.45 23.11 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.968 -0.56 . . . . 2.0 110.186 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.72 162.43 24.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.412 2.075 . . . . 0.5 112.38 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' N ' ' HG3' ' A' ' 25' ' ' PRO . 53.7 Cg_exo -54.39 178.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.929 2.419 . . . . 0.71 113.37 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.69 161.02 30.59 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.66 112.517 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.4 tttt -53.23 132.53 51.72 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 110.244 -0.28 . . . . 1.52 110.244 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.594 ' HG3' HG23 ' A' ' 76' ' ' VAL . 4.5 Cg_exo -82.01 136.89 9.44 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.445 2.097 . . . . 0.44 112.396 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -130.87 121.23 18.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.09 110.849 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.7 Cg_exo -65.71 100.71 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.439 2.093 . . . . 0.64 113.417 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -58.95 -35.01 72.43 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.869 -0.789 . . . . 1.64 108.869 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -142.07 151.45 42.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.661 -1.154 . . . . 0.72 108.339 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.053 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -139.84 113.61 6.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.129 -0.629 . . . . 0.96 112.301 -179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.002 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.61 151.27 23.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.65 -0.705 . . . . 1.46 109.865 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HB2' ' HG3' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -64.29 -10.52 24.5 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.61 0.596 . . . . 2.42 112.61 -179.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 17' ' ' THR . 6.6 m-70 -135.07 20.09 3.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.672 0.273 . . . . 1.02 111.323 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 168.13 114.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.68 109.956 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 ' CD1' ' A' ' 66' ' ' LEU . 14.5 m -108.4 146.68 13.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.594 -0.442 . . . . 0.8 110.632 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.533 ' C ' HD13 ' A' ' 20' ' ' LEU . 4.1 m -110.58 120.21 41.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.347 -0.388 . . . . 0.35 111.979 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.867 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -132.36 171.1 14.16 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.662 0.744 . . . . 0.52 111.804 178.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -158.67 173.22 16.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.024 -0.989 . . . . 1.84 109.123 179.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 3.1 p90 -138.37 -168.36 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.595 0.591 . . . . 0.4 112.595 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 24' ' ' LYS . . . -96.67 -13.41 22.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.416 0.895 . . . . 0.83 113.416 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.464 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 74.34 149.84 0.13 Allowed Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 110.121 -0.325 . . . . 2.11 110.121 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.464 ' HD2' ' CD ' ' A' ' 24' ' ' LYS . 20.0 Cg_exo -65.96 -167.35 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.33 2.02 . . . . 0.89 113.047 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -148.74 -45.01 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.687 -0.688 . . . . 2.77 110.787 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.1 77.16 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 1.37 111.283 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 22.6 p -92.47 46.73 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.41 . . . . 0.91 109.95 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.16 -98.43 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.546 -0.835 . . . . 1.01 111.653 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.2 29.48 2.92 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 110.578 -1.009 . . . . 0.98 110.578 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -117.38 174.39 6.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.091 -0.555 . . . . 0.87 111.071 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.7 -0.58 4.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.809 -0.632 . . . . 2.26 111.457 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 ' CD1' ' HG2' ' A' ' 25' ' ' PRO . 23.3 mt 63.25 136.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.178 -0.304 . . . . 1.71 110.178 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 16.9 p -107.69 -15.25 14.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.715 0.635 . . . . 1.15 112.715 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -167.43 158.58 11.68 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.397 0.518 . . . . 1.58 112.397 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CE1' HG21 ' A' ' 33' ' ' ILE . 26.3 m-85 -117.36 131.4 56.79 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.861 -0.609 . . . . 0.76 110.014 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 50' ' ' LYS . 5.6 mt -104.84 132.49 51.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.852 -0.613 . . . . 1.14 111.023 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 63' ' ' VAL . 5.1 t -110.33 103.96 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.265 -0.425 . . . . 0.63 111.278 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB2' ' HD2' ' A' ' 75' ' ' ARG . 14.0 mt-10 -85.42 131.2 34.43 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.532 -0.544 . . . . 1.67 109.532 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -102.32 129.26 48.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.136 0.493 . . . . 1.97 111.854 -179.209 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 5.4 ttp180 -105.9 92.59 4.23 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.634 -0.712 . . . . 1.44 109.488 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -62.96 146.75 52.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.013 -0.54 . . . . 1.59 109.574 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.54 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 10.0 mt -127.12 131.0 23.65 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.871 -0.332 . . . . 0.9 110.808 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 6.7 Cg_endo -88.5 38.98 3.14 Favored 'Cis proline' 0 C--N 1.352 0.726 0 C-N-CA 124.542 -1.024 . . . . 1.43 113.026 0.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -114.2 56.05 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.758 0.314 . . . . 2.66 110.607 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . -62.17 169.61 13.27 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.792 -0.718 . . . . 1.12 113.262 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER 161.51 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.657 0.265 . . . . 2.41 111.628 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.515 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 68.5 m95 63.17 107.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.248 -0.279 . . . . 0.65 110.248 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -144.34 121.58 11.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.838 0.351 . . . . 1.28 110.796 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 6.2 ptpt -51.03 111.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.452 . . . . 1.3 111.105 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -100.92 -11.94 19.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.896 -0.593 . . . . 0.86 111.258 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.565 ' CB ' HD11 ' A' ' 56' ' ' ILE . 6.1 p-10 -74.21 -60.94 2.04 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.654 -0.418 . . . . 2.01 111.871 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 4.8 t80 78.37 -51.32 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.549 0.214 . . . . 2.08 111.409 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -173.94 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.036 0.446 . . . . 1.89 111.47 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.0 80.13 1.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.786 -0.643 . . . . 1.87 110.764 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.565 HD11 ' CB ' ' A' ' 52' ' ' ASN . 70.3 mt -71.11 103.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.847 -0.615 . . . . 0.69 110.733 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.36 -50.82 2.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.384 -0.371 . . . . 1.6 111.665 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -56.66 -20.26 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.137 0.421 . . . . 1.54 112.137 -179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.2 p-10 89.17 -25.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.71 0.804 . . . . 1.75 111.65 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -81.93 86.56 6.5 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.751 -0.833 . . . . 2.05 108.751 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 62' ' ' THR . 55.0 t80 -120.8 165.56 14.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.328 0.585 . . . . 0.48 111.998 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 18' ' ' VAL . 54.9 m -123.7 122.26 37.63 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.37 -0.832 . . . . 0.42 110.84 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.867 HG23 HD21 ' A' ' 20' ' ' LEU . 9.6 t -81.91 95.7 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.159 0.504 . . . . 1.08 110.834 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 17' ' ' THR . 41.3 t -83.26 -158.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.495 -0.775 . . . . 1.33 110.74 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 57.72 19.62 36.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.511 -0.852 . . . . 0.9 112.248 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.037 ' CD1' HG13 ' A' ' 18' ' ' VAL . 68.7 mt -75.12 -176.97 3.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.947 0.403 . . . . 1.47 110.607 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -144.59 144.29 31.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.496 . . . . 1.06 110.68 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 15' ' ' ARG . 22.2 tt0 -70.67 146.92 49.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.216 -0.447 . . . . 1.91 110.971 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.2 t0 60.4 41.23 16.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.989 -0.551 . . . . 1.87 111.16 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -150.69 124.67 9.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.732 0.301 . . . . 0.49 111.347 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -77.74 129.48 35.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.056 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 68.8 m-85 -126.86 126.15 42.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.143 0.794 . . . . 0.56 113.143 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -100.01 137.72 38.07 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.219 -0.66 . . . . 1.5 109.219 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.993 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -123.89 116.88 23.64 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.486 0.921 . . . . 0.6 113.486 -178.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.513 ' CZ ' ' CE2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -102.25 145.76 28.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.855 -0.612 . . . . 2.11 110.967 179.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.594 HG23 ' HG3' ' A' ' 8' ' ' PRO . 46.9 t -105.94 104.59 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.479 0.548 . . . . 0.6 112.479 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.445 HG12 ' CA ' ' A' ' 88' ' ' PRO . 30.2 mt -105.03 147.77 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 106.9 -1.519 . . . . 0.7 106.9 177.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -166.04 144.04 5.63 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.16 -1.016 . . . . 0.6 112.74 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.02 -172.35 4.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 1.98 110.136 179.123 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 50.0 p30 -126.09 -128.52 0.24 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 116.391 -0.368 . . . . 2.19 110.279 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 80' ' ' ASN . . . -116.06 -28.15 6.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.158 0.89 . . . . 1.08 111.24 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -82.02 4.75 21.66 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.179 0.437 . . . . 1.06 112.179 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -5.13 78.73 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.425 -0.893 . . . . 0.93 113.303 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.528 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -75.8 161.98 28.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 117.118 0.459 . . . . 1.38 110.448 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.9 tp -115.26 120.41 64.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 0.79 112.629 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 2.0 p -74.48 113.72 26.76 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.262 -0.644 . . . . 0.59 109.262 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -39.35 163.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.749 2.3 . . . . 0.85 113.041 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' CA ' HG12 ' A' ' 77' ' ' ILE . 28.1 Cg_endo -63.99 144.96 89.18 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.826 2.351 . . . . 0.76 113.126 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.0 m -98.99 127.17 44.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.593 -0.73 . . . . 1.28 109.963 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt0 -20.97 98.33 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 O-C-N 124.587 1.179 . . . . 1.77 113.067 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 42.0 Cg_exo -35.67 166.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.57 2.847 . . . . 0.55 115.574 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.514 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 1.5 m -93.32 141.49 28.39 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 113.696 -1.593 . . . . 1.23 109.02 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.596 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -39.87 139.42 0.65 Allowed 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 123.731 0.644 . . . . 1.63 111.412 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.37 102.23 2.12 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.017 -0.538 . . . . 0.41 109.923 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 13' ' ' ILE . 4.4 mp -84.26 111.74 20.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.941 0.401 . . . . 0.44 111.226 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.473 HG22 ' HG2' ' A' ' 98' ' ' ARG . 66.8 m -47.63 -30.11 3.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.44 111.254 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.471 ' H ' HG22 ' A' ' 95' ' ' ILE . 79.2 m 49.6 89.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 1.1 110.323 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -141.77 -85.95 0.17 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 3.0 111.28 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.072 ' OD1' ' HB2' ' A' ' 102' ' ' GLU . 4.5 p-10 -101.72 2.37 38.49 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.051 -0.522 . . . . 2.14 111.374 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.053 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 43.4 29.2 0.22 Allowed 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 112.359 0.503 . . . . 2.06 112.359 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.928 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.7 p -162.62 27.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.781 -0.645 . . . . 2.8 110.507 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.072 ' HB2' ' OD1' ' A' ' 99' ' ' ASP . 1.4 mt-10 -137.96 -43.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.857 -0.61 . . . . 4.58 110.966 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.28 -0.867 . . . . 3.79 111.212 -179.968 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.748 0.309 . . . . 2.74 111.322 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -90.89 156.21 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.098 2.532 . . . . 2.06 112.472 -179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.761 HD12 ' OD1' ' A' ' 80' ' ' ASN . 4.9 tt -113.36 151.52 15.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.067 0.461 . . . . 0.68 111.312 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.325 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -133.86 128.17 19.65 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.615 -0.721 . . . . 2.0 109.875 179.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.62 176.37 9.17 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.42 2.08 . . . . 0.5 112.379 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.458 ' HG3' ' CE1' ' A' ' 36' ' ' TYR . 21.0 Cg_exo -65.39 178.29 2.17 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.809 2.339 . . . . 0.71 112.729 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.06 172.49 55.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.988 -0.625 . . . . 0.66 112.614 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' NZ ' ' OE2' ' A' ' 90' ' ' GLU . 10.0 tttp -58.66 120.44 45.49 Favored Pre-proline 0 C--N 1.33 -0.251 0 O-C-N 123.021 -0.105 . . . . 1.52 110.722 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.761 ' CG ' HG23 ' A' ' 76' ' ' VAL . 22.2 Cg_exo -67.58 127.09 15.79 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.415 2.077 . . . . 0.44 112.802 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.6 p -133.18 107.46 12.37 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 115.821 -0.627 . . . . 1.09 111.158 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.1 Cg_exo -37.67 142.58 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.827 2.352 . . . . 0.64 113.292 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 19' ' ' THR . 0.5 OUTLIER -97.71 -44.63 6.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.747 -1.115 . . . . 1.64 108.372 179.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -148.11 155.61 41.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.997 -1.456 . . . . 0.72 109.061 179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.01 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -143.85 100.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 120.436 -0.505 . . . . 0.96 111.69 -179.625 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.252 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -98.87 50.13 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 1.46 110.943 179.726 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.831 ' HG3' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 56.68 -70.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 O-C-N 123.998 0.811 . . . . 2.42 112.075 179.31 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 8.4 m170 -77.41 -26.85 52.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 1.02 111.255 -179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -125.23 112.12 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.819 0.343 . . . . 0.68 111.148 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.968 HG13 HG22 ' A' ' 13' ' ' ILE . 72.9 t -107.23 110.68 32.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.086 -0.506 . . . . 0.8 111.171 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 79.4 m -88.43 149.19 23.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.122 -0.49 . . . . 0.35 110.678 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -149.88 154.71 38.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.533 0.682 . . . . 0.52 112.148 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 22' ' ' TRP . 1.0 OUTLIER -143.86 144.83 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.737 -1.12 . . . . 1.84 110.171 179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 10.9 p90 -140.57 -172.31 3.42 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.882 -0.327 . . . . 0.4 111.545 -179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.73 159.36 14.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.319 0.581 . . . . 0.83 112.337 -179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.4 139.59 28.36 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.32 -0.854 . . . . 2.11 110.057 179.737 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 1.2 Cg_endo -44.85 169.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.336 2.024 . . . . 0.89 111.869 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -119.04 -4.87 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.099 0.407 . . . . 2.77 112.099 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.747 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.5 t80 -141.42 -73.89 0.32 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 1.37 111.933 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 1.325 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.8 p 79.6 -39.28 0.2 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.225 0.61 . . . . 0.91 112.315 -179.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.7 -82.81 0.33 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.498 -0.858 . . . . 1.01 111.554 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.18 27.57 0.79 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.114 -1.194 . . . . 0.98 110.114 178.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.523 ' CE2' ' OD1' ' A' ' 80' ' ' ASN . 1.7 m-85 -116.94 -177.07 3.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 114.705 -0.748 . . . . 0.87 111.404 -178.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -135.56 -3.06 2.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.652 -0.704 . . . . 2.26 111.923 179.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.471 ' CD1' ' HG3' ' A' ' 25' ' ' PRO . 15.0 mt 60.76 140.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-O 120.8 0.334 . . . . 1.71 110.506 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -123.96 6.74 8.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.359 0.503 . . . . 1.15 112.359 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER 178.0 162.47 0.61 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.134 0.492 . . . . 1.58 111.965 179.867 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.722 ' O ' HD12 ' A' ' 56' ' ' ILE . 42.5 m-85 -128.76 101.11 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.411 -0.813 . . . . 0.76 110.3 179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.8 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.2 OUTLIER -87.62 122.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.623 -0.262 . . . . 1.14 110.888 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.6 p -110.84 128.61 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.044 0.449 . . . . 0.63 110.815 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mt-10 -90.0 136.17 33.21 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.91 -0.586 . . . . 1.67 112.227 -179.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.947 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -99.8 132.43 45.16 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.419 0.896 . . . . 1.97 113.419 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 7.5 ttm180 -115.4 107.61 15.43 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.134 -0.484 . . . . 1.44 110.077 178.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.03 90.6 5.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.869 -0.605 . . . . 1.59 111.015 -179.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 94' ' ' ALA . 15.8 mt -66.05 150.22 96.9 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.45 -0.341 . . . . 0.9 110.611 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.78 -9.25 47.24 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.086 -1.214 . . . . 1.43 112.794 0.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -60.26 -61.98 2.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.907 0.384 . . . . 2.66 110.725 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 85.36 142.92 6.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.916 -0.659 . . . . 1.12 112.839 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 176.3 64.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 2.41 110.692 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 80.9 m95 -33.89 98.82 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.446 -0.797 . . . . 0.65 111.881 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -125.23 139.52 53.65 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.189 0.519 . . . . 1.28 112.271 -179.326 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HD2' HG21 ' A' ' 37' ' ' ILE . 4.2 mtmt -57.33 86.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.549 -0.751 . . . . 1.3 110.868 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.947 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -59.31 -51.98 67.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.097 0.475 . . . . 0.86 110.683 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.806 ' CB ' HD11 ' A' ' 56' ' ' ILE . 7.0 p-10 -61.49 150.94 34.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.01 111.189 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.88 27.67 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.786 -0.643 . . . . 2.08 110.544 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -130.68 30.41 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.89 110.727 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.52 111.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 1.87 110.734 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 52' ' ' ASN . 19.6 mt -101.32 71.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.69 111.275 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 0.4 OUTLIER -50.84 -80.38 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.125 -0.489 . . . . 1.6 110.85 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.97 168.63 5.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.996 -0.372 . . . . 1.54 109.996 179.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -88.81 47.11 1.46 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.992 0.425 . . . . 1.75 111.533 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -144.32 101.28 3.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.776 -0.647 . . . . 2.05 109.308 179.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.616 ' HB2' HG23 ' A' ' 56' ' ' ILE . 77.0 t80 -134.53 165.22 25.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.48 112.135 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.483 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 85.1 m -131.27 116.59 17.82 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.489 -0.778 . . . . 0.42 110.861 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 18' ' ' VAL . 7.2 m -77.42 110.06 12.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 1.08 111.045 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.24 126.18 51.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.059 -0.518 . . . . 1.33 111.098 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.97 -1.31 2.8 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.539 -0.839 . . . . 0.9 113.659 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -51.77 -175.48 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.189 0.519 . . . . 1.47 111.302 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.1 m -135.45 117.02 14.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.631 -0.713 . . . . 1.06 110.7 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 1.4 tt0 -47.3 132.53 12.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.061 -0.518 . . . . 1.91 111.32 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 6.3 t0 73.77 67.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.104 -0.498 . . . . 1.87 111.243 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 177.27 124.2 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.49 111.064 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.37 130.81 43.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.36 110.454 179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 38.4 m-85 -126.07 122.93 37.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.56 112.017 -179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.2 tt0 -107.22 141.32 38.72 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.282 -0.636 . . . . 1.5 109.282 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.576 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.55 125.16 16.8 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.153 1.168 . . . . 0.6 114.153 -179.24 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.775 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -100.38 165.83 11.26 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.034 -0.53 . . . . 2.11 109.78 178.592 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.761 HG23 ' CG ' ' A' ' 8' ' ' PRO . 46.9 t -122.95 114.08 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 113.557 0.947 . . . . 0.6 113.557 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.451 HG12 ' CA ' ' A' ' 88' ' ' PRO . 56.6 mt -108.11 154.85 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.562 -1.644 . . . . 0.7 106.562 177.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -167.39 131.27 1.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 118.955 -1.098 . . . . 0.6 113.473 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 2.8 mttp -83.67 143.32 30.14 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.655 -0.702 . . . . 1.98 109.288 178.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.761 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -78.89 -106.71 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.077 -0.511 . . . . 2.19 111.902 -178.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.01 -28.36 2.4 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.783 0.72 . . . . 1.08 112.622 -179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -94.85 20.78 8.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.429 0.529 . . . . 1.06 112.429 -179.053 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 87.72 -17.04 47.49 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.378 -0.915 . . . . 0.93 112.772 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -63.08 112.86 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.339 . . . . 1.38 110.414 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.4 tt -77.81 112.18 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.494 . . . . 0.79 112.005 -179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.5 p -66.06 122.11 79.52 Favored Pre-proline 0 C--O 1.238 0.464 0 CA-C-N 115.854 -0.612 . . . . 0.59 109.896 179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -35.04 158.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.415 2.744 . . . . 0.85 113.45 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' CA ' HG12 ' A' ' 77' ' ' ILE . 12.0 Cg_exo -71.22 148.21 55.23 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.871 2.381 . . . . 0.76 112.423 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.42 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 3.0 m -97.32 129.49 44.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 1.28 109.748 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.642 ' OE2' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -30.8 111.67 0.29 Allowed Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.805 0.691 . . . . 1.77 112.372 -179.476 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.7 Cg_exo -37.93 148.28 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.762 2.308 . . . . 0.55 113.629 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.423 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -85.66 139.66 31.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.062 -0.972 . . . . 1.23 109.457 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.646 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -32.72 139.51 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 O-C-N 124.28 0.988 . . . . 1.63 112.363 -179.75 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -75.47 109.93 9.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.558 -0.746 . . . . 0.41 110.731 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.646 HD12 ' O ' ' A' ' 93' ' ' ASP . 5.1 mp -92.54 115.77 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.029 0.443 . . . . 0.44 111.225 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 86.1 m -47.22 -30.81 3.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.869 -0.605 . . . . 0.44 111.535 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.536 ' H ' HG22 ' A' ' 95' ' ' ILE . 91.5 m 54.19 62.39 2.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.91 0.386 . . . . 1.1 110.182 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -97.71 -86.84 0.34 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.084 -0.507 . . . . 3.0 111.623 -179.548 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -116.83 28.33 8.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 2.14 110.662 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.252 ' OD2' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 49.05 22.86 0.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 2.06 111.543 -179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.98 -20.96 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 116.244 -0.434 . . . . 2.8 110.849 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.093 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.61 43.31 6.45 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.092 0.472 . . . . 4.58 111.458 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.61 ' N ' ' OE1' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.179 -0.915 . . . . 3.79 111.27 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.421 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.429 0.157 . . . . 2.74 111.362 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.457 ' HG2' ' CE1' ' A' ' 27' ' ' TYR . 1.1 Cg_endo -82.72 53.04 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.883 2.388 . . . . 2.06 111.765 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.739 HD12 ' CG ' ' A' ' 80' ' ' ASN . 2.0 tt -49.43 136.14 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.779 -0.646 . . . . 0.68 111.842 -179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -117.42 137.0 23.69 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.055 -0.52 . . . . 2.0 110.419 179.534 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -83.03 160.14 15.66 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.443 2.096 . . . . 0.5 112.418 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.32 172.3 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.822 2.348 . . . . 0.71 112.98 -179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.88 174.21 20.69 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.66 112.817 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -66.63 138.08 95.36 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 110.544 -0.169 . . . . 1.52 110.544 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 7.2 Cg_exo -77.87 139.32 17.43 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.818 2.345 . . . . 0.44 112.502 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.9 p -145.9 126.37 7.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.33 -0.395 . . . . 1.09 111.456 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.695 ' CG ' HD11 ' A' ' 95' ' ' ILE . 16.9 Cg_exo -66.87 141.21 58.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.76 2.307 . . . . 0.64 113.757 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.4 mm? -107.32 -36.17 6.59 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.627 -0.879 . . . . 1.64 108.627 178.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -139.36 150.73 45.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.614 -1.176 . . . . 0.72 108.297 179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.929 HG21 HG12 ' A' ' 95' ' ' ILE . 1.0 OUTLIER -143.86 101.98 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.259 -0.576 . . . . 0.96 112.068 -179.279 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -93.89 56.89 2.37 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 115.881 -0.599 . . . . 1.46 110.863 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 47.84 -74.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.024 0.827 . . . . 2.42 112.886 179.389 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.54 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -73.99 -37.8 64.32 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.99 0.367 . . . . 1.02 111.99 -179.268 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HB3' ' A' ' 64' ' ' SER . 72.3 p -122.46 110.27 15.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.718 0.294 . . . . 0.68 111.02 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.052 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 4.1 m -99.29 152.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.886 0.374 . . . . 0.8 111.288 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.595 ' C ' HD13 ' A' ' 20' ' ' LEU . 13.9 m -118.21 123.92 46.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 0.35 111.32 -179.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.737 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.52 162.74 32.27 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.413 0.625 . . . . 0.52 111.336 179.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.963 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -151.3 158.46 43.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 1.84 110.12 179.384 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.504 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.6 p90 -137.42 -167.82 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.4 111.316 -179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -96.11 -166.59 1.45 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 121.354 0.597 . . . . 0.83 112.367 -179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.446 ' HD3' ' HG2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -114.59 141.45 26.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.148 -0.933 . . . . 2.11 110.228 -179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.649 ' HB2' HG23 ' A' ' 28' ' ' THR . 12.1 Cg_endo -55.35 172.63 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.247 1.965 . . . . 0.89 112.186 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -121.26 -39.17 2.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 2.77 111.106 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' CE1' ' HG2' ' A' ' 1' ' ' PRO . 1.8 t80 -120.28 71.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 1.37 111.478 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 25' ' ' PRO . 73.8 p -91.01 44.24 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.501 -0.318 . . . . 0.91 110.539 179.474 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.07 -93.25 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.704 -0.76 . . . . 1.01 112.501 -179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.95 49.26 0.55 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.987 -1.245 . . . . 0.98 109.987 179.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.688 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -136.57 177.45 7.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.984 -0.608 . . . . 0.87 110.929 -178.208 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -138.53 6.31 2.5 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.09 0.404 . . . . 2.26 112.09 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.768 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.5 mt 58.52 150.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 120.851 0.358 . . . . 1.71 111.042 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 p -131.73 15.09 4.87 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.0 0.37 . . . . 1.15 112.0 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.616 ' H ' HG22 ' A' ' 33' ' ' ILE . 42.3 t 179.25 124.26 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.64 0.257 . . . . 1.58 111.092 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.768 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.8 m-85 -105.38 88.21 2.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.238 -0.437 . . . . 0.76 111.195 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.483 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.4 mm -69.39 151.96 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.95 -0.3 . . . . 1.14 110.323 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -140.17 103.98 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.272 0.558 . . . . 0.63 110.782 179.76 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.51 161.92 29.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.367 -0.833 . . . . 1.67 110.04 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -136.41 153.35 51.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.915 0.388 . . . . 1.97 111.391 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 23.7 ttm180 -134.69 121.33 20.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.748 -0.66 . . . . 1.44 110.801 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.818 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.56 91.62 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.593 . . . . 1.59 110.859 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.61 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -56.3 152.52 23.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.15 -0.477 . . . . 0.9 110.53 179.924 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -90.37 30.4 11.85 Favored 'Cis proline' 0 C--N 1.348 0.533 0 C-N-CA 123.911 -1.287 . . . . 1.43 112.573 0.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 173.99 99.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.368 . . . . 2.66 111.139 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.818 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -135.35 -123.12 2.29 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.685 -0.769 . . . . 1.12 112.89 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -135.03 -169.83 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.431 0.158 . . . . 2.41 110.716 -179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 4.4 m95 -136.33 49.67 2.09 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.65 110.946 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.5 148.3 25.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.304 -0.407 . . . . 1.28 111.231 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HE2' HG23 ' A' ' 37' ' ' ILE . 8.2 ptmm? -79.16 89.61 4.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.127 -0.488 . . . . 1.3 110.875 179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -49.02 -41.83 36.04 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.01 0.433 . . . . 0.86 110.575 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.54 ' CB ' HD11 ' A' ' 56' ' ' ILE . 8.8 t30 -60.46 100.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.796 -0.638 . . . . 2.01 110.159 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -104.86 28.66 6.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 2.08 111.321 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.3 t -130.47 -70.64 0.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.821 0.344 . . . . 1.89 111.005 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 170.58 153.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 1.87 110.588 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.738 HG23 ' HB2' ' A' ' 61' ' ' PHE . 16.8 mt -142.09 56.53 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.69 111.253 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.8 tp -48.46 -38.24 19.43 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.909 0.385 . . . . 1.6 110.747 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.721 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -92.77 166.74 12.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 1.54 110.161 179.67 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 56.6 p30 -89.22 15.12 9.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.496 -0.32 . . . . 1.75 111.651 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.963 ' OE1' ' HB3' ' A' ' 21' ' ' LYS . 19.7 tp10 -122.71 99.56 6.46 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.615 -0.513 . . . . 2.05 109.615 179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.738 ' HB2' HG23 ' A' ' 56' ' ' ILE . 26.1 t80 -131.71 166.6 21.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.007 0.432 . . . . 0.48 111.424 -179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 18' ' ' VAL . 21.6 m -117.58 120.67 38.76 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 115.713 -0.676 . . . . 0.42 111.076 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.587 HG23 HD21 ' A' ' 20' ' ' LEU . 12.5 t -84.14 104.29 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-O 121.16 0.505 . . . . 1.08 111.507 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.774 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -94.5 -168.64 1.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.461 -0.79 . . . . 1.33 110.404 179.759 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.44 11.82 49.13 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.572 -0.823 . . . . 0.9 112.893 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.01 ' CD1' HG13 ' A' ' 18' ' ' VAL . 16.2 mt -69.18 -159.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.927 -0.397 . . . . 1.47 109.927 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.7 m -147.69 147.73 30.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.902 0.382 . . . . 1.06 110.594 179.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 5.1 mt-10 -81.78 145.82 30.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.495 . . . . 1.91 110.988 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t0 67.65 39.4 2.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 1.87 111.058 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.95 122.91 3.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.49 111.452 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -68.78 133.22 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.36 109.884 179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.43 ' HA ' HD22 ' A' ' 43' ' ' LEU . 35.6 m-85 -124.38 127.37 47.46 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.691 0.626 . . . . 0.56 112.691 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.503 ' CG ' HD21 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -98.05 138.24 35.66 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.178 -1.045 . . . . 1.5 108.178 178.225 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.052 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.42 108.7 10.48 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.523 -1.271 . . . . 0.6 113.937 -179.419 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -88.67 159.72 17.7 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.112 -0.329 . . . . 2.11 110.112 179.041 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.649 HG23 ' CG ' ' A' ' 8' ' ' PRO . 64.6 t -121.2 122.84 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.427 0.632 . . . . 0.6 112.585 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 88' ' ' PRO . 39.5 mt -117.06 155.17 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.719 -1.215 . . . . 0.7 107.719 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -172.4 138.73 0.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 119.378 -0.929 . . . . 0.6 112.178 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 33' ' ' ILE . 5.2 ptpt -84.57 176.53 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 1.98 110.766 179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.739 ' CG ' HD12 ' A' ' 2' ' ' ILE . 2.4 p-10 -124.57 163.61 21.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.871 -0.604 . . . . 2.19 111.208 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -47.82 -25.53 1.32 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 1.08 111.906 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -77.22 -12.39 59.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.897 0.332 . . . . 1.06 111.897 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.06 -17.75 57.68 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.49 -0.862 . . . . 0.93 112.425 -179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -57.33 -162.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.54 0.209 . . . . 1.38 110.492 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.665 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -145.0 105.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.086 0.47 . . . . 0.79 112.001 179.837 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -63.44 119.56 54.55 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.734 -0.839 . . . . 0.59 108.734 179.175 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.6 Cg_endo -48.98 159.25 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.89 2.393 . . . . 0.85 113.242 -179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 77' ' ' ILE . 24.0 Cg_endo -62.56 150.78 86.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.907 2.405 . . . . 0.76 113.264 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.4 m -106.53 132.8 52.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.805 . . . . 1.28 109.651 179.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 13.7 tt0 -30.25 111.91 0.29 Allowed Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.867 0.73 . . . . 1.77 112.325 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.49 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 71.7 Cg_exo -45.66 139.57 10.15 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.787 2.324 . . . . 0.55 114.324 -179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -53.75 144.54 17.87 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.834 -0.802 . . . . 1.23 108.834 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 4.7 m-20 -14.62 -89.72 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.743 1.902 . . . . 1.63 113.793 -179.07 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.61 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . 158.43 106.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 123.967 0.907 . . . . 0.41 109.239 -179.451 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.929 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -98.04 112.99 31.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.756 -0.378 . . . . 0.44 111.956 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.4 m -47.44 -32.53 5.17 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.276 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.482 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 55.65 82.45 0.1 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.839 -0.618 . . . . 1.1 110.163 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.2 -88.19 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.743 -0.662 . . . . 3.0 111.392 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.13 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 2.4 p30 -124.77 9.02 8.22 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.478 -0.328 . . . . 2.14 111.568 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.432 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 42.3 t0 50.46 26.14 2.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.969 0.414 . . . . 2.06 110.893 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 101' ' ' VAL . 14.6 p -142.54 14.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 2.8 111.667 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.13 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.7 OUTLIER -136.29 -58.22 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.063 0.458 . . . . 4.58 110.328 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.336 -0.84 . . . . 3.79 111.196 179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.551 0.215 . . . . 2.74 111.078 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.76 -167.01 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.426 2.084 . . . . 2.06 112.318 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.446 HG12 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -158.26 145.78 8.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.68 111.22 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 2' ' ' ILE . 6.3 m-20 -128.87 132.09 24.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.99 -0.55 . . . . 2.0 110.077 179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.01 158.1 53.15 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.368 2.045 . . . . 0.5 112.4 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 36' ' ' TYR . 9.9 Cg_endo -52.03 175.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.943 2.429 . . . . 0.71 112.763 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.91 168.62 49.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.024 -0.608 . . . . 0.66 112.665 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -59.73 121.89 61.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 110.461 -0.199 . . . . 1.52 110.461 179.8 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.653 ' CG ' HG23 ' A' ' 76' ' ' VAL . 32.1 Cg_exo -62.17 147.85 94.29 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.426 2.084 . . . . 0.44 112.451 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -151.52 110.48 2.97 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.314 -0.403 . . . . 1.09 111.954 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.5 Cg_exo -59.63 127.34 23.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.613 2.209 . . . . 0.64 113.52 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -94.16 -26.37 16.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.373 -0.831 . . . . 1.64 109.081 178.512 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.442 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 7.5 t30 -145.85 149.53 34.45 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.696 -0.684 . . . . 0.72 109.897 179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.051 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.56 103.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.973 0.415 . . . . 0.96 111.132 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.218 ' CA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -104.48 60.42 0.71 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.883 -0.599 . . . . 1.46 111.544 -179.754 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.166 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 59.12 -70.71 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 O-C-N 123.671 0.607 . . . . 2.42 112.445 179.042 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.0 m170 -87.31 -27.18 23.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.185 -0.461 . . . . 1.02 111.762 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.8 p -111.86 103.47 11.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.821 0.343 . . . . 0.68 111.424 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.051 HG13 HG22 ' A' ' 13' ' ' ILE . 86.9 t -102.07 95.73 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.8 111.038 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 78.3 m -80.96 142.52 33.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.248 -0.433 . . . . 0.35 111.636 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.731 ' HA ' HD22 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -154.85 164.77 38.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.43 -0.805 . . . . 0.52 112.009 -179.702 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.846 ' HB3' ' CD ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.47 176.14 10.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.107 -0.951 . . . . 1.84 109.302 178.448 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.5 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.8 p90 -158.01 -177.54 6.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.275 0.56 . . . . 0.4 112.303 -179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.28 178.65 4.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.147 -0.933 . . . . 0.83 110.65 179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.51 157.07 40.74 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.403 -0.362 . . . . 2.11 110.21 179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HG2' HG22 ' A' ' 28' ' ' THR . 37.1 Cg_exo -56.45 -157.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.506 2.138 . . . . 0.89 112.443 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -26.19 7.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 2.77 111.32 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -134.24 -67.73 0.57 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 111.856 0.317 . . . . 1.37 111.856 -179.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.551 HG22 ' HG2' ' A' ' 25' ' ' PRO . 2.8 p 65.31 34.63 8.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.839 0.352 . . . . 0.91 110.515 -179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.39 -95.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.53 -0.843 . . . . 1.01 111.813 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -147.65 28.85 1.46 Allowed Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.526 -1.029 . . . . 0.98 110.526 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.61 ' HE1' ' HB2' ' A' ' 82' ' ' ALA . 0.9 OUTLIER -107.01 179.18 4.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.193 -0.503 . . . . 0.87 111.591 -178.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -133.41 -0.41 3.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.66 -0.7 . . . . 2.26 111.706 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 35' ' ' SER . 2.9 mt 60.89 129.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.111 0 CA-C-O 120.932 0.396 . . . . 1.71 110.901 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -116.71 25.99 10.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.442 -0.345 . . . . 1.15 111.63 -179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.564 ' H ' HG22 ' A' ' 33' ' ' ILE . 1.7 m 172.09 164.64 0.11 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.732 0.301 . . . . 1.58 111.169 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.769 ' O ' HD12 ' A' ' 56' ' ' ILE . 40.7 m-85 -142.36 106.18 4.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.177 -0.465 . . . . 0.76 110.504 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -87.35 94.62 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.83 -0.623 . . . . 1.14 111.039 -179.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.3 p -86.42 114.58 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.148 0.499 . . . . 0.63 110.75 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 2.0 mm-40 -86.0 156.79 20.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.634 -0.712 . . . . 1.67 110.922 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.719 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -122.62 142.99 50.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 1.97 111.316 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -119.03 114.01 21.84 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.037 -0.529 . . . . 1.44 110.584 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.763 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -79.7 102.08 8.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.55 . . . . 1.59 110.492 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.618 HD12 ' HB1' ' A' ' 94' ' ' ALA . 46.8 mt -80.09 156.12 74.52 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.964 -0.562 . . . . 0.9 110.583 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.42 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 89.1 Cg_endo -86.26 28.64 9.63 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.88 -1.3 . . . . 1.43 113.489 0.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.3 -86.18 0.46 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.636 0.255 . . . . 2.66 110.555 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 117.43 170.69 15.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.456 -0.878 . . . . 1.12 113.208 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.763 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 1.0 OUTLIER 176.68 -35.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.956 0.407 . . . . 2.41 110.566 -179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.524 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 34.0 m95 62.92 81.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.948 -0.569 . . . . 0.65 111.406 179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -122.54 128.67 51.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.759 -0.655 . . . . 1.28 110.234 179.786 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -55.11 87.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 1.3 110.76 -179.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.719 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -51.4 -47.56 62.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 0.86 111.226 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' HB2' HD11 ' A' ' 56' ' ' ILE . 2.0 t30 -44.79 -79.2 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 2.01 110.983 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER 84.46 -43.12 0.08 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.181 0.437 . . . . 2.08 112.181 179.624 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.2 m -67.02 -86.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 1.89 111.28 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 140.13 1.05 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.847 0.356 . . . . 1.87 110.798 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.769 HD12 ' O ' ' A' ' 36' ' ' TYR . 51.4 mt -130.16 67.55 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 0.69 110.982 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.09 -65.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.18 -0.463 . . . . 1.6 110.751 179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -74.42 179.27 4.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.993 -0.549 . . . . 1.54 110.115 179.568 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 5.3 p-10 -93.7 13.24 22.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.398 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.846 ' CD ' ' HB3' ' A' ' 21' ' ' LYS . 16.1 tp10 -117.63 105.48 12.08 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.981 -0.377 . . . . 2.05 109.981 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.691 ' HB2' HG23 ' A' ' 56' ' ' ILE . 37.3 t80 -137.51 165.99 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.48 111.156 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.51 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 98.9 m -122.53 120.42 33.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.42 111.372 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 51' ' ' ALA . 5.5 t -83.17 85.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.865 -0.607 . . . . 1.08 111.029 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.7 t -86.98 -169.78 2.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.618 -0.719 . . . . 1.33 110.632 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 56.22 25.1 46.81 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.618 -0.801 . . . . 0.9 112.411 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.682 ' CD1' HG23 ' A' ' 18' ' ' VAL . 44.1 mt -77.63 -178.04 5.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.47 111.104 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 134.14 54.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.052 -0.522 . . . . 1.06 110.496 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.68 152.09 28.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 1.91 111.223 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 1.1 t70 66.73 60.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.959 -0.564 . . . . 1.87 110.985 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 178.13 130.84 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.49 111.359 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 128.63 36.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.335 -0.393 . . . . 0.36 110.194 179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.46 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 44.9 m-85 -124.21 124.92 43.51 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.846 0.684 . . . . 0.56 112.846 -178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.631 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 19.8 mt-10 -100.03 141.12 33.28 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.798 -0.815 . . . . 1.5 108.798 178.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.701 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -130.88 120.8 24.17 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.358 1.244 . . . . 0.6 114.358 -178.704 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.8 OUTLIER -105.47 169.85 8.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.746 -0.661 . . . . 2.11 109.778 178.493 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' CG ' ' A' ' 8' ' ' PRO . 61.2 t -125.54 105.28 14.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.428 0.899 . . . . 0.6 113.428 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.631 HD11 ' HG3' ' A' ' 88' ' ' PRO . 44.3 mt -100.59 130.57 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 106.934 -1.506 . . . . 0.7 106.934 177.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -156.91 147.74 21.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 119.452 -0.899 . . . . 0.6 113.046 -178.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.3 mttt -77.31 -167.54 0.93 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.445 -0.798 . . . . 1.98 110.345 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 31' ' ' PHE . 49.7 p30 -129.78 -119.5 0.23 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.475 -0.565 . . . . 2.19 109.475 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.02 1.14 5.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 119.49 1.041 . . . . 1.08 111.71 179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HB2' ' HE1' ' A' ' 31' ' ' PHE . . . -112.01 4.32 18.02 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 111.597 0.221 . . . . 1.06 111.597 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.84 -11.76 64.32 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.344 -0.932 . . . . 0.93 112.929 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.96 177.03 1.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.936 0.368 . . . . 1.38 110.394 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -130.88 101.31 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.79 111.989 -179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER -57.57 118.35 24.91 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 108.553 -0.906 . . . . 0.59 108.553 178.817 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 2.0 Cg_endo -42.8 171.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.896 2.397 . . . . 0.85 113.313 -178.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HG3' HD11 ' A' ' 77' ' ' ILE . 6.7 Cg_exo -71.3 130.73 17.9 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.778 2.318 . . . . 0.76 112.778 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 90' ' ' GLU . 0.5 OUTLIER -87.86 108.26 19.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.765 -0.652 . . . . 1.28 109.932 179.378 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -10.3 115.3 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.458 1.103 . . . . 1.77 113.401 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 89.2 Cg_exo -47.91 163.34 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.736 2.291 . . . . 0.55 114.217 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.38 151.99 19.95 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.05 -0.977 . . . . 1.23 109.48 179.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.57 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -32.33 140.36 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 124.3 1.0 . . . . 1.63 112.455 179.914 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.739 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -79.01 113.08 16.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.767 -0.651 . . . . 0.41 111.138 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 97' ' ' CYS . 5.3 mp -97.57 116.29 39.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.936 0.398 . . . . 0.44 110.828 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.6 m -46.17 -26.94 0.86 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.885 -0.598 . . . . 0.44 111.47 -179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 95' ' ' ILE . 34.2 m 47.34 78.49 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.571 -0.286 . . . . 1.1 111.273 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -121.87 -79.55 0.61 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.096 0.474 . . . . 3.0 110.99 179.999 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.03 ' OD1' ' HB ' ' A' ' 101' ' ' VAL . 3.3 p30 -122.66 26.33 8.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.52 -0.764 . . . . 2.14 110.451 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.218 ' OD1' ' CA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.98 24.1 0.82 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.002 -0.545 . . . . 2.06 111.225 -179.237 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.03 ' HB ' ' OD1' ' A' ' 99' ' ' ASP . 58.9 t -123.77 -13.96 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 2.8 111.435 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' OE1' ' CA ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.31 28.96 0.33 Allowed 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 120.841 0.353 . . . . 4.58 111.468 179.841 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.31 -0.853 . . . . 3.79 111.095 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.68 0.276 . . . . 2.74 111.148 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.62 110.26 1.4 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.687 2.258 . . . . 2.06 112.332 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.669 HD11 ' OD1' ' A' ' 80' ' ' ASN . 2.0 tt -81.47 147.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.305 -0.407 . . . . 0.68 111.064 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' ILE . 13.1 m-20 -136.77 133.48 18.9 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 2.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.67 174.95 9.91 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.665 2.243 . . . . 0.5 112.439 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 24.5 Cg_exo -63.97 -164.22 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.9 2.4 . . . . 0.71 113.175 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 23' ' ' ALA . . . -102.38 -151.89 24.0 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.675 -0.693 . . . . 0.66 112.852 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -88.24 125.24 64.58 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.056 -0.085 . . . . 1.52 110.791 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_exo -80.09 141.79 14.95 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.763 2.308 . . . . 0.44 112.314 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.23 116.11 4.7 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.077 -0.511 . . . . 1.09 111.463 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CG ' HD11 ' A' ' 95' ' ' ILE . 23.0 Cg_exo -62.0 104.22 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.577 2.185 . . . . 0.64 113.081 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.634 HD12 HG22 ' A' ' 19' ' ' THR . 0.3 OUTLIER -64.99 -35.05 79.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.48 0.657 . . . . 1.64 109.601 179.211 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.3 153.49 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.941 -1.027 . . . . 0.72 108.77 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.812 HG21 HG12 ' A' ' 95' ' ' ILE . 1.2 pt -144.88 108.5 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.704 -0.399 . . . . 0.96 111.882 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -101.48 59.89 0.89 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.106 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER 49.34 -75.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.951 0.782 . . . . 2.42 112.59 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.548 ' N ' ' O ' ' A' ' 14' ' ' THR . 31.8 m170 -82.27 -34.72 28.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.231 -0.441 . . . . 1.02 111.609 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 p -119.05 106.19 12.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.883 0.373 . . . . 0.68 110.923 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.921 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 10.3 m -104.57 154.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.8 111.163 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.634 HG22 HD12 ' A' ' 11' ' ' LEU . 3.4 m -123.07 123.63 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.35 111.259 -179.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -131.2 159.58 37.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.52 111.714 179.212 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HB2' HD11 ' A' ' 11' ' ' LEU . 2.0 tppt? -140.83 157.24 45.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.814 -1.085 . . . . 1.84 109.776 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 25.5 p90 -149.12 -176.1 5.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.294 0.568 . . . . 0.4 112.264 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -94.49 121.87 36.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.399 -0.819 . . . . 0.83 110.7 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 150.12 96.41 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 121.0 -0.28 . . . . 2.11 110.576 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HG2' HD11 ' A' ' 33' ' ' ILE . 77.6 Cg_exo -43.52 173.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.89 112.823 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -26.16 7.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.145 0.424 . . . . 2.77 112.145 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.4 t80 -124.45 -70.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.178 0.436 . . . . 1.37 112.178 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.537 HG21 HD11 ' A' ' 33' ' ' ILE . 20.0 p 56.04 55.01 7.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.713 0.292 . . . . 0.91 110.655 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.82 -93.07 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 CA-C-N 116.055 -0.521 . . . . 1.01 112.657 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.54 34.48 0.89 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.127 -1.589 . . . . 0.98 109.127 178.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.734 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.5 OUTLIER -113.63 142.99 45.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.275 -0.963 . . . . 0.87 111.54 -178.318 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' CD ' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -92.25 -8.18 46.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.112 -0.495 . . . . 2.26 111.459 179.606 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.653 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 71.47 -75.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 1.71 111.539 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.592 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.1 p 72.96 18.34 4.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.838 0.31 . . . . 1.15 111.838 179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.5 OUTLIER 179.85 145.8 0.21 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.073 0.463 . . . . 1.58 112.121 -179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.701 ' O ' HD12 ' A' ' 56' ' ' ILE . 89.6 m-85 -133.05 104.14 6.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.859 -0.61 . . . . 0.76 111.083 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD11 ' HD2' ' A' ' 79' ' ' LYS . 15.3 mt -78.66 93.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.395 -0.366 . . . . 1.14 110.463 179.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.5 p -91.08 106.76 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.63 111.384 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 50' ' ' LYS . 1.4 mm-40 -71.29 167.13 20.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.372 -0.831 . . . . 1.67 111.143 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.804 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -129.74 151.99 49.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.192 -0.458 . . . . 1.97 111.399 -179.716 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.3 ttm180 -138.49 104.61 5.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.739 -0.664 . . . . 1.44 109.904 179.413 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.772 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -71.35 105.84 3.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 1.59 111.027 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.647 HD23 ' HB1' ' A' ' 94' ' ' ALA . 0.9 OUTLIER -76.94 151.06 81.84 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.297 -0.411 . . . . 0.9 110.641 179.742 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -92.87 22.15 30.1 Favored 'Cis proline' 0 N--CA 1.458 -0.613 0 C-N-CA 123.987 -1.256 . . . . 1.43 112.576 0.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -148.64 75.07 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.448 -0.342 . . . . 2.66 111.274 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -131.67 177.46 18.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 1.12 112.415 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HG3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -116.69 -148.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 110.595 -0.15 . . . . 2.41 110.595 179.982 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CZ3' ' HB2' ' A' ' 41' ' ' ARG . 16.1 m95 -136.71 74.27 1.48 Allowed 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 120.996 0.427 . . . . 0.65 110.981 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.654 HD23 ' HG3' ' A' ' 47' ' ' ARG . 1.5 mm? -110.81 137.16 48.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.829 -0.623 . . . . 1.28 110.795 179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.474 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 14.9 ptmt -52.54 92.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.06 -0.518 . . . . 1.3 111.837 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.804 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -54.15 -49.11 70.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.456 0.646 . . . . 0.86 109.867 179.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.548 ' HB2' HD11 ' A' ' 56' ' ' ILE . 3.1 t30 -44.43 -75.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.1 -0.955 . . . . 2.01 110.822 179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.7 43.09 22.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.391 -0.368 . . . . 2.08 110.774 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 t -152.35 -71.5 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 1.89 111.119 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 179.24 143.78 0.14 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.888 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.701 HD12 ' O ' ' A' ' 36' ' ' TYR . 37.2 mt -149.14 64.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.69 110.975 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -46.22 -69.59 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 1.6 111.345 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.56 179.57 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.502 -0.317 . . . . 1.54 110.741 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.9 p-10 -86.53 10.62 14.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.298 -0.41 . . . . 1.75 111.699 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -107.98 104.32 13.74 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.551 -0.537 . . . . 2.05 109.551 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.594 ' HB2' HG23 ' A' ' 56' ' ' ILE . 43.6 t80 -131.13 164.27 25.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.391 0.615 . . . . 0.48 111.84 -179.087 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.674 HG23 ' O ' ' A' ' 18' ' ' VAL . 98.6 m -127.91 115.74 19.03 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.966 -1.016 . . . . 0.42 109.506 179.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.57 HG22 ' HE2' ' A' ' 61' ' ' PHE . 15.4 t -76.09 111.6 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.042 0.448 . . . . 1.08 111.701 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.03 140.23 39.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.637 -0.71 . . . . 1.33 110.706 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.86 -17.07 7.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.705 -0.76 . . . . 0.9 112.569 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.777 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -50.94 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.963 0.411 . . . . 1.47 111.042 179.951 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.4 m -142.43 154.69 44.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 1.06 110.568 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.97 143.74 47.52 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 1.91 110.937 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 67.43 54.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.083 -0.508 . . . . 1.87 111.418 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.53 124.66 0.7 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.746 0.307 . . . . 0.49 111.564 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -69.98 137.53 51.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.147 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 34.5 m-85 -131.78 118.83 20.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.291 0.848 . . . . 0.56 113.291 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.502 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.1 mm-40 -100.59 140.5 34.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.157 -0.683 . . . . 1.5 109.157 178.308 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.921 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 2.2 m-85 -123.06 106.72 11.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.419 1.266 . . . . 0.6 114.419 -178.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.636 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -76.08 151.81 36.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.643 -0.708 . . . . 2.11 110.292 178.602 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.2 t -125.42 118.3 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.092 0.473 . . . . 0.6 112.242 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 65.4 mt -124.69 163.91 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.849 -0.797 . . . . 0.7 108.849 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 77' ' ' ILE . . . -163.13 127.64 2.99 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.826 -0.749 . . . . 0.6 112.124 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HD2' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -87.44 24.4 1.66 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.622 0.601 . . . . 1.98 112.622 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.669 ' OD1' HD11 ' A' ' 2' ' ' ILE . 2.8 m120 44.4 -173.31 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.502 0.668 . . . . 2.19 112.643 179.017 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -63.7 -37.07 85.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.299 -0.864 . . . . 1.08 112.347 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.06 33.71 3.17 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.964 0.728 . . . . 1.06 112.964 -178.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' LYS . . . 65.24 9.89 44.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.255 -0.974 . . . . 0.93 113.37 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -66.4 103.17 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.177 -0.675 . . . . 1.38 109.177 179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -60.32 110.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.678 0.752 . . . . 0.79 112.579 -178.486 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 41.1 p -87.88 110.87 38.53 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.651 -1.159 . . . . 0.59 108.673 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -35.03 160.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.641 2.894 . . . . 0.85 113.609 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 24.1 Cg_exo -62.46 150.52 87.15 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.78 2.32 . . . . 0.76 112.8 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.0 m -120.88 108.9 14.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.587 -0.733 . . . . 1.28 109.8 179.41 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -6.0 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 124.534 1.146 . . . . 1.77 113.317 -179.665 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' CZ2' ' A' ' 48' ' ' TRP . 56.7 Cg_exo -50.4 135.63 39.69 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.508 2.139 . . . . 0.55 113.763 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -53.48 152.13 5.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.648 -0.871 . . . . 1.23 108.648 178.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -41.87 154.72 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 O-C-N 123.769 0.668 . . . . 1.63 110.616 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -85.41 114.16 22.25 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.658 -0.701 . . . . 0.41 110.03 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 13' ' ' ILE . 3.2 mp -92.94 113.15 27.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.93 -0.577 . . . . 0.44 111.084 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.6 m -51.13 -27.07 7.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.678 -179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.475 ' H ' HG22 ' A' ' 95' ' ' ILE . 76.6 m 53.22 84.82 0.05 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.1 110.539 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -97.38 0.4 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.547 -0.297 . . . . 3.0 111.499 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.878 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -93.21 0.67 57.17 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.651 0.241 . . . . 2.14 111.651 -179.779 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.418 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 1.4 p30 52.52 21.63 1.86 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 112.016 0.376 . . . . 2.06 112.016 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.878 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -119.5 -13.04 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 116.649 -0.25 . . . . 2.8 110.972 179.57 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -162.55 27.99 0.1 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.784 0.326 . . . . 4.58 111.221 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.213 -0.899 . . . . 3.79 111.082 179.9 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.437 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 120.748 0.309 . . . . 2.74 111.014 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 0' ' ' SER . 94.0 Cg_endo -90.11 66.3 1.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.934 2.422 . . . . 2.06 112.439 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.681 HD11 ' ND2' ' A' ' 80' ' ' ASN . 4.5 tt -52.28 149.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.68 110.844 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.267 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -134.62 127.65 18.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 2.0 110.596 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.62 154.62 31.05 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.405 2.07 . . . . 0.5 112.186 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 1.9 Cg_endo -45.68 176.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.897 2.398 . . . . 0.71 112.79 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.65 170.64 50.4 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.896 -0.668 . . . . 0.66 112.649 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.2 tttp -56.59 128.62 75.19 Favored Pre-proline 0 C--N 1.332 -0.184 0 N-CA-C 110.185 -0.302 . . . . 1.52 110.185 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HG3' HG12 ' A' ' 76' ' ' VAL . 6.2 Cg_exo -80.35 133.56 9.72 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.628 2.219 . . . . 0.44 112.109 -179.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 p -126.85 117.27 22.33 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 1.09 110.948 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' THR . 25.3 Cg_exo -63.03 93.05 0.15 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.479 2.119 . . . . 0.64 113.032 -179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 19' ' ' THR . 1.8 mt -52.85 -42.08 64.86 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.636 0.732 . . . . 1.64 109.14 179.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.44 151.69 51.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.626 -1.17 . . . . 0.72 108.456 178.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.672 HG21 HG12 ' A' ' 95' ' ' ILE . 2.3 pt -142.84 100.38 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.386 -0.525 . . . . 0.96 112.346 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.77 144.19 27.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 1.46 110.211 179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -47.63 -24.34 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.389 0.514 . . . . 2.42 112.389 -179.091 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.734 ' O ' HG23 ' A' ' 17' ' ' THR . 6.7 m-70 -130.37 30.76 4.69 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.904 -0.318 . . . . 1.02 111.633 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER 172.2 111.79 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.406 -0.361 . . . . 0.68 110.62 179.83 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 ' CD1' ' A' ' 66' ' ' LEU . 4.4 m -111.21 133.34 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.154 0.502 . . . . 0.8 110.375 179.357 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 3.2 m -102.99 111.47 23.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.169 -0.469 . . . . 0.35 111.996 -178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.807 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -120.17 143.53 48.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.631 0.729 . . . . 0.52 111.235 178.646 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' CE ' ' HB2' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -131.92 144.24 50.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.746 -1.116 . . . . 1.84 110.206 -179.756 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 27.4 p90 -129.15 -177.1 4.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.362 0.601 . . . . 0.4 112.304 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.14 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.506 -0.77 . . . . 0.83 111.162 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -84.4 140.09 38.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.885 -0.598 . . . . 2.11 110.251 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.7 Cg_endo -44.63 172.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.668 2.245 . . . . 0.89 112.236 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.55 -29.03 9.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.093 -0.503 . . . . 2.77 111.479 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 7.2 t80 -130.44 -69.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.877 0.325 . . . . 1.37 111.877 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 1.267 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.4 p 52.43 48.67 22.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.154 0.502 . . . . 0.91 110.495 -179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.51 -94.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.681 -0.691 . . . . 1.01 112.77 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.69 35.57 0.93 Allowed Glycine 0 N--CA 1.452 -0.277 0 N-CA-C 110.891 -0.884 . . . . 0.98 110.891 179.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -116.85 -172.16 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.276 -0.462 . . . . 0.87 111.152 -178.982 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.4 ptmt -147.23 26.24 1.08 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.953 -0.567 . . . . 2.26 111.476 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.891 HG22 ' H ' ' A' ' 35' ' ' SER . 1.5 mp 65.71 -71.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 1.71 110.676 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.594 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.68 -12.12 1.0 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.318 0.488 . . . . 1.15 112.318 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.891 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -169.72 102.63 0.32 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.56 0.219 . . . . 1.58 111.32 -179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.555 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 47.8 m-85 -80.0 147.96 31.34 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.205 -0.295 . . . . 0.76 110.205 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.481 HG22 ' CB ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -129.39 111.11 21.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.499 -0.319 . . . . 1.14 111.115 -179.642 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.4 t -91.41 99.14 9.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.69 0.281 . . . . 0.63 111.392 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -75.63 128.34 35.03 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.978 -0.378 . . . . 1.67 109.978 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -109.16 131.28 55.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.252 0.464 . . . . 1.97 112.252 -179.425 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -106.18 111.56 24.22 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.789 -1.189 . . . . 1.44 107.789 177.976 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' N ' ' HA3' ' A' ' 46' ' ' GLY . 0.3 OUTLIER -74.69 81.54 2.05 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.269 -0.878 . . . . 1.59 111.088 -179.034 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.771 HD21 ' HG3' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -53.54 155.87 5.0 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.825 -0.625 . . . . 0.9 110.694 179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 5.8 Cg_exo -79.13 1.64 33.22 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.027 -1.239 . . . . 1.43 113.029 0.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -104.5 -75.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.745 0.307 . . . . 2.66 110.881 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . 50.22 179.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.831 -0.7 . . . . 1.12 112.957 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.9 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -169.49 32.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.97 0.414 . . . . 2.41 110.905 179.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.541 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 65.5 m95 40.34 97.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.705 -0.68 . . . . 0.65 112.203 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -133.52 128.99 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.34 -0.391 . . . . 1.28 110.679 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' HG22 ' A' ' 37' ' ' ILE . 1.1 ptmm? -56.68 83.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 1.3 111.494 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.554 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -67.26 -38.86 85.81 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.88 0.371 . . . . 0.86 110.244 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HB2' HD11 ' A' ' 56' ' ' ILE . 14.2 p-10 -36.82 -44.42 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.515 -0.766 . . . . 2.01 111.71 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.13 43.47 2.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.115 -0.493 . . . . 2.08 111.785 179.344 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m -152.79 -175.45 5.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.991 0.424 . . . . 1.89 111.622 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -96.1 89.28 5.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.905 -0.589 . . . . 1.87 110.641 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.747 HD13 ' CG ' ' A' ' 61' ' ' PHE . 25.2 mt -85.43 75.53 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.69 111.251 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 57' ' ' LEU . 4.5 mt -58.0 -61.97 2.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 1.6 111.223 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.2 163.13 27.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.794 0.33 . . . . 1.54 110.27 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.506 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 20.2 p30 -80.5 2.7 24.25 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.281 -0.418 . . . . 1.75 111.675 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 21.1 tt0 -102.13 101.54 11.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.586 -0.524 . . . . 2.05 109.586 179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CG ' HD13 ' A' ' 56' ' ' ILE . 70.2 t80 -135.27 164.38 27.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.14 0.495 . . . . 0.48 111.506 -179.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.503 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 92.9 m -124.31 123.49 40.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.42 110.36 179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.704 HG23 HD21 ' A' ' 20' ' ' LEU . 6.7 t -79.94 94.53 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 116.063 -0.517 . . . . 1.08 110.49 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 84.6 p -86.61 -171.18 3.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.494 -0.775 . . . . 1.33 110.811 -179.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.82 9.75 53.45 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.449 -0.881 . . . . 0.9 112.525 -179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.061 ' CD1' HG13 ' A' ' 18' ' ' VAL . 13.8 mt -60.85 -179.34 0.13 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.827 0.313 . . . . 1.47 110.407 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -137.13 128.11 27.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.914 0.388 . . . . 1.06 110.809 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.17 155.5 13.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.007 -0.542 . . . . 1.91 111.133 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 97' ' ' CYS . 3.5 t70 53.37 46.07 27.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 1.87 110.959 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -159.58 118.71 2.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.402 -0.363 . . . . 0.49 111.371 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -70.29 133.64 47.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.36 110.114 179.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -129.92 126.44 37.89 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.605 0.595 . . . . 0.56 112.605 -178.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.771 ' HG3' HD21 ' A' ' 43' ' ' LEU . 1.9 mt-10 -102.85 143.36 32.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.143 -1.058 . . . . 1.5 108.143 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.999 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -136.69 115.93 12.58 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.16 1.541 . . . . 0.6 115.16 -178.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -99.36 169.22 9.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.171 -1.418 . . . . 2.11 107.171 176.778 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG13 ' HB3' ' A' ' 89' ' ' SER . 0.7 OUTLIER -134.75 112.54 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 118.867 -1.133 . . . . 0.6 113.323 -179.836 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.524 ' CG2' HD11 ' A' ' 85' ' ' ILE . 79.0 mt -102.73 145.13 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 107.227 -1.397 . . . . 0.7 107.227 177.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.78 119.88 2.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.72 -0.792 . . . . 0.6 111.898 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -59.07 -161.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.461 -0.496 . . . . 1.98 109.954 179.523 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.681 ' ND2' HD11 ' A' ' 2' ' ' ILE . 6.1 m-80 -150.91 165.72 32.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.249 0.547 . . . . 2.19 110.885 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.25 -29.57 0.14 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.282 -0.872 . . . . 1.08 112.656 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.14 25.54 11.67 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.36 2.2 53.7 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.623 -0.799 . . . . 0.93 113.294 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.615 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -64.63 102.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.088 0.444 . . . . 1.38 109.914 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -68.23 114.41 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 113.023 0.749 . . . . 0.79 113.023 -178.798 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.433 ' N ' HD12 ' A' ' 85' ' ' ILE . 14.2 p -78.94 115.0 48.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.29 -0.868 . . . . 0.59 109.927 179.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.11 155.85 2.63 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.16 1.907 . . . . 0.85 111.881 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.457 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 15.0 Cg_endo -58.69 126.85 22.45 Favored 'Trans proline' 0 CA--C 1.518 -0.289 0 C-N-CA 122.807 2.338 . . . . 0.76 113.443 -179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.52 ' HB3' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -78.64 132.46 37.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.92 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -22.42 107.34 0.12 Allowed Pre-proline 0 N--CA 1.476 0.825 0 O-C-N 124.168 0.917 . . . . 1.77 113.33 -179.414 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 86.8 Cg_exo -45.3 142.87 5.82 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.825 2.35 . . . . 0.55 113.26 -179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.485 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -79.48 150.38 31.24 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 109.758 -0.46 . . . . 1.23 109.758 179.029 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -37.16 151.2 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 O-C-N 124.143 0.902 . . . . 1.63 111.656 179.814 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -80.5 113.8 18.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 0.41 110.364 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.672 HG12 HG21 ' A' ' 13' ' ' ILE . 4.3 mp -96.6 112.77 29.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.917 0.389 . . . . 0.44 111.468 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 84.5 m -54.4 -36.13 63.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.074 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 61.0 93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.365 -0.38 . . . . 1.1 110.27 179.954 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -140.07 -84.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.418 . . . . 3.0 111.788 -179.625 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.532 ' CG ' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -108.16 -9.53 15.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.197 -0.456 . . . . 2.14 111.94 -179.631 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 54.22 27.92 8.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.768 0.318 . . . . 2.06 111.075 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.532 HG12 ' CG ' ' A' ' 99' ' ' ASP . 8.6 p -135.36 5.27 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 2.8 111.842 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.1 pp20? -156.84 -41.0 0.07 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 111.649 0.24 . . . . 4.58 111.649 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.205 -0.902 . . . . 3.79 111.23 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.537 0.208 . . . . 2.74 111.204 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -87.03 150.35 8.24 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.766 2.311 . . . . 2.06 111.887 179.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.501 HD11 ' ND2' ' A' ' 80' ' ' ASN . 9.0 tt -118.07 150.91 20.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.032 0.444 . . . . 0.68 111.475 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.443 ' N ' HG12 ' A' ' 2' ' ' ILE . 91.7 m-20 -129.82 132.63 24.28 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 2.0 110.548 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.59 171.12 16.2 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.494 2.129 . . . . 0.5 112.66 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 12.4 Cg_endo -55.7 171.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.043 2.495 . . . . 0.71 112.837 -179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -93.97 113.6 4.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 121.049 -0.596 . . . . 0.66 113.083 -179.763 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER 10.87 109.15 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.995 0 C-N-CA 124.572 1.149 . . . . 1.52 113.767 179.48 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.46 ' CG ' HG23 ' A' ' 76' ' ' VAL . 19.9 Cg_exo -68.8 139.08 42.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.787 2.325 . . . . 0.44 112.96 -179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.02 112.21 10.37 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.038 -0.528 . . . . 1.09 111.508 -179.573 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 20.9 Cg_exo -64.89 112.39 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.829 2.352 . . . . 0.64 113.696 -179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.72 -35.85 72.92 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 108.854 -0.795 . . . . 1.64 108.854 178.7 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.93 135.97 40.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.774 -1.103 . . . . 0.72 108.895 179.099 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.018 HG22 HG13 ' A' ' 18' ' ' VAL . 2.1 pt -134.27 70.61 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 112.269 0.47 . . . . 0.96 112.269 -178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 156.96 34.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.46 110.151 179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.69 -8.65 36.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.887 -0.325 . . . . 2.42 111.464 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.414 ' O ' HG23 ' A' ' 17' ' ' THR . 11.1 m-70 -128.88 18.2 6.16 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.507 0.194 . . . . 1.02 111.357 179.73 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER 177.23 124.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.806 0.336 . . . . 0.68 110.925 -179.849 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 HG22 ' A' ' 13' ' ' ILE . 23.1 t -114.28 113.81 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.8 111.104 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.839 ' C ' HD13 ' A' ' 20' ' ' LEU . 17.4 m -100.26 127.4 46.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.984 -0.553 . . . . 0.35 111.23 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -138.07 150.3 46.77 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.745 0.783 . . . . 0.52 111.976 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.087 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -132.52 147.36 52.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.425 -1.262 . . . . 1.84 109.337 179.596 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.523 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 8.3 p90 -132.47 -175.75 3.86 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.236 0.541 . . . . 0.4 112.375 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.85 177.31 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.332 -0.849 . . . . 0.83 111.329 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -98.16 139.4 21.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.625 -0.716 . . . . 2.11 110.25 179.733 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.816 ' HB2' HG23 ' A' ' 28' ' ' THR . 2.9 Cg_endo -47.52 178.47 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.89 112.039 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -113.15 -15.44 12.77 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 2.77 112.081 -179.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -139.15 -66.26 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.313 0.486 . . . . 1.37 112.313 -179.594 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.816 HG23 ' HB2' ' A' ' 25' ' ' PRO . 54.4 p 54.57 45.03 27.77 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.308 -0.405 . . . . 0.91 110.532 -179.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 44.46 -93.99 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.738 -0.744 . . . . 1.01 112.379 179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -149.68 42.19 0.8 Allowed Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.662 -1.375 . . . . 0.98 109.662 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -127.98 -177.32 4.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.997 -0.602 . . . . 0.87 111.298 -178.211 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.69 ' HD2' HG22 ' A' ' 34' ' ' THR . 0.5 OUTLIER -136.54 19.97 3.11 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.338 -0.392 . . . . 2.26 111.747 -179.456 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.059 HG23 ' HB1' ' A' ' 78' ' ' ALA . 3.5 mp 64.15 -74.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.693 0.282 . . . . 1.71 111.279 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.69 HG22 ' HD2' ' A' ' 32' ' ' LYS . 2.5 p 58.05 32.39 21.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 1.15 111.132 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.602 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t 170.72 110.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.58 110.845 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.661 ' O ' HD12 ' A' ' 56' ' ' ILE . 23.4 m-85 -111.75 87.8 2.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.971 0.415 . . . . 0.76 111.061 179.809 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.678 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -79.03 88.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.78 -0.645 . . . . 1.14 111.43 -179.927 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.27 127.58 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.8 -0.444 . . . . 0.63 109.8 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.9 143.73 28.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.812 -0.631 . . . . 1.67 111.563 -179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.683 ' HD3' HG11 ' A' ' 63' ' ' VAL . 3.5 mtmp? -98.35 148.38 23.73 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.267 -0.424 . . . . 1.97 110.871 179.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.6 OUTLIER -144.77 86.58 1.81 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.359 -0.382 . . . . 1.44 110.604 179.126 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.173 ' OD2' ' O ' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -48.51 150.02 1.47 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.125 -0.489 . . . . 1.59 110.725 179.236 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 42' ' ' ASP . 1.8 mm? -123.78 101.11 36.66 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.033 -0.667 . . . . 0.9 111.291 179.022 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 42' ' ' ASP . 6.3 Cg_endo -87.57 -136.56 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.053 -1.228 . . . . 1.43 110.212 -0.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.173 ' O ' ' OD2' ' A' ' 42' ' ' ASP . 0.2 OUTLIER 42.63 42.22 2.74 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.783 0.325 . . . . 2.66 111.441 179.708 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA3' ' N ' ' A' ' 42' ' ' ASP . . . -118.23 148.26 18.54 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.183 -1.008 . . . . 1.12 113.861 -179.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.818 ' HG2' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -147.91 122.17 9.6 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.432 -0.581 . . . . 2.41 109.432 179.44 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 40.9 m95 -43.81 94.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.65 111.149 -179.496 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.818 HD13 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -119.32 130.88 55.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.849 -0.614 . . . . 1.28 110.712 -179.866 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.678 ' HE3' HG21 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -68.67 69.57 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 1.3 110.819 179.938 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -47.74 -38.82 16.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.86 111.355 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.554 ' HB3' HD11 ' A' ' 56' ' ' ILE . 5.3 p-10 -51.28 -58.65 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 2.01 111.616 -179.574 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CB ' ' O ' ' A' ' 52' ' ' ASN . 0.4 OUTLIER 80.0 -51.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.585 0.231 . . . . 2.08 111.221 -179.547 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -169.93 0.19 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.806 0.336 . . . . 1.89 111.111 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.27 107.5 19.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 1.87 111.014 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.661 HD12 ' O ' ' A' ' 36' ' ' TYR . 24.0 mt -87.13 75.31 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.69 110.728 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 34' ' ' THR . 1.9 mt -52.52 -78.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.983 -0.553 . . . . 1.6 111.289 -179.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 175.97 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.677 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 51.1 p30 -94.1 21.89 6.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.889 -0.596 . . . . 1.75 111.157 -179.887 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.087 ' OE2' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -125.43 109.49 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.35 -0.386 . . . . 2.05 110.196 179.731 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CG ' HD13 ' A' ' 56' ' ' ILE . 64.5 t80 -136.45 164.61 27.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.178 0.513 . . . . 0.48 111.669 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.515 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 95.9 m -127.26 117.37 22.14 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.612 -0.722 . . . . 0.42 110.783 179.61 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HD3' ' A' ' 40' ' ' LYS . 6.6 t -82.05 118.77 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 1.08 111.158 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -173.42 2.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 1.33 110.89 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.54 28.36 73.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.639 -0.791 . . . . 0.9 112.281 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' CD1' HG23 ' A' ' 18' ' ' VAL . 7.3 mt -82.04 174.25 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.153 0.502 . . . . 1.47 111.318 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.9 m -125.38 99.25 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.69 -0.686 . . . . 1.06 110.224 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' HG2' ' N ' ' A' ' 69' ' ' ASP . 42.9 tt0 -43.74 148.13 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 1.91 111.728 -179.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 35.0 t0 75.41 65.48 0.06 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.87 111.059 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 69' ' ' ASP . . . 171.49 127.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.49 111.006 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.55 136.3 54.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.068 -0.345 . . . . 0.36 110.068 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 37.3 m-85 -133.31 121.95 23.14 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.293 0.849 . . . . 0.56 113.293 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 11.8 mt-10 -102.58 131.96 48.98 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.391 -0.596 . . . . 1.5 109.391 178.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.63 ' HE2' HD13 ' A' ' 95' ' ' ILE . 0.6 OUTLIER -124.87 118.99 27.55 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.673 0.99 . . . . 0.6 113.673 -178.77 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' NH1' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -94.67 144.73 25.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 2.11 110.381 178.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 5' ' ' PRO . 86.8 t -98.23 115.82 39.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.357 -0.537 . . . . 0.6 110.845 179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 78' ' ' ALA . 2.3 mt -110.29 167.87 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.542 -0.911 . . . . 0.7 108.542 179.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 1.059 ' HB1' HG23 ' A' ' 33' ' ' ILE . . . -159.14 -174.41 4.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.412 -0.588 . . . . 0.6 109.412 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 14.4 mttt -117.32 -77.75 0.57 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.157 0.503 . . . . 1.98 110.535 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HD11 ' A' ' 2' ' ' ILE . 1.0 OUTLIER 125.79 140.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.196 1.798 . . . . 2.19 109.93 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -32.75 -44.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.217 0.821 . . . . 1.08 113.217 179.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.665 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -107.75 49.53 0.8 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.489 0.552 . . . . 1.06 112.489 -179.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 43.56 40.93 5.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.662 -0.78 . . . . 0.93 113.314 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.465 ' HB3' ' CB ' ' A' ' 80' ' ' ASN . . . -89.1 24.46 2.12 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.554 0.216 . . . . 1.38 111.227 179.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.655 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.2 tp 18.5 112.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 115.373 1.62 . . . . 0.79 115.373 -179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.671 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -85.64 111.81 40.07 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.66 -0.867 . . . . 0.59 108.66 177.957 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 28.6 Cg_endo -60.98 167.26 9.16 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.209 1.94 . . . . 0.85 112.523 -179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HB3' ' CD ' ' A' ' 75' ' ' ARG . 9.7 Cg_endo -53.8 136.31 65.32 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.052 2.501 . . . . 0.76 113.269 -179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.34 112.71 24.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.966 -0.561 . . . . 1.28 110.794 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 5.96 100.18 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 125.019 1.328 . . . . 1.77 114.435 179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 82.7 Cg_exo -46.29 145.8 5.4 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.8 2.333 . . . . 0.55 113.358 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -78.19 143.9 36.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.074 -0.713 . . . . 1.23 109.074 179.068 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -30.93 148.96 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.298 0.999 . . . . 1.63 112.016 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.71 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -81.75 103.82 11.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.347 -0.388 . . . . 0.41 110.794 -179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.63 HD13 ' HE2' ' A' ' 74' ' ' PHE . 5.3 mp -83.86 116.01 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.537 -179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 98' ' ' ARG . 48.2 m -56.21 -30.41 62.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.943 0.401 . . . . 0.44 110.425 179.62 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.431 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.9 OUTLIER 53.62 61.31 3.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 1.1 111.148 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.509 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -101.73 -77.21 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.04 0.448 . . . . 3.0 110.309 179.895 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.059 ' OD2' ' HB3' ' A' ' 102' ' ' GLU . 2.2 p-10 -126.08 -0.13 7.17 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.616 -0.72 . . . . 2.14 111.244 179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.5 p30 46.85 26.03 0.52 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.108 0.48 . . . . 2.06 112.167 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.2 p -170.35 30.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.595 -0.729 . . . . 2.8 110.28 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.059 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -123.18 -30.6 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.702 -0.681 . . . . 4.58 111.613 -179.843 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 3.79 111.106 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.44 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.619 0.247 . . . . 2.74 111.163 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.664 ' O ' HG22 ' A' ' 2' ' ' ILE . 5.6 Cg_exo -78.77 -38.18 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.808 2.339 . . . . 2.06 112.131 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 1' ' ' PRO . 9.9 tt 53.64 138.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 123.952 0.783 . . . . 0.68 112.803 -179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.343 ' OD2' ' CB ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -133.57 120.71 15.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.711 . . . . 2.0 110.853 179.693 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.41 170.44 20.28 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.202 1.935 . . . . 0.5 112.398 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.527 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 7.1 Cg_endo -54.48 -171.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.754 2.303 . . . . 0.71 113.21 -179.404 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.07 166.64 22.37 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.867 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.6 tptm -49.03 122.72 11.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 110.059 -0.348 . . . . 1.52 110.059 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.488 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.5 Cg_exo -77.41 128.77 9.81 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.242 1.961 . . . . 0.44 112.401 -179.55 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.624 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -120.12 112.85 34.43 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.063 -0.517 . . . . 1.09 111.1 -179.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 24.3 Cg_exo -60.59 124.74 15.67 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.142 1.894 . . . . 0.64 113.223 -179.62 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.635 HD11 ' CB ' ' A' ' 21' ' ' LYS . 1.4 mp -89.76 -29.42 18.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.83 -0.623 . . . . 1.64 109.809 179.118 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.421 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -152.45 110.14 3.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.476 -0.783 . . . . 0.72 110.226 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.731 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.8 131.74 66.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.394 0.616 . . . . 0.96 112.151 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -119.55 157.53 28.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.309 -0.86 . . . . 1.46 110.125 179.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.48 -9.07 16.15 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.325 0.491 . . . . 2.42 112.325 -179.637 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.718 ' O ' HG23 ' A' ' 17' ' ' THR . 1.5 m-70 -135.38 17.47 3.39 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.793 0.294 . . . . 1.02 111.793 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.832 ' N ' HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER 171.31 117.32 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.509 -0.182 . . . . 0.68 110.509 -179.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.076 ' CG1' HD11 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -104.14 165.0 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 120.592 -0.443 . . . . 0.8 111.64 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.659 ' C ' HD13 ' A' ' 20' ' ' LEU . 22.6 m -140.87 123.9 16.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.48 -0.327 . . . . 0.35 111.251 -179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.778 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -136.55 159.56 41.43 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.664 0.745 . . . . 0.52 112.007 179.225 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.635 ' CB ' HD11 ' A' ' 11' ' ' LEU . 24.0 tptp -139.1 136.36 35.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.407 -1.27 . . . . 1.84 109.803 179.722 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 24.0 p90 -123.35 -177.93 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.281 0.562 . . . . 0.4 112.336 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.93 161.08 16.84 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.201 -0.909 . . . . 0.83 111.042 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -90.06 135.96 29.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.297 -0.411 . . . . 2.11 110.715 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HG3' HD11 ' A' ' 33' ' ' ILE . 11.5 Cg_endo -56.12 171.77 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.455 2.103 . . . . 0.89 112.005 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.29 -50.88 1.19 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.658 0.265 . . . . 2.77 111.208 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.343 ' CB ' ' OD2' ' A' ' 3' ' ' ASP . 1.2 t80 -98.92 71.09 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 1.37 111.74 -179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 66.8 p -94.27 48.72 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.91 110.131 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.02 -94.92 0.01 OUTLIER Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.967 -0.561 . . . . 1.01 112.344 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -142.55 33.94 1.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.936 -0.865 . . . . 0.98 110.936 179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.58 ' HE1' ' HB3' ' A' ' 82' ' ' ALA . 0.4 OUTLIER -118.66 175.76 5.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.253 -0.473 . . . . 0.87 111.299 -178.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.73 3.88 3.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.068 -0.514 . . . . 2.26 111.505 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.513 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.1 mt 59.75 144.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 120.96 0.409 . . . . 1.71 111.864 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.7 p -129.51 -5.11 4.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.946 -0.57 . . . . 1.15 112.258 -179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.27 143.86 3.68 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 111.919 0.34 . . . . 1.58 111.919 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 33' ' ' ILE . 33.7 m-85 -116.3 113.1 22.5 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.76 110.269 179.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' A' ' 50' ' ' LYS . 2.7 mt -92.12 119.59 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.799 0.333 . . . . 1.14 110.987 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.29 93.51 3.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.442 0.534 . . . . 0.63 112.442 -179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.97 ' OE1' ' CA ' ' A' ' 49' ' ' LEU . 4.9 mm-40 -72.93 146.33 46.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.147 -0.686 . . . . 1.67 109.147 178.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.727 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.35 141.62 51.96 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.215 0.531 . . . . 1.97 112.025 -179.414 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.7 ttm180 -104.64 106.55 17.1 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.389 -0.823 . . . . 1.44 109.464 179.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.052 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -71.84 91.89 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.475 -0.784 . . . . 1.59 111.071 -179.379 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.55 HD12 ' HB1' ' A' ' 94' ' ' ALA . 13.7 mt -75.96 146.0 78.45 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.112 -0.495 . . . . 0.9 110.328 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -89.78 27.85 15.27 Favored 'Cis proline' 0 C--N 1.347 0.467 0 C-N-CA 123.801 -1.333 . . . . 1.43 112.88 0.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -88.73 -73.97 0.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.761 0.315 . . . . 2.66 111.169 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' HA2' ' CG ' ' A' ' 41' ' ' ARG . . . 100.27 152.58 26.54 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.624 -0.798 . . . . 1.12 112.778 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.052 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 170.91 -31.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.735 0.303 . . . . 2.41 111.181 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.908 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 61.4 m95 58.62 75.33 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.405 -0.361 . . . . 0.65 111.375 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.97 ' CA ' ' OE1' ' A' ' 39' ' ' GLU . 1.2 mm? -117.42 130.91 56.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.204 -0.453 . . . . 1.28 110.341 179.643 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.541 ' CB ' HG22 ' A' ' 37' ' ' ILE . 5.2 ptmm? -52.69 97.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.926 -179.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.727 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -58.94 -41.05 86.46 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.194 -0.669 . . . . 0.86 109.194 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 10.1 t30 -58.56 164.35 2.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.061 -0.972 . . . . 2.01 110.405 179.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.37 31.91 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.165 -0.471 . . . . 2.08 110.801 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.1 37.24 0.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 1.89 110.91 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 61.57 153.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.101 -0.499 . . . . 1.87 110.757 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.677 HD13 ' CG ' ' A' ' 61' ' ' PHE . 47.9 mt -147.23 60.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.69 110.44 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.409 ' O ' ' CE2' ' A' ' 36' ' ' TYR . 2.3 tm? -46.03 -50.66 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.811 -0.631 . . . . 1.6 111.841 -179.549 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -87.23 160.19 18.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.985 0.422 . . . . 1.54 111.048 -179.656 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.3 m-20 -76.27 -1.15 25.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.89 -0.596 . . . . 1.75 111.694 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.865 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -102.54 103.92 14.29 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.745 -0.465 . . . . 2.05 109.745 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.677 ' CG ' HD13 ' A' ' 56' ' ' ILE . 43.6 t80 -140.22 166.4 24.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.124 0.488 . . . . 0.48 111.9 -178.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 18' ' ' VAL . 95.4 m -117.23 119.42 35.14 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.48 -0.782 . . . . 0.42 110.797 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 51' ' ' ALA . 19.8 t -82.12 99.31 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.204 0.526 . . . . 1.08 111.297 -179.639 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 1.1 p -81.56 -157.6 0.19 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.533 -0.758 . . . . 1.33 111.207 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.418 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 54.03 45.54 71.77 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.727 -0.749 . . . . 0.9 112.154 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 18' ' ' VAL . 9.8 mt -87.61 -176.85 5.71 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.167 0.508 . . . . 1.47 111.205 -179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -153.36 115.04 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.717 . . . . 1.06 110.332 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 132.83 30.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.952 0.406 . . . . 1.91 111.236 -179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.33 60.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.991 -0.55 . . . . 1.87 111.089 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' ' HE2' ' A' ' 72' ' ' TYR . . . -169.92 119.12 0.61 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.49 111.652 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.3 125.97 28.67 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.631 -0.507 . . . . 0.36 109.631 179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 55.0 m-85 -121.95 122.18 38.78 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.4 0.518 . . . . 0.56 112.4 -178.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' OE1' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -101.18 131.95 46.9 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.312 -0.996 . . . . 1.5 108.312 178.386 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.95 ' CE2' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -112.2 109.69 19.53 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.157 1.54 . . . . 0.6 115.157 -177.849 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 ttp180 -97.72 124.54 42.1 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.681 -1.6 . . . . 2.11 106.681 177.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -105.87 119.64 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 119.103 -1.039 . . . . 0.6 113.716 -178.476 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' A' ' 88' ' ' PRO . 80.8 mt -101.41 163.78 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.537 -1.653 . . . . 0.7 106.537 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 77' ' ' ILE . . . -174.32 123.15 0.3 Allowed 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.022 -1.071 . . . . 0.6 112.755 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 85' ' ' ILE . 21.9 mttt -60.8 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.002 -0.74 . . . . 1.98 109.002 178.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' A' ' 2' ' ' ILE . 36.3 m-20 -138.38 -101.95 0.18 Allowed 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 120.514 -0.474 . . . . 2.19 111.387 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -132.32 -41.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 1.08 111.598 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . . . -101.97 40.96 1.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 1.06 111.962 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.91 9.6 53.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.579 -0.82 . . . . 0.93 113.154 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.81 87.3 4.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.84 0.352 . . . . 1.38 110.322 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.712 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -58.76 111.36 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.79 111.682 -179.378 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -73.57 119.05 73.94 Favored Pre-proline 0 C--O 1.238 0.454 0 N-CA-C 109.454 -0.573 . . . . 0.59 109.454 179.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 1.8 Cg_endo -43.4 166.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.677 2.251 . . . . 0.85 112.461 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.607 ' HG3' HD11 ' A' ' 77' ' ' ILE . 23.9 Cg_exo -64.36 149.21 90.54 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.676 2.251 . . . . 0.76 112.571 -179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.596 ' HB2' HG13 ' A' ' 76' ' ' VAL . 5.8 m -103.12 125.4 49.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.533 -0.758 . . . . 1.28 109.263 179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 62.9 mt-10 -22.07 117.45 0.15 Allowed Pre-proline 0 N--CA 1.478 0.968 0 O-C-N 124.094 0.871 . . . . 1.77 112.793 -179.185 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' PHE . 66.1 Cg_exo -45.27 165.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.981 2.454 . . . . 0.55 114.513 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 74' ' ' PHE . 0.4 OUTLIER -100.82 146.36 27.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.339 -1.3 . . . . 1.23 109.166 178.764 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.761 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -37.09 130.66 0.83 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.864 0.728 . . . . 1.63 111.644 179.891 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.636 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -65.92 101.33 0.65 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.879 -0.6 . . . . 0.41 110.854 -179.702 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.827 HD13 ' CZ ' ' A' ' 74' ' ' PHE . 4.8 mp -82.22 113.55 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.462 179.8 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.1 m -51.64 -28.06 13.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.44 111.159 -179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.468 ' H ' HG22 ' A' ' 95' ' ' ILE . 60.7 m 55.24 76.07 0.28 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.505 -0.316 . . . . 1.1 110.841 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -134.43 -87.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 3.0 111.073 -179.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.976 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -103.14 -3.06 26.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.199 -0.455 . . . . 2.14 111.356 179.709 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.7 p30 49.72 25.75 1.61 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.888 0.375 . . . . 2.06 111.415 -179.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.976 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 11.9 t -116.65 -22.76 4.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.947 -0.57 . . . . 2.8 110.643 179.393 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -117.31 -15.05 10.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 4.58 111.295 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.223 -0.894 . . . . 3.79 111.096 -179.972 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.453 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.653 0.263 . . . . 2.74 111.131 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 7.9 Cg_exo -72.22 137.12 28.07 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.864 2.376 . . . . 2.06 111.675 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.501 HD12 ' ND2' ' A' ' 80' ' ' ASN . 0.7 OUTLIER -115.2 124.46 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.68 111.685 -179.737 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.927 ' OD1' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -114.06 135.56 22.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.769 -0.65 . . . . 2.0 109.937 179.395 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -85.36 174.04 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.672 2.248 . . . . 0.5 113.101 -179.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.68 174.6 1.13 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.119 2.546 . . . . 0.71 113.462 -179.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.08 169.67 42.37 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.297 -0.865 . . . . 0.66 112.627 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 65.4 tttt -58.57 127.28 81.68 Favored Pre-proline 0 C--N 1.329 -0.283 0 N-CA-C 110.581 -0.155 . . . . 1.52 110.581 179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.0 Cg_exo -76.79 149.38 29.56 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.502 2.135 . . . . 0.44 113.078 -179.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.8 p -144.16 113.4 5.27 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.284 -0.871 . . . . 1.09 110.015 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.7 Cg_exo -49.0 94.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.283 1.989 . . . . 0.64 113.553 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -57.66 -27.73 63.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.268 -0.878 . . . . 1.64 110.135 179.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.61 ' C ' HD13 ' A' ' 13' ' ' ILE . 1.8 t30 -161.41 161.33 30.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.569 -0.741 . . . . 0.72 109.91 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.771 ' CG2' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -150.84 115.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.001 0.429 . . . . 0.96 111.301 179.731 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -104.48 47.62 0.87 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.793 -0.64 . . . . 1.46 110.79 -179.908 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' CG ' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.81 -70.63 0.02 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.746 -0.661 . . . . 2.42 111.516 179.473 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.503 ' N ' ' O ' ' A' ' 14' ' ' THR . 1.5 m-70 -82.79 -22.98 34.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.204 -0.453 . . . . 1.02 111.289 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.16 102.9 7.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.578 -0.283 . . . . 0.68 111.224 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.982 HG11 ' CE2' ' A' ' 74' ' ' PHE . 77.5 t -93.66 120.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.043 0.449 . . . . 0.8 110.816 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.625 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -98.6 126.42 44.17 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.767 -0.651 . . . . 0.35 111.346 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -130.47 139.88 50.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.948 0.88 . . . . 0.52 111.69 178.437 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -116.97 172.78 7.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.192 -1.367 . . . . 1.84 109.317 179.681 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.52 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 46.0 p90 -168.34 165.51 12.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.126 -0.63 . . . . 0.4 112.503 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 156.07 23.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.963 -1.017 . . . . 0.83 110.685 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -87.98 156.46 52.17 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.725 -0.472 . . . . 2.11 109.725 179.469 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CG ' ' CG2' ' A' ' 28' ' ' THR . 9.5 Cg_endo -53.15 -170.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.371 2.048 . . . . 0.89 111.954 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.53 13.21 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.883 0.327 . . . . 2.77 111.883 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.768 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 3.6 t80 -168.91 -68.11 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 112.572 0.582 . . . . 1.37 112.572 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.927 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 52.0 p 53.8 38.81 29.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.003 0.43 . . . . 0.91 110.074 -178.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 42.64 -125.15 4.25 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.852 -0.613 . . . . 1.01 112.175 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.45 4.38 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.451 -1.859 . . . . 0.98 108.451 178.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.608 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.6 m-85 -112.99 -165.78 1.02 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 113.888 -1.156 . . . . 0.87 111.607 -178.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' C ' HD12 ' A' ' 33' ' ' ILE . 1.1 pttt -163.84 38.4 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.971 -0.559 . . . . 2.26 112.084 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.799 HG21 ' CE1' ' A' ' 36' ' ' TYR . 3.8 mp 66.29 -61.88 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.94 0.719 . . . . 1.71 112.94 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 80' ' ' ASN . 2.4 p 83.08 -38.19 0.09 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 123.631 0.772 . . . . 1.15 111.856 -178.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -167.61 140.08 3.23 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.832 0.348 . . . . 1.58 111.406 -179.565 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.799 ' CE1' HG21 ' A' ' 33' ' ' ILE . 52.7 m-85 -99.6 139.94 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.76 110.218 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER -129.97 98.1 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.671 -0.24 . . . . 1.14 111.05 -179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -91.69 126.7 44.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.133 0.492 . . . . 0.63 110.862 179.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -93.37 152.28 19.23 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.532 -0.758 . . . . 1.67 110.675 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.766 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 6.4 ptpt -116.14 144.14 44.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 1.97 111.521 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 1.1 ttt180 -119.38 104.86 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.78 -0.645 . . . . 1.44 109.979 179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.72 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.65 89.1 2.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.741 -0.663 . . . . 1.59 110.556 -179.863 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -67.09 144.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.69 -0.686 . . . . 0.9 110.895 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -95.24 27.92 17.96 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.052 -1.229 . . . . 1.43 112.807 0.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -134.68 42.6 2.81 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 2.66 111.368 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -95.13 150.66 19.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.56 -0.828 . . . . 1.12 112.224 179.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' CD ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -131.45 29.0 4.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.389 . . . . 2.41 110.935 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 77.9 m95 51.36 100.26 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.999 -0.546 . . . . 0.65 111.133 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 ' CD ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -127.67 141.84 51.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.967 -0.561 . . . . 1.28 110.558 179.951 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 49.5 mtpt -49.36 91.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.358 -0.383 . . . . 1.3 110.95 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -65.26 -48.21 74.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.86 110.754 179.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.8 p-10 -74.28 114.61 12.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.95 -0.568 . . . . 2.01 110.746 179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.54 30.34 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.288 -0.414 . . . . 2.08 110.913 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -138.02 21.2 2.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 1.89 111.352 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.15 144.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.866 0.365 . . . . 1.87 111.174 179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.584 HD11 ' CB ' ' A' ' 52' ' ' ASN . 26.0 mt -134.87 112.74 15.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.082 -0.508 . . . . 0.69 111.009 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -94.58 -47.75 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.756 0.312 . . . . 1.6 110.862 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.57 157.66 18.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.891 -0.411 . . . . 1.54 109.891 179.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -73.53 -3.76 29.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.417 -0.356 . . . . 1.75 111.521 -179.924 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 tt0 -97.76 96.15 8.04 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.421 -0.585 . . . . 2.05 109.421 179.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' CG ' HD13 ' A' ' 56' ' ' ILE . 72.3 t80 -121.68 163.86 18.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 0.48 111.57 -178.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.475 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 59.9 m -132.19 112.67 12.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.529 -0.759 . . . . 0.42 111.06 179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.648 HG13 ' HB1' ' A' ' 51' ' ' ALA . 4.6 t -74.73 113.43 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.939 -0.573 . . . . 1.08 110.872 179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.96 136.49 44.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.705 -0.679 . . . . 1.33 111.012 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.3 9.16 6.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.866 -0.683 . . . . 0.9 112.714 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.584 ' HG ' HG23 ' A' ' 18' ' ' VAL . 4.5 mm? -51.19 -177.6 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.05 0.452 . . . . 1.47 110.954 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.439 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 58.9 m -143.7 96.7 2.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.704 -0.68 . . . . 1.06 110.0 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 2.3 tt0 -40.56 139.17 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.526 . . . . 1.91 111.839 -179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.553 ' HB3' ' O ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER 75.57 33.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.913 -0.585 . . . . 1.87 110.902 -179.885 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.37 136.34 13.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.358 -0.383 . . . . 0.49 111.212 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -80.89 132.13 35.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.286 -0.415 . . . . 0.36 110.701 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.439 ' OH ' ' HB ' ' A' ' 67' ' ' THR . 46.9 m-85 -127.31 130.67 49.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.56 111.94 -179.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 3.7 mt-10 -104.65 148.81 26.14 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.596 -0.52 . . . . 1.5 109.596 178.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.982 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.19 116.08 10.87 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.821 1.415 . . . . 0.6 114.821 -179.264 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.728 ' O ' HG23 ' A' ' 38' ' ' VAL . 4.8 ptp180 -109.99 178.65 4.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.455 -0.943 . . . . 2.11 108.455 177.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -153.66 133.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 122.678 1.228 . . . . 0.6 114.198 179.15 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -115.17 152.72 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 112.599 -2.092 . . . . 0.7 106.964 178.273 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -160.26 147.56 16.17 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.229 -0.989 . . . . 0.6 112.146 -179.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' HG2' HD12 ' A' ' 85' ' ' ILE . 13.0 mmtp -68.81 -138.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.847 -0.615 . . . . 1.98 110.442 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -156.08 -66.2 0.11 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.843 0.83 . . . . 2.19 111.513 -179.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . 179.52 -38.56 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.351 -0.84 . . . . 1.08 110.879 179.269 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.69 -4.01 57.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 1.06 112.192 -179.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.83 -16.2 40.07 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.317 -0.944 . . . . 0.93 112.506 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -68.18 149.99 48.87 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.797 -0.446 . . . . 1.38 109.797 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.1 tp -102.41 112.21 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.381 0.511 . . . . 0.79 112.381 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.1 p -68.33 123.73 88.17 Favored Pre-proline 0 C--O 1.239 0.513 0 CA-C-N 115.794 -0.639 . . . . 0.59 109.936 179.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -38.57 162.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.26 2.64 . . . . 0.85 113.394 -179.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' N ' HG23 ' A' ' 77' ' ' ILE . 21.0 Cg_exo -67.95 170.84 13.41 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.227 2.618 . . . . 0.76 112.927 -179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -128.4 127.32 42.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.363 -0.835 . . . . 1.28 109.474 179.173 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.48 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 3.2 tt0 -27.06 129.58 0.19 Allowed Pre-proline 0 N--CA 1.474 0.752 0 O-C-N 123.89 0.743 . . . . 1.77 112.597 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 25.0 Cg_exo -62.33 169.84 7.43 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.385 2.057 . . . . 0.55 113.765 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.427 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.34 136.62 38.24 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.754 -1.112 . . . . 1.23 109.042 179.109 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -37.68 135.34 0.62 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 124.006 0.817 . . . . 1.63 111.584 -179.748 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.776 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -63.07 132.33 51.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.768 -0.651 . . . . 0.41 111.415 -179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.4 mp -118.39 119.73 62.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.332 -0.395 . . . . 0.44 110.917 179.501 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m -48.07 -30.01 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.927 -0.579 . . . . 0.44 111.173 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.618 ' H ' HG22 ' A' ' 95' ' ' ILE . 15.4 m 55.45 36.79 27.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 1.1 111.032 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -93.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 3.0 110.941 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 41.3 p30 -106.3 23.99 13.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 2.14 110.547 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 15' ' ' ARG . 49.3 t0 63.68 12.7 6.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.991 -0.55 . . . . 2.06 111.966 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.44 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.0 OUTLIER -107.18 -23.72 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.912 -0.403 . . . . 2.8 109.912 179.118 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.883 ' OE2' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 37.69 96.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.745 -0.661 . . . . 4.58 112.013 179.759 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.228 -0.892 . . . . 3.79 111.193 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.1 m . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.745 0.307 . . . . 2.74 111.295 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.491 ' HD2' ' CE1' ' A' ' 27' ' ' TYR . 84.8 Cg_endo -86.29 137.98 5.41 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.895 2.396 . . . . 2.06 112.341 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.702 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.4 tt -106.04 145.94 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.68 111.278 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.907 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -126.34 133.16 24.69 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 2.0 110.055 179.451 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 94.4 Cg_endo -77.89 172.0 16.35 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.353 2.035 . . . . 0.5 112.655 -179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.535 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.7 Cg_endo -59.64 148.89 85.68 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 123.078 2.519 . . . . 0.71 112.623 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.64 161.81 4.45 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.615 -0.802 . . . . 0.66 112.092 179.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -58.01 132.67 83.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.982 -0.377 . . . . 1.52 109.982 179.757 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.487 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 2.7 Cg_exo -79.26 127.91 7.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.493 2.129 . . . . 0.44 112.812 -179.409 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.21 110.38 30.9 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.863 -0.608 . . . . 1.09 110.379 179.709 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.659 ' HG2' HD11 ' A' ' 95' ' ' ILE . 33.6 Cg_exo -56.42 102.57 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.122 1.881 . . . . 0.64 113.599 -179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.265 HD11 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -66.82 -31.05 71.42 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.02 -0.733 . . . . 1.64 109.02 178.674 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.436 ' C ' HD13 ' A' ' 13' ' ' ILE . 3.3 t30 -150.33 161.65 42.05 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.098 -0.956 . . . . 0.72 110.161 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.703 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -151.79 86.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.286 0.565 . . . . 0.96 110.228 179.593 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.4 OUTLIER -77.7 64.15 2.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.365 -0.834 . . . . 1.46 112.427 -179.1 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.473 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER 19.84 47.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.447 0.906 . . . . 2.42 113.447 179.281 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.759 ' C ' HD23 ' A' ' 66' ' ' LEU . 0.4 OUTLIER 165.31 -28.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.582 -0.736 . . . . 1.02 110.395 179.239 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.96 89.5 3.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.68 109.713 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.954 HG11 ' CE2' ' A' ' 74' ' ' PHE . 75.3 t -78.68 114.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.023 -0.535 . . . . 0.8 110.046 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 HD12 ' A' ' 11' ' ' LEU . 6.1 m -96.68 109.22 21.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.35 112.527 -178.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.791 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -118.1 145.79 44.6 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.569 0.699 . . . . 0.52 111.463 178.81 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.445 ' HB2' ' CD ' ' A' ' 60' ' ' GLU . 7.3 tptp -134.07 143.39 48.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.733 -1.121 . . . . 1.84 109.508 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 13.6 p90 -132.68 -177.04 4.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.239 0.542 . . . . 0.4 111.983 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.59 -173.93 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.475 -0.784 . . . . 0.83 111.109 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -114.62 131.69 23.25 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.017 -0.538 . . . . 2.11 110.727 179.929 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' CB ' HG23 ' A' ' 28' ' ' THR . 3.0 Cg_exo -35.84 157.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.487 2.791 . . . . 0.89 112.809 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -97.29 -15.57 20.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.028 -0.533 . . . . 2.77 111.63 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.799 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.8 t80 -134.52 -72.01 0.49 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.324 0.49 . . . . 1.37 112.324 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.907 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 4.4 p 50.44 57.55 6.48 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.91 110.49 -179.148 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 41.84 -93.68 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.748 -0.66 . . . . 1.01 112.52 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -155.25 32.8 0.65 Allowed Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.376 -1.09 . . . . 0.98 110.376 179.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CG ' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -108.98 -167.68 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.867 -0.667 . . . . 0.87 111.649 -178.561 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 34' ' ' THR . 29.5 ttpt -144.04 20.44 1.77 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.607 -0.724 . . . . 2.26 111.581 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.873 HG22 ' H ' ' A' ' 35' ' ' SER . 1.6 mp 62.82 -77.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.623 0.249 . . . . 1.71 111.037 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.6 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.3 p 80.08 -7.9 1.59 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.607 0.595 . . . . 1.15 112.607 179.299 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -161.94 117.96 2.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.401 0.519 . . . . 1.58 112.401 -179.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.514 ' CE1' HG21 ' A' ' 33' ' ' ILE . 61.1 m-85 -103.7 146.22 28.91 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.32 -0.4 . . . . 0.76 110.414 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.454 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -137.11 107.47 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.553 -0.294 . . . . 1.14 110.219 179.875 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.45 117.72 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.423 0.63 . . . . 0.63 111.387 -179.747 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' OE1' ' N ' ' A' ' 50' ' ' LYS . 3.0 mm-40 -85.95 159.78 19.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.247 -0.888 . . . . 1.67 110.57 179.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 3.0 mtmp? -120.99 154.04 36.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.513 0.673 . . . . 1.97 111.804 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 10.5 ttm180 -128.67 96.2 4.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.223 -1.029 . . . . 1.44 108.223 177.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -69.73 83.83 0.45 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.109 -0.951 . . . . 1.59 110.053 -179.149 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 ' HG3' ' A' ' 73' ' ' GLU . 19.1 mt -59.45 150.87 63.08 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.736 -179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.03 3.19 37.28 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.713 -1.37 . . . . 1.43 113.207 0.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.82 -89.15 0.22 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.116 -0.234 . . . . 2.66 111.019 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.89 158.38 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.818 -0.706 . . . . 1.12 113.036 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.612 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -156.57 24.42 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 2.41 110.988 179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.542 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 31.7 m95 53.8 83.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.422 . . . . 0.65 111.423 179.649 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.612 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -123.33 124.27 42.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.756 0.313 . . . . 1.28 110.667 179.855 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HB3' HG22 ' A' ' 37' ' ' ILE . 15.5 ptmt -54.27 95.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 1.3 111.033 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG3' ' A' ' 40' ' ' LYS . . . -65.75 -35.47 80.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.109 0.48 . . . . 0.86 110.281 179.517 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.507 ' CG ' HD11 ' A' ' 56' ' ' ILE . 1.8 t30 -66.09 120.58 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.624 -0.716 . . . . 2.01 110.546 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.1 23.7 14.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.072 -0.513 . . . . 2.08 110.501 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.25 130.4 22.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.949 -0.568 . . . . 1.89 110.6 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.15 114.49 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 1.87 111.861 -179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.683 HD13 ' CG ' ' A' ' 61' ' ' PHE . 55.2 mt -96.04 88.29 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.827 -0.624 . . . . 0.69 110.426 179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.77 -64.87 0.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.48 -0.327 . . . . 1.6 111.198 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.08 165.91 12.62 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.435 -0.348 . . . . 1.54 110.418 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.54 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.4 p30 -90.47 15.5 10.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.194 -0.457 . . . . 1.75 111.357 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.445 ' CD ' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tp10 -116.42 95.65 5.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.696 -0.483 . . . . 2.05 109.696 179.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.683 ' CG ' HD13 ' A' ' 56' ' ' ILE . 93.6 t80 -118.14 162.85 17.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.299 0.571 . . . . 0.48 112.091 -179.144 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 97.5 m -135.01 108.77 8.02 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.294 -0.866 . . . . 0.42 110.397 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.671 HG11 ' HD3' ' A' ' 40' ' ' LYS . 38.6 t -68.34 105.8 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.689 -0.687 . . . . 1.08 111.052 -179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 t -100.92 164.3 11.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.058 -0.519 . . . . 1.33 110.754 179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.11 28.53 68.19 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.098 -0.801 . . . . 0.9 111.098 -179.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.88 HD22 HG23 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -84.31 155.84 22.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.425 -0.388 . . . . 1.47 110.344 -179.521 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.614 ' N ' HD12 ' A' ' 66' ' ' LEU . 2.5 m -91.7 127.17 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.921 0.391 . . . . 1.06 111.482 -179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HA ' ' SG ' ' A' ' 97' ' ' CYS . 2.2 tt0 -76.95 163.32 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.208 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.81 43.21 5.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.832 -0.622 . . . . 1.87 111.002 179.69 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.41 122.99 1.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.009 -0.541 . . . . 0.49 110.736 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.72 116.55 12.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.008 0.432 . . . . 0.36 110.772 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 42.5 m-85 -110.05 132.48 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.824 -0.626 . . . . 0.56 112.139 -179.357 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' HG3' HD11 ' A' ' 43' ' ' LEU . 6.9 mt-10 -102.08 134.28 45.57 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.193 -1.04 . . . . 1.5 108.193 177.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -128.82 118.92 23.56 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.215 1.561 . . . . 0.6 115.215 -178.588 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.542 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -108.01 -175.27 2.73 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.832 -1.173 . . . . 2.11 107.832 177.232 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -155.99 125.86 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.233 -0.987 . . . . 0.6 113.213 179.09 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 86' ' ' SER . 20.2 mt -103.33 150.3 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 113.644 -1.616 . . . . 0.7 107.9 178.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -160.35 120.99 2.95 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.025 -1.07 . . . . 0.6 113.254 -179.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 19.0 mttp -66.6 -176.07 0.44 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.98 109.994 178.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.786 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.1 p30 -135.0 169.11 17.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.829 -0.623 . . . . 2.19 110.599 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -42.79 -27.46 0.18 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.693 -0.685 . . . . 1.08 112.155 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -89.88 -16.97 28.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.798 0.666 . . . . 1.06 112.798 -179.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.27 -23.07 27.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.297 -0.954 . . . . 0.93 112.128 -179.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.786 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -55.05 115.43 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.999 -0.371 . . . . 1.38 109.999 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -72.62 110.22 5.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.578 0.584 . . . . 0.79 112.578 -179.061 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.478 ' O ' HG23 ' A' ' 77' ' ' ILE . 7.7 p -65.86 116.4 32.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.59 110.087 179.251 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -36.78 157.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.888 2.392 . . . . 0.85 112.844 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 31.7 Cg_endo -64.28 121.56 9.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.753 2.302 . . . . 0.76 113.34 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.501 ' OG ' HG13 ' A' ' 76' ' ' VAL . 7.8 p -71.38 132.9 45.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.843 -0.617 . . . . 1.28 109.62 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 46.0 mt-10 -28.89 125.7 0.25 Allowed Pre-proline 0 N--CA 1.474 0.756 0 O-C-N 123.868 0.73 . . . . 1.77 112.625 -179.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 63.0 Cg_exo -54.12 174.15 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.541 2.161 . . . . 0.55 113.822 -179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -106.38 142.18 36.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.767 -1.106 . . . . 1.23 109.927 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.5 t0 -38.83 136.12 0.79 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.872 0.733 . . . . 1.63 111.051 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -68.28 103.34 1.57 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.487 -0.324 . . . . 0.41 111.479 -179.353 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.8 mp -88.41 115.15 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.437 -0.347 . . . . 0.44 110.751 179.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' NH1' ' A' ' 98' ' ' ARG . 99.0 m -49.02 -35.94 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.44 111.408 -179.705 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.416 ' SG ' HD11 ' A' ' 66' ' ' LEU . 51.6 t 61.59 95.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.197 -0.297 . . . . 1.1 110.197 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HD2' ' HG3' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -147.22 -86.54 0.1 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.271 0.471 . . . . 3.0 112.271 -179.26 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.955 ' O ' HG12 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -104.56 7.09 35.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.192 0.441 . . . . 2.14 112.192 -179.308 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.413 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 43.09 27.72 0.12 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.484 0.549 . . . . 2.06 112.484 179.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.955 HG12 ' O ' ' A' ' 99' ' ' ASP . 6.2 p -158.32 25.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.356 0.598 . . . . 2.8 111.061 -179.743 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.614 ' HG2' ' CG ' ' A' ' 99' ' ' ASP . 21.6 pt-20 -159.93 -44.53 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.87 -0.605 . . . . 4.58 110.9 179.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.212 -0.899 . . . . 3.79 111.146 179.958 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.616 0.246 . . . . 2.74 111.115 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.3 158.11 41.19 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.872 2.381 . . . . 2.06 112.264 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.883 HD11 ' OD1' ' A' ' 80' ' ' ASN . 2.6 tt -141.2 147.12 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.037 -0.529 . . . . 0.68 110.923 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 2' ' ' ILE . 17.4 m-20 -136.89 121.85 12.76 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.357 -0.383 . . . . 2.0 111.138 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.87 169.46 17.7 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.307 2.005 . . . . 0.5 111.716 179.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 10.7 Cg_endo -53.74 162.98 3.17 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.655 2.237 . . . . 0.71 112.542 -179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.69 170.74 27.37 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.934 -0.651 . . . . 0.66 112.66 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -55.93 127.19 68.19 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.639 -0.134 . . . . 1.52 110.639 179.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 6.1 Cg_exo -76.0 128.81 10.98 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.119 1.879 . . . . 0.44 112.199 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.63 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.8 p -130.5 110.19 16.22 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.216 -0.447 . . . . 1.09 111.462 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.0 Cg_exo -58.24 103.28 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.48 2.12 . . . . 0.64 113.476 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.618 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -65.35 -29.68 70.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.356 0.598 . . . . 1.64 109.629 178.945 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' C ' HD13 ' A' ' 13' ' ' ILE . 2.6 t30 -150.79 154.01 36.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.27 -0.877 . . . . 0.72 109.22 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.057 HG22 HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -144.03 114.2 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.039 0.447 . . . . 0.96 112.018 -179.621 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' OD2' ' A' ' 100' ' ' ASP . 0.7 OUTLIER -100.22 156.29 17.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.713 -0.676 . . . . 1.46 110.268 179.64 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -56.9 -23.24 43.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.349 -0.387 . . . . 2.42 110.995 -179.721 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.469 ' O ' HG23 ' A' ' 17' ' ' THR . 75.9 m-70 -140.12 26.5 2.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.371 -0.377 . . . . 1.02 111.117 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -170.43 97.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.68 111.147 179.849 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.057 HG13 HG22 ' A' ' 13' ' ' ILE . 89.4 t -94.77 129.11 45.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.051 0.453 . . . . 0.8 110.964 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.658 ' C ' HD13 ' A' ' 20' ' ' LEU . 6.9 m -106.0 125.92 51.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.681 -0.69 . . . . 0.35 111.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.827 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.87 153.19 49.6 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.808 0.813 . . . . 0.52 111.895 179.424 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -128.35 -174.54 3.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.254 -1.339 . . . . 1.84 109.871 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.506 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 48.5 p90 179.98 160.24 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.981 0.42 . . . . 0.4 111.687 179.724 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.53 146.13 45.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.706 -0.679 . . . . 0.83 111.319 -179.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -82.39 139.76 44.92 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 2.11 110.573 179.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.763 ' HG2' HD11 ' A' ' 33' ' ' ILE . 93.9 Cg_exo -43.69 163.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.381 2.054 . . . . 0.89 112.066 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -121.55 -38.51 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.482 . . . . 2.77 111.282 -179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.93 -70.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.896 -0.321 . . . . 1.37 111.476 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 25' ' ' PRO . 21.1 p 46.75 41.3 10.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.215 0.531 . . . . 0.91 110.568 -179.598 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 46.9 -97.3 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.488 -0.778 . . . . 1.01 112.506 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -145.75 60.71 0.48 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 110.739 -0.944 . . . . 0.98 110.739 179.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 5.2 m-85 -130.45 -172.28 2.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.19 0.519 . . . . 0.87 112.023 -178.451 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.66 14.69 1.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.482 -0.781 . . . . 2.26 111.647 179.432 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.763 HD11 ' HG2' ' A' ' 25' ' ' PRO . 17.5 mt 56.61 153.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.401 0.62 . . . . 1.71 112.538 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 33' ' ' ILE . 2.9 p -127.98 55.74 1.63 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.273 -0.876 . . . . 1.15 110.566 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 34' ' ' THR . 0.2 OUTLIER 87.18 154.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.565 -0.743 . . . . 1.58 110.485 -179.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 82.0 m-85 -105.99 156.64 18.18 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.277 0.561 . . . . 0.76 111.921 -179.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.487 HG22 ' H ' ' A' ' 38' ' ' VAL . 4.1 mt -121.69 168.0 14.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.299 -0.864 . . . . 1.14 109.563 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 74' ' ' PHE . 4.7 t -146.03 99.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 111.982 0.364 . . . . 0.63 111.982 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 6.3 mt-10 -77.26 126.85 31.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.154 0.502 . . . . 1.67 110.27 179.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 51' ' ' ALA . 2.5 mmtp -94.2 131.37 39.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.29 -0.868 . . . . 1.97 112.63 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 4.1 ttm180 -111.07 105.32 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.784 -0.45 . . . . 1.44 109.784 178.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.299 ' OD2' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.43 94.14 3.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.996 -0.547 . . . . 1.59 111.191 -179.611 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 94' ' ' ALA . 12.9 mt -79.23 153.34 76.88 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.99 -0.55 . . . . 0.9 110.557 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.18 29.74 7.34 Favored 'Cis proline' 0 C--N 1.346 0.407 0 C-N-CA 124.123 -1.199 . . . . 1.43 113.149 0.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -100.8 -85.31 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.61 0.243 . . . . 2.66 111.312 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 127.89 162.78 11.18 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.663 -0.78 . . . . 1.12 112.78 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.299 ' HG2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 173.7 -32.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 2.41 111.522 179.887 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 40.6 m95 48.87 75.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.667 -0.242 . . . . 0.65 110.517 -179.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.03 137.57 52.81 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.896 0.379 . . . . 1.28 111.809 -179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 16.8 ptmt -65.26 85.75 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.125 -179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.76 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -58.64 -37.64 76.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.86 111.179 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 4.8 t30 -47.26 -67.03 0.31 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.294 -0.412 . . . . 2.01 110.546 179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 49.37 35.19 7.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.425 -0.352 . . . . 2.08 111.181 179.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 t -139.8 -78.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.275 -0.421 . . . . 1.89 111.014 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.403 ' ND2' ' OG ' ' A' ' 35' ' ' SER . 0.2 OUTLIER -179.22 142.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 1.87 111.027 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 HG23 ' HB2' ' A' ' 61' ' ' PHE . 3.5 mt -144.98 74.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.69 111.016 -179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 57' ' ' LEU . 1.1 mt -68.16 -37.1 80.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 1.6 111.157 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.1 pt-20 -100.68 167.19 10.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 1.54 110.597 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.2 OUTLIER -77.0 -9.94 59.03 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.101 -0.499 . . . . 1.75 111.613 -179.739 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HG3' ' HG2' ' A' ' 21' ' ' LYS . 4.9 tt0 -96.3 102.43 14.22 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 120.833 0.349 . . . . 2.05 110.296 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.726 ' HB2' HG23 ' A' ' 56' ' ' ILE . 57.9 t80 -136.57 163.37 30.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.107 -0.497 . . . . 0.48 111.677 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.491 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 75.7 m -126.05 119.55 27.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.851 -0.613 . . . . 0.42 111.252 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.76 HG13 ' HB3' ' A' ' 51' ' ' ALA . 12.1 t -83.88 102.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.869 -0.605 . . . . 1.08 111.009 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -102.38 168.15 9.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.937 -0.574 . . . . 1.33 111.012 -179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.25 12.04 52.77 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.787 -0.72 . . . . 0.9 112.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER -86.55 -174.1 4.83 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.778 0.289 . . . . 1.47 110.835 179.947 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.441 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 2.0 m -128.31 154.69 45.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 1.06 111.099 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 3.2 tm-20 -77.42 158.19 30.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 1.91 110.93 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.3 t70 56.54 59.98 3.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 1.87 110.943 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.32 123.5 0.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.49 111.144 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.48 129.79 39.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.04 0.448 . . . . 0.36 110.453 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 51.5 m-85 -126.77 129.51 48.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.56 112.075 -179.142 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 3.5 mt-10 -107.78 144.99 34.16 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.814 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.73 119.43 14.09 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.543 1.312 . . . . 0.6 114.543 -178.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.85 146.59 26.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.466 -0.333 . . . . 2.11 110.366 178.434 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 89' ' ' SER . 57.1 t -93.98 119.54 42.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.166 0.508 . . . . 0.6 110.935 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 87' ' ' PRO . 1.1 mt -118.99 144.39 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.271 -1.011 . . . . 0.7 108.271 179.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -178.57 142.52 0.23 Allowed 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.6 111.959 -179.599 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.601 ' HE3' HD12 ' A' ' 85' ' ' ILE . 12.5 mttp -77.35 -178.64 5.26 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.152 -0.619 . . . . 1.98 109.677 179.015 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.883 ' OD1' HD11 ' A' ' 2' ' ' ILE . 4.4 m120 -112.69 -86.93 0.56 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.921 -0.581 . . . . 2.19 110.3 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -155.19 -42.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.491 0.552 . . . . 1.08 112.491 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.64 46.14 0.98 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.658 0.614 . . . . 1.06 112.658 -178.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.14 -2.02 62.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.163 -1.017 . . . . 0.93 113.288 179.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.821 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -77.05 105.47 8.15 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.039 -0.726 . . . . 1.38 109.039 179.369 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.625 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tt -97.31 111.0 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.548 0.944 . . . . 0.79 113.548 -178.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.75 111.38 6.8 Favored Pre-proline 0 C--O 1.237 0.4 0 N-CA-C 106.411 -1.7 . . . . 0.59 106.411 177.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.769 ' HB2' ' HD3' ' A' ' 88' ' ' PRO . 73.0 Cg_endo -66.39 -99.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 121.814 1.676 . . . . 0.85 113.843 -177.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 87' ' ' PRO . 72.5 Cg_endo -106.73 134.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.374 1.906 0 CA-C-N 124.815 2.755 . . . . 0.76 114.168 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.471 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 29.3 m -109.22 88.51 2.75 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.254 -0.43 . . . . 1.28 110.181 178.585 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 18.88 100.53 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.541 1.136 . . . . 1.77 113.973 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 53.0 Cg_exo -51.17 145.72 25.39 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.479 2.119 . . . . 0.55 113.616 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 8' ' ' PRO . 75.2 m -73.49 141.21 46.79 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.23 109.274 178.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.7 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -39.73 144.94 0.15 Allowed 'General case' 0 CA--C 1.519 -0.247 0 O-C-N 124.035 0.834 . . . . 1.63 110.865 179.462 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.659 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -71.15 110.78 6.02 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.551 -0.46 . . . . 0.41 110.491 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.949 HG12 HG21 ' A' ' 13' ' ' ILE . 4.9 mp -92.55 109.87 22.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.007 0.432 . . . . 0.44 111.333 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 33.8 m -45.43 -32.94 2.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.708 -179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 99.5 m 52.53 59.3 4.59 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.949 0.404 . . . . 1.1 110.379 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.817 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -90.47 -75.65 0.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.912 -0.586 . . . . 3.0 112.463 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.817 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 4.0 p-10 -119.75 30.56 6.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.121 -0.49 . . . . 2.14 111.754 -179.004 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 15' ' ' ARG . 53.0 t0 44.39 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.076 0.465 . . . . 2.06 111.835 -179.448 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 99' ' ' ASP . 11.1 p -162.23 27.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.998 -0.546 . . . . 2.8 110.417 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -42.3 139.04 1.54 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.991 -0.549 . . . . 4.58 111.48 -179.83 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -0.894 . . . . 3.79 111.096 -179.954 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.802 0.334 . . . . 2.74 111.313 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -89.6 75.08 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.182 2.588 . . . . 2.06 112.363 -179.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.677 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.3 tt -67.1 147.27 12.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.096 -0.502 . . . . 0.68 110.754 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -125.81 133.23 24.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 2.0 110.636 179.858 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -82.0 160.7 18.3 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.28 1.987 . . . . 0.5 112.097 179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.0 176.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.665 2.243 . . . . 0.71 113.067 -179.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.78 171.44 53.56 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.557 -0.747 . . . . 0.66 112.882 -179.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -63.52 118.29 42.86 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 110.19 -0.3 . . . . 1.52 110.19 179.585 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 31.5 Cg_exo -64.74 135.49 45.2 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.067 . . . . 0.44 112.801 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.45 103.65 11.31 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.036 -0.529 . . . . 1.09 111.693 -179.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 33.1 Cg_exo -48.7 117.69 2.88 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.055 1.836 . . . . 0.64 112.366 179.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.956 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -75.5 -32.72 60.64 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.1 -0.704 . . . . 1.64 109.1 178.86 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -148.81 157.48 43.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.878 -1.055 . . . . 0.72 108.914 179.43 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.856 HG22 ' HB ' ' A' ' 18' ' ' VAL . 1.9 pt -140.34 97.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.513 . . . . 0.96 111.437 -179.646 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -87.13 48.09 1.6 Allowed 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 115.635 -0.711 . . . . 1.46 112.279 -179.259 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.85 -75.24 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.678 0.621 . . . . 2.42 112.678 178.698 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.2 m-70 -71.93 -27.8 63.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.459 -0.337 . . . . 1.02 111.614 -179.39 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.6 p -139.48 121.97 16.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.465 -0.334 . . . . 0.68 110.309 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.974 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 16.8 m -109.45 135.57 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.486 0.66 . . . . 0.8 112.168 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.732 HG22 HD12 ' A' ' 11' ' ' LEU . 18.9 m -93.6 140.19 29.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.68 -0.691 . . . . 0.35 109.942 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.92 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.96 152.54 38.8 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.657 0.598 . . . . 0.52 112.251 -179.854 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.435 ' CG ' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -140.94 145.41 36.02 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.127 -0.942 . . . . 1.84 110.438 179.825 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 20.3 p90 -140.03 -176.91 4.76 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.058 0.456 . . . . 0.4 111.864 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.45 165.97 12.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.523 -0.762 . . . . 0.83 110.705 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.24 147.07 32.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 120.682 0.277 . . . . 2.11 110.801 -179.991 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' CB ' HG23 ' A' ' 28' ' ' THR . 1.9 Cg_endo -42.77 167.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.032 2.488 . . . . 0.89 112.047 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.58 -28.47 8.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 2.77 111.759 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -123.15 -69.62 0.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 1.37 111.312 -179.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.595 HG23 ' CB ' ' A' ' 25' ' ' PRO . 13.7 p 51.14 53.04 13.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.91 111.007 -179.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.14 -92.26 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.789 -0.72 . . . . 1.01 112.31 179.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.96 32.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.776 -0.93 . . . . 0.98 110.776 179.379 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.788 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -120.1 -179.2 3.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.22 -0.49 . . . . 0.87 111.509 -178.787 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 11.36 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.728 -0.669 . . . . 2.26 111.398 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.762 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.6 mp 60.09 145.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.064 0.459 . . . . 1.71 110.897 -179.747 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.4 p -126.68 5.61 6.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.922 -0.581 . . . . 1.15 111.277 179.861 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.58 123.14 0.64 Allowed 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 120.746 0.308 . . . . 1.58 110.987 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.762 ' CE1' HG21 ' A' ' 33' ' ' ILE . 22.3 m-85 -100.88 92.4 5.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.76 110.575 179.561 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.482 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 5.8 mm -69.69 138.23 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.463 -0.335 . . . . 1.14 111.0 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.93 101.19 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.45 -0.341 . . . . 0.63 111.677 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' OE2' ' HA ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -77.46 138.69 39.39 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.914 -0.772 . . . . 1.67 108.914 178.815 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -121.1 135.23 55.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.015 0.436 . . . . 1.97 111.64 -179.45 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 20.0 ttm180 -114.17 113.28 24.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.605 -0.725 . . . . 1.44 110.455 179.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.16 112.98 11.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.902 -0.59 . . . . 1.59 110.502 179.946 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 41' ' ' ARG . 2.2 mm? -80.39 149.22 68.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.476 -0.329 . . . . 0.9 110.975 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.55 17.21 41.12 Favored 'Cis proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.885 -1.298 . . . . 1.43 112.66 0.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -151.08 93.16 1.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 2.66 111.372 -179.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -144.07 -165.52 10.96 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.838 -0.696 . . . . 1.12 112.138 179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.43 148.38 33.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.931 0.396 . . . . 2.41 110.842 179.894 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 50.6 m95 -68.88 97.56 0.85 Allowed 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.678 -0.692 . . . . 0.65 110.907 -179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -128.37 126.42 40.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.604 179.919 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 10.2 ptmm? -58.32 87.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.871 -179.754 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.449 ' CB ' ' HG2' ' A' ' 40' ' ' LYS . . . -74.29 -35.23 63.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.953 0.406 . . . . 0.86 110.373 179.794 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 56' ' ' ILE . 11.4 p-10 -44.28 -47.75 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.849 -0.614 . . . . 2.01 111.386 179.85 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 41.27 30.03 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 2.08 111.982 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -118.81 -161.34 0.84 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.44 -0.345 . . . . 1.89 110.711 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.85 61.86 0.62 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.935 -179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.875 HD12 ' CG ' ' A' ' 61' ' ' PHE . 2.4 mm -57.95 95.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.449 -0.341 . . . . 0.69 110.131 179.747 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -120.21 -8.03 9.74 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.017 0.377 . . . . 1.6 112.017 -179.536 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -110.28 9.14 23.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.157 0.428 . . . . 1.54 112.157 -179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 13.0 p30 53.05 21.26 2.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.98 0.419 . . . . 1.75 111.59 -179.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.435 ' OE1' ' CG ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -130.85 78.67 1.85 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.679 -1.23 . . . . 2.05 107.679 178.902 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.875 ' CG ' HD12 ' A' ' 56' ' ' ILE . 82.3 t80 -120.03 164.63 15.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.519 0.676 . . . . 0.48 112.378 -178.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 18' ' ' VAL . 48.8 m -124.43 120.86 33.28 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.765 -1.107 . . . . 0.42 109.972 178.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.92 HG23 HD11 ' A' ' 20' ' ' LEU . 21.3 t -76.26 100.76 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.962 -0.563 . . . . 1.08 111.307 -179.521 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.23 137.13 32.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.243 -0.89 . . . . 1.33 110.44 179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.14 -17.41 4.33 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.787 -0.72 . . . . 0.9 111.945 -179.602 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.92 HD23 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -52.05 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.676 0.274 . . . . 1.47 110.311 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.2 m -148.03 141.81 25.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.481 -0.327 . . . . 1.06 110.563 -179.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 3.0 tt0 -57.49 139.26 53.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.298 -0.41 . . . . 1.91 110.967 -179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.885 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 67.86 61.0 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 1.87 111.06 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.29 120.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.37 -0.377 . . . . 0.49 111.443 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.74 135.56 51.46 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.159 -0.682 . . . . 0.36 109.159 179.078 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 33.1 m-85 -129.94 115.87 17.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.258 0.836 . . . . 0.56 113.258 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.792 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 7.8 mt-10 -99.27 134.18 42.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.917 -1.142 . . . . 1.5 107.917 178.087 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.974 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.42 118.34 14.24 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.901 1.074 . . . . 0.6 113.901 -179.066 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' HG3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.46 172.98 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.028 -1.101 . . . . 2.11 108.028 177.945 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -138.78 116.22 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.927 . . . . 0.6 112.176 179.446 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 86' ' ' SER . 69.6 mt -99.2 142.15 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.784 -1.191 . . . . 0.7 107.784 178.3 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -148.91 116.08 6.09 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 119.433 -0.907 . . . . 0.6 112.729 -179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.696 ' HG2' HD12 ' A' ' 85' ' ' ILE . 8.6 mtpt -63.28 -167.66 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.638 -0.505 . . . . 1.98 109.638 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.761 HD21 ' HB3' ' A' ' 84' ' ' ALA . 22.5 p30 -143.95 169.86 17.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.267 0.556 . . . . 2.19 111.684 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.01 -30.18 0.99 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.315 -0.857 . . . . 1.08 111.941 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.788 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -81.85 -22.55 36.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.848 0.314 . . . . 1.06 111.848 -179.48 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.67 -21.54 18.66 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.368 -0.92 . . . . 0.93 111.935 -179.51 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -52.22 161.03 0.68 Allowed 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 110.087 -0.338 . . . . 1.38 110.087 179.581 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.696 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -112.56 109.76 29.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.247 0.462 . . . . 0.79 112.247 -179.596 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.581 ' O ' HG23 ' A' ' 77' ' ' ILE . 16.0 p -66.88 115.87 29.5 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 109.167 -0.679 . . . . 0.59 109.167 179.009 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -38.87 159.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.672 2.248 . . . . 0.85 112.812 -179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' CG ' ' NH1' ' A' ' 75' ' ' ARG . 28.4 Cg_endo -64.75 124.4 13.12 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.704 2.269 . . . . 0.76 112.976 -179.665 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.456 ' HB2' HG13 ' A' ' 76' ' ' VAL . 45.6 m -76.76 115.64 16.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 1.28 109.636 179.062 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -12.19 118.44 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 124.588 1.155 . . . . 1.77 113.534 -179.34 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' HD3' ' A' ' 75' ' ' ARG . 70.2 Cg_exo -52.26 131.68 40.84 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.575 2.184 . . . . 0.55 113.606 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.97 144.99 56.92 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.585 -0.895 . . . . 1.23 108.585 178.687 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.638 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -34.21 141.75 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.956 0.785 . . . . 1.63 112.352 -179.553 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . . . -73.15 107.19 5.35 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.76 -0.655 . . . . 0.41 109.977 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 13' ' ' ILE . 5.1 mp -86.79 112.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.874 -179.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.2 m -48.09 -32.32 6.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.656 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.441 ' H ' HG22 ' A' ' 95' ' ' ILE . 81.5 m 54.83 83.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.86 -0.609 . . . . 1.1 110.993 179.669 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 -91.26 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.314 -0.403 . . . . 3.0 110.269 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.966 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.8 p-10 -97.44 17.86 16.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.846 0.355 . . . . 2.14 110.063 179.064 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.0 p30 47.82 26.02 0.83 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.04 -0.527 . . . . 2.06 111.436 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 99' ' ' ASP . 23.5 t -119.99 -20.92 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 2.8 111.188 179.586 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.741 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 37.69 63.04 0.82 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.02 0.438 . . . . 4.58 112.089 179.933 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.227 -0.892 . . . . 3.79 111.21 179.855 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 1' ' ' PRO . 85.8 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.602 0.239 . . . . 2.74 111.112 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.571 ' O ' HG22 ' A' ' 2' ' ' ILE . 36.1 Cg_exo -60.37 -54.03 2.47 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.411 2.074 . . . . 2.06 111.761 179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 1' ' ' PRO . 0.0 OUTLIER 57.31 142.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.519 -0.764 . . . . 0.68 111.882 179.754 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -142.7 134.29 13.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 2.0 111.067 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -79.19 159.96 26.49 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.607 2.205 . . . . 0.5 112.719 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 51.1 Cg_exo -55.09 172.63 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.713 2.275 . . . . 0.71 112.491 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -62.8 -163.42 0.37 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.66 112.221 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 4.7 tttp -87.4 142.9 33.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.57 0.185 . . . . 1.52 110.532 179.849 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HG3' HG23 ' A' ' 76' ' ' VAL . 2.2 Cg_endo -83.24 132.5 6.09 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.659 2.239 . . . . 0.44 112.494 -179.722 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.74 110.73 10.31 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.444 . . . . 1.09 110.69 179.796 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.9 Cg_exo -59.54 139.93 91.55 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.117 1.878 . . . . 0.64 113.887 -179.152 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.777 ' HG ' HG22 ' A' ' 19' ' ' THR . 0.1 OUTLIER -105.71 -26.83 11.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.957 -1.019 . . . . 1.64 109.162 178.971 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.469 ' C ' HD13 ' A' ' 13' ' ' ILE . 1.2 t30 -161.79 158.01 25.04 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.774 -0.648 . . . . 0.72 110.452 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.4 95.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.127 0.489 . . . . 0.96 110.469 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.21 56.61 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.568 -0.742 . . . . 1.46 112.166 -179.258 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.518 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER 58.07 -68.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.548 0.573 . . . . 2.42 112.548 178.371 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.549 ' N ' ' O ' ' A' ' 14' ' ' THR . 24.4 m-70 -95.89 -7.25 37.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 1.02 111.883 -179.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 64' ' ' SER . 6.6 p -133.0 98.73 4.37 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 120.721 -0.392 . . . . 0.68 111.762 -179.783 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.76 HG12 ' CD1' ' A' ' 20' ' ' LEU . 84.6 t -86.62 141.84 13.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-N 116.242 -0.435 . . . . 0.8 109.945 179.356 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.777 HG22 ' HG ' ' A' ' 11' ' ' LEU . 88.0 m -123.89 115.53 21.44 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 112.872 0.693 . . . . 0.35 112.872 -178.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.777 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.54 150.03 51.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.639 0.733 . . . . 0.52 111.465 178.499 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.61 140.86 37.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.721 -1.127 . . . . 1.84 110.207 -179.417 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -131.25 -176.81 4.14 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.443 0.639 . . . . 0.4 112.47 -179.34 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.453 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -85.44 -162.5 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.592 -0.731 . . . . 0.83 111.026 179.839 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -122.44 153.07 62.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 2.11 111.005 -179.76 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' O ' ' CD ' ' A' ' 24' ' ' LYS . 50.4 Cg_exo -55.81 179.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.771 2.314 . . . . 0.89 113.248 -179.69 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -121.85 -28.59 4.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 2.77 111.914 -179.611 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -124.81 -69.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.015 0.376 . . . . 1.37 112.015 -179.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 4.1 p 51.61 49.8 20.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 0.91 110.648 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 43.27 -104.44 0.05 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.113 -0.565 . . . . 1.01 112.692 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.16 2.56 Favored Glycine 0 C--N 1.33 0.245 0 N-CA-C 110.563 -1.015 . . . . 0.98 110.563 179.259 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.525 ' CD2' ' OD1' ' A' ' 80' ' ' ASN . 1.2 m-85 -108.85 178.14 4.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.634 -0.783 . . . . 0.87 111.47 -178.442 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.13 6.02 2.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.889 -0.596 . . . . 2.26 111.84 179.672 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 18.8 mt 60.02 134.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.23 0.076 0 CA-C-O 121.126 0.488 . . . . 1.71 111.083 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.427 ' C ' ' HG ' ' A' ' 35' ' ' SER . 3.7 p -122.92 -3.65 8.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.201 0.445 . . . . 1.15 112.201 -179.331 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.427 ' HG ' ' C ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -168.63 116.1 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.103 0.408 . . . . 1.58 112.103 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.581 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 19.5 m-85 -90.52 142.15 28.04 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.849 0.356 . . . . 0.76 110.152 179.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD12 HG22 ' A' ' 77' ' ' ILE . 3.3 mt -111.94 166.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.123 -0.49 . . . . 1.14 110.712 -179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.495 ' H ' HG22 ' A' ' 37' ' ' ILE . 2.8 t -141.44 101.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.442 -0.345 . . . . 0.63 111.386 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -75.93 137.9 40.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.677 -0.49 . . . . 1.67 109.677 179.279 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.845 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -115.62 152.54 32.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.14 0.495 . . . . 1.97 111.532 -179.426 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 9.2 ttm180 -143.04 118.8 10.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.634 -0.712 . . . . 1.44 110.62 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.08 ' OD1' ' CA ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -62.35 -15.41 48.19 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.305 -0.407 . . . . 1.59 111.862 179.851 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 73' ' ' GLU . 77.5 mt 57.05 148.42 0.05 OUTLIER Pre-proline 0 C--N 1.317 -0.825 0 CA-C-N 115.771 -0.65 . . . . 0.9 111.755 179.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.86 13.22 46.17 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 123.744 -1.357 . . . . 1.43 112.4 -0.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -124.29 -67.9 0.89 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.383 -0.371 . . . . 2.66 110.418 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 1.08 ' CA ' ' OD1' ' A' ' 42' ' ' ASP . . . 42.04 -129.7 4.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.118 -0.563 . . . . 1.12 113.107 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.414 ' CD ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 170.67 110.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.061 0.458 . . . . 2.41 110.781 -179.863 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 74.4 m95 -52.0 104.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.648 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -142.75 136.29 28.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.213 -0.449 . . . . 1.28 111.106 -179.654 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.2 ptmm? -52.61 119.08 4.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.079 -0.509 . . . . 1.3 111.167 -179.898 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.845 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -109.21 -29.51 8.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.074 -0.512 . . . . 0.86 110.619 179.74 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 15.1 p-10 -52.45 -50.21 63.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.95 -0.568 . . . . 2.01 111.174 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 51.77 24.95 2.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.396 -0.366 . . . . 2.08 110.808 -179.85 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.29 -159.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 1.89 110.719 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.36 59.36 0.9 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.417 -0.356 . . . . 1.87 111.134 179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.57 HD13 ' CB ' ' A' ' 61' ' ' PHE . 15.4 mt -52.42 155.68 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.762 -0.459 . . . . 0.69 109.762 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.1 tp -164.79 -36.21 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.81 0.671 . . . . 1.6 112.81 -179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.83 22.94 2.9 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.241 0.46 . . . . 1.54 112.241 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.522 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 17.9 p30 50.52 22.82 1.13 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.962 -0.563 . . . . 1.75 111.775 -179.467 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -133.0 91.84 2.94 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.261 -1.014 . . . . 2.05 108.261 178.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CB ' HD13 ' A' ' 56' ' ' ILE . 72.1 t80 -122.31 165.55 16.06 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.245 0.545 . . . . 0.48 111.946 -178.385 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.518 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 24.6 m -129.24 107.05 9.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.404 -0.816 . . . . 0.42 111.124 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.1 t -67.47 108.41 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 1.08 110.718 179.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.635 ' HB3' HG22 ' A' ' 17' ' ' THR . 4.6 p -110.15 144.24 39.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.658 -0.701 . . . . 1.33 110.966 -179.849 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.67 10.54 14.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.686 -0.769 . . . . 0.9 112.902 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 16' ' ' HIS . 3.7 mm? -52.58 -176.42 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.105 0.452 . . . . 1.47 110.68 179.916 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -105.71 -18.56 14.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.951 -0.568 . . . . 1.06 110.955 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 68.0 141.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.894 0.378 . . . . 1.91 110.63 -179.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.49 25.05 6.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 1.87 110.203 -179.367 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.09 141.58 25.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.878 -0.601 . . . . 0.49 110.693 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 96' ' ' THR . . . -80.81 132.41 35.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.189 0.518 . . . . 0.36 110.9 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 49.5 m-85 -132.39 133.39 43.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.498 -0.773 . . . . 0.56 112.154 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.62 ' HB2' HD11 ' A' ' 43' ' ' LEU . 7.0 tt0 -106.21 143.75 33.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.173 -1.047 . . . . 1.5 108.173 178.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.529 ' HZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.83 117.96 16.48 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.066 1.506 . . . . 0.6 115.066 -178.337 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -99.9 156.52 17.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.283 -0.417 . . . . 2.11 109.895 177.815 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 8' ' ' PRO . 71.9 t -104.57 128.89 57.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.252 0.548 . . . . 0.6 111.498 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 37' ' ' ILE . 11.0 mt -132.85 155.74 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.551 -1.278 . . . . 0.7 107.551 179.131 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -176.86 131.34 0.19 Allowed 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.467 -0.893 . . . . 0.6 112.799 -179.628 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.3 ptpt -87.92 111.73 21.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.738 -0.838 . . . . 1.98 108.738 178.407 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.525 ' OD1' ' CD2' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -46.39 -103.94 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.851 1.056 . . . . 2.19 113.851 -177.933 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.15 -52.05 1.65 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.043 0.757 . . . . 1.08 113.043 -178.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -74.14 0.76 12.92 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.084 0.772 . . . . 1.06 113.084 -178.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.7 -17.6 38.9 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.184 -1.008 . . . . 0.93 112.259 -179.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.6 97.13 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.08 -0.711 . . . . 1.38 109.08 179.23 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -67.11 118.53 10.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.486 0.921 . . . . 0.79 113.486 -178.173 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 12.2 p -71.29 110.45 7.44 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 107.945 -1.132 . . . . 0.59 107.945 178.123 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -56.44 175.23 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.82 2.347 . . . . 0.85 114.324 -178.168 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HB3' ' NH1' ' A' ' 75' ' ' ARG . 86.2 Cg_exo -45.79 135.78 13.35 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.621 2.881 . . . . 0.76 113.866 -179.373 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.8 m -119.84 95.55 4.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.036 -0.529 . . . . 1.28 111.416 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 20.96 105.83 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 113.996 1.11 . . . . 1.77 113.996 179.435 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.6 Cg_exo -60.66 136.86 69.62 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.531 2.154 . . . . 0.55 112.643 179.587 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -71.6 146.85 48.11 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.021 -0.536 . . . . 1.23 110.23 179.627 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -34.09 146.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 O-C-N 124.348 1.03 . . . . 1.63 112.159 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' CB ' ' CD1' ' A' ' 43' ' ' LEU . . . -81.56 118.13 22.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.784 -0.644 . . . . 0.41 110.947 -179.906 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.701 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.7 mp -108.59 119.47 58.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.342 -0.39 . . . . 0.44 111.503 -179.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 53.1 m -52.21 -22.81 4.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.056 179.904 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.701 ' H ' HG22 ' A' ' 95' ' ' ILE . 1.9 m 57.93 58.0 3.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.235 0.541 . . . . 1.1 110.176 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.632 ' NH1' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -78.82 -132.77 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.433 -0.803 . . . . 3.0 110.759 -179.594 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.981 ' OD1' ' CG1' ' A' ' 101' ' ' VAL . 2.6 p30 -93.41 35.81 1.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.175 0.443 . . . . 2.14 110.824 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.518 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 24.2 t0 34.44 32.38 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.26 0.552 . . . . 2.06 112.312 -179.181 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.981 ' CG1' ' OD1' ' A' ' 99' ' ' ASP . 9.9 p -169.84 27.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.857 -0.61 . . . . 2.8 111.449 179.742 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' HB3' ' OD2' ' A' ' 99' ' ' ASP . 0.2 OUTLIER -113.06 -19.93 11.69 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.728 -0.389 . . . . 4.58 111.279 179.848 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.632 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.221 -0.895 . . . . 3.79 111.048 179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.691 0.281 . . . . 2.74 111.203 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 29' ' ' GLY . 5.4 Cg_exo -78.17 122.05 5.55 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.977 2.451 . . . . 2.06 111.937 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.732 HD12 ' OD1' ' A' ' 80' ' ' ASN . 1.6 tt -113.33 145.95 18.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.888 0.375 . . . . 0.68 111.181 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.452 ' N ' HG12 ' A' ' 2' ' ' ILE . 2.6 m-20 -130.41 138.61 33.42 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 2.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -84.27 161.91 13.2 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.854 2.369 . . . . 0.5 112.552 -179.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 12.3 Cg_endo -56.33 -174.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.062 2.508 . . . . 0.71 112.981 -179.677 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 178.05 49.14 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.967 -0.56 . . . . 0.66 112.838 -179.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.9 122.81 85.28 Favored Pre-proline 0 C--N 1.332 -0.167 0 N-CA-C 110.198 -0.297 . . . . 1.52 110.198 179.648 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.603 ' CG ' HG12 ' A' ' 76' ' ' VAL . 29.3 Cg_exo -67.66 141.78 56.11 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.651 2.234 . . . . 0.44 112.816 -179.523 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.55 108.01 7.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.7 -0.682 . . . . 1.09 110.848 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.544 ' CB ' HD23 ' A' ' 20' ' ' LEU . 24.4 Cg_exo -51.06 123.2 11.37 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.14 1.893 . . . . 0.64 113.048 -179.518 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -84.03 -31.67 25.29 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.084 -0.71 . . . . 1.64 109.084 178.41 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.11 147.97 27.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.879 -1.055 . . . . 0.72 108.934 179.634 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.969 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -132.58 98.39 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.335 -0.546 . . . . 0.96 111.441 -179.556 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -85.45 50.96 2.06 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.628 -0.714 . . . . 1.46 111.576 -179.719 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.77 -75.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.661 0.615 . . . . 2.42 112.661 178.933 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 14' ' ' THR . 12.3 m-70 -73.6 -24.92 60.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.333 0.494 . . . . 1.02 112.333 -179.132 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -137.59 122.09 18.4 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.226 -0.287 . . . . 0.68 110.226 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.969 ' HB ' HG22 ' A' ' 13' ' ' ILE . 12.6 m -111.64 121.92 65.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.625 0.726 . . . . 0.8 112.647 -179.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 15.5 m -83.69 138.37 33.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.92 -1.037 . . . . 0.35 110.35 179.676 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.816 HD11 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -147.61 164.12 34.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.642 0.588 . . . . 0.52 111.724 179.909 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.929 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -139.31 178.93 6.84 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.648 -0.706 . . . . 1.84 110.352 179.437 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.513 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 47.6 p90 -172.31 167.18 5.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.393 0.616 . . . . 0.4 112.533 179.717 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.83 148.95 29.74 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.19 -0.914 . . . . 0.83 110.657 179.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.61 149.13 43.53 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.496 -0.32 . . . . 2.11 110.842 179.819 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 86.5 Cg_exo -44.65 176.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.024 2.483 . . . . 0.89 112.919 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.75 -30.64 4.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.908 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -114.01 -71.72 0.73 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.143 0.423 . . . . 1.37 112.143 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 12.1 p 54.38 37.11 26.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.91 110.808 -179.451 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 1' ' ' PRO . . . 50.38 -92.65 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.644 -0.788 . . . . 1.01 112.229 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.3 27.38 1.54 Allowed Glycine 0 N--CA 1.453 -0.193 0 N-CA-C 111.46 -0.656 . . . . 0.98 111.46 179.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.513 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -102.55 -177.27 3.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 0.87 111.567 -179.17 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.81 2.99 2.22 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.431 0.53 . . . . 2.26 112.431 179.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.7 mp 60.65 136.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.107 0.479 . . . . 1.71 111.436 -179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.2 p -124.7 9.64 8.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 1.15 111.779 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.7 t -179.29 138.39 0.14 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.831 0.348 . . . . 1.58 111.752 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.63 ' O ' HD12 ' A' ' 56' ' ' ILE . 32.8 m-85 -114.35 103.96 11.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 0.76 110.496 179.504 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 76' ' ' VAL . 4.5 mm -79.83 128.36 38.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 1.14 110.883 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.7 t -106.98 111.02 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 111.832 0.308 . . . . 0.63 111.832 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.801 ' CD ' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -86.81 136.36 33.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 1.67 108.834 178.745 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.608 ' CD ' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -125.54 143.78 50.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.338 0.59 . . . . 1.97 112.274 -179.001 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG3' ' HA3' ' A' ' 46' ' ' GLY . 20.3 ttp180 -110.53 108.5 18.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.151 -0.931 . . . . 1.44 109.905 179.426 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.954 ' OD2' ' NH2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.83 92.69 3.63 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.698 -0.683 . . . . 1.59 109.839 179.809 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.852 HD11 ' HG2' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -68.17 142.86 95.37 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.941 -0.572 . . . . 0.9 111.172 -179.405 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -94.2 16.25 41.64 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 124.047 -1.231 . . . . 1.43 112.793 0.109 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.37 67.78 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.579 -0.282 . . . . 2.66 111.642 -179.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -110.57 176.54 18.93 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.571 -0.823 . . . . 1.12 112.681 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.954 ' NH2' ' OD2' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -151.58 19.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 111.246 -179.827 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.471 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 82.2 m95 49.74 98.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.536 -0.302 . . . . 0.65 111.106 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -143.14 155.29 44.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.943 0.402 . . . . 1.28 110.851 179.198 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -71.84 116.83 12.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.089 0.471 . . . . 1.3 111.563 -179.427 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HB2' ' CD ' ' A' ' 40' ' ' LYS . . . -93.14 -39.79 10.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 0.86 110.609 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.638 ' CB ' HD11 ' A' ' 56' ' ' ILE . 13.9 p-10 -49.92 -48.62 51.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 2.01 111.049 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 45.05 30.43 0.59 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 2.08 111.297 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.2 m -139.29 -164.64 1.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 1.89 111.153 -179.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.86 107.7 19.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 1.87 111.022 -179.854 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.638 HD11 ' CB ' ' A' ' 52' ' ' ASN . 44.1 mt -108.48 65.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.69 110.704 179.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mt -47.66 -66.75 0.35 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.475 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -76.15 162.47 27.96 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.933 0.397 . . . . 1.54 110.555 179.975 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 6.7 p30 -75.9 -2.39 30.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.894 -0.594 . . . . 1.75 111.659 -179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB3' ' HG3' ' A' ' 58' ' ' GLU . 16.7 tt0 -93.48 99.55 12.01 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.457 -0.571 . . . . 2.05 109.457 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.621 ' CG ' HD13 ' A' ' 56' ' ' ILE . 73.0 t80 -134.51 164.58 27.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.316 0.579 . . . . 0.48 112.024 -178.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.8 m -124.3 124.86 43.32 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.246 -0.888 . . . . 0.42 109.974 179.32 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 20' ' ' LEU . 9.9 t -80.55 96.07 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.098 0.475 . . . . 1.08 111.365 -179.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.25 132.51 35.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.669 -0.696 . . . . 1.33 110.83 179.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.82 -25.65 2.93 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.529 -0.76 . . . . 0.9 111.325 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.708 ' CD2' HG13 ' A' ' 18' ' ' VAL . 6.9 mp -49.14 158.29 0.37 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.958 0.408 . . . . 1.47 110.928 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -124.91 144.14 50.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.06 -0.518 . . . . 1.06 110.805 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.3 OUTLIER -60.21 143.73 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 1.91 111.16 -179.844 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.6 OUTLIER 69.87 44.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 1.87 111.213 179.891 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.41 122.2 4.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.858 0.361 . . . . 0.49 111.808 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -74.81 128.84 36.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 0.36 109.861 179.168 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 47.0 m-85 -125.13 125.14 43.26 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.082 0.771 . . . . 0.56 113.082 -178.701 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.852 ' HG2' HD11 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -102.37 137.94 39.96 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 107.885 -1.154 . . . . 1.5 107.885 178.013 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.887 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -142.75 126.58 17.13 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.208 1.558 . . . . 0.6 115.208 -178.781 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' NE ' ' HG3' ' A' ' 91' ' ' PRO . 0.7 OUTLIER -106.02 -173.04 2.2 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.954 -1.128 . . . . 2.11 107.954 177.384 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.603 HG12 ' CG ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -151.34 117.58 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 118.989 -1.084 . . . . 0.6 113.336 179.953 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.801 HD12 ' CD ' ' A' ' 39' ' ' GLU . 65.4 mt -100.18 146.11 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.832 -1.544 . . . . 0.7 106.832 177.288 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -158.33 135.69 10.15 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 119.75 -0.78 . . . . 0.6 112.286 -178.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 7.1 mttp -73.6 -152.38 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.733 -0.84 . . . . 1.98 108.733 178.792 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.732 ' OD1' HD12 ' A' ' 2' ' ' ILE . 0.1 OUTLIER -147.29 -108.91 0.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 120.452 -0.499 . . . . 2.19 110.724 179.576 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -129.36 -12.06 4.52 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.978 0.808 . . . . 1.08 112.5 179.617 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -105.1 -1.07 26.03 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 111.754 0.279 . . . . 1.06 111.754 -179.911 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.51 -18.88 43.63 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.427 -0.892 . . . . 0.93 112.481 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.28 153.61 11.88 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 122.744 -0.268 . . . . 1.38 110.316 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -113.63 106.62 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.069 0.462 . . . . 0.79 111.681 -179.725 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -65.42 127.44 92.95 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 115.93 -0.577 . . . . 0.59 109.738 179.585 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -41.35 168.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.88 2.387 . . . . 0.85 113.365 -179.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.586 ' HG3' HD11 ' A' ' 77' ' ' ILE . 2.9 Cg_exo -75.74 121.35 6.25 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.254 2.636 . . . . 0.76 112.6 -179.744 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.588 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -66.79 132.84 48.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.156 -0.683 . . . . 1.28 109.156 178.998 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -33.6 121.71 0.48 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 122.869 0.468 . . . . 1.77 112.169 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HG3' ' NE ' ' A' ' 75' ' ' ARG . 56.3 Cg_exo -52.98 155.31 11.46 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.94 2.426 . . . . 0.55 113.977 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.94 149.72 21.05 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.632 -0.713 . . . . 1.23 109.832 178.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -42.47 148.26 0.23 Allowed 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 124.21 0.944 . . . . 1.63 111.222 179.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.786 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . . . -75.24 124.23 26.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.825 -0.625 . . . . 0.41 111.62 -179.636 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.659 HG12 HG21 ' A' ' 13' ' ' ILE . 4.0 mp -102.99 109.3 26.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.44 110.517 179.483 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 80.6 m -46.63 -28.57 1.51 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.813 0.339 . . . . 0.44 111.004 -179.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.641 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 52.04 83.43 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.081 -0.509 . . . . 1.1 110.515 179.811 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.405 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -131.79 -87.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.722 0.296 . . . . 3.0 111.278 -179.873 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.945 ' O ' HG23 ' A' ' 101' ' ' VAL . 3.5 p-10 -98.59 9.88 42.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.337 -0.392 . . . . 2.14 111.304 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.4 p30 44.92 27.97 0.32 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.999 0.428 . . . . 2.06 111.252 -179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 99' ' ' ASP . 47.8 t -130.29 -4.78 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.926 -0.579 . . . . 2.8 111.932 -179.834 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' C ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 44.39 43.75 6.38 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-O 121.051 0.453 . . . . 4.58 111.614 179.681 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.233 -0.889 . . . . 3.79 110.979 179.882 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.454 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.603 0.24 . . . . 2.74 111.403 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 0' ' ' SER . 10.6 Cg_exo -71.83 -179.42 3.8 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 2.06 112.128 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.899 HD11 ' ND2' ' A' ' 80' ' ' ASN . 2.2 tt -156.11 141.42 9.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.939 -0.573 . . . . 0.68 110.722 179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.12 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -129.0 119.39 19.82 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.404 . . . . 2.0 110.537 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.9 161.89 37.46 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.164 1.909 . . . . 0.5 111.983 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.96 167.0 18.87 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.645 2.23 . . . . 0.71 113.158 -179.312 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.68 154.96 25.87 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.789 -0.641 . . . . 0.66 112.94 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 90' ' ' GLU . 2.6 tttt -53.65 138.83 51.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.103 -0.332 . . . . 1.52 110.103 179.704 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.513 ' CG ' HG23 ' A' ' 76' ' ' VAL . 4.2 Cg_exo -80.63 115.35 3.09 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.448 2.098 . . . . 0.44 111.901 179.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.5 p -109.29 109.74 60.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.538 -0.301 . . . . 1.09 110.649 179.821 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 72.9 Cg_exo -41.66 125.0 2.75 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.341 2.027 . . . . 0.64 113.123 -179.287 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -89.59 -33.26 16.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.49 -0.777 . . . . 1.64 109.61 179.833 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -158.35 111.1 2.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.72 109.565 179.22 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.037 HG22 HG13 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -102.74 140.07 22.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.357 0.598 . . . . 0.96 112.4 -179.229 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.917 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -136.42 141.59 43.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.299 -0.864 . . . . 1.46 110.197 179.777 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -43.14 -24.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.155 0.798 . . . . 2.42 113.155 -179.239 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.406 ' O ' HG23 ' A' ' 17' ' ' THR . 11.0 m170 -122.73 -0.15 9.17 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.784 -0.572 . . . . 1.02 112.497 -179.589 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -161.27 120.29 2.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.68 110.95 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.037 HG13 HG22 ' A' ' 13' ' ' ILE . 61.2 t -108.16 128.31 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.168 -0.469 . . . . 0.8 111.176 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.884 ' C ' HD13 ' A' ' 20' ' ' LEU . 21.7 m -106.48 133.43 51.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.35 110.938 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.884 HD13 ' C ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -136.34 147.0 47.19 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.681 0.753 . . . . 0.52 112.033 179.493 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -130.25 131.12 45.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.473 -1.24 . . . . 1.84 109.646 179.682 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.501 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 6.5 p90 -118.01 -176.04 2.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.003 0.43 . . . . 0.4 111.946 -179.565 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.32 177.94 4.7 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.721 -0.672 . . . . 0.83 112.052 -179.498 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.27 142.17 25.83 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.34 -0.845 . . . . 2.11 110.266 179.801 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 78.3 Cg_exo -51.86 -161.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.888 2.392 . . . . 0.89 113.595 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -133.3 -43.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 2.77 111.267 -179.507 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.032 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 4.7 t80 -111.2 -70.66 0.8 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.453 -0.34 . . . . 1.37 111.885 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 1.12 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 p 55.16 43.84 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.922 -0.399 . . . . 0.91 109.922 -179.243 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.37 -91.44 0.01 OUTLIER Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.733 -0.667 . . . . 1.01 112.769 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -151.95 37.87 0.81 Allowed Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 109.872 -1.291 . . . . 0.98 109.872 179.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -117.65 -179.27 3.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.631 -0.785 . . . . 0.87 111.055 -178.67 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.09 -6.77 4.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.958 -0.565 . . . . 2.26 112.29 -179.744 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 79' ' ' LYS . 11.9 mt 62.26 142.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.687 0.28 . . . . 1.71 110.648 -179.642 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 p -138.93 42.66 2.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.541 -0.3 . . . . 1.15 111.428 -179.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 172.31 165.45 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.416 -0.356 . . . . 1.58 110.69 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 61.2 m-85 -153.53 74.93 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.76 110.889 179.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.484 ' CG2' ' CB ' ' A' ' 50' ' ' LYS . 2.6 mt -57.42 133.52 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.06 -0.518 . . . . 1.14 110.865 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 61' ' ' PHE . 2.5 t -105.1 104.79 17.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.342 -0.39 . . . . 0.63 111.302 179.999 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.948 ' OE2' ' O ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -78.98 130.12 35.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.686 -0.487 . . . . 1.67 109.686 179.394 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.812 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -112.67 143.92 43.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.886 0.374 . . . . 1.97 110.983 -179.877 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.515 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 4.1 ttm180 -117.36 105.38 12.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.944 -0.571 . . . . 1.44 110.575 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.745 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.59 98.56 3.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.781 -0.645 . . . . 1.59 110.907 -179.742 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 94' ' ' ALA . 15.6 mt -83.2 154.7 66.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.214 -0.448 . . . . 0.9 110.902 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.33 37.96 5.76 Favored 'Cis proline' 0 C--N 1.348 0.539 0 C-N-CA 124.056 -1.227 . . . . 1.43 112.835 0.297 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -167.19 79.46 0.2 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.93 0.395 . . . . 2.66 111.305 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . -152.92 -169.71 18.42 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.932 -0.576 . . . . 1.12 111.85 179.715 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.776 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -144.2 159.75 42.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.138 0.494 . . . . 2.41 111.278 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.948 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 70.0 m95 -64.52 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.722 -0.672 . . . . 0.65 111.017 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.776 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -116.69 128.49 55.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.351 -0.386 . . . . 1.28 111.086 -179.813 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -56.89 117.57 4.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 1.3 111.234 -179.879 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.812 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -95.86 -33.72 12.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.066 -0.515 . . . . 0.86 110.811 179.702 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.508 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 4.3 p-10 -47.64 -59.12 3.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.037 -0.529 . . . . 2.01 111.558 -179.822 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.3 t80 45.41 37.76 3.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 2.08 111.181 -179.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -145.44 20.37 1.53 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.89 111.422 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.71 116.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.999 0.428 . . . . 1.87 111.262 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.73 HD12 ' CD1' ' A' ' 61' ' ' PHE . 15.4 mm -105.4 85.04 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.69 111.324 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 tp -59.12 -77.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 1.6 110.45 179.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.22 176.72 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.407 -0.36 . . . . 1.54 110.35 179.643 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -95.74 32.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.376 . . . . 1.75 111.746 -179.616 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -131.58 97.85 4.34 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.727 -0.471 . . . . 2.05 109.727 179.513 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.73 ' CD1' HD12 ' A' ' 56' ' ' ILE . 83.3 t80 -133.29 163.16 29.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.259 0.552 . . . . 0.48 111.927 -179.345 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.528 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 46.0 m -130.25 112.69 13.58 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.175 -0.92 . . . . 0.42 110.824 179.152 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.701 HG23 HD21 ' A' ' 20' ' ' LEU . 5.0 t -72.06 119.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 1.08 111.05 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.78 142.47 46.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.923 -0.58 . . . . 1.33 110.992 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.18 5.44 6.17 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.786 -0.721 . . . . 0.9 112.798 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD13 ' N ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -71.92 -172.54 0.86 Allowed 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.071 0.435 . . . . 1.47 110.929 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 m -142.12 147.26 36.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.012 0.434 . . . . 1.06 111.017 -179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 5.8 tt0 -63.82 138.53 58.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.823 -0.626 . . . . 1.91 111.455 -179.766 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.14 57.68 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.057 -0.52 . . . . 1.87 111.008 179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.62 118.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.49 111.182 179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.34 123.73 22.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.18 -0.464 . . . . 0.36 110.464 179.563 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' CE1' ' A' ' 74' ' ' PHE . 37.8 m-85 -119.12 127.93 53.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.583 0.586 . . . . 0.56 112.583 -178.875 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.421 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 2.2 tt0 -104.32 145.88 29.61 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.9 -0.778 . . . . 1.5 108.9 178.641 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -142.45 130.04 21.41 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.228 1.195 . . . . 0.6 114.228 -179.186 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -115.67 -178.85 3.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.684 -0.689 . . . . 2.11 109.814 178.312 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG23 ' CG ' ' A' ' 8' ' ' PRO . 39.5 t -132.56 110.35 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 120.132 -0.627 . . . . 0.6 112.632 -179.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.641 HD12 ' HG3' ' A' ' 39' ' ' GLU . 59.2 mt -105.48 142.17 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 107.067 -1.457 . . . . 0.7 107.067 177.514 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -150.66 -171.23 3.87 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.765 -0.774 . . . . 0.6 111.655 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 33' ' ' ILE . 7.1 mttt -129.78 -175.38 3.58 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 1.98 109.705 179.419 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.899 ' ND2' HD11 ' A' ' 2' ' ' ILE . 4.4 m-80 -132.9 162.07 32.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.978 0.418 . . . . 2.19 111.464 -179.749 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.36 -28.69 0.36 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.874 -0.603 . . . . 1.08 112.544 -179.706 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -85.87 -7.6 58.6 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.709 0.633 . . . . 1.06 112.709 -179.125 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 79' ' ' LYS . . . 102.91 -16.71 54.09 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.241 -0.981 . . . . 0.93 112.458 -179.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.18 161.92 1.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.93 -0.396 . . . . 1.38 109.93 179.731 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.697 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.7 OUTLIER -115.73 98.5 6.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.79 111.583 -179.795 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.49 ' HA ' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -54.09 116.58 10.69 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 109.32 -0.622 . . . . 0.59 109.32 179.237 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -41.58 168.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.938 2.425 . . . . 0.85 113.072 -179.358 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . 22.5 Cg_exo -65.15 121.54 9.03 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.937 2.425 . . . . 0.76 113.281 -179.651 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -78.35 124.2 27.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.663 -0.699 . . . . 1.28 109.233 179.021 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 mm-40 -22.68 117.97 0.17 Allowed Pre-proline 0 N--CA 1.479 0.986 0 O-C-N 124.015 0.822 . . . . 1.77 113.084 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 31.4 Cg_exo -60.28 163.72 14.18 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.881 2.387 . . . . 0.55 113.999 -179.233 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.451 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -98.94 147.78 24.64 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.207 -0.906 . . . . 1.23 109.661 179.317 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -36.73 158.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 124.016 0.823 . . . . 1.63 111.86 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -87.9 111.16 21.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.969 -0.559 . . . . 0.41 111.494 -179.658 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.552 HG22 ' SG ' ' A' ' 97' ' ' CYS . 4.5 mp -84.06 110.56 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.288 -0.415 . . . . 0.44 110.516 179.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 m -46.09 -38.35 7.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.014 0.435 . . . . 0.44 110.645 179.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 95' ' ' ILE . 70.8 m 59.37 68.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 1.1 110.189 179.788 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -103.64 -77.61 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.108 -0.496 . . . . 3.0 111.288 -179.265 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.394 ' CG ' ' HG2' ' A' ' 102' ' ' GLU . 33.8 p30 -138.49 17.81 2.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.884 -0.598 . . . . 2.14 111.034 -179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.917 ' OD1' ' HA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 44.2 30.18 0.42 Allowed 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.376 0.608 . . . . 2.06 111.653 -179.919 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.96 HG12 ' O ' ' A' ' 99' ' ' ASP . 7.3 p -170.94 33.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.06 -0.973 . . . . 2.8 110.172 179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.394 ' HG2' ' CG ' ' A' ' 99' ' ' ASP . 7.1 mm-40 -113.97 -25.18 8.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.434 -0.803 . . . . 4.58 110.896 -179.956 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.337 -0.839 . . . . 3.79 111.238 -179.95 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.441 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.682 0.277 . . . . 2.74 111.278 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.478 ' HG2' ' CE2' ' A' ' 27' ' ' TYR . 88.8 Cg_endo -93.57 52.37 0.37 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.092 2.528 . . . . 2.06 112.365 -179.945 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.961 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.1 tt -43.13 142.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.29 -0.414 . . . . 0.68 111.45 -179.833 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -117.84 133.82 23.32 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 2.0 111.148 -179.653 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -83.0 146.15 12.71 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.482 2.121 . . . . 0.5 112.176 179.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 77.6 Cg_exo -46.41 159.7 0.26 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.282 2.655 . . . . 0.71 114.011 -179.533 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.39 -158.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.136 -0.938 . . . . 0.66 112.802 179.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HD3' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -86.24 124.62 69.88 Favored Pre-proline 0 C--O 1.233 0.193 0 N-CA-C 110.684 -0.117 . . . . 1.52 110.684 179.728 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' HD3' ' A' ' 7' ' ' LYS . 5.5 Cg_exo -74.13 117.12 4.88 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.472 2.114 . . . . 0.44 111.633 179.764 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.33 111.84 26.1 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.189 -0.46 . . . . 1.09 110.438 -179.827 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 80.5 Cg_exo -33.84 145.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.839 2.359 . . . . 0.64 113.581 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.28 HD12 ' OE2' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -107.76 -41.74 4.92 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.402 -1.272 . . . . 1.64 108.932 -179.941 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.435 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -164.35 107.77 0.93 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.497 -1.229 . . . . 0.72 110.135 179.903 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.995 HG22 HG13 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -88.56 102.27 12.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.6 -0.727 . . . . 0.96 111.877 -179.75 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -91.51 43.53 1.15 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.453 -0.794 . . . . 1.46 111.079 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.454 ' C ' ' HG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER 55.61 -74.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.591 -0.731 . . . . 2.42 112.287 179.269 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.489 ' N ' ' O ' ' A' ' 14' ' ' THR . 2.5 m-70 -74.27 -27.67 60.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.917 0.389 . . . . 1.02 111.053 -179.251 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.6 p -129.08 104.09 7.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.007 -0.542 . . . . 0.68 109.621 179.312 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 13' ' ' ILE . 73.8 t -89.44 114.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.949 -0.568 . . . . 0.8 111.548 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 70.4 m -88.41 148.81 24.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.931 0.396 . . . . 0.35 111.425 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -152.68 158.7 42.74 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.44 -0.8 . . . . 0.52 111.269 179.628 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.044 ' HB2' ' OE2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -146.0 142.16 28.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.414 -0.812 . . . . 1.84 110.225 179.593 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 11.6 p90 -125.05 -174.06 2.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.871 0.367 . . . . 0.4 111.941 -179.676 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -94.25 -23.04 18.03 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.984 -0.553 . . . . 0.83 112.47 -179.352 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' CG ' ' O ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER 75.39 166.03 0.13 Allowed Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.403 -179.387 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 59.8 Cg_endo -70.59 -173.85 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.575 2.183 . . . . 0.89 112.785 -179.798 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -129.71 -40.11 1.4 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 2.77 111.359 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 1' ' ' PRO . 28.2 t80 -93.58 -70.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.938 -0.305 . . . . 1.37 111.268 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.437 ' O ' ' CD2' ' A' ' 31' ' ' PHE . 7.4 p 58.43 42.44 21.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.91 110.907 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -97.8 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.601 -0.809 . . . . 1.01 112.337 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.15 30.5 2.53 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 110.478 -1.049 . . . . 0.98 110.478 179.164 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -114.55 171.57 7.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.883 -0.659 . . . . 0.87 111.097 -178.845 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 4.15 3.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.183 -0.462 . . . . 2.26 111.75 179.44 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 36' ' ' TYR . 1.3 mt 55.01 117.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 CA-C-O 121.362 0.601 . . . . 1.71 112.21 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 p -98.38 -11.53 22.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.47 -0.787 . . . . 1.15 110.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.68 138.01 4.92 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.807 0.337 . . . . 1.58 111.562 -179.801 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.645 ' CE1' HG21 ' A' ' 33' ' ' ILE . 93.1 m-85 -108.21 115.25 29.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.76 110.945 179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 ' HB3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -95.77 106.46 18.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.337 -0.392 . . . . 1.14 110.66 179.65 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.65 135.88 31.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.41 0.624 . . . . 0.63 111.475 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' CB ' ' HB3' ' A' ' 48' ' ' TRP . 4.9 mt-10 -91.13 143.9 26.19 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.872 -1.058 . . . . 1.67 110.845 -179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.896 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -108.57 151.58 25.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.199 -0.455 . . . . 1.97 111.007 -179.99 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.547 ' O ' HD22 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -132.11 102.82 5.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.154 -0.475 . . . . 1.44 110.527 179.709 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.83 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -77.17 96.28 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.341 -0.39 . . . . 1.59 110.548 -179.982 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 71' ' ' ALA . 1.3 mm? -75.12 147.31 83.18 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.4 -0.364 . . . . 0.9 110.687 -179.899 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -90.38 3.66 68.12 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.942 -1.274 . . . . 1.43 113.226 0.304 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -125.38 74.67 1.4 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.924 0.393 . . . . 2.66 110.913 -179.718 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -136.96 -177.76 15.29 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.858 -0.686 . . . . 1.12 112.644 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 140.82 17.52 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.034 0.445 . . . . 2.41 110.698 179.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' NE1' ' CZ ' ' A' ' 41' ' ' ARG . 64.6 m95 -55.11 104.54 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.625 -0.716 . . . . 0.65 110.818 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -136.77 117.36 13.87 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.761 -0.654 . . . . 1.28 110.67 179.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' HB3' HG22 ' A' ' 37' ' ' ILE . 3.1 ptmm? -45.45 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.942 -0.572 . . . . 1.3 111.339 -179.661 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.896 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.9 -17.49 61.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.86 111.244 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.705 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.9 p-10 -81.94 113.05 19.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 2.01 110.817 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.69 25.44 11.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.206 -0.452 . . . . 2.08 110.659 179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.3 p -125.9 -160.91 1.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.067 -0.515 . . . . 1.89 110.806 -179.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.04 88.5 2.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.331 -0.395 . . . . 1.87 111.177 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.765 HG23 ' HB2' ' A' ' 61' ' ' PHE . 12.8 mt -75.74 62.72 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.69 111.065 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mt -49.29 -75.57 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.988 -0.551 . . . . 1.6 111.095 -179.894 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -179.51 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.34 -0.391 . . . . 1.54 110.721 179.822 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 33.3 p30 -93.98 17.01 13.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.75 111.361 -179.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.28 ' OE2' HD12 ' A' ' 11' ' ' LEU . 3.1 tp10 -118.34 108.29 14.9 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.897 -0.409 . . . . 2.05 109.897 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.765 ' HB2' HG23 ' A' ' 56' ' ' ILE . 61.7 t80 -141.12 165.56 27.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.097 0.475 . . . . 0.48 111.379 -179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 12.0 m -127.37 115.74 19.42 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.703 -0.681 . . . . 0.42 110.769 179.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 51' ' ' ALA . 22.6 t -75.42 139.16 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.67 -0.696 . . . . 1.08 111.382 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.5 p -124.11 -171.08 2.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.738 -0.664 . . . . 1.33 110.607 179.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.08 0.88 90.09 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.59 -0.732 . . . . 0.9 112.479 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 66' ' ' LEU . 3.6 mp -71.23 163.91 26.71 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.336 0.589 . . . . 1.47 111.839 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.6 m -128.73 112.19 13.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.29 -0.868 . . . . 1.06 109.809 179.464 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 69' ' ' ASP . 7.8 tt0 -41.23 150.85 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.271 0.557 . . . . 1.91 112.453 -179.09 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.845 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 73.18 39.84 0.58 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.398 -0.819 . . . . 1.87 110.782 -179.867 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -160.39 135.16 7.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.417 -0.356 . . . . 0.49 111.352 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.69 129.41 37.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.36 110.191 179.581 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.708 ' CE2' ' HB3' ' A' ' 42' ' ' ASP . 49.4 m-85 -124.34 118.21 26.23 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.063 0.394 . . . . 0.56 112.063 -179.5 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 1.4 mt-10 -101.39 135.4 42.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 1.5 109.139 179.072 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -130.53 122.1 26.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.895 1.443 . . . . 0.6 114.895 -178.857 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.519 ' HD3' ' CH2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -104.54 154.48 19.86 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.505 -0.924 . . . . 2.11 108.505 177.254 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.4 OUTLIER -114.24 119.13 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 119.323 -0.951 . . . . 0.6 113.41 -179.243 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 86' ' ' SER . 61.3 mt -111.25 150.64 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.018 -1.446 . . . . 0.7 107.423 178.323 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -168.14 127.54 1.25 Allowed 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.066 -1.053 . . . . 0.6 113.278 -179.642 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -85.19 80.12 9.32 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.733 -0.839 . . . . 1.98 108.733 178.185 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 18.1 m-20 -17.1 -92.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 113.88 -1.509 . . . . 2.19 114.339 -178.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -128.61 -48.23 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.051 0.759 . . . . 1.08 113.051 -179.101 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.696 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -99.93 43.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.264 0.468 . . . . 1.06 112.264 -178.819 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 76.43 -3.13 55.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.462 -0.875 . . . . 0.93 113.246 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.961 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -58.93 85.98 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.111 0.455 . . . . 1.38 109.946 179.641 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -66.47 117.2 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.086 -0.506 . . . . 0.79 112.344 -179.083 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 77' ' ' ILE . 3.2 t -80.69 110.61 17.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 107.669 -1.234 . . . . 0.59 107.669 178.346 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.45 162.79 7.54 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.403 2.069 . . . . 0.85 113.185 -178.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 75' ' ' ARG . 63.4 Cg_exo -36.18 91.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.32 2.68 . . . . 0.76 113.288 -179.728 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.509 ' OG ' HG13 ' A' ' 76' ' ' VAL . 52.9 p -73.13 99.0 2.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.657 -0.417 . . . . 1.28 110.707 179.705 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' ' CD ' ' A' ' 8' ' ' PRO . 10.9 mt-10 18.61 107.66 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 124.688 1.242 . . . . 1.77 113.917 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 98.5 Cg_exo -44.87 177.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.498 2.132 . . . . 0.55 113.741 179.483 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER -113.15 140.52 47.84 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.225 -1.352 . . . . 1.23 108.764 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.736 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -36.94 134.42 0.52 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.638 0.586 . . . . 1.63 111.634 -179.925 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.844 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -70.18 107.92 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.41 110.966 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -91.05 112.73 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.878 0.37 . . . . 0.44 110.882 179.748 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.1 m -59.03 -23.79 62.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.892 -0.594 . . . . 0.44 111.174 -179.77 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.454 ' HG ' ' C ' ' A' ' 15' ' ' ARG . 18.9 t 56.02 101.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.14 0.495 . . . . 1.1 110.218 -179.319 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.87 -77.18 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 3.0 109.638 179.987 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.928 ' O ' HG23 ' A' ' 101' ' ' VAL . 20.7 p-10 -106.35 21.36 17.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.267 -0.879 . . . . 2.14 110.099 179.019 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.435 ' HB3' ' HG3' ' A' ' 15' ' ' ARG . 2.1 p30 47.25 27.79 0.91 Allowed 'General case' 0 C--O 1.231 0.101 0 CA-C-N 115.983 -0.553 . . . . 2.06 111.03 -179.639 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.928 HG23 ' O ' ' A' ' 99' ' ' ASP . 57.7 t -119.46 -21.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.576 -0.738 . . . . 2.8 111.355 179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.788 ' O ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 42.75 85.39 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.081 0.467 . . . . 4.58 111.703 -179.985 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.238 -0.887 . . . . 3.79 111.17 179.957 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.775 0.321 . . . . 2.74 111.256 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.495 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 94.4 Cg_endo -85.13 72.47 4.57 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.846 2.364 . . . . 2.06 112.345 -179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.623 HD12 ' ND2' ' A' ' 80' ' ' ASN . 1.7 tt -57.56 124.53 11.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.42 . . . . 0.68 111.406 -179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.88 ' OD1' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -102.46 128.24 28.64 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 2.0 110.423 179.798 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.45 173.1 14.77 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.512 2.141 . . . . 0.5 112.926 -179.54 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 33.7 Cg_exo -58.91 177.46 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.052 2.501 . . . . 0.71 113.172 -179.577 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.77 -152.62 22.13 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.48 -0.782 . . . . 0.66 112.734 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -85.48 122.3 73.47 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 120.301 0.096 . . . . 1.52 111.102 -179.897 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 7' ' ' LYS . 4.2 Cg_exo -76.95 134.08 14.34 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.498 2.132 . . . . 0.44 111.69 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 9.3 t -141.09 120.07 8.21 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 111.951 0.352 . . . . 1.09 111.951 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.61 ' HG2' HD11 ' A' ' 95' ' ' ILE . 20.3 Cg_exo -65.78 102.21 0.51 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.683 2.256 . . . . 0.64 112.92 -179.956 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -60.21 -45.27 93.73 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.847 -0.797 . . . . 1.64 108.847 179.046 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.17 138.27 54.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.741 -1.118 . . . . 0.72 108.426 178.718 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.826 HG21 HG12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -133.64 99.05 2.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.094 -0.642 . . . . 0.96 112.203 -179.331 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.39 148.97 23.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.544 -0.753 . . . . 1.46 110.079 179.346 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -60.93 -13.66 17.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.979 0.363 . . . . 2.42 111.979 -179.412 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.677 ' O ' HG23 ' A' ' 17' ' ' THR . 1.9 m-70 -134.68 31.45 3.37 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.673 0.273 . . . . 1.02 111.656 179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.773 HG22 ' HB3' ' A' ' 64' ' ' SER . 0.3 OUTLIER 162.14 125.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.627 -0.508 . . . . 0.68 109.627 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.028 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 11.8 m -120.4 149.41 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.269 -0.572 . . . . 0.8 111.492 179.774 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.633 ' C ' HD13 ' A' ' 20' ' ' LEU . 3.2 m -120.73 123.44 42.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.897 -0.592 . . . . 0.35 111.046 -179.345 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.881 HD21 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -129.56 161.71 29.89 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.808 0.813 . . . . 0.52 112.48 179.647 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.934 ' HG2' ' OE1' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -133.55 168.78 18.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.212 -1.358 . . . . 1.84 110.153 179.853 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.493 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.6 p90 -158.03 172.38 18.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.426 . . . . 0.4 111.304 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.12 139.77 30.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.877 -0.601 . . . . 0.83 111.964 -179.347 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -79.04 140.93 57.88 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 2.11 109.733 179.274 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HB2' HG23 ' A' ' 28' ' ' THR . 10.5 Cg_endo -53.14 -175.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.215 1.943 . . . . 0.89 111.619 179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.3 -37.56 2.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.365 -0.379 . . . . 2.77 111.55 -179.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.88 ' HB3' ' OD1' ' A' ' 3' ' ' ASP . 5.5 t80 -95.03 -71.09 0.68 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.551 -0.295 . . . . 1.37 111.579 -179.626 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.877 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 68.9 p 49.59 43.76 24.15 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.971 0.415 . . . . 0.91 110.509 -179.448 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.24 -93.89 0.01 OUTLIER Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.996 -0.547 . . . . 1.01 112.614 -179.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -142.48 39.71 1.34 Allowed Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 111.057 -0.817 . . . . 0.98 111.057 179.537 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.477 ' CD2' ' O ' ' A' ' 28' ' ' THR . 0.1 OUTLIER -124.5 176.99 6.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.529 -0.336 . . . . 0.87 110.909 -179.05 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.75 3.59 3.53 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.27 -0.423 . . . . 2.26 111.775 179.66 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.7 mt 58.77 117.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-O 121.091 0.472 . . . . 1.71 111.241 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.414 ' C ' ' HG ' ' A' ' 35' ' ' SER . 1.5 p -102.73 11.19 37.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.751 -0.658 . . . . 1.15 111.731 -179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -168.62 170.92 9.18 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.037 0.446 . . . . 1.58 111.502 -179.92 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.6 m-85 -154.06 75.47 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.534 -0.757 . . . . 0.76 109.917 179.578 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mt -50.14 144.11 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.564 -0.744 . . . . 1.14 111.497 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.879 HG11 HG21 ' A' ' 63' ' ' VAL . 3.6 t -129.23 107.01 14.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.348 -0.387 . . . . 0.63 111.407 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -93.2 149.03 21.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.092 -0.504 . . . . 1.67 110.431 179.735 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.739 ' HD2' ' HB2' ' A' ' 51' ' ' ALA . 0.3 OUTLIER -115.49 139.62 49.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.196 0.522 . . . . 1.97 112.116 179.737 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.554 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.4 OUTLIER -112.37 96.34 5.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.185 -0.916 . . . . 1.44 108.622 178.304 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.769 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -67.89 105.03 1.85 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.858 -0.61 . . . . 1.59 110.798 -179.136 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' HD2' ' A' ' 41' ' ' ARG . 10.6 mt -76.73 150.72 81.99 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.857 -0.61 . . . . 0.9 111.147 -179.807 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -87.89 9.05 64.13 Favored 'Cis proline' 0 C--N 1.35 0.622 0 C-N-CA 123.756 -1.352 . . . . 1.43 113.179 0.281 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -80.5 -88.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.49 -0.189 . . . . 2.66 110.49 179.699 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . 115.72 175.37 18.13 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.647 -0.787 . . . . 1.12 113.568 179.258 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' HG3' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 164.8 -25.64 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.267 0.227 . . . . 2.41 111.381 -179.923 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 85.4 m95 50.81 87.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.793 0.33 . . . . 0.65 111.065 -179.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -125.77 127.96 46.98 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.396 -0.365 . . . . 1.28 111.018 179.589 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 50' ' ' LYS . 16.8 ptmt -54.16 109.86 0.53 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.223 -0.444 . . . . 1.3 110.905 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.739 ' HB2' ' HD2' ' A' ' 40' ' ' LYS . . . -81.77 -35.95 29.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.86 110.709 179.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' CG ' HD11 ' A' ' 56' ' ' ILE . 1.2 t30 -48.36 -62.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.647 -0.706 . . . . 2.01 110.661 179.976 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.3 t80 51.61 37.18 19.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.766 0.317 . . . . 2.08 111.101 179.761 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 t -145.02 -82.91 0.15 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.335 -0.393 . . . . 1.89 110.811 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 172.85 120.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 1.87 111.192 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.858 HD12 ' CD1' ' A' ' 61' ' ' PHE . 8.2 mm -103.46 69.39 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.129 -0.487 . . . . 0.69 110.8 179.756 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.472 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -53.98 -46.48 71.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.97 0.414 . . . . 1.6 110.259 179.912 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.702 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pt-20 -99.61 154.35 18.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.864 -0.607 . . . . 1.54 109.996 179.571 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -68.21 -9.55 47.91 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.468 -0.333 . . . . 1.75 111.414 179.98 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.934 ' OE1' ' HG2' ' A' ' 21' ' ' LYS . 5.1 tp10 -93.59 98.61 11.27 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.836 -0.431 . . . . 2.05 109.836 179.711 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.858 ' CD1' HD12 ' A' ' 56' ' ' ILE . 70.4 t80 -133.98 164.01 28.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.103 0.478 . . . . 0.48 111.566 -179.427 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.531 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 19.2 m -117.38 116.44 27.19 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.626 -0.716 . . . . 0.42 110.808 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.881 HG23 HD21 ' A' ' 20' ' ' LEU . 65.1 t -86.53 96.38 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.0 0.428 . . . . 1.08 110.471 179.666 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.773 ' HB3' HG22 ' A' ' 17' ' ' THR . 1.2 p -85.59 158.54 20.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.785 -0.643 . . . . 1.33 110.373 179.799 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.5 -8.4 8.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.347 -0.842 . . . . 0.9 111.793 -179.304 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 18' ' ' VAL . 3.3 mm? -44.7 171.77 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.096 0.474 . . . . 1.47 111.356 179.676 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.6 m -147.59 123.86 10.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.868 -0.605 . . . . 1.06 110.714 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.1 mt-10 -48.43 137.14 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 1.91 111.191 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER 61.12 46.77 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.007 -0.542 . . . . 1.87 111.523 179.905 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 96' ' ' THR . . . -156.81 122.51 4.78 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.842 0.353 . . . . 0.49 111.526 179.791 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.57 135.71 45.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.36 110.086 179.318 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CD1' ' NZ ' ' A' ' 40' ' ' LYS . 42.5 m-85 -131.56 126.71 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.769 0.655 . . . . 0.56 112.769 -178.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 2.8 mt-10 -106.56 139.28 41.27 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.868 -0.789 . . . . 1.5 108.868 178.354 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.028 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -125.65 114.99 19.41 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.367 1.247 . . . . 0.6 114.367 -178.52 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 1.3 ttp85 -92.7 139.93 30.05 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.119 -0.492 . . . . 2.11 111.247 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 89' ' ' SER . 58.6 t -100.16 134.39 39.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.32 0.581 . . . . 0.6 111.0 179.816 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.9 mt -132.48 149.55 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.563 -1.273 . . . . 0.7 107.563 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -171.3 141.26 1.56 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.079 -1.048 . . . . 0.6 112.526 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 8.2 mttt -82.1 -123.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.79 -0.641 . . . . 1.98 110.65 179.634 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.623 ' ND2' HD12 ' A' ' 2' ' ' ILE . 54.5 p30 -170.02 -122.26 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.394 0.543 . . . . 2.19 109.583 -179.698 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -129.0 -1.16 5.24 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.432 1.014 . . . . 1.08 112.085 179.873 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.13 -1.32 14.42 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 111.894 0.331 . . . . 1.06 111.894 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.75 -19.53 41.3 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.188 -1.006 . . . . 0.93 113.014 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.588 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -61.41 158.53 14.47 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.949 -0.389 . . . . 1.38 109.949 179.742 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.7 tt -120.99 118.18 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 113.09 0.774 . . . . 0.79 113.09 -179.362 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -74.02 111.93 14.56 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 107.205 -1.406 . . . . 0.59 107.205 177.835 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.444 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 18.7 Cg_endo -57.86 170.82 1.82 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.149 2.566 . . . . 0.85 114.557 -178.051 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 7.6 Cg_exo -32.48 142.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 124.385 3.39 . . . . 0.76 113.821 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLU . 15.9 m -131.24 104.74 7.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.518 -0.764 . . . . 1.28 110.243 179.185 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 3.6 110.27 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.137 0 C-N-CA 124.872 1.269 . . . . 1.77 113.568 -179.974 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.515 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 23.9 Cg_exo -63.71 153.19 76.78 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.37 2.047 . . . . 0.55 114.421 -179.3 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.96 145.94 44.28 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.945 -1.025 . . . . 1.23 109.491 179.023 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -34.71 154.5 0.01 OUTLIER 'General case' 0 C--O 1.231 0.114 0 O-C-N 124.135 0.897 . . . . 1.63 112.207 -179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.21 111.23 19.18 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.48 179.252 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.826 HG12 HG21 ' A' ' 13' ' ' ILE . 4.1 mp -94.2 111.89 26.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.914 -0.314 . . . . 0.44 111.391 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 70' ' ' ALA . 12.4 m -48.37 -30.53 5.05 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.023 -0.535 . . . . 0.44 110.72 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.683 ' SG ' HD12 ' A' ' 66' ' ' LEU . 82.5 m 49.85 86.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.065 -0.516 . . . . 1.1 111.088 179.678 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.9 -84.99 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.34 -0.391 . . . . 3.0 110.519 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.574 ' O ' HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -99.92 -11.61 20.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.059 -0.519 . . . . 2.14 111.011 179.469 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 57.55 20.06 5.86 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.417 -0.356 . . . . 2.06 111.562 179.642 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -126.68 -2.97 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.671 -0.24 . . . . 2.8 111.446 179.766 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.1 -69.13 0.51 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.973 0.416 . . . . 4.58 110.436 -179.828 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.203 -0.903 . . . . 3.79 111.623 179.745 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.476 0.179 . . . . 2.74 111.041 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.41 175.48 9.58 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.506 2.137 . . . . 2.06 112.439 -179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.658 HD11 ' OD1' ' A' ' 80' ' ' ASN . 1.2 tt -143.12 144.62 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.68 110.714 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -130.56 131.89 23.63 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 2.0 110.738 179.83 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.21 162.43 28.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.435 2.09 . . . . 0.5 112.509 -179.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 19.2 Cg_endo -57.09 -179.56 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.01 2.474 . . . . 0.71 112.554 -179.907 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.29 -161.83 8.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.869 -0.681 . . . . 0.66 112.813 -179.794 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.94 118.88 70.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.559 -0.163 . . . . 1.52 110.559 179.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 36.7 Cg_exo -62.52 133.77 44.44 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.54 2.16 . . . . 0.44 112.74 -179.84 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.0 104.91 9.63 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.02 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 47.0 Cg_exo -51.01 99.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.261 1.974 . . . . 0.64 113.206 -179.594 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.878 HD11 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mt -55.56 -37.21 67.71 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.054 -0.721 . . . . 1.64 109.054 179.065 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 4.2 t30 -136.5 153.72 50.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.765 -1.107 . . . . 0.72 108.648 179.007 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.278 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 3.6 pt -143.78 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.402 -0.519 . . . . 0.96 112.208 -179.004 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.625 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -94.7 137.91 33.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.219 0.533 . . . . 1.46 110.117 179.412 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -40.47 -26.11 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.359 0.874 . . . . 2.42 113.359 -178.9 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -115.53 -19.96 10.4 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.53 -0.468 . . . . 1.02 111.966 -179.848 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.486 ' HA ' HD22 ' A' ' 66' ' ' LEU . 49.9 p -147.8 122.26 9.73 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.555 0.216 . . . . 0.68 110.659 -179.843 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.018 HG13 ' CD2' ' A' ' 66' ' ' LEU . 17.7 m -111.04 125.59 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.954 0.353 . . . . 0.8 111.954 -179.889 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 47.2 m -87.05 144.53 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.35 110.035 179.083 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.758 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -143.91 151.45 39.83 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.82 0.7 . . . . 0.52 112.521 -179.885 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.878 ' HB2' HD11 ' A' ' 11' ' ' LEU . 19.3 tptp -144.66 148.15 33.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.765 -1.107 . . . . 1.84 110.091 179.64 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.503 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 28.2 p90 -140.87 -176.51 4.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.4 112.248 -179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -82.44 -159.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.384 -0.825 . . . . 0.83 111.068 179.956 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -130.83 142.42 45.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.058 -0.519 . . . . 2.11 110.158 179.952 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.76 ' C ' ' OE1' ' A' ' 26' ' ' GLU . 88.2 Cg_exo -43.96 171.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.349 2.033 . . . . 0.89 112.458 179.826 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.76 ' OE1' ' C ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -106.92 -42.16 5.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 2.77 112.059 -179.608 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -118.03 -70.65 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.218 0.451 . . . . 1.37 112.218 -179.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 ' CG2' ' CB ' ' A' ' 25' ' ' PRO . 6.4 p 60.31 46.23 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.824 0.345 . . . . 0.91 110.454 -179.253 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.71 -109.63 0.35 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.814 -0.708 . . . . 1.01 112.193 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.69 31.9 3.45 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.525 -1.03 . . . . 0.98 110.525 179.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -114.38 -177.59 3.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.098 -0.551 . . . . 0.87 111.468 -178.908 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.53 15.38 1.44 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.919 -0.582 . . . . 2.26 111.743 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 ' CZ ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER 61.05 152.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.551 0.215 . . . . 1.71 111.27 179.699 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -140.5 8.26 2.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.548 0.573 . . . . 1.15 112.548 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.0 t -178.06 125.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 1.58 110.979 179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.691 ' O ' HD12 ' A' ' 56' ' ' ILE . 7.7 m-85 -108.64 98.14 7.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.76 111.553 -179.894 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.653 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.8 OUTLIER -91.21 124.72 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.956 -0.565 . . . . 1.14 110.157 179.477 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -110.18 119.1 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.265 0.555 . . . . 0.63 111.538 -179.507 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -73.91 137.45 43.67 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.402 -0.817 . . . . 1.67 109.397 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HD2' ' CD1' ' A' ' 72' ' ' TYR . 3.9 ttpm? -104.1 146.32 28.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.344 -0.389 . . . . 1.97 110.348 -179.226 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' HG2' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -128.75 86.55 2.46 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.05 0.452 . . . . 1.44 110.579 179.711 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.857 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -62.36 86.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.509 -0.769 . . . . 1.59 110.612 -179.828 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.71 HD12 ' CB ' ' A' ' 94' ' ' ALA . 76.5 mt -66.36 149.02 98.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.974 -0.557 . . . . 0.9 111.049 -179.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -93.23 27.38 18.68 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.893 -1.295 . . . . 1.43 112.719 0.337 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -136.25 45.16 2.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.512 -0.313 . . . . 2.66 111.369 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -87.28 179.0 48.03 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.474 -0.87 . . . . 1.12 112.344 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' N ' ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -158.79 31.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.873 0.368 . . . . 2.41 110.952 -179.727 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 53.4 m95 45.32 74.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.65 111.236 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' HE ' ' A' ' 47' ' ' ARG . 1.3 mp -109.31 133.08 53.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 1.28 111.016 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.653 ' HD2' HG21 ' A' ' 37' ' ' ILE . 8.4 mtmm -50.17 98.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.046 -0.524 . . . . 1.3 110.79 -179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -64.73 -53.56 45.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 0.86 110.772 -179.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 2.7 p-10 -71.0 129.12 38.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 2.01 110.873 179.843 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -124.62 34.92 4.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.372 -0.376 . . . . 2.08 111.077 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.9 m -130.41 -84.93 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 1.89 110.923 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -178.37 118.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.942 0.401 . . . . 1.87 110.964 -179.958 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.9 mt -109.04 74.34 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.69 110.968 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -56.74 -65.63 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 1.6 111.001 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.94 -178.48 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.547 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 10.9 p30 -92.56 2.88 56.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 1.75 111.672 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -102.98 101.82 11.83 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 110.049 -0.352 . . . . 2.05 110.049 179.524 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.661 ' HB2' HG23 ' A' ' 56' ' ' ILE . 72.8 t80 -135.06 163.92 28.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.48 111.44 -179.454 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 80.2 m -125.63 125.22 42.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.42 110.387 179.345 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.758 ' CG2' HD11 ' A' ' 20' ' ' LEU . 17.0 t -83.43 90.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.208 0.527 . . . . 1.08 111.691 -179.355 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.9 p -92.46 137.9 31.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.395 -0.821 . . . . 1.33 110.623 179.784 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.83 -5.61 7.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.9 112.456 -179.642 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.018 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -48.91 -179.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.121 0.486 . . . . 1.47 111.591 179.807 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -141.19 118.72 11.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 1.06 110.132 179.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 15' ' ' ARG . 0.6 OUTLIER -45.59 155.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.183 -0.462 . . . . 1.91 111.483 -179.561 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' CYS . 4.0 m-20 52.87 55.03 9.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 1.87 111.175 -179.884 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -168.71 121.17 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.326 -0.397 . . . . 0.49 111.296 179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.15 138.03 55.34 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.92 -0.4 . . . . 0.36 109.92 179.481 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.537 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.8 m-85 -128.83 112.97 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.713 1.005 . . . . 0.56 113.713 -178.37 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.6 tt0 -102.35 134.7 45.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 108.234 -1.024 . . . . 1.5 108.234 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.845 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.35 125.89 19.06 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.819 1.415 . . . . 0.6 114.819 -178.644 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -103.62 165.49 11.01 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.257 -0.883 . . . . 2.11 109.025 178.202 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -131.68 122.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 113.487 0.921 . . . . 0.6 113.487 179.688 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 86' ' ' SER . 29.4 mt -106.59 147.91 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 113.667 -1.606 . . . . 0.7 107.486 177.996 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -159.16 112.78 2.32 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.152 -1.019 . . . . 0.6 112.688 -179.412 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 mttp -56.21 -175.87 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.31 -0.626 . . . . 1.98 109.31 178.64 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.658 ' OD1' HD11 ' A' ' 2' ' ' ILE . 3.5 m120 -133.52 170.78 15.01 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.858 -0.337 . . . . 2.19 110.559 -179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.1 -27.81 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.58 0.585 . . . . 1.08 112.58 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -106.6 14.68 26.7 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.852 0.686 . . . . 1.06 112.852 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.96 -18.07 46.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.465 -0.874 . . . . 0.93 112.947 179.659 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.5 105.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.788 0.328 . . . . 1.38 110.903 179.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER -68.98 97.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.79 111.65 -179.462 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.553 ' O ' HG23 ' A' ' 77' ' ' ILE . 21.5 p -60.38 111.54 4.17 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 120.203 -0.599 . . . . 0.59 109.939 179.588 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -41.18 146.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.758 2.305 . . . . 0.85 112.683 -179.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HA ' ' CG1' ' A' ' 77' ' ' ILE . 1.6 Cg_endo -46.52 140.57 11.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.691 2.26 . . . . 0.76 112.807 -179.665 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 90' ' ' GLU . 2.0 m -96.42 108.67 21.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.811 . . . . 1.28 110.386 179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -2.95 108.83 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 124.715 1.206 . . . . 1.77 113.748 -179.935 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.511 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 78.3 Cg_exo -46.73 139.36 13.93 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.328 2.019 . . . . 0.55 113.28 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -76.27 147.41 38.28 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.893 -0.594 . . . . 1.23 109.51 179.338 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -39.08 147.1 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 123.967 0.792 . . . . 1.63 111.577 179.964 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.79 117.22 18.96 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.719 -0.673 . . . . 0.41 111.261 -179.71 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.711 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -95.48 113.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.597 179.408 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.431 ' HB ' ' NH1' ' A' ' 98' ' ' ARG . 84.5 m -51.82 -32.96 33.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 0.44 111.036 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 69' ' ' ASP . 3.6 m 54.57 89.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.1 110.138 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.431 ' NH1' ' HB ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -129.21 -78.0 0.56 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.223 0.535 . . . . 3.0 110.69 -179.803 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.151 ' OD2' ' HB ' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -126.19 0.98 7.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.49 -0.777 . . . . 2.14 111.052 179.717 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.278 ' OD2' ' O ' ' A' ' 13' ' ' ILE . 0.3 OUTLIER 49.43 24.22 1.04 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.784 0.326 . . . . 2.06 111.244 -179.706 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.151 ' HB ' ' OD2' ' A' ' 99' ' ' ASP . 53.5 t -132.37 0.64 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.317 -0.402 . . . . 2.8 112.016 179.876 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.007 ' HG2' ' OD1' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -119.75 -4.53 10.22 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.694 0.283 . . . . 4.58 111.21 179.702 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.247 -0.883 . . . . 3.79 111.069 179.797 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.454 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 111.52 0.193 . . . . 2.74 111.52 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 0' ' ' SER . 13.0 Cg_exo -71.1 -175.94 1.67 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.536 2.158 . . . . 2.06 111.85 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.457 HD12 ' OD1' ' A' ' 80' ' ' ASN . 2.8 tt -160.75 144.82 4.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.955 0.407 . . . . 0.68 111.238 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -132.12 125.95 20.29 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 2.0 110.497 179.982 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.15 161.18 41.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.357 2.038 . . . . 0.5 112.324 -179.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.42 -173.46 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.792 2.328 . . . . 0.71 112.969 -179.766 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -78.02 -154.13 6.84 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.488 -0.778 . . . . 0.66 113.017 -179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -94.36 141.83 24.05 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 120.293 0.092 . . . . 1.52 110.932 -179.83 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.662 ' HG3' HG23 ' A' ' 76' ' ' VAL . 1.4 Cg_endo -83.34 127.11 4.41 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.901 2.401 . . . . 0.44 112.411 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.99 102.75 10.02 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 1.09 110.97 -179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 83.9 Cg_exo -37.05 140.13 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.818 2.345 . . . . 0.64 112.88 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -108.39 -28.76 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.151 -179.769 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -160.45 109.16 1.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.797 -0.638 . . . . 0.72 109.911 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.747 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -106.6 148.51 10.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.714 1.005 . . . . 0.96 113.714 -178.883 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.437 ' CG2' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -141.38 165.88 26.29 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.197 -0.91 . . . . 1.46 110.867 179.382 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.19 ' HD2' ' OD2' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -42.69 -41.72 3.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.241 -0.891 . . . . 2.42 112.865 -179.44 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 66' ' ' LEU . 4.5 m-70 -132.87 27.46 4.27 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.938 0.718 . . . . 1.02 112.938 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.693 ' N ' HD21 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -166.3 112.74 0.85 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.499 -0.48 . . . . 0.68 111.354 179.04 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.032 HG13 HD22 ' A' ' 66' ' ' LEU . 1.7 m -110.61 127.64 67.5 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 C-N-CA 120.156 -0.618 . . . . 0.8 111.82 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 7.5 m -97.81 144.61 27.23 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.307 -0.627 . . . . 0.35 109.307 179.161 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.656 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -146.86 152.98 39.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.413 0.625 . . . . 0.52 112.323 -179.732 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -133.24 137.71 46.2 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.007 -0.997 . . . . 1.84 110.238 179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.7 p90 -138.0 178.25 7.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.865 0.364 . . . . 0.4 111.062 -179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.443 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -93.0 -167.78 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 0.83 110.899 179.816 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -137.15 161.58 60.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.849 0.357 . . . . 2.11 111.129 179.789 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.652 ' HB2' HG23 ' A' ' 28' ' ' THR . 31.4 Cg_exo -59.66 -177.67 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.878 2.386 . . . . 0.89 113.192 -179.568 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -137.17 7.51 2.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.536 179.761 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.685 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 20.8 t80 -142.84 -67.37 0.37 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.876 0.369 . . . . 1.37 110.858 179.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 25' ' ' PRO . 50.8 p 48.23 44.92 19.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.515 . . . . 0.91 110.776 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.61 -102.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 1.01 112.254 -179.982 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.05 26.68 4.18 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.204 -0.759 . . . . 0.98 111.204 179.234 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -115.03 -174.57 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.954 0.407 . . . . 0.87 111.055 -179.34 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 1.8 ttpt -145.04 25.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.91 -0.586 . . . . 2.26 110.833 -179.982 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.856 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.2 mm 60.77 148.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.866 0.365 . . . . 1.71 110.712 -179.897 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -135.46 17.93 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.266 -0.424 . . . . 1.15 111.025 179.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.654 ' H ' HG22 ' A' ' 33' ' ' ILE . 7.1 t 170.55 160.34 0.07 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.156 0.503 . . . . 1.58 111.383 -179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.856 ' CE1' HG21 ' A' ' 33' ' ' ILE . 37.8 m-85 -137.41 78.49 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 0.76 109.946 179.428 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.818 HG21 ' HE2' ' A' ' 50' ' ' LYS . 12.7 mt -80.66 118.26 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.88 -0.6 . . . . 1.14 111.663 -179.505 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.586 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -100.19 127.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.63 110.266 179.732 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 1.4 mm-40 -84.5 131.96 34.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.025 -0.534 . . . . 1.67 111.375 -179.583 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.666 ' HD3' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -95.23 140.59 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.719 -0.673 . . . . 1.97 112.659 -179.435 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.552 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 2.7 ttt180 -127.34 104.57 8.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 1.44 110.098 178.527 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.679 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -75.48 84.96 2.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 1.59 110.681 -179.79 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -51.01 154.7 2.41 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.485 -0.779 . . . . 0.9 110.828 -179.96 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.89 15.35 36.5 Favored 'Cis proline' 0 C--N 1.349 0.574 0 C-N-CA 123.875 -1.302 . . . . 1.43 112.951 0.376 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -117.61 -77.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.331 . . . . 2.66 111.111 -179.878 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' HA2' ' OD1' ' A' ' 42' ' ' ASP . . . 52.87 -178.16 0.11 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.63 -0.795 . . . . 1.12 112.006 -179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -163.94 29.73 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.791 0.329 . . . . 2.41 111.257 -179.823 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.552 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 61.1 m95 47.5 93.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.65 110.92 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -129.14 131.74 47.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.692 -0.403 . . . . 1.28 111.29 -179.656 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.818 ' HE2' HG21 ' A' ' 37' ' ' ILE . 17.7 ptpt -63.19 74.28 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.824 -0.626 . . . . 1.3 111.389 -179.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' CB ' ' HG3' ' A' ' 40' ' ' LYS . . . -55.64 -43.11 75.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.86 110.26 179.61 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.547 ' HB2' HD11 ' A' ' 56' ' ' ILE . 16.5 p-10 -42.07 -46.51 4.28 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.987 -0.551 . . . . 2.01 111.253 179.713 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.65 36.84 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 2.08 110.997 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m -144.35 -162.99 1.59 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.156 -0.475 . . . . 1.89 110.624 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' A' ' 35' ' ' SER . 0.1 OUTLIER -111.58 88.69 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 1.87 110.828 -179.906 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' CD1' ' A' ' 61' ' ' PHE . 10.2 mm -70.52 67.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.426 . . . . 0.69 111.1 179.861 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.19 -58.88 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.765 0.317 . . . . 1.6 110.363 179.784 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG22 ' A' ' 56' ' ' ILE . 3.8 pm0 -76.88 160.67 29.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.173 -0.677 . . . . 1.54 109.173 179.055 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 48.6 p30 -84.16 10.28 10.64 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.561 -0.456 . . . . 1.75 112.057 -179.651 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -115.02 98.79 7.01 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.365 -0.605 . . . . 2.05 109.365 179.349 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.845 ' CD1' HD12 ' A' ' 56' ' ' ILE . 81.2 t80 -130.02 163.65 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.447 0.641 . . . . 0.48 112.251 -179.041 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.522 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 25.7 m -117.15 114.91 24.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.013 -0.994 . . . . 0.42 110.872 179.232 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HD3' ' A' ' 40' ' ' LYS . 44.8 t -81.65 84.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.777 -0.647 . . . . 1.08 110.739 179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.677 ' HB3' HG22 ' A' ' 17' ' ' THR . 51.8 p -83.37 -179.78 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.72 . . . . 1.33 110.673 -179.792 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.18 -20.83 34.58 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.581 -0.819 . . . . 0.9 112.446 -179.894 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.032 HD22 HG13 ' A' ' 18' ' ' VAL . 1.3 pp -51.95 179.33 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.683 0.278 . . . . 1.47 110.482 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 3.0 m -140.55 127.56 20.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.929 0.395 . . . . 1.06 111.247 -179.482 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -54.52 157.34 2.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.11 0.481 . . . . 1.91 111.477 -179.877 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 97' ' ' CYS . 0.4 OUTLIER 68.84 47.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.577 -0.738 . . . . 1.87 110.649 -179.605 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.9 123.78 0.43 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.49 111.594 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -70.05 134.16 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.659 -0.497 . . . . 0.36 109.659 179.11 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.569 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 43.0 m-85 -127.37 118.22 23.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.819 0.674 . . . . 0.56 112.819 -178.677 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' HG3' ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -103.53 139.18 39.21 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.348 -0.612 . . . . 1.5 109.348 178.709 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -141.02 127.24 19.64 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.63 1.344 . . . . 0.6 114.63 -179.438 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -96.59 163.23 13.11 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.492 -0.777 . . . . 2.11 109.344 178.184 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.662 HG23 ' HG3' ' A' ' 8' ' ' PRO . 60.6 t -115.52 123.5 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 112.807 0.669 . . . . 0.6 112.807 -179.383 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -114.05 155.61 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 114.79 -1.095 . . . . 0.7 109.248 179.023 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -165.52 127.77 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.884 -0.726 . . . . 0.6 111.931 179.02 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 9.8 mttt -77.85 -157.12 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.082 -0.508 . . . . 1.98 110.358 179.828 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.513 HD21 ' HB3' ' A' ' 84' ' ' ALA . 6.9 p-10 -155.64 162.88 40.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.336 0.589 . . . . 2.19 111.415 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.11 -41.17 1.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 1.08 112.784 -179.756 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.691 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -70.34 -14.12 62.44 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.411 0.523 . . . . 1.06 112.411 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.51 -7.83 59.89 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.435 -0.888 . . . . 0.93 112.108 -179.201 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -66.56 170.02 6.83 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 110.004 -0.369 . . . . 1.38 110.004 179.634 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.683 HD11 HG23 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -119.02 120.25 63.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.512 0.56 . . . . 0.79 112.512 -179.294 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.45 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.2 p -81.64 118.8 73.58 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 108.076 -1.083 . . . . 0.59 108.076 178.344 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -46.47 158.91 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.761 2.307 . . . . 0.85 113.08 -178.863 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.0 Cg_endo -67.59 162.53 38.74 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.82 2.347 . . . . 0.76 113.896 -179.208 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 m -114.14 135.26 54.23 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.099 -0.955 . . . . 1.28 109.839 179.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -19.69 106.71 0.08 OUTLIER Pre-proline 0 N--CA 1.475 0.806 0 O-C-N 124.497 1.123 . . . . 1.77 113.48 -179.445 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.483 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 87.6 Cg_exo -43.83 141.79 3.95 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.57 2.18 . . . . 0.55 113.222 -179.944 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -76.11 147.13 38.8 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.626 -0.715 . . . . 1.23 109.817 179.418 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -37.21 146.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 O-C-N 124.207 0.942 . . . . 1.63 111.797 -179.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.761 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.78 108.91 11.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.932 -0.576 . . . . 0.41 110.66 179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 13' ' ' ILE . 4.6 mp -86.23 113.44 24.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.44 110.72 179.856 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 92.6 m -50.89 -46.32 60.53 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.44 110.033 179.748 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 69' ' ' ASP . 2.3 m 57.53 107.76 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 115.685 -0.689 . . . . 1.1 109.697 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.942 ' HD3' ' OD1' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -140.6 -85.35 0.21 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.975 0.417 . . . . 3.0 110.474 -179.602 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.97 ' O ' HG23 ' A' ' 101' ' ' VAL . 12.2 p-10 -106.65 32.18 4.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 2.14 109.183 179.245 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.437 ' OD1' ' CG2' ' A' ' 14' ' ' THR . 0.5 OUTLIER 47.93 24.17 0.57 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.192 -0.913 . . . . 2.06 111.356 -179.126 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 99' ' ' ASP . 21.0 t -123.87 -17.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.962 -0.563 . . . . 2.8 111.444 179.502 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.775 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 39.35 95.22 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.945 0.403 . . . . 4.58 111.772 179.97 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.344 -0.836 . . . . 3.79 111.065 179.911 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.678 0.275 . . . . 2.74 111.049 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.674 ' O ' HG22 ' A' ' 2' ' ' ILE . 14.5 Cg_exo -70.98 -41.52 2.68 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.878 2.385 . . . . 2.06 111.808 -179.878 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 1' ' ' PRO . 13.3 tt 52.87 150.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 124.114 0.884 . . . . 0.68 112.794 179.861 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -135.62 109.59 10.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.277 -0.874 . . . . 2.0 110.053 179.903 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.65 153.23 79.09 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.272 1.981 . . . . 0.5 112.271 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.64 179.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.889 2.392 . . . . 0.71 112.976 -179.5 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -77.22 -178.22 47.16 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.909 -0.587 . . . . 0.66 113.088 -179.644 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 10.6 tttt -69.28 136.11 88.95 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 120.448 0.166 . . . . 1.52 111.276 -179.875 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.59 ' HG3' HG23 ' A' ' 76' ' ' VAL . 5.1 Cg_exo -75.72 131.34 13.38 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.521 2.148 . . . . 0.44 112.201 179.665 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 21' ' ' LYS . 2.5 p -132.5 100.06 15.35 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.09 110.797 179.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 17.3 Cg_exo -52.63 122.66 11.3 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.025 1.816 . . . . 0.64 113.697 -179.234 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -82.95 -31.73 27.51 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.551 -0.907 . . . . 1.64 108.551 178.347 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.59 138.16 37.66 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.979 -1.009 . . . . 0.72 108.634 179.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.03 HG22 HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -139.43 94.92 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.306 -0.558 . . . . 0.96 112.308 -179.139 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 163.12 15.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.726 -0.67 . . . . 1.46 110.133 179.264 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -61.46 -21.38 64.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.36 -0.382 . . . . 2.42 111.944 -179.42 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 17' ' ' THR . 37.4 m170 -126.34 16.02 7.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 1.02 111.471 179.542 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 ' C ' HG23 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -158.68 159.28 35.14 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.826 -0.435 . . . . 0.68 109.826 179.683 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.03 HG13 HG22 ' A' ' 13' ' ' ILE . 82.5 t -156.2 91.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.924 -0.311 . . . . 0.8 111.563 -179.161 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 30.9 m -79.07 145.47 33.79 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.309 -0.405 . . . . 0.35 110.363 179.432 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.657 ' CD2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -149.13 161.8 41.25 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.736 0.779 . . . . 0.52 112.898 -179.072 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.225 ' HB2' ' OE1' ' A' ' 60' ' ' GLU . 1.0 OUTLIER -141.18 142.03 34.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.32 -1.309 . . . . 1.84 109.249 179.213 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.509 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 14.7 p90 -137.88 -174.28 3.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.73 0.3 . . . . 0.4 111.145 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -95.63 163.4 13.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.83 111.267 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -111.56 145.1 31.93 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 116.108 -0.496 . . . . 2.11 110.077 179.874 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HB2' HG23 ' A' ' 28' ' ' THR . 5.2 Cg_exo -77.82 162.61 29.51 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.31 2.007 . . . . 0.89 112.169 179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -112.78 -22.62 10.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 2.77 111.192 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -85.01 -72.61 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 1.37 111.137 -179.839 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.57 HG23 ' HB2' ' A' ' 25' ' ' PRO . 31.7 p 41.4 45.56 2.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.67 -0.241 . . . . 0.91 111.497 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.25 -92.53 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.703 -0.76 . . . . 1.01 112.409 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -153.14 43.14 0.64 Allowed Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.187 -1.165 . . . . 0.98 110.187 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -123.72 -176.43 3.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.147 -0.527 . . . . 0.87 111.368 -178.519 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 21.5 tttt -123.63 -20.28 5.55 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.084 -0.507 . . . . 2.26 111.975 -179.53 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt 68.51 112.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.688 -0.486 . . . . 1.71 109.688 -178.998 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -114.07 33.13 5.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.917 0.339 . . . . 1.15 111.917 -179.211 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.09 144.81 0.08 Allowed 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.278 0.473 . . . . 1.58 112.278 179.78 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.884 ' O ' HD12 ' A' ' 56' ' ' ILE . 57.0 m-85 -127.48 85.15 2.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.707 -0.678 . . . . 0.76 110.282 179.243 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.6 OUTLIER -79.76 105.02 8.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 1.14 111.487 -179.795 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.676 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -96.07 138.34 21.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.991 -0.744 . . . . 0.63 108.991 179.065 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HA ' ' CA ' ' A' ' 50' ' ' LYS . 6.0 mt-10 -96.76 152.36 18.75 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.052 0.22 . . . . 1.67 110.492 -179.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.505 ' HD2' ' CE1' ' A' ' 72' ' ' TYR . 8.8 ttpp -108.42 155.46 20.54 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 116.417 -0.356 . . . . 1.97 110.651 -179.06 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.611 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -134.08 103.6 5.86 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.733 -0.387 . . . . 1.44 110.085 178.993 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' HA ' ' CE1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -79.98 83.15 5.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 1.59 110.349 -179.741 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 94' ' ' ALA . 20.4 mt -61.24 159.67 28.27 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 0.9 111.077 -179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 43' ' ' LEU . 2.1 Cg_endo -82.63 24.47 9.08 Favored 'Cis proline' 0 C--N 1.352 0.763 0 C-N-CA 124.561 -1.016 . . . . 1.43 113.775 0.715 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -142.11 -80.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.844 0.354 . . . . 2.66 110.631 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 38.31 -161.9 0.01 OUTLIER Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.925 -0.579 . . . . 1.12 113.7 179.816 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -158.44 145.75 17.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.592 -0.522 . . . . 2.41 109.592 179.676 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.611 ' CZ2' ' HD2' ' A' ' 41' ' ' ARG . 74.7 m95 -63.61 78.59 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.08 -179.669 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -116.54 106.29 13.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.796 -0.638 . . . . 1.28 111.001 -179.615 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER 20.4 -151.03 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 O-C-N 124.82 1.325 . . . . 1.3 113.924 179.303 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.09 ' HB1' HG13 ' A' ' 63' ' ' VAL . . . 175.98 -39.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.001 -0.437 . . . . 0.86 110.451 -179.451 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.618 ' CB ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -75.28 -38.04 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.839 -0.619 . . . . 2.01 110.81 -179.969 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.2 t80 57.75 34.57 24.59 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.948 0.351 . . . . 2.08 111.948 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 11.2 t -170.23 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.797 0.295 . . . . 1.89 111.797 179.691 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 52' ' ' ASN . 10.1 t-20 -165.52 125.64 1.81 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.847 0.356 . . . . 1.87 110.412 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.884 HD12 ' O ' ' A' ' 36' ' ' TYR . 25.5 mt -109.86 75.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.459 . . . . 0.69 110.977 -179.916 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.4 tm? -53.22 -70.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 1.6 110.947 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -71.2 170.4 13.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.137 -0.32 . . . . 1.54 110.137 179.639 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 46.8 p-10 -84.69 6.1 25.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 1.75 111.874 -179.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.225 ' OE1' ' HB2' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -115.06 105.57 13.11 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.134 -0.691 . . . . 2.05 109.134 179.121 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.861 ' HB2' HG23 ' A' ' 56' ' ' ILE . 55.9 t80 -136.7 164.17 28.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.331 0.493 . . . . 0.48 112.331 -178.813 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 91.6 m -115.71 105.64 12.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.854 -0.612 . . . . 0.42 111.647 179.673 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.09 HG13 ' HB1' ' A' ' 51' ' ' ALA . 73.9 t -75.44 118.79 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.475 -0.784 . . . . 1.08 111.012 179.762 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.0 p -123.65 155.0 38.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 1.33 111.371 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.36 -4.03 8.24 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.9 112.862 179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.664 HD22 HG23 ' A' ' 18' ' ' VAL . 6.6 mp -65.81 165.94 11.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.105 0.479 . . . . 1.47 111.866 -179.592 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.8 m -121.49 127.38 50.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.601 -0.727 . . . . 1.06 110.347 179.72 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -48.97 145.25 4.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.486 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 97' ' ' CYS . 18.8 t0 68.22 54.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.837 -0.62 . . . . 1.87 111.527 179.576 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.77 120.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.541 -0.3 . . . . 0.49 111.335 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.544 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.56 135.86 53.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.467 -0.333 . . . . 0.36 110.236 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.505 ' CE1' ' HD2' ' A' ' 40' ' ' LYS . 20.7 m-85 -128.06 123.47 34.68 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.433 0.901 . . . . 0.56 113.433 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -106.19 140.72 38.71 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.378 -0.971 . . . . 1.5 108.378 178.119 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.51 129.02 28.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 114.719 1.377 . . . . 0.6 114.719 -178.482 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -103.82 146.2 28.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.031 -0.531 . . . . 2.11 110.142 178.282 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HB ' ' A' ' 38' ' ' VAL . 44.8 t -99.71 108.78 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 120.28 -0.568 . . . . 0.6 112.427 -179.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.49 HG12 ' CA ' ' A' ' 88' ' ' PRO . 77.1 mt -101.5 150.21 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.579 -1.267 . . . . 0.7 107.579 177.768 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -161.51 145.13 12.69 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.073 -1.051 . . . . 0.6 112.505 -179.642 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 4.4 ptpt -92.66 -161.23 0.81 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.555 . . . . 1.98 110.402 179.545 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.562 HD21 ' HB3' ' A' ' 84' ' ' ALA . 4.8 p-10 -150.46 165.92 31.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.989 0.423 . . . . 2.19 111.233 -179.274 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -43.47 -26.93 0.24 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.021 -0.536 . . . . 1.08 112.251 179.846 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.15 -20.34 21.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.969 0.359 . . . . 1.06 111.969 -179.382 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 80' ' ' ASN . . . 97.62 -1.45 60.04 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.702 -0.761 . . . . 0.93 112.81 -179.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -73.1 76.84 1.24 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.991 0.424 . . . . 1.38 110.421 179.672 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.526 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -34.24 125.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.879 1.066 . . . . 0.79 113.879 -178.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.518 ' HB3' HD11 ' A' ' 2' ' ' ILE . 14.0 p -90.6 124.97 61.07 Favored Pre-proline 0 C--O 1.241 0.642 0 CA-C-N 115.05 -0.977 . . . . 0.59 109.596 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -40.55 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.852 2.368 . . . . 0.85 112.832 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.49 ' CA ' HG12 ' A' ' 77' ' ' ILE . 8.0 Cg_exo -72.21 149.35 51.46 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.804 2.336 . . . . 0.76 112.885 -179.737 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 m -95.2 129.11 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.841 -0.618 . . . . 1.28 109.733 179.349 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.5 tp10 -20.17 103.15 0.07 OUTLIER Pre-proline 0 N--CA 1.479 0.991 0 O-C-N 124.494 1.121 . . . . 1.77 112.886 -179.575 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' HG3' ' CD ' ' A' ' 75' ' ' ARG . 36.5 Cg_exo -38.12 150.04 0.06 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.806 2.337 . . . . 0.55 114.041 -179.443 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.21 145.6 26.32 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.336 -0.847 . . . . 1.23 109.054 178.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -35.12 151.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 O-C-N 124.229 0.956 . . . . 1.63 111.894 -179.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -84.69 121.12 27.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.41 111.251 -179.536 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.8 mp -103.6 112.12 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.427 -0.351 . . . . 0.44 111.169 179.888 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 88.0 m -42.82 -34.11 0.88 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.44 111.965 -179.561 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.6 ' SG ' HD23 ' A' ' 66' ' ' LEU . 94.9 m 51.4 82.31 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.734 0.302 . . . . 1.1 110.586 -179.773 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 -81.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.112 0.482 . . . . 3.0 110.761 -179.733 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.245 ' CG ' ' HG3' ' A' ' 102' ' ' GLU . 2.4 p30 -117.79 -11.38 10.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.738 -0.664 . . . . 2.14 111.24 179.588 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 58.25 16.5 4.02 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 111.782 0.29 . . . . 2.06 111.782 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.646 ' O ' HG12 ' A' ' 101' ' ' VAL . 86.4 t -136.45 6.95 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 120.926 0.393 . . . . 2.8 111.148 179.627 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.245 ' HG3' ' CG ' ' A' ' 99' ' ' ASP . 6.1 mt-10 -126.02 -0.2 7.21 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.287 -0.258 . . . . 4.58 111.12 179.429 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.142 -0.932 . . . . 3.79 111.135 179.717 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.446 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.642 0.258 . . . . 2.74 111.261 . . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.446 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 91.9 Cg_endo -83.77 -167.75 0.48 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.723 2.282 . . . . 2.06 112.282 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 86' ' ' SER . 6.8 tt -155.59 146.36 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.68 111.199 179.807 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.95 130.09 23.09 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.829 -0.623 . . . . 2.0 110.023 179.644 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -81.59 173.86 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.189 1.926 . . . . 0.5 112.739 -179.453 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 53.1 Cg_exo -54.98 173.14 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.201 2.601 . . . . 0.71 113.419 -179.401 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.15 -163.41 39.18 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-N 115.759 -0.655 . . . . 0.66 112.773 -179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.3 tmtt? -78.63 114.83 46.79 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 110.549 -0.167 . . . . 1.52 110.549 179.799 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.682 ' HG2' HG12 ' A' ' 76' ' ' VAL . 20.4 Cg_exo -72.17 149.56 52.1 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.969 2.446 . . . . 0.44 113.487 -179.26 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -146.97 107.99 3.97 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.629 -0.714 . . . . 1.09 111.201 179.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HG3' HD22 ' A' ' 20' ' ' LEU . 38.7 Cg_exo -59.06 94.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.508 2.139 . . . . 0.64 113.041 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -51.25 -46.02 62.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.503 0.668 . . . . 1.64 109.454 179.244 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -122.3 150.27 42.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.959 -1.018 . . . . 0.72 108.408 178.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.816 ' HB ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -144.07 80.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.29 -0.564 . . . . 0.96 111.956 -179.219 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.08 156.53 35.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 1.46 110.288 179.594 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -61.4 -11.84 11.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.887 0.699 . . . . 2.42 112.887 -179.043 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.792 ' O ' HG23 ' A' ' 17' ' ' THR . 2.3 m-70 -140.07 20.19 2.45 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.811 -0.356 . . . . 1.02 111.581 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.6 OUTLIER 179.14 109.58 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.315 -0.402 . . . . 0.68 110.383 179.742 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.039 HG13 ' CD1' ' A' ' 66' ' ' LEU . 25.9 m -108.6 126.16 65.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.955 0.407 . . . . 0.8 111.364 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 54.7 m -96.61 137.76 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.97 -0.292 . . . . 0.35 111.054 179.709 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.654 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -139.56 164.25 30.4 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 124.061 0.85 . . . . 0.52 112.426 -179.737 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.692 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -152.48 153.7 34.04 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.933 -1.031 . . . . 1.84 110.519 179.614 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 31.7 p90 -146.93 -171.5 3.78 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.533 0.568 . . . . 0.4 112.533 -179.462 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.31 -158.37 0.18 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.584 -0.735 . . . . 0.83 110.834 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -142.75 139.21 16.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 2.11 110.475 -179.963 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HB3' HG23 ' A' ' 28' ' ' THR . 84.3 Cg_exo -34.42 148.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.124 2.549 . . . . 0.89 112.778 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.726 ' CA ' ' OE1' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -98.48 11.67 37.51 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.954 -0.566 . . . . 2.77 111.802 -179.592 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -169.95 -66.9 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.37 111.753 -179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' HB3' ' A' ' 25' ' ' PRO . 1.2 p 52.05 47.6 24.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.008 0.432 . . . . 0.91 110.197 -179.307 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.29 -108.65 0.23 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.802 -0.713 . . . . 1.01 112.31 -179.758 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.39 29.56 4.03 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.784 -0.926 . . . . 0.98 110.784 179.176 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' CD2' ' HB2' ' A' ' 80' ' ' ASN . 0.0 OUTLIER -114.74 -174.48 2.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.13 -0.535 . . . . 0.87 110.814 -178.967 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' THR . 2.0 pttt -143.08 32.94 1.36 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 2.26 111.594 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.838 HG21 ' CE1' ' A' ' 36' ' ' TYR . 7.7 mm 65.56 -71.02 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 1.71 111.365 179.861 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 81.59 -10.18 1.19 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.634 0.605 . . . . 1.15 112.634 179.63 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.808 ' H ' HG22 ' A' ' 33' ' ' ILE . 2.1 t -179.65 140.93 0.15 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.763 -0.375 . . . . 1.58 111.995 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.838 ' CE1' HG21 ' A' ' 33' ' ' ILE . 69.2 m-85 -116.59 138.73 51.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.164 -0.471 . . . . 0.76 110.852 179.409 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' CG2' ' HG2' ' A' ' 50' ' ' LYS . 5.0 mt -116.43 129.32 73.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.446 -0.343 . . . . 1.14 110.423 179.707 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.57 113.52 44.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.814 0.34 . . . . 0.63 111.813 -179.825 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 50.8 mt-10 -83.02 132.85 35.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 1.67 110.151 179.271 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.664 ' CE ' HD23 ' A' ' 66' ' ' LEU . 2.1 tttp -95.42 128.14 42.03 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 113.554 0.946 . . . . 1.97 113.554 -178.426 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 8.4 ttm180 -108.52 95.16 5.47 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.873 -0.603 . . . . 1.44 110.196 178.539 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.099 ' OD2' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -64.17 142.17 58.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.15 -0.477 . . . . 1.59 109.753 179.619 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.601 HD12 ' HB1' ' A' ' 94' ' ' ALA . 29.9 mt -123.71 133.11 24.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 120.754 -0.378 . . . . 0.9 110.919 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 43' ' ' LEU . 66.8 Cg_endo -90.96 47.7 1.32 Allowed 'Cis proline' 0 C--N 1.351 0.689 0 C-N-CA 124.28 -1.134 . . . . 1.43 113.125 0.495 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.414 ' O ' ' CG ' ' A' ' 42' ' ' ASP . 1.7 m120 -127.13 57.5 1.47 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.884 0.373 . . . . 2.66 110.801 -179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' ASP . . . -42.65 160.48 0.05 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.044 -0.526 . . . . 1.12 113.42 -179.634 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.099 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 5.4 ptm180 -179.86 -32.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.041 0.385 . . . . 2.41 112.041 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 64.0 m95 61.41 81.53 0.19 Allowed 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.296 -0.631 . . . . 0.65 109.296 -179.12 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.471 HD23 ' HG3' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -118.57 135.92 54.15 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.386 0.513 . . . . 1.28 112.386 -178.739 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' HG2' ' CG2' ' A' ' 37' ' ' ILE . 3.2 mtpm? -46.96 94.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.911 -0.586 . . . . 1.3 111.015 179.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -80.45 -42.29 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.089 -0.505 . . . . 0.86 111.551 -179.665 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.695 ' CB ' HD11 ' A' ' 56' ' ' ILE . 8.0 p-10 -54.21 -58.76 6.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.639 -0.255 . . . . 2.01 111.319 -179.678 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 39.56 49.27 1.96 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.053 0.39 . . . . 2.08 112.053 179.796 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.8 p -161.22 26.71 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.729 0.27 . . . . 1.89 111.729 179.911 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.32 113.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.844 0.354 . . . . 1.87 111.225 179.67 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.805 HG23 ' HB2' ' A' ' 61' ' ' PHE . 28.1 mt -109.94 71.12 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.69 110.827 179.587 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 34' ' ' THR . 4.9 mt -50.39 -59.57 3.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 1.6 111.3 -179.803 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 56' ' ' ILE . 5.7 pt-20 -86.93 158.91 19.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.917 0.389 . . . . 1.54 110.334 179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.497 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 4.7 p-10 -69.99 -7.93 44.88 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.024 -0.535 . . . . 1.75 111.772 -179.764 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -98.22 105.07 17.17 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.443 -0.577 . . . . 2.05 109.443 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.805 ' HB2' HG23 ' A' ' 56' ' ' ILE . 53.2 t80 -142.47 165.42 27.44 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.188 -0.46 . . . . 0.48 111.711 -179.002 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.5 m -120.96 121.37 37.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.42 111.074 179.778 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.654 ' CG2' HD11 ' A' ' 20' ' ' LEU . 14.5 t -81.7 110.8 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 116.113 -0.494 . . . . 1.08 111.637 -179.654 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' OG ' ' N ' ' A' ' 65' ' ' GLY . 47.6 t -97.38 -159.54 0.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.858 -0.61 . . . . 1.33 110.495 179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 61.19 23.48 62.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.64 -0.79 . . . . 0.9 112.114 -179.863 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.039 ' CD1' HG13 ' A' ' 18' ' ' VAL . 14.2 mt -76.03 169.8 17.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 1.47 110.944 -179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.42 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 2.1 m -134.17 141.32 47.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 1.06 110.564 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 15' ' ' ARG . 29.8 mt-10 -75.12 144.41 42.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.128 -0.487 . . . . 1.91 111.215 -179.783 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.9 t0 67.82 40.32 2.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 1.87 110.849 179.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . -155.53 115.34 3.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 0.49 111.42 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -67.72 130.34 42.69 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.49 -0.559 . . . . 0.36 109.49 179.082 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD1' ' HD3' ' A' ' 40' ' ' LYS . 57.8 m-85 -124.89 119.44 28.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.871 1.064 . . . . 0.56 113.871 -177.968 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 94' ' ' ALA . 5.8 mt-10 -102.66 139.97 37.55 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.684 -1.228 . . . . 1.5 107.684 177.631 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.92 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -132.91 122.07 23.79 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.028 1.492 . . . . 0.6 115.028 -178.574 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 91' ' ' PRO . 19.9 ttm-85 -94.93 143.81 26.17 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 114.509 -1.223 . . . . 2.11 109.086 178.087 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.682 HG12 ' HG2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -121.06 120.1 61.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 119.121 -1.031 . . . . 0.6 112.538 179.458 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -110.58 165.42 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-N 113.861 -1.518 . . . . 0.7 107.689 178.537 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -165.81 149.23 7.78 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 118.934 -1.106 . . . . 0.6 112.376 -179.839 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.692 ' HG2' HD12 ' A' ' 85' ' ' ILE . 4.0 mttt -99.12 -177.61 3.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.308 -0.406 . . . . 1.98 109.973 179.097 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.701 ' OD1' HD12 ' A' ' 2' ' ' ILE . 7.8 p-10 -136.41 166.72 22.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.06 -0.518 . . . . 2.19 110.907 -179.682 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.756 -0.656 . . . . 1.08 112.482 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.529 ' HB3' ' ND2' ' A' ' 80' ' ' ASN . . . -89.08 -20.28 24.52 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.654 0.613 . . . . 1.06 112.654 -179.25 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 98.81 -1.09 57.95 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.423 -0.894 . . . . 0.93 112.603 -179.59 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.48 ' O ' HD13 ' A' ' 2' ' ' ILE . . . -74.23 77.89 1.81 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.964 0.411 . . . . 1.38 110.297 179.74 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.692 HD12 ' HG2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -36.23 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.285 0.846 . . . . 0.79 113.285 -179.152 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.706 ' HB3' HD11 ' A' ' 2' ' ' ILE . 33.8 p -62.93 117.66 34.71 Favored Pre-proline 0 C--O 1.241 0.653 0 CA-C-N 115.599 -0.728 . . . . 0.59 109.415 178.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -35.32 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.363 2.709 . . . . 0.85 113.398 -179.342 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.515 ' N ' HG23 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -59.22 168.28 4.99 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.219 2.613 . . . . 0.76 113.499 -179.612 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.509 ' HB2' HG13 ' A' ' 76' ' ' VAL . 19.9 m -124.61 129.62 50.9 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.084 -0.962 . . . . 1.28 109.706 178.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 mt-10 -25.03 118.57 0.21 Allowed Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.688 0.795 . . . . 1.77 112.604 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 51.5 Cg_exo -55.53 154.68 23.87 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.363 2.042 . . . . 0.55 114.249 -179.211 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -84.78 146.43 27.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.08 -0.963 . . . . 1.23 109.092 178.961 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -40.31 146.81 0.12 Allowed 'General case' 0 C--N 1.333 -0.149 0 O-C-N 123.623 0.577 . . . . 1.63 111.428 -179.794 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -76.14 122.13 23.86 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.659 . . . . 0.41 110.671 -179.739 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.816 HG21 ' HB ' ' A' ' 13' ' ' ILE . 3.9 mp -102.28 109.09 25.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.632 -179.565 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 76.0 m -48.18 -36.11 13.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.087 -179.897 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.3 m 50.65 98.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 1.1 111.173 179.782 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -72.38 0.61 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.152 -0.476 . . . . 3.0 110.513 179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.713 ' O ' HG12 ' A' ' 101' ' ' VAL . 6.4 p-10 -141.52 10.91 2.08 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.769 -0.65 . . . . 2.14 111.726 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 t0 38.72 31.63 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.083 0.468 . . . . 2.06 111.624 -179.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 99' ' ' ASP . 14.2 p -159.29 24.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.676 -0.693 . . . . 2.8 110.928 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.87 -42.44 0.27 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.408 -0.36 . . . . 4.58 111.512 -179.776 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.161 -0.924 . . . . 3.79 111.207 179.99 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.744 0.307 . . . . 2.74 111.47 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -94.05 -164.7 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.449 2.766 . . . . 2.06 111.944 179.889 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.713 HD12 ' OD1' ' A' ' 80' ' ' ASN . 3.1 tt -164.36 150.2 2.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.186 0.517 . . . . 0.68 111.88 179.624 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.52 ' N ' HG12 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -125.99 136.51 28.57 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.436 -0.802 . . . . 2.0 109.55 179.262 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.21 161.37 23.18 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.192 1.928 . . . . 0.5 112.429 -179.616 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.0 Cg_exo -54.22 164.5 2.69 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.864 2.376 . . . . 0.71 113.108 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.45 169.17 29.5 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.511 -0.768 . . . . 0.66 112.229 179.803 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -68.55 126.61 92.9 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 110.066 -0.346 . . . . 1.52 110.066 179.61 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 32.9 Cg_exo -62.85 153.19 74.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.28 1.987 . . . . 0.44 113.422 -179.289 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -149.79 96.19 3.6 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.236 -0.893 . . . . 1.09 109.641 179.368 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 86.2 Cg_exo -40.36 118.84 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.178 1.919 . . . . 0.64 113.224 -179.129 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.949 ' CD2' ' OE2' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -84.99 -26.84 26.84 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.509 -0.923 . . . . 1.64 108.509 178.844 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.624 ' C ' HD13 ' A' ' 13' ' ' ILE . 2.0 t30 -147.87 153.08 38.66 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.642 -1.244 . . . . 0.72 107.642 178.169 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.849 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -147.51 134.72 13.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.118 -0.633 . . . . 0.96 112.225 -179.133 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.634 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -145.92 146.93 31.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.958 -0.565 . . . . 1.46 111.251 179.435 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.489 ' CD ' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -24.62 -48.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.541 -1.209 . . . . 2.42 114.002 -179.336 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.671 ' HA ' HD12 ' A' ' 66' ' ' LEU . 29.3 m-70 -128.78 22.03 5.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.675 0.621 . . . . 1.02 112.675 -179.016 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 16' ' ' HIS . 38.7 p -162.49 114.42 1.62 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.995 -0.372 . . . . 0.68 109.995 179.169 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.061 HG13 HD21 ' A' ' 66' ' ' LEU . 5.3 m -128.83 121.6 54.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.953 0.882 . . . . 0.8 113.025 -179.405 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 60.1 m -82.33 148.91 28.03 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 115.184 -0.916 . . . . 0.35 110.686 179.654 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -150.71 147.73 27.7 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 124.337 1.023 . . . . 0.52 111.189 179.721 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.208 ' HD3' ' OE1' ' A' ' 60' ' ' GLU . 19.3 tptm -129.54 151.86 49.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.275 -0.875 . . . . 1.84 110.718 179.793 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.494 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 49.1 p90 -150.36 -179.04 6.88 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 121.057 0.455 . . . . 0.4 112.17 179.801 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.78 162.15 13.16 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.722 -0.672 . . . . 0.83 111.597 -179.417 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -98.13 152.85 38.22 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.421 -0.354 . . . . 2.11 110.891 179.802 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 11.7 Cg_endo -55.1 141.28 80.03 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.013 2.475 . . . . 0.89 113.524 -179.501 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.68 -7.28 59.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 2.77 112.095 -179.917 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -134.1 -67.11 0.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.883 -0.327 . . . . 1.37 111.677 -179.877 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 28' ' ' THR . 4.5 t 35.85 49.59 0.58 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.302 0.573 . . . . 0.91 111.838 -179.201 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.47 -123.06 8.08 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.574 -0.739 . . . . 1.01 112.416 179.995 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.64 31.84 4.66 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.952 -0.859 . . . . 0.98 110.952 179.398 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 0.4 OUTLIER -103.47 -170.7 1.82 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.351 0.596 . . . . 0.87 112.238 -178.875 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 34' ' ' THR . 9.5 ttpt -145.84 24.74 1.33 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.069 -0.969 . . . . 2.26 110.744 179.856 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.039 HG21 ' CE1' ' A' ' 36' ' ' TYR . 24.2 mm 66.49 -70.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 116.248 -0.433 . . . . 1.71 111.119 179.918 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.4 p 83.36 -11.52 0.91 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.909 -0.587 . . . . 1.15 112.232 179.684 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.873 ' H ' HG22 ' A' ' 33' ' ' ILE . 6.9 t -178.98 140.81 0.17 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.773 0.321 . . . . 1.58 111.807 -179.875 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.039 ' CE1' HG21 ' A' ' 33' ' ' ILE . 59.2 m-85 -119.65 139.84 51.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.126 0.489 . . . . 0.76 111.11 179.596 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 76' ' ' VAL . 17.3 mt -116.97 130.84 71.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 1.14 110.088 179.367 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.423 HG23 ' CD1' ' A' ' 56' ' ' ILE . 31.9 t -104.68 109.48 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.293 0.479 . . . . 0.63 112.293 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.43 ' CB ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -81.87 107.93 14.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.557 -0.534 . . . . 1.67 109.557 178.979 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.765 ' HD3' ' HB2' ' A' ' 51' ' ' ALA . 2.3 ptmt -97.46 151.53 19.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.175 -0.466 . . . . 1.97 111.322 -179.368 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.439 ' HG2' ' CD2' ' A' ' 43' ' ' LEU . 12.2 ttp180 -139.01 120.29 14.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.123 -0.49 . . . . 1.44 111.366 -179.905 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.48 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -82.86 90.76 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.739 -0.664 . . . . 1.59 109.616 179.432 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -83.82 150.61 59.41 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.04 -0.527 . . . . 0.9 111.414 -179.228 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -94.01 28.35 17.24 Favored 'Cis proline' 0 C--N 1.35 0.652 0 C-N-CA 124.003 -1.249 . . . . 1.43 112.705 0.081 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -139.69 69.99 1.36 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 2.66 110.941 -179.893 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.42 -169.88 30.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.814 -0.708 . . . . 1.12 112.297 179.986 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' NE ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.05 168.28 25.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.072 0.463 . . . . 2.41 111.223 179.971 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.649 ' O ' HD22 ' A' ' 49' ' ' LEU . 70.7 m95 -69.71 118.43 12.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.715 -0.675 . . . . 0.65 111.393 -179.764 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.649 HD22 ' O ' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -147.38 127.55 13.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.062 -0.517 . . . . 1.28 110.705 179.994 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' CB ' ' CG2' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -65.27 83.41 0.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.063 -0.517 . . . . 1.3 111.368 -179.737 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.765 ' HB2' ' HD3' ' A' ' 40' ' ' LYS . . . -60.6 -38.67 85.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.86 110.434 179.672 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' OD1' ' CE1' ' A' ' 61' ' ' PHE . 4.2 t30 -40.13 -84.47 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.91 -0.586 . . . . 2.01 111.197 -179.997 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.8 t80 60.22 15.7 5.51 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.036 0.384 . . . . 2.08 112.036 179.568 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -122.75 22.42 9.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.71 0.291 . . . . 1.89 110.939 179.826 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 66.99 133.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.936 0.398 . . . . 1.87 111.224 179.834 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 61' ' ' PHE . 13.2 mt -129.38 74.1 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.69 110.857 179.993 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -56.69 16.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.47 -0.332 . . . . 1.6 111.057 -179.957 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.28 160.53 15.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 1.54 110.808 179.967 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 1.7 m-20 -70.46 -8.4 50.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.968 -0.56 . . . . 1.75 111.525 -179.869 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 1.208 ' OE1' ' HD3' ' A' ' 21' ' ' LYS . 14.7 tp10 -93.13 96.11 9.84 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.732 -0.47 . . . . 2.05 109.732 179.68 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.713 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.1 t80 -131.65 165.9 22.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.104 -0.498 . . . . 0.48 111.576 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 4.0 m -121.92 121.96 38.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.801 -0.636 . . . . 0.42 111.256 179.636 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.929 ' CG2' HD11 ' A' ' 20' ' ' LEU . 7.5 t -81.16 74.57 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.197 0.522 . . . . 1.08 110.294 -179.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 83.2 p -78.66 164.39 24.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.326 -0.852 . . . . 1.33 110.91 -179.589 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -9.97 64.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.586 -0.816 . . . . 0.9 113.009 179.922 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.061 HD21 HG13 ' A' ' 18' ' ' VAL . 4.4 pp -60.89 166.1 3.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 117.244 0.522 . . . . 1.47 110.694 -179.977 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 16' ' ' HIS . 0.3 OUTLIER -104.64 157.94 16.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.008 -0.542 . . . . 1.06 111.185 -179.478 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HG2' ' CD2' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -106.85 167.24 10.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.939 -0.573 . . . . 1.91 112.413 -179.289 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 2.2 t70 73.27 55.94 0.11 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.542 -0.753 . . . . 1.87 111.214 179.887 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 43' ' ' LEU . . . 165.58 138.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.785 -0.643 . . . . 0.49 110.363 179.818 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -56.87 133.85 54.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.9 0.381 . . . . 0.36 110.393 179.816 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.485 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 2.3 m-85 -126.35 116.68 21.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.947 -0.569 . . . . 0.56 111.898 -178.852 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 43' ' ' LEU . 2.2 mt-10 -106.13 145.85 30.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.93 -0.577 . . . . 1.5 109.495 179.027 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.009 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -138.98 115.52 10.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.348 1.24 . . . . 0.6 114.348 -179.242 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' HD3' ' CB ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -98.9 -178.45 3.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.794 -0.817 . . . . 2.11 108.794 177.922 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG1' ' HG3' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -150.48 130.7 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 119.309 -0.956 . . . . 0.6 112.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.759 HG22 HD11 ' A' ' 85' ' ' ILE . 55.6 mt -114.7 151.91 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.45 -1.25 . . . . 0.7 108.593 178.916 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.89 136.54 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.62 -0.832 . . . . 0.6 112.771 -179.662 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.58 -158.93 0.45 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.934 -0.576 . . . . 1.98 109.912 179.228 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' A' ' 2' ' ' ILE . 2.8 p-10 -160.34 176.31 11.84 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.402 0.62 . . . . 2.19 111.82 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -42.45 -29.55 0.28 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.068 -0.969 . . . . 1.08 112.169 179.796 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -94.22 -20.33 19.93 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.91 0.337 . . . . 1.06 111.91 -179.453 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 97.36 -2.7 61.16 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.48 -0.867 . . . . 0.93 112.981 -179.974 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.22 85.93 0.26 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.987 0.422 . . . . 1.38 110.391 179.77 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.759 HD11 HG22 ' A' ' 77' ' ' ILE . 5.3 tp -46.32 122.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 112.658 0.614 . . . . 0.79 112.658 -179.116 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' ILE . 26.7 p -82.31 120.98 78.17 Favored Pre-proline 0 C--O 1.236 0.395 0 CA-C-N 115.297 -0.865 . . . . 0.59 109.258 178.889 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 60.4 Cg_exo -38.54 163.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.904 2.403 . . . . 0.85 113.219 -179.495 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.619 ' HG3' HD11 ' A' ' 77' ' ' ILE . 4.2 Cg_exo -75.1 118.1 5.12 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.781 2.321 . . . . 0.76 112.72 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 3.3 t -68.5 137.84 54.73 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.822 -0.626 . . . . 1.28 109.968 179.516 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -32.68 125.74 0.39 Allowed Pre-proline 0 N--CA 1.47 0.525 0 O-C-N 124.027 0.829 . . . . 1.77 112.347 -179.451 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.524 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 38.6 Cg_exo -60.98 134.12 51.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.543 2.162 . . . . 0.55 113.206 -179.679 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.445 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -64.46 153.43 38.87 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.742 -0.663 . . . . 1.23 109.955 179.193 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -30.42 145.03 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.387 1.054 . . . . 1.63 112.652 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -84.56 112.24 20.24 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.702 -0.681 . . . . 0.41 109.718 179.376 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 97' ' ' CYS . 3.8 mp -97.77 113.89 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.813 -179.276 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 71.7 m -46.36 -28.89 1.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.128 0.49 . . . . 0.44 110.025 179.153 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.599 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.3 OUTLIER 45.27 55.44 6.4 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.634 -0.712 . . . . 1.1 111.266 179.555 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -79.88 -93.59 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.714 -0.394 . . . . 3.0 110.97 -179.694 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -110.93 39.22 2.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.112 0.482 . . . . 2.14 109.707 179.829 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.489 ' HB2' ' CD ' ' A' ' 15' ' ' ARG . 28.1 t0 47.73 22.38 0.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.866 -0.606 . . . . 2.06 111.192 -178.558 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.15 -26.95 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.928 -0.578 . . . . 2.8 110.06 179.405 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.588 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 50.4 54.07 11.8 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.869 -0.605 . . . . 4.58 110.774 -179.939 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.24 -0.886 . . . . 3.79 111.098 -179.862 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.599 0.237 . . . . 2.74 111.239 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -84.24 160.5 13.23 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.809 2.339 . . . . 2.06 111.762 179.677 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.526 HD12 ' CB ' ' A' ' 84' ' ' ALA . 5.0 tt -167.7 150.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.973 0.416 . . . . 0.68 111.975 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.465 ' N ' HG12 ' A' ' 2' ' ' ILE . 73.1 m-20 -139.67 130.71 14.54 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.769 -0.651 . . . . 2.0 110.226 179.496 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.21 164.07 29.63 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.262 1.975 . . . . 0.5 112.511 -179.654 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 11.9 Cg_endo -56.52 177.25 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.155 2.57 . . . . 0.71 113.219 -179.579 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.05 171.88 54.54 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.828 -0.624 . . . . 0.66 112.375 179.859 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -61.59 127.73 89.06 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.227 -0.286 . . . . 1.52 110.227 179.718 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.55 ' HG3' HG12 ' A' ' 76' ' ' VAL . 14.8 Cg_exo -73.67 150.04 44.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.566 2.178 . . . . 0.44 112.874 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.7 p -146.24 106.08 4.13 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 115.839 -0.619 . . . . 1.09 110.98 179.717 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 16.9 Cg_exo -59.89 111.45 0.98 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.346 2.031 . . . . 0.64 113.305 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.706 HD21 ' HB2' ' A' ' 21' ' ' LYS . 1.5 mm? -71.64 -39.35 70.45 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.643 -0.873 . . . . 1.64 108.643 178.791 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.65 148.99 51.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.591 -1.186 . . . . 0.72 108.572 179.119 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.795 HD12 ' CG2' ' A' ' 95' ' ' ILE . 4.4 pt -142.78 89.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.989 0.423 . . . . 0.96 111.539 -179.253 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.901 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -79.58 149.01 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 1.46 110.785 -179.866 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.901 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -40.41 -35.94 0.49 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.083 0.772 . . . . 2.42 113.083 -179.212 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.816 ' O ' HG23 ' A' ' 17' ' ' THR . 3.4 m-70 -135.25 31.62 3.19 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 1.02 111.437 -179.332 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -178.62 108.54 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.68 110.226 179.578 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 66' ' ' LEU . 9.5 m -112.82 143.38 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 120.415 -0.514 . . . . 0.8 111.159 -179.91 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 53.2 m -106.72 136.82 45.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.438 -0.346 . . . . 0.35 110.817 179.565 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.957 HD21 ' CG2' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.04 160.81 37.5 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.094 0.871 . . . . 0.52 112.569 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.706 ' HB2' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -148.4 147.11 28.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.909 -1.041 . . . . 1.84 110.456 179.465 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CD1' ' HB2' ' A' ' 5' ' ' PRO . 30.3 p90 -137.68 -175.12 3.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.133 0.492 . . . . 0.4 111.927 -179.575 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.86 156.86 16.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.577 -0.738 . . . . 0.83 110.908 179.725 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' CD ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -92.97 147.39 33.8 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.336 -0.393 . . . . 2.11 110.408 179.621 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 28' ' ' THR . 35.1 Cg_endo -63.72 173.08 4.94 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.325 2.017 . . . . 0.89 112.325 179.941 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -123.79 13.49 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 2.77 111.627 -179.853 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -144.01 -73.91 0.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 1.37 111.919 179.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.5 p 43.63 56.81 4.29 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.878 0.371 . . . . 0.91 110.811 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 42.16 -100.4 0.02 OUTLIER Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.543 . . . . 1.01 112.483 -179.528 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.8 34.33 1.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.009 -1.237 . . . . 0.98 110.009 179.152 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.617 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -116.11 -168.01 1.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.664 -0.768 . . . . 0.87 111.388 -178.717 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 34' ' ' THR . 0.0 OUTLIER -146.21 45.74 1.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.621 -0.718 . . . . 2.26 111.305 -179.958 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.812 HG22 ' H ' ' A' ' 35' ' ' SER . 12.2 mm 52.98 -87.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.43 -0.35 . . . . 1.71 111.086 179.731 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.561 HG23 ' C ' ' A' ' 33' ' ' ILE . 1.2 p 74.39 23.58 1.96 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.564 0.579 . . . . 1.15 112.564 179.261 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.812 ' H ' HG22 ' A' ' 33' ' ' ILE . 4.3 t 168.91 101.58 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.937 0.347 . . . . 1.58 111.937 179.562 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.845 ' O ' HD12 ' A' ' 56' ' ' ILE . 18.4 m-85 -102.61 93.52 5.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.56 . . . . 0.76 110.831 179.498 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.46 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 2.0 mt -85.9 114.68 26.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.747 0.308 . . . . 1.14 110.922 179.96 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 75' ' ' ARG . 14.4 t -89.27 121.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.278 -0.419 . . . . 0.63 111.737 -179.704 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -95.16 129.86 42.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 1.67 109.895 179.214 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.821 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -110.21 140.13 44.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.217 0.532 . . . . 1.97 111.968 -179.416 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HG3' ' HA2' ' A' ' 46' ' ' GLY . 13.0 ttm180 -111.9 112.63 24.43 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.366 -0.834 . . . . 1.44 109.616 179.047 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -81.8 101.22 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.601 -0.727 . . . . 1.59 110.644 -179.594 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 94' ' ' ALA . 10.0 mt -76.67 155.53 83.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.055 -0.521 . . . . 0.9 110.48 -179.895 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -87.57 9.06 63.62 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.142 -1.191 . . . . 1.43 113.287 0.519 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.77 -74.06 0.35 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.825 0.345 . . . . 2.66 110.195 179.75 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.517 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 98.06 155.96 29.75 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.735 . . . . 1.12 113.915 179.018 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 161.26 62.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 122.928 0.491 . . . . 2.41 109.799 -179.939 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.528 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 80.9 m95 -28.79 105.08 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.469 0.708 . . . . 0.65 112.593 -179.422 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.66 130.66 42.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.2 -0.454 . . . . 1.28 110.986 -179.988 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 2.5 ptmm? -56.19 91.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.887 -0.597 . . . . 1.3 111.481 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.821 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.36 -55.41 31.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.1 0.476 . . . . 0.86 110.142 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.647 ' CB ' HD11 ' A' ' 56' ' ' ILE . 9.1 p-10 -44.58 112.55 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.624 -0.717 . . . . 2.01 111.023 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.56 43.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 2.08 111.598 -179.604 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 t -168.18 172.2 8.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.391 . . . . 1.89 111.221 179.843 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 115.37 18.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.006 -0.543 . . . . 1.87 110.869 179.946 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.845 HD12 ' O ' ' A' ' 36' ' ' TYR . 35.6 mt -96.63 89.53 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.038 -0.528 . . . . 0.69 110.929 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 34' ' ' THR . 2.5 mt -61.22 -79.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 1.6 111.253 -179.798 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 172.18 1.4 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.54 110.726 -179.995 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 31.2 p30 -88.15 12.35 13.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 1.75 111.687 -179.851 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 53.5 tt0 -109.49 108.9 19.56 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.621 -0.511 . . . . 2.05 109.621 179.278 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.566 ' CE1' ' O ' ' A' ' 62' ' ' THR . 55.4 t80 -145.0 165.08 29.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.059 0.457 . . . . 0.48 112.055 -178.874 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.566 ' O ' ' CE1' ' A' ' 61' ' ' PHE . 99.5 m -119.22 112.89 20.05 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-N 115.671 -0.695 . . . . 0.42 110.26 179.497 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.957 ' CG2' HD21 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -79.76 89.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.762 -0.654 . . . . 1.08 110.51 -179.495 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.798 ' CB ' HG22 ' A' ' 17' ' ' THR . 25.4 t -88.05 -178.07 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.203 -0.908 . . . . 1.33 110.929 -179.49 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . . . 84.01 7.17 85.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.687 -0.768 . . . . 0.9 112.79 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 18' ' ' VAL . 2.8 pp -84.61 172.07 11.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.186 0.493 . . . . 1.47 110.887 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 68' ' ' GLU . 1.7 m -121.41 173.3 7.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.868 -0.605 . . . . 1.06 111.376 -179.218 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 67' ' ' THR . 2.7 tt0 -91.86 170.52 9.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.978 -0.555 . . . . 1.91 111.202 -179.93 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.814 ' CG ' ' O ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER 47.03 35.26 3.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 1.87 111.194 179.831 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -147.7 114.84 6.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.49 111.395 -179.832 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -68.19 123.47 20.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.672 -0.492 . . . . 0.36 109.672 179.283 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.523 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 58.0 m-85 -116.99 121.85 42.57 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.357 0.873 . . . . 0.56 113.357 -178.361 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 92' ' ' SER . 3.4 tt0 -102.85 136.76 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.829 -1.175 . . . . 1.5 107.829 177.832 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.707 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.26 126.53 21.39 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.933 1.457 . . . . 0.6 114.933 -178.519 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -101.0 -177.16 3.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.846 -1.07 . . . . 2.11 108.423 177.756 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.8 OUTLIER -147.89 106.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 119.656 -0.818 . . . . 0.6 112.655 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.465 HD11 ' HG3' ' A' ' 88' ' ' PRO . 42.7 mt -88.07 154.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.557 -1.646 . . . . 0.7 106.557 177.455 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.18 126.72 4.28 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 118.927 -1.109 . . . . 0.6 113.198 -179.144 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HG2' HD12 ' A' ' 85' ' ' ILE . 2.1 mttt -76.6 -159.87 0.13 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.637 -0.71 . . . . 1.98 109.394 178.681 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 4.5 m-80 -149.82 176.94 10.27 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.056 0.455 . . . . 2.19 111.338 -179.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -45.6 -26.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 1.08 111.682 179.773 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.26 10.36 29.85 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.427 0.528 . . . . 1.06 112.427 -179.571 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.46 -14.61 57.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.349 -0.929 . . . . 0.93 112.853 179.875 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' A' ' 2' ' ' ILE . . . -46.42 102.51 0.03 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.813 0.34 . . . . 1.38 111.258 -179.97 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.693 ' O ' HG23 ' A' ' 85' ' ' ILE . 2.0 tp -69.98 101.05 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.493 . . . . 0.79 111.819 -179.623 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.1 p -69.56 126.35 92.54 Favored Pre-proline 0 C--O 1.239 0.517 0 N-CA-C 109.502 -0.555 . . . . 0.59 109.502 179.371 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -39.2 160.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.716 2.278 . . . . 0.85 112.446 -179.53 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.5 Cg_exo -67.53 124.61 12.21 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.684 2.256 . . . . 0.76 113.054 -179.483 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.792 ' HB2' HG13 ' A' ' 76' ' ' VAL . 3.2 m -70.99 130.47 41.67 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.776 -0.647 . . . . 1.28 109.44 179.17 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -31.99 124.34 0.37 Allowed Pre-proline 0 N--CA 1.474 0.727 0 N-CA-C 112.538 0.57 . . . . 1.77 112.538 -179.316 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 32.2 Cg_exo -59.39 147.6 90.47 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.833 2.355 . . . . 0.55 113.387 -179.559 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.435 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.15 147.59 28.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.695 -0.684 . . . . 1.23 109.885 179.291 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.63 137.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.239 0 O-C-N 124.186 0.929 . . . . 1.63 111.736 -179.921 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -66.38 120.49 13.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.76 -0.655 . . . . 0.41 110.789 179.88 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.795 ' CG2' HD12 ' A' ' 13' ' ' ILE . 4.0 mp -100.42 109.54 25.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.44 111.337 -179.886 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.0 m -45.79 -48.88 15.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.27 -0.423 . . . . 0.44 111.32 -179.702 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' ASP . 0.8 OUTLIER 64.65 86.62 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.446 . . . . 1.1 110.42 -179.952 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.31 -86.24 0.65 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.865 -0.607 . . . . 3.0 111.071 -179.758 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.707 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 14.7 p30 -105.43 14.59 28.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.162 -0.472 . . . . 2.14 111.097 179.886 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.5 t0 50.35 26.76 2.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.023 0.44 . . . . 2.06 110.606 -179.827 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.707 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 4.8 p -125.02 -9.63 6.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.688 -0.687 . . . . 2.8 111.607 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 55.0 mt-10 -144.21 -78.07 0.21 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.759 0.314 . . . . 4.58 111.213 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.169 -0.92 . . . . 3.79 110.94 -179.92 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 1' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 120.731 0.301 . . . . 2.74 111.461 . . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 0' ' ' SER . 1.3 Cg_endo -85.25 57.49 4.7 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.248 2.632 . . . . 2.06 112.047 -179.918 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.74 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.3 tt -44.33 148.68 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.68 111.52 -179.926 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' ILE . 8.1 t70 -126.49 129.06 24.22 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.961 -0.563 . . . . 2.0 110.78 179.932 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.01 171.87 14.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.489 2.126 . . . . 0.5 112.276 -179.957 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 19.5 Cg_exo -66.86 -174.72 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.803 2.335 . . . . 0.71 113.182 -179.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.35 -177.81 49.67 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.4 -0.818 . . . . 0.66 112.852 -179.794 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -67.14 116.4 35.65 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.391 0.139 . . . . 1.52 110.681 179.866 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 22' ' ' TRP . 31.7 Cg_exo -62.76 142.75 90.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.595 2.197 . . . . 0.44 112.374 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 9' ' ' VAL . 14.6 p -145.95 104.42 4.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 1.09 111.976 -179.476 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 52.9 Cg_exo -50.26 113.24 0.94 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.532 2.155 . . . . 0.64 112.751 -179.963 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -63.86 -46.49 84.72 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.774 -0.825 . . . . 1.64 108.774 178.977 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.29 151.25 50.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.28 -1.327 . . . . 0.72 108.321 179.016 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.587 ' HB ' HG21 ' A' ' 95' ' ' ILE . 4.4 pt -143.17 70.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.399 -0.52 . . . . 0.96 111.567 -179.104 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -72.44 146.88 46.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.613 -0.721 . . . . 1.46 110.468 179.864 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -65.99 61.24 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.764 0.792 . . . . 2.42 112.387 -179.413 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 15' ' ' ARG . 0.9 OUTLIER 167.82 -29.22 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.758 -0.655 . . . . 1.02 110.509 179.09 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -146.4 126.12 13.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.472 -0.566 . . . . 0.68 109.472 179.27 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.026 HG13 ' CD1' ' A' ' 66' ' ' LEU . 3.9 m -116.77 120.57 65.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.189 0.44 . . . . 0.8 112.189 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.587 ' OG1' HG23 ' A' ' 62' ' ' THR . 97.6 m -91.63 142.34 27.73 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.692 -0.231 . . . . 0.35 110.892 179.303 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -140.4 156.03 46.53 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 124.146 0.904 . . . . 0.52 112.992 -179.641 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 1.8 tppp? -145.15 159.11 43.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.316 -1.311 . . . . 1.84 109.59 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 40.0 p90 -155.66 -176.45 5.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.13 0.49 . . . . 0.4 112.086 -179.879 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -94.95 133.37 38.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.569 -0.741 . . . . 0.83 111.685 -179.664 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -70.64 141.56 87.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.009 -0.541 . . . . 2.11 109.686 179.35 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 6.3 Cg_endo -48.62 175.97 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.095 1.863 . . . . 0.89 111.431 179.705 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -123.7 -25.66 4.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.33 0.493 . . . . 2.77 112.33 -179.367 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -106.45 -70.94 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.005 0.372 . . . . 1.37 112.005 -179.603 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.475 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 3.2 p 52.08 41.18 29.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.649 0.261 . . . . 0.91 110.36 -179.313 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.87 -91.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.861 -0.685 . . . . 1.01 112.232 -179.805 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -147.73 35.53 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 N-CA-C 110.077 -1.209 . . . . 0.98 110.077 179.141 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CE1' ' HB2' ' A' ' 82' ' ' ALA . 0.5 OUTLIER -117.39 172.31 7.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.898 -0.651 . . . . 0.87 111.635 -178.464 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -123.86 -3.45 8.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.852 -0.613 . . . . 2.26 111.519 179.828 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 35' ' ' SER . 16.2 mt 64.01 155.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.132 0 N-CA-C 110.505 -0.183 . . . . 1.71 110.505 -179.908 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 4.6 p -139.56 8.27 2.38 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.482 0.549 . . . . 1.15 112.482 -179.522 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.44 ' H ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER 178.49 149.39 0.22 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.826 0.346 . . . . 1.58 111.923 -179.994 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.8 m-85 -126.38 119.83 28.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.983 -0.553 . . . . 0.76 110.101 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.84 116.15 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.73 0.3 . . . . 1.14 111.471 -179.585 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -106.44 104.48 17.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.303 0.573 . . . . 0.63 110.671 179.588 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HB3' ' N ' ' A' ' 49' ' ' LEU . 4.8 mt-10 -73.52 157.33 36.97 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.284 -0.871 . . . . 1.67 110.38 179.621 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.6 OUTLIER -118.23 137.41 53.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.97 111.466 -179.569 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.566 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -113.9 120.2 39.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.966 -0.561 . . . . 1.44 110.726 179.656 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.837 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -79.71 77.7 6.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 1.59 110.552 179.846 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.637 ' CD1' ' HB2' ' A' ' 94' ' ' ALA . 52.8 mt -53.3 145.16 27.33 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.637 -0.71 . . . . 0.9 111.151 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -93.42 27.03 19.26 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.903 -1.29 . . . . 1.43 112.708 0.174 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -153.6 81.89 1.17 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.781 0.324 . . . . 2.66 111.861 -179.835 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.75 -152.83 10.44 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.942 -0.647 . . . . 1.12 111.968 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.853 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -167.15 29.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.027 0.413 . . . . 2.41 111.759 179.894 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' CZ2' ' NH1' ' A' ' 41' ' ' ARG . 69.1 m95 41.06 101.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.832 0.678 . . . . 0.65 112.832 179.422 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -131.48 117.97 19.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.031 -0.531 . . . . 1.28 110.045 179.085 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -43.5 106.54 0.07 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.935 0.398 . . . . 1.3 111.484 -179.503 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' HB3' HG13 ' A' ' 63' ' ' VAL . . . -73.04 -36.54 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.959 -0.564 . . . . 0.86 111.285 -179.867 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.687 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.3 p-10 -69.58 -173.55 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.336 -0.393 . . . . 2.01 110.958 -179.853 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 52' ' ' ASN . 4.0 t80 176.93 -22.08 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.515 -0.766 . . . . 2.08 111.799 179.889 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.99 35.78 0.8 Allowed 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.075 0.398 . . . . 1.89 112.075 -179.497 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.51 122.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.859 0.361 . . . . 1.87 111.294 179.594 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 52' ' ' ASN . 35.2 mt -114.27 68.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.69 110.987 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -73.44 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 1.6 111.158 -179.892 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 60' ' ' GLU . 1.7 pm0 -70.2 166.53 19.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.99 0.424 . . . . 1.54 110.759 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.7 p30 -78.83 1.69 22.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.904 -0.589 . . . . 1.75 111.537 179.873 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.452 ' HB2' ' CE ' ' A' ' 21' ' ' LYS . 7.1 tt0 -98.56 100.14 11.35 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.966 -0.383 . . . . 2.05 109.966 179.608 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' HB2' HG23 ' A' ' 56' ' ' ILE . 60.8 t80 -136.81 164.45 28.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.238 0.542 . . . . 0.48 111.648 -179.502 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.587 HG23 ' OG1' ' A' ' 19' ' ' THR . 5.6 m -125.55 125.14 42.75 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.463 -0.79 . . . . 0.42 110.398 179.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' LEU . 9.1 t -87.53 91.69 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.214 0.531 . . . . 1.08 110.747 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 17' ' ' THR . 24.2 p -85.52 -157.95 0.35 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.375 -0.829 . . . . 1.33 110.825 -179.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 49.55 27.78 9.19 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.578 -0.82 . . . . 0.9 112.086 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.026 ' CD1' HG13 ' A' ' 18' ' ' VAL . 27.8 mt -75.61 164.98 25.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.934 0.397 . . . . 1.47 111.025 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.424 ' HB ' ' OH ' ' A' ' 72' ' ' TYR . 1.8 m -115.27 101.59 9.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.557 . . . . 1.06 110.363 179.756 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 7.6 tt0 -49.25 150.15 1.84 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.489 -0.323 . . . . 1.91 111.179 -179.748 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 68' ' ' GLU . 20.2 m-20 70.92 46.73 0.46 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.983 -0.553 . . . . 1.87 110.676 -179.625 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB3' ' CE2' ' A' ' 72' ' ' TYR . . . -167.83 121.42 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.034 -0.53 . . . . 0.49 111.139 -179.927 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -74.86 117.41 16.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.055 -0.35 . . . . 0.36 110.055 179.477 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.556 ' CE2' ' HB3' ' A' ' 70' ' ' ALA . 78.2 m-85 -113.78 128.95 56.62 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' PRO . 5.8 mt-10 -95.41 146.4 24.43 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.469 -0.937 . . . . 1.5 108.469 178.271 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.825 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -123.85 108.94 13.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.376 1.621 . . . . 0.6 115.376 -178.177 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' CZ ' ' HD3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -97.71 133.8 41.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.133 -0.94 . . . . 2.11 109.374 178.304 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -117.01 125.36 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 119.141 -1.023 . . . . 0.6 113.678 179.811 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.785 HG23 ' O ' ' A' ' 86' ' ' SER . 37.0 mt -114.74 145.57 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 113.589 -1.642 . . . . 0.7 108.03 178.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -154.34 125.39 7.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.858 -0.737 . . . . 0.6 112.541 -179.521 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.54 ' HB3' HD12 ' A' ' 85' ' ' ILE . 15.5 ptpt -79.85 156.14 27.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.25 179.276 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.74 ' ND2' HD12 ' A' ' 2' ' ' ILE . 5.0 p30 -102.36 172.92 6.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.465 0.65 . . . . 2.19 112.185 -179.32 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.26 -46.73 9.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.949 -1.023 . . . . 1.08 111.963 179.72 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.76 ' HB2' ' CE1' ' A' ' 31' ' ' PHE . . . -65.64 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 1.06 111.887 -179.273 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.22 -21.56 21.98 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.532 -0.842 . . . . 0.93 112.208 -179.809 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.633 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -49.18 154.03 0.88 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.989 -0.374 . . . . 1.38 109.989 179.542 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' ILE . 4.1 tp -108.58 115.78 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.255 0.465 . . . . 0.79 112.255 -179.38 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.785 ' O ' HG23 ' A' ' 77' ' ' ILE . 24.1 p -69.72 113.84 20.23 Favored Pre-proline 0 C--O 1.235 0.34 0 N-CA-C 108.033 -1.099 . . . . 0.59 108.033 178.583 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.19 150.25 14.6 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.319 2.013 . . . . 0.85 113.005 -178.905 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' CA ' HG12 ' A' ' 77' ' ' ILE . 10.7 Cg_exo -38.93 141.51 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.46 2.774 . . . . 0.76 113.961 -179.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 90' ' ' GLU . 16.0 m -106.01 110.6 22.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.957 -1.02 . . . . 1.28 109.698 179.054 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.7 tp10 -5.12 116.08 0.02 OUTLIER Pre-proline 0 N--CA 1.483 1.205 0 O-C-N 124.815 1.322 . . . . 1.77 113.471 -179.534 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 81.2 Cg_exo -51.05 142.29 35.0 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.451 2.1 . . . . 0.55 114.554 -179.14 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.418 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -75.56 152.15 37.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 178.427 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -41.89 145.73 0.31 Allowed 'General case' 0 CA--C 1.521 -0.156 0 O-C-N 123.343 0.402 . . . . 1.63 110.978 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.643 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -78.8 121.48 24.84 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.993 -0.549 . . . . 0.41 111.07 -179.416 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.587 HG21 ' HB ' ' A' ' 13' ' ' ILE . 4.1 mp -100.77 114.94 41.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.266 -0.425 . . . . 0.44 111.175 -179.995 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.0 m -51.47 -44.21 62.37 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.919 -0.582 . . . . 0.44 110.655 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 68' ' ' GLU . 50.3 t 62.43 67.94 0.69 Allowed 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 116.17 -0.468 . . . . 1.1 110.958 179.651 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.77 -84.61 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 3.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 2.7 p30 -122.58 -0.67 9.15 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.878 -0.601 . . . . 2.14 111.109 179.719 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.49 26.1 1.08 Allowed 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.991 0.424 . . . . 2.06 111.236 -179.969 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 101' ' ' VAL . 14.9 p -156.14 24.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 2.8 110.815 179.765 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' OE2' ' N ' ' A' ' 99' ' ' ASP . 2.4 mp0 -126.65 -41.49 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.119 -0.491 . . . . 4.58 110.88 -179.693 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.251 -0.88 . . . . 3.79 111.158 -179.818 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 111.677 0.251 . . . . 2.74 111.677 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.27 59.32 6.95 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.416 2.077 . . . . 2.06 112.364 -179.855 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.448 ' CD1' ' OD1' ' A' ' 80' ' ' ASN . 5.5 tt -46.64 149.16 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.68 111.475 -179.977 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -129.78 124.99 22.02 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.787 -0.642 . . . . 2.0 111.194 179.699 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.07 161.76 35.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.427 2.084 . . . . 0.5 111.976 179.793 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 18.2 Cg_endo -59.06 170.39 2.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.592 2.195 . . . . 0.71 112.783 -179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.531 ' HA3' ' HB3' ' A' ' 23' ' ' ALA . . . -70.55 167.66 49.94 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.695 -0.684 . . . . 0.66 112.882 -179.749 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 tmtt? -51.43 119.37 12.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.505 -0.183 . . . . 1.52 110.505 179.806 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' CG ' HG23 ' A' ' 76' ' ' VAL . 16.5 Cg_exo -70.06 152.8 67.91 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.398 2.066 . . . . 0.44 111.491 179.909 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.1 p -151.96 121.22 3.42 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.243 0.46 . . . . 1.09 112.243 -179.068 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HG2' HD11 ' A' ' 95' ' ' ILE . 16.2 Cg_exo -65.75 111.95 2.07 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.552 2.168 . . . . 0.64 112.192 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.671 HD22 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -76.45 -33.09 58.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.92 0.39 . . . . 1.64 110.625 179.711 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' O ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -148.56 126.02 11.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.006 -0.543 . . . . 0.72 110.113 179.891 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.872 HG22 ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -114.9 128.11 72.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.955 0.407 . . . . 0.96 111.606 -179.605 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -115.18 44.51 1.81 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.784 -0.644 . . . . 1.46 112.099 -179.318 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 66' ' ' LEU . 11.8 mtm180 55.64 -72.89 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.138 0.792 . . . . 2.42 113.138 178.749 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m170 -75.8 -29.89 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 1.02 110.934 -179.441 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.497 ' HA ' HD22 ' A' ' 66' ' ' LEU . 60.4 p -134.27 128.84 34.65 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.656 -0.498 . . . . 0.68 109.656 179.419 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.023 HG13 ' CD2' ' A' ' 66' ' ' LEU . 3.6 m -115.44 154.37 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.452 -0.499 . . . . 0.8 111.215 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 13.4 m -119.72 114.76 22.65 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.334 -0.394 . . . . 0.35 111.779 -178.997 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.855 ' CD1' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.04 158.0 40.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.686 0.755 . . . . 0.52 111.154 178.879 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' CG ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.18 -179.2 5.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.652 -1.158 . . . . 1.84 109.591 179.813 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 24.7 p90 -162.08 175.46 11.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.328 0.585 . . . . 0.4 112.24 179.521 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HB3' ' HA3' ' A' ' 6' ' ' GLY . . . -88.18 175.21 7.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.315 -0.857 . . . . 0.83 110.699 179.807 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.64 141.47 24.7 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.41 -0.359 . . . . 2.11 110.476 179.883 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.696 ' HB2' HG23 ' A' ' 28' ' ' THR . 11.1 Cg_endo -54.48 -176.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.7 2.267 . . . . 0.89 112.464 -179.963 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.23 -27.25 4.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 2.77 111.948 -179.77 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -113.84 -69.54 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.95 0.352 . . . . 1.37 111.95 -179.556 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 25' ' ' PRO . 46.0 p 52.59 48.27 22.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.919 0.39 . . . . 0.91 110.227 -179.359 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.78 -101.16 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.657 -0.782 . . . . 1.01 112.03 -179.837 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.63 31.77 2.1 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 110.516 -1.034 . . . . 0.98 110.516 179.22 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB2' ' HB3' ' A' ' 80' ' ' ASN . 1.6 m-85 -107.44 -172.76 2.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.836 -0.682 . . . . 0.87 111.92 -178.806 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.428 ' O ' ' CE ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -144.25 7.08 1.34 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.923 -1.035 . . . . 2.26 111.832 179.187 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.013 HG21 ' CE1' ' A' ' 36' ' ' TYR . 2.1 mt 52.25 115.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.26 0.552 . . . . 1.71 112.329 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 p -117.12 22.76 12.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.018 -0.537 . . . . 1.15 111.357 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 0.0 OUTLIER 175.69 113.32 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.226 0.454 . . . . 1.58 112.226 -179.865 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 33' ' ' ILE . 43.2 m-85 -97.45 138.08 35.43 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 110.095 -0.335 . . . . 0.76 110.095 178.884 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 0.7 OUTLIER -125.77 111.99 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.894 0.378 . . . . 1.14 110.67 179.485 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -99.37 115.8 41.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.364 -179.644 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.569 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.2 mt-10 -76.51 142.65 40.81 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.714 -0.675 . . . . 1.67 110.32 179.7 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.65 ' HE3' ' HB2' ' A' ' 51' ' ' ALA . 27.5 ttmt -106.11 146.02 30.72 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 120.749 0.309 . . . . 1.97 110.642 -179.577 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -129.8 100.77 5.6 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.547 -0.461 . . . . 1.44 110.483 178.931 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.53 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 0.2 OUTLIER -70.6 78.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.618 -0.719 . . . . 1.59 110.689 -179.927 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.665 HD12 ' HB1' ' A' ' 94' ' ' ALA . 81.2 mt -50.44 154.88 1.98 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 0.9 111.02 -179.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -87.91 27.57 13.36 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.76 -1.35 . . . . 1.43 112.759 0.349 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -126.33 -79.3 0.6 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.574 0.225 . . . . 2.66 110.996 -179.922 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 48.84 -178.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.823 -0.703 . . . . 1.12 112.907 179.845 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -162.27 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.954 0.407 . . . . 2.41 110.552 179.95 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' HB2' ' A' ' 41' ' ' ARG . 62.2 m95 43.93 89.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.942 -0.572 . . . . 0.65 111.635 179.94 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.629 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -121.25 127.91 51.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.369 -0.378 . . . . 1.28 110.602 179.915 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -52.32 90.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.347 . . . . 1.3 110.627 -179.992 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.797 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -60.2 -46.06 91.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.022 -0.535 . . . . 0.86 110.635 -179.974 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.814 ' HB2' HD11 ' A' ' 56' ' ' ILE . 10.9 p-10 -64.99 102.01 0.57 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 2.01 111.587 -179.828 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.84 -15.65 47.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.085 -0.507 . . . . 2.08 110.664 179.27 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 p -86.62 -155.82 0.28 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 116.38 -0.373 . . . . 1.89 110.471 179.913 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.22 107.77 15.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.798 0.333 . . . . 1.87 111.618 -179.708 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 52' ' ' ASN . 6.9 mm -79.53 143.11 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.635 -0.505 . . . . 0.69 109.635 178.989 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 mt -145.34 -68.02 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.792 0.33 . . . . 1.6 111.716 -179.843 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER -54.93 -18.32 4.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 1.54 112.228 -179.731 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER 91.29 -18.45 0.15 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 123.877 0.871 . . . . 1.75 110.803 -179.58 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -88.92 85.26 6.69 Favored 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 108.555 -0.905 . . . . 2.05 108.555 178.836 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.737 ' CD1' HD12 ' A' ' 56' ' ' ILE . 50.2 t80 -114.47 165.2 12.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.484 0.659 . . . . 0.48 111.694 -178.61 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 18' ' ' VAL . 91.9 m -123.4 116.99 24.16 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.893 -1.049 . . . . 0.42 110.025 178.994 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.797 HG13 ' CB ' ' A' ' 51' ' ' ALA . 48.8 t -83.9 86.54 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 116.117 -0.492 . . . . 1.08 111.375 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.56 134.41 35.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.586 -0.734 . . . . 1.33 110.509 179.81 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.85 -14.3 2.87 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.83 . . . . 0.9 112.919 -179.847 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.023 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -53.31 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 120.881 0.372 . . . . 1.47 110.609 179.94 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.2 m -148.75 142.3 25.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 1.06 111.11 -179.938 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 1.282 ' OE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -59.0 137.27 58.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 1.91 111.193 179.879 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 97' ' ' CYS . 21.1 t70 70.09 49.33 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.065 -0.516 . . . . 1.87 111.221 -179.981 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.87 120.51 2.33 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.873 0.368 . . . . 0.49 111.49 179.916 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.58 132.63 44.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.36 109.983 179.239 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.541 ' HB3' ' CE2' ' A' ' 74' ' ' PHE . 14.7 m-85 -127.52 122.11 32.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.014 0.746 . . . . 0.56 113.014 -178.662 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -106.89 138.12 43.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.603 -0.888 . . . . 1.5 108.603 178.502 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.954 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -134.21 115.39 14.12 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.41 1.263 . . . . 0.6 114.41 -178.702 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.32 167.77 11.52 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.806 -0.442 . . . . 2.11 109.806 178.395 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG23 ' CG ' ' A' ' 8' ' ' PRO . 28.5 t -122.43 121.18 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 113.706 1.002 . . . . 0.6 113.706 -179.531 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 86' ' ' SER . 70.1 mt -120.46 143.46 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 106.967 -1.494 . . . . 0.7 106.967 178.007 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -164.61 132.09 3.21 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.701 1.0 . . . . 0.6 113.701 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -82.61 105.95 14.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.709 -0.848 . . . . 1.98 108.709 178.245 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . 3.3 m120 -40.1 -93.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.681 -0.69 . . . . 2.19 112.712 -178.721 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.435 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -131.93 -41.76 1.02 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.178 -0.327 . . . . 1.08 111.643 -179.426 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -93.46 31.67 1.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.364 -0.38 . . . . 1.06 111.796 -179.684 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . 77.84 -2.35 64.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.477 -0.868 . . . . 0.93 112.994 179.971 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 2' ' ' ILE . . . -60.64 83.94 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.014 0.435 . . . . 1.38 110.256 179.728 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.92 110.76 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.79 111.904 -179.325 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 77' ' ' ILE . 5.0 p -70.64 118.13 61.88 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.101 -0.704 . . . . 0.59 109.101 179.205 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.442 ' CB ' ' HD2' ' A' ' 88' ' ' PRO . 3.1 Cg_endo -47.15 172.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.623 2.215 . . . . 0.85 112.615 -179.192 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 87' ' ' PRO . 17.0 Cg_endo -56.66 132.28 50.77 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.799 2.333 . . . . 0.76 112.46 -179.847 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m -105.99 98.14 7.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.292 -0.413 . . . . 1.28 111.155 -179.985 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mt-10 15.55 106.53 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 124.394 1.078 . . . . 1.77 113.858 179.58 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 53.1 Cg_exo -54.84 126.11 21.36 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.439 2.092 . . . . 0.55 113.89 -179.825 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.425 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 0.0 OUTLIER -54.77 147.64 14.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.431 -0.581 . . . . 1.23 109.431 178.996 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -36.77 143.48 0.08 Allowed 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 124.181 0.926 . . . . 1.63 111.779 179.951 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -78.01 109.83 12.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.41 109.901 179.712 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.82 HG12 HG21 ' A' ' 13' ' ' ILE . 4.8 mp -91.53 109.46 21.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.485 -179.444 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 98.8 m -45.96 -28.54 1.17 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.77 179.677 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.76 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 87.0 m 52.6 80.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 1.1 110.172 179.832 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 1.282 ' HA ' ' OE1' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -123.2 -79.74 0.62 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.947 0.403 . . . . 3.0 111.686 -179.394 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.87 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.6 p30 -112.44 22.23 14.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.01 -0.541 . . . . 2.14 111.402 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 p30 51.88 21.68 1.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 2.06 111.675 -179.767 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 99' ' ' ASP . 15.2 t -119.63 -15.06 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 2.8 111.07 179.536 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.874 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 0.0 OUTLIER 42.87 55.21 4.47 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.032 0.444 . . . . 4.58 111.541 179.891 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.209 -0.901 . . . . 3.79 111.162 -179.986 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.717 0.294 . . . . 2.74 111.128 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.04 132.92 20.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.702 2.268 . . . . 2.06 111.84 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.659 HD12 ' ND2' ' A' ' 80' ' ' ASN . 2.6 tt -130.84 142.3 43.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.68 111.31 -179.897 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.039 ' OD2' ' HB3' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -122.11 129.77 24.98 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 2.0 110.294 179.88 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.72 154.28 15.41 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.424 2.083 . . . . 0.5 112.809 -179.628 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 78.2 Cg_exo -46.02 152.12 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.187 2.592 . . . . 0.71 113.485 -179.854 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.36 -171.35 0.13 Allowed Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.432 -0.804 . . . . 0.66 113.103 -179.776 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 5.7 tttt -77.07 129.39 78.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.457 -0.201 . . . . 1.52 110.457 179.824 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.649 ' CG ' HG23 ' A' ' 76' ' ' VAL . 2.7 Cg_exo -78.48 128.43 8.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.608 2.206 . . . . 0.44 112.896 -179.555 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.9 p -130.59 116.21 17.25 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.09 111.103 179.713 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 23.1 Cg_exo -62.91 128.52 23.3 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.707 2.271 . . . . 0.64 113.605 -179.467 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 21' ' ' LYS . 1.6 mp -93.63 -27.79 16.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 1.64 109.693 179.059 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.42 151.16 32.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.715 -0.675 . . . . 0.72 110.229 179.836 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.193 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -149.08 111.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.077 0.465 . . . . 0.96 111.503 -179.794 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.338 ' HA ' ' CG ' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -106.46 56.72 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.68 -0.691 . . . . 1.46 111.171 -179.956 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.955 ' N ' ' OD1' ' A' ' 100' ' ' ASP . 0.5 OUTLIER 56.27 -69.97 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.881 0.738 . . . . 2.42 112.853 179.016 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 14' ' ' THR . 13.1 m-70 -83.99 -20.28 33.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.404 -0.362 . . . . 1.02 111.82 -179.33 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' HB3' ' A' ' 64' ' ' SER . 49.7 p -126.01 112.25 15.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.68 111.745 -179.603 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.004 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -106.39 120.55 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.8 110.478 179.606 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.706 ' C ' HD13 ' A' ' 20' ' ' LEU . 19.8 m -104.34 128.16 52.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.35 111.843 -179.16 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.765 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.45 160.41 39.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.722 0.772 . . . . 0.52 111.8 178.964 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.822 ' HB3' HD11 ' A' ' 11' ' ' LEU . 8.6 tptm -142.57 139.19 31.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.514 -1.221 . . . . 1.84 109.861 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.554 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 14.5 p90 -126.55 -174.86 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.4 111.555 -179.714 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 171.81 8.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.874 -0.603 . . . . 0.83 111.475 -179.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 25' ' ' PRO . 2.2 tptm -116.2 124.47 29.59 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.924 -0.58 . . . . 2.11 110.06 179.842 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.58 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 6.5 Cg_endo -46.98 175.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.719 2.28 . . . . 0.89 112.725 -179.908 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.54 3.35 5.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.579 -0.737 . . . . 2.77 110.846 179.718 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.039 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 3.7 t80 -121.87 -74.04 0.63 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.557 0.206 . . . . 1.37 111.557 -179.558 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 1.006 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 16.6 p 41.29 56.75 3.06 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.524 0.202 . . . . 0.91 111.254 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 34.13 -102.46 0.01 OUTLIER Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.04 -0.527 . . . . 1.01 113.418 -179.717 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -133.68 28.85 3.2 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.968 -0.853 . . . . 0.98 110.968 179.232 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -110.42 -176.19 2.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.356 -0.422 . . . . 0.87 111.14 -179.138 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -137.89 1.01 2.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.976 -0.556 . . . . 2.26 112.218 179.685 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.596 HG21 ' CE1' ' A' ' 36' ' ' TYR . 8.3 mt 57.51 116.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-O 121.071 0.462 . . . . 1.71 111.088 -179.749 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -103.16 10.84 37.64 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.435 0.532 . . . . 1.15 112.435 -179.12 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -179.01 156.85 0.82 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.961 0.41 . . . . 1.58 111.898 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.813 ' O ' HD12 ' A' ' 56' ' ' ILE . 28.5 m-85 -126.21 112.48 15.81 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.893 -0.594 . . . . 0.76 110.84 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.548 HD12 ' HA ' ' A' ' 78' ' ' ALA . 0.5 OUTLIER -94.55 99.79 10.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.827 -0.624 . . . . 1.14 110.718 -179.85 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.654 ' HB ' HG22 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -92.26 113.7 27.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.127 0.489 . . . . 0.63 110.488 179.861 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' CD ' HD12 ' A' ' 77' ' ' ILE . 3.3 mp0 -81.5 144.73 31.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.605 -0.725 . . . . 1.67 110.911 -179.784 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -111.79 139.13 47.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 1.97 110.917 179.893 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.519 ' HD2' ' CZ2' ' A' ' 48' ' ' TRP . 15.7 ttm180 -106.97 110.83 23.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.235 -0.438 . . . . 1.44 110.382 179.405 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -82.66 91.21 6.93 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.715 -0.675 . . . . 1.59 110.307 179.866 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' O ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -68.0 154.53 93.62 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.519 -0.764 . . . . 0.9 110.983 -179.783 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -86.05 4.41 66.12 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 123.685 -1.381 . . . . 1.43 112.999 0.255 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -78.86 -68.03 0.69 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.941 0.4 . . . . 2.66 110.451 179.896 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' CA ' ' HG3' ' A' ' 41' ' ' ARG . . . 88.06 177.14 47.68 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.769 -0.729 . . . . 1.12 113.016 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.663 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER 164.47 -28.0 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.699 0.285 . . . . 2.41 110.718 179.938 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.533 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 51.4 m95 63.31 87.77 0.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.284 -0.416 . . . . 0.65 111.138 179.894 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.663 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -123.45 141.47 51.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.116 -179.834 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -58.5 117.64 4.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 1.3 110.747 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.691 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -86.95 -49.59 7.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.86 111.267 -179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.896 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.7 p-10 -42.41 -54.18 3.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 2.01 112.101 -179.707 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.8 t80 46.59 44.24 13.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.686 0.279 . . . . 2.08 111.347 -179.87 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.0 t -152.5 -84.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.48 -0.327 . . . . 1.89 111.156 179.924 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -178.13 110.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.406 . . . . 1.87 110.556 179.967 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' HB3' ' A' ' 52' ' ' ASN . 11.2 mt -108.74 80.89 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.69 111.103 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.8 tm? -64.7 -65.69 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 1.6 110.961 -179.962 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -75.43 160.16 30.55 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.989 -0.374 . . . . 1.54 109.989 179.737 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 0.4 OUTLIER -74.16 -3.57 30.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.304 -0.407 . . . . 1.75 111.556 -179.87 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -100.0 101.34 12.4 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.801 0.334 . . . . 2.05 110.151 179.853 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.683 ' HB2' HG23 ' A' ' 56' ' ' ILE . 50.3 t80 -135.07 162.97 30.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.258 0.551 . . . . 0.48 111.719 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.685 HG23 ' OG1' ' A' ' 19' ' ' THR . 51.6 m -122.58 109.94 14.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.52 -0.764 . . . . 0.42 110.354 179.167 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.691 HG13 ' CB ' ' A' ' 51' ' ' ALA . 98.9 t -81.79 93.96 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.74 -0.664 . . . . 1.08 111.002 -179.716 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.745 ' HB3' HG22 ' A' ' 17' ' ' THR . 3.0 p -98.79 144.56 27.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 1.33 110.872 -179.968 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.44 -9.31 5.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.672 -0.775 . . . . 0.9 112.986 179.995 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.67 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER -54.83 -172.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.03 0.443 . . . . 1.47 111.063 -179.93 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 m -129.27 131.8 47.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.777 -0.647 . . . . 1.06 110.442 179.641 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 1.3 mt-10 -61.31 150.27 35.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.306 -0.406 . . . . 1.91 111.104 -179.758 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t0 62.75 48.56 4.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 1.87 110.814 -179.999 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.02 126.13 2.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.498 . . . . 0.49 111.319 -179.968 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.758 ' O ' HD12 ' A' ' 43' ' ' LEU . . . -71.52 134.57 46.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.242 -0.436 . . . . 0.36 110.604 179.694 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 46.1 m-85 -133.02 130.82 39.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.414 0.524 . . . . 0.56 112.414 -179.19 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 94' ' ' ALA . 2.0 mt-10 -105.94 148.42 27.67 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.396 -0.594 . . . . 1.5 109.396 178.791 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.891 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -137.59 117.89 13.65 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.717 1.377 . . . . 0.6 114.717 -179.228 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -104.56 158.33 16.56 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.931 -0.766 . . . . 2.11 108.931 177.663 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 38' ' ' VAL . 99.3 t -115.19 109.93 30.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 119.584 -0.846 . . . . 0.6 113.02 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.483 HD12 ' CD ' ' A' ' 39' ' ' GLU . 68.3 mt -105.37 157.18 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.021 -1.474 . . . . 0.7 107.021 177.723 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.548 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -176.88 136.28 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 119.054 -1.058 . . . . 0.6 112.684 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 3.0 ptpp? -75.63 -150.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.106 -0.701 . . . . 1.98 109.106 178.846 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.755 HD21 ' HB3' ' A' ' 84' ' ' ALA . 25.4 p30 -147.43 -107.33 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.212 -0.595 . . . . 2.19 111.291 -179.723 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -127.47 -43.04 1.62 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.709 0.686 . . . . 1.08 110.423 179.847 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.94 -9.9 59.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.92 -0.582 . . . . 1.06 111.749 179.803 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.81 -18.84 28.84 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.475 -0.869 . . . . 0.93 112.398 -179.743 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.755 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -52.82 158.29 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.58 0.229 . . . . 1.38 110.72 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 6.3 tp -114.79 117.88 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.838 0.352 . . . . 0.79 111.649 -179.931 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 1.0 OUTLIER -77.83 122.7 85.99 Favored Pre-proline 0 C--O 1.237 0.441 0 N-CA-C 109.719 -0.474 . . . . 0.59 109.719 179.328 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -41.47 170.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.353 2.702 . . . . 0.85 113.649 -179.419 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' CA ' HG12 ' A' ' 77' ' ' ILE . 1.1 Cg_endo -83.56 129.67 5.02 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.361 2.707 . . . . 0.76 112.469 -179.91 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.423 ' OG ' ' HB ' ' A' ' 76' ' ' VAL . 78.2 p -85.19 125.06 32.53 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.994 -0.372 . . . . 1.28 109.994 179.349 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.6 OUTLIER -17.65 106.89 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 124.696 1.248 . . . . 1.77 113.497 -179.476 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 54.4 Cg_exo -45.25 152.53 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.503 2.135 . . . . 0.55 113.302 -179.78 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.436 ' OG ' ' CG ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -83.76 144.04 29.59 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.421 -0.808 . . . . 1.23 109.005 179.063 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -34.93 146.53 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.213 0.946 . . . . 1.63 111.73 -179.624 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.564 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . . . -76.66 125.31 29.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.694 -0.684 . . . . 0.41 110.69 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 97' ' ' CYS . 4.1 mp -109.56 115.44 49.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.755 0.312 . . . . 0.44 110.956 179.72 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 97.0 m -48.2 -30.61 4.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.981 -0.554 . . . . 0.44 111.262 -179.642 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.498 ' H ' HG22 ' A' ' 95' ' ' ILE . 57.2 m 51.88 72.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.892 0.377 . . . . 1.1 110.212 -179.779 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.73 -80.64 0.58 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.085 -0.507 . . . . 3.0 111.421 -179.485 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.87 ' O ' HG23 ' A' ' 101' ' ' VAL . 20.7 p-10 -114.73 27.95 9.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.667 -0.697 . . . . 2.14 110.819 -179.734 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.338 ' CG ' ' HA ' ' A' ' 14' ' ' THR . 0.2 OUTLIER 48.18 25.3 0.81 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.085 0.469 . . . . 2.06 111.091 -179.323 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.87 HG23 ' O ' ' A' ' 99' ' ' ASP . 47.0 t -127.4 -11.87 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.829 -0.623 . . . . 2.8 111.496 179.731 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.513 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER 50.84 29.69 4.55 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.96 0.409 . . . . 4.58 111.024 179.732 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.513 ' HB2' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.249 -0.882 . . . . 3.79 111.019 -179.983 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 88.9 p . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 120.405 0.145 . . . . 2.74 111.16 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 27' ' ' TYR . 89.1 Cg_endo -85.4 -165.62 0.29 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.661 2.241 . . . . 2.06 112.466 -179.905 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.672 HD11 ' HB3' ' A' ' 86' ' ' SER . 7.0 tt -161.16 151.22 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.97 0.414 . . . . 0.68 111.506 -179.972 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 1.24 ' OD2' ' N ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -140.55 130.77 13.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 2.0 110.132 179.757 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -81.67 166.94 17.2 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.437 2.091 . . . . 0.5 112.843 -179.592 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 22' ' ' TRP . 24.1 Cg_endo -61.74 -175.86 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.111 2.541 . . . . 0.71 113.404 -179.489 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.45 168.61 36.68 Favored Glycine 0 C--N 1.332 0.353 0 CA-C-N 115.578 -0.737 . . . . 0.66 112.445 179.938 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 7.3 tttt -59.32 130.56 87.35 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.724 0.262 . . . . 1.52 110.353 179.808 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HG3' ' CG1' ' A' ' 76' ' ' VAL . 3.4 Cg_exo -79.46 153.99 24.09 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.523 2.149 . . . . 0.44 112.86 -179.413 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.34 116.35 7.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 1.09 110.351 179.977 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' THR . 14.2 Cg_exo -66.81 91.54 0.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 121.953 1.769 . . . . 0.64 113.191 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD11 ' CG2' ' A' ' 19' ' ' THR . 0.0 OUTLIER -46.75 -42.77 17.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.293 0.568 . . . . 1.64 110.283 179.449 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -134.58 153.21 52.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.216 -0.902 . . . . 0.72 109.278 179.631 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 ' HB ' ' A' ' 18' ' ' VAL . 2.6 pt -140.4 94.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.109 0.48 . . . . 0.96 111.235 -179.543 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.2 OUTLIER -91.63 55.61 2.78 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.677 -0.692 . . . . 1.46 112.282 -179.202 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 2.5 mtm180 53.58 -71.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.678 0.992 . . . . 2.42 113.678 178.638 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 12.6 m170 -84.8 -32.61 23.27 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.281 0.474 . . . . 1.02 112.281 -178.726 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 ' CB ' ' HA ' ' A' ' 64' ' ' SER . 19.9 p -126.4 101.7 6.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.673 0.273 . . . . 0.68 111.075 -179.714 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.069 HG13 ' CD2' ' A' ' 66' ' ' LEU . 32.5 m -98.72 138.28 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.756 -0.378 . . . . 0.8 110.423 179.505 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 91.1 m -101.13 119.95 39.51 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.74 0.644 . . . . 0.35 112.74 -179.099 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.706 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.95 150.81 51.07 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.794 0.806 . . . . 0.52 111.834 178.221 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -139.49 159.2 42.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.719 -1.128 . . . . 1.84 109.364 179.607 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.514 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 18.5 p90 -141.93 -176.87 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.087 0.773 . . . . 0.4 113.087 -178.922 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.23 -158.13 0.27 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.774 -1.103 . . . . 0.83 110.643 179.387 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.71 148.84 71.69 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.417 -0.356 . . . . 2.11 110.738 179.606 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 80.7 Cg_exo -49.1 -173.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.983 2.455 . . . . 0.89 113.084 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.78 -29.79 4.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.04 -0.527 . . . . 2.77 111.649 -179.834 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 1.24 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 8.2 t80 -129.4 -69.2 0.7 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 111.961 0.356 . . . . 1.37 111.961 -179.563 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.865 ' H ' ' CG ' ' A' ' 3' ' ' ASP . 16.1 p 58.49 46.16 15.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.91 110.566 -179.308 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 45.22 -98.51 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.929 -0.653 . . . . 1.01 112.551 179.905 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.36 22.85 2.87 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.336 -0.706 . . . . 0.98 111.336 179.354 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CE2' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -103.29 -176.12 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.935 0.398 . . . . 0.87 111.206 -179.178 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 32' ' ' LYS . 0.1 OUTLIER -134.89 5.69 3.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.855 -0.611 . . . . 2.26 111.437 179.482 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.646 HG21 ' CE1' ' A' ' 36' ' ' TYR . 12.1 mt 57.55 97.98 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-O 121.151 0.5 . . . . 1.71 110.868 -179.725 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -104.63 29.44 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.52 -0.764 . . . . 1.15 111.306 -179.424 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.83 116.77 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.917 0.389 . . . . 1.58 111.996 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.646 ' CE1' HG21 ' A' ' 33' ' ' ILE . 48.2 m-85 -110.42 107.46 17.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.127 -0.488 . . . . 0.76 110.3 179.267 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 50' ' ' LYS . 1.6 mm -90.92 116.47 32.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.658 0.266 . . . . 1.14 111.075 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG23 HD12 ' A' ' 56' ' ' ILE . 3.2 t -90.74 118.27 35.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.31 -0.404 . . . . 0.63 111.811 -179.762 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HG3' HD12 ' A' ' 77' ' ' ILE . 2.8 mm-40 -96.9 135.03 39.46 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.422 -0.584 . . . . 1.67 109.422 178.901 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.636 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -112.32 145.75 39.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 1.97 112.229 -179.269 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.2 ttm180 -117.86 103.42 9.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.295 -0.866 . . . . 1.44 110.233 179.46 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.691 ' OD1' ' N ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -73.05 92.7 1.7 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.031 0.443 . . . . 1.59 110.9 -179.771 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.753 HD11 ' HG3' ' A' ' 73' ' ' GLU . 27.5 mt -70.82 149.42 95.09 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.786 -0.643 . . . . 0.9 110.692 179.97 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.5 -18.1 18.52 Favored 'Cis proline' 0 C--N 1.347 0.494 0 C-N-CA 123.845 -1.315 . . . . 1.43 113.01 0.423 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -52.22 -90.95 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.062 -0.255 . . . . 2.66 110.672 -179.717 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' HA3' ' CG ' ' A' ' 41' ' ' ARG . . . 88.06 123.36 1.94 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.318 -0.944 . . . . 1.12 113.305 179.52 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.658 ' NE ' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -151.94 17.22 0.67 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.858 0.318 . . . . 2.41 111.858 179.678 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.529 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 69.0 m95 28.66 98.47 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.953 0.723 . . . . 0.65 112.953 179.901 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.658 HD22 ' NE ' ' A' ' 47' ' ' ARG . 1.1 mp -135.65 133.48 38.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.936 0.398 . . . . 1.28 111.214 179.929 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 37' ' ' ILE . 9.8 ptmm? -51.11 106.95 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.854 -0.612 . . . . 1.3 111.112 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.636 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -72.39 -56.84 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.86 110.714 179.819 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 9.4 p-10 -57.66 113.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.508 . . . . 2.01 110.571 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -102.21 24.0 10.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 2.08 111.224 -179.809 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 t -125.56 -82.42 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.887 0.375 . . . . 1.89 110.77 -179.935 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.95 141.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 1.87 110.56 179.947 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.638 HD13 ' CG ' ' A' ' 61' ' ' PHE . 30.9 mt -125.56 79.81 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 0.69 111.19 -179.651 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.84 -66.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 1.6 110.923 179.998 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.06 -179.72 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.481 -0.327 . . . . 1.54 110.424 179.738 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 30.1 p30 -96.69 10.05 39.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.319 -0.401 . . . . 1.75 111.618 179.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -111.28 95.84 5.76 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.757 -0.46 . . . . 2.05 109.757 179.498 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.638 ' CG ' HD13 ' A' ' 56' ' ' ILE . 76.6 t80 -128.26 164.83 21.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.196 0.522 . . . . 0.48 111.531 -179.26 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.512 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 83.9 m -127.38 124.03 37.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.578 -0.737 . . . . 0.42 110.333 179.253 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 20' ' ' LEU . 4.4 t -81.36 82.49 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.17 0.509 . . . . 1.08 109.941 179.694 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.444 ' HA ' ' CB ' ' A' ' 17' ' ' THR . 33.2 t -68.27 -39.05 82.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.403 -0.817 . . . . 1.33 111.514 -179.18 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.68 62.22 0.47 Allowed Glycine 0 C--N 1.321 -0.301 0 C-N-CA 120.811 -0.709 . . . . 0.9 111.69 179.733 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.069 ' CD2' HG13 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -131.66 149.19 52.58 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.385 -0.598 . . . . 1.47 109.385 -179.118 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -105.23 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.074 0.464 . . . . 1.06 111.87 -179.207 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 67' ' ' THR . 19.7 tt0 -103.75 165.14 11.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.511 -0.768 . . . . 1.91 111.28 -179.46 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 47.65 68.91 0.58 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.993 -0.549 . . . . 1.87 111.125 179.826 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' CD2' ' A' ' 72' ' ' TYR . . . 176.87 110.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.49 110.882 179.904 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -63.05 110.2 1.74 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.21 0.529 . . . . 0.36 110.641 -179.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 82.7 m-85 -103.75 125.54 50.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.545 -0.752 . . . . 0.56 112.728 -178.999 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.753 ' HG3' HD11 ' A' ' 43' ' ' LEU . 20.1 mt-10 -103.36 137.2 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.863 -1.162 . . . . 1.5 107.863 177.704 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.013 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.1 OUTLIER -129.61 116.97 19.66 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.307 1.595 . . . . 0.6 115.307 -178.717 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -102.21 177.8 4.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 107.579 -1.267 . . . . 2.11 107.579 176.856 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.579 HG13 ' OG ' ' A' ' 89' ' ' SER . 0.1 OUTLIER -145.14 111.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 118.969 -1.093 . . . . 0.6 112.753 -179.835 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 HD12 ' HG3' ' A' ' 39' ' ' GLU . 25.1 mt -92.99 142.15 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 107.691 -1.226 . . . . 0.7 107.691 177.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -154.1 120.7 5.51 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.836 -0.746 . . . . 0.6 111.945 -178.951 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.774 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -56.3 -100.24 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.367 -0.533 . . . . 1.98 109.969 179.633 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.83 HD21 ' HB3' ' A' ' 84' ' ' ALA . 18.6 p30 171.41 -111.31 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.935 -0.765 . . . . 2.19 108.935 179.65 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -135.09 5.54 3.3 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 119.054 0.843 . . . . 1.08 111.53 179.015 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.94 0.02 7.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.736 -0.211 . . . . 1.06 111.236 179.956 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.7 -12.82 61.16 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 120.334 -0.936 . . . . 0.93 113.186 179.864 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.83 ' HB3' HD21 ' A' ' 80' ' ' ASN . . . -67.87 114.35 6.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.739 0.304 . . . . 1.38 110.335 179.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 79' ' ' LYS . 3.6 tp -72.77 121.3 23.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 0.79 112.255 -179.235 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.672 ' HB3' HD11 ' A' ' 2' ' ' ILE . 1.3 p -89.36 127.0 56.65 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 109.674 -0.491 . . . . 0.59 109.674 179.264 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -32.97 155.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.547 2.832 . . . . 0.85 113.844 -179.16 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.46 ' HG3' HD11 ' A' ' 77' ' ' ILE . 14.6 Cg_exo -68.06 120.97 7.94 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.698 2.265 . . . . 0.76 112.685 179.944 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.579 ' OG ' HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -62.75 133.07 54.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.351 -0.611 . . . . 1.28 109.351 179.167 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.7 OUTLIER -31.53 116.58 0.37 Allowed Pre-proline 0 N--CA 1.473 0.681 0 O-C-N 123.682 0.614 . . . . 1.77 112.425 -179.305 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 75' ' ' ARG . 68.6 Cg_exo -40.67 169.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.011 2.474 . . . . 0.55 114.252 -179.565 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -103.08 141.46 35.79 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.73 -1.123 . . . . 1.23 109.729 179.834 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -41.85 130.54 3.37 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 123.71 0.631 . . . . 1.63 111.078 179.606 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.832 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -59.88 133.97 56.6 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.861 -0.609 . . . . 0.41 111.552 -179.557 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.733 HG12 HG21 ' A' ' 13' ' ' ILE . 3.5 mp -116.79 113.19 42.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.71 179.507 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.1 m -53.42 -16.0 1.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.056 0.761 . . . . 0.44 113.056 -179.106 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 p 42.08 64.9 0.98 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.254 0.55 . . . . 1.1 111.127 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HD2' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -86.28 -90.28 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.399 -0.819 . . . . 3.0 111.429 -179.492 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.407 ' OD1' ' CG1' ' A' ' 101' ' ' VAL . 2.2 p30 -133.19 31.29 3.83 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.846 0.355 . . . . 2.14 110.713 -179.748 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.439 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 26.0 t0 38.44 28.76 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.019 -0.537 . . . . 2.06 112.249 -179.617 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.407 ' CG1' ' OD1' ' A' ' 99' ' ' ASP . 12.7 p -163.19 24.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.187 -0.461 . . . . 2.8 111.189 -179.965 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.24 ' HG3' ' OD2' ' A' ' 99' ' ' ASP . 6.6 mt-10 -116.78 -25.22 7.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.355 . . . . 4.58 111.413 -179.716 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.21 -0.9 . . . . 3.79 110.896 179.889 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.367 0.127 . . . . 2.74 111.113 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.95 -155.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.459 2.106 . . . . 2.06 112.087 179.83 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.72 HD12 ' HB1' ' A' ' 84' ' ' ALA . 1.6 tt -172.73 144.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.97 -0.559 . . . . 0.68 111.012 179.637 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.36 122.7 26.67 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.13 -0.486 . . . . 2.0 110.112 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 59.6 Cg_endo -71.57 155.88 58.63 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.036 1.824 . . . . 0.5 112.181 -179.751 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 4' ' ' PRO . 30.9 Cg_exo -59.73 172.75 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.317 2.011 . . . . 0.71 112.242 -179.757 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.55 168.58 51.05 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.93 -0.652 . . . . 0.66 113.031 -179.693 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HG2' ' CD ' ' A' ' 8' ' ' PRO . 5.6 tttt -63.17 141.13 97.75 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 110.026 -0.361 . . . . 1.52 110.026 179.663 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.629 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.6 Cg_exo -83.4 142.08 10.41 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.417 2.078 . . . . 0.44 112.589 -179.729 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -143.74 118.33 6.11 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.164 -0.471 . . . . 1.09 110.588 179.749 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HG2' HD11 ' A' ' 95' ' ' ILE . 11.6 Cg_exo -67.0 123.02 10.43 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.196 1.931 . . . . 0.64 113.521 -179.439 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -34.38 20.48 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.901 -0.778 . . . . 1.64 108.901 178.701 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 143.48 35.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.794 -1.094 . . . . 0.72 109.047 179.386 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 2.6 pt -136.94 102.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.026 0.441 . . . . 0.96 112.044 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 16' ' ' HIS . 0.0 OUTLIER -97.72 59.17 1.47 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.756 -0.656 . . . . 1.46 111.115 -179.999 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.447 ' HG3' ' HB2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 51.53 -74.06 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.553 -0.748 . . . . 2.42 112.273 179.045 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 14' ' ' THR . 7.2 m-70 -79.69 -45.85 18.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.931 0.396 . . . . 1.02 110.894 -179.944 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 64' ' ' SER . 1.4 p -99.12 104.61 16.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 0.68 111.061 -179.905 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 61.7 t -101.22 118.95 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.911 -0.586 . . . . 0.8 110.219 179.761 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.501 ' C ' HD13 ' A' ' 20' ' ' LEU . 27.3 m -95.29 117.72 30.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.979 -0.555 . . . . 0.35 112.12 -179.117 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.794 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.37 159.49 40.89 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.447 0.641 . . . . 0.52 111.165 178.541 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.505 ' CD ' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -145.64 148.21 32.85 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.911 -1.04 . . . . 1.84 109.692 -179.987 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' N ' ' CD ' ' A' ' 21' ' ' LYS . 1.2 p90 -116.46 -111.06 0.35 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 120.487 -0.485 . . . . 0.4 112.078 -179.994 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -157.48 -159.55 0.85 Allowed 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.993 -0.442 . . . . 0.83 111.196 -179.189 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HD3' ' CD ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.73 132.61 24.29 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 2.11 110.61 179.981 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HB2' ' CG2' ' A' ' 28' ' ' THR . 14.3 Cg_endo -57.04 -175.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.432 2.088 . . . . 0.89 112.102 179.887 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.51 -43.19 2.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 2.77 111.955 -179.375 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -97.03 -66.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.047 0.388 . . . . 1.37 112.047 -179.32 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.482 ' CG2' ' HB2' ' A' ' 25' ' ' PRO . 27.8 p 55.18 32.0 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 0.91 110.493 -179.345 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.14 -94.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.481 -0.866 . . . . 1.01 111.866 -179.824 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -143.89 41.68 1.11 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.513 -1.035 . . . . 0.98 110.513 179.261 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 6.4 m-85 -121.7 -179.15 4.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.181 -0.51 . . . . 0.87 111.752 -178.859 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 1.9 tttt -133.13 -32.96 1.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.739 -0.664 . . . . 2.26 111.998 -179.972 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.76 HG21 ' CE1' ' A' ' 36' ' ' TYR . 4.0 mt 80.98 107.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.083 0.468 . . . . 1.71 110.821 -179.542 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.1 p -102.7 12.32 36.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.686 -0.688 . . . . 1.15 111.69 -179.546 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.529 ' HG ' HD22 ' A' ' 55' ' ' ASN . 3.0 t -178.23 137.09 0.17 Allowed 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.485 0.55 . . . . 1.58 112.485 -179.747 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.76 ' CE1' HG21 ' A' ' 33' ' ' ILE . 55.2 m-85 -112.6 151.17 30.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.819 . . . . 0.76 109.637 178.684 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.73 123.98 70.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.74 0.305 . . . . 1.14 111.055 -179.529 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 HG21 ' HD2' ' A' ' 61' ' ' PHE . 1.4 t -103.75 101.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 0.63 111.36 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 0.4 OUTLIER -74.54 144.61 43.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.34 -0.615 . . . . 1.67 109.34 179.267 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.02 145.73 47.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.133 0.492 . . . . 1.97 111.6 -179.226 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 3.8 ttm180 -133.57 94.32 3.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.789 -0.641 . . . . 1.44 111.056 -179.963 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.483 ' OD1' ' CE2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -57.43 164.67 1.79 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.409 -0.96 . . . . 1.59 108.409 179.121 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.701 HD12 ' HB1' ' A' ' 94' ' ' ALA . 35.2 mt -142.25 129.97 11.48 Favored Pre-proline 0 C--N 1.321 -0.659 0 C-N-CA 120.227 -0.589 . . . . 0.9 111.067 -179.875 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.79 33.83 3.92 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.08 -1.217 . . . . 1.43 113.653 0.743 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -112.12 51.92 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 2.66 111.202 179.895 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' HG3' ' A' ' 41' ' ' ARG . . . -60.65 -178.58 2.14 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.773 -0.727 . . . . 1.12 112.815 -179.998 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.74 -28.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.585 0.217 . . . . 2.41 111.585 -179.968 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.539 ' CZ3' ' HG2' ' A' ' 75' ' ' ARG . 24.3 m95 65.42 72.59 0.42 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.792 0.329 . . . . 0.65 111.251 -179.981 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.431 ' O ' ' CG ' ' A' ' 40' ' ' LYS . 2.6 mp -119.86 133.84 55.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 1.28 110.605 179.812 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.06 86.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 1.3 110.787 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.705 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -53.22 -41.62 65.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.101 -0.5 . . . . 0.86 111.175 -179.668 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.715 ' CG ' HD11 ' A' ' 56' ' ' ILE . 5.4 t30 -44.37 -90.59 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.309 -0.405 . . . . 2.01 111.427 -179.768 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 t80 73.1 39.55 0.61 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.724 0.297 . . . . 2.08 110.712 -179.609 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 m -157.13 24.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.313 -0.403 . . . . 1.89 111.551 -179.911 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.529 HD22 ' HG ' ' A' ' 35' ' ' SER . 1.9 t-20 63.85 121.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.82 0.343 . . . . 1.87 111.219 179.611 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.841 HD12 ' CG ' ' A' ' 61' ' ' PHE . 38.9 mm -108.5 75.18 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.199 -0.455 . . . . 0.69 110.972 179.58 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' HA ' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -48.66 -67.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.731 0.301 . . . . 1.6 111.001 -179.995 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.626 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.8 pm0 -82.38 163.43 21.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.415 -0.357 . . . . 1.54 110.158 179.635 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 34.1 p30 -76.89 -1.09 26.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.369 -0.378 . . . . 1.75 111.73 -179.829 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -104.52 98.35 8.13 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.865 0.364 . . . . 2.05 110.051 179.711 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.841 ' CG ' HD12 ' A' ' 56' ' ' ILE . 64.6 t80 -128.84 164.72 22.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.48 111.439 -179.39 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.529 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 51.1 m -128.76 106.85 9.21 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.319 -0.855 . . . . 0.42 110.826 179.302 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 18' ' ' VAL . 27.0 m -61.77 134.92 26.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.08 110.868 179.843 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.467 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.1 OUTLIER -130.72 133.45 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.138 0.494 . . . . 1.33 111.502 -179.524 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.25 21.83 4.33 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.9 112.293 179.917 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.714 HD22 HG23 ' A' ' 18' ' ' VAL . 3.0 mp -79.69 176.65 9.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.185 0.517 . . . . 1.47 111.749 -179.504 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 134.27 55.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.394 -0.821 . . . . 1.06 110.124 179.419 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 97' ' ' CYS . 22.8 mt-10 -73.73 174.2 8.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.949 0.404 . . . . 1.91 111.736 -179.501 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 97' ' ' CYS . 6.2 t70 52.83 27.44 5.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.905 -0.588 . . . . 1.87 110.973 -179.962 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -150.33 126.02 10.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 0.49 110.871 179.803 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' CB ' HD12 ' A' ' 43' ' ' LEU . . . -66.03 127.87 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.362 -0.381 . . . . 0.36 110.607 179.78 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.555 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 3.6 m-85 -115.91 125.71 52.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.56 112.014 -179.087 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 92' ' ' SER . 5.2 tt0 -106.33 148.41 28.06 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.873 -0.788 . . . . 1.5 108.873 179.001 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.554 ' CZ ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.93 118.76 12.47 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.032 1.493 . . . . 0.6 115.032 -178.718 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -100.35 178.06 4.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.004 -0.544 . . . . 2.11 109.831 178.102 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.629 HG23 ' HG3' ' A' ' 8' ' ' PRO . 75.4 t -134.68 122.07 37.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 113.245 0.831 . . . . 0.6 113.245 -179.53 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' CG1' ' HA ' ' A' ' 88' ' ' PRO . 91.9 mt -122.56 142.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.147 -1.427 . . . . 0.7 107.147 178.188 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -169.31 134.35 1.5 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 114.49 1.292 . . . . 0.6 114.49 -178.836 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -83.75 136.93 33.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 107.887 -1.153 . . . . 1.98 107.887 177.529 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 5.9 m-20 -76.69 -92.5 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.468 0.544 . . . . 2.19 112.468 -178.566 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' N ' ' HB3' ' A' ' 31' ' ' PHE . . . -126.31 -40.96 1.93 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.444 0.535 . . . . 1.08 112.444 -178.99 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.741 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -100.43 36.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.339 0.496 . . . . 1.06 112.339 -179.078 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.96 -0.67 57.67 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.517 -0.849 . . . . 0.93 113.486 179.575 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.72 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.11 85.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 117.032 0.416 . . . . 1.38 110.176 179.677 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -64.41 121.39 13.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.169 0.509 . . . . 0.79 111.98 -179.26 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 22.9 p -78.31 123.94 85.75 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.473 -0.785 . . . . 0.59 109.311 179.159 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.7 Cg_endo -48.54 171.02 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.872 2.381 . . . . 0.85 113.172 -179.211 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' HB2' ' NH1' ' A' ' 75' ' ' ARG . 14.4 Cg_exo -67.53 112.79 2.71 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.76 112.862 -179.596 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -74.36 132.58 42.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 1.28 110.037 179.367 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 2.7 mm-40 -31.01 113.75 0.33 Allowed Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 123.761 0.663 . . . . 1.77 112.355 -179.599 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 75' ' ' ARG . 44.1 Cg_exo -56.07 138.63 83.3 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.541 2.161 . . . . 0.55 113.057 -179.658 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -69.94 146.49 51.13 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.279 -0.638 . . . . 1.23 109.279 179.193 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' O ' HD12 ' A' ' 95' ' ' ILE . 3.6 m-20 -35.76 139.43 0.14 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.094 0.871 . . . . 1.63 111.843 -179.865 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -75.65 108.86 8.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 0.41 111.175 -179.709 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 13' ' ' ILE . 5.0 mp -91.29 114.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.197 -0.456 . . . . 0.44 111.122 -179.712 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 97.5 m -36.22 -32.77 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.214 -0.448 . . . . 0.44 111.862 -179.96 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.557 ' H ' HG22 ' A' ' 95' ' ' ILE . 9.3 m 51.28 96.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.428 -0.351 . . . . 1.1 110.117 179.773 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.99 -90.92 0.12 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.341 -0.391 . . . . 3.0 111.669 -179.317 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.855 ' OD1' ' N ' ' A' ' 101' ' ' VAL . 0.7 OUTLIER -105.71 6.59 32.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.805 0.298 . . . . 2.14 111.805 -179.609 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.447 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 53.5 t0 58.79 17.8 5.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.862 0.319 . . . . 2.06 111.862 179.755 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.855 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 3.6 p -111.77 -20.94 5.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.347 -0.388 . . . . 2.8 110.27 179.52 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.499 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.2 mm-40 40.28 51.56 2.77 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.205 -0.452 . . . . 4.58 111.861 179.498 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.162 -0.923 . . . . 3.79 111.111 179.974 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.692 0.282 . . . . 2.74 111.303 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.83 172.69 3.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.044 2.496 . . . . 2.06 112.009 179.919 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.887 HD11 ' ND2' ' A' ' 80' ' ' ASN . 6.9 tt -161.27 145.65 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.68 111.041 -179.867 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -128.81 114.26 19.06 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.453 . . . . 2.0 110.792 -179.962 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.75 154.61 54.16 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.395 2.063 . . . . 0.5 112.007 179.907 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.81 174.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.692 2.261 . . . . 0.71 112.826 -179.708 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.77 171.48 44.73 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.993 -0.622 . . . . 0.66 112.658 179.982 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -63.64 135.9 96.48 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 110.49 -0.189 . . . . 1.52 110.49 179.802 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.58 ' HG3' HG23 ' A' ' 76' ' ' VAL . 3.0 Cg_endo -80.9 129.76 7.2 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.457 2.104 . . . . 0.44 112.861 -179.697 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.9 p -132.83 106.01 12.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 115.917 -0.583 . . . . 1.09 110.793 179.613 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 50.5 Cg_exo -49.03 131.76 26.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.334 2.022 . . . . 0.64 113.691 -179.069 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -86.75 -39.92 15.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.861 -0.792 . . . . 1.64 108.861 178.689 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -136.35 150.37 48.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.406 -1.27 . . . . 0.72 108.607 179.576 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.031 HG22 HG13 ' A' ' 18' ' ' VAL . 1.9 pt -143.44 83.46 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.262 -0.575 . . . . 0.96 112.516 -179.157 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.23 159.73 29.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.729 -0.669 . . . . 1.46 110.507 179.476 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -17.37 7.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.42 111.961 -179.554 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.745 ' O ' HG23 ' A' ' 17' ' ' THR . 10.7 m-70 -141.91 34.39 1.57 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.973 0.36 . . . . 1.02 111.973 -179.754 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 16' ' ' HIS . 0.5 OUTLIER 179.66 120.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.648 -0.251 . . . . 0.68 110.387 179.714 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.031 HG13 HG22 ' A' ' 13' ' ' ILE . 95.2 t -117.86 111.28 33.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.18 0.514 . . . . 0.8 112.045 -179.317 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 92.4 m -85.21 142.28 29.54 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.004 -0.543 . . . . 0.35 110.266 179.154 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -146.79 161.13 41.3 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.428 0.633 . . . . 0.52 112.298 -179.857 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -149.3 144.37 26.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.878 -1.056 . . . . 1.84 110.49 179.742 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.507 ' CZ2' ' HA ' ' A' ' 59' ' ' ASN . 9.4 p90 -138.23 -173.38 3.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.431 . . . . 0.4 110.734 -179.973 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.2 -166.89 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.83 110.381 179.534 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -132.23 155.61 81.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.786 0.327 . . . . 2.11 110.942 179.907 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.588 ' HB2' HG23 ' A' ' 28' ' ' THR . 14.6 Cg_exo -69.25 163.41 37.96 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.445 2.097 . . . . 0.89 111.835 179.802 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -123.96 -0.66 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.234 -0.439 . . . . 2.77 111.493 179.652 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -128.6 -70.34 0.68 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.658 0.266 . . . . 1.37 111.644 -179.805 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 25' ' ' PRO . 30.4 p 48.83 57.43 6.4 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.598 -0.274 . . . . 0.91 110.733 -179.575 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 40.46 -92.17 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.301 -0.476 . . . . 1.01 112.799 -179.733 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -145.96 32.66 1.54 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 110.236 -1.146 . . . . 0.98 110.236 179.177 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.627 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 0.1 OUTLIER -119.44 -179.04 3.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.953 -0.624 . . . . 0.87 111.374 -178.716 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.08 3.75 2.92 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.249 -0.432 . . . . 2.26 112.164 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 36' ' ' TYR . 10.1 mt 60.05 154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.752 0.31 . . . . 1.71 110.635 -179.935 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 33' ' ' ILE . 8.3 p -145.2 15.14 1.49 Allowed 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.002 0.371 . . . . 1.15 112.002 -179.646 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.1 t -177.65 133.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.597 0.237 . . . . 1.58 111.214 -179.915 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.657 ' O ' HD12 ' A' ' 56' ' ' ILE . 25.9 m-85 -109.58 105.18 14.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.054 0.454 . . . . 0.76 110.642 179.592 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.554 HG23 ' HE2' ' A' ' 50' ' ' LYS . 2.3 mt -84.91 152.02 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.019 -0.537 . . . . 1.14 111.039 -179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 75' ' ' ARG . 2.5 t -131.53 111.76 19.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.082 -0.508 . . . . 0.63 110.568 179.65 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . 4.8 mt-10 -87.12 143.88 27.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.006 -0.368 . . . . 1.67 110.006 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.729 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -122.34 141.24 51.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.122 0.487 . . . . 1.97 112.23 -179.0 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 23.0 ttp180 -112.02 112.14 23.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.741 -0.663 . . . . 1.44 109.614 178.932 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 1.368 ' OD1' ' CG ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -76.9 96.99 4.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.845 -0.616 . . . . 1.59 110.887 -179.594 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 94' ' ' ALA . 7.6 mt -80.26 154.1 74.45 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.9 110.785 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -86.61 12.32 51.47 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 123.691 -1.379 . . . . 1.43 112.89 0.192 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -77.96 -82.94 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.945 0.402 . . . . 2.66 110.632 179.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA2' ' HG3' ' A' ' 41' ' ' ARG . . . 123.8 143.2 6.2 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.864 -0.684 . . . . 1.12 112.484 179.792 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.368 ' CG ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER 171.83 55.94 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.466 0.174 . . . . 2.41 111.158 -179.847 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.624 ' CZ3' ' HD2' ' A' ' 75' ' ' ARG . 14.1 m95 -36.97 107.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.378 -0.374 . . . . 0.65 111.725 -179.994 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -143.47 136.89 28.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.049 0.452 . . . . 1.28 111.065 179.976 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.554 ' HE2' HG23 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -55.22 104.33 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.996 -0.547 . . . . 1.3 111.173 -179.921 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -61.42 -47.01 87.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.037 0.446 . . . . 0.86 110.259 179.557 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.564 ' CB ' HD11 ' A' ' 56' ' ' ILE . 1.9 t30 -68.35 116.98 9.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.788 -0.642 . . . . 2.01 110.189 179.639 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -114.31 46.69 1.32 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 2.08 111.117 -179.993 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 t -150.12 -83.91 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.409 -0.36 . . . . 1.89 110.962 -179.958 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.78 147.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.357 -0.383 . . . . 1.87 110.777 -179.961 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.705 HD13 ' CG ' ' A' ' 61' ' ' PHE . 14.3 mt -142.0 75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.69 111.31 -179.827 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD13 ' C ' ' A' ' 57' ' ' LEU . 3.4 tm? -59.76 -53.06 62.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.407 . . . . 1.6 110.718 179.835 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.4 pt-20 -80.29 161.58 25.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.127 179.684 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 22' ' ' TRP . 45.2 p-10 -81.45 6.08 15.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.059 -0.519 . . . . 1.75 111.918 -179.756 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 22.1 tt0 -106.58 104.31 13.97 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.591 -0.522 . . . . 2.05 109.591 179.413 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.705 ' CG ' HD13 ' A' ' 56' ' ' ILE . 63.9 t80 -137.77 163.81 30.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.48 112.184 -179.255 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.527 ' N ' ' CD1' ' A' ' 61' ' ' PHE . 65.5 m -122.2 107.15 11.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.628 -0.715 . . . . 0.42 111.358 179.697 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 18' ' ' VAL . 2.2 m -72.05 94.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.759 -0.655 . . . . 1.08 110.436 179.57 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -100.44 155.62 17.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.589 0.709 . . . . 1.33 111.068 179.989 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.0 22.67 3.81 Favored Glycine 0 C--N 1.315 -0.626 0 CA-C-N 114.664 -1.153 . . . . 0.9 112.314 179.793 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.637 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -85.8 -172.49 4.13 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.898 0.38 . . . . 1.47 110.932 -179.753 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -148.28 116.11 6.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.039 -0.528 . . . . 1.06 110.654 179.998 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.611 ' OE2' HG11 ' A' ' 101' ' ' VAL . 1.7 tt0 -41.53 137.86 1.46 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.096 -0.502 . . . . 1.91 111.563 -179.953 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 t70 75.69 47.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 1.87 111.085 179.978 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.6 121.18 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.49 110.983 179.778 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -72.0 127.42 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.158 0.504 . . . . 0.36 111.086 -179.971 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . 55.3 m-85 -124.35 127.28 47.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.503 -0.771 . . . . 0.56 112.307 -179.225 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' HB3' ' CH2' ' A' ' 48' ' ' TRP . 3.1 tp10 -99.8 147.41 25.51 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.036 -0.727 . . . . 1.5 109.036 178.812 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.743 ' HE2' HD13 ' A' ' 95' ' ' ILE . 15.0 m-85 -137.18 116.95 13.07 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.969 1.47 . . . . 0.6 114.969 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.624 ' HD2' ' CZ3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -107.43 171.05 7.6 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.963 -0.755 . . . . 2.11 108.963 177.587 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.58 HG23 ' HG3' ' A' ' 8' ' ' PRO . 77.0 t -126.24 108.81 19.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.951 0.723 . . . . 0.6 112.951 -179.532 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.596 HD11 ' HG3' ' A' ' 88' ' ' PRO . 31.4 mt -102.83 139.19 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.528 -1.286 . . . . 0.7 107.528 177.946 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -153.76 129.75 10.28 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.64 -0.824 . . . . 0.6 112.064 -179.53 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 40.8 mttt -78.75 -178.22 5.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.28 -0.418 . . . . 1.98 110.486 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.887 ' ND2' HD11 ' A' ' 2' ' ' ILE . 3.5 m-80 -129.02 172.58 11.24 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.003 -0.544 . . . . 2.19 110.812 179.839 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -44.1 -28.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.719 -0.673 . . . . 1.08 111.785 179.658 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -112.14 34.77 4.07 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.136 0.421 . . . . 1.06 112.136 -179.439 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 42.68 37.81 2.87 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.67 -0.776 . . . . 0.93 113.02 179.611 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.01 8.24 8.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.287 0.477 . . . . 1.38 112.287 -179.956 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.5 OUTLIER 35.7 97.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 113.496 0.924 . . . . 0.79 113.496 179.738 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 2' ' ' ILE . 1.0 OUTLIER -75.73 116.64 57.13 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.53 -0.915 . . . . 0.59 108.53 178.461 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -35.16 158.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.405 2.737 . . . . 0.85 113.39 -178.843 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.596 ' HG3' HD11 ' A' ' 77' ' ' ILE . 12.6 Cg_exo -68.06 142.77 57.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.627 2.218 . . . . 0.76 112.23 179.871 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 50.5 m -92.25 118.64 31.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.958 -0.565 . . . . 1.28 110.125 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' SER . 42.5 mt-10 -19.66 104.94 0.07 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.021 0.929 . . . . 1.77 113.151 -179.461 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.475 ' CD ' ' HB3' ' A' ' 75' ' ' ARG . 55.5 Cg_exo -39.98 161.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.608 2.205 . . . . 0.55 113.246 -179.471 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.46 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -97.04 143.51 27.81 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.501 -0.772 . . . . 1.23 109.339 179.175 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HA ' ' OE2' ' A' ' 73' ' ' GLU . 2.6 m-20 -35.31 129.01 0.54 Allowed 'General case' 0 N--CA 1.469 0.521 0 O-C-N 124.027 0.83 . . . . 1.63 112.077 -179.286 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -50.19 133.06 23.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 0.41 111.397 -179.853 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.743 HD13 ' HE2' ' A' ' 74' ' ' PHE . 3.2 mp -113.24 106.76 21.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.731 -0.668 . . . . 0.44 111.686 -179.789 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ALA . 6.7 m -52.54 -23.02 5.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.841 179.688 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.452 ' H ' HG22 ' A' ' 95' ' ' ILE . 0.8 OUTLIER 60.29 38.35 19.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.985 0.422 . . . . 1.1 110.235 -179.834 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.713 ' O ' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -132.97 -38.42 0.98 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.793 -0.64 . . . . 3.0 111.946 -179.635 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.429 ' N ' ' HD2' ' A' ' 98' ' ' ARG . 3.9 p-10 -49.0 -26.27 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 2.14 111.624 -179.405 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -8.07 55.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.115 -0.493 . . . . 2.06 111.531 179.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 98' ' ' ARG . 11.8 p -124.67 4.96 4.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.852 -0.613 . . . . 2.8 109.873 179.026 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 3.4 mm-40 -149.49 -80.34 0.13 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.919 0.39 . . . . 4.58 111.029 -179.999 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.276 -0.869 . . . . 3.79 111.059 -179.991 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 1' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.729 0.299 . . . . 2.74 111.27 . . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.666 ' O ' HG22 ' A' ' 2' ' ' ILE . 86.7 Cg_endo -78.25 -26.11 6.53 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.637 2.225 . . . . 2.06 112.463 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.916 HD11 ' ND2' ' A' ' 80' ' ' ASN . 5.2 tt 52.61 146.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 124.019 0.824 . . . . 0.68 112.439 -179.775 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.981 ' OD2' ' N ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -141.93 123.59 8.91 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.605 . . . . 2.0 110.43 -179.962 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.08 166.92 28.43 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.321 2.014 . . . . 0.5 112.256 -179.913 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' TRP . 52.2 Cg_exo -52.24 173.96 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.667 2.245 . . . . 0.71 112.749 -179.626 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.56 39.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.071 -0.585 . . . . 0.66 112.78 -179.831 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 tptm -65.44 118.12 47.44 Favored Pre-proline 0 CA--C 1.532 0.254 0 O-C-N 123.043 -0.092 . . . . 1.52 110.772 179.879 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.688 ' CG ' HG23 ' A' ' 76' ' ' VAL . 15.5 Cg_exo -69.77 127.94 15.31 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.418 2.079 . . . . 0.44 112.731 -179.68 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -131.96 113.6 14.97 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.74 -0.664 . . . . 1.09 111.405 -179.491 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 71.5 Cg_exo -47.32 112.1 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.52 2.146 . . . . 0.64 113.193 -179.61 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER -74.12 -35.86 64.15 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.736 -0.838 . . . . 1.64 108.736 179.174 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.436 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 3.9 t30 -143.91 153.29 42.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.486 -1.234 . . . . 0.72 107.718 178.621 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.824 HG21 HG12 ' A' ' 95' ' ' ILE . 0.9 OUTLIER -142.93 141.31 27.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.809 -0.756 . . . . 0.96 113.019 -178.793 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -139.94 136.44 33.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.21 -0.904 . . . . 1.46 109.863 179.263 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HD2' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -42.68 -24.83 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.005 0.743 . . . . 2.42 113.005 -179.023 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -118.11 -12.98 9.96 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.744 -0.598 . . . . 1.02 112.517 -179.504 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -153.46 125.6 7.95 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.246 -0.279 . . . . 0.68 110.246 -179.905 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.085 HG21 ' CZ ' ' A' ' 74' ' ' PHE . 5.3 m -118.64 145.86 24.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.669 -0.413 . . . . 0.8 111.81 -179.809 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.701 ' OG1' HG23 ' A' ' 62' ' ' THR . 9.0 m -111.36 127.72 55.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.04 -0.527 . . . . 0.35 111.072 -179.745 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.776 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -129.06 139.27 52.09 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.865 0.841 . . . . 0.52 111.355 178.769 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -121.67 155.49 35.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.124 -1.398 . . . . 1.84 108.973 179.632 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.538 ' CD1' ' HB3' ' A' ' 5' ' ' PRO . 26.6 p90 -152.55 -174.48 4.92 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.213 -0.595 . . . . 0.4 111.966 -179.729 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.77 168.2 10.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.052 -0.522 . . . . 0.83 112.046 -179.389 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' CD ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -97.76 141.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.775 -0.648 . . . . 2.11 110.434 179.888 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.496 ' HB2' HG23 ' A' ' 28' ' ' THR . 88.8 Cg_exo -47.38 176.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.346 2.031 . . . . 0.89 112.246 179.958 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -121.18 -29.54 4.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.418 -0.355 . . . . 2.77 111.799 -179.7 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' HB3' ' OD2' ' A' ' 3' ' ' ASP . 10.8 t80 -113.77 -71.48 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.986 0.365 . . . . 1.37 111.986 -179.376 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.981 ' N ' ' OD2' ' A' ' 3' ' ' ASP . 47.7 p 50.48 43.92 27.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.895 0.378 . . . . 0.91 110.985 -179.593 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.18 -91.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.814 -0.707 . . . . 1.01 112.49 179.89 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' THR . . . -150.27 32.6 1.04 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.637 -0.985 . . . . 0.98 110.637 179.561 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' CB ' ' HB3' ' A' ' 80' ' ' ASN . 0.5 OUTLIER -112.08 175.14 5.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.007 -0.596 . . . . 0.87 111.147 -179.076 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 18.1 ttpt -126.17 -17.71 5.17 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.061 -0.518 . . . . 2.26 112.015 -179.799 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 32' ' ' LYS . 35.9 mt 70.84 129.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-O 120.685 0.279 . . . . 1.71 110.713 -179.589 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -126.77 25.46 6.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 1.15 111.671 -179.619 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.6 t -178.75 127.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.842 0.353 . . . . 1.58 111.259 179.903 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.547 ' O ' HD12 ' A' ' 56' ' ' ILE . 5.5 m-85 -114.36 95.46 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.047 -0.524 . . . . 0.76 111.172 -179.916 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.61 HG21 ' HE3' ' A' ' 50' ' ' LYS . 1.3 mt -87.32 112.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 1.14 111.003 -179.972 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 75' ' ' ARG . 1.3 p -102.58 116.68 46.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.864 -0.607 . . . . 0.63 111.103 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.53 ' HG3' HD12 ' A' ' 77' ' ' ILE . 1.8 mt-10 -81.12 154.92 26.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 1.67 109.857 179.502 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.64 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 23.0 pttt -127.94 146.57 50.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.187 0.518 . . . . 1.97 111.494 -179.759 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.52 ' NE ' ' CZ2' ' A' ' 48' ' ' TRP . 10.3 ttp180 -116.08 108.19 15.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.452 -0.794 . . . . 1.44 110.045 179.472 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.826 ' N ' ' OD1' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -74.97 87.3 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.881 -0.6 . . . . 1.59 110.54 -179.836 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.605 HD11 ' OE1' ' A' ' 73' ' ' GLU . 33.1 mt -65.07 153.95 87.91 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.9 110.879 -179.88 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -88.62 24.49 20.2 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 123.846 -1.314 . . . . 1.43 112.976 0.386 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -154.8 70.28 0.77 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.781 0.324 . . . . 2.66 111.592 -179.936 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.41 -161.59 35.88 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.676 -0.773 . . . . 1.12 112.019 179.606 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -160.03 26.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.723 0.296 . . . . 2.41 111.166 -179.991 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ2' ' NE ' ' A' ' 41' ' ' ARG . 38.5 m95 42.71 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.544 179.828 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.463 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -132.27 130.41 40.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.908 0.385 . . . . 1.28 111.202 -179.961 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HE3' HG21 ' A' ' 37' ' ' ILE . 3.3 ptmt -54.96 88.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 1.3 110.787 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.675 ' CB ' HG13 ' A' ' 63' ' ' VAL . . . -52.5 -54.59 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.978 0.418 . . . . 0.86 110.907 179.979 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.663 ' CB ' HD11 ' A' ' 56' ' ' ILE . 5.4 p-10 -62.47 128.81 37.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.814 -179.929 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.71 -2.36 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 2.08 111.714 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.15 -168.8 1.35 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.815 0.341 . . . . 1.89 110.941 179.939 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.77 115.97 26.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 1.87 111.18 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.663 HD11 ' CB ' ' A' ' 52' ' ' ASN . 54.5 mt -99.27 60.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.69 110.59 179.711 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -43.38 -64.48 0.63 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.242 -0.435 . . . . 1.6 111.648 -179.77 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -72.57 171.52 12.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.785 0.326 . . . . 1.54 110.533 179.847 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.478 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 0.5 OUTLIER -89.49 11.76 18.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.246 -0.434 . . . . 1.75 111.412 179.978 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -110.66 100.07 8.91 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 110.099 -0.334 . . . . 2.05 110.099 179.446 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.542 ' CG ' HD13 ' A' ' 56' ' ' ILE . 61.3 t80 -131.66 164.75 25.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.139 0.495 . . . . 0.48 111.715 -179.465 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.701 HG23 ' OG1' ' A' ' 19' ' ' THR . 2.1 m -124.76 123.46 40.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.657 -0.702 . . . . 0.42 110.744 179.631 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.675 HG13 ' CB ' ' A' ' 51' ' ' ALA . 16.5 t -83.76 97.44 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.171 0.51 . . . . 1.08 111.189 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 134.98 36.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.457 -0.792 . . . . 1.33 110.701 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.09 -16.28 4.45 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.552 -0.749 . . . . 0.9 111.469 -179.295 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.857 ' CD2' HG13 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -51.38 172.16 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 120.805 0.335 . . . . 1.47 110.649 179.656 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.4 m -137.27 152.8 50.2 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.184 -0.462 . . . . 1.06 111.057 -179.413 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ARG . 2.5 tt0 -61.1 155.49 20.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.122 -0.49 . . . . 1.91 111.197 179.943 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 97' ' ' CYS . 60.2 m-20 47.36 60.62 3.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.96 -0.564 . . . . 1.87 111.55 179.952 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.34 116.3 0.96 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.688 0.28 . . . . 0.49 111.375 179.646 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 94' ' ' ALA . . . -71.66 125.4 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.677 -0.49 . . . . 0.36 109.677 179.234 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 44.1 m-85 -117.28 124.37 48.86 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.066 0.765 . . . . 0.56 113.066 -178.869 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.605 ' OE1' HD11 ' A' ' 43' ' ' LEU . 1.6 mt-10 -102.46 135.1 44.68 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.496 -0.928 . . . . 1.5 108.496 178.208 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 1.085 ' CZ ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.46 111.28 12.15 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.082 1.142 . . . . 0.6 114.082 -178.337 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.585 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 ptp180 -91.27 146.67 23.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.739 -0.664 . . . . 2.11 109.694 178.471 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.688 HG23 ' CG ' ' A' ' 8' ' ' PRO . 98.7 t -106.13 110.09 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.919 0.711 . . . . 0.6 112.919 -179.297 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' HG3' ' A' ' 39' ' ' GLU . 85.0 mt -106.59 154.54 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 107.805 -1.183 . . . . 0.7 107.805 177.991 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -167.63 120.87 0.93 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.203 -0.999 . . . . 0.6 113.145 -179.851 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 13.8 ptpt -72.41 156.94 38.53 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.556 -0.535 . . . . 1.98 109.556 178.795 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.916 ' ND2' HD11 ' A' ' 2' ' ' ILE . 2.6 m-80 -100.86 170.87 8.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.533 0.682 . . . . 2.19 112.406 -178.842 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 31' ' ' PHE . . . -39.2 -58.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.731 -1.122 . . . . 1.08 112.112 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.51 -12.94 17.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.948 -0.569 . . . . 1.06 112.296 -179.686 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 -14.61 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.536 -0.84 . . . . 0.93 112.176 -179.733 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -51.46 155.96 1.38 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 110.171 -0.307 . . . . 1.38 110.171 179.709 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.549 ' O ' HG23 ' A' ' 85' ' ' ILE . 1.0 OUTLIER -107.71 117.37 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.29 0.478 . . . . 0.79 112.29 -179.399 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 78' ' ' ALA . 7.0 p -79.88 111.43 21.58 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-N 115.667 -0.697 . . . . 0.59 109.581 179.051 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.74 160.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.004 2.469 . . . . 0.85 112.932 -179.782 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' CB ' ' HD3' ' A' ' 75' ' ' ARG . 41.0 Cg_endo -68.77 134.79 31.08 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.675 2.25 . . . . 0.76 112.853 -179.859 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 90' ' ' GLU . 19.8 m -90.84 111.07 22.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 1.28 109.919 179.28 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -4.12 108.33 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.091 0 C-N-CA 124.717 1.207 . . . . 1.77 113.573 -179.677 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 84.3 Cg_exo -41.8 131.31 4.13 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.677 2.251 . . . . 0.55 113.712 -179.711 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -63.21 148.21 48.76 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.884 -0.598 . . . . 1.23 109.468 178.959 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -33.07 142.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 O-C-N 124.386 1.054 . . . . 1.63 112.409 -179.999 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.723 ' HB1' ' HB1' ' A' ' 71' ' ' ALA . . . -77.46 106.61 9.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.41 110.372 179.716 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.824 HG12 HG21 ' A' ' 13' ' ' ILE . 5.0 mp -85.69 108.66 17.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.743 0.306 . . . . 0.44 110.571 -179.923 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 67.9 m -42.53 -40.07 2.51 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.959 0.409 . . . . 0.44 111.027 179.956 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 15' ' ' ARG . 94.0 m 60.84 75.2 0.42 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.1 111.415 179.31 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -108.88 -79.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.09 0.471 . . . . 3.0 110.109 179.605 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.358 ' OD2' HG23 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -126.03 0.22 7.22 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.703 -0.681 . . . . 2.14 111.314 179.471 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.63 17.97 1.34 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.676 0.621 . . . . 2.06 112.676 179.629 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 1.358 HG23 ' OD2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -129.85 -0.36 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 111.624 0.231 . . . . 2.8 111.624 179.556 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -122.29 -14.97 7.79 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.04 0.385 . . . . 4.58 112.04 -179.514 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 3.79 111.135 -179.904 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.428 ' CB ' ' HD3' ' A' ' 1' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.574 0.226 . . . . 2.74 111.319 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 0' ' ' SER . 7.8 Cg_exo -73.24 138.83 28.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.703 2.268 . . . . 2.06 111.244 179.78 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.573 HD12 ' HB1' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -129.38 147.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.01 0.433 . . . . 0.68 111.854 -179.443 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' N ' HG12 ' A' ' 2' ' ' ILE . 4.2 m-20 -134.56 127.24 18.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 2.0 110.127 179.69 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.26 163.08 38.9 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.239 1.959 . . . . 0.5 112.444 -179.714 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' CB ' ' CD1' ' A' ' 22' ' ' TRP . 37.0 Cg_exo -57.8 178.19 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.779 2.319 . . . . 0.71 112.782 -179.732 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.89 174.56 43.02 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.913 -0.66 . . . . 0.66 112.819 -179.988 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -68.63 130.66 91.78 Favored Pre-proline 0 N--CA 1.462 0.152 0 CA-C-N 116.64 0.22 . . . . 1.52 110.415 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HG3' HG12 ' A' ' 76' ' ' VAL . 17.0 Cg_exo -72.7 138.37 29.02 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.386 2.057 . . . . 0.44 113.124 -179.287 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.7 p -140.93 116.74 7.45 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 115.819 -0.628 . . . . 1.09 110.534 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 35.7 Cg_exo -58.91 138.36 85.21 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.546 2.164 . . . . 0.64 113.973 -179.207 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.605 HD22 ' HA ' ' A' ' 20' ' ' LEU . 1.3 mm? -104.17 -33.13 8.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.525 -0.761 . . . . 1.64 109.064 178.649 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.23 153.29 41.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.051 -0.977 . . . . 0.72 109.498 179.557 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.13 HG22 HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -148.62 108.68 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.124 0.487 . . . . 0.96 111.929 -179.549 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.092 ' CA ' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -105.41 53.04 0.72 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.679 -0.691 . . . . 1.46 111.212 -179.924 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 1.104 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 0.0 OUTLIER 52.26 -73.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.98 0.8 . . . . 2.42 112.548 179.239 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 14' ' ' THR . 9.0 m-70 -70.64 -29.49 65.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.269 -0.423 . . . . 1.02 111.598 -179.349 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.692 HG22 ' HB2' ' A' ' 64' ' ' SER . 62.3 p -128.78 126.2 39.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.759 0.314 . . . . 0.68 111.332 -179.815 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.13 HG13 HG22 ' A' ' 13' ' ' ILE . 87.4 t -113.06 128.73 69.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.317 -0.401 . . . . 0.8 110.802 179.836 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' LEU . 14.2 m -102.41 124.1 47.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.35 111.461 -179.392 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.815 HD11 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -137.14 162.09 34.37 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.535 0.683 . . . . 0.52 111.585 179.384 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -152.35 151.64 31.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.97 -1.014 . . . . 1.84 110.536 -179.635 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CD1' ' CB ' ' A' ' 5' ' ' PRO . 11.1 p90 -136.88 -173.58 3.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.022 0.439 . . . . 0.4 111.463 -179.948 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.91 173.52 8.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.834 -0.621 . . . . 0.83 111.088 179.922 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.47 149.54 36.18 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.451 -0.34 . . . . 2.11 110.631 179.857 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.12 -162.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.938 2.426 . . . . 0.89 113.036 -179.652 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -146.37 -48.49 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.77 111.139 -179.67 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -95.03 -72.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.479 -0.328 . . . . 1.37 111.35 -179.846 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 p 69.39 -45.14 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.055 0.761 . . . . 0.91 113.055 -179.7 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.57 -22.32 10.16 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.269 -0.967 . . . . 1.01 112.302 -179.889 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.74 -26.45 0.83 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 109.496 -1.442 . . . . 0.98 109.496 -179.241 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 82' ' ' ALA . 8.8 m-85 -60.9 -175.31 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.275 -0.963 . . . . 0.87 110.366 179.13 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 24.33 0.31 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.136 -0.484 . . . . 2.26 111.098 179.584 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 7.0 mt 42.97 98.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.136 0.493 . . . . 1.71 112.195 179.845 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' SER . 3.0 p -94.59 14.13 21.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.84 -0.618 . . . . 1.15 111.282 179.755 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' THR . 28.7 t 176.68 122.86 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.797 0.332 . . . . 1.58 111.568 -179.939 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.838 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.4 m-85 -106.86 117.28 33.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.76 110.226 179.502 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.613 HG21 ' HD2' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -97.28 135.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.654 -0.248 . . . . 1.14 110.959 -179.624 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.0 t -112.99 113.49 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.755 0.312 . . . . 0.63 111.249 179.84 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 48' ' ' TRP . 5.3 mt-10 -87.57 127.52 35.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 1.67 110.158 179.474 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.893 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 3.9 pttm -106.56 147.31 29.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.045 0.45 . . . . 1.97 111.724 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.3 ttp180 -129.13 117.48 20.87 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.59 -0.732 . . . . 1.44 110.428 179.455 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.947 ' OD1' ' HA3' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -74.77 123.92 25.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 1.59 110.178 179.813 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 94' ' ' ALA . 4.2 mt -113.99 150.23 43.18 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.428 -0.351 . . . . 0.9 111.479 -179.538 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' ND2' ' A' ' 45' ' ' ASN . 8.8 Cg_endo -88.71 33.01 7.61 Favored 'Cis proline' 0 C--N 1.351 0.705 0 C-N-CA 123.994 -1.253 . . . . 1.43 112.499 0.308 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.41 ' ND2' ' HD2' ' A' ' 44' ' ' PRO . 1.2 m-80 -154.17 98.82 2.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.9 0.381 . . . . 2.66 110.852 -179.989 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.947 ' HA3' ' OD1' ' A' ' 42' ' ' ASP . . . 177.28 -168.69 40.57 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.752 . . . . 1.12 112.179 -179.953 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HD3' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -152.34 166.19 32.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.442 . . . . 2.41 111.37 179.877 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' CH2' ' CG ' ' A' ' 91' ' ' PRO . 73.2 m95 -68.47 120.12 14.03 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.574 -0.739 . . . . 0.65 111.894 -179.536 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.667 HD23 ' HD3' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -143.38 129.39 19.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.853 -0.612 . . . . 1.28 110.585 179.79 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.613 ' HD2' HG21 ' A' ' 37' ' ' ILE . 11.6 mtmm -50.54 92.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.3 110.805 -179.778 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.893 ' HB2' ' HG2' ' A' ' 40' ' ' LYS . . . -62.68 -52.76 62.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.86 110.871 179.893 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.73 ' CB ' HD11 ' A' ' 56' ' ' ILE . 4.6 p-10 -59.22 157.01 11.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.801 -0.636 . . . . 2.01 111.261 -179.891 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -165.52 28.81 0.05 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.702 -0.681 . . . . 2.08 110.716 179.558 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 p -128.71 36.56 4.22 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.459 -0.337 . . . . 1.89 111.234 -179.761 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.14 99.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 1.87 110.896 179.962 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.838 HD12 ' O ' ' A' ' 36' ' ' TYR . 15.8 mt -90.63 93.7 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.503 . . . . 0.69 111.467 -179.842 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.436 HD13 ' C ' ' A' ' 57' ' ' LEU . 2.9 tm? -76.83 -55.09 5.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.541 -0.299 . . . . 1.6 111.197 -179.974 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -82.05 173.11 12.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.805 0.336 . . . . 1.54 110.511 179.871 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.485 ' O ' ' CZ3' ' A' ' 22' ' ' TRP . 35.1 p30 -84.66 -2.12 57.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.227 -0.442 . . . . 1.75 111.502 179.98 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -104.17 102.07 11.8 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 110.162 -0.31 . . . . 2.05 110.162 179.741 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' HB2' HG23 ' A' ' 56' ' ' ILE . 44.8 t80 -135.22 164.85 26.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.286 -0.415 . . . . 0.48 111.329 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.496 ' N ' ' CG ' ' A' ' 61' ' ' PHE . 93.1 m -121.04 114.09 20.99 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.978 -0.556 . . . . 0.42 111.529 -179.925 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.815 HG22 HD11 ' A' ' 20' ' ' LEU . 6.8 m -76.72 91.72 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.723 -0.671 . . . . 1.08 111.424 179.752 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.692 ' HB2' HG22 ' A' ' 17' ' ' THR . 13.9 p -93.01 178.73 5.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.874 -0.603 . . . . 1.33 110.896 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.9 10.89 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.806 -0.712 . . . . 0.9 112.478 -179.986 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' CD1' HG23 ' A' ' 18' ' ' VAL . 15.3 mt -104.58 -161.65 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 1.47 111.168 -179.837 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.4 m -141.15 146.85 37.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.044 -0.525 . . . . 1.06 111.159 -179.892 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -78.14 149.19 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.039 -0.528 . . . . 1.91 110.916 -179.94 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.36 43.97 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 1.87 110.733 -179.977 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -162.96 125.01 2.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 0.49 111.439 -179.833 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 43' ' ' LEU . . . -67.4 137.24 55.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.36 110.256 179.521 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.481 ' CE1' ' HB3' ' A' ' 42' ' ' ASP . 36.0 m-85 -132.3 119.4 20.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.598 0.592 . . . . 0.56 112.598 -179.198 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -98.41 147.31 24.84 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.602 -0.888 . . . . 1.5 108.602 178.531 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.685 ' CE1' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.74 115.48 11.39 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.648 1.351 . . . . 0.6 114.648 -178.632 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.487 ' HG2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 ptt85 -104.84 167.95 9.38 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.6 -0.889 . . . . 2.11 108.6 177.674 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.726 HG13 ' HB2' ' A' ' 89' ' ' SER . 0.4 OUTLIER -134.28 129.8 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 119.472 -0.891 . . . . 0.6 113.386 -179.654 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 86' ' ' SER . 76.5 mt -118.63 151.89 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 114.376 -1.284 . . . . 0.7 108.045 178.366 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 36' ' ' TYR . . . -158.09 130.83 7.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.646 -0.822 . . . . 0.6 112.676 -179.543 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.0 OUTLIER -86.18 63.88 8.26 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.566 0.698 . . . . 1.98 109.537 178.831 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 33' ' ' ILE . 4.3 m-20 9.22 -104.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 113.302 -1.772 . . . . 2.19 114.201 -179.949 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.456 ' CB ' ' HB3' ' A' ' 31' ' ' PHE . . . -122.57 -44.68 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 122.014 -0.429 . . . . 1.08 111.859 -179.66 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.615 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . . . -105.82 45.07 0.99 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.068 0.396 . . . . 1.06 112.068 -179.371 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.41 1.35 60.65 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.378 -0.915 . . . . 0.93 113.276 179.622 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.06 88.05 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.675 -0.491 . . . . 1.38 109.675 179.535 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 85' ' ' ILE . 0.6 OUTLIER -59.35 112.04 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.399 0.618 . . . . 0.79 112.516 -178.824 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 77' ' ' ILE . 49.5 p -85.55 111.7 39.01 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 114.941 -1.027 . . . . 0.59 108.973 178.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 86' ' ' SER . 6.4 Cg_exo -38.32 157.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.9 2.4 . . . . 0.85 112.879 -179.053 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' CA ' HG12 ' A' ' 77' ' ' ILE . 18.4 Cg_endo -60.66 132.06 40.98 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.803 2.335 . . . . 0.76 113.081 -179.709 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.726 ' HB2' HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -89.02 108.27 19.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.411 -0.813 . . . . 1.28 109.498 179.155 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -6.24 120.93 0.01 OUTLIER Pre-proline 0 N--CA 1.479 0.992 0 O-C-N 124.803 1.314 . . . . 1.77 113.674 -179.492 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' CG ' ' CH2' ' A' ' 48' ' ' TRP . 50.4 Cg_exo -54.58 143.04 70.05 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.383 2.056 . . . . 0.55 113.307 -179.695 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.75 146.77 35.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.048 -0.723 . . . . 1.23 109.048 178.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.509 ' O ' HD12 ' A' ' 95' ' ' ILE . 4.1 m-20 -33.41 131.23 0.22 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.175 0.922 . . . . 1.63 112.238 -179.849 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 43' ' ' LEU . . . -70.67 116.53 11.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.41 111.232 -179.843 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 93' ' ' ASP . 4.9 mp -99.86 120.15 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.822 0.344 . . . . 0.44 111.16 179.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.5 m -46.99 -36.51 7.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.44 111.127 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 95' ' ' ILE . 92.8 m 60.39 88.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 1.1 110.498 179.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.19 -81.94 0.47 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.086 -0.506 . . . . 3.0 110.953 -179.678 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.406 ' OD2' ' CG ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -108.25 5.99 26.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.825 -0.625 . . . . 2.14 111.325 179.751 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 1.104 ' OD2' ' N ' ' A' ' 15' ' ' ARG . 0.4 OUTLIER 44.39 27.91 0.26 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.23 0.538 . . . . 2.06 112.225 179.943 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.817 HG12 ' O ' ' A' ' 99' ' ' ASP . 11.8 p -168.9 30.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.492 -0.776 . . . . 2.8 110.338 179.583 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 1.406 ' CG ' ' OD2' ' A' ' 99' ' ' ASP . 0.3 OUTLIER -119.7 -32.14 4.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.73 -0.668 . . . . 4.58 111.259 -179.794 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.232 -0.889 . . . . 3.79 111.199 179.834 . . . . . . . . 1 1 . 1 stop_ save_